data_2kjz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kjz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.4 m80 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.49 114.29 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.932 2.421 . . . . 0.0 112.285 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.701 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.8 p-10 -99.01 11.43 39.02 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.352 0.596 . . . . 0.0 110.302 171.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.441 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -129.59 125.0 35.17 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.778 1.231 . . . . 0.0 107.875 -170.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -120.48 138.82 53.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.258 1.023 . . . . 0.0 108.503 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 55.8 mt -115.4 133.57 61.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 123.497 0.719 . . . . 0.0 109.066 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.478 HD11 HD21 ' A' ' 47' ' ' LEU . 9.1 mp -112.32 124.3 52.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -79.3 115.96 19.26 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.686 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' SER . 35.7 m -114.49 167.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.789 0.836 . . . . 0.0 109.191 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -96.68 -62.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.234 0.614 . . . . 0.0 110.322 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.16 96.31 13.0 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 123.351 0.66 . . . . 0.0 109.666 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 1.1 Cg_endo -44.9 -52.97 5.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.541 2.827 . . . . 0.0 115.809 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.41 -57.42 2.35 Favored 'Trans proline' 0 C--N 1.403 3.399 0 C-N-CA 122.416 2.077 . . . . 0.0 113.191 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.5 -37.41 77.17 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.4 m -77.43 -26.65 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.44 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 68.4 m -80.3 -38.95 29.69 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 82.9 mm-40 -67.01 -34.04 76.88 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.264 173.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -61.52 -49.45 76.67 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.673 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.2 m-85 -69.62 -27.18 64.86 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.616 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.6 mtpt -57.08 -51.75 68.04 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.144 0.429 . . . . 0.0 111.789 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.03 -32.26 39.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.916 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.0 tp -59.11 -53.24 60.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.041 0.936 . . . . 0.0 111.839 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.6 mt -83.11 -47.2 11.89 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.2 38.99 2.94 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.42 171.12 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.328 1.051 . . . . 0.0 110.654 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.88 139.03 33.87 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 43.2 Cg_endo -66.15 108.76 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.489 2.126 . . . . 0.0 111.593 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 39' ' ' PHE . 3.7 p -64.81 -39.28 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.286 0.634 . . . . 0.0 109.973 176.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.705 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 35.9 mm-40 -118.51 149.11 41.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.305 1.042 . . . . 0.0 108.647 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 p -160.93 152.95 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.303 0.641 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 52.4 m -148.8 159.65 37.44 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.725 1.21 . . . . 0.0 108.448 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.59 -27.43 32.83 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.94 2.426 . . . . 0.0 113.798 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 14' ' ' PRO . 12.4 t -127.92 16.83 6.8 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.0 t80 -156.15 162.19 40.25 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.894 -0.504 . . . . 0.0 110.55 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 47.1 t -151.67 157.09 41.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.698 0.799 . . . . 0.0 109.351 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.705 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -152.31 128.92 10.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.422 ' HA ' HG11 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -135.16 141.86 46.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.443 1.097 . . . . 0.0 108.823 170.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.557 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.3 t -115.5 127.92 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD12 ' SD ' ' A' ' 45' ' ' MET . 10.0 mp -91.06 148.81 22.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.253 0.621 . . . . 0.0 110.187 -170.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.57 -8.51 34.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 111.809 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.81 -19.5 65.91 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.171 0.989 . . . . 0.0 111.724 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.04 47.35 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.724 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -113.37 174.72 5.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.877 0.871 . . . . 0.0 109.036 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HG3' HG22 ' A' ' 40' ' ' VAL . 82.7 tttt -139.23 140.92 37.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.478 HD21 HD11 ' A' ' 9' ' ' LEU . 2.5 tt -140.07 123.26 16.84 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.817 0.341 . . . . 0.0 110.114 -171.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -104.68 160.3 15.59 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.793 0.711 . . . . 0.0 111.568 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 82.3 mt -126.11 106.46 9.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 164.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.585 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 4.9 t90 -105.08 123.19 47.39 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.6 t -70.7 130.82 42.76 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -65.48 -21.68 66.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 112.364 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -76.56 -8.28 56.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.392 0.277 . . . . 0.0 111.398 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -131.86 9.2 4.54 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.353 0.661 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.21 145.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.49 117.75 21.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 141.64 68.38 Favored 'Cis proline' 0 C--N 1.39 2.755 0 CA-C-N 119.935 1.013 . . . . 0.0 113.953 2.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.44 122.33 16.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.13 0.972 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.66 109.54 5.03 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.79 0.836 . . . . 0.0 109.996 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -85.36 85.5 7.44 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 121.875 0.845 . . . . 0.0 108.775 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.09 147.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 p -144.1 121.69 11.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.94 5.37 68.23 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.202 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.73 -34.78 72.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 121.303 0.391 . . . . 0.0 112.44 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' B' ' 10' ' ' TYR . . . -170.47 -161.54 21.23 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.214 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.55 110.26 0.24 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 114' ' ' ARG . 24.1 mt-10 -123.99 130.09 52.0 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -171.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HB2' HD23 ' A' ' 9' ' ' LEU . 17.7 tp -115.84 101.57 8.91 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -88.08 109.87 20.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.834 0.35 . . . . 0.0 110.752 -171.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 117' ' ' VAL . 22.4 m-85 -89.35 107.6 19.16 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -88.06 130.71 34.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.443 0.64 . . . . 0.0 111.273 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.08 159.13 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.816 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -66.15 -34.25 77.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -173.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.416 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 9.9 p30 -163.94 -179.9 6.57 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.513 0.673 . . . . 0.0 112.333 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.56 -29.7 70.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.492 1.517 . . . . 0.0 112.978 -165.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.86 -41.47 74.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.248 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.552 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 64.9 mm-40 -64.23 -23.87 67.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.655 0.782 . . . . 0.0 112.123 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.14 -42.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 121.533 0.682 . . . . 0.0 110.221 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.45 -29.7 59.74 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.471 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -66.01 -46.64 77.21 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.488 0.661 . . . . 0.0 109.522 173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.2 m -65.46 -32.96 74.86 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.131 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.57 -61.37 2.65 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 123.687 0.795 . . . . 0.0 109.982 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.61 -35.57 80.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.31 -172.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.64 -46.67 93.24 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.593 0.558 . . . . 0.0 113.151 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.438 ' HB3' HG23 ' A' ' 90' ' ' VAL . 45.7 m0 -62.53 -43.23 99.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.438 0.695 . . . . 0.0 110.597 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -58.56 -43.13 89.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 110.596 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.19 -24.27 60.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.548 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 t -91.32 -0.22 57.62 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.301 1.041 . . . . 0.0 112.656 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.48 39.67 4.97 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.604 0.601 . . . . 0.0 114.604 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 85' ' ' TRP . 55.9 t -87.24 145.28 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.32 -51.07 67.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.96 0.504 . . . . 0.0 110.768 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.494 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 28.8 tpp 65.65 82.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.047 0.842 . . . . 0.0 111.898 169.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.41 84.01 2.22 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.569 0.7 . . . . 0.0 110.875 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 106' ' ' THR . 54.1 tp60 179.09 138.79 0.1 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.011 1.324 . . . . 0.0 108.679 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -83.49 121.88 76.71 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -63.04 102.21 0.3 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.639 2.226 . . . . 0.0 110.045 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.15 150.01 48.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.25 0.62 . . . . 0.0 111.363 -170.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -71.62 100.77 2.36 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.4 ttm -92.29 173.99 7.53 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.071 0.948 . . . . 0.0 109.498 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.66 -34.46 71.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.409 1.084 . . . . 0.0 111.732 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -87.69 -5.38 58.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.065 0.946 . . . . 0.0 110.978 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.61 -170.01 19.97 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.142 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -75.17 102.34 4.92 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 t -107.65 149.24 28.33 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.709 0.766 . . . . 0.0 110.019 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 1.8 t80 -144.68 140.53 28.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.016 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 26.5 m -136.63 127.66 27.76 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.404 ' HB3' HG12 ' A' ' 90' ' ' VAL . . . -106.3 171.95 7.08 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.844 0.457 . . . . 0.0 110.401 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.38 121.5 20.11 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.486 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 3.9 p-10 -77.76 177.31 2.81 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.999 0.92 . . . . 0.0 111.531 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 41.9 Cg_exo -42.05 -43.37 7.25 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.632 2.888 . . . . 0.0 114.946 170.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.56 -8.15 55.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.501 0.72 . . . . 0.0 111.247 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.5 m 64.6 87.55 0.11 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.055 1.342 . . . . 0.0 111.829 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -124.29 144.15 50.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.505 ' HD2' ' HG2' ' A' ' 67' ' ' GLU . 64.6 mtt180 -75.93 94.74 3.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.82 99.21 11.91 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.463 ' HG3' ' HZ3' ' B' ' 50' ' ' TRP . 2.6 tmt_? -98.2 96.11 7.87 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.789 0.836 . . . . 0.0 111.641 -165.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 70' ' ' PHE . 18.6 t -90.54 120.09 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -132.08 159.16 39.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.268 0.485 . . . . 0.0 112.276 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.91 112.03 17.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -74.03 129.27 37.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.579 0.352 . . . . 0.0 110.768 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.055 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.015 -0.516 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.12 114.68 0.67 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.278 2.652 . . . . 0.0 112.486 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.724 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.6 p-10 -99.31 10.86 40.6 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.439 0.637 . . . . 0.0 109.955 171.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.463 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -129.05 124.43 34.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.192 . . . . 0.0 107.812 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -120.02 139.01 53.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.069 0.948 . . . . 0.0 108.443 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 54.9 mt -116.07 133.87 61.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.484 HD21 HD21 ' B' ' 47' ' ' LEU . 3.4 mm? -112.85 124.33 52.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.422 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 5.2 p90 -80.21 116.74 20.47 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.696 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' B' ' 51' ' ' SER . 33.9 m -114.5 167.08 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.733 0.813 . . . . 0.0 109.118 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -96.62 -62.56 1.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.316 0.647 . . . . 0.0 110.087 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -105.98 97.5 15.61 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.339 0.655 . . . . 0.0 109.572 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.403 ' HG2' ' HA ' ' B' ' 35' ' ' THR . 74.2 Cg_exo -46.81 -52.04 8.23 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 123.426 2.751 . . . . 0.0 115.246 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.4 -57.58 2.26 Favored 'Trans proline' 0 C--N 1.404 3.493 0 C-N-CA 122.681 2.254 . . . . 0.0 113.041 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.99 74.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.31 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -77.34 -27.12 52.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.436 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.444 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 99.3 m -79.96 -38.76 31.61 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.522 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 87.1 mm-40 -67.3 -33.34 75.07 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.532 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -62.25 -48.9 77.88 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.789 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 23.9 m-85 -69.73 -27.59 65.09 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.562 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.8 mtpt -56.91 -51.68 68.14 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.238 0.472 . . . . 0.0 111.93 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.59 -32.56 41.96 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.081 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 18.5 tp -59.25 -53.08 62.37 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.046 0.938 . . . . 0.0 111.835 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.413 ' HB2' HG22 ' B' ' 27' ' ' VAL . 11.9 mt -83.36 -47.18 11.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.988 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.98 39.42 2.89 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.4 m -128.58 170.23 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.476 1.111 . . . . 0.0 110.665 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -125.28 141.31 38.35 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 57.5 Cg_endo -68.13 109.53 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.301 2.001 . . . . 0.0 111.248 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.15 -39.07 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.113 0.565 . . . . 0.0 109.75 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.724 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 24.1 mm-40 -118.59 149.16 41.83 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.725 1.21 . . . . 0.0 108.915 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -161.08 153.15 19.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 51.0 m -149.55 160.24 34.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.804 1.242 . . . . 0.0 108.502 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.5 -27.26 39.81 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.043 2.495 . . . . 0.0 113.596 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.403 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 11.6 t -128.05 16.92 6.73 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 73.4 t80 -156.04 161.58 40.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.783 -0.573 . . . . 0.0 110.406 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 73.9 m -150.76 157.84 43.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.963 0.905 . . . . 0.0 109.752 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.724 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 4.6 tt -152.97 128.26 9.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.442 ' HE1' HD23 ' B' ' 47' ' ' LEU . 0.5 OUTLIER -134.75 141.98 46.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.402 1.081 . . . . 0.0 108.995 169.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.534 HG21 ' HG3' ' B' ' 46' ' ' LYS . 14.8 t -115.33 127.9 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.485 HD12 ' SD ' ' B' ' 45' ' ' MET . 9.8 mp -90.83 148.96 22.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.301 0.64 . . . . 0.0 110.239 -170.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -8.61 36.05 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.301 1.04 . . . . 0.0 111.796 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -66.22 -18.98 65.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.464 1.105 . . . . 0.0 111.699 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.06 16.16 48.79 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.433 -0.348 . . . . 0.0 112.232 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.701 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -113.43 175.04 5.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.776 0.83 . . . . 0.0 109.046 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.534 ' HG3' HG21 ' B' ' 40' ' ' VAL . 81.6 tttt -139.98 140.64 36.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.484 HD21 HD21 ' B' ' 9' ' ' LEU . 2.8 tt -140.16 123.27 16.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.728 0.411 . . . . 0.0 110.09 -171.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . 0.463 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -104.88 160.15 15.48 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.87 0.748 . . . . 0.0 111.522 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 81.6 mt -126.2 106.29 9.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 164.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.463 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 5.3 t90 -104.91 123.32 47.54 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 11.4 t -70.69 130.6 42.19 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -65.92 -20.62 66.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.843 0.857 . . . . 0.0 112.447 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -77.18 -8.2 57.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.313 0.245 . . . . 0.0 110.869 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -132.01 9.12 4.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.308 0.643 . . . . 0.0 111.24 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.73 145.79 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -127.41 116.72 21.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.438 ' HG3' ' HB2' ' A' ' 94' ' ' GLN . 10.4 Cg_exo -71.15 140.06 62.25 Favored 'Cis proline' 0 C--N 1.39 2.746 0 CA-C-N 120.205 1.109 . . . . 0.0 113.455 3.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -60.42 121.2 11.49 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.431 1.092 . . . . 0.0 112.005 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.47 109.65 5.11 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.678 0.791 . . . . 0.0 109.876 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 p -85.11 85.36 7.48 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-O 122.109 0.957 . . . . 0.0 108.858 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.71 148.73 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.2 p -145.1 121.66 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.541 1.136 . . . . 0.0 108.003 167.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.54 4.98 69.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.19 -34.75 76.08 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.79 0.295 . . . . 0.0 112.518 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.74 -162.43 23.07 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.747 -0.227 . . . . 0.0 112.731 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.4 110.71 0.24 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.172 0.572 . . . . 0.0 111.746 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.6 mt-10 -124.09 129.82 51.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -171.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' B' ' 68' ' ' LEU . 5.5 mt -114.06 102.17 9.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.19 110.04 20.38 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.342 0.519 . . . . 0.0 111.008 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.6 107.43 19.08 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.465 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.8 mtm105 -87.86 129.5 35.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.336 0.589 . . . . 0.0 110.98 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.84 159.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.111 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 8.7 pt-20 -66.5 -33.52 75.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.19 179.83 6.62 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.455 0.645 . . . . 0.0 112.5 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.973 -165.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.81 -42.0 77.89 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -64.54 -23.73 67.37 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.022 0.826 . . . . 0.0 112.129 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 -42.43 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.476 0.655 . . . . 0.0 110.288 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.0 -30.66 62.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.029 1.331 . . . . 0.0 111.404 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.0 mt-10 -66.64 -46.21 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.407 0.622 . . . . 0.0 109.651 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.0 m -65.62 -33.18 75.3 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.07 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -58.33 -61.48 2.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.836 0.854 . . . . 0.0 109.899 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.506 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.72 -35.58 80.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.222 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.72 93.15 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.857 0.723 . . . . 0.0 113.029 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -62.82 -43.26 99.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.335 0.654 . . . . 0.0 110.432 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 31.9 ttpt -58.39 -43.32 88.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.035 0.834 . . . . 0.0 110.627 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.68 -24.32 61.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.909 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 38.1 t -91.0 -0.44 57.75 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.41 1.084 . . . . 0.0 112.424 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.91 41.37 4.67 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 114.284 0.473 . . . . 0.0 114.284 169.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' B' ' 92' ' ' MET . 3.8 p -88.95 146.48 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.53 67.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.805 0.442 . . . . 0.0 110.507 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.53 ' HB2' HG12 ' B' ' 90' ' ' VAL . 57.4 ttm 63.76 83.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.693 0.797 . . . . 0.0 112.843 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 83.91 2.21 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.638 0.733 . . . . 0.0 110.682 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' B' ' 106' ' ' THR . 57.2 tp60 179.41 139.48 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.756 1.222 . . . . 0.0 108.591 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.05 121.16 74.13 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 26.7 Cg_endo -62.48 102.22 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.566 2.177 . . . . 0.0 110.088 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.38 150.86 48.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.011 0.524 . . . . 0.0 111.548 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -72.74 100.87 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.798 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.453 ' SD ' HG23 ' B' ' 104' ' ' THR . 4.5 mtt -90.69 175.15 7.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.234 1.014 . . . . 0.0 110.213 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.08 -34.6 73.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.092 0.957 . . . . 0.0 111.024 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -87.42 -5.81 58.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.175 0.99 . . . . 0.0 111.037 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.81 -169.53 20.25 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.23 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -75.66 102.51 5.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.453 HG23 ' SD ' ' B' ' 99' ' ' MET . 14.0 t -107.82 149.09 28.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 110.061 -173.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 11.3 t80 -144.32 141.13 29.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.038 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 28.9 m -136.77 127.38 26.99 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.1 171.79 7.15 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.657 0.383 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.03 122.65 22.11 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.468 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.7 p-10 -79.2 177.21 3.03 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.013 0.925 . . . . 0.0 111.219 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.1 Cg_exo -41.83 -43.19 6.72 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.485 2.79 . . . . 0.0 115.16 170.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.27 -9.22 53.6 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.726 0.81 . . . . 0.0 110.766 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 24.3 m 65.22 87.45 0.12 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.194 1.397 . . . . 0.0 111.66 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -124.47 143.79 50.45 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.449 ' HB2' ' HG2' ' B' ' 67' ' ' GLU . 67.4 mtm-85 -76.24 94.68 3.58 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -92.83 99.11 11.84 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.585 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 2.8 tmt_? -96.0 94.93 7.87 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.258 -165.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 t -90.32 120.32 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.451 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.3 p90 -131.98 159.34 39.02 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.506 0.594 . . . . 0.0 112.345 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.46 111.32 16.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.8 124.28 25.05 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.331 0.395 . . . . 0.0 110.256 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.79 93.5 7.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 111.265 -176.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m80 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.7 95.03 0.92 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.773 2.315 . . . . 0.0 112.416 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.698 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.5 p-10 -83.53 3.56 31.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.384 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -124.33 118.61 27.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.0 t -117.3 137.75 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.619 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 50.8 mt -119.66 137.49 53.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 47' ' ' LEU . 4.6 mm? -88.47 106.96 18.62 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 168.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -58.51 104.26 0.21 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.398 163.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.511 HG13 ' HE1' ' A' ' 113' ' ' HIS . 27.8 m -118.8 173.81 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.412 1.085 . . . . 0.0 108.614 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.0 -64.74 1.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.99 0.916 . . . . 0.0 109.974 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -72.51 110.78 8.9 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.959 -170.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.3 Cg_exo -60.21 -62.25 0.16 Allowed 'Trans proline' 0 CA--C 1.576 2.618 0 C-N-CA 121.655 1.57 . . . . 0.0 113.324 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 22.3 Cg_exo -64.7 -52.11 1.5 Allowed 'Trans proline' 0 C--N 1.406 3.6 0 CA-C-N 122.984 2.101 . . . . 0.0 111.64 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.88 89.52 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.303 -165.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.47 -41.28 47.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 71.2 m -56.9 -46.02 82.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.562 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.6 mm100 -65.37 -38.25 89.47 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.515 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -63.89 -45.7 88.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.327 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.68 -29.22 65.48 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.875 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -56.25 -48.32 76.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.44 0.564 . . . . 0.0 111.952 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 -38.74 50.47 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.075 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.51 -40.99 93.4 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.256 1.422 . . . . 0.0 113.02 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 31.05 6.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.262 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.76 166.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.057 0.943 . . . . 0.0 110.322 -175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -113.71 149.32 41.54 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.443 0.697 . . . . 0.0 110.051 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 11.9 Cg_exo -71.37 111.91 3.21 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.912 2.408 . . . . 0.0 111.131 173.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.24 -37.27 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.337 0.655 . . . . 0.0 109.936 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm-40 -109.6 121.99 46.44 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.7 p -131.34 131.14 43.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.99 0.516 . . . . 0.0 110.118 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -144.13 152.98 55.93 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.222 1.409 . . . . 0.0 108.294 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.39 -10.44 13.42 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.661 2.241 . . . . 0.0 114.364 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -129.5 -1.02 4.97 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -153.94 148.56 26.31 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 122.096 -0.378 . . . . 0.0 110.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -137.91 149.68 46.42 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 109.638 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -143.77 122.27 12.44 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HZ ' HD11 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -133.54 137.19 45.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.42 1.488 . . . . 0.0 108.17 173.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 HG22 ' HG3' ' A' ' 46' ' ' LYS . 22.0 t -116.27 127.5 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.838 0.855 . . . . 0.0 108.764 -172.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.9 mt -87.07 150.61 23.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.836 0.351 . . . . 0.0 110.122 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.88 -8.12 45.94 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 0.0 111.97 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' B' ' 5' ' ' ASP . 1.5 m-20 -72.77 -8.43 55.4 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.086 0.954 . . . . 0.0 112.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.11 16.75 42.94 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.727 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -119.61 171.93 8.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.799 0.84 . . . . 0.0 109.476 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 40' ' ' VAL . 66.0 tttt -132.77 141.08 48.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.429 HD23 HD21 ' A' ' 9' ' ' LEU . 1.1 tt -138.45 122.04 17.39 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.202 0.525 . . . . 0.0 110.444 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.409 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -103.8 171.49 20.04 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.888 0.756 . . . . 0.0 112.26 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.479 HD11 ' HZ ' ' A' ' 39' ' ' PHE . 1.1 tp -140.37 118.84 12.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.45 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.1 t90 -115.44 122.67 46.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -84.28 125.3 32.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.988 0.515 . . . . 0.0 109.972 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.564 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 37.7 ptt180 -69.48 -9.35 53.37 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -167.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -75.02 -8.58 56.92 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -135.33 6.44 3.29 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.772 0.429 . . . . 0.0 111.089 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 52' ' ' ARG . 7.1 p -60.9 147.85 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.977 0.511 . . . . 0.0 110.814 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -119.25 115.08 34.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' B' ' 94' ' ' GLN . 81.7 Cg_endo -79.23 142.59 67.13 Favored 'Cis proline' 0 C--N 1.381 2.252 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.582 2.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -51.17 115.22 1.45 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 111.688 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.57 151.65 41.76 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.497 1.119 . . . . 0.0 109.094 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.564 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 20.1 m -134.95 87.09 2.31 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.09 123.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.769 0.828 . . . . 0.0 108.988 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 p -136.4 125.39 24.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.019 0.927 . . . . 0.0 109.651 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.71 67.47 0.83 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA2' HG12 ' B' ' 61' ' ' VAL . . . -169.72 54.15 0.2 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.98 169.6 19.15 Favored Glycine 0 C--O 1.242 0.62 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 80.88 106.84 0.31 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.6 pt-20 -130.61 146.39 52.1 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.721 0.808 . . . . 0.0 109.59 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.7 tp -117.19 103.88 10.63 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.95 0.9 . . . . 0.0 108.637 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.0 113.78 23.97 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.222 0.464 . . . . 0.0 111.312 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.64 110.14 21.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.037 1.335 . . . . 0.0 108.458 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -89.72 124.67 34.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.542 0.687 . . . . 0.0 112.421 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.59 158.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.795 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.0 pt-20 -64.46 -39.39 93.73 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -161.4 178.25 9.34 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.219 0.533 . . . . 0.0 112.073 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.2 -28.13 66.36 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.208 1.403 . . . . 0.0 112.462 -167.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.08 -50.71 69.49 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.507 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.6 mm-40 -64.3 -24.4 67.64 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.303 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.16 -45.68 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.361 0.601 . . . . 0.0 110.028 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.18 -29.98 63.22 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.54 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 33.1 mt-10 -66.51 -47.71 72.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -66.59 -29.25 69.27 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.706 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -60.11 -61.21 2.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.732 0.813 . . . . 0.0 109.593 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.02 -32.6 73.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.296 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.81 -45.69 91.87 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.648 0.593 . . . . 0.0 112.759 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.417 ' HB3' HG22 ' A' ' 90' ' ' VAL . 44.4 m0 -66.01 -41.11 91.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.524 0.73 . . . . 0.0 110.046 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.477 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 31.9 ttpt -58.28 -43.6 88.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 0.0 110.612 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.32 -27.36 61.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.761 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -94.48 8.67 41.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.56 0.744 . . . . 0.0 111.829 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.58 54.03 3.23 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 167.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 107' ' ' ALA . 60.0 t -102.87 142.63 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.42 -47.29 82.53 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.132 0.573 . . . . 0.0 111.367 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.477 ' HE1' ' HB2' ' A' ' 86' ' ' LYS . 53.3 ttm 60.24 83.53 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 165.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.57 85.15 2.31 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 122.037 -0.414 . . . . 0.0 110.651 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 25.0 tm0? 177.93 121.1 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.665 1.186 . . . . 0.0 108.426 172.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -72.22 114.05 26.05 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 17.7 Cg_endo -56.22 112.93 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.945 2.43 . . . . 0.0 111.186 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.4 147.71 50.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.63 0.772 . . . . 0.0 110.657 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HZ3' ' HB2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -75.26 100.93 4.5 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.608 ' HG2' ' H ' ' A' ' 101' ' ' PHE . 55.4 ttm -90.2 161.87 15.51 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.48 -28.49 54.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.735 0.814 . . . . 0.0 110.781 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.608 ' H ' ' HG2' ' A' ' 99' ' ' MET . 74.5 m-85 -110.14 88.34 2.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 109.509 171.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.64 162.34 0.94 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.615 ' HB2' ' HZ3' ' A' ' 98' ' ' LYS . 82.7 t80 -78.2 101.83 7.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -107.65 145.38 33.41 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.512 0.673 . . . . 0.0 110.471 -165.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.575 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 4.9 t80 -137.1 130.66 31.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.531 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.0 m -120.85 122.78 41.03 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.448 0.642 . . . . 0.0 110.108 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HB2' HG11 ' A' ' 90' ' ' VAL . . . -105.16 172.86 6.56 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.464 0.706 . . . . 0.0 109.988 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.85 118.12 12.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -68.01 168.25 13.97 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.675 0.79 . . . . 0.0 110.101 171.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.77 -27.26 15.04 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.114 2.543 . . . . 0.0 114.825 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.3 8.06 41.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.794 0.837 . . . . 0.0 111.229 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 m 70.45 30.04 3.32 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.134 1.373 . . . . 0.0 113.896 165.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.511 ' HE1' HG13 ' A' ' 11' ' ' VAL . 14.1 m80 -84.32 178.59 7.71 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -110.96 117.34 33.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -106.12 100.61 10.15 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -101.04 97.85 8.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -167.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.3 t -88.11 118.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.08 167.05 15.9 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.197 0.453 . . . . 0.0 110.957 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -126.82 110.69 13.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -82.1 115.79 21.38 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.724 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 m80 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.54 94.92 0.93 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.476 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.727 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 7.1 p-10 -83.05 3.4 30.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.105 0.562 . . . . 0.0 111.517 172.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -124.45 118.44 26.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -117.43 137.89 52.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.636 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 44.2 mt -119.72 137.08 54.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.443 HD22 HD22 ' B' ' 47' ' ' LEU . 4.6 mm? -88.14 106.86 18.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.43 105.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.06 163.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.48 HG13 ' HE1' ' B' ' 113' ' ' HIS . 22.4 m -119.1 173.79 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.621 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -105.93 -65.16 1.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.754 0.822 . . . . 0.0 109.882 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -72.12 110.78 8.63 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.782 -170.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.538 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 27.4 Cg_exo -59.99 -63.07 0.13 Allowed 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 121.691 1.594 . . . . 0.0 113.353 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 33.3 Cg_exo -63.08 -53.0 1.74 Allowed 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 123.195 2.177 . . . . 0.0 112.275 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.67 89.71 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.395 -165.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.11 -41.45 50.19 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.436 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.605 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 18.0 mm100 -65.71 -38.4 89.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.517 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -64.35 -44.89 90.04 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.749 0.656 . . . . 0.0 110.229 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -70.71 -29.51 65.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.904 -0.569 . . . . 0.0 109.884 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 58.9 mtpt -56.1 -48.38 76.26 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.486 0.585 . . . . 0.0 112.087 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.18 -38.98 50.52 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.04 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp -59.89 -41.4 91.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.203 1.401 . . . . 0.0 113.007 -174.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.469 ' HB2' HG22 ' B' ' 27' ' ' VAL . 19.7 mt -91.6 -41.27 10.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.315 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.44 30.87 7.07 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.28 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.0 m -132.86 167.11 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.093 0.957 . . . . 0.0 110.53 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -114.27 149.53 42.23 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.663 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 7.2 Cg_exo -72.12 111.48 3.19 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.91 2.406 . . . . 0.0 111.016 174.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.75 -36.72 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.949 0.5 . . . . 0.0 110.068 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.714 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.5 mm-40 -110.12 121.28 44.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -130.79 130.58 43.89 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.165 0.586 . . . . 0.0 110.111 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 91.9 p -143.94 155.98 58.88 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.461 1.104 . . . . 0.0 108.441 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.32 -10.2 17.8 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.685 2.257 . . . . 0.0 113.779 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -129.42 -1.17 5.0 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.9 148.91 26.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.184 0.447 . . . . 0.0 110.018 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 14.2 m -137.67 149.78 46.83 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.634 0.774 . . . . 0.0 109.2 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.714 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -143.98 121.6 11.82 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.94 138.52 46.94 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.156 1.383 . . . . 0.0 108.45 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.527 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.7 t -117.26 127.21 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.869 0.867 . . . . 0.0 108.756 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.456 HD12 ' SD ' ' B' ' 45' ' ' MET . 63.2 mt -87.1 150.58 23.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.95 -7.99 45.15 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.37 1.068 . . . . 0.0 111.89 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -73.28 -8.09 54.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.095 0.958 . . . . 0.0 111.948 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.04 16.81 42.94 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.698 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.4 ppp? -119.79 171.67 8.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.692 0.797 . . . . 0.0 109.378 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.527 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.6 141.17 48.56 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -173.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.443 HD22 HD22 ' B' ' 9' ' ' LEU . 1.1 tt -138.44 122.16 17.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 -172.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.86 170.57 19.11 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.863 0.745 . . . . 0.0 112.045 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 79.1 mt -138.59 119.83 14.69 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 164.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.407 ' HZ2' ' HE3' ' A' ' 99' ' ' MET . 5.4 t90 -115.27 122.68 46.71 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 39.1 m -83.59 125.49 31.86 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.784 0.434 . . . . 0.0 110.099 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 39.0 ptt180 -69.5 -8.45 47.1 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.92 -8.61 57.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.702 0.401 . . . . 0.0 111.48 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -135.52 4.78 3.14 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.184 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' B' ' 52' ' ' ARG . 7.5 p -57.8 147.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.128 0.571 . . . . 0.0 111.147 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.69 114.97 33.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.453 0.701 . . . . 0.0 109.143 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.33 143.09 68.68 Favored 'Cis proline' 0 C--N 1.382 2.31 0 C-N-CA 124.504 -1.04 . . . . 0.0 112.347 2.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.88 116.44 2.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.074 0.949 . . . . 0.0 110.861 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.63 151.22 41.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.988 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 49.5 m -134.67 86.96 2.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.405 HG12 ' HA2' ' A' ' 64' ' ' GLY . 7.5 p -156.27 123.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.244 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.4 p -135.49 126.46 27.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.834 0.854 . . . . 0.0 109.621 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.9 67.87 0.86 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.08 54.22 0.2 Allowed Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.88 169.76 19.25 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 80.74 107.26 0.3 Allowed Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.619 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 6.5 pt-20 -131.3 145.7 51.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.081 0.952 . . . . 0.0 109.079 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.5 tp -117.46 103.79 10.45 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.89 114.16 24.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.192 0.451 . . . . 0.0 111.252 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -91.2 109.98 21.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.918 1.287 . . . . 0.0 108.39 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.421 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.4 mtm180 -89.69 123.77 34.01 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.497 0.665 . . . . 0.0 111.991 -176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 159.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.781 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.46 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.9 pt-20 -64.79 -38.71 91.89 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -161.9 179.14 8.28 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.986 0.422 . . . . 0.0 112.064 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.0 -27.19 68.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.212 -166.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.526 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.11 -50.57 69.98 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.946 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.46 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 82.1 mm-40 -65.0 -24.1 67.41 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.39 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.18 -45.76 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.261 0.624 . . . . 0.0 110.087 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.24 -30.6 65.03 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.623 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 25.8 mt-10 -66.56 -47.22 73.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 109.421 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -66.91 -29.25 69.08 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.688 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.03 -61.39 2.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 0.0 109.621 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.535 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -67.17 -32.26 73.23 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.31 -173.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.65 -46.04 91.12 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.755 0.659 . . . . 0.0 112.826 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.51 -41.02 89.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.397 0.679 . . . . 0.0 109.708 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.8 ttpt -57.78 -43.62 85.67 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.769 0.827 . . . . 0.0 110.403 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.53 61.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.462 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -94.53 8.77 41.07 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.607 0.763 . . . . 0.0 111.685 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.97 54.49 3.19 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.629 HG12 ' HB2' ' B' ' 92' ' ' MET . 5.4 p -103.16 143.41 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 170.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.74 83.5 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.049 0.539 . . . . 0.0 111.284 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.629 ' HB2' HG12 ' B' ' 90' ' ' VAL . 53.6 ttm 59.64 83.64 0.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.418 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -118.57 85.74 2.41 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 122.027 -0.421 . . . . 0.0 110.498 175.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.488 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 45.1 tp60 177.2 119.89 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.099 1.36 . . . . 0.0 109.119 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.55 112.51 14.19 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.58 0.752 . . . . 0.0 109.08 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.594 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 10.9 Cg_endo -53.98 111.99 0.85 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.186 2.591 . . . . 0.0 111.835 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.38 147.62 50.27 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.686 0.794 . . . . 0.0 110.582 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.6 ' HZ3' ' HB2' ' B' ' 103' ' ' TYR . 0.0 OUTLIER -74.8 100.73 4.12 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.587 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 51.5 ttm -90.43 161.5 15.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.6 -28.06 53.01 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.623 0.769 . . . . 0.0 110.98 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.587 ' H ' ' HG2' ' B' ' 99' ' ' MET . 53.7 m-85 -110.02 88.18 2.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.391 1.077 . . . . 0.0 109.724 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.54 162.74 0.96 Allowed Glycine 0 C--N 1.354 1.56 0 N-CA-C 116.137 1.215 . . . . 0.0 116.137 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.6 ' HB2' ' HZ3' ' B' ' 98' ' ' LYS . 84.7 t80 -78.89 101.96 7.98 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.7 t -107.62 145.34 33.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.585 0.707 . . . . 0.0 110.617 -165.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 6.2 t80 -137.41 131.62 32.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.928 1.291 . . . . 0.0 108.421 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 16.5 m -121.8 122.55 39.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 109.896 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.29 172.74 6.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.283 0.633 . . . . 0.0 109.702 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.53 117.21 12.22 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -66.81 168.99 8.86 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.62 0.768 . . . . 0.0 110.175 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.94 -27.37 20.76 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.336 2.69 . . . . 0.0 114.449 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.77 8.1 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.741 0.816 . . . . 0.0 111.488 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 51.1 m 70.04 30.74 3.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.223 1.409 . . . . 0.0 113.824 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.48 ' HE1' HG13 ' B' ' 11' ' ' VAL . 14.3 m80 -84.4 179.08 7.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 75.9 mmt-85 -111.32 117.82 34.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 37.7 mt -106.41 101.2 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -99.72 96.65 7.75 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.3 118.36 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.421 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.9 p90 -125.96 167.16 15.67 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.163 0.438 . . . . 0.0 110.988 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -127.0 110.73 13.28 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -82.7 118.18 23.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 93.85 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.349 0.66 . . . . 0.0 110.027 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.607 -176.698 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m80 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 41.5 Cg_endo -82.71 52.4 4.04 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.381 2.721 . . . . 0.0 111.768 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.881 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 36.7 t70 -75.64 5.07 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.215 1.006 . . . . 0.0 111.764 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.416 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -124.46 126.56 46.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.0 t -120.44 145.02 47.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 52.7 mt -122.07 144.4 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.775 0.83 . . . . 0.0 108.921 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 47' ' ' LEU . 4.3 mm? -91.64 134.27 34.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.42 ' OH ' HG13 ' A' ' 55' ' ' VAL . 10.8 t80 -85.02 99.4 10.99 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.36 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.481 HG12 ' NE2' ' A' ' 113' ' ' HIS . 3.0 m -112.89 159.43 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.561 0.745 . . . . 0.0 109.075 -172.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.34 -59.78 1.87 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -102.37 101.82 21.83 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.245 0.618 . . . . 0.0 109.696 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.562 ' HG3' ' HB2' ' A' ' 51' ' ' SER . 44.5 Cg_exo -55.21 -55.93 2.75 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.056 2.504 . . . . 0.0 114.908 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.76 -54.74 4.34 Favored 'Trans proline' 0 C--N 1.403 3.407 0 CA-C-N 122.545 1.945 . . . . 0.0 112.379 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.07 96.52 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.74 0.65 . . . . 0.0 111.703 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -66.53 -47.08 74.04 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 96.5 m -67.48 -40.48 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.575 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.1 mm100 -64.49 -38.29 90.49 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.273 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -64.94 -42.23 94.83 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.389 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.736 ' HH ' HD22 ' A' ' 115' ' ' LEU . 49.7 m-85 -68.52 -29.67 68.31 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.533 0.606 . . . . 0.0 110.466 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -56.83 -49.43 75.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.204 0.526 . . . . 0.0 111.879 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.87 -40.07 63.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.92 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.7 tp -58.94 -42.7 90.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.478 1.511 . . . . 0.0 113.068 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.527 ' HB2' HG22 ' A' ' 27' ' ' VAL . 16.3 mt -96.66 -31.99 12.42 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.16 26.88 27.29 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.325 0.391 . . . . 0.0 112.313 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.9 m -123.42 -178.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.967 0.907 . . . . 0.0 109.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -142.07 151.41 58.89 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 37.6 Cg_endo -63.76 121.26 8.92 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.896 2.397 . . . . 0.0 112.773 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.34 -35.16 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.442 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 15.5 mm-40 -121.03 116.63 25.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.939 1.296 . . . . 0.0 108.233 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.5 p -123.04 131.26 53.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.253 0.621 . . . . 0.0 110.097 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -138.67 151.14 68.15 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.864 1.266 . . . . 0.0 108.292 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.64 -10.12 23.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.817 2.344 . . . . 0.0 113.389 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.441 ' HA ' ' HG2' ' A' ' 14' ' ' PRO . 4.9 t -125.96 -3.57 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -159.17 151.47 21.25 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.7 m -141.62 158.6 43.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.769 0.428 . . . . 0.0 110.349 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -154.27 126.02 7.63 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.9 p90 -134.0 150.4 51.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.476 1.11 . . . . 0.0 109.09 165.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 46' ' ' LYS . 13.4 t -120.96 131.42 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.03 165.4 15.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.644 0.378 . . . . 0.0 111.464 -171.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.08 75.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.518 1.127 . . . . 0.0 112.869 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -69.91 -20.75 63.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.13 0.572 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 5.35 37.32 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.871 -0.961 . . . . 0.0 114.181 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.495 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.3 ppp? -74.06 166.26 23.7 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.346 1.073 . . . . 0.0 109.206 169.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.515 ' HG3' HG23 ' A' ' 40' ' ' VAL . 49.3 tttt -126.97 139.69 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 9' ' ' LEU . 3.5 tt -137.62 118.36 14.08 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.89 0.376 . . . . 0.0 110.387 -172.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.416 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -105.2 168.97 15.99 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 124.226 0.917 . . . . 0.0 111.958 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.61 106.29 6.91 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.564 ' HB2' HG22 ' A' ' 8' ' ' ILE . 5.1 t90 -105.55 125.59 51.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.562 ' HB2' ' HG3' ' A' ' 14' ' ' PRO . 23.3 t -77.48 137.07 38.45 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.592 0.558 . . . . 0.0 110.597 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -71.59 -10.14 59.31 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.501 0.72 . . . . 0.0 112.906 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -85.14 -21.19 29.34 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.215 0.206 . . . . 0.0 110.731 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 51' ' ' SER . 7.1 t -116.27 4.59 13.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.148 0.579 . . . . 0.0 111.326 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 58' ' ' LYS . 13.1 p -72.71 145.4 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.97 116.54 26.05 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.4 Cg_exo -77.16 138.19 52.35 Favored 'Cis proline' 0 C--N 1.383 2.387 0 CA-C-N 119.727 0.938 . . . . 0.0 112.038 2.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.558 ' HA ' HG11 ' A' ' 55' ' ' VAL . 2.8 tmmm? -65.25 112.42 3.44 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.962 0.789 . . . . 0.0 109.722 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.27 128.89 55.51 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.306 1.042 . . . . 0.0 110.015 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -90.52 84.38 5.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 m -159.27 150.86 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 124.688 1.195 . . . . 0.0 109.274 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.87 127.11 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.703 1.601 . . . . 0.0 107.915 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.89 -46.56 0.29 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.72 144.71 9.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.33 -29.93 0.15 Allowed Glycine 0 N--CA 1.469 0.876 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 149.56 18.33 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.192 -1.004 . . . . 0.0 110.695 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 7.4 mm-40 -101.71 151.56 21.89 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 173.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.497 HD23 HD21 ' A' ' 9' ' ' LEU . 41.4 tp -109.99 101.92 10.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -87.54 117.96 26.69 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' HB2' HG22 ' A' ' 117' ' ' VAL . 8.7 m-85 -96.47 121.46 38.31 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.782 1.233 . . . . 0.0 107.896 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 39.9 mtm105 -99.98 126.74 46.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.23 162.45 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.174 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.38 -33.68 69.75 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.82 179.39 7.12 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.055 0.843 . . . . 0.0 112.288 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.44 -34.27 75.12 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.432 1.093 . . . . 0.0 112.272 -165.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.24 -43.87 96.83 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.213 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -65.22 -21.75 66.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.874 0.87 . . . . 0.0 112.738 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.17 -38.12 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.071 0.463 . . . . 0.0 110.06 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.35 -32.29 64.46 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.306 1.042 . . . . 0.0 111.324 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.0 mt-10 -68.76 -40.1 79.93 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.656 0.741 . . . . 0.0 109.192 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.5 m -68.62 -32.7 72.76 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.65 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -62.78 -60.76 3.04 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.821 0.819 . . . . 0.0 109.458 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.49 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.4 -37.28 85.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.841 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.35 -46.12 91.49 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.98 0.8 . . . . 0.0 113.638 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.428 ' CH2' ' HB3' ' A' ' 115' ' ' LEU . 36.3 m0 -61.23 -50.35 73.45 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.235 0.614 . . . . 0.0 109.996 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 92' ' ' MET . 32.7 ttpt -52.58 -45.16 66.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.142 0.977 . . . . 0.0 110.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.98 61.08 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.294 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -97.77 11.12 38.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.814 0.845 . . . . 0.0 112.828 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 15.01 21.22 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.49 136.03 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 117.545 0.673 . . . . 0.0 110.321 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.68 72.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.428 1.091 . . . . 0.0 111.754 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.501 ' HE2' ' HB2' ' A' ' 86' ' ' LYS . 49.7 tpp 69.02 83.59 0.16 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.157 0.911 . . . . 0.0 112.849 165.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.27 86.47 2.28 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.0 0.52 . . . . 0.0 111.537 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.545 ' HG2' ' H ' ' A' ' 106' ' ' THR . 55.6 tp60 -179.67 140.77 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.882 0.873 . . . . 0.0 109.645 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -92.24 113.79 60.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 104' ' ' THR . 20.9 Cg_endo -61.63 108.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.243 1.962 . . . . 0.0 110.598 174.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.64 49.28 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.335 0.654 . . . . 0.0 110.219 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -63.07 106.26 0.82 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.588 0.755 . . . . 0.0 110.975 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.472 ' HE1' ' HZ2' ' B' ' 50' ' ' TRP . 3.3 ttt -93.99 -176.38 3.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.843 0.857 . . . . 0.0 109.737 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.31 -27.67 68.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.02 174.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.73 92.72 3.38 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.8 161.74 3.24 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 36.0 t80 -69.09 103.76 1.96 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.138 1.375 . . . . 0.0 108.61 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 99' ' ' MET . 13.7 t -103.03 141.55 35.63 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.86 0.754 . . . . 0.0 111.683 -162.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -151.62 127.61 10.38 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.754 1.221 . . . . 0.0 109.636 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.546 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 42.3 m -135.24 125.82 26.93 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.07 162.05 21.92 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.062 0.545 . . . . 0.0 112.169 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.89 112.42 24.64 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.581 0.753 . . . . 0.0 109.599 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.539 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.4 p30 -71.96 177.27 1.77 Allowed Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.437 1.095 . . . . 0.0 112.05 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 25.5 Cg_exo -40.64 -50.48 3.86 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.949 3.099 . . . . 0.0 115.544 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.419 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 9.9 t70 -79.62 -17.86 52.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.6 m 71.93 61.32 0.14 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.412 1.485 . . . . 0.0 110.886 174.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.481 ' NE2' HG12 ' A' ' 11' ' ' VAL . 8.6 m80 -91.71 175.07 7.03 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.603 -1.18 . . . . 0.0 107.975 168.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -94.43 99.04 11.3 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.736 HD22 ' HH ' ' A' ' 21' ' ' TYR . 81.9 mt -106.12 104.03 13.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.631 0.372 . . . . 0.0 110.011 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.529 ' NH1' ' HB3' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -93.31 147.18 23.15 Favored 'General case' 0 C--O 1.205 -1.269 0 C-N-CA 124.022 0.929 . . . . 0.0 110.01 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 70' ' ' PHE . 12.2 t -139.66 140.0 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.529 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 5.4 p90 -133.81 171.1 14.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.096 0.407 . . . . 0.0 111.635 172.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -131.06 113.95 14.56 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 166.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -75.11 129.25 37.23 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 O-C-N 123.722 0.639 . . . . 0.0 110.264 -174.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 m80 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.475 ' HG3' HD22 ' A' ' 25' ' ' LEU . 42.0 Cg_endo -82.74 51.69 3.8 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.28 2.654 . . . . 0.0 111.89 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 30.3 t70 -75.96 5.92 5.89 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.179 0.99 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.01 126.08 45.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 15.2 t -120.4 145.66 46.97 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 59.4 mt -122.67 144.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 123.825 0.85 . . . . 0.0 108.768 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.516 HD22 HD21 ' B' ' 47' ' ' LEU . 4.3 mm? -91.59 134.12 34.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.404 ' OH ' HG12 ' B' ' 55' ' ' VAL . 9.0 t80 -84.85 99.3 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.448 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.484 HG12 ' NE2' ' B' ' 113' ' ' HIS . 3.2 m -112.72 159.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.691 0.796 . . . . 0.0 109.032 -172.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 -60.28 1.82 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -102.29 101.71 20.99 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.295 0.638 . . . . 0.0 109.881 -173.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' B' ' 51' ' ' SER . 32.5 Cg_exo -55.67 -55.55 2.93 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.952 2.435 . . . . 0.0 114.701 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.77 -54.82 4.2 Favored 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.594 1.962 . . . . 0.0 112.276 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.31 96.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.072 0.549 . . . . 0.0 111.768 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 69.1 m -65.31 -47.15 77.57 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 123.726 0.641 . . . . 0.0 109.364 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 51.9 m -67.46 -41.17 85.1 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -170.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.555 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 11.7 mm100 -64.09 -38.43 91.05 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.514 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.83 -41.95 95.34 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.394 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.458 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 42.6 m-85 -68.6 -29.9 68.53 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.579 0.627 . . . . 0.0 110.487 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -56.6 -49.48 74.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.194 0.521 . . . . 0.0 111.695 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.26 63.22 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.975 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.458 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 31.0 tp -58.93 -42.2 89.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.37 1.468 . . . . 0.0 113.232 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.514 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.4 mt -97.55 -30.53 12.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.74 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.67 30.4 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.6 m -122.93 -177.71 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.121 0.968 . . . . 0.0 109.823 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' B' ' 22' ' ' LYS . 6.5 p-10 -143.04 151.81 56.79 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 109.365 174.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 18.7 Cg_exo -65.53 121.25 8.61 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.95 2.433 . . . . 0.0 112.263 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.519 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.2 p -64.9 -36.68 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 21.0 mm-40 -120.89 116.83 25.91 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.872 1.269 . . . . 0.0 107.966 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -123.62 131.62 53.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.988 0.515 . . . . 0.0 109.933 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -138.97 150.34 64.87 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.833 1.253 . . . . 0.0 108.345 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.93 -10.33 22.41 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.507 2.138 . . . . 0.0 113.576 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.462 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 5.6 t -126.19 -3.27 6.92 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -159.14 151.64 21.51 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 73.3 m -141.87 159.08 42.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.628 0.371 . . . . 0.0 110.391 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 24.2 tp -154.81 125.56 7.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.6 p90 -133.89 150.2 51.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.253 1.021 . . . . 0.0 109.134 165.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' B' ' 46' ' ' LYS . 18.5 t -120.77 131.46 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.91 165.18 16.11 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.691 0.397 . . . . 0.0 111.553 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.69 76.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.641 1.177 . . . . 0.0 112.851 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -69.99 -20.47 63.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.004 0.522 . . . . 0.0 111.068 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.31 5.0 37.73 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-O 118.817 -0.99 . . . . 0.0 113.988 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.881 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 6.8 ptm -73.68 166.84 22.55 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.538 1.169 . . . . 0.0 109.27 169.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.524 ' HG3' HG23 ' B' ' 40' ' ' VAL . 73.1 tttt -127.25 139.5 52.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.516 HD21 HD22 ' B' ' 9' ' ' LEU . 3.6 tt -137.56 118.7 14.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.973 0.416 . . . . 0.0 110.254 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.93 169.09 16.34 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.315 0.96 . . . . 0.0 111.958 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.85 106.03 6.69 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 166.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.578 ' HB2' HG22 ' B' ' 8' ' ' ILE . 4.5 t90 -105.46 125.63 51.21 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.565 ' HB2' ' HG3' ' B' ' 14' ' ' PRO . 21.6 t -77.29 137.13 38.61 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.681 0.613 . . . . 0.0 110.716 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -71.92 -9.78 58.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -85.32 -20.14 30.44 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.493 0.317 . . . . 0.0 111.389 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.437 HG23 ' HB3' ' B' ' 51' ' ' SER . 11.9 t -117.02 4.41 12.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.392 0.677 . . . . 0.0 111.029 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' B' ' 58' ' ' LYS . 8.4 p -73.57 146.71 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.29 116.14 23.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -77.65 139.2 56.27 Favored 'Cis proline' 0 C--N 1.387 2.595 0 C-N-CA 124.706 -0.956 . . . . 0.0 111.869 3.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.494 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.1 tmmm? -66.18 112.5 3.96 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.85 0.719 . . . . 0.0 109.395 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.93 129.3 55.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.19 0.996 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 27.5 p -90.98 85.58 6.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.52 149.77 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.339 1.056 . . . . 0.0 109.567 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -168.83 128.1 1.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.958 1.703 . . . . 0.0 107.65 169.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.21 -47.55 0.29 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.82 144.66 9.66 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.41 -29.87 0.15 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 149.45 18.1 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.162 -1.019 . . . . 0.0 110.657 170.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.596 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 11.2 mm-40 -101.51 151.85 21.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.507 HD23 HD21 ' B' ' 9' ' ' LEU . 44.1 tp -110.14 101.78 10.54 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -87.58 118.0 26.77 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.575 0.702 . . . . 0.0 111.208 -170.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 5.9 m-85 -96.05 121.55 37.92 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 42.2 mtm105 -100.4 125.01 46.63 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.68 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.91 163.2 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.135 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.464 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.1 pt-20 -71.3 -34.58 70.73 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.403 HD21 ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -163.21 179.84 7.15 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.155 0.889 . . . . 0.0 112.482 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.13 -33.86 75.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.43 1.092 . . . . 0.0 111.891 -165.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.987 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.464 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.5 mm-40 -65.62 -22.06 66.63 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.691 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.64 -38.95 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 122.748 0.419 . . . . 0.0 109.924 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.93 -31.82 64.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.154 0.981 . . . . 0.0 111.436 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.9 mt-10 -69.88 -38.93 76.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.634 0.73 . . . . 0.0 109.53 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 68.3 m -68.34 -33.53 74.45 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.616 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -62.47 -61.01 2.74 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.739 0.781 . . . . 0.0 109.542 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.6 -36.9 84.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.667 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.84 89.03 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 124.001 0.813 . . . . 0.0 113.63 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . 0.416 ' HB3' HG23 ' B' ' 90' ' ' VAL . 42.1 m0 -60.6 -50.28 74.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.351 0.66 . . . . 0.0 109.551 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.522 ' HB2' ' HE2' ' B' ' 92' ' ' MET . 31.5 ttpt -53.42 -44.64 68.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.132 0.895 . . . . 0.0 111.003 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.69 61.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 m -98.19 10.64 40.08 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.722 0.809 . . . . 0.0 112.884 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.58 14.77 20.85 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' B' ' 85' ' ' TRP . 54.4 t -78.66 135.69 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 117.554 0.677 . . . . 0.0 110.413 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.95 -37.48 71.59 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.468 1.107 . . . . 0.0 111.764 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.522 ' HE2' ' HB2' ' B' ' 86' ' ' LYS . 45.0 tpp 69.83 83.16 0.15 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.126 0.891 . . . . 0.0 112.707 165.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.49 87.08 2.32 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.745 0.418 . . . . 0.0 111.512 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.531 ' HG2' ' H ' ' B' ' 106' ' ' THR . 56.9 tp60 179.66 141.77 0.13 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.118 0.967 . . . . 0.0 109.856 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -93.51 113.24 59.69 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.26 108.64 0.53 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.472 2.115 . . . . 0.0 110.974 173.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.46 49.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.466 0.706 . . . . 0.0 110.541 -175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' B' ' 103' ' ' TYR . 5.6 mmmm -62.48 106.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.817 0.847 . . . . 0.0 110.981 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.486 ' SD ' HG21 ' B' ' 104' ' ' THR . 3.3 ttt -93.9 -175.96 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.675 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.54 -27.96 68.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.585 . . . . 0.0 111.015 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -128.89 92.24 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.286 1.034 . . . . 0.0 109.152 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 161.64 2.83 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 34.0 t80 -68.87 103.25 1.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 108.851 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.486 HG21 ' SD ' ' B' ' 99' ' ' MET . 5.3 t -103.67 142.11 34.9 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.163 0.892 . . . . 0.0 111.518 -161.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.483 ' HZ ' ' SD ' ' B' ' 92' ' ' MET . 14.2 t80 -151.6 127.81 10.53 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.499 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.531 ' H ' ' HG2' ' B' ' 94' ' ' GLN . 60.4 m -134.99 125.92 27.55 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.43 162.03 22.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.007 0.523 . . . . 0.0 112.154 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.9 113.28 26.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.663 0.785 . . . . 0.0 109.165 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.55 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.8 p-10 -73.27 177.89 1.77 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 124.366 1.066 . . . . 0.0 111.745 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.7 Cg_exo -41.04 -50.3 4.24 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.919 3.079 . . . . 0.0 115.531 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.65 -17.64 53.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 71.72 61.1 0.15 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 125.329 1.451 . . . . 0.0 111.005 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.484 ' NE2' HG12 ' B' ' 11' ' ' VAL . 7.6 m80 -91.29 175.29 6.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.15 168.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -95.01 98.7 10.87 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.95 103.54 13.13 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 46.4 ttt180 -89.83 148.49 23.16 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 123.279 0.632 . . . . 0.0 110.455 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.23 140.59 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.526 1.13 . . . . 0.0 108.176 163.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' B' ' 103' ' ' TYR . 7.2 p90 -133.7 170.63 15.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' B' ' 103' ' ' TYR . . . -130.49 113.79 14.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -74.68 130.24 39.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 99.87 0.89 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.94 0.896 . . . . 0.0 110.998 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.405 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.444 176.448 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.48 93.79 0.99 Allowed 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.195 1.93 . . . . 0.0 111.381 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.57 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.3 p-10 -109.25 14.63 23.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 0.0 109.454 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.595 ' HD2' ' HD3' ' B' ' 71' ' ' ARG . 0.7 OUTLIER -131.5 141.91 49.86 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.919 -165.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 145.16 30.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.733 1.213 . . . . 0.0 108.117 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 51.4 mt -118.59 140.65 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.034 0.534 . . . . 0.0 110.661 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.56 118.53 37.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -74.42 122.5 23.09 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.981 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' SER . 11.7 m -122.14 163.7 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.17 -52.26 3.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -103.98 98.18 12.97 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.455 0.702 . . . . 0.0 110.079 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.49 -48.72 17.85 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.506 2.804 . . . . 0.0 115.858 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.89 -63.48 0.2 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 123.106 2.145 . . . . 0.0 112.419 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.62 89.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 0.0 112.125 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -66.82 -47.94 70.46 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.442 0.639 . . . . 0.0 110.425 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 65.8 m -75.96 -34.92 59.83 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.0 mm-40 -66.45 -33.74 76.39 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.102 0.876 . . . . 0.0 109.259 172.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 81.9 t80 -66.73 -42.83 85.67 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.002 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.547 ' HH ' HD21 ' A' ' 115' ' ' LEU . 45.8 m-85 -71.21 -29.02 64.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.375 0.534 . . . . 0.0 110.377 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.0 mtpt -57.39 -48.9 77.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.935 0.398 . . . . 0.0 111.902 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.77 -35.68 62.56 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.024 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 12.9 tp -64.52 -30.58 71.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.602 1.161 . . . . 0.0 112.737 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' HB2' HG22 ' A' ' 27' ' ' VAL . 83.4 mt -104.03 -41.13 5.94 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.982 0.913 . . . . 0.0 109.565 176.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.73 34.06 6.16 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.0 m -123.72 -177.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.521 1.128 . . . . 0.0 110.484 -176.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -148.52 146.74 23.25 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.485 1.114 . . . . 0.0 108.833 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 19.1 Cg_exo -64.41 108.12 0.95 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.598 2.198 . . . . 0.0 111.909 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.1 -38.7 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.7 mm-40 -111.9 121.8 46.03 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -121.97 140.9 51.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.56 . . . . 0.0 110.358 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.402 ' HB3' ' HB3' ' A' ' 36' ' ' PHE . 43.5 t -141.6 149.8 55.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.872 1.269 . . . . 0.0 107.949 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.22 -24.86 61.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.843 2.362 . . . . 0.0 113.572 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.3 t -128.01 9.2 6.27 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.402 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 85.9 t80 -149.22 150.59 32.85 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.708 0.403 . . . . 0.0 110.505 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 42.7 m -134.51 143.17 47.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.553 0.741 . . . . 0.0 109.697 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -138.51 119.62 14.53 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 6.8 p90 -131.98 147.86 52.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 108.127 167.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 1.6 p -126.33 134.98 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 109.306 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.446 HD12 HD13 ' A' ' 47' ' ' LEU . 6.1 mp -95.26 150.78 19.87 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.261 -167.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.66 -9.14 57.8 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.952 0.901 . . . . 0.0 110.744 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 58.9 m-20 -70.73 -9.31 56.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.28 1.032 . . . . 0.0 111.441 170.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.7 63.99 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.041 0.353 . . . . 0.0 113.38 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' B' ' 4' ' ' PRO . 18.6 ptm -113.37 167.72 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.694 0.797 . . . . 0.0 109.175 177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 62.3 tttt -132.86 136.57 46.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.671 0.388 . . . . 0.0 109.991 -174.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.446 HD13 HD12 ' A' ' 41' ' ' LEU . 12.9 mt -125.38 123.7 39.91 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.714 0.805 . . . . 0.0 112.295 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.83 145.72 16.82 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 169.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 10.4 mp -117.29 105.19 11.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 161.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.33 129.79 54.86 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 69.2 m -72.5 130.82 41.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.27 0.356 . . . . 0.0 111.286 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 -66.15 -21.36 66.33 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.957 0.903 . . . . 0.0 111.913 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -81.33 -6.7 59.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.152 0.581 . . . . 0.0 111.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.446 HG21 ' HB2' ' A' ' 51' ' ' SER . 13.5 t -127.25 4.65 6.36 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.452 0.701 . . . . 0.0 110.784 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 p -71.18 149.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.86 0.464 . . . . 0.0 111.47 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -130.6 121.47 19.23 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.874 0.87 . . . . 0.0 109.392 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.56 141.1 68.83 Favored 'Cis proline' 0 C--N 1.385 2.497 0 CA-C-N 119.943 1.015 . . . . 0.0 112.345 -1.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -55.1 132.04 46.43 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.114 0.966 . . . . 0.0 112.215 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.79 109.73 4.49 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.723 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.8 m -83.04 87.32 6.89 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.2 m -148.34 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.942 0.897 . . . . 0.0 109.445 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 p -150.81 135.57 17.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.655 1.182 . . . . 0.0 108.594 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.28 35.18 57.04 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.337 0.398 . . . . 0.0 113.139 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.53 29.25 2.61 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.21 -172.06 32.14 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 115.858 -0.171 . . . . 0.0 112.867 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' B' ' 66' ' ' GLY . . . 70.48 107.45 0.04 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.673 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 36.1 mt-10 -122.76 134.47 54.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.76 109.57 15.76 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.98 121.96 34.85 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.249 0.547 . . . . 0.0 110.767 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.517 ' HB2' HG21 ' A' ' 117' ' ' VAL . 40.6 m-85 -102.87 107.64 18.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.789 1.636 . . . . 0.0 108.747 -177.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.58 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 25.4 mtm180 -92.54 132.46 36.82 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 112.053 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 161.86 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.316 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.2 pt-20 -65.8 -41.31 92.07 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -160.83 -178.87 7.12 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.57 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.42 -33.18 65.58 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.745 1.618 . . . . 0.0 113.072 -169.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.11 -46.0 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.84 0.456 . . . . 0.0 110.408 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.444 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 79.9 mm-40 -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.194 0.998 . . . . 0.0 112.537 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.2 -44.07 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.495 0.718 . . . . 0.0 109.841 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.36 -35.63 73.68 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.516 1.126 . . . . 0.0 111.035 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -65.93 -41.02 91.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.251 0.548 . . . . 0.0 109.866 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -63.47 -41.14 98.59 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.612 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' O ' ' HE2' ' A' ' 92' ' ' MET . 42.9 t80 -57.89 -57.8 11.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.398 0.679 . . . . 0.0 110.693 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -63.04 -41.2 99.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.254 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.44 -47.27 86.0 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.869 0.73 . . . . 0.0 113.547 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -62.1 -45.44 93.47 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.658 0.783 . . . . 0.0 109.826 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.4 ttpt -55.64 -43.0 75.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.115 0.966 . . . . 0.0 110.83 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.63 -26.94 61.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.239 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -93.29 8.21 41.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.937 0.895 . . . . 0.0 112.618 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.6 45.33 4.64 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 166.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 107' ' ' ALA . 8.0 p -98.46 152.18 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 170.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.38 -62.34 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 30.2 ttp 61.24 82.75 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.173 0.989 . . . . 0.0 112.849 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 84.92 2.14 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.832 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 179.91 135.22 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 0.0 108.615 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.98 129.96 77.08 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.539 0.524 . . . . 0.0 109.923 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.58 96.42 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.752 2.301 . . . . 0.0 109.849 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.34 160.48 36.15 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.09 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 101.05 6.35 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.065 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.425 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 21.7 ttt -100.75 -178.92 3.92 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.982 1.313 . . . . 0.0 110.023 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 99' ' ' MET . 15.1 mm-40 -52.13 -41.02 62.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.654 1.182 . . . . 0.0 112.432 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 55.8 m-85 -96.55 11.96 33.29 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.614 -173.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.28 -165.47 12.79 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.86 112.04 19.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -141.87 169.24 17.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.839 0.455 . . . . 0.0 111.611 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.411 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 37.0 p90 -152.98 175.61 12.77 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.852 166.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 114' ' ' ARG . 90.7 m -137.39 130.66 30.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.022 0.439 . . . . 0.0 110.178 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.22 168.18 9.24 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.443 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.7 112.33 6.82 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 5.9 p-10 -68.01 174.39 2.41 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.253 1.021 . . . . 0.0 111.134 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 16.0 Cg_exo -37.26 -49.94 1.66 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.197 3.265 . . . . 0.0 115.321 172.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -10.79 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.678 0.791 . . . . 0.0 111.177 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m 69.84 92.78 0.08 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.535 1.534 . . . . 0.0 112.188 168.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.456 ' CE1' HG12 ' A' ' 11' ' ' VAL . 16.4 m80 -124.21 149.2 46.66 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.673 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 22.0 ttp180 -81.03 95.16 6.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.291 0.567 . . . . 0.0 110.115 -171.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.547 HD21 ' HH ' ' A' ' 21' ' ' TYR . 63.6 mt -92.76 101.59 13.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -171.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -92.84 95.54 9.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.805 0.842 . . . . 0.0 110.869 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 70' ' ' PHE . 36.5 t -97.21 117.05 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -133.81 161.62 34.24 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.8 111.46 15.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 166.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 35.8 t80 -77.48 127.31 32.3 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 m80 . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.424 ' O ' ' SD ' ' A' ' 45' ' ' MET . 73.7 Cg_endo -75.7 94.47 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.065 1.843 . . . . 0.0 111.267 164.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 8.7 p-10 -109.78 14.65 23.16 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.551 0.74 . . . . 0.0 109.487 168.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.58 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.3 OUTLIER -131.15 141.25 50.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.895 1.278 . . . . 0.0 107.687 -165.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.449 ' N ' ' HD1' ' B' ' 6' ' ' PHE . 5.6 t -145.13 145.1 31.25 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.693 1.197 . . . . 0.0 108.261 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.3 mt -118.31 140.19 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.103 0.561 . . . . 0.0 110.73 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.3 117.48 34.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -73.07 122.93 22.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.139 0.976 . . . . 0.0 111.397 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' B' ' 51' ' ' SER . 11.3 m -122.44 163.67 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -98.43 -52.14 3.74 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -104.06 98.65 14.2 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.397 0.679 . . . . 0.0 110.5 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.69 -48.61 18.52 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.609 2.873 . . . . 0.0 115.927 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 15.6 Cg_endo -55.14 -63.89 0.17 Allowed 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 123.002 2.108 . . . . 0.0 112.272 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.99 88.85 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.334 0.654 . . . . 0.0 112.088 -167.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -66.46 -48.16 70.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.494 0.664 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 89.1 m -75.65 -34.9 60.52 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -168.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 85.3 mm-40 -67.17 -33.96 76.51 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.3 1.0 . . . . 0.0 109.056 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 85.7 t80 -66.05 -43.35 87.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.004 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.606 ' HH ' HD22 ' B' ' 115' ' ' LEU . 40.8 m-85 -70.68 -29.45 65.78 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.418 0.553 . . . . 0.0 110.142 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.3 mtpt -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.125 0.488 . . . . 0.0 112.04 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.8 62.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.158 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 13.3 tp -63.88 -30.72 71.78 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.581 1.152 . . . . 0.0 112.734 -175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' B' ' 27' ' ' VAL . 66.7 mt -104.47 -41.09 5.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 109.45 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.78 34.1 6.13 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' B' ' 25' ' ' LEU . 35.6 m -124.19 -177.82 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.399 1.08 . . . . 0.0 110.833 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -147.23 146.6 25.94 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.203 1.001 . . . . 0.0 108.966 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 35.9 Cg_endo -63.38 108.54 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.408 2.072 . . . . 0.0 112.115 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -64.33 -38.38 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.31 0.644 . . . . 0.0 110.243 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 17.9 mm-40 -112.04 121.56 45.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.7 p -122.12 140.67 52.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.119 0.568 . . . . 0.0 110.488 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.7 t -141.71 149.47 53.62 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.963 1.305 . . . . 0.0 107.89 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.77 -24.99 58.45 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.7 2.267 . . . . 0.0 113.587 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -127.87 8.95 6.31 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -149.0 150.6 33.09 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.606 0.362 . . . . 0.0 110.41 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 15.1 m -134.2 143.5 47.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.462 0.705 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tm? -139.4 119.15 13.2 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 5.9 p90 -131.91 148.0 52.51 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 167.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.53 HG22 ' HG3' ' B' ' 46' ' ' LYS . 5.6 t -125.92 134.28 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -172.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.484 HD23 HD12 ' B' ' 25' ' ' LEU . 52.3 mt -94.22 150.91 19.87 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.67 0.788 . . . . 0.0 110.775 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -9.42 58.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.082 0.953 . . . . 0.0 110.697 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 69.7 m-20 -70.63 -9.01 56.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.028 0.931 . . . . 0.0 111.699 170.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.16 11.54 62.87 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 116.59 -0.277 . . . . 0.0 113.342 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -115.1 167.2 11.03 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.88 0.872 . . . . 0.0 108.895 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.53 ' HG3' HG22 ' B' ' 40' ' ' VAL . 78.3 tttt -132.51 135.37 45.95 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.146 0.578 . . . . 0.0 109.659 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.453 ' HG ' ' SD ' ' B' ' 45' ' ' MET . 36.8 mt -124.94 123.87 40.83 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.775 0.83 . . . . 0.0 112.216 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.33 145.66 16.61 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 10.5 mp -117.53 105.2 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 161.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.419 ' HZ2' ' HE3' ' A' ' 99' ' ' MET . 7.8 t90 -107.26 129.97 54.81 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 69.5 m -72.73 130.48 40.61 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.199 0.312 . . . . 0.0 111.483 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.452 ' HD3' HG22 ' B' ' 62' ' ' THR . 31.7 ptt180 -66.48 -20.91 66.16 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.722 0.809 . . . . 0.0 111.995 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -81.05 -7.16 59.5 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.872 0.469 . . . . 0.0 111.514 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.429 HG21 ' HB2' ' B' ' 51' ' ' SER . 14.1 t -126.88 5.44 6.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.295 0.638 . . . . 0.0 110.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 p -71.57 149.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.808 0.443 . . . . 0.0 111.354 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -131.03 121.32 18.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.5 141.54 70.24 Favored 'Cis proline' 0 C--N 1.389 2.682 0 C-N-CA 124.622 -0.991 . . . . 0.0 112.294 -1.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -55.9 132.28 49.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.026 0.93 . . . . 0.0 111.928 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.04 109.52 4.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.578 0.751 . . . . 0.0 109.635 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -82.66 87.82 6.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.67 139.35 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.102 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.452 HG22 ' HD3' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -150.14 135.33 17.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.823 1.249 . . . . 0.0 108.65 174.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.01 58.91 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.375 0.422 . . . . 0.0 113.329 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.05 28.79 2.69 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.23 -172.11 32.15 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.749 -0.225 . . . . 0.0 112.997 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . 70.61 107.41 0.04 OUTLIER Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -177.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.67 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 35.0 mt-10 -122.72 134.54 54.45 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -119.82 109.48 15.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.95 122.3 35.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.388 0.613 . . . . 0.0 110.85 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.507 ' HB2' HG22 ' B' ' 117' ' ' VAL . 40.6 m-85 -103.22 107.67 18.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.754 1.621 . . . . 0.0 108.474 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.595 ' HD3' ' HD2' ' A' ' 6' ' ' PHE . 27.8 mtm180 -92.76 131.53 37.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.197 0.522 . . . . 0.0 111.84 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.17 162.33 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.271 1.028 . . . . 0.0 110.239 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.562 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.3 pt-20 -66.31 -40.17 89.79 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.57 -179.13 7.06 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.989 0.813 . . . . 0.0 112.676 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.99 -33.32 64.73 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.776 1.63 . . . . 0.0 113.421 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.01 78.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.562 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.7 mm-40 -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.358 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.96 -44.76 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.552 0.692 . . . . 0.0 109.715 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.75 -36.44 78.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.298 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -65.46 -41.57 93.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.349 0.595 . . . . 0.0 110.025 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.7 m -62.77 -41.23 99.14 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.659 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.406 ' O ' ' HE1' ' B' ' 92' ' ' MET . 43.7 t80 -58.12 -57.44 12.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.448 0.699 . . . . 0.0 110.616 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.452 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -63.52 -41.01 98.51 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.235 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.67 82.57 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.801 0.688 . . . . 0.0 113.41 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -61.77 -45.82 92.24 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.637 0.775 . . . . 0.0 109.884 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.1 ttpt -54.74 -43.41 72.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.171 0.988 . . . . 0.0 111.04 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.77 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.798 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -93.53 8.51 40.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.024 0.93 . . . . 0.0 112.374 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.17 45.77 4.64 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 114.859 0.703 . . . . 0.0 114.859 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.422 HG22 ' HB1' ' B' ' 107' ' ' ALA . 8.3 p -98.56 152.02 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.48 -61.93 1.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 30.3 ttp 60.86 83.11 0.15 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.231 1.012 . . . . 0.0 112.79 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.35 85.48 2.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.352 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 179.71 134.22 0.1 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 108.384 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -75.83 130.04 79.7 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.63 0.581 . . . . 0.0 109.893 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.98 95.78 0.67 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.731 2.287 . . . . 0.0 110.083 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.16 160.15 36.91 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -168.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 101.08 5.9 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.962 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 22.4 ttt -100.89 -178.78 3.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.134 1.374 . . . . 0.0 109.84 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.86 -40.79 63.71 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.559 1.144 . . . . 0.0 112.182 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 55.0 m-85 -96.3 11.94 32.85 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.863 0.865 . . . . 0.0 111.673 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.84 -165.3 12.92 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.07 112.2 19.58 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -142.0 169.32 17.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.817 0.447 . . . . 0.0 111.588 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' B' ' 92' ' ' MET . 37.0 p90 -153.12 175.72 12.7 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.316 1.047 . . . . 0.0 108.731 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.629 HG21 ' HG3' ' B' ' 114' ' ' ARG . 96.8 m -137.49 130.8 30.91 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 110.138 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.32 168.45 9.06 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.505 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.86 112.23 6.71 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.6 p-10 -67.51 174.3 2.26 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.334 1.054 . . . . 0.0 111.551 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 17.3 Cg_exo -37.67 -49.78 1.92 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.938 3.092 . . . . 0.0 115.225 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.26 -10.21 50.4 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.46 0.704 . . . . 0.0 111.368 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 70.07 92.18 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.578 1.551 . . . . 0.0 112.047 168.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.459 ' CE1' HG12 ' B' ' 11' ' ' VAL . 15.7 m80 -123.77 149.37 45.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 170.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.67 ' HB3' ' HG2' ' B' ' 67' ' ' GLU . 21.8 ttp180 -81.15 95.34 6.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.136 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.606 HD22 ' HH ' ' B' ' 21' ' ' TYR . 62.3 mt -93.24 101.72 13.99 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -171.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -90.97 94.72 9.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.892 0.877 . . . . 0.0 111.131 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' B' ' 70' ' ' PHE . 36.8 t -97.61 117.47 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.353 0.979 . . . . 0.0 108.366 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -133.77 161.42 34.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 111.35 15.47 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 166.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 35.2 t80 -77.98 132.55 37.89 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.79 95.22 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.274 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.096 0 CA-C-O 118.963 -0.91 . . . . 0.0 111.033 -174.421 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -94.05 92.29 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.291 2.66 . . . . 0.0 113.066 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.607 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.1 p-10 -103.17 9.46 38.28 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.613 0.72 . . . . 0.0 110.044 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -132.59 136.23 46.42 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.793 1.237 . . . . 0.0 108.116 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HB ' HG21 ' B' ' 7' ' ' THR . 9.9 t -131.56 142.67 49.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.684 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 57.2 mt -120.79 134.83 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD12 HD22 ' A' ' 68' ' ' LEU . 94.0 mt -82.11 131.58 35.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -85.31 105.04 15.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.803 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.472 HG11 HD23 ' A' ' 49' ' ' LEU . 2.4 m -116.35 176.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.97 -57.95 2.2 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.052 0.941 . . . . 0.0 109.678 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -89.18 105.64 10.94 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.748 1.219 . . . . 0.0 109.309 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.7 Cg_exo -56.79 -55.91 2.35 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.95 2.434 . . . . 0.0 113.704 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 51.6 Cg_exo -55.81 -65.82 0.1 Allowed 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 122.109 1.789 . . . . 0.0 112.686 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -165.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.7 p -63.33 -55.43 24.65 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 99.6 m -67.3 -39.33 85.95 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -168.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.532 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 23.7 mm-40 -62.38 -41.11 98.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.817 1.247 . . . . 0.0 109.45 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 86.4 t80 -65.37 -39.98 92.98 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 110.049 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.432 ' OH ' HD21 ' A' ' 115' ' ' LEU . 61.4 m-85 -71.28 -31.42 67.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.594 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.1 mtpt -56.53 -46.33 80.66 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -37.7 51.17 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.272 175.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 14.9 tp -62.93 -30.91 71.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.268 1.027 . . . . 0.0 112.536 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB2' HG21 ' A' ' 27' ' ' VAL . 46.1 mt -104.94 -37.63 6.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.008 0.923 . . . . 0.0 109.152 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.08 9.95 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -172.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG21 ' HB2' ' A' ' 25' ' ' LEU . 23.9 m -128.15 159.37 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.963 0.905 . . . . 0.0 110.174 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -112.22 148.7 39.66 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.609 0.764 . . . . 0.0 109.625 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 16.8 Cg_exo -67.18 108.03 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.784 2.323 . . . . 0.0 111.076 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.549 HG11 ' HA ' ' A' ' 39' ' ' PHE . 7.3 p -63.4 -34.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.706 0.629 . . . . 0.0 110.679 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.7 mm-40 -115.63 85.36 2.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -86.71 129.45 34.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.266 0.626 . . . . 0.0 110.095 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -137.49 150.78 69.57 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.745 0.818 . . . . 0.0 109.193 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.76 -42.78 42.85 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.714 2.943 . . . . 0.0 114.812 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -127.17 24.51 6.33 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.252 0.548 . . . . 0.0 112.276 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -153.77 152.42 30.71 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.562 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 33.5 t -134.66 142.65 46.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.387 0.675 . . . . 0.0 109.366 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -141.06 122.31 14.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.549 ' HA ' HG11 ' A' ' 30' ' ' VAL . 5.5 p90 -129.74 146.61 51.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.839 0.856 . . . . 0.0 108.993 164.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.543 HG22 ' HG3' ' A' ' 46' ' ' LYS . 6.1 t -118.88 135.12 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.416 HD12 ' SD ' ' A' ' 45' ' ' MET . 38.5 mt -96.21 158.76 15.29 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.933 0.493 . . . . 0.0 110.517 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.59 -20.95 66.12 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.965 0.906 . . . . 0.0 112.465 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.898 0.879 . . . . 0.0 111.393 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.59 -14.17 42.46 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.717 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -72.91 154.96 40.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HG3' HG22 ' A' ' 40' ' ' VAL . 81.6 tttt -119.23 139.74 51.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.55 115.52 11.55 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -168.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.35 170.7 21.6 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 123.901 0.763 . . . . 0.0 111.533 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 6.3 mp -139.5 107.7 5.77 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 165.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.475 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.9 t90 -105.09 124.05 48.87 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -76.79 139.25 40.31 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.374 0.67 . . . . 0.0 111.102 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' HG21 ' A' ' 62' ' ' THR . 39.2 ptt180 -73.0 -14.82 61.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.147 0.579 . . . . 0.0 112.244 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -85.72 -6.51 59.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 122.511 0.325 . . . . 0.0 111.157 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -129.37 8.51 5.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.367 0.667 . . . . 0.0 110.976 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.855 HG21 HH22 ' B' ' 116' ' ' ARG . 12.5 p -74.62 148.84 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.031 0.532 . . . . 0.0 111.734 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -128.19 116.03 20.19 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.827 0.851 . . . . 0.0 109.568 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.22 144.47 78.05 Favored 'Cis proline' 0 C--N 1.387 2.579 0 C-N-CA 124.52 -1.033 . . . . 0.0 112.743 1.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.509 ' HA ' HG13 ' A' ' 55' ' ' VAL . 12.0 mmmm -53.17 114.11 1.35 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.694 0.798 . . . . 0.0 111.511 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.59 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.307 1.043 . . . . 0.0 109.44 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -98.09 89.3 4.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.28 0.632 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.74 124.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.102 0.561 . . . . 0.0 111.136 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' HD3' ' A' ' 52' ' ' ARG . 9.4 p -151.92 178.67 9.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.252 1.421 . . . . 0.0 108.631 171.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.59 -31.94 6.72 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -172.52 31.19 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 119.95 0.65 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.22 125.07 0.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.721 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.7 pt-20 -131.79 145.04 51.36 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 9' ' ' LEU . 39.9 tp -108.49 104.52 13.87 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -88.0 117.13 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 110.761 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -97.74 112.67 24.47 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.7 mtm105 -90.64 135.08 33.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.883 0.473 . . . . 0.0 111.696 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.91 173.3 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.283 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -74.84 -45.39 43.57 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.769 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.41 HD21 ' HG3' ' A' ' 73' ' ' GLU . 7.4 p30 -157.62 175.22 14.21 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.701 0.682 . . . . 0.0 112.393 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.01 -32.39 67.88 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.525 -166.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.59 -44.94 85.08 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.401 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.0 mm-40 -64.39 -25.45 68.03 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.72 -39.4 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.397 0.618 . . . . 0.0 109.866 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.22 -32.14 68.43 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.543 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.6 mt-10 -65.85 -41.31 91.88 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.593 0.711 . . . . 0.0 109.665 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.7 m -71.25 -29.13 64.73 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.834 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.58 -61.1 2.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 0.0 109.632 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.433 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.94 -36.49 82.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.725 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.24 68.45 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.994 0.809 . . . . 0.0 113.712 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -63.1 -42.9 99.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.369 0.668 . . . . 0.0 110.333 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.7 ttpt -55.42 -47.0 76.64 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.953 0.783 . . . . 0.0 110.474 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.9 -15.28 59.73 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.414 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -92.12 -2.48 56.58 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.11 0.964 . . . . 0.0 111.939 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.92 3.25 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.914 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.13 150.79 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.22 -36.46 81.72 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.882 0.473 . . . . 0.0 111.8 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.421 ' HE2' ' HB2' ' A' ' 86' ' ' LYS . 61.5 tpp 65.83 83.14 0.17 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 168.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 85.89 2.25 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.491 0.662 . . . . 0.0 111.381 173.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 179.34 126.36 0.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.412 1.485 . . . . 0.0 108.639 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -79.85 109.95 14.04 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 167.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.2 119.38 6.25 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.786 2.324 . . . . 0.0 111.09 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 146.29 50.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.225 0.61 . . . . 0.0 110.745 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -73.92 101.94 3.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.851 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.7 ttm -98.35 174.76 6.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.879 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.95 -39.81 63.2 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.096 0.958 . . . . 0.0 112.233 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -91.55 6.97 43.6 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.583 0.753 . . . . 0.0 111.659 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 -163.78 12.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.003 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -76.13 102.15 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -113.06 147.51 37.12 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.186 0.517 . . . . 0.0 110.556 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -143.31 138.74 29.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.688 1.195 . . . . 0.0 109.536 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.6 m -134.91 119.91 18.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.027 0.83 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.57 161.03 14.98 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 122.966 0.506 . . . . 0.0 110.989 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.8 114.68 23.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.501 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 6.1 p-10 -70.3 176.67 1.72 Allowed Pre-proline 0 CA--C 1.567 1.608 0 C-N-CA 124.071 0.948 . . . . 0.0 111.336 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 1.4 Cg_endo -42.83 -41.71 8.74 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.853 3.035 . . . . 0.0 115.034 173.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -78.88 -25.97 43.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.542 0.337 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 t 73.38 85.86 0.11 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.811 1.644 . . . . 0.0 110.003 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.42 ' CE1' HG13 ' A' ' 11' ' ' VAL . 13.7 m80 -113.87 -173.98 2.38 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 3.0 mmp_? -100.57 112.73 25.15 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.432 HD21 ' OH ' ' A' ' 21' ' ' TYR . 84.2 mt -114.96 103.63 11.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.825 0.45 . . . . 0.0 110.188 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.619 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 51.4 ttt180 -90.69 140.16 30.04 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -174.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.24 119.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 164.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -128.49 164.87 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.288 0.494 . . . . 0.0 111.812 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.68 111.2 9.19 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -80.25 114.3 19.05 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.534 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.147 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -94.44 93.13 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.203 2.602 . . . . 0.0 113.174 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.717 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 11.4 p-10 -104.58 9.66 35.27 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.798 0.809 . . . . 0.0 109.606 171.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.01 135.79 45.64 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 108.033 -168.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.413 HG21 ' HB ' ' A' ' 7' ' ' THR . 11.5 t -131.35 143.12 50.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.721 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 50.4 mt -121.12 134.53 64.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.463 HD12 HD22 ' B' ' 68' ' ' LEU . 93.2 mt -81.71 131.69 35.27 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 173.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.429 ' OH ' HG13 ' B' ' 55' ' ' VAL . 23.1 t80 -85.43 105.07 15.79 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.752 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' B' ' 113' ' ' HIS . 2.5 m -116.14 176.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.969 0.908 . . . . 0.0 108.664 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.16 -57.29 2.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 109.775 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -89.82 105.92 12.59 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.478 1.111 . . . . 0.0 109.453 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.43 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 28.1 Cg_exo -56.78 -55.95 2.32 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.984 2.456 . . . . 0.0 113.799 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 53.7 Cg_exo -55.61 -66.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.402 3.362 0 CA-C-N 122.255 1.841 . . . . 0.0 112.728 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.85 81.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -62.67 -55.95 22.18 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 98.2 m -66.95 -39.31 87.24 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -168.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.567 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 20.8 mm-40 -62.25 -41.35 98.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.762 1.225 . . . . 0.0 109.264 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 90.1 t80 -65.07 -40.28 94.47 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.058 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.442 ' OH ' HD21 ' B' ' 115' ' ' LEU . 62.6 m-85 -71.2 -31.45 67.62 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.507 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 60.8 mtpt -56.28 -46.6 79.65 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.41 -37.57 51.54 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.53 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.6 tp -62.97 -30.91 71.95 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.471 1.109 . . . . 0.0 112.56 -174.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' B' ' 27' ' ' VAL . 46.6 mt -104.88 -37.71 6.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 109.071 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 33.25 9.66 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' B' ' 25' ' ' LEU . 21.5 m -128.8 158.57 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.043 0.937 . . . . 0.0 109.958 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -110.8 148.43 38.55 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 123.855 0.862 . . . . 0.0 109.693 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.547 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 20.3 Cg_exo -66.66 108.01 1.36 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.628 2.218 . . . . 0.0 111.338 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -63.2 -34.76 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.253 0.621 . . . . 0.0 110.593 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 30.7 mm-40 -115.62 85.59 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 34.1 p -86.74 129.55 34.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.334 0.653 . . . . 0.0 110.014 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -137.25 150.36 68.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.112 0.965 . . . . 0.0 109.382 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.52 -42.88 40.98 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.706 2.937 . . . . 0.0 114.725 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.7 t -127.26 24.36 6.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.949 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -153.75 152.43 30.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.529 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 39.3 t -134.94 142.79 46.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.269 0.627 . . . . 0.0 109.333 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.646 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.4 tm? -140.85 122.84 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.565 ' HA ' HG12 ' B' ' 30' ' ' VAL . 3.6 p90 -129.74 146.67 51.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 109.07 164.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.532 HG21 ' HG3' ' B' ' 46' ' ' LYS . 9.5 t -118.65 134.52 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.01 158.35 15.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.952 0.501 . . . . 0.0 110.647 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -22.19 66.53 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.121 0.969 . . . . 0.0 112.65 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.5 ' OD1' ' HG3' ' B' ' 45' ' ' MET . 18.9 p30 -66.66 -20.85 66.08 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 0.0 111.767 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.56 -13.22 42.93 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.241 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.607 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -73.5 155.41 39.24 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.532 ' HG3' HG21 ' B' ' 40' ' ' VAL . 79.2 tttt -119.41 140.11 50.93 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 tt -137.61 115.26 11.3 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.687 -168.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.05 170.79 21.95 Favored Glycine 0 C--N 1.349 1.284 0 C-N-CA 124.042 0.83 . . . . 0.0 111.579 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 5.4 mp -139.51 107.45 5.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 165.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -104.85 124.47 49.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.414 ' HB2' HG23 ' B' ' 54' ' ' THR . 15.8 m -76.77 139.39 40.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.385 0.674 . . . . 0.0 110.884 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -72.83 -15.12 61.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.274 0.63 . . . . 0.0 112.318 -173.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -85.82 -6.42 59.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.699 0.4 . . . . 0.0 110.824 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.414 HG23 ' HB2' ' B' ' 51' ' ' SER . 14.6 t -129.65 7.79 5.29 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.472 0.709 . . . . 0.0 111.162 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.429 HG13 ' OH ' ' B' ' 10' ' ' TYR . 8.4 p -74.61 149.68 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -128.59 115.86 19.56 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.177 0.991 . . . . 0.0 109.284 172.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.35 143.74 75.68 Favored 'Cis proline' 0 C--N 1.387 2.561 0 C-N-CA 124.626 -0.989 . . . . 0.0 112.675 1.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -52.22 114.39 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.591 0.756 . . . . 0.0 111.674 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.55 132.55 45.62 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 109.458 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 40.3 m -98.37 89.47 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.183 0.593 . . . . 0.0 109.421 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 p -155.58 124.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.193 0.597 . . . . 0.0 111.162 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -152.47 178.14 9.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.293 1.437 . . . . 0.0 108.665 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.44 -31.84 6.77 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-O 121.04 0.244 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.63 -172.66 31.38 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.83 119.71 0.63 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 75.23 126.06 0.18 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.684 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 3.7 pt-20 -132.98 143.4 49.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 110.218 -175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.463 HD22 HD12 ' B' ' 9' ' ' LEU . 43.0 tp -108.35 104.31 13.65 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.732 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -87.61 116.75 25.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.148 0.499 . . . . 0.0 110.861 -171.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -97.05 112.62 24.3 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.408 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 31.4 mtm180 -91.03 135.19 33.92 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 122.941 0.496 . . . . 0.0 111.622 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' B' ' 77' ' ' GLN . 1.3 p -140.4 173.14 10.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.131 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.77 -45.44 43.77 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -157.59 175.09 14.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 0.675 . . . . 0.0 112.292 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -58.78 -32.07 68.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.219 1.407 . . . . 0.0 112.398 -166.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.554 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.84 -45.03 83.74 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.349 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.509 ' HB3' HG21 ' B' ' 72' ' ' VAL . 73.1 mm-40 -64.5 -25.14 67.86 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.958 0.786 . . . . 0.0 112.574 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -71.43 -39.39 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.189 0.596 . . . . 0.0 109.728 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.96 -32.28 69.11 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 110.551 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.7 mt-10 -65.63 -41.06 93.11 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.615 0.721 . . . . 0.0 109.684 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 12.5 m -71.43 -29.43 64.87 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.828 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.8 -61.03 2.92 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.396 0.678 . . . . 0.0 109.475 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.436 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.73 -36.82 83.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.676 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 -50.52 66.18 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.608 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -63.19 -43.12 99.11 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.207 0.603 . . . . 0.0 110.27 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.444 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 33.9 ttpt -54.72 -47.41 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.765 0.826 . . . . 0.0 110.583 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.65 -15.67 59.75 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.612 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -92.22 -1.82 56.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 112.01 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.29 3.36 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.189 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.85 150.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.444 ' HE1' ' HB2' ' B' ' 86' ' ' LYS . 61.2 tpp 65.82 83.18 0.17 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 168.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 85.91 2.25 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.442 0.639 . . . . 0.0 111.167 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 179.62 126.47 0.07 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.21 1.404 . . . . 0.0 108.387 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.99 110.71 17.14 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.547 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 17.3 Cg_endo -55.67 119.71 7.03 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.79 2.327 . . . . 0.0 110.409 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 145.81 50.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 0.0 111.034 -170.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -72.29 101.67 2.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.206 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.6 ttm -98.63 174.62 6.33 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.663 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -52.77 -40.28 63.02 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.825 0.85 . . . . 0.0 112.373 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.44 6.74 42.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.643 0.777 . . . . 0.0 111.989 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.69 -163.1 12.21 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -77.33 102.36 6.73 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -113.18 147.33 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.178 0.591 . . . . 0.0 110.487 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 4.7 t80 -143.31 138.9 29.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.733 1.213 . . . . 0.0 109.58 -176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 11.1 m -135.1 119.92 18.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.041 0.837 . . . . 0.0 110.347 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.76 160.68 15.29 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.929 0.492 . . . . 0.0 110.986 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.38 114.97 24.32 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.465 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.0 p-10 -70.19 177.56 1.33 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 124.182 0.993 . . . . 0.0 111.288 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 49.4 Cg_exo -43.75 -41.47 11.57 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.456 2.771 . . . . 0.0 115.265 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.95 -25.75 43.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 22.6 t 73.25 86.11 0.11 Allowed 'General case' 0 C--N 1.348 0.522 0 C-N-CA 125.777 1.631 . . . . 0.0 109.952 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.426 ' CE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -113.84 -173.88 2.36 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 67' ' ' GLU . 3.9 mmp_? -100.37 113.01 25.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.442 HD21 ' OH ' ' B' ' 21' ' ' TYR . 85.4 mt -115.3 104.37 11.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.797 0.439 . . . . 0.0 109.969 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.855 HH22 HG21 ' A' ' 55' ' ' VAL . 22.3 mmt180 -88.32 140.94 28.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.508 0.723 . . . . 0.0 110.726 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 59.8 t -135.52 120.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 162.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -128.73 165.44 20.9 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.384 0.538 . . . . 0.0 111.888 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.12 110.97 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -79.64 113.3 17.69 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 103.38 1.14 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.976 0.51 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.461 ' HD2' HD23 ' B' ' 41' ' ' LEU . 59.5 Cg_endo -90.89 97.09 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.865 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.3 p-10 -90.28 11.93 19.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.339 0.59 . . . . 0.0 110.694 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.442 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.6 t80 -133.08 135.05 45.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.811 1.244 . . . . 0.0 108.28 -168.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 140.8 41.97 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.349 1.059 . . . . 0.0 108.216 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.527 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 60.7 mt -119.21 141.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.7 138.01 46.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.504 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.5 132.93 35.33 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.488 176.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' SER . 29.0 m -130.6 158.7 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 121.653 -0.654 . . . . 0.0 110.451 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 22.9 t70 -95.34 -57.29 2.45 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.0 99.11 2.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.53 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 12' ' ' ASP . 50.1 Cg_exo -49.02 -55.69 3.91 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 122.756 2.304 . . . . 0.0 114.42 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -59.88 -54.91 1.96 Allowed 'Trans proline' 0 C--N 1.397 3.098 0 CA-C-N 122.16 1.807 . . . . 0.0 112.022 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.05 73.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.134 0.974 . . . . 0.0 111.823 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -79.89 -18.16 51.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.516 -173.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -76.98 -38.51 53.05 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 84.7 mm-40 -67.24 -30.23 70.08 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.52 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -60.45 -48.45 81.69 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.91 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.5 m-85 -68.71 -30.54 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.028 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.0 mtpt -57.78 -49.17 77.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.86 -31.89 51.73 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.715 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.441 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.5 tp -62.07 -50.78 70.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.681 1.192 . . . . 0.0 112.295 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HB2' HG21 ' A' ' 27' ' ' VAL . 14.9 mt -83.57 -47.58 11.15 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 29.56 5.25 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.998 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 25' ' ' LEU . 27.0 m -131.63 175.95 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.026 0.93 . . . . 0.0 110.358 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -124.24 151.25 65.76 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.128 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.55 106.45 1.25 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.78 2.32 . . . . 0.0 111.544 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.419 HG12 ' HG2' ' A' ' 31' ' ' GLU . 7.4 p -63.44 -39.45 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.507 0.723 . . . . 0.0 110.31 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 29.1 mm-40 -114.63 98.28 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.3 p -99.27 138.21 36.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.742 0.817 . . . . 0.0 110.917 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -143.39 150.58 52.01 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.975 1.31 . . . . 0.0 108.233 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.59 -22.35 51.24 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.859 2.373 . . . . 0.0 114.147 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -128.46 9.92 6.12 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.98 139.2 20.22 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.876 -0.515 . . . . 0.0 110.047 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -129.45 138.95 51.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.642 0.777 . . . . 0.0 109.203 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tm? -132.07 120.35 22.23 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.71 113.53 13.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.684 1.194 . . . . 0.0 109.098 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 HG23 ' HG3' ' A' ' 46' ' ' LYS . 12.6 t -94.65 139.68 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.226 1.01 . . . . 0.0 110.03 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -98.66 147.78 24.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.858 0.463 . . . . 0.0 110.244 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -4.81 34.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.756 0.822 . . . . 0.0 111.829 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -69.0 -10.2 56.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.453 1.101 . . . . 0.0 112.231 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.58 15.64 42.68 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.863 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -126.43 172.13 10.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.555 0.742 . . . . 0.0 109.185 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 40' ' ' VAL . 76.4 tttt -136.54 135.29 38.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.09 0.556 . . . . 0.0 109.601 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.2 mt -124.72 124.55 42.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.571 0.749 . . . . 0.0 111.059 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.84 167.3 18.45 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.269 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 tp -144.86 105.23 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.467 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.0 t90 -104.73 123.14 47.12 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 50.2 m -74.47 112.31 10.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.07 -1.93 1.12 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 114.532 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -79.48 -25.47 41.86 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.959 0.8 . . . . 0.0 110.802 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -112.69 12.58 19.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.441 0.696 . . . . 0.0 111.298 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 8.8 p -63.97 138.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.971 0.415 . . . . 0.0 111.49 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.21 114.49 33.43 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.16 140.52 64.87 Favored 'Cis proline' 0 C--N 1.385 2.464 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.073 3.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -49.12 125.48 10.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.101 1.36 . . . . 0.0 111.974 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.19 109.43 3.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.065 0.946 . . . . 0.0 110.498 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.8 t -97.32 88.55 4.46 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.48 135.99 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.596 0.758 . . . . 0.0 109.712 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 p -142.42 125.22 16.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.204 1.002 . . . . 0.0 110.182 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.57 -108.64 0.37 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.79 129.51 9.92 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.67 -32.23 0.03 OUTLIER Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.95 151.62 10.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.663 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 47.0 mt-10 -114.4 165.46 12.7 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.548 0.739 . . . . 0.0 110.787 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.91 103.56 9.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.58 118.49 30.08 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.231 0.469 . . . . 0.0 111.518 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -95.73 108.38 20.69 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.109 1.364 . . . . 0.0 107.688 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.437 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 38.6 mtm180 -85.3 130.06 34.68 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.438 0.637 . . . . 0.0 112.094 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.42 157.05 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.819 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.418 ' HG3' HD21 ' A' ' 74' ' ' ASN . 9.7 pt-20 -67.62 -38.36 83.8 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -172.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.418 HD21 ' HG3' ' A' ' 73' ' ' GLU . 7.0 p30 -157.2 176.71 12.36 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.711 0.687 . . . . 0.0 112.631 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.57 -32.86 65.61 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.81 1.644 . . . . 0.0 112.66 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.36 -44.06 79.93 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.012 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -66.36 -24.5 66.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.837 0.855 . . . . 0.0 112.241 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.41 -41.73 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.57 -30.87 68.75 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.489 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.3 mt-10 -68.06 -43.46 78.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -70.37 -28.85 65.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.52 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -64.15 -61.31 2.33 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.777 0.799 . . . . 0.0 109.133 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.76 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.895 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.22 91.46 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.39 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -61.51 -48.51 80.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.635 . . . . 0.0 110.385 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 32.5 ttpt -54.42 -43.53 71.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.841 0.856 . . . . 0.0 110.956 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.59 58.28 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.264 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -94.47 7.71 44.62 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.272 1.029 . . . . 0.0 112.183 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.61 24.5 30.5 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.421 170.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -84.0 133.58 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.531 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -56.71 -34.6 67.61 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.256 1.022 . . . . 0.0 112.625 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 86' ' ' LYS . 49.8 tpp 67.85 82.99 0.17 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 163.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.33 86.36 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 177.65 136.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.631 1.572 . . . . 0.0 109.173 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.3 108.79 15.62 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 165.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 12.5 Cg_endo -55.53 118.79 5.59 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.819 2.346 . . . . 0.0 111.448 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.07 155.32 48.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.325 0.65 . . . . 0.0 110.419 -175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.25 118.61 13.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 110.813 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.8 ttm -115.52 166.81 11.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.069 0.948 . . . . 0.0 108.954 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -49.97 -40.32 43.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.696 1.598 . . . . 0.0 113.071 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -86.97 -19.97 27.97 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.357 0.663 . . . . 0.0 111.676 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.67 175.36 28.5 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 120.326 -0.152 . . . . 0.0 112.932 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.552 ' HB3' ' HB1' ' A' ' 119' ' ' ALA . 42.5 t80 -71.85 101.94 2.75 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -107.49 150.07 27.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.471 0.653 . . . . 0.0 112.165 -161.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 20.0 t80 -150.45 146.21 26.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.8 m -142.69 129.32 20.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.095 0.558 . . . . 0.0 109.65 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.17 149.02 43.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.464 0.706 . . . . 0.0 111.212 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.24 167.09 10.27 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.531 ' HA ' ' H ' ' A' ' 91' ' ' ALA . 1.9 p-10 -133.07 -178.81 0.92 Allowed Pre-proline 0 CA--C 1.562 1.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -169.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 36.8 Cg_endo -62.92 -1.64 2.94 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.314 2.01 . . . . 0.0 114.943 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.73 0.13 13.12 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.481 0.582 . . . . 0.0 111.754 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m 70.14 33.85 2.57 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.829 1.252 . . . . 0.0 112.812 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.481 ' HB2' HD13 ' A' ' 115' ' ' LEU . 18.2 m170 -75.27 170.29 16.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.525 0.73 . . . . 0.0 110.032 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.663 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 13.6 mmm180 -118.91 108.91 15.38 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 113' ' ' HIS . 3.4 mp -121.41 108.9 14.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -93.38 147.23 23.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.897 0.479 . . . . 0.0 110.428 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.87 133.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.3 p90 -135.97 162.05 33.94 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.605 0.639 . . . . 0.0 111.738 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 103' ' ' TYR . . . -111.07 124.38 52.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 171.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -81.66 108.77 15.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.129 0.422 . . . . 0.0 110.437 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.847 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 119.551 -0.261 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -91.61 96.95 0.21 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.664 2.243 . . . . 0.0 112.262 170.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.863 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.7 p-10 -90.18 12.29 18.44 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.372 0.606 . . . . 0.0 110.824 170.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.472 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -133.34 135.16 44.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.923 1.289 . . . . 0.0 108.164 -168.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -137.49 140.97 41.48 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.424 1.089 . . . . 0.0 108.146 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.8 140.51 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.343 0.657 . . . . 0.0 109.695 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.85 139.26 43.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -83.4 133.08 34.95 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.21 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' B' ' 51' ' ' SER . 35.9 m -129.07 158.65 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.122 0.569 . . . . 0.0 110.693 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -95.76 -58.33 2.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -92.13 100.7 3.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.885 . . . . 0.0 109.233 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.87 -55.72 3.79 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.431 2.087 . . . . 0.0 114.332 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.416 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 31.8 Cg_exo -59.16 -55.56 1.83 Allowed 'Trans proline' 0 C--N 1.395 2.974 0 CA-C-N 122.285 1.852 . . . . 0.0 112.275 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.72 74.99 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.969 -167.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -79.77 -18.37 51.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.563 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.6 m -77.93 -37.79 46.94 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 28.0 mm-40 -67.25 -30.71 70.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.297 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.77 -48.61 81.0 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.08 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.409 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 34.4 m-85 -68.59 -30.73 69.54 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.166 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -57.19 -49.63 75.39 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.739 0.7 . . . . 0.0 112.791 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.18 50.82 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.95 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 24.5 tp -62.25 -50.74 70.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.578 1.151 . . . . 0.0 112.159 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.437 ' HB2' HG21 ' B' ' 27' ' ' VAL . 16.8 mt -83.92 -47.35 11.13 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.25 30.47 5.03 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.101 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' B' ' 25' ' ' LEU . 31.4 m -131.86 175.31 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.321 1.048 . . . . 0.0 110.052 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -124.24 151.71 66.47 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.26 106.41 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.57 2.18 . . . . 0.0 111.296 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.03 -39.28 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.486 0.714 . . . . 0.0 110.142 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 65.1 mm-40 -115.13 98.79 6.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.922 0.889 . . . . 0.0 108.678 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.8 p -99.87 137.85 37.76 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.762 0.825 . . . . 0.0 110.764 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 150.8 54.66 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.018 1.327 . . . . 0.0 107.96 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.04 -21.89 52.74 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.788 2.325 . . . . 0.0 114.252 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -128.49 8.98 5.98 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -150.27 139.63 21.37 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.4 m -129.42 139.1 51.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.585 0.754 . . . . 0.0 109.111 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -132.24 119.96 21.53 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.18 113.25 13.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.683 1.193 . . . . 0.0 109.095 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.53 HG21 ' HG3' ' B' ' 46' ' ' LYS . 14.7 t -94.92 139.99 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.967 0.907 . . . . 0.0 110.115 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.461 HD23 ' HD2' ' A' ' 4' ' ' PRO . 10.0 mp -98.93 146.93 25.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.143 0.577 . . . . 0.0 110.324 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.16 -5.17 33.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.923 0.889 . . . . 0.0 111.549 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.63 -9.32 53.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.612 1.165 . . . . 0.0 112.101 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.11 15.68 43.94 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.865 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -126.38 171.51 10.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.658 0.783 . . . . 0.0 109.162 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.53 ' HG3' HG21 ' B' ' 40' ' ' VAL . 81.5 tttt -136.26 135.23 38.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.127 0.571 . . . . 0.0 109.503 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.428 ' HG ' ' HE1' ' B' ' 45' ' ' MET . 6.1 mt -124.61 124.39 42.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.526 0.73 . . . . 0.0 111.064 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . 0.472 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -101.58 167.31 18.78 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.199 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.7 tp -144.78 105.45 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -104.78 122.97 46.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 50.9 m -74.54 112.8 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -63.35 -2.38 1.46 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.273 1.429 . . . . 0.0 114.503 -170.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -79.08 -25.77 43.07 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.866 0.757 . . . . 0.0 110.656 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -112.81 12.06 19.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.372 0.669 . . . . 0.0 111.426 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' B' ' 58' ' ' LYS . 7.2 p -62.33 138.7 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.68 114.8 32.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.31 139.8 62.23 Favored 'Cis proline' 0 C--N 1.381 2.243 0 C-N-CA 124.525 -1.031 . . . . 0.0 113.51 3.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' B' ' 55' ' ' VAL . 26.9 mmmt -48.87 125.4 10.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.173 1.389 . . . . 0.0 112.232 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.43 109.98 3.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.062 0.945 . . . . 0.0 110.298 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.2 t -97.83 88.27 4.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.38 136.2 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.657 0.783 . . . . 0.0 109.679 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -143.76 124.93 14.51 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.001 0.92 . . . . 0.0 110.077 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.38 -108.43 0.36 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.65 129.5 9.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.44 -33.48 0.03 OUTLIER Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.64 152.57 11.1 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.527 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 2.2 pm0 -118.09 163.84 16.01 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.87 0.868 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -120.44 103.2 8.99 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.41 119.93 31.11 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.231 0.469 . . . . 0.0 111.536 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -97.66 108.01 20.63 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -85.28 128.37 34.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.014 0.525 . . . . 0.0 111.906 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.42 157.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.051 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.26 -38.27 84.84 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -157.73 177.77 11.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.633 0.651 . . . . 0.0 112.52 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.86 -32.55 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.967 1.707 . . . . 0.0 112.545 -167.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -67.56 -43.86 79.62 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.431 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -66.37 -24.32 66.48 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.038 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -69.61 -42.23 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.54 -30.46 68.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 16.0 mt-10 -68.16 -43.22 78.72 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.342 0.592 . . . . 0.0 109.503 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -70.4 -28.77 65.34 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.591 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -64.62 -61.06 2.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.582 0.706 . . . . 0.0 109.114 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.24 90.53 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.929 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.56 90.54 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.199 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -60.93 -49.04 79.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 0.0 110.222 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -53.8 -44.28 70.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.008 0.923 . . . . 0.0 110.911 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.53 -22.5 58.99 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.3 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -94.48 7.8 44.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.194 0.998 . . . . 0.0 112.087 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.44 31.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 116.123 -0.489 . . . . 0.0 114.319 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.77 134.09 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . 0.514 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -57.43 -34.44 68.95 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.116 0.967 . . . . 0.0 112.53 -172.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.421 ' SD ' ' HZ ' ' B' ' 105' ' ' PHE . 50.0 tpp 67.07 83.31 0.17 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.464 HD11 ' HB1' ' B' ' 108' ' ' ALA . 0.0 OUTLIER -133.65 85.85 2.24 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 178.69 138.9 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.265 1.426 . . . . 0.0 109.279 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -83.12 109.98 20.65 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 165.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.563 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 18.2 Cg_endo -57.4 119.32 6.51 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.606 2.204 . . . . 0.0 110.796 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.78 154.2 48.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.377 0.671 . . . . 0.0 110.412 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.459 ' HZ1' ' HB3' ' B' ' 98' ' ' LYS . 3.7 mmmp? -68.47 118.94 12.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 54.2 ttm -115.59 166.04 12.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.11 0.964 . . . . 0.0 109.126 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.02 -39.91 28.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.445 1.498 . . . . 0.0 113.349 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.99 -19.06 27.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.537 0.335 . . . . 0.0 111.485 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.33 173.94 27.39 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.987 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.591 ' HB3' ' HB1' ' B' ' 119' ' ' ALA . 45.4 t80 -70.72 102.08 2.23 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 150.11 27.14 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.521 0.677 . . . . 0.0 112.081 -162.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 16.4 t80 -150.42 146.49 26.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.182 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 20.1 m -143.69 128.27 18.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' B' ' 105' ' ' PHE . . . -121.13 149.03 43.39 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.28 0.632 . . . . 0.0 110.995 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . 0.464 ' HB1' HD11 ' B' ' 93' ' ' LEU . . . -108.35 165.01 11.82 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.514 ' HA ' ' H ' ' B' ' 91' ' ' ALA . 1.9 p-10 -130.49 -177.63 0.7 Allowed Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.003 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 45.5 Cg_endo -63.8 -0.92 2.91 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.447 2.098 . . . . 0.0 114.773 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' B' ' 11' ' ' VAL . 3.1 t70 -115.98 0.14 12.96 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.093 0.557 . . . . 0.0 111.78 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.9 m 69.41 34.29 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.603 1.161 . . . . 0.0 112.725 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -75.18 171.34 14.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.602 0.761 . . . . 0.0 110.301 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.51 108.31 13.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -121.07 108.18 13.52 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.48 ' NH1' ' HG3' ' B' ' 67' ' ' GLU . 55.5 mtt180 -90.57 147.72 23.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.033 0.533 . . . . 0.0 111.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.99 132.81 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -135.85 161.95 34.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.549 0.613 . . . . 0.0 111.658 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' B' ' 103' ' ' TYR . . . -110.99 123.71 50.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -79.17 104.59 9.9 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.52 99.25 8.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.107 -175.485 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 78.6 Cg_endo -81.77 72.08 6.45 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.493 2.129 . . . . 0.0 111.253 166.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.2 p-10 -80.43 9.88 5.35 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.404 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -134.56 134.32 41.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 107.717 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -138.2 139.58 39.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.237 1.015 . . . . 0.0 108.786 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.609 HG12 ' HA3' ' A' ' 48' ' ' GLY . 49.5 mt -128.03 143.03 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.134 0.573 . . . . 0.0 110.173 -172.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.418 HD22 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -108.63 144.95 35.69 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 32.1 m-85 -93.57 123.5 36.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.199 1.0 . . . . 0.0 111.207 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.89 161.02 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.188 0.995 . . . . 0.0 110.409 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.89 -63.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.132 0.973 . . . . 0.0 110.759 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -97.14 100.14 7.21 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.075 0.55 . . . . 0.0 110.154 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.446 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 35.1 Cg_exo -55.56 -51.63 9.44 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.296 2.664 . . . . 0.0 115.033 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.77 -51.62 10.76 Favored 'Trans proline' 0 C--N 1.405 3.525 0 CA-C-N 122.646 1.981 . . . . 0.0 112.48 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.92 -39.94 69.14 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 p -77.83 -34.85 51.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.817 0.447 . . . . 0.0 110.515 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 70.9 m -62.39 -47.78 82.63 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.521 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.3 mm100 -62.69 -35.51 79.92 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.125 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -64.89 -45.82 84.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.8 0.688 . . . . 0.0 109.415 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 20.5 m-85 -68.03 -32.89 73.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.279 -0.391 . . . . 0.0 109.997 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 63.2 mtpt -57.31 -47.89 80.35 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.34 -34.27 48.63 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.298 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.8 tp -60.21 -31.35 70.08 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.865 1.266 . . . . 0.0 112.473 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 HD21 ' HG3' ' B' ' 4' ' ' PRO . 26.1 mt -99.95 -48.56 4.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.16 28.63 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.995 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.01 -178.34 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.613 1.165 . . . . 0.0 110.747 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -130.76 142.93 47.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 124.342 1.057 . . . . 0.0 108.762 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 34.1 Cg_endo -63.93 119.94 7.16 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.602 2.201 . . . . 0.0 112.449 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.999 0.92 . . . . 0.0 110.455 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 57.9 mm-40 -116.23 90.04 3.24 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.3 p -90.04 149.48 22.5 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.894 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -151.76 151.48 28.46 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 125.037 1.335 . . . . 0.0 107.627 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.78 -20.1 68.09 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.451 2.101 . . . . 0.0 113.607 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -128.38 12.36 6.47 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.9 152.79 28.71 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -143.86 138.58 28.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 12.7 tp -126.42 115.72 20.05 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.3 p90 -131.21 112.89 13.21 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.922 1.289 . . . . 0.0 109.16 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.596 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 3.8 p -106.71 142.28 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.24 1.016 . . . . 0.0 110.079 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.16 157.25 17.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.622 0.769 . . . . 0.0 111.134 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -22.61 65.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.479 1.112 . . . . 0.0 112.593 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -70.19 -18.6 63.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.258 0.623 . . . . 0.0 112.032 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.48 15.82 16.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.445 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -103.23 154.03 19.76 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.017 0.909 . . . . 0.0 108.697 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.596 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.2 tttt -125.3 131.02 53.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.418 HD21 HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -128.54 127.66 42.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.346 0.659 . . . . 0.0 109.883 -168.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.609 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -104.81 169.78 17.29 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.54 104.79 4.26 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.419 ' HB2' HG21 ' A' ' 8' ' ' ILE . 4.5 t90 -106.75 127.48 53.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 27.9 m -72.96 129.95 39.27 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.244 0.34 . . . . 0.0 110.126 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -68.34 -10.94 58.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.687 0.795 . . . . 0.0 112.493 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -81.95 -23.47 36.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -116.93 7.83 13.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.269 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.68 140.53 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 122.712 0.405 . . . . 0.0 111.508 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HB3' HE22 ' B' ' 94' ' ' GLN . 70.7 mt-10 -125.56 114.6 25.18 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 170.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HG2' ' CZ ' ' B' ' 114' ' ' ARG . 59.0 Cg_endo -78.14 141.51 66.06 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 124.491 -1.046 . . . . 0.0 113.194 4.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -49.43 123.0 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.252 1.421 . . . . 0.0 112.452 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB2' ' NH2' ' B' ' 114' ' ' ARG . . . -155.57 109.18 2.79 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.318 1.047 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.8 p -85.08 87.08 7.34 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.0 124.19 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.7 p -151.51 122.34 7.55 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.302 1.441 . . . . 0.0 107.78 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.71 52.55 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.06 -132.18 10.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.89 -62.98 4.35 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.35 154.38 18.99 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 168.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 2.4 pt-20 -130.06 166.18 20.68 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.011 0.924 . . . . 0.0 110.27 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.2 tp -125.46 102.39 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.829 0.852 . . . . 0.0 109.457 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.822 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -92.48 110.72 22.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -169.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 12.3 m-85 -88.99 116.86 27.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.435 1.094 . . . . 0.0 108.419 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -95.21 130.7 41.85 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.87 162.74 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.345 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.526 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.9 pt-20 -66.12 -43.44 87.14 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.472 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.446 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 8.9 p30 -160.44 179.62 8.47 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.584 0.629 . . . . 0.0 112.568 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.79 -30.67 63.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -168.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.5 -52.56 64.01 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.786 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.526 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 81.0 mm-40 -65.76 -22.78 66.61 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.736 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.25 -46.09 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.465 0.65 . . . . 0.0 109.73 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.89 -28.54 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 110.676 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 35.8 mt-10 -65.06 -48.2 74.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.234 0.613 . . . . 0.0 110.013 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.8 m -68.31 -30.1 69.01 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -55.62 -58.72 6.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.96 0.904 . . . . 0.0 109.98 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.47 -35.53 80.49 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.493 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.09 -42.62 96.51 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 123.645 0.591 . . . . 0.0 113.588 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -66.6 -39.73 88.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.058 0.543 . . . . 0.0 110.233 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.509 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 32.7 ttpt -57.51 -44.84 85.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.474 0.71 . . . . 0.0 110.262 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.33 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 t -99.64 9.91 42.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.211 1.004 . . . . 0.0 112.378 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 55.57 2.77 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 165.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.5 p -102.79 148.71 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 168.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -57.15 5.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.552 0.341 . . . . 0.0 110.459 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.533 ' HB2' HG13 ' A' ' 90' ' ' VAL . 21.1 ttp 64.23 82.51 0.18 Allowed 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.225 0.953 . . . . 0.0 113.104 168.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.81 85.94 2.24 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 106' ' ' THR . 46.9 tp60 179.57 133.17 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.761 1.224 . . . . 0.0 108.954 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -83.45 122.47 77.01 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.254 0.622 . . . . 0.0 109.413 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 106.62 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.533 2.155 . . . . 0.0 110.835 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 152.36 50.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.089 0.556 . . . . 0.0 111.312 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -70.4 102.17 2.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.217 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.3 ttm -94.8 169.2 10.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.357 1.063 . . . . 0.0 109.193 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -43.64 -41.5 4.7 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.139 1.376 . . . . 0.0 113.568 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -87.96 -15.29 36.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.575 0.75 . . . . 0.0 111.907 -172.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.16 -170.83 25.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.969 -0.35 . . . . 0.0 112.59 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -76.71 101.69 5.89 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -108.07 149.38 28.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 110.344 -171.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.4 t80 -144.4 147.91 33.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.746 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 4.8 m -140.6 136.75 33.08 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.151 0.432 . . . . 0.0 110.924 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.38 172.78 6.64 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.837 0.855 . . . . 0.0 110.967 171.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.29 113.26 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.02 169.05 20.72 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.422 0.689 . . . . 0.0 110.016 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.5 -33.88 31.72 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.268 2.645 . . . . 0.0 114.59 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.0 12.0 23.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.08 0.552 . . . . 0.0 111.207 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 59.5 72.63 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 112.874 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -126.59 172.24 10.43 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.59 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 65.5 mmt-85 -102.52 104.87 15.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.81 102.59 14.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.824 HH22 HG21 ' B' ' 55' ' ' VAL . 15.3 mmt180 -88.04 147.52 24.94 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 123.578 0.751 . . . . 0.0 110.389 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 15.4 t -137.99 127.29 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 161.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -141.01 158.56 43.77 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.02 111.06 17.84 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -73.0 120.93 19.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.788 0.435 . . . . 0.0 109.831 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.511 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.423 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 63.0 Cg_endo -82.99 71.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.622 2.214 . . . . 0.0 110.819 167.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.02 9.48 4.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.791 0.836 . . . . 0.0 111.27 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -134.51 134.29 41.29 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.097 1.359 . . . . 0.0 107.677 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -138.38 139.66 39.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.461 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 16.8 mt -128.74 143.35 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.081 0.553 . . . . 0.0 110.103 -172.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -110.01 144.06 39.11 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -91.87 123.94 35.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.12 0.968 . . . . 0.0 111.142 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.406 HG13 ' HE1' ' B' ' 113' ' ' HIS . 20.5 m -125.3 160.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 123.956 0.902 . . . . 0.0 110.308 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.75 -63.89 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.129 0.971 . . . . 0.0 111.154 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -96.12 98.42 4.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 123.625 0.77 . . . . 0.0 109.682 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -53.8 -52.72 7.82 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.854 2.37 . . . . 0.0 115.842 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.24 -52.64 8.54 Favored 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 123.162 2.165 . . . . 0.0 112.7 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.37 -40.08 70.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.482 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 75.8 p -77.49 -34.91 54.11 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.743 0.417 . . . . 0.0 110.765 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.5 m -63.04 -46.88 85.44 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.515 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 13.8 mm100 -63.54 -35.18 79.64 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.809 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 66.1 t80 -64.88 -45.52 85.64 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.776 0.672 . . . . 0.0 109.42 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.404 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 30.3 m-85 -68.29 -32.79 73.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.225 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.515 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 62.7 mtpt -57.11 -48.03 79.64 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.3 -34.31 48.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 20.8 tp -60.25 -30.99 69.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.595 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' A' ' 4' ' ' PRO . 25.1 mt -100.47 -48.31 4.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.7 4.88 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.953 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.447 HG13 HD23 ' B' ' 41' ' ' LEU . 24.2 m -129.62 -178.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.648 1.179 . . . . 0.0 111.064 -174.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -130.41 144.81 54.82 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.816 0.847 . . . . 0.0 109.231 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 18.4 Cg_exo -65.86 120.64 7.85 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.411 2.074 . . . . 0.0 112.21 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.438 HG11 ' HG2' ' B' ' 31' ' ' GLU . 8.9 p -64.55 -42.32 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.159 0.984 . . . . 0.0 110.802 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 50.3 mm-40 -119.17 89.13 3.07 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -90.1 149.74 22.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -151.81 151.31 28.05 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.1 -20.29 70.88 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.422 2.081 . . . . 0.0 113.683 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -128.2 11.44 6.45 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.043 0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -155.6 153.01 29.43 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -143.93 138.45 28.52 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.599 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 12.9 tp -126.42 115.94 20.38 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.4 p90 -131.11 113.24 13.66 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.961 1.304 . . . . 0.0 109.215 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.627 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 4.3 p -107.1 141.94 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.267 1.027 . . . . 0.0 110.033 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.447 HD23 HG13 ' B' ' 27' ' ' VAL . 13.7 mt -105.5 157.27 17.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.529 0.732 . . . . 0.0 110.382 -169.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -21.72 64.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.381 1.072 . . . . 0.0 112.332 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.04 -18.38 62.57 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.99 0.516 . . . . 0.0 111.23 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.42 16.09 15.58 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 114.484 0.554 . . . . 0.0 114.484 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.478 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.2 ppp? -104.2 153.43 20.98 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.104 0.952 . . . . 0.0 108.607 170.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.627 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 53.6 tttt -124.69 130.97 53.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.92 127.96 44.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.31 0.644 . . . . 0.0 110.063 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.27 169.67 17.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 123.821 0.724 . . . . 0.0 111.293 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.66 104.51 4.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.443 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -106.7 126.85 52.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -72.75 129.6 38.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.66 -11.1 57.5 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.013 0.925 . . . . 0.0 112.38 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.02 -24.09 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.01 0.524 . . . . 0.0 111.141 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -116.62 8.66 13.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.282 0.633 . . . . 0.0 111.324 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.824 HG21 HH22 ' A' ' 116' ' ' ARG . 7.1 p -68.15 140.1 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.793 0.437 . . . . 0.0 111.382 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -124.84 114.0 26.78 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.5 141.49 64.83 Favored 'Cis proline' 0 C--N 1.381 2.287 0 C-N-CA 124.439 -1.067 . . . . 0.0 113.147 5.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.449 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.0 mmmt -49.55 123.14 7.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.144 1.378 . . . . 0.0 112.34 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.98 108.55 2.63 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.114 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.9 p -84.44 87.1 7.21 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.75 124.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.368 0.667 . . . . 0.0 110.482 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -152.51 121.87 6.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.997 1.319 . . . . 0.0 107.776 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.04 0.01 OUTLIER Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.48 -132.47 10.94 Favored Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.15 4.34 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.01 153.71 18.56 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.478 ' CG ' ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -128.61 168.13 16.18 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 110.542 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 tp -126.25 102.15 7.06 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.93 0.892 . . . . 0.0 109.437 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.747 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -92.57 111.32 22.87 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.756 0.312 . . . . 0.0 111.725 -169.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m-85 -89.37 116.96 27.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.47 1.108 . . . . 0.0 108.337 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -96.05 128.28 42.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.448 0.642 . . . . 0.0 111.566 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.78 164.14 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.646 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.519 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.28 -43.25 86.91 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.382 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -160.65 178.19 9.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.99 -32.02 52.78 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.197 1.799 . . . . 0.0 113.076 -170.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -61.32 -52.92 62.68 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.884 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.519 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 61.2 mm-40 -64.97 -23.1 67.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.763 1.225 . . . . 0.0 112.618 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.81 -45.84 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.386 0.613 . . . . 0.0 109.764 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.17 57.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.96 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.9 mt-10 -64.53 -48.72 74.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.208 0.603 . . . . 0.0 109.74 174.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -68.48 -29.58 68.24 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.891 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.76 -58.95 5.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.22 1.008 . . . . 0.0 109.666 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.459 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.67 -35.47 80.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.484 -174.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.46 96.9 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 123.337 0.398 . . . . 0.0 113.487 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -66.87 -39.39 87.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.989 0.516 . . . . 0.0 110.092 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.528 ' HB2' ' HE2' ' B' ' 92' ' ' MET . 33.0 ttpt -57.88 -44.74 86.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.644 0.778 . . . . 0.0 110.478 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.7 67.39 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.792 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.8 t -99.91 9.79 42.38 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.097 0.959 . . . . 0.0 112.333 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.25 55.27 2.79 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 165.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.7 p -103.11 148.68 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.1 -56.88 6.36 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.57 0.348 . . . . 0.0 110.413 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.528 ' HE2' ' HB2' ' B' ' 86' ' ' LYS . 19.5 ttp 64.07 82.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 85.82 2.23 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.747 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' B' ' 106' ' ' THR . 5.8 tp60 -179.42 133.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.916 1.286 . . . . 0.0 108.836 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -82.79 122.48 78.26 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.607 0.763 . . . . 0.0 109.355 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 19.0 Cg_endo -59.47 106.66 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.566 2.177 . . . . 0.0 110.181 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.3 152.47 50.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.287 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -71.52 102.67 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.75 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.8 ttm -94.67 169.13 10.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.635 1.174 . . . . 0.0 109.321 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -43.61 -41.87 4.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.487 1.515 . . . . 0.0 112.864 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.04 -14.93 37.7 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.632 0.773 . . . . 0.0 112.027 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.98 -171.05 25.06 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.988 -0.34 . . . . 0.0 112.553 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -76.33 101.42 5.49 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -107.86 149.46 28.24 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.583 0.706 . . . . 0.0 110.331 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 1.9 t80 -144.59 148.29 34.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.701 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 17.1 m -141.33 136.5 31.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.122 0.487 . . . . 0.0 110.474 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.39 172.88 6.58 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.957 0.903 . . . . 0.0 110.838 171.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.5 112.52 10.33 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.452 ' HB3' HD13 ' B' ' 115' ' ' LEU . 6.6 p-10 -72.9 167.57 32.7 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -48.34 -33.85 23.51 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.394 2.729 . . . . 0.0 114.864 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -92.24 12.22 23.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.123 0.569 . . . . 0.0 111.134 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 m 59.06 72.15 0.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.064 1.345 . . . . 0.0 112.738 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.406 ' HE1' HG13 ' B' ' 11' ' ' VAL . 8.6 m80 -125.64 171.58 10.47 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.556 ' NH2' ' HB2' ' A' ' 59' ' ' ALA . 17.2 mmt180 -101.17 105.04 16.13 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' B' ' 109' ' ' ASP . 39.0 mt -97.2 103.04 14.94 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 23.9 ttt180 -87.66 147.43 25.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.5 0.72 . . . . 0.0 110.404 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -137.86 127.22 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 160.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -141.22 158.69 43.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.65 110.8 17.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.74 123.39 23.22 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.86 100.79 13.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.965 0.506 . . . . 0.0 109.961 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.78 -1.011 . . . . 0.0 111.156 179.02 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 98.6 Cg_endo -86.38 143.39 7.57 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.213 1.942 . . . . 0.0 112.037 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.647 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 36.0 t70 -143.61 19.37 1.85 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.659 1.219 . . . . 0.0 109.009 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.73 148.09 35.16 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.653 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.458 HG23 HD22 ' A' ' 47' ' ' LEU . 3.8 t -151.72 139.21 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.869 0.868 . . . . 0.0 108.691 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.525 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 68.1 mt -123.71 137.7 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.577 0.751 . . . . 0.0 109.904 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.66 130.23 45.87 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' O ' HG22 ' A' ' 62' ' ' THR . 28.0 m-85 -80.42 115.19 19.82 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.27 0.628 . . . . 0.0 109.629 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 113' ' ' HIS . 32.9 m -114.09 160.78 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.772 0.829 . . . . 0.0 109.241 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -97.08 -59.3 1.82 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.147 0.579 . . . . 0.0 110.497 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -98.48 100.77 9.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.305 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.28 -51.97 10.05 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.441 2.761 . . . . 0.0 115.523 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.21 -50.21 9.13 Favored 'Trans proline' 0 C--N 1.398 3.158 0 CA-C-N 122.136 1.798 . . . . 0.0 112.561 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.29 62.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.6 p -76.83 -36.21 57.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.479 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 95.2 m -64.51 -43.84 92.78 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 36.9 mt-30 -64.99 -35.11 80.12 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.205 174.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.3 t80 -66.15 -42.82 88.54 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 123.776 0.673 . . . . 0.0 109.552 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 34.1 m-85 -70.04 -28.39 65.43 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.789 -0.625 . . . . 0.0 109.873 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 60.6 mtpt -57.0 -50.61 72.18 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 118.789 0.722 . . . . 0.0 111.822 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.45 60.84 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.253 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 19.1 tp -61.79 -42.56 99.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.744 1.217 . . . . 0.0 112.388 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HB2' HG21 ' A' ' 27' ' ' VAL . 18.4 mt -90.15 -43.01 10.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.67 28.62 6.95 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.2 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 25' ' ' LEU . 29.4 m -131.64 173.87 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.929 0.892 . . . . 0.0 110.224 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -124.84 150.22 65.22 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.965 0.906 . . . . 0.0 109.213 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.93 118.14 5.4 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.013 2.475 . . . . 0.0 112.267 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.8 -40.04 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.717 0.636 . . . . 0.0 110.298 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 36.3 mm-40 -117.92 146.7 43.76 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.326 1.05 . . . . 0.0 109.196 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.4 p -143.8 135.37 26.1 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -145.26 157.4 53.22 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.876 1.271 . . . . 0.0 108.772 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.12 -28.99 35.19 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 123.468 2.779 . . . . 0.0 113.999 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 5.19 7.98 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.57 130.23 12.31 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.833 -0.542 . . . . 0.0 111.194 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -117.62 130.89 56.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 7.1 tt -121.93 132.39 54.52 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.26 150.63 46.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.82 1.248 . . . . 0.0 108.687 167.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 2.0 p -130.46 132.64 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.59 155.89 20.27 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.368 0.667 . . . . 0.0 110.767 -165.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.15 -16.98 64.22 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.642 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -74.41 -15.38 60.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.132 0.973 . . . . 0.0 111.363 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.8 -19.88 30.04 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.896 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.7 ppp? -81.36 168.45 18.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.376 0.588 . . . . 0.0 109.929 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.542 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.6 tttt -133.83 140.2 46.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.502 0.321 . . . . 0.0 110.924 -169.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.458 HD22 HG23 ' A' ' 7' ' ' THR . 55.0 mt -131.39 126.38 35.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.866 0.867 . . . . 0.0 111.898 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.437 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -102.79 167.9 17.78 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 174.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.54 108.41 6.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.416 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.1 t90 -104.81 118.53 36.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 25.2 p -75.85 127.7 33.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.189 0.518 . . . . 0.0 109.842 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' HD3' HG21 ' A' ' 62' ' ' THR . 40.3 ptt180 -74.43 -2.44 25.48 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.827 1.251 . . . . 0.0 114.015 -165.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -69.84 -18.63 63.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.835 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -148.03 21.76 1.1 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.857 0.463 . . . . 0.0 110.774 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.7 p -59.37 147.2 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.806 0.442 . . . . 0.0 111.313 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HB2' ' HE2' ' B' ' 99' ' ' MET . 50.2 mt-10 -124.84 113.51 26.87 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.536 0.734 . . . . 0.0 109.117 175.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.547 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 1.2 Cg_endo -78.19 143.96 74.31 Favored 'Cis proline' 0 C--N 1.38 2.232 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.406 5.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -54.69 119.6 5.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.034 0.934 . . . . 0.0 111.674 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.73 4.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.191 0.996 . . . . 0.0 109.441 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.7 m -91.48 82.86 5.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 m -155.4 131.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.012 1.325 . . . . 0.0 108.424 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.485 HG21 ' HD3' ' A' ' 52' ' ' ARG . 15.0 p -145.44 122.28 11.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.311 1.044 . . . . 0.0 108.634 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.72 -95.51 0.14 Allowed Glycine 0 C--N 1.349 1.305 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.639 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.95 -154.12 30.11 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.81 -48.09 3.81 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.29 132.48 3.75 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HG2' ' HB ' ' B' ' 8' ' ' ILE . 15.8 pt-20 -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.08 0.952 . . . . 0.0 110.971 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.13 105.6 13.11 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.727 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -91.72 115.17 27.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.659 0.663 . . . . 0.0 112.546 -169.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.7 m-85 -96.44 115.75 27.94 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.728 1.211 . . . . 0.0 108.334 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' ' CE1' ' A' ' 118' ' ' TYR . 42.0 mtm180 -96.51 131.06 43.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.556 0.693 . . . . 0.0 111.494 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -125.45 165.98 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.186 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.1 pt-20 -65.45 -41.56 93.29 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.395 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.44 -178.68 3.63 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.218 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -58.99 -30.31 67.87 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.222 1.409 . . . . 0.0 112.887 -165.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.57 87.63 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.119 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.544 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 77.4 mm-40 -67.39 -22.33 65.56 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.646 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.78 -44.89 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.16 -32.17 68.6 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.497 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.98 -42.14 81.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.722 0.772 . . . . 0.0 110.197 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.6 m -72.36 -28.12 62.83 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.702 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -58.72 -61.75 2.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.839 0.856 . . . . 0.0 109.682 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.89 67.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.632 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.87 -51.57 56.32 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.877 0.736 . . . . 0.0 113.012 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -63.74 -40.46 96.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.082 0.553 . . . . 0.0 110.099 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -56.15 -45.78 79.51 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.412 0.625 . . . . 0.0 110.828 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.34 -20.17 60.19 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.166 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.2 t -98.64 10.3 41.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.061 0.944 . . . . 0.0 112.14 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.55 5.82 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 168.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.89 153.56 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.51 2.75 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.829 0.452 . . . . 0.0 110.373 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 11.3 ttp 67.47 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.973 0.795 . . . . 0.0 112.859 171.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.32 85.13 2.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.194 0.521 . . . . 0.0 110.617 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 106' ' ' THR . 51.3 tp60 179.85 131.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.338 . . . . 0.0 109.145 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.59 117.79 69.21 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.65 105.19 0.1 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.397 2.732 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.9 148.93 25.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 110.815 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -90.46 99.02 12.12 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.469 ' HE1' ' HB2' ' B' ' 56' ' ' GLU . 64.7 mtt -102.95 -174.65 2.6 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.42 0.688 . . . . 0.0 111.885 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -55.91 -39.84 72.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.07 1.348 . . . . 0.0 112.766 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 89.9 m-85 -88.63 -4.83 58.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.279 0.632 . . . . 0.0 111.614 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.86 -160.22 21.74 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.731 -0.483 . . . . 0.0 113.413 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -80.26 100.47 8.36 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -109.18 153.59 23.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.596 0.758 . . . . 0.0 111.026 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.8 t80 -149.4 145.03 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.728 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.503 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 12.3 m -137.94 128.93 27.25 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.322 0.51 . . . . 0.0 109.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.89 174.63 5.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.997 0.919 . . . . 0.0 110.589 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.08 119.3 12.08 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.572 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.8 p-10 -73.87 -175.13 0.39 Allowed Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.588 0.755 . . . . 0.0 111.316 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 11.5 Cg_exo -38.91 -48.47 2.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.589 2.859 . . . . 0.0 114.846 165.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 62' ' ' THR . 57.9 m-20 -89.73 3.92 51.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.393 0.677 . . . . 0.0 111.321 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.2 m 71.96 16.16 5.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 113.654 161.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.441 ' CE1' HG11 ' A' ' 11' ' ' VAL . 15.9 m80 -59.11 137.35 57.99 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -70.98 99.61 1.82 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.36 102.26 14.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.727 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 14.2 tpt180 -87.71 142.45 27.82 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.403 1.081 . . . . 0.0 110.664 -170.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 39.0 t -138.73 128.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.439 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.0 p90 -135.39 158.59 43.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.545 0.611 . . . . 0.0 111.931 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 113.04 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 34.8 t80 -78.43 114.91 17.76 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 O-C-N 124.199 0.937 . . . . 0.0 109.914 179.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 90.0 Cg_endo -86.72 141.84 6.59 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.342 2.028 . . . . 0.0 112.37 170.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.688 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 22.2 t70 -141.77 20.31 2.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.557 1.17 . . . . 0.0 109.221 171.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -143.47 148.0 35.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.751 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.435 HG21 HD22 ' B' ' 47' ' ' LEU . 3.7 t -151.83 139.3 19.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.541 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 46.8 mt -123.74 137.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.641 0.776 . . . . 0.0 109.879 -170.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.4 130.41 45.67 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.415 ' O ' HG22 ' B' ' 62' ' ' THR . 27.1 m-85 -80.44 115.6 20.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.604 172.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' B' ' 113' ' ' HIS . 32.7 m -114.43 160.72 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.705 0.802 . . . . 0.0 109.274 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.29 -58.56 1.98 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.712 0.405 . . . . 0.0 110.737 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -98.6 100.66 9.86 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.118 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.66 -52.18 9.57 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.319 2.679 . . . . 0.0 115.378 -172.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 25.4 Cg_endo -58.76 -50.73 8.49 Favored 'Trans proline' 0 C--N 1.398 3.139 0 CA-C-N 122.132 1.797 . . . . 0.0 112.532 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -37.66 64.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.635 -166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.5 p -76.51 -36.23 57.87 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.62 0.575 . . . . 0.0 109.453 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 96.9 m -65.04 -43.41 92.43 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' B' ' 15' ' ' PRO . 45.7 mt-30 -65.19 -35.34 80.77 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.793 174.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 75.5 t80 -65.81 -43.01 89.93 Favored 'General case' 0 C--N 1.347 0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.446 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 32.3 m-85 -69.81 -28.62 65.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.788 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' B' ' 18' ' ' THR . 57.3 mtpt -57.16 -50.52 72.58 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.794 0.724 . . . . 0.0 112.112 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.58 61.8 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.536 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 19.0 tp -61.54 -42.69 99.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.599 1.159 . . . . 0.0 112.581 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' B' ' 27' ' ' VAL . 18.9 mt -90.24 -42.56 10.94 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.97 29.31 6.91 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.899 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' B' ' 25' ' ' LEU . 28.2 m -131.42 174.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 124.097 0.959 . . . . 0.0 110.568 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -124.75 150.61 66.13 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.73 0.812 . . . . 0.0 109.155 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.16 118.92 5.96 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.49 2.127 . . . . 0.0 112.661 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.44 -40.05 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.27 0.628 . . . . 0.0 110.381 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 31.1 mm-40 -118.0 147.34 43.29 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.159 0.983 . . . . 0.0 108.666 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.3 p -144.27 135.38 25.36 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 57.1 m -145.02 156.41 55.01 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.106 1.362 . . . . 0.0 108.66 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.15 -30.17 24.63 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 124.039 3.159 . . . . 0.0 114.353 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -125.21 5.77 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -151.75 129.9 11.91 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.455 0.571 . . . . 0.0 111.086 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 42.6 m -117.21 130.73 56.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 39.9 tp -121.54 131.92 54.41 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.465 0.706 . . . . 0.0 109.608 -176.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.92 150.79 47.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.617 1.167 . . . . 0.0 108.455 167.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.484 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 2.7 p -130.29 133.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 41.2 mt -86.49 155.73 20.4 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.923 -165.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -16.76 64.33 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.667 0.787 . . . . 0.0 111.342 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -14.53 60.31 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.709 0.804 . . . . 0.0 111.086 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.65 -19.78 30.53 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-O 119.753 -0.471 . . . . 0.0 113.874 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.647 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.8 ppp? -81.35 168.13 18.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.416 0.608 . . . . 0.0 110.061 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.484 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 78.3 tttt -133.96 140.29 46.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.488 0.315 . . . . 0.0 110.997 -169.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.435 HD22 HG21 ' B' ' 7' ' ' THR . 46.3 mt -131.47 126.25 34.54 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.843 0.857 . . . . 0.0 111.88 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.64 167.77 17.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -137.63 108.41 6.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.413 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 5.1 t90 -104.9 118.4 36.43 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 55.3 p -75.18 127.69 33.76 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.182 0.515 . . . . 0.0 110.084 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.494 ' HD3' HG21 ' B' ' 62' ' ' THR . 35.3 ptt180 -74.81 -2.97 29.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.688 1.195 . . . . 0.0 113.982 -165.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -19.45 64.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.618 0.767 . . . . 0.0 111.928 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -147.86 21.79 1.12 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.896 0.478 . . . . 0.0 110.625 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -59.57 146.98 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.757 0.423 . . . . 0.0 111.098 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 99' ' ' MET . 42.5 mt-10 -123.98 115.1 27.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 174.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.72 143.33 75.59 Favored 'Cis proline' 0 C--N 1.387 2.564 0 C-N-CA 124.462 -1.057 . . . . 0.0 112.955 2.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -53.22 119.32 4.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.972 0.909 . . . . 0.0 112.173 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.32 108.54 4.79 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.075 0.95 . . . . 0.0 109.147 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.2 m -91.13 82.87 5.52 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.4 131.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.892 1.277 . . . . 0.0 108.425 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.494 HG21 ' HD3' ' B' ' 52' ' ' ARG . 17.2 p -145.41 121.89 11.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.269 1.028 . . . . 0.0 108.526 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.07 -95.51 0.14 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 112.592 -0.203 . . . . 0.0 112.592 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.03 -154.14 30.19 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.9 -48.15 3.82 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.19 132.11 3.64 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.525 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 pt-20 -106.63 166.65 10.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.935 0.894 . . . . 0.0 110.853 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 tp -115.48 104.87 12.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.507 0.723 . . . . 0.0 109.247 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.773 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.22 115.62 28.17 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.611 0.641 . . . . 0.0 112.243 -168.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 7.8 m-85 -96.61 115.84 28.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.886 1.274 . . . . 0.0 108.368 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -96.48 128.59 43.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.273 0.629 . . . . 0.0 111.146 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.79 167.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.627 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.591 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.47 -40.86 89.59 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -167.75 -179.69 4.39 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.172 0.511 . . . . 0.0 112.362 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.31 -30.74 66.91 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.35 1.46 . . . . 0.0 112.89 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.44 -46.16 87.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.952 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.591 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.9 mm-40 -67.56 -21.98 65.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.904 0.882 . . . . 0.0 112.503 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.81 -43.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.39 -30.62 63.39 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.656 1.182 . . . . 0.0 110.982 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.1 mt-10 -69.17 -42.41 75.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.707 0.765 . . . . 0.0 110.189 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -71.89 -28.32 63.43 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.75 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -58.3 -62.28 1.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 0.0 109.359 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.407 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -69.39 -29.87 67.73 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.541 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.97 53.74 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.02 0.825 . . . . 0.0 113.027 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.7 -40.5 96.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.118 0.567 . . . . 0.0 110.073 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.8 ttpt -56.34 -45.25 80.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.637 . . . . 0.0 110.656 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 -20.82 60.01 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.172 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -98.36 10.85 39.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.125 0.97 . . . . 0.0 112.516 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.62 42.87 5.96 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.61 153.32 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.13 -59.64 2.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.812 0.445 . . . . 0.0 110.363 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 30.9 ttm 67.37 84.97 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.866 0.729 . . . . 0.0 112.377 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.27 84.2 1.93 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.126 0.489 . . . . 0.0 110.645 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 55.6 tp60 -178.74 132.23 0.13 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.649 1.18 . . . . 0.0 108.833 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -86.36 118.02 69.64 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 9.8 Cg_endo -52.66 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.547 2.831 . . . . 0.0 112.106 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.28 148.86 25.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.125 0.97 . . . . 0.0 110.772 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.575 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 0.0 OUTLIER -89.81 99.36 12.38 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.51 ' HE2' ' HB2' ' A' ' 56' ' ' GLU . 66.1 mtt -103.05 -173.56 2.34 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.288 0.635 . . . . 0.0 111.745 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -57.24 -39.49 75.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.052 1.341 . . . . 0.0 112.548 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 78.7 m-85 -88.76 -5.13 58.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.511 0.725 . . . . 0.0 111.399 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.67 -160.19 21.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.302 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.575 ' HB2' ' HZ1' ' B' ' 98' ' ' LYS . 17.2 t80 -80.64 100.8 8.85 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.453 HG22 ' SD ' ' B' ' 99' ' ' MET . 12.0 t -109.45 153.99 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.838 -170.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 14.3 t80 -149.41 145.43 26.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.543 -177.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 9.4 m -138.25 129.08 26.81 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.04 174.48 5.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 110.822 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.83 120.43 13.29 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.6 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.7 p-10 -75.54 -174.29 0.38 Allowed Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.683 0.793 . . . . 0.0 110.953 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.5 Cg_exo -40.34 -48.01 4.18 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.412 2.741 . . . . 0.0 114.519 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.43 ' O ' ' HB ' ' B' ' 62' ' ' THR . 65.0 m-20 -90.1 4.1 51.37 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.356 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 29.0 m 71.67 17.76 5.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.436 ' CE1' HG11 ' B' ' 11' ' ' VAL . 16.3 m80 -60.79 137.71 58.18 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -71.05 99.49 1.83 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.388 0.613 . . . . 0.0 109.439 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.8 mt -96.38 102.85 14.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.773 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 14.0 tpt180 -86.61 142.6 28.14 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.475 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -138.91 128.75 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -135.37 158.82 43.4 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.867 0.758 . . . . 0.0 111.744 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.7 112.57 21.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 84.9 t80 -76.59 108.99 9.97 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.3 101.47 8.95 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m80 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.62 103.77 0.23 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.325 2.683 . . . . 0.0 113.002 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.694 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 9.1 p-10 -97.71 12.49 33.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 166.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.6 129.09 43.94 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.873 -168.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -130.36 137.98 50.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.158 0.983 . . . . 0.0 108.348 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -124.33 141.83 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.2 131.93 55.69 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CE1' HG21 ' A' ' 55' ' ' VAL . 10.1 m-85 -71.7 120.35 17.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.881 0.873 . . . . 0.0 111.616 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' SER . 33.2 m -117.71 161.42 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.01 -54.32 3.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -94.95 103.79 12.77 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.597 0.759 . . . . 0.0 109.586 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.17 -57.67 1.38 Allowed 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.983 2.456 . . . . 0.0 114.493 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 38.5 Cg_exo -57.27 -57.3 1.33 Allowed 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.628 1.974 . . . . 0.0 111.852 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.13 89.52 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.922 -169.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -78.26 -24.45 46.84 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 28.0 m -73.51 -43.4 60.15 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 75.5 mm-40 -68.47 -29.7 68.38 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.557 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -61.24 -50.79 71.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.816 0.697 . . . . 0.0 109.6 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.32 -31.92 71.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.592 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -57.45 -47.92 80.52 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.27 57.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.035 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.5 -36.9 79.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.473 1.109 . . . . 0.0 112.903 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB2' HG21 ' A' ' 27' ' ' VAL . 23.8 mt -98.61 -31.44 11.94 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.168 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.83 31.48 20.79 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 25' ' ' LEU . 22.7 m -123.81 174.66 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.251 1.02 . . . . 0.0 110.599 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.96 143.09 47.57 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.852 0.861 . . . . 0.0 109.306 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.46 132.9 28.51 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.674 2.25 . . . . 0.0 112.828 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG12 ' HG2' ' A' ' 31' ' ' GLU . 7.8 p -71.09 -38.56 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.534 0.734 . . . . 0.0 109.907 171.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 40.3 mm-40 -118.21 134.0 55.4 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 p -141.07 126.15 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.443 0.697 . . . . 0.0 109.23 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -140.17 157.55 68.71 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.759 1.223 . . . . 0.0 109.212 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.25 -24.49 77.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.917 2.412 . . . . 0.0 113.831 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.4 t -127.1 13.49 7.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -155.99 154.34 30.94 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.969 -0.457 . . . . 0.0 110.411 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 t -144.69 157.62 44.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.153 0.981 . . . . 0.0 108.403 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -154.41 118.12 4.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.57 135.97 51.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 109.104 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 HG21 ' HG3' ' A' ' 46' ' ' LYS . 16.1 t -115.87 126.25 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 0.0 108.925 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 45' ' ' MET . 10.3 mp -90.16 152.55 21.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.761 0.424 . . . . 0.0 110.257 -170.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -14.17 61.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.949 0.899 . . . . 0.0 111.699 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.55 -22.42 66.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.28 1.032 . . . . 0.0 111.789 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.66 1.08 40.0 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.818 -0.435 . . . . 0.0 113.343 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.713 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -95.34 169.99 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HG3' HG21 ' A' ' 40' ' ' VAL . 79.3 tttt -133.7 135.9 44.34 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.59 123.99 20.73 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.895 0.478 . . . . 0.0 110.013 -170.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.15 167.75 15.21 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.48 111.81 11.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -103.91 125.03 50.02 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.9 m -79.97 109.54 14.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 28.8 ptt-85 -67.71 -11.29 58.01 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.436 1.094 . . . . 0.0 113.618 -167.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -65.91 -17.83 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.937 0.495 . . . . 0.0 111.31 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -147.88 76.84 1.4 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.959 1.362 . . . . 0.0 109.161 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 10' ' ' TYR . 7.3 p -113.74 152.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.031 174.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.21 112.22 46.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.808 0.843 . . . . 0.0 109.852 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.9 142.0 61.19 Favored 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.157 1.092 . . . . 0.0 112.413 1.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -49.31 111.02 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.036 0.935 . . . . 0.0 111.78 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.98 107.16 4.17 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.12 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.544 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.3 p -113.53 85.6 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.455 0.645 . . . . 0.0 109.508 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.95 129.06 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.996 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -144.39 157.04 44.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.336 1.055 . . . . 0.0 109.007 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 -43.06 0.57 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.05 150.1 22.3 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.47 120.97 4.82 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.28 89.78 0.22 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.77 0.335 . . . . 0.0 112.601 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' CG ' ' HB ' ' B' ' 8' ' ' ILE . 2.9 pt-20 -102.5 164.39 11.69 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.451 0.643 . . . . 0.0 109.926 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.85 101.66 7.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.81 108.92 19.77 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.135 0.493 . . . . 0.0 111.167 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.38 116.21 24.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.277 1.431 . . . . 0.0 109.106 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -95.86 127.17 41.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.369 0.604 . . . . 0.0 112.075 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.29 161.92 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.787 1.235 . . . . 0.0 110.391 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.5 pt-20 -63.95 -38.74 92.21 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -163.85 -179.62 6.43 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 118.405 0.548 . . . . 0.0 112.013 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.4 -32.27 70.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.268 . . . . 0.0 112.595 -166.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.24 -48.17 82.7 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.027 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.418 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.5 mm-40 -65.26 -20.58 66.49 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.632 1.173 . . . . 0.0 112.993 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.6 -43.25 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.375 0.607 . . . . 0.0 109.924 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.66 -31.4 63.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.753 1.221 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 43.4 mt-10 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.122 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -69.62 -32.24 70.83 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.872 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.405 ' O ' ' HE1' ' A' ' 92' ' ' MET . 55.7 t80 -56.14 -57.33 12.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.912 0.885 . . . . 0.0 109.407 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.22 90.84 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.721 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.43 93.92 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 123.849 0.718 . . . . 0.0 114.097 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.87 -44.1 97.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.34 0.656 . . . . 0.0 109.869 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.09 -46.47 79.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.674 0.79 . . . . 0.0 110.42 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.9 -27.32 66.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.842 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.7 t -93.14 -10.61 35.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.801 0.84 . . . . 0.0 112.575 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 58.39 0.95 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 169.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.3 143.61 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.23 65.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.567 0.747 . . . . 0.0 111.48 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 53.3 ttm 65.03 83.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 165.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 83.69 2.0 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.499 0.666 . . . . 0.0 111.068 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 177.81 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.707 1.603 . . . . 0.0 108.652 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -80.15 118.5 72.72 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.416 ' HB2' ' HH ' ' A' ' 103' ' ' TYR . 61.4 Cg_exo -49.85 102.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.926 3.084 . . . . 0.0 112.873 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.99 141.0 41.72 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.941 0.896 . . . . 0.0 110.262 -175.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.504 ' HZ2' ' HB2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER -75.94 100.27 4.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.7 ttm -96.96 162.1 13.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.427 0.691 . . . . 0.0 109.331 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.17 -28.63 68.09 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.001 0.92 . . . . 0.0 112.45 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.7 -24.74 49.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.479 0.712 . . . . 0.0 110.523 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.16 175.93 21.99 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' HB2' ' HZ2' ' A' ' 98' ' ' LYS . 57.1 t80 -74.05 101.01 3.75 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -111.67 147.56 35.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.409 0.623 . . . . 0.0 111.459 -165.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.511 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 5.8 t80 -144.21 144.03 31.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.692 1.197 . . . . 0.0 109.426 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.408 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 12.8 m -133.07 128.11 35.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.06 174.09 6.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.893 0.877 . . . . 0.0 110.033 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.03 122.59 17.36 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.505 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.1 p-10 -71.63 176.23 2.35 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.352 0.661 . . . . 0.0 109.352 172.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 27.8 Cg_endo -59.65 -12.92 19.34 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 122.305 2.004 . . . . 0.0 114.086 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.11 1.08 49.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.165 0.586 . . . . 0.0 111.677 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.3 p 66.3 33.47 7.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.821 1.649 . . . . 0.0 112.816 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -74.33 173.14 10.66 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.5 mmt-85 -108.6 105.01 14.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -99.95 99.92 10.75 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.454 HH21 HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -98.48 96.62 8.12 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.511 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 27.6 t -86.51 119.24 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -139.46 161.04 38.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.53 112.81 18.96 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -69.31 141.1 54.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.612 0.765 . . . . 0.0 110.834 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 123.509 0.723 . . . . 0.0 110.269 179.177 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 m170 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -90.94 104.1 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.315 2.677 . . . . 0.0 112.996 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.713 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.2 p-10 -98.31 13.49 31.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.617 0.723 . . . . 0.0 109.975 166.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -129.27 128.7 43.76 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.887 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -130.35 138.14 50.26 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.47 ' HB ' ' CG ' ' A' ' 67' ' ' GLU . 31.1 mt -125.36 141.88 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.05 133.96 54.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.426 ' CE1' HG23 ' B' ' 55' ' ' VAL . 69.2 m-85 -76.58 120.75 22.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.925 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 51' ' ' SER . 34.1 m -117.68 160.85 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -98.12 -54.85 2.95 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.36 0.264 . . . . 0.0 110.427 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -93.76 103.55 10.47 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.862 0.865 . . . . 0.0 109.345 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.4 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 39.3 Cg_exo -55.86 -58.53 1.04 Allowed 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.253 2.635 . . . . 0.0 114.621 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.469 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 52.6 Cg_exo -56.34 -57.57 1.39 Allowed 'Trans proline' 0 C--N 1.404 3.478 0 CA-C-N 122.751 2.018 . . . . 0.0 112.09 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.92 90.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.794 -168.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.0 m -78.03 -24.99 47.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.357 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 41.8 m -73.08 -42.87 62.54 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 77.3 mm-40 -68.96 -29.52 67.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.571 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.66 -50.62 71.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.905 0.753 . . . . 0.0 109.59 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.674 ' HH ' HD23 ' B' ' 115' ' ' LEU . 32.6 m-85 -67.97 -32.2 72.46 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.772 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.536 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 58.6 mtpt -57.09 -48.19 79.19 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.289 0.566 . . . . 0.0 112.466 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 -35.3 57.3 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.907 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.45 -36.71 78.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.353 1.061 . . . . 0.0 112.928 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.508 ' HB2' HG21 ' B' ' 27' ' ' VAL . 24.0 mt -99.01 -31.03 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.13 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 31.74 21.33 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' B' ' 25' ' ' LEU . 32.8 m -124.71 174.26 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.076 0.95 . . . . 0.0 110.838 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.07 139.1 34.51 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.892 0.877 . . . . 0.0 109.14 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 51.0 Cg_exo -60.84 131.88 39.65 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.291 2.661 . . . . 0.0 114.417 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' B' ' 31' ' ' GLU . 7.6 p -71.34 -36.88 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.794 0.838 . . . . 0.0 110.157 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 38.7 mm-40 -121.31 133.0 55.12 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 53.1 m -141.41 126.12 17.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 67.5 m -140.08 157.05 69.95 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.815 1.246 . . . . 0.0 109.091 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.06 -24.88 75.62 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.115 2.543 . . . . 0.0 114.11 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.1 t -127.34 13.65 7.12 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -156.13 154.39 30.82 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.877 -0.515 . . . . 0.0 110.355 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -144.8 157.04 44.32 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.16 0.984 . . . . 0.0 108.46 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tt -153.96 118.4 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -126.63 135.17 50.85 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.97 1.308 . . . . 0.0 109.161 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.559 HG21 ' HG3' ' B' ' 46' ' ' LYS . 18.6 t -114.5 126.43 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 109.047 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.493 HD22 HG13 ' B' ' 27' ' ' VAL . 16.6 mt -90.35 153.01 20.76 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -170.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.0 -13.73 62.2 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.892 0.877 . . . . 0.0 111.531 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -22.42 66.74 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 111.957 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 1.87 42.08 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.76 -0.467 . . . . 0.0 113.123 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.694 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -95.67 169.89 9.71 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.361 0.581 . . . . 0.0 109.826 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG21 ' B' ' 40' ' ' VAL . 76.3 tttt -133.25 136.56 45.63 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.79 123.91 20.36 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.928 0.491 . . . . 0.0 110.132 -170.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.98 167.85 15.39 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.57 111.53 10.74 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 162.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -103.69 125.41 50.16 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 20.4 m -80.1 109.62 14.73 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.624 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 32.7 ptt-85 -68.6 -10.25 54.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.358 1.063 . . . . 0.0 113.757 -167.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.83 -18.24 65.2 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.488 177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -147.52 77.02 1.42 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.544 1.164 . . . . 0.0 109.098 168.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.426 HG23 ' CE1' ' B' ' 10' ' ' TYR . 7.4 p -113.46 152.27 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.015 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -114.59 112.42 45.73 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.76 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 82.3 Cg_endo -80.19 142.74 62.85 Favored 'Cis proline' 0 C--N 1.386 2.546 0 CA-C-N 119.589 0.889 . . . . 0.0 112.508 1.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -50.42 111.4 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.923 0.889 . . . . 0.0 111.564 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.12 107.42 4.21 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.143 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.624 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 30.5 p -114.33 85.45 2.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.681 0.753 . . . . 0.0 109.474 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.81 130.11 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.089 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -145.67 156.02 43.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.719 1.208 . . . . 0.0 108.814 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.86 -43.47 0.55 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 149.59 21.73 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.19 121.05 4.81 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 76.55 89.81 0.27 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.51 163.4 12.25 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.98 0.912 . . . . 0.0 109.178 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 tp -120.87 101.35 7.64 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 109.63 20.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.359 0.527 . . . . 0.0 111.343 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -87.01 116.35 25.0 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 108.918 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -95.98 126.19 41.05 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.217 0.532 . . . . 0.0 111.499 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.25 162.58 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.533 1.133 . . . . 0.0 110.48 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.548 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.4 pt-20 -64.21 -38.81 92.37 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -163.6 179.81 6.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.329 0.513 . . . . 0.0 112.149 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.88 -32.1 69.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.115 1.366 . . . . 0.0 112.804 -167.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -47.51 85.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.279 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.548 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 84.5 mm-40 -66.48 -19.59 65.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.212 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.49 -44.38 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.39 0.614 . . . . 0.0 109.597 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.82 -33.43 70.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.113 1.365 . . . . 0.0 111.367 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -65.23 -46.88 78.83 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.73 0.776 . . . . 0.0 109.91 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -68.93 -32.28 71.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.924 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.27 -57.55 11.77 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.576 0.75 . . . . 0.0 109.288 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.04 91.29 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.649 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.26 -44.23 94.04 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 123.726 0.641 . . . . 0.0 113.809 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . 0.439 ' HB3' HG11 ' B' ' 90' ' ' VAL . 37.6 m0 -62.89 -44.03 97.19 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.192 0.597 . . . . 0.0 109.902 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.478 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 32.4 ttpt -56.89 -45.96 82.22 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 110.324 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.87 -27.14 66.42 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.904 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.1 t -93.6 -10.31 35.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.855 0.862 . . . . 0.0 112.22 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.12 58.84 0.96 Allowed Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 114.09 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' B' ' 92' ' ' MET . 5.1 p -104.4 144.73 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.48 63.92 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.246 0.618 . . . . 0.0 111.387 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.57 ' HB2' HG12 ' B' ' 90' ' ' VAL . 51.8 ttm 65.31 83.81 0.16 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.953 0.783 . . . . 0.0 113.06 165.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.19 84.09 2.09 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.413 0.625 . . . . 0.0 110.851 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' B' ' 106' ' ' THR . 51.5 tp60 177.22 121.57 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.762 1.625 . . . . 0.0 108.304 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -78.56 119.31 76.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.556 ' HB2' ' HH ' ' B' ' 103' ' ' TYR . 53.1 Cg_exo -50.73 102.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.806 3.004 . . . . 0.0 112.556 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.09 140.52 42.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.0 0.92 . . . . 0.0 110.244 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.546 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -75.81 100.63 4.81 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.495 ' SD ' ' HD2' ' B' ' 101' ' ' PHE . 56.0 ttm -97.05 162.56 13.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.449 0.7 . . . . 0.0 109.356 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.84 -29.58 68.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.122 0.969 . . . . 0.0 112.018 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.495 ' HD2' ' SD ' ' B' ' 99' ' ' MET . 49.2 m-85 -77.29 -25.38 51.27 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.401 0.681 . . . . 0.0 110.369 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.77 176.5 22.97 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.962 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.556 ' HH ' ' HB2' ' B' ' 96' ' ' PRO . 66.8 t80 -74.39 101.48 4.11 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -112.36 147.47 36.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.185 0.517 . . . . 0.0 111.473 -165.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.527 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 6.2 t80 -144.31 143.97 31.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.67 1.188 . . . . 0.0 109.366 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.492 HG21 ' HG3' ' B' ' 114' ' ' ARG . 32.6 m -133.31 127.85 34.49 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.4 0.619 . . . . 0.0 110.276 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.72 174.1 6.03 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.992 0.917 . . . . 0.0 110.206 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.2 121.41 15.85 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.588 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 1.2 p30 -69.54 175.99 1.92 Allowed Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 123.67 0.788 . . . . 0.0 110.171 171.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 31.5 Cg_endo -60.48 -12.2 19.8 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.381 2.054 . . . . 0.0 113.901 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -97.57 0.47 47.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.2 0.6 . . . . 0.0 111.417 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 27.6 t 66.96 33.46 5.8 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.272 1.429 . . . . 0.0 112.245 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -75.18 173.36 10.91 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.492 ' HG3' HG21 ' B' ' 106' ' ' THR . 5.4 mpt_? -107.98 104.9 14.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.674 HD23 ' HH ' ' B' ' 21' ' ' TYR . 69.5 mt -100.0 100.54 11.45 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 -97.91 95.47 7.52 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -166.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.527 ' HB ' ' HD2' ' B' ' 105' ' ' PHE . 36.0 t -86.29 119.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -139.22 160.86 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.56 112.58 18.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.45 138.4 55.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.087 0.555 . . . . 0.0 109.96 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.64 97.89 0.84 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.881 0.472 . . . . 0.0 109.999 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.063 -178.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HG3' HD22 ' B' ' 25' ' ' LEU . 87.7 Cg_endo -85.76 86.17 1.03 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.696 2.264 . . . . 0.0 111.493 168.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.64 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 14.3 t70 -102.58 11.44 37.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.142 0.972 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -133.01 131.56 40.84 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -169.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.21 144.18 51.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.853 0.861 . . . . 0.0 109.167 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.468 HD12 ' NH2' ' B' ' 116' ' ' ARG . 1.8 mt -126.77 138.93 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.635 0.774 . . . . 0.0 109.51 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.447 HD11 HD21 ' A' ' 68' ' ' LEU . 96.1 mt -95.24 137.44 34.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -77.05 98.88 5.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.076 177.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 49' ' ' LEU . 20.1 m -109.74 169.78 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.23 -60.5 1.87 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.088 0.555 . . . . 0.0 110.003 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -102.32 98.39 10.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.941 0.896 . . . . 0.0 110.4 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.4 Cg_exo -49.12 -49.9 14.18 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.683 2.922 . . . . 0.0 115.984 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.77 -58.96 0.39 Allowed 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.217 1.828 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.86 89.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -59.51 -52.31 66.11 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 122.215 1.007 . . . . 0.0 109.507 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 59.1 m -80.49 -33.68 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -163.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.545 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 83.6 mm-40 -65.39 -37.46 87.06 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.888 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.97 -44.29 97.54 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.511 ' HH ' HD11 ' A' ' 115' ' ' LEU . 58.3 m-85 -71.46 -28.27 63.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.214 176.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.6 mtpt -56.49 -51.05 69.96 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.315 0.507 . . . . 0.0 111.875 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.41 -38.09 56.15 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.311 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD22 HD12 ' A' ' 115' ' ' LEU . 11.6 tp -59.79 -36.63 77.13 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.175 0.99 . . . . 0.0 112.34 -175.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 HD22 ' HG3' ' B' ' 4' ' ' PRO . 46.4 mt -96.9 -40.96 8.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.113 0.965 . . . . 0.0 109.357 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.83 30.85 8.11 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.605 0.566 . . . . 0.0 112.071 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 25' ' ' LEU . 33.7 m -129.75 -178.39 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.427 1.091 . . . . 0.0 109.902 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.7 154.32 72.99 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.253 0.621 . . . . 0.0 109.753 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 11.4 Cg_exo -70.57 117.39 5.11 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.941 2.427 . . . . 0.0 111.954 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 39' ' ' PHE . 5.8 p -65.42 -40.52 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 47.3 mm-40 -113.41 128.76 56.56 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.755 0.822 . . . . 0.0 109.482 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -127.73 131.9 49.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.862 0.865 . . . . 0.0 109.267 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 t -137.22 147.72 59.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.25 -15.32 34.03 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.921 2.414 . . . . 0.0 114.226 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.49 7.74 5.84 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -157.97 153.37 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.612 0.365 . . . . 0.0 110.122 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 24.4 m -138.06 148.23 44.85 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.191 0.596 . . . . 0.0 109.612 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -146.16 129.2 16.51 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HA ' HG11 ' A' ' 30' ' ' VAL . 2.6 p90 -134.49 148.18 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.176 0.99 . . . . 0.0 108.981 163.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.546 HG23 ' HG3' ' A' ' 46' ' ' LYS . 17.5 t -119.4 127.95 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.431 HD11 ' SD ' ' A' ' 45' ' ' MET . 37.7 mt -89.87 142.4 27.73 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -169.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.3 -14.3 62.89 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.069 0.948 . . . . 0.0 112.219 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' B' ' 5' ' ' ASP . 66.5 t30 -71.78 -9.87 58.94 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 110.912 174.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.2 32.91 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.483 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.655 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -97.01 172.29 7.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.009 0.904 . . . . 0.0 110.095 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 40' ' ' VAL . 86.5 tttt -135.03 141.82 46.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.05 0.54 . . . . 0.0 109.679 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.88 123.41 15.0 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.829 0.452 . . . . 0.0 110.452 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -107.77 167.86 13.68 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.537 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.467 HD21 HG11 ' A' ' 11' ' ' VAL . 6.3 mp -134.04 107.96 8.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 166.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.54 ' HE3' ' NH2' ' B' ' 116' ' ' ARG . 6.0 t90 -105.19 130.52 53.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 37.4 m -80.01 121.57 25.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.041 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -65.73 -14.09 60.61 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.986 1.314 . . . . 0.0 113.492 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -76.24 -8.2 56.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.573 0.349 . . . . 0.0 111.101 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.1 t -136.9 6.39 2.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.117 0.567 . . . . 0.0 111.344 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.8 147.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.716 0.406 . . . . 0.0 110.885 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -128.25 111.25 19.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.754 0.822 . . . . 0.0 108.875 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.7 140.49 66.8 Favored 'Cis proline' 0 C--N 1.389 2.666 0 C-N-CA 124.76 -0.933 . . . . 0.0 113.736 4.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -50.56 116.53 1.96 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.757 1.223 . . . . 0.0 113.04 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.52 107.1 3.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.799 1.24 . . . . 0.0 108.194 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -97.85 87.29 3.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.89 142.4 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 108.828 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.439 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 8.1 p -151.53 132.41 14.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.197 1.399 . . . . 0.0 108.267 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.19 -65.2 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 N-CA-C 112.054 -0.419 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.49 64.26 0.1 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.04 131.7 8.07 Favored Glycine 0 N--CA 1.464 0.566 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.732 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 73.43 129.43 0.14 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 15.9 mt-10 -120.97 147.95 44.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.05 0.54 . . . . 0.0 109.599 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -120.47 106.37 11.75 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.0 122.85 34.9 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.482 0.658 . . . . 0.0 111.338 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -102.56 108.35 19.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 107.529 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 29.2 mtm180 -91.29 123.49 34.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 112.201 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.19 158.9 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.747 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.8 pt-20 -69.36 -34.17 74.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.066 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.441 HD21 ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -161.72 177.45 9.92 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 118.697 0.68 . . . . 0.0 112.55 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.06 -33.21 70.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.732 1.613 . . . . 0.0 112.84 -167.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.95 77.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.74 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.558 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 21.8 mm-40 -66.18 -24.42 66.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.791 0.836 . . . . 0.0 112.032 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.19 -43.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.541 0.686 . . . . 0.0 109.647 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.39 -33.66 74.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.241 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -65.58 -45.26 83.93 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.293 0.568 . . . . 0.0 109.941 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.6 m -68.87 -28.46 66.73 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.013 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.9 -61.26 2.74 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.6 0.714 . . . . 0.0 109.948 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.78 -34.23 77.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.494 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.23 -46.75 93.3 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 124.206 0.941 . . . . 0.0 113.36 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -63.71 -45.88 87.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.211 0.604 . . . . 0.0 110.197 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 30.7 ttpt -57.01 -42.61 80.63 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.798 0.686 . . . . 0.0 110.836 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.09 -27.62 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.06 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -90.88 8.93 32.51 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.306 1.042 . . . . 0.0 112.643 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 46.47 4.61 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.147 169.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 p -101.6 148.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.1 79.07 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.931 0.492 . . . . 0.0 111.418 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.495 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 55.5 tpp 64.19 82.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.74 0.816 . . . . 0.0 112.891 166.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -134.11 84.92 2.15 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.086 0.47 . . . . 0.0 111.523 176.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 178.36 138.31 0.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.577 1.151 . . . . 0.0 109.565 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.85 119.97 68.83 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -54.12 111.41 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.938 2.425 . . . . 0.0 110.627 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.96 147.16 49.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.19 0.596 . . . . 0.0 111.231 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.02 104.8 4.23 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.608 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.418 ' SD ' ' CZ2' ' B' ' 50' ' ' TRP . 51.0 ttm -102.25 171.15 7.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.451 0.7 . . . . 0.0 109.939 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -49.63 -34.06 17.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.345 1.458 . . . . 0.0 113.092 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -101.68 -5.71 24.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.785 0.834 . . . . 0.0 111.469 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.16 -178.81 20.54 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.43 ' HB3' ' HB2' ' A' ' 119' ' ' ALA . 51.3 t80 -80.5 102.58 9.8 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.7 t -122.52 157.71 31.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.592 0.711 . . . . 0.0 111.466 -166.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.56 153.24 33.01 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.292 1.437 . . . . 0.0 108.249 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.474 HG23 ' HG3' ' A' ' 114' ' ' ARG . 23.5 m -146.81 127.68 14.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.149 0.431 . . . . 0.0 110.673 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.09 170.97 7.63 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.127 0.571 . . . . 0.0 110.724 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.4 117.42 23.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.773 0.429 . . . . 0.0 109.965 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.25 168.86 17.89 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.902 1.281 . . . . 0.0 110.856 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.31 -35.72 54.65 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.195 2.597 . . . . 0.0 114.499 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -87.48 1.18 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.307 0.643 . . . . 0.0 111.467 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 63.24 57.82 1.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.807 1.243 . . . . 0.0 112.36 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -93.19 -145.93 0.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 172.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.475 ' NH1' ' HG2' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -145.5 90.63 2.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.511 HD11 ' HH ' ' A' ' 21' ' ' TYR . 69.1 mt -96.07 104.82 16.78 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -171.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.732 HH12 HG22 ' B' ' 55' ' ' VAL . 1.8 mtp180 -101.98 146.52 27.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.374 0.27 . . . . 0.0 110.913 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.3 t -127.69 127.57 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 166.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -130.46 155.5 46.34 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.16 0.436 . . . . 0.0 111.275 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -109.37 121.15 44.54 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.97 108.62 10.16 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.34 0.4 . . . . 0.0 110.488 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 123.236 0.614 . . . . 0.0 109.64 176.059 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 . . . . . 0 CA--C 1.556 1.177 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.524 ' HG3' HD22 ' A' ' 25' ' ' LEU . 86.5 Cg_endo -86.06 86.18 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.49 2.127 . . . . 0.0 111.522 168.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.655 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 9.0 p-10 -102.9 10.78 38.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.538 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.46 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -132.17 131.84 42.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -169.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -128.06 143.71 51.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.009 0.924 . . . . 0.0 108.968 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 35.8 mt -125.28 139.36 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.499 HD21 HD21 ' B' ' 47' ' ' LEU . 4.0 mm? -95.32 137.38 34.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.43 ' HE2' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -76.03 97.62 4.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.212 1.405 . . . . 0.0 109.593 177.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -109.48 170.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.21 -60.26 1.91 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.984 0.514 . . . . 0.0 110.335 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -102.23 97.72 9.09 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.147 0.979 . . . . 0.0 110.49 -169.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.447 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.1 Cg_exo -48.88 -51.65 10.12 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.79 2.993 . . . . 0.0 115.675 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.21 -60.16 0.42 Allowed 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.099 1.786 . . . . 0.0 111.536 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.61 88.97 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.945 0.498 . . . . 0.0 112.163 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 34.1 m -59.1 -52.07 67.31 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.352 1.072 . . . . 0.0 109.677 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 70.7 m -80.46 -33.75 36.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -163.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 82.8 mm-40 -65.33 -38.39 90.01 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.715 172.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.445 ' CZ ' HG22 ' B' ' 90' ' ' VAL . 41.9 t80 -59.82 -45.82 91.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.33 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.67 ' HH ' HD21 ' B' ' 115' ' ' LEU . 36.1 m-85 -69.89 -29.42 66.62 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.805 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 52.3 mtpt -56.11 -51.21 68.72 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.182 0.515 . . . . 0.0 111.672 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.75 -38.42 54.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.439 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 8.5 tp -58.94 -36.64 75.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.424 1.09 . . . . 0.0 112.476 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.524 HD22 ' HG3' ' A' ' 4' ' ' PRO . 53.5 mt -96.93 -41.18 8.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.347 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.14 30.41 8.29 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' B' ' 25' ' ' LEU . 27.2 m -129.63 -177.98 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.411 1.084 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -139.05 155.04 72.94 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 123.338 0.655 . . . . 0.0 109.622 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 3.0 Cg_exo -71.84 117.05 4.95 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.867 2.378 . . . . 0.0 111.458 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -65.36 -39.87 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 51.6 mm-40 -114.08 128.26 56.3 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.506 0.722 . . . . 0.0 109.436 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 48.2 t -127.03 132.37 50.75 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.064 0.945 . . . . 0.0 109.245 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.0 t -137.52 148.01 59.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.805 1.242 . . . . 0.0 107.745 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.44 -15.14 39.05 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.693 2.262 . . . . 0.0 113.952 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.45 7.96 5.89 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -157.83 153.68 26.8 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 122.078 -0.389 . . . . 0.0 110.2 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 18.1 m -138.28 147.91 44.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.22 0.608 . . . . 0.0 109.541 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.619 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.3 tm? -145.98 129.66 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.532 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 3.7 p90 -134.84 148.64 50.2 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 108.721 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -120.52 127.8 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 36.8 mt -89.02 142.32 27.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.243 0.617 . . . . 0.0 109.405 -168.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.21 62.8 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.58 -10.21 59.41 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.761 0.825 . . . . 0.0 110.61 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.27 -4.35 33.34 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.215 -0.77 . . . . 0.0 114.175 170.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.64 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -96.25 172.61 7.85 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.047 0.923 . . . . 0.0 110.297 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -135.78 141.93 44.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.796 0.438 . . . . 0.0 109.951 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.499 HD21 HD21 ' B' ' 9' ' ' LEU . 3.6 tt -141.73 123.03 14.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.01 0.433 . . . . 0.0 110.589 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . 0.431 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -106.7 167.23 13.88 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 123.927 0.775 . . . . 0.0 111.372 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 9.2 mp -134.0 108.32 8.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 166.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.486 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -105.83 130.62 53.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 42.3 m -81.06 121.27 25.86 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.597 0.561 . . . . 0.0 110.933 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -64.97 -14.83 61.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.105 1.362 . . . . 0.0 113.809 -170.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -75.94 -7.49 54.71 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.819 0.448 . . . . 0.0 111.721 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.9 t -137.14 7.17 2.88 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.378 0.671 . . . . 0.0 111.198 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.732 HG22 HH12 ' A' ' 116' ' ' ARG . 9.8 p -62.82 148.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 122.265 0.226 . . . . 0.0 110.48 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -127.73 110.99 20.57 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.585 0.754 . . . . 0.0 109.357 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.475 ' HG2' ' NH1' ' A' ' 114' ' ' ARG . 85.8 Cg_endo -75.39 139.77 63.16 Favored 'Cis proline' 0 C--N 1.388 2.612 0 CA-C-N 119.85 0.982 . . . . 0.0 113.805 4.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -49.58 116.32 1.71 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.735 1.214 . . . . 0.0 113.179 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.29 107.2 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.691 1.196 . . . . 0.0 108.471 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -97.81 87.48 4.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.22 141.99 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.427 1.091 . . . . 0.0 108.98 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 11.1 p -151.22 133.11 15.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.709 1.203 . . . . 0.0 108.186 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.73 -66.08 0.05 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.0 62.89 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.16 130.57 7.83 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 119.442 -0.644 . . . . 0.0 111.674 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.732 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 74.06 130.02 0.18 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 27.0 mt-10 -121.93 147.2 46.33 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -120.46 106.45 11.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.732 ' HA ' ' HG2' ' B' ' 116' ' ' ARG . . . -91.3 122.25 33.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.95 108.31 19.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.588 1.555 . . . . 0.0 107.523 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.403 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 56.9 mtm180 -91.97 122.75 34.78 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.419 0.628 . . . . 0.0 111.968 -174.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.406 HG22 ' O ' ' B' ' 118' ' ' TYR . 22.7 m -125.11 159.27 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.708 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.426 ' HG3' HD21 ' B' ' 74' ' ' ASN . 9.5 pt-20 -69.39 -34.66 74.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.423 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.426 HD21 ' HG3' ' B' ' 73' ' ' GLU . 6.0 p30 -161.18 176.67 11.02 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.714 0.688 . . . . 0.0 112.412 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -59.11 -32.34 69.74 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.704 1.602 . . . . 0.0 113.063 -168.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.97 -39.34 76.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.641 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -65.75 -24.37 66.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.589 0.756 . . . . 0.0 112.45 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.614 HG12 HG11 ' B' ' 117' ' ' VAL . 97.2 t -68.34 -42.96 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.503 0.721 . . . . 0.0 109.829 172.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.15 -33.05 71.3 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.788 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 29.5 mt-10 -65.77 -45.9 80.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.419 0.628 . . . . 0.0 109.987 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 92.7 m -67.3 -29.81 69.5 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.996 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -59.89 -61.21 2.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.67 0.788 . . . . 0.0 110.093 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.91 76.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.42 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.33 90.18 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.122 0.888 . . . . 0.0 113.088 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . 0.497 ' HB3' HG23 ' B' ' 90' ' ' VAL . 44.9 m0 -62.55 -46.86 86.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.347 0.659 . . . . 0.0 110.038 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.564 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 30.9 ttpt -55.89 -42.81 76.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.367 0.667 . . . . 0.0 111.065 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.73 -27.7 63.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.873 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -91.04 9.26 31.55 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 112.233 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.98 46.88 4.64 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.09 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' B' ' 85' ' ' TRP . 48.7 t -101.97 147.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.06 77.48 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.048 0.539 . . . . 0.0 111.449 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.564 ' HE1' ' HB2' ' B' ' 86' ' ' LYS . 51.3 tpp 64.34 82.53 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.705 0.802 . . . . 0.0 112.799 166.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 85.17 2.18 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 178.07 138.17 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.401 1.081 . . . . 0.0 109.301 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -90.21 119.88 69.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.427 ' HA ' ' HB2' ' B' ' 105' ' ' PHE . 51.1 Cg_exo -54.18 111.51 0.73 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.719 2.279 . . . . 0.0 110.699 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.83 146.77 49.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.338 0.655 . . . . 0.0 111.279 -170.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.602 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 0.2 OUTLIER -72.84 104.87 4.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.838 0.855 . . . . 0.0 109.812 177.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 51.9 ttm -101.93 170.14 8.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.07 0.948 . . . . 0.0 109.66 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -48.74 -34.47 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.257 1.423 . . . . 0.0 113.216 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -101.96 -5.4 24.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.773 0.829 . . . . 0.0 111.67 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.6 -178.6 20.93 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.311 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.602 ' HB2' ' HZ1' ' B' ' 98' ' ' LYS . 52.1 t80 -80.99 102.59 10.26 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -122.61 158.05 30.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.664 0.745 . . . . 0.0 111.505 -167.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' B' ' 96' ' ' PRO . 3.0 t80 -153.2 152.73 31.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.365 1.466 . . . . 0.0 108.075 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.62 HG23 ' HG3' ' B' ' 114' ' ' ARG . 29.0 m -145.82 127.74 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.685 0.394 . . . . 0.0 110.21 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.56 171.22 7.51 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.06 0.544 . . . . 0.0 110.78 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.77 116.92 22.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.423 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.3 p30 -70.95 169.41 14.87 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.691 1.197 . . . . 0.0 111.242 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 10.9 Cg_endo -52.16 -35.63 63.52 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.431 2.754 . . . . 0.0 113.901 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.42 1.26 53.92 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.253 0.621 . . . . 0.0 111.461 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 62.69 57.99 1.69 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.63 1.172 . . . . 0.0 112.624 166.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -92.68 -146.23 0.22 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.62 ' HG3' HG23 ' B' ' 106' ' ' THR . 0.1 OUTLIER -144.72 89.63 2.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HH ' ' B' ' 21' ' ' TYR . 85.8 mt -95.49 104.23 16.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -171.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.732 ' HG2' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -99.74 147.77 25.09 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.827 0.285 . . . . 0.0 111.696 -176.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.614 HG11 HG12 ' B' ' 78' ' ' VAL . 7.5 p -128.97 128.47 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 164.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.406 ' O ' HG22 ' B' ' 72' ' ' VAL . 14.3 p90 -130.13 155.56 45.99 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 122.199 -0.313 . . . . 0.0 111.062 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -109.62 120.92 43.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -76.27 107.0 8.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.364 0.415 . . . . 0.0 110.05 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.31 104.0 10.56 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.854 -0.97 . . . . 0.0 110.919 -177.454 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.0 m80 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 119.624 -0.227 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' HD22 ' B' ' 25' ' ' LEU . 69.4 Cg_endo -87.73 87.49 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.697 2.264 . . . . 0.0 111.364 170.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.797 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.7 p-10 -83.61 1.53 41.82 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.419 0.628 . . . . 0.0 110.815 172.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.06 120.5 31.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -172.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -111.96 137.66 49.66 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 46.3 mt -113.19 128.1 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.41 HD21 HD23 ' A' ' 47' ' ' LEU . 4.2 mm? -93.93 145.13 24.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.63 ' HE1' HG23 ' A' ' 55' ' ' VAL . 38.4 t80 -102.57 105.14 15.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.192 -170.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.79 157.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.534 0.734 . . . . 0.0 109.199 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 12.6 p-10 -104.76 -43.01 5.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.528 0.731 . . . . 0.0 110.84 -177.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -94.53 105.62 19.28 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.256 0.623 . . . . 0.0 109.909 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.27 -59.46 0.89 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 C-N-CA 122.153 1.902 . . . . 0.0 113.461 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 40.6 Cg_endo -64.38 -56.5 0.43 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 122.433 1.905 . . . . 0.0 111.494 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.22 83.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.735 0.814 . . . . 0.0 112.206 -168.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -72.53 -39.69 67.35 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -65.69 -39.49 91.34 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 77.8 mm-40 -67.6 -34.53 77.19 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.372 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -64.69 -46.13 83.68 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.524 0.515 . . . . 0.0 109.911 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -65.62 -32.07 73.44 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.07 -51.07 69.16 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.284 0.564 . . . . 0.0 112.322 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.12 -39.91 65.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.152 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 tp -58.2 -47.02 84.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.145 1.378 . . . . 0.0 113.183 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB2' HG23 ' A' ' 27' ' ' VAL . 15.5 mt -86.44 -43.73 12.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.06 26.05 8.07 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 -174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 25' ' ' LEU . 31.1 m -127.73 167.4 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.06 0.944 . . . . 0.0 110.243 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.01 151.28 46.36 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.783 0.833 . . . . 0.0 109.34 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 14.8 Cg_exo -67.88 117.05 4.62 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.545 2.163 . . . . 0.0 111.814 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 40' ' ' VAL . 7.5 p -63.22 -38.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.751 . . . . 0.0 109.962 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 30.5 mm-40 -123.47 129.86 51.86 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.01 1.324 . . . . 0.0 107.775 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.6 p -136.26 135.36 38.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.308 0.575 . . . . 0.0 109.896 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.3 m -141.65 153.58 65.23 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.922 1.289 . . . . 0.0 108.512 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -56.92 -22.48 46.33 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.066 2.511 . . . . 0.0 113.726 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 t -128.12 10.49 6.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -158.83 137.46 10.98 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -123.71 153.96 40.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.389 0.676 . . . . 0.0 109.727 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 21.3 tp -147.43 125.66 12.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.435 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -132.79 142.25 48.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 108.367 168.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.576 HG23 ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -119.38 131.48 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.0 mt -94.41 149.85 20.84 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -10.45 29.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.19 0.996 . . . . 0.0 112.029 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -65.12 -20.44 66.46 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.852 1.261 . . . . 0.0 112.237 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 -7.27 47.18 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -90.35 173.12 8.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.56 0.744 . . . . 0.0 110.38 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' HG3' HG23 ' A' ' 40' ' ' VAL . 76.8 tttt -141.8 139.53 32.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 9' ' ' LEU . 2.2 tt -138.09 120.13 15.54 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.494 0.318 . . . . 0.0 110.6 -169.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.19 165.73 17.26 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.625 0.631 . . . . 0.0 111.693 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.89 111.92 10.86 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -104.74 125.17 50.55 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.7 m -77.71 128.78 34.61 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.641 0.588 . . . . 0.0 109.874 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 13.6 ptm180 -66.88 -10.66 50.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -82.56 -12.64 57.59 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 118.047 0.385 . . . . 0.0 111.137 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 0.6 8.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.122 0.569 . . . . 0.0 111.123 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG23 ' HE1' ' A' ' 10' ' ' TYR . 10.7 p -61.13 140.13 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.189 0.519 . . . . 0.0 112.279 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.73 116.38 26.41 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 6.8 Cg_exo -72.38 144.04 79.24 Favored 'Cis proline' 0 C--N 1.383 2.384 0 C-N-CA 124.683 -0.966 . . . . 0.0 112.794 -3.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.555 ' HA ' HG12 ' A' ' 55' ' ' VAL . 13.7 mmmm -50.2 130.16 22.32 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.764 0.825 . . . . 0.0 111.833 173.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.555 ' HB1' ' HH ' ' A' ' 10' ' ' TYR . . . -145.99 136.33 23.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.751 0.821 . . . . 0.0 109.958 -176.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 p -108.5 88.35 2.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.521 0.729 . . . . 0.0 109.485 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -161.37 144.04 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.773 0.829 . . . . 0.0 110.22 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 p -141.47 138.62 32.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.381 1.072 . . . . 0.0 108.356 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.71 20.07 79.65 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 22.23 30.42 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.79 -162.07 23.79 Favored Glycine 0 N--CA 1.473 1.154 0 CA-C-N 117.083 0.442 . . . . 0.0 112.308 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.58 95.9 0.05 OUTLIER Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.49 ' HG2' ' NE ' ' A' ' 116' ' ' ARG . 1.9 mp0 -103.7 158.53 16.32 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 112.049 -170.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.8 mt -118.89 102.4 8.76 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.498 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.95 106.31 17.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.505 ' HB2' HG21 ' A' ' 117' ' ' VAL . 7.8 m-85 -83.95 112.21 19.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -90.18 127.43 36.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.421 0.629 . . . . 0.0 112.243 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.65 158.29 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.23 -38.05 89.65 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -160.43 177.37 10.64 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.512 0.596 . . . . 0.0 112.155 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.25 -28.62 69.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.944 1.298 . . . . 0.0 112.771 -165.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.78 -46.95 76.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.978 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -64.86 -22.43 66.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 0.0 112.651 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.26 -42.41 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.313 0.645 . . . . 0.0 109.668 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.03 -27.59 54.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.681 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 40.6 mt-10 -69.26 -43.85 73.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.668 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -65.74 -36.14 82.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.28 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.434 ' O ' ' HE2' ' A' ' 92' ' ' MET . 35.6 t80 -59.33 -57.18 14.15 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.794 0.807 . . . . 0.0 109.356 176.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.87 83.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.209 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.69 90.76 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.64 0.587 . . . . 0.0 114.361 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -67.44 -41.85 84.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.062 0.545 . . . . 0.0 110.155 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -58.8 -40.14 83.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.983 0.913 . . . . 0.0 110.297 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.77 66.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.461 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m -104.96 15.14 28.26 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.889 0.876 . . . . 0.0 113.205 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.45 30.32 19.36 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 163.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.09 127.45 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.251 0.62 . . . . 0.0 109.543 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.0 71.07 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.684 0.794 . . . . 0.0 111.393 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.434 ' HE2' ' O ' ' A' ' 82' ' ' PHE . 6.7 ptm 52.15 80.95 0.09 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.291 1.436 . . . . 0.0 113.381 169.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.78 82.45 2.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 -177.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -174.86 138.18 0.46 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.346 1.058 . . . . 0.0 109.066 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -80.49 122.4 82.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 105' ' ' PHE . 27.1 Cg_endo -63.54 112.35 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.575 2.183 . . . . 0.0 110.209 175.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.39 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.454 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.576 ' HZ1' ' HB2' ' A' ' 103' ' ' TYR . 19.3 mmtm -71.06 118.02 13.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.397 1.079 . . . . 0.0 111.506 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.5 tpp -110.09 176.62 4.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.507 1.523 . . . . 0.0 108.996 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -48.21 -41.01 26.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.75 1.22 . . . . 0.0 113.133 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -106.88 19.83 19.91 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.566 0.746 . . . . 0.0 111.603 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -167.83 12.42 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.986 0.354 . . . . 0.0 113.986 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.576 ' HB2' ' HZ1' ' A' ' 98' ' ' LYS . 13.0 t80 -78.53 110.01 13.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.437 0.695 . . . . 0.0 109.707 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -138.77 168.69 19.25 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -168.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 96' ' ' PRO . 22.8 p90 -157.42 169.35 24.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.028 0.931 . . . . 0.0 109.311 169.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 13.6 m -137.47 124.92 22.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.65 158.33 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.378 1.071 . . . . 0.0 110.78 -174.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.02 111.08 17.03 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.4 167.87 28.76 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.605 0.762 . . . . 0.0 110.258 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -43.02 -38.82 7.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.693 2.929 . . . . 0.0 115.652 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -89.14 2.02 54.77 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.833 0.453 . . . . 0.0 111.771 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.2 m 63.43 81.48 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.675 1.19 . . . . 0.0 111.354 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -131.53 165.37 23.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 18.5 mtm180 -97.0 106.46 18.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.08 102.71 11.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.232 0.613 . . . . 0.0 109.683 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.708 ' HD2' HD13 ' B' ' 8' ' ' ILE . 72.1 mtt-85 -89.66 148.55 23.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.693 0.397 . . . . 0.0 110.383 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 70' ' ' PHE . 40.5 t -137.38 127.96 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 166.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -130.75 167.58 18.61 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.27 0.941 . . . . 0.0 112.885 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.7 115.8 12.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.586 1.154 . . . . 0.0 108.08 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -79.77 117.39 20.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.672 0 C-N-CA 123.638 0.775 . . . . 0.0 109.417 177.074 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.35 87.57 0.66 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.53 2.153 . . . . 0.0 111.467 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.809 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 10.4 p-10 -83.43 1.67 40.4 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.014 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 0.9 OUTLIER -125.35 119.34 28.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -171.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -111.25 137.69 48.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.708 HD13 ' HD2' ' A' ' 116' ' ' ARG . 22.1 mt -113.84 127.66 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.14 145.26 24.54 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -102.63 105.84 16.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.622 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.13 157.35 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.696 0.798 . . . . 0.0 109.114 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -105.33 -42.8 5.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.511 0.724 . . . . 0.0 111.028 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.91 106.51 22.32 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.102 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.442 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 38.6 Cg_exo -55.03 -59.09 0.89 Allowed 'Trans proline' 0 CA--C 1.572 2.406 0 C-N-CA 122.049 1.833 . . . . 0.0 113.429 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 22.6 Cg_exo -64.78 -56.93 0.34 Allowed 'Trans proline' 0 C--N 1.4 3.259 0 CA-C-N 122.465 1.916 . . . . 0.0 111.316 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -44.8 81.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.598 0.759 . . . . 0.0 112.551 -168.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -70.79 -40.87 72.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 77.7 m -65.61 -39.36 91.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.543 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 79.7 mm-40 -67.85 -34.17 76.18 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.516 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.98 -45.96 83.46 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.206 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -65.77 -31.86 73.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.7 mtpt -56.03 -50.91 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.312 0.577 . . . . 0.0 112.266 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.24 -39.91 65.1 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.303 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -58.33 -46.83 85.46 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.174 1.39 . . . . 0.0 113.055 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.498 ' HB2' HG23 ' B' ' 27' ' ' VAL . 13.7 mt -87.1 -42.98 12.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.36 25.86 8.56 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.993 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' B' ' 25' ' ' LEU . 33.4 m -127.26 167.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.934 0.894 . . . . 0.0 110.303 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.15 150.75 45.74 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.794 0.837 . . . . 0.0 109.483 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.436 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 42.2 Cg_endo -67.14 117.18 4.61 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.355 2.036 . . . . 0.0 112.218 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' B' ' 31' ' ' GLU . 7.1 p -63.68 -38.46 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.392 0.677 . . . . 0.0 109.97 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 34.6 mm-40 -122.69 129.94 52.38 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.925 1.29 . . . . 0.0 107.522 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -136.23 136.04 39.56 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.03 0.532 . . . . 0.0 110.066 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 55.6 m -142.49 151.64 58.16 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.921 1.288 . . . . 0.0 108.578 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.91 -23.62 28.38 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.19 2.593 . . . . 0.0 114.733 -176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -128.12 10.82 6.42 Favored 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -158.56 137.91 11.65 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -124.32 153.47 41.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.326 0.65 . . . . 0.0 110.035 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 35.8 tp -146.75 126.22 13.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 0.9 OUTLIER -132.93 142.31 48.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.569 1.148 . . . . 0.0 108.421 168.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.3 t -119.49 130.93 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.76 149.61 21.09 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -10.43 25.7 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.461 1.104 . . . . 0.0 112.071 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -65.36 -20.42 66.38 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.719 1.208 . . . . 0.0 112.244 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.31 -7.14 46.91 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.797 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -90.29 173.23 8.25 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.468 0.707 . . . . 0.0 110.491 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.572 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -141.7 139.62 32.98 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.34 120.15 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . 0.411 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.02 165.53 17.4 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 123.78 0.705 . . . . 0.0 111.549 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.6 mt -134.25 111.66 10.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.546 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.0 t90 -104.71 125.36 50.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -77.86 128.76 34.47 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 123.581 0.551 . . . . 0.0 110.044 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -67.35 -10.65 53.09 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -81.93 -13.46 57.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.042 0.383 . . . . 0.0 111.388 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -124.13 1.77 8.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.182 0.593 . . . . 0.0 111.271 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.546 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 14.1 p -62.29 138.83 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.032 0.444 . . . . 0.0 111.757 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -122.1 116.83 29.77 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -73.6 145.21 83.4 Favored 'Cis proline' 0 C--N 1.384 2.442 0 C-N-CA 124.564 -1.015 . . . . 0.0 111.966 -2.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.507 ' HA ' HG12 ' B' ' 55' ' ' VAL . 12.4 mmmm -51.24 130.73 27.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.668 0.787 . . . . 0.0 111.628 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.17 23.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.925 0.89 . . . . 0.0 109.642 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.2 p -108.59 88.53 2.75 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.634 0.774 . . . . 0.0 109.175 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -161.86 143.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.785 0.834 . . . . 0.0 110.193 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -141.43 138.85 33.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.62 1.168 . . . . 0.0 108.425 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.79 79.76 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.13 21.74 32.84 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 114.419 0.528 . . . . 0.0 114.419 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.63 -160.27 23.72 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 117.053 0.427 . . . . 0.0 112.683 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.99 96.54 0.03 OUTLIER Glycine 0 C--N 1.351 1.41 0 C-N-CA 122.995 0.331 . . . . 0.0 112.557 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.509 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.3 mt-10 -103.36 159.84 15.21 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.114 0.483 . . . . 0.0 112.155 -170.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.56 102.24 8.5 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.444 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.448 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -86.21 107.3 17.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.011 0.434 . . . . 0.0 110.056 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.52 ' HB2' HG22 ' B' ' 117' ' ' VAL . 7.8 m-85 -85.97 111.93 20.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.407 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 32.3 mtm180 -90.18 126.33 35.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.29 0.567 . . . . 0.0 112.014 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 23.4 m -127.23 158.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.337 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.9 pt-20 -64.32 -37.74 88.58 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -160.76 178.2 9.69 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.777 0.717 . . . . 0.0 112.078 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.43 -28.93 69.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.162 1.385 . . . . 0.0 112.475 -164.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.75 -46.54 78.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.468 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 69.6 mm-40 -65.57 -22.45 66.69 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.264 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -66.35 -42.58 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.397 0.679 . . . . 0.0 109.626 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.87 -27.96 55.22 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.451 1.1 . . . . 0.0 110.401 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 43.5 mt-10 -68.41 -44.69 74.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.076 0.55 . . . . 0.0 109.867 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -65.27 -35.96 82.62 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.413 175.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.433 ' O ' ' HE1' ' B' ' 92' ' ' MET . 30.2 t80 -59.23 -56.96 15.41 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.75 0.786 . . . . 0.0 109.4 176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.14 83.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.33 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.75 90.75 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.44 0.463 . . . . 0.0 113.97 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -67.15 -42.49 84.29 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.061 0.545 . . . . 0.0 109.992 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -58.01 -40.77 81.61 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.944 . . . . 0.0 110.14 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.2 67.24 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.411 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -104.35 15.11 28.92 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.05 0.94 . . . . 0.0 113.421 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.58 19.31 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 163.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.6 127.32 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.253 0.621 . . . . 0.0 109.386 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.7 -53.07 61.94 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.652 0.781 . . . . 0.0 111.268 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.433 ' HE1' ' O ' ' B' ' 82' ' ' PHE . 22.9 ttp 54.19 81.04 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.793 1.237 . . . . 0.0 112.868 169.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 83.38 2.18 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -176.43 134.74 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.226 1.01 . . . . 0.0 108.366 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -79.16 123.7 84.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' B' ' 105' ' ' PHE . 40.0 Cg_endo -65.41 112.26 2.07 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.527 2.151 . . . . 0.0 109.709 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.16 163.36 33.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.341 0.591 . . . . 0.0 111.59 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.568 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 18.4 mmtm -71.22 118.59 14.21 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.299 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 37.0 ttm -112.02 179.42 4.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.561 1.145 . . . . 0.0 108.966 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.19 -41.61 49.8 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.697 1.199 . . . . 0.0 112.019 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -106.54 20.0 19.66 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.559 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.11 -167.68 12.38 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.568 ' HB2' ' HZ1' ' B' ' 98' ' ' LYS . 18.5 t80 -78.7 110.19 13.62 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.533 0.733 . . . . 0.0 109.777 -168.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.447 ' OG1' ' HD2' ' B' ' 116' ' ' ARG . 13.7 t -139.95 169.44 17.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -168.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.443 ' HB3' ' HA ' ' B' ' 96' ' ' PRO . 32.0 p90 -157.63 169.14 25.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.107 0.963 . . . . 0.0 109.232 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.492 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 20.6 m -136.62 125.19 23.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.57 158.21 16.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.42 1.088 . . . . 0.0 110.882 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.1 111.36 17.34 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.69 167.36 34.09 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.907 0.883 . . . . 0.0 110.402 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -42.16 -39.19 5.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 124.039 3.159 . . . . 0.0 115.346 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -89.38 2.36 54.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m 62.98 80.82 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.681 1.192 . . . . 0.0 111.589 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -130.49 165.66 22.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -95.66 106.13 18.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -108.41 102.62 11.71 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 0.8 OUTLIER -87.11 147.98 25.42 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.356 0.663 . . . . 0.0 109.922 -178.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' B' ' 70' ' ' PHE . 42.3 t -137.44 128.36 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 164.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -130.71 167.05 19.45 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.368 0.986 . . . . 0.0 113.102 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.1 116.13 13.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.19 122.56 26.99 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.91 99.78 1.83 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 0.0 109.86 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.17 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.111 -175.394 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.42 ' HB3' HD22 ' B' ' 43' ' ' ASN . 23.0 m80 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 119.861 -0.114 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -97.36 96.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.869 2.379 . . . . 0.0 112.48 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.681 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.1 p-10 -93.72 13.6 21.76 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.295 0.569 . . . . 0.0 110.534 169.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.98 115.69 19.62 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.87 146.56 34.89 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.269 1.027 . . . . 0.0 108.691 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.477 HD13 ' HD2' ' B' ' 116' ' ' ARG . 55.9 mt -122.5 137.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.039 0.935 . . . . 0.0 109.037 176.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.744 HD23 ' HG ' ' A' ' 68' ' ' LEU . 4.3 mm? -91.42 123.23 34.69 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 168.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.578 ' HE1' HG23 ' A' ' 55' ' ' VAL . 57.6 t80 -78.96 106.83 11.27 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.687 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.71 175.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.248 1.019 . . . . 0.0 109.908 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.55 -61.46 1.49 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.59 0.756 . . . . 0.0 109.811 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.52 110.61 35.58 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 123.787 0.835 . . . . 0.0 110.093 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -58.8 -64.36 0.11 Allowed 'Trans proline' 0 CA--C 1.568 2.178 0 C-N-CA 122.323 2.015 . . . . 0.0 113.614 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.08 -38.75 35.14 Favored 'Trans proline' 0 C--N 1.402 3.343 0 CA-C-N 122.533 1.94 . . . . 0.0 111.204 -170.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.47 93.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.312 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -70.85 -35.34 72.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.3 m -58.41 -53.24 60.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.565 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 24.5 mm-40 -68.56 -37.07 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.258 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.1 t80 -59.46 -44.06 93.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.772 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 5.4 m-85 -72.99 -28.45 62.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.468 0.707 . . . . 0.0 110.73 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.3 -50.79 70.41 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.936 0.789 . . . . 0.0 112.037 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.23 -34.38 49.3 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.142 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.9 tp -61.42 -53.58 54.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.661 1.184 . . . . 0.0 111.988 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB2' HG23 ' A' ' 27' ' ' VAL . 11.1 mt -76.62 -51.82 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.68 5.82 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.257 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 25' ' ' LEU . 21.0 m -131.35 176.21 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.359 1.063 . . . . 0.0 110.075 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.27 156.11 46.04 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.77 112.53 3.56 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 121.534 1.489 . . . . 0.0 110.554 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -37.45 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.892 0.477 . . . . 0.0 110.157 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 11.9 mm-40 -111.82 134.47 53.36 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 p -143.35 132.36 22.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 110.709 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -143.42 155.81 60.74 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.285 1.434 . . . . 0.0 108.263 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.3 -10.2 20.37 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.865 2.377 . . . . 0.0 114.123 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 t -126.56 -0.75 6.83 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -157.67 142.43 16.56 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -131.51 146.54 52.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.25 0.62 . . . . 0.0 110.106 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.0 tm? -133.68 120.27 20.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -108.11 140.52 41.18 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.686 1.595 . . . . 0.0 107.051 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' HG3' ' A' ' 46' ' ' LYS . 26.4 t -124.21 126.8 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.456 HD12 ' SD ' ' A' ' 45' ' ' MET . 8.6 mp -99.79 148.72 24.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.169 0.587 . . . . 0.0 109.731 -172.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.96 -5.92 29.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.039 0.936 . . . . 0.0 111.928 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -21.67 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.121 0.968 . . . . 0.0 112.168 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.64 17.56 16.73 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.682 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -124.06 175.09 7.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.817 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HG3' HG23 ' A' ' 40' ' ' VAL . 78.3 tttt -145.91 140.62 27.1 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 68' ' ' LEU . 2.7 tt -138.32 120.66 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.203 0.601 . . . . 0.0 110.287 -169.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.85 166.55 15.76 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.667 0.651 . . . . 0.0 112.055 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.419 HD23 ' HB2' ' A' ' 9' ' ' LEU . 95.3 mt -134.87 104.92 6.18 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.523 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.6 t90 -109.62 119.3 38.97 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 p -81.01 140.92 34.88 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.343 0.402 . . . . 0.0 111.159 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.502 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 29.3 ptt180 -69.68 -18.65 63.57 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -78.99 -8.58 59.05 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -127.84 7.68 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.874 0.47 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG23 ' HE1' ' A' ' 10' ' ' TYR . 9.9 p -75.8 150.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.61 0.243 . . . . 0.0 110.91 -175.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -126.37 115.58 23.33 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.77 0.828 . . . . 0.0 108.861 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 89.1 Cg_endo -77.01 141.01 68.02 Favored 'Cis proline' 0 C--N 1.386 2.511 0 C-N-CA 124.584 -1.007 . . . . 0.0 112.389 5.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 123.84 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.729 0.811 . . . . 0.0 110.29 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB1' ' HH ' ' A' ' 10' ' ' TYR . . . -149.38 170.74 17.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.541 1.137 . . . . 0.0 108.545 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.502 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 32.5 t -147.19 90.65 1.9 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.413 0.285 . . . . 0.0 110.237 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.08 144.15 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 109.685 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -146.62 124.14 11.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.45 -69.25 0.17 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.27 149.26 20.9 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.34 -22.64 0.2 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.683 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . -164.01 116.12 0.69 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.87 144.65 30.25 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.744 ' HG ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -108.93 101.62 10.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -169.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -90.23 111.71 22.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.732 0.696 . . . . 0.0 111.52 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -91.18 111.97 23.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.117 1.367 . . . . 0.0 107.399 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.536 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 36.8 mtm180 -89.98 129.4 36.31 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.503 0.668 . . . . 0.0 112.336 -174.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.69 159.09 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.016 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.6 pt-20 -66.69 -34.91 78.91 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -163.27 178.29 8.3 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 118.757 0.708 . . . . 0.0 112.345 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.56 -31.27 67.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.408 1.483 . . . . 0.0 112.771 -168.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.97 -46.55 77.67 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.232 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.495 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 71.7 mm-40 -63.69 -22.71 67.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.181 0.993 . . . . 0.0 112.98 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.75 -42.04 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.212 0.605 . . . . 0.0 109.802 171.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -75.81 -29.06 58.56 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.164 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 36.5 mt-10 -71.81 -44.7 63.49 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.276 0.56 . . . . 0.0 109.641 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -65.38 -33.4 75.87 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.437 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' O ' ' HE3' ' A' ' 92' ' ' MET . 40.0 t80 -56.33 -59.4 5.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.701 0.8 . . . . 0.0 109.621 174.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.71 -38.26 89.73 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.714 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 -41.83 97.11 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.653 0.596 . . . . 0.0 113.632 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -64.41 -42.55 96.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.324 0.649 . . . . 0.0 110.305 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 31.8 ttpt -59.15 -42.97 91.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.017 0.927 . . . . 0.0 110.539 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.38 65.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.318 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.9 t -98.36 14.27 28.61 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.427 1.091 . . . . 0.0 112.944 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.09 29.06 35.13 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 165.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.7 t -86.47 130.61 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.11 99.62 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.954 0.902 . . . . 0.0 112.325 -172.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.477 ' HE3' ' O ' ' A' ' 82' ' ' PHE . 7.5 ptm 49.54 81.48 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.889 1.676 . . . . 0.0 114.301 166.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.01 83.04 1.76 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.476 0.655 . . . . 0.0 110.084 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? 178.07 120.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.434 1.493 . . . . 0.0 107.113 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.4 117.02 62.69 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.53 110.73 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 123.887 3.058 . . . . 0.0 113.329 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.58 146.04 44.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.226 1.01 . . . . 0.0 110.371 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 98.64 4.09 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 tpp -78.26 163.98 25.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.836 0.854 . . . . 0.0 109.49 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.23 -28.26 69.03 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.107 0.563 . . . . 0.0 111.795 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -99.67 15.41 26.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.972 0.909 . . . . 0.0 111.466 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.03 180.0 16.76 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.539 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -73.77 103.0 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -109.84 158.11 18.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.396 0.617 . . . . 0.0 111.401 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -143.93 142.09 30.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.21 1.404 . . . . 0.0 108.795 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.4 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 31.1 m -132.69 121.93 23.85 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.522 1.056 . . . . 0.0 110.76 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.69 150.48 26.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.103 0.961 . . . . 0.0 112.228 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.95 172.53 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.3 p-10 -144.34 -176.94 0.59 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 5.2 Cg_exo -38.14 -51.67 1.97 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.621 2.881 . . . . 0.0 114.016 168.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.08 -15.0 59.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.006 0.522 . . . . 0.0 111.684 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.02 52.24 0.2 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.65 1.18 . . . . 0.0 111.156 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -80.3 175.11 10.94 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.255 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -122.84 105.64 10.2 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -118.18 103.69 10.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.143 0.977 . . . . 0.0 109.206 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.551 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 77.9 ttt180 -88.17 146.14 25.55 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 123.266 0.626 . . . . 0.0 110.188 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.9 t -131.94 119.22 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 163.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 4.3 p90 -125.71 164.91 19.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.563 0.62 . . . . 0.0 111.223 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.83 111.65 13.31 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -75.04 117.2 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.438 0.563 . . . . 0.0 109.75 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 121.11 0.481 . . . . 0.0 109.708 -179.022 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 119.745 -0.169 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.489 ' HB2' HD22 ' A' ' 68' ' ' LEU . 46.5 Cg_endo -97.55 96.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.985 2.456 . . . . 0.0 112.432 170.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.682 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.8 p-10 -93.55 13.82 20.74 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.351 0.596 . . . . 0.0 110.692 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.15 115.59 19.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.74 146.71 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.283 1.033 . . . . 0.0 108.775 171.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.51 HD11 HH11 ' A' ' 116' ' ' ARG . 50.5 mt -122.57 137.47 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.002 0.921 . . . . 0.0 108.903 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.456 ' HG ' ' OH ' ' B' ' 21' ' ' TYR . 4.5 mm? -90.95 122.8 33.93 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.522 ' HE1' HG23 ' B' ' 55' ' ' VAL . 59.6 t80 -78.23 107.33 10.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.913 173.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.1 175.72 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.247 1.019 . . . . 0.0 109.788 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -105.9 -61.15 1.54 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.49 0.716 . . . . 0.0 110.233 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -87.15 110.82 36.4 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.896 0.878 . . . . 0.0 109.969 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.49 -65.67 0.08 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 122.369 2.046 . . . . 0.0 113.155 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.39 -38.94 49.79 Favored 'Trans proline' 0 C--N 1.403 3.441 0 CA-C-N 122.471 1.918 . . . . 0.0 111.81 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.17 -41.71 94.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -70.25 -35.39 73.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.498 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 33.3 m -58.12 -53.91 52.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.83 -37.37 81.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.126 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 73.7 t80 -59.71 -44.05 93.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.94 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.53 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 6.2 m-85 -72.98 -28.06 62.17 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.817 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' B' ' 18' ' ' THR . 58.4 mtpt -56.68 -50.64 71.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.95 0.795 . . . . 0.0 111.92 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.04 -34.6 50.4 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.971 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 21.8 tp -61.55 -53.41 56.64 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.558 1.143 . . . . 0.0 112.186 -174.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.433 ' HB2' HG21 ' B' ' 27' ' ' VAL . 12.3 mt -76.73 -51.13 12.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.64 25.06 6.13 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.232 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' B' ' 25' ' ' LEU . 28.5 m -130.8 176.19 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.302 1.041 . . . . 0.0 110.073 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -115.37 155.93 46.42 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.633 0.773 . . . . 0.0 109.13 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.69 112.65 3.58 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.604 1.536 . . . . 0.0 110.536 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.33 -37.46 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.838 0.455 . . . . 0.0 110.245 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.696 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.3 mm-40 -111.69 134.62 53.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 45.5 p -143.47 132.48 22.91 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 110.542 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -143.72 156.31 59.52 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.509 1.524 . . . . 0.0 108.133 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.06 -9.63 22.43 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.542 2.161 . . . . 0.0 113.57 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -126.7 -0.75 6.74 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -157.9 142.4 16.24 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 31.1 m -131.46 146.63 52.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.311 0.644 . . . . 0.0 110.056 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.696 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -134.12 119.91 19.47 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.77 140.75 40.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.652 1.581 . . . . 0.0 106.921 173.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.551 HG23 ' HG3' ' B' ' 46' ' ' LYS . 28.1 t -124.39 126.56 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.483 HD12 ' SD ' ' B' ' 45' ' ' MET . 9.6 mp -99.73 149.17 23.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.105 0.562 . . . . 0.0 109.887 -172.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.91 -6.3 31.97 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.957 0.903 . . . . 0.0 112.064 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 m-20 -68.23 -21.64 64.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.118 0.967 . . . . 0.0 112.025 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.31 17.77 16.8 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.126 -0.389 . . . . 0.0 112.126 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.681 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -123.78 174.8 7.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.692 0.797 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' B' ' 40' ' ' VAL . 79.4 tttt -145.47 140.48 27.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.91 121.17 16.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 -169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.99 166.35 15.56 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.744 0.688 . . . . 0.0 112.001 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' B' ' 9' ' ' LEU . 93.3 mt -134.59 105.02 6.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 166.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -109.86 118.98 37.91 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 74.2 p -80.78 140.91 35.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.467 0.307 . . . . 0.0 110.947 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 36.2 ptt180 -70.06 -18.56 63.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -170.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -79.09 -8.58 59.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -127.78 7.22 6.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.853 0.461 . . . . 0.0 111.107 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.522 HG23 ' HE1' ' B' ' 10' ' ' TYR . 8.0 p -75.6 150.08 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.271 -0.268 . . . . 0.0 110.897 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.65 116.71 24.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.634 0.774 . . . . 0.0 109.521 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 87.1 Cg_endo -76.51 140.47 65.68 Favored 'Cis proline' 0 C--N 1.388 2.647 0 C-N-CA 124.593 -1.003 . . . . 0.0 112.407 4.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 123.29 14.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.676 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . 0.475 ' HB1' ' HH ' ' B' ' 10' ' ' TYR . . . -148.74 170.96 17.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.716 1.206 . . . . 0.0 108.515 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.432 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 33.9 t -147.3 90.97 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.853 0.359 . . . . 0.0 110.42 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.52 143.4 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.717 0.807 . . . . 0.0 109.692 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.6 p -145.56 124.3 12.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.221 1.008 . . . . 0.0 108.716 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.67 -68.85 0.17 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.702 ' HA2' ' HD2' ' B' ' 114' ' ' ARG . . . -151.55 148.16 18.88 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.77 -23.39 0.2 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.683 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . -163.71 116.65 0.72 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -101.95 144.64 30.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 108.806 -171.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 tp -109.39 101.23 10.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.81 111.76 22.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.192 0.451 . . . . 0.0 111.462 -169.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.1 112.21 24.02 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.068 1.347 . . . . 0.0 107.446 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.432 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.8 mtm180 -90.16 127.84 36.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -174.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.5 160.1 40.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.283 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.445 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.4 pt-20 -67.54 -34.55 77.31 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -173.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.412 HD21 ' HG3' ' B' ' 73' ' ' GLU . 8.0 p30 -163.3 178.55 8.05 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.962 0.801 . . . . 0.0 112.562 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.85 -30.74 67.94 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.284 1.433 . . . . 0.0 112.567 -167.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.5 -46.5 76.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.076 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.445 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 60.9 mm-40 -63.6 -23.12 67.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.312 1.045 . . . . 0.0 112.465 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -42.25 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 121.325 0.583 . . . . 0.0 109.903 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.27 -29.1 60.06 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.296 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 28.8 mt-10 -71.97 -44.94 62.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.166 0.508 . . . . 0.0 109.853 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 57.4 m -64.79 -33.64 76.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.269 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.454 ' O ' ' HE1' ' B' ' 92' ' ' MET . 39.7 t80 -56.18 -59.86 4.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.719 0.807 . . . . 0.0 109.385 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.51 89.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.559 -173.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.75 96.71 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.652 0.595 . . . . 0.0 113.456 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -64.66 -42.05 95.67 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.261 0.625 . . . . 0.0 110.061 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -60.22 -42.41 95.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.511 0.724 . . . . 0.0 110.664 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.27 66.29 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.578 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 26.8 t -98.67 14.25 29.22 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.375 1.07 . . . . 0.0 112.545 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.25 29.25 34.12 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -86.56 130.51 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.89 99.34 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.799 0.84 . . . . 0.0 112.597 -172.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 8.2 ptm 49.31 81.5 0.05 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.823 1.649 . . . . 0.0 114.316 166.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.36 83.03 1.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.611 -0.68 . . . . 0.0 110.37 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 24.6 tm0? 178.14 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -77.95 116.46 58.71 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.473 -0.775 . . . . 0.0 108.925 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.94 111.05 0.19 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.994 3.129 . . . . 0.0 113.216 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.12 145.98 45.51 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 110.534 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -75.28 98.61 3.84 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.418 ' HG3' ' H ' ' B' ' 101' ' ' PHE . 35.5 tpp -78.35 163.36 25.75 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.0 0.92 . . . . 0.0 109.495 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.48 -28.87 68.68 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.149 0.579 . . . . 0.0 111.777 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.418 ' H ' ' HG3' ' B' ' 99' ' ' MET . 71.3 m-85 -99.37 15.04 27.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.944 0.898 . . . . 0.0 111.38 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' B' ' 99' ' ' MET . . . 119.5 179.9 16.63 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.512 167.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' B' ' 98' ' ' LYS . 36.0 t80 -73.4 102.92 3.89 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -109.81 158.3 18.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.432 0.634 . . . . 0.0 111.511 -169.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.439 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 3.6 t80 -143.99 142.24 30.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.396 1.478 . . . . 0.0 108.579 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.419 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 m -133.06 121.89 23.34 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.372 0.987 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.16 150.29 27.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.113 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.91 171.33 8.14 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 165.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.431 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.0 p-10 -142.27 -176.81 0.59 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.631 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 22.0 Cg_exo -37.65 -52.11 1.66 Allowed 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.302 2.668 . . . . 0.0 114.403 166.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.96 -14.16 59.88 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.9 0.48 . . . . 0.0 111.719 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m 71.96 52.33 0.21 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.884 1.274 . . . . 0.0 111.044 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -79.86 176.18 9.96 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.116 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.702 ' HD2' ' HA2' ' B' ' 64' ' ' GLY . 0.0 OUTLIER -125.33 104.32 8.41 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 34.3 mt -118.12 103.8 10.22 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.222 1.009 . . . . 0.0 109.35 -170.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 58.8 mtt-85 -87.04 147.07 25.86 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 123.075 0.55 . . . . 0.0 110.911 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.56 118.89 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 163.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.432 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 9.6 p90 -125.7 164.89 19.65 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.482 0.583 . . . . 0.0 110.879 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.81 111.16 12.81 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.9 119.08 16.64 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 118.333 0.515 . . . . 0.0 110.51 -172.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.91 111.44 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.985 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.146 178.628 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 m80 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.97 129.1 11.21 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.925 2.417 . . . . 0.0 112.308 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.6 p-10 -113.19 10.87 18.66 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.571 0.701 . . . . 0.0 110.281 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.65 120.81 30.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -168.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -118.2 138.01 52.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.762 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 63.2 mt -123.98 126.59 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 84.9 mt -97.56 159.59 14.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -106.85 135.62 48.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.051 0.94 . . . . 0.0 109.428 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.4 m -127.94 179.38 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.288 0.949 . . . . 0.0 109.724 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -136.42 47.62 2.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 16' ' ' ALA . 51.6 t30 167.48 83.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.367 -168.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.4 -53.64 6.56 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 122.618 2.212 . . . . 0.0 114.606 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.59 -64.89 0.16 Allowed 'Trans proline' 0 C--N 1.403 3.424 0 CA-C-N 122.267 1.845 . . . . 0.0 113.509 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . . . -79.27 -37.37 38.01 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.993 -164.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -79.22 -24.43 43.1 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.863 0.102 . . . . 0.0 110.883 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 26.3 m -73.68 -42.71 60.92 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 172.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -64.37 -28.57 69.78 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.258 173.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.01 -48.07 72.39 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.536 0.523 . . . . 0.0 109.705 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.455 ' HH ' HD22 ' A' ' 115' ' ' LEU . 31.9 m-85 -68.53 -29.8 68.46 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.431 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -57.86 -48.29 80.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 118.145 0.429 . . . . 0.0 111.999 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.97 63.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.783 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.25 -30.21 70.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.654 1.182 . . . . 0.0 112.654 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB2' HG22 ' A' ' 27' ' ' VAL . 73.4 mt -106.12 -28.81 10.26 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.886 0.874 . . . . 0.0 110.248 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.89 21.97 47.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.229 0.331 . . . . 0.0 112.709 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.1 m -116.15 -178.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.042 0.937 . . . . 0.0 111.002 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -134.91 153.73 78.82 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.929 0.892 . . . . 0.0 109.236 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.71 134.11 23.34 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.629 2.22 . . . . 0.0 112.131 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' HG2' ' A' ' 31' ' ' GLU . 6.0 p -69.82 -41.88 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 170.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 31.7 mm-40 -121.89 143.61 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.23 1.012 . . . . 0.0 109.027 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -140.31 141.09 35.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.2 m -144.21 161.86 42.88 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.66 1.184 . . . . 0.0 108.767 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -53.11 -28.93 43.25 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 123.056 2.504 . . . . 0.0 113.624 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 t -127.69 -3.43 5.97 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -139.51 141.07 37.33 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.385 0.539 . . . . 0.0 110.447 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 t -125.03 137.88 54.22 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.554 1.142 . . . . 0.0 108.773 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.9 tp -127.52 114.38 17.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HE1' ' HG ' ' A' ' 49' ' ' LEU . 2.7 p90 -129.68 108.35 10.13 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.98 1.312 . . . . 0.0 108.608 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 46' ' ' LYS . 20.5 t -89.85 134.54 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.421 HD13 ' SD ' ' A' ' 45' ' ' MET . 56.5 mt -95.4 140.33 30.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.615 0.366 . . . . 0.0 110.844 -173.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.2 27.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.524 1.13 . . . . 0.0 112.289 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' B' ' 5' ' ' ASP . 53.6 t30 -68.91 -15.68 63.55 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.588 1.155 . . . . 0.0 110.912 173.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.55 16.76 13.51 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 122.94 0.305 . . . . 0.0 113.172 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.536 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -126.38 176.04 7.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.404 0.682 . . . . 0.0 109.568 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG23 ' A' ' 40' ' ' VAL . 80.2 tttt -134.47 134.8 41.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.008 0.523 . . . . 0.0 109.887 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.463 HD11 HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -131.05 143.18 50.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 -173.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.31 169.17 18.27 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.028 0.823 . . . . 0.0 111.984 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HG ' ' HE1' ' A' ' 39' ' ' PHE . 80.8 mt -140.57 130.26 24.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.37 1.468 . . . . 0.0 107.768 164.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -127.92 128.37 45.0 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 49.6 m -80.42 125.17 29.6 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.977 0.511 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -65.62 -15.73 63.03 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.796 1.238 . . . . 0.0 114.283 -166.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -67.68 -24.01 65.37 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.187 0.595 . . . . 0.0 111.409 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -143.63 23.03 1.79 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.879 0.471 . . . . 0.0 110.617 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.47 150.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB2' ' HE1' ' B' ' 99' ' ' MET . 48.0 mt-10 -126.63 115.61 22.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.875 -0.516 . . . . 0.0 110.008 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 11.9 Cg_exo -70.65 142.63 72.78 Favored 'Cis proline' 0 C--N 1.387 2.574 0 CA-C-N 119.313 0.79 . . . . 0.0 112.519 -1.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.49 109.86 1.77 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.412 0.625 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.07 41.29 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 110.144 -168.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -79.62 88.94 5.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.2 m -126.48 131.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -158.77 123.96 4.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.301 1.44 . . . . 0.0 108.312 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.1 -36.14 0.71 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 113' ' ' HIS . . . 154.22 -62.39 0.36 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 69.03 -116.75 7.46 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -172.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.91 40.65 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.746 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 7.8 pt-20 -103.87 162.6 12.98 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.886 0.85 . . . . 0.0 112.124 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 47' ' ' LEU . 64.6 tp -119.08 102.5 8.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.069 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.9 115.1 23.32 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.394 0.543 . . . . 0.0 112.072 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.82 107.67 19.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.565 1.546 . . . . 0.0 108.431 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.67 133.89 34.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.568 . . . . 0.0 112.497 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -138.38 161.57 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.623 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.1 pt-20 -65.51 -42.1 92.43 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -171.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.4 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.4 p30 -158.65 179.83 8.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 111.812 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -56.07 -34.97 66.46 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.684 -166.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.68 -46.49 82.17 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.156 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 72.0 mm-40 -63.83 -24.31 67.7 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.964 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.19 -43.85 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.729 0.776 . . . . 0.0 110.271 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.88 -28.34 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.108 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.6 mt-10 -69.38 -45.04 70.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.35 0.595 . . . . 0.0 109.504 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -63.11 -36.24 82.93 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.404 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -54.8 -56.46 19.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.865 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.94 84.29 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.93 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.0 94.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.67 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.499 ' HB3' HG12 ' A' ' 90' ' ' VAL . 33.5 m0 -63.86 -44.89 91.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.467 0.707 . . . . 0.0 110.044 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.409 ' HB2' ' SD ' ' A' ' 92' ' ' MET . 32.2 ttpt -58.66 -42.26 88.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 110.582 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.57 65.15 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.804 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.0 m -103.38 17.8 23.25 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.314 1.046 . . . . 0.0 111.946 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.06 7.99 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 163.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 92' ' ' MET . 4.1 p -96.84 142.35 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -41.46 83.99 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.154 0.582 . . . . 0.0 111.374 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.607 ' HB3' HG13 ' A' ' 90' ' ' VAL . 9.6 ptm 48.26 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.919 1.687 . . . . 0.0 113.992 168.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.51 85.83 2.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.644 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 179.52 130.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.898 1.279 . . . . 0.0 108.703 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -82.57 115.0 55.79 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 166.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.63 118.2 3.91 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.163 2.575 . . . . 0.0 112.064 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.14 147.23 52.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.602 0.761 . . . . 0.0 110.167 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -68.44 123.03 19.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.421 0.688 . . . . 0.0 110.778 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' B' ' 56' ' ' GLU . 47.5 ttm -121.91 170.73 9.51 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.078 1.351 . . . . 0.0 109.283 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.12 -42.85 60.96 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.511 1.124 . . . . 0.0 112.283 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -90.55 1.22 56.93 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.317 0.647 . . . . 0.0 111.988 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.45 -172.37 18.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.285 168.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 119' ' ' ALA . 35.4 t80 -73.14 101.52 3.34 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -113.19 153.59 28.06 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.542 0.687 . . . . 0.0 111.369 -166.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.07 138.16 20.3 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.119 1.368 . . . . 0.0 108.528 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -129.64 125.4 36.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.588 0.631 . . . . 0.0 109.654 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.84 172.06 7.0 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.07 0.948 . . . . 0.0 110.839 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.27 124.25 25.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.609 0.763 . . . . 0.0 109.347 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 169.14 3.21 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 123.856 0.862 . . . . 0.0 111.572 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.73 -28.83 39.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.93 2.42 . . . . 0.0 113.069 168.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -93.56 13.97 20.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.205 1.002 . . . . 0.0 111.884 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m 54.96 81.19 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.57 1.548 . . . . 0.0 112.481 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.2 m170 -118.34 -173.26 2.43 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 12.1 mmm180 -121.76 112.64 18.64 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.455 HD22 ' HH ' ' A' ' 21' ' ' TYR . 71.4 mt -120.46 101.86 8.06 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -96.6 96.25 8.52 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -171.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -84.33 114.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -128.23 161.4 29.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.227 0.467 . . . . 0.0 111.365 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -118.23 117.84 30.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.984 0.914 . . . . 0.0 109.063 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -79.25 120.36 23.63 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.806 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.66 129.49 10.92 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.746 2.298 . . . . 0.0 112.231 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.536 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.2 p-10 -112.75 9.86 19.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.588 0.755 . . . . 0.0 110.299 171.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.7 120.73 30.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 138.03 52.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.746 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 48.7 mt -124.05 125.9 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 49' ' ' LEU . 11.2 mp -96.82 159.65 14.8 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.401 ' O ' ' NE2' ' B' ' 113' ' ' HIS . 15.4 p90 -107.05 135.14 49.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.169 0.988 . . . . 0.0 109.432 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' B' ' 51' ' ' SER . 21.2 m -127.59 179.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.29 0.95 . . . . 0.0 109.702 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.17 47.12 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 108.861 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' B' ' 16' ' ' ALA . 56.0 t30 167.67 83.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.451 -167.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.08 -53.31 6.97 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.519 2.146 . . . . 0.0 114.562 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.5 -65.38 0.14 Allowed 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.171 1.914 . . . . 0.0 113.41 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' ND2' ' B' ' 13' ' ' ASN . . . -79.09 -37.36 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.928 -164.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.9 t -78.96 -23.72 44.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.51 0.141 . . . . 0.0 110.807 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 92.3 m -74.77 -42.01 58.97 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -64.59 -28.89 69.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.98 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -65.66 -48.16 73.06 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.116 0.566 . . . . 0.0 109.949 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.445 ' HH ' HD22 ' B' ' 115' ' ' LEU . 35.2 m-85 -68.56 -29.77 68.4 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.66 175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 18' ' ' THR . 53.9 mtpt -57.63 -48.44 79.43 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.208 0.458 . . . . 0.0 112.03 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.4 -39.19 62.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.604 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.0 -29.93 69.99 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.929 1.292 . . . . 0.0 112.54 -174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.471 ' HB2' HG23 ' B' ' 27' ' ' VAL . 69.3 mt -106.4 -28.97 10.02 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.043 0.937 . . . . 0.0 110.212 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.2 21.54 48.71 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.336 0.398 . . . . 0.0 112.65 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' B' ' 25' ' ' LEU . 24.9 m -115.87 -178.59 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.125 0.97 . . . . 0.0 110.943 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -134.98 153.15 78.37 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 109.099 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.02 133.58 23.55 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.607 2.204 . . . . 0.0 112.377 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.424 HG11 ' HG2' ' B' ' 31' ' ' GLU . 5.6 p -68.87 -42.06 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.424 ' HG2' HG11 ' B' ' 30' ' ' VAL . 46.2 mm-40 -122.02 143.25 49.61 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 40.0 p -140.32 140.79 35.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.521 0.728 . . . . 0.0 109.214 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 73.3 m -144.3 162.13 41.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.775 1.23 . . . . 0.0 108.821 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -53.52 -28.56 45.77 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.128 2.552 . . . . 0.0 113.871 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -128.06 -3.35 5.74 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -139.53 141.72 37.27 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.759 0.709 . . . . 0.0 110.359 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -126.17 137.46 53.57 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.549 1.14 . . . . 0.0 108.903 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.57 114.97 18.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.522 ' HE1' ' HG ' ' B' ' 49' ' ' LEU . 2.6 p90 -129.86 108.61 10.28 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.928 1.291 . . . . 0.0 108.54 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.57 HG23 ' HG3' ' B' ' 46' ' ' LYS . 21.6 t -89.85 134.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.814 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.409 HD13 ' SD ' ' B' ' 45' ' ' MET . 53.9 mt -95.43 140.64 30.0 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 -173.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.05 -6.32 27.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.534 1.134 . . . . 0.0 112.371 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 5' ' ' ASP . 3.9 t30 -69.4 -15.48 63.31 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.066 0.946 . . . . 0.0 110.953 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 16.79 13.31 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 122.937 0.304 . . . . 0.0 113.313 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.52 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -126.13 175.97 7.38 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.53 0.732 . . . . 0.0 109.735 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' B' ' 40' ' ' VAL . 83.0 tttt -134.19 134.84 42.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.016 0.526 . . . . 0.0 109.862 -174.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.476 HD12 HD23 ' B' ' 68' ' ' LEU . 0.4 OUTLIER -131.2 142.94 50.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.786 0.434 . . . . 0.0 110.926 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.97 169.02 17.94 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 124.146 0.879 . . . . 0.0 111.88 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.522 ' HG ' ' HE1' ' B' ' 39' ' ' PHE . 81.3 mt -140.74 130.27 24.02 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.369 1.467 . . . . 0.0 107.947 164.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -128.23 128.15 44.17 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.6 m -80.41 125.14 29.55 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.886 0.474 . . . . 0.0 110.894 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -65.17 -16.01 63.05 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.971 1.309 . . . . 0.0 114.248 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -67.56 -23.55 65.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.261 0.625 . . . . 0.0 111.505 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.8 t -144.09 22.14 1.73 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.847 0.459 . . . . 0.0 110.421 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.18 150.47 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.259 0.623 . . . . 0.0 109.45 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.406 ' HB2' ' HE1' ' A' ' 99' ' ' MET . 49.5 mt-10 -126.78 117.36 22.46 Favored Pre-proline 0 N--CA 1.484 1.274 0 O-C-N 121.826 -0.546 . . . . 0.0 110.572 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.81 142.53 64.77 Favored 'Cis proline' 0 C--N 1.388 2.656 0 CA-C-N 119.362 0.808 . . . . 0.0 113.248 -4.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.04 110.57 1.85 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.238 0.615 . . . . 0.0 110.073 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.41 123.98 40.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.522 1.129 . . . . 0.0 110.094 -169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 52.9 m -79.04 88.91 4.78 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.5 131.21 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.56 124.18 4.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.254 1.422 . . . . 0.0 108.545 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -35.45 0.71 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' B' ' 113' ' ' HIS . . . 153.87 -62.72 0.37 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.577 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 69.25 -116.99 7.52 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -172.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 150.85 40.94 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 173.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.762 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 5.6 pt-20 -103.57 162.93 12.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.821 0.82 . . . . 0.0 112.219 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.476 HD23 HD12 ' B' ' 47' ' ' LEU . 59.4 tp -119.83 101.77 8.11 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.687 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.93 115.66 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.477 0.58 . . . . 0.0 112.025 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.32 107.09 18.97 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.544 1.538 . . . . 0.0 108.141 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.461 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.6 mtm180 -90.05 133.55 34.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.187 0.518 . . . . 0.0 112.134 -174.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -137.27 162.38 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.449 1.1 . . . . 0.0 110.6 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 16.1 pt-20 -65.41 -42.14 92.86 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.437 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -158.61 179.79 8.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.173 0.511 . . . . 0.0 112.367 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.44 -35.05 65.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.644 1.578 . . . . 0.0 112.741 -166.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.39 -46.01 81.79 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.048 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.574 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.7 mm-40 -64.24 -24.22 67.59 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.742 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.95 -43.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.761 0.791 . . . . 0.0 110.334 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -76.69 -28.26 55.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.843 -173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.8 mt-10 -68.89 -45.75 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 174.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -62.22 -35.97 80.54 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.732 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.432 ' O ' ' HE1' ' B' ' 92' ' ' MET . 31.0 t80 -56.18 -56.01 26.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.078 0.951 . . . . 0.0 109.745 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.8 84.26 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.687 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.97 -40.49 95.31 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.858 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.47 -44.78 93.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.637 0.775 . . . . 0.0 110.211 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.16 -41.2 92.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.42 0.688 . . . . 0.0 110.487 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.86 -26.96 64.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.791 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 43.6 m -103.82 17.88 23.15 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.269 1.028 . . . . 0.0 111.823 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.07 47.29 8.53 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 163.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.45 141.16 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.88 87.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.231 0.612 . . . . 0.0 111.336 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 7.7 ptp 48.02 82.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.789 1.636 . . . . 0.0 114.289 168.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.15 84.78 2.03 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.735 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -178.31 131.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.978 1.311 . . . . 0.0 108.608 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -82.7 114.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.521 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 6.2 Cg_endo -50.24 118.39 3.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.227 2.618 . . . . 0.0 112.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.57 148.56 52.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.593 0.757 . . . . 0.0 110.375 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.533 ' HZ2' ' HB2' ' B' ' 103' ' ' TYR . 0.3 OUTLIER -70.2 123.19 21.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.604 0.762 . . . . 0.0 109.986 178.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.4 ' HE1' ' HB2' ' A' ' 56' ' ' GLU . 45.7 ttm -121.94 170.84 9.4 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.934 1.293 . . . . 0.0 109.052 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.6 -43.3 56.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.714 1.206 . . . . 0.0 112.236 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.69 1.39 56.88 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.261 0.624 . . . . 0.0 112.184 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 127.69 -172.18 18.95 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.332 -0.395 . . . . 0.0 113.39 169.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.533 ' HB2' ' HZ2' ' B' ' 98' ' ' LYS . 34.3 t80 -75.09 101.75 4.65 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -113.39 153.5 28.47 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.405 0.621 . . . . 0.0 111.404 -165.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 3.5 t80 -149.86 138.44 20.76 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.119 1.368 . . . . 0.0 108.488 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.528 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 m -129.7 125.81 36.81 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.1 172.1 6.99 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.07 0.948 . . . . 0.0 110.959 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.04 125.68 28.58 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.576 0.75 . . . . 0.0 109.224 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.16 170.87 3.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.932 0.893 . . . . 0.0 110.912 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.4 -28.1 52.17 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.815 2.343 . . . . 0.0 112.722 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.67 13.79 21.09 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.031 0.932 . . . . 0.0 111.76 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m 55.25 80.97 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.25 1.42 . . . . 0.0 112.506 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.472 ' HA ' ' HA2' ' B' ' 64' ' ' GLY . 16.4 m170 -118.25 -173.03 2.38 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.612 ' HB3' ' HB3' ' B' ' 67' ' ' GLU . 10.9 mmm180 -121.49 112.65 18.77 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.445 HD22 ' HH ' ' B' ' 21' ' ' TYR . 71.9 mt -120.28 101.72 8.0 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -94.41 95.13 8.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.51 115.17 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -128.14 161.61 28.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.372 0.533 . . . . 0.0 111.502 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -118.24 118.97 33.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 0.0 108.805 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -81.12 127.04 32.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.48 94.32 4.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.018 0.927 . . . . 0.0 108.527 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.789 -1.006 . . . . 0.0 111.342 -179.366 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.432 ' HB3' HD22 ' B' ' 43' ' ' ASN . 15.4 m170 . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 119.559 -0.258 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.97 156.79 3.33 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.905 2.403 . . . . 0.0 112.815 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.2 p-10 -148.38 16.83 1.04 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.39 1.076 . . . . 0.0 109.662 167.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.09 136.67 49.58 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -144.95 140.59 28.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.579 HG12 ' HA3' ' A' ' 48' ' ' GLY . 19.4 mt -122.84 131.93 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.396 0.678 . . . . 0.0 109.664 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD23 HD22 ' A' ' 47' ' ' LEU . 4.0 mm? -103.06 145.21 30.24 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -98.28 127.51 44.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 m -127.82 160.96 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.34 0.656 . . . . 0.0 109.966 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.78 -60.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.103 0.961 . . . . 0.0 110.963 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -95.6 99.08 4.27 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 123.418 0.687 . . . . 0.0 109.728 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.05 -54.0 5.81 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 123.129 2.552 . . . . 0.0 115.639 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.79 -53.74 4.12 Favored 'Trans proline' 0 C--N 1.4 3.277 0 CA-C-N 122.363 1.88 . . . . 0.0 112.323 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.44 88.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.512 -168.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -79.88 -26.78 40.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.319 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -72.43 -38.67 68.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.071 0.462 . . . . 0.0 112.003 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.6 mm-40 -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.837 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.0 t80 -67.01 -42.32 85.15 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.631 0.582 . . . . 0.0 109.649 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -71.37 -29.81 65.4 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.008 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 53.3 mtpt -57.65 -49.78 75.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 111.875 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.58 -30.59 57.07 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.1 tp -62.44 -52.65 62.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.597 1.159 . . . . 0.0 111.785 -177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.4 mt -82.48 -40.62 20.84 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.456 1.102 . . . . 0.0 108.99 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.48 25.5 10.02 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.184 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 25' ' ' LEU . 28.3 m -126.21 177.89 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.854 0.861 . . . . 0.0 110.63 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.07 154.92 76.62 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.504 1.122 . . . . 0.0 108.644 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.61 125.07 13.72 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 121.96 1.773 . . . . 0.0 111.966 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.406 HG13 ' HG2' ' A' ' 31' ' ' GLU . 6.7 p -71.58 -39.83 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.17 0.51 . . . . 0.0 109.645 171.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.6 mm-40 -115.55 113.31 23.45 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 p -114.74 147.87 39.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.423 0.689 . . . . 0.0 110.877 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.3 t -148.29 151.7 37.57 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.76 1.224 . . . . 0.0 108.228 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.54 -20.61 69.34 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.349 2.033 . . . . 0.0 112.94 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -128.73 13.69 6.41 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -157.35 158.14 35.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 35.6 t -145.99 141.96 28.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.583 0.753 . . . . 0.0 109.018 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.5 tm? -137.59 114.67 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.22 112.95 15.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.463 1.105 . . . . 0.0 109.078 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 46' ' ' LYS . 14.8 t -93.47 128.02 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.443 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.1 mt -91.37 141.82 28.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 110.068 -168.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.98 -9.61 40.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.676 0.791 . . . . 0.0 112.082 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.596 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 4.6 m-20 -69.5 -1.21 8.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.14 0.976 . . . . 0.0 112.91 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.0 48.81 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 117.813 0.279 . . . . 0.0 112.706 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.72 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -129.07 172.54 11.29 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.659 0.784 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -128.33 135.98 50.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.582 0.753 . . . . 0.0 109.264 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.473 HD11 HD13 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -131.25 124.73 31.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.579 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -100.34 166.85 19.97 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 37' ' ' SER . 10.1 tp -143.52 105.31 4.34 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.41 ' HB2' HG21 ' A' ' 8' ' ' ILE . 2.8 t90 -105.09 131.78 52.15 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -73.35 126.45 30.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -68.75 -13.0 62.11 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 112.558 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -81.77 -8.25 59.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.236 0.614 . . . . 0.0 111.311 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 t -136.58 10.82 3.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 111.177 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.4 146.91 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.04 107.99 10.5 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.633 0.773 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HD3' ' HG3' ' B' ' 94' ' ' GLN . 93.7 Cg_endo -73.74 133.47 30.97 Favored 'Cis proline' 0 C--N 1.382 2.307 0 CA-C-N 120.541 1.229 . . . . 0.0 114.157 13.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -59.74 124.74 21.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.577 1.151 . . . . 0.0 110.8 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.97 108.1 3.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.856 0.863 . . . . 0.0 109.535 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.7 t -89.41 87.0 6.92 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.75 138.22 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 109.252 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 p -150.44 122.28 8.13 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.5 -92.06 0.14 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.83 64.14 3.96 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 123.011 0.338 . . . . 0.0 112.495 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' B' ' 65' ' ' GLY . . . -98.83 173.91 27.32 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.54 159.27 45.48 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.632 -0.538 . . . . 0.0 112.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 9.6 pt-20 -102.31 145.44 29.46 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.603 0.701 . . . . 0.0 111.145 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.77 102.76 11.52 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 108.009 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.79 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -89.25 114.91 26.32 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.01 0.433 . . . . 0.0 112.035 -168.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.78 120.31 33.89 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.015 1.326 . . . . 0.0 108.374 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 32.3 mtm180 -96.4 127.48 42.43 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.812 0.815 . . . . 0.0 112.302 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.16 157.62 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.916 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -68.21 -34.87 77.04 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.89 -179.43 6.28 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.978 0.808 . . . . 0.0 112.752 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.35 -31.72 69.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.483 1.513 . . . . 0.0 113.016 -166.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.89 -44.87 79.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.08 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -65.82 -24.31 66.87 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.65 -44.91 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.574 0.749 . . . . 0.0 109.973 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.62 -28.34 56.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.694 0.798 . . . . 0.0 111.509 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 31.7 mt-10 -62.03 -44.24 97.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.611 0.719 . . . . 0.0 109.534 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -69.61 -35.0 74.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.988 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -54.52 -59.9 4.07 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.555 1.142 . . . . 0.0 109.977 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.463 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -64.42 -35.37 80.69 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.589 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.87 -46.81 79.97 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.836 0.71 . . . . 0.0 113.994 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -65.68 -40.82 92.77 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.898 0.479 . . . . 0.0 109.76 175.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.9 ttpt -57.64 -45.09 85.91 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.61 0.764 . . . . 0.0 110.479 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.75 -24.28 61.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -98.11 14.56 27.15 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.937 0.895 . . . . 0.0 111.689 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.86 41.17 8.31 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 115.222 164.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.1 p -89.21 149.4 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.04 -54.44 11.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.961 0.504 . . . . 0.0 110.796 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.502 ' HB2' HG13 ' A' ' 90' ' ' VAL . 47.5 ttm 68.67 84.94 0.14 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.246 0.966 . . . . 0.0 113.027 169.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.85 84.38 2.16 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.553 0.692 . . . . 0.0 110.965 173.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 178.04 122.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.768 1.627 . . . . 0.0 107.736 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.02 121.8 86.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 0.0 109.72 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 46.3 Cg_endo -64.95 108.34 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.766 2.31 . . . . 0.0 110.084 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.15 48.71 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.207 0.603 . . . . 0.0 110.543 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HZ1' ' HB2' ' A' ' 103' ' ' TYR . 5.0 mmtm -67.81 131.63 45.89 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.421 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.499 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 12.4 ttt -141.04 -178.07 5.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.016 0.926 . . . . 0.0 109.245 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' H ' ' HG2' ' A' ' 99' ' ' MET . 7.4 mp0 -58.8 -37.36 76.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.609 1.164 . . . . 0.0 111.899 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 33.9 m-85 -84.33 -8.4 59.02 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.84 0.856 . . . . 0.0 111.119 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 116.41 -157.12 15.22 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.493 ' HB2' ' HZ1' ' A' ' 98' ' ' LYS . 26.9 t80 -79.35 103.48 9.3 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.916 0.858 . . . . 0.0 108.956 -176.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.439 HG23 ' SD ' ' A' ' 99' ' ' MET . 13.1 t -109.48 152.76 24.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.38 0.61 . . . . 0.0 110.84 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 6.5 t80 -143.19 145.22 32.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.921 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 m -135.73 132.65 37.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.485 0.584 . . . . 0.0 110.591 172.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.58 172.59 6.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.67 0.788 . . . . 0.0 110.341 170.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.64 116.06 12.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.511 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 7.2 p-10 -71.26 171.45 8.71 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 123.309 0.644 . . . . 0.0 110.277 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 9.6 Cg_endo -50.62 -40.09 55.63 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.873 2.382 . . . . 0.0 113.463 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.12 -1.04 54.23 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.637 0.775 . . . . 0.0 110.73 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m 64.6 75.24 0.38 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.784 1.234 . . . . 0.0 112.08 164.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.45 162.65 22.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 1.1 mpt_? -90.35 111.27 22.43 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.51 104.19 16.2 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.79 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 7.4 tpt180 -89.49 146.09 24.86 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.198 0.599 . . . . 0.0 110.144 -172.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.26 122.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 164.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.532 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 5.3 p90 -127.48 156.82 41.53 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.602 0.637 . . . . 0.0 110.928 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.409 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.48 112.57 17.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 171.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 49.7 t80 -77.74 116.39 18.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -171.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.644 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.579 178.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 29.2 m80 . . . . . 0 CA--C 1.55 0.973 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -91.83 155.4 3.4 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.983 2.456 . . . . 0.0 112.959 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.72 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 4.5 p-10 -146.58 17.28 1.3 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.301 1.04 . . . . 0.0 110.155 167.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.5 136.65 49.18 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.84 140.67 28.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.404 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 11.2 mt -122.9 132.43 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.341 0.656 . . . . 0.0 109.545 -176.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.96 145.37 30.51 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -99.29 127.35 45.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.465 1.106 . . . . 0.0 110.517 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.67 160.9 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.241 0.616 . . . . 0.0 109.95 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -95.54 -60.9 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.278 1.031 . . . . 0.0 110.883 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -95.93 99.05 4.48 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 123.564 0.746 . . . . 0.0 109.333 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.76 -54.86 4.39 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.107 2.538 . . . . 0.0 115.552 -169.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 -54.15 4.22 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 122.461 1.915 . . . . 0.0 112.123 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.83 89.06 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.465 -168.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 85.9 p -79.5 -27.82 41.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 39.9 m -71.32 -38.97 71.67 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.527 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 83.0 mm-40 -65.6 -33.93 77.05 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.729 172.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 53.2 t80 -66.79 -41.96 86.76 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -71.82 -29.69 64.69 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.258 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.527 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 10.3 mtpm? -57.87 -49.1 77.87 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.267 0.485 . . . . 0.0 112.177 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.68 57.15 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.656 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.486 HD13 HD12 ' B' ' 115' ' ' LEU . 13.4 tp -62.75 -52.78 61.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.447 1.099 . . . . 0.0 112.014 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.0 mt -82.21 -40.55 21.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.913 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.01 9.82 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.011 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.0 m -125.88 178.39 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.97 155.27 77.97 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.166 0.986 . . . . 0.0 108.526 171.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.34 124.59 13.13 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.125 1.884 . . . . 0.0 112.172 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.5 p -71.22 -40.4 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.08 0.552 . . . . 0.0 109.588 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 68.0 mm-40 -114.35 113.84 25.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 73.8 p -115.33 147.96 39.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.999 0.52 . . . . 0.0 110.83 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.2 t -148.48 151.27 35.97 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.532 1.133 . . . . 0.0 108.34 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.96 -20.68 68.38 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.424 2.082 . . . . 0.0 113.117 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -128.66 13.62 6.44 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -157.13 158.37 36.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.843 -0.536 . . . . 0.0 109.688 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . 34.7 t -146.07 141.83 27.97 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 109.086 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.637 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -137.52 114.6 10.79 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.04 113.08 15.97 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.527 1.131 . . . . 0.0 109.15 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' B' ' 46' ' ' LYS . 17.2 t -93.69 127.55 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.341 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.518 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.2 mt -91.26 141.36 28.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.062 0.545 . . . . 0.0 110.227 -169.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.36 -9.4 33.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.038 0.935 . . . . 0.0 112.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 4.2 m-20 -69.61 -1.93 10.21 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.159 0.983 . . . . 0.0 112.679 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.25 17.51 46.33 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.723 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.685 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -128.92 173.08 10.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.549 0.74 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.541 ' HG3' HG21 ' B' ' 40' ' ' VAL . 87.8 tttt -128.66 136.25 50.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.403 0.681 . . . . 0.0 109.482 -176.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.478 HD11 HD13 ' B' ' 41' ' ' LEU . 0.7 OUTLIER -131.06 124.68 31.38 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.27 166.36 20.93 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' B' ' 37' ' ' SER . 9.5 tp -143.46 105.07 4.32 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -105.08 132.06 51.78 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 52.8 m -73.54 126.17 29.62 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -68.64 -13.12 62.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.581 0.752 . . . . 0.0 112.552 -172.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -81.41 -8.35 59.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.309 0.644 . . . . 0.0 111.331 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.3 t -136.59 10.87 3.18 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.255 0.622 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.82 146.99 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.97 108.85 10.64 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.584 0.754 . . . . 0.0 109.049 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.57 134.04 32.64 Favored 'Cis proline' 0 C--N 1.383 2.381 0 CA-C-N 120.339 1.157 . . . . 0.0 114.215 11.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -60.61 124.06 19.26 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.651 1.181 . . . . 0.0 111.22 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.32 108.02 3.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 109.508 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.4 p -89.2 86.07 6.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.32 140.43 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.166 0.986 . . . . 0.0 108.584 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -152.33 122.31 7.06 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.9 -91.84 0.14 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.22 63.81 4.29 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 123.041 0.353 . . . . 0.0 113.315 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' A' ' 65' ' ' GLY . . . -99.43 173.98 26.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.915 -0.381 . . . . 0.0 112.27 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.53 159.6 45.03 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 124.019 0.482 . . . . 0.0 112.097 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' B' ' 114' ' ' ARG . 9.2 pt-20 -101.99 145.35 29.4 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.458 0.647 . . . . 0.0 110.895 -176.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -110.06 102.92 11.59 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.737 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.29 114.83 26.25 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.183 0.516 . . . . 0.0 111.933 -168.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -93.36 120.51 33.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.041 1.336 . . . . 0.0 108.523 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.481 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 33.3 mtm105 -97.36 126.08 42.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.64 0.734 . . . . 0.0 112.188 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.98 157.82 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.348 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.1 pt-20 -67.04 -35.11 79.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -164.45 -179.05 5.76 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.91 -31.75 70.11 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.688 -166.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.28 -45.34 80.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.01 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.433 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 83.1 mm-40 -65.42 -24.1 67.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.261 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.68 -44.51 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.382 0.673 . . . . 0.0 109.858 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.21 -28.15 53.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.587 0.755 . . . . 0.0 111.364 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 40.4 mt-10 -62.54 -43.85 97.8 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.758 0.79 . . . . 0.0 109.325 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 54.3 m -69.89 -35.02 74.3 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.14 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -54.59 -59.68 4.37 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.47 1.108 . . . . 0.0 110.223 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -64.67 -34.87 79.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.539 -175.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.88 -47.29 76.3 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 123.729 0.643 . . . . 0.0 113.804 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.54 -41.09 93.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 34.3 ttpt -57.27 -45.0 84.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.591 0.756 . . . . 0.0 110.482 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.62 61.62 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.072 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -97.5 14.82 25.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.041 0.937 . . . . 0.0 111.931 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.67 41.43 8.29 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' B' ' 92' ' ' MET . 3.3 p -89.6 149.4 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.25 -54.69 10.03 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.795 0.438 . . . . 0.0 110.691 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.519 ' HB2' HG11 ' B' ' 90' ' ' VAL . 49.1 ttm 68.76 84.99 0.14 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.944 0.777 . . . . 0.0 112.922 168.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.94 84.29 2.14 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 121.571 0.701 . . . . 0.0 110.821 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.413 ' HG3' ' HD3' ' A' ' 57' ' ' PRO . 24.1 tm0? 178.27 122.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.468 1.507 . . . . 0.0 107.14 173.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.41 120.63 82.55 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.366 0.667 . . . . 0.0 109.939 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.542 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 37.0 Cg_endo -63.38 108.41 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.795 2.33 . . . . 0.0 110.514 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.49 156.62 47.93 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.011 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -68.31 131.89 46.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.283 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.489 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 8.8 ttt -141.19 -178.42 5.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.96 0.904 . . . . 0.0 108.897 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . 0.489 ' H ' ' HG2' ' B' ' 99' ' ' MET . 7.3 mp0 -58.55 -37.61 76.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.429 1.092 . . . . 0.0 112.187 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -83.61 -8.69 59.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.778 0.831 . . . . 0.0 111.16 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 116.76 -156.65 15.5 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -79.61 103.49 9.55 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.044 0.922 . . . . 0.0 108.92 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.474 HG23 ' SD ' ' B' ' 99' ' ' MET . 14.8 t -109.75 152.47 25.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.958 0.503 . . . . 0.0 110.582 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.542 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 7.3 t80 -142.98 144.72 32.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.8 1.24 . . . . 0.0 109.971 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -135.17 132.16 37.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.417 0.553 . . . . 0.0 110.705 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.56 172.63 6.71 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.718 0.807 . . . . 0.0 110.35 170.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.87 115.39 11.92 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.513 ' HB3' HD11 ' B' ' 115' ' ' LEU . 4.3 p-10 -69.8 170.83 8.54 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.58 0.752 . . . . 0.0 110.728 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 9.6 Cg_endo -50.66 -40.18 55.91 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.789 2.326 . . . . 0.0 113.199 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.76 -0.87 52.75 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.482 0.713 . . . . 0.0 111.053 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.0 m 64.17 74.75 0.4 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.741 1.217 . . . . 0.0 112.043 165.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -122.62 162.61 21.58 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 166.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 2.6 mpt_? -90.01 112.08 23.39 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' B' ' 109' ' ' ASP . 33.0 mt -98.97 104.37 16.4 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.737 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 30.4 mmt180 -87.55 146.24 25.87 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 123.804 0.841 . . . . 0.0 110.834 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 t -139.56 122.01 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 163.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.481 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.0 p90 -127.13 156.56 41.56 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.866 0.757 . . . . 0.0 111.132 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.409 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -123.57 112.52 17.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.38 118.76 20.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.4 94.35 6.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.347 -179.388 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.471 ' HB3' ' ND2' ' B' ' 43' ' ' ASN . 17.9 m-70 . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HG3' HD23 ' B' ' 25' ' ' LEU . 51.2 Cg_endo -90.83 48.65 0.75 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.361 2.708 . . . . 0.0 112.672 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.566 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 5.9 p-10 -75.47 14.81 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.173 0.989 . . . . 0.0 112.609 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.464 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.2 t80 -133.37 129.93 38.1 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.134 1.374 . . . . 0.0 108.137 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 8.2 t -127.33 140.86 51.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.237 1.015 . . . . 0.0 108.576 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 61.4 mt -118.8 137.24 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.494 HD21 HD23 ' A' ' 47' ' ' LEU . 4.3 mm? -96.72 146.28 25.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.572 ' HE1' HG21 ' A' ' 55' ' ' VAL . 22.8 t80 -101.32 95.72 6.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.341 -167.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.443 HG11 ' HE1' ' A' ' 113' ' ' HIS . 27.0 m -108.87 -179.85 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.33 -53.87 1.7 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.876 0.47 . . . . 0.0 110.258 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.74 105.55 9.19 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 123.567 0.747 . . . . 0.0 110.764 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.68 -55.48 3.5 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 C-N-CA 122.735 2.29 . . . . 0.0 114.081 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.44 -58.9 0.5 Allowed 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 122.271 1.847 . . . . 0.0 112.312 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.71 95.51 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.337 -166.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.9 p -76.68 -34.83 58.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.287 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 99.3 m -69.11 -39.12 79.14 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.55 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 12.4 mm100 -64.3 -35.47 80.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.411 172.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 77.7 t80 -68.28 -39.46 82.14 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.27 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -70.41 -30.55 67.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.208 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.4 mtpt -57.13 -47.76 80.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.946 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.28 -34.53 55.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.223 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.0 tp -61.13 -31.46 71.16 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.861 1.265 . . . . 0.0 112.646 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.558 HD23 ' HG3' ' B' ' 4' ' ' PRO . 87.3 mt -105.46 -40.08 5.92 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.364 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.34 29.65 10.0 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.51 -179.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.218 1.007 . . . . 0.0 109.616 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.83 150.8 68.93 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.546 0.738 . . . . 0.0 109.078 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.97 111.9 2.78 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.812 2.342 . . . . 0.0 112.099 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -64.02 -42.28 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.759 0.824 . . . . 0.0 110.598 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 28.5 mm-40 -111.49 145.49 38.94 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -154.55 152.23 29.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.326 0.584 . . . . 0.0 109.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 15.2 m -139.86 163.95 41.2 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.44 1.496 . . . . 0.0 107.655 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.19 -30.51 80.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.331 2.021 . . . . 0.0 113.069 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -130.04 23.11 5.29 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.548 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 88.7 t80 -153.63 159.28 42.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.091 0.556 . . . . 0.0 109.72 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.4 m -149.36 154.56 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 110.077 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -148.36 123.14 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.96 131.54 47.49 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.961 1.304 . . . . 0.0 108.46 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 46' ' ' LYS . 33.8 t -109.6 126.29 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.74 0.816 . . . . 0.0 109.175 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.31 145.17 26.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.219 0.608 . . . . 0.0 109.652 -170.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.66 -5.56 12.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.974 0.91 . . . . 0.0 112.585 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -67.06 -9.12 35.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.445 1.098 . . . . 0.0 112.743 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.69 59.68 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -119.98 164.22 16.42 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.125 0.97 . . . . 0.0 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 40' ' ' VAL . 73.6 tttt -132.02 138.83 48.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.494 HD23 HD21 ' A' ' 9' ' ' LEU . 1.2 tt -137.24 122.6 19.45 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.464 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -102.96 170.11 19.58 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.95 0.786 . . . . 0.0 111.653 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.73 109.59 5.77 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.454 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 1.9 t-105 -109.26 127.75 54.52 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -79.59 122.86 27.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.006 0.522 . . . . 0.0 110.118 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.35 -15.87 63.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.399 1.08 . . . . 0.0 112.686 -169.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -72.03 -8.88 57.11 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 122.842 0.457 . . . . 0.0 111.233 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -135.1 6.36 3.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.334 0.653 . . . . 0.0 111.244 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.572 HG21 ' HE1' ' A' ' 10' ' ' TYR . 8.3 p -62.75 148.63 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.539 0.335 . . . . 0.0 111.34 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -122.98 113.9 29.76 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.356 0.663 . . . . 0.0 109.783 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.41 144.92 80.67 Favored 'Cis proline' 0 C--N 1.379 2.174 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.084 1.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -52.86 128.29 26.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.66 1.184 . . . . 0.0 112.218 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . . . -150.87 121.14 7.28 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.236 0.614 . . . . 0.0 110.98 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -91.29 86.94 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.34 124.64 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -152.33 123.69 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.114 1.366 . . . . 0.0 107.98 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.63 67.43 0.02 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -82.09 1.69 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.0 -142.92 45.68 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.377 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' B' ' 66' ' ' GLY . . . -65.96 151.76 51.93 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.2 mt-10 -102.14 152.89 20.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.164 0.507 . . . . 0.0 110.585 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.4 tp -118.84 102.23 8.65 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.08 115.63 26.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.19 0.519 . . . . 0.0 111.332 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 30.8 m-85 -95.38 108.25 20.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 0.0 108.235 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -92.38 128.08 38.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.586 0.707 . . . . 0.0 111.975 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.8 m -128.41 160.95 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.962 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 13.0 pt-20 -66.79 -35.19 79.49 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.457 HD21 ' HG3' ' A' ' 73' ' ' GLU . 7.3 p30 -165.05 178.56 6.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.7 0.682 . . . . 0.0 112.281 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.16 -31.98 63.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.786 1.634 . . . . 0.0 113.1 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.25 -46.87 84.87 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 123.902 0.751 . . . . 0.0 110.101 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.564 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 83.3 mm-40 -67.9 -23.03 65.06 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.653 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.62 -41.68 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.65 0.738 . . . . 0.0 109.904 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.27 -33.82 65.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 110.971 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 41.5 mt-10 -65.91 -44.69 84.45 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.626 0.727 . . . . 0.0 109.312 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -63.49 -37.61 87.95 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.952 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -55.13 -61.54 2.25 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.271 1.029 . . . . 0.0 110.466 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -68.79 -32.69 72.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.301 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.24 -46.39 90.99 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.483 0.489 . . . . 0.0 112.94 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.52 -43.74 98.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.258 0.623 . . . . 0.0 109.529 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -55.84 -45.76 78.31 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.451 0.7 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.74 61.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.297 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 t -100.56 4.1 43.22 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 111.829 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.57 52.91 2.72 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.401 167.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' A' ' 92' ' ' MET . 4.8 p -94.76 153.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.14 -53.93 15.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.698 0.399 . . . . 0.0 110.771 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.523 ' HB2' HG11 ' A' ' 90' ' ' VAL . 48.6 ttm 64.53 83.8 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 169.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 82.55 1.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.305 0.574 . . . . 0.0 110.599 173.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HB2' ' HD3' ' B' ' 57' ' ' PRO . 56.9 tp60 176.71 130.46 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.867 1.667 . . . . 0.0 108.303 172.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -82.15 123.68 79.3 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.438 ' HB2' ' HH ' ' A' ' 103' ' ' TYR . 73.5 Cg_exo -48.19 107.05 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.469 2.779 . . . . 0.0 111.972 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.06 50.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.777 0.831 . . . . 0.0 111.254 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 98' ' ' LYS . 2.2 mmmm -70.77 100.63 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.545 0.738 . . . . 0.0 110.308 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.7 ttm -101.34 169.4 8.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.258 1.023 . . . . 0.0 108.815 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.12 -41.6 48.97 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.35 1.06 . . . . 0.0 112.136 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.08 -12.12 60.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.581 0.752 . . . . 0.0 111.164 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.96 -173.5 21.55 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.467 0.556 . . . . 0.0 111.933 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.438 ' HH ' ' HB2' ' A' ' 96' ' ' PRO . 28.4 t80 -77.14 100.81 5.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.2 t -113.44 147.5 37.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -167.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -140.78 134.21 29.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.098 0.959 . . . . 0.0 109.296 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.8 m -120.26 118.26 29.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.796 0.438 . . . . 0.0 110.272 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.01 169.69 8.35 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.143 0.577 . . . . 0.0 109.894 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.85 127.73 29.39 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.73 169.53 2.5 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.542 0.737 . . . . 0.0 110.791 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -49.51 -31.81 25.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.573 2.182 . . . . 0.0 112.444 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.52 4.0 41.76 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.543 1.137 . . . . 0.0 112.263 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.4 m 59.31 84.2 0.12 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.702 1.201 . . . . 0.0 112.259 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.443 ' HE1' HG11 ' A' ' 11' ' ' VAL . 22.5 m170 -122.73 176.57 5.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.075 0.55 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 67' ' ' GLU . 24.9 mmt180 -100.3 112.46 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.1 mt -111.78 100.32 8.84 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -99.5 93.33 5.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.247 0.219 . . . . 0.0 110.971 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.48 116.21 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -125.19 168.49 13.37 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.027 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.85 112.04 13.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.75 114.42 18.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.648 0 C-N-CA 123.576 0.75 . . . . 0.0 109.535 -179.353 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.558 ' HG3' HD23 ' A' ' 25' ' ' LEU . 54.3 Cg_endo -90.57 49.69 0.89 Allowed 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.444 2.762 . . . . 0.0 112.851 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.457 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.9 p-10 -75.69 14.24 0.67 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.304 1.041 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.466 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.3 t80 -133.48 129.25 36.94 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.222 1.409 . . . . 0.0 108.2 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 8.2 t -126.85 141.3 51.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 55.6 mt -119.79 137.19 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.55 145.43 25.72 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.47 97.74 8.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.223 -169.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.433 HG11 ' HE1' ' B' ' 113' ' ' HIS . 30.5 m -109.14 179.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -123.78 -53.45 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.727 0.411 . . . . 0.0 110.405 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.11 105.12 8.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 123.635 0.774 . . . . 0.0 109.828 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.23 -55.25 3.83 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.576 2.184 . . . . 0.0 114.357 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 -58.63 0.52 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 CA-C-N 122.243 1.837 . . . . 0.0 112.248 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.36 -44.37 94.98 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.282 -166.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m -76.35 -34.57 58.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.662 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 63.3 m -69.34 -39.43 78.15 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.9 mm-40 -63.89 -35.89 82.15 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.527 172.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 58.2 t80 -68.08 -39.51 82.89 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.322 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -70.18 -30.64 67.81 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.329 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 61.2 mtpt -57.07 -47.63 80.52 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.59 -34.52 53.49 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.264 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 11.8 tp -60.66 -31.93 71.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.699 1.2 . . . . 0.0 112.641 -177.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.509 HD23 ' HG3' ' A' ' 4' ' ' PRO . 91.4 mt -105.07 -40.26 5.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.511 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.38 29.62 10.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 123.725 0.64 . . . . 0.0 111.823 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' B' ' 25' ' ' LEU . 29.4 m -126.62 -179.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.318 1.047 . . . . 0.0 109.809 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.33 150.81 70.0 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.432 0.693 . . . . 0.0 109.209 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 54.6 Cg_endo -68.53 111.92 2.69 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.469 2.113 . . . . 0.0 112.26 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 p -64.17 -42.33 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.773 0.829 . . . . 0.0 110.287 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.556 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 18.9 mm-40 -111.41 145.93 38.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 108.302 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -154.85 152.05 29.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.279 0.562 . . . . 0.0 110.014 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.542 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 24.9 m -139.39 163.4 45.8 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.401 1.48 . . . . 0.0 107.616 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.77 -30.99 69.96 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.483 2.122 . . . . 0.0 113.325 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -130.29 23.0 5.19 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.542 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 70.0 t80 -153.75 159.2 41.87 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -149.37 154.42 38.9 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.826 0.851 . . . . 0.0 109.955 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -148.2 122.91 9.88 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.6 p90 -128.6 132.58 48.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.853 1.261 . . . . 0.0 108.544 173.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.537 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.5 t -109.99 126.47 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.667 0.787 . . . . 0.0 109.143 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.38 145.15 27.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.174 0.589 . . . . 0.0 109.537 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.16 -5.66 14.51 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.876 0.87 . . . . 0.0 112.655 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.56 ' HB2' ' HG2' ' B' ' 45' ' ' MET . 13.5 m120 -65.8 -10.42 37.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.642 1.177 . . . . 0.0 112.649 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.53 58.58 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 14.9 ptm -118.76 165.2 14.3 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.238 1.015 . . . . 0.0 109.249 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.537 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.77 139.46 47.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.1 tt -137.79 122.73 18.96 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.036 0.446 . . . . 0.0 110.502 -171.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . 0.466 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.94 169.44 19.0 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 123.997 0.808 . . . . 0.0 111.434 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 45.8 mt -139.94 110.05 6.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -107.76 128.6 54.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -79.69 122.82 27.04 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.071 0.548 . . . . 0.0 110.185 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -69.89 -15.08 63.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.323 1.049 . . . . 0.0 112.621 -169.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -72.62 -8.48 55.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 122.684 0.394 . . . . 0.0 111.132 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.2 t -134.81 4.16 3.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.569 0.748 . . . . 0.0 111.414 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.02 148.23 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.867 0.467 . . . . 0.0 111.562 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -123.68 113.81 28.67 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.804 0.841 . . . . 0.0 109.527 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 94' ' ' GLN . 83.8 Cg_endo -76.76 145.56 81.87 Favored 'Cis proline' 0 C--N 1.382 2.338 0 C-N-CA 124.516 -1.035 . . . . 0.0 113.16 1.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.589 ' HZ1' ' HB2' ' B' ' 58' ' ' LYS . 0.1 OUTLIER -53.68 128.66 30.3 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.553 1.141 . . . . 0.0 111.992 178.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.32 120.88 7.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.389 0.675 . . . . 0.0 110.886 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 35.6 p -91.12 87.25 6.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.34 124.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.364 0.665 . . . . 0.0 109.739 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -152.64 123.07 7.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.305 1.442 . . . . 0.0 108.123 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.85 67.83 0.02 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.67 -82.24 1.68 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.29 -142.33 44.3 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.809 -0.439 . . . . 0.0 112.452 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 66' ' ' GLY . . . -66.86 152.46 52.66 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 174.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 10.4 mt-10 -103.9 152.08 22.38 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.042 0.537 . . . . 0.0 110.197 -172.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 tp -118.81 102.34 8.74 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.2 116.09 27.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.216 0.531 . . . . 0.0 111.194 -170.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.47 ' HB2' HG23 ' B' ' 117' ' ' VAL . 29.0 m-85 -96.28 107.96 20.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.135 1.374 . . . . 0.0 108.297 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -91.86 126.4 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.599 0.714 . . . . 0.0 111.89 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.25 161.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.148 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.88 -34.62 78.19 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -174.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -165.78 179.0 6.19 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.648 0.658 . . . . 0.0 112.212 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.39 -31.49 65.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.519 1.528 . . . . 0.0 113.03 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.43 -46.42 86.39 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.181 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.456 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 72.4 mm-40 -68.16 -23.38 64.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.322 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.59 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.574 0.702 . . . . 0.0 109.69 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.48 -32.99 62.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.933 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 33.4 mt-10 -65.9 -44.31 85.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.534 0.683 . . . . 0.0 109.495 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.8 m -64.66 -36.45 84.3 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.991 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -55.03 -61.68 2.15 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.41 1.084 . . . . 0.0 110.28 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.11 -32.32 71.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.368 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.48 -45.66 92.55 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.53 0.519 . . . . 0.0 112.935 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -63.89 -43.19 96.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.333 0.653 . . . . 0.0 109.924 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.483 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 33.6 ttpt -55.65 -45.76 77.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.592 0.757 . . . . 0.0 110.184 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.62 -20.73 61.23 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.345 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.95 4.15 44.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.796 0.838 . . . . 0.0 112.475 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 52.86 2.74 Favored Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 114.471 168.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' B' ' 92' ' ' MET . 4.9 p -94.57 153.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.82 -54.0 15.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.742 0.417 . . . . 0.0 110.991 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.528 ' HB2' HG11 ' B' ' 90' ' ' VAL . 52.9 ttm 64.43 83.7 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.841 0.713 . . . . 0.0 112.67 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.73 82.46 1.86 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.442 0.639 . . . . 0.0 110.741 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 176.2 129.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.717 1.607 . . . . 0.0 108.242 172.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.89 123.45 82.22 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 168.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.33 107.11 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.499 2.799 . . . . 0.0 111.876 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.29 141.35 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 111.085 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.477 ' HZ3' ' HB2' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -73.24 100.42 3.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.405 0.682 . . . . 0.0 109.358 174.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -100.59 170.38 8.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.912 0.885 . . . . 0.0 109.181 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.6 -41.62 54.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.236 1.014 . . . . 0.0 111.746 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -79.93 -11.21 59.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.644 0.777 . . . . 0.0 111.249 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.68 -172.79 21.78 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.9 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.477 ' HB2' ' HZ3' ' B' ' 98' ' ' LYS . 27.9 t80 -78.56 101.05 7.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -113.7 147.51 38.06 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.895 0.478 . . . . 0.0 110.781 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.77 134.34 30.09 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 109.117 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 1.9 m -120.9 118.42 29.88 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.92 169.94 8.19 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.058 0.543 . . . . 0.0 109.704 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.2 128.51 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.86 170.22 2.73 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.597 0.759 . . . . 0.0 110.41 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.89 -31.88 28.27 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.779 2.319 . . . . 0.0 112.2 165.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.31 4.92 40.91 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.36 1.064 . . . . 0.0 112.047 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 61.0 m 58.53 84.67 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.802 1.241 . . . . 0.0 112.573 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.433 ' HE1' HG11 ' B' ' 11' ' ' VAL . 15.3 m170 -122.78 176.57 5.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.108 0.563 . . . . 0.0 109.612 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -100.75 112.48 24.9 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.32 100.6 8.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.575 HH11 ' HG3' ' B' ' 116' ' ' ARG . 8.3 mmt85 -96.8 92.19 6.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.876 -172.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' B' ' 70' ' ' PHE . 5.9 t -91.74 115.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -124.71 169.02 12.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.789 0.268 . . . . 0.0 111.128 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.95 111.76 13.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.61 115.46 19.23 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.71 0.25 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.835 -174.418 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.0 94.77 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.801 2.334 . . . . 0.0 112.064 171.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.638 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.6 p-10 -96.61 16.7 18.15 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.424 0.63 . . . . 0.0 110.997 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.7 131.57 46.37 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.935 1.294 . . . . 0.0 107.562 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 142.97 49.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.362 1.065 . . . . 0.0 109.03 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 45.7 mt -124.0 139.1 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.546 0.739 . . . . 0.0 110.133 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.464 HD23 HD22 ' A' ' 47' ' ' LEU . 3.7 mm? -112.02 143.5 42.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.051 0.941 . . . . 0.0 108.556 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.13 106.48 13.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.495 1.118 . . . . 0.0 111.347 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' SER . 14.8 m -107.24 149.38 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -97.06 -52.15 3.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.13 100.58 13.59 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.11 0.964 . . . . 0.0 109.646 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -53.67 -52.71 7.89 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.246 2.631 . . . . 0.0 115.384 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 47.3 Cg_exo -56.68 -51.16 9.69 Favored 'Trans proline' 0 C--N 1.4 3.255 0 CA-C-N 122.267 1.845 . . . . 0.0 112.414 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.19 -38.01 52.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.968 -165.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -78.76 -29.25 45.02 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.235 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 75.9 m -64.95 -48.29 74.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 81.5 mm-40 -66.36 -31.66 72.57 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.196 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -62.96 -48.94 76.73 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.855 0.722 . . . . 0.0 110.045 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -71.81 -29.07 64.05 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.409 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 18' ' ' THR . 56.3 mtpt -56.26 -45.64 79.98 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.753 0.706 . . . . 0.0 112.069 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -42.54 35.8 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.464 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.9 -46.33 85.09 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.904 1.282 . . . . 0.0 112.298 -172.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.39 -47.64 9.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.2 33.75 4.78 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.804 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.18 172.19 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.14 0.976 . . . . 0.0 110.312 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.2 146.75 54.99 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 57.3 Cg_endo -71.26 121.08 7.46 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.994 1.796 . . . . 0.0 112.19 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.76 -44.13 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.545 0.738 . . . . 0.0 110.636 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.6 mm-40 -120.86 107.23 12.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -111.08 144.86 39.54 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.173 0.511 . . . . 0.0 110.696 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -142.07 155.63 65.26 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.715 1.206 . . . . 0.0 108.432 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.92 -10.19 27.55 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.278 1.985 . . . . 0.0 113.146 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -129.29 5.3 5.24 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -157.01 154.84 30.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 70.5 m -140.88 139.89 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.608 0.763 . . . . 0.0 109.256 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 27.7 tp -131.62 121.02 23.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 2.2 p90 -134.28 150.32 50.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.969 0.907 . . . . 0.0 108.943 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.527 HG22 ' HG3' ' A' ' 46' ' ' LYS . 19.2 t -126.46 133.9 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.476 ' HB2' ' HG3' ' A' ' 45' ' ' MET . 10.0 mp -97.73 144.72 27.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.25 -10.67 33.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.134 0.974 . . . . 0.0 112.673 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.04 -22.35 66.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.256 1.022 . . . . 0.0 112.127 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.17 16.04 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -116.23 171.88 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.851 0.86 . . . . 0.0 109.022 176.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -142.84 143.11 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.464 HD22 HD23 ' A' ' 9' ' ' LEU . 2.0 tt -142.3 122.19 13.59 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.99 0.424 . . . . 0.0 110.397 -169.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.26 151.97 17.56 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 76.5 mt -116.83 109.61 17.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 162.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.463 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.4 t90 -103.83 124.28 48.64 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 48.8 m -72.51 115.88 12.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -64.77 -8.57 15.46 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.73 1.212 . . . . 0.0 113.873 -169.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -9.89 59.7 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.574 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -135.23 3.01 3.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.837 0.455 . . . . 0.0 111.398 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 13.8 p -64.78 140.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.827 0.451 . . . . 0.0 110.948 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.38 106.76 21.33 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 3.0 Cg_endo -77.25 142.32 71.55 Favored 'Cis proline' 0 C--N 1.383 2.361 0 CA-C-N 120.156 1.091 . . . . 0.0 113.182 10.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HA ' HG12 ' A' ' 55' ' ' VAL . 2.8 tppp? -59.46 109.63 0.93 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.03 0.932 . . . . 0.0 111.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.67 107.58 10.71 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.817 1.247 . . . . 0.0 107.953 174.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 m -100.0 87.84 3.6 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.28 143.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.335 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 112' ' ' SER . 6.3 p -148.95 -176.43 5.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.431 1.092 . . . . 0.0 109.739 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.57 -71.37 2.47 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 32.71 7.27 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.37 59.76 4.94 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 146.14 7.2 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.314 0.483 . . . . 0.0 112.245 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 19.8 mt-10 -103.82 140.87 37.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.08 100.64 7.47 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.709 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -89.36 114.65 26.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.141 0.496 . . . . 0.0 111.777 -168.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -90.42 115.02 27.27 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.564 1.545 . . . . 0.0 107.585 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.652 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 31.3 mtm105 -91.34 128.37 37.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.13 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.17 159.15 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.018 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.597 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.4 pt-20 -65.52 -37.23 86.18 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -173.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -162.83 -177.76 5.71 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 118.407 0.549 . . . . 0.0 112.225 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.09 -34.1 71.6 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.75 1.22 . . . . 0.0 112.469 -166.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.26 -41.37 85.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.603 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.597 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 76.3 mm-40 -66.69 -23.06 66.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.079 0.952 . . . . 0.0 112.424 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.33 -40.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.932 0.493 . . . . 0.0 109.882 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.73 -31.37 61.81 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.974 0.91 . . . . 0.0 110.978 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.2 mt-10 -66.33 -47.43 73.55 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -62.99 -36.5 83.75 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.484 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' O ' ' HE1' ' A' ' 92' ' ' MET . 71.8 t80 -56.31 -61.39 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.211 1.004 . . . . 0.0 110.361 175.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.33 77.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.491 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.8 93.6 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.535 0.522 . . . . 0.0 113.373 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -66.65 -39.97 88.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.418 0.687 . . . . 0.0 109.965 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -60.39 -42.54 96.11 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.648 0.779 . . . . 0.0 110.362 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.31 65.14 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.738 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.0 t -95.84 7.2 46.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.315 1.046 . . . . 0.0 112.759 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.53 51.36 6.05 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.927 -0.579 . . . . 0.0 114.306 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.64 137.71 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.461 0.704 . . . . 0.0 109.169 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.05 97.98 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.805 0.842 . . . . 0.0 112.207 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 12.0 ptm 49.27 82.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.085 1.754 . . . . 0.0 115.409 164.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.65 86.12 2.38 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.095 0.558 . . . . 0.0 110.446 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 178.38 116.57 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.619 1.568 . . . . 0.0 107.551 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.83 124.36 89.25 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.52 97.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.965 2.444 . . . . 0.0 111.334 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.42 36.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.014 0.926 . . . . 0.0 110.187 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 98.5 2.37 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ttt -90.79 166.38 13.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.802 0.841 . . . . 0.0 109.233 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.34 -41.15 79.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.984 0.914 . . . . 0.0 111.972 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -81.34 -15.35 55.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.142 0.577 . . . . 0.0 111.693 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.55 179.4 22.66 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.182 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -78.05 105.72 9.44 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 118' ' ' TYR . 12.6 t -122.01 155.51 35.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.472 0.654 . . . . 0.0 111.455 -171.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -141.21 150.31 42.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.006 1.722 . . . . 0.0 108.304 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.7 m -136.09 133.66 37.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.996 0.816 . . . . 0.0 111.349 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.71 171.22 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.953 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.42 126.63 29.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.936 170.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.83 172.52 1.37 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.741 1.216 . . . . 0.0 111.798 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -56.18 -35.68 95.64 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.169 1.913 . . . . 0.0 111.446 161.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.86 -18.59 43.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.592 1.157 . . . . 0.0 110.898 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 62' ' ' THR . 22.2 m 68.13 101.69 0.05 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 126.262 1.825 . . . . 0.0 111.793 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.454 ' CE1' HG13 ' A' ' 11' ' ' VAL . 17.3 m80 -127.35 175.72 7.98 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -96.22 95.04 7.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 92.5 mt -95.6 104.4 16.31 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.709 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 9.9 mmm180 -86.15 143.52 27.97 Favored 'General case' 0 C--O 1.214 -0.816 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.43 111.25 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 166.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.652 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 3.6 p90 -120.84 167.18 12.79 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.264 0.483 . . . . 0.0 110.819 -172.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.25 110.9 8.07 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.409 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 52.0 t80 -76.65 116.9 17.74 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.135 0.425 . . . . 0.0 110.198 -168.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.317 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -88.55 94.83 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.619 2.212 . . . . 0.0 112.144 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.688 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.3 p-10 -96.29 16.48 18.25 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.343 0.592 . . . . 0.0 111.023 171.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.72 131.33 46.28 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.038 1.335 . . . . 0.0 107.587 -173.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 t -132.63 143.07 49.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.328 1.051 . . . . 0.0 108.964 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 16.7 mt -124.23 139.23 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.61 0.764 . . . . 0.0 109.971 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.87 143.09 44.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.047 0.939 . . . . 0.0 108.685 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -80.79 106.48 12.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.447 1.099 . . . . 0.0 111.181 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' B' ' 51' ' ' SER . 15.3 m -107.35 149.66 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -97.45 -52.31 3.84 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.202 -170.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -101.54 100.02 12.98 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.267 1.027 . . . . 0.0 109.685 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.45 -53.05 7.56 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.413 2.742 . . . . 0.0 115.766 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 22.6 Cg_endo -56.9 -50.92 10.11 Favored 'Trans proline' 0 C--N 1.399 3.234 0 CA-C-N 122.084 1.78 . . . . 0.0 112.077 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.09 -38.41 52.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.088 -165.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -78.94 -28.22 43.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.222 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 83.9 m -66.84 -47.25 72.54 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.0 mt-30 -65.1 -33.29 75.69 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.249 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 81.0 t80 -62.45 -48.71 78.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.531 0.732 . . . . 0.0 110.136 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.656 ' HH ' HD22 ' B' ' 115' ' ' LEU . 41.6 m-85 -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.564 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -55.99 -45.59 78.96 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.87 0.759 . . . . 0.0 111.985 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.52 33.59 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.46 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.3 tp -58.2 -46.23 86.18 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.809 1.244 . . . . 0.0 112.247 -172.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 21' ' ' TYR . 10.8 mt -86.24 -47.74 9.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.79 32.93 4.89 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.597 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.92 171.74 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.164 0.986 . . . . 0.0 110.373 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -124.36 148.17 57.34 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 61.1 Cg_endo -72.7 120.96 7.0 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 121.876 1.718 . . . . 0.0 112.13 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.69 -44.36 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.564 0.746 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 58.8 mm-40 -120.4 108.32 13.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.27 1.028 . . . . 0.0 108.292 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 p -112.33 145.01 40.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.22 0.608 . . . . 0.0 110.347 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -143.02 153.67 60.74 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.141 1.376 . . . . 0.0 108.241 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.56 -10.58 26.89 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.319 2.013 . . . . 0.0 113.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.0 t -129.19 5.69 5.31 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.82 154.97 30.74 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 35.5 t -140.75 140.16 34.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.46 HD12 ' HE2' ' B' ' 46' ' ' LYS . 40.6 tp -132.15 120.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.485 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 2.4 p90 -134.01 150.42 51.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 0.0 108.885 170.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.56 HG23 ' HG3' ' B' ' 46' ' ' LYS . 17.5 t -126.84 134.13 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.512 ' HB2' ' HG3' ' B' ' 45' ' ' MET . 9.9 mp -97.53 144.36 27.31 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -10.2 30.04 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.152 0.981 . . . . 0.0 112.554 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.45 -22.2 66.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.406 1.082 . . . . 0.0 112.054 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.36 15.88 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.638 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -116.75 172.25 7.36 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.56 ' HG3' HG23 ' B' ' 40' ' ' VAL . 86.4 tttt -142.91 143.18 31.93 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.28 122.46 13.83 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.13 17.6 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 174.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 76.6 mt -117.04 109.63 17.21 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.425 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -103.82 124.39 48.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.8 m -72.55 116.42 12.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -65.55 -8.27 18.91 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.607 1.163 . . . . 0.0 113.789 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -79.34 -10.34 59.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.231 0.612 . . . . 0.0 111.548 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -134.78 2.43 3.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.88 0.472 . . . . 0.0 111.293 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.425 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 12.2 p -64.68 141.29 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.631 0.373 . . . . 0.0 110.851 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.07 107.66 19.9 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 123.909 0.884 . . . . 0.0 109.058 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.47 142.4 73.01 Favored 'Cis proline' 0 C--N 1.387 2.603 0 CA-C-N 119.906 1.002 . . . . 0.0 113.466 8.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -58.91 110.17 0.97 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.058 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.82 107.34 10.41 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.823 1.249 . . . . 0.0 108.102 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -99.57 87.8 3.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.64 142.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.182 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' B' ' 112' ' ' SER . 6.2 p -147.65 -176.24 5.17 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.544 1.138 . . . . 0.0 110.149 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.4 -71.66 2.46 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.12 32.58 7.37 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.44 59.74 4.94 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 145.94 7.08 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.288 0.471 . . . . 0.0 112.197 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.608 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 18.4 mt-10 -103.62 141.1 36.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.86 100.33 7.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.08 114.76 26.04 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 0.0 111.925 -169.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -90.62 114.52 26.8 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 125.525 1.53 . . . . 0.0 107.453 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.575 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 36.4 mtm105 -90.65 127.08 36.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.934 -175.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.22 159.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.159 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.1 pt-20 -65.51 -37.36 86.55 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 10.3 p30 -163.06 -177.37 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 118.5 0.591 . . . . 0.0 112.205 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -59.52 -33.68 71.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -166.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.09 84.66 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.806 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -67.05 -22.58 65.86 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.572 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.83 -40.71 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.852 172.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.22 -31.27 62.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.05 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.42 -47.51 73.02 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.113 0.483 . . . . 0.0 109.765 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -35.74 81.39 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.487 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.429 ' O ' ' HE1' ' B' ' 92' ' ' MET . 55.0 t80 -56.86 -61.35 2.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.696 0.798 . . . . 0.0 110.304 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.451 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -65.41 -34.0 77.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.653 -171.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.06 93.34 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.553 0.533 . . . . 0.0 113.326 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -66.28 -40.12 89.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.498 0.719 . . . . 0.0 109.905 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.6 ttpt -60.12 -42.58 95.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.636 0.774 . . . . 0.0 110.46 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.35 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.746 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 30.2 t -96.1 7.73 45.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.241 1.016 . . . . 0.0 112.762 -175.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 52.12 5.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.268 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.07 137.39 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.735 0.814 . . . . 0.0 109.201 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.78 97.99 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.904 0.882 . . . . 0.0 112.38 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.613 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 12.0 ptm 49.22 82.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 164.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.68 86.26 2.4 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.285 0.634 . . . . 0.0 110.405 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.548 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 52.0 tp60 177.78 116.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.768 1.627 . . . . 0.0 107.638 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.64 125.09 90.03 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.465 ' HB2' ' HH ' ' B' ' 103' ' ' TYR . 33.9 Cg_exo -56.06 97.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.936 2.424 . . . . 0.0 110.943 172.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.65 146.93 37.79 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.02 0.928 . . . . 0.0 110.337 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.492 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -72.14 98.39 2.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 171.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 8.3 ttt -91.06 166.79 12.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.634 0.774 . . . . 0.0 109.104 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.0 -41.16 77.98 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.688 0.795 . . . . 0.0 112.079 -176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -81.54 -15.54 54.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.62 179.42 22.74 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.032 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.492 ' HB2' ' HZ1' ' B' ' 98' ' ' LYS . 50.2 t80 -77.74 105.96 9.25 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -174.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 11.1 t -122.37 155.53 35.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.554 0.692 . . . . 0.0 111.395 -170.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -141.35 150.26 42.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.889 1.676 . . . . 0.0 108.318 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.5 m -136.05 133.6 37.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.992 0.815 . . . . 0.0 111.352 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.76 171.15 7.49 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.931 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.19 129.34 35.62 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.4 174.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.692 1.197 . . . . 0.0 110.8 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.11 -34.92 99.02 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.05 1.834 . . . . 0.0 110.828 162.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -82.36 -18.27 42.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.718 1.207 . . . . 0.0 110.818 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' B' ' 62' ' ' THR . 40.3 m 67.79 101.85 0.05 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.15 1.78 . . . . 0.0 111.656 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.441 ' CE1' HG13 ' B' ' 11' ' ' VAL . 19.5 m80 -127.48 175.47 8.21 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 165.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.517 ' HA ' ' HE ' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -96.09 95.4 8.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.656 HD22 ' HH ' ' B' ' 21' ' ' TYR . 93.9 mt -95.64 104.83 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.665 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 34.3 mmt180 -84.47 143.57 29.29 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 25.2 t -137.42 111.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.575 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.5 p90 -120.65 167.46 12.42 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.023 0.374 . . . . 0.0 110.896 -172.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.73 111.44 8.19 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 167.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -77.65 123.47 26.69 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.196 0.453 . . . . 0.0 110.493 -168.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.39 94.59 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 118.891 -0.95 . . . . 0.0 110.923 -176.276 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 119.766 -0.159 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.36 56.47 1.41 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.476 2.784 . . . . 0.0 111.836 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.587 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.0 p-10 -78.36 4.07 13.96 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.886 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.0 OUTLIER -124.23 125.11 43.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -120.0 137.23 54.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 49.2 mt -116.14 135.07 57.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.364 0.666 . . . . 0.0 109.361 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 156.3 18.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.314 1.054 . . . . 0.0 108.308 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.509 ' HH ' ' HB2' ' A' ' 59' ' ' ALA . 4.0 t80 -110.04 108.36 18.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.823 -173.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.451 HG13 ' NE2' ' A' ' 113' ' ' HIS . 9.9 m -125.12 159.84 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.367 0.603 . . . . 0.0 110.957 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -97.41 -62.7 1.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.396 1.078 . . . . 0.0 109.461 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.28 106.52 13.86 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.224 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.49 -59.72 0.62 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 122.624 2.216 . . . . 0.0 113.959 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 29.8 Cg_endo -57.32 -50.65 10.44 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.355 1.877 . . . . 0.0 111.61 -174.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.07 90.57 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.262 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.47 ' HG ' HD21 ' A' ' 49' ' ' LEU . 38.8 t -78.69 -20.72 49.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.755 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 m -76.41 -45.49 31.36 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.679 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 57.7 mm-40 -68.61 -30.19 68.87 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.41 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 36.4 t80 -60.85 -51.25 70.12 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 124.115 0.885 . . . . 0.0 110.847 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.738 ' HH ' HD22 ' A' ' 115' ' ' LEU . 67.3 m-85 -71.39 -27.76 63.55 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.784 177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.5 mtpt -56.19 -50.83 70.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.392 0.542 . . . . 0.0 112.408 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.61 56.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.113 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 11.7 tp -60.91 -43.65 98.26 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.408 1.083 . . . . 0.0 112.15 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.477 ' HB2' HG21 ' A' ' 27' ' ' VAL . 22.5 mt -95.21 -35.29 11.9 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.971 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.7 37.13 6.2 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 25' ' ' LEU . 33.9 m -130.56 -177.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.489 1.116 . . . . 0.0 110.472 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.75 149.79 57.76 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.03 108.96 2.06 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.806 2.337 . . . . 0.0 111.697 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.76 -31.51 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.586 0.754 . . . . 0.0 110.571 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 48.5 mt-10 -119.42 143.15 47.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.291 1.037 . . . . 0.0 108.213 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -159.54 153.72 23.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.817 0.818 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -144.23 164.15 30.71 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 126.069 1.748 . . . . 0.0 107.473 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.58 -16.16 34.76 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.334 2.022 . . . . 0.0 113.484 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.8 t -127.92 13.05 6.79 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -154.38 159.94 41.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -153.37 153.91 33.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.489 1.116 . . . . 0.0 109.469 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.7 tm? -146.33 123.71 11.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -130.81 137.24 49.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.601 1.16 . . . . 0.0 108.307 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.7 t -112.09 123.0 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.618 HD11 ' SD ' ' A' ' 45' ' ' MET . 76.2 mt -89.34 148.73 23.36 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.96 0.504 . . . . 0.0 110.188 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -7.01 19.12 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.22 1.008 . . . . 0.0 113.513 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -82.03 4.41 22.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 111.789 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.3 64.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.629 -0.189 . . . . 0.0 112.629 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.618 ' SD ' HD11 ' A' ' 41' ' ' LEU . 5.1 ppp? -117.61 171.54 7.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.631 0.772 . . . . 0.0 109.779 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 40' ' ' VAL . 83.0 tttt -135.35 139.43 44.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.34 123.99 21.04 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.174 0.512 . . . . 0.0 110.113 -172.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.94 169.97 20.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.828 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.47 HD21 ' HG ' ' A' ' 17' ' ' SER . 4.9 tp -139.92 104.78 4.94 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.479 ' HZ2' ' HE2' ' B' ' 99' ' ' MET . 5.0 t90 -114.71 128.92 56.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.6 m -78.71 134.95 37.05 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.168 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.0 -19.96 64.97 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.755 0.822 . . . . 0.0 113.2 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -8.41 58.78 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -129.77 7.72 5.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.858 0.463 . . . . 0.0 111.33 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG13 ' OH ' ' A' ' 10' ' ' TYR . 11.8 p -69.87 147.43 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HB3' ' NE2' ' B' ' 94' ' ' GLN . 35.6 mt-10 -128.25 113.65 19.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 0.0 109.52 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.72 143.19 77.06 Favored 'Cis proline' 0 C--N 1.388 2.636 0 CA-C-N 119.723 0.937 . . . . 0.0 112.674 2.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -50.09 124.31 9.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.501 1.12 . . . . 0.0 112.063 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB2' ' HH ' ' A' ' 10' ' ' TYR . . . -144.41 155.68 43.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.172 0.989 . . . . 0.0 109.333 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.3 m -132.79 94.23 3.35 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.97 125.18 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.13 0.972 . . . . 0.0 108.855 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -140.09 142.62 36.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.761 0.824 . . . . 0.0 109.373 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.51 23.22 73.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.624 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.471 ' HA3' HG21 ' B' ' 61' ' ' VAL . . . -160.84 140.74 6.88 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.27 -156.23 26.85 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.59 172.0 54.81 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.525 0.191 . . . . 0.0 112.713 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 68.9 mt-10 -99.49 152.03 20.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.8 tp -110.09 100.55 9.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 171.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -84.61 113.76 21.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.007 0.432 . . . . 0.0 111.571 -167.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -93.12 106.62 18.56 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.854 1.262 . . . . 0.0 107.921 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -90.62 131.37 36.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.122 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.04 165.08 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.49 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.408 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.1 pt-20 -69.38 -43.81 72.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -155.25 177.99 10.72 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.703 0.683 . . . . 0.0 112.626 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.15 -32.96 70.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.158 1.383 . . . . 0.0 112.421 -167.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.34 -42.77 74.85 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.634 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.408 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 78.9 mm-40 -64.58 -24.16 67.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.644 0.778 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.24 -40.08 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.349 0.595 . . . . 0.0 110.003 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.1 -30.22 62.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.195 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -67.77 -42.99 80.84 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 109.141 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.7 m -65.01 -37.93 89.26 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.357 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.407 ' O ' ' HE1' ' A' ' 92' ' ' MET . 34.9 t80 -57.94 -60.92 2.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.921 0.888 . . . . 0.0 109.628 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -60.83 -39.17 88.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.733 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.6 -39.35 86.64 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.415 0.447 . . . . 0.0 113.828 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -67.89 -42.48 81.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.374 0.669 . . . . 0.0 109.64 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.7 ttpt -57.63 -43.88 85.16 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.791 0.836 . . . . 0.0 110.387 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.9 -30.56 71.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.692 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.5 m -102.24 14.8 30.98 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.099 0.959 . . . . 0.0 112.094 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 46.36 5.68 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 163.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -101.72 132.23 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.144 0.578 . . . . 0.0 109.745 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.51 95.13 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.918 0.887 . . . . 0.0 111.708 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 4.8 ptm 50.3 81.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.567 1.547 . . . . 0.0 113.771 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.4 ' N ' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.52 83.67 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.61 -0.681 . . . . 0.0 109.962 -178.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.458 ' HB2' ' HD3' ' B' ' 57' ' ' PRO . 5.7 tp60 177.39 134.68 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.52 1.528 . . . . 0.0 108.028 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -79.31 120.67 81.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 15.6 Cg_endo -58.71 106.3 0.27 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.642 2.228 . . . . 0.0 110.378 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.85 152.36 46.41 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.309 0.644 . . . . 0.0 110.21 -175.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -62.42 137.79 58.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.543 0.737 . . . . 0.0 110.466 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.418 ' SD ' HG23 ' A' ' 104' ' ' THR . 20.1 ttt -142.82 175.76 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 109.392 -175.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -51.35 -32.37 25.44 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.453 1.501 . . . . 0.0 112.921 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.42 -5.22 23.12 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.663 0.785 . . . . 0.0 111.384 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.91 -167.51 20.18 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.078 176.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.7 101.59 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.418 HG23 ' SD ' ' A' ' 99' ' ' MET . 9.4 t -115.63 149.1 38.84 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.376 -167.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 3.2 t80 -146.51 129.41 16.33 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.573 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -120.66 119.22 32.21 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.26 159.04 16.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 -175.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.1 127.49 19.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.64 178.89 2.09 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.134 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -32.83 94.08 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.743 2.295 . . . . 0.0 113.644 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.83 -4.92 46.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.758 0.423 . . . . 0.0 111.18 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.0 m 72.45 60.02 0.13 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.118 1.367 . . . . 0.0 110.995 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.451 ' NE2' HG13 ' A' ' 11' ' ' VAL . 19.7 m170 -97.67 -167.09 1.47 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.17 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.43 93.87 1.94 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.738 HD22 ' HH ' ' A' ' 21' ' ' TYR . 59.7 mt -116.79 101.95 8.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.833 -170.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 2.3 tmm_? -102.8 99.26 9.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.004 0.521 . . . . 0.0 111.29 -169.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.03 140.6 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.5 0.72 . . . . 0.0 109.226 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.498 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 16.7 p90 -143.66 161.69 37.88 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.659 0.663 . . . . 0.0 112.607 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -110.67 129.87 55.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.71 124.52 23.52 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.274 0.359 . . . . 0.0 110.367 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.545 0 O-C-N 123.772 0.67 . . . . 0.0 110.48 -178.018 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.8 56.01 1.66 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.499 2.799 . . . . 0.0 111.95 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.559 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.9 p-10 -77.59 3.91 12.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.685 0.794 . . . . 0.0 112.146 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -123.85 124.85 43.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -120.32 137.53 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 37.0 mt -117.3 134.76 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.374 0.67 . . . . 0.0 109.468 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.491 HD12 HD23 ' B' ' 68' ' ' LEU . 65.9 mt -90.56 155.69 18.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.334 1.064 . . . . 0.0 108.973 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.03 107.83 19.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 112.93 -1.941 . . . . 0.0 108.184 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.98 160.05 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.377 0.608 . . . . 0.0 110.838 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.81 -62.12 1.29 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.41 1.084 . . . . 0.0 109.713 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -90.78 105.92 13.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.391 0.676 . . . . 0.0 109.495 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.407 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 33.3 Cg_exo -56.4 -60.97 0.38 Allowed 'Trans proline' 0 CA--C 1.573 2.443 0 C-N-CA 122.435 2.09 . . . . 0.0 113.878 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 51.9 Cg_exo -54.7 -51.99 9.12 Favored 'Trans proline' 0 C--N 1.41 3.789 0 CA-C-N 122.47 1.918 . . . . 0.0 112.405 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.13 92.94 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.4 t -78.45 -20.61 50.62 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.1 m -76.88 -45.33 28.59 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.45 0.643 . . . . 0.0 111.652 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.49 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.2 mm-40 -67.92 -30.78 70.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.464 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 74.9 t80 -60.4 -50.91 71.7 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.786 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -72.19 -27.43 62.55 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.201 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 56.4 mtpt -56.27 -50.94 69.93 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.53 -36.06 57.91 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.051 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 8.8 tp -60.94 -43.25 98.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.074 0.95 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.487 ' HB2' HG22 ' B' ' 27' ' ' VAL . 27.0 mt -95.35 -35.49 11.75 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.07 36.85 6.17 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' B' ' 25' ' ' LEU . 34.2 m -130.38 -177.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.562 1.145 . . . . 0.0 110.256 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -140.75 149.21 55.85 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.66 0.784 . . . . 0.0 109.489 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.91 108.51 1.71 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.48 2.12 . . . . 0.0 112.019 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.18 -31.97 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.608 0.763 . . . . 0.0 110.516 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.665 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 45.4 mt-10 -119.31 143.42 47.38 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 167.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 21.5 t -159.54 153.63 23.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.651 0.739 . . . . 0.0 111.111 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 35.6 m -143.96 165.11 25.86 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 126.109 1.764 . . . . 0.0 107.357 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.12 -15.58 40.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.045 1.83 . . . . 0.0 113.103 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.3 t -128.11 13.02 6.7 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -154.3 159.55 41.3 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.013 -0.429 . . . . 0.0 110.78 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 60.6 m -153.3 154.01 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.555 1.142 . . . . 0.0 109.529 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.665 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -146.37 123.45 11.45 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -130.09 138.44 50.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.286 1.035 . . . . 0.0 108.654 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.513 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.3 t -112.51 123.41 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' B' ' 45' ' ' MET . 80.5 mt -89.98 148.6 22.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.837 0.455 . . . . 0.0 110.282 -168.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -7.56 21.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.119 0.968 . . . . 0.0 113.578 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -81.57 4.63 20.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.745 0.818 . . . . 0.0 112.251 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.06 11.86 64.4 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.668 ' SD ' HD11 ' B' ' 41' ' ' LEU . 5.0 ppp? -117.56 171.62 7.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.501 0.72 . . . . 0.0 109.597 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.513 ' HG3' HG22 ' B' ' 40' ' ' VAL . 84.3 tttt -135.73 140.05 44.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.2 tt -138.18 123.76 19.68 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.184 0.516 . . . . 0.0 110.269 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.88 168.98 19.67 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.844 0.735 . . . . 0.0 112.724 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -137.81 105.2 5.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.48 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.5 t90 -114.32 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 50.9 m -78.72 134.61 37.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.423 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -68.02 -19.26 64.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 0.0 112.965 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -79.42 -9.15 59.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.5 0.32 . . . . 0.0 111.295 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.5 t -128.92 7.48 5.58 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.024 0.529 . . . . 0.0 111.318 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.48 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 11.8 p -69.66 147.15 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.454 ' HB3' ' NE2' ' A' ' 94' ' ' GLN . 26.3 mt-10 -128.7 113.91 19.2 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.319 0.648 . . . . 0.0 110.056 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 94' ' ' GLN . 97.7 Cg_endo -73.0 143.57 78.26 Favored 'Cis proline' 0 C--N 1.387 2.583 0 CA-C-N 119.472 0.847 . . . . 0.0 113.226 2.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 126.14 18.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.097 0.959 . . . . 0.0 110.527 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.96 155.96 44.24 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.454 1.102 . . . . 0.0 109.715 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.4 m -132.7 92.55 3.07 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.617 0.767 . . . . 0.0 109.013 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.471 HG21 ' HA3' ' A' ' 64' ' ' GLY . 79.2 t -141.69 125.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.312 1.045 . . . . 0.0 108.568 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.7 p -140.07 141.71 36.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.83 0.852 . . . . 0.0 109.215 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.9 24.5 69.3 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.477 0.485 . . . . 0.0 112.395 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.85 139.26 5.87 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.86 -155.35 26.5 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 10' ' ' TYR . . . -77.43 172.64 55.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.556 ' HA ' ' HG3' ' B' ' 114' ' ' ARG . 6.0 mm-40 -99.68 151.24 21.44 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.491 HD23 HD12 ' B' ' 9' ' ' LEU . 50.1 tp -109.78 101.1 10.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -84.9 113.99 21.79 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.125 0.42 . . . . 0.0 111.604 -167.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -93.53 106.51 18.47 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -90.67 131.05 36.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.145 0.497 . . . . 0.0 111.893 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.65 165.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.4 1.08 . . . . 0.0 110.541 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.0 pt-20 -69.2 -44.1 72.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.518 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 9.9 p30 -155.23 178.15 10.54 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.762 0.71 . . . . 0.0 112.7 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.753 1.621 . . . . 0.0 112.608 -167.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.49 -42.26 75.01 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.708 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.505 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.3 mm-40 -65.39 -24.03 67.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.697 0.799 . . . . 0.0 112.458 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.35 -40.52 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.353 0.597 . . . . 0.0 110.009 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.28 -30.43 63.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.303 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 18.5 mt-10 -67.96 -43.0 80.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.702 0.763 . . . . 0.0 109.213 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.3 m -64.96 -37.58 88.13 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.193 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.516 ' O ' ' HE2' ' B' ' 92' ' ' MET . 23.8 t80 -58.49 -60.92 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.767 0.827 . . . . 0.0 109.531 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.424 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -60.66 -38.56 85.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.902 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.69 -39.72 86.03 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.43 0.456 . . . . 0.0 113.878 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -67.85 -42.06 81.96 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.394 0.678 . . . . 0.0 109.679 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 31.9 ttpt -58.89 -43.33 90.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 0.0 110.229 177.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.77 -30.24 70.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.664 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.6 m -102.55 14.93 30.68 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.926 0.891 . . . . 0.0 112.256 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.82 47.1 5.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.219 -0.9 . . . . 0.0 114.957 163.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.59 131.69 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.213 0.605 . . . . 0.0 109.499 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.89 92.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.86 0.864 . . . . 0.0 112.114 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.516 ' HE2' ' O ' ' B' ' 82' ' ' PHE . 13.5 ptp 48.94 82.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.655 1.582 . . . . 0.0 114.128 172.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.67 83.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.453 0.644 . . . . 0.0 109.941 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 56' ' ' GLU . 5.7 tp60 177.45 133.78 0.06 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 108.14 174.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -78.07 121.38 83.91 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.527 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 20.0 Cg_endo -60.12 106.34 0.33 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.654 2.236 . . . . 0.0 110.117 172.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.78 152.25 46.42 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.263 0.625 . . . . 0.0 110.158 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -62.89 138.48 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.328 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.502 ' SD ' HG23 ' B' ' 104' ' ' THR . 11.4 ttt -143.26 175.22 10.06 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.73 0.812 . . . . 0.0 109.007 -174.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . 0.467 ' H ' ' HG2' ' B' ' 99' ' ' MET . 11.3 tp10 -51.98 -32.57 34.17 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.113 1.365 . . . . 0.0 112.964 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.07 -6.37 23.42 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.614 0.765 . . . . 0.0 111.281 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 128.84 -168.2 20.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.528 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -76.02 101.23 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.502 HG23 ' SD ' ' B' ' 99' ' ' MET . 14.4 t -115.1 149.06 38.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.501 0.667 . . . . 0.0 111.328 -167.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 2.6 t80 -146.48 129.37 16.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.465 1.506 . . . . 0.0 108.537 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 119.54 33.09 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.114 0.483 . . . . 0.0 109.812 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -107.35 158.71 16.94 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.875 0.87 . . . . 0.0 112.464 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.65 129.72 23.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.516 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.2 p-10 -88.33 179.94 1.51 Allowed Pre-proline 0 CA--C 1.575 1.905 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.346 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 25.4 Cg_endo -58.72 -32.22 96.53 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.499 2.132 . . . . 0.0 113.239 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.66 -5.3 47.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.787 0.435 . . . . 0.0 110.908 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m 72.7 60.4 0.12 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.137 1.375 . . . . 0.0 110.66 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -97.9 -168.23 1.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.377 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.556 ' HG3' ' HA ' ' B' ' 67' ' ' GLU . 4.2 tpp180 -149.13 94.94 2.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -175.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.01 101.78 8.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.017 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 3.4 tmt_? -100.28 98.12 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.167 0.587 . . . . 0.0 112.079 -169.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.29 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -143.48 161.42 38.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.714 0.688 . . . . 0.0 112.375 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.406 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -110.75 130.59 55.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 168.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -68.91 123.38 20.83 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.161 0.288 . . . . 0.0 110.664 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.86 106.64 17.21 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.973 -0.904 . . . . 0.0 111.064 -179.052 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -91.02 101.26 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.139 2.559 . . . . 0.0 112.737 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.75 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 4.2 p30 -85.03 -2.23 57.73 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.218 0.532 . . . . 0.0 111.06 169.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -118.46 112.27 19.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -168.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -109.76 131.71 54.82 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.52 132.42 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.92 173.23 7.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.091 0.948 . . . . 0.0 108.941 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -130.38 120.29 24.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.442 -174.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.483 HG12 ' NE2' ' A' ' 113' ' ' HIS . 10.3 m -125.89 155.84 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.861 0.864 . . . . 0.0 109.679 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.84 -56.83 3.17 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -94.93 110.36 49.34 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.163 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 31.8 Cg_exo -54.94 -57.25 1.8 Allowed 'Trans proline' 0 CA--C 1.573 2.455 0 C-N-CA 122.749 2.3 . . . . 0.0 114.232 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 34.9 Cg_exo -58.32 -58.63 0.7 Allowed 'Trans proline' 0 C--N 1.401 3.319 0 CA-C-N 122.181 1.815 . . . . 0.0 112.146 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.71 95.22 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.753 0.821 . . . . 0.0 112.36 -167.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -76.42 -33.84 58.79 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 88.9 m -73.1 -39.77 65.52 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -59.75 -36.87 77.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.89 172.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.27 -44.51 94.91 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 110.233 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.473 ' HH ' HD22 ' A' ' 115' ' ' LEU . 60.8 m-85 -70.91 -29.16 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.02 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 18' ' ' THR . 60.1 mtpt -56.63 -47.7 79.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.805 0.729 . . . . 0.0 112.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.87 47.28 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.758 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp -63.7 -40.59 97.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.516 1.126 . . . . 0.0 112.332 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 27' ' ' VAL . 32.2 mt -93.46 -38.55 11.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.18 24.85 18.22 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.537 0.523 . . . . 0.0 111.809 -173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.3 m -118.58 174.91 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.024 0.93 . . . . 0.0 110.449 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.9 143.97 51.28 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 108.968 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.71 112.4 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.634 2.223 . . . . 0.0 111.402 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.74 -36.51 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.447 0.699 . . . . 0.0 109.769 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.8 mm-40 -112.02 87.03 2.47 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.5 p -90.19 127.62 36.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.43 0.692 . . . . 0.0 109.214 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -140.61 152.81 67.14 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.985 0.914 . . . . 0.0 108.538 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -46.35 -44.68 20.04 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.871 3.048 . . . . 0.0 114.646 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -126.92 15.94 7.39 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.6 151.3 37.87 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -140.58 142.72 35.07 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -139.53 121.08 15.17 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -133.05 131.72 40.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.554 1.141 . . . . 0.0 108.637 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG21 ' HG3' ' A' ' 46' ' ' LYS . 16.2 t -109.49 129.62 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.039 -173.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 ' SD ' ' A' ' 45' ' ' MET . 49.4 mt -94.27 143.0 26.76 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.786 0.434 . . . . 0.0 110.445 -171.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -5.76 19.43 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.376 1.07 . . . . 0.0 112.299 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.7 OUTLIER -67.34 -19.51 65.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.769 1.228 . . . . 0.0 111.627 177.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.44 16.62 15.56 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.721 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -125.66 176.26 7.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.518 0.727 . . . . 0.0 109.54 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HG3' HG21 ' A' ' 40' ' ' VAL . 76.6 tttt -140.32 137.53 34.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.02 118.55 18.94 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.772 0.429 . . . . 0.0 110.084 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.31 163.22 21.88 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.521 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -141.43 104.85 4.66 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.439 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.7 t90 -111.09 134.83 52.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.902 0.881 . . . . 0.0 108.678 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 54' ' ' THR . 35.9 m -75.83 136.39 40.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.751 0.31 . . . . 0.0 111.249 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -72.5 -9.86 59.08 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.993 0.917 . . . . 0.0 112.455 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -86.89 -8.8 56.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.202 0.601 . . . . 0.0 111.181 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.404 HG23 ' HB2' ' A' ' 51' ' ' SER . 15.4 t -135.04 8.24 3.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.177 0.591 . . . . 0.0 111.339 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.2 p -68.28 143.45 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 122.58 0.352 . . . . 0.0 111.372 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.495 ' HB2' ' HE2' ' B' ' 99' ' ' MET . 52.1 mt-10 -125.39 117.23 25.11 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.556 1.142 . . . . 0.0 108.706 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 12.4 Cg_exo -70.88 144.13 78.07 Favored 'Cis proline' 0 C--N 1.386 2.531 0 CA-C-N 119.681 0.922 . . . . 0.0 112.992 -1.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.467 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.17 128.76 37.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.149 0.98 . . . . 0.0 111.958 -177.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.45 109.03 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.764 1.226 . . . . 0.0 108.531 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.2 p -87.83 89.15 7.88 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.3 142.84 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.523 0.729 . . . . 0.0 109.847 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -138.96 135.55 34.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.226 1.01 . . . . 0.0 109.22 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.38 51.75 49.67 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.61 0.569 . . . . 0.0 114.227 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.18 44.99 0.42 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.87 -169.51 11.69 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.781 -0.209 . . . . 0.0 113.125 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.97 170.12 47.67 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 124.38 0.694 . . . . 0.0 113.009 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -98.53 160.04 14.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.918 0.887 . . . . 0.0 110.561 -171.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.09 101.23 10.66 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.54 103.53 14.48 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -82.46 106.17 14.11 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -84.72 128.89 34.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.816 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.74 157.92 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.811 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HG3' HD21 ' A' ' 74' ' ' ASN . 10.9 pt-20 -68.17 -42.06 80.58 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.93 -172.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.406 HD21 ' HG3' ' A' ' 73' ' ' GLU . 9.5 p30 -151.05 174.38 13.24 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-O 121.49 0.662 . . . . 0.0 112.059 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.51 -27.64 69.11 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.41 -165.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.06 -42.11 76.69 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.304 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -62.87 -23.73 67.47 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.588 0.755 . . . . 0.0 112.568 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.5 -42.83 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.429 0.633 . . . . 0.0 110.457 171.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.76 -30.77 67.35 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.66 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -70.68 -43.11 69.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.371 0.605 . . . . 0.0 109.683 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -30.23 69.07 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.759 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.402 ' O ' ' HE1' ' A' ' 92' ' ' MET . 43.1 t80 -62.25 -60.88 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.898 0.879 . . . . 0.0 109.005 176.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.43 89.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.766 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.2 -45.13 94.45 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 124.115 0.885 . . . . 0.0 113.908 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.404 ' HB3' HG12 ' A' ' 90' ' ' VAL . 41.1 m0 -64.2 -45.52 87.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.17 0.588 . . . . 0.0 110.288 175.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.3 -46.02 76.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.576 0.75 . . . . 0.0 110.269 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.61 63.42 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.52 14.46 29.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 112.539 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 55.27 3.61 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.439 -0.8 . . . . 0.0 114.776 166.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.4 p -104.33 148.79 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.63 56.42 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.879 0.471 . . . . 0.0 111.456 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.557 ' HB2' HG13 ' A' ' 90' ' ' VAL . 55.5 ttm 63.56 84.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 166.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 86.75 2.63 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 121.332 0.587 . . . . 0.0 110.83 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 106' ' ' THR . 55.7 tp60 179.02 122.57 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.519 1.528 . . . . 0.0 108.187 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.54 114.94 49.7 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HB2' ' HH ' ' A' ' 103' ' ' TYR . 76.4 Cg_exo -48.61 107.26 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.385 2.723 . . . . 0.0 112.256 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.81 145.51 42.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 110.021 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HZ2' ' HB2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -72.67 112.24 8.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.4 tpp -100.46 162.63 12.81 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.64 -23.08 62.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.237 0.615 . . . . 0.0 111.007 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.72 90.77 3.39 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.374 1.07 . . . . 0.0 108.555 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.48 152.08 1.12 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.558 ' HB3' ' HB2' ' A' ' 119' ' ' ALA . 84.8 t80 -71.97 101.06 2.6 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 165.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -109.25 151.26 26.77 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.813 0.816 . . . . 0.0 112.04 -161.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.74 149.75 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.563 1.545 . . . . 0.0 108.498 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 87.6 m -141.23 128.3 20.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.751 0.705 . . . . 0.0 110.497 171.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.99 155.91 18.91 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.137 0.575 . . . . 0.0 109.79 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.73 126.31 52.45 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.54 156.5 22.86 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.055 0.942 . . . . 0.0 111.484 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.56 -21.91 73.17 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.739 2.293 . . . . 0.0 112.431 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -92.29 -20.69 20.86 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.142 0.977 . . . . 0.0 110.559 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.2 m 72.63 90.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.873 1.669 . . . . 0.0 110.967 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.483 ' NE2' HG12 ' A' ' 11' ' ' VAL . 10.5 m80 -113.18 -92.32 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 113' ' ' HIS . 4.7 tpt180 167.98 109.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.281 1.032 . . . . 0.0 109.348 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.473 HD22 ' HH ' ' A' ' 21' ' ' TYR . 90.9 mt -126.6 110.33 13.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.141 0.577 . . . . 0.0 111.175 -176.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -95.3 147.55 23.37 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.337 0.517 . . . . 0.0 110.685 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.04 125.58 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -130.62 151.77 50.71 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.092 0.86 . . . . 0.0 111.489 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -103.81 117.55 34.63 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -77.64 111.96 13.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.329 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.3 m80 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.66 -0.209 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -91.75 101.91 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.014 2.476 . . . . 0.0 112.237 173.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.721 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.9 p-10 -86.01 -1.68 57.58 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.416 0.627 . . . . 0.0 111.019 169.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.402 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.1 t80 -118.53 112.45 19.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -169.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -109.78 131.55 54.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 52.3 mt -113.8 132.86 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -97.49 172.05 7.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.918 0.866 . . . . 0.0 109.005 173.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' B' ' 50' ' ' TRP . 30.9 m-85 -128.22 122.11 30.99 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.897 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.443 HG12 ' NE2' ' B' ' 113' ' ' HIS . 6.2 m -125.93 155.94 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.81 0.844 . . . . 0.0 109.523 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -88.01 -56.77 3.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.179 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -94.42 109.31 42.2 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.244 0.618 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.41 -56.92 2.1 Favored 'Trans proline' 0 CA--C 1.574 2.491 0 C-N-CA 122.68 2.254 . . . . 0.0 114.269 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.37 -58.79 0.54 Allowed 'Trans proline' 0 C--N 1.402 3.369 0 CA-C-N 122.179 1.814 . . . . 0.0 111.714 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.06 92.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.788 0.835 . . . . 0.0 112.494 -167.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -76.31 -33.82 59.04 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.023 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -73.11 -39.78 65.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.527 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 0.0 OUTLIER -59.61 -37.33 78.29 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.712 172.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.409 ' CE1' HG23 ' B' ' 90' ' ' VAL . 78.2 t80 -62.5 -45.36 93.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.467 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.487 ' HH ' HD23 ' B' ' 115' ' ' LEU . 63.7 m-85 -70.44 -29.27 65.81 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.025 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.527 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 63.4 mtpt -56.94 -47.33 80.9 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.794 0.725 . . . . 0.0 112.867 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.86 44.54 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.872 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -63.45 -40.23 96.6 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.614 1.166 . . . . 0.0 112.533 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 34.3 mt -93.57 -39.13 11.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.24 25.91 15.36 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.848 -173.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -119.38 175.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.093 0.957 . . . . 0.0 110.406 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.31 140.66 37.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.22 111.54 0.85 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.915 2.41 . . . . 0.0 112.29 173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.91 -35.88 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 109.88 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 26.8 mm-40 -112.35 87.63 2.62 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.5 p -90.66 128.18 36.54 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -141.51 153.37 65.44 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -47.83 -44.29 27.29 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.764 2.976 . . . . 0.0 114.569 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -126.57 16.14 7.59 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -145.58 151.65 38.45 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -140.63 142.17 35.02 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.665 0.786 . . . . 0.0 108.889 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.3 tm? -138.98 121.14 15.77 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' B' ' 49' ' ' LEU . 4.1 p90 -133.04 132.0 41.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 108.607 173.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.527 HG23 ' HG3' ' B' ' 46' ' ' LYS . 21.5 t -110.45 129.46 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.921 0.888 . . . . 0.0 109.012 -173.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.481 HD21 ' SD ' ' B' ' 45' ' ' MET . 7.8 mp -93.66 142.76 26.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 0.0 110.135 -170.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.44 -5.89 21.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.986 0.914 . . . . 0.0 112.385 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' N ' HD21 ' B' ' 43' ' ' ASN . 0.8 OUTLIER -66.69 -19.74 65.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.659 1.183 . . . . 0.0 111.976 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.29 16.79 15.26 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.176 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.75 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.5 ppp? -125.52 175.95 7.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.747 0.819 . . . . 0.0 109.723 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.527 ' HG3' HG23 ' B' ' 40' ' ' VAL . 81.3 tttt -140.36 137.68 34.26 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -133.03 118.84 19.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.753 0.421 . . . . 0.0 110.234 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . 0.402 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -97.47 163.33 21.76 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.4 HD13 ' HZ ' ' B' ' 39' ' ' PHE . 1.1 tp -141.75 104.68 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 171.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.433 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 3.3 t90 -111.43 134.78 52.77 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 35.3 m -76.12 136.56 39.83 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 111.355 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -72.48 -9.88 59.1 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.917 0.887 . . . . 0.0 112.335 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -87.18 -8.18 57.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.28 0.632 . . . . 0.0 111.095 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.2 t -135.42 8.8 3.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.907 0.483 . . . . 0.0 111.342 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' B' ' 58' ' ' LYS . 4.0 p -67.93 143.3 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.38 0.272 . . . . 0.0 111.272 176.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -123.81 117.49 27.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.246 1.018 . . . . 0.0 109.181 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.3 143.41 76.32 Favored 'Cis proline' 0 C--N 1.381 2.277 0 CA-C-N 120.098 1.071 . . . . 0.0 113.105 -1.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.487 ' HA ' HG11 ' B' ' 55' ' ' VAL . 3.1 tppp? -58.84 127.81 34.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.992 0.917 . . . . 0.0 112.66 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.08 108.92 3.1 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.78 1.232 . . . . 0.0 108.677 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -87.0 89.73 8.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.16 0.584 . . . . 0.0 109.507 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 142.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.551 0.741 . . . . 0.0 110.422 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -139.24 136.55 35.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 109.479 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.75 51.84 50.48 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.752 0.658 . . . . 0.0 114.172 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.05 45.72 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.45 -170.63 12.03 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.455 -0.372 . . . . 0.0 113.124 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.4 170.56 47.99 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.258 0.622 . . . . 0.0 112.975 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -99.93 159.81 14.8 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.589 0.756 . . . . 0.0 110.77 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.78 101.36 10.81 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.58 103.69 14.65 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -82.81 105.78 14.1 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 41.0 mtm105 -84.6 127.99 34.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.689 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.56 157.79 43.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.963 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.26 -42.39 83.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.037 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.99 174.33 13.27 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 121.497 0.665 . . . . 0.0 111.876 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.61 -27.7 69.12 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.139 -1.392 . . . . 0.0 112.461 -165.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.99 -41.84 77.3 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -63.56 -23.71 67.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.561 0.745 . . . . 0.0 112.392 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.33 -42.65 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.252 0.621 . . . . 0.0 110.631 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.43 -31.12 68.17 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.594 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.2 mt-10 -70.98 -42.69 69.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.408 0.623 . . . . 0.0 109.557 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -69.19 -29.81 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.401 ' O ' ' HE1' ' B' ' 92' ' ' MET . 38.0 t80 -62.64 -60.68 3.17 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.549 0.74 . . . . 0.0 109.143 176.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.17 88.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.801 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.06 94.38 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 124.041 0.838 . . . . 0.0 113.615 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -63.88 -45.7 88.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.308 0.643 . . . . 0.0 110.235 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.82 -45.7 78.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.582 0.753 . . . . 0.0 110.454 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.91 63.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.028 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -99.45 14.15 30.81 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.959 0.903 . . . . 0.0 112.43 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 54.25 3.65 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.709 -0.678 . . . . 0.0 114.751 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' B' ' 20' ' ' PHE . 38.3 t -104.26 147.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.248 0.619 . . . . 0.0 109.339 170.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.15 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.092 0.557 . . . . 0.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.401 ' HE1' ' O ' ' B' ' 82' ' ' PHE . 55.0 ttm 63.84 84.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 166.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.62 86.77 2.64 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.863 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.518 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 22.9 tm0? 178.82 122.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.072 1.349 . . . . 0.0 107.644 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -79.58 114.48 45.94 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.484 ' HB2' ' HH ' ' B' ' 103' ' ' TYR . 75.2 Cg_exo -48.64 107.53 0.14 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.567 2.845 . . . . 0.0 112.178 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.84 145.31 42.3 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.942 0.897 . . . . 0.0 109.941 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.63 ' HZ3' ' HB2' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -72.28 112.38 8.3 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.495 ' HE2' ' HB2' ' A' ' 56' ' ' GLU . 16.5 ttm -101.18 162.91 12.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.78 -23.9 63.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 0.0 111.106 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . 0.441 ' H ' ' HG2' ' B' ' 99' ' ' MET . 96.3 m-85 -119.51 91.49 3.56 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.552 1.141 . . . . 0.0 109.033 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.78 151.56 1.13 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . 0.63 ' HB2' ' HZ3' ' B' ' 98' ' ' LYS . 80.1 t80 -71.8 100.87 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.3 t -108.77 151.14 26.61 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.948 0.88 . . . . 0.0 111.893 -161.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.518 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 9.6 t80 -141.15 149.23 41.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.036 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.514 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 62.6 m -141.57 128.19 20.25 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.982 0.81 . . . . 0.0 110.69 171.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.23 155.77 19.14 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.279 0.632 . . . . 0.0 109.935 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.61 128.43 54.53 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.22 156.86 57.54 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.197 0.999 . . . . 0.0 110.361 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.0 -21.71 72.38 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -92.93 -20.12 20.94 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.962 0.905 . . . . 0.0 110.377 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 40.2 m 71.9 90.99 0.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.965 1.706 . . . . 0.0 111.108 -176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.443 ' NE2' HG12 ' B' ' 11' ' ' VAL . 12.4 m170 -113.88 -91.68 0.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 167.32 109.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.577 1.151 . . . . 0.0 109.176 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.487 HD23 ' HH ' ' B' ' 21' ' ' TYR . 86.2 mt -126.36 110.19 13.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.11 0.564 . . . . 0.0 111.153 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -92.56 147.86 22.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.215 0.606 . . . . 0.0 110.581 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -134.74 125.74 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 163.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' B' ' 71' ' ' ARG . 12.4 p90 -130.15 151.77 50.31 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.295 0.952 . . . . 0.0 111.479 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' B' ' 103' ' ' TYR . . . -104.11 116.46 32.24 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -74.84 107.61 7.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.24 100.19 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.905 0.753 . . . . 0.0 109.737 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.089 -174.393 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 70.1 Cg_endo -74.2 101.14 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.69 2.26 . . . . 0.0 111.563 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.588 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 27.0 t70 -113.52 1.78 15.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.031 0.932 . . . . 0.0 110.477 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -126.57 112.86 16.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -107.71 136.97 46.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 53.0 mt -119.99 135.0 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.617 0.767 . . . . 0.0 109.765 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.468 HD21 HD21 ' A' ' 47' ' ' LEU . 4.4 mm? -108.94 142.91 38.9 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -97.03 123.57 40.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.942 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' SER . 22.9 m -127.91 162.12 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.669 -0.644 . . . . 0.0 109.823 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -116.85 45.8 1.78 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.724 1.21 . . . . 0.0 108.917 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 16' ' ' ALA . 47.9 t30 178.85 74.99 0.14 Allowed Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.868 -158.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.0 Cg_exo -58.62 -63.12 0.15 Allowed 'Trans proline' 0 CA--C 1.579 2.77 0 C-N-CA 122.183 1.922 . . . . 0.0 113.889 -177.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 32.8 Cg_exo -60.27 -60.47 0.27 Allowed 'Trans proline' 0 C--N 1.404 3.465 0 CA-C-N 123.111 2.147 . . . . 0.0 112.331 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.454 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . . . -67.74 -39.18 84.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.589 -165.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.0 t -76.9 -28.53 55.36 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 86.3 m -71.77 -34.25 69.3 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.567 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 15.1 mm100 -64.41 -37.14 86.46 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.467 170.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.15 -43.09 88.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 12.2 m-85 -68.53 -31.21 70.29 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.796 176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -57.31 -46.14 83.49 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.269 0.486 . . . . 0.0 112.117 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.07 -35.42 56.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.418 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.9 tp -60.89 -41.52 96.21 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.247 1.419 . . . . 0.0 112.48 -177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 HD22 ' HG3' ' B' ' 4' ' ' PRO . 25.3 mt -92.49 -45.18 8.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.256 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.5 28.23 6.45 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.044 -172.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.7 m -129.77 -178.97 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.063 0.945 . . . . 0.0 110.47 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -126.39 156.11 73.22 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.485 1.114 . . . . 0.0 108.504 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 47.7 Cg_endo -66.95 125.55 13.84 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.184 1.922 . . . . 0.0 112.413 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 40' ' ' VAL . 7.3 p -70.72 -35.81 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.549 0.739 . . . . 0.0 110.246 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 72.2 mm-40 -126.3 138.84 53.64 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 108.273 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -142.12 135.4 29.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 110.321 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 42.0 m -137.36 157.62 73.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.504 1.522 . . . . 0.0 108.398 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.8 -41.32 38.9 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.113 2.542 . . . . 0.0 114.098 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -127.92 21.95 6.31 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 85.2 t80 -149.99 152.94 35.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.09 0.556 . . . . 0.0 109.679 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 34.7 m -144.48 157.22 44.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.818 0.847 . . . . 0.0 109.455 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.7 tp -152.02 125.19 8.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.454 ' CZ ' ' HG ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -133.38 114.8 14.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.654 1.182 . . . . 0.0 109.194 174.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 30' ' ' VAL . 3.9 p -93.26 133.01 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.607 0.763 . . . . 0.0 109.589 174.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.433 HD13 ' SD ' ' A' ' 45' ' ' MET . 9.0 mp -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.213 0.605 . . . . 0.0 110.078 -170.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.48 -7.45 49.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.309 0.644 . . . . 0.0 111.528 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -73.54 -15.29 61.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.451 0.7 . . . . 0.0 110.221 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.36 -12.02 36.5 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 123.44 0.543 . . . . 0.0 113.808 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.597 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.5 ppp? -86.32 169.78 12.64 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.31 0.555 . . . . 0.0 110.216 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.67 138.27 48.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.452 0.301 . . . . 0.0 110.681 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.468 HD21 HD21 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -136.12 130.6 33.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.032 0.533 . . . . 0.0 110.345 -170.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.76 166.17 13.12 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.627 0.632 . . . . 0.0 112.081 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HG ' ' CZ ' ' A' ' 39' ' ' PHE . 17.5 mt -136.47 106.98 6.48 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.456 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.5 t90 -109.8 129.45 55.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 53.3 m -72.33 129.97 39.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -67.27 -18.7 65.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -75.88 -23.65 55.62 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.69 0.396 . . . . 0.0 110.94 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 51' ' ' SER . 14.3 t -115.7 6.27 14.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.564 0.746 . . . . 0.0 111.479 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 9.5 p -71.72 151.97 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.35 117.03 17.68 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 122.994 0.518 . . . . 0.0 110.96 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.5 Cg_exo -73.59 140.46 67.35 Favored 'Cis proline' 0 C--N 1.391 2.799 0 CA-C-N 119.673 0.919 . . . . 0.0 111.163 0.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -60.46 110.1 1.18 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 110.083 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.1 108.61 19.77 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.461 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 p -81.47 85.96 6.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.55 141.74 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.089 0.955 . . . . 0.0 109.557 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -161.02 142.02 11.57 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.232 1.413 . . . . 0.0 108.827 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.62 -38.87 0.61 Allowed Glycine 0 C--N 1.345 1.081 0 O-C-N 123.129 0.268 . . . . 0.0 112.487 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.69 -77.42 0.05 OUTLIER Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.43 -137.14 19.89 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.06 167.19 54.62 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 16.8 mt-10 -103.75 152.48 21.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.0 tp -117.71 98.61 6.46 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -90.95 114.71 27.28 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.392 0.615 . . . . 0.0 111.354 -169.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.0 m-85 -88.68 122.08 31.73 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.065 1.346 . . . . 0.0 108.79 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HE ' ' HB3' ' B' ' 5' ' ' ASP . 41.3 mtm180 -99.01 129.88 45.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.501 0.667 . . . . 0.0 111.913 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.82 165.61 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.701 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.567 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.3 pt-20 -66.83 -39.73 87.77 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.2 p30 -162.5 -179.92 7.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.74 0.7 . . . . 0.0 112.094 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.02 -29.95 68.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.935 1.294 . . . . 0.0 112.913 -165.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.96 -47.8 76.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.046 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.567 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.5 mm-40 -64.7 -23.06 67.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.966 -1.016 . . . . 0.0 112.497 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.528 HG11 HG13 ' A' ' 117' ' ' VAL . 63.9 t -66.51 -46.04 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.539 0.736 . . . . 0.0 109.729 174.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 27.6 t70 -72.65 -28.81 62.95 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.242 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.3 mt-10 -69.52 -41.35 76.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.397 0.618 . . . . 0.0 110.012 175.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.6 m -66.98 -32.86 74.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.858 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.44 ' O ' ' HE3' ' A' ' 92' ' ' MET . 37.0 t80 -54.13 -59.98 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.987 0.915 . . . . 0.0 109.515 172.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.432 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -61.08 -38.8 87.55 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.688 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.54 92.13 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 123.617 0.573 . . . . 0.0 114.257 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -63.71 -45.49 89.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.497 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.6 ttpt -56.07 -45.39 79.32 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.964 0.906 . . . . 0.0 110.256 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.51 68.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.976 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 m -98.89 13.63 31.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.144 0.978 . . . . 0.0 112.616 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.33 54.81 2.74 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.309 -0.859 . . . . 0.0 114.568 164.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 92' ' ' MET . 3.7 p -102.83 152.85 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.63 -47.83 65.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.076 0.398 . . . . 0.0 110.957 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.497 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 52.6 ttm 65.34 84.02 0.16 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 170.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.87 83.21 2.14 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 120.962 0.41 . . . . 0.0 111.013 173.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 17.4 tm0? 178.46 140.04 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -87.72 123.32 69.47 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.678 0.791 . . . . 0.0 110.882 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.64 98.17 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.426 2.084 . . . . 0.0 110.409 174.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.08 157.51 43.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.796 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.01 104.76 4.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.965 0.906 . . . . 0.0 108.977 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 ttt -100.61 173.83 6.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.818 0.847 . . . . 0.0 109.983 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -55.93 -36.45 67.76 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.596 1.158 . . . . 0.0 112.177 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 -8.39 51.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.735 0.814 . . . . 0.0 110.845 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 126.63 -173.25 18.19 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.029 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.27 105.97 7.62 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 t -131.53 166.76 20.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.718 0.407 . . . . 0.0 111.934 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.46 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -155.72 160.15 40.1 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.737 169.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 3.0 m -133.45 127.3 33.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.219 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 105' ' ' PHE . . . -107.33 152.67 23.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 110.474 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.32 116.57 32.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.466 ' HB3' HD12 ' A' ' 115' ' ' LEU . 4.0 p-10 -68.81 170.45 8.41 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.675 0.79 . . . . 0.0 110.923 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -46.19 -39.54 20.89 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 123.412 2.742 . . . . 0.0 114.457 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.0 -11.96 55.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.579 0.752 . . . . 0.0 111.254 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 73.07 80.93 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.62 1.568 . . . . 0.0 111.679 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -120.07 -179.51 3.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.554 ' HD2' ' HD2' ' B' ' 57' ' ' PRO . 50.0 mmt-85 -103.27 99.16 9.0 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 109' ' ' ASP . 51.4 mt -97.12 103.37 15.29 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 25.7 mmt180 -89.11 148.54 23.63 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 123.967 0.907 . . . . 0.0 110.355 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.528 HG13 HG11 ' A' ' 78' ' ' VAL . 9.3 p -138.67 130.57 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 159.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -137.56 163.3 31.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.439 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.15 111.72 16.24 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.76 119.67 15.24 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.63 0.581 . . . . 0.0 110.557 -169.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 122.996 0.518 . . . . 0.0 110.692 -177.512 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 119.702 -0.19 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 58.9 Cg_endo -72.95 101.55 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.695 2.264 . . . . 0.0 111.941 172.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.597 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 12.2 t70 -114.93 2.82 14.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.719 0.771 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.441 ' CD1' ' HG2' ' B' ' 46' ' ' LYS . 3.8 t80 -126.78 112.65 15.63 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -169.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -107.43 137.21 45.88 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 43.7 mt -120.35 135.57 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.511 0.724 . . . . 0.0 109.636 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.33 142.11 42.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.43 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 25.1 p90 -95.12 124.67 39.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.824 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' B' ' 51' ' ' SER . 36.0 m -128.76 163.5 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.931 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -118.81 44.83 2.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.488 1.115 . . . . 0.0 108.19 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 179.39 74.84 0.16 Allowed Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.662 -158.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.483 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 23.8 Cg_exo -58.61 -63.81 0.13 Allowed 'Trans proline' 0 CA--C 1.578 2.718 0 C-N-CA 122.154 1.903 . . . . 0.0 114.016 -177.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 31.8 Cg_exo -59.51 -60.66 0.29 Allowed 'Trans proline' 0 C--N 1.404 3.464 0 CA-C-N 123.035 2.12 . . . . 0.0 112.575 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.45 85.77 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.679 -165.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -76.76 -28.6 55.79 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.3 m -71.58 -34.21 69.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.618 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.1 mm100 -63.88 -37.67 88.25 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.416 170.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.31 -42.63 88.01 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.704 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -68.15 -31.8 71.63 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.139 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.618 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 54.3 mtpt -56.84 -46.34 81.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.263 0.554 . . . . 0.0 111.805 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.36 -35.03 54.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.226 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.47 -41.08 96.71 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.341 . . . . 0.0 112.547 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.442 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -92.75 -44.89 8.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.16 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 28.79 6.34 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.986 -172.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' B' ' 25' ' ' LEU . 25.8 m -130.77 -179.49 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.927 0.891 . . . . 0.0 110.598 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.67 156.31 71.11 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 124.363 1.065 . . . . 0.0 108.368 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 13.9 Cg_exo -67.82 126.0 14.0 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.39 2.06 . . . . 0.0 111.806 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.533 HG12 HG21 ' B' ' 40' ' ' VAL . 13.5 p -71.91 -33.69 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.287 0.635 . . . . 0.0 110.281 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 60.4 mm-40 -128.28 138.3 52.35 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.9 m -142.56 136.14 28.95 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.108 0.563 . . . . 0.0 110.28 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 35.2 m -137.74 160.02 66.55 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 125.295 1.438 . . . . 0.0 108.442 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -52.36 -40.11 71.55 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.136 2.557 . . . . 0.0 113.212 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -127.97 21.91 6.29 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 87.0 t80 -149.39 153.21 37.03 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.074 0.549 . . . . 0.0 109.745 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 71.1 m -144.57 156.97 44.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.785 0.834 . . . . 0.0 109.696 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 3.0 tt -151.77 126.47 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 0.4 OUTLIER -134.36 113.53 12.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.934 1.294 . . . . 0.0 108.865 176.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' B' ' 46' ' ' LYS . 7.0 t -92.92 132.2 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.655 0.782 . . . . 0.0 109.336 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.421 HD23 HD11 ' B' ' 25' ' ' LEU . 36.0 mt -89.25 150.01 22.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.872 0.469 . . . . 0.0 110.262 -171.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.19 -7.96 52.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 111.609 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -71.91 -16.62 62.12 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.621 0.769 . . . . 0.0 110.379 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -12.17 35.49 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 123.436 0.541 . . . . 0.0 113.886 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.588 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -86.68 170.11 12.09 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.307 0.553 . . . . 0.0 109.958 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.586 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.7 tttt -131.51 137.34 48.49 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.961 0.504 . . . . 0.0 110.6 -175.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.67 131.43 35.7 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.334 -171.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.23 167.61 13.36 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.193 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.22 105.77 5.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.425 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -109.72 129.33 55.62 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 62.5 m -72.25 129.8 39.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -67.27 -18.82 65.36 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -170.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.85 -23.95 55.74 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.653 0.381 . . . . 0.0 110.59 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -115.6 6.58 14.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.425 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 7.9 p -72.09 152.41 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 122.05 -0.406 . . . . 0.0 109.99 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.436 ' HB2' HH22 ' A' ' 116' ' ' ARG . 30.6 mt-10 -130.86 116.49 17.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 122.976 0.51 . . . . 0.0 110.903 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 2.6 Cg_exo -73.35 140.49 67.48 Favored 'Cis proline' 0 C--N 1.387 2.554 0 CA-C-N 119.838 0.978 . . . . 0.0 111.068 0.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.35 110.1 1.16 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.926 0.766 . . . . 0.0 110.146 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.01 108.69 19.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.664 1.186 . . . . 0.0 108.376 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.3 p -81.42 85.19 6.5 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.94 143.32 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.867 0.867 . . . . 0.0 109.276 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.43 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 1.0 OUTLIER -162.31 141.41 9.29 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.335 1.454 . . . . 0.0 108.808 171.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.23 -38.08 0.59 Allowed Glycine 0 C--N 1.343 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 112.719 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.5 -77.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.49 -137.03 19.7 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.89 167.03 54.65 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.5 mt-10 -103.48 152.63 21.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.006 0.431 . . . . 0.0 110.525 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 57.5 tp -117.63 98.86 6.6 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.623 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.02 115.04 27.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.492 0.663 . . . . 0.0 111.381 -169.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 6.5 m-85 -89.2 122.47 32.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.949 1.3 . . . . 0.0 108.538 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.555 ' HE ' ' HB3' ' A' ' 5' ' ' ASP . 38.9 mtm105 -99.17 128.89 45.37 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.417 0.687 . . . . 0.0 111.678 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.95 165.94 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.791 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.569 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.71 -39.91 88.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -174.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -162.49 -179.54 7.02 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.543 0.61 . . . . 0.0 112.151 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.62 -29.97 69.57 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.006 1.322 . . . . 0.0 112.784 -164.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.517 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -64.49 -48.08 76.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.569 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.3 mm-40 -64.8 -22.92 67.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.118 0.967 . . . . 0.0 112.45 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.68 -45.55 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.611 0.719 . . . . 0.0 109.7 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -72.95 -28.84 62.66 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.966 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.8 mt-10 -69.32 -41.41 76.74 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.466 0.65 . . . . 0.0 109.95 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 23.7 m -68.22 -31.81 71.58 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.669 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -54.27 -59.52 4.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.744 0.818 . . . . 0.0 109.893 172.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.46 86.89 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.552 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.35 92.05 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 123.836 0.71 . . . . 0.0 114.064 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -64.35 -45.56 87.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.959 0.504 . . . . 0.0 109.908 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -56.49 -44.27 80.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.912 0.885 . . . . 0.0 110.404 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.52 -29.34 67.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.93 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 13.1 33.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.967 0.907 . . . . 0.0 112.447 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.03 2.69 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.603 165.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' B' ' 92' ' ' MET . 3.9 p -102.98 152.83 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.95 67.69 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.146 0.43 . . . . 0.0 111.097 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.491 ' HB2' HG11 ' B' ' 90' ' ' VAL . 48.5 tpp 64.84 83.63 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.896 0.748 . . . . 0.0 112.727 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.74 82.83 2.11 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 15.4 tm0? 178.81 140.89 0.1 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.081 1.353 . . . . 0.0 107.477 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.0 123.39 67.54 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.573 0.749 . . . . 0.0 110.517 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.78 98.54 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.472 2.114 . . . . 0.0 110.244 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.14 157.36 44.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.79 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.97 105.16 4.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.926 0.89 . . . . 0.0 108.85 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.44 ' SD ' HG21 ' B' ' 104' ' ' THR . 10.8 ttt -100.87 172.99 6.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.204 1.002 . . . . 0.0 109.901 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -55.34 -36.71 66.56 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.45 1.1 . . . . 0.0 112.424 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.64 -8.3 52.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.787 0.835 . . . . 0.0 110.953 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 126.52 -173.14 18.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.133 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -76.74 106.49 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.44 HG21 ' SD ' ' B' ' 99' ' ' MET . 11.9 t -132.0 166.19 22.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 0.0 111.82 -169.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.405 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 6.4 p90 -153.71 162.35 41.32 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.409 168.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 29.2 m -134.54 127.69 31.81 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.48 152.44 24.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.388 0.675 . . . . 0.0 110.523 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.11 117.61 34.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.487 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 5.8 p-10 -71.12 171.72 8.02 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.702 -0.666 . . . . 0.0 110.288 176.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 7.7 Cg_endo -46.9 -39.63 24.73 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.464 2.776 . . . . 0.0 114.194 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.18 -10.7 57.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.133 0.573 . . . . 0.0 111.604 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 15.3 m 72.98 82.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.108 1.363 . . . . 0.0 111.565 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.408 ' HE1' HG11 ' B' ' 11' ' ' VAL . 13.4 m80 -123.25 179.99 4.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -103.93 99.15 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.91 103.83 15.81 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.623 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 44.0 ttm-85 -89.02 148.2 23.87 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.618 0.767 . . . . 0.0 110.516 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' B' ' 70' ' ' PHE . 21.5 t -136.58 131.18 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -136.99 163.94 29.53 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -124.67 111.71 15.91 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.86 119.32 13.9 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.757 0.661 . . . . 0.0 110.623 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 95.05 1.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.021 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.369 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -87.26 83.44 1.01 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.842 2.361 . . . . 0.0 111.765 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.775 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.9 p-10 -84.8 4.92 30.73 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 172.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.7 t80 -123.41 127.66 48.76 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.093 1.357 . . . . 0.0 107.681 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -126.36 136.1 52.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.959 0.904 . . . . 0.0 108.584 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 50.9 mt -119.56 137.16 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.696 0.798 . . . . 0.0 109.53 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.4 mt -108.08 140.56 41.09 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.484 ' HE2' ' HA ' ' A' ' 62' ' ' THR . 36.3 p90 -85.7 130.98 34.42 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.262 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.489 HG13 ' NE2' ' A' ' 113' ' ' HIS . 5.3 m -129.5 151.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.479 0.657 . . . . 0.0 110.575 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.46 -55.36 3.69 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.22 1.008 . . . . 0.0 109.938 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -105.15 98.4 15.97 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.54 0.736 . . . . 0.0 109.927 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.78 -53.92 6.19 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.518 2.812 . . . . 0.0 115.185 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.29 -54.19 5.87 Favored 'Trans proline' 0 C--N 1.402 3.363 0 C-N-CA 122.53 2.153 . . . . 0.0 113.023 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.18 61.83 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.296 -168.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -77.38 -35.16 54.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.723 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 78.6 m -67.16 -43.31 82.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.563 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 19.4 mm100 -61.47 -35.02 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.63 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 t80 -64.05 -44.26 93.01 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 124.058 0.849 . . . . 0.0 110.142 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.701 ' HH ' HD23 ' A' ' 115' ' ' LEU . 62.0 m-85 -71.55 -30.06 65.46 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.854 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.563 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -56.31 -50.51 71.23 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.252 0.549 . . . . 0.0 111.991 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -33.76 52.41 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.72 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 19.4 tp -60.99 -48.62 80.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.707 1.203 . . . . 0.0 112.801 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' HB2' HG23 ' A' ' 27' ' ' VAL . 35.4 mt -84.94 -40.79 16.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.301 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 33.61 6.39 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -173.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 25' ' ' LEU . 31.4 m -128.27 -178.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.29 1.036 . . . . 0.0 110.595 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -132.95 141.17 40.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.988 0.915 . . . . 0.0 108.865 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 18.9 Cg_exo -66.06 110.82 1.82 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.613 2.209 . . . . 0.0 111.793 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.99 -39.68 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 17.9 mm-40 -112.51 109.04 18.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.2 p -113.88 141.97 46.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.277 0.631 . . . . 0.0 109.655 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 66.1 m -142.94 160.92 51.22 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.988 1.315 . . . . 0.0 108.894 -175.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.43 -30.85 91.74 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.736 2.29 . . . . 0.0 113.013 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.5 t -127.55 19.39 6.78 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.173 0.589 . . . . 0.0 111.894 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.407 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.3 t80 -159.1 156.78 29.77 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.881 0.472 . . . . 0.0 110.345 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 m -146.47 150.31 35.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.474 1.11 . . . . 0.0 108.358 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -144.44 116.97 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -128.85 122.97 31.55 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.037 1.335 . . . . 0.0 108.542 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 46' ' ' LYS . 15.6 t -106.21 134.0 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.979 0.912 . . . . 0.0 109.425 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.435 HD12 ' SD ' ' A' ' 45' ' ' MET . 85.5 mt -95.19 147.18 23.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.562 0.345 . . . . 0.0 110.107 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -12.45 52.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.302 1.041 . . . . 0.0 112.199 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.5 -8.92 29.61 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.175 0.99 . . . . 0.0 112.931 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.1 53.75 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.803 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -114.56 170.84 8.01 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.9 0.88 . . . . 0.0 108.938 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' ' 40' ' ' VAL . 75.9 tttt -133.75 134.22 42.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.28 118.13 22.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.775 0.43 . . . . 0.0 109.878 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -96.56 166.54 24.08 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.717 0.675 . . . . 0.0 111.521 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 tp -143.38 102.44 3.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.489 ' HZ2' ' HE1' ' B' ' 99' ' ' MET . 6.2 t90 -111.05 130.29 55.65 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.2 m -68.28 126.91 31.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.154 0.284 . . . . 0.0 110.244 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 24.7 ptt180 -68.79 -13.4 62.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.922 0.889 . . . . 0.0 112.605 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -14.4 59.51 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.47 0.308 . . . . 0.0 110.878 176.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.416 HG22 ' HE1' ' A' ' 50' ' ' TRP . 13.6 t -128.36 10.5 6.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.62 0.768 . . . . 0.0 110.785 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.411 ' HA ' ' CE2' ' A' ' 50' ' ' TRP . 10.3 p -69.79 149.31 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 173.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -130.37 123.8 20.76 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 122.983 0.513 . . . . 0.0 110.638 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.84 137.84 50.29 Favored 'Cis proline' 0 C--N 1.387 2.604 0 C-N-CA 124.453 -1.061 . . . . 0.0 111.432 -6.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.81 110.68 0.45 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.516 0.726 . . . . 0.0 110.886 -175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.47 110.0 22.16 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 p -83.13 87.22 6.92 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -153.31 150.96 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.738 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.484 ' HA ' ' HE2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -163.72 147.92 10.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.245 1.418 . . . . 0.0 109.279 170.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.28 -7.91 76.47 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.961 -0.563 . . . . 0.0 114.098 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 114' ' ' ARG . . . -159.24 122.95 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 133.98 111.93 1.26 Allowed Glycine 0 C--N 1.34 0.781 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.414 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 77.25 109.82 0.15 Allowed Glycine 0 C--N 1.346 1.135 0 O-C-N 124.134 0.549 . . . . 0.0 111.735 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.522 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.8 mm-40 -98.24 136.7 38.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -107.85 99.6 9.05 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -87.56 113.7 23.49 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -163.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -90.6 111.33 22.6 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 108.327 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -92.28 127.09 37.64 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.529 0.68 . . . . 0.0 111.818 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.11 162.14 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.522 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.6 pt-20 -67.9 -35.6 78.76 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -163.25 -179.95 6.97 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.686 0.675 . . . . 0.0 112.746 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -61.58 -29.67 70.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.247 1.419 . . . . 0.0 112.725 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.07 -44.27 72.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.063 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.593 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 75.0 mm-40 -63.63 -23.05 67.22 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.696 0.798 . . . . 0.0 112.467 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -65.89 -41.63 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 0.0 110.519 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.62 -27.94 45.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.127 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.5 mt-10 -66.6 -41.48 88.39 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.89 0.852 . . . . 0.0 109.513 173.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -64.47 -38.1 89.85 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.606 . . . . 0.0 110.93 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.456 ' O ' ' HE3' ' A' ' 92' ' ' MET . 42.3 t80 -55.99 -60.48 3.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.764 0.826 . . . . 0.0 109.845 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.59 -36.44 82.63 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.199 -172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.68 -47.76 83.61 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.71 0.631 . . . . 0.0 113.655 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -65.15 -39.17 92.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.41 0.684 . . . . 0.0 110.185 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -61.46 -43.07 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.376 0.671 . . . . 0.0 110.009 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.11 67.56 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.736 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 t -100.73 7.45 43.84 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.3 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.42 56.91 2.43 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 166.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 92' ' ' MET . 5.8 p -104.75 146.1 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.58 -39.39 67.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.721 0.408 . . . . 0.0 111.519 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.456 ' HE3' ' O ' ' A' ' 82' ' ' PHE . 4.1 ptm 49.68 79.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.138 1.775 . . . . 0.0 113.862 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.406 HD11 ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -109.1 83.29 1.73 Allowed 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.489 -0.757 . . . . 0.0 109.424 177.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 18.2 tm0? 178.85 127.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -76.02 125.78 87.64 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 104' ' ' THR . 42.8 Cg_endo -65.71 98.47 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.295 1.997 . . . . 0.0 109.948 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.14 160.89 39.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.581 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HZ1' ' HB2' ' A' ' 103' ' ' TYR . 17.5 mmtm -69.72 142.65 53.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.326 0.65 . . . . 0.0 110.762 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ttp -147.48 -178.07 6.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.972 0.909 . . . . 0.0 108.66 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.07 -37.28 61.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.867 1.267 . . . . 0.0 113.194 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.37 8.64 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.536 0.735 . . . . 0.0 111.486 -172.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.93 -160.44 13.48 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.481 ' HB2' ' HZ1' ' A' ' 98' ' ' LYS . 11.6 t80 -79.3 109.5 13.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 8.9 t -105.42 147.65 28.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.338 0.655 . . . . 0.0 111.551 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.449 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 17.3 t80 -154.5 136.35 14.51 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.828 1.251 . . . . 0.0 109.57 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.1 m -137.72 123.55 20.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.37 139.95 42.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.36 0.664 . . . . 0.0 111.524 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.72 126.78 55.41 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 13.3 p-10 -78.6 179.78 1.63 Allowed Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.831 175.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 46.8 Cg_exo -44.52 -40.51 13.71 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.827 2.352 . . . . 0.0 114.188 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.35 -21.87 59.49 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.686 0.394 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.69 74.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.438 1.495 . . . . 0.0 110.846 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.489 ' NE2' HG13 ' A' ' 11' ' ' VAL . 19.2 m170 -103.86 -171.57 1.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.413 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.516 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 19.5 mmm180 -120.29 96.77 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.701 HD23 ' HH ' ' A' ' 21' ' ' TYR . 58.9 mt -109.36 99.34 8.6 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -96.47 95.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.321 0.648 . . . . 0.0 111.329 -169.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.74 133.54 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.403 ' HE2' ' HB2' ' A' ' 120' ' ' PHE . 9.1 p90 -136.8 177.96 7.44 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.816 0.734 . . . . 0.0 112.319 172.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.25 111.88 6.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.403 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 38.5 t80 -84.56 119.2 24.92 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 C-N-CA 123.51 0.724 . . . . 0.0 110.375 179.105 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m170 . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.0 83.35 1.08 Allowed 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.911 2.407 . . . . 0.0 111.563 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ASP . . . . . 0.803 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.2 p-10 -84.46 4.68 30.56 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.292 0.568 . . . . 0.0 111.228 172.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -123.37 127.34 48.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.11 1.364 . . . . 0.0 107.502 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 t -126.3 135.99 52.21 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 108.857 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.8 mt -119.46 136.78 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 109.548 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.49 140.42 40.48 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' TYR . . . . . 0.493 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 36.0 p90 -85.46 130.91 34.48 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.106 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.586 HG12 ' NE2' ' B' ' 113' ' ' HIS . 7.1 m -128.93 151.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.257 0.551 . . . . 0.0 110.536 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.69 -55.83 3.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.318 1.047 . . . . 0.0 109.721 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -105.5 97.36 14.05 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 124.081 0.953 . . . . 0.0 109.758 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.31 -54.59 5.13 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.594 2.863 . . . . 0.0 115.379 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.86 -54.54 5.26 Favored 'Trans proline' 0 C--N 1.403 3.398 0 C-N-CA 122.38 2.053 . . . . 0.0 113.409 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.2 61.65 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.439 -168.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 82.8 p -77.7 -34.49 52.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 73.2 m -67.65 -43.71 79.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' GLN . . . . . 0.52 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.0 mm100 -62.12 -34.73 76.89 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.954 173.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 84.6 t80 -63.68 -44.54 93.4 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.023 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' TYR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 50.1 m-85 -70.8 -30.58 67.07 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.917 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 62.1 mtpt -56.45 -50.17 72.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.087 0.47 . . . . 0.0 112.125 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.69 -34.14 52.94 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.662 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 15.4 tp -60.54 -49.29 78.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.68 1.192 . . . . 0.0 113.092 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.49 ' HB2' HG23 ' B' ' 27' ' ' VAL . 34.9 mt -84.26 -40.96 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.28 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.26 33.75 6.41 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.49 HG23 ' HB2' ' B' ' 25' ' ' LEU . 31.5 m -128.62 -178.75 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.059 . . . . 0.0 110.573 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.43 142.35 44.59 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.926 0.89 . . . . 0.0 109.209 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.519 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 16.7 Cg_exo -67.39 110.56 2.07 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.355 2.036 . . . . 0.0 111.828 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.72 -39.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.794 0.838 . . . . 0.0 110.388 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.614 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 23.4 mm-40 -112.99 108.95 18.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -113.84 142.2 46.39 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.368 0.667 . . . . 0.0 109.81 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 50.4 m -142.87 161.48 48.64 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.784 1.234 . . . . 0.0 109.028 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.11 -30.61 89.43 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.471 2.114 . . . . 0.0 112.965 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -127.72 19.62 6.66 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.222 0.609 . . . . 0.0 111.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' PHE . . . . . 0.415 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 77.0 t80 -159.12 156.88 29.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.794 0.438 . . . . 0.0 110.232 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 68.6 m -146.55 150.5 35.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.475 1.11 . . . . 0.0 108.318 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -144.72 117.0 8.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -129.12 123.65 32.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.899 1.28 . . . . 0.0 108.492 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' B' ' 46' ' ' LYS . 19.9 t -107.29 133.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.785 0.834 . . . . 0.0 109.244 -172.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.449 HD12 ' SD ' ' B' ' 45' ' ' MET . 85.5 mt -95.0 147.48 23.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.685 0.394 . . . . 0.0 110.091 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -12.24 52.76 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.158 0.983 . . . . 0.0 112.216 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.93 -8.55 30.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.096 0.959 . . . . 0.0 112.682 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.13 16.15 54.44 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' MET . . . . . 0.775 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -114.84 170.79 8.07 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.82 0.848 . . . . 0.0 108.862 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.551 ' HG3' HG22 ' B' ' 40' ' ' VAL . 80.2 tttt -133.61 134.22 42.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -176.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.501 HD11 HD11 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -128.27 118.19 22.82 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -174.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.73 24.71 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 123.698 0.666 . . . . 0.0 111.623 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' B' ' 37' ' ' SER . 6.8 tp -143.64 102.23 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' TRP . . . . . 0.459 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 6.2 t90 -110.92 130.4 55.59 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 35.9 m -68.3 127.26 32.28 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.286 0.366 . . . . 0.0 110.131 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' B' ' 10' ' ' TYR . 21.1 ptt180 -69.42 -12.78 61.94 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.846 0.858 . . . . 0.0 112.604 -173.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -77.95 -15.46 58.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.508 0.323 . . . . 0.0 110.523 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -127.98 10.37 6.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.607 0.763 . . . . 0.0 111.036 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' B' ' 58' ' ' LYS . 7.8 p -69.99 150.01 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -131.32 123.07 19.37 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.002 0.521 . . . . 0.0 111.13 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.97 136.6 45.15 Favored 'Cis proline' 0 C--N 1.389 2.688 0 C-N-CA 124.348 -1.105 . . . . 0.0 110.969 -4.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.409 ' HA ' HG11 ' B' ' 55' ' ' VAL . 1.5 tmmm? -48.28 110.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.387 0.675 . . . . 0.0 111.284 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.51 109.94 22.08 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.4 p -83.59 85.92 7.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 29.2 m -150.68 151.89 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.247 1.019 . . . . 0.0 109.636 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.493 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 0.3 OUTLIER -164.57 147.91 9.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.006 1.322 . . . . 0.0 109.457 169.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.99 76.64 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.412 0.445 . . . . 0.0 113.779 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . 0.536 ' HA2' ' HD3' ' B' ' 114' ' ' ARG . . . -159.35 122.88 1.18 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 133.83 112.15 1.29 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.514 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 77.28 109.69 0.15 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 173.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.5 mm-40 -98.22 138.16 35.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -170.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.501 HD11 HD11 ' B' ' 47' ' ' LEU . 0.6 OUTLIER -110.68 98.75 7.84 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.04 113.14 23.38 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -161.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -89.85 111.5 22.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.877 1.271 . . . . 0.0 108.578 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -92.99 126.3 38.0 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.51 0.671 . . . . 0.0 111.838 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.63 162.6 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.559 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLU . . . . . 0.546 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.8 pt-20 -67.74 -35.17 78.26 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -163.63 179.71 7.0 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.685 0.675 . . . . 0.0 112.769 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.66 -29.58 70.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.207 1.403 . . . . 0.0 112.764 -166.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.03 -44.03 73.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.078 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLN . . . . . 0.546 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.1 mm-40 -63.84 -23.08 67.21 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.915 0.886 . . . . 0.0 112.548 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.77 -41.55 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.291 0.636 . . . . 0.0 110.41 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.44 -27.37 41.67 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.114 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.6 mt-10 -66.57 -41.37 88.68 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.758 0.79 . . . . 0.0 109.372 173.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.8 m -64.62 -37.87 89.06 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.928 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.01 -60.52 3.36 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 109.722 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.469 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.86 -36.19 81.76 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.237 -172.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.86 84.07 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.578 0.549 . . . . 0.0 113.684 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -65.74 -38.72 89.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.301 0.64 . . . . 0.0 110.261 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.7 ttpt -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 109.982 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.589 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -101.14 7.38 43.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.129 0.972 . . . . 0.0 112.565 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 57.47 2.4 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 115.382 0.913 . . . . 0.0 115.382 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 p -104.87 146.14 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.14 68.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.937 0.495 . . . . 0.0 111.747 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' MET . . . . . 0.471 ' HE2' ' HZ ' ' B' ' 105' ' ' PHE . 10.2 ptp 49.17 80.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.965 1.706 . . . . 0.0 113.911 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.4 ' N ' HD11 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -109.15 83.17 1.71 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.849 0.833 . . . . 0.0 109.62 177.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 178.58 126.64 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.153 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -75.37 126.84 87.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 123.328 0.392 . . . . 0.0 110.455 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' B' ' 104' ' ' THR . 55.8 Cg_endo -67.11 98.53 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.418 2.079 . . . . 0.0 109.732 172.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.33 160.73 39.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -69.38 141.78 54.08 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.881 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' MET . . . . . 0.51 ' HE2' HG23 ' B' ' 104' ' ' THR . 1.1 ptp -145.35 -176.38 5.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.153 0.981 . . . . 0.0 109.281 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -55.66 -36.56 67.21 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.539 1.135 . . . . 0.0 112.61 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.94 8.73 42.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.453 0.701 . . . . 0.0 111.941 -173.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.76 -159.97 13.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.654 -0.579 . . . . 0.0 111.654 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -79.95 109.6 14.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.51 HG23 ' HE2' ' B' ' 99' ' ' MET . 6.9 t -105.99 149.27 26.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.268 0.556 . . . . 0.0 111.369 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' PHE . . . . . 0.471 ' HZ ' ' HE2' ' B' ' 92' ' ' MET . 14.4 t80 -155.77 137.14 13.97 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.867 1.267 . . . . 0.0 109.416 168.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 49.2 m -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.15 139.63 42.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.468 0.707 . . . . 0.0 111.51 -173.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.07 129.11 56.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.418 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 16.4 p-10 -81.52 -179.99 1.69 Allowed Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.977 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 43.3 Cg_exo -44.46 -40.71 13.63 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.473 2.115 . . . . 0.0 114.409 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.7 -22.15 60.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.974 0.51 . . . . 0.0 110.658 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m 72.62 74.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.4 1.48 . . . . 0.0 110.66 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' HIS . . . . . 0.586 ' NE2' HG12 ' B' ' 11' ' ' VAL . 22.1 m170 -103.56 -171.36 1.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.402 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.536 ' HD3' ' HA2' ' B' ' 64' ' ' GLY . 22.6 mmm180 -120.4 96.71 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.2 99.52 8.79 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.47 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -95.23 94.93 8.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.874 0.47 . . . . 0.0 111.886 -169.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.0 t -85.55 133.86 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -137.5 177.68 7.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.059 0.845 . . . . 0.0 112.279 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.08 111.41 5.92 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -83.07 113.44 20.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.55 92.92 3.5 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.024 0.828 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -176.239 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.39 0.138 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 m -93.67 124.07 37.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -98.2 121.21 57.83 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.925 0.89 . . . . 0.0 110.529 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.49 114.29 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.932 2.421 . . . . 0.0 112.285 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.701 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.8 p-10 -99.01 11.43 39.02 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.352 0.596 . . . . 0.0 110.302 171.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.441 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -129.59 125.0 35.17 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.778 1.231 . . . . 0.0 107.875 -170.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -120.48 138.82 53.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.258 1.023 . . . . 0.0 108.503 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 55.8 mt -115.4 133.57 61.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 123.497 0.719 . . . . 0.0 109.066 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.478 HD11 HD21 ' A' ' 47' ' ' LEU . 9.1 mp -112.32 124.3 52.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -79.3 115.96 19.26 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.686 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' SER . 35.7 m -114.49 167.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.789 0.836 . . . . 0.0 109.191 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -96.68 -62.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.234 0.614 . . . . 0.0 110.322 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.16 96.31 13.0 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 123.351 0.66 . . . . 0.0 109.666 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 1.1 Cg_endo -44.9 -52.97 5.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.541 2.827 . . . . 0.0 115.809 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.41 -57.42 2.35 Favored 'Trans proline' 0 C--N 1.403 3.399 0 C-N-CA 122.416 2.077 . . . . 0.0 113.191 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.5 -37.41 77.17 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.4 m -77.43 -26.65 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.44 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 68.4 m -80.3 -38.95 29.69 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 82.9 mm-40 -67.01 -34.04 76.88 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.264 173.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -61.52 -49.45 76.67 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.673 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.2 m-85 -69.62 -27.18 64.86 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.616 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.6 mtpt -57.08 -51.75 68.04 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.144 0.429 . . . . 0.0 111.789 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.03 -32.26 39.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.916 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.0 tp -59.11 -53.24 60.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.041 0.936 . . . . 0.0 111.839 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.6 mt -83.11 -47.2 11.89 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.2 38.99 2.94 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 m -128.42 171.12 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.328 1.051 . . . . 0.0 110.654 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.88 139.03 33.87 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 43.2 Cg_endo -66.15 108.76 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.489 2.126 . . . . 0.0 111.593 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 39' ' ' PHE . 3.7 p -64.81 -39.28 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.286 0.634 . . . . 0.0 109.973 176.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.705 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 35.9 mm-40 -118.51 149.11 41.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.305 1.042 . . . . 0.0 108.647 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 p -160.93 152.95 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.303 0.641 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 52.4 m -148.8 159.65 37.44 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.725 1.21 . . . . 0.0 108.448 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.59 -27.43 32.83 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.94 2.426 . . . . 0.0 113.798 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 14' ' ' PRO . 12.4 t -127.92 16.83 6.8 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.0 t80 -156.15 162.19 40.25 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.894 -0.504 . . . . 0.0 110.55 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 47.1 t -151.67 157.09 41.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.698 0.799 . . . . 0.0 109.351 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.705 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -152.31 128.92 10.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.422 ' HA ' HG11 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -135.16 141.86 46.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.443 1.097 . . . . 0.0 108.823 170.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.557 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.3 t -115.5 127.92 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD12 ' SD ' ' A' ' 45' ' ' MET . 10.0 mp -91.06 148.81 22.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.253 0.621 . . . . 0.0 110.187 -170.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.57 -8.51 34.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 111.809 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.81 -19.5 65.91 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.171 0.989 . . . . 0.0 111.724 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.04 47.35 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.724 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -113.37 174.72 5.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.877 0.871 . . . . 0.0 109.036 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HG3' HG22 ' A' ' 40' ' ' VAL . 82.7 tttt -139.23 140.92 37.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.478 HD21 HD11 ' A' ' 9' ' ' LEU . 2.5 tt -140.07 123.26 16.84 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.817 0.341 . . . . 0.0 110.114 -171.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -104.68 160.3 15.59 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.793 0.711 . . . . 0.0 111.568 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 82.3 mt -126.11 106.46 9.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 164.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.585 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 4.9 t90 -105.08 123.19 47.39 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.6 t -70.7 130.82 42.76 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -65.48 -21.68 66.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 112.364 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -76.56 -8.28 56.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.392 0.277 . . . . 0.0 111.398 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -131.86 9.2 4.54 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.353 0.661 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.21 145.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.49 117.75 21.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 141.64 68.38 Favored 'Cis proline' 0 C--N 1.39 2.755 0 CA-C-N 119.935 1.013 . . . . 0.0 113.953 2.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.44 122.33 16.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.13 0.972 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.66 109.54 5.03 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.79 0.836 . . . . 0.0 109.996 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -85.36 85.5 7.44 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 121.875 0.845 . . . . 0.0 108.775 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.09 147.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 p -144.1 121.69 11.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.94 5.37 68.23 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.202 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.73 -34.78 72.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 121.303 0.391 . . . . 0.0 112.44 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' B' ' 10' ' ' TYR . . . -170.47 -161.54 21.23 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.214 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.55 110.26 0.24 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 114' ' ' ARG . 24.1 mt-10 -123.99 130.09 52.0 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -171.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HB2' HD23 ' A' ' 9' ' ' LEU . 17.7 tp -115.84 101.57 8.91 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -88.08 109.87 20.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.834 0.35 . . . . 0.0 110.752 -171.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' A' ' 117' ' ' VAL . 22.4 m-85 -89.35 107.6 19.16 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -88.06 130.71 34.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.443 0.64 . . . . 0.0 111.273 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.08 159.13 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.816 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -66.15 -34.25 77.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -173.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.416 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 9.9 p30 -163.94 -179.9 6.57 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.513 0.673 . . . . 0.0 112.333 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.56 -29.7 70.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.492 1.517 . . . . 0.0 112.978 -165.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.86 -41.47 74.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.248 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.552 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 64.9 mm-40 -64.23 -23.87 67.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.655 0.782 . . . . 0.0 112.123 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.14 -42.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 121.533 0.682 . . . . 0.0 110.221 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.45 -29.7 59.74 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.471 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -66.01 -46.64 77.21 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.488 0.661 . . . . 0.0 109.522 173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.2 m -65.46 -32.96 74.86 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.131 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.57 -61.37 2.65 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 123.687 0.795 . . . . 0.0 109.982 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.61 -35.57 80.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.31 -172.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.64 -46.67 93.24 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.593 0.558 . . . . 0.0 113.151 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.438 ' HB3' HG23 ' A' ' 90' ' ' VAL . 45.7 m0 -62.53 -43.23 99.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.438 0.695 . . . . 0.0 110.597 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -58.56 -43.13 89.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 110.596 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.19 -24.27 60.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.548 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 t -91.32 -0.22 57.62 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.301 1.041 . . . . 0.0 112.656 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.48 39.67 4.97 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.604 0.601 . . . . 0.0 114.604 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 85' ' ' TRP . 55.9 t -87.24 145.28 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.32 -51.07 67.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.96 0.504 . . . . 0.0 110.768 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.494 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 28.8 tpp 65.65 82.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.047 0.842 . . . . 0.0 111.898 169.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.41 84.01 2.22 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.569 0.7 . . . . 0.0 110.875 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 106' ' ' THR . 54.1 tp60 179.09 138.79 0.1 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.011 1.324 . . . . 0.0 108.679 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -83.49 121.88 76.71 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -63.04 102.21 0.3 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.639 2.226 . . . . 0.0 110.045 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.15 150.01 48.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.25 0.62 . . . . 0.0 111.363 -170.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -71.62 100.77 2.36 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.4 ttm -92.29 173.99 7.53 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.071 0.948 . . . . 0.0 109.498 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.66 -34.46 71.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.409 1.084 . . . . 0.0 111.732 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -87.69 -5.38 58.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.065 0.946 . . . . 0.0 110.978 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.61 -170.01 19.97 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.142 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -75.17 102.34 4.92 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 t -107.65 149.24 28.33 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.709 0.766 . . . . 0.0 110.019 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 1.8 t80 -144.68 140.53 28.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.016 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 26.5 m -136.63 127.66 27.76 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.404 ' HB3' HG12 ' A' ' 90' ' ' VAL . . . -106.3 171.95 7.08 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.844 0.457 . . . . 0.0 110.401 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.38 121.5 20.11 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.486 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 3.9 p-10 -77.76 177.31 2.81 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.999 0.92 . . . . 0.0 111.531 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 41.9 Cg_exo -42.05 -43.37 7.25 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.632 2.888 . . . . 0.0 114.946 170.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.56 -8.15 55.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.501 0.72 . . . . 0.0 111.247 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.5 m 64.6 87.55 0.11 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.055 1.342 . . . . 0.0 111.829 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -124.29 144.15 50.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.505 ' HD2' ' HG2' ' A' ' 67' ' ' GLU . 64.6 mtt180 -75.93 94.74 3.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.82 99.21 11.91 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.463 ' HG3' ' HZ3' ' B' ' 50' ' ' TRP . 2.6 tmt_? -98.2 96.11 7.87 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.789 0.836 . . . . 0.0 111.641 -165.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 70' ' ' PHE . 18.6 t -90.54 120.09 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -132.08 159.16 39.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.268 0.485 . . . . 0.0 112.276 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.91 112.03 17.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -74.03 129.27 37.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.579 0.352 . . . . 0.0 110.768 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.21 103.33 14.07 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.662 179.413 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.293 0.092 . . . . 0.0 110.942 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 27.4 m -88.92 123.18 33.02 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.95 0.5 . . . . 0.0 109.659 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -98.19 120.79 58.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.807 0.843 . . . . 0.0 110.108 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.12 114.68 0.67 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.278 2.652 . . . . 0.0 112.486 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.724 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.6 p-10 -99.31 10.86 40.6 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.439 0.637 . . . . 0.0 109.955 171.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.463 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -129.05 124.43 34.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.192 . . . . 0.0 107.812 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -120.02 139.01 53.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.069 0.948 . . . . 0.0 108.443 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 54.9 mt -116.07 133.87 61.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.484 HD21 HD21 ' B' ' 47' ' ' LEU . 3.4 mm? -112.85 124.33 52.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.422 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 5.2 p90 -80.21 116.74 20.47 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.696 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' B' ' 51' ' ' SER . 33.9 m -114.5 167.08 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.733 0.813 . . . . 0.0 109.118 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -96.62 -62.56 1.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.316 0.647 . . . . 0.0 110.087 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -105.98 97.5 15.61 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.339 0.655 . . . . 0.0 109.572 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.403 ' HG2' ' HA ' ' B' ' 35' ' ' THR . 74.2 Cg_exo -46.81 -52.04 8.23 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 123.426 2.751 . . . . 0.0 115.246 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.4 -57.58 2.26 Favored 'Trans proline' 0 C--N 1.404 3.493 0 C-N-CA 122.681 2.254 . . . . 0.0 113.041 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.99 74.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.31 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -77.34 -27.12 52.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.436 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.444 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 99.3 m -79.96 -38.76 31.61 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.522 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 87.1 mm-40 -67.3 -33.34 75.07 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.532 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -62.25 -48.9 77.88 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.789 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 23.9 m-85 -69.73 -27.59 65.09 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.562 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.8 mtpt -56.91 -51.68 68.14 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.238 0.472 . . . . 0.0 111.93 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.59 -32.56 41.96 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.081 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 18.5 tp -59.25 -53.08 62.37 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.046 0.938 . . . . 0.0 111.835 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.413 ' HB2' HG22 ' B' ' 27' ' ' VAL . 11.9 mt -83.36 -47.18 11.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.988 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.98 39.42 2.89 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.4 m -128.58 170.23 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.476 1.111 . . . . 0.0 110.665 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -125.28 141.31 38.35 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 57.5 Cg_endo -68.13 109.53 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.301 2.001 . . . . 0.0 111.248 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.15 -39.07 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.113 0.565 . . . . 0.0 109.75 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.724 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 24.1 mm-40 -118.59 149.16 41.83 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.725 1.21 . . . . 0.0 108.915 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -161.08 153.15 19.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 51.0 m -149.55 160.24 34.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.804 1.242 . . . . 0.0 108.502 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.5 -27.26 39.81 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.043 2.495 . . . . 0.0 113.596 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.403 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 11.6 t -128.05 16.92 6.73 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 73.4 t80 -156.04 161.58 40.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.783 -0.573 . . . . 0.0 110.406 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 73.9 m -150.76 157.84 43.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.963 0.905 . . . . 0.0 109.752 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.724 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 4.6 tt -152.97 128.26 9.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.442 ' HE1' HD23 ' B' ' 47' ' ' LEU . 0.5 OUTLIER -134.75 141.98 46.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.402 1.081 . . . . 0.0 108.995 169.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.534 HG21 ' HG3' ' B' ' 46' ' ' LYS . 14.8 t -115.33 127.9 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.485 HD12 ' SD ' ' B' ' 45' ' ' MET . 9.8 mp -90.83 148.96 22.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.301 0.64 . . . . 0.0 110.239 -170.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -8.61 36.05 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.301 1.04 . . . . 0.0 111.796 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -66.22 -18.98 65.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.464 1.105 . . . . 0.0 111.699 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.06 16.16 48.79 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.433 -0.348 . . . . 0.0 112.232 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.701 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -113.43 175.04 5.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.776 0.83 . . . . 0.0 109.046 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.534 ' HG3' HG21 ' B' ' 40' ' ' VAL . 81.6 tttt -139.98 140.64 36.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.484 HD21 HD21 ' B' ' 9' ' ' LEU . 2.8 tt -140.16 123.27 16.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.728 0.411 . . . . 0.0 110.09 -171.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.463 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -104.88 160.15 15.48 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.87 0.748 . . . . 0.0 111.522 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 81.6 mt -126.2 106.29 9.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 164.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.463 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 5.3 t90 -104.91 123.32 47.54 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 11.4 t -70.69 130.6 42.19 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -65.92 -20.62 66.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.843 0.857 . . . . 0.0 112.447 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -77.18 -8.2 57.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.313 0.245 . . . . 0.0 110.869 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -132.01 9.12 4.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.308 0.643 . . . . 0.0 111.24 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.73 145.79 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -127.41 116.72 21.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.438 ' HG3' ' HB2' ' A' ' 94' ' ' GLN . 10.4 Cg_exo -71.15 140.06 62.25 Favored 'Cis proline' 0 C--N 1.39 2.746 0 CA-C-N 120.205 1.109 . . . . 0.0 113.455 3.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -60.42 121.2 11.49 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.431 1.092 . . . . 0.0 112.005 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.47 109.65 5.11 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.678 0.791 . . . . 0.0 109.876 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 p -85.11 85.36 7.48 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-O 122.109 0.957 . . . . 0.0 108.858 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.71 148.73 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.2 p -145.1 121.66 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.541 1.136 . . . . 0.0 108.003 167.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.54 4.98 69.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.19 -34.75 76.08 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.79 0.295 . . . . 0.0 112.518 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.74 -162.43 23.07 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.747 -0.227 . . . . 0.0 112.731 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.4 110.71 0.24 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.172 0.572 . . . . 0.0 111.746 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.6 mt-10 -124.09 129.82 51.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -171.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' B' ' 68' ' ' LEU . 5.5 mt -114.06 102.17 9.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.19 110.04 20.38 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.342 0.519 . . . . 0.0 111.008 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.6 107.43 19.08 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.465 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.8 mtm105 -87.86 129.5 35.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.336 0.589 . . . . 0.0 110.98 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.84 159.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.111 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 8.7 pt-20 -66.5 -33.52 75.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.19 179.83 6.62 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.455 0.645 . . . . 0.0 112.5 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.973 -165.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.81 -42.0 77.89 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -64.54 -23.73 67.37 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.022 0.826 . . . . 0.0 112.129 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 -42.43 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.476 0.655 . . . . 0.0 110.288 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.0 -30.66 62.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.029 1.331 . . . . 0.0 111.404 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.0 mt-10 -66.64 -46.21 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.407 0.622 . . . . 0.0 109.651 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.0 m -65.62 -33.18 75.3 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.07 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -58.33 -61.48 2.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.836 0.854 . . . . 0.0 109.899 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.506 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.72 -35.58 80.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.222 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.72 93.15 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.857 0.723 . . . . 0.0 113.029 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -62.82 -43.26 99.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.335 0.654 . . . . 0.0 110.432 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 31.9 ttpt -58.39 -43.32 88.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.035 0.834 . . . . 0.0 110.627 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.68 -24.32 61.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.909 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 38.1 t -91.0 -0.44 57.75 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.41 1.084 . . . . 0.0 112.424 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.91 41.37 4.67 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 114.284 0.473 . . . . 0.0 114.284 169.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' B' ' 92' ' ' MET . 3.8 p -88.95 146.48 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.53 67.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.805 0.442 . . . . 0.0 110.507 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.53 ' HB2' HG12 ' B' ' 90' ' ' VAL . 57.4 ttm 63.76 83.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.693 0.797 . . . . 0.0 112.843 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 83.91 2.21 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.638 0.733 . . . . 0.0 110.682 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' B' ' 106' ' ' THR . 57.2 tp60 179.41 139.48 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.756 1.222 . . . . 0.0 108.591 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.05 121.16 74.13 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 26.7 Cg_endo -62.48 102.22 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.566 2.177 . . . . 0.0 110.088 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.38 150.86 48.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.011 0.524 . . . . 0.0 111.548 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -72.74 100.87 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.798 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.453 ' SD ' HG23 ' B' ' 104' ' ' THR . 4.5 mtt -90.69 175.15 7.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.234 1.014 . . . . 0.0 110.213 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.08 -34.6 73.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.092 0.957 . . . . 0.0 111.024 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -87.42 -5.81 58.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.175 0.99 . . . . 0.0 111.037 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.81 -169.53 20.25 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.23 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -75.66 102.51 5.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.453 HG23 ' SD ' ' B' ' 99' ' ' MET . 14.0 t -107.82 149.09 28.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 110.061 -173.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 11.3 t80 -144.32 141.13 29.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.038 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 28.9 m -136.77 127.38 26.99 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.1 171.79 7.15 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.657 0.383 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.03 122.65 22.11 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.468 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.7 p-10 -79.2 177.21 3.03 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.013 0.925 . . . . 0.0 111.219 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.1 Cg_exo -41.83 -43.19 6.72 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.485 2.79 . . . . 0.0 115.16 170.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.27 -9.22 53.6 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.726 0.81 . . . . 0.0 110.766 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 24.3 m 65.22 87.45 0.12 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.194 1.397 . . . . 0.0 111.66 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -124.47 143.79 50.45 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.449 ' HB2' ' HG2' ' B' ' 67' ' ' GLU . 67.4 mtm-85 -76.24 94.68 3.58 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -92.83 99.11 11.84 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.585 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 2.8 tmt_? -96.0 94.93 7.87 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.258 -165.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 t -90.32 120.32 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.451 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.3 p90 -131.98 159.34 39.02 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.506 0.594 . . . . 0.0 112.345 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.46 111.32 16.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.8 124.28 25.05 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.331 0.395 . . . . 0.0 110.256 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.79 93.5 7.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 111.265 -176.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.442 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.621 0.248 . . . . 0.0 111.294 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.7 m -93.46 127.46 39.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.793 0.837 . . . . 0.0 109.89 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -104.1 106.82 55.04 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.09 0.956 . . . . 0.0 110.623 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.7 95.03 0.92 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.773 2.315 . . . . 0.0 112.416 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.698 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.5 p-10 -83.53 3.56 31.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.384 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -124.33 118.61 27.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.0 t -117.3 137.75 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.619 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 50.8 mt -119.66 137.49 53.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 47' ' ' LEU . 4.6 mm? -88.47 106.96 18.62 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 168.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -58.51 104.26 0.21 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.398 163.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.511 HG13 ' HE1' ' A' ' 113' ' ' HIS . 27.8 m -118.8 173.81 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.412 1.085 . . . . 0.0 108.614 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.0 -64.74 1.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.99 0.916 . . . . 0.0 109.974 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -72.51 110.78 8.9 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.959 -170.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.3 Cg_exo -60.21 -62.25 0.16 Allowed 'Trans proline' 0 CA--C 1.576 2.618 0 C-N-CA 121.655 1.57 . . . . 0.0 113.324 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 22.3 Cg_exo -64.7 -52.11 1.5 Allowed 'Trans proline' 0 C--N 1.406 3.6 0 CA-C-N 122.984 2.101 . . . . 0.0 111.64 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.88 89.52 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.303 -165.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.47 -41.28 47.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 71.2 m -56.9 -46.02 82.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.562 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.6 mm100 -65.37 -38.25 89.47 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.515 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -63.89 -45.7 88.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.327 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.68 -29.22 65.48 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.875 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -56.25 -48.32 76.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.44 0.564 . . . . 0.0 111.952 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 -38.74 50.47 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.075 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.51 -40.99 93.4 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.256 1.422 . . . . 0.0 113.02 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.6 mt -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 31.05 6.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.262 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.76 166.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.057 0.943 . . . . 0.0 110.322 -175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -113.71 149.32 41.54 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.443 0.697 . . . . 0.0 110.051 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.475 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 11.9 Cg_exo -71.37 111.91 3.21 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.912 2.408 . . . . 0.0 111.131 173.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.24 -37.27 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.337 0.655 . . . . 0.0 109.936 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm-40 -109.6 121.99 46.44 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.7 p -131.34 131.14 43.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.99 0.516 . . . . 0.0 110.118 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -144.13 152.98 55.93 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.222 1.409 . . . . 0.0 108.294 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.39 -10.44 13.42 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.661 2.241 . . . . 0.0 114.364 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -129.5 -1.02 4.97 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -153.94 148.56 26.31 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 122.096 -0.378 . . . . 0.0 110.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -137.91 149.68 46.42 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 109.638 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -143.77 122.27 12.44 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HZ ' HD11 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -133.54 137.19 45.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.42 1.488 . . . . 0.0 108.17 173.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 HG22 ' HG3' ' A' ' 46' ' ' LYS . 22.0 t -116.27 127.5 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.838 0.855 . . . . 0.0 108.764 -172.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.9 mt -87.07 150.61 23.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.836 0.351 . . . . 0.0 110.122 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.88 -8.12 45.94 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 0.0 111.97 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' B' ' 5' ' ' ASP . 1.5 m-20 -72.77 -8.43 55.4 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.086 0.954 . . . . 0.0 112.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.11 16.75 42.94 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.727 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -119.61 171.93 8.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.799 0.84 . . . . 0.0 109.476 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 40' ' ' VAL . 66.0 tttt -132.77 141.08 48.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.429 HD23 HD21 ' A' ' 9' ' ' LEU . 1.1 tt -138.45 122.04 17.39 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.202 0.525 . . . . 0.0 110.444 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -103.8 171.49 20.04 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.888 0.756 . . . . 0.0 112.26 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.479 HD11 ' HZ ' ' A' ' 39' ' ' PHE . 1.1 tp -140.37 118.84 12.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.45 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.1 t90 -115.44 122.67 46.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -84.28 125.3 32.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.988 0.515 . . . . 0.0 109.972 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.564 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 37.7 ptt180 -69.48 -9.35 53.37 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -167.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -75.02 -8.58 56.92 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -135.33 6.44 3.29 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.772 0.429 . . . . 0.0 111.089 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 52' ' ' ARG . 7.1 p -60.9 147.85 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.977 0.511 . . . . 0.0 110.814 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -119.25 115.08 34.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' B' ' 94' ' ' GLN . 81.7 Cg_endo -79.23 142.59 67.13 Favored 'Cis proline' 0 C--N 1.381 2.252 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.582 2.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -51.17 115.22 1.45 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 111.688 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.57 151.65 41.76 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.497 1.119 . . . . 0.0 109.094 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.564 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 20.1 m -134.95 87.09 2.31 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.09 123.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.769 0.828 . . . . 0.0 108.988 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 p -136.4 125.39 24.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.019 0.927 . . . . 0.0 109.651 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.71 67.47 0.83 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' HA2' HG12 ' B' ' 61' ' ' VAL . . . -169.72 54.15 0.2 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.98 169.6 19.15 Favored Glycine 0 C--O 1.242 0.62 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 80.88 106.84 0.31 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.6 pt-20 -130.61 146.39 52.1 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.721 0.808 . . . . 0.0 109.59 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.7 tp -117.19 103.88 10.63 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.95 0.9 . . . . 0.0 108.637 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.0 113.78 23.97 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.222 0.464 . . . . 0.0 111.312 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.64 110.14 21.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.037 1.335 . . . . 0.0 108.458 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -89.72 124.67 34.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.542 0.687 . . . . 0.0 112.421 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.59 158.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.795 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.0 pt-20 -64.46 -39.39 93.73 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -161.4 178.25 9.34 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.219 0.533 . . . . 0.0 112.073 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.2 -28.13 66.36 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.208 1.403 . . . . 0.0 112.462 -167.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.08 -50.71 69.49 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.507 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.6 mm-40 -64.3 -24.4 67.64 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.303 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.16 -45.68 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.361 0.601 . . . . 0.0 110.028 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.18 -29.98 63.22 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.54 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 33.1 mt-10 -66.51 -47.71 72.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -66.59 -29.25 69.27 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.706 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -60.11 -61.21 2.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.732 0.813 . . . . 0.0 109.593 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.02 -32.6 73.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.296 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.81 -45.69 91.87 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.648 0.593 . . . . 0.0 112.759 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.417 ' HB3' HG22 ' A' ' 90' ' ' VAL . 44.4 m0 -66.01 -41.11 91.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.524 0.73 . . . . 0.0 110.046 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.477 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 31.9 ttpt -58.28 -43.6 88.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 0.0 110.612 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.32 -27.36 61.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.761 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -94.48 8.67 41.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.56 0.744 . . . . 0.0 111.829 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.58 54.03 3.23 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 167.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 107' ' ' ALA . 60.0 t -102.87 142.63 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.42 -47.29 82.53 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.132 0.573 . . . . 0.0 111.367 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.477 ' HE1' ' HB2' ' A' ' 86' ' ' LYS . 53.3 ttm 60.24 83.53 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 165.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.57 85.15 2.31 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 122.037 -0.414 . . . . 0.0 110.651 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 25.0 tm0? 177.93 121.1 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.665 1.186 . . . . 0.0 108.426 172.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -72.22 114.05 26.05 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 17.7 Cg_endo -56.22 112.93 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.945 2.43 . . . . 0.0 111.186 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.4 147.71 50.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.63 0.772 . . . . 0.0 110.657 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.615 ' HZ3' ' HB2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -75.26 100.93 4.5 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.608 ' HG2' ' H ' ' A' ' 101' ' ' PHE . 55.4 ttm -90.2 161.87 15.51 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.48 -28.49 54.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.735 0.814 . . . . 0.0 110.781 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.608 ' H ' ' HG2' ' A' ' 99' ' ' MET . 74.5 m-85 -110.14 88.34 2.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 109.509 171.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.64 162.34 0.94 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.615 ' HB2' ' HZ3' ' A' ' 98' ' ' LYS . 82.7 t80 -78.2 101.83 7.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -107.65 145.38 33.41 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.512 0.673 . . . . 0.0 110.471 -165.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.575 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 4.9 t80 -137.1 130.66 31.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.531 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.0 m -120.85 122.78 41.03 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.448 0.642 . . . . 0.0 110.108 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HB2' HG11 ' A' ' 90' ' ' VAL . . . -105.16 172.86 6.56 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.464 0.706 . . . . 0.0 109.988 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.85 118.12 12.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -68.01 168.25 13.97 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.675 0.79 . . . . 0.0 110.101 171.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.77 -27.26 15.04 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.114 2.543 . . . . 0.0 114.825 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.3 8.06 41.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.794 0.837 . . . . 0.0 111.229 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 m 70.45 30.04 3.32 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.134 1.373 . . . . 0.0 113.896 165.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.511 ' HE1' HG13 ' A' ' 11' ' ' VAL . 14.1 m80 -84.32 178.59 7.71 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -110.96 117.34 33.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -106.12 100.61 10.15 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -101.04 97.85 8.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -167.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.3 t -88.11 118.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.08 167.05 15.9 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.197 0.453 . . . . 0.0 110.957 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -126.82 110.69 13.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -82.1 115.79 21.38 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.19 94.11 4.05 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.367 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.482 -178.247 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ptt? . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 8.5 m -101.56 124.18 46.81 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -103.5 106.6 52.71 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 124.426 1.09 . . . . 0.0 110.441 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.54 94.92 0.93 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.476 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.727 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 7.1 p-10 -83.05 3.4 30.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.105 0.562 . . . . 0.0 111.517 172.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -124.45 118.44 26.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -168.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -117.43 137.89 52.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.636 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 44.2 mt -119.72 137.08 54.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.443 HD22 HD22 ' B' ' 47' ' ' LEU . 4.6 mm? -88.14 106.86 18.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.43 105.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.06 163.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.48 HG13 ' HE1' ' B' ' 113' ' ' HIS . 22.4 m -119.1 173.79 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.621 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -105.93 -65.16 1.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.754 0.822 . . . . 0.0 109.882 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -72.12 110.78 8.63 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.782 -170.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.538 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 27.4 Cg_exo -59.99 -63.07 0.13 Allowed 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 121.691 1.594 . . . . 0.0 113.353 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 33.3 Cg_exo -63.08 -53.0 1.74 Allowed 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 123.195 2.177 . . . . 0.0 112.275 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.67 89.71 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.395 -165.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.11 -41.45 50.19 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.436 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.605 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 18.0 mm100 -65.71 -38.4 89.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.517 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -64.35 -44.89 90.04 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.749 0.656 . . . . 0.0 110.229 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -70.71 -29.51 65.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.904 -0.569 . . . . 0.0 109.884 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.605 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 58.9 mtpt -56.1 -48.38 76.26 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.486 0.585 . . . . 0.0 112.087 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.18 -38.98 50.52 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.04 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp -59.89 -41.4 91.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.203 1.401 . . . . 0.0 113.007 -174.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.469 ' HB2' HG22 ' B' ' 27' ' ' VAL . 19.7 mt -91.6 -41.27 10.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.315 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.44 30.87 7.07 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.28 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.0 m -132.86 167.11 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.093 0.957 . . . . 0.0 110.53 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -114.27 149.53 42.23 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.663 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 7.2 Cg_exo -72.12 111.48 3.19 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.91 2.406 . . . . 0.0 111.016 174.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.75 -36.72 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.949 0.5 . . . . 0.0 110.068 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.714 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.5 mm-40 -110.12 121.28 44.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -130.79 130.58 43.89 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.165 0.586 . . . . 0.0 110.111 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 91.9 p -143.94 155.98 58.88 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.461 1.104 . . . . 0.0 108.441 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.32 -10.2 17.8 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.685 2.257 . . . . 0.0 113.779 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -129.42 -1.17 5.0 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.9 148.91 26.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.184 0.447 . . . . 0.0 110.018 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 14.2 m -137.67 149.78 46.83 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.634 0.774 . . . . 0.0 109.2 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.714 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -143.98 121.6 11.82 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.94 138.52 46.94 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.156 1.383 . . . . 0.0 108.45 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.527 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.7 t -117.26 127.21 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.869 0.867 . . . . 0.0 108.756 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.456 HD12 ' SD ' ' B' ' 45' ' ' MET . 63.2 mt -87.1 150.58 23.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.95 -7.99 45.15 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.37 1.068 . . . . 0.0 111.89 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -73.28 -8.09 54.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.095 0.958 . . . . 0.0 111.948 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.04 16.81 42.94 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.698 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.4 ppp? -119.79 171.67 8.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.692 0.797 . . . . 0.0 109.378 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.527 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.6 141.17 48.56 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -173.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.443 HD22 HD22 ' B' ' 9' ' ' LEU . 1.1 tt -138.44 122.16 17.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 -172.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.86 170.57 19.11 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.863 0.745 . . . . 0.0 112.045 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 79.1 mt -138.59 119.83 14.69 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 164.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.407 ' HZ2' ' HE3' ' A' ' 99' ' ' MET . 5.4 t90 -115.27 122.68 46.71 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 39.1 m -83.59 125.49 31.86 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.784 0.434 . . . . 0.0 110.099 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 39.0 ptt180 -69.5 -8.45 47.1 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.92 -8.61 57.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.702 0.401 . . . . 0.0 111.48 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -135.52 4.78 3.14 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.184 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' B' ' 52' ' ' ARG . 7.5 p -57.8 147.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.128 0.571 . . . . 0.0 111.147 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.69 114.97 33.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.453 0.701 . . . . 0.0 109.143 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.33 143.09 68.68 Favored 'Cis proline' 0 C--N 1.382 2.31 0 C-N-CA 124.504 -1.04 . . . . 0.0 112.347 2.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.88 116.44 2.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.074 0.949 . . . . 0.0 110.861 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.63 151.22 41.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.988 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 49.5 m -134.67 86.96 2.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.405 HG12 ' HA2' ' A' ' 64' ' ' GLY . 7.5 p -156.27 123.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.244 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.4 p -135.49 126.46 27.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.834 0.854 . . . . 0.0 109.621 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.9 67.87 0.86 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.08 54.22 0.2 Allowed Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.88 169.76 19.25 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.541 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 80.74 107.26 0.3 Allowed Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.619 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 6.5 pt-20 -131.3 145.7 51.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.081 0.952 . . . . 0.0 109.079 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.5 tp -117.46 103.79 10.45 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.89 114.16 24.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.192 0.451 . . . . 0.0 111.252 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -91.2 109.98 21.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.918 1.287 . . . . 0.0 108.39 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.421 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.4 mtm180 -89.69 123.77 34.01 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.497 0.665 . . . . 0.0 111.991 -176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 159.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.781 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.46 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.9 pt-20 -64.79 -38.71 91.89 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -161.9 179.14 8.28 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.986 0.422 . . . . 0.0 112.064 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.0 -27.19 68.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.212 -166.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.526 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.11 -50.57 69.98 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.946 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.46 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 82.1 mm-40 -65.0 -24.1 67.41 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.39 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.18 -45.76 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.261 0.624 . . . . 0.0 110.087 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.24 -30.6 65.03 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.623 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 25.8 mt-10 -66.56 -47.22 73.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 109.421 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -66.91 -29.25 69.08 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.688 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.03 -61.39 2.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 0.0 109.621 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.535 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -67.17 -32.26 73.23 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.31 -173.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.65 -46.04 91.12 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.755 0.659 . . . . 0.0 112.826 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.51 -41.02 89.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.397 0.679 . . . . 0.0 109.708 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.8 ttpt -57.78 -43.62 85.67 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.769 0.827 . . . . 0.0 110.403 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.53 61.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.462 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -94.53 8.77 41.07 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.607 0.763 . . . . 0.0 111.685 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.97 54.49 3.19 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.629 HG12 ' HB2' ' B' ' 92' ' ' MET . 5.4 p -103.16 143.41 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 170.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.74 83.5 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.049 0.539 . . . . 0.0 111.284 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.629 ' HB2' HG12 ' B' ' 90' ' ' VAL . 53.6 ttm 59.64 83.64 0.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.418 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -118.57 85.74 2.41 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 122.027 -0.421 . . . . 0.0 110.498 175.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.488 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 45.1 tp60 177.2 119.89 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.099 1.36 . . . . 0.0 109.119 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.55 112.51 14.19 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.58 0.752 . . . . 0.0 109.08 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.594 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 10.9 Cg_endo -53.98 111.99 0.85 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.186 2.591 . . . . 0.0 111.835 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.38 147.62 50.27 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.686 0.794 . . . . 0.0 110.582 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.6 ' HZ3' ' HB2' ' B' ' 103' ' ' TYR . 0.0 OUTLIER -74.8 100.73 4.12 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.587 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 51.5 ttm -90.43 161.5 15.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.6 -28.06 53.01 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.623 0.769 . . . . 0.0 110.98 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.587 ' H ' ' HG2' ' B' ' 99' ' ' MET . 53.7 m-85 -110.02 88.18 2.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.391 1.077 . . . . 0.0 109.724 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.54 162.74 0.96 Allowed Glycine 0 C--N 1.354 1.56 0 N-CA-C 116.137 1.215 . . . . 0.0 116.137 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.6 ' HB2' ' HZ3' ' B' ' 98' ' ' LYS . 84.7 t80 -78.89 101.96 7.98 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.7 t -107.62 145.34 33.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.585 0.707 . . . . 0.0 110.617 -165.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 6.2 t80 -137.41 131.62 32.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.928 1.291 . . . . 0.0 108.421 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 16.5 m -121.8 122.55 39.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 109.896 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.29 172.74 6.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.283 0.633 . . . . 0.0 109.702 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.53 117.21 12.22 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -66.81 168.99 8.86 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.62 0.768 . . . . 0.0 110.175 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.94 -27.37 20.76 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.336 2.69 . . . . 0.0 114.449 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.77 8.1 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.741 0.816 . . . . 0.0 111.488 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 51.1 m 70.04 30.74 3.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.223 1.409 . . . . 0.0 113.824 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.48 ' HE1' HG13 ' B' ' 11' ' ' VAL . 14.3 m80 -84.4 179.08 7.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 75.9 mmt-85 -111.32 117.82 34.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 37.7 mt -106.41 101.2 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -99.72 96.65 7.75 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.3 118.36 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.421 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.9 p90 -125.96 167.16 15.67 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.163 0.438 . . . . 0.0 110.988 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -127.0 110.73 13.28 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -82.7 118.18 23.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 93.85 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.349 0.66 . . . . 0.0 110.027 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.607 -176.698 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.845 0.355 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' B' ' 70' ' ' PHE . 35.7 m -136.15 143.37 44.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.359 1.064 . . . . 0.0 110.803 -163.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -123.18 117.46 28.21 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.537 0.735 . . . . 0.0 110.489 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 41.5 Cg_endo -82.71 52.4 4.04 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.381 2.721 . . . . 0.0 111.768 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.881 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 36.7 t70 -75.64 5.07 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.215 1.006 . . . . 0.0 111.764 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.416 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -124.46 126.56 46.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.0 t -120.44 145.02 47.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 52.7 mt -122.07 144.4 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.775 0.83 . . . . 0.0 108.921 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 47' ' ' LEU . 4.3 mm? -91.64 134.27 34.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.42 ' OH ' HG13 ' A' ' 55' ' ' VAL . 10.8 t80 -85.02 99.4 10.99 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.36 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.481 HG12 ' NE2' ' A' ' 113' ' ' HIS . 3.0 m -112.89 159.43 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.561 0.745 . . . . 0.0 109.075 -172.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.34 -59.78 1.87 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -102.37 101.82 21.83 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.245 0.618 . . . . 0.0 109.696 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.562 ' HG3' ' HB2' ' A' ' 51' ' ' SER . 44.5 Cg_exo -55.21 -55.93 2.75 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.056 2.504 . . . . 0.0 114.908 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.76 -54.74 4.34 Favored 'Trans proline' 0 C--N 1.403 3.407 0 CA-C-N 122.545 1.945 . . . . 0.0 112.379 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.07 96.52 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.74 0.65 . . . . 0.0 111.703 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -66.53 -47.08 74.04 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 96.5 m -67.48 -40.48 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.575 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.1 mm100 -64.49 -38.29 90.49 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.273 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -64.94 -42.23 94.83 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.389 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.736 ' HH ' HD22 ' A' ' 115' ' ' LEU . 49.7 m-85 -68.52 -29.67 68.31 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.533 0.606 . . . . 0.0 110.466 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -56.83 -49.43 75.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.204 0.526 . . . . 0.0 111.879 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.87 -40.07 63.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.92 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.7 tp -58.94 -42.7 90.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.478 1.511 . . . . 0.0 113.068 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.527 ' HB2' HG22 ' A' ' 27' ' ' VAL . 16.3 mt -96.66 -31.99 12.42 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.16 26.88 27.29 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.325 0.391 . . . . 0.0 112.313 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.9 m -123.42 -178.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.967 0.907 . . . . 0.0 109.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -142.07 151.41 58.89 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 37.6 Cg_endo -63.76 121.26 8.92 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.896 2.397 . . . . 0.0 112.773 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.34 -35.16 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.442 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 15.5 mm-40 -121.03 116.63 25.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.939 1.296 . . . . 0.0 108.233 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.5 p -123.04 131.26 53.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.253 0.621 . . . . 0.0 110.097 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -138.67 151.14 68.15 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.864 1.266 . . . . 0.0 108.292 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.64 -10.12 23.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.817 2.344 . . . . 0.0 113.389 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.441 ' HA ' ' HG2' ' A' ' 14' ' ' PRO . 4.9 t -125.96 -3.57 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -159.17 151.47 21.25 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.7 m -141.62 158.6 43.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.769 0.428 . . . . 0.0 110.349 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -154.27 126.02 7.63 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.9 p90 -134.0 150.4 51.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.476 1.11 . . . . 0.0 109.09 165.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 46' ' ' LYS . 13.4 t -120.96 131.42 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.03 165.4 15.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.644 0.378 . . . . 0.0 111.464 -171.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.08 75.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.518 1.127 . . . . 0.0 112.869 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -69.91 -20.75 63.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.13 0.572 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 5.35 37.32 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.871 -0.961 . . . . 0.0 114.181 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.495 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.3 ppp? -74.06 166.26 23.7 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.346 1.073 . . . . 0.0 109.206 169.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.515 ' HG3' HG23 ' A' ' 40' ' ' VAL . 49.3 tttt -126.97 139.69 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 9' ' ' LEU . 3.5 tt -137.62 118.36 14.08 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.89 0.376 . . . . 0.0 110.387 -172.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.416 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -105.2 168.97 15.99 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 124.226 0.917 . . . . 0.0 111.958 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.61 106.29 6.91 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.564 ' HB2' HG22 ' A' ' 8' ' ' ILE . 5.1 t90 -105.55 125.59 51.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.562 ' HB2' ' HG3' ' A' ' 14' ' ' PRO . 23.3 t -77.48 137.07 38.45 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.592 0.558 . . . . 0.0 110.597 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -71.59 -10.14 59.31 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.501 0.72 . . . . 0.0 112.906 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -85.14 -21.19 29.34 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.215 0.206 . . . . 0.0 110.731 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 51' ' ' SER . 7.1 t -116.27 4.59 13.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.148 0.579 . . . . 0.0 111.326 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 58' ' ' LYS . 13.1 p -72.71 145.4 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.97 116.54 26.05 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.4 Cg_exo -77.16 138.19 52.35 Favored 'Cis proline' 0 C--N 1.383 2.387 0 CA-C-N 119.727 0.938 . . . . 0.0 112.038 2.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.558 ' HA ' HG11 ' A' ' 55' ' ' VAL . 2.8 tmmm? -65.25 112.42 3.44 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.962 0.789 . . . . 0.0 109.722 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.27 128.89 55.51 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.306 1.042 . . . . 0.0 110.015 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -90.52 84.38 5.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 m -159.27 150.86 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 124.688 1.195 . . . . 0.0 109.274 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.87 127.11 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.703 1.601 . . . . 0.0 107.915 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.89 -46.56 0.29 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.72 144.71 9.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.33 -29.93 0.15 Allowed Glycine 0 N--CA 1.469 0.876 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 149.56 18.33 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.192 -1.004 . . . . 0.0 110.695 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 7.4 mm-40 -101.71 151.56 21.89 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 173.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.497 HD23 HD21 ' A' ' 9' ' ' LEU . 41.4 tp -109.99 101.92 10.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -87.54 117.96 26.69 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' HB2' HG22 ' A' ' 117' ' ' VAL . 8.7 m-85 -96.47 121.46 38.31 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.782 1.233 . . . . 0.0 107.896 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 39.9 mtm105 -99.98 126.74 46.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.23 162.45 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.174 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.38 -33.68 69.75 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.82 179.39 7.12 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.055 0.843 . . . . 0.0 112.288 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.44 -34.27 75.12 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.432 1.093 . . . . 0.0 112.272 -165.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.24 -43.87 96.83 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.213 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -65.22 -21.75 66.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.874 0.87 . . . . 0.0 112.738 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.17 -38.12 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.071 0.463 . . . . 0.0 110.06 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.35 -32.29 64.46 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.306 1.042 . . . . 0.0 111.324 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.0 mt-10 -68.76 -40.1 79.93 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.656 0.741 . . . . 0.0 109.192 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.5 m -68.62 -32.7 72.76 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.65 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -62.78 -60.76 3.04 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.821 0.819 . . . . 0.0 109.458 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.49 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.4 -37.28 85.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.841 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.35 -46.12 91.49 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.98 0.8 . . . . 0.0 113.638 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.428 ' CH2' ' HB3' ' A' ' 115' ' ' LEU . 36.3 m0 -61.23 -50.35 73.45 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.235 0.614 . . . . 0.0 109.996 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 92' ' ' MET . 32.7 ttpt -52.58 -45.16 66.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.142 0.977 . . . . 0.0 110.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.98 61.08 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.294 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -97.77 11.12 38.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.814 0.845 . . . . 0.0 112.828 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 15.01 21.22 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.49 136.03 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 117.545 0.673 . . . . 0.0 110.321 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.68 72.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.428 1.091 . . . . 0.0 111.754 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.501 ' HE2' ' HB2' ' A' ' 86' ' ' LYS . 49.7 tpp 69.02 83.59 0.16 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.157 0.911 . . . . 0.0 112.849 165.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.27 86.47 2.28 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.0 0.52 . . . . 0.0 111.537 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.545 ' HG2' ' H ' ' A' ' 106' ' ' THR . 55.6 tp60 -179.67 140.77 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.882 0.873 . . . . 0.0 109.645 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -92.24 113.79 60.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 104' ' ' THR . 20.9 Cg_endo -61.63 108.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.243 1.962 . . . . 0.0 110.598 174.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.64 49.28 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.335 0.654 . . . . 0.0 110.219 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -63.07 106.26 0.82 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.588 0.755 . . . . 0.0 110.975 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.472 ' HE1' ' HZ2' ' B' ' 50' ' ' TRP . 3.3 ttt -93.99 -176.38 3.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.843 0.857 . . . . 0.0 109.737 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.31 -27.67 68.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.02 174.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.73 92.72 3.38 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.8 161.74 3.24 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 36.0 t80 -69.09 103.76 1.96 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.138 1.375 . . . . 0.0 108.61 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 99' ' ' MET . 13.7 t -103.03 141.55 35.63 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.86 0.754 . . . . 0.0 111.683 -162.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -151.62 127.61 10.38 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.754 1.221 . . . . 0.0 109.636 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.546 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 42.3 m -135.24 125.82 26.93 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.07 162.05 21.92 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.062 0.545 . . . . 0.0 112.169 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.89 112.42 24.64 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.581 0.753 . . . . 0.0 109.599 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.539 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.4 p30 -71.96 177.27 1.77 Allowed Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.437 1.095 . . . . 0.0 112.05 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 25.5 Cg_exo -40.64 -50.48 3.86 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.949 3.099 . . . . 0.0 115.544 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.419 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 9.9 t70 -79.62 -17.86 52.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.6 m 71.93 61.32 0.14 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.412 1.485 . . . . 0.0 110.886 174.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.481 ' NE2' HG12 ' A' ' 11' ' ' VAL . 8.6 m80 -91.71 175.07 7.03 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.603 -1.18 . . . . 0.0 107.975 168.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -94.43 99.04 11.3 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.736 HD22 ' HH ' ' A' ' 21' ' ' TYR . 81.9 mt -106.12 104.03 13.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.631 0.372 . . . . 0.0 110.011 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.529 ' NH1' ' HB3' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -93.31 147.18 23.15 Favored 'General case' 0 C--O 1.205 -1.269 0 C-N-CA 124.022 0.929 . . . . 0.0 110.01 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 70' ' ' PHE . 12.2 t -139.66 140.0 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.529 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 5.4 p90 -133.81 171.1 14.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.096 0.407 . . . . 0.0 111.635 172.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -131.06 113.95 14.56 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 166.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -75.11 129.25 37.23 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 93.27 1.9 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.722 0.639 . . . . 0.0 110.264 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.219 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.311 0.101 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.448 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 20.9 m -142.3 140.44 32.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.484 0.314 . . . . 0.0 111.056 -167.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -122.69 117.59 28.77 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.566 0.747 . . . . 0.0 110.056 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.475 ' HG3' HD22 ' A' ' 25' ' ' LEU . 42.0 Cg_endo -82.74 51.69 3.8 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.28 2.654 . . . . 0.0 111.89 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 30.3 t70 -75.96 5.92 5.89 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.179 0.99 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.01 126.08 45.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 15.2 t -120.4 145.66 46.97 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 59.4 mt -122.67 144.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 123.825 0.85 . . . . 0.0 108.768 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.516 HD22 HD21 ' B' ' 47' ' ' LEU . 4.3 mm? -91.59 134.12 34.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.404 ' OH ' HG12 ' B' ' 55' ' ' VAL . 9.0 t80 -84.85 99.3 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.448 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.484 HG12 ' NE2' ' B' ' 113' ' ' HIS . 3.2 m -112.72 159.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.691 0.796 . . . . 0.0 109.032 -172.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 -60.28 1.82 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -102.29 101.71 20.99 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.295 0.638 . . . . 0.0 109.881 -173.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' B' ' 51' ' ' SER . 32.5 Cg_exo -55.67 -55.55 2.93 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.952 2.435 . . . . 0.0 114.701 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.77 -54.82 4.2 Favored 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.594 1.962 . . . . 0.0 112.276 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.31 96.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.072 0.549 . . . . 0.0 111.768 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 69.1 m -65.31 -47.15 77.57 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 123.726 0.641 . . . . 0.0 109.364 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 51.9 m -67.46 -41.17 85.1 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -170.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.555 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 11.7 mm100 -64.09 -38.43 91.05 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.514 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.83 -41.95 95.34 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.394 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.458 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 42.6 m-85 -68.6 -29.9 68.53 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.579 0.627 . . . . 0.0 110.487 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -56.6 -49.48 74.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.194 0.521 . . . . 0.0 111.695 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.26 63.22 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.975 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.458 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 31.0 tp -58.93 -42.2 89.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.37 1.468 . . . . 0.0 113.232 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.514 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.4 mt -97.55 -30.53 12.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.74 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.67 30.4 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.6 m -122.93 -177.71 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.121 0.968 . . . . 0.0 109.823 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.432 ' HA ' ' HG2' ' B' ' 22' ' ' LYS . 6.5 p-10 -143.04 151.81 56.79 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 109.365 174.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 18.7 Cg_exo -65.53 121.25 8.61 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.95 2.433 . . . . 0.0 112.263 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.519 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.2 p -64.9 -36.68 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 21.0 mm-40 -120.89 116.83 25.91 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.872 1.269 . . . . 0.0 107.966 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -123.62 131.62 53.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.988 0.515 . . . . 0.0 109.933 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -138.97 150.34 64.87 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.833 1.253 . . . . 0.0 108.345 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.93 -10.33 22.41 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.507 2.138 . . . . 0.0 113.576 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.462 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 5.6 t -126.19 -3.27 6.92 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -159.14 151.64 21.51 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 73.3 m -141.87 159.08 42.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.628 0.371 . . . . 0.0 110.391 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 24.2 tp -154.81 125.56 7.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.6 p90 -133.89 150.2 51.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.253 1.021 . . . . 0.0 109.134 165.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' B' ' 46' ' ' LYS . 18.5 t -120.77 131.46 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.91 165.18 16.11 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.691 0.397 . . . . 0.0 111.553 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.69 76.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.641 1.177 . . . . 0.0 112.851 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -69.99 -20.47 63.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.004 0.522 . . . . 0.0 111.068 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.31 5.0 37.73 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-O 118.817 -0.99 . . . . 0.0 113.988 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.881 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 6.8 ptm -73.68 166.84 22.55 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.538 1.169 . . . . 0.0 109.27 169.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.524 ' HG3' HG23 ' B' ' 40' ' ' VAL . 73.1 tttt -127.25 139.5 52.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.516 HD21 HD22 ' B' ' 9' ' ' LEU . 3.6 tt -137.56 118.7 14.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.973 0.416 . . . . 0.0 110.254 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.93 169.09 16.34 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.315 0.96 . . . . 0.0 111.958 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.85 106.03 6.69 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 166.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.578 ' HB2' HG22 ' B' ' 8' ' ' ILE . 4.5 t90 -105.46 125.63 51.21 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.565 ' HB2' ' HG3' ' B' ' 14' ' ' PRO . 21.6 t -77.29 137.13 38.61 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.681 0.613 . . . . 0.0 110.716 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -71.92 -9.78 58.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -85.32 -20.14 30.44 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.493 0.317 . . . . 0.0 111.389 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.437 HG23 ' HB3' ' B' ' 51' ' ' SER . 11.9 t -117.02 4.41 12.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.392 0.677 . . . . 0.0 111.029 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' B' ' 58' ' ' LYS . 8.4 p -73.57 146.71 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.29 116.14 23.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -77.65 139.2 56.27 Favored 'Cis proline' 0 C--N 1.387 2.595 0 C-N-CA 124.706 -0.956 . . . . 0.0 111.869 3.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.494 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.1 tmmm? -66.18 112.5 3.96 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.85 0.719 . . . . 0.0 109.395 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.93 129.3 55.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.19 0.996 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 27.5 p -90.98 85.58 6.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.52 149.77 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.339 1.056 . . . . 0.0 109.567 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -168.83 128.1 1.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.958 1.703 . . . . 0.0 107.65 169.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.21 -47.55 0.29 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.82 144.66 9.66 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.41 -29.87 0.15 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 149.45 18.1 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.162 -1.019 . . . . 0.0 110.657 170.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.596 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 11.2 mm-40 -101.51 151.85 21.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.507 HD23 HD21 ' B' ' 9' ' ' LEU . 44.1 tp -110.14 101.78 10.54 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -87.58 118.0 26.77 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.575 0.702 . . . . 0.0 111.208 -170.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.453 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 5.9 m-85 -96.05 121.55 37.92 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 42.2 mtm105 -100.4 125.01 46.63 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.68 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.91 163.2 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.135 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.464 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.1 pt-20 -71.3 -34.58 70.73 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.403 HD21 ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -163.21 179.84 7.15 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.155 0.889 . . . . 0.0 112.482 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.13 -33.86 75.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.43 1.092 . . . . 0.0 111.891 -165.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.987 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.464 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.5 mm-40 -65.62 -22.06 66.63 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.691 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.64 -38.95 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 122.748 0.419 . . . . 0.0 109.924 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.93 -31.82 64.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.154 0.981 . . . . 0.0 111.436 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.9 mt-10 -69.88 -38.93 76.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.634 0.73 . . . . 0.0 109.53 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 68.3 m -68.34 -33.53 74.45 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.616 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -62.47 -61.01 2.74 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.739 0.781 . . . . 0.0 109.542 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.6 -36.9 84.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.667 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.84 89.03 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 124.001 0.813 . . . . 0.0 113.63 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . 0.416 ' HB3' HG23 ' B' ' 90' ' ' VAL . 42.1 m0 -60.6 -50.28 74.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.351 0.66 . . . . 0.0 109.551 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.522 ' HB2' ' HE2' ' B' ' 92' ' ' MET . 31.5 ttpt -53.42 -44.64 68.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.132 0.895 . . . . 0.0 111.003 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.69 61.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 m -98.19 10.64 40.08 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.722 0.809 . . . . 0.0 112.884 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.58 14.77 20.85 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' B' ' 85' ' ' TRP . 54.4 t -78.66 135.69 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 117.554 0.677 . . . . 0.0 110.413 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.95 -37.48 71.59 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.468 1.107 . . . . 0.0 111.764 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.522 ' HE2' ' HB2' ' B' ' 86' ' ' LYS . 45.0 tpp 69.83 83.16 0.15 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.126 0.891 . . . . 0.0 112.707 165.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.49 87.08 2.32 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.745 0.418 . . . . 0.0 111.512 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.531 ' HG2' ' H ' ' B' ' 106' ' ' THR . 56.9 tp60 179.66 141.77 0.13 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.118 0.967 . . . . 0.0 109.856 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -93.51 113.24 59.69 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.26 108.64 0.53 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.472 2.115 . . . . 0.0 110.974 173.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.46 49.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.466 0.706 . . . . 0.0 110.541 -175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' B' ' 103' ' ' TYR . 5.6 mmmm -62.48 106.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.817 0.847 . . . . 0.0 110.981 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.486 ' SD ' HG21 ' B' ' 104' ' ' THR . 3.3 ttt -93.9 -175.96 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.675 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -66.54 -27.96 68.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.585 . . . . 0.0 111.015 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -128.89 92.24 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.286 1.034 . . . . 0.0 109.152 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 161.64 2.83 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 34.0 t80 -68.87 103.25 1.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 108.851 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.486 HG21 ' SD ' ' B' ' 99' ' ' MET . 5.3 t -103.67 142.11 34.9 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.163 0.892 . . . . 0.0 111.518 -161.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.483 ' HZ ' ' SD ' ' B' ' 92' ' ' MET . 14.2 t80 -151.6 127.81 10.53 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.499 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.531 ' H ' ' HG2' ' B' ' 94' ' ' GLN . 60.4 m -134.99 125.92 27.55 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.43 162.03 22.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.007 0.523 . . . . 0.0 112.154 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.9 113.28 26.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.663 0.785 . . . . 0.0 109.165 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.55 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.8 p-10 -73.27 177.89 1.77 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 124.366 1.066 . . . . 0.0 111.745 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.7 Cg_exo -41.04 -50.3 4.24 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.919 3.079 . . . . 0.0 115.531 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.65 -17.64 53.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 71.72 61.1 0.15 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 125.329 1.451 . . . . 0.0 111.005 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.484 ' NE2' HG12 ' B' ' 11' ' ' VAL . 7.6 m80 -91.29 175.29 6.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.15 168.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -95.01 98.7 10.87 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.95 103.54 13.13 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 46.4 ttt180 -89.83 148.49 23.16 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 123.279 0.632 . . . . 0.0 110.455 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.23 140.59 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.526 1.13 . . . . 0.0 108.176 163.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' B' ' 103' ' ' TYR . 7.2 p90 -133.7 170.63 15.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' B' ' 103' ' ' TYR . . . -130.49 113.79 14.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -74.68 130.24 39.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 99.87 0.89 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.94 0.896 . . . . 0.0 110.998 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.405 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.444 176.448 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HB2' ' OE1' ' B' ' 77' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' B' ' 70' ' ' PHE . 54.4 m -140.82 145.96 36.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.444 0.698 . . . . 0.0 111.396 -168.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -133.88 96.95 15.8 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.601 0.76 . . . . 0.0 109.818 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.48 93.79 0.99 Allowed 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.195 1.93 . . . . 0.0 111.381 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.57 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.3 p-10 -109.25 14.63 23.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 0.0 109.454 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.595 ' HD2' ' HD3' ' B' ' 71' ' ' ARG . 0.7 OUTLIER -131.5 141.91 49.86 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.919 -165.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 145.16 30.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.733 1.213 . . . . 0.0 108.117 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 51.4 mt -118.59 140.65 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.034 0.534 . . . . 0.0 110.661 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.56 118.53 37.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -74.42 122.5 23.09 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.981 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' SER . 11.7 m -122.14 163.7 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.17 -52.26 3.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -103.98 98.18 12.97 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.455 0.702 . . . . 0.0 110.079 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.49 -48.72 17.85 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.506 2.804 . . . . 0.0 115.858 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.89 -63.48 0.2 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 123.106 2.145 . . . . 0.0 112.419 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.62 89.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 0.0 112.125 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -66.82 -47.94 70.46 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.442 0.639 . . . . 0.0 110.425 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 65.8 m -75.96 -34.92 59.83 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.0 mm-40 -66.45 -33.74 76.39 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.102 0.876 . . . . 0.0 109.259 172.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 81.9 t80 -66.73 -42.83 85.67 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.002 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.547 ' HH ' HD21 ' A' ' 115' ' ' LEU . 45.8 m-85 -71.21 -29.02 64.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.375 0.534 . . . . 0.0 110.377 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.0 mtpt -57.39 -48.9 77.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.935 0.398 . . . . 0.0 111.902 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.77 -35.68 62.56 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.024 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 12.9 tp -64.52 -30.58 71.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.602 1.161 . . . . 0.0 112.737 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' HB2' HG22 ' A' ' 27' ' ' VAL . 83.4 mt -104.03 -41.13 5.94 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.982 0.913 . . . . 0.0 109.565 176.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.73 34.06 6.16 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.0 m -123.72 -177.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.521 1.128 . . . . 0.0 110.484 -176.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -148.52 146.74 23.25 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.485 1.114 . . . . 0.0 108.833 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 19.1 Cg_exo -64.41 108.12 0.95 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.598 2.198 . . . . 0.0 111.909 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.1 -38.7 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.7 mm-40 -111.9 121.8 46.03 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -121.97 140.9 51.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.56 . . . . 0.0 110.358 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.402 ' HB3' ' HB3' ' A' ' 36' ' ' PHE . 43.5 t -141.6 149.8 55.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.872 1.269 . . . . 0.0 107.949 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.22 -24.86 61.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.843 2.362 . . . . 0.0 113.572 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.3 t -128.01 9.2 6.27 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.402 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 85.9 t80 -149.22 150.59 32.85 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.708 0.403 . . . . 0.0 110.505 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 42.7 m -134.51 143.17 47.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.553 0.741 . . . . 0.0 109.697 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -138.51 119.62 14.53 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 6.8 p90 -131.98 147.86 52.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 108.127 167.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 1.6 p -126.33 134.98 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 109.306 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.446 HD12 HD13 ' A' ' 47' ' ' LEU . 6.1 mp -95.26 150.78 19.87 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.261 -167.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.66 -9.14 57.8 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.952 0.901 . . . . 0.0 110.744 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 58.9 m-20 -70.73 -9.31 56.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.28 1.032 . . . . 0.0 111.441 170.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.7 63.99 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.041 0.353 . . . . 0.0 113.38 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' B' ' 4' ' ' PRO . 18.6 ptm -113.37 167.72 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.694 0.797 . . . . 0.0 109.175 177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 62.3 tttt -132.86 136.57 46.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.671 0.388 . . . . 0.0 109.991 -174.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.446 HD13 HD12 ' A' ' 41' ' ' LEU . 12.9 mt -125.38 123.7 39.91 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.714 0.805 . . . . 0.0 112.295 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.83 145.72 16.82 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 169.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 10.4 mp -117.29 105.19 11.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 161.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.33 129.79 54.86 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 69.2 m -72.5 130.82 41.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.27 0.356 . . . . 0.0 111.286 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 -66.15 -21.36 66.33 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.957 0.903 . . . . 0.0 111.913 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -81.33 -6.7 59.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.152 0.581 . . . . 0.0 111.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.446 HG21 ' HB2' ' A' ' 51' ' ' SER . 13.5 t -127.25 4.65 6.36 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.452 0.701 . . . . 0.0 110.784 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 p -71.18 149.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.86 0.464 . . . . 0.0 111.47 -177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -130.6 121.47 19.23 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.874 0.87 . . . . 0.0 109.392 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.56 141.1 68.83 Favored 'Cis proline' 0 C--N 1.385 2.497 0 CA-C-N 119.943 1.015 . . . . 0.0 112.345 -1.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -55.1 132.04 46.43 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.114 0.966 . . . . 0.0 112.215 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.79 109.73 4.49 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.723 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.8 m -83.04 87.32 6.89 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.2 m -148.34 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.942 0.897 . . . . 0.0 109.445 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 p -150.81 135.57 17.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.655 1.182 . . . . 0.0 108.594 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.28 35.18 57.04 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.337 0.398 . . . . 0.0 113.139 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.53 29.25 2.61 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.21 -172.06 32.14 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 115.858 -0.171 . . . . 0.0 112.867 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' B' ' 66' ' ' GLY . . . 70.48 107.45 0.04 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.673 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 36.1 mt-10 -122.76 134.47 54.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.76 109.57 15.76 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.98 121.96 34.85 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.249 0.547 . . . . 0.0 110.767 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.517 ' HB2' HG21 ' A' ' 117' ' ' VAL . 40.6 m-85 -102.87 107.64 18.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.789 1.636 . . . . 0.0 108.747 -177.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.58 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 25.4 mtm180 -92.54 132.46 36.82 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 112.053 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 161.86 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.316 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.2 pt-20 -65.8 -41.31 92.07 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -160.83 -178.87 7.12 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.57 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.42 -33.18 65.58 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.745 1.618 . . . . 0.0 113.072 -169.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.11 -46.0 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.84 0.456 . . . . 0.0 110.408 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.444 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 79.9 mm-40 -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.194 0.998 . . . . 0.0 112.537 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.2 -44.07 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.495 0.718 . . . . 0.0 109.841 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.36 -35.63 73.68 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.516 1.126 . . . . 0.0 111.035 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -65.93 -41.02 91.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.251 0.548 . . . . 0.0 109.866 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -63.47 -41.14 98.59 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.612 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.412 ' O ' ' HE2' ' A' ' 92' ' ' MET . 42.9 t80 -57.89 -57.8 11.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.398 0.679 . . . . 0.0 110.693 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -63.04 -41.2 99.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.254 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.44 -47.27 86.0 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.869 0.73 . . . . 0.0 113.547 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -62.1 -45.44 93.47 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.658 0.783 . . . . 0.0 109.826 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.4 ttpt -55.64 -43.0 75.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.115 0.966 . . . . 0.0 110.83 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.63 -26.94 61.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.239 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -93.29 8.21 41.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.937 0.895 . . . . 0.0 112.618 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.6 45.33 4.64 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 166.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 107' ' ' ALA . 8.0 p -98.46 152.18 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 170.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.38 -62.34 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 30.2 ttp 61.24 82.75 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.173 0.989 . . . . 0.0 112.849 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 84.92 2.14 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.832 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 179.91 135.22 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 0.0 108.615 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.98 129.96 77.08 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.539 0.524 . . . . 0.0 109.923 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.58 96.42 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.752 2.301 . . . . 0.0 109.849 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.34 160.48 36.15 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.09 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 101.05 6.35 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.065 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.425 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 21.7 ttt -100.75 -178.92 3.92 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.982 1.313 . . . . 0.0 110.023 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 99' ' ' MET . 15.1 mm-40 -52.13 -41.02 62.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.654 1.182 . . . . 0.0 112.432 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 55.8 m-85 -96.55 11.96 33.29 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.614 -173.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.28 -165.47 12.79 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.86 112.04 19.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -141.87 169.24 17.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.839 0.455 . . . . 0.0 111.611 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 37.0 p90 -152.98 175.61 12.77 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.852 166.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 114' ' ' ARG . 90.7 m -137.39 130.66 30.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.022 0.439 . . . . 0.0 110.178 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.22 168.18 9.24 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.443 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.7 112.33 6.82 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 5.9 p-10 -68.01 174.39 2.41 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.253 1.021 . . . . 0.0 111.134 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 16.0 Cg_exo -37.26 -49.94 1.66 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.197 3.265 . . . . 0.0 115.321 172.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -10.79 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.678 0.791 . . . . 0.0 111.177 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m 69.84 92.78 0.08 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.535 1.534 . . . . 0.0 112.188 168.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.456 ' CE1' HG12 ' A' ' 11' ' ' VAL . 16.4 m80 -124.21 149.2 46.66 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.673 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 22.0 ttp180 -81.03 95.16 6.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.291 0.567 . . . . 0.0 110.115 -171.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.547 HD21 ' HH ' ' A' ' 21' ' ' TYR . 63.6 mt -92.76 101.59 13.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -171.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -92.84 95.54 9.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.805 0.842 . . . . 0.0 110.869 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' A' ' 70' ' ' PHE . 36.5 t -97.21 117.05 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -133.81 161.62 34.24 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.8 111.46 15.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 166.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 35.8 t80 -77.48 127.31 32.3 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.79 94.34 8.68 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -178.015 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.432 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 27.1 m -141.97 145.78 34.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.393 0.677 . . . . 0.0 110.993 -166.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 96.86 16.52 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.735 0.814 . . . . 0.0 109.898 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.424 ' O ' ' SD ' ' A' ' 45' ' ' MET . 73.7 Cg_endo -75.7 94.47 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.065 1.843 . . . . 0.0 111.267 164.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 8.7 p-10 -109.78 14.65 23.16 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.551 0.74 . . . . 0.0 109.487 168.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.58 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.3 OUTLIER -131.15 141.25 50.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.895 1.278 . . . . 0.0 107.687 -165.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.449 ' N ' ' HD1' ' B' ' 6' ' ' PHE . 5.6 t -145.13 145.1 31.25 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.693 1.197 . . . . 0.0 108.261 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.3 mt -118.31 140.19 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.103 0.561 . . . . 0.0 110.73 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.3 117.48 34.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -73.07 122.93 22.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.139 0.976 . . . . 0.0 111.397 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' B' ' 51' ' ' SER . 11.3 m -122.44 163.67 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -98.43 -52.14 3.74 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -104.06 98.65 14.2 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.397 0.679 . . . . 0.0 110.5 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.69 -48.61 18.52 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.609 2.873 . . . . 0.0 115.927 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 15.6 Cg_endo -55.14 -63.89 0.17 Allowed 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 123.002 2.108 . . . . 0.0 112.272 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.99 88.85 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.334 0.654 . . . . 0.0 112.088 -167.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -66.46 -48.16 70.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.494 0.664 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 89.1 m -75.65 -34.9 60.52 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -168.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 85.3 mm-40 -67.17 -33.96 76.51 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.3 1.0 . . . . 0.0 109.056 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 85.7 t80 -66.05 -43.35 87.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.004 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.606 ' HH ' HD22 ' B' ' 115' ' ' LEU . 40.8 m-85 -70.68 -29.45 65.78 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.418 0.553 . . . . 0.0 110.142 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.3 mtpt -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.125 0.488 . . . . 0.0 112.04 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.8 62.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.158 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 13.3 tp -63.88 -30.72 71.78 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.581 1.152 . . . . 0.0 112.734 -175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' B' ' 27' ' ' VAL . 66.7 mt -104.47 -41.09 5.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 109.45 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.78 34.1 6.13 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.517 HG21 ' HB2' ' B' ' 25' ' ' LEU . 35.6 m -124.19 -177.82 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.399 1.08 . . . . 0.0 110.833 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -147.23 146.6 25.94 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.203 1.001 . . . . 0.0 108.966 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 35.9 Cg_endo -63.38 108.54 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.408 2.072 . . . . 0.0 112.115 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -64.33 -38.38 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.31 0.644 . . . . 0.0 110.243 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 17.9 mm-40 -112.04 121.56 45.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.7 p -122.12 140.67 52.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.119 0.568 . . . . 0.0 110.488 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.7 t -141.71 149.47 53.62 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.963 1.305 . . . . 0.0 107.89 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.77 -24.99 58.45 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.7 2.267 . . . . 0.0 113.587 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -127.87 8.95 6.31 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -149.0 150.6 33.09 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.606 0.362 . . . . 0.0 110.41 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 15.1 m -134.2 143.5 47.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.462 0.705 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tm? -139.4 119.15 13.2 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 5.9 p90 -131.91 148.0 52.51 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 167.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.53 HG22 ' HG3' ' B' ' 46' ' ' LYS . 5.6 t -125.92 134.28 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -172.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.484 HD23 HD12 ' B' ' 25' ' ' LEU . 52.3 mt -94.22 150.91 19.87 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.67 0.788 . . . . 0.0 110.775 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -9.42 58.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.082 0.953 . . . . 0.0 110.697 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 69.7 m-20 -70.63 -9.01 56.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.028 0.931 . . . . 0.0 111.699 170.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.16 11.54 62.87 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 116.59 -0.277 . . . . 0.0 113.342 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.57 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -115.1 167.2 11.03 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.88 0.872 . . . . 0.0 108.895 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.53 ' HG3' HG22 ' B' ' 40' ' ' VAL . 78.3 tttt -132.51 135.37 45.95 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.146 0.578 . . . . 0.0 109.659 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.453 ' HG ' ' SD ' ' B' ' 45' ' ' MET . 36.8 mt -124.94 123.87 40.83 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.775 0.83 . . . . 0.0 112.216 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.33 145.66 16.61 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 10.5 mp -117.53 105.2 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 161.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.419 ' HZ2' ' HE3' ' A' ' 99' ' ' MET . 7.8 t90 -107.26 129.97 54.81 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 69.5 m -72.73 130.48 40.61 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.199 0.312 . . . . 0.0 111.483 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.452 ' HD3' HG22 ' B' ' 62' ' ' THR . 31.7 ptt180 -66.48 -20.91 66.16 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.722 0.809 . . . . 0.0 111.995 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -81.05 -7.16 59.5 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.872 0.469 . . . . 0.0 111.514 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.429 HG21 ' HB2' ' B' ' 51' ' ' SER . 14.1 t -126.88 5.44 6.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.295 0.638 . . . . 0.0 110.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 p -71.57 149.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.808 0.443 . . . . 0.0 111.354 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -131.03 121.32 18.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.5 141.54 70.24 Favored 'Cis proline' 0 C--N 1.389 2.682 0 C-N-CA 124.622 -0.991 . . . . 0.0 112.294 -1.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -55.9 132.28 49.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.026 0.93 . . . . 0.0 111.928 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.04 109.52 4.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.578 0.751 . . . . 0.0 109.635 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -82.66 87.82 6.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.67 139.35 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.102 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.452 HG22 ' HD3' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -150.14 135.33 17.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.823 1.249 . . . . 0.0 108.65 174.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.01 58.91 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.375 0.422 . . . . 0.0 113.329 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.05 28.79 2.69 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.23 -172.11 32.15 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.749 -0.225 . . . . 0.0 112.997 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.448 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . 70.61 107.41 0.04 OUTLIER Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -177.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.67 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 35.0 mt-10 -122.72 134.54 54.45 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -119.82 109.48 15.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.95 122.3 35.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.388 0.613 . . . . 0.0 110.85 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.507 ' HB2' HG22 ' B' ' 117' ' ' VAL . 40.6 m-85 -103.22 107.67 18.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.754 1.621 . . . . 0.0 108.474 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.595 ' HD3' ' HD2' ' A' ' 6' ' ' PHE . 27.8 mtm180 -92.76 131.53 37.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.197 0.522 . . . . 0.0 111.84 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.17 162.33 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.271 1.028 . . . . 0.0 110.239 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.562 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.3 pt-20 -66.31 -40.17 89.79 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.57 -179.13 7.06 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.989 0.813 . . . . 0.0 112.676 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.99 -33.32 64.73 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.776 1.63 . . . . 0.0 113.421 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.01 78.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.562 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.7 mm-40 -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.358 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.96 -44.76 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.552 0.692 . . . . 0.0 109.715 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.75 -36.44 78.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.298 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -65.46 -41.57 93.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.349 0.595 . . . . 0.0 110.025 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.7 m -62.77 -41.23 99.14 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.659 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.406 ' O ' ' HE1' ' B' ' 92' ' ' MET . 43.7 t80 -58.12 -57.44 12.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.448 0.699 . . . . 0.0 110.616 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.452 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -63.52 -41.01 98.51 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.235 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.67 82.57 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.801 0.688 . . . . 0.0 113.41 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -61.77 -45.82 92.24 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.637 0.775 . . . . 0.0 109.884 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.1 ttpt -54.74 -43.41 72.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.171 0.988 . . . . 0.0 111.04 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.77 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.798 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -93.53 8.51 40.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.024 0.93 . . . . 0.0 112.374 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.17 45.77 4.64 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 114.859 0.703 . . . . 0.0 114.859 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.422 HG22 ' HB1' ' B' ' 107' ' ' ALA . 8.3 p -98.56 152.02 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.48 -61.93 1.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 30.3 ttp 60.86 83.11 0.15 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.231 1.012 . . . . 0.0 112.79 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.35 85.48 2.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.352 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 179.71 134.22 0.1 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 108.384 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -75.83 130.04 79.7 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.63 0.581 . . . . 0.0 109.893 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.98 95.78 0.67 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.731 2.287 . . . . 0.0 110.083 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.16 160.15 36.91 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -168.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 101.08 5.9 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.962 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 22.4 ttt -100.89 -178.78 3.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.134 1.374 . . . . 0.0 109.84 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -52.86 -40.79 63.71 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.559 1.144 . . . . 0.0 112.182 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 55.0 m-85 -96.3 11.94 32.85 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.863 0.865 . . . . 0.0 111.673 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.84 -165.3 12.92 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.07 112.2 19.58 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -142.0 169.32 17.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.817 0.447 . . . . 0.0 111.588 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' B' ' 92' ' ' MET . 37.0 p90 -153.12 175.72 12.7 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.316 1.047 . . . . 0.0 108.731 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.629 HG21 ' HG3' ' B' ' 114' ' ' ARG . 96.8 m -137.49 130.8 30.91 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 110.138 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.32 168.45 9.06 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.505 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.86 112.23 6.71 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.6 p-10 -67.51 174.3 2.26 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.334 1.054 . . . . 0.0 111.551 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 17.3 Cg_exo -37.67 -49.78 1.92 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.938 3.092 . . . . 0.0 115.225 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.26 -10.21 50.4 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.46 0.704 . . . . 0.0 111.368 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 70.07 92.18 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.578 1.551 . . . . 0.0 112.047 168.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.459 ' CE1' HG12 ' B' ' 11' ' ' VAL . 15.7 m80 -123.77 149.37 45.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 170.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.67 ' HB3' ' HG2' ' B' ' 67' ' ' GLU . 21.8 ttp180 -81.15 95.34 6.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.136 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.606 HD22 ' HH ' ' B' ' 21' ' ' TYR . 62.3 mt -93.24 101.72 13.99 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -171.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -90.97 94.72 9.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.892 0.877 . . . . 0.0 111.131 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' B' ' 70' ' ' PHE . 36.8 t -97.61 117.47 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.353 0.979 . . . . 0.0 108.366 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -133.77 161.42 34.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 111.35 15.47 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 166.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 35.2 t80 -77.98 132.55 37.89 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.79 95.22 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.274 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.096 0 CA-C-O 118.963 -0.91 . . . . 0.0 111.033 -174.421 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 ptm . . . . . 0 CA--C 1.55 0.956 0 CA-C-O 120.035 -0.031 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.583 HG21 ' HB3' ' B' ' 70' ' ' PHE . 9.8 m -140.7 138.14 34.02 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.309 0.644 . . . . 0.0 110.836 -158.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -137.27 134.94 18.99 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.1 0.56 . . . . 0.0 111.752 -173.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -94.05 92.29 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.291 2.66 . . . . 0.0 113.066 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.607 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.1 p-10 -103.17 9.46 38.28 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.613 0.72 . . . . 0.0 110.044 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -132.59 136.23 46.42 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.793 1.237 . . . . 0.0 108.116 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HB ' HG21 ' B' ' 7' ' ' THR . 9.9 t -131.56 142.67 49.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.684 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 57.2 mt -120.79 134.83 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD12 HD22 ' A' ' 68' ' ' LEU . 94.0 mt -82.11 131.58 35.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -85.31 105.04 15.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.803 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.472 HG11 HD23 ' A' ' 49' ' ' LEU . 2.4 m -116.35 176.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.97 -57.95 2.2 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.052 0.941 . . . . 0.0 109.678 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -89.18 105.64 10.94 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.748 1.219 . . . . 0.0 109.309 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.7 Cg_exo -56.79 -55.91 2.35 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.95 2.434 . . . . 0.0 113.704 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 51.6 Cg_exo -55.81 -65.82 0.1 Allowed 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 122.109 1.789 . . . . 0.0 112.686 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -165.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.7 p -63.33 -55.43 24.65 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 99.6 m -67.3 -39.33 85.95 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -168.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.532 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 23.7 mm-40 -62.38 -41.11 98.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.817 1.247 . . . . 0.0 109.45 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 86.4 t80 -65.37 -39.98 92.98 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 110.049 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.432 ' OH ' HD21 ' A' ' 115' ' ' LEU . 61.4 m-85 -71.28 -31.42 67.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.594 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.1 mtpt -56.53 -46.33 80.66 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -37.7 51.17 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.272 175.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 14.9 tp -62.93 -30.91 71.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.268 1.027 . . . . 0.0 112.536 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB2' HG21 ' A' ' 27' ' ' VAL . 46.1 mt -104.94 -37.63 6.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.008 0.923 . . . . 0.0 109.152 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.08 9.95 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -172.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG21 ' HB2' ' A' ' 25' ' ' LEU . 23.9 m -128.15 159.37 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.963 0.905 . . . . 0.0 110.174 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -112.22 148.7 39.66 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.609 0.764 . . . . 0.0 109.625 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 16.8 Cg_exo -67.18 108.03 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.784 2.323 . . . . 0.0 111.076 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.549 HG11 ' HA ' ' A' ' 39' ' ' PHE . 7.3 p -63.4 -34.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.706 0.629 . . . . 0.0 110.679 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.7 mm-40 -115.63 85.36 2.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -86.71 129.45 34.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.266 0.626 . . . . 0.0 110.095 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -137.49 150.78 69.57 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.745 0.818 . . . . 0.0 109.193 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.76 -42.78 42.85 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.714 2.943 . . . . 0.0 114.812 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -127.17 24.51 6.33 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.252 0.548 . . . . 0.0 112.276 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -153.77 152.42 30.71 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.562 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 33.5 t -134.66 142.65 46.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.387 0.675 . . . . 0.0 109.366 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -141.06 122.31 14.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.549 ' HA ' HG11 ' A' ' 30' ' ' VAL . 5.5 p90 -129.74 146.61 51.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.839 0.856 . . . . 0.0 108.993 164.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.543 HG22 ' HG3' ' A' ' 46' ' ' LYS . 6.1 t -118.88 135.12 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.416 HD12 ' SD ' ' A' ' 45' ' ' MET . 38.5 mt -96.21 158.76 15.29 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.933 0.493 . . . . 0.0 110.517 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.59 -20.95 66.12 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.965 0.906 . . . . 0.0 112.465 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.898 0.879 . . . . 0.0 111.393 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.59 -14.17 42.46 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.717 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -72.91 154.96 40.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HG3' HG22 ' A' ' 40' ' ' VAL . 81.6 tttt -119.23 139.74 51.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.55 115.52 11.55 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -168.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.35 170.7 21.6 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 123.901 0.763 . . . . 0.0 111.533 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 6.3 mp -139.5 107.7 5.77 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 165.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.475 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.9 t90 -105.09 124.05 48.87 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -76.79 139.25 40.31 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.374 0.67 . . . . 0.0 111.102 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' HG21 ' A' ' 62' ' ' THR . 39.2 ptt180 -73.0 -14.82 61.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.147 0.579 . . . . 0.0 112.244 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -85.72 -6.51 59.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 122.511 0.325 . . . . 0.0 111.157 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -129.37 8.51 5.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.367 0.667 . . . . 0.0 110.976 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.855 HG21 HH22 ' B' ' 116' ' ' ARG . 12.5 p -74.62 148.84 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.031 0.532 . . . . 0.0 111.734 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -128.19 116.03 20.19 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.827 0.851 . . . . 0.0 109.568 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.22 144.47 78.05 Favored 'Cis proline' 0 C--N 1.387 2.579 0 C-N-CA 124.52 -1.033 . . . . 0.0 112.743 1.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.509 ' HA ' HG13 ' A' ' 55' ' ' VAL . 12.0 mmmm -53.17 114.11 1.35 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.694 0.798 . . . . 0.0 111.511 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.59 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.307 1.043 . . . . 0.0 109.44 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -98.09 89.3 4.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.28 0.632 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.74 124.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.102 0.561 . . . . 0.0 111.136 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' HD3' ' A' ' 52' ' ' ARG . 9.4 p -151.92 178.67 9.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.252 1.421 . . . . 0.0 108.631 171.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.59 -31.94 6.72 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -172.52 31.19 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 119.95 0.65 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.22 125.07 0.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.721 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.7 pt-20 -131.79 145.04 51.36 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 9' ' ' LEU . 39.9 tp -108.49 104.52 13.87 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -88.0 117.13 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 110.761 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.407 ' HB3' ' CG2' ' B' ' 2' ' ' THR . 7.6 m-85 -97.74 112.67 24.47 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.7 mtm105 -90.64 135.08 33.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.883 0.473 . . . . 0.0 111.696 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.91 173.3 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.283 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -74.84 -45.39 43.57 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.769 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.41 HD21 ' HG3' ' A' ' 73' ' ' GLU . 7.4 p30 -157.62 175.22 14.21 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.701 0.682 . . . . 0.0 112.393 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.01 -32.39 67.88 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.525 -166.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.59 -44.94 85.08 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.401 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.0 mm-40 -64.39 -25.45 68.03 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.72 -39.4 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.397 0.618 . . . . 0.0 109.866 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.22 -32.14 68.43 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.543 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.6 mt-10 -65.85 -41.31 91.88 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.593 0.711 . . . . 0.0 109.665 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.7 m -71.25 -29.13 64.73 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.834 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.58 -61.1 2.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 0.0 109.632 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.433 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.94 -36.49 82.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.725 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.24 68.45 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.994 0.809 . . . . 0.0 113.712 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -63.1 -42.9 99.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.369 0.668 . . . . 0.0 110.333 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.7 ttpt -55.42 -47.0 76.64 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.953 0.783 . . . . 0.0 110.474 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.9 -15.28 59.73 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.414 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -92.12 -2.48 56.58 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.11 0.964 . . . . 0.0 111.939 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.92 3.25 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.914 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.13 150.79 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.22 -36.46 81.72 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.882 0.473 . . . . 0.0 111.8 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.421 ' HE2' ' HB2' ' A' ' 86' ' ' LYS . 61.5 tpp 65.83 83.14 0.17 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 168.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 85.89 2.25 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.491 0.662 . . . . 0.0 111.381 173.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 179.34 126.36 0.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.412 1.485 . . . . 0.0 108.639 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -79.85 109.95 14.04 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 167.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.2 119.38 6.25 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.786 2.324 . . . . 0.0 111.09 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 146.29 50.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.225 0.61 . . . . 0.0 110.745 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -73.92 101.94 3.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.851 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.7 ttm -98.35 174.76 6.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.879 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.95 -39.81 63.2 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.096 0.958 . . . . 0.0 112.233 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -91.55 6.97 43.6 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.583 0.753 . . . . 0.0 111.659 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 -163.78 12.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.003 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -76.13 102.15 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -113.06 147.51 37.12 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.186 0.517 . . . . 0.0 110.556 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -143.31 138.74 29.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.688 1.195 . . . . 0.0 109.536 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.6 m -134.91 119.91 18.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.027 0.83 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.57 161.03 14.98 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 122.966 0.506 . . . . 0.0 110.989 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.8 114.68 23.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.501 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 6.1 p-10 -70.3 176.67 1.72 Allowed Pre-proline 0 CA--C 1.567 1.608 0 C-N-CA 124.071 0.948 . . . . 0.0 111.336 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 1.4 Cg_endo -42.83 -41.71 8.74 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.853 3.035 . . . . 0.0 115.034 173.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -78.88 -25.97 43.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.542 0.337 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 t 73.38 85.86 0.11 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.811 1.644 . . . . 0.0 110.003 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.42 ' CE1' HG13 ' A' ' 11' ' ' VAL . 13.7 m80 -113.87 -173.98 2.38 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 3.0 mmp_? -100.57 112.73 25.15 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.432 HD21 ' OH ' ' A' ' 21' ' ' TYR . 84.2 mt -114.96 103.63 11.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.825 0.45 . . . . 0.0 110.188 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.619 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 51.4 ttt180 -90.69 140.16 30.04 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -174.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.24 119.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 164.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -128.49 164.87 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.288 0.494 . . . . 0.0 111.812 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.68 111.2 9.19 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -80.25 114.3 19.05 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.01 91.95 0.7 Allowed 'General case' 0 C--N 1.348 0.534 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.233 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.519 -175.754 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tmm? . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 61.8 m -67.31 135.93 54.08 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.044 1.337 . . . . 0.0 112.056 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -136.64 135.13 19.99 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 122.832 0.453 . . . . 0.0 111.027 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -94.44 93.13 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.203 2.602 . . . . 0.0 113.174 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.717 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 11.4 p-10 -104.58 9.66 35.27 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.798 0.809 . . . . 0.0 109.606 171.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.01 135.79 45.64 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 108.033 -168.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.413 HG21 ' HB ' ' A' ' 7' ' ' THR . 11.5 t -131.35 143.12 50.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.721 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 50.4 mt -121.12 134.53 64.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.463 HD12 HD22 ' B' ' 68' ' ' LEU . 93.2 mt -81.71 131.69 35.27 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 173.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.429 ' OH ' HG13 ' B' ' 55' ' ' VAL . 23.1 t80 -85.43 105.07 15.79 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.752 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' B' ' 113' ' ' HIS . 2.5 m -116.14 176.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.969 0.908 . . . . 0.0 108.664 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.16 -57.29 2.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 109.775 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -89.82 105.92 12.59 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.478 1.111 . . . . 0.0 109.453 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.43 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 28.1 Cg_exo -56.78 -55.95 2.32 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.984 2.456 . . . . 0.0 113.799 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 53.7 Cg_exo -55.61 -66.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.402 3.362 0 CA-C-N 122.255 1.841 . . . . 0.0 112.728 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.85 81.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -62.67 -55.95 22.18 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 98.2 m -66.95 -39.31 87.24 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -168.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.567 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 20.8 mm-40 -62.25 -41.35 98.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.762 1.225 . . . . 0.0 109.264 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 90.1 t80 -65.07 -40.28 94.47 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.058 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.442 ' OH ' HD21 ' B' ' 115' ' ' LEU . 62.6 m-85 -71.2 -31.45 67.62 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.507 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 60.8 mtpt -56.28 -46.6 79.65 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.41 -37.57 51.54 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.53 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.6 tp -62.97 -30.91 71.95 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.471 1.109 . . . . 0.0 112.56 -174.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' B' ' 27' ' ' VAL . 46.6 mt -104.88 -37.71 6.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 109.071 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 33.25 9.66 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' B' ' 25' ' ' LEU . 21.5 m -128.8 158.57 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.043 0.937 . . . . 0.0 109.958 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -110.8 148.43 38.55 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 123.855 0.862 . . . . 0.0 109.693 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.547 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 20.3 Cg_exo -66.66 108.01 1.36 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.628 2.218 . . . . 0.0 111.338 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -63.2 -34.76 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.253 0.621 . . . . 0.0 110.593 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 30.7 mm-40 -115.62 85.59 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 34.1 p -86.74 129.55 34.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.334 0.653 . . . . 0.0 110.014 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -137.25 150.36 68.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.112 0.965 . . . . 0.0 109.382 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.52 -42.88 40.98 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.706 2.937 . . . . 0.0 114.725 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.7 t -127.26 24.36 6.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.949 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -153.75 152.43 30.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.529 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 39.3 t -134.94 142.79 46.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.269 0.627 . . . . 0.0 109.333 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.646 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.4 tm? -140.85 122.84 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.565 ' HA ' HG12 ' B' ' 30' ' ' VAL . 3.6 p90 -129.74 146.67 51.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 109.07 164.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.532 HG21 ' HG3' ' B' ' 46' ' ' LYS . 9.5 t -118.65 134.52 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.01 158.35 15.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.952 0.501 . . . . 0.0 110.647 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -22.19 66.53 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.121 0.969 . . . . 0.0 112.65 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.5 ' OD1' ' HG3' ' B' ' 45' ' ' MET . 18.9 p30 -66.66 -20.85 66.08 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 0.0 111.767 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.56 -13.22 42.93 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.241 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.607 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -73.5 155.41 39.24 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.532 ' HG3' HG21 ' B' ' 40' ' ' VAL . 79.2 tttt -119.41 140.11 50.93 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 tt -137.61 115.26 11.3 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.687 -168.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.05 170.79 21.95 Favored Glycine 0 C--N 1.349 1.284 0 C-N-CA 124.042 0.83 . . . . 0.0 111.579 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 5.4 mp -139.51 107.45 5.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 165.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -104.85 124.47 49.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.414 ' HB2' HG23 ' B' ' 54' ' ' THR . 15.8 m -76.77 139.39 40.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.385 0.674 . . . . 0.0 110.884 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -72.83 -15.12 61.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.274 0.63 . . . . 0.0 112.318 -173.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -85.82 -6.42 59.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.699 0.4 . . . . 0.0 110.824 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.414 HG23 ' HB2' ' B' ' 51' ' ' SER . 14.6 t -129.65 7.79 5.29 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.472 0.709 . . . . 0.0 111.162 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.429 HG13 ' OH ' ' B' ' 10' ' ' TYR . 8.4 p -74.61 149.68 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -128.59 115.86 19.56 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.177 0.991 . . . . 0.0 109.284 172.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.35 143.74 75.68 Favored 'Cis proline' 0 C--N 1.387 2.561 0 C-N-CA 124.626 -0.989 . . . . 0.0 112.675 1.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -52.22 114.39 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.591 0.756 . . . . 0.0 111.674 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.55 132.55 45.62 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 109.458 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 40.3 m -98.37 89.47 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.183 0.593 . . . . 0.0 109.421 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 p -155.58 124.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.193 0.597 . . . . 0.0 111.162 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -152.47 178.14 9.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.293 1.437 . . . . 0.0 108.665 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.44 -31.84 6.77 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-O 121.04 0.244 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.63 -172.66 31.38 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.83 119.71 0.63 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 75.23 126.06 0.18 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.684 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 3.7 pt-20 -132.98 143.4 49.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 110.218 -175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.463 HD22 HD12 ' B' ' 9' ' ' LEU . 43.0 tp -108.35 104.31 13.65 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.732 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -87.61 116.75 25.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.148 0.499 . . . . 0.0 110.861 -171.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.583 ' HB3' HG21 ' A' ' 2' ' ' THR . 7.6 m-85 -97.05 112.62 24.3 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.408 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 31.4 mtm180 -91.03 135.19 33.92 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 122.941 0.496 . . . . 0.0 111.622 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' B' ' 77' ' ' GLN . 1.3 p -140.4 173.14 10.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.131 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.77 -45.44 43.77 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -157.59 175.09 14.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 0.675 . . . . 0.0 112.292 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -58.78 -32.07 68.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.219 1.407 . . . . 0.0 112.398 -166.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.554 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.84 -45.03 83.74 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.349 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.509 ' HB3' HG21 ' B' ' 72' ' ' VAL . 73.1 mm-40 -64.5 -25.14 67.86 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.958 0.786 . . . . 0.0 112.574 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -71.43 -39.39 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.189 0.596 . . . . 0.0 109.728 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.96 -32.28 69.11 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 110.551 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.7 mt-10 -65.63 -41.06 93.11 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.615 0.721 . . . . 0.0 109.684 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 12.5 m -71.43 -29.43 64.87 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.828 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.8 -61.03 2.92 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.396 0.678 . . . . 0.0 109.475 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.436 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.73 -36.82 83.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.676 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 -50.52 66.18 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.608 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -63.19 -43.12 99.11 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.207 0.603 . . . . 0.0 110.27 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.444 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 33.9 ttpt -54.72 -47.41 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.765 0.826 . . . . 0.0 110.583 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.65 -15.67 59.75 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.612 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -92.22 -1.82 56.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 112.01 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.29 3.36 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.189 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.85 150.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.444 ' HE1' ' HB2' ' B' ' 86' ' ' LYS . 61.2 tpp 65.82 83.18 0.17 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 168.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 85.91 2.25 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.442 0.639 . . . . 0.0 111.167 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 179.62 126.47 0.07 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.21 1.404 . . . . 0.0 108.387 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.99 110.71 17.14 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.547 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 17.3 Cg_endo -55.67 119.71 7.03 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.79 2.327 . . . . 0.0 110.409 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 145.81 50.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 0.0 111.034 -170.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -72.29 101.67 2.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.206 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.6 ttm -98.63 174.62 6.33 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.663 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -52.77 -40.28 63.02 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.825 0.85 . . . . 0.0 112.373 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.44 6.74 42.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.643 0.777 . . . . 0.0 111.989 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.69 -163.1 12.21 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -77.33 102.36 6.73 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -113.18 147.33 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.178 0.591 . . . . 0.0 110.487 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 4.7 t80 -143.31 138.9 29.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.733 1.213 . . . . 0.0 109.58 -176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 11.1 m -135.1 119.92 18.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.041 0.837 . . . . 0.0 110.347 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.76 160.68 15.29 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.929 0.492 . . . . 0.0 110.986 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.38 114.97 24.32 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.465 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.0 p-10 -70.19 177.56 1.33 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 124.182 0.993 . . . . 0.0 111.288 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 49.4 Cg_exo -43.75 -41.47 11.57 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.456 2.771 . . . . 0.0 115.265 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.95 -25.75 43.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 22.6 t 73.25 86.11 0.11 Allowed 'General case' 0 C--N 1.348 0.522 0 C-N-CA 125.777 1.631 . . . . 0.0 109.952 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.426 ' CE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -113.84 -173.88 2.36 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 67' ' ' GLU . 3.9 mmp_? -100.37 113.01 25.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.442 HD21 ' OH ' ' B' ' 21' ' ' TYR . 85.4 mt -115.3 104.37 11.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.797 0.439 . . . . 0.0 109.969 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.855 HH22 HG21 ' A' ' 55' ' ' VAL . 22.3 mmt180 -88.32 140.94 28.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.508 0.723 . . . . 0.0 110.726 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 59.8 t -135.52 120.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 162.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -128.73 165.44 20.9 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.384 0.538 . . . . 0.0 111.888 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.12 110.97 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -79.64 113.3 17.69 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 103.38 1.14 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.976 0.51 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.4 m -95.48 141.46 28.99 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -98.98 110.18 56.71 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.879 0.872 . . . . 0.0 110.886 -172.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.461 ' HD2' HD23 ' B' ' 41' ' ' LEU . 59.5 Cg_endo -90.89 97.09 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.865 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.3 p-10 -90.28 11.93 19.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.339 0.59 . . . . 0.0 110.694 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.442 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.6 t80 -133.08 135.05 45.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.811 1.244 . . . . 0.0 108.28 -168.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 140.8 41.97 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.349 1.059 . . . . 0.0 108.216 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.527 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 60.7 mt -119.21 141.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.7 138.01 46.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.504 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.5 132.93 35.33 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.488 176.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' SER . 29.0 m -130.6 158.7 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 121.653 -0.654 . . . . 0.0 110.451 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 22.9 t70 -95.34 -57.29 2.45 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.0 99.11 2.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.53 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 12' ' ' ASP . 50.1 Cg_exo -49.02 -55.69 3.91 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 122.756 2.304 . . . . 0.0 114.42 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -59.88 -54.91 1.96 Allowed 'Trans proline' 0 C--N 1.397 3.098 0 CA-C-N 122.16 1.807 . . . . 0.0 112.022 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.05 73.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.134 0.974 . . . . 0.0 111.823 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -79.89 -18.16 51.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.516 -173.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -76.98 -38.51 53.05 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 84.7 mm-40 -67.24 -30.23 70.08 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.52 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -60.45 -48.45 81.69 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.91 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.5 m-85 -68.71 -30.54 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.028 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.0 mtpt -57.78 -49.17 77.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.86 -31.89 51.73 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.715 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.441 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.5 tp -62.07 -50.78 70.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.681 1.192 . . . . 0.0 112.295 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HB2' HG21 ' A' ' 27' ' ' VAL . 14.9 mt -83.57 -47.58 11.15 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 29.56 5.25 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.998 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 25' ' ' LEU . 27.0 m -131.63 175.95 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.026 0.93 . . . . 0.0 110.358 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -124.24 151.25 65.76 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.128 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.55 106.45 1.25 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.78 2.32 . . . . 0.0 111.544 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.419 HG12 ' HG2' ' A' ' 31' ' ' GLU . 7.4 p -63.44 -39.45 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.507 0.723 . . . . 0.0 110.31 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 29.1 mm-40 -114.63 98.28 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.3 p -99.27 138.21 36.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.742 0.817 . . . . 0.0 110.917 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -143.39 150.58 52.01 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.975 1.31 . . . . 0.0 108.233 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.59 -22.35 51.24 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.859 2.373 . . . . 0.0 114.147 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -128.46 9.92 6.12 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.98 139.2 20.22 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.876 -0.515 . . . . 0.0 110.047 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -129.45 138.95 51.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.642 0.777 . . . . 0.0 109.203 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tm? -132.07 120.35 22.23 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.71 113.53 13.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.684 1.194 . . . . 0.0 109.098 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 HG23 ' HG3' ' A' ' 46' ' ' LYS . 12.6 t -94.65 139.68 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.226 1.01 . . . . 0.0 110.03 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -98.66 147.78 24.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.858 0.463 . . . . 0.0 110.244 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -4.81 34.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.756 0.822 . . . . 0.0 111.829 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -69.0 -10.2 56.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.453 1.101 . . . . 0.0 112.231 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.58 15.64 42.68 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.863 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -126.43 172.13 10.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.555 0.742 . . . . 0.0 109.185 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 40' ' ' VAL . 76.4 tttt -136.54 135.29 38.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.09 0.556 . . . . 0.0 109.601 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.2 mt -124.72 124.55 42.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.571 0.749 . . . . 0.0 111.059 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.84 167.3 18.45 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.269 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 tp -144.86 105.23 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.467 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.0 t90 -104.73 123.14 47.12 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 50.2 m -74.47 112.31 10.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.07 -1.93 1.12 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 114.532 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -79.48 -25.47 41.86 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.959 0.8 . . . . 0.0 110.802 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -112.69 12.58 19.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.441 0.696 . . . . 0.0 111.298 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 8.8 p -63.97 138.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.971 0.415 . . . . 0.0 111.49 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.21 114.49 33.43 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.16 140.52 64.87 Favored 'Cis proline' 0 C--N 1.385 2.464 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.073 3.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -49.12 125.48 10.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.101 1.36 . . . . 0.0 111.974 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.19 109.43 3.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.065 0.946 . . . . 0.0 110.498 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.8 t -97.32 88.55 4.46 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.48 135.99 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.596 0.758 . . . . 0.0 109.712 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 p -142.42 125.22 16.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.204 1.002 . . . . 0.0 110.182 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.57 -108.64 0.37 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.79 129.51 9.92 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.67 -32.23 0.03 OUTLIER Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.95 151.62 10.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.663 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 47.0 mt-10 -114.4 165.46 12.7 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.548 0.739 . . . . 0.0 110.787 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.91 103.56 9.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.58 118.49 30.08 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.231 0.469 . . . . 0.0 111.518 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -95.73 108.38 20.69 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.109 1.364 . . . . 0.0 107.688 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.437 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 38.6 mtm180 -85.3 130.06 34.68 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.438 0.637 . . . . 0.0 112.094 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.42 157.05 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.819 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' HG3' HD21 ' A' ' 74' ' ' ASN . 9.7 pt-20 -67.62 -38.36 83.8 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -172.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.418 HD21 ' HG3' ' A' ' 73' ' ' GLU . 7.0 p30 -157.2 176.71 12.36 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.711 0.687 . . . . 0.0 112.631 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.57 -32.86 65.61 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.81 1.644 . . . . 0.0 112.66 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.36 -44.06 79.93 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.012 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -66.36 -24.5 66.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.837 0.855 . . . . 0.0 112.241 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.41 -41.73 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.57 -30.87 68.75 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.489 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.3 mt-10 -68.06 -43.46 78.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -70.37 -28.85 65.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.52 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -64.15 -61.31 2.33 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.777 0.799 . . . . 0.0 109.133 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.76 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.895 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.22 91.46 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.39 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -61.51 -48.51 80.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.635 . . . . 0.0 110.385 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 32.5 ttpt -54.42 -43.53 71.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.841 0.856 . . . . 0.0 110.956 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.59 58.28 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.264 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -94.47 7.71 44.62 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.272 1.029 . . . . 0.0 112.183 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.61 24.5 30.5 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.421 170.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -84.0 133.58 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.531 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -56.71 -34.6 67.61 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.256 1.022 . . . . 0.0 112.625 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 86' ' ' LYS . 49.8 tpp 67.85 82.99 0.17 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 163.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.33 86.36 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 177.65 136.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.631 1.572 . . . . 0.0 109.173 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.3 108.79 15.62 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 165.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 12.5 Cg_endo -55.53 118.79 5.59 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.819 2.346 . . . . 0.0 111.448 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.07 155.32 48.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.325 0.65 . . . . 0.0 110.419 -175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.25 118.61 13.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 110.813 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.8 ttm -115.52 166.81 11.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.069 0.948 . . . . 0.0 108.954 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -49.97 -40.32 43.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.696 1.598 . . . . 0.0 113.071 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -86.97 -19.97 27.97 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.357 0.663 . . . . 0.0 111.676 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.67 175.36 28.5 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 120.326 -0.152 . . . . 0.0 112.932 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.552 ' HB3' ' HB1' ' A' ' 119' ' ' ALA . 42.5 t80 -71.85 101.94 2.75 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -107.49 150.07 27.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.471 0.653 . . . . 0.0 112.165 -161.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 20.0 t80 -150.45 146.21 26.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.8 m -142.69 129.32 20.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.095 0.558 . . . . 0.0 109.65 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.17 149.02 43.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.464 0.706 . . . . 0.0 111.212 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.24 167.09 10.27 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.531 ' HA ' ' H ' ' A' ' 91' ' ' ALA . 1.9 p-10 -133.07 -178.81 0.92 Allowed Pre-proline 0 CA--C 1.562 1.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -169.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 36.8 Cg_endo -62.92 -1.64 2.94 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.314 2.01 . . . . 0.0 114.943 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.73 0.13 13.12 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.481 0.582 . . . . 0.0 111.754 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m 70.14 33.85 2.57 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.829 1.252 . . . . 0.0 112.812 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.481 ' HB2' HD13 ' A' ' 115' ' ' LEU . 18.2 m170 -75.27 170.29 16.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.525 0.73 . . . . 0.0 110.032 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.663 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 13.6 mmm180 -118.91 108.91 15.38 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.481 HD13 ' HB2' ' A' ' 113' ' ' HIS . 3.4 mp -121.41 108.9 14.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -93.38 147.23 23.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.897 0.479 . . . . 0.0 110.428 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.87 133.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.3 p90 -135.97 162.05 33.94 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.605 0.639 . . . . 0.0 111.738 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 103' ' ' TYR . . . -111.07 124.38 52.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 171.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -81.66 108.77 15.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.129 0.422 . . . . 0.0 110.437 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.64 95.1 2.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.809 -0.995 . . . . 0.0 112.004 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.538 0.208 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 19.5 m -132.88 142.39 48.9 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -98.08 110.7 57.05 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 123.892 0.877 . . . . 0.0 111.005 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -91.61 96.95 0.21 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.664 2.243 . . . . 0.0 112.262 170.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.863 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.7 p-10 -90.18 12.29 18.44 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.372 0.606 . . . . 0.0 110.824 170.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.472 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -133.34 135.16 44.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.923 1.289 . . . . 0.0 108.164 -168.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -137.49 140.97 41.48 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.424 1.089 . . . . 0.0 108.146 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.8 140.51 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.343 0.657 . . . . 0.0 109.695 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.85 139.26 43.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -83.4 133.08 34.95 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.21 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' B' ' 51' ' ' SER . 35.9 m -129.07 158.65 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.122 0.569 . . . . 0.0 110.693 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -95.76 -58.33 2.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -92.13 100.7 3.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.885 . . . . 0.0 109.233 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.87 -55.72 3.79 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.431 2.087 . . . . 0.0 114.332 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.416 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 31.8 Cg_exo -59.16 -55.56 1.83 Allowed 'Trans proline' 0 C--N 1.395 2.974 0 CA-C-N 122.285 1.852 . . . . 0.0 112.275 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.72 74.99 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.969 -167.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -79.77 -18.37 51.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.563 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.6 m -77.93 -37.79 46.94 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 28.0 mm-40 -67.25 -30.71 70.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.297 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.77 -48.61 81.0 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.08 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.409 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 34.4 m-85 -68.59 -30.73 69.54 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.166 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -57.19 -49.63 75.39 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.739 0.7 . . . . 0.0 112.791 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.18 50.82 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.95 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 24.5 tp -62.25 -50.74 70.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.578 1.151 . . . . 0.0 112.159 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.437 ' HB2' HG21 ' B' ' 27' ' ' VAL . 16.8 mt -83.92 -47.35 11.13 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.25 30.47 5.03 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.101 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' B' ' 25' ' ' LEU . 31.4 m -131.86 175.31 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.321 1.048 . . . . 0.0 110.052 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -124.24 151.71 66.47 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.26 106.41 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.57 2.18 . . . . 0.0 111.296 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.03 -39.28 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.486 0.714 . . . . 0.0 110.142 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 65.1 mm-40 -115.13 98.79 6.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.922 0.889 . . . . 0.0 108.678 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.8 p -99.87 137.85 37.76 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.762 0.825 . . . . 0.0 110.764 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 150.8 54.66 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.018 1.327 . . . . 0.0 107.96 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.04 -21.89 52.74 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.788 2.325 . . . . 0.0 114.252 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -128.49 8.98 5.98 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -150.27 139.63 21.37 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.4 m -129.42 139.1 51.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.585 0.754 . . . . 0.0 109.111 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -132.24 119.96 21.53 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.18 113.25 13.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.683 1.193 . . . . 0.0 109.095 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.53 HG21 ' HG3' ' B' ' 46' ' ' LYS . 14.7 t -94.92 139.99 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.967 0.907 . . . . 0.0 110.115 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.461 HD23 ' HD2' ' A' ' 4' ' ' PRO . 10.0 mp -98.93 146.93 25.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.143 0.577 . . . . 0.0 110.324 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.16 -5.17 33.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.923 0.889 . . . . 0.0 111.549 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.63 -9.32 53.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.612 1.165 . . . . 0.0 112.101 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.11 15.68 43.94 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.865 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -126.38 171.51 10.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.658 0.783 . . . . 0.0 109.162 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.53 ' HG3' HG21 ' B' ' 40' ' ' VAL . 81.5 tttt -136.26 135.23 38.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.127 0.571 . . . . 0.0 109.503 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.428 ' HG ' ' HE1' ' B' ' 45' ' ' MET . 6.1 mt -124.61 124.39 42.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.526 0.73 . . . . 0.0 111.064 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.472 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -101.58 167.31 18.78 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.199 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.7 tp -144.78 105.45 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -104.78 122.97 46.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 50.9 m -74.54 112.8 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -63.35 -2.38 1.46 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.273 1.429 . . . . 0.0 114.503 -170.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -79.08 -25.77 43.07 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.866 0.757 . . . . 0.0 110.656 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -112.81 12.06 19.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.372 0.669 . . . . 0.0 111.426 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' B' ' 58' ' ' LYS . 7.2 p -62.33 138.7 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.68 114.8 32.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.31 139.8 62.23 Favored 'Cis proline' 0 C--N 1.381 2.243 0 C-N-CA 124.525 -1.031 . . . . 0.0 113.51 3.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.41 ' HA ' HG12 ' B' ' 55' ' ' VAL . 26.9 mmmt -48.87 125.4 10.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.173 1.389 . . . . 0.0 112.232 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.43 109.98 3.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.062 0.945 . . . . 0.0 110.298 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.2 t -97.83 88.27 4.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.38 136.2 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.657 0.783 . . . . 0.0 109.679 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -143.76 124.93 14.51 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.001 0.92 . . . . 0.0 110.077 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.38 -108.43 0.36 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.65 129.5 9.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.44 -33.48 0.03 OUTLIER Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.64 152.57 11.1 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.527 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 2.2 pm0 -118.09 163.84 16.01 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.87 0.868 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -120.44 103.2 8.99 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.41 119.93 31.11 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.231 0.469 . . . . 0.0 111.536 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -97.66 108.01 20.63 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -85.28 128.37 34.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.014 0.525 . . . . 0.0 111.906 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.42 157.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.051 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.26 -38.27 84.84 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -157.73 177.77 11.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.633 0.651 . . . . 0.0 112.52 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.86 -32.55 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.967 1.707 . . . . 0.0 112.545 -167.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -67.56 -43.86 79.62 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.431 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -66.37 -24.32 66.48 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.038 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -69.61 -42.23 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.54 -30.46 68.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 16.0 mt-10 -68.16 -43.22 78.72 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.342 0.592 . . . . 0.0 109.503 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -70.4 -28.77 65.34 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.591 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -64.62 -61.06 2.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.582 0.706 . . . . 0.0 109.114 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.24 90.53 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.929 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.56 90.54 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.199 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -60.93 -49.04 79.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 0.0 110.222 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -53.8 -44.28 70.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.008 0.923 . . . . 0.0 110.911 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.53 -22.5 58.99 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.3 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -94.48 7.8 44.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.194 0.998 . . . . 0.0 112.087 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.44 31.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 116.123 -0.489 . . . . 0.0 114.319 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.77 134.09 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . 0.514 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -57.43 -34.44 68.95 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.116 0.967 . . . . 0.0 112.53 -172.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.421 ' SD ' ' HZ ' ' B' ' 105' ' ' PHE . 50.0 tpp 67.07 83.31 0.17 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.464 HD11 ' HB1' ' B' ' 108' ' ' ALA . 0.0 OUTLIER -133.65 85.85 2.24 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 178.69 138.9 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.265 1.426 . . . . 0.0 109.279 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -83.12 109.98 20.65 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 165.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.563 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 18.2 Cg_endo -57.4 119.32 6.51 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.606 2.204 . . . . 0.0 110.796 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.78 154.2 48.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.377 0.671 . . . . 0.0 110.412 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.459 ' HZ1' ' HB3' ' B' ' 98' ' ' LYS . 3.7 mmmp? -68.47 118.94 12.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 54.2 ttm -115.59 166.04 12.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.11 0.964 . . . . 0.0 109.126 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.02 -39.91 28.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.445 1.498 . . . . 0.0 113.349 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.99 -19.06 27.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.537 0.335 . . . . 0.0 111.485 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.33 173.94 27.39 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.987 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.591 ' HB3' ' HB1' ' B' ' 119' ' ' ALA . 45.4 t80 -70.72 102.08 2.23 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 150.11 27.14 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.521 0.677 . . . . 0.0 112.081 -162.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 16.4 t80 -150.42 146.49 26.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.182 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 20.1 m -143.69 128.27 18.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' B' ' 105' ' ' PHE . . . -121.13 149.03 43.39 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.28 0.632 . . . . 0.0 110.995 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . 0.464 ' HB1' HD11 ' B' ' 93' ' ' LEU . . . -108.35 165.01 11.82 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.514 ' HA ' ' H ' ' B' ' 91' ' ' ALA . 1.9 p-10 -130.49 -177.63 0.7 Allowed Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.003 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 45.5 Cg_endo -63.8 -0.92 2.91 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.447 2.098 . . . . 0.0 114.773 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' B' ' 11' ' ' VAL . 3.1 t70 -115.98 0.14 12.96 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.093 0.557 . . . . 0.0 111.78 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.9 m 69.41 34.29 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.603 1.161 . . . . 0.0 112.725 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -75.18 171.34 14.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.602 0.761 . . . . 0.0 110.301 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.51 108.31 13.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -121.07 108.18 13.52 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.48 ' NH1' ' HG3' ' B' ' 67' ' ' GLU . 55.5 mtt180 -90.57 147.72 23.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.033 0.533 . . . . 0.0 111.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.99 132.81 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -135.85 161.95 34.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.549 0.613 . . . . 0.0 111.658 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' B' ' 103' ' ' TYR . . . -110.99 123.71 50.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -79.17 104.59 9.9 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.52 99.25 8.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.107 -175.485 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.4 m -134.35 142.78 47.33 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -98.68 109.69 54.22 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.847 0.859 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 78.6 Cg_endo -81.77 72.08 6.45 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.493 2.129 . . . . 0.0 111.253 166.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.2 p-10 -80.43 9.88 5.35 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.404 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -134.56 134.32 41.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 107.717 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -138.2 139.58 39.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.237 1.015 . . . . 0.0 108.786 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.609 HG12 ' HA3' ' A' ' 48' ' ' GLY . 49.5 mt -128.03 143.03 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.134 0.573 . . . . 0.0 110.173 -172.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD22 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -108.63 144.95 35.69 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 32.1 m-85 -93.57 123.5 36.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.199 1.0 . . . . 0.0 111.207 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.89 161.02 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.188 0.995 . . . . 0.0 110.409 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.89 -63.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.132 0.973 . . . . 0.0 110.759 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -97.14 100.14 7.21 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.075 0.55 . . . . 0.0 110.154 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.446 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 35.1 Cg_exo -55.56 -51.63 9.44 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.296 2.664 . . . . 0.0 115.033 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.77 -51.62 10.76 Favored 'Trans proline' 0 C--N 1.405 3.525 0 CA-C-N 122.646 1.981 . . . . 0.0 112.48 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.92 -39.94 69.14 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 p -77.83 -34.85 51.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.817 0.447 . . . . 0.0 110.515 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 70.9 m -62.39 -47.78 82.63 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.521 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.3 mm100 -62.69 -35.51 79.92 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.125 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -64.89 -45.82 84.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.8 0.688 . . . . 0.0 109.415 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 20.5 m-85 -68.03 -32.89 73.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.279 -0.391 . . . . 0.0 109.997 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 63.2 mtpt -57.31 -47.89 80.35 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.34 -34.27 48.63 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.298 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.8 tp -60.21 -31.35 70.08 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.865 1.266 . . . . 0.0 112.473 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 HD21 ' HG3' ' B' ' 4' ' ' PRO . 26.1 mt -99.95 -48.56 4.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.16 28.63 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.995 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.01 -178.34 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.613 1.165 . . . . 0.0 110.747 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -130.76 142.93 47.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 124.342 1.057 . . . . 0.0 108.762 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 34.1 Cg_endo -63.93 119.94 7.16 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.602 2.201 . . . . 0.0 112.449 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.999 0.92 . . . . 0.0 110.455 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 57.9 mm-40 -116.23 90.04 3.24 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.3 p -90.04 149.48 22.5 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.894 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -151.76 151.48 28.46 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 125.037 1.335 . . . . 0.0 107.627 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.78 -20.1 68.09 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.451 2.101 . . . . 0.0 113.607 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -128.38 12.36 6.47 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.9 152.79 28.71 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -143.86 138.58 28.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.579 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 12.7 tp -126.42 115.72 20.05 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.3 p90 -131.21 112.89 13.21 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.922 1.289 . . . . 0.0 109.16 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.596 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 3.8 p -106.71 142.28 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.24 1.016 . . . . 0.0 110.079 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.16 157.25 17.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.622 0.769 . . . . 0.0 111.134 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -22.61 65.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.479 1.112 . . . . 0.0 112.593 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -70.19 -18.6 63.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.258 0.623 . . . . 0.0 112.032 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.48 15.82 16.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.445 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -103.23 154.03 19.76 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.017 0.909 . . . . 0.0 108.697 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.596 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.2 tttt -125.3 131.02 53.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.418 HD21 HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -128.54 127.66 42.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.346 0.659 . . . . 0.0 109.883 -168.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.609 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -104.81 169.78 17.29 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.54 104.79 4.26 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.419 ' HB2' HG21 ' A' ' 8' ' ' ILE . 4.5 t90 -106.75 127.48 53.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.446 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 27.9 m -72.96 129.95 39.27 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.244 0.34 . . . . 0.0 110.126 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -68.34 -10.94 58.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.687 0.795 . . . . 0.0 112.493 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -81.95 -23.47 36.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -116.93 7.83 13.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.269 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.68 140.53 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 122.712 0.405 . . . . 0.0 111.508 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HB3' HE22 ' B' ' 94' ' ' GLN . 70.7 mt-10 -125.56 114.6 25.18 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 170.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HG2' ' CZ ' ' B' ' 114' ' ' ARG . 59.0 Cg_endo -78.14 141.51 66.06 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 124.491 -1.046 . . . . 0.0 113.194 4.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -49.43 123.0 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.252 1.421 . . . . 0.0 112.452 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.556 ' HB2' ' NH2' ' B' ' 114' ' ' ARG . . . -155.57 109.18 2.79 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.318 1.047 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.8 p -85.08 87.08 7.34 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.0 124.19 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.7 p -151.51 122.34 7.55 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.302 1.441 . . . . 0.0 107.78 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.71 52.55 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.06 -132.18 10.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.89 -62.98 4.35 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.35 154.38 18.99 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 168.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 2.4 pt-20 -130.06 166.18 20.68 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.011 0.924 . . . . 0.0 110.27 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.2 tp -125.46 102.39 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.829 0.852 . . . . 0.0 109.457 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.822 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -92.48 110.72 22.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -169.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.517 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 12.3 m-85 -88.99 116.86 27.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.435 1.094 . . . . 0.0 108.419 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -95.21 130.7 41.85 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.87 162.74 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.345 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.526 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.9 pt-20 -66.12 -43.44 87.14 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.472 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.446 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 8.9 p30 -160.44 179.62 8.47 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.584 0.629 . . . . 0.0 112.568 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.79 -30.67 63.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -168.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.5 -52.56 64.01 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.786 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.526 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 81.0 mm-40 -65.76 -22.78 66.61 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.736 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.25 -46.09 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.465 0.65 . . . . 0.0 109.73 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.89 -28.54 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 110.676 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 35.8 mt-10 -65.06 -48.2 74.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.234 0.613 . . . . 0.0 110.013 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.435 HG23 ' HE3' ' B' ' 1' ' ' MET . 15.8 m -68.31 -30.1 69.01 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.918 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -55.62 -58.72 6.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.96 0.904 . . . . 0.0 109.98 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.47 -35.53 80.49 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.493 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.09 -42.62 96.51 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 123.645 0.591 . . . . 0.0 113.588 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -66.6 -39.73 88.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.058 0.543 . . . . 0.0 110.233 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.509 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 32.7 ttpt -57.51 -44.84 85.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.474 0.71 . . . . 0.0 110.262 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.33 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 t -99.64 9.91 42.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.211 1.004 . . . . 0.0 112.378 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 55.57 2.77 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 165.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.5 p -102.79 148.71 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 168.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -57.15 5.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.552 0.341 . . . . 0.0 110.459 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.533 ' HB2' HG13 ' A' ' 90' ' ' VAL . 21.1 ttp 64.23 82.51 0.18 Allowed 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.225 0.953 . . . . 0.0 113.104 168.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.81 85.94 2.24 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 106' ' ' THR . 46.9 tp60 179.57 133.17 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.761 1.224 . . . . 0.0 108.954 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -83.45 122.47 77.01 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.254 0.622 . . . . 0.0 109.413 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 106.62 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.533 2.155 . . . . 0.0 110.835 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 152.36 50.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.089 0.556 . . . . 0.0 111.312 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -70.4 102.17 2.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.217 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.3 ttm -94.8 169.2 10.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.357 1.063 . . . . 0.0 109.193 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -43.64 -41.5 4.7 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.139 1.376 . . . . 0.0 113.568 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -87.96 -15.29 36.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.575 0.75 . . . . 0.0 111.907 -172.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.16 -170.83 25.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.969 -0.35 . . . . 0.0 112.59 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -76.71 101.69 5.89 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -108.07 149.38 28.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 110.344 -171.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.4 t80 -144.4 147.91 33.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.746 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 4.8 m -140.6 136.75 33.08 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.151 0.432 . . . . 0.0 110.924 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.38 172.78 6.64 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.837 0.855 . . . . 0.0 110.967 171.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.29 113.26 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.02 169.05 20.72 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.422 0.689 . . . . 0.0 110.016 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.5 -33.88 31.72 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.268 2.645 . . . . 0.0 114.59 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.0 12.0 23.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.08 0.552 . . . . 0.0 111.207 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 59.5 72.63 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 112.874 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -126.59 172.24 10.43 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.59 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 65.5 mmt-85 -102.52 104.87 15.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.81 102.59 14.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.824 HH22 HG21 ' B' ' 55' ' ' VAL . 15.3 mmt180 -88.04 147.52 24.94 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 123.578 0.751 . . . . 0.0 110.389 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 15.4 t -137.99 127.29 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 161.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -141.01 158.56 43.77 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.02 111.06 17.84 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -73.0 120.93 19.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.788 0.435 . . . . 0.0 109.831 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.83 93.08 6.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.179 -175.55 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.435 ' HE3' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.7 0.286 . . . . 0.0 110.96 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 84.8 m -141.85 142.9 33.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.116 0.967 . . . . 0.0 108.61 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -99.24 110.93 59.9 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.592 0.757 . . . . 0.0 110.231 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 63.0 Cg_endo -82.99 71.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.622 2.214 . . . . 0.0 110.819 167.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.02 9.48 4.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.791 0.836 . . . . 0.0 111.27 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -134.51 134.29 41.29 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.097 1.359 . . . . 0.0 107.677 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -138.38 139.66 39.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.461 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 16.8 mt -128.74 143.35 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.081 0.553 . . . . 0.0 110.103 -172.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -110.01 144.06 39.11 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -91.87 123.94 35.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.12 0.968 . . . . 0.0 111.142 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.406 HG13 ' HE1' ' B' ' 113' ' ' HIS . 20.5 m -125.3 160.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 123.956 0.902 . . . . 0.0 110.308 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.75 -63.89 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.129 0.971 . . . . 0.0 111.154 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -96.12 98.42 4.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 123.625 0.77 . . . . 0.0 109.682 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -53.8 -52.72 7.82 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.854 2.37 . . . . 0.0 115.842 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.24 -52.64 8.54 Favored 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 123.162 2.165 . . . . 0.0 112.7 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.37 -40.08 70.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.482 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 75.8 p -77.49 -34.91 54.11 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.743 0.417 . . . . 0.0 110.765 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.5 m -63.04 -46.88 85.44 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.515 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 13.8 mm100 -63.54 -35.18 79.64 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.809 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 66.1 t80 -64.88 -45.52 85.64 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.776 0.672 . . . . 0.0 109.42 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.404 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 30.3 m-85 -68.29 -32.79 73.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.225 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.515 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 62.7 mtpt -57.11 -48.03 79.64 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.3 -34.31 48.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 20.8 tp -60.25 -30.99 69.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.595 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' A' ' 4' ' ' PRO . 25.1 mt -100.47 -48.31 4.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.7 4.88 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.953 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.447 HG13 HD23 ' B' ' 41' ' ' LEU . 24.2 m -129.62 -178.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.648 1.179 . . . . 0.0 111.064 -174.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -130.41 144.81 54.82 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.816 0.847 . . . . 0.0 109.231 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 18.4 Cg_exo -65.86 120.64 7.85 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.411 2.074 . . . . 0.0 112.21 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.438 HG11 ' HG2' ' B' ' 31' ' ' GLU . 8.9 p -64.55 -42.32 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.159 0.984 . . . . 0.0 110.802 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 50.3 mm-40 -119.17 89.13 3.07 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -90.1 149.74 22.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -151.81 151.31 28.05 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.1 -20.29 70.88 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.422 2.081 . . . . 0.0 113.683 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -128.2 11.44 6.45 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.043 0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -155.6 153.01 29.43 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -143.93 138.45 28.52 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.599 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 12.9 tp -126.42 115.94 20.38 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.4 p90 -131.11 113.24 13.66 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.961 1.304 . . . . 0.0 109.215 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.627 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 4.3 p -107.1 141.94 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.267 1.027 . . . . 0.0 110.033 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.447 HD23 HG13 ' B' ' 27' ' ' VAL . 13.7 mt -105.5 157.27 17.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.529 0.732 . . . . 0.0 110.382 -169.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -21.72 64.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.381 1.072 . . . . 0.0 112.332 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.04 -18.38 62.57 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.99 0.516 . . . . 0.0 111.23 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.42 16.09 15.58 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 114.484 0.554 . . . . 0.0 114.484 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.478 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.2 ppp? -104.2 153.43 20.98 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.104 0.952 . . . . 0.0 108.607 170.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.627 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 53.6 tttt -124.69 130.97 53.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.92 127.96 44.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.31 0.644 . . . . 0.0 110.063 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.27 169.67 17.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 123.821 0.724 . . . . 0.0 111.293 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.66 104.51 4.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.443 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -106.7 126.85 52.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -72.75 129.6 38.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.66 -11.1 57.5 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.013 0.925 . . . . 0.0 112.38 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.02 -24.09 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.01 0.524 . . . . 0.0 111.141 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -116.62 8.66 13.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.282 0.633 . . . . 0.0 111.324 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.824 HG21 HH22 ' A' ' 116' ' ' ARG . 7.1 p -68.15 140.1 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.793 0.437 . . . . 0.0 111.382 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -124.84 114.0 26.78 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.5 141.49 64.83 Favored 'Cis proline' 0 C--N 1.381 2.287 0 C-N-CA 124.439 -1.067 . . . . 0.0 113.147 5.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.449 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.0 mmmt -49.55 123.14 7.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.144 1.378 . . . . 0.0 112.34 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.98 108.55 2.63 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.114 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.9 p -84.44 87.1 7.21 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.75 124.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.368 0.667 . . . . 0.0 110.482 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -152.51 121.87 6.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.997 1.319 . . . . 0.0 107.776 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.04 0.01 OUTLIER Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.48 -132.47 10.94 Favored Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.15 4.34 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.01 153.71 18.56 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.478 ' CG ' ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -128.61 168.13 16.18 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 110.542 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 tp -126.25 102.15 7.06 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.93 0.892 . . . . 0.0 109.437 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.747 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -92.57 111.32 22.87 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.756 0.312 . . . . 0.0 111.725 -169.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m-85 -89.37 116.96 27.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.47 1.108 . . . . 0.0 108.337 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -96.05 128.28 42.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.448 0.642 . . . . 0.0 111.566 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.78 164.14 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.646 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.519 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.28 -43.25 86.91 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.382 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -160.65 178.19 9.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.99 -32.02 52.78 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.197 1.799 . . . . 0.0 113.076 -170.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -61.32 -52.92 62.68 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.884 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.519 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 61.2 mm-40 -64.97 -23.1 67.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.763 1.225 . . . . 0.0 112.618 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.81 -45.84 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.386 0.613 . . . . 0.0 109.764 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.17 57.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.96 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.9 mt-10 -64.53 -48.72 74.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.208 0.603 . . . . 0.0 109.74 174.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -68.48 -29.58 68.24 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.891 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.76 -58.95 5.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.22 1.008 . . . . 0.0 109.666 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.459 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.67 -35.47 80.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.484 -174.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.46 96.9 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 123.337 0.398 . . . . 0.0 113.487 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -66.87 -39.39 87.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.989 0.516 . . . . 0.0 110.092 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.528 ' HB2' ' HE2' ' B' ' 92' ' ' MET . 33.0 ttpt -57.88 -44.74 86.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.644 0.778 . . . . 0.0 110.478 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.7 67.39 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.792 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.8 t -99.91 9.79 42.38 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.097 0.959 . . . . 0.0 112.333 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.25 55.27 2.79 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 165.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.7 p -103.11 148.68 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.1 -56.88 6.36 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.57 0.348 . . . . 0.0 110.413 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.528 ' HE2' ' HB2' ' B' ' 86' ' ' LYS . 19.5 ttp 64.07 82.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 85.82 2.23 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.747 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' B' ' 106' ' ' THR . 5.8 tp60 -179.42 133.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.916 1.286 . . . . 0.0 108.836 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -82.79 122.48 78.26 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.607 0.763 . . . . 0.0 109.355 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 19.0 Cg_endo -59.47 106.66 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.566 2.177 . . . . 0.0 110.181 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.3 152.47 50.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.287 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -71.52 102.67 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.75 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.8 ttm -94.67 169.13 10.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.635 1.174 . . . . 0.0 109.321 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -43.61 -41.87 4.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.487 1.515 . . . . 0.0 112.864 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.04 -14.93 37.7 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.632 0.773 . . . . 0.0 112.027 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.98 -171.05 25.06 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.988 -0.34 . . . . 0.0 112.553 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -76.33 101.42 5.49 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -107.86 149.46 28.24 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.583 0.706 . . . . 0.0 110.331 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 1.9 t80 -144.59 148.29 34.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.701 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 17.1 m -141.33 136.5 31.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.122 0.487 . . . . 0.0 110.474 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.39 172.88 6.58 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.957 0.903 . . . . 0.0 110.838 171.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.5 112.52 10.33 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.452 ' HB3' HD13 ' B' ' 115' ' ' LEU . 6.6 p-10 -72.9 167.57 32.7 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -48.34 -33.85 23.51 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.394 2.729 . . . . 0.0 114.864 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -92.24 12.22 23.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.123 0.569 . . . . 0.0 111.134 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 m 59.06 72.15 0.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.064 1.345 . . . . 0.0 112.738 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.406 ' HE1' HG13 ' B' ' 11' ' ' VAL . 8.6 m80 -125.64 171.58 10.47 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.556 ' NH2' ' HB2' ' A' ' 59' ' ' ALA . 17.2 mmt180 -101.17 105.04 16.13 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' B' ' 109' ' ' ASP . 39.0 mt -97.2 103.04 14.94 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 23.9 ttt180 -87.66 147.43 25.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.5 0.72 . . . . 0.0 110.404 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -137.86 127.22 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 160.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -141.22 158.69 43.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.65 110.8 17.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.74 123.39 23.22 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.86 100.79 13.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.965 0.506 . . . . 0.0 109.961 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.78 -1.011 . . . . 0.0 111.156 179.02 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.5 m -138.63 140.04 38.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.957 0.408 . . . . 0.0 111.655 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -130.75 148.02 68.47 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.151 0.98 . . . . 0.0 108.616 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 98.6 Cg_endo -86.38 143.39 7.57 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.213 1.942 . . . . 0.0 112.037 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.647 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 36.0 t70 -143.61 19.37 1.85 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.659 1.219 . . . . 0.0 109.009 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.73 148.09 35.16 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.653 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.458 HG23 HD22 ' A' ' 47' ' ' LEU . 3.8 t -151.72 139.21 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.869 0.868 . . . . 0.0 108.691 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.525 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 68.1 mt -123.71 137.7 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.577 0.751 . . . . 0.0 109.904 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.66 130.23 45.87 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' O ' HG22 ' A' ' 62' ' ' THR . 28.0 m-85 -80.42 115.19 19.82 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.27 0.628 . . . . 0.0 109.629 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 113' ' ' HIS . 32.9 m -114.09 160.78 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.772 0.829 . . . . 0.0 109.241 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -97.08 -59.3 1.82 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.147 0.579 . . . . 0.0 110.497 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -98.48 100.77 9.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.305 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.28 -51.97 10.05 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.441 2.761 . . . . 0.0 115.523 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.21 -50.21 9.13 Favored 'Trans proline' 0 C--N 1.398 3.158 0 CA-C-N 122.136 1.798 . . . . 0.0 112.561 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.29 62.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.6 p -76.83 -36.21 57.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.479 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 95.2 m -64.51 -43.84 92.78 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 36.9 mt-30 -64.99 -35.11 80.12 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.205 174.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.3 t80 -66.15 -42.82 88.54 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 123.776 0.673 . . . . 0.0 109.552 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.445 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 34.1 m-85 -70.04 -28.39 65.43 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.789 -0.625 . . . . 0.0 109.873 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 60.6 mtpt -57.0 -50.61 72.18 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 118.789 0.722 . . . . 0.0 111.822 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.45 60.84 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.253 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 19.1 tp -61.79 -42.56 99.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.744 1.217 . . . . 0.0 112.388 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.436 ' HB2' HG21 ' A' ' 27' ' ' VAL . 18.4 mt -90.15 -43.01 10.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.67 28.62 6.95 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.2 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG21 ' HB2' ' A' ' 25' ' ' LEU . 29.4 m -131.64 173.87 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.929 0.892 . . . . 0.0 110.224 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -124.84 150.22 65.22 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.965 0.906 . . . . 0.0 109.213 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.93 118.14 5.4 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.013 2.475 . . . . 0.0 112.267 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.8 -40.04 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.717 0.636 . . . . 0.0 110.298 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 36.3 mm-40 -117.92 146.7 43.76 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.326 1.05 . . . . 0.0 109.196 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.4 p -143.8 135.37 26.1 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -145.26 157.4 53.22 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.876 1.271 . . . . 0.0 108.772 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.12 -28.99 35.19 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 123.468 2.779 . . . . 0.0 113.999 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 5.19 7.98 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.57 130.23 12.31 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.833 -0.542 . . . . 0.0 111.194 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -117.62 130.89 56.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 7.1 tt -121.93 132.39 54.52 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.26 150.63 46.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.82 1.248 . . . . 0.0 108.687 167.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 2.0 p -130.46 132.64 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.59 155.89 20.27 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.368 0.667 . . . . 0.0 110.767 -165.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.15 -16.98 64.22 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.642 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -74.41 -15.38 60.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.132 0.973 . . . . 0.0 111.363 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.8 -19.88 30.04 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.896 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.7 ppp? -81.36 168.45 18.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.376 0.588 . . . . 0.0 109.929 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.6 tttt -133.83 140.2 46.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.502 0.321 . . . . 0.0 110.924 -169.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.458 HD22 HG23 ' A' ' 7' ' ' THR . 55.0 mt -131.39 126.38 35.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.866 0.867 . . . . 0.0 111.898 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.437 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -102.79 167.9 17.78 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 174.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.54 108.41 6.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.416 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.1 t90 -104.81 118.53 36.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 25.2 p -75.85 127.7 33.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.189 0.518 . . . . 0.0 109.842 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' HD3' HG21 ' A' ' 62' ' ' THR . 40.3 ptt180 -74.43 -2.44 25.48 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.827 1.251 . . . . 0.0 114.015 -165.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -69.84 -18.63 63.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.835 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -148.03 21.76 1.1 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.857 0.463 . . . . 0.0 110.774 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.7 p -59.37 147.2 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.806 0.442 . . . . 0.0 111.313 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HB2' ' HE2' ' B' ' 99' ' ' MET . 50.2 mt-10 -124.84 113.51 26.87 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.536 0.734 . . . . 0.0 109.117 175.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.547 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 1.2 Cg_endo -78.19 143.96 74.31 Favored 'Cis proline' 0 C--N 1.38 2.232 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.406 5.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -54.69 119.6 5.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.034 0.934 . . . . 0.0 111.674 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.73 4.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.191 0.996 . . . . 0.0 109.441 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.7 m -91.48 82.86 5.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 m -155.4 131.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.012 1.325 . . . . 0.0 108.424 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.485 HG21 ' HD3' ' A' ' 52' ' ' ARG . 15.0 p -145.44 122.28 11.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.311 1.044 . . . . 0.0 108.634 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.72 -95.51 0.14 Allowed Glycine 0 C--N 1.349 1.305 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.639 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.95 -154.12 30.11 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.81 -48.09 3.81 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.29 132.48 3.75 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HG2' ' HB ' ' B' ' 8' ' ' ILE . 15.8 pt-20 -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.08 0.952 . . . . 0.0 110.971 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.13 105.6 13.11 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.727 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -91.72 115.17 27.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.659 0.663 . . . . 0.0 112.546 -169.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.7 m-85 -96.44 115.75 27.94 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.728 1.211 . . . . 0.0 108.334 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HG2' ' CE1' ' A' ' 118' ' ' TYR . 42.0 mtm180 -96.51 131.06 43.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.556 0.693 . . . . 0.0 111.494 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -125.45 165.98 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.186 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.544 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.1 pt-20 -65.45 -41.56 93.29 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.395 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.44 -178.68 3.63 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.218 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -58.99 -30.31 67.87 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.222 1.409 . . . . 0.0 112.887 -165.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.57 87.63 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.119 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.544 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 77.4 mm-40 -67.39 -22.33 65.56 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.646 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.78 -44.89 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.16 -32.17 68.6 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.497 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.98 -42.14 81.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.722 0.772 . . . . 0.0 110.197 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.6 m -72.36 -28.12 62.83 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.702 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -58.72 -61.75 2.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.839 0.856 . . . . 0.0 109.682 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.89 67.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.632 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.87 -51.57 56.32 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.877 0.736 . . . . 0.0 113.012 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -63.74 -40.46 96.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.082 0.553 . . . . 0.0 110.099 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -56.15 -45.78 79.51 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.412 0.625 . . . . 0.0 110.828 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.34 -20.17 60.19 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.166 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.2 t -98.64 10.3 41.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.061 0.944 . . . . 0.0 112.14 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.55 5.82 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 168.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.89 153.56 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.51 2.75 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.829 0.452 . . . . 0.0 110.373 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 11.3 ttp 67.47 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.973 0.795 . . . . 0.0 112.859 171.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.32 85.13 2.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.194 0.521 . . . . 0.0 110.617 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 106' ' ' THR . 51.3 tp60 179.85 131.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.338 . . . . 0.0 109.145 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.59 117.79 69.21 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.65 105.19 0.1 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.397 2.732 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.9 148.93 25.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 110.815 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -90.46 99.02 12.12 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.469 ' HE1' ' HB2' ' B' ' 56' ' ' GLU . 64.7 mtt -102.95 -174.65 2.6 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.42 0.688 . . . . 0.0 111.885 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -55.91 -39.84 72.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.07 1.348 . . . . 0.0 112.766 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 89.9 m-85 -88.63 -4.83 58.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.279 0.632 . . . . 0.0 111.614 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.86 -160.22 21.74 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.731 -0.483 . . . . 0.0 113.413 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -80.26 100.47 8.36 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -109.18 153.59 23.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.596 0.758 . . . . 0.0 111.026 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.8 t80 -149.4 145.03 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.728 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.503 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 12.3 m -137.94 128.93 27.25 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.322 0.51 . . . . 0.0 109.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.89 174.63 5.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.997 0.919 . . . . 0.0 110.589 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.08 119.3 12.08 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.572 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.8 p-10 -73.87 -175.13 0.39 Allowed Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.588 0.755 . . . . 0.0 111.316 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 11.5 Cg_exo -38.91 -48.47 2.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.589 2.859 . . . . 0.0 114.846 165.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 62' ' ' THR . 57.9 m-20 -89.73 3.92 51.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.393 0.677 . . . . 0.0 111.321 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.2 m 71.96 16.16 5.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 113.654 161.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.441 ' CE1' HG11 ' A' ' 11' ' ' VAL . 15.9 m80 -59.11 137.35 57.99 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -70.98 99.61 1.82 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.36 102.26 14.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.727 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 14.2 tpt180 -87.71 142.45 27.82 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.403 1.081 . . . . 0.0 110.664 -170.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 39.0 t -138.73 128.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.439 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.0 p90 -135.39 158.59 43.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.545 0.611 . . . . 0.0 111.931 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 113.04 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 34.8 t80 -78.43 114.91 17.76 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.26 93.89 0.66 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.199 0.937 . . . . 0.0 109.914 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.5 178.711 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.42 0.152 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 97.6 m -141.53 141.28 33.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.482 0.713 . . . . 0.0 111.332 -169.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -129.91 148.14 68.38 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 108.707 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 90.0 Cg_endo -86.72 141.84 6.59 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.342 2.028 . . . . 0.0 112.37 170.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.688 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 22.2 t70 -141.77 20.31 2.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.557 1.17 . . . . 0.0 109.221 171.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -143.47 148.0 35.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.751 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.435 HG21 HD22 ' B' ' 47' ' ' LEU . 3.7 t -151.83 139.3 19.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.541 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 46.8 mt -123.74 137.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.641 0.776 . . . . 0.0 109.879 -170.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.4 130.41 45.67 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.415 ' O ' HG22 ' B' ' 62' ' ' THR . 27.1 m-85 -80.44 115.6 20.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.604 172.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' B' ' 113' ' ' HIS . 32.7 m -114.43 160.72 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.705 0.802 . . . . 0.0 109.274 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.29 -58.56 1.98 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.712 0.405 . . . . 0.0 110.737 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -98.6 100.66 9.86 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.118 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.66 -52.18 9.57 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.319 2.679 . . . . 0.0 115.378 -172.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 25.4 Cg_endo -58.76 -50.73 8.49 Favored 'Trans proline' 0 C--N 1.398 3.139 0 CA-C-N 122.132 1.797 . . . . 0.0 112.532 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -37.66 64.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.635 -166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.5 p -76.51 -36.23 57.87 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.62 0.575 . . . . 0.0 109.453 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 96.9 m -65.04 -43.41 92.43 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' B' ' 15' ' ' PRO . 45.7 mt-30 -65.19 -35.34 80.77 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.793 174.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 75.5 t80 -65.81 -43.01 89.93 Favored 'General case' 0 C--N 1.347 0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.446 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 32.3 m-85 -69.81 -28.62 65.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.788 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' B' ' 18' ' ' THR . 57.3 mtpt -57.16 -50.52 72.58 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.794 0.724 . . . . 0.0 112.112 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.58 61.8 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.536 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 19.0 tp -61.54 -42.69 99.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.599 1.159 . . . . 0.0 112.581 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' B' ' 27' ' ' VAL . 18.9 mt -90.24 -42.56 10.94 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.97 29.31 6.91 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.899 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' B' ' 25' ' ' LEU . 28.2 m -131.42 174.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 124.097 0.959 . . . . 0.0 110.568 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -124.75 150.61 66.13 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.73 0.812 . . . . 0.0 109.155 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.16 118.92 5.96 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.49 2.127 . . . . 0.0 112.661 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.44 -40.05 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.27 0.628 . . . . 0.0 110.381 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 31.1 mm-40 -118.0 147.34 43.29 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.159 0.983 . . . . 0.0 108.666 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.3 p -144.27 135.38 25.36 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 57.1 m -145.02 156.41 55.01 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.106 1.362 . . . . 0.0 108.66 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.15 -30.17 24.63 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 124.039 3.159 . . . . 0.0 114.353 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -125.21 5.77 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -151.75 129.9 11.91 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.455 0.571 . . . . 0.0 111.086 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 42.6 m -117.21 130.73 56.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 39.9 tp -121.54 131.92 54.41 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.465 0.706 . . . . 0.0 109.608 -176.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.92 150.79 47.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.617 1.167 . . . . 0.0 108.455 167.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.484 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 2.7 p -130.29 133.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 41.2 mt -86.49 155.73 20.4 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.923 -165.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -16.76 64.33 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.667 0.787 . . . . 0.0 111.342 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -14.53 60.31 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.709 0.804 . . . . 0.0 111.086 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.65 -19.78 30.53 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-O 119.753 -0.471 . . . . 0.0 113.874 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.647 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.8 ppp? -81.35 168.13 18.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.416 0.608 . . . . 0.0 110.061 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.484 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 78.3 tttt -133.96 140.29 46.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.488 0.315 . . . . 0.0 110.997 -169.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.435 HD22 HG21 ' B' ' 7' ' ' THR . 46.3 mt -131.47 126.25 34.54 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.843 0.857 . . . . 0.0 111.88 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.64 167.77 17.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -137.63 108.41 6.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.413 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 5.1 t90 -104.9 118.4 36.43 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 55.3 p -75.18 127.69 33.76 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.182 0.515 . . . . 0.0 110.084 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.494 ' HD3' HG21 ' B' ' 62' ' ' THR . 35.3 ptt180 -74.81 -2.97 29.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.688 1.195 . . . . 0.0 113.982 -165.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -19.45 64.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.618 0.767 . . . . 0.0 111.928 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -147.86 21.79 1.12 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.896 0.478 . . . . 0.0 110.625 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -59.57 146.98 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.757 0.423 . . . . 0.0 111.098 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 99' ' ' MET . 42.5 mt-10 -123.98 115.1 27.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 174.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.72 143.33 75.59 Favored 'Cis proline' 0 C--N 1.387 2.564 0 C-N-CA 124.462 -1.057 . . . . 0.0 112.955 2.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -53.22 119.32 4.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.972 0.909 . . . . 0.0 112.173 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.32 108.54 4.79 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.075 0.95 . . . . 0.0 109.147 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.2 m -91.13 82.87 5.52 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.4 131.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.892 1.277 . . . . 0.0 108.425 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.494 HG21 ' HD3' ' B' ' 52' ' ' ARG . 17.2 p -145.41 121.89 11.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.269 1.028 . . . . 0.0 108.526 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.07 -95.51 0.14 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 112.592 -0.203 . . . . 0.0 112.592 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.03 -154.14 30.19 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.9 -48.15 3.82 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.19 132.11 3.64 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.525 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 pt-20 -106.63 166.65 10.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.935 0.894 . . . . 0.0 110.853 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 tp -115.48 104.87 12.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.507 0.723 . . . . 0.0 109.247 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.773 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.22 115.62 28.17 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.611 0.641 . . . . 0.0 112.243 -168.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 7.8 m-85 -96.61 115.84 28.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.886 1.274 . . . . 0.0 108.368 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -96.48 128.59 43.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.273 0.629 . . . . 0.0 111.146 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.79 167.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.627 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.591 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.47 -40.86 89.59 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -167.75 -179.69 4.39 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.172 0.511 . . . . 0.0 112.362 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.31 -30.74 66.91 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.35 1.46 . . . . 0.0 112.89 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.44 -46.16 87.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.952 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.591 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.9 mm-40 -67.56 -21.98 65.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.904 0.882 . . . . 0.0 112.503 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.81 -43.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.39 -30.62 63.39 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.656 1.182 . . . . 0.0 110.982 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.1 mt-10 -69.17 -42.41 75.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.707 0.765 . . . . 0.0 110.189 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -71.89 -28.32 63.43 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.75 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -58.3 -62.28 1.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 0.0 109.359 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.407 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -69.39 -29.87 67.73 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.541 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.97 53.74 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.02 0.825 . . . . 0.0 113.027 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.7 -40.5 96.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.118 0.567 . . . . 0.0 110.073 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.8 ttpt -56.34 -45.25 80.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.637 . . . . 0.0 110.656 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 -20.82 60.01 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.172 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -98.36 10.85 39.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.125 0.97 . . . . 0.0 112.516 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.62 42.87 5.96 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.61 153.32 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.13 -59.64 2.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.812 0.445 . . . . 0.0 110.363 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 30.9 ttm 67.37 84.97 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.866 0.729 . . . . 0.0 112.377 170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.27 84.2 1.93 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.126 0.489 . . . . 0.0 110.645 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 55.6 tp60 -178.74 132.23 0.13 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.649 1.18 . . . . 0.0 108.833 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -86.36 118.02 69.64 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 9.8 Cg_endo -52.66 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.547 2.831 . . . . 0.0 112.106 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.28 148.86 25.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.125 0.97 . . . . 0.0 110.772 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.575 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 0.0 OUTLIER -89.81 99.36 12.38 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.51 ' HE2' ' HB2' ' A' ' 56' ' ' GLU . 66.1 mtt -103.05 -173.56 2.34 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.288 0.635 . . . . 0.0 111.745 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -57.24 -39.49 75.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.052 1.341 . . . . 0.0 112.548 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 78.7 m-85 -88.76 -5.13 58.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.511 0.725 . . . . 0.0 111.399 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.67 -160.19 21.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.302 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.575 ' HB2' ' HZ1' ' B' ' 98' ' ' LYS . 17.2 t80 -80.64 100.8 8.85 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.453 HG22 ' SD ' ' B' ' 99' ' ' MET . 12.0 t -109.45 153.99 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.838 -170.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 14.3 t80 -149.41 145.43 26.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.543 -177.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 9.4 m -138.25 129.08 26.81 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.04 174.48 5.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 110.822 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.83 120.43 13.29 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.6 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.7 p-10 -75.54 -174.29 0.38 Allowed Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.683 0.793 . . . . 0.0 110.953 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.5 Cg_exo -40.34 -48.01 4.18 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.412 2.741 . . . . 0.0 114.519 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.43 ' O ' ' HB ' ' B' ' 62' ' ' THR . 65.0 m-20 -90.1 4.1 51.37 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.356 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 29.0 m 71.67 17.76 5.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.436 ' CE1' HG11 ' B' ' 11' ' ' VAL . 16.3 m80 -60.79 137.71 58.18 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -71.05 99.49 1.83 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.388 0.613 . . . . 0.0 109.439 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.8 mt -96.38 102.85 14.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.773 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 14.0 tpt180 -86.61 142.6 28.14 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.475 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -138.91 128.75 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -135.37 158.82 43.4 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.867 0.758 . . . . 0.0 111.744 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.7 112.57 21.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 84.9 t80 -76.59 108.99 9.97 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.3 101.47 8.95 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.9 m -140.29 120.2 13.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.965 -0.46 . . . . 0.0 111.374 -166.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -135.88 134.16 20.38 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.093 0.957 . . . . 0.0 110.044 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.62 103.77 0.23 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.325 2.683 . . . . 0.0 113.002 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.694 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 9.1 p-10 -97.71 12.49 33.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 166.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.6 129.09 43.94 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.873 -168.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 t -130.36 137.98 50.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.158 0.983 . . . . 0.0 108.348 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -124.33 141.83 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.2 131.93 55.69 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.522 ' CE1' HG21 ' A' ' 55' ' ' VAL . 10.1 m-85 -71.7 120.35 17.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.881 0.873 . . . . 0.0 111.616 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' SER . 33.2 m -117.71 161.42 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.01 -54.32 3.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -94.95 103.79 12.77 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.597 0.759 . . . . 0.0 109.586 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.17 -57.67 1.38 Allowed 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.983 2.456 . . . . 0.0 114.493 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 38.5 Cg_exo -57.27 -57.3 1.33 Allowed 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.628 1.974 . . . . 0.0 111.852 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.13 89.52 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.922 -169.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -78.26 -24.45 46.84 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.433 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 28.0 m -73.51 -43.4 60.15 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 75.5 mm-40 -68.47 -29.7 68.38 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.557 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -61.24 -50.79 71.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.816 0.697 . . . . 0.0 109.6 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.32 -31.92 71.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.592 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -57.45 -47.92 80.52 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.27 57.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.035 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.5 -36.9 79.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.473 1.109 . . . . 0.0 112.903 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB2' HG21 ' A' ' 27' ' ' VAL . 23.8 mt -98.61 -31.44 11.94 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.168 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.83 31.48 20.79 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 25' ' ' LEU . 22.7 m -123.81 174.66 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.251 1.02 . . . . 0.0 110.599 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.96 143.09 47.57 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.852 0.861 . . . . 0.0 109.306 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.46 132.9 28.51 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.674 2.25 . . . . 0.0 112.828 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG12 ' HG2' ' A' ' 31' ' ' GLU . 7.8 p -71.09 -38.56 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.534 0.734 . . . . 0.0 109.907 171.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 40.3 mm-40 -118.21 134.0 55.4 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 p -141.07 126.15 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.443 0.697 . . . . 0.0 109.23 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -140.17 157.55 68.71 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.759 1.223 . . . . 0.0 109.212 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.25 -24.49 77.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.917 2.412 . . . . 0.0 113.831 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.4 t -127.1 13.49 7.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -155.99 154.34 30.94 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.969 -0.457 . . . . 0.0 110.411 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 t -144.69 157.62 44.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.153 0.981 . . . . 0.0 108.403 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -154.41 118.12 4.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.57 135.97 51.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 109.104 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 HG21 ' HG3' ' A' ' 46' ' ' LYS . 16.1 t -115.87 126.25 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 0.0 108.925 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 45' ' ' MET . 10.3 mp -90.16 152.55 21.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.761 0.424 . . . . 0.0 110.257 -170.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -14.17 61.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.949 0.899 . . . . 0.0 111.699 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.55 -22.42 66.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.28 1.032 . . . . 0.0 111.789 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.66 1.08 40.0 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.818 -0.435 . . . . 0.0 113.343 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.713 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -95.34 169.99 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HG3' HG21 ' A' ' 40' ' ' VAL . 79.3 tttt -133.7 135.9 44.34 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.59 123.99 20.73 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.895 0.478 . . . . 0.0 110.013 -170.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.15 167.75 15.21 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.48 111.81 11.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -103.91 125.03 50.02 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.9 m -79.97 109.54 14.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 28.8 ptt-85 -67.71 -11.29 58.01 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.436 1.094 . . . . 0.0 113.618 -167.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -65.91 -17.83 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.937 0.495 . . . . 0.0 111.31 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -147.88 76.84 1.4 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.959 1.362 . . . . 0.0 109.161 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 10' ' ' TYR . 7.3 p -113.74 152.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.031 174.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.21 112.22 46.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.808 0.843 . . . . 0.0 109.852 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.9 142.0 61.19 Favored 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.157 1.092 . . . . 0.0 112.413 1.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -49.31 111.02 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.036 0.935 . . . . 0.0 111.78 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.98 107.16 4.17 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.12 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.544 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.3 p -113.53 85.6 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.455 0.645 . . . . 0.0 109.508 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.95 129.06 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.996 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -144.39 157.04 44.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.336 1.055 . . . . 0.0 109.007 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 -43.06 0.57 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.05 150.1 22.3 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.47 120.97 4.82 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.28 89.78 0.22 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.77 0.335 . . . . 0.0 112.601 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' CG ' ' HB ' ' B' ' 8' ' ' ILE . 2.9 pt-20 -102.5 164.39 11.69 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.451 0.643 . . . . 0.0 109.926 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.85 101.66 7.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.81 108.92 19.77 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.135 0.493 . . . . 0.0 111.167 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.38 116.21 24.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.277 1.431 . . . . 0.0 109.106 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -95.86 127.17 41.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.369 0.604 . . . . 0.0 112.075 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.29 161.92 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.787 1.235 . . . . 0.0 110.391 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.5 pt-20 -63.95 -38.74 92.21 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -163.85 -179.62 6.43 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 118.405 0.548 . . . . 0.0 112.013 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.4 -32.27 70.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.268 . . . . 0.0 112.595 -166.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.24 -48.17 82.7 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.027 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.418 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.5 mm-40 -65.26 -20.58 66.49 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.632 1.173 . . . . 0.0 112.993 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.6 -43.25 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.375 0.607 . . . . 0.0 109.924 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.66 -31.4 63.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.753 1.221 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 43.4 mt-10 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.122 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -69.62 -32.24 70.83 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.872 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.405 ' O ' ' HE1' ' A' ' 92' ' ' MET . 55.7 t80 -56.14 -57.33 12.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.912 0.885 . . . . 0.0 109.407 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.22 90.84 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.721 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.43 93.92 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 123.849 0.718 . . . . 0.0 114.097 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.87 -44.1 97.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.34 0.656 . . . . 0.0 109.869 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.09 -46.47 79.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.674 0.79 . . . . 0.0 110.42 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.9 -27.32 66.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.842 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.7 t -93.14 -10.61 35.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.801 0.84 . . . . 0.0 112.575 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 58.39 0.95 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 169.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.3 143.61 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.23 65.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.567 0.747 . . . . 0.0 111.48 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 53.3 ttm 65.03 83.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 165.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 83.69 2.0 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.499 0.666 . . . . 0.0 111.068 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 177.81 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.707 1.603 . . . . 0.0 108.652 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -80.15 118.5 72.72 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.416 ' HB2' ' HH ' ' A' ' 103' ' ' TYR . 61.4 Cg_exo -49.85 102.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.926 3.084 . . . . 0.0 112.873 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.99 141.0 41.72 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.941 0.896 . . . . 0.0 110.262 -175.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.504 ' HZ2' ' HB2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER -75.94 100.27 4.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.7 ttm -96.96 162.1 13.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.427 0.691 . . . . 0.0 109.331 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.17 -28.63 68.09 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.001 0.92 . . . . 0.0 112.45 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.7 -24.74 49.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.479 0.712 . . . . 0.0 110.523 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.16 175.93 21.99 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' HB2' ' HZ2' ' A' ' 98' ' ' LYS . 57.1 t80 -74.05 101.01 3.75 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -111.67 147.56 35.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.409 0.623 . . . . 0.0 111.459 -165.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.511 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 5.8 t80 -144.21 144.03 31.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.692 1.197 . . . . 0.0 109.426 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.408 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 12.8 m -133.07 128.11 35.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.06 174.09 6.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.893 0.877 . . . . 0.0 110.033 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.03 122.59 17.36 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.505 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.1 p-10 -71.63 176.23 2.35 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.352 0.661 . . . . 0.0 109.352 172.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 27.8 Cg_endo -59.65 -12.92 19.34 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 122.305 2.004 . . . . 0.0 114.086 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.11 1.08 49.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.165 0.586 . . . . 0.0 111.677 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.3 p 66.3 33.47 7.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.821 1.649 . . . . 0.0 112.816 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -74.33 173.14 10.66 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.5 mmt-85 -108.6 105.01 14.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -99.95 99.92 10.75 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.454 HH21 HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -98.48 96.62 8.12 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.511 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 27.6 t -86.51 119.24 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -139.46 161.04 38.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.53 112.81 18.96 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -69.31 141.1 54.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.612 0.765 . . . . 0.0 110.834 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.93 98.73 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.509 0.723 . . . . 0.0 110.269 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.742 -1.032 . . . . 0.0 110.821 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.508 0.194 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 91.0 m -141.89 121.12 13.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.007 -168.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -135.82 133.97 20.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.751 0.82 . . . . 0.0 110.317 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -90.94 104.1 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.315 2.677 . . . . 0.0 112.996 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.713 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.2 p-10 -98.31 13.49 31.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.617 0.723 . . . . 0.0 109.975 166.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -129.27 128.7 43.76 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.887 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -130.35 138.14 50.26 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.47 ' HB ' ' CG ' ' A' ' 67' ' ' GLU . 31.1 mt -125.36 141.88 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.05 133.96 54.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.426 ' CE1' HG23 ' B' ' 55' ' ' VAL . 69.2 m-85 -76.58 120.75 22.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.925 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 51' ' ' SER . 34.1 m -117.68 160.85 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -98.12 -54.85 2.95 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.36 0.264 . . . . 0.0 110.427 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -93.76 103.55 10.47 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.862 0.865 . . . . 0.0 109.345 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.4 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 39.3 Cg_exo -55.86 -58.53 1.04 Allowed 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.253 2.635 . . . . 0.0 114.621 -174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.469 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 52.6 Cg_exo -56.34 -57.57 1.39 Allowed 'Trans proline' 0 C--N 1.404 3.478 0 CA-C-N 122.751 2.018 . . . . 0.0 112.09 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.92 90.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.794 -168.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.0 m -78.03 -24.99 47.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.357 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 41.8 m -73.08 -42.87 62.54 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 77.3 mm-40 -68.96 -29.52 67.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.571 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.66 -50.62 71.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.905 0.753 . . . . 0.0 109.59 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.674 ' HH ' HD23 ' B' ' 115' ' ' LEU . 32.6 m-85 -67.97 -32.2 72.46 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.772 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.536 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 58.6 mtpt -57.09 -48.19 79.19 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.289 0.566 . . . . 0.0 112.466 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 -35.3 57.3 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.907 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.45 -36.71 78.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.353 1.061 . . . . 0.0 112.928 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.508 ' HB2' HG21 ' B' ' 27' ' ' VAL . 24.0 mt -99.01 -31.03 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.13 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 31.74 21.33 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' B' ' 25' ' ' LEU . 32.8 m -124.71 174.26 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.076 0.95 . . . . 0.0 110.838 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.07 139.1 34.51 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.892 0.877 . . . . 0.0 109.14 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 51.0 Cg_exo -60.84 131.88 39.65 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.291 2.661 . . . . 0.0 114.417 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.445 HG12 ' HG2' ' B' ' 31' ' ' GLU . 7.6 p -71.34 -36.88 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.794 0.838 . . . . 0.0 110.157 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 38.7 mm-40 -121.31 133.0 55.12 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 53.1 m -141.41 126.12 17.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 67.5 m -140.08 157.05 69.95 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.815 1.246 . . . . 0.0 109.091 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.06 -24.88 75.62 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.115 2.543 . . . . 0.0 114.11 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.1 t -127.34 13.65 7.12 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -156.13 154.39 30.82 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.877 -0.515 . . . . 0.0 110.355 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -144.8 157.04 44.32 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.16 0.984 . . . . 0.0 108.46 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tt -153.96 118.4 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -126.63 135.17 50.85 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.97 1.308 . . . . 0.0 109.161 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.559 HG21 ' HG3' ' B' ' 46' ' ' LYS . 18.6 t -114.5 126.43 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 109.047 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.493 HD22 HG13 ' B' ' 27' ' ' VAL . 16.6 mt -90.35 153.01 20.76 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -170.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.0 -13.73 62.2 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.892 0.877 . . . . 0.0 111.531 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -22.42 66.74 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 111.957 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 1.87 42.08 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.76 -0.467 . . . . 0.0 113.123 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.694 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -95.67 169.89 9.71 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.361 0.581 . . . . 0.0 109.826 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG21 ' B' ' 40' ' ' VAL . 76.3 tttt -133.25 136.56 45.63 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.79 123.91 20.36 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.928 0.491 . . . . 0.0 110.132 -170.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.98 167.85 15.39 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.57 111.53 10.74 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 162.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -103.69 125.41 50.16 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 20.4 m -80.1 109.62 14.73 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.624 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 32.7 ptt-85 -68.6 -10.25 54.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.358 1.063 . . . . 0.0 113.757 -167.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.83 -18.24 65.2 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.488 177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -147.52 77.02 1.42 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.544 1.164 . . . . 0.0 109.098 168.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.426 HG23 ' CE1' ' B' ' 10' ' ' TYR . 7.4 p -113.46 152.27 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.015 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -114.59 112.42 45.73 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.76 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 82.3 Cg_endo -80.19 142.74 62.85 Favored 'Cis proline' 0 C--N 1.386 2.546 0 CA-C-N 119.589 0.889 . . . . 0.0 112.508 1.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -50.42 111.4 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.923 0.889 . . . . 0.0 111.564 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.12 107.42 4.21 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.143 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.624 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 30.5 p -114.33 85.45 2.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.681 0.753 . . . . 0.0 109.474 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.81 130.11 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.089 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -145.67 156.02 43.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.719 1.208 . . . . 0.0 108.814 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.86 -43.47 0.55 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 149.59 21.73 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.19 121.05 4.81 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 76.55 89.81 0.27 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.51 163.4 12.25 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.98 0.912 . . . . 0.0 109.178 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 tp -120.87 101.35 7.64 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 109.63 20.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.359 0.527 . . . . 0.0 111.343 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -87.01 116.35 25.0 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 108.918 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -95.98 126.19 41.05 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.217 0.532 . . . . 0.0 111.499 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.25 162.58 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.533 1.133 . . . . 0.0 110.48 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.548 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.4 pt-20 -64.21 -38.81 92.37 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -163.6 179.81 6.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.329 0.513 . . . . 0.0 112.149 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.88 -32.1 69.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.115 1.366 . . . . 0.0 112.804 -167.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -47.51 85.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.279 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.548 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 84.5 mm-40 -66.48 -19.59 65.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.212 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.49 -44.38 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.39 0.614 . . . . 0.0 109.597 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.82 -33.43 70.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.113 1.365 . . . . 0.0 111.367 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -65.23 -46.88 78.83 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.73 0.776 . . . . 0.0 109.91 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -68.93 -32.28 71.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.924 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.27 -57.55 11.77 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.576 0.75 . . . . 0.0 109.288 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.04 91.29 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.649 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.26 -44.23 94.04 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 123.726 0.641 . . . . 0.0 113.809 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . 0.439 ' HB3' HG11 ' B' ' 90' ' ' VAL . 37.6 m0 -62.89 -44.03 97.19 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.192 0.597 . . . . 0.0 109.902 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.478 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 32.4 ttpt -56.89 -45.96 82.22 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 110.324 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.87 -27.14 66.42 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.904 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.1 t -93.6 -10.31 35.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.855 0.862 . . . . 0.0 112.22 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.12 58.84 0.96 Allowed Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 114.09 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' B' ' 92' ' ' MET . 5.1 p -104.4 144.73 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.48 63.92 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.246 0.618 . . . . 0.0 111.387 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.57 ' HB2' HG12 ' B' ' 90' ' ' VAL . 51.8 ttm 65.31 83.81 0.16 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.953 0.783 . . . . 0.0 113.06 165.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.19 84.09 2.09 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.413 0.625 . . . . 0.0 110.851 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' B' ' 106' ' ' THR . 51.5 tp60 177.22 121.57 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.762 1.625 . . . . 0.0 108.304 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -78.56 119.31 76.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.556 ' HB2' ' HH ' ' B' ' 103' ' ' TYR . 53.1 Cg_exo -50.73 102.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.806 3.004 . . . . 0.0 112.556 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.09 140.52 42.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.0 0.92 . . . . 0.0 110.244 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.546 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -75.81 100.63 4.81 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.495 ' SD ' ' HD2' ' B' ' 101' ' ' PHE . 56.0 ttm -97.05 162.56 13.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.449 0.7 . . . . 0.0 109.356 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.84 -29.58 68.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.122 0.969 . . . . 0.0 112.018 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.495 ' HD2' ' SD ' ' B' ' 99' ' ' MET . 49.2 m-85 -77.29 -25.38 51.27 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.401 0.681 . . . . 0.0 110.369 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.77 176.5 22.97 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.962 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.556 ' HH ' ' HB2' ' B' ' 96' ' ' PRO . 66.8 t80 -74.39 101.48 4.11 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -112.36 147.47 36.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.185 0.517 . . . . 0.0 111.473 -165.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.527 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 6.2 t80 -144.31 143.97 31.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.67 1.188 . . . . 0.0 109.366 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.492 HG21 ' HG3' ' B' ' 114' ' ' ARG . 32.6 m -133.31 127.85 34.49 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.4 0.619 . . . . 0.0 110.276 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.72 174.1 6.03 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.992 0.917 . . . . 0.0 110.206 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.2 121.41 15.85 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.588 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 1.2 p30 -69.54 175.99 1.92 Allowed Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 123.67 0.788 . . . . 0.0 110.171 171.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 31.5 Cg_endo -60.48 -12.2 19.8 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.381 2.054 . . . . 0.0 113.901 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -97.57 0.47 47.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.2 0.6 . . . . 0.0 111.417 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 27.6 t 66.96 33.46 5.8 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.272 1.429 . . . . 0.0 112.245 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -75.18 173.36 10.91 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.492 ' HG3' HG21 ' B' ' 106' ' ' THR . 5.4 mpt_? -107.98 104.9 14.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.674 HD23 ' HH ' ' B' ' 21' ' ' TYR . 69.5 mt -100.0 100.54 11.45 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 -97.91 95.47 7.52 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -166.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.527 ' HB ' ' HD2' ' B' ' 105' ' ' PHE . 36.0 t -86.29 119.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -139.22 160.86 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.56 112.58 18.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.45 138.4 55.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.087 0.555 . . . . 0.0 109.96 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.64 97.89 0.84 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.881 0.472 . . . . 0.0 109.999 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.063 -178.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 111.282 0.104 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.489 HG23 ' HB3' ' B' ' 70' ' ' PHE . 53.1 m -140.41 147.32 39.53 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.101 0.56 . . . . 0.0 111.495 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -102.37 114.93 65.19 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.275 1.03 . . . . 0.0 109.835 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HG3' HD22 ' B' ' 25' ' ' LEU . 87.7 Cg_endo -85.76 86.17 1.03 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.696 2.264 . . . . 0.0 111.493 168.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.64 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 14.3 t70 -102.58 11.44 37.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.142 0.972 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -133.01 131.56 40.84 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -169.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.21 144.18 51.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.853 0.861 . . . . 0.0 109.167 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.468 HD12 ' NH2' ' B' ' 116' ' ' ARG . 1.8 mt -126.77 138.93 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.635 0.774 . . . . 0.0 109.51 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.447 HD11 HD21 ' A' ' 68' ' ' LEU . 96.1 mt -95.24 137.44 34.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -77.05 98.88 5.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.076 177.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 49' ' ' LEU . 20.1 m -109.74 169.78 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.23 -60.5 1.87 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.088 0.555 . . . . 0.0 110.003 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -102.32 98.39 10.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.941 0.896 . . . . 0.0 110.4 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.4 Cg_exo -49.12 -49.9 14.18 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.683 2.922 . . . . 0.0 115.984 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.77 -58.96 0.39 Allowed 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.217 1.828 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.86 89.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -59.51 -52.31 66.11 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 122.215 1.007 . . . . 0.0 109.507 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 59.1 m -80.49 -33.68 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -163.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.545 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 83.6 mm-40 -65.39 -37.46 87.06 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.888 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.97 -44.29 97.54 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.511 ' HH ' HD11 ' A' ' 115' ' ' LEU . 58.3 m-85 -71.46 -28.27 63.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.214 176.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.6 mtpt -56.49 -51.05 69.96 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.315 0.507 . . . . 0.0 111.875 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.41 -38.09 56.15 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.311 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' O ' ' HE2' ' B' ' 1' ' ' MET . 11.6 tp -59.79 -36.63 77.13 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.175 0.99 . . . . 0.0 112.34 -175.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.524 HD22 ' HG3' ' B' ' 4' ' ' PRO . 46.4 mt -96.9 -40.96 8.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.113 0.965 . . . . 0.0 109.357 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.83 30.85 8.11 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.605 0.566 . . . . 0.0 112.071 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG21 ' HB2' ' A' ' 25' ' ' LEU . 33.7 m -129.75 -178.39 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.427 1.091 . . . . 0.0 109.902 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.7 154.32 72.99 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.253 0.621 . . . . 0.0 109.753 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 11.4 Cg_exo -70.57 117.39 5.11 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.941 2.427 . . . . 0.0 111.954 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 39' ' ' PHE . 5.8 p -65.42 -40.52 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 47.3 mm-40 -113.41 128.76 56.56 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.755 0.822 . . . . 0.0 109.482 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -127.73 131.9 49.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.862 0.865 . . . . 0.0 109.267 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 t -137.22 147.72 59.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.25 -15.32 34.03 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.921 2.414 . . . . 0.0 114.226 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.49 7.74 5.84 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -157.97 153.37 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.612 0.365 . . . . 0.0 110.122 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 24.4 m -138.06 148.23 44.85 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.191 0.596 . . . . 0.0 109.612 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -146.16 129.2 16.51 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.564 ' HA ' HG11 ' A' ' 30' ' ' VAL . 2.6 p90 -134.49 148.18 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.176 0.99 . . . . 0.0 108.981 163.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.546 HG23 ' HG3' ' A' ' 46' ' ' LYS . 17.5 t -119.4 127.95 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.431 HD11 ' SD ' ' A' ' 45' ' ' MET . 37.7 mt -89.87 142.4 27.73 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -169.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.3 -14.3 62.89 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.069 0.948 . . . . 0.0 112.219 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' B' ' 5' ' ' ASP . 66.5 t30 -71.78 -9.87 58.94 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 110.912 174.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.2 32.91 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.483 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.655 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -97.01 172.29 7.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.009 0.904 . . . . 0.0 110.095 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 40' ' ' VAL . 86.5 tttt -135.03 141.82 46.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.05 0.54 . . . . 0.0 109.679 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.88 123.41 15.0 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.829 0.452 . . . . 0.0 110.452 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -107.77 167.86 13.68 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.537 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.467 HD21 HG11 ' A' ' 11' ' ' VAL . 6.3 mp -134.04 107.96 8.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 166.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.54 ' HE3' ' NH2' ' B' ' 116' ' ' ARG . 6.0 t90 -105.19 130.52 53.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 37.4 m -80.01 121.57 25.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.041 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -65.73 -14.09 60.61 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.986 1.314 . . . . 0.0 113.492 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -76.24 -8.2 56.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.573 0.349 . . . . 0.0 111.101 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.1 t -136.9 6.39 2.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.117 0.567 . . . . 0.0 111.344 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.8 147.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.716 0.406 . . . . 0.0 110.885 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -128.25 111.25 19.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.754 0.822 . . . . 0.0 108.875 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.7 140.49 66.8 Favored 'Cis proline' 0 C--N 1.389 2.666 0 C-N-CA 124.76 -0.933 . . . . 0.0 113.736 4.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -50.56 116.53 1.96 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.757 1.223 . . . . 0.0 113.04 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.52 107.1 3.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.799 1.24 . . . . 0.0 108.194 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -97.85 87.29 3.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.89 142.4 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 108.828 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.439 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 8.1 p -151.53 132.41 14.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.197 1.399 . . . . 0.0 108.267 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.19 -65.2 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 N-CA-C 112.054 -0.419 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.49 64.26 0.1 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.04 131.7 8.07 Favored Glycine 0 N--CA 1.464 0.566 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.732 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 73.43 129.43 0.14 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 15.9 mt-10 -120.97 147.95 44.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.05 0.54 . . . . 0.0 109.599 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -120.47 106.37 11.75 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.0 122.85 34.9 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.482 0.658 . . . . 0.0 111.338 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' B' ' 2' ' ' THR . 16.3 m-85 -102.56 108.35 19.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 107.529 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.46 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 29.2 mtm180 -91.29 123.49 34.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 112.201 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.19 158.9 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.747 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.8 pt-20 -69.36 -34.17 74.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.066 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.441 HD21 ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -161.72 177.45 9.92 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 118.697 0.68 . . . . 0.0 112.55 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.06 -33.21 70.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.732 1.613 . . . . 0.0 112.84 -167.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.95 77.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.74 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.558 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 21.8 mm-40 -66.18 -24.42 66.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.791 0.836 . . . . 0.0 112.032 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.19 -43.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.541 0.686 . . . . 0.0 109.647 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.39 -33.66 74.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.241 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -65.58 -45.26 83.93 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.293 0.568 . . . . 0.0 109.941 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.6 m -68.87 -28.46 66.73 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.013 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.9 -61.26 2.74 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.6 0.714 . . . . 0.0 109.948 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.78 -34.23 77.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.494 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.23 -46.75 93.3 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 124.206 0.941 . . . . 0.0 113.36 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -63.71 -45.88 87.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.211 0.604 . . . . 0.0 110.197 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 30.7 ttpt -57.01 -42.61 80.63 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.798 0.686 . . . . 0.0 110.836 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.09 -27.62 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.06 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -90.88 8.93 32.51 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.306 1.042 . . . . 0.0 112.643 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 46.47 4.61 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.147 169.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 p -101.6 148.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.1 79.07 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.931 0.492 . . . . 0.0 111.418 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.495 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 55.5 tpp 64.19 82.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.74 0.816 . . . . 0.0 112.891 166.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -134.11 84.92 2.15 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.086 0.47 . . . . 0.0 111.523 176.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 178.36 138.31 0.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.577 1.151 . . . . 0.0 109.565 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.85 119.97 68.83 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -54.12 111.41 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.938 2.425 . . . . 0.0 110.627 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.96 147.16 49.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.19 0.596 . . . . 0.0 111.231 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.02 104.8 4.23 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.608 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.418 ' SD ' ' CZ2' ' B' ' 50' ' ' TRP . 51.0 ttm -102.25 171.15 7.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.451 0.7 . . . . 0.0 109.939 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -49.63 -34.06 17.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.345 1.458 . . . . 0.0 113.092 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -101.68 -5.71 24.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.785 0.834 . . . . 0.0 111.469 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.16 -178.81 20.54 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.43 ' HB3' ' HB2' ' A' ' 119' ' ' ALA . 51.3 t80 -80.5 102.58 9.8 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.7 t -122.52 157.71 31.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.592 0.711 . . . . 0.0 111.466 -166.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.56 153.24 33.01 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.292 1.437 . . . . 0.0 108.249 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.474 HG23 ' HG3' ' A' ' 114' ' ' ARG . 23.5 m -146.81 127.68 14.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.149 0.431 . . . . 0.0 110.673 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.09 170.97 7.63 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.127 0.571 . . . . 0.0 110.724 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.4 117.42 23.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.773 0.429 . . . . 0.0 109.965 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.25 168.86 17.89 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.902 1.281 . . . . 0.0 110.856 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.31 -35.72 54.65 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.195 2.597 . . . . 0.0 114.499 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -87.48 1.18 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.307 0.643 . . . . 0.0 111.467 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 63.24 57.82 1.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.807 1.243 . . . . 0.0 112.36 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -93.19 -145.93 0.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 172.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.475 ' NH1' ' HG2' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -145.5 90.63 2.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.511 HD11 ' HH ' ' A' ' 21' ' ' TYR . 69.1 mt -96.07 104.82 16.78 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -171.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.732 HH12 HG22 ' B' ' 55' ' ' VAL . 1.8 mtp180 -101.98 146.52 27.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.374 0.27 . . . . 0.0 110.913 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.3 t -127.69 127.57 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 166.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -130.46 155.5 46.34 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.16 0.436 . . . . 0.0 111.275 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -109.37 121.15 44.54 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.97 108.62 10.16 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.34 0.4 . . . . 0.0 110.488 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.79 95.04 1.46 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.236 0.614 . . . . 0.0 109.64 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.19 -177.614 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.472 ' HE2' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.477 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.461 HG23 ' HB3' ' A' ' 70' ' ' PHE . 61.6 m -63.24 148.34 48.46 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 124.118 0.967 . . . . 0.0 111.592 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -100.96 114.49 65.82 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.009 0.923 . . . . 0.0 110.319 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.524 ' HG3' HD22 ' A' ' 25' ' ' LEU . 86.5 Cg_endo -86.06 86.18 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.49 2.127 . . . . 0.0 111.522 168.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.655 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 9.0 p-10 -102.9 10.78 38.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.538 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.46 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -132.17 131.84 42.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -169.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -128.06 143.71 51.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.009 0.924 . . . . 0.0 108.968 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 35.8 mt -125.28 139.36 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.499 HD21 HD21 ' B' ' 47' ' ' LEU . 4.0 mm? -95.32 137.38 34.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.43 ' HE2' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -76.03 97.62 4.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.212 1.405 . . . . 0.0 109.593 177.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 m -109.48 170.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.21 -60.26 1.91 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.984 0.514 . . . . 0.0 110.335 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -102.23 97.72 9.09 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.147 0.979 . . . . 0.0 110.49 -169.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.447 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.1 Cg_exo -48.88 -51.65 10.12 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.79 2.993 . . . . 0.0 115.675 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.21 -60.16 0.42 Allowed 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.099 1.786 . . . . 0.0 111.536 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.61 88.97 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.945 0.498 . . . . 0.0 112.163 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 34.1 m -59.1 -52.07 67.31 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.352 1.072 . . . . 0.0 109.677 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 70.7 m -80.46 -33.75 36.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -163.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 82.8 mm-40 -65.33 -38.39 90.01 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.715 172.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.445 ' CZ ' HG22 ' B' ' 90' ' ' VAL . 41.9 t80 -59.82 -45.82 91.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.33 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.67 ' HH ' HD21 ' B' ' 115' ' ' LEU . 36.1 m-85 -69.89 -29.42 66.62 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.805 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 52.3 mtpt -56.11 -51.21 68.72 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.182 0.515 . . . . 0.0 111.672 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.75 -38.42 54.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.439 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 8.5 tp -58.94 -36.64 75.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.424 1.09 . . . . 0.0 112.476 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.524 HD22 ' HG3' ' A' ' 4' ' ' PRO . 53.5 mt -96.93 -41.18 8.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.347 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.14 30.41 8.29 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' B' ' 25' ' ' LEU . 27.2 m -129.63 -177.98 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.411 1.084 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -139.05 155.04 72.94 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 123.338 0.655 . . . . 0.0 109.622 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 3.0 Cg_exo -71.84 117.05 4.95 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.867 2.378 . . . . 0.0 111.458 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -65.36 -39.87 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 51.6 mm-40 -114.08 128.26 56.3 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.506 0.722 . . . . 0.0 109.436 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 48.2 t -127.03 132.37 50.75 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.064 0.945 . . . . 0.0 109.245 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.0 t -137.52 148.01 59.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.805 1.242 . . . . 0.0 107.745 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.44 -15.14 39.05 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.693 2.262 . . . . 0.0 113.952 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.45 7.96 5.89 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -157.83 153.68 26.8 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 122.078 -0.389 . . . . 0.0 110.2 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 18.1 m -138.28 147.91 44.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.22 0.608 . . . . 0.0 109.541 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.619 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.3 tm? -145.98 129.66 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.532 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 3.7 p90 -134.84 148.64 50.2 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 108.721 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -120.52 127.8 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 36.8 mt -89.02 142.32 27.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.243 0.617 . . . . 0.0 109.405 -168.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.21 62.8 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.58 -10.21 59.41 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.761 0.825 . . . . 0.0 110.61 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.27 -4.35 33.34 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.215 -0.77 . . . . 0.0 114.175 170.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.64 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -96.25 172.61 7.85 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.047 0.923 . . . . 0.0 110.297 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -135.78 141.93 44.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.796 0.438 . . . . 0.0 109.951 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.499 HD21 HD21 ' B' ' 9' ' ' LEU . 3.6 tt -141.73 123.03 14.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.01 0.433 . . . . 0.0 110.589 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.431 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -106.7 167.23 13.88 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 123.927 0.775 . . . . 0.0 111.372 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 9.2 mp -134.0 108.32 8.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 166.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.486 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -105.83 130.62 53.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 42.3 m -81.06 121.27 25.86 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.597 0.561 . . . . 0.0 110.933 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -64.97 -14.83 61.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.105 1.362 . . . . 0.0 113.809 -170.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -75.94 -7.49 54.71 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.819 0.448 . . . . 0.0 111.721 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.9 t -137.14 7.17 2.88 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.378 0.671 . . . . 0.0 111.198 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.732 HG22 HH12 ' A' ' 116' ' ' ARG . 9.8 p -62.82 148.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 122.265 0.226 . . . . 0.0 110.48 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -127.73 110.99 20.57 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.585 0.754 . . . . 0.0 109.357 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.475 ' HG2' ' NH1' ' A' ' 114' ' ' ARG . 85.8 Cg_endo -75.39 139.77 63.16 Favored 'Cis proline' 0 C--N 1.388 2.612 0 CA-C-N 119.85 0.982 . . . . 0.0 113.805 4.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -49.58 116.32 1.71 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.735 1.214 . . . . 0.0 113.179 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.29 107.2 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.691 1.196 . . . . 0.0 108.471 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -97.81 87.48 4.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.22 141.99 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.427 1.091 . . . . 0.0 108.98 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 11.1 p -151.22 133.11 15.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.709 1.203 . . . . 0.0 108.186 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.73 -66.08 0.05 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.0 62.89 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.16 130.57 7.83 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 119.442 -0.644 . . . . 0.0 111.674 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.732 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 74.06 130.02 0.18 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 27.0 mt-10 -121.93 147.2 46.33 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -120.46 106.45 11.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.732 ' HA ' ' HG2' ' B' ' 116' ' ' ARG . . . -91.3 122.25 33.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.489 ' HB3' HG23 ' A' ' 2' ' ' THR . 12.5 m-85 -101.95 108.31 19.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.588 1.555 . . . . 0.0 107.523 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.403 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 56.9 mtm180 -91.97 122.75 34.78 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.419 0.628 . . . . 0.0 111.968 -174.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.406 HG22 ' O ' ' B' ' 118' ' ' TYR . 22.7 m -125.11 159.27 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.708 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.426 ' HG3' HD21 ' B' ' 74' ' ' ASN . 9.5 pt-20 -69.39 -34.66 74.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.423 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.426 HD21 ' HG3' ' B' ' 73' ' ' GLU . 6.0 p30 -161.18 176.67 11.02 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.714 0.688 . . . . 0.0 112.412 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -59.11 -32.34 69.74 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.704 1.602 . . . . 0.0 113.063 -168.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.97 -39.34 76.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.641 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -65.75 -24.37 66.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.589 0.756 . . . . 0.0 112.45 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.614 HG12 HG11 ' B' ' 117' ' ' VAL . 97.2 t -68.34 -42.96 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.503 0.721 . . . . 0.0 109.829 172.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.15 -33.05 71.3 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.788 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 29.5 mt-10 -65.77 -45.9 80.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.419 0.628 . . . . 0.0 109.987 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 92.7 m -67.3 -29.81 69.5 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.996 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -59.89 -61.21 2.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.67 0.788 . . . . 0.0 110.093 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.91 76.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.42 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.33 90.18 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.122 0.888 . . . . 0.0 113.088 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . 0.497 ' HB3' HG23 ' B' ' 90' ' ' VAL . 44.9 m0 -62.55 -46.86 86.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.347 0.659 . . . . 0.0 110.038 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.564 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 30.9 ttpt -55.89 -42.81 76.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.367 0.667 . . . . 0.0 111.065 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.73 -27.7 63.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.873 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -91.04 9.26 31.55 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 112.233 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.98 46.88 4.64 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.09 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.497 HG23 ' HB3' ' B' ' 85' ' ' TRP . 48.7 t -101.97 147.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.06 77.48 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.048 0.539 . . . . 0.0 111.449 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.564 ' HE1' ' HB2' ' B' ' 86' ' ' LYS . 51.3 tpp 64.34 82.53 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.705 0.802 . . . . 0.0 112.799 166.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 85.17 2.18 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 178.07 138.17 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.401 1.081 . . . . 0.0 109.301 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -90.21 119.88 69.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.427 ' HA ' ' HB2' ' B' ' 105' ' ' PHE . 51.1 Cg_exo -54.18 111.51 0.73 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.719 2.279 . . . . 0.0 110.699 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.83 146.77 49.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.338 0.655 . . . . 0.0 111.279 -170.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.602 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 0.2 OUTLIER -72.84 104.87 4.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.838 0.855 . . . . 0.0 109.812 177.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 51.9 ttm -101.93 170.14 8.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.07 0.948 . . . . 0.0 109.66 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -48.74 -34.47 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.257 1.423 . . . . 0.0 113.216 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -101.96 -5.4 24.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.773 0.829 . . . . 0.0 111.67 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.6 -178.6 20.93 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.311 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.602 ' HB2' ' HZ1' ' B' ' 98' ' ' LYS . 52.1 t80 -80.99 102.59 10.26 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -122.61 158.05 30.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.664 0.745 . . . . 0.0 111.505 -167.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.427 ' HB2' ' HA ' ' B' ' 96' ' ' PRO . 3.0 t80 -153.2 152.73 31.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.365 1.466 . . . . 0.0 108.075 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.62 HG23 ' HG3' ' B' ' 114' ' ' ARG . 29.0 m -145.82 127.74 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.685 0.394 . . . . 0.0 110.21 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.56 171.22 7.51 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.06 0.544 . . . . 0.0 110.78 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.77 116.92 22.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.423 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.3 p30 -70.95 169.41 14.87 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.691 1.197 . . . . 0.0 111.242 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 10.9 Cg_endo -52.16 -35.63 63.52 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.431 2.754 . . . . 0.0 113.901 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.42 1.26 53.92 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.253 0.621 . . . . 0.0 111.461 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 62.69 57.99 1.69 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.63 1.172 . . . . 0.0 112.624 166.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -92.68 -146.23 0.22 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.62 ' HG3' HG23 ' B' ' 106' ' ' THR . 0.1 OUTLIER -144.72 89.63 2.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.67 HD21 ' HH ' ' B' ' 21' ' ' TYR . 85.8 mt -95.49 104.23 16.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -171.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.732 ' HG2' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -99.74 147.77 25.09 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.827 0.285 . . . . 0.0 111.696 -176.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.614 HG11 HG12 ' B' ' 78' ' ' VAL . 7.5 p -128.97 128.47 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 164.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.406 ' O ' HG22 ' B' ' 72' ' ' VAL . 14.3 p90 -130.13 155.56 45.99 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 122.199 -0.313 . . . . 0.0 111.062 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -109.62 120.92 43.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -76.27 107.0 8.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.364 0.415 . . . . 0.0 110.05 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.31 104.0 10.56 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.854 -0.97 . . . . 0.0 110.919 -177.454 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HE3' HG22 ' B' ' 81' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.684 -0.117 . . . . 0.0 110.684 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.431 ' N ' ' SD ' ' A' ' 1' ' ' MET . 16.4 m -82.1 148.28 28.64 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -108.69 127.72 26.88 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.798 0.839 . . . . 0.0 110.614 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' HD22 ' B' ' 25' ' ' LEU . 69.4 Cg_endo -87.73 87.49 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.697 2.264 . . . . 0.0 111.364 170.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.797 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.7 p-10 -83.61 1.53 41.82 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.419 0.628 . . . . 0.0 110.815 172.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.06 120.5 31.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -172.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -111.96 137.66 49.66 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 46.3 mt -113.19 128.1 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.41 HD21 HD23 ' A' ' 47' ' ' LEU . 4.2 mm? -93.93 145.13 24.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.63 ' HE1' HG23 ' A' ' 55' ' ' VAL . 38.4 t80 -102.57 105.14 15.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.192 -170.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.79 157.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.534 0.734 . . . . 0.0 109.199 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 12.6 p-10 -104.76 -43.01 5.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.528 0.731 . . . . 0.0 110.84 -177.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -94.53 105.62 19.28 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.256 0.623 . . . . 0.0 109.909 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.27 -59.46 0.89 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 C-N-CA 122.153 1.902 . . . . 0.0 113.461 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 40.6 Cg_endo -64.38 -56.5 0.43 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 122.433 1.905 . . . . 0.0 111.494 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.22 83.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.735 0.814 . . . . 0.0 112.206 -168.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -72.53 -39.69 67.35 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -65.69 -39.49 91.34 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 77.8 mm-40 -67.6 -34.53 77.19 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.372 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -64.69 -46.13 83.68 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.524 0.515 . . . . 0.0 109.911 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -65.62 -32.07 73.44 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.07 -51.07 69.16 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.284 0.564 . . . . 0.0 112.322 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.12 -39.91 65.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.152 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 tp -58.2 -47.02 84.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.145 1.378 . . . . 0.0 113.183 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB2' HG23 ' A' ' 27' ' ' VAL . 15.5 mt -86.44 -43.73 12.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.06 26.05 8.07 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 -174.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 25' ' ' LEU . 31.1 m -127.73 167.4 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.06 0.944 . . . . 0.0 110.243 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.01 151.28 46.36 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.783 0.833 . . . . 0.0 109.34 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 14.8 Cg_exo -67.88 117.05 4.62 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.545 2.163 . . . . 0.0 111.814 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 40' ' ' VAL . 7.5 p -63.22 -38.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.751 . . . . 0.0 109.962 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 30.5 mm-40 -123.47 129.86 51.86 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.01 1.324 . . . . 0.0 107.775 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.6 p -136.26 135.36 38.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.308 0.575 . . . . 0.0 109.896 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.3 m -141.65 153.58 65.23 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.922 1.289 . . . . 0.0 108.512 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -56.92 -22.48 46.33 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.066 2.511 . . . . 0.0 113.726 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 t -128.12 10.49 6.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -158.83 137.46 10.98 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -123.71 153.96 40.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.389 0.676 . . . . 0.0 109.727 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 21.3 tp -147.43 125.66 12.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.435 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -132.79 142.25 48.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 108.367 168.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.576 HG23 ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -119.38 131.48 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.0 mt -94.41 149.85 20.84 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -10.45 29.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.19 0.996 . . . . 0.0 112.029 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -65.12 -20.44 66.46 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.852 1.261 . . . . 0.0 112.237 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 -7.27 47.18 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -90.35 173.12 8.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.56 0.744 . . . . 0.0 110.38 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' HG3' HG23 ' A' ' 40' ' ' VAL . 76.8 tttt -141.8 139.53 32.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 9' ' ' LEU . 2.2 tt -138.09 120.13 15.54 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.494 0.318 . . . . 0.0 110.6 -169.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.19 165.73 17.26 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.625 0.631 . . . . 0.0 111.693 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.89 111.92 10.86 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -104.74 125.17 50.55 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.7 m -77.71 128.78 34.61 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.641 0.588 . . . . 0.0 109.874 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 13.6 ptm180 -66.88 -10.66 50.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -82.56 -12.64 57.59 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 118.047 0.385 . . . . 0.0 111.137 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 0.6 8.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.122 0.569 . . . . 0.0 111.123 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG23 ' HE1' ' A' ' 10' ' ' TYR . 10.7 p -61.13 140.13 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.189 0.519 . . . . 0.0 112.279 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.73 116.38 26.41 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 6.8 Cg_exo -72.38 144.04 79.24 Favored 'Cis proline' 0 C--N 1.383 2.384 0 C-N-CA 124.683 -0.966 . . . . 0.0 112.794 -3.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.555 ' HA ' HG12 ' A' ' 55' ' ' VAL . 13.7 mmmm -50.2 130.16 22.32 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.764 0.825 . . . . 0.0 111.833 173.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.555 ' HB1' ' HH ' ' A' ' 10' ' ' TYR . . . -145.99 136.33 23.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.751 0.821 . . . . 0.0 109.958 -176.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 p -108.5 88.35 2.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.521 0.729 . . . . 0.0 109.485 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -161.37 144.04 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.773 0.829 . . . . 0.0 110.22 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 p -141.47 138.62 32.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.381 1.072 . . . . 0.0 108.356 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.71 20.07 79.65 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 22.23 30.42 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.79 -162.07 23.79 Favored Glycine 0 N--CA 1.473 1.154 0 CA-C-N 117.083 0.442 . . . . 0.0 112.308 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.58 95.9 0.05 OUTLIER Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' HG2' ' NE ' ' A' ' 116' ' ' ARG . 1.9 mp0 -103.7 158.53 16.32 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 112.049 -170.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.8 mt -118.89 102.4 8.76 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.498 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.95 106.31 17.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.505 ' HB2' HG21 ' A' ' 117' ' ' VAL . 7.8 m-85 -83.95 112.21 19.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -90.18 127.43 36.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.421 0.629 . . . . 0.0 112.243 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.65 158.29 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.23 -38.05 89.65 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -160.43 177.37 10.64 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.512 0.596 . . . . 0.0 112.155 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.25 -28.62 69.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.944 1.298 . . . . 0.0 112.771 -165.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.78 -46.95 76.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.978 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -64.86 -22.43 66.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 0.0 112.651 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.26 -42.41 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.313 0.645 . . . . 0.0 109.668 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.03 -27.59 54.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.681 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 40.6 mt-10 -69.26 -43.85 73.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.668 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.402 HG22 ' HE3' ' B' ' 1' ' ' MET . 86.9 m -65.74 -36.14 82.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.28 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.434 ' O ' ' HE2' ' A' ' 92' ' ' MET . 35.6 t80 -59.33 -57.18 14.15 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.794 0.807 . . . . 0.0 109.356 176.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.87 83.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.209 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.69 90.76 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.64 0.587 . . . . 0.0 114.361 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -67.44 -41.85 84.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.062 0.545 . . . . 0.0 110.155 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -58.8 -40.14 83.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.983 0.913 . . . . 0.0 110.297 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.77 66.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.461 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m -104.96 15.14 28.26 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.889 0.876 . . . . 0.0 113.205 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.45 30.32 19.36 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 163.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.09 127.45 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.251 0.62 . . . . 0.0 109.543 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.0 71.07 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.684 0.794 . . . . 0.0 111.393 -177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.434 ' HE2' ' O ' ' A' ' 82' ' ' PHE . 6.7 ptm 52.15 80.95 0.09 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.291 1.436 . . . . 0.0 113.381 169.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.78 82.45 2.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 -177.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -174.86 138.18 0.46 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.346 1.058 . . . . 0.0 109.066 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -80.49 122.4 82.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 105' ' ' PHE . 27.1 Cg_endo -63.54 112.35 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.575 2.183 . . . . 0.0 110.209 175.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.39 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.454 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.576 ' HZ1' ' HB2' ' A' ' 103' ' ' TYR . 19.3 mmtm -71.06 118.02 13.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.397 1.079 . . . . 0.0 111.506 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.5 tpp -110.09 176.62 4.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.507 1.523 . . . . 0.0 108.996 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -48.21 -41.01 26.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.75 1.22 . . . . 0.0 113.133 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -106.88 19.83 19.91 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.566 0.746 . . . . 0.0 111.603 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -167.83 12.42 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.986 0.354 . . . . 0.0 113.986 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.576 ' HB2' ' HZ1' ' A' ' 98' ' ' LYS . 13.0 t80 -78.53 110.01 13.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.437 0.695 . . . . 0.0 109.707 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -138.77 168.69 19.25 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -168.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 96' ' ' PRO . 22.8 p90 -157.42 169.35 24.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.028 0.931 . . . . 0.0 109.311 169.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 13.6 m -137.47 124.92 22.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.65 158.33 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.378 1.071 . . . . 0.0 110.78 -174.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.02 111.08 17.03 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.4 167.87 28.76 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.605 0.762 . . . . 0.0 110.258 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -43.02 -38.82 7.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.693 2.929 . . . . 0.0 115.652 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -89.14 2.02 54.77 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.833 0.453 . . . . 0.0 111.771 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.2 m 63.43 81.48 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.675 1.19 . . . . 0.0 111.354 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -131.53 165.37 23.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 18.5 mtm180 -97.0 106.46 18.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.08 102.71 11.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.232 0.613 . . . . 0.0 109.683 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.708 ' HD2' HD13 ' B' ' 8' ' ' ILE . 72.1 mtt-85 -89.66 148.55 23.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.693 0.397 . . . . 0.0 110.383 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 70' ' ' PHE . 40.5 t -137.38 127.96 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 166.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -130.75 167.58 18.61 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.27 0.941 . . . . 0.0 112.885 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.7 115.8 12.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.586 1.154 . . . . 0.0 108.08 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -79.77 117.39 20.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.56 99.17 2.46 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.638 0.775 . . . . 0.0 109.417 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.12 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.402 ' HE3' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.582 0.229 . . . . 0.0 110.916 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -79.29 148.86 31.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.774 0.83 . . . . 0.0 109.529 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -108.39 126.89 28.56 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.009 0.924 . . . . 0.0 110.028 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.35 87.57 0.66 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.53 2.153 . . . . 0.0 111.467 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.809 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 10.4 p-10 -83.43 1.67 40.4 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.014 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 0.9 OUTLIER -125.35 119.34 28.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -171.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -111.25 137.69 48.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.708 HD13 ' HD2' ' A' ' 116' ' ' ARG . 22.1 mt -113.84 127.66 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.14 145.26 24.54 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -102.63 105.84 16.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.622 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.13 157.35 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.696 0.798 . . . . 0.0 109.114 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -105.33 -42.8 5.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.511 0.724 . . . . 0.0 111.028 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.91 106.51 22.32 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.102 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.442 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 38.6 Cg_exo -55.03 -59.09 0.89 Allowed 'Trans proline' 0 CA--C 1.572 2.406 0 C-N-CA 122.049 1.833 . . . . 0.0 113.429 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 22.6 Cg_exo -64.78 -56.93 0.34 Allowed 'Trans proline' 0 C--N 1.4 3.259 0 CA-C-N 122.465 1.916 . . . . 0.0 111.316 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -44.8 81.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.598 0.759 . . . . 0.0 112.551 -168.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -70.79 -40.87 72.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 77.7 m -65.61 -39.36 91.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.543 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 79.7 mm-40 -67.85 -34.17 76.18 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.516 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.98 -45.96 83.46 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.206 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -65.77 -31.86 73.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.543 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.7 mtpt -56.03 -50.91 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.312 0.577 . . . . 0.0 112.266 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.24 -39.91 65.1 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.303 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -58.33 -46.83 85.46 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.174 1.39 . . . . 0.0 113.055 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.498 ' HB2' HG23 ' B' ' 27' ' ' VAL . 13.7 mt -87.1 -42.98 12.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.36 25.86 8.56 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.993 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' B' ' 25' ' ' LEU . 33.4 m -127.26 167.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.934 0.894 . . . . 0.0 110.303 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.15 150.75 45.74 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.794 0.837 . . . . 0.0 109.483 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.436 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 42.2 Cg_endo -67.14 117.18 4.61 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.355 2.036 . . . . 0.0 112.218 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.525 HG12 ' HG2' ' B' ' 31' ' ' GLU . 7.1 p -63.68 -38.46 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.392 0.677 . . . . 0.0 109.97 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 34.6 mm-40 -122.69 129.94 52.38 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.925 1.29 . . . . 0.0 107.522 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -136.23 136.04 39.56 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.03 0.532 . . . . 0.0 110.066 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 55.6 m -142.49 151.64 58.16 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.921 1.288 . . . . 0.0 108.578 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.91 -23.62 28.38 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.19 2.593 . . . . 0.0 114.733 -176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -128.12 10.82 6.42 Favored 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -158.56 137.91 11.65 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -124.32 153.47 41.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.326 0.65 . . . . 0.0 110.035 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 35.8 tp -146.75 126.22 13.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 0.9 OUTLIER -132.93 142.31 48.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.569 1.148 . . . . 0.0 108.421 168.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.3 t -119.49 130.93 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.76 149.61 21.09 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -10.43 25.7 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.461 1.104 . . . . 0.0 112.071 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -65.36 -20.42 66.38 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.719 1.208 . . . . 0.0 112.244 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.31 -7.14 46.91 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.797 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -90.29 173.23 8.25 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.468 0.707 . . . . 0.0 110.491 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.572 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -141.7 139.62 32.98 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.34 120.15 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.411 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.02 165.53 17.4 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 123.78 0.705 . . . . 0.0 111.549 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.6 mt -134.25 111.66 10.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.546 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.0 t90 -104.71 125.36 50.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -77.86 128.76 34.47 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 123.581 0.551 . . . . 0.0 110.044 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -67.35 -10.65 53.09 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -81.93 -13.46 57.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.042 0.383 . . . . 0.0 111.388 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -124.13 1.77 8.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.182 0.593 . . . . 0.0 111.271 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.546 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 14.1 p -62.29 138.83 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.032 0.444 . . . . 0.0 111.757 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -122.1 116.83 29.77 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -73.6 145.21 83.4 Favored 'Cis proline' 0 C--N 1.384 2.442 0 C-N-CA 124.564 -1.015 . . . . 0.0 111.966 -2.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.507 ' HA ' HG12 ' B' ' 55' ' ' VAL . 12.4 mmmm -51.24 130.73 27.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.668 0.787 . . . . 0.0 111.628 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.17 23.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.925 0.89 . . . . 0.0 109.642 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.2 p -108.59 88.53 2.75 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.634 0.774 . . . . 0.0 109.175 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -161.86 143.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.785 0.834 . . . . 0.0 110.193 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -141.43 138.85 33.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.62 1.168 . . . . 0.0 108.425 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.79 79.76 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.13 21.74 32.84 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 114.419 0.528 . . . . 0.0 114.419 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.63 -160.27 23.72 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 117.053 0.427 . . . . 0.0 112.683 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.99 96.54 0.03 OUTLIER Glycine 0 C--N 1.351 1.41 0 C-N-CA 122.995 0.331 . . . . 0.0 112.557 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.509 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.3 mt-10 -103.36 159.84 15.21 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.114 0.483 . . . . 0.0 112.155 -170.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.56 102.24 8.5 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.444 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.448 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -86.21 107.3 17.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.011 0.434 . . . . 0.0 110.056 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.52 ' HB2' HG22 ' B' ' 117' ' ' VAL . 7.8 m-85 -85.97 111.93 20.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.407 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 32.3 mtm180 -90.18 126.33 35.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.29 0.567 . . . . 0.0 112.014 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 23.4 m -127.23 158.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.337 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.9 pt-20 -64.32 -37.74 88.58 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -160.76 178.2 9.69 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.777 0.717 . . . . 0.0 112.078 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.43 -28.93 69.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.162 1.385 . . . . 0.0 112.475 -164.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.75 -46.54 78.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.468 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 69.6 mm-40 -65.57 -22.45 66.69 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.264 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -66.35 -42.58 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.397 0.679 . . . . 0.0 109.626 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.87 -27.96 55.22 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.451 1.1 . . . . 0.0 110.401 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 43.5 mt-10 -68.41 -44.69 74.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.076 0.55 . . . . 0.0 109.867 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.507 HG22 ' HE3' ' A' ' 1' ' ' MET . 85.6 m -65.27 -35.96 82.62 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.413 175.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.433 ' O ' ' HE1' ' B' ' 92' ' ' MET . 30.2 t80 -59.23 -56.96 15.41 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.75 0.786 . . . . 0.0 109.4 176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.14 83.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.33 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.75 90.75 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.44 0.463 . . . . 0.0 113.97 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -67.15 -42.49 84.29 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.061 0.545 . . . . 0.0 109.992 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -58.01 -40.77 81.61 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.944 . . . . 0.0 110.14 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.2 67.24 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.411 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -104.35 15.11 28.92 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.05 0.94 . . . . 0.0 113.421 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.58 19.31 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 163.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.6 127.32 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.253 0.621 . . . . 0.0 109.386 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.7 -53.07 61.94 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.652 0.781 . . . . 0.0 111.268 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.433 ' HE1' ' O ' ' B' ' 82' ' ' PHE . 22.9 ttp 54.19 81.04 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.793 1.237 . . . . 0.0 112.868 169.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 83.38 2.18 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -176.43 134.74 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.226 1.01 . . . . 0.0 108.366 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -79.16 123.7 84.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' B' ' 105' ' ' PHE . 40.0 Cg_endo -65.41 112.26 2.07 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.527 2.151 . . . . 0.0 109.709 176.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.16 163.36 33.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.341 0.591 . . . . 0.0 111.59 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.568 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 18.4 mmtm -71.22 118.59 14.21 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.299 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 37.0 ttm -112.02 179.42 4.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.561 1.145 . . . . 0.0 108.966 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.19 -41.61 49.8 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.697 1.199 . . . . 0.0 112.019 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -106.54 20.0 19.66 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.559 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.11 -167.68 12.38 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.568 ' HB2' ' HZ1' ' B' ' 98' ' ' LYS . 18.5 t80 -78.7 110.19 13.62 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.533 0.733 . . . . 0.0 109.777 -168.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.447 ' OG1' ' HD2' ' B' ' 116' ' ' ARG . 13.7 t -139.95 169.44 17.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -168.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.443 ' HB3' ' HA ' ' B' ' 96' ' ' PRO . 32.0 p90 -157.63 169.14 25.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.107 0.963 . . . . 0.0 109.232 170.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.492 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 20.6 m -136.62 125.19 23.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.57 158.21 16.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.42 1.088 . . . . 0.0 110.882 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.1 111.36 17.34 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.69 167.36 34.09 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.907 0.883 . . . . 0.0 110.402 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -42.16 -39.19 5.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 124.039 3.159 . . . . 0.0 115.346 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -89.38 2.36 54.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m 62.98 80.82 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.681 1.192 . . . . 0.0 111.589 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -130.49 165.66 22.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -95.66 106.13 18.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -108.41 102.62 11.71 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 0.8 OUTLIER -87.11 147.98 25.42 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.356 0.663 . . . . 0.0 109.922 -178.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' B' ' 70' ' ' PHE . 42.3 t -137.44 128.36 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 164.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -130.71 167.05 19.45 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.368 0.986 . . . . 0.0 113.102 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.1 116.13 13.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.19 122.56 26.99 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.91 99.78 1.83 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 0.0 109.86 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.17 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.111 -175.394 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.676 0.274 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.5 m -85.36 134.71 34.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.42 ' HB3' HD22 ' B' ' 43' ' ' ASN . 23.0 m80 -93.38 116.29 66.27 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.849 0.859 . . . . 0.0 110.934 -174.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -97.36 96.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.869 2.379 . . . . 0.0 112.48 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.681 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.1 p-10 -93.72 13.6 21.76 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.295 0.569 . . . . 0.0 110.534 169.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.98 115.69 19.62 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.87 146.56 34.89 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.269 1.027 . . . . 0.0 108.691 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.477 HD13 ' HD2' ' B' ' 116' ' ' ARG . 55.9 mt -122.5 137.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.039 0.935 . . . . 0.0 109.037 176.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.744 HD23 ' HG ' ' A' ' 68' ' ' LEU . 4.3 mm? -91.42 123.23 34.69 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 168.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.578 ' HE1' HG23 ' A' ' 55' ' ' VAL . 57.6 t80 -78.96 106.83 11.27 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.687 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.71 175.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.248 1.019 . . . . 0.0 109.908 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.55 -61.46 1.49 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.59 0.756 . . . . 0.0 109.811 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.52 110.61 35.58 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 123.787 0.835 . . . . 0.0 110.093 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -58.8 -64.36 0.11 Allowed 'Trans proline' 0 CA--C 1.568 2.178 0 C-N-CA 122.323 2.015 . . . . 0.0 113.614 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.08 -38.75 35.14 Favored 'Trans proline' 0 C--N 1.402 3.343 0 CA-C-N 122.533 1.94 . . . . 0.0 111.204 -170.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.47 93.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.312 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -70.85 -35.34 72.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.3 m -58.41 -53.24 60.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.565 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 24.5 mm-40 -68.56 -37.07 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.258 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.1 t80 -59.46 -44.06 93.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.772 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 5.4 m-85 -72.99 -28.45 62.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.468 0.707 . . . . 0.0 110.73 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.3 -50.79 70.41 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.936 0.789 . . . . 0.0 112.037 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.23 -34.38 49.3 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.142 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.9 tp -61.42 -53.58 54.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.661 1.184 . . . . 0.0 111.988 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB2' HG23 ' A' ' 27' ' ' VAL . 11.1 mt -76.62 -51.82 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.68 5.82 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.257 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 25' ' ' LEU . 21.0 m -131.35 176.21 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.359 1.063 . . . . 0.0 110.075 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.27 156.11 46.04 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.77 112.53 3.56 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 121.534 1.489 . . . . 0.0 110.554 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -37.45 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.892 0.477 . . . . 0.0 110.157 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 11.9 mm-40 -111.82 134.47 53.36 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 p -143.35 132.36 22.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 110.709 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -143.42 155.81 60.74 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.285 1.434 . . . . 0.0 108.263 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.3 -10.2 20.37 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.865 2.377 . . . . 0.0 114.123 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 t -126.56 -0.75 6.83 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -157.67 142.43 16.56 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -131.51 146.54 52.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.25 0.62 . . . . 0.0 110.106 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.0 tm? -133.68 120.27 20.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -108.11 140.52 41.18 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.686 1.595 . . . . 0.0 107.051 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' HG3' ' A' ' 46' ' ' LYS . 26.4 t -124.21 126.8 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.456 HD12 ' SD ' ' A' ' 45' ' ' MET . 8.6 mp -99.79 148.72 24.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.169 0.587 . . . . 0.0 109.731 -172.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.96 -5.92 29.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.039 0.936 . . . . 0.0 111.928 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -21.67 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.121 0.968 . . . . 0.0 112.168 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.64 17.56 16.73 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.682 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -124.06 175.09 7.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.817 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HG3' HG23 ' A' ' 40' ' ' VAL . 78.3 tttt -145.91 140.62 27.1 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.472 HD11 HD11 ' A' ' 68' ' ' LEU . 2.7 tt -138.32 120.66 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.203 0.601 . . . . 0.0 110.287 -169.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.85 166.55 15.76 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.667 0.651 . . . . 0.0 112.055 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.419 HD23 ' HB2' ' A' ' 9' ' ' LEU . 95.3 mt -134.87 104.92 6.18 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.523 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.6 t90 -109.62 119.3 38.97 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 p -81.01 140.92 34.88 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.343 0.402 . . . . 0.0 111.159 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.502 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 29.3 ptt180 -69.68 -18.65 63.57 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -78.99 -8.58 59.05 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -127.84 7.68 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.874 0.47 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG23 ' HE1' ' A' ' 10' ' ' TYR . 9.9 p -75.8 150.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.61 0.243 . . . . 0.0 110.91 -175.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -126.37 115.58 23.33 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.77 0.828 . . . . 0.0 108.861 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 89.1 Cg_endo -77.01 141.01 68.02 Favored 'Cis proline' 0 C--N 1.386 2.511 0 C-N-CA 124.584 -1.007 . . . . 0.0 112.389 5.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 123.84 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.729 0.811 . . . . 0.0 110.29 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB1' ' HH ' ' A' ' 10' ' ' TYR . . . -149.38 170.74 17.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.541 1.137 . . . . 0.0 108.545 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.502 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 32.5 t -147.19 90.65 1.9 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.413 0.285 . . . . 0.0 110.237 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.08 144.15 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 109.685 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -146.62 124.14 11.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.45 -69.25 0.17 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.27 149.26 20.9 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.34 -22.64 0.2 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.683 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . -164.01 116.12 0.69 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.87 144.65 30.25 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.744 ' HG ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -108.93 101.62 10.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -169.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -90.23 111.71 22.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.732 0.696 . . . . 0.0 111.52 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -91.18 111.97 23.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.117 1.367 . . . . 0.0 107.399 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.536 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 36.8 mtm180 -89.98 129.4 36.31 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.503 0.668 . . . . 0.0 112.336 -174.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.69 159.09 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.016 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.6 pt-20 -66.69 -34.91 78.91 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -163.27 178.29 8.3 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 118.757 0.708 . . . . 0.0 112.345 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.56 -31.27 67.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.408 1.483 . . . . 0.0 112.771 -168.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.97 -46.55 77.67 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.232 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.495 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 71.7 mm-40 -63.69 -22.71 67.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.181 0.993 . . . . 0.0 112.98 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.75 -42.04 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.212 0.605 . . . . 0.0 109.802 171.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -75.81 -29.06 58.56 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.164 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 36.5 mt-10 -71.81 -44.7 63.49 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.276 0.56 . . . . 0.0 109.641 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -65.38 -33.4 75.87 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.437 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' O ' ' HE3' ' A' ' 92' ' ' MET . 40.0 t80 -56.33 -59.4 5.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.701 0.8 . . . . 0.0 109.621 174.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.71 -38.26 89.73 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.714 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 -41.83 97.11 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.653 0.596 . . . . 0.0 113.632 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -64.41 -42.55 96.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.324 0.649 . . . . 0.0 110.305 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 31.8 ttpt -59.15 -42.97 91.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.017 0.927 . . . . 0.0 110.539 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.38 65.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.318 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.9 t -98.36 14.27 28.61 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.427 1.091 . . . . 0.0 112.944 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.09 29.06 35.13 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 165.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.7 t -86.47 130.61 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.85 -42.11 99.62 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.954 0.902 . . . . 0.0 112.325 -172.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.477 ' HE3' ' O ' ' A' ' 82' ' ' PHE . 7.5 ptm 49.54 81.48 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.889 1.676 . . . . 0.0 114.301 166.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.01 83.04 1.76 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.476 0.655 . . . . 0.0 110.084 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? 178.07 120.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.434 1.493 . . . . 0.0 107.113 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.4 117.02 62.69 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.53 110.73 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 123.887 3.058 . . . . 0.0 113.329 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.58 146.04 44.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.226 1.01 . . . . 0.0 110.371 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 98.64 4.09 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 tpp -78.26 163.98 25.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.836 0.854 . . . . 0.0 109.49 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.23 -28.26 69.03 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.107 0.563 . . . . 0.0 111.795 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -99.67 15.41 26.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.972 0.909 . . . . 0.0 111.466 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.03 180.0 16.76 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.539 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -73.77 103.0 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -109.84 158.11 18.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.396 0.617 . . . . 0.0 111.401 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -143.93 142.09 30.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.21 1.404 . . . . 0.0 108.795 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.4 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 31.1 m -132.69 121.93 23.85 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.522 1.056 . . . . 0.0 110.76 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.69 150.48 26.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.103 0.961 . . . . 0.0 112.228 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.95 172.53 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.3 p-10 -144.34 -176.94 0.59 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 5.2 Cg_exo -38.14 -51.67 1.97 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.621 2.881 . . . . 0.0 114.016 168.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.08 -15.0 59.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.006 0.522 . . . . 0.0 111.684 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.02 52.24 0.2 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.65 1.18 . . . . 0.0 111.156 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -80.3 175.11 10.94 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.255 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -122.84 105.64 10.2 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -118.18 103.69 10.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.143 0.977 . . . . 0.0 109.206 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.551 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 77.9 ttt180 -88.17 146.14 25.55 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 123.266 0.626 . . . . 0.0 110.188 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.9 t -131.94 119.22 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 163.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.536 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 4.3 p90 -125.71 164.91 19.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.563 0.62 . . . . 0.0 111.223 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.83 111.65 13.31 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -75.04 117.2 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.438 0.563 . . . . 0.0 109.75 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.84 100.56 2.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.11 0.481 . . . . 0.0 109.708 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.272 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.669 0.271 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 17.9 m -126.67 136.28 52.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -93.04 115.98 65.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.959 0.904 . . . . 0.0 110.666 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.489 ' HB2' HD22 ' A' ' 68' ' ' LEU . 46.5 Cg_endo -97.55 96.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.985 2.456 . . . . 0.0 112.432 170.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.682 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.8 p-10 -93.55 13.82 20.74 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.351 0.596 . . . . 0.0 110.692 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.15 115.59 19.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.74 146.71 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.283 1.033 . . . . 0.0 108.775 171.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.51 HD11 HH11 ' A' ' 116' ' ' ARG . 50.5 mt -122.57 137.47 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.002 0.921 . . . . 0.0 108.903 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.456 ' HG ' ' OH ' ' B' ' 21' ' ' TYR . 4.5 mm? -90.95 122.8 33.93 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.522 ' HE1' HG23 ' B' ' 55' ' ' VAL . 59.6 t80 -78.23 107.33 10.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.913 173.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.1 175.72 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.247 1.019 . . . . 0.0 109.788 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -105.9 -61.15 1.54 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.49 0.716 . . . . 0.0 110.233 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -87.15 110.82 36.4 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.896 0.878 . . . . 0.0 109.969 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.49 -65.67 0.08 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 122.369 2.046 . . . . 0.0 113.155 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.39 -38.94 49.79 Favored 'Trans proline' 0 C--N 1.403 3.441 0 CA-C-N 122.471 1.918 . . . . 0.0 111.81 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.17 -41.71 94.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -70.25 -35.39 73.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.498 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 33.3 m -58.12 -53.91 52.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.83 -37.37 81.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.126 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 73.7 t80 -59.71 -44.05 93.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.94 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.53 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 6.2 m-85 -72.98 -28.06 62.17 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.817 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' B' ' 18' ' ' THR . 58.4 mtpt -56.68 -50.64 71.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.95 0.795 . . . . 0.0 111.92 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.04 -34.6 50.4 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.971 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 21.8 tp -61.55 -53.41 56.64 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.558 1.143 . . . . 0.0 112.186 -174.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.433 ' HB2' HG21 ' B' ' 27' ' ' VAL . 12.3 mt -76.73 -51.13 12.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.64 25.06 6.13 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.232 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' B' ' 25' ' ' LEU . 28.5 m -130.8 176.19 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.302 1.041 . . . . 0.0 110.073 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -115.37 155.93 46.42 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.633 0.773 . . . . 0.0 109.13 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.69 112.65 3.58 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.604 1.536 . . . . 0.0 110.536 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.33 -37.46 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.838 0.455 . . . . 0.0 110.245 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.696 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.3 mm-40 -111.69 134.62 53.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 45.5 p -143.47 132.48 22.91 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 110.542 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -143.72 156.31 59.52 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.509 1.524 . . . . 0.0 108.133 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.06 -9.63 22.43 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.542 2.161 . . . . 0.0 113.57 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -126.7 -0.75 6.74 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -157.9 142.4 16.24 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 31.1 m -131.46 146.63 52.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.311 0.644 . . . . 0.0 110.056 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.696 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -134.12 119.91 19.47 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.77 140.75 40.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.652 1.581 . . . . 0.0 106.921 173.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.551 HG23 ' HG3' ' B' ' 46' ' ' LYS . 28.1 t -124.39 126.56 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.483 HD12 ' SD ' ' B' ' 45' ' ' MET . 9.6 mp -99.73 149.17 23.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.105 0.562 . . . . 0.0 109.887 -172.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.91 -6.3 31.97 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.957 0.903 . . . . 0.0 112.064 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 m-20 -68.23 -21.64 64.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.118 0.967 . . . . 0.0 112.025 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.31 17.77 16.8 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.126 -0.389 . . . . 0.0 112.126 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.681 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -123.78 174.8 7.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.692 0.797 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.551 ' HG3' HG23 ' B' ' 40' ' ' VAL . 79.4 tttt -145.47 140.48 27.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.91 121.17 16.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 -169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.99 166.35 15.56 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.744 0.688 . . . . 0.0 112.001 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' B' ' 9' ' ' LEU . 93.3 mt -134.59 105.02 6.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 166.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -109.86 118.98 37.91 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 74.2 p -80.78 140.91 35.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.467 0.307 . . . . 0.0 110.947 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.432 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 36.2 ptt180 -70.06 -18.56 63.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -170.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -79.09 -8.58 59.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -127.78 7.22 6.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.853 0.461 . . . . 0.0 111.107 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.522 HG23 ' HE1' ' B' ' 10' ' ' TYR . 8.0 p -75.6 150.08 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.271 -0.268 . . . . 0.0 110.897 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.65 116.71 24.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.634 0.774 . . . . 0.0 109.521 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 87.1 Cg_endo -76.51 140.47 65.68 Favored 'Cis proline' 0 C--N 1.388 2.647 0 C-N-CA 124.593 -1.003 . . . . 0.0 112.407 4.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 123.29 14.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.676 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.475 ' HB1' ' HH ' ' B' ' 10' ' ' TYR . . . -148.74 170.96 17.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.716 1.206 . . . . 0.0 108.515 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.432 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 33.9 t -147.3 90.97 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.853 0.359 . . . . 0.0 110.42 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.52 143.4 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.717 0.807 . . . . 0.0 109.692 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.6 p -145.56 124.3 12.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.221 1.008 . . . . 0.0 108.716 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.67 -68.85 0.17 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.702 ' HA2' ' HD2' ' B' ' 114' ' ' ARG . . . -151.55 148.16 18.88 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.77 -23.39 0.2 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.683 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . -163.71 116.65 0.72 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -101.95 144.64 30.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 108.806 -171.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 tp -109.39 101.23 10.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.81 111.76 22.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.192 0.451 . . . . 0.0 111.462 -169.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.1 112.21 24.02 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.068 1.347 . . . . 0.0 107.446 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.432 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.8 mtm180 -90.16 127.84 36.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -174.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.5 160.1 40.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.283 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.445 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.4 pt-20 -67.54 -34.55 77.31 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -173.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.412 HD21 ' HG3' ' B' ' 73' ' ' GLU . 8.0 p30 -163.3 178.55 8.05 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.962 0.801 . . . . 0.0 112.562 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.85 -30.74 67.94 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.284 1.433 . . . . 0.0 112.567 -167.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.5 -46.5 76.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.076 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.445 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 60.9 mm-40 -63.6 -23.12 67.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.312 1.045 . . . . 0.0 112.465 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -42.25 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 121.325 0.583 . . . . 0.0 109.903 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.27 -29.1 60.06 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.296 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 28.8 mt-10 -71.97 -44.94 62.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.166 0.508 . . . . 0.0 109.853 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 57.4 m -64.79 -33.64 76.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.269 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.454 ' O ' ' HE1' ' B' ' 92' ' ' MET . 39.7 t80 -56.18 -59.86 4.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.719 0.807 . . . . 0.0 109.385 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.51 89.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.559 -173.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.75 96.71 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.652 0.595 . . . . 0.0 113.456 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -64.66 -42.05 95.67 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.261 0.625 . . . . 0.0 110.061 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -60.22 -42.41 95.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.511 0.724 . . . . 0.0 110.664 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.27 66.29 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.578 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 26.8 t -98.67 14.25 29.22 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.375 1.07 . . . . 0.0 112.545 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.25 29.25 34.12 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -86.56 130.51 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.89 99.34 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.799 0.84 . . . . 0.0 112.597 -172.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 8.2 ptm 49.31 81.5 0.05 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.823 1.649 . . . . 0.0 114.316 166.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.36 83.03 1.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.611 -0.68 . . . . 0.0 110.37 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 24.6 tm0? 178.14 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -77.95 116.46 58.71 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.473 -0.775 . . . . 0.0 108.925 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.94 111.05 0.19 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.994 3.129 . . . . 0.0 113.216 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.12 145.98 45.51 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 110.534 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -75.28 98.61 3.84 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.418 ' HG3' ' H ' ' B' ' 101' ' ' PHE . 35.5 tpp -78.35 163.36 25.75 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.0 0.92 . . . . 0.0 109.495 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.48 -28.87 68.68 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.149 0.579 . . . . 0.0 111.777 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.418 ' H ' ' HG3' ' B' ' 99' ' ' MET . 71.3 m-85 -99.37 15.04 27.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.944 0.898 . . . . 0.0 111.38 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' B' ' 99' ' ' MET . . . 119.5 179.9 16.63 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.512 167.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' B' ' 98' ' ' LYS . 36.0 t80 -73.4 102.92 3.89 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -109.81 158.3 18.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.432 0.634 . . . . 0.0 111.511 -169.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.439 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 3.6 t80 -143.99 142.24 30.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.396 1.478 . . . . 0.0 108.579 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.419 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 m -133.06 121.89 23.34 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.372 0.987 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.16 150.29 27.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.113 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.91 171.33 8.14 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 165.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.431 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.0 p-10 -142.27 -176.81 0.59 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.631 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 22.0 Cg_exo -37.65 -52.11 1.66 Allowed 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.302 2.668 . . . . 0.0 114.403 166.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.96 -14.16 59.88 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.9 0.48 . . . . 0.0 111.719 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m 71.96 52.33 0.21 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.884 1.274 . . . . 0.0 111.044 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -79.86 176.18 9.96 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.116 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.702 ' HD2' ' HA2' ' B' ' 64' ' ' GLY . 0.0 OUTLIER -125.33 104.32 8.41 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 34.3 mt -118.12 103.8 10.22 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.222 1.009 . . . . 0.0 109.35 -170.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 58.8 mtt-85 -87.04 147.07 25.86 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 123.075 0.55 . . . . 0.0 110.911 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.56 118.89 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 163.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.432 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 9.6 p90 -125.7 164.89 19.65 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.482 0.583 . . . . 0.0 110.879 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.81 111.16 12.81 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.9 119.08 16.64 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 118.333 0.515 . . . . 0.0 110.51 -172.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.91 111.44 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.985 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.146 178.628 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HE3' HG22 ' B' ' 81' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.461 ' N ' ' SD ' ' A' ' 1' ' ' MET . 26.9 m -113.57 131.48 56.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -121.71 117.61 29.91 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.766 0.826 . . . . 0.0 109.206 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.97 129.1 11.21 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.925 2.417 . . . . 0.0 112.308 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.6 p-10 -113.19 10.87 18.66 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.571 0.701 . . . . 0.0 110.281 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.65 120.81 30.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -168.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -118.2 138.01 52.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.762 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 63.2 mt -123.98 126.59 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 84.9 mt -97.56 159.59 14.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -106.85 135.62 48.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.051 0.94 . . . . 0.0 109.428 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.4 m -127.94 179.38 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.288 0.949 . . . . 0.0 109.724 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -136.42 47.62 2.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 16' ' ' ALA . 51.6 t30 167.48 83.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.367 -168.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.4 -53.64 6.56 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 122.618 2.212 . . . . 0.0 114.606 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.59 -64.89 0.16 Allowed 'Trans proline' 0 C--N 1.403 3.424 0 CA-C-N 122.267 1.845 . . . . 0.0 113.509 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.513 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . . . -79.27 -37.37 38.01 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.993 -164.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -79.22 -24.43 43.1 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.863 0.102 . . . . 0.0 110.883 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 26.3 m -73.68 -42.71 60.92 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 172.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -64.37 -28.57 69.78 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.258 173.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.01 -48.07 72.39 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.536 0.523 . . . . 0.0 109.705 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.455 ' HH ' HD22 ' A' ' 115' ' ' LEU . 31.9 m-85 -68.53 -29.8 68.46 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.431 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -57.86 -48.29 80.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 118.145 0.429 . . . . 0.0 111.999 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.97 63.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.783 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.25 -30.21 70.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.654 1.182 . . . . 0.0 112.654 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB2' HG22 ' A' ' 27' ' ' VAL . 73.4 mt -106.12 -28.81 10.26 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.886 0.874 . . . . 0.0 110.248 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.89 21.97 47.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.229 0.331 . . . . 0.0 112.709 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.1 m -116.15 -178.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.042 0.937 . . . . 0.0 111.002 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -134.91 153.73 78.82 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.929 0.892 . . . . 0.0 109.236 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.71 134.11 23.34 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.629 2.22 . . . . 0.0 112.131 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG12 ' HG2' ' A' ' 31' ' ' GLU . 6.0 p -69.82 -41.88 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 170.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 31.7 mm-40 -121.89 143.61 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.23 1.012 . . . . 0.0 109.027 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -140.31 141.09 35.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.2 m -144.21 161.86 42.88 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.66 1.184 . . . . 0.0 108.767 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -53.11 -28.93 43.25 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 123.056 2.504 . . . . 0.0 113.624 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 t -127.69 -3.43 5.97 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -139.51 141.07 37.33 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.385 0.539 . . . . 0.0 110.447 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 t -125.03 137.88 54.22 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.554 1.142 . . . . 0.0 108.773 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.679 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.9 tp -127.52 114.38 17.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HE1' ' HG ' ' A' ' 49' ' ' LEU . 2.7 p90 -129.68 108.35 10.13 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.98 1.312 . . . . 0.0 108.608 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 46' ' ' LYS . 20.5 t -89.85 134.54 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.421 HD13 ' SD ' ' A' ' 45' ' ' MET . 56.5 mt -95.4 140.33 30.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.615 0.366 . . . . 0.0 110.844 -173.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.2 27.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.524 1.13 . . . . 0.0 112.289 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' B' ' 5' ' ' ASP . 53.6 t30 -68.91 -15.68 63.55 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.588 1.155 . . . . 0.0 110.912 173.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.55 16.76 13.51 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 122.94 0.305 . . . . 0.0 113.172 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.536 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -126.38 176.04 7.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.404 0.682 . . . . 0.0 109.568 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG23 ' A' ' 40' ' ' VAL . 80.2 tttt -134.47 134.8 41.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.008 0.523 . . . . 0.0 109.887 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.463 HD11 HD23 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -131.05 143.18 50.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 -173.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.31 169.17 18.27 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.028 0.823 . . . . 0.0 111.984 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HG ' ' HE1' ' A' ' 39' ' ' PHE . 80.8 mt -140.57 130.26 24.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.37 1.468 . . . . 0.0 107.768 164.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -127.92 128.37 45.0 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 49.6 m -80.42 125.17 29.6 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.977 0.511 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -65.62 -15.73 63.03 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.796 1.238 . . . . 0.0 114.283 -166.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -67.68 -24.01 65.37 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.187 0.595 . . . . 0.0 111.409 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -143.63 23.03 1.79 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.879 0.471 . . . . 0.0 110.617 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.47 150.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB2' ' HE1' ' B' ' 99' ' ' MET . 48.0 mt-10 -126.63 115.61 22.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.875 -0.516 . . . . 0.0 110.008 -177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 11.9 Cg_exo -70.65 142.63 72.78 Favored 'Cis proline' 0 C--N 1.387 2.574 0 CA-C-N 119.313 0.79 . . . . 0.0 112.519 -1.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.49 109.86 1.77 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.412 0.625 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.07 41.29 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 110.144 -168.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -79.62 88.94 5.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.2 m -126.48 131.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -158.77 123.96 4.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.301 1.44 . . . . 0.0 108.312 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.1 -36.14 0.71 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 113' ' ' HIS . . . 154.22 -62.39 0.36 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 69.03 -116.75 7.46 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -172.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.91 40.65 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.746 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 7.8 pt-20 -103.87 162.6 12.98 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.886 0.85 . . . . 0.0 112.124 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 47' ' ' LEU . 64.6 tp -119.08 102.5 8.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.069 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.9 115.1 23.32 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.394 0.543 . . . . 0.0 112.072 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.82 107.67 19.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.565 1.546 . . . . 0.0 108.431 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.67 133.89 34.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.568 . . . . 0.0 112.497 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -138.38 161.57 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.623 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.1 pt-20 -65.51 -42.1 92.43 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -171.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.4 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.4 p30 -158.65 179.83 8.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 111.812 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -56.07 -34.97 66.46 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.684 -166.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.68 -46.49 82.17 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.156 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 72.0 mm-40 -63.83 -24.31 67.7 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.964 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.19 -43.85 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.729 0.776 . . . . 0.0 110.271 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.88 -28.34 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.108 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.6 mt-10 -69.38 -45.04 70.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.35 0.595 . . . . 0.0 109.504 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -63.11 -36.24 82.93 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.404 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -54.8 -56.46 19.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.865 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.94 84.29 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.93 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.0 94.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.67 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.499 ' HB3' HG12 ' A' ' 90' ' ' VAL . 33.5 m0 -63.86 -44.89 91.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.467 0.707 . . . . 0.0 110.044 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.409 ' HB2' ' SD ' ' A' ' 92' ' ' MET . 32.2 ttpt -58.66 -42.26 88.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 110.582 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.57 65.15 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.804 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.0 m -103.38 17.8 23.25 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.314 1.046 . . . . 0.0 111.946 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.06 7.99 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 163.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 92' ' ' MET . 4.1 p -96.84 142.35 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -41.46 83.99 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.154 0.582 . . . . 0.0 111.374 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.607 ' HB3' HG13 ' A' ' 90' ' ' VAL . 9.6 ptm 48.26 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.919 1.687 . . . . 0.0 113.992 168.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.51 85.83 2.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.644 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 179.52 130.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.898 1.279 . . . . 0.0 108.703 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -82.57 115.0 55.79 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 166.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.63 118.2 3.91 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.163 2.575 . . . . 0.0 112.064 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.14 147.23 52.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.602 0.761 . . . . 0.0 110.167 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -68.44 123.03 19.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.421 0.688 . . . . 0.0 110.778 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.406 ' HE1' ' HB2' ' B' ' 56' ' ' GLU . 47.5 ttm -121.91 170.73 9.51 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.078 1.351 . . . . 0.0 109.283 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.12 -42.85 60.96 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.511 1.124 . . . . 0.0 112.283 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -90.55 1.22 56.93 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.317 0.647 . . . . 0.0 111.988 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.45 -172.37 18.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.285 168.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 119' ' ' ALA . 35.4 t80 -73.14 101.52 3.34 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -113.19 153.59 28.06 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.542 0.687 . . . . 0.0 111.369 -166.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.07 138.16 20.3 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.119 1.368 . . . . 0.0 108.528 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -129.64 125.4 36.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.588 0.631 . . . . 0.0 109.654 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.84 172.06 7.0 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.07 0.948 . . . . 0.0 110.839 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.27 124.25 25.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.609 0.763 . . . . 0.0 109.347 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 169.14 3.21 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 123.856 0.862 . . . . 0.0 111.572 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.73 -28.83 39.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.93 2.42 . . . . 0.0 113.069 168.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -93.56 13.97 20.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.205 1.002 . . . . 0.0 111.884 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m 54.96 81.19 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.57 1.548 . . . . 0.0 112.481 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.2 m170 -118.34 -173.26 2.43 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.593 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 12.1 mmm180 -121.76 112.64 18.64 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.455 HD22 ' HH ' ' A' ' 21' ' ' TYR . 71.4 mt -120.46 101.86 8.06 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -96.6 96.25 8.52 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -171.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -84.33 114.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -128.23 161.4 29.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.227 0.467 . . . . 0.0 111.365 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -118.23 117.84 30.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.984 0.914 . . . . 0.0 109.063 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -79.25 120.36 23.63 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.9 96.92 0.15 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.153 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.911 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 18.3 m -67.6 131.43 45.61 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.216 1.007 . . . . 0.0 112.676 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -121.49 117.96 30.0 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 123.934 0.893 . . . . 0.0 109.477 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.66 129.49 10.92 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.746 2.298 . . . . 0.0 112.231 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.536 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.2 p-10 -112.75 9.86 19.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.588 0.755 . . . . 0.0 110.299 171.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.7 120.73 30.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 138.03 52.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.746 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 48.7 mt -124.05 125.9 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 49' ' ' LEU . 11.2 mp -96.82 159.65 14.8 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.401 ' O ' ' NE2' ' B' ' 113' ' ' HIS . 15.4 p90 -107.05 135.14 49.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.169 0.988 . . . . 0.0 109.432 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' B' ' 51' ' ' SER . 21.2 m -127.59 179.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.29 0.95 . . . . 0.0 109.702 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.17 47.12 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 108.861 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' B' ' 16' ' ' ALA . 56.0 t30 167.67 83.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.451 -167.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.08 -53.31 6.97 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.519 2.146 . . . . 0.0 114.562 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.5 -65.38 0.14 Allowed 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.171 1.914 . . . . 0.0 113.41 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' ND2' ' B' ' 13' ' ' ASN . . . -79.09 -37.36 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.928 -164.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.9 t -78.96 -23.72 44.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.51 0.141 . . . . 0.0 110.807 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 92.3 m -74.77 -42.01 58.97 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -64.59 -28.89 69.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.98 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -65.66 -48.16 73.06 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.116 0.566 . . . . 0.0 109.949 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.445 ' HH ' HD22 ' B' ' 115' ' ' LEU . 35.2 m-85 -68.56 -29.77 68.4 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.66 175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 18' ' ' THR . 53.9 mtpt -57.63 -48.44 79.43 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.208 0.458 . . . . 0.0 112.03 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.4 -39.19 62.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.604 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.0 -29.93 69.99 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.929 1.292 . . . . 0.0 112.54 -174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.471 ' HB2' HG23 ' B' ' 27' ' ' VAL . 69.3 mt -106.4 -28.97 10.02 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.043 0.937 . . . . 0.0 110.212 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.2 21.54 48.71 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.336 0.398 . . . . 0.0 112.65 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' B' ' 25' ' ' LEU . 24.9 m -115.87 -178.59 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.125 0.97 . . . . 0.0 110.943 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -134.98 153.15 78.37 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 109.099 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.02 133.58 23.55 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.607 2.204 . . . . 0.0 112.377 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.424 HG11 ' HG2' ' B' ' 31' ' ' GLU . 5.6 p -68.87 -42.06 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.424 ' HG2' HG11 ' B' ' 30' ' ' VAL . 46.2 mm-40 -122.02 143.25 49.61 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 40.0 p -140.32 140.79 35.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.521 0.728 . . . . 0.0 109.214 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 73.3 m -144.3 162.13 41.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.775 1.23 . . . . 0.0 108.821 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -53.52 -28.56 45.77 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.128 2.552 . . . . 0.0 113.871 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -128.06 -3.35 5.74 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -139.53 141.72 37.27 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.759 0.709 . . . . 0.0 110.359 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -126.17 137.46 53.57 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.549 1.14 . . . . 0.0 108.903 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.57 114.97 18.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.522 ' HE1' ' HG ' ' B' ' 49' ' ' LEU . 2.6 p90 -129.86 108.61 10.28 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.928 1.291 . . . . 0.0 108.54 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.57 HG23 ' HG3' ' B' ' 46' ' ' LYS . 21.6 t -89.85 134.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.814 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.409 HD13 ' SD ' ' B' ' 45' ' ' MET . 53.9 mt -95.43 140.64 30.0 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 -173.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.05 -6.32 27.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.534 1.134 . . . . 0.0 112.371 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 5' ' ' ASP . 3.9 t30 -69.4 -15.48 63.31 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.066 0.946 . . . . 0.0 110.953 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 16.79 13.31 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 122.937 0.304 . . . . 0.0 113.313 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.52 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -126.13 175.97 7.38 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.53 0.732 . . . . 0.0 109.735 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' B' ' 40' ' ' VAL . 83.0 tttt -134.19 134.84 42.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.016 0.526 . . . . 0.0 109.862 -174.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.476 HD12 HD23 ' B' ' 68' ' ' LEU . 0.4 OUTLIER -131.2 142.94 50.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.786 0.434 . . . . 0.0 110.926 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.97 169.02 17.94 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 124.146 0.879 . . . . 0.0 111.88 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.522 ' HG ' ' HE1' ' B' ' 39' ' ' PHE . 81.3 mt -140.74 130.27 24.02 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.369 1.467 . . . . 0.0 107.947 164.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -128.23 128.15 44.17 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.6 m -80.41 125.14 29.55 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.886 0.474 . . . . 0.0 110.894 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -65.17 -16.01 63.05 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.971 1.309 . . . . 0.0 114.248 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -67.56 -23.55 65.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.261 0.625 . . . . 0.0 111.505 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.8 t -144.09 22.14 1.73 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.847 0.459 . . . . 0.0 110.421 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.18 150.47 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.259 0.623 . . . . 0.0 109.45 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.406 ' HB2' ' HE1' ' A' ' 99' ' ' MET . 49.5 mt-10 -126.78 117.36 22.46 Favored Pre-proline 0 N--CA 1.484 1.274 0 O-C-N 121.826 -0.546 . . . . 0.0 110.572 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.81 142.53 64.77 Favored 'Cis proline' 0 C--N 1.388 2.656 0 CA-C-N 119.362 0.808 . . . . 0.0 113.248 -4.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.04 110.57 1.85 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.238 0.615 . . . . 0.0 110.073 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.41 123.98 40.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.522 1.129 . . . . 0.0 110.094 -169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 52.9 m -79.04 88.91 4.78 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.5 131.21 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.56 124.18 4.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.254 1.422 . . . . 0.0 108.545 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -35.45 0.71 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' B' ' 113' ' ' HIS . . . 153.87 -62.72 0.37 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.577 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 69.25 -116.99 7.52 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -172.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 150.85 40.94 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 173.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.762 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 5.6 pt-20 -103.57 162.93 12.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.821 0.82 . . . . 0.0 112.219 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.476 HD23 HD12 ' B' ' 47' ' ' LEU . 59.4 tp -119.83 101.77 8.11 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.687 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.93 115.66 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.477 0.58 . . . . 0.0 112.025 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.32 107.09 18.97 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.544 1.538 . . . . 0.0 108.141 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.461 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.6 mtm180 -90.05 133.55 34.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.187 0.518 . . . . 0.0 112.134 -174.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -137.27 162.38 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.449 1.1 . . . . 0.0 110.6 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 16.1 pt-20 -65.41 -42.14 92.86 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.437 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -158.61 179.79 8.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.173 0.511 . . . . 0.0 112.367 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.44 -35.05 65.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.644 1.578 . . . . 0.0 112.741 -166.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.39 -46.01 81.79 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.048 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.574 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.7 mm-40 -64.24 -24.22 67.59 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.742 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.95 -43.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.761 0.791 . . . . 0.0 110.334 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -76.69 -28.26 55.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.843 -173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.8 mt-10 -68.89 -45.75 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 174.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.485 HG22 ' HE3' ' A' ' 1' ' ' MET . 95.5 m -62.22 -35.97 80.54 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.732 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.432 ' O ' ' HE1' ' B' ' 92' ' ' MET . 31.0 t80 -56.18 -56.01 26.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.078 0.951 . . . . 0.0 109.745 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.8 84.26 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.687 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.97 -40.49 95.31 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.858 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.47 -44.78 93.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.637 0.775 . . . . 0.0 110.211 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.16 -41.2 92.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.42 0.688 . . . . 0.0 110.487 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.86 -26.96 64.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.791 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 43.6 m -103.82 17.88 23.15 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.269 1.028 . . . . 0.0 111.823 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.07 47.29 8.53 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 163.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.45 141.16 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.88 87.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.231 0.612 . . . . 0.0 111.336 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 7.7 ptp 48.02 82.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.789 1.636 . . . . 0.0 114.289 168.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.15 84.78 2.03 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.735 177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -178.31 131.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.978 1.311 . . . . 0.0 108.608 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -82.7 114.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.521 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 6.2 Cg_endo -50.24 118.39 3.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.227 2.618 . . . . 0.0 112.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.57 148.56 52.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.593 0.757 . . . . 0.0 110.375 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.533 ' HZ2' ' HB2' ' B' ' 103' ' ' TYR . 0.3 OUTLIER -70.2 123.19 21.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.604 0.762 . . . . 0.0 109.986 178.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.4 ' HE1' ' HB2' ' A' ' 56' ' ' GLU . 45.7 ttm -121.94 170.84 9.4 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.934 1.293 . . . . 0.0 109.052 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.6 -43.3 56.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.714 1.206 . . . . 0.0 112.236 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.69 1.39 56.88 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.261 0.624 . . . . 0.0 112.184 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 127.69 -172.18 18.95 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.332 -0.395 . . . . 0.0 113.39 169.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.533 ' HB2' ' HZ2' ' B' ' 98' ' ' LYS . 34.3 t80 -75.09 101.75 4.65 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -113.39 153.5 28.47 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.405 0.621 . . . . 0.0 111.404 -165.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 3.5 t80 -149.86 138.44 20.76 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.119 1.368 . . . . 0.0 108.488 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.528 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 m -129.7 125.81 36.81 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.1 172.1 6.99 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.07 0.948 . . . . 0.0 110.959 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.04 125.68 28.58 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.576 0.75 . . . . 0.0 109.224 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.16 170.87 3.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.932 0.893 . . . . 0.0 110.912 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.4 -28.1 52.17 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.815 2.343 . . . . 0.0 112.722 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.67 13.79 21.09 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.031 0.932 . . . . 0.0 111.76 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m 55.25 80.97 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.25 1.42 . . . . 0.0 112.506 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.472 ' HA ' ' HA2' ' B' ' 64' ' ' GLY . 16.4 m170 -118.25 -173.03 2.38 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.612 ' HB3' ' HB3' ' B' ' 67' ' ' GLU . 10.9 mmm180 -121.49 112.65 18.77 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.445 HD22 ' HH ' ' B' ' 21' ' ' TYR . 71.9 mt -120.28 101.72 8.0 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -94.41 95.13 8.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.51 115.17 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -128.14 161.61 28.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.372 0.533 . . . . 0.0 111.502 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -118.24 118.97 33.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 0.0 108.805 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -81.12 127.04 32.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.48 94.32 4.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.018 0.927 . . . . 0.0 108.527 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.789 -1.006 . . . . 0.0 111.342 -179.366 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.761 0.315 . . . . 0.0 110.599 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -83.71 130.55 34.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.642 0.777 . . . . 0.0 109.623 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.432 ' HB3' HD22 ' B' ' 43' ' ' ASN . 15.4 m170 -96.45 112.78 61.07 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 -173.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.97 156.79 3.33 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.905 2.403 . . . . 0.0 112.815 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.2 p-10 -148.38 16.83 1.04 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.39 1.076 . . . . 0.0 109.662 167.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.09 136.67 49.58 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -144.95 140.59 28.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.579 HG12 ' HA3' ' A' ' 48' ' ' GLY . 19.4 mt -122.84 131.93 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.396 0.678 . . . . 0.0 109.664 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD23 HD22 ' A' ' 47' ' ' LEU . 4.0 mm? -103.06 145.21 30.24 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -98.28 127.51 44.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 m -127.82 160.96 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.34 0.656 . . . . 0.0 109.966 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.78 -60.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.103 0.961 . . . . 0.0 110.963 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -95.6 99.08 4.27 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 123.418 0.687 . . . . 0.0 109.728 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.05 -54.0 5.81 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 123.129 2.552 . . . . 0.0 115.639 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.79 -53.74 4.12 Favored 'Trans proline' 0 C--N 1.4 3.277 0 CA-C-N 122.363 1.88 . . . . 0.0 112.323 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.44 88.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.512 -168.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -79.88 -26.78 40.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.319 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -72.43 -38.67 68.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.071 0.462 . . . . 0.0 112.003 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.6 mm-40 -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.837 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.0 t80 -67.01 -42.32 85.15 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.631 0.582 . . . . 0.0 109.649 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -71.37 -29.81 65.4 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.008 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 53.3 mtpt -57.65 -49.78 75.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 111.875 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.58 -30.59 57.07 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.1 tp -62.44 -52.65 62.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.597 1.159 . . . . 0.0 111.785 -177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.4 mt -82.48 -40.62 20.84 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.456 1.102 . . . . 0.0 108.99 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.48 25.5 10.02 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.184 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 25' ' ' LEU . 28.3 m -126.21 177.89 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.854 0.861 . . . . 0.0 110.63 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.07 154.92 76.62 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.504 1.122 . . . . 0.0 108.644 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.61 125.07 13.72 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 121.96 1.773 . . . . 0.0 111.966 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.406 HG13 ' HG2' ' A' ' 31' ' ' GLU . 6.7 p -71.58 -39.83 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.17 0.51 . . . . 0.0 109.645 171.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.6 mm-40 -115.55 113.31 23.45 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 p -114.74 147.87 39.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.423 0.689 . . . . 0.0 110.877 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.3 t -148.29 151.7 37.57 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.76 1.224 . . . . 0.0 108.228 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.54 -20.61 69.34 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.349 2.033 . . . . 0.0 112.94 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -128.73 13.69 6.41 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -157.35 158.14 35.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.485 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 35.6 t -145.99 141.96 28.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.583 0.753 . . . . 0.0 109.018 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.5 tm? -137.59 114.67 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.22 112.95 15.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.463 1.105 . . . . 0.0 109.078 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 46' ' ' LYS . 14.8 t -93.47 128.02 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.443 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.1 mt -91.37 141.82 28.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 110.068 -168.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.98 -9.61 40.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.676 0.791 . . . . 0.0 112.082 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.596 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 4.6 m-20 -69.5 -1.21 8.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.14 0.976 . . . . 0.0 112.91 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.0 48.81 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 117.813 0.279 . . . . 0.0 112.706 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.72 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -129.07 172.54 11.29 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.659 0.784 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -128.33 135.98 50.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.582 0.753 . . . . 0.0 109.264 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.473 HD11 HD13 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -131.25 124.73 31.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.579 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -100.34 166.85 19.97 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 37' ' ' SER . 10.1 tp -143.52 105.31 4.34 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.41 ' HB2' HG21 ' A' ' 8' ' ' ILE . 2.8 t90 -105.09 131.78 52.15 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -73.35 126.45 30.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -68.75 -13.0 62.11 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 112.558 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -81.77 -8.25 59.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.236 0.614 . . . . 0.0 111.311 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 t -136.58 10.82 3.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 111.177 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.4 146.91 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.04 107.99 10.5 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.633 0.773 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HD3' ' HG3' ' B' ' 94' ' ' GLN . 93.7 Cg_endo -73.74 133.47 30.97 Favored 'Cis proline' 0 C--N 1.382 2.307 0 CA-C-N 120.541 1.229 . . . . 0.0 114.157 13.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -59.74 124.74 21.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.577 1.151 . . . . 0.0 110.8 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.97 108.1 3.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.856 0.863 . . . . 0.0 109.535 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.7 t -89.41 87.0 6.92 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.75 138.22 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 109.252 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 p -150.44 122.28 8.13 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.5 -92.06 0.14 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.83 64.14 3.96 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 123.011 0.338 . . . . 0.0 112.495 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' B' ' 65' ' ' GLY . . . -98.83 173.91 27.32 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.54 159.27 45.48 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.632 -0.538 . . . . 0.0 112.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 9.6 pt-20 -102.31 145.44 29.46 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.603 0.701 . . . . 0.0 111.145 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.77 102.76 11.52 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 108.009 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.79 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -89.25 114.91 26.32 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.01 0.433 . . . . 0.0 112.035 -168.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.78 120.31 33.89 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.015 1.326 . . . . 0.0 108.374 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 32.3 mtm180 -96.4 127.48 42.43 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.812 0.815 . . . . 0.0 112.302 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.16 157.62 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.916 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -68.21 -34.87 77.04 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.89 -179.43 6.28 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.978 0.808 . . . . 0.0 112.752 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.35 -31.72 69.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.483 1.513 . . . . 0.0 113.016 -166.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.89 -44.87 79.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.08 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -65.82 -24.31 66.87 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.65 -44.91 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.574 0.749 . . . . 0.0 109.973 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.62 -28.34 56.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.694 0.798 . . . . 0.0 111.509 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 31.7 mt-10 -62.03 -44.24 97.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.611 0.719 . . . . 0.0 109.534 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -69.61 -35.0 74.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.988 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -54.52 -59.9 4.07 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.555 1.142 . . . . 0.0 109.977 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.463 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -64.42 -35.37 80.69 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.589 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.87 -46.81 79.97 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.836 0.71 . . . . 0.0 113.994 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -65.68 -40.82 92.77 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.898 0.479 . . . . 0.0 109.76 175.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.9 ttpt -57.64 -45.09 85.91 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.61 0.764 . . . . 0.0 110.479 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.75 -24.28 61.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -98.11 14.56 27.15 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.937 0.895 . . . . 0.0 111.689 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.86 41.17 8.31 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 115.222 164.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.502 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.1 p -89.21 149.4 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.04 -54.44 11.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.961 0.504 . . . . 0.0 110.796 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.502 ' HB2' HG13 ' A' ' 90' ' ' VAL . 47.5 ttm 68.67 84.94 0.14 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.246 0.966 . . . . 0.0 113.027 169.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.85 84.38 2.16 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.553 0.692 . . . . 0.0 110.965 173.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 178.04 122.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.768 1.627 . . . . 0.0 107.736 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.02 121.8 86.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 0.0 109.72 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 46.3 Cg_endo -64.95 108.34 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.766 2.31 . . . . 0.0 110.084 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.15 48.71 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.207 0.603 . . . . 0.0 110.543 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HZ1' ' HB2' ' A' ' 103' ' ' TYR . 5.0 mmtm -67.81 131.63 45.89 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.421 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.499 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 12.4 ttt -141.04 -178.07 5.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.016 0.926 . . . . 0.0 109.245 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' H ' ' HG2' ' A' ' 99' ' ' MET . 7.4 mp0 -58.8 -37.36 76.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.609 1.164 . . . . 0.0 111.899 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 33.9 m-85 -84.33 -8.4 59.02 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.84 0.856 . . . . 0.0 111.119 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 116.41 -157.12 15.22 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.493 ' HB2' ' HZ1' ' A' ' 98' ' ' LYS . 26.9 t80 -79.35 103.48 9.3 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.916 0.858 . . . . 0.0 108.956 -176.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.439 HG23 ' SD ' ' A' ' 99' ' ' MET . 13.1 t -109.48 152.76 24.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.38 0.61 . . . . 0.0 110.84 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 6.5 t80 -143.19 145.22 32.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.921 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.4 m -135.73 132.65 37.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.485 0.584 . . . . 0.0 110.591 172.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.58 172.59 6.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.67 0.788 . . . . 0.0 110.341 170.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.64 116.06 12.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.511 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 7.2 p-10 -71.26 171.45 8.71 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 123.309 0.644 . . . . 0.0 110.277 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 9.6 Cg_endo -50.62 -40.09 55.63 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.873 2.382 . . . . 0.0 113.463 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.12 -1.04 54.23 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.637 0.775 . . . . 0.0 110.73 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m 64.6 75.24 0.38 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.784 1.234 . . . . 0.0 112.08 164.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.45 162.65 22.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 1.1 mpt_? -90.35 111.27 22.43 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.51 104.19 16.2 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.79 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 7.4 tpt180 -89.49 146.09 24.86 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.198 0.599 . . . . 0.0 110.144 -172.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.26 122.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 164.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.532 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 5.3 p90 -127.48 156.82 41.53 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.602 0.637 . . . . 0.0 110.928 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.48 112.57 17.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 171.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 49.7 t80 -77.74 116.39 18.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -171.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.5 94.38 9.69 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.579 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -178.707 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.453 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.901 0.382 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.1 m -79.94 130.97 35.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 109.874 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -98.23 112.3 61.74 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.776 0.83 . . . . 0.0 110.754 -171.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -91.83 155.4 3.4 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.983 2.456 . . . . 0.0 112.959 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.72 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 4.5 p-10 -146.58 17.28 1.3 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.301 1.04 . . . . 0.0 110.155 167.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.5 136.65 49.18 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.84 140.67 28.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.404 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 11.2 mt -122.9 132.43 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.341 0.656 . . . . 0.0 109.545 -176.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.96 145.37 30.51 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -99.29 127.35 45.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.465 1.106 . . . . 0.0 110.517 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.67 160.9 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.241 0.616 . . . . 0.0 109.95 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -95.54 -60.9 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.278 1.031 . . . . 0.0 110.883 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -95.93 99.05 4.48 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 123.564 0.746 . . . . 0.0 109.333 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.76 -54.86 4.39 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.107 2.538 . . . . 0.0 115.552 -169.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 -54.15 4.22 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 122.461 1.915 . . . . 0.0 112.123 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.83 89.06 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.465 -168.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 85.9 p -79.5 -27.82 41.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.427 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 39.9 m -71.32 -38.97 71.67 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.527 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 83.0 mm-40 -65.6 -33.93 77.05 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.729 172.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 53.2 t80 -66.79 -41.96 86.76 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -71.82 -29.69 64.69 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.258 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.527 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 10.3 mtpm? -57.87 -49.1 77.87 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.267 0.485 . . . . 0.0 112.177 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.68 57.15 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.656 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.486 HD13 HD12 ' B' ' 115' ' ' LEU . 13.4 tp -62.75 -52.78 61.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.447 1.099 . . . . 0.0 112.014 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.0 mt -82.21 -40.55 21.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.913 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.01 9.82 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.011 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.0 m -125.88 178.39 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.97 155.27 77.97 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.166 0.986 . . . . 0.0 108.526 171.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.34 124.59 13.13 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.125 1.884 . . . . 0.0 112.172 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.5 p -71.22 -40.4 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.08 0.552 . . . . 0.0 109.588 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 68.0 mm-40 -114.35 113.84 25.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 73.8 p -115.33 147.96 39.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.999 0.52 . . . . 0.0 110.83 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.2 t -148.48 151.27 35.97 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.532 1.133 . . . . 0.0 108.34 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.96 -20.68 68.38 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.424 2.082 . . . . 0.0 113.117 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -128.66 13.62 6.44 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -157.13 158.37 36.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.843 -0.536 . . . . 0.0 109.688 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . 34.7 t -146.07 141.83 27.97 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 109.086 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.637 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -137.52 114.6 10.79 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.04 113.08 15.97 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.527 1.131 . . . . 0.0 109.15 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.541 HG21 ' HG3' ' B' ' 46' ' ' LYS . 17.2 t -93.69 127.55 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.341 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.518 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.2 mt -91.26 141.36 28.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.062 0.545 . . . . 0.0 110.227 -169.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.36 -9.4 33.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.038 0.935 . . . . 0.0 112.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.55 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 4.2 m-20 -69.61 -1.93 10.21 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.159 0.983 . . . . 0.0 112.679 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.25 17.51 46.33 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.723 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.685 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -128.92 173.08 10.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.549 0.74 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.541 ' HG3' HG21 ' B' ' 40' ' ' VAL . 87.8 tttt -128.66 136.25 50.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.403 0.681 . . . . 0.0 109.482 -176.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.478 HD11 HD13 ' B' ' 41' ' ' LEU . 0.7 OUTLIER -131.06 124.68 31.38 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.27 166.36 20.93 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' B' ' 37' ' ' SER . 9.5 tp -143.46 105.07 4.32 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -105.08 132.06 51.78 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 52.8 m -73.54 126.17 29.62 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -68.64 -13.12 62.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.581 0.752 . . . . 0.0 112.552 -172.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -81.41 -8.35 59.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.309 0.644 . . . . 0.0 111.331 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.3 t -136.59 10.87 3.18 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.255 0.622 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.82 146.99 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.97 108.85 10.64 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.584 0.754 . . . . 0.0 109.049 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.57 134.04 32.64 Favored 'Cis proline' 0 C--N 1.383 2.381 0 CA-C-N 120.339 1.157 . . . . 0.0 114.215 11.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -60.61 124.06 19.26 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.651 1.181 . . . . 0.0 111.22 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.32 108.02 3.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 109.508 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.4 p -89.2 86.07 6.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.32 140.43 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.166 0.986 . . . . 0.0 108.584 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -152.33 122.31 7.06 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.9 -91.84 0.14 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.22 63.81 4.29 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 123.041 0.353 . . . . 0.0 113.315 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' A' ' 65' ' ' GLY . . . -99.43 173.98 26.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.915 -0.381 . . . . 0.0 112.27 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.53 159.6 45.03 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 124.019 0.482 . . . . 0.0 112.097 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.504 ' HB3' ' HB2' ' B' ' 114' ' ' ARG . 9.2 pt-20 -101.99 145.35 29.4 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.458 0.647 . . . . 0.0 110.895 -176.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -110.06 102.92 11.59 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.737 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.29 114.83 26.25 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.183 0.516 . . . . 0.0 111.933 -168.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -93.36 120.51 33.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.041 1.336 . . . . 0.0 108.523 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.481 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 33.3 mtm105 -97.36 126.08 42.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.64 0.734 . . . . 0.0 112.188 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.98 157.82 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.348 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.1 pt-20 -67.04 -35.11 79.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -164.45 -179.05 5.76 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.91 -31.75 70.11 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.688 -166.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.28 -45.34 80.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.01 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.433 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 83.1 mm-40 -65.42 -24.1 67.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.261 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.68 -44.51 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.382 0.673 . . . . 0.0 109.858 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.21 -28.15 53.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.587 0.755 . . . . 0.0 111.364 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 40.4 mt-10 -62.54 -43.85 97.8 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.758 0.79 . . . . 0.0 109.325 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 54.3 m -69.89 -35.02 74.3 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.14 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -54.59 -59.68 4.37 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.47 1.108 . . . . 0.0 110.223 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -64.67 -34.87 79.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.539 -175.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.88 -47.29 76.3 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 123.729 0.643 . . . . 0.0 113.804 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.54 -41.09 93.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 34.3 ttpt -57.27 -45.0 84.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.591 0.756 . . . . 0.0 110.482 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.62 61.62 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.072 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -97.5 14.82 25.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.041 0.937 . . . . 0.0 111.931 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.67 41.43 8.29 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' B' ' 92' ' ' MET . 3.3 p -89.6 149.4 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.25 -54.69 10.03 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.795 0.438 . . . . 0.0 110.691 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.519 ' HB2' HG11 ' B' ' 90' ' ' VAL . 49.1 ttm 68.76 84.99 0.14 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.944 0.777 . . . . 0.0 112.922 168.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.94 84.29 2.14 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 121.571 0.701 . . . . 0.0 110.821 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.413 ' HG3' ' HD3' ' A' ' 57' ' ' PRO . 24.1 tm0? 178.27 122.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.468 1.507 . . . . 0.0 107.14 173.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.41 120.63 82.55 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.366 0.667 . . . . 0.0 109.939 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.542 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 37.0 Cg_endo -63.38 108.41 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.795 2.33 . . . . 0.0 110.514 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.49 156.62 47.93 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.011 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -68.31 131.89 46.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.283 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.489 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 8.8 ttt -141.19 -178.42 5.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.96 0.904 . . . . 0.0 108.897 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.489 ' H ' ' HG2' ' B' ' 99' ' ' MET . 7.3 mp0 -58.55 -37.61 76.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.429 1.092 . . . . 0.0 112.187 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -83.61 -8.69 59.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.778 0.831 . . . . 0.0 111.16 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 116.76 -156.65 15.5 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -79.61 103.49 9.55 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.044 0.922 . . . . 0.0 108.92 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.474 HG23 ' SD ' ' B' ' 99' ' ' MET . 14.8 t -109.75 152.47 25.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.958 0.503 . . . . 0.0 110.582 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.542 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 7.3 t80 -142.98 144.72 32.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.8 1.24 . . . . 0.0 109.971 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -135.17 132.16 37.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.417 0.553 . . . . 0.0 110.705 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.56 172.63 6.71 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.718 0.807 . . . . 0.0 110.35 170.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.87 115.39 11.92 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.513 ' HB3' HD11 ' B' ' 115' ' ' LEU . 4.3 p-10 -69.8 170.83 8.54 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.58 0.752 . . . . 0.0 110.728 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 9.6 Cg_endo -50.66 -40.18 55.91 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.789 2.326 . . . . 0.0 113.199 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.76 -0.87 52.75 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.482 0.713 . . . . 0.0 111.053 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.0 m 64.17 74.75 0.4 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.741 1.217 . . . . 0.0 112.043 165.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -122.62 162.61 21.58 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 166.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 2.6 mpt_? -90.01 112.08 23.39 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' B' ' 109' ' ' ASP . 33.0 mt -98.97 104.37 16.4 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.737 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 30.4 mmt180 -87.55 146.24 25.87 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 123.804 0.841 . . . . 0.0 110.834 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 t -139.56 122.01 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 163.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.481 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.0 p90 -127.13 156.56 41.56 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.866 0.757 . . . . 0.0 111.132 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.409 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -123.57 112.52 17.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.38 118.76 20.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.4 94.35 6.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.347 -179.388 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HE2' ' HG1' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.444 ' HA ' HG11 ' B' ' 72' ' ' VAL . 85.3 m -141.32 146.98 37.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.788 0.835 . . . . 0.0 111.395 -165.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.471 ' HB3' ' ND2' ' B' ' 43' ' ' ASN . 17.9 m-70 -136.78 103.05 9.23 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 124.376 1.071 . . . . 0.0 108.491 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HG3' HD23 ' B' ' 25' ' ' LEU . 51.2 Cg_endo -90.83 48.65 0.75 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.361 2.708 . . . . 0.0 112.672 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.566 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 5.9 p-10 -75.47 14.81 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.173 0.989 . . . . 0.0 112.609 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.464 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.2 t80 -133.37 129.93 38.1 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.134 1.374 . . . . 0.0 108.137 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 8.2 t -127.33 140.86 51.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.237 1.015 . . . . 0.0 108.576 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 61.4 mt -118.8 137.24 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.494 HD21 HD23 ' A' ' 47' ' ' LEU . 4.3 mm? -96.72 146.28 25.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.572 ' HE1' HG21 ' A' ' 55' ' ' VAL . 22.8 t80 -101.32 95.72 6.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.341 -167.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG11 ' HE1' ' A' ' 113' ' ' HIS . 27.0 m -108.87 -179.85 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.33 -53.87 1.7 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.876 0.47 . . . . 0.0 110.258 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.74 105.55 9.19 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 123.567 0.747 . . . . 0.0 110.764 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.68 -55.48 3.5 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 C-N-CA 122.735 2.29 . . . . 0.0 114.081 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.44 -58.9 0.5 Allowed 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 122.271 1.847 . . . . 0.0 112.312 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.71 95.51 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.337 -166.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.9 p -76.68 -34.83 58.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.287 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 99.3 m -69.11 -39.12 79.14 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.55 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 12.4 mm100 -64.3 -35.47 80.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.411 172.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 77.7 t80 -68.28 -39.46 82.14 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.27 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -70.41 -30.55 67.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.208 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.4 mtpt -57.13 -47.76 80.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.946 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.28 -34.53 55.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.223 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.0 tp -61.13 -31.46 71.16 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.861 1.265 . . . . 0.0 112.646 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.558 HD23 ' HG3' ' B' ' 4' ' ' PRO . 87.3 mt -105.46 -40.08 5.92 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.364 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.34 29.65 10.0 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.51 -179.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.218 1.007 . . . . 0.0 109.616 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.83 150.8 68.93 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.546 0.738 . . . . 0.0 109.078 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.97 111.9 2.78 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.812 2.342 . . . . 0.0 112.099 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -64.02 -42.28 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.759 0.824 . . . . 0.0 110.598 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 28.5 mm-40 -111.49 145.49 38.94 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -154.55 152.23 29.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.326 0.584 . . . . 0.0 109.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 15.2 m -139.86 163.95 41.2 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.44 1.496 . . . . 0.0 107.655 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.19 -30.51 80.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.331 2.021 . . . . 0.0 113.069 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -130.04 23.11 5.29 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.548 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 88.7 t80 -153.63 159.28 42.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.091 0.556 . . . . 0.0 109.72 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.4 m -149.36 154.56 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 110.077 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -148.36 123.14 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.96 131.54 47.49 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.961 1.304 . . . . 0.0 108.46 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 46' ' ' LYS . 33.8 t -109.6 126.29 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.74 0.816 . . . . 0.0 109.175 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.31 145.17 26.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.219 0.608 . . . . 0.0 109.652 -170.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.66 -5.56 12.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.974 0.91 . . . . 0.0 112.585 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -67.06 -9.12 35.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.445 1.098 . . . . 0.0 112.743 175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.69 59.68 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -119.98 164.22 16.42 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.125 0.97 . . . . 0.0 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 40' ' ' VAL . 73.6 tttt -132.02 138.83 48.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.494 HD23 HD21 ' A' ' 9' ' ' LEU . 1.2 tt -137.24 122.6 19.45 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.464 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -102.96 170.11 19.58 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.95 0.786 . . . . 0.0 111.653 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.73 109.59 5.77 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.454 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 1.9 t-105 -109.26 127.75 54.52 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -79.59 122.86 27.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.006 0.522 . . . . 0.0 110.118 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.35 -15.87 63.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.399 1.08 . . . . 0.0 112.686 -169.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -72.03 -8.88 57.11 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 122.842 0.457 . . . . 0.0 111.233 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -135.1 6.36 3.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.334 0.653 . . . . 0.0 111.244 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.572 HG21 ' HE1' ' A' ' 10' ' ' TYR . 8.3 p -62.75 148.63 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.539 0.335 . . . . 0.0 111.34 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -122.98 113.9 29.76 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.356 0.663 . . . . 0.0 109.783 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.41 144.92 80.67 Favored 'Cis proline' 0 C--N 1.379 2.174 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.084 1.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -52.86 128.29 26.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.66 1.184 . . . . 0.0 112.218 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' HB2' ' OH ' ' A' ' 10' ' ' TYR . . . -150.87 121.14 7.28 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.236 0.614 . . . . 0.0 110.98 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -91.29 86.94 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.34 124.64 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -152.33 123.69 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.114 1.366 . . . . 0.0 107.98 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.63 67.43 0.02 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -82.09 1.69 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.0 -142.92 45.68 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.377 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' B' ' 66' ' ' GLY . . . -65.96 151.76 51.93 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.2 mt-10 -102.14 152.89 20.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.164 0.507 . . . . 0.0 110.585 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.4 tp -118.84 102.23 8.65 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.08 115.63 26.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.19 0.519 . . . . 0.0 111.332 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 30.8 m-85 -95.38 108.25 20.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 0.0 108.235 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -92.38 128.08 38.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.586 0.707 . . . . 0.0 111.975 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' B' ' 2' ' ' THR . 24.8 m -128.41 160.95 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 13.0 pt-20 -66.79 -35.19 79.49 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.457 HD21 ' HG3' ' A' ' 73' ' ' GLU . 7.3 p30 -165.05 178.56 6.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.7 0.682 . . . . 0.0 112.281 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.16 -31.98 63.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.786 1.634 . . . . 0.0 113.1 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.25 -46.87 84.87 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 123.902 0.751 . . . . 0.0 110.101 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.564 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 83.3 mm-40 -67.9 -23.03 65.06 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.653 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.62 -41.68 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.65 0.738 . . . . 0.0 109.904 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.27 -33.82 65.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 110.971 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 41.5 mt-10 -65.91 -44.69 84.45 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.626 0.727 . . . . 0.0 109.312 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -63.49 -37.61 87.95 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.952 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -55.13 -61.54 2.25 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.271 1.029 . . . . 0.0 110.466 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -68.79 -32.69 72.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.301 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.24 -46.39 90.99 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.483 0.489 . . . . 0.0 112.94 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.52 -43.74 98.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.258 0.623 . . . . 0.0 109.529 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -55.84 -45.76 78.31 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.451 0.7 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.74 61.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.297 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 t -100.56 4.1 43.22 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 111.829 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.57 52.91 2.72 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.401 167.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG11 ' HB2' ' A' ' 92' ' ' MET . 4.8 p -94.76 153.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.14 -53.93 15.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.698 0.399 . . . . 0.0 110.771 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.523 ' HB2' HG11 ' A' ' 90' ' ' VAL . 48.6 ttm 64.53 83.8 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 169.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 82.55 1.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.305 0.574 . . . . 0.0 110.599 173.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HB2' ' HD3' ' B' ' 57' ' ' PRO . 56.9 tp60 176.71 130.46 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.867 1.667 . . . . 0.0 108.303 172.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -82.15 123.68 79.3 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.438 ' HB2' ' HH ' ' A' ' 103' ' ' TYR . 73.5 Cg_exo -48.19 107.05 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.469 2.779 . . . . 0.0 111.972 174.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.06 50.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.777 0.831 . . . . 0.0 111.254 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 98' ' ' LYS . 2.2 mmmm -70.77 100.63 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.545 0.738 . . . . 0.0 110.308 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.7 ttm -101.34 169.4 8.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.258 1.023 . . . . 0.0 108.815 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.12 -41.6 48.97 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.35 1.06 . . . . 0.0 112.136 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.08 -12.12 60.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.581 0.752 . . . . 0.0 111.164 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.96 -173.5 21.55 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.467 0.556 . . . . 0.0 111.933 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.438 ' HH ' ' HB2' ' A' ' 96' ' ' PRO . 28.4 t80 -77.14 100.81 5.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.2 t -113.44 147.5 37.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -167.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -140.78 134.21 29.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.098 0.959 . . . . 0.0 109.296 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.8 m -120.26 118.26 29.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.796 0.438 . . . . 0.0 110.272 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.01 169.69 8.35 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.143 0.577 . . . . 0.0 109.894 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.85 127.73 29.39 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.73 169.53 2.5 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.542 0.737 . . . . 0.0 110.791 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -49.51 -31.81 25.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.573 2.182 . . . . 0.0 112.444 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.52 4.0 41.76 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.543 1.137 . . . . 0.0 112.263 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.4 m 59.31 84.2 0.12 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.702 1.201 . . . . 0.0 112.259 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.443 ' HE1' HG11 ' A' ' 11' ' ' VAL . 22.5 m170 -122.73 176.57 5.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.075 0.55 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 67' ' ' GLU . 24.9 mmt180 -100.3 112.46 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.1 mt -111.78 100.32 8.84 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -99.5 93.33 5.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.247 0.219 . . . . 0.0 110.971 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.48 116.21 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -125.19 168.49 13.37 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.027 -174.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.85 112.04 13.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.75 114.42 18.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.9 95.31 6.7 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.576 0.75 . . . . 0.0 109.535 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 CA-C-O 119.167 -0.796 . . . . 0.0 112.383 178.472 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptm . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.405 ' HA ' HG11 ' A' ' 72' ' ' VAL . 27.6 m -143.12 144.53 32.26 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -135.47 103.73 10.28 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.592 1.157 . . . . 0.0 108.889 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.558 ' HG3' HD23 ' A' ' 25' ' ' LEU . 54.3 Cg_endo -90.57 49.69 0.89 Allowed 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.444 2.762 . . . . 0.0 112.851 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.457 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.9 p-10 -75.69 14.24 0.67 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.304 1.041 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.466 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.3 t80 -133.48 129.25 36.94 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.222 1.409 . . . . 0.0 108.2 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 8.2 t -126.85 141.3 51.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 55.6 mt -119.79 137.19 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.55 145.43 25.72 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.47 97.74 8.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.223 -169.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.433 HG11 ' HE1' ' B' ' 113' ' ' HIS . 30.5 m -109.14 179.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -123.78 -53.45 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.727 0.411 . . . . 0.0 110.405 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.11 105.12 8.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 123.635 0.774 . . . . 0.0 109.828 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.23 -55.25 3.83 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.576 2.184 . . . . 0.0 114.357 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 -58.63 0.52 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 CA-C-N 122.243 1.837 . . . . 0.0 112.248 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.36 -44.37 94.98 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.282 -166.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m -76.35 -34.57 58.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.662 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 63.3 m -69.34 -39.43 78.15 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.9 mm-40 -63.89 -35.89 82.15 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.527 172.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 58.2 t80 -68.08 -39.51 82.89 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.322 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -70.18 -30.64 67.81 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.329 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 61.2 mtpt -57.07 -47.63 80.52 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.59 -34.52 53.49 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.264 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 11.8 tp -60.66 -31.93 71.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.699 1.2 . . . . 0.0 112.641 -177.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.509 HD23 ' HG3' ' A' ' 4' ' ' PRO . 91.4 mt -105.07 -40.26 5.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.511 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.38 29.62 10.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 123.725 0.64 . . . . 0.0 111.823 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' B' ' 25' ' ' LEU . 29.4 m -126.62 -179.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.318 1.047 . . . . 0.0 109.809 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.33 150.81 70.0 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.432 0.693 . . . . 0.0 109.209 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 54.6 Cg_endo -68.53 111.92 2.69 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.469 2.113 . . . . 0.0 112.26 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 p -64.17 -42.33 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.773 0.829 . . . . 0.0 110.287 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.556 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 18.9 mm-40 -111.41 145.93 38.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 108.302 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -154.85 152.05 29.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.279 0.562 . . . . 0.0 110.014 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.542 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 24.9 m -139.39 163.4 45.8 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.401 1.48 . . . . 0.0 107.616 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.77 -30.99 69.96 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.483 2.122 . . . . 0.0 113.325 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -130.29 23.0 5.19 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.542 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 70.0 t80 -153.75 159.2 41.87 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -149.37 154.42 38.9 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.826 0.851 . . . . 0.0 109.955 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -148.2 122.91 9.88 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.6 p90 -128.6 132.58 48.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.853 1.261 . . . . 0.0 108.544 173.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.537 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.5 t -109.99 126.47 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.667 0.787 . . . . 0.0 109.143 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.38 145.15 27.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.174 0.589 . . . . 0.0 109.537 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.16 -5.66 14.51 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.876 0.87 . . . . 0.0 112.655 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.56 ' HB2' ' HG2' ' B' ' 45' ' ' MET . 13.5 m120 -65.8 -10.42 37.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.642 1.177 . . . . 0.0 112.649 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.53 58.58 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 14.9 ptm -118.76 165.2 14.3 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.238 1.015 . . . . 0.0 109.249 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.537 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.77 139.46 47.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.1 tt -137.79 122.73 18.96 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.036 0.446 . . . . 0.0 110.502 -171.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.466 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.94 169.44 19.0 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 123.997 0.808 . . . . 0.0 111.434 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 45.8 mt -139.94 110.05 6.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -107.76 128.6 54.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -79.69 122.82 27.04 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.071 0.548 . . . . 0.0 110.185 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -69.89 -15.08 63.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.323 1.049 . . . . 0.0 112.621 -169.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -72.62 -8.48 55.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 122.684 0.394 . . . . 0.0 111.132 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.2 t -134.81 4.16 3.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.569 0.748 . . . . 0.0 111.414 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.02 148.23 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.867 0.467 . . . . 0.0 111.562 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -123.68 113.81 28.67 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.804 0.841 . . . . 0.0 109.527 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 94' ' ' GLN . 83.8 Cg_endo -76.76 145.56 81.87 Favored 'Cis proline' 0 C--N 1.382 2.338 0 C-N-CA 124.516 -1.035 . . . . 0.0 113.16 1.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.589 ' HZ1' ' HB2' ' B' ' 58' ' ' LYS . 0.1 OUTLIER -53.68 128.66 30.3 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.553 1.141 . . . . 0.0 111.992 178.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.32 120.88 7.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.389 0.675 . . . . 0.0 110.886 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 35.6 p -91.12 87.25 6.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.34 124.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.364 0.665 . . . . 0.0 109.739 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -152.64 123.07 7.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.305 1.442 . . . . 0.0 108.123 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.85 67.83 0.02 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.67 -82.24 1.68 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.29 -142.33 44.3 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.809 -0.439 . . . . 0.0 112.452 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 66' ' ' GLY . . . -66.86 152.46 52.66 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 174.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 10.4 mt-10 -103.9 152.08 22.38 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.042 0.537 . . . . 0.0 110.197 -172.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 tp -118.81 102.34 8.74 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.2 116.09 27.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.216 0.531 . . . . 0.0 111.194 -170.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.47 ' HB2' HG23 ' B' ' 117' ' ' VAL . 29.0 m-85 -96.28 107.96 20.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.135 1.374 . . . . 0.0 108.297 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -91.86 126.4 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.599 0.714 . . . . 0.0 111.89 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 2' ' ' THR . 29.6 m -126.25 161.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.148 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.456 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.88 -34.62 78.19 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -174.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -165.78 179.0 6.19 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.648 0.658 . . . . 0.0 112.212 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.39 -31.49 65.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.519 1.528 . . . . 0.0 113.03 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.43 -46.42 86.39 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.181 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.456 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 72.4 mm-40 -68.16 -23.38 64.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.322 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.59 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.574 0.702 . . . . 0.0 109.69 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.48 -32.99 62.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.933 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 33.4 mt-10 -65.9 -44.31 85.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.534 0.683 . . . . 0.0 109.495 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.8 m -64.66 -36.45 84.3 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.991 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -55.03 -61.68 2.15 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.41 1.084 . . . . 0.0 110.28 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.11 -32.32 71.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.368 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.48 -45.66 92.55 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.53 0.519 . . . . 0.0 112.935 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -63.89 -43.19 96.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.333 0.653 . . . . 0.0 109.924 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.483 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 33.6 ttpt -55.65 -45.76 77.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.592 0.757 . . . . 0.0 110.184 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.62 -20.73 61.23 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.345 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.95 4.15 44.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.796 0.838 . . . . 0.0 112.475 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 52.86 2.74 Favored Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 114.471 168.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' B' ' 92' ' ' MET . 4.9 p -94.57 153.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.82 -54.0 15.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.742 0.417 . . . . 0.0 110.991 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.528 ' HB2' HG11 ' B' ' 90' ' ' VAL . 52.9 ttm 64.43 83.7 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.841 0.713 . . . . 0.0 112.67 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.73 82.46 1.86 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.442 0.639 . . . . 0.0 110.741 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 176.2 129.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.717 1.607 . . . . 0.0 108.242 172.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.89 123.45 82.22 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 168.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.33 107.11 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.499 2.799 . . . . 0.0 111.876 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.29 141.35 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 111.085 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.477 ' HZ3' ' HB2' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -73.24 100.42 3.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.405 0.682 . . . . 0.0 109.358 174.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -100.59 170.38 8.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.912 0.885 . . . . 0.0 109.181 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.6 -41.62 54.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.236 1.014 . . . . 0.0 111.746 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -79.93 -11.21 59.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.644 0.777 . . . . 0.0 111.249 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.68 -172.79 21.78 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.9 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.477 ' HB2' ' HZ3' ' B' ' 98' ' ' LYS . 27.9 t80 -78.56 101.05 7.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -113.7 147.51 38.06 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.895 0.478 . . . . 0.0 110.781 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.77 134.34 30.09 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 109.117 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 1.9 m -120.9 118.42 29.88 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.92 169.94 8.19 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.058 0.543 . . . . 0.0 109.704 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.2 128.51 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.86 170.22 2.73 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.597 0.759 . . . . 0.0 110.41 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.89 -31.88 28.27 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.779 2.319 . . . . 0.0 112.2 165.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.31 4.92 40.91 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.36 1.064 . . . . 0.0 112.047 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 61.0 m 58.53 84.67 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.802 1.241 . . . . 0.0 112.573 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.433 ' HE1' HG11 ' B' ' 11' ' ' VAL . 15.3 m170 -122.78 176.57 5.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.108 0.563 . . . . 0.0 109.612 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -100.75 112.48 24.9 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.32 100.6 8.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.575 HH11 ' HG3' ' B' ' 116' ' ' ARG . 8.3 mmt85 -96.8 92.19 6.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.876 -172.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' B' ' 70' ' ' PHE . 5.9 t -91.74 115.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -124.71 169.02 12.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.789 0.268 . . . . 0.0 111.128 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.95 111.76 13.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.61 115.46 19.23 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.71 0.25 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.835 -174.418 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.476 0.179 . . . . 0.0 111.058 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -91.8 133.48 35.59 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -96.67 112.12 59.3 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.052 0.941 . . . . 0.0 110.746 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.0 94.77 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.801 2.334 . . . . 0.0 112.064 171.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.638 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.6 p-10 -96.61 16.7 18.15 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.424 0.63 . . . . 0.0 110.997 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.7 131.57 46.37 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.935 1.294 . . . . 0.0 107.562 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 142.97 49.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.362 1.065 . . . . 0.0 109.03 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 45.7 mt -124.0 139.1 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.546 0.739 . . . . 0.0 110.133 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.464 HD23 HD22 ' A' ' 47' ' ' LEU . 3.7 mm? -112.02 143.5 42.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.051 0.941 . . . . 0.0 108.556 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.13 106.48 13.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.495 1.118 . . . . 0.0 111.347 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' SER . 14.8 m -107.24 149.38 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -97.06 -52.15 3.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.13 100.58 13.59 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.11 0.964 . . . . 0.0 109.646 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -53.67 -52.71 7.89 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.246 2.631 . . . . 0.0 115.384 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 47.3 Cg_exo -56.68 -51.16 9.69 Favored 'Trans proline' 0 C--N 1.4 3.255 0 CA-C-N 122.267 1.845 . . . . 0.0 112.414 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.19 -38.01 52.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.968 -165.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -78.76 -29.25 45.02 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.235 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.452 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 75.9 m -64.95 -48.29 74.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 81.5 mm-40 -66.36 -31.66 72.57 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.196 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -62.96 -48.94 76.73 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.855 0.722 . . . . 0.0 110.045 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -71.81 -29.07 64.05 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.409 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 18' ' ' THR . 56.3 mtpt -56.26 -45.64 79.98 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.753 0.706 . . . . 0.0 112.069 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -42.54 35.8 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.464 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.9 -46.33 85.09 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.904 1.282 . . . . 0.0 112.298 -172.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.39 -47.64 9.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.2 33.75 4.78 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.804 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.18 172.19 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.14 0.976 . . . . 0.0 110.312 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.2 146.75 54.99 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 57.3 Cg_endo -71.26 121.08 7.46 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.994 1.796 . . . . 0.0 112.19 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.76 -44.13 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.545 0.738 . . . . 0.0 110.636 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.6 mm-40 -120.86 107.23 12.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -111.08 144.86 39.54 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.173 0.511 . . . . 0.0 110.696 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -142.07 155.63 65.26 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.715 1.206 . . . . 0.0 108.432 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.92 -10.19 27.55 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.278 1.985 . . . . 0.0 113.146 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -129.29 5.3 5.24 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -157.01 154.84 30.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 70.5 m -140.88 139.89 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.608 0.763 . . . . 0.0 109.256 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 27.7 tp -131.62 121.02 23.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 2.2 p90 -134.28 150.32 50.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.969 0.907 . . . . 0.0 108.943 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 HG22 ' HG3' ' A' ' 46' ' ' LYS . 19.2 t -126.46 133.9 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.476 ' HB2' ' HG3' ' A' ' 45' ' ' MET . 10.0 mp -97.73 144.72 27.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.25 -10.67 33.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.134 0.974 . . . . 0.0 112.673 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.04 -22.35 66.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.256 1.022 . . . . 0.0 112.127 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.17 16.04 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.688 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -116.23 171.88 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.851 0.86 . . . . 0.0 109.022 176.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -142.84 143.11 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.464 HD22 HD23 ' A' ' 9' ' ' LEU . 2.0 tt -142.3 122.19 13.59 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.99 0.424 . . . . 0.0 110.397 -169.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.26 151.97 17.56 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 76.5 mt -116.83 109.61 17.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 162.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.463 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.4 t90 -103.83 124.28 48.64 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 48.8 m -72.51 115.88 12.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -64.77 -8.57 15.46 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.73 1.212 . . . . 0.0 113.873 -169.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -9.89 59.7 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.574 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -135.23 3.01 3.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.837 0.455 . . . . 0.0 111.398 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 13.8 p -64.78 140.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.827 0.451 . . . . 0.0 110.948 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.38 106.76 21.33 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 3.0 Cg_endo -77.25 142.32 71.55 Favored 'Cis proline' 0 C--N 1.383 2.361 0 CA-C-N 120.156 1.091 . . . . 0.0 113.182 10.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HA ' HG12 ' A' ' 55' ' ' VAL . 2.8 tppp? -59.46 109.63 0.93 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.03 0.932 . . . . 0.0 111.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.67 107.58 10.71 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.817 1.247 . . . . 0.0 107.953 174.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 m -100.0 87.84 3.6 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.28 143.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.335 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 112' ' ' SER . 6.3 p -148.95 -176.43 5.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.431 1.092 . . . . 0.0 109.739 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.57 -71.37 2.47 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 32.71 7.27 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.37 59.76 4.94 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 146.14 7.2 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.314 0.483 . . . . 0.0 112.245 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 19.8 mt-10 -103.82 140.87 37.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.08 100.64 7.47 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.709 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -89.36 114.65 26.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.141 0.496 . . . . 0.0 111.777 -168.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -90.42 115.02 27.27 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.564 1.545 . . . . 0.0 107.585 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.652 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 31.3 mtm105 -91.34 128.37 37.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.13 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.17 159.15 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.018 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.597 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.4 pt-20 -65.52 -37.23 86.18 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -173.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -162.83 -177.76 5.71 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 118.407 0.549 . . . . 0.0 112.225 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.09 -34.1 71.6 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.75 1.22 . . . . 0.0 112.469 -166.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.26 -41.37 85.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.603 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.597 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 76.3 mm-40 -66.69 -23.06 66.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.079 0.952 . . . . 0.0 112.424 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.33 -40.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.932 0.493 . . . . 0.0 109.882 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.73 -31.37 61.81 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.974 0.91 . . . . 0.0 110.978 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.2 mt-10 -66.33 -47.43 73.55 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -62.99 -36.5 83.75 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.484 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' O ' ' HE1' ' A' ' 92' ' ' MET . 71.8 t80 -56.31 -61.39 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.211 1.004 . . . . 0.0 110.361 175.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.33 77.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.491 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.8 93.6 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.535 0.522 . . . . 0.0 113.373 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -66.65 -39.97 88.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.418 0.687 . . . . 0.0 109.965 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -60.39 -42.54 96.11 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.648 0.779 . . . . 0.0 110.362 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.31 65.14 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.738 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.0 t -95.84 7.2 46.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.315 1.046 . . . . 0.0 112.759 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.53 51.36 6.05 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.927 -0.579 . . . . 0.0 114.306 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.64 137.71 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.461 0.704 . . . . 0.0 109.169 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.05 97.98 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.805 0.842 . . . . 0.0 112.207 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.606 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 12.0 ptm 49.27 82.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.085 1.754 . . . . 0.0 115.409 164.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.65 86.12 2.38 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.095 0.558 . . . . 0.0 110.446 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 178.38 116.57 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.619 1.568 . . . . 0.0 107.551 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.83 124.36 89.25 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.52 97.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.965 2.444 . . . . 0.0 111.334 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.42 36.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.014 0.926 . . . . 0.0 110.187 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 98.5 2.37 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ttt -90.79 166.38 13.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.802 0.841 . . . . 0.0 109.233 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.34 -41.15 79.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.984 0.914 . . . . 0.0 111.972 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -81.34 -15.35 55.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.142 0.577 . . . . 0.0 111.693 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.55 179.4 22.66 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.182 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -78.05 105.72 9.44 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 118' ' ' TYR . 12.6 t -122.01 155.51 35.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.472 0.654 . . . . 0.0 111.455 -171.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -141.21 150.31 42.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.006 1.722 . . . . 0.0 108.304 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.7 m -136.09 133.66 37.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.996 0.816 . . . . 0.0 111.349 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.71 171.22 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.953 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.42 126.63 29.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.936 170.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.83 172.52 1.37 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.741 1.216 . . . . 0.0 111.798 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -56.18 -35.68 95.64 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.169 1.913 . . . . 0.0 111.446 161.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.86 -18.59 43.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.592 1.157 . . . . 0.0 110.898 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 62' ' ' THR . 22.2 m 68.13 101.69 0.05 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 126.262 1.825 . . . . 0.0 111.793 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.454 ' CE1' HG13 ' A' ' 11' ' ' VAL . 17.3 m80 -127.35 175.72 7.98 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -96.22 95.04 7.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 107' ' ' ALA . 92.5 mt -95.6 104.4 16.31 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.709 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 9.9 mmm180 -86.15 143.52 27.97 Favored 'General case' 0 C--O 1.214 -0.816 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.43 111.25 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 166.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.652 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 3.6 p90 -120.84 167.18 12.79 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.264 0.483 . . . . 0.0 110.819 -172.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.25 110.9 8.07 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.409 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 52.0 t80 -76.65 116.9 17.74 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.135 0.425 . . . . 0.0 110.198 -168.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.25 95.51 8.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.889 -0.951 . . . . 0.0 110.875 179.055 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.641 0.257 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -81.8 134.23 35.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.37 0.668 . . . . 0.0 109.525 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -97.28 111.72 58.98 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 123.858 0.863 . . . . 0.0 110.426 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -88.55 94.83 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.619 2.212 . . . . 0.0 112.144 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.688 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.3 p-10 -96.29 16.48 18.25 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.343 0.592 . . . . 0.0 111.023 171.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.72 131.33 46.28 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.038 1.335 . . . . 0.0 107.587 -173.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 t -132.63 143.07 49.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.328 1.051 . . . . 0.0 108.964 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 16.7 mt -124.23 139.23 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.61 0.764 . . . . 0.0 109.971 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.87 143.09 44.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.047 0.939 . . . . 0.0 108.685 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -80.79 106.48 12.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.447 1.099 . . . . 0.0 111.181 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' B' ' 51' ' ' SER . 15.3 m -107.35 149.66 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -97.45 -52.31 3.84 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.202 -170.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -101.54 100.02 12.98 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.267 1.027 . . . . 0.0 109.685 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.45 -53.05 7.56 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.413 2.742 . . . . 0.0 115.766 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 22.6 Cg_endo -56.9 -50.92 10.11 Favored 'Trans proline' 0 C--N 1.399 3.234 0 CA-C-N 122.084 1.78 . . . . 0.0 112.077 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.09 -38.41 52.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.088 -165.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -78.94 -28.22 43.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.222 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 83.9 m -66.84 -47.25 72.54 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.0 mt-30 -65.1 -33.29 75.69 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.249 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 81.0 t80 -62.45 -48.71 78.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.531 0.732 . . . . 0.0 110.136 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.656 ' HH ' HD22 ' B' ' 115' ' ' LEU . 41.6 m-85 -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.564 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -55.99 -45.59 78.96 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.87 0.759 . . . . 0.0 111.985 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.52 33.59 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.46 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.3 tp -58.2 -46.23 86.18 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.809 1.244 . . . . 0.0 112.247 -172.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' B' ' 21' ' ' TYR . 10.8 mt -86.24 -47.74 9.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.79 32.93 4.89 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.597 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.92 171.74 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.164 0.986 . . . . 0.0 110.373 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -124.36 148.17 57.34 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 61.1 Cg_endo -72.7 120.96 7.0 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 121.876 1.718 . . . . 0.0 112.13 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.69 -44.36 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.564 0.746 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 58.8 mm-40 -120.4 108.32 13.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.27 1.028 . . . . 0.0 108.292 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 p -112.33 145.01 40.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.22 0.608 . . . . 0.0 110.347 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -143.02 153.67 60.74 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.141 1.376 . . . . 0.0 108.241 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.56 -10.58 26.89 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.319 2.013 . . . . 0.0 113.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.0 t -129.19 5.69 5.31 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.82 154.97 30.74 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 35.5 t -140.75 140.16 34.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.46 HD12 ' HE2' ' B' ' 46' ' ' LYS . 40.6 tp -132.15 120.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.485 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 2.4 p90 -134.01 150.42 51.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 0.0 108.885 170.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.56 HG23 ' HG3' ' B' ' 46' ' ' LYS . 17.5 t -126.84 134.13 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.512 ' HB2' ' HG3' ' B' ' 45' ' ' MET . 9.9 mp -97.53 144.36 27.31 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -10.2 30.04 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.152 0.981 . . . . 0.0 112.554 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.45 -22.2 66.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.406 1.082 . . . . 0.0 112.054 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.36 15.88 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.638 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -116.75 172.25 7.36 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.56 ' HG3' HG23 ' B' ' 40' ' ' VAL . 86.4 tttt -142.91 143.18 31.93 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.28 122.46 13.83 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.13 17.6 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 174.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 76.6 mt -117.04 109.63 17.21 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.425 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -103.82 124.39 48.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.8 m -72.55 116.42 12.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -65.55 -8.27 18.91 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.607 1.163 . . . . 0.0 113.789 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -79.34 -10.34 59.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.231 0.612 . . . . 0.0 111.548 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -134.78 2.43 3.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.88 0.472 . . . . 0.0 111.293 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.425 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 12.2 p -64.68 141.29 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.631 0.373 . . . . 0.0 110.851 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.07 107.66 19.9 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 123.909 0.884 . . . . 0.0 109.058 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.47 142.4 73.01 Favored 'Cis proline' 0 C--N 1.387 2.603 0 CA-C-N 119.906 1.002 . . . . 0.0 113.466 8.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -58.91 110.17 0.97 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.058 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.82 107.34 10.41 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.823 1.249 . . . . 0.0 108.102 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -99.57 87.8 3.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.64 142.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.182 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' B' ' 112' ' ' SER . 6.2 p -147.65 -176.24 5.17 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.544 1.138 . . . . 0.0 110.149 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.4 -71.66 2.46 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.12 32.58 7.37 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.44 59.74 4.94 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 145.94 7.08 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.288 0.471 . . . . 0.0 112.197 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.608 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 18.4 mt-10 -103.62 141.1 36.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.86 100.33 7.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.08 114.76 26.04 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 0.0 111.925 -169.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -90.62 114.52 26.8 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 125.525 1.53 . . . . 0.0 107.453 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.575 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 36.4 mtm105 -90.65 127.08 36.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.934 -175.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.22 159.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.159 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.1 pt-20 -65.51 -37.36 86.55 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 10.3 p30 -163.06 -177.37 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 118.5 0.591 . . . . 0.0 112.205 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -59.52 -33.68 71.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -166.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.09 84.66 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.806 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.537 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -67.05 -22.58 65.86 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.572 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.83 -40.71 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.852 172.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.22 -31.27 62.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.05 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.42 -47.51 73.02 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.113 0.483 . . . . 0.0 109.765 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -35.74 81.39 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.487 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.429 ' O ' ' HE1' ' B' ' 92' ' ' MET . 55.0 t80 -56.86 -61.35 2.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.696 0.798 . . . . 0.0 110.304 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.451 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -65.41 -34.0 77.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.653 -171.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.06 93.34 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.553 0.533 . . . . 0.0 113.326 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -66.28 -40.12 89.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.498 0.719 . . . . 0.0 109.905 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.6 ttpt -60.12 -42.58 95.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.636 0.774 . . . . 0.0 110.46 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.35 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.746 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 30.2 t -96.1 7.73 45.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.241 1.016 . . . . 0.0 112.762 -175.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 52.12 5.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.268 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.07 137.39 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.735 0.814 . . . . 0.0 109.201 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.78 97.99 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.904 0.882 . . . . 0.0 112.38 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.613 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 12.0 ptm 49.22 82.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 164.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.68 86.26 2.4 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.285 0.634 . . . . 0.0 110.405 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.548 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 52.0 tp60 177.78 116.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.768 1.627 . . . . 0.0 107.638 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.64 125.09 90.03 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.465 ' HB2' ' HH ' ' B' ' 103' ' ' TYR . 33.9 Cg_exo -56.06 97.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.936 2.424 . . . . 0.0 110.943 172.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.65 146.93 37.79 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.02 0.928 . . . . 0.0 110.337 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.492 ' HZ1' ' HB2' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -72.14 98.39 2.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 171.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 8.3 ttt -91.06 166.79 12.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.634 0.774 . . . . 0.0 109.104 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.0 -41.16 77.98 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.688 0.795 . . . . 0.0 112.079 -176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -81.54 -15.54 54.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.62 179.42 22.74 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.032 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.492 ' HB2' ' HZ1' ' B' ' 98' ' ' LYS . 50.2 t80 -77.74 105.96 9.25 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -174.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 11.1 t -122.37 155.53 35.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.554 0.692 . . . . 0.0 111.395 -170.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -141.35 150.26 42.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.889 1.676 . . . . 0.0 108.318 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.5 m -136.05 133.6 37.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.992 0.815 . . . . 0.0 111.352 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.76 171.15 7.49 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.931 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.19 129.34 35.62 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.4 174.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.692 1.197 . . . . 0.0 110.8 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.11 -34.92 99.02 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.05 1.834 . . . . 0.0 110.828 162.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -82.36 -18.27 42.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.718 1.207 . . . . 0.0 110.818 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' B' ' 62' ' ' THR . 40.3 m 67.79 101.85 0.05 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.15 1.78 . . . . 0.0 111.656 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.441 ' CE1' HG13 ' B' ' 11' ' ' VAL . 19.5 m80 -127.48 175.47 8.21 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 165.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.517 ' HA ' ' HE ' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -96.09 95.4 8.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.656 HD22 ' HH ' ' B' ' 21' ' ' TYR . 93.9 mt -95.64 104.83 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.665 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 34.3 mmt180 -84.47 143.57 29.29 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 25.2 t -137.42 111.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.575 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.5 p90 -120.65 167.46 12.42 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.023 0.374 . . . . 0.0 110.896 -172.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.73 111.44 8.19 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 167.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -77.65 123.47 26.69 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.196 0.453 . . . . 0.0 110.493 -168.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.39 94.59 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 118.891 -0.95 . . . . 0.0 110.923 -176.276 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 m -85.84 145.82 27.03 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.012 0.525 . . . . 0.0 110.056 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -102.35 107.67 54.28 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.692 0.797 . . . . 0.0 110.908 -173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.36 56.47 1.41 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.476 2.784 . . . . 0.0 111.836 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.587 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.0 p-10 -78.36 4.07 13.96 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.886 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.0 OUTLIER -124.23 125.11 43.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -120.0 137.23 54.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 49.2 mt -116.14 135.07 57.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.364 0.666 . . . . 0.0 109.361 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 156.3 18.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.314 1.054 . . . . 0.0 108.308 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.509 ' HH ' ' HB2' ' A' ' 59' ' ' ALA . 4.0 t80 -110.04 108.36 18.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.823 -173.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.451 HG13 ' NE2' ' A' ' 113' ' ' HIS . 9.9 m -125.12 159.84 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.367 0.603 . . . . 0.0 110.957 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -97.41 -62.7 1.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.396 1.078 . . . . 0.0 109.461 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.28 106.52 13.86 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.224 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.49 -59.72 0.62 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 122.624 2.216 . . . . 0.0 113.959 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 29.8 Cg_endo -57.32 -50.65 10.44 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.355 1.877 . . . . 0.0 111.61 -174.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.07 90.57 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.262 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.47 ' HG ' HD21 ' A' ' 49' ' ' LEU . 38.8 t -78.69 -20.72 49.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.755 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 m -76.41 -45.49 31.36 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.679 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 57.7 mm-40 -68.61 -30.19 68.87 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.41 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 36.4 t80 -60.85 -51.25 70.12 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 124.115 0.885 . . . . 0.0 110.847 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.738 ' HH ' HD22 ' A' ' 115' ' ' LEU . 67.3 m-85 -71.39 -27.76 63.55 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.784 177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.5 mtpt -56.19 -50.83 70.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.392 0.542 . . . . 0.0 112.408 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.61 56.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.113 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 11.7 tp -60.91 -43.65 98.26 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.408 1.083 . . . . 0.0 112.15 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.477 ' HB2' HG21 ' A' ' 27' ' ' VAL . 22.5 mt -95.21 -35.29 11.9 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.971 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.7 37.13 6.2 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 25' ' ' LEU . 33.9 m -130.56 -177.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.489 1.116 . . . . 0.0 110.472 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.75 149.79 57.76 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.03 108.96 2.06 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.806 2.337 . . . . 0.0 111.697 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.76 -31.51 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.586 0.754 . . . . 0.0 110.571 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 48.5 mt-10 -119.42 143.15 47.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.291 1.037 . . . . 0.0 108.213 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -159.54 153.72 23.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.817 0.818 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -144.23 164.15 30.71 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 126.069 1.748 . . . . 0.0 107.473 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.58 -16.16 34.76 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.334 2.022 . . . . 0.0 113.484 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.8 t -127.92 13.05 6.79 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -154.38 159.94 41.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -153.37 153.91 33.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.489 1.116 . . . . 0.0 109.469 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.7 tm? -146.33 123.71 11.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -130.81 137.24 49.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.601 1.16 . . . . 0.0 108.307 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.7 t -112.09 123.0 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.618 HD11 ' SD ' ' A' ' 45' ' ' MET . 76.2 mt -89.34 148.73 23.36 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.96 0.504 . . . . 0.0 110.188 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -7.01 19.12 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.22 1.008 . . . . 0.0 113.513 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -82.03 4.41 22.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 111.789 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.3 64.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.629 -0.189 . . . . 0.0 112.629 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.618 ' SD ' HD11 ' A' ' 41' ' ' LEU . 5.1 ppp? -117.61 171.54 7.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.631 0.772 . . . . 0.0 109.779 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 40' ' ' VAL . 83.0 tttt -135.35 139.43 44.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.34 123.99 21.04 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.174 0.512 . . . . 0.0 110.113 -172.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.94 169.97 20.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.828 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.47 HD21 ' HG ' ' A' ' 17' ' ' SER . 4.9 tp -139.92 104.78 4.94 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 170.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.479 ' HZ2' ' HE2' ' B' ' 99' ' ' MET . 5.0 t90 -114.71 128.92 56.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.6 m -78.71 134.95 37.05 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.168 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.0 -19.96 64.97 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.755 0.822 . . . . 0.0 113.2 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -8.41 58.78 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -129.77 7.72 5.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.858 0.463 . . . . 0.0 111.33 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG13 ' OH ' ' A' ' 10' ' ' TYR . 11.8 p -69.87 147.43 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HB3' ' NE2' ' B' ' 94' ' ' GLN . 35.6 mt-10 -128.25 113.65 19.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 0.0 109.52 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.72 143.19 77.06 Favored 'Cis proline' 0 C--N 1.388 2.636 0 CA-C-N 119.723 0.937 . . . . 0.0 112.674 2.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -50.09 124.31 9.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.501 1.12 . . . . 0.0 112.063 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB2' ' HH ' ' A' ' 10' ' ' TYR . . . -144.41 155.68 43.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.172 0.989 . . . . 0.0 109.333 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.3 m -132.79 94.23 3.35 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.97 125.18 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.13 0.972 . . . . 0.0 108.855 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -140.09 142.62 36.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.761 0.824 . . . . 0.0 109.373 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.51 23.22 73.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.624 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.471 ' HA3' HG21 ' B' ' 61' ' ' VAL . . . -160.84 140.74 6.88 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.27 -156.23 26.85 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.59 172.0 54.81 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.525 0.191 . . . . 0.0 112.713 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 68.9 mt-10 -99.49 152.03 20.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.8 tp -110.09 100.55 9.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 171.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -84.61 113.76 21.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.007 0.432 . . . . 0.0 111.571 -167.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -93.12 106.62 18.56 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.854 1.262 . . . . 0.0 107.921 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -90.62 131.37 36.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.122 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.04 165.08 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.49 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.408 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.1 pt-20 -69.38 -43.81 72.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -155.25 177.99 10.72 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.703 0.683 . . . . 0.0 112.626 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.15 -32.96 70.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.158 1.383 . . . . 0.0 112.421 -167.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.34 -42.77 74.85 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.634 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.408 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 78.9 mm-40 -64.58 -24.16 67.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.644 0.778 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.24 -40.08 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.349 0.595 . . . . 0.0 110.003 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.1 -30.22 62.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.195 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -67.77 -42.99 80.84 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 109.141 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.7 m -65.01 -37.93 89.26 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.357 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.407 ' O ' ' HE1' ' A' ' 92' ' ' MET . 34.9 t80 -57.94 -60.92 2.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.921 0.888 . . . . 0.0 109.628 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -60.83 -39.17 88.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.733 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.6 -39.35 86.64 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.415 0.447 . . . . 0.0 113.828 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -67.89 -42.48 81.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.374 0.669 . . . . 0.0 109.64 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.7 ttpt -57.63 -43.88 85.16 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.791 0.836 . . . . 0.0 110.387 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.9 -30.56 71.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.692 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.5 m -102.24 14.8 30.98 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.099 0.959 . . . . 0.0 112.094 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 46.36 5.68 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 163.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -101.72 132.23 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.144 0.578 . . . . 0.0 109.745 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.51 95.13 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.918 0.887 . . . . 0.0 111.708 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 4.8 ptm 50.3 81.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.567 1.547 . . . . 0.0 113.771 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.4 ' N ' HD11 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.52 83.67 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.61 -0.681 . . . . 0.0 109.962 -178.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.458 ' HB2' ' HD3' ' B' ' 57' ' ' PRO . 5.7 tp60 177.39 134.68 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.52 1.528 . . . . 0.0 108.028 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -79.31 120.67 81.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 15.6 Cg_endo -58.71 106.3 0.27 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.642 2.228 . . . . 0.0 110.378 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.85 152.36 46.41 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.309 0.644 . . . . 0.0 110.21 -175.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -62.42 137.79 58.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.543 0.737 . . . . 0.0 110.466 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.418 ' SD ' HG23 ' A' ' 104' ' ' THR . 20.1 ttt -142.82 175.76 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 109.392 -175.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -51.35 -32.37 25.44 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.453 1.501 . . . . 0.0 112.921 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.42 -5.22 23.12 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.663 0.785 . . . . 0.0 111.384 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.91 -167.51 20.18 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.078 176.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.7 101.59 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.418 HG23 ' SD ' ' A' ' 99' ' ' MET . 9.4 t -115.63 149.1 38.84 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.376 -167.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 3.2 t80 -146.51 129.41 16.33 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.573 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -120.66 119.22 32.21 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.26 159.04 16.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 -175.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.1 127.49 19.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 170.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.64 178.89 2.09 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.134 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -32.83 94.08 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.743 2.295 . . . . 0.0 113.644 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.83 -4.92 46.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.758 0.423 . . . . 0.0 111.18 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.0 m 72.45 60.02 0.13 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.118 1.367 . . . . 0.0 110.995 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.451 ' NE2' HG13 ' A' ' 11' ' ' VAL . 19.7 m170 -97.67 -167.09 1.47 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.17 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.43 93.87 1.94 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.738 HD22 ' HH ' ' A' ' 21' ' ' TYR . 59.7 mt -116.79 101.95 8.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.833 -170.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 2.3 tmm_? -102.8 99.26 9.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.004 0.521 . . . . 0.0 111.29 -169.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.03 140.6 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.5 0.72 . . . . 0.0 109.226 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.498 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 16.7 p90 -143.66 161.69 37.88 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.659 0.663 . . . . 0.0 112.607 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -110.67 129.87 55.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.71 124.52 23.52 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.274 0.359 . . . . 0.0 110.367 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.75 94.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.772 0.67 . . . . 0.0 110.48 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.801 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -177.391 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m -77.4 145.91 36.92 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 110.233 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -102.73 107.42 54.35 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.8 56.01 1.66 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.499 2.799 . . . . 0.0 111.95 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.559 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.9 p-10 -77.59 3.91 12.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.685 0.794 . . . . 0.0 112.146 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -123.85 124.85 43.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -120.32 137.53 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 37.0 mt -117.3 134.76 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.374 0.67 . . . . 0.0 109.468 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.491 HD12 HD23 ' B' ' 68' ' ' LEU . 65.9 mt -90.56 155.69 18.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.334 1.064 . . . . 0.0 108.973 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.03 107.83 19.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 112.93 -1.941 . . . . 0.0 108.184 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.98 160.05 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.377 0.608 . . . . 0.0 110.838 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.81 -62.12 1.29 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.41 1.084 . . . . 0.0 109.713 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -90.78 105.92 13.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.391 0.676 . . . . 0.0 109.495 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.407 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 33.3 Cg_exo -56.4 -60.97 0.38 Allowed 'Trans proline' 0 CA--C 1.573 2.443 0 C-N-CA 122.435 2.09 . . . . 0.0 113.878 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 51.9 Cg_exo -54.7 -51.99 9.12 Favored 'Trans proline' 0 C--N 1.41 3.789 0 CA-C-N 122.47 1.918 . . . . 0.0 112.405 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.13 92.94 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.4 t -78.45 -20.61 50.62 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.1 m -76.88 -45.33 28.59 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.45 0.643 . . . . 0.0 111.652 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.49 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.2 mm-40 -67.92 -30.78 70.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.464 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 74.9 t80 -60.4 -50.91 71.7 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.786 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -72.19 -27.43 62.55 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.201 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 56.4 mtpt -56.27 -50.94 69.93 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.53 -36.06 57.91 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.051 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 8.8 tp -60.94 -43.25 98.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.074 0.95 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.487 ' HB2' HG22 ' B' ' 27' ' ' VAL . 27.0 mt -95.35 -35.49 11.75 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.07 36.85 6.17 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' B' ' 25' ' ' LEU . 34.2 m -130.38 -177.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.562 1.145 . . . . 0.0 110.256 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -140.75 149.21 55.85 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.66 0.784 . . . . 0.0 109.489 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.91 108.51 1.71 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.48 2.12 . . . . 0.0 112.019 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.18 -31.97 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.608 0.763 . . . . 0.0 110.516 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.665 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 45.4 mt-10 -119.31 143.42 47.38 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 167.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 21.5 t -159.54 153.63 23.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.651 0.739 . . . . 0.0 111.111 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 35.6 m -143.96 165.11 25.86 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 126.109 1.764 . . . . 0.0 107.357 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.12 -15.58 40.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.045 1.83 . . . . 0.0 113.103 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.3 t -128.11 13.02 6.7 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -154.3 159.55 41.3 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.013 -0.429 . . . . 0.0 110.78 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 60.6 m -153.3 154.01 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.555 1.142 . . . . 0.0 109.529 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.665 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -146.37 123.45 11.45 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -130.09 138.44 50.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.286 1.035 . . . . 0.0 108.654 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.513 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.3 t -112.51 123.41 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' B' ' 45' ' ' MET . 80.5 mt -89.98 148.6 22.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.837 0.455 . . . . 0.0 110.282 -168.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -7.56 21.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.119 0.968 . . . . 0.0 113.578 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -81.57 4.63 20.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.745 0.818 . . . . 0.0 112.251 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.06 11.86 64.4 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.668 ' SD ' HD11 ' B' ' 41' ' ' LEU . 5.0 ppp? -117.56 171.62 7.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.501 0.72 . . . . 0.0 109.597 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.513 ' HG3' HG22 ' B' ' 40' ' ' VAL . 84.3 tttt -135.73 140.05 44.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.2 tt -138.18 123.76 19.68 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.184 0.516 . . . . 0.0 110.269 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.88 168.98 19.67 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.844 0.735 . . . . 0.0 112.724 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -137.81 105.2 5.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 169.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.48 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.5 t90 -114.32 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 50.9 m -78.72 134.61 37.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.423 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -68.02 -19.26 64.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 0.0 112.965 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -79.42 -9.15 59.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.5 0.32 . . . . 0.0 111.295 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.5 t -128.92 7.48 5.58 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.024 0.529 . . . . 0.0 111.318 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.48 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 11.8 p -69.66 147.15 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.454 ' HB3' ' NE2' ' A' ' 94' ' ' GLN . 26.3 mt-10 -128.7 113.91 19.2 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.319 0.648 . . . . 0.0 110.056 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 94' ' ' GLN . 97.7 Cg_endo -73.0 143.57 78.26 Favored 'Cis proline' 0 C--N 1.387 2.583 0 CA-C-N 119.472 0.847 . . . . 0.0 113.226 2.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 126.14 18.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.097 0.959 . . . . 0.0 110.527 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.96 155.96 44.24 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.454 1.102 . . . . 0.0 109.715 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.4 m -132.7 92.55 3.07 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.617 0.767 . . . . 0.0 109.013 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.471 HG21 ' HA3' ' A' ' 64' ' ' GLY . 79.2 t -141.69 125.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.312 1.045 . . . . 0.0 108.568 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.7 p -140.07 141.71 36.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.83 0.852 . . . . 0.0 109.215 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.9 24.5 69.3 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.477 0.485 . . . . 0.0 112.395 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.85 139.26 5.87 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.86 -155.35 26.5 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 10' ' ' TYR . . . -77.43 172.64 55.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.556 ' HA ' ' HG3' ' B' ' 114' ' ' ARG . 6.0 mm-40 -99.68 151.24 21.44 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.491 HD23 HD12 ' B' ' 9' ' ' LEU . 50.1 tp -109.78 101.1 10.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -84.9 113.99 21.79 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.125 0.42 . . . . 0.0 111.604 -167.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -93.53 106.51 18.47 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -90.67 131.05 36.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.145 0.497 . . . . 0.0 111.893 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.65 165.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.4 1.08 . . . . 0.0 110.541 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.0 pt-20 -69.2 -44.1 72.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.518 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 9.9 p30 -155.23 178.15 10.54 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.762 0.71 . . . . 0.0 112.7 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.753 1.621 . . . . 0.0 112.608 -167.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.424 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.49 -42.26 75.01 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.708 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.505 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.3 mm-40 -65.39 -24.03 67.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.697 0.799 . . . . 0.0 112.458 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.35 -40.52 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.353 0.597 . . . . 0.0 110.009 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.28 -30.43 63.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.303 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 18.5 mt-10 -67.96 -43.0 80.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.702 0.763 . . . . 0.0 109.213 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.3 m -64.96 -37.58 88.13 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.193 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.516 ' O ' ' HE2' ' B' ' 92' ' ' MET . 23.8 t80 -58.49 -60.92 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.767 0.827 . . . . 0.0 109.531 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.424 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -60.66 -38.56 85.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.902 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.69 -39.72 86.03 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.43 0.456 . . . . 0.0 113.878 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -67.85 -42.06 81.96 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.394 0.678 . . . . 0.0 109.679 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 31.9 ttpt -58.89 -43.33 90.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 0.0 110.229 177.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.77 -30.24 70.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.664 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.6 m -102.55 14.93 30.68 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.926 0.891 . . . . 0.0 112.256 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.82 47.1 5.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.219 -0.9 . . . . 0.0 114.957 163.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.59 131.69 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.213 0.605 . . . . 0.0 109.499 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.89 92.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.86 0.864 . . . . 0.0 112.114 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.516 ' HE2' ' O ' ' B' ' 82' ' ' PHE . 13.5 ptp 48.94 82.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.655 1.582 . . . . 0.0 114.128 172.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.67 83.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.453 0.644 . . . . 0.0 109.941 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.479 ' NE2' ' HB3' ' A' ' 56' ' ' GLU . 5.7 tp60 177.45 133.78 0.06 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 108.14 174.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -78.07 121.38 83.91 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.527 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 20.0 Cg_endo -60.12 106.34 0.33 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.654 2.236 . . . . 0.0 110.117 172.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.78 152.25 46.42 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.263 0.625 . . . . 0.0 110.158 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -62.89 138.48 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.328 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.502 ' SD ' HG23 ' B' ' 104' ' ' THR . 11.4 ttt -143.26 175.22 10.06 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.73 0.812 . . . . 0.0 109.007 -174.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.467 ' H ' ' HG2' ' B' ' 99' ' ' MET . 11.3 tp10 -51.98 -32.57 34.17 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.113 1.365 . . . . 0.0 112.964 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.07 -6.37 23.42 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.614 0.765 . . . . 0.0 111.281 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 128.84 -168.2 20.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.528 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -76.02 101.23 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.502 HG23 ' SD ' ' B' ' 99' ' ' MET . 14.4 t -115.1 149.06 38.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.501 0.667 . . . . 0.0 111.328 -167.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 2.6 t80 -146.48 129.37 16.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.465 1.506 . . . . 0.0 108.537 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 119.54 33.09 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.114 0.483 . . . . 0.0 109.812 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -107.35 158.71 16.94 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.875 0.87 . . . . 0.0 112.464 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.65 129.72 23.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.516 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.2 p-10 -88.33 179.94 1.51 Allowed Pre-proline 0 CA--C 1.575 1.905 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.346 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 25.4 Cg_endo -58.72 -32.22 96.53 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.499 2.132 . . . . 0.0 113.239 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.66 -5.3 47.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.787 0.435 . . . . 0.0 110.908 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m 72.7 60.4 0.12 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.137 1.375 . . . . 0.0 110.66 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -97.9 -168.23 1.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.377 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.556 ' HG3' ' HA ' ' B' ' 67' ' ' GLU . 4.2 tpp180 -149.13 94.94 2.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -175.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.01 101.78 8.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.017 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 3.4 tmt_? -100.28 98.12 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.167 0.587 . . . . 0.0 112.079 -169.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.29 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -143.48 161.42 38.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.714 0.688 . . . . 0.0 112.375 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.406 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -110.75 130.59 55.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 168.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -68.91 123.38 20.83 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.161 0.288 . . . . 0.0 110.664 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.86 106.64 17.21 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.973 -0.904 . . . . 0.0 111.064 -179.052 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.338 0.113 . . . . 0.0 110.836 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m -80.36 144.92 32.34 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -115.17 128.26 26.09 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.503 0.721 . . . . 0.0 109.854 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -91.02 101.26 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.139 2.559 . . . . 0.0 112.737 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.75 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 4.2 p30 -85.03 -2.23 57.73 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.218 0.532 . . . . 0.0 111.06 169.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -118.46 112.27 19.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -168.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -109.76 131.71 54.82 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.52 132.42 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.92 173.23 7.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.091 0.948 . . . . 0.0 108.941 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -130.38 120.29 24.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.442 -174.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG12 ' NE2' ' A' ' 113' ' ' HIS . 10.3 m -125.89 155.84 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.861 0.864 . . . . 0.0 109.679 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.84 -56.83 3.17 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -94.93 110.36 49.34 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.163 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 31.8 Cg_exo -54.94 -57.25 1.8 Allowed 'Trans proline' 0 CA--C 1.573 2.455 0 C-N-CA 122.749 2.3 . . . . 0.0 114.232 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 34.9 Cg_exo -58.32 -58.63 0.7 Allowed 'Trans proline' 0 C--N 1.401 3.319 0 CA-C-N 122.181 1.815 . . . . 0.0 112.146 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.71 95.22 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.753 0.821 . . . . 0.0 112.36 -167.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -76.42 -33.84 58.79 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 88.9 m -73.1 -39.77 65.52 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -59.75 -36.87 77.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.89 172.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.27 -44.51 94.91 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 110.233 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.473 ' HH ' HD22 ' A' ' 115' ' ' LEU . 60.8 m-85 -70.91 -29.16 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.02 175.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 18' ' ' THR . 60.1 mtpt -56.63 -47.7 79.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.805 0.729 . . . . 0.0 112.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.87 47.28 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.758 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp -63.7 -40.59 97.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.516 1.126 . . . . 0.0 112.332 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 27' ' ' VAL . 32.2 mt -93.46 -38.55 11.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.18 24.85 18.22 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.537 0.523 . . . . 0.0 111.809 -173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.3 m -118.58 174.91 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.024 0.93 . . . . 0.0 110.449 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.9 143.97 51.28 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 108.968 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.71 112.4 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.634 2.223 . . . . 0.0 111.402 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.74 -36.51 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.447 0.699 . . . . 0.0 109.769 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.8 mm-40 -112.02 87.03 2.47 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.5 p -90.19 127.62 36.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.43 0.692 . . . . 0.0 109.214 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -140.61 152.81 67.14 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.985 0.914 . . . . 0.0 108.538 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -46.35 -44.68 20.04 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.871 3.048 . . . . 0.0 114.646 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -126.92 15.94 7.39 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.6 151.3 37.87 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -140.58 142.72 35.07 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -139.53 121.08 15.17 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -133.05 131.72 40.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.554 1.141 . . . . 0.0 108.637 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG21 ' HG3' ' A' ' 46' ' ' LYS . 16.2 t -109.49 129.62 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.039 -173.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD11 ' SD ' ' A' ' 45' ' ' MET . 49.4 mt -94.27 143.0 26.76 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.786 0.434 . . . . 0.0 110.445 -171.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -5.76 19.43 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.376 1.07 . . . . 0.0 112.299 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.7 OUTLIER -67.34 -19.51 65.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.769 1.228 . . . . 0.0 111.627 177.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.44 16.62 15.56 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.721 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -125.66 176.26 7.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.518 0.727 . . . . 0.0 109.54 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HG3' HG21 ' A' ' 40' ' ' VAL . 76.6 tttt -140.32 137.53 34.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.02 118.55 18.94 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.772 0.429 . . . . 0.0 110.084 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.31 163.22 21.88 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.521 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 tp -141.43 104.85 4.66 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.439 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.7 t90 -111.09 134.83 52.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.902 0.881 . . . . 0.0 108.678 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 54' ' ' THR . 35.9 m -75.83 136.39 40.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.751 0.31 . . . . 0.0 111.249 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -72.5 -9.86 59.08 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.993 0.917 . . . . 0.0 112.455 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -86.89 -8.8 56.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.202 0.601 . . . . 0.0 111.181 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.404 HG23 ' HB2' ' A' ' 51' ' ' SER . 15.4 t -135.04 8.24 3.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.177 0.591 . . . . 0.0 111.339 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.2 p -68.28 143.45 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 122.58 0.352 . . . . 0.0 111.372 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.495 ' HB2' ' HE2' ' B' ' 99' ' ' MET . 52.1 mt-10 -125.39 117.23 25.11 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.556 1.142 . . . . 0.0 108.706 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 12.4 Cg_exo -70.88 144.13 78.07 Favored 'Cis proline' 0 C--N 1.386 2.531 0 CA-C-N 119.681 0.922 . . . . 0.0 112.992 -1.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.467 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.17 128.76 37.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.149 0.98 . . . . 0.0 111.958 -177.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.45 109.03 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.764 1.226 . . . . 0.0 108.531 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.2 p -87.83 89.15 7.88 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.3 142.84 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.523 0.729 . . . . 0.0 109.847 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -138.96 135.55 34.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.226 1.01 . . . . 0.0 109.22 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.38 51.75 49.67 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.61 0.569 . . . . 0.0 114.227 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.18 44.99 0.42 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.87 -169.51 11.69 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.781 -0.209 . . . . 0.0 113.125 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.97 170.12 47.67 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 124.38 0.694 . . . . 0.0 113.009 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -98.53 160.04 14.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.918 0.887 . . . . 0.0 110.561 -171.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.09 101.23 10.66 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.54 103.53 14.48 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -82.46 106.17 14.11 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -84.72 128.89 34.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.816 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.74 157.92 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.811 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HG3' HD21 ' A' ' 74' ' ' ASN . 10.9 pt-20 -68.17 -42.06 80.58 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.93 -172.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.406 HD21 ' HG3' ' A' ' 73' ' ' GLU . 9.5 p30 -151.05 174.38 13.24 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-O 121.49 0.662 . . . . 0.0 112.059 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.51 -27.64 69.11 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.41 -165.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.06 -42.11 76.69 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.304 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -62.87 -23.73 67.47 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.588 0.755 . . . . 0.0 112.568 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.5 -42.83 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.429 0.633 . . . . 0.0 110.457 171.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.76 -30.77 67.35 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.66 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -70.68 -43.11 69.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.371 0.605 . . . . 0.0 109.683 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -30.23 69.07 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.759 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' O ' ' HE1' ' A' ' 92' ' ' MET . 43.1 t80 -62.25 -60.88 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.898 0.879 . . . . 0.0 109.005 176.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.43 89.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.766 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.2 -45.13 94.45 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 124.115 0.885 . . . . 0.0 113.908 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.404 ' HB3' HG12 ' A' ' 90' ' ' VAL . 41.1 m0 -64.2 -45.52 87.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.17 0.588 . . . . 0.0 110.288 175.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.3 -46.02 76.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.576 0.75 . . . . 0.0 110.269 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.61 63.42 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.52 14.46 29.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 112.539 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 55.27 3.61 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.439 -0.8 . . . . 0.0 114.776 166.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.4 p -104.33 148.79 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.63 56.42 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.879 0.471 . . . . 0.0 111.456 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.557 ' HB2' HG13 ' A' ' 90' ' ' VAL . 55.5 ttm 63.56 84.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 166.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 86.75 2.63 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 121.332 0.587 . . . . 0.0 110.83 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 106' ' ' THR . 55.7 tp60 179.02 122.57 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.519 1.528 . . . . 0.0 108.187 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.54 114.94 49.7 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.434 ' HB2' ' HH ' ' A' ' 103' ' ' TYR . 76.4 Cg_exo -48.61 107.26 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.385 2.723 . . . . 0.0 112.256 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.81 145.51 42.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 110.021 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HZ2' ' HB2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -72.67 112.24 8.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.4 tpp -100.46 162.63 12.81 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.64 -23.08 62.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.237 0.615 . . . . 0.0 111.007 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -120.72 90.77 3.39 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.374 1.07 . . . . 0.0 108.555 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.48 152.08 1.12 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.558 ' HB3' ' HB2' ' A' ' 119' ' ' ALA . 84.8 t80 -71.97 101.06 2.6 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 165.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -109.25 151.26 26.77 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.813 0.816 . . . . 0.0 112.04 -161.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.74 149.75 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.563 1.545 . . . . 0.0 108.498 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 87.6 m -141.23 128.3 20.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.751 0.705 . . . . 0.0 110.497 171.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.99 155.91 18.91 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.137 0.575 . . . . 0.0 109.79 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.73 126.31 52.45 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.54 156.5 22.86 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.055 0.942 . . . . 0.0 111.484 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.56 -21.91 73.17 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.739 2.293 . . . . 0.0 112.431 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -92.29 -20.69 20.86 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.142 0.977 . . . . 0.0 110.559 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.2 m 72.63 90.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.873 1.669 . . . . 0.0 110.967 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.483 ' NE2' HG12 ' A' ' 11' ' ' VAL . 10.5 m80 -113.18 -92.32 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 113' ' ' HIS . 4.7 tpt180 167.98 109.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.281 1.032 . . . . 0.0 109.348 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.473 HD22 ' HH ' ' A' ' 21' ' ' TYR . 90.9 mt -126.6 110.33 13.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.141 0.577 . . . . 0.0 111.175 -176.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -95.3 147.55 23.37 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.337 0.517 . . . . 0.0 110.685 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.04 125.58 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -130.62 151.77 50.71 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.092 0.86 . . . . 0.0 111.489 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . . . -103.81 117.55 34.63 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -77.64 111.96 13.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.67 94.78 1.04 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.084 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.364 -175.28 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 11.9 m -133.42 146.59 51.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -115.75 129.13 25.4 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.499 0.72 . . . . 0.0 110.572 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -91.75 101.91 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.014 2.476 . . . . 0.0 112.237 173.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.721 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.9 p-10 -86.01 -1.68 57.58 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.416 0.627 . . . . 0.0 111.019 169.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.402 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.1 t80 -118.53 112.45 19.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -169.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -109.78 131.55 54.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 52.3 mt -113.8 132.86 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -97.49 172.05 7.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.918 0.866 . . . . 0.0 109.005 173.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' B' ' 50' ' ' TRP . 30.9 m-85 -128.22 122.11 30.99 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.897 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.443 HG12 ' NE2' ' B' ' 113' ' ' HIS . 6.2 m -125.93 155.94 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.81 0.844 . . . . 0.0 109.523 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -88.01 -56.77 3.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.179 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -94.42 109.31 42.2 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.244 0.618 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.41 -56.92 2.1 Favored 'Trans proline' 0 CA--C 1.574 2.491 0 C-N-CA 122.68 2.254 . . . . 0.0 114.269 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.37 -58.79 0.54 Allowed 'Trans proline' 0 C--N 1.402 3.369 0 CA-C-N 122.179 1.814 . . . . 0.0 111.714 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.06 92.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.788 0.835 . . . . 0.0 112.494 -167.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -76.31 -33.82 59.04 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.023 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.463 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -73.11 -39.78 65.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.527 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 0.0 OUTLIER -59.61 -37.33 78.29 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.712 172.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.409 ' CE1' HG23 ' B' ' 90' ' ' VAL . 78.2 t80 -62.5 -45.36 93.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.467 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.487 ' HH ' HD23 ' B' ' 115' ' ' LEU . 63.7 m-85 -70.44 -29.27 65.81 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.025 174.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.527 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 63.4 mtpt -56.94 -47.33 80.9 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.794 0.725 . . . . 0.0 112.867 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.86 44.54 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.872 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -63.45 -40.23 96.6 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.614 1.166 . . . . 0.0 112.533 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 34.3 mt -93.57 -39.13 11.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.24 25.91 15.36 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.848 -173.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 m -119.38 175.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.093 0.957 . . . . 0.0 110.406 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.31 140.66 37.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.22 111.54 0.85 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.915 2.41 . . . . 0.0 112.29 173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.91 -35.88 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 109.88 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 26.8 mm-40 -112.35 87.63 2.62 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.5 p -90.66 128.18 36.54 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -141.51 153.37 65.44 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -47.83 -44.29 27.29 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.764 2.976 . . . . 0.0 114.569 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -126.57 16.14 7.59 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -145.58 151.65 38.45 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -140.63 142.17 35.02 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.665 0.786 . . . . 0.0 108.889 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.3 tm? -138.98 121.14 15.77 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.4 ' HZ ' HD13 ' B' ' 49' ' ' LEU . 4.1 p90 -133.04 132.0 41.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 108.607 173.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.527 HG23 ' HG3' ' B' ' 46' ' ' LYS . 21.5 t -110.45 129.46 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.921 0.888 . . . . 0.0 109.012 -173.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.481 HD21 ' SD ' ' B' ' 45' ' ' MET . 7.8 mp -93.66 142.76 26.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 0.0 110.135 -170.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.44 -5.89 21.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.986 0.914 . . . . 0.0 112.385 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' N ' HD21 ' B' ' 43' ' ' ASN . 0.8 OUTLIER -66.69 -19.74 65.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.659 1.183 . . . . 0.0 111.976 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.29 16.79 15.26 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.176 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.75 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.5 ppp? -125.52 175.95 7.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.747 0.819 . . . . 0.0 109.723 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.527 ' HG3' HG23 ' B' ' 40' ' ' VAL . 81.3 tttt -140.36 137.68 34.26 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -133.03 118.84 19.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.753 0.421 . . . . 0.0 110.234 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.402 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -97.47 163.33 21.76 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.4 HD13 ' HZ ' ' B' ' 39' ' ' PHE . 1.1 tp -141.75 104.68 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 171.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.433 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 3.3 t90 -111.43 134.78 52.77 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 35.3 m -76.12 136.56 39.83 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 111.355 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -72.48 -9.88 59.1 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.917 0.887 . . . . 0.0 112.335 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -87.18 -8.18 57.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.28 0.632 . . . . 0.0 111.095 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.2 t -135.42 8.8 3.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.907 0.483 . . . . 0.0 111.342 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' B' ' 58' ' ' LYS . 4.0 p -67.93 143.3 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.38 0.272 . . . . 0.0 111.272 176.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -123.81 117.49 27.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.246 1.018 . . . . 0.0 109.181 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.3 143.41 76.32 Favored 'Cis proline' 0 C--N 1.381 2.277 0 CA-C-N 120.098 1.071 . . . . 0.0 113.105 -1.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.487 ' HA ' HG11 ' B' ' 55' ' ' VAL . 3.1 tppp? -58.84 127.81 34.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.992 0.917 . . . . 0.0 112.66 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.08 108.92 3.1 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.78 1.232 . . . . 0.0 108.677 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -87.0 89.73 8.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.16 0.584 . . . . 0.0 109.507 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 142.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.551 0.741 . . . . 0.0 110.422 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -139.24 136.55 35.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 109.479 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.75 51.84 50.48 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.752 0.658 . . . . 0.0 114.172 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.05 45.72 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.45 -170.63 12.03 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.455 -0.372 . . . . 0.0 113.124 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.4 170.56 47.99 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.258 0.622 . . . . 0.0 112.975 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -99.93 159.81 14.8 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.589 0.756 . . . . 0.0 110.77 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.78 101.36 10.81 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.58 103.69 14.65 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -82.81 105.78 14.1 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 41.0 mtm105 -84.6 127.99 34.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.689 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.56 157.79 43.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.963 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.26 -42.39 83.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.037 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.99 174.33 13.27 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 121.497 0.665 . . . . 0.0 111.876 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.61 -27.7 69.12 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.139 -1.392 . . . . 0.0 112.461 -165.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.99 -41.84 77.3 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -63.56 -23.71 67.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.561 0.745 . . . . 0.0 112.392 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.33 -42.65 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.252 0.621 . . . . 0.0 110.631 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.43 -31.12 68.17 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.594 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.2 mt-10 -70.98 -42.69 69.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.408 0.623 . . . . 0.0 109.557 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -69.19 -29.81 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.401 ' O ' ' HE1' ' B' ' 92' ' ' MET . 38.0 t80 -62.64 -60.68 3.17 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.549 0.74 . . . . 0.0 109.143 176.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.17 88.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.801 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.06 94.38 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 124.041 0.838 . . . . 0.0 113.615 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -63.88 -45.7 88.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.308 0.643 . . . . 0.0 110.235 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.82 -45.7 78.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.582 0.753 . . . . 0.0 110.454 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.91 63.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.028 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -99.45 14.15 30.81 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.959 0.903 . . . . 0.0 112.43 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 54.25 3.65 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.709 -0.678 . . . . 0.0 114.751 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' B' ' 20' ' ' PHE . 38.3 t -104.26 147.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.248 0.619 . . . . 0.0 109.339 170.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.15 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.092 0.557 . . . . 0.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.401 ' HE1' ' O ' ' B' ' 82' ' ' PHE . 55.0 ttm 63.84 84.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 166.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.62 86.77 2.64 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.863 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.518 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 22.9 tm0? 178.82 122.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.072 1.349 . . . . 0.0 107.644 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -79.58 114.48 45.94 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.484 ' HB2' ' HH ' ' B' ' 103' ' ' TYR . 75.2 Cg_exo -48.64 107.53 0.14 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.567 2.845 . . . . 0.0 112.178 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.84 145.31 42.3 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.942 0.897 . . . . 0.0 109.941 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.63 ' HZ3' ' HB2' ' B' ' 103' ' ' TYR . 0.1 OUTLIER -72.28 112.38 8.3 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.495 ' HE2' ' HB2' ' A' ' 56' ' ' GLU . 16.5 ttm -101.18 162.91 12.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.78 -23.9 63.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 0.0 111.106 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . 0.441 ' H ' ' HG2' ' B' ' 99' ' ' MET . 96.3 m-85 -119.51 91.49 3.56 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.552 1.141 . . . . 0.0 109.033 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.78 151.56 1.13 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . 0.63 ' HB2' ' HZ3' ' B' ' 98' ' ' LYS . 80.1 t80 -71.8 100.87 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.3 t -108.77 151.14 26.61 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.948 0.88 . . . . 0.0 111.893 -161.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.518 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 9.6 t80 -141.15 149.23 41.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.036 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.514 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 62.6 m -141.57 128.19 20.25 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.982 0.81 . . . . 0.0 110.69 171.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.23 155.77 19.14 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.279 0.632 . . . . 0.0 109.935 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.61 128.43 54.53 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.22 156.86 57.54 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.197 0.999 . . . . 0.0 110.361 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.0 -21.71 72.38 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -92.93 -20.12 20.94 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.962 0.905 . . . . 0.0 110.377 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 40.2 m 71.9 90.99 0.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.965 1.706 . . . . 0.0 111.108 -176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.443 ' NE2' HG12 ' B' ' 11' ' ' VAL . 12.4 m170 -113.88 -91.68 0.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 167.32 109.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.577 1.151 . . . . 0.0 109.176 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.487 HD23 ' HH ' ' B' ' 21' ' ' TYR . 86.2 mt -126.36 110.19 13.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.11 0.564 . . . . 0.0 111.153 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -92.56 147.86 22.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.215 0.606 . . . . 0.0 110.581 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -134.74 125.74 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 163.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' B' ' 71' ' ' ARG . 12.4 p90 -130.15 151.77 50.31 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.295 0.952 . . . . 0.0 111.479 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' B' ' 103' ' ' TYR . . . -104.11 116.46 32.24 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -74.84 107.61 7.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.24 100.19 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.905 0.753 . . . . 0.0 109.737 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.089 -174.393 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.429 0.156 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.445 HG21 ' HB3' ' B' ' 70' ' ' PHE . 72.3 m -133.95 135.19 43.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.933 0.893 . . . . 0.0 110.101 -168.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.25 101.3 28.5 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.137 0.575 . . . . 0.0 111.516 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 70.1 Cg_endo -74.2 101.14 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.69 2.26 . . . . 0.0 111.563 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.588 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 27.0 t70 -113.52 1.78 15.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.031 0.932 . . . . 0.0 110.477 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -126.57 112.86 16.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -107.71 136.97 46.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 53.0 mt -119.99 135.0 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.617 0.767 . . . . 0.0 109.765 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.468 HD21 HD21 ' A' ' 47' ' ' LEU . 4.4 mm? -108.94 142.91 38.9 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -97.03 123.57 40.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.942 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' SER . 22.9 m -127.91 162.12 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.669 -0.644 . . . . 0.0 109.823 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -116.85 45.8 1.78 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.724 1.21 . . . . 0.0 108.917 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 16' ' ' ALA . 47.9 t30 178.85 74.99 0.14 Allowed Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.868 -158.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.0 Cg_exo -58.62 -63.12 0.15 Allowed 'Trans proline' 0 CA--C 1.579 2.77 0 C-N-CA 122.183 1.922 . . . . 0.0 113.889 -177.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 32.8 Cg_exo -60.27 -60.47 0.27 Allowed 'Trans proline' 0 C--N 1.404 3.465 0 CA-C-N 123.111 2.147 . . . . 0.0 112.331 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.454 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . . . -67.74 -39.18 84.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.589 -165.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.0 t -76.9 -28.53 55.36 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 86.3 m -71.77 -34.25 69.3 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.567 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 15.1 mm100 -64.41 -37.14 86.46 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.467 170.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.15 -43.09 88.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 12.2 m-85 -68.53 -31.21 70.29 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.796 176.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -57.31 -46.14 83.49 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.269 0.486 . . . . 0.0 112.117 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.07 -35.42 56.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.418 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.9 tp -60.89 -41.52 96.21 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.247 1.419 . . . . 0.0 112.48 -177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 HD22 ' HG3' ' B' ' 4' ' ' PRO . 25.3 mt -92.49 -45.18 8.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.256 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.5 28.23 6.45 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.044 -172.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.7 m -129.77 -178.97 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.063 0.945 . . . . 0.0 110.47 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -126.39 156.11 73.22 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.485 1.114 . . . . 0.0 108.504 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 47.7 Cg_endo -66.95 125.55 13.84 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.184 1.922 . . . . 0.0 112.413 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 40' ' ' VAL . 7.3 p -70.72 -35.81 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.549 0.739 . . . . 0.0 110.246 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 72.2 mm-40 -126.3 138.84 53.64 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 108.273 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -142.12 135.4 29.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 110.321 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 42.0 m -137.36 157.62 73.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.504 1.522 . . . . 0.0 108.398 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.8 -41.32 38.9 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.113 2.542 . . . . 0.0 114.098 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -127.92 21.95 6.31 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.419 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 85.2 t80 -149.99 152.94 35.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.09 0.556 . . . . 0.0 109.679 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 34.7 m -144.48 157.22 44.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.818 0.847 . . . . 0.0 109.455 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.7 tp -152.02 125.19 8.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.454 ' CZ ' ' HG ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -133.38 114.8 14.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.654 1.182 . . . . 0.0 109.194 174.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 30' ' ' VAL . 3.9 p -93.26 133.01 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.607 0.763 . . . . 0.0 109.589 174.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.433 HD13 ' SD ' ' A' ' 45' ' ' MET . 9.0 mp -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.213 0.605 . . . . 0.0 110.078 -170.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.48 -7.45 49.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.309 0.644 . . . . 0.0 111.528 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -73.54 -15.29 61.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.451 0.7 . . . . 0.0 110.221 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.36 -12.02 36.5 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 123.44 0.543 . . . . 0.0 113.808 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.597 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.5 ppp? -86.32 169.78 12.64 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.31 0.555 . . . . 0.0 110.216 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.67 138.27 48.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.452 0.301 . . . . 0.0 110.681 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.468 HD21 HD21 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -136.12 130.6 33.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.032 0.533 . . . . 0.0 110.345 -170.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.76 166.17 13.12 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.627 0.632 . . . . 0.0 112.081 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HG ' ' CZ ' ' A' ' 39' ' ' PHE . 17.5 mt -136.47 106.98 6.48 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.456 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.5 t90 -109.8 129.45 55.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 53.3 m -72.33 129.97 39.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -67.27 -18.7 65.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -170.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -75.88 -23.65 55.62 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.69 0.396 . . . . 0.0 110.94 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 51' ' ' SER . 14.3 t -115.7 6.27 14.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.564 0.746 . . . . 0.0 111.479 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 9.5 p -71.72 151.97 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.35 117.03 17.68 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 122.994 0.518 . . . . 0.0 110.96 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.5 Cg_exo -73.59 140.46 67.35 Favored 'Cis proline' 0 C--N 1.391 2.799 0 CA-C-N 119.673 0.919 . . . . 0.0 111.163 0.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -60.46 110.1 1.18 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 110.083 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.1 108.61 19.77 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.461 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 p -81.47 85.96 6.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.55 141.74 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.089 0.955 . . . . 0.0 109.557 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -161.02 142.02 11.57 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.232 1.413 . . . . 0.0 108.827 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.62 -38.87 0.61 Allowed Glycine 0 C--N 1.345 1.081 0 O-C-N 123.129 0.268 . . . . 0.0 112.487 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.69 -77.42 0.05 OUTLIER Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.43 -137.14 19.89 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.06 167.19 54.62 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 16.8 mt-10 -103.75 152.48 21.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.0 tp -117.71 98.61 6.46 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -90.95 114.71 27.28 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.392 0.615 . . . . 0.0 111.354 -169.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.0 m-85 -88.68 122.08 31.73 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.065 1.346 . . . . 0.0 108.79 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.413 ' HE ' ' HB3' ' B' ' 5' ' ' ASP . 41.3 mtm180 -99.01 129.88 45.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.501 0.667 . . . . 0.0 111.913 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.82 165.61 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.701 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.567 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.3 pt-20 -66.83 -39.73 87.77 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.2 p30 -162.5 -179.92 7.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.74 0.7 . . . . 0.0 112.094 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.02 -29.95 68.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.935 1.294 . . . . 0.0 112.913 -165.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.96 -47.8 76.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.046 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.567 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.5 mm-40 -64.7 -23.06 67.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.966 -1.016 . . . . 0.0 112.497 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.528 HG11 HG13 ' A' ' 117' ' ' VAL . 63.9 t -66.51 -46.04 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.539 0.736 . . . . 0.0 109.729 174.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 27.6 t70 -72.65 -28.81 62.95 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.242 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.3 mt-10 -69.52 -41.35 76.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.397 0.618 . . . . 0.0 110.012 175.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.6 m -66.98 -32.86 74.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.858 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.44 ' O ' ' HE3' ' A' ' 92' ' ' MET . 37.0 t80 -54.13 -59.98 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.987 0.915 . . . . 0.0 109.515 172.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.432 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -61.08 -38.8 87.55 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.688 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.54 92.13 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 123.617 0.573 . . . . 0.0 114.257 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -63.71 -45.49 89.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.497 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.6 ttpt -56.07 -45.39 79.32 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.964 0.906 . . . . 0.0 110.256 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.51 68.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.976 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 m -98.89 13.63 31.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.144 0.978 . . . . 0.0 112.616 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.33 54.81 2.74 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.309 -0.859 . . . . 0.0 114.568 164.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 92' ' ' MET . 3.7 p -102.83 152.85 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.63 -47.83 65.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.076 0.398 . . . . 0.0 110.957 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.497 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 52.6 ttm 65.34 84.02 0.16 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 170.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.87 83.21 2.14 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 120.962 0.41 . . . . 0.0 111.013 173.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 17.4 tm0? 178.46 140.04 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -87.72 123.32 69.47 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.678 0.791 . . . . 0.0 110.882 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.64 98.17 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.426 2.084 . . . . 0.0 110.409 174.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.08 157.51 43.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.796 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.01 104.76 4.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.965 0.906 . . . . 0.0 108.977 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 ttt -100.61 173.83 6.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.818 0.847 . . . . 0.0 109.983 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -55.93 -36.45 67.76 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.596 1.158 . . . . 0.0 112.177 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 -8.39 51.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.735 0.814 . . . . 0.0 110.845 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 126.63 -173.25 18.19 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.029 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.27 105.97 7.62 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 t -131.53 166.76 20.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.718 0.407 . . . . 0.0 111.934 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.46 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -155.72 160.15 40.1 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.737 169.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 3.0 m -133.45 127.3 33.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.219 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 105' ' ' PHE . . . -107.33 152.67 23.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 110.474 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.32 116.57 32.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.466 ' HB3' HD12 ' A' ' 115' ' ' LEU . 4.0 p-10 -68.81 170.45 8.41 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.675 0.79 . . . . 0.0 110.923 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -46.19 -39.54 20.89 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 123.412 2.742 . . . . 0.0 114.457 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.0 -11.96 55.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.579 0.752 . . . . 0.0 111.254 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 73.07 80.93 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.62 1.568 . . . . 0.0 111.679 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -120.07 -179.51 3.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.554 ' HD2' ' HD2' ' B' ' 57' ' ' PRO . 50.0 mmt-85 -103.27 99.16 9.0 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 109' ' ' ASP . 51.4 mt -97.12 103.37 15.29 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 25.7 mmt180 -89.11 148.54 23.63 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 123.967 0.907 . . . . 0.0 110.355 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.528 HG13 HG11 ' A' ' 78' ' ' VAL . 9.3 p -138.67 130.57 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 159.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -137.56 163.3 31.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.439 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.15 111.72 16.24 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.76 119.67 15.24 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.63 0.581 . . . . 0.0 110.557 -169.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.94 95.04 4.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.996 0.518 . . . . 0.0 110.692 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.815 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.433 179.1 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.673 0.273 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 88.1 m -139.61 135.69 33.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 110.535 -164.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.08 99.6 28.3 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.162 0.585 . . . . 0.0 110.969 -168.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 58.9 Cg_endo -72.95 101.55 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.695 2.264 . . . . 0.0 111.941 172.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.597 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 12.2 t70 -114.93 2.82 14.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.719 0.771 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.441 ' CD1' ' HG2' ' B' ' 46' ' ' LYS . 3.8 t80 -126.78 112.65 15.63 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -169.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -107.43 137.21 45.88 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 43.7 mt -120.35 135.57 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.511 0.724 . . . . 0.0 109.636 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.33 142.11 42.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.43 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 25.1 p90 -95.12 124.67 39.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.824 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' B' ' 51' ' ' SER . 36.0 m -128.76 163.5 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.931 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -118.81 44.83 2.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.488 1.115 . . . . 0.0 108.19 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 179.39 74.84 0.16 Allowed Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.662 -158.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.483 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 23.8 Cg_exo -58.61 -63.81 0.13 Allowed 'Trans proline' 0 CA--C 1.578 2.718 0 C-N-CA 122.154 1.903 . . . . 0.0 114.016 -177.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 31.8 Cg_exo -59.51 -60.66 0.29 Allowed 'Trans proline' 0 C--N 1.404 3.464 0 CA-C-N 123.035 2.12 . . . . 0.0 112.575 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.45 85.77 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.679 -165.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -76.76 -28.6 55.79 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.3 m -71.58 -34.21 69.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.618 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.1 mm100 -63.88 -37.67 88.25 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.416 170.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.31 -42.63 88.01 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.704 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -68.15 -31.8 71.63 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.139 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.618 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 54.3 mtpt -56.84 -46.34 81.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.263 0.554 . . . . 0.0 111.805 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.36 -35.03 54.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.226 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.47 -41.08 96.71 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.341 . . . . 0.0 112.547 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.442 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -92.75 -44.89 8.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.16 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 28.79 6.34 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.986 -172.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' B' ' 25' ' ' LEU . 25.8 m -130.77 -179.49 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.927 0.891 . . . . 0.0 110.598 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.67 156.31 71.11 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 124.363 1.065 . . . . 0.0 108.368 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 13.9 Cg_exo -67.82 126.0 14.0 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.39 2.06 . . . . 0.0 111.806 178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.533 HG12 HG21 ' B' ' 40' ' ' VAL . 13.5 p -71.91 -33.69 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.287 0.635 . . . . 0.0 110.281 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 60.4 mm-40 -128.28 138.3 52.35 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.9 m -142.56 136.14 28.95 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.108 0.563 . . . . 0.0 110.28 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 35.2 m -137.74 160.02 66.55 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 125.295 1.438 . . . . 0.0 108.442 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -52.36 -40.11 71.55 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.136 2.557 . . . . 0.0 113.212 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -127.97 21.91 6.29 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 87.0 t80 -149.39 153.21 37.03 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.074 0.549 . . . . 0.0 109.745 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 71.1 m -144.57 156.97 44.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.785 0.834 . . . . 0.0 109.696 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 3.0 tt -151.77 126.47 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 0.4 OUTLIER -134.36 113.53 12.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.934 1.294 . . . . 0.0 108.865 176.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.586 HG22 ' HG3' ' B' ' 46' ' ' LYS . 7.0 t -92.92 132.2 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.655 0.782 . . . . 0.0 109.336 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.421 HD23 HD11 ' B' ' 25' ' ' LEU . 36.0 mt -89.25 150.01 22.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.872 0.469 . . . . 0.0 110.262 -171.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.19 -7.96 52.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 111.609 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -71.91 -16.62 62.12 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.621 0.769 . . . . 0.0 110.379 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -12.17 35.49 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 123.436 0.541 . . . . 0.0 113.886 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.588 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -86.68 170.11 12.09 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.307 0.553 . . . . 0.0 109.958 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.586 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.7 tttt -131.51 137.34 48.49 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.961 0.504 . . . . 0.0 110.6 -175.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.67 131.43 35.7 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.334 -171.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.23 167.61 13.36 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.193 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.22 105.77 5.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.425 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -109.72 129.33 55.62 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 62.5 m -72.25 129.8 39.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -67.27 -18.82 65.36 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -170.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.85 -23.95 55.74 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.653 0.381 . . . . 0.0 110.59 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -115.6 6.58 14.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.425 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 7.9 p -72.09 152.41 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 122.05 -0.406 . . . . 0.0 109.99 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.436 ' HB2' HH22 ' A' ' 116' ' ' ARG . 30.6 mt-10 -130.86 116.49 17.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 122.976 0.51 . . . . 0.0 110.903 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 2.6 Cg_exo -73.35 140.49 67.48 Favored 'Cis proline' 0 C--N 1.387 2.554 0 CA-C-N 119.838 0.978 . . . . 0.0 111.068 0.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.35 110.1 1.16 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.926 0.766 . . . . 0.0 110.146 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.01 108.69 19.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.664 1.186 . . . . 0.0 108.376 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.3 p -81.42 85.19 6.5 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.94 143.32 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.867 0.867 . . . . 0.0 109.276 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.43 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 1.0 OUTLIER -162.31 141.41 9.29 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.335 1.454 . . . . 0.0 108.808 171.343 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.23 -38.08 0.59 Allowed Glycine 0 C--N 1.343 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 112.719 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.5 -77.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.49 -137.03 19.7 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.89 167.03 54.65 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.5 mt-10 -103.48 152.63 21.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.006 0.431 . . . . 0.0 110.525 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 57.5 tp -117.63 98.86 6.6 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.623 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.02 115.04 27.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.492 0.663 . . . . 0.0 111.381 -169.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 6.5 m-85 -89.2 122.47 32.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.949 1.3 . . . . 0.0 108.538 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.555 ' HE ' ' HB3' ' A' ' 5' ' ' ASP . 38.9 mtm105 -99.17 128.89 45.37 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.417 0.687 . . . . 0.0 111.678 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.95 165.94 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.791 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.569 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.71 -39.91 88.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -174.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -162.49 -179.54 7.02 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.543 0.61 . . . . 0.0 112.151 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.62 -29.97 69.57 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.006 1.322 . . . . 0.0 112.784 -164.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.517 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -64.49 -48.08 76.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.569 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.3 mm-40 -64.8 -22.92 67.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.118 0.967 . . . . 0.0 112.45 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.68 -45.55 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.611 0.719 . . . . 0.0 109.7 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -72.95 -28.84 62.66 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.966 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.8 mt-10 -69.32 -41.41 76.74 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.466 0.65 . . . . 0.0 109.95 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 23.7 m -68.22 -31.81 71.58 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.669 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -54.27 -59.52 4.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.744 0.818 . . . . 0.0 109.893 172.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.46 86.89 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.552 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.35 92.05 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 123.836 0.71 . . . . 0.0 114.064 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -64.35 -45.56 87.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.959 0.504 . . . . 0.0 109.908 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -56.49 -44.27 80.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.912 0.885 . . . . 0.0 110.404 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.52 -29.34 67.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.93 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 13.1 33.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.967 0.907 . . . . 0.0 112.447 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.03 2.69 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.603 165.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' B' ' 92' ' ' MET . 3.9 p -102.98 152.83 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.95 67.69 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.146 0.43 . . . . 0.0 111.097 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.491 ' HB2' HG11 ' B' ' 90' ' ' VAL . 48.5 tpp 64.84 83.63 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.896 0.748 . . . . 0.0 112.727 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.74 82.83 2.11 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . 0.405 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 15.4 tm0? 178.81 140.89 0.1 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.081 1.353 . . . . 0.0 107.477 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.0 123.39 67.54 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.573 0.749 . . . . 0.0 110.517 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.78 98.54 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.472 2.114 . . . . 0.0 110.244 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.14 157.36 44.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.79 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.97 105.16 4.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.926 0.89 . . . . 0.0 108.85 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.44 ' SD ' HG21 ' B' ' 104' ' ' THR . 10.8 ttt -100.87 172.99 6.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.204 1.002 . . . . 0.0 109.901 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -55.34 -36.71 66.56 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.45 1.1 . . . . 0.0 112.424 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.64 -8.3 52.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.787 0.835 . . . . 0.0 110.953 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 126.52 -173.14 18.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.133 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -76.74 106.49 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.44 HG21 ' SD ' ' B' ' 99' ' ' MET . 11.9 t -132.0 166.19 22.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 0.0 111.82 -169.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.405 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 6.4 p90 -153.71 162.35 41.32 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.409 168.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 29.2 m -134.54 127.69 31.81 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.48 152.44 24.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.388 0.675 . . . . 0.0 110.523 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.11 117.61 34.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.487 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 5.8 p-10 -71.12 171.72 8.02 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.702 -0.666 . . . . 0.0 110.288 176.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 7.7 Cg_endo -46.9 -39.63 24.73 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.464 2.776 . . . . 0.0 114.194 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.18 -10.7 57.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.133 0.573 . . . . 0.0 111.604 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 15.3 m 72.98 82.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.108 1.363 . . . . 0.0 111.565 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.408 ' HE1' HG11 ' B' ' 11' ' ' VAL . 13.4 m80 -123.25 179.99 4.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -103.93 99.15 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.91 103.83 15.81 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.623 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 44.0 ttm-85 -89.02 148.2 23.87 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.618 0.767 . . . . 0.0 110.516 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' B' ' 70' ' ' PHE . 21.5 t -136.58 131.18 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -136.99 163.94 29.53 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . 0.432 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -124.67 111.71 15.91 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.86 119.32 13.9 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.757 0.661 . . . . 0.0 110.623 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 95.05 1.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.021 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.369 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -71.1 138.51 49.78 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.069 0.548 . . . . 0.0 109.758 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -96.98 112.2 59.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 0.0 110.705 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -87.26 83.44 1.01 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.842 2.361 . . . . 0.0 111.765 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.775 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.9 p-10 -84.8 4.92 30.73 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 172.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.7 t80 -123.41 127.66 48.76 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.093 1.357 . . . . 0.0 107.681 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -126.36 136.1 52.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.959 0.904 . . . . 0.0 108.584 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 50.9 mt -119.56 137.16 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.696 0.798 . . . . 0.0 109.53 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 97.4 mt -108.08 140.56 41.09 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.484 ' HE2' ' HA ' ' A' ' 62' ' ' THR . 36.3 p90 -85.7 130.98 34.42 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.262 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.489 HG13 ' NE2' ' A' ' 113' ' ' HIS . 5.3 m -129.5 151.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.479 0.657 . . . . 0.0 110.575 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.46 -55.36 3.69 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.22 1.008 . . . . 0.0 109.938 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -105.15 98.4 15.97 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.54 0.736 . . . . 0.0 109.927 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.78 -53.92 6.19 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.518 2.812 . . . . 0.0 115.185 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.29 -54.19 5.87 Favored 'Trans proline' 0 C--N 1.402 3.363 0 C-N-CA 122.53 2.153 . . . . 0.0 113.023 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.18 61.83 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.296 -168.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -77.38 -35.16 54.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.723 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 78.6 m -67.16 -43.31 82.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.563 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 19.4 mm100 -61.47 -35.02 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.63 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 t80 -64.05 -44.26 93.01 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 124.058 0.849 . . . . 0.0 110.142 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.701 ' HH ' HD23 ' A' ' 115' ' ' LEU . 62.0 m-85 -71.55 -30.06 65.46 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.854 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.563 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -56.31 -50.51 71.23 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.252 0.549 . . . . 0.0 111.991 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -33.76 52.41 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.72 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 19.4 tp -60.99 -48.62 80.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.707 1.203 . . . . 0.0 112.801 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' HB2' HG23 ' A' ' 27' ' ' VAL . 35.4 mt -84.94 -40.79 16.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.301 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 33.61 6.39 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -173.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 25' ' ' LEU . 31.4 m -128.27 -178.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.29 1.036 . . . . 0.0 110.595 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -132.95 141.17 40.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.988 0.915 . . . . 0.0 108.865 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 18.9 Cg_exo -66.06 110.82 1.82 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.613 2.209 . . . . 0.0 111.793 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.99 -39.68 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 17.9 mm-40 -112.51 109.04 18.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.2 p -113.88 141.97 46.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.277 0.631 . . . . 0.0 109.655 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 66.1 m -142.94 160.92 51.22 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.988 1.315 . . . . 0.0 108.894 -175.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.43 -30.85 91.74 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.736 2.29 . . . . 0.0 113.013 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.5 t -127.55 19.39 6.78 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.173 0.589 . . . . 0.0 111.894 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.407 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.3 t80 -159.1 156.78 29.77 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.881 0.472 . . . . 0.0 110.345 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 m -146.47 150.31 35.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.474 1.11 . . . . 0.0 108.358 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -144.44 116.97 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -128.85 122.97 31.55 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.037 1.335 . . . . 0.0 108.542 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 46' ' ' LYS . 15.6 t -106.21 134.0 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.979 0.912 . . . . 0.0 109.425 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.435 HD12 ' SD ' ' A' ' 45' ' ' MET . 85.5 mt -95.19 147.18 23.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.562 0.345 . . . . 0.0 110.107 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -12.45 52.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.302 1.041 . . . . 0.0 112.199 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.5 -8.92 29.61 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.175 0.99 . . . . 0.0 112.931 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.1 53.75 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.803 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -114.56 170.84 8.01 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.9 0.88 . . . . 0.0 108.938 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.525 ' HG3' HG22 ' A' ' 40' ' ' VAL . 75.9 tttt -133.75 134.22 42.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.28 118.13 22.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.775 0.43 . . . . 0.0 109.878 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -96.56 166.54 24.08 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.717 0.675 . . . . 0.0 111.521 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 tp -143.38 102.44 3.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.489 ' HZ2' ' HE1' ' B' ' 99' ' ' MET . 6.2 t90 -111.05 130.29 55.65 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.2 m -68.28 126.91 31.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.154 0.284 . . . . 0.0 110.244 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 24.7 ptt180 -68.79 -13.4 62.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.922 0.889 . . . . 0.0 112.605 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -14.4 59.51 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.47 0.308 . . . . 0.0 110.878 176.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.416 HG22 ' HE1' ' A' ' 50' ' ' TRP . 13.6 t -128.36 10.5 6.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.62 0.768 . . . . 0.0 110.785 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.411 ' HA ' ' CE2' ' A' ' 50' ' ' TRP . 10.3 p -69.79 149.31 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 173.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -130.37 123.8 20.76 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 122.983 0.513 . . . . 0.0 110.638 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.84 137.84 50.29 Favored 'Cis proline' 0 C--N 1.387 2.604 0 C-N-CA 124.453 -1.061 . . . . 0.0 111.432 -6.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.81 110.68 0.45 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.516 0.726 . . . . 0.0 110.886 -175.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.47 110.0 22.16 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 p -83.13 87.22 6.92 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -153.31 150.96 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.738 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.484 ' HA ' ' HE2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -163.72 147.92 10.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.245 1.418 . . . . 0.0 109.279 170.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.28 -7.91 76.47 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.961 -0.563 . . . . 0.0 114.098 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 114' ' ' ARG . . . -159.24 122.95 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 133.98 111.93 1.26 Allowed Glycine 0 C--N 1.34 0.781 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.414 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 77.25 109.82 0.15 Allowed Glycine 0 C--N 1.346 1.135 0 O-C-N 124.134 0.549 . . . . 0.0 111.735 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.522 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.8 mm-40 -98.24 136.7 38.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 tp -107.85 99.6 9.05 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -87.56 113.7 23.49 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -163.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -90.6 111.33 22.6 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 108.327 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -92.28 127.09 37.64 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.529 0.68 . . . . 0.0 111.818 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.11 162.14 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.522 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.6 pt-20 -67.9 -35.6 78.76 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -163.25 -179.95 6.97 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.686 0.675 . . . . 0.0 112.746 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -61.58 -29.67 70.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.247 1.419 . . . . 0.0 112.725 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.07 -44.27 72.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.063 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 75.0 mm-40 -63.63 -23.05 67.22 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.696 0.798 . . . . 0.0 112.467 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -65.89 -41.63 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 0.0 110.519 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.62 -27.94 45.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.127 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.5 mt-10 -66.6 -41.48 88.39 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.89 0.852 . . . . 0.0 109.513 173.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -64.47 -38.1 89.85 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.606 . . . . 0.0 110.93 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.456 ' O ' ' HE3' ' A' ' 92' ' ' MET . 42.3 t80 -55.99 -60.48 3.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.764 0.826 . . . . 0.0 109.845 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.59 -36.44 82.63 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.199 -172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.68 -47.76 83.61 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.71 0.631 . . . . 0.0 113.655 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -65.15 -39.17 92.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.41 0.684 . . . . 0.0 110.185 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -61.46 -43.07 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.376 0.671 . . . . 0.0 110.009 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.11 67.56 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.736 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 t -100.73 7.45 43.84 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.3 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.42 56.91 2.43 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 166.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 92' ' ' MET . 5.8 p -104.75 146.1 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.58 -39.39 67.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.721 0.408 . . . . 0.0 111.519 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.456 ' HE3' ' O ' ' A' ' 82' ' ' PHE . 4.1 ptm 49.68 79.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.138 1.775 . . . . 0.0 113.862 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.406 HD11 ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -109.1 83.29 1.73 Allowed 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.489 -0.757 . . . . 0.0 109.424 177.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 18.2 tm0? 178.85 127.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -76.02 125.78 87.64 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 104' ' ' THR . 42.8 Cg_endo -65.71 98.47 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.295 1.997 . . . . 0.0 109.948 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.14 160.89 39.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.581 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.481 ' HZ1' ' HB2' ' A' ' 103' ' ' TYR . 17.5 mmtm -69.72 142.65 53.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.326 0.65 . . . . 0.0 110.762 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ttp -147.48 -178.07 6.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.972 0.909 . . . . 0.0 108.66 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.07 -37.28 61.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.867 1.267 . . . . 0.0 113.194 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.37 8.64 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.536 0.735 . . . . 0.0 111.486 -172.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.93 -160.44 13.48 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.481 ' HB2' ' HZ1' ' A' ' 98' ' ' LYS . 11.6 t80 -79.3 109.5 13.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 8.9 t -105.42 147.65 28.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.338 0.655 . . . . 0.0 111.551 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.449 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 17.3 t80 -154.5 136.35 14.51 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.828 1.251 . . . . 0.0 109.57 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.1 m -137.72 123.55 20.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.37 139.95 42.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.36 0.664 . . . . 0.0 111.524 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.72 126.78 55.41 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 13.3 p-10 -78.6 179.78 1.63 Allowed Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.831 175.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 46.8 Cg_exo -44.52 -40.51 13.71 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.827 2.352 . . . . 0.0 114.188 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.35 -21.87 59.49 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.686 0.394 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.69 74.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.438 1.495 . . . . 0.0 110.846 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.489 ' NE2' HG13 ' A' ' 11' ' ' VAL . 19.2 m170 -103.86 -171.57 1.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.413 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.516 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 19.5 mmm180 -120.29 96.77 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.701 HD23 ' HH ' ' A' ' 21' ' ' TYR . 58.9 mt -109.36 99.34 8.6 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -96.47 95.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.321 0.648 . . . . 0.0 111.329 -169.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.74 133.54 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.403 ' HE2' ' HB2' ' A' ' 120' ' ' PHE . 9.1 p90 -136.8 177.96 7.44 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.816 0.734 . . . . 0.0 112.319 172.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.25 111.88 6.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.403 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 38.5 t80 -84.56 119.2 24.92 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.6 100.5 3.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.51 0.724 . . . . 0.0 110.375 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -178.935 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ppp? . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.264 0.078 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.2 m -136.81 138.71 41.12 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -97.04 112.18 59.96 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 0.0 111.043 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.0 83.35 1.08 Allowed 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.911 2.407 . . . . 0.0 111.563 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASP . . . . . 0.803 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.2 p-10 -84.46 4.68 30.56 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.292 0.568 . . . . 0.0 111.228 172.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -123.37 127.34 48.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.11 1.364 . . . . 0.0 107.502 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 t -126.3 135.99 52.21 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 108.857 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.8 mt -119.46 136.78 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 109.548 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.49 140.42 40.48 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' TYR . . . . . 0.493 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 36.0 p90 -85.46 130.91 34.48 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.106 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.586 HG12 ' NE2' ' B' ' 113' ' ' HIS . 7.1 m -128.93 151.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.257 0.551 . . . . 0.0 110.536 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.69 -55.83 3.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.318 1.047 . . . . 0.0 109.721 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -105.5 97.36 14.05 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 124.081 0.953 . . . . 0.0 109.758 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -51.31 -54.59 5.13 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.594 2.863 . . . . 0.0 115.379 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.86 -54.54 5.26 Favored 'Trans proline' 0 C--N 1.403 3.398 0 C-N-CA 122.38 2.053 . . . . 0.0 113.409 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.2 61.65 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.439 -168.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 82.8 p -77.7 -34.49 52.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 73.2 m -67.65 -43.71 79.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . 0.52 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.0 mm100 -62.12 -34.73 76.89 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.954 173.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 84.6 t80 -63.68 -44.54 93.4 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.023 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 50.1 m-85 -70.8 -30.58 67.07 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.917 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 62.1 mtpt -56.45 -50.17 72.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.087 0.47 . . . . 0.0 112.125 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.69 -34.14 52.94 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.662 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 15.4 tp -60.54 -49.29 78.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.68 1.192 . . . . 0.0 113.092 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.49 ' HB2' HG23 ' B' ' 27' ' ' VAL . 34.9 mt -84.26 -40.96 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.28 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.26 33.75 6.41 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.49 HG23 ' HB2' ' B' ' 25' ' ' LEU . 31.5 m -128.62 -178.75 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.059 . . . . 0.0 110.573 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.43 142.35 44.59 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.926 0.89 . . . . 0.0 109.209 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.519 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 16.7 Cg_exo -67.39 110.56 2.07 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.355 2.036 . . . . 0.0 111.828 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.72 -39.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.794 0.838 . . . . 0.0 110.388 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.614 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 23.4 mm-40 -112.99 108.95 18.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -113.84 142.2 46.39 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.368 0.667 . . . . 0.0 109.81 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 50.4 m -142.87 161.48 48.64 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.784 1.234 . . . . 0.0 109.028 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.11 -30.61 89.43 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.471 2.114 . . . . 0.0 112.965 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -127.72 19.62 6.66 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.222 0.609 . . . . 0.0 111.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.415 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 77.0 t80 -159.12 156.88 29.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.794 0.438 . . . . 0.0 110.232 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 68.6 m -146.55 150.5 35.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.475 1.11 . . . . 0.0 108.318 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -144.72 117.0 8.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -129.12 123.65 32.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.899 1.28 . . . . 0.0 108.492 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' B' ' 46' ' ' LYS . 19.9 t -107.29 133.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.785 0.834 . . . . 0.0 109.244 -172.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.449 HD12 ' SD ' ' B' ' 45' ' ' MET . 85.5 mt -95.0 147.48 23.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.685 0.394 . . . . 0.0 110.091 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -12.24 52.76 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.158 0.983 . . . . 0.0 112.216 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.93 -8.55 30.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.096 0.959 . . . . 0.0 112.682 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.13 16.15 54.44 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' MET . . . . . 0.775 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -114.84 170.79 8.07 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.82 0.848 . . . . 0.0 108.862 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.551 ' HG3' HG22 ' B' ' 40' ' ' VAL . 80.2 tttt -133.61 134.22 42.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -176.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.501 HD11 HD11 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -128.27 118.19 22.82 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -174.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.73 24.71 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 123.698 0.666 . . . . 0.0 111.623 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' B' ' 37' ' ' SER . 6.8 tp -143.64 102.23 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' TRP . . . . . 0.459 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 6.2 t90 -110.92 130.4 55.59 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 35.9 m -68.3 127.26 32.28 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.286 0.366 . . . . 0.0 110.131 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' B' ' 10' ' ' TYR . 21.1 ptt180 -69.42 -12.78 61.94 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.846 0.858 . . . . 0.0 112.604 -173.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -77.95 -15.46 58.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.508 0.323 . . . . 0.0 110.523 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -127.98 10.37 6.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.607 0.763 . . . . 0.0 111.036 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' B' ' 58' ' ' LYS . 7.8 p -69.99 150.01 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -131.32 123.07 19.37 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.002 0.521 . . . . 0.0 111.13 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.97 136.6 45.15 Favored 'Cis proline' 0 C--N 1.389 2.688 0 C-N-CA 124.348 -1.105 . . . . 0.0 110.969 -4.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.409 ' HA ' HG11 ' B' ' 55' ' ' VAL . 1.5 tmmm? -48.28 110.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.387 0.675 . . . . 0.0 111.284 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.51 109.94 22.08 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.4 p -83.59 85.92 7.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 29.2 m -150.68 151.89 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.247 1.019 . . . . 0.0 109.636 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.493 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 0.3 OUTLIER -164.57 147.91 9.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.006 1.322 . . . . 0.0 109.457 169.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.99 76.64 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.412 0.445 . . . . 0.0 113.779 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.536 ' HA2' ' HD3' ' B' ' 114' ' ' ARG . . . -159.35 122.88 1.18 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 133.83 112.15 1.29 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.514 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 77.28 109.69 0.15 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 173.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.5 mm-40 -98.22 138.16 35.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -170.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.501 HD11 HD11 ' B' ' 47' ' ' LEU . 0.6 OUTLIER -110.68 98.75 7.84 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.04 113.14 23.38 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -161.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -89.85 111.5 22.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.877 1.271 . . . . 0.0 108.578 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -92.99 126.3 38.0 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.51 0.671 . . . . 0.0 111.838 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.63 162.6 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.559 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLU . . . . . 0.546 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.8 pt-20 -67.74 -35.17 78.26 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -163.63 179.71 7.0 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.685 0.675 . . . . 0.0 112.769 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.66 -29.58 70.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.207 1.403 . . . . 0.0 112.764 -166.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.03 -44.03 73.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.078 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLN . . . . . 0.546 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.1 mm-40 -63.84 -23.08 67.21 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.915 0.886 . . . . 0.0 112.548 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.77 -41.55 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.291 0.636 . . . . 0.0 110.41 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.44 -27.37 41.67 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.114 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.6 mt-10 -66.57 -41.37 88.68 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.758 0.79 . . . . 0.0 109.372 173.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.8 m -64.62 -37.87 89.06 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.928 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.01 -60.52 3.36 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 109.722 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.469 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.86 -36.19 81.76 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.237 -172.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.86 84.07 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.578 0.549 . . . . 0.0 113.684 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -65.74 -38.72 89.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.301 0.64 . . . . 0.0 110.261 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.7 ttpt -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 109.982 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.589 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -101.14 7.38 43.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.129 0.972 . . . . 0.0 112.565 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 57.47 2.4 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 115.382 0.913 . . . . 0.0 115.382 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 p -104.87 146.14 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.14 68.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.937 0.495 . . . . 0.0 111.747 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' MET . . . . . 0.471 ' HE2' ' HZ ' ' B' ' 105' ' ' PHE . 10.2 ptp 49.17 80.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.965 1.706 . . . . 0.0 113.911 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.4 ' N ' HD11 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -109.15 83.17 1.71 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.849 0.833 . . . . 0.0 109.62 177.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 178.58 126.64 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.153 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -75.37 126.84 87.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 123.328 0.392 . . . . 0.0 110.455 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' B' ' 104' ' ' THR . 55.8 Cg_endo -67.11 98.53 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.418 2.079 . . . . 0.0 109.732 172.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.33 160.73 39.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -69.38 141.78 54.08 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.881 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' MET . . . . . 0.51 ' HE2' HG23 ' B' ' 104' ' ' THR . 1.1 ptp -145.35 -176.38 5.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.153 0.981 . . . . 0.0 109.281 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -55.66 -36.56 67.21 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.539 1.135 . . . . 0.0 112.61 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.94 8.73 42.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.453 0.701 . . . . 0.0 111.941 -173.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.76 -159.97 13.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.654 -0.579 . . . . 0.0 111.654 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -79.95 109.6 14.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.51 HG23 ' HE2' ' B' ' 99' ' ' MET . 6.9 t -105.99 149.27 26.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.268 0.556 . . . . 0.0 111.369 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' PHE . . . . . 0.471 ' HZ ' ' HE2' ' B' ' 92' ' ' MET . 14.4 t80 -155.77 137.14 13.97 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.867 1.267 . . . . 0.0 109.416 168.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 49.2 m -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.15 139.63 42.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.468 0.707 . . . . 0.0 111.51 -173.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.07 129.11 56.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.418 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 16.4 p-10 -81.52 -179.99 1.69 Allowed Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.977 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 43.3 Cg_exo -44.46 -40.71 13.63 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.473 2.115 . . . . 0.0 114.409 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.7 -22.15 60.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.974 0.51 . . . . 0.0 110.658 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m 72.62 74.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.4 1.48 . . . . 0.0 110.66 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' HIS . . . . . 0.586 ' NE2' HG12 ' B' ' 11' ' ' VAL . 22.1 m170 -103.56 -171.36 1.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.402 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.536 ' HD3' ' HA2' ' B' ' 64' ' ' GLY . 22.6 mmm180 -120.4 96.71 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.2 99.52 8.79 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.47 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -95.23 94.93 8.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.874 0.47 . . . . 0.0 111.886 -169.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.0 t -85.55 133.86 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -137.5 177.68 7.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.059 0.845 . . . . 0.0 112.279 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.08 111.41 5.92 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -83.07 113.44 20.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.55 92.92 3.5 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.024 0.828 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -176.239 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.4 m80 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.49 114.29 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.932 2.421 . . . . 0.0 112.285 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.711 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.8 p-10 -99.01 11.43 39.02 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.352 0.596 . . . . 0.0 110.302 171.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -129.59 125.0 35.17 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.778 1.231 . . . . 0.0 107.875 -170.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -120.48 138.82 53.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.258 1.023 . . . . 0.0 108.503 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 55.8 mt -115.4 133.57 61.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 123.497 0.719 . . . . 0.0 109.066 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 HD21 ' A' ' 47' ' ' LEU . 9.1 mp -112.32 124.3 52.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 4.8 p90 -79.3 115.96 19.26 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.686 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 51' ' ' SER . 35.7 m -114.49 167.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.789 0.836 . . . . 0.0 109.191 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -96.68 -62.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.234 0.614 . . . . 0.0 110.322 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -106.16 96.31 13.0 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 123.351 0.66 . . . . 0.0 109.666 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 1.1 Cg_endo -44.9 -52.97 5.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.541 2.827 . . . . 0.0 115.809 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.41 -57.42 2.35 Favored 'Trans proline' 0 C--N 1.403 3.399 0 C-N-CA 122.416 2.077 . . . . 0.0 113.191 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.5 -37.41 77.17 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.4 m -77.43 -26.65 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.44 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 68.4 m -80.3 -38.95 29.69 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 82.9 mm-40 -67.01 -34.04 76.88 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.264 173.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -61.52 -49.45 76.67 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.673 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.2 m-85 -69.62 -27.18 64.86 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.616 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.6 mtpt -57.08 -51.75 68.04 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.144 0.429 . . . . 0.0 111.789 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.03 -32.26 39.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.916 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.0 tp -59.11 -53.24 60.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.041 0.936 . . . . 0.0 111.839 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB2' HG22 ' A' ' 27' ' ' VAL . 12.6 mt -83.11 -47.2 11.89 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.2 38.99 2.94 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 25' ' ' LEU . 30.4 m -128.42 171.12 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.328 1.051 . . . . 0.0 110.654 -176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.88 139.03 33.87 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.15 108.76 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.489 2.126 . . . . 0.0 111.593 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.81 -39.28 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.286 0.634 . . . . 0.0 109.973 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.721 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 35.9 mm-40 -118.51 149.11 41.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.305 1.042 . . . . 0.0 108.647 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 p -160.93 152.95 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.303 0.641 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 52.4 m -148.8 159.65 37.44 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.725 1.21 . . . . 0.0 108.448 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.59 -27.43 32.83 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.94 2.426 . . . . 0.0 113.798 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 14' ' ' PRO . 12.4 t -127.92 16.83 6.8 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.0 t80 -156.15 162.19 40.25 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.894 -0.504 . . . . 0.0 110.55 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 47.1 t -151.67 157.09 41.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.698 0.799 . . . . 0.0 109.351 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -152.31 128.92 10.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.16 141.86 46.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.443 1.097 . . . . 0.0 108.823 170.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.3 t -115.5 127.92 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.495 HD13 ' SD ' ' A' ' 45' ' ' MET . 10.0 mp -91.06 148.81 22.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.253 0.621 . . . . 0.0 110.187 -170.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.57 -8.51 34.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 111.809 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.81 -19.5 65.91 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.171 0.989 . . . . 0.0 111.724 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.04 47.35 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.736 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -113.37 174.72 5.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.877 0.871 . . . . 0.0 109.036 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HG3' HG22 ' A' ' 40' ' ' VAL . 82.7 tttt -139.23 140.92 37.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 9' ' ' LEU . 2.5 tt -140.07 123.26 16.84 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.817 0.341 . . . . 0.0 110.114 -171.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -104.68 160.3 15.59 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.793 0.711 . . . . 0.0 111.568 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 82.3 mt -126.11 106.46 9.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 164.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.589 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 4.9 t90 -105.08 123.19 47.39 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.6 t -70.7 130.82 42.76 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -65.48 -21.68 66.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 112.364 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -76.56 -8.28 56.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.392 0.277 . . . . 0.0 111.398 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -131.86 9.2 4.54 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.353 0.661 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.21 145.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.49 117.75 21.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 141.64 68.38 Favored 'Cis proline' 0 C--N 1.39 2.755 0 CA-C-N 119.935 1.013 . . . . 0.0 113.953 2.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.44 122.33 16.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.13 0.972 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.66 109.54 5.03 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.79 0.836 . . . . 0.0 109.996 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -85.36 85.5 7.44 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 121.875 0.845 . . . . 0.0 108.775 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.09 147.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 p -144.1 121.69 11.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.94 5.37 68.23 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.202 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.73 -34.78 72.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 121.303 0.391 . . . . 0.0 112.44 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' B' ' 10' ' ' TYR . . . -170.47 -161.54 21.23 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.214 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.55 110.26 0.24 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.497 ' HG2' ' HD2' ' A' ' 114' ' ' ARG . 24.1 mt-10 -123.99 130.09 52.0 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -171.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 9' ' ' LEU . 17.7 tp -115.84 101.57 8.91 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -88.08 109.87 20.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.834 0.35 . . . . 0.0 110.752 -171.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.493 ' HB2' HG22 ' A' ' 117' ' ' VAL . 22.4 m-85 -89.35 107.6 19.16 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -88.06 130.71 34.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.443 0.64 . . . . 0.0 111.273 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.08 159.13 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.816 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -66.15 -34.25 77.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -173.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 9.9 p30 -163.94 -179.9 6.57 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.513 0.673 . . . . 0.0 112.333 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.56 -29.7 70.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.492 1.517 . . . . 0.0 112.978 -165.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.86 -41.47 74.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.248 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.568 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 64.9 mm-40 -64.23 -23.87 67.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.655 0.782 . . . . 0.0 112.123 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.14 -42.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 121.533 0.682 . . . . 0.0 110.221 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.45 -29.7 59.74 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.471 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -66.01 -46.64 77.21 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.488 0.661 . . . . 0.0 109.522 173.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.2 m -65.46 -32.96 74.86 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.131 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.57 -61.37 2.65 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 123.687 0.795 . . . . 0.0 109.982 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.61 -35.57 80.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.31 -172.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.64 -46.67 93.24 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.593 0.558 . . . . 0.0 113.151 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.44 ' HB3' HG21 ' A' ' 90' ' ' VAL . 45.7 m0 -62.53 -43.23 99.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.438 0.695 . . . . 0.0 110.597 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -58.56 -43.13 89.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 110.596 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.19 -24.27 60.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.548 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 t -91.32 -0.22 57.62 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.301 1.041 . . . . 0.0 112.656 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.48 39.67 4.97 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.604 0.601 . . . . 0.0 114.604 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 85' ' ' TRP . 55.9 t -87.24 145.28 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.32 -51.07 67.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.96 0.504 . . . . 0.0 110.768 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.494 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 28.8 tpp 65.65 82.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.047 0.842 . . . . 0.0 111.898 169.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.41 84.01 2.22 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.569 0.7 . . . . 0.0 110.875 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 106' ' ' THR . 54.1 tp60 179.09 138.79 0.1 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.011 1.324 . . . . 0.0 108.679 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -83.49 121.88 76.71 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -63.04 102.21 0.3 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.639 2.226 . . . . 0.0 110.045 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.15 150.01 48.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.25 0.62 . . . . 0.0 111.363 -170.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -71.62 100.77 2.36 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.4 ttm -92.29 173.99 7.53 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.071 0.948 . . . . 0.0 109.498 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.66 -34.46 71.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.409 1.084 . . . . 0.0 111.732 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -87.69 -5.38 58.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.065 0.946 . . . . 0.0 110.978 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.61 -170.01 19.97 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.142 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -75.17 102.34 4.92 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 t -107.65 149.24 28.33 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.709 0.766 . . . . 0.0 110.019 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 1.8 t80 -144.68 140.53 28.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.016 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 26.5 m -136.63 127.66 27.76 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -106.3 171.95 7.08 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.844 0.457 . . . . 0.0 110.401 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.38 121.5 20.11 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 3.9 p-10 -77.76 177.31 2.81 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.999 0.92 . . . . 0.0 111.531 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 41.9 Cg_exo -42.05 -43.37 7.25 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.632 2.888 . . . . 0.0 114.946 170.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.56 -8.15 55.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.501 0.72 . . . . 0.0 111.247 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.5 m 64.6 87.55 0.11 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.055 1.342 . . . . 0.0 111.829 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -124.29 144.15 50.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.497 ' HD2' ' HG2' ' A' ' 67' ' ' GLU . 64.6 mtt180 -75.93 94.74 3.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.82 99.21 11.91 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.465 ' HG3' ' HZ3' ' B' ' 50' ' ' TRP . 2.6 tmt_? -98.2 96.11 7.87 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.789 0.836 . . . . 0.0 111.641 -165.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 70' ' ' PHE . 18.6 t -90.54 120.09 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -132.08 159.16 39.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.268 0.485 . . . . 0.0 112.276 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.91 112.03 17.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -74.03 129.27 37.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.579 0.352 . . . . 0.0 110.768 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.055 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.015 -0.516 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.12 114.68 0.67 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.278 2.652 . . . . 0.0 112.486 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.736 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.6 p-10 -99.31 10.86 40.6 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.439 0.637 . . . . 0.0 109.955 171.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.472 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -129.05 124.43 34.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.192 . . . . 0.0 107.812 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -120.02 139.01 53.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.069 0.948 . . . . 0.0 108.443 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 54.9 mt -116.07 133.87 61.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.526 HD23 HD21 ' B' ' 47' ' ' LEU . 3.4 mm? -112.85 124.33 52.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.444 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 5.2 p90 -80.21 116.74 20.47 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.696 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 51' ' ' SER . 33.9 m -114.5 167.08 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.733 0.813 . . . . 0.0 109.118 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -96.62 -62.56 1.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.316 0.647 . . . . 0.0 110.087 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -105.98 97.5 15.61 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.339 0.655 . . . . 0.0 109.572 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.438 ' HG2' ' HA ' ' B' ' 35' ' ' THR . 74.2 Cg_exo -46.81 -52.04 8.23 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 123.426 2.751 . . . . 0.0 115.246 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.4 -57.58 2.26 Favored 'Trans proline' 0 C--N 1.404 3.493 0 C-N-CA 122.681 2.254 . . . . 0.0 113.041 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.99 74.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.31 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -77.34 -27.12 52.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.436 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 99.3 m -79.96 -38.76 31.61 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.525 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 87.1 mm-40 -67.3 -33.34 75.07 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.532 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -62.25 -48.9 77.88 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.789 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 23.9 m-85 -69.73 -27.59 65.09 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.562 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.8 mtpt -56.91 -51.68 68.14 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.238 0.472 . . . . 0.0 111.93 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.59 -32.56 41.96 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.081 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 18.5 tp -59.25 -53.08 62.37 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.046 0.938 . . . . 0.0 111.835 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.422 ' HB2' HG22 ' B' ' 27' ' ' VAL . 11.9 mt -83.36 -47.18 11.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.988 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.98 39.42 2.89 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.4 m -128.58 170.23 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.476 1.111 . . . . 0.0 110.665 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -125.28 141.31 38.35 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 57.5 Cg_endo -68.13 109.53 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.301 2.001 . . . . 0.0 111.248 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.15 -39.07 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.113 0.565 . . . . 0.0 109.75 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 24.1 mm-40 -118.59 149.16 41.83 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.725 1.21 . . . . 0.0 108.915 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -161.08 153.15 19.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 51.0 m -149.55 160.24 34.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.804 1.242 . . . . 0.0 108.502 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.5 -27.26 39.81 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.043 2.495 . . . . 0.0 113.596 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.438 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 11.6 t -128.05 16.92 6.73 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.477 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 73.4 t80 -156.04 161.58 40.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.783 -0.573 . . . . 0.0 110.406 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 73.9 m -150.76 157.84 43.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.963 0.905 . . . . 0.0 109.752 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 4.6 tt -152.97 128.26 9.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.452 ' HE1' HD22 ' B' ' 47' ' ' LEU . 0.5 OUTLIER -134.75 141.98 46.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.402 1.081 . . . . 0.0 108.995 169.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.553 HG22 ' HG3' ' B' ' 46' ' ' LYS . 14.8 t -115.33 127.9 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.491 HD13 ' SD ' ' B' ' 45' ' ' MET . 9.8 mp -90.83 148.96 22.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.301 0.64 . . . . 0.0 110.239 -170.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -8.61 36.05 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.301 1.04 . . . . 0.0 111.796 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -66.22 -18.98 65.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.464 1.105 . . . . 0.0 111.699 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.06 16.16 48.79 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.433 -0.348 . . . . 0.0 112.232 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.711 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -113.43 175.04 5.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.776 0.83 . . . . 0.0 109.046 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.6 tttt -139.98 140.64 36.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.526 HD21 HD23 ' B' ' 9' ' ' LEU . 2.8 tt -140.16 123.27 16.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.728 0.411 . . . . 0.0 110.09 -171.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.472 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -104.88 160.15 15.48 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.87 0.748 . . . . 0.0 111.522 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 81.6 mt -126.2 106.29 9.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 164.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.465 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 5.3 t90 -104.91 123.32 47.54 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 11.4 t -70.69 130.6 42.19 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.411 ' O ' HG12 ' B' ' 55' ' ' VAL . 31.8 ptt180 -65.92 -20.62 66.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.843 0.857 . . . . 0.0 112.447 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -77.18 -8.2 57.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.313 0.245 . . . . 0.0 110.869 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -132.01 9.12 4.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.308 0.643 . . . . 0.0 111.24 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 52' ' ' ARG . 9.0 p -71.73 145.79 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -127.41 116.72 21.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 94' ' ' GLN . 10.4 Cg_exo -71.15 140.06 62.25 Favored 'Cis proline' 0 C--N 1.39 2.746 0 CA-C-N 120.205 1.109 . . . . 0.0 113.455 3.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -60.42 121.2 11.49 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.431 1.092 . . . . 0.0 112.005 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.47 109.65 5.11 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.678 0.791 . . . . 0.0 109.876 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 p -85.11 85.36 7.48 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-O 122.109 0.957 . . . . 0.0 108.858 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.71 148.73 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.2 p -145.1 121.66 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.541 1.136 . . . . 0.0 108.003 167.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.54 4.98 69.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.19 -34.75 76.08 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.79 0.295 . . . . 0.0 112.518 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.74 -162.43 23.07 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.747 -0.227 . . . . 0.0 112.731 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.4 110.71 0.24 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.172 0.572 . . . . 0.0 111.746 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.6 mt-10 -124.09 129.82 51.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -171.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 68' ' ' LEU . 5.5 mt -114.06 102.17 9.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.19 110.04 20.38 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.342 0.519 . . . . 0.0 111.008 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.6 107.43 19.08 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.495 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.8 mtm105 -87.86 129.5 35.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.336 0.589 . . . . 0.0 110.98 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.84 159.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.111 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 8.7 pt-20 -66.5 -33.52 75.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.19 179.83 6.62 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.455 0.645 . . . . 0.0 112.5 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.973 -165.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.81 -42.0 77.89 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.439 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -64.54 -23.73 67.37 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.022 0.826 . . . . 0.0 112.129 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 -42.43 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.476 0.655 . . . . 0.0 110.288 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.0 -30.66 62.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.029 1.331 . . . . 0.0 111.404 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.0 mt-10 -66.64 -46.21 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.407 0.622 . . . . 0.0 109.651 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.0 m -65.62 -33.18 75.3 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.07 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -58.33 -61.48 2.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.836 0.854 . . . . 0.0 109.899 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.52 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.72 -35.58 80.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.222 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.72 93.15 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.857 0.723 . . . . 0.0 113.029 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -62.82 -43.26 99.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.335 0.654 . . . . 0.0 110.432 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 31.9 ttpt -58.39 -43.32 88.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.035 0.834 . . . . 0.0 110.627 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.68 -24.32 61.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.909 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 38.1 t -91.0 -0.44 57.75 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.41 1.084 . . . . 0.0 112.424 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.91 41.37 4.67 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 114.284 0.473 . . . . 0.0 114.284 169.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.8 p -88.95 146.48 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.53 67.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.805 0.442 . . . . 0.0 110.507 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.544 ' HB2' HG13 ' B' ' 90' ' ' VAL . 57.4 ttm 63.76 83.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.693 0.797 . . . . 0.0 112.843 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 83.91 2.21 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.638 0.733 . . . . 0.0 110.682 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' B' ' 106' ' ' THR . 57.2 tp60 179.41 139.48 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.756 1.222 . . . . 0.0 108.591 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.05 121.16 74.13 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 26.7 Cg_endo -62.48 102.22 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.566 2.177 . . . . 0.0 110.088 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.38 150.86 48.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.011 0.524 . . . . 0.0 111.548 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -72.74 100.87 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.798 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.44 ' SD ' HG21 ' B' ' 104' ' ' THR . 4.5 mtt -90.69 175.15 7.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.234 1.014 . . . . 0.0 110.213 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.08 -34.6 73.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.092 0.957 . . . . 0.0 111.024 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -87.42 -5.81 58.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.175 0.99 . . . . 0.0 111.037 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.81 -169.53 20.25 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.23 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -75.66 102.51 5.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.44 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.0 t -107.82 149.09 28.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 110.061 -173.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 11.3 t80 -144.32 141.13 29.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.038 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 28.9 m -136.77 127.38 26.99 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.1 171.79 7.15 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.657 0.383 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.03 122.65 22.11 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.472 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.7 p-10 -79.2 177.21 3.03 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.013 0.925 . . . . 0.0 111.219 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.1 Cg_exo -41.83 -43.19 6.72 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.485 2.79 . . . . 0.0 115.16 170.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.27 -9.22 53.6 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.726 0.81 . . . . 0.0 110.766 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 24.3 m 65.22 87.45 0.12 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.194 1.397 . . . . 0.0 111.66 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -124.47 143.79 50.45 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.454 ' HB2' ' HG2' ' B' ' 67' ' ' GLU . 67.4 mtm-85 -76.24 94.68 3.58 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -92.83 99.11 11.84 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.589 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 2.8 tmt_? -96.0 94.93 7.87 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.258 -165.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 t -90.32 120.32 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.454 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.3 p90 -131.98 159.34 39.02 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.506 0.594 . . . . 0.0 112.345 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.46 111.32 16.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.8 124.28 25.05 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.331 0.395 . . . . 0.0 110.256 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.79 93.5 7.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 111.265 -176.955 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m80 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.7 95.03 0.92 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.773 2.315 . . . . 0.0 112.416 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.701 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.5 p-10 -83.53 3.56 31.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.384 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -124.33 118.61 27.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.0 t -117.3 137.75 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.624 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 50.8 mt -119.66 137.49 53.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 47' ' ' LEU . 4.6 mm? -88.47 106.96 18.62 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 168.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -58.51 104.26 0.21 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.398 163.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.55 HG12 ' HE1' ' A' ' 113' ' ' HIS . 27.8 m -118.8 173.81 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.412 1.085 . . . . 0.0 108.614 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.0 -64.74 1.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.99 0.916 . . . . 0.0 109.974 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -72.51 110.78 8.9 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.959 -170.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.3 Cg_exo -60.21 -62.25 0.16 Allowed 'Trans proline' 0 CA--C 1.576 2.618 0 C-N-CA 121.655 1.57 . . . . 0.0 113.324 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 22.3 Cg_exo -64.7 -52.11 1.5 Allowed 'Trans proline' 0 C--N 1.406 3.6 0 CA-C-N 122.984 2.101 . . . . 0.0 111.64 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.88 89.52 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.303 -165.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.47 -41.28 47.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 71.2 m -56.9 -46.02 82.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.565 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.6 mm100 -65.37 -38.25 89.47 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.515 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CZ ' HG22 ' A' ' 90' ' ' VAL . 77.6 t80 -63.89 -45.7 88.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.327 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.68 -29.22 65.48 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.875 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -56.25 -48.32 76.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.44 0.564 . . . . 0.0 111.952 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 -38.74 50.47 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.075 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.51 -40.99 93.4 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.256 1.422 . . . . 0.0 113.02 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' A' ' 27' ' ' VAL . 18.6 mt -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 31.05 6.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.262 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 25' ' ' LEU . 26.8 m -132.76 166.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.057 0.943 . . . . 0.0 110.322 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -113.71 149.32 41.54 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.443 0.697 . . . . 0.0 110.051 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 11.9 Cg_exo -71.37 111.91 3.21 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.912 2.408 . . . . 0.0 111.131 173.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.24 -37.27 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.337 0.655 . . . . 0.0 109.936 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm-40 -109.6 121.99 46.44 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.7 p -131.34 131.14 43.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.99 0.516 . . . . 0.0 110.118 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -144.13 152.98 55.93 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.222 1.409 . . . . 0.0 108.294 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.39 -10.44 13.42 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.661 2.241 . . . . 0.0 114.364 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -129.5 -1.02 4.97 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -153.94 148.56 26.31 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 122.096 -0.378 . . . . 0.0 110.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -137.91 149.68 46.42 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 109.638 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -143.77 122.27 12.44 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.48 ' HZ ' HD13 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -133.54 137.19 45.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.42 1.488 . . . . 0.0 108.17 173.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 46' ' ' LYS . 22.0 t -116.27 127.5 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.838 0.855 . . . . 0.0 108.764 -172.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.9 mt -87.07 150.61 23.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.836 0.351 . . . . 0.0 110.122 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.88 -8.12 45.94 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 0.0 111.97 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.439 HD22 ' HB3' ' B' ' 5' ' ' ASP . 1.5 m-20 -72.77 -8.43 55.4 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.086 0.954 . . . . 0.0 112.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.11 16.75 42.94 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.724 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -119.61 171.93 8.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.799 0.84 . . . . 0.0 109.476 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 40' ' ' VAL . 66.0 tttt -132.77 141.08 48.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 9' ' ' LEU . 1.1 tt -138.45 122.04 17.39 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.202 0.525 . . . . 0.0 110.444 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.8 171.49 20.04 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.888 0.756 . . . . 0.0 112.26 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.48 HD13 ' HZ ' ' A' ' 39' ' ' PHE . 1.1 tp -140.37 118.84 12.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.1 t90 -115.44 122.67 46.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -84.28 125.3 32.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.988 0.515 . . . . 0.0 109.972 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 37.7 ptt180 -69.48 -9.35 53.37 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -167.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -75.02 -8.58 56.92 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -135.33 6.44 3.29 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.772 0.429 . . . . 0.0 111.089 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 52' ' ' ARG . 7.1 p -60.9 147.85 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.977 0.511 . . . . 0.0 110.814 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -119.25 115.08 34.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' B' ' 94' ' ' GLN . 81.7 Cg_endo -79.23 142.59 67.13 Favored 'Cis proline' 0 C--N 1.381 2.252 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.582 2.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -51.17 115.22 1.45 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 111.688 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.57 151.65 41.76 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.497 1.119 . . . . 0.0 109.094 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 20.1 m -134.95 87.09 2.31 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.09 123.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.769 0.828 . . . . 0.0 108.988 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 p -136.4 125.39 24.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.019 0.927 . . . . 0.0 109.651 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.71 67.47 0.83 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' HA2' HG13 ' B' ' 61' ' ' VAL . . . -169.72 54.15 0.2 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.98 169.6 19.15 Favored Glycine 0 C--O 1.242 0.62 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 80.88 106.84 0.31 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.6 pt-20 -130.61 146.39 52.1 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.721 0.808 . . . . 0.0 109.59 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.7 tp -117.19 103.88 10.63 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.95 0.9 . . . . 0.0 108.637 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.0 113.78 23.97 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.222 0.464 . . . . 0.0 111.312 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.64 110.14 21.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.037 1.335 . . . . 0.0 108.458 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -89.72 124.67 34.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.542 0.687 . . . . 0.0 112.421 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.59 158.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.795 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.0 pt-20 -64.46 -39.39 93.73 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -161.4 178.25 9.34 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.219 0.533 . . . . 0.0 112.073 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.2 -28.13 66.36 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.208 1.403 . . . . 0.0 112.462 -167.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.08 -50.71 69.49 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.54 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.6 mm-40 -64.3 -24.4 67.64 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.303 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.16 -45.68 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.361 0.601 . . . . 0.0 110.028 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.18 -29.98 63.22 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.54 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 33.1 mt-10 -66.51 -47.71 72.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -66.59 -29.25 69.27 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.706 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -60.11 -61.21 2.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.732 0.813 . . . . 0.0 109.593 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.02 -32.6 73.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.296 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.81 -45.69 91.87 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.648 0.593 . . . . 0.0 112.759 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.427 ' HB3' HG21 ' A' ' 90' ' ' VAL . 44.4 m0 -66.01 -41.11 91.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.524 0.73 . . . . 0.0 110.046 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.28 -43.6 88.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 0.0 110.612 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.32 -27.36 61.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.761 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -94.48 8.67 41.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.56 0.744 . . . . 0.0 111.829 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.58 54.03 3.23 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 167.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.47 HG11 ' HB1' ' A' ' 107' ' ' ALA . 60.0 t -102.87 142.63 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.42 -47.29 82.53 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.132 0.573 . . . . 0.0 111.367 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 ttm 60.24 83.53 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 165.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.57 85.15 2.31 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 122.037 -0.414 . . . . 0.0 110.651 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? 177.93 121.1 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.665 1.186 . . . . 0.0 108.426 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -72.22 114.05 26.05 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 17.7 Cg_endo -56.22 112.93 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.945 2.43 . . . . 0.0 111.186 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.4 147.71 50.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.63 0.772 . . . . 0.0 110.657 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -75.26 100.93 4.5 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.105 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.643 ' HG2' ' H ' ' A' ' 101' ' ' PHE . 55.4 ttm -90.2 161.87 15.51 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.48 -28.49 54.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.735 0.814 . . . . 0.0 110.781 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.643 ' H ' ' HG2' ' A' ' 99' ' ' MET . 74.5 m-85 -110.14 88.34 2.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 109.509 171.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.64 162.34 0.94 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 82.7 t80 -78.2 101.83 7.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -107.65 145.38 33.41 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.512 0.673 . . . . 0.0 110.471 -165.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 4.9 t80 -137.1 130.66 31.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.531 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.0 m -120.85 122.78 41.03 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.448 0.642 . . . . 0.0 110.108 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -105.16 172.86 6.56 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.464 0.706 . . . . 0.0 109.988 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.85 118.12 12.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -68.01 168.25 13.97 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.675 0.79 . . . . 0.0 110.101 171.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.77 -27.26 15.04 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.114 2.543 . . . . 0.0 114.825 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.3 8.06 41.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.794 0.837 . . . . 0.0 111.229 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 m 70.45 30.04 3.32 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.134 1.373 . . . . 0.0 113.896 165.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.55 ' HE1' HG12 ' A' ' 11' ' ' VAL . 14.1 m80 -84.32 178.59 7.71 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -110.96 117.34 33.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -106.12 100.61 10.15 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -101.04 97.85 8.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -167.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.3 t -88.11 118.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.08 167.05 15.9 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.197 0.453 . . . . 0.0 110.957 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -126.82 110.69 13.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -82.1 115.79 21.38 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.724 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 m80 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.54 94.92 0.93 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.476 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.724 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 7.1 p-10 -83.05 3.4 30.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.105 0.562 . . . . 0.0 111.517 172.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.406 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.5 t80 -124.45 118.44 26.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -168.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -117.43 137.89 52.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.645 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 44.2 mt -119.72 137.08 54.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.45 HD23 HD21 ' B' ' 47' ' ' LEU . 4.6 mm? -88.14 106.86 18.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.43 105.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.06 163.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.522 HG12 ' HE1' ' B' ' 113' ' ' HIS . 22.4 m -119.1 173.79 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.621 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -105.93 -65.16 1.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.754 0.822 . . . . 0.0 109.882 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -72.12 110.78 8.63 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.782 -170.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.52 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 27.4 Cg_exo -59.99 -63.07 0.13 Allowed 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 121.691 1.594 . . . . 0.0 113.353 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 33.3 Cg_exo -63.08 -53.0 1.74 Allowed 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 123.195 2.177 . . . . 0.0 112.275 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.67 89.71 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.395 -165.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.11 -41.45 50.19 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.61 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 18.0 mm100 -65.71 -38.4 89.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.517 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -64.35 -44.89 90.04 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.749 0.656 . . . . 0.0 110.229 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -70.71 -29.51 65.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.904 -0.569 . . . . 0.0 109.884 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.61 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 58.9 mtpt -56.1 -48.38 76.26 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.486 0.585 . . . . 0.0 112.087 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.18 -38.98 50.52 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.04 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp -59.89 -41.4 91.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.203 1.401 . . . . 0.0 113.007 -174.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.482 ' HB2' HG22 ' B' ' 27' ' ' VAL . 19.7 mt -91.6 -41.27 10.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.315 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.44 30.87 7.07 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.28 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.0 m -132.86 167.11 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.093 0.957 . . . . 0.0 110.53 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -114.27 149.53 42.23 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.663 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 7.2 Cg_exo -72.12 111.48 3.19 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.91 2.406 . . . . 0.0 111.016 174.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.75 -36.72 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.949 0.5 . . . . 0.0 110.068 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.713 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.5 mm-40 -110.12 121.28 44.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -130.79 130.58 43.89 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.165 0.586 . . . . 0.0 110.111 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 91.9 p -143.94 155.98 58.88 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.461 1.104 . . . . 0.0 108.441 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.32 -10.2 17.8 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.685 2.257 . . . . 0.0 113.779 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -129.42 -1.17 5.0 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.9 148.91 26.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.184 0.447 . . . . 0.0 110.018 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 14.2 m -137.67 149.78 46.83 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.634 0.774 . . . . 0.0 109.2 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -143.98 121.6 11.82 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.94 138.52 46.94 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.156 1.383 . . . . 0.0 108.45 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.7 t -117.26 127.21 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.869 0.867 . . . . 0.0 108.756 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.478 HD12 ' SD ' ' B' ' 45' ' ' MET . 63.2 mt -87.1 150.58 23.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.95 -7.99 45.15 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.37 1.068 . . . . 0.0 111.89 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -73.28 -8.09 54.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.095 0.958 . . . . 0.0 111.948 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.04 16.81 42.94 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.701 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.4 ppp? -119.79 171.67 8.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.692 0.797 . . . . 0.0 109.378 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.6 141.17 48.56 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -173.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.45 HD21 HD23 ' B' ' 9' ' ' LEU . 1.1 tt -138.44 122.16 17.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 -172.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.406 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -103.86 170.57 19.11 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.863 0.745 . . . . 0.0 112.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 79.1 mt -138.59 119.83 14.69 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 164.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -115.27 122.68 46.71 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 39.1 m -83.59 125.49 31.86 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.784 0.434 . . . . 0.0 110.099 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 39.0 ptt180 -69.5 -8.45 47.1 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.92 -8.61 57.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.702 0.401 . . . . 0.0 111.48 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -135.52 4.78 3.14 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.184 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' B' ' 52' ' ' ARG . 7.5 p -57.8 147.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.128 0.571 . . . . 0.0 111.147 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.69 114.97 33.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.453 0.701 . . . . 0.0 109.143 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.33 143.09 68.68 Favored 'Cis proline' 0 C--N 1.382 2.31 0 C-N-CA 124.504 -1.04 . . . . 0.0 112.347 2.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.88 116.44 2.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.074 0.949 . . . . 0.0 110.861 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.63 151.22 41.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.988 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 49.5 m -134.67 86.96 2.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.412 HG13 ' HA2' ' A' ' 64' ' ' GLY . 7.5 p -156.27 123.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.244 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.4 p -135.49 126.46 27.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.834 0.854 . . . . 0.0 109.621 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.9 67.87 0.86 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.08 54.22 0.2 Allowed Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.88 169.76 19.25 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 80.74 107.26 0.3 Allowed Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.624 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 6.5 pt-20 -131.3 145.7 51.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.081 0.952 . . . . 0.0 109.079 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.5 tp -117.46 103.79 10.45 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.89 114.16 24.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.192 0.451 . . . . 0.0 111.252 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -91.2 109.98 21.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.918 1.287 . . . . 0.0 108.39 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.434 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.4 mtm180 -89.69 123.77 34.01 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.497 0.665 . . . . 0.0 111.991 -176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 159.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.781 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.9 pt-20 -64.79 -38.71 91.89 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -161.9 179.14 8.28 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.986 0.422 . . . . 0.0 112.064 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.0 -27.19 68.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.212 -166.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.11 -50.57 69.98 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.946 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.48 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 82.1 mm-40 -65.0 -24.1 67.41 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.39 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.18 -45.76 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.261 0.624 . . . . 0.0 110.087 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.24 -30.6 65.03 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.623 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 25.8 mt-10 -66.56 -47.22 73.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 109.421 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -66.91 -29.25 69.08 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.688 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.03 -61.39 2.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 0.0 109.621 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -67.17 -32.26 73.23 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.31 -173.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.65 -46.04 91.12 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.755 0.659 . . . . 0.0 112.826 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.51 -41.02 89.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.397 0.679 . . . . 0.0 109.708 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.8 ttpt -57.78 -43.62 85.67 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.769 0.827 . . . . 0.0 110.403 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.53 61.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.462 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -94.53 8.77 41.07 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.607 0.763 . . . . 0.0 111.685 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.97 54.49 3.19 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' B' ' 92' ' ' MET . 5.4 p -103.16 143.41 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 170.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.74 83.5 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.049 0.539 . . . . 0.0 111.284 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.647 ' HB2' HG13 ' B' ' 90' ' ' VAL . 53.6 ttm 59.64 83.64 0.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -118.57 85.74 2.41 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 122.027 -0.421 . . . . 0.0 110.498 175.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.485 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 45.1 tp60 177.2 119.89 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.099 1.36 . . . . 0.0 109.119 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.55 112.51 14.19 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.58 0.752 . . . . 0.0 109.08 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.597 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 10.9 Cg_endo -53.98 111.99 0.85 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.186 2.591 . . . . 0.0 111.835 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.38 147.62 50.27 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.686 0.794 . . . . 0.0 110.582 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 100.73 4.12 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.634 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 51.5 ttm -90.43 161.5 15.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.6 -28.06 53.01 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.623 0.769 . . . . 0.0 110.98 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.634 ' H ' ' HG2' ' B' ' 99' ' ' MET . 53.7 m-85 -110.02 88.18 2.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.391 1.077 . . . . 0.0 109.724 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.54 162.74 0.96 Allowed Glycine 0 C--N 1.354 1.56 0 N-CA-C 116.137 1.215 . . . . 0.0 116.137 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 84.7 t80 -78.89 101.96 7.98 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.7 t -107.62 145.34 33.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.585 0.707 . . . . 0.0 110.617 -165.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 6.2 t80 -137.41 131.62 32.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.928 1.291 . . . . 0.0 108.421 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 16.5 m -121.8 122.55 39.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 109.896 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.29 172.74 6.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.283 0.633 . . . . 0.0 109.702 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.53 117.21 12.22 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -66.81 168.99 8.86 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.62 0.768 . . . . 0.0 110.175 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.94 -27.37 20.76 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.336 2.69 . . . . 0.0 114.449 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.77 8.1 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.741 0.816 . . . . 0.0 111.488 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 51.1 m 70.04 30.74 3.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.223 1.409 . . . . 0.0 113.824 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.522 ' HE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -84.4 179.08 7.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 75.9 mmt-85 -111.32 117.82 34.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 37.7 mt -106.41 101.2 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -99.72 96.65 7.75 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.3 118.36 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.434 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.9 p90 -125.96 167.16 15.67 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.163 0.438 . . . . 0.0 110.988 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -127.0 110.73 13.28 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -82.7 118.18 23.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 93.85 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.349 0.66 . . . . 0.0 110.027 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.607 -176.698 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m80 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HG3' HD22 ' B' ' 25' ' ' LEU . 41.5 Cg_endo -82.71 52.4 4.04 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.381 2.721 . . . . 0.0 111.768 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.903 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 36.7 t70 -75.64 5.07 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.215 1.006 . . . . 0.0 111.764 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.419 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -124.46 126.56 46.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.0 t -120.44 145.02 47.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 50' ' ' TRP . 52.7 mt -122.07 144.4 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.775 0.83 . . . . 0.0 108.921 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.567 HD21 HD22 ' A' ' 68' ' ' LEU . 4.3 mm? -91.64 134.27 34.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.42 ' OH ' HG11 ' A' ' 55' ' ' VAL . 10.8 t80 -85.02 99.4 10.99 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.36 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.5 HG12 ' NE2' ' A' ' 113' ' ' HIS . 3.0 m -112.89 159.43 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.561 0.745 . . . . 0.0 109.075 -172.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.34 -59.78 1.87 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -102.37 101.82 21.83 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.245 0.618 . . . . 0.0 109.696 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HG3' ' HB2' ' A' ' 51' ' ' SER . 44.5 Cg_exo -55.21 -55.93 2.75 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.056 2.504 . . . . 0.0 114.908 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.76 -54.74 4.34 Favored 'Trans proline' 0 C--N 1.403 3.407 0 CA-C-N 122.545 1.945 . . . . 0.0 112.379 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.07 96.52 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.74 0.65 . . . . 0.0 111.703 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -66.53 -47.08 74.04 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 96.5 m -67.48 -40.48 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.572 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.1 mm100 -64.49 -38.29 90.49 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.273 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -64.94 -42.23 94.83 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.389 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.425 ' OH ' ' HG ' ' A' ' 9' ' ' LEU . 49.7 m-85 -68.52 -29.67 68.31 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.533 0.606 . . . . 0.0 110.466 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -56.83 -49.43 75.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.204 0.526 . . . . 0.0 111.879 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.87 -40.07 63.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.92 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.7 tp -58.94 -42.7 90.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.478 1.511 . . . . 0.0 113.068 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' HB2' HG22 ' A' ' 27' ' ' VAL . 16.3 mt -96.66 -31.99 12.42 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.16 26.88 27.29 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.325 0.391 . . . . 0.0 112.313 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.9 m -123.42 -178.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.967 0.907 . . . . 0.0 109.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -142.07 151.41 58.89 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 37.6 Cg_endo -63.76 121.26 8.92 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.896 2.397 . . . . 0.0 112.773 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.34 -35.16 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.442 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 15.5 mm-40 -121.03 116.63 25.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.939 1.296 . . . . 0.0 108.233 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.5 p -123.04 131.26 53.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.253 0.621 . . . . 0.0 110.097 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -138.67 151.14 68.15 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.864 1.266 . . . . 0.0 108.292 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.64 -10.12 23.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.817 2.344 . . . . 0.0 113.389 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.481 ' HA ' ' HG2' ' A' ' 14' ' ' PRO . 4.9 t -125.96 -3.57 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -159.17 151.47 21.25 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.7 m -141.62 158.6 43.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.769 0.428 . . . . 0.0 110.349 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -154.27 126.02 7.63 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.9 p90 -134.0 150.4 51.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.476 1.11 . . . . 0.0 109.09 165.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.531 HG22 ' HG3' ' A' ' 46' ' ' LYS . 13.4 t -120.96 131.42 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.03 165.4 15.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.644 0.378 . . . . 0.0 111.464 -171.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.08 75.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.518 1.127 . . . . 0.0 112.869 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -69.91 -20.75 63.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.13 0.572 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 5.35 37.32 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.871 -0.961 . . . . 0.0 114.181 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.493 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.3 ppp? -74.06 166.26 23.7 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.346 1.073 . . . . 0.0 109.206 169.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HG3' HG22 ' A' ' 40' ' ' VAL . 49.3 tttt -126.97 139.69 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 9' ' ' LEU . 3.5 tt -137.62 118.36 14.08 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.89 0.376 . . . . 0.0 110.387 -172.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -105.2 168.97 15.99 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 124.226 0.917 . . . . 0.0 111.958 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.61 106.29 6.91 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.609 ' HB2' HG21 ' A' ' 8' ' ' ILE . 5.1 t90 -105.55 125.59 51.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.569 ' HB2' ' HG3' ' A' ' 14' ' ' PRO . 23.3 t -77.48 137.07 38.45 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.592 0.558 . . . . 0.0 110.597 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -71.59 -10.14 59.31 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.501 0.72 . . . . 0.0 112.906 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -85.14 -21.19 29.34 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.215 0.206 . . . . 0.0 110.731 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 51' ' ' SER . 7.1 t -116.27 4.59 13.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.148 0.579 . . . . 0.0 111.326 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.1 p -72.71 145.4 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.97 116.54 26.05 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.4 Cg_exo -77.16 138.19 52.35 Favored 'Cis proline' 0 C--N 1.383 2.387 0 CA-C-N 119.727 0.938 . . . . 0.0 112.038 2.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HA ' HG13 ' A' ' 55' ' ' VAL . 2.8 tmmm? -65.25 112.42 3.44 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.962 0.789 . . . . 0.0 109.722 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.27 128.89 55.51 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.306 1.042 . . . . 0.0 110.015 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -90.52 84.38 5.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 m -159.27 150.86 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 124.688 1.195 . . . . 0.0 109.274 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.87 127.11 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.703 1.601 . . . . 0.0 107.915 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.89 -46.56 0.29 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.72 144.71 9.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.33 -29.93 0.15 Allowed Glycine 0 N--CA 1.469 0.876 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 149.56 18.33 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.192 -1.004 . . . . 0.0 110.695 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 7.4 mm-40 -101.71 151.56 21.89 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 173.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.567 HD22 HD21 ' A' ' 9' ' ' LEU . 41.4 tp -109.99 101.92 10.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -87.54 117.96 26.69 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.522 ' HB2' HG22 ' A' ' 117' ' ' VAL . 8.7 m-85 -96.47 121.46 38.31 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.782 1.233 . . . . 0.0 107.896 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.441 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 39.9 mtm105 -99.98 126.74 46.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.23 162.45 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.174 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.38 -33.68 69.75 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.82 179.39 7.12 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.055 0.843 . . . . 0.0 112.288 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.44 -34.27 75.12 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.432 1.093 . . . . 0.0 112.272 -165.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.24 -43.87 96.83 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.213 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -65.22 -21.75 66.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.874 0.87 . . . . 0.0 112.738 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.17 -38.12 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.071 0.463 . . . . 0.0 110.06 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.35 -32.29 64.46 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.306 1.042 . . . . 0.0 111.324 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.0 mt-10 -68.76 -40.1 79.93 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.656 0.741 . . . . 0.0 109.192 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.414 HG21 HG21 ' A' ' 117' ' ' VAL . 99.5 m -68.62 -32.7 72.76 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.65 174.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -62.78 -60.76 3.04 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.821 0.819 . . . . 0.0 109.458 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.4 -37.28 85.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.841 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.35 -46.12 91.49 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.98 0.8 . . . . 0.0 113.638 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 115' ' ' LEU . 36.3 m0 -61.23 -50.35 73.45 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.235 0.614 . . . . 0.0 109.996 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.7 ttpt -52.58 -45.16 66.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.142 0.977 . . . . 0.0 110.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.98 61.08 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.294 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -97.77 11.12 38.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.814 0.845 . . . . 0.0 112.828 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 15.01 21.22 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.49 136.03 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 117.545 0.673 . . . . 0.0 110.321 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.68 72.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.428 1.091 . . . . 0.0 111.754 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.617 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 49.7 tpp 69.02 83.59 0.16 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.157 0.911 . . . . 0.0 112.849 165.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.27 86.47 2.28 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.0 0.52 . . . . 0.0 111.537 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.572 ' HG2' ' H ' ' A' ' 106' ' ' THR . 55.6 tp60 -179.67 140.77 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.882 0.873 . . . . 0.0 109.645 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -92.24 113.79 60.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' THR . 20.9 Cg_endo -61.63 108.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.243 1.962 . . . . 0.0 110.598 174.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.64 49.28 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.335 0.654 . . . . 0.0 110.219 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -63.07 106.26 0.82 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.588 0.755 . . . . 0.0 110.975 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 104' ' ' THR . 3.3 ttt -93.99 -176.38 3.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.843 0.857 . . . . 0.0 109.737 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 99' ' ' MET . 8.7 mm-40 -66.31 -27.67 68.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.02 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.73 92.72 3.38 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.8 161.74 3.24 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 36.0 t80 -69.09 103.76 1.96 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.138 1.375 . . . . 0.0 108.61 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 13.7 t -103.03 141.55 35.63 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.86 0.754 . . . . 0.0 111.683 -162.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -151.62 127.61 10.38 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.754 1.221 . . . . 0.0 109.636 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 42.3 m -135.24 125.82 26.93 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.07 162.05 21.92 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.062 0.545 . . . . 0.0 112.169 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.89 112.42 24.64 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.581 0.753 . . . . 0.0 109.599 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.547 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.4 p30 -71.96 177.27 1.77 Allowed Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.437 1.095 . . . . 0.0 112.05 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 25.5 Cg_exo -40.64 -50.48 3.86 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.949 3.099 . . . . 0.0 115.544 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 9.9 t70 -79.62 -17.86 52.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.6 m 71.93 61.32 0.14 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.412 1.485 . . . . 0.0 110.886 174.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.5 ' NE2' HG12 ' A' ' 11' ' ' VAL . 8.6 m80 -91.71 175.07 7.03 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.603 -1.18 . . . . 0.0 107.975 168.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -94.43 99.04 11.3 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HB3' ' CH2' ' A' ' 85' ' ' TRP . 81.9 mt -106.12 104.03 13.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.631 0.372 . . . . 0.0 110.011 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.545 ' NH1' ' HB3' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -93.31 147.18 23.15 Favored 'General case' 0 C--O 1.205 -1.269 0 C-N-CA 124.022 0.929 . . . . 0.0 110.01 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 70' ' ' PHE . 12.2 t -139.66 140.0 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 5.4 p90 -133.81 171.1 14.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.096 0.407 . . . . 0.0 111.635 172.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -131.06 113.95 14.56 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 166.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -75.11 129.25 37.23 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 O-C-N 123.722 0.639 . . . . 0.0 110.264 -174.997 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 m80 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.474 ' HG3' HD22 ' A' ' 25' ' ' LEU . 42.0 Cg_endo -82.74 51.69 3.8 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.28 2.654 . . . . 0.0 111.89 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.493 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 30.3 t70 -75.96 5.92 5.89 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.179 0.99 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.01 126.08 45.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 15.2 t -120.4 145.66 46.97 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' B' ' 50' ' ' TRP . 59.4 mt -122.67 144.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 123.825 0.85 . . . . 0.0 108.768 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.572 HD21 HD22 ' B' ' 68' ' ' LEU . 4.3 mm? -91.59 134.12 34.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.85 99.3 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.448 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.511 HG12 ' NE2' ' B' ' 113' ' ' HIS . 3.2 m -112.72 159.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.691 0.796 . . . . 0.0 109.032 -172.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 -60.28 1.82 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -102.29 101.71 20.99 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.295 0.638 . . . . 0.0 109.881 -173.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' B' ' 51' ' ' SER . 32.5 Cg_exo -55.67 -55.55 2.93 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.952 2.435 . . . . 0.0 114.701 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.77 -54.82 4.2 Favored 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.594 1.962 . . . . 0.0 112.276 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.31 96.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.072 0.549 . . . . 0.0 111.768 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 69.1 m -65.31 -47.15 77.57 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 123.726 0.641 . . . . 0.0 109.364 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 51.9 m -67.46 -41.17 85.1 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -170.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.559 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 11.7 mm100 -64.09 -38.43 91.05 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.514 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.83 -41.95 95.34 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.394 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 42.6 m-85 -68.6 -29.9 68.53 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.579 0.627 . . . . 0.0 110.487 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -56.6 -49.48 74.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.194 0.521 . . . . 0.0 111.695 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.26 63.22 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.975 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 31.0 tp -58.93 -42.2 89.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.37 1.468 . . . . 0.0 113.232 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.54 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.4 mt -97.55 -30.53 12.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.74 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.67 30.4 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.6 m -122.93 -177.71 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.121 0.968 . . . . 0.0 109.823 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' B' ' 22' ' ' LYS . 6.5 p-10 -143.04 151.81 56.79 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 109.365 174.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 18.7 Cg_exo -65.53 121.25 8.61 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.95 2.433 . . . . 0.0 112.263 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.513 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.2 p -64.9 -36.68 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 21.0 mm-40 -120.89 116.83 25.91 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.872 1.269 . . . . 0.0 107.966 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -123.62 131.62 53.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.988 0.515 . . . . 0.0 109.933 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -138.97 150.34 64.87 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.833 1.253 . . . . 0.0 108.345 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.93 -10.33 22.41 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.507 2.138 . . . . 0.0 113.576 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 5.6 t -126.19 -3.27 6.92 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -159.14 151.64 21.51 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 73.3 m -141.87 159.08 42.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.628 0.371 . . . . 0.0 110.391 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 24.2 tp -154.81 125.56 7.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.6 p90 -133.89 150.2 51.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.253 1.021 . . . . 0.0 109.134 165.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.553 HG22 ' HG3' ' B' ' 46' ' ' LYS . 18.5 t -120.77 131.46 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.91 165.18 16.11 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.691 0.397 . . . . 0.0 111.553 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.69 76.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.641 1.177 . . . . 0.0 112.851 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -69.99 -20.47 63.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.004 0.522 . . . . 0.0 111.068 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.31 5.0 37.73 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-O 118.817 -0.99 . . . . 0.0 113.988 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.903 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 6.8 ptm -73.68 166.84 22.55 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.538 1.169 . . . . 0.0 109.27 169.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' B' ' 40' ' ' VAL . 73.1 tttt -127.25 139.5 52.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.534 HD21 HD23 ' B' ' 9' ' ' LEU . 3.6 tt -137.56 118.7 14.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.973 0.416 . . . . 0.0 110.254 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.93 169.09 16.34 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.315 0.96 . . . . 0.0 111.958 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.85 106.03 6.69 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 166.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.609 ' HB2' HG21 ' B' ' 8' ' ' ILE . 4.5 t90 -105.46 125.63 51.21 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.573 ' HB2' ' HG3' ' B' ' 14' ' ' PRO . 21.6 t -77.29 137.13 38.61 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.681 0.613 . . . . 0.0 110.716 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -71.92 -9.78 58.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -85.32 -20.14 30.44 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.493 0.317 . . . . 0.0 111.389 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.477 HG22 ' HB3' ' B' ' 51' ' ' SER . 11.9 t -117.02 4.41 12.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.392 0.677 . . . . 0.0 111.029 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' B' ' 58' ' ' LYS . 8.4 p -73.57 146.71 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.29 116.14 23.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -77.65 139.2 56.27 Favored 'Cis proline' 0 C--N 1.387 2.595 0 C-N-CA 124.706 -0.956 . . . . 0.0 111.869 3.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.517 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.1 tmmm? -66.18 112.5 3.96 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.85 0.719 . . . . 0.0 109.395 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.93 129.3 55.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.19 0.996 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 27.5 p -90.98 85.58 6.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 62' ' ' THR . 7.9 p -161.52 149.77 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.339 1.056 . . . . 0.0 109.567 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.434 HG23 ' O ' ' B' ' 61' ' ' VAL . 2.1 p -168.83 128.1 1.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.958 1.703 . . . . 0.0 107.65 169.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.21 -47.55 0.29 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.82 144.66 9.66 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.41 -29.87 0.15 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 149.45 18.1 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.162 -1.019 . . . . 0.0 110.657 170.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.596 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 11.2 mm-40 -101.51 151.85 21.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.572 HD22 HD21 ' B' ' 9' ' ' LEU . 44.1 tp -110.14 101.78 10.54 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -87.58 118.0 26.77 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.575 0.702 . . . . 0.0 111.208 -170.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -96.05 121.55 37.92 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 42.2 mtm105 -100.4 125.01 46.63 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.68 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.91 163.2 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.135 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.1 pt-20 -71.3 -34.58 70.73 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.428 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -163.21 179.84 7.15 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.155 0.889 . . . . 0.0 112.482 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.13 -33.86 75.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.43 1.092 . . . . 0.0 111.891 -165.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.56 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.987 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.5 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.5 mm-40 -65.62 -22.06 66.63 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.691 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.64 -38.95 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 122.748 0.419 . . . . 0.0 109.924 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.93 -31.82 64.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.154 0.981 . . . . 0.0 111.436 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.9 mt-10 -69.88 -38.93 76.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.634 0.73 . . . . 0.0 109.53 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 68.3 m -68.34 -33.53 74.45 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.616 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -62.47 -61.01 2.74 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.739 0.781 . . . . 0.0 109.542 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.6 -36.9 84.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.667 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.84 89.03 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 124.001 0.813 . . . . 0.0 113.63 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' TRP . . . . . 0.409 ' HB3' HG21 ' B' ' 90' ' ' VAL . 42.1 m0 -60.6 -50.28 74.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.351 0.66 . . . . 0.0 109.551 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.612 ' HB2' ' HE3' ' B' ' 92' ' ' MET . 31.5 ttpt -53.42 -44.64 68.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.132 0.895 . . . . 0.0 111.003 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.69 61.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 m -98.19 10.64 40.08 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.722 0.809 . . . . 0.0 112.884 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.58 14.77 20.85 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' B' ' 85' ' ' TRP . 54.4 t -78.66 135.69 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 117.554 0.677 . . . . 0.0 110.413 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.95 -37.48 71.59 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.468 1.107 . . . . 0.0 111.764 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.612 ' HE3' ' HB2' ' B' ' 86' ' ' LYS . 45.0 tpp 69.83 83.16 0.15 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.126 0.891 . . . . 0.0 112.707 165.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.49 87.08 2.32 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.745 0.418 . . . . 0.0 111.512 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' B' ' 106' ' ' THR . 56.9 tp60 179.66 141.77 0.13 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.118 0.967 . . . . 0.0 109.856 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -93.51 113.24 59.69 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' B' ' 104' ' ' THR . 33.3 Cg_exo -60.26 108.64 0.53 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.472 2.115 . . . . 0.0 110.974 173.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.46 49.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.466 0.706 . . . . 0.0 110.541 -175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -62.48 106.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.817 0.847 . . . . 0.0 110.981 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.469 ' SD ' HG21 ' B' ' 104' ' ' THR . 3.3 ttt -93.9 -175.96 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.675 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' B' ' 99' ' ' MET . 10.4 mm-40 -66.54 -27.96 68.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.585 . . . . 0.0 111.015 174.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -128.89 92.24 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.286 1.034 . . . . 0.0 109.152 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 161.64 2.83 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 34.0 t80 -68.87 103.25 1.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 108.851 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.469 HG21 ' SD ' ' B' ' 99' ' ' MET . 5.3 t -103.67 142.11 34.9 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.163 0.892 . . . . 0.0 111.518 -161.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.487 ' HZ ' ' SD ' ' B' ' 92' ' ' MET . 14.2 t80 -151.6 127.81 10.53 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.499 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 60.4 m -134.99 125.92 27.55 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.43 162.03 22.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.007 0.523 . . . . 0.0 112.154 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.9 113.28 26.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.663 0.785 . . . . 0.0 109.165 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.555 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.8 p-10 -73.27 177.89 1.77 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 124.366 1.066 . . . . 0.0 111.745 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.7 Cg_exo -41.04 -50.3 4.24 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.919 3.079 . . . . 0.0 115.531 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 10.5 t70 -79.65 -17.64 53.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 71.72 61.1 0.15 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 125.329 1.451 . . . . 0.0 111.005 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.511 ' NE2' HG12 ' B' ' 11' ' ' VAL . 7.6 m80 -91.29 175.29 6.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.15 168.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -95.01 98.7 10.87 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.95 103.54 13.13 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 46.4 ttt180 -89.83 148.49 23.16 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 123.279 0.632 . . . . 0.0 110.455 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.23 140.59 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.526 1.13 . . . . 0.0 108.176 163.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' B' ' 103' ' ' TYR . 7.2 p90 -133.7 170.63 15.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -130.49 113.79 14.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -74.68 130.24 39.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 99.87 0.89 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.94 0.896 . . . . 0.0 110.998 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.405 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.444 176.448 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.48 93.79 0.99 Allowed 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.195 1.93 . . . . 0.0 111.381 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 6.3 p-10 -109.25 14.63 23.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 0.0 109.454 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HD2' ' HD3' ' B' ' 71' ' ' ARG . 0.7 OUTLIER -131.5 141.91 49.86 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.919 -165.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 145.16 30.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.733 1.213 . . . . 0.0 108.117 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 51.4 mt -118.59 140.65 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.034 0.534 . . . . 0.0 110.661 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.56 118.53 37.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -74.42 122.5 23.09 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.981 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' SER . 11.7 m -122.14 163.7 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.17 -52.26 3.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -103.98 98.18 12.97 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.455 0.702 . . . . 0.0 110.079 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.49 -48.72 17.85 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.506 2.804 . . . . 0.0 115.858 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.89 -63.48 0.2 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 123.106 2.145 . . . . 0.0 112.419 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.62 89.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 0.0 112.125 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -66.82 -47.94 70.46 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.442 0.639 . . . . 0.0 110.425 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 65.8 m -75.96 -34.92 59.83 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.0 mm-40 -66.45 -33.74 76.39 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.102 0.876 . . . . 0.0 109.259 172.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 81.9 t80 -66.73 -42.83 85.67 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.002 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -71.21 -29.02 64.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.375 0.534 . . . . 0.0 110.377 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.0 mtpt -57.39 -48.9 77.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.935 0.398 . . . . 0.0 111.902 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.77 -35.68 62.56 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.024 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 12.9 tp -64.52 -30.58 71.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.602 1.161 . . . . 0.0 112.737 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' HG22 ' A' ' 27' ' ' VAL . 83.4 mt -104.03 -41.13 5.94 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.982 0.913 . . . . 0.0 109.565 176.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.73 34.06 6.16 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.0 m -123.72 -177.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.521 1.128 . . . . 0.0 110.484 -176.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -148.52 146.74 23.25 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.485 1.114 . . . . 0.0 108.833 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 19.1 Cg_exo -64.41 108.12 0.95 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.598 2.198 . . . . 0.0 111.909 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.1 -38.7 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.7 mm-40 -111.9 121.8 46.03 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -121.97 140.9 51.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.56 . . . . 0.0 110.358 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 36' ' ' PHE . 43.5 t -141.6 149.8 55.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.872 1.269 . . . . 0.0 107.949 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.22 -24.86 61.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.843 2.362 . . . . 0.0 113.572 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.3 t -128.01 9.2 6.27 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 85.9 t80 -149.22 150.59 32.85 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.708 0.403 . . . . 0.0 110.505 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 42.7 m -134.51 143.17 47.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.553 0.741 . . . . 0.0 109.697 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -138.51 119.62 14.53 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 6.8 p90 -131.98 147.86 52.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 108.127 167.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 1.6 p -126.33 134.98 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 109.306 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 47' ' ' LEU . 6.1 mp -95.26 150.78 19.87 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.261 -167.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.66 -9.14 57.8 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.952 0.901 . . . . 0.0 110.744 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 58.9 m-20 -70.73 -9.31 56.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.28 1.032 . . . . 0.0 111.441 170.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.7 63.99 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.041 0.353 . . . . 0.0 113.38 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' B' ' 4' ' ' PRO . 18.6 ptm -113.37 167.72 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.694 0.797 . . . . 0.0 109.175 177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 62.3 tttt -132.86 136.57 46.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.671 0.388 . . . . 0.0 109.991 -174.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 HD11 ' A' ' 41' ' ' LEU . 12.9 mt -125.38 123.7 39.91 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.714 0.805 . . . . 0.0 112.295 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.83 145.72 16.82 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 169.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 10.4 mp -117.29 105.19 11.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 161.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.33 129.79 54.86 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 69.2 m -72.5 130.82 41.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.27 0.356 . . . . 0.0 111.286 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 55' ' ' VAL . 42.6 ptt85 -66.15 -21.36 66.33 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.957 0.903 . . . . 0.0 111.913 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -81.33 -6.7 59.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.152 0.581 . . . . 0.0 111.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' HB2' ' A' ' 51' ' ' SER . 13.5 t -127.25 4.65 6.36 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.452 0.701 . . . . 0.0 110.784 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 52' ' ' ARG . 5.3 p -71.18 149.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.86 0.464 . . . . 0.0 111.47 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -130.6 121.47 19.23 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.874 0.87 . . . . 0.0 109.392 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.56 141.1 68.83 Favored 'Cis proline' 0 C--N 1.385 2.497 0 CA-C-N 119.943 1.015 . . . . 0.0 112.345 -1.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -55.1 132.04 46.43 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.114 0.966 . . . . 0.0 112.215 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.79 109.73 4.49 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.723 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.8 m -83.04 87.32 6.89 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.2 m -148.34 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.942 0.897 . . . . 0.0 109.445 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 p -150.81 135.57 17.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.655 1.182 . . . . 0.0 108.594 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.28 35.18 57.04 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.337 0.398 . . . . 0.0 113.139 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.53 29.25 2.61 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.21 -172.06 32.14 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 115.858 -0.171 . . . . 0.0 112.867 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' B' ' 66' ' ' GLY . . . 70.48 107.45 0.04 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.675 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 36.1 mt-10 -122.76 134.47 54.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.76 109.57 15.76 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.98 121.96 34.85 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.249 0.547 . . . . 0.0 110.767 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.528 ' HB2' HG22 ' A' ' 117' ' ' VAL . 40.6 m-85 -102.87 107.64 18.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.789 1.636 . . . . 0.0 108.747 -177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.6 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 25.4 mtm180 -92.54 132.46 36.82 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 112.053 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 161.86 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.316 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.2 pt-20 -65.8 -41.31 92.07 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -160.83 -178.87 7.12 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.57 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.42 -33.18 65.58 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.745 1.618 . . . . 0.0 113.072 -169.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.11 -46.0 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.84 0.456 . . . . 0.0 110.408 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.468 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 79.9 mm-40 -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.194 0.998 . . . . 0.0 112.537 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.2 -44.07 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.495 0.718 . . . . 0.0 109.841 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.36 -35.63 73.68 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.516 1.126 . . . . 0.0 111.035 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -65.93 -41.02 91.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.251 0.548 . . . . 0.0 109.866 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -63.47 -41.14 98.59 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.612 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.89 -57.8 11.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.398 0.679 . . . . 0.0 110.693 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.498 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -63.04 -41.2 99.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.254 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.44 -47.27 86.0 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.869 0.73 . . . . 0.0 113.547 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -62.1 -45.44 93.47 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.658 0.783 . . . . 0.0 109.826 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.4 ttpt -55.64 -43.0 75.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.115 0.966 . . . . 0.0 110.83 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.63 -26.94 61.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.239 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -93.29 8.21 41.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.937 0.895 . . . . 0.0 112.618 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.6 45.33 4.64 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 166.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.482 HG21 ' HB1' ' A' ' 107' ' ' ALA . 8.0 p -98.46 152.18 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 170.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.38 -62.34 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.601 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 30.2 ttp 61.24 82.75 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.173 0.989 . . . . 0.0 112.849 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 84.92 2.14 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.832 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 179.91 135.22 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 0.0 108.615 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.98 129.96 77.08 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.539 0.524 . . . . 0.0 109.923 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.58 96.42 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.752 2.301 . . . . 0.0 109.849 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.34 160.48 36.15 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.09 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 101.05 6.35 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.065 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 21.7 ttt -100.75 -178.92 3.92 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.982 1.313 . . . . 0.0 110.023 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 99' ' ' MET . 15.1 mm-40 -52.13 -41.02 62.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.654 1.182 . . . . 0.0 112.432 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 55.8 m-85 -96.55 11.96 33.29 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.614 -173.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.28 -165.47 12.79 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.86 112.04 19.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -141.87 169.24 17.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.839 0.455 . . . . 0.0 111.611 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.411 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 37.0 p90 -152.98 175.61 12.77 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.852 166.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.635 HG21 ' HG3' ' A' ' 114' ' ' ARG . 90.7 m -137.39 130.66 30.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.022 0.439 . . . . 0.0 110.178 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.22 168.18 9.24 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.443 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.7 112.33 6.82 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 5.9 p-10 -68.01 174.39 2.41 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.253 1.021 . . . . 0.0 111.134 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 16.0 Cg_exo -37.26 -49.94 1.66 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.197 3.265 . . . . 0.0 115.321 172.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -10.79 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.678 0.791 . . . . 0.0 111.177 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m 69.84 92.78 0.08 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.535 1.534 . . . . 0.0 112.188 168.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.459 ' CE1' HG12 ' A' ' 11' ' ' VAL . 16.4 m80 -124.21 149.2 46.66 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.675 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 22.0 ttp180 -81.03 95.16 6.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.291 0.567 . . . . 0.0 110.115 -171.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 mt -92.76 101.59 13.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -92.84 95.54 9.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.805 0.842 . . . . 0.0 110.869 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 70' ' ' PHE . 36.5 t -97.21 117.05 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -133.81 161.62 34.24 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.8 111.46 15.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 166.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 35.8 t80 -77.48 127.31 32.3 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 m80 . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.424 ' O ' ' SD ' ' A' ' 45' ' ' MET . 73.7 Cg_endo -75.7 94.47 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.065 1.843 . . . . 0.0 111.267 164.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 8.7 p-10 -109.78 14.65 23.16 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.551 0.74 . . . . 0.0 109.487 168.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.6 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.3 OUTLIER -131.15 141.25 50.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.895 1.278 . . . . 0.0 107.687 -165.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.464 HG23 HD23 ' B' ' 47' ' ' LEU . 5.6 t -145.13 145.1 31.25 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.693 1.197 . . . . 0.0 108.261 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.3 mt -118.31 140.19 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.103 0.561 . . . . 0.0 110.73 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.3 117.48 34.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.425 ' H ' ' HD1' ' B' ' 10' ' ' TYR . 5.6 p90 -73.07 122.93 22.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.139 0.976 . . . . 0.0 111.397 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' B' ' 51' ' ' SER . 11.3 m -122.44 163.67 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -98.43 -52.14 3.74 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -104.06 98.65 14.2 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.397 0.679 . . . . 0.0 110.5 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.69 -48.61 18.52 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.609 2.873 . . . . 0.0 115.927 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 15.6 Cg_endo -55.14 -63.89 0.17 Allowed 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 123.002 2.108 . . . . 0.0 112.272 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.99 88.85 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.334 0.654 . . . . 0.0 112.088 -167.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -66.46 -48.16 70.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.494 0.664 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 89.1 m -75.65 -34.9 60.52 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -168.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 85.3 mm-40 -67.17 -33.96 76.51 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.3 1.0 . . . . 0.0 109.056 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 85.7 t80 -66.05 -43.35 87.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.004 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.416 ' CD2' HD21 ' B' ' 49' ' ' LEU . 40.8 m-85 -70.68 -29.45 65.78 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.418 0.553 . . . . 0.0 110.142 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' B' ' 18' ' ' THR . 57.3 mtpt -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.125 0.488 . . . . 0.0 112.04 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.8 62.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.158 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 13.3 tp -63.88 -30.72 71.78 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.581 1.152 . . . . 0.0 112.734 -175.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' B' ' 27' ' ' VAL . 66.7 mt -104.47 -41.09 5.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 109.45 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.78 34.1 6.13 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.6 m -124.19 -177.82 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.399 1.08 . . . . 0.0 110.833 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -147.23 146.6 25.94 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.203 1.001 . . . . 0.0 108.966 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 35.9 Cg_endo -63.38 108.54 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.408 2.072 . . . . 0.0 112.115 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -64.33 -38.38 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.31 0.644 . . . . 0.0 110.243 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 17.9 mm-40 -112.04 121.56 45.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.7 p -122.12 140.67 52.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.119 0.568 . . . . 0.0 110.488 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' B' ' 36' ' ' PHE . 30.7 t -141.71 149.47 53.62 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.963 1.305 . . . . 0.0 107.89 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.77 -24.99 58.45 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.7 2.267 . . . . 0.0 113.587 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -127.87 8.95 6.31 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' B' ' 33' ' ' SER . 85.8 t80 -149.0 150.6 33.09 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.606 0.362 . . . . 0.0 110.41 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 15.1 m -134.2 143.5 47.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.462 0.705 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tm? -139.4 119.15 13.2 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 5.9 p90 -131.91 148.0 52.51 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 167.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' B' ' 46' ' ' LYS . 5.6 t -125.92 134.28 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -172.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.524 HD21 HD13 ' B' ' 25' ' ' LEU . 52.3 mt -94.22 150.91 19.87 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.67 0.788 . . . . 0.0 110.775 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -9.42 58.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.082 0.953 . . . . 0.0 110.697 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 69.7 m-20 -70.63 -9.01 56.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.028 0.931 . . . . 0.0 111.699 170.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.16 11.54 62.87 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 116.59 -0.277 . . . . 0.0 113.342 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.578 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -115.1 167.2 11.03 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.88 0.872 . . . . 0.0 108.895 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' B' ' 40' ' ' VAL . 78.3 tttt -132.51 135.37 45.95 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.146 0.578 . . . . 0.0 109.659 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.464 HD23 HG23 ' B' ' 7' ' ' THR . 36.8 mt -124.94 123.87 40.83 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.775 0.83 . . . . 0.0 112.216 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.33 145.66 16.61 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 10.5 mp -117.53 105.2 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 161.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.26 129.97 54.81 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 69.5 m -72.73 130.48 40.61 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.199 0.312 . . . . 0.0 111.483 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.452 ' HD3' HG23 ' B' ' 62' ' ' THR . 31.7 ptt180 -66.48 -20.91 66.16 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.722 0.809 . . . . 0.0 111.995 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -81.05 -7.16 59.5 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.872 0.469 . . . . 0.0 111.514 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 51' ' ' SER . 14.1 t -126.88 5.44 6.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.295 0.638 . . . . 0.0 110.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.442 HG12 ' O ' ' B' ' 52' ' ' ARG . 5.5 p -71.57 149.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.808 0.443 . . . . 0.0 111.354 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -131.03 121.32 18.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.5 141.54 70.24 Favored 'Cis proline' 0 C--N 1.389 2.682 0 C-N-CA 124.622 -0.991 . . . . 0.0 112.294 -1.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -55.9 132.28 49.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.026 0.93 . . . . 0.0 111.928 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.04 109.52 4.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.578 0.751 . . . . 0.0 109.635 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -82.66 87.82 6.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.67 139.35 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.102 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.452 HG23 ' HD3' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -150.14 135.33 17.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.823 1.249 . . . . 0.0 108.65 174.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.01 58.91 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.375 0.422 . . . . 0.0 113.329 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.05 28.79 2.69 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.23 -172.11 32.15 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.749 -0.225 . . . . 0.0 112.997 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . 70.61 107.41 0.04 OUTLIER Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.672 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 35.0 mt-10 -122.72 134.54 54.45 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -119.82 109.48 15.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.95 122.3 35.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.388 0.613 . . . . 0.0 110.85 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.529 ' HB2' HG22 ' B' ' 117' ' ' VAL . 40.6 m-85 -103.22 107.67 18.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.754 1.621 . . . . 0.0 108.474 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.603 ' HD3' ' HD2' ' A' ' 6' ' ' PHE . 27.8 mtm180 -92.76 131.53 37.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.197 0.522 . . . . 0.0 111.84 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.17 162.33 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.271 1.028 . . . . 0.0 110.239 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.3 pt-20 -66.31 -40.17 89.79 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.57 -179.13 7.06 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.989 0.813 . . . . 0.0 112.676 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.99 -33.32 64.73 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.776 1.63 . . . . 0.0 113.421 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.01 78.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.586 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.7 mm-40 -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.358 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.96 -44.76 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.552 0.692 . . . . 0.0 109.715 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.75 -36.44 78.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.298 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -65.46 -41.57 93.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.349 0.595 . . . . 0.0 110.025 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.7 m -62.77 -41.23 99.14 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.659 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -58.12 -57.44 12.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.448 0.699 . . . . 0.0 110.616 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -63.52 -41.01 98.51 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.235 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.67 82.57 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.801 0.688 . . . . 0.0 113.41 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -61.77 -45.82 92.24 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.637 0.775 . . . . 0.0 109.884 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.1 ttpt -54.74 -43.41 72.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.171 0.988 . . . . 0.0 111.04 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.77 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.798 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -93.53 8.51 40.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.024 0.93 . . . . 0.0 112.374 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.17 45.77 4.64 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 114.859 0.703 . . . . 0.0 114.859 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.478 HG21 ' HB1' ' B' ' 107' ' ' ALA . 8.3 p -98.56 152.02 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.48 -61.93 1.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.607 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 30.3 ttp 60.86 83.11 0.15 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.231 1.012 . . . . 0.0 112.79 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.45 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -106.35 85.48 2.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.352 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 179.71 134.22 0.1 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 108.384 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -75.83 130.04 79.7 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.63 0.581 . . . . 0.0 109.893 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.98 95.78 0.67 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.731 2.287 . . . . 0.0 110.083 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.16 160.15 36.91 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -168.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 101.08 5.9 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.962 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.43 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 22.4 ttt -100.89 -178.78 3.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.134 1.374 . . . . 0.0 109.84 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' B' ' 99' ' ' MET . 5.7 mm-40 -52.86 -40.79 63.71 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.559 1.144 . . . . 0.0 112.182 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 55.0 m-85 -96.3 11.94 32.85 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.863 0.865 . . . . 0.0 111.673 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.84 -165.3 12.92 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.07 112.2 19.58 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -142.0 169.32 17.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.817 0.447 . . . . 0.0 111.588 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' B' ' 92' ' ' MET . 37.0 p90 -153.12 175.72 12.7 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.316 1.047 . . . . 0.0 108.731 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.656 HG21 ' HG3' ' B' ' 114' ' ' ARG . 96.8 m -137.49 130.8 30.91 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 110.138 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.32 168.45 9.06 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.505 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.86 112.23 6.71 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.483 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.6 p-10 -67.51 174.3 2.26 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.334 1.054 . . . . 0.0 111.551 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 17.3 Cg_exo -37.67 -49.78 1.92 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.938 3.092 . . . . 0.0 115.225 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.26 -10.21 50.4 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.46 0.704 . . . . 0.0 111.368 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 70.07 92.18 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.578 1.551 . . . . 0.0 112.047 168.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.466 ' CE1' HG12 ' B' ' 11' ' ' VAL . 15.7 m80 -123.77 149.37 45.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 170.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.672 ' HB3' ' HG2' ' B' ' 67' ' ' GLU . 21.8 ttp180 -81.15 95.34 6.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.136 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 mt -93.24 101.72 13.99 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -171.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -90.97 94.72 9.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.892 0.877 . . . . 0.0 111.131 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' B' ' 70' ' ' PHE . 36.8 t -97.61 117.47 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.353 0.979 . . . . 0.0 108.366 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -133.77 161.42 34.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 111.35 15.47 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 166.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 35.2 t80 -77.98 132.55 37.89 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.79 95.22 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.274 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.096 0 CA-C-O 118.963 -0.91 . . . . 0.0 111.033 -174.421 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -94.05 92.29 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.291 2.66 . . . . 0.0 113.066 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.1 p-10 -103.17 9.46 38.28 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.613 0.72 . . . . 0.0 110.044 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -132.59 136.23 46.42 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.793 1.237 . . . . 0.0 108.116 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -131.56 142.67 49.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.699 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 57.2 mt -120.79 134.83 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 68' ' ' LEU . 94.0 mt -82.11 131.58 35.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' B' ' 66' ' ' GLY . 23.7 t80 -85.31 105.04 15.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.803 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 49' ' ' LEU . 2.4 m -116.35 176.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.97 -57.95 2.2 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.052 0.941 . . . . 0.0 109.678 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -89.18 105.64 10.94 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.748 1.219 . . . . 0.0 109.309 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.79 -55.91 2.35 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.95 2.434 . . . . 0.0 113.704 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.81 -65.82 0.1 Allowed 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 122.109 1.789 . . . . 0.0 112.686 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -165.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.7 p -63.33 -55.43 24.65 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 99.6 m -67.3 -39.33 85.95 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -168.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.525 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 23.7 mm-40 -62.38 -41.11 98.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.817 1.247 . . . . 0.0 109.45 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 86.4 t80 -65.37 -39.98 92.98 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 110.049 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.442 ' OH ' HD21 ' A' ' 115' ' ' LEU . 61.4 m-85 -71.28 -31.42 67.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.594 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.1 mtpt -56.53 -46.33 80.66 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -37.7 51.17 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.272 175.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 14.9 tp -62.93 -30.91 71.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.268 1.027 . . . . 0.0 112.536 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 27' ' ' VAL . 46.1 mt -104.94 -37.63 6.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.008 0.923 . . . . 0.0 109.152 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.08 9.95 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -172.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 25' ' ' LEU . 23.9 m -128.15 159.37 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.963 0.905 . . . . 0.0 110.174 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -112.22 148.7 39.66 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.609 0.764 . . . . 0.0 109.625 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 16.8 Cg_exo -67.18 108.03 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.784 2.323 . . . . 0.0 111.076 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 39' ' ' PHE . 7.3 p -63.4 -34.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.706 0.629 . . . . 0.0 110.679 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.7 mm-40 -115.63 85.36 2.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -86.71 129.45 34.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.266 0.626 . . . . 0.0 110.095 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -137.49 150.78 69.57 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.745 0.818 . . . . 0.0 109.193 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.76 -42.78 42.85 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.714 2.943 . . . . 0.0 114.812 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -127.17 24.51 6.33 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.252 0.548 . . . . 0.0 112.276 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -153.77 152.42 30.71 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 33.5 t -134.66 142.65 46.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.387 0.675 . . . . 0.0 109.366 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -141.06 122.31 14.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 5.5 p90 -129.74 146.61 51.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.839 0.856 . . . . 0.0 108.993 164.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 46' ' ' LYS . 6.1 t -118.88 135.12 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.433 HD12 ' SD ' ' A' ' 45' ' ' MET . 38.5 mt -96.21 158.76 15.29 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.933 0.493 . . . . 0.0 110.517 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.59 -20.95 66.12 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.965 0.906 . . . . 0.0 112.465 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.898 0.879 . . . . 0.0 111.393 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.59 -14.17 42.46 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.733 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -72.91 154.96 40.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' HG22 ' A' ' 40' ' ' VAL . 81.6 tttt -119.23 139.74 51.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.55 115.52 11.55 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -168.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.35 170.7 21.6 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 123.901 0.763 . . . . 0.0 111.533 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 6.3 mp -139.5 107.7 5.77 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 165.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.9 t90 -105.09 124.05 48.87 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -76.79 139.25 40.31 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.374 0.67 . . . . 0.0 111.102 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.442 ' HD3' HG23 ' A' ' 62' ' ' THR . 39.2 ptt180 -73.0 -14.82 61.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.147 0.579 . . . . 0.0 112.244 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -85.72 -6.51 59.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 122.511 0.325 . . . . 0.0 111.157 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -129.37 8.51 5.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.367 0.667 . . . . 0.0 110.976 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.869 HG23 HH22 ' B' ' 116' ' ' ARG . 12.5 p -74.62 148.84 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.031 0.532 . . . . 0.0 111.734 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -128.19 116.03 20.19 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.827 0.851 . . . . 0.0 109.568 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.22 144.47 78.05 Favored 'Cis proline' 0 C--N 1.387 2.579 0 C-N-CA 124.52 -1.033 . . . . 0.0 112.743 1.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 55' ' ' VAL . 12.0 mmmm -53.17 114.11 1.35 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.694 0.798 . . . . 0.0 111.511 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.59 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.307 1.043 . . . . 0.0 109.44 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -98.09 89.3 4.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.28 0.632 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.74 124.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.102 0.561 . . . . 0.0 111.136 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.442 HG23 ' HD3' ' A' ' 52' ' ' ARG . 9.4 p -151.92 178.67 9.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.252 1.421 . . . . 0.0 108.631 171.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.59 -31.94 6.72 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -172.52 31.19 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 119.95 0.65 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.22 125.07 0.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.74 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.7 pt-20 -131.79 145.04 51.36 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -108.49 104.52 13.87 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -88.0 117.13 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 110.761 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -97.74 112.67 24.47 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 31.7 mtm105 -90.64 135.08 33.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.883 0.473 . . . . 0.0 111.696 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.91 173.3 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.283 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.584 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -74.84 -45.39 43.57 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.769 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.457 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.4 p30 -157.62 175.22 14.21 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.701 0.682 . . . . 0.0 112.393 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.01 -32.39 67.88 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.525 -166.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.59 -44.94 85.08 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.401 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.0 mm-40 -64.39 -25.45 68.03 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.72 -39.4 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.397 0.618 . . . . 0.0 109.866 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.22 -32.14 68.43 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.543 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.6 mt-10 -65.85 -41.31 91.88 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.593 0.711 . . . . 0.0 109.665 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 117' ' ' VAL . 14.7 m -71.25 -29.13 64.73 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.834 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.58 -61.1 2.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 0.0 109.632 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.46 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.94 -36.49 82.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.725 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.24 68.45 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.994 0.809 . . . . 0.0 113.712 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -63.1 -42.9 99.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.369 0.668 . . . . 0.0 110.333 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.7 ttpt -55.42 -47.0 76.64 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.953 0.783 . . . . 0.0 110.474 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.9 -15.28 59.73 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.414 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -92.12 -2.48 56.58 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.11 0.964 . . . . 0.0 111.939 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.92 3.25 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.914 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.13 150.79 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.22 -36.46 81.72 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.882 0.473 . . . . 0.0 111.8 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.5 tpp 65.83 83.14 0.17 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 85.89 2.25 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.491 0.662 . . . . 0.0 111.381 173.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 179.34 126.36 0.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.412 1.485 . . . . 0.0 108.639 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -79.85 109.95 14.04 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 167.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.2 119.38 6.25 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.786 2.324 . . . . 0.0 111.09 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 146.29 50.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.225 0.61 . . . . 0.0 110.745 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -73.92 101.94 3.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.851 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.7 ttm -98.35 174.76 6.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.879 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.95 -39.81 63.2 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.096 0.958 . . . . 0.0 112.233 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -91.55 6.97 43.6 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.583 0.753 . . . . 0.0 111.659 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 -163.78 12.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.003 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -76.13 102.15 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -113.06 147.51 37.12 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.186 0.517 . . . . 0.0 110.556 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -143.31 138.74 29.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.688 1.195 . . . . 0.0 109.536 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.6 m -134.91 119.91 18.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.027 0.83 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.57 161.03 14.98 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 122.966 0.506 . . . . 0.0 110.989 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.8 114.68 23.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 6.1 p-10 -70.3 176.67 1.72 Allowed Pre-proline 0 CA--C 1.567 1.608 0 C-N-CA 124.071 0.948 . . . . 0.0 111.336 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 1.4 Cg_endo -42.83 -41.71 8.74 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.853 3.035 . . . . 0.0 115.034 173.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -78.88 -25.97 43.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.542 0.337 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 t 73.38 85.86 0.11 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.811 1.644 . . . . 0.0 110.003 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.465 ' CE1' HG12 ' A' ' 11' ' ' VAL . 13.7 m80 -113.87 -173.98 2.38 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 3.0 mmp_? -100.57 112.73 25.15 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.442 HD21 ' OH ' ' A' ' 21' ' ' TYR . 84.2 mt -114.96 103.63 11.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.825 0.45 . . . . 0.0 110.188 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.61 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 51.4 ttt180 -90.69 140.16 30.04 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -174.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 81' ' ' THR . 40.4 t -134.24 119.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 164.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -128.49 164.87 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.288 0.494 . . . . 0.0 111.812 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.68 111.2 9.19 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -80.25 114.3 19.05 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.534 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.147 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -94.44 93.13 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.203 2.602 . . . . 0.0 113.174 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.733 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 11.4 p-10 -104.58 9.66 35.27 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.798 0.809 . . . . 0.0 109.606 171.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.01 135.79 45.64 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 108.033 -168.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -131.35 143.12 50.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.74 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 50.4 mt -121.12 134.53 64.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.486 HD11 HD22 ' B' ' 68' ' ' LEU . 93.2 mt -81.71 131.69 35.27 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 173.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.429 ' HE2' HG21 ' B' ' 55' ' ' VAL . 23.1 t80 -85.43 105.07 15.79 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.752 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.462 HG12 ' CE1' ' B' ' 113' ' ' HIS . 2.5 m -116.14 176.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.969 0.908 . . . . 0.0 108.664 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.16 -57.29 2.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 109.775 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -89.82 105.92 12.59 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.478 1.111 . . . . 0.0 109.453 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 28.1 Cg_exo -56.78 -55.95 2.32 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.984 2.456 . . . . 0.0 113.799 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 53.7 Cg_exo -55.61 -66.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.402 3.362 0 CA-C-N 122.255 1.841 . . . . 0.0 112.728 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.85 81.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -62.67 -55.95 22.18 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.437 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 98.2 m -66.95 -39.31 87.24 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -168.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.571 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 20.8 mm-40 -62.25 -41.35 98.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.762 1.225 . . . . 0.0 109.264 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 90.1 t80 -65.07 -40.28 94.47 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.058 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.452 ' OH ' HD21 ' B' ' 115' ' ' LEU . 62.6 m-85 -71.2 -31.45 67.62 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.507 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 60.8 mtpt -56.28 -46.6 79.65 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.41 -37.57 51.54 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.53 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.6 tp -62.97 -30.91 71.95 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.471 1.109 . . . . 0.0 112.56 -174.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' B' ' 27' ' ' VAL . 46.6 mt -104.88 -37.71 6.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 109.071 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 33.25 9.66 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' B' ' 25' ' ' LEU . 21.5 m -128.8 158.57 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.043 0.937 . . . . 0.0 109.958 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -110.8 148.43 38.55 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 123.855 0.862 . . . . 0.0 109.693 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 20.3 Cg_exo -66.66 108.01 1.36 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.628 2.218 . . . . 0.0 111.338 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -63.2 -34.76 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.253 0.621 . . . . 0.0 110.593 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.657 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 30.7 mm-40 -115.62 85.59 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 34.1 p -86.74 129.55 34.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.334 0.653 . . . . 0.0 110.014 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -137.25 150.36 68.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.112 0.965 . . . . 0.0 109.382 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.52 -42.88 40.98 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.706 2.937 . . . . 0.0 114.725 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.7 t -127.26 24.36 6.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.949 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -153.75 152.43 30.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 39.3 t -134.94 142.79 46.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.269 0.627 . . . . 0.0 109.333 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.657 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.4 tm? -140.85 122.84 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' B' ' 30' ' ' VAL . 3.6 p90 -129.74 146.67 51.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 109.07 164.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' B' ' 46' ' ' LYS . 9.5 t -118.65 134.52 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.01 158.35 15.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.952 0.501 . . . . 0.0 110.647 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -22.19 66.53 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.121 0.969 . . . . 0.0 112.65 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' B' ' 45' ' ' MET . 18.9 p30 -66.66 -20.85 66.08 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 0.0 111.767 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.56 -13.22 42.93 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.241 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.622 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -73.5 155.41 39.24 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.566 ' HG3' HG22 ' B' ' 40' ' ' VAL . 79.2 tttt -119.41 140.11 50.93 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 tt -137.61 115.26 11.3 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.687 -168.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.05 170.79 21.95 Favored Glycine 0 C--N 1.349 1.284 0 C-N-CA 124.042 0.83 . . . . 0.0 111.579 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 5.4 mp -139.51 107.45 5.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 165.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -104.85 124.47 49.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.448 ' HB2' HG22 ' B' ' 54' ' ' THR . 15.8 m -76.77 139.39 40.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.385 0.674 . . . . 0.0 110.884 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -72.83 -15.12 61.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.274 0.63 . . . . 0.0 112.318 -173.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -85.82 -6.42 59.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.699 0.4 . . . . 0.0 110.824 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.448 HG22 ' HB2' ' B' ' 51' ' ' SER . 14.6 t -129.65 7.79 5.29 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.472 0.709 . . . . 0.0 111.162 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.429 HG21 ' HE2' ' B' ' 10' ' ' TYR . 8.4 p -74.61 149.68 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -128.59 115.86 19.56 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.177 0.991 . . . . 0.0 109.284 172.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.35 143.74 75.68 Favored 'Cis proline' 0 C--N 1.387 2.561 0 C-N-CA 124.626 -0.989 . . . . 0.0 112.675 1.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -52.22 114.39 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.591 0.756 . . . . 0.0 111.674 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.55 132.55 45.62 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 109.458 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 40.3 m -98.37 89.47 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.183 0.593 . . . . 0.0 109.421 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 p -155.58 124.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.193 0.597 . . . . 0.0 111.162 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -152.47 178.14 9.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.293 1.437 . . . . 0.0 108.665 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.44 -31.84 6.77 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-O 121.04 0.244 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.63 -172.66 31.38 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.83 119.71 0.63 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 75.23 126.06 0.18 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.699 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 3.7 pt-20 -132.98 143.4 49.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 110.218 -175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.486 HD22 HD11 ' B' ' 9' ' ' LEU . 43.0 tp -108.35 104.31 13.65 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -87.61 116.75 25.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.148 0.499 . . . . 0.0 110.861 -171.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.401 ' HB2' HG22 ' B' ' 117' ' ' VAL . 7.6 m-85 -97.05 112.62 24.3 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.415 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 31.4 mtm180 -91.03 135.19 33.92 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 122.941 0.496 . . . . 0.0 111.622 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.611 HG21 ' HB3' ' B' ' 77' ' ' GLN . 1.3 p -140.4 173.14 10.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.131 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.77 -45.44 43.77 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -157.59 175.09 14.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 0.675 . . . . 0.0 112.292 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -58.78 -32.07 68.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.219 1.407 . . . . 0.0 112.398 -166.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.84 -45.03 83.74 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.349 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.611 ' HB3' HG21 ' B' ' 72' ' ' VAL . 73.1 mm-40 -64.5 -25.14 67.86 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.958 0.786 . . . . 0.0 112.574 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -71.43 -39.39 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.189 0.596 . . . . 0.0 109.728 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.96 -32.28 69.11 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 110.551 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.7 mt-10 -65.63 -41.06 93.11 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.615 0.721 . . . . 0.0 109.684 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.459 HG21 HG21 ' B' ' 117' ' ' VAL . 12.5 m -71.43 -29.43 64.87 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.8 -61.03 2.92 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.396 0.678 . . . . 0.0 109.475 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.458 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.73 -36.82 83.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.676 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 -50.52 66.18 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.608 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -63.19 -43.12 99.11 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.207 0.603 . . . . 0.0 110.27 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.9 ttpt -54.72 -47.41 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.765 0.826 . . . . 0.0 110.583 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.65 -15.67 59.75 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.612 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -92.22 -1.82 56.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 112.01 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.29 3.36 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.189 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.85 150.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp 65.82 83.18 0.17 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 85.91 2.25 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.442 0.639 . . . . 0.0 111.167 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 179.62 126.47 0.07 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.21 1.404 . . . . 0.0 108.387 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.99 110.71 17.14 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 17.3 Cg_endo -55.67 119.71 7.03 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.79 2.327 . . . . 0.0 110.409 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 145.81 50.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 0.0 111.034 -170.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -72.29 101.67 2.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.206 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.6 ttm -98.63 174.62 6.33 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.663 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -52.77 -40.28 63.02 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.825 0.85 . . . . 0.0 112.373 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.44 6.74 42.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.643 0.777 . . . . 0.0 111.989 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.69 -163.1 12.21 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -77.33 102.36 6.73 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -113.18 147.33 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.178 0.591 . . . . 0.0 110.487 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 4.7 t80 -143.31 138.9 29.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.733 1.213 . . . . 0.0 109.58 -176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 11.1 m -135.1 119.92 18.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.041 0.837 . . . . 0.0 110.347 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.76 160.68 15.29 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.929 0.492 . . . . 0.0 110.986 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.38 114.97 24.32 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.477 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.0 p-10 -70.19 177.56 1.33 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 124.182 0.993 . . . . 0.0 111.288 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 49.4 Cg_exo -43.75 -41.47 11.57 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.456 2.771 . . . . 0.0 115.265 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.95 -25.75 43.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 22.6 t 73.25 86.11 0.11 Allowed 'General case' 0 C--N 1.348 0.522 0 C-N-CA 125.777 1.631 . . . . 0.0 109.952 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.462 ' CE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -113.84 -173.88 2.36 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' B' ' 67' ' ' GLU . 3.9 mmp_? -100.37 113.01 25.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.452 HD21 ' OH ' ' B' ' 21' ' ' TYR . 85.4 mt -115.3 104.37 11.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.797 0.439 . . . . 0.0 109.969 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.869 HH22 HG23 ' A' ' 55' ' ' VAL . 22.3 mmt180 -88.32 140.94 28.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.508 0.723 . . . . 0.0 110.726 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.459 HG21 HG21 ' B' ' 81' ' ' THR . 59.8 t -135.52 120.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 162.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -128.73 165.44 20.9 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.384 0.538 . . . . 0.0 111.888 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.12 110.97 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -79.64 113.3 17.69 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 103.38 1.14 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.976 0.51 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.733 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.455 ' HD2' HD21 ' B' ' 41' ' ' LEU . 59.5 Cg_endo -90.89 97.09 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.878 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.3 p-10 -90.28 11.93 19.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.339 0.59 . . . . 0.0 110.694 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.449 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.6 t80 -133.08 135.05 45.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.811 1.244 . . . . 0.0 108.28 -168.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 140.8 41.97 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.349 1.059 . . . . 0.0 108.216 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.543 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 60.7 mt -119.21 141.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.7 138.01 46.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.5 132.93 35.33 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.488 176.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 51' ' ' SER . 29.0 m -130.6 158.7 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 121.653 -0.654 . . . . 0.0 110.451 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 22.9 t70 -95.34 -57.29 2.45 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.0 99.11 2.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.53 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 12' ' ' ASP . 50.1 Cg_exo -49.02 -55.69 3.91 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 122.756 2.304 . . . . 0.0 114.42 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -59.88 -54.91 1.96 Allowed 'Trans proline' 0 C--N 1.397 3.098 0 CA-C-N 122.16 1.807 . . . . 0.0 112.022 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.05 73.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.134 0.974 . . . . 0.0 111.823 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -79.89 -18.16 51.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.516 -173.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -76.98 -38.51 53.05 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 84.7 mm-40 -67.24 -30.23 70.08 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.52 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -60.45 -48.45 81.69 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.91 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.5 m-85 -68.71 -30.54 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.028 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.0 mtpt -57.78 -49.17 77.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.86 -31.89 51.73 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.715 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.5 tp -62.07 -50.78 70.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.681 1.192 . . . . 0.0 112.295 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 27' ' ' VAL . 14.9 mt -83.57 -47.58 11.15 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 29.56 5.25 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.998 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 25' ' ' LEU . 27.0 m -131.63 175.95 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.026 0.93 . . . . 0.0 110.358 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -124.24 151.25 65.76 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.128 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.55 106.45 1.25 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.78 2.32 . . . . 0.0 111.544 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.416 HG13 ' HG2' ' A' ' 31' ' ' GLU . 7.4 p -63.44 -39.45 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.507 0.723 . . . . 0.0 110.31 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 29.1 mm-40 -114.63 98.28 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.3 p -99.27 138.21 36.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.742 0.817 . . . . 0.0 110.917 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -143.39 150.58 52.01 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.975 1.31 . . . . 0.0 108.233 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.59 -22.35 51.24 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.859 2.373 . . . . 0.0 114.147 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -128.46 9.92 6.12 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.98 139.2 20.22 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.876 -0.515 . . . . 0.0 110.047 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -129.45 138.95 51.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.642 0.777 . . . . 0.0 109.203 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tm? -132.07 120.35 22.23 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.71 113.53 13.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.684 1.194 . . . . 0.0 109.098 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' A' ' 46' ' ' LYS . 12.6 t -94.65 139.68 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.226 1.01 . . . . 0.0 110.03 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -98.66 147.78 24.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.858 0.463 . . . . 0.0 110.244 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -4.81 34.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.756 0.822 . . . . 0.0 111.829 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -69.0 -10.2 56.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.453 1.101 . . . . 0.0 112.231 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.58 15.64 42.68 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.874 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -126.43 172.13 10.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.555 0.742 . . . . 0.0 109.185 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.4 tttt -136.54 135.29 38.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.09 0.556 . . . . 0.0 109.601 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.408 HD11 ' HG2' ' B' ' 4' ' ' PRO . 8.2 mt -124.72 124.55 42.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.571 0.749 . . . . 0.0 111.059 -176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.449 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.84 167.3 18.45 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.269 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 49' ' ' LEU . 5.5 tp -144.86 105.23 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.0 t90 -104.73 123.14 47.12 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 50.2 m -74.47 112.31 10.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.07 -1.93 1.12 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 114.532 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -79.48 -25.47 41.86 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.959 0.8 . . . . 0.0 110.802 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -112.69 12.58 19.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.441 0.696 . . . . 0.0 111.298 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 8.8 p -63.97 138.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.971 0.415 . . . . 0.0 111.49 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.21 114.49 33.43 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.16 140.52 64.87 Favored 'Cis proline' 0 C--N 1.385 2.464 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.073 3.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HA ' HG13 ' A' ' 55' ' ' VAL . 24.5 mmmt -49.12 125.48 10.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.101 1.36 . . . . 0.0 111.974 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.19 109.43 3.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.065 0.946 . . . . 0.0 110.498 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.8 t -97.32 88.55 4.46 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.48 135.99 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.596 0.758 . . . . 0.0 109.712 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 p -142.42 125.22 16.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.204 1.002 . . . . 0.0 110.182 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.57 -108.64 0.37 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.79 129.51 9.92 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.67 -32.23 0.03 OUTLIER Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.95 151.62 10.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.668 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 47.0 mt-10 -114.4 165.46 12.7 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.548 0.739 . . . . 0.0 110.787 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.91 103.56 9.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.58 118.49 30.08 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.231 0.469 . . . . 0.0 111.518 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -95.73 108.38 20.69 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.109 1.364 . . . . 0.0 107.688 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 38.6 mtm180 -85.3 130.06 34.68 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.438 0.637 . . . . 0.0 112.094 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.42 157.05 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.819 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HG3' HD22 ' A' ' 74' ' ' ASN . 9.7 pt-20 -67.62 -38.36 83.8 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -172.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.451 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.0 p30 -157.2 176.71 12.36 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.711 0.687 . . . . 0.0 112.631 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.57 -32.86 65.61 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.81 1.644 . . . . 0.0 112.66 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.563 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.36 -44.06 79.93 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.012 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -66.36 -24.5 66.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.837 0.855 . . . . 0.0 112.241 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.41 -41.73 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.57 -30.87 68.75 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.489 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.3 mt-10 -68.06 -43.46 78.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -70.37 -28.85 65.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.52 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -64.15 -61.31 2.33 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.777 0.799 . . . . 0.0 109.133 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.76 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.895 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.22 91.46 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.39 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -61.51 -48.51 80.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.635 . . . . 0.0 110.385 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.5 ttpt -54.42 -43.53 71.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.841 0.856 . . . . 0.0 110.956 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.59 58.28 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.264 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -94.47 7.71 44.62 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.272 1.029 . . . . 0.0 112.183 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.61 24.5 30.5 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.421 170.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -84.0 133.58 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.528 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -56.71 -34.6 67.61 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.256 1.022 . . . . 0.0 112.625 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.494 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 49.8 tpp 67.85 82.99 0.17 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 163.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -134.33 86.36 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 177.65 136.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.631 1.572 . . . . 0.0 109.173 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.3 108.79 15.62 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 165.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 12.5 Cg_endo -55.53 118.79 5.59 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.819 2.346 . . . . 0.0 111.448 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.07 155.32 48.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.325 0.65 . . . . 0.0 110.419 -175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.25 118.61 13.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 110.813 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.8 ttm -115.52 166.81 11.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.069 0.948 . . . . 0.0 108.954 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -49.97 -40.32 43.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.696 1.598 . . . . 0.0 113.071 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -86.97 -19.97 27.97 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.357 0.663 . . . . 0.0 111.676 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.67 175.36 28.5 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 120.326 -0.152 . . . . 0.0 112.932 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 42.5 t80 -71.85 101.94 2.75 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -107.49 150.07 27.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.471 0.653 . . . . 0.0 112.165 -161.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 20.0 t80 -150.45 146.21 26.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.8 m -142.69 129.32 20.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.095 0.558 . . . . 0.0 109.65 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.17 149.02 43.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.464 0.706 . . . . 0.0 111.212 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.414 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -108.24 167.09 10.27 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' A' ' 91' ' ' ALA . 1.9 p-10 -133.07 -178.81 0.92 Allowed Pre-proline 0 CA--C 1.562 1.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -169.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 36.8 Cg_endo -62.92 -1.64 2.94 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.314 2.01 . . . . 0.0 114.943 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.73 0.13 13.12 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.481 0.582 . . . . 0.0 111.754 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m 70.14 33.85 2.57 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.829 1.252 . . . . 0.0 112.812 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.51 ' HB2' HD11 ' A' ' 115' ' ' LEU . 18.2 m170 -75.27 170.29 16.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.525 0.73 . . . . 0.0 110.032 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.668 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 13.6 mmm180 -118.91 108.91 15.38 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 113' ' ' HIS . 3.4 mp -121.41 108.9 14.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -93.38 147.23 23.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.897 0.479 . . . . 0.0 110.428 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.87 133.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.3 p90 -135.97 162.05 33.94 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.605 0.639 . . . . 0.0 111.738 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -111.07 124.38 52.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 171.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -81.66 108.77 15.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.129 0.422 . . . . 0.0 110.437 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.847 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 119.551 -0.261 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.408 ' HG2' HD11 ' A' ' 47' ' ' LEU . 54.1 Cg_endo -91.61 96.95 0.21 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.664 2.243 . . . . 0.0 112.262 170.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.874 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.7 p-10 -90.18 12.29 18.44 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.372 0.606 . . . . 0.0 110.824 170.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.478 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -133.34 135.16 44.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.923 1.289 . . . . 0.0 108.164 -168.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -137.49 140.97 41.48 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.424 1.089 . . . . 0.0 108.146 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.8 140.51 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.343 0.657 . . . . 0.0 109.695 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.85 139.26 43.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -83.4 133.08 34.95 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.21 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' B' ' 51' ' ' SER . 35.9 m -129.07 158.65 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.122 0.569 . . . . 0.0 110.693 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -95.76 -58.33 2.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -92.13 100.7 3.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.885 . . . . 0.0 109.233 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.87 -55.72 3.79 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.431 2.087 . . . . 0.0 114.332 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 31.8 Cg_exo -59.16 -55.56 1.83 Allowed 'Trans proline' 0 C--N 1.395 2.974 0 CA-C-N 122.285 1.852 . . . . 0.0 112.275 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.72 74.99 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.969 -167.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -79.77 -18.37 51.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.563 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.6 m -77.93 -37.79 46.94 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 174.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 28.0 mm-40 -67.25 -30.71 70.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.297 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.77 -48.61 81.0 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.08 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 34.4 m-85 -68.59 -30.73 69.54 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.166 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -57.19 -49.63 75.39 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.739 0.7 . . . . 0.0 112.791 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.18 50.82 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.95 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 24.5 tp -62.25 -50.74 70.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.578 1.151 . . . . 0.0 112.159 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.446 ' HB2' HG22 ' B' ' 27' ' ' VAL . 16.8 mt -83.92 -47.35 11.13 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.25 30.47 5.03 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.101 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' B' ' 25' ' ' LEU . 31.4 m -131.86 175.31 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.321 1.048 . . . . 0.0 110.052 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -124.24 151.71 66.47 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.26 106.41 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.57 2.18 . . . . 0.0 111.296 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.03 -39.28 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.486 0.714 . . . . 0.0 110.142 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 65.1 mm-40 -115.13 98.79 6.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.922 0.889 . . . . 0.0 108.678 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.8 p -99.87 137.85 37.76 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.762 0.825 . . . . 0.0 110.764 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 150.8 54.66 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.018 1.327 . . . . 0.0 107.96 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.04 -21.89 52.74 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.788 2.325 . . . . 0.0 114.252 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -128.49 8.98 5.98 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -150.27 139.63 21.37 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.4 m -129.42 139.1 51.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.585 0.754 . . . . 0.0 109.111 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -132.24 119.96 21.53 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.18 113.25 13.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.683 1.193 . . . . 0.0 109.095 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' B' ' 46' ' ' LYS . 14.7 t -94.92 139.99 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.967 0.907 . . . . 0.0 110.115 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 4' ' ' PRO . 10.0 mp -98.93 146.93 25.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.143 0.577 . . . . 0.0 110.324 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.16 -5.17 33.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.923 0.889 . . . . 0.0 111.549 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.63 -9.32 53.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.612 1.165 . . . . 0.0 112.101 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.11 15.68 43.94 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.878 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -126.38 171.51 10.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.658 0.783 . . . . 0.0 109.162 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.5 tttt -136.26 135.23 38.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.127 0.571 . . . . 0.0 109.503 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mt -124.61 124.39 42.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.526 0.73 . . . . 0.0 111.064 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.478 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -101.58 167.31 18.78 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.199 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' B' ' 49' ' ' LEU . 5.7 tp -144.78 105.45 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -104.78 122.97 46.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 50.9 m -74.54 112.8 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -63.35 -2.38 1.46 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.273 1.429 . . . . 0.0 114.503 -170.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -79.08 -25.77 43.07 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.866 0.757 . . . . 0.0 110.656 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -112.81 12.06 19.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.372 0.669 . . . . 0.0 111.426 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' B' ' 58' ' ' LYS . 7.2 p -62.33 138.7 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.68 114.8 32.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.31 139.8 62.23 Favored 'Cis proline' 0 C--N 1.381 2.243 0 C-N-CA 124.525 -1.031 . . . . 0.0 113.51 3.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.436 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.9 mmmt -48.87 125.4 10.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.173 1.389 . . . . 0.0 112.232 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.43 109.98 3.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.062 0.945 . . . . 0.0 110.298 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.2 t -97.83 88.27 4.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.38 136.2 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.657 0.783 . . . . 0.0 109.679 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -143.76 124.93 14.51 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.001 0.92 . . . . 0.0 110.077 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.38 -108.43 0.36 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.65 129.5 9.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.44 -33.48 0.03 OUTLIER Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.64 152.57 11.1 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.543 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 2.2 pm0 -118.09 163.84 16.01 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.87 0.868 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -120.44 103.2 8.99 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.41 119.93 31.11 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.231 0.469 . . . . 0.0 111.536 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -97.66 108.01 20.63 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.404 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 34.8 mtm180 -85.28 128.37 34.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.014 0.525 . . . . 0.0 111.906 -177.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.42 157.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.051 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.26 -38.27 84.84 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -157.73 177.77 11.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.633 0.651 . . . . 0.0 112.52 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.86 -32.55 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.967 1.707 . . . . 0.0 112.545 -167.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -67.56 -43.86 79.62 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.431 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -66.37 -24.32 66.48 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.038 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -69.61 -42.23 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.54 -30.46 68.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 16.0 mt-10 -68.16 -43.22 78.72 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.342 0.592 . . . . 0.0 109.503 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -70.4 -28.77 65.34 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.591 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -64.62 -61.06 2.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.582 0.706 . . . . 0.0 109.114 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.24 90.53 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.929 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.56 90.54 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.199 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -60.93 -49.04 79.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 0.0 110.222 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.475 ' HB2' ' HE3' ' B' ' 92' ' ' MET . 31.8 ttpt -53.8 -44.28 70.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.008 0.923 . . . . 0.0 110.911 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.53 -22.5 58.99 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.3 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -94.48 7.8 44.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.194 0.998 . . . . 0.0 112.087 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.44 31.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 116.123 -0.489 . . . . 0.0 114.319 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.77 134.09 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.52 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -57.43 -34.44 68.95 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.116 0.967 . . . . 0.0 112.53 -172.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.475 ' HE3' ' HB2' ' B' ' 86' ' ' LYS . 50.0 tpp 67.07 83.31 0.17 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' B' ' 108' ' ' ALA . 0.0 OUTLIER -133.65 85.85 2.24 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 178.69 138.9 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.265 1.426 . . . . 0.0 109.279 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -83.12 109.98 20.65 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 165.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.556 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 18.2 Cg_endo -57.4 119.32 6.51 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.606 2.204 . . . . 0.0 110.796 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.78 154.2 48.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.377 0.671 . . . . 0.0 110.412 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -68.47 118.94 12.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 54.2 ttm -115.59 166.04 12.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.11 0.964 . . . . 0.0 109.126 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.02 -39.91 28.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.445 1.498 . . . . 0.0 113.349 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.99 -19.06 27.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.537 0.335 . . . . 0.0 111.485 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.33 173.94 27.39 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.987 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.583 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 45.4 t80 -70.72 102.08 2.23 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 150.11 27.14 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.521 0.677 . . . . 0.0 112.081 -162.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 16.4 t80 -150.42 146.49 26.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.182 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 20.1 m -143.69 128.27 18.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' B' ' 105' ' ' PHE . . . -121.13 149.03 43.39 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.28 0.632 . . . . 0.0 110.995 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ALA . . . . . 0.522 ' HB3' HD11 ' B' ' 93' ' ' LEU . . . -108.35 165.01 11.82 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.52 ' HA ' ' H ' ' B' ' 91' ' ' ALA . 1.9 p-10 -130.49 -177.63 0.7 Allowed Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.003 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 45.5 Cg_endo -63.8 -0.92 2.91 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.447 2.098 . . . . 0.0 114.773 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.44 ' OD1' ' HA ' ' B' ' 11' ' ' VAL . 3.1 t70 -115.98 0.14 12.96 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.093 0.557 . . . . 0.0 111.78 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.9 m 69.41 34.29 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.603 1.161 . . . . 0.0 112.725 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -75.18 171.34 14.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.602 0.761 . . . . 0.0 110.301 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.51 108.31 13.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -121.07 108.18 13.52 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.48 ' NH1' ' HG3' ' B' ' 67' ' ' GLU . 55.5 mtt180 -90.57 147.72 23.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.033 0.533 . . . . 0.0 111.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.99 132.81 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -135.85 161.95 34.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.549 0.613 . . . . 0.0 111.658 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -110.99 123.71 50.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -79.17 104.59 9.9 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.52 99.25 8.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.107 -175.485 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HG3' HD22 ' B' ' 25' ' ' LEU . 78.6 Cg_endo -81.77 72.08 6.45 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.493 2.129 . . . . 0.0 111.253 166.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.486 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.2 p-10 -80.43 9.88 5.35 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.404 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -134.56 134.32 41.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 107.717 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -138.2 139.58 39.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.237 1.015 . . . . 0.0 108.786 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.593 HG12 ' HA3' ' A' ' 48' ' ' GLY . 49.5 mt -128.03 143.03 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.134 0.573 . . . . 0.0 110.173 -172.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -108.63 144.95 35.69 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 32.1 m-85 -93.57 123.5 36.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.199 1.0 . . . . 0.0 111.207 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.412 HG12 ' HE1' ' A' ' 113' ' ' HIS . 23.9 m -124.89 161.02 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.188 0.995 . . . . 0.0 110.409 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.89 -63.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.132 0.973 . . . . 0.0 110.759 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -97.14 100.14 7.21 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.075 0.55 . . . . 0.0 110.154 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 35.1 Cg_exo -55.56 -51.63 9.44 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.296 2.664 . . . . 0.0 115.033 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.77 -51.62 10.76 Favored 'Trans proline' 0 C--N 1.405 3.525 0 CA-C-N 122.646 1.981 . . . . 0.0 112.48 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.92 -39.94 69.14 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 p -77.83 -34.85 51.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.817 0.447 . . . . 0.0 110.515 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 70.9 m -62.39 -47.78 82.63 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.524 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.3 mm100 -62.69 -35.51 79.92 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.125 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -64.89 -45.82 84.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.8 0.688 . . . . 0.0 109.415 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 20.5 m-85 -68.03 -32.89 73.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.279 -0.391 . . . . 0.0 109.997 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 63.2 mtpt -57.31 -47.89 80.35 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.34 -34.27 48.63 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.298 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.8 tp -60.21 -31.35 70.08 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.865 1.266 . . . . 0.0 112.473 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.501 HD22 ' HG3' ' B' ' 4' ' ' PRO . 26.1 mt -99.95 -48.56 4.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.16 28.63 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.995 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.01 -178.34 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.613 1.165 . . . . 0.0 110.747 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -130.76 142.93 47.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 124.342 1.057 . . . . 0.0 108.762 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 34.1 Cg_endo -63.93 119.94 7.16 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.602 2.201 . . . . 0.0 112.449 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.999 0.92 . . . . 0.0 110.455 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 57.9 mm-40 -116.23 90.04 3.24 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.3 p -90.04 149.48 22.5 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.894 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -151.76 151.48 28.46 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 125.037 1.335 . . . . 0.0 107.627 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.78 -20.1 68.09 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.451 2.101 . . . . 0.0 113.607 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -128.38 12.36 6.47 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.9 152.79 28.71 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -143.86 138.58 28.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 12.7 tp -126.42 115.72 20.05 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.3 p90 -131.21 112.89 13.21 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.922 1.289 . . . . 0.0 109.16 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.592 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 3.8 p -106.71 142.28 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.24 1.016 . . . . 0.0 110.079 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.16 157.25 17.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.622 0.769 . . . . 0.0 111.134 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -22.61 65.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.479 1.112 . . . . 0.0 112.593 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -70.19 -18.6 63.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.258 0.623 . . . . 0.0 112.032 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.48 15.82 16.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.445 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -103.23 154.03 19.76 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.017 0.909 . . . . 0.0 108.697 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.2 tttt -125.3 131.02 53.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -128.54 127.66 42.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.346 0.659 . . . . 0.0 109.883 -168.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -104.81 169.78 17.29 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.54 104.79 4.26 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.438 ' HB2' HG21 ' A' ' 8' ' ' ILE . 4.5 t90 -106.75 127.48 53.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.451 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 27.9 m -72.96 129.95 39.27 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.244 0.34 . . . . 0.0 110.126 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -68.34 -10.94 58.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.687 0.795 . . . . 0.0 112.493 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -81.95 -23.47 36.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -116.93 7.83 13.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.269 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 58' ' ' LYS . 10.5 p -67.68 140.53 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 122.712 0.405 . . . . 0.0 111.508 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HB3' HE22 ' B' ' 94' ' ' GLN . 70.7 mt-10 -125.56 114.6 25.18 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 170.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.503 ' HG2' ' CZ ' ' B' ' 114' ' ' ARG . 59.0 Cg_endo -78.14 141.51 66.06 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 124.491 -1.046 . . . . 0.0 113.194 4.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HA ' HG13 ' A' ' 55' ' ' VAL . 27.4 mmmt -49.43 123.0 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.252 1.421 . . . . 0.0 112.452 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HB2' ' NH2' ' B' ' 114' ' ' ARG . . . -155.57 109.18 2.79 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.318 1.047 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.8 p -85.08 87.08 7.34 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.0 124.19 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.7 p -151.51 122.34 7.55 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.302 1.441 . . . . 0.0 107.78 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.71 52.55 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.06 -132.18 10.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.89 -62.98 4.35 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.35 154.38 18.99 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 168.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 2.4 pt-20 -130.06 166.18 20.68 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.011 0.924 . . . . 0.0 110.27 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.2 tp -125.46 102.39 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.829 0.852 . . . . 0.0 109.457 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -92.48 110.72 22.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -169.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 12.3 m-85 -88.99 116.86 27.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.435 1.094 . . . . 0.0 108.419 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -95.21 130.7 41.85 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.87 162.74 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.345 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.9 pt-20 -66.12 -43.44 87.14 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.472 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 8.9 p30 -160.44 179.62 8.47 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.584 0.629 . . . . 0.0 112.568 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.79 -30.67 63.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -168.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.5 -52.56 64.01 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.786 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 81.0 mm-40 -65.76 -22.78 66.61 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.736 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.25 -46.09 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.465 0.65 . . . . 0.0 109.73 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.89 -28.54 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 110.676 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 35.8 mt-10 -65.06 -48.2 74.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.234 0.613 . . . . 0.0 110.013 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.8 m -68.31 -30.1 69.01 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -55.62 -58.72 6.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.96 0.904 . . . . 0.0 109.98 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.47 -35.53 80.49 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.493 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.09 -42.62 96.51 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 123.645 0.591 . . . . 0.0 113.588 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -66.6 -39.73 88.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.058 0.543 . . . . 0.0 110.233 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.431 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 32.7 ttpt -57.51 -44.84 85.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.474 0.71 . . . . 0.0 110.262 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.33 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 t -99.64 9.91 42.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.211 1.004 . . . . 0.0 112.378 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 55.57 2.77 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 165.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.5 p -102.79 148.71 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 168.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -57.15 5.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.552 0.341 . . . . 0.0 110.459 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.546 ' HB2' HG13 ' A' ' 90' ' ' VAL . 21.1 ttp 64.23 82.51 0.18 Allowed 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.225 0.953 . . . . 0.0 113.104 168.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.81 85.94 2.24 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 106' ' ' THR . 46.9 tp60 179.57 133.17 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.761 1.224 . . . . 0.0 108.954 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -83.45 122.47 77.01 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.254 0.622 . . . . 0.0 109.413 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 106.62 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.533 2.155 . . . . 0.0 110.835 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 152.36 50.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.089 0.556 . . . . 0.0 111.312 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -70.4 102.17 2.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.217 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.3 ttm -94.8 169.2 10.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.357 1.063 . . . . 0.0 109.193 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -43.64 -41.5 4.7 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.139 1.376 . . . . 0.0 113.568 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -87.96 -15.29 36.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.575 0.75 . . . . 0.0 111.907 -172.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.16 -170.83 25.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.969 -0.35 . . . . 0.0 112.59 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -76.71 101.69 5.89 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -108.07 149.38 28.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 110.344 -171.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.4 t80 -144.4 147.91 33.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.746 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 4.8 m -140.6 136.75 33.08 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.151 0.432 . . . . 0.0 110.924 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.38 172.78 6.64 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.837 0.855 . . . . 0.0 110.967 171.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.29 113.26 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.02 169.05 20.72 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.422 0.689 . . . . 0.0 110.016 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.5 -33.88 31.72 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.268 2.645 . . . . 0.0 114.59 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.0 12.0 23.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.08 0.552 . . . . 0.0 111.207 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 59.5 72.63 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 112.874 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.412 ' HE1' HG12 ' A' ' 11' ' ' VAL . 8.4 m80 -126.59 172.24 10.43 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.618 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 65.5 mmt-85 -102.52 104.87 15.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.81 102.59 14.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.849 HH22 HG23 ' B' ' 55' ' ' VAL . 15.3 mmt180 -88.04 147.52 24.94 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 123.578 0.751 . . . . 0.0 110.389 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.426 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 15.4 t -137.99 127.29 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 161.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -141.01 158.56 43.77 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.02 111.06 17.84 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -73.0 120.93 19.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.788 0.435 . . . . 0.0 109.831 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.511 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.423 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.501 ' HG3' HD22 ' A' ' 25' ' ' LEU . 63.0 Cg_endo -82.99 71.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.622 2.214 . . . . 0.0 110.819 167.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.02 9.48 4.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.791 0.836 . . . . 0.0 111.27 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -134.51 134.29 41.29 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.097 1.359 . . . . 0.0 107.677 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -138.38 139.66 39.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.468 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 16.8 mt -128.74 143.35 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.081 0.553 . . . . 0.0 110.103 -172.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -110.01 144.06 39.11 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -91.87 123.94 35.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.12 0.968 . . . . 0.0 111.142 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.423 HG12 ' HE1' ' B' ' 113' ' ' HIS . 20.5 m -125.3 160.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 123.956 0.902 . . . . 0.0 110.308 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.75 -63.89 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.129 0.971 . . . . 0.0 111.154 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -96.12 98.42 4.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 123.625 0.77 . . . . 0.0 109.682 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -53.8 -52.72 7.82 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.854 2.37 . . . . 0.0 115.842 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.24 -52.64 8.54 Favored 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 123.162 2.165 . . . . 0.0 112.7 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.37 -40.08 70.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.482 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 75.8 p -77.49 -34.91 54.11 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.743 0.417 . . . . 0.0 110.765 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.5 m -63.04 -46.88 85.44 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.521 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 13.8 mm100 -63.54 -35.18 79.64 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.809 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 66.1 t80 -64.88 -45.52 85.64 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.776 0.672 . . . . 0.0 109.42 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.408 ' O ' ' HG ' ' B' ' 25' ' ' LEU . 30.3 m-85 -68.29 -32.79 73.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.225 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 62.7 mtpt -57.11 -48.03 79.64 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.3 -34.31 48.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 20.8 tp -60.25 -30.99 69.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.595 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.492 HD22 ' HG3' ' A' ' 4' ' ' PRO . 25.1 mt -100.47 -48.31 4.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.7 4.88 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.953 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.543 HG11 HD22 ' B' ' 41' ' ' LEU . 24.2 m -129.62 -178.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.648 1.179 . . . . 0.0 111.064 -174.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -130.41 144.81 54.82 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.816 0.847 . . . . 0.0 109.231 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 18.4 Cg_exo -65.86 120.64 7.85 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.411 2.074 . . . . 0.0 112.21 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' B' ' 31' ' ' GLU . 8.9 p -64.55 -42.32 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.159 0.984 . . . . 0.0 110.802 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 50.3 mm-40 -119.17 89.13 3.07 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -90.1 149.74 22.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -151.81 151.31 28.05 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.1 -20.29 70.88 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.422 2.081 . . . . 0.0 113.683 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -128.2 11.44 6.45 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.043 0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -155.6 153.01 29.43 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -143.93 138.45 28.52 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 12.9 tp -126.42 115.94 20.38 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.424 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.4 p90 -131.11 113.24 13.66 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.961 1.304 . . . . 0.0 109.215 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.628 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 4.3 p -107.1 141.94 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.267 1.027 . . . . 0.0 110.033 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.543 HD22 HG11 ' B' ' 27' ' ' VAL . 13.7 mt -105.5 157.27 17.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.529 0.732 . . . . 0.0 110.382 -169.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -21.72 64.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.381 1.072 . . . . 0.0 112.332 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.04 -18.38 62.57 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.99 0.516 . . . . 0.0 111.23 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.42 16.09 15.58 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 114.484 0.554 . . . . 0.0 114.484 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.2 ppp? -104.2 153.43 20.98 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.104 0.952 . . . . 0.0 108.607 170.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.628 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 53.6 tttt -124.69 130.97 53.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.92 127.96 44.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.31 0.644 . . . . 0.0 110.063 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.27 169.67 17.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 123.821 0.724 . . . . 0.0 111.293 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.66 104.51 4.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -106.7 126.85 52.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -72.75 129.6 38.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.66 -11.1 57.5 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.013 0.925 . . . . 0.0 112.38 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.02 -24.09 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.01 0.524 . . . . 0.0 111.141 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -116.62 8.66 13.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.282 0.633 . . . . 0.0 111.324 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.849 HG23 HH22 ' A' ' 116' ' ' ARG . 7.1 p -68.15 140.1 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.793 0.437 . . . . 0.0 111.382 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -124.84 114.0 26.78 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.5 141.49 64.83 Favored 'Cis proline' 0 C--N 1.381 2.287 0 C-N-CA 124.439 -1.067 . . . . 0.0 113.147 5.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.49 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.0 mmmt -49.55 123.14 7.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.144 1.378 . . . . 0.0 112.34 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.98 108.55 2.63 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.114 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.9 p -84.44 87.1 7.21 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.75 124.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.368 0.667 . . . . 0.0 110.482 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -152.51 121.87 6.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.997 1.319 . . . . 0.0 107.776 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.04 0.01 OUTLIER Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.48 -132.47 10.94 Favored Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.15 4.34 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.01 153.71 18.56 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.491 ' CG ' ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -128.61 168.13 16.18 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 110.542 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 tp -126.25 102.15 7.06 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.93 0.892 . . . . 0.0 109.437 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -92.57 111.32 22.87 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.756 0.312 . . . . 0.0 111.725 -169.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m-85 -89.37 116.96 27.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.47 1.108 . . . . 0.0 108.337 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -96.05 128.28 42.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.448 0.642 . . . . 0.0 111.566 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.78 164.14 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.646 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.28 -43.25 86.91 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.382 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -160.65 178.19 9.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.99 -32.02 52.78 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.197 1.799 . . . . 0.0 113.076 -170.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.557 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -61.32 -52.92 62.68 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.884 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 61.2 mm-40 -64.97 -23.1 67.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.763 1.225 . . . . 0.0 112.618 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.81 -45.84 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.386 0.613 . . . . 0.0 109.764 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.17 57.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.96 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.9 mt-10 -64.53 -48.72 74.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.208 0.603 . . . . 0.0 109.74 174.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -68.48 -29.58 68.24 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.891 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.76 -58.95 5.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.22 1.008 . . . . 0.0 109.666 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.67 -35.47 80.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.484 -174.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.46 96.9 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 123.337 0.398 . . . . 0.0 113.487 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -66.87 -39.39 87.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.989 0.516 . . . . 0.0 110.092 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.0 ttpt -57.88 -44.74 86.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.644 0.778 . . . . 0.0 110.478 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.7 67.39 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.792 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.8 t -99.91 9.79 42.38 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.097 0.959 . . . . 0.0 112.333 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.25 55.27 2.79 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 165.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.7 p -103.11 148.68 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.1 -56.88 6.36 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.57 0.348 . . . . 0.0 110.413 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 19.5 ttp 64.07 82.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 85.82 2.23 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.747 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' B' ' 106' ' ' THR . 5.8 tp60 -179.42 133.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.916 1.286 . . . . 0.0 108.836 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLN . . . . . 0.401 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 86.6 mt-30 -82.79 122.48 78.26 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.607 0.763 . . . . 0.0 109.355 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.523 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 19.0 Cg_endo -59.47 106.66 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.566 2.177 . . . . 0.0 110.181 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.3 152.47 50.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.287 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -71.52 102.67 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.75 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.8 ttm -94.67 169.13 10.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.635 1.174 . . . . 0.0 109.321 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -43.61 -41.87 4.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.487 1.515 . . . . 0.0 112.864 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.04 -14.93 37.7 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.632 0.773 . . . . 0.0 112.027 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.98 -171.05 25.06 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.988 -0.34 . . . . 0.0 112.553 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -76.33 101.42 5.49 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -107.86 149.46 28.24 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.583 0.706 . . . . 0.0 110.331 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 1.9 t80 -144.59 148.29 34.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.701 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 17.1 m -141.33 136.5 31.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.122 0.487 . . . . 0.0 110.474 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.39 172.88 6.58 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.957 0.903 . . . . 0.0 110.838 171.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.5 112.52 10.33 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.436 ' HB3' HD11 ' B' ' 115' ' ' LEU . 6.6 p-10 -72.9 167.57 32.7 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -48.34 -33.85 23.51 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.394 2.729 . . . . 0.0 114.864 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -92.24 12.22 23.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.123 0.569 . . . . 0.0 111.134 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 m 59.06 72.15 0.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.064 1.345 . . . . 0.0 112.738 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.423 ' HE1' HG12 ' B' ' 11' ' ' VAL . 8.6 m80 -125.64 171.58 10.47 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.57 ' NH2' ' HB2' ' A' ' 59' ' ' ALA . 17.2 mmt180 -101.17 105.04 16.13 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' B' ' 109' ' ' ASP . 39.0 mt -97.2 103.04 14.94 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.737 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 23.9 ttt180 -87.66 147.43 25.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.5 0.72 . . . . 0.0 110.404 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -137.86 127.22 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 160.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -141.22 158.69 43.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.65 110.8 17.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.74 123.39 23.22 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.86 100.79 13.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.965 0.506 . . . . 0.0 109.961 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.78 -1.011 . . . . 0.0 111.156 179.02 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 98.6 Cg_endo -86.38 143.39 7.57 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.213 1.942 . . . . 0.0 112.037 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.66 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 36.0 t70 -143.61 19.37 1.85 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.659 1.219 . . . . 0.0 109.009 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.73 148.09 35.16 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.653 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.494 HG23 HD23 ' A' ' 47' ' ' LEU . 3.8 t -151.72 139.21 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.869 0.868 . . . . 0.0 108.691 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.545 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 68.1 mt -123.71 137.7 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.577 0.751 . . . . 0.0 109.904 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.66 130.23 45.87 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 62' ' ' THR . 28.0 m-85 -80.42 115.19 19.82 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.27 0.628 . . . . 0.0 109.629 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG12 ' CE1' ' A' ' 113' ' ' HIS . 32.9 m -114.09 160.78 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.772 0.829 . . . . 0.0 109.241 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -97.08 -59.3 1.82 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.147 0.579 . . . . 0.0 110.497 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -98.48 100.77 9.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.305 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.28 -51.97 10.05 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.441 2.761 . . . . 0.0 115.523 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.21 -50.21 9.13 Favored 'Trans proline' 0 C--N 1.398 3.158 0 CA-C-N 122.136 1.798 . . . . 0.0 112.561 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.29 62.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.6 p -76.83 -36.21 57.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.479 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 95.2 m -64.51 -43.84 92.78 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 36.9 mt-30 -64.99 -35.11 80.12 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.205 174.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.3 t80 -66.15 -42.82 88.54 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 123.776 0.673 . . . . 0.0 109.552 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 34.1 m-85 -70.04 -28.39 65.43 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.789 -0.625 . . . . 0.0 109.873 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 60.6 mtpt -57.0 -50.61 72.18 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 118.789 0.722 . . . . 0.0 111.822 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.45 60.84 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.253 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 19.1 tp -61.79 -42.56 99.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.744 1.217 . . . . 0.0 112.388 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' HB2' HG22 ' A' ' 27' ' ' VAL . 18.4 mt -90.15 -43.01 10.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.67 28.62 6.95 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.2 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 25' ' ' LEU . 29.4 m -131.64 173.87 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.929 0.892 . . . . 0.0 110.224 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -124.84 150.22 65.22 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.965 0.906 . . . . 0.0 109.213 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.93 118.14 5.4 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.013 2.475 . . . . 0.0 112.267 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.8 -40.04 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.717 0.636 . . . . 0.0 110.298 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 36.3 mm-40 -117.92 146.7 43.76 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.326 1.05 . . . . 0.0 109.196 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.4 p -143.8 135.37 26.1 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -145.26 157.4 53.22 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.876 1.271 . . . . 0.0 108.772 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.12 -28.99 35.19 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 123.468 2.779 . . . . 0.0 113.999 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 5.19 7.98 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.57 130.23 12.31 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.833 -0.542 . . . . 0.0 111.194 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -117.62 130.89 56.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 7.1 tt -121.93 132.39 54.52 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.26 150.63 46.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.82 1.248 . . . . 0.0 108.687 167.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 2.0 p -130.46 132.64 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.59 155.89 20.27 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.368 0.667 . . . . 0.0 110.767 -165.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.15 -16.98 64.22 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.642 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -74.41 -15.38 60.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.132 0.973 . . . . 0.0 111.363 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.8 -19.88 30.04 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.896 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.703 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.7 ppp? -81.36 168.45 18.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.376 0.588 . . . . 0.0 109.929 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.6 tttt -133.83 140.2 46.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.502 0.321 . . . . 0.0 110.924 -169.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 7' ' ' THR . 55.0 mt -131.39 126.38 35.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.866 0.867 . . . . 0.0 111.898 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -102.79 167.9 17.78 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 174.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.54 108.41 6.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.1 t90 -104.81 118.53 36.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 25.2 p -75.85 127.7 33.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.189 0.518 . . . . 0.0 109.842 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.486 ' HD3' HG23 ' A' ' 62' ' ' THR . 40.3 ptt180 -74.43 -2.44 25.48 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.827 1.251 . . . . 0.0 114.015 -165.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -69.84 -18.63 63.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.835 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -148.03 21.76 1.1 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.857 0.463 . . . . 0.0 110.774 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 58' ' ' LYS . 8.7 p -59.37 147.2 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.806 0.442 . . . . 0.0 111.313 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.84 113.51 26.87 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.536 0.734 . . . . 0.0 109.117 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 1.2 Cg_endo -78.19 143.96 74.31 Favored 'Cis proline' 0 C--N 1.38 2.232 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.406 5.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HA ' HG13 ' A' ' 55' ' ' VAL . 11.9 mmmm -54.69 119.6 5.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.034 0.934 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.73 4.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.191 0.996 . . . . 0.0 109.441 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.7 m -91.48 82.86 5.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 m -155.4 131.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.012 1.325 . . . . 0.0 108.424 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.486 HG23 ' HD3' ' A' ' 52' ' ' ARG . 15.0 p -145.44 122.28 11.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.311 1.044 . . . . 0.0 108.634 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.72 -95.51 0.14 Allowed Glycine 0 C--N 1.349 1.305 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.639 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.95 -154.12 30.11 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.81 -48.09 3.81 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.29 132.48 3.75 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.563 ' HG2' ' HB ' ' B' ' 8' ' ' ILE . 15.8 pt-20 -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.08 0.952 . . . . 0.0 110.971 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.13 105.6 13.11 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -91.72 115.17 27.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.659 0.663 . . . . 0.0 112.546 -169.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.7 m-85 -96.44 115.75 27.94 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.728 1.211 . . . . 0.0 108.334 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.46 HH21 ' HB3' ' B' ' 5' ' ' ASP . 42.0 mtm180 -96.51 131.06 43.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.556 0.693 . . . . 0.0 111.494 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -125.45 165.98 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.186 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.1 pt-20 -65.45 -41.56 93.29 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.395 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.44 -178.68 3.63 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.218 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -58.99 -30.31 67.87 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.222 1.409 . . . . 0.0 112.887 -165.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.57 87.63 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.119 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.56 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 77.4 mm-40 -67.39 -22.33 65.56 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.646 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.78 -44.89 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.16 -32.17 68.6 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.497 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.98 -42.14 81.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.722 0.772 . . . . 0.0 110.197 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.6 m -72.36 -28.12 62.83 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.702 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -58.72 -61.75 2.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.839 0.856 . . . . 0.0 109.682 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.89 67.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.632 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.87 -51.57 56.32 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.877 0.736 . . . . 0.0 113.012 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -63.74 -40.46 96.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.082 0.553 . . . . 0.0 110.099 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 31.5 ttpt -56.15 -45.78 79.51 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.412 0.625 . . . . 0.0 110.828 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.34 -20.17 60.19 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.166 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.2 t -98.64 10.3 41.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.061 0.944 . . . . 0.0 112.14 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.55 5.82 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 168.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.89 153.56 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.51 2.75 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.829 0.452 . . . . 0.0 110.373 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 11.3 ttp 67.47 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.973 0.795 . . . . 0.0 112.859 171.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.32 85.13 2.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.194 0.521 . . . . 0.0 110.617 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 106' ' ' THR . 51.3 tp60 179.85 131.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.338 . . . . 0.0 109.145 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.59 117.79 69.21 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.65 105.19 0.1 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.397 2.732 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.9 148.93 25.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 110.815 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -90.46 99.02 12.12 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -102.95 -174.65 2.6 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.42 0.688 . . . . 0.0 111.885 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -55.91 -39.84 72.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.07 1.348 . . . . 0.0 112.766 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 89.9 m-85 -88.63 -4.83 58.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.279 0.632 . . . . 0.0 111.614 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.86 -160.22 21.74 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.731 -0.483 . . . . 0.0 113.413 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -80.26 100.47 8.36 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -109.18 153.59 23.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.596 0.758 . . . . 0.0 111.026 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.8 t80 -149.4 145.03 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.728 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 12.3 m -137.94 128.93 27.25 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.322 0.51 . . . . 0.0 109.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.89 174.63 5.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.997 0.919 . . . . 0.0 110.589 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.08 119.3 12.08 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.574 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.8 p-10 -73.87 -175.13 0.39 Allowed Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.588 0.755 . . . . 0.0 111.316 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 11.5 Cg_exo -38.91 -48.47 2.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.589 2.859 . . . . 0.0 114.846 165.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 113' ' ' HIS . 57.9 m-20 -89.73 3.92 51.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.393 0.677 . . . . 0.0 111.321 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.2 m 71.96 16.16 5.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 113.654 161.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.448 ' CE1' HG12 ' A' ' 11' ' ' VAL . 15.9 m80 -59.11 137.35 57.99 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -70.98 99.61 1.82 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.36 102.26 14.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.714 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 14.2 tpt180 -87.71 142.45 27.82 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.403 1.081 . . . . 0.0 110.664 -170.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.455 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 39.0 t -138.73 128.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.0 p90 -135.39 158.59 43.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.545 0.611 . . . . 0.0 111.931 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 113.04 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 34.8 t80 -78.43 114.91 17.76 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 O-C-N 124.199 0.937 . . . . 0.0 109.914 179.826 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 90.0 Cg_endo -86.72 141.84 6.59 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.342 2.028 . . . . 0.0 112.37 170.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.703 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 22.2 t70 -141.77 20.31 2.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.557 1.17 . . . . 0.0 109.221 171.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -143.47 148.0 35.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.751 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.474 HG23 HD23 ' B' ' 47' ' ' LEU . 3.7 t -151.83 139.3 19.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.563 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 46.8 mt -123.74 137.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.641 0.776 . . . . 0.0 109.879 -170.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.4 130.41 45.67 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.432 ' O ' HG22 ' B' ' 62' ' ' THR . 27.1 m-85 -80.44 115.6 20.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.604 172.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.443 HG12 ' CE1' ' B' ' 113' ' ' HIS . 32.7 m -114.43 160.72 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.705 0.802 . . . . 0.0 109.274 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.29 -58.56 1.98 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.712 0.405 . . . . 0.0 110.737 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -98.6 100.66 9.86 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.118 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.66 -52.18 9.57 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.319 2.679 . . . . 0.0 115.378 -172.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 25.4 Cg_endo -58.76 -50.73 8.49 Favored 'Trans proline' 0 C--N 1.398 3.139 0 CA-C-N 122.132 1.797 . . . . 0.0 112.532 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -37.66 64.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.635 -166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.5 p -76.51 -36.23 57.87 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.62 0.575 . . . . 0.0 109.453 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 96.9 m -65.04 -43.41 92.43 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' B' ' 15' ' ' PRO . 45.7 mt-30 -65.19 -35.34 80.77 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.793 174.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 75.5 t80 -65.81 -43.01 89.93 Favored 'General case' 0 C--N 1.347 0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 32.3 m-85 -69.81 -28.62 65.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.788 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 18' ' ' THR . 57.3 mtpt -57.16 -50.52 72.58 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.794 0.724 . . . . 0.0 112.112 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.58 61.8 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.536 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 19.0 tp -61.54 -42.69 99.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.599 1.159 . . . . 0.0 112.581 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -90.24 -42.56 10.94 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.97 29.31 6.91 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.899 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' B' ' 25' ' ' LEU . 28.2 m -131.42 174.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 124.097 0.959 . . . . 0.0 110.568 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -124.75 150.61 66.13 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.73 0.812 . . . . 0.0 109.155 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.16 118.92 5.96 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.49 2.127 . . . . 0.0 112.661 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.44 -40.05 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.27 0.628 . . . . 0.0 110.381 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.766 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 31.1 mm-40 -118.0 147.34 43.29 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.159 0.983 . . . . 0.0 108.666 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.3 p -144.27 135.38 25.36 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 57.1 m -145.02 156.41 55.01 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.106 1.362 . . . . 0.0 108.66 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.15 -30.17 24.63 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 124.039 3.159 . . . . 0.0 114.353 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -125.21 5.77 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -151.75 129.9 11.91 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.455 0.571 . . . . 0.0 111.086 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 42.6 m -117.21 130.73 56.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 39.9 tp -121.54 131.92 54.41 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.465 0.706 . . . . 0.0 109.608 -176.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.92 150.79 47.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.617 1.167 . . . . 0.0 108.455 167.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.483 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 2.7 p -130.29 133.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 41.2 mt -86.49 155.73 20.4 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.923 -165.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -16.76 64.33 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.667 0.787 . . . . 0.0 111.342 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -75.79 -14.53 60.31 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.709 0.804 . . . . 0.0 111.086 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.65 -19.78 30.53 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-O 119.753 -0.471 . . . . 0.0 113.874 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.66 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.8 ppp? -81.35 168.13 18.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.416 0.608 . . . . 0.0 110.061 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 78.3 tttt -133.96 140.29 46.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.488 0.315 . . . . 0.0 110.997 -169.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.474 HD23 HG23 ' B' ' 7' ' ' THR . 46.3 mt -131.47 126.25 34.54 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.843 0.857 . . . . 0.0 111.88 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.64 167.77 17.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -137.63 108.41 6.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.408 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 5.1 t90 -104.9 118.4 36.43 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 55.3 p -75.18 127.69 33.76 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.182 0.515 . . . . 0.0 110.084 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.497 ' HD3' HG23 ' B' ' 62' ' ' THR . 35.3 ptt180 -74.81 -2.97 29.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.688 1.195 . . . . 0.0 113.982 -165.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -19.45 64.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.618 0.767 . . . . 0.0 111.928 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -147.86 21.79 1.12 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.896 0.478 . . . . 0.0 110.625 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -59.57 146.98 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.757 0.423 . . . . 0.0 111.098 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.98 115.1 27.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.72 143.33 75.59 Favored 'Cis proline' 0 C--N 1.387 2.564 0 C-N-CA 124.462 -1.057 . . . . 0.0 112.955 2.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -53.22 119.32 4.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.972 0.909 . . . . 0.0 112.173 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.32 108.54 4.79 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.075 0.95 . . . . 0.0 109.147 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.2 m -91.13 82.87 5.52 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.4 131.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.892 1.277 . . . . 0.0 108.425 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.497 HG23 ' HD3' ' B' ' 52' ' ' ARG . 17.2 p -145.41 121.89 11.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.269 1.028 . . . . 0.0 108.526 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.07 -95.51 0.14 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 112.592 -0.203 . . . . 0.0 112.592 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.03 -154.14 30.19 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.9 -48.15 3.82 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.19 132.11 3.64 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.545 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 pt-20 -106.63 166.65 10.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.935 0.894 . . . . 0.0 110.853 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 tp -115.48 104.87 12.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.507 0.723 . . . . 0.0 109.247 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.747 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.22 115.62 28.17 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.611 0.641 . . . . 0.0 112.243 -168.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 7.8 m-85 -96.61 115.84 28.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.886 1.274 . . . . 0.0 108.368 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -96.48 128.59 43.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.273 0.629 . . . . 0.0 111.146 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.79 167.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.627 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.47 -40.86 89.59 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -167.75 -179.69 4.39 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.172 0.511 . . . . 0.0 112.362 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.31 -30.74 66.91 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.35 1.46 . . . . 0.0 112.89 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.586 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.44 -46.16 87.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.952 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.9 mm-40 -67.56 -21.98 65.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.904 0.882 . . . . 0.0 112.503 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.81 -43.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.39 -30.62 63.39 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.656 1.182 . . . . 0.0 110.982 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.1 mt-10 -69.17 -42.41 75.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.707 0.765 . . . . 0.0 110.189 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -71.89 -28.32 63.43 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.75 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.422 ' O ' ' HE1' ' B' ' 92' ' ' MET . 13.0 t80 -58.3 -62.28 1.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 0.0 109.359 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.427 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -69.39 -29.87 67.73 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.541 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.97 53.74 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.02 0.825 . . . . 0.0 113.027 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.7 -40.5 96.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.118 0.567 . . . . 0.0 110.073 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.8 ttpt -56.34 -45.25 80.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.637 . . . . 0.0 110.656 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 -20.82 60.01 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.172 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -98.36 10.85 39.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.125 0.97 . . . . 0.0 112.516 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.62 42.87 5.96 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.61 153.32 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.13 -59.64 2.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.812 0.445 . . . . 0.0 110.363 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.422 ' HE1' ' O ' ' B' ' 82' ' ' PHE . 30.9 ttm 67.37 84.97 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.866 0.729 . . . . 0.0 112.377 170.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.27 84.2 1.93 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.126 0.489 . . . . 0.0 110.645 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 55.6 tp60 -178.74 132.23 0.13 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.649 1.18 . . . . 0.0 108.833 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLN . . . . . 0.405 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 96.8 mt-30 -86.36 118.02 69.64 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 9.8 Cg_endo -52.66 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.547 2.831 . . . . 0.0 112.106 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.28 148.86 25.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.125 0.97 . . . . 0.0 110.772 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.81 99.36 12.38 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.446 ' SD ' HG21 ' B' ' 104' ' ' THR . 66.1 mtt -103.05 -173.56 2.34 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.288 0.635 . . . . 0.0 111.745 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -57.24 -39.49 75.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.052 1.341 . . . . 0.0 112.548 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 78.7 m-85 -88.76 -5.13 58.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.511 0.725 . . . . 0.0 111.399 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.67 -160.19 21.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.302 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -80.64 100.8 8.85 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.446 HG21 ' SD ' ' B' ' 99' ' ' MET . 12.0 t -109.45 153.99 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.838 -170.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 14.3 t80 -149.41 145.43 26.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.543 -177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.503 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 9.4 m -138.25 129.08 26.81 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.04 174.48 5.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 110.822 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.83 120.43 13.29 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.607 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.7 p-10 -75.54 -174.29 0.38 Allowed Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.683 0.793 . . . . 0.0 110.953 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.5 Cg_exo -40.34 -48.01 4.18 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.412 2.741 . . . . 0.0 114.519 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.427 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 65.0 m-20 -90.1 4.1 51.37 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.356 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 29.0 m 71.67 17.76 5.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.443 ' CE1' HG12 ' B' ' 11' ' ' VAL . 16.3 m80 -60.79 137.71 58.18 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -71.05 99.49 1.83 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.388 0.613 . . . . 0.0 109.439 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.8 mt -96.38 102.85 14.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 14.0 tpt180 -86.61 142.6 28.14 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.475 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -138.91 128.75 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -135.37 158.82 43.4 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.867 0.758 . . . . 0.0 111.744 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.7 112.57 21.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 84.9 t80 -76.59 108.99 9.97 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.3 101.47 8.95 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m80 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.62 103.77 0.23 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.325 2.683 . . . . 0.0 113.002 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.707 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 9.1 p-10 -97.71 12.49 33.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 166.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.6 129.09 43.94 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.873 -168.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.1 t -130.36 137.98 50.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.158 0.983 . . . . 0.0 108.348 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -124.33 141.83 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.2 131.93 55.69 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 55' ' ' VAL . 10.1 m-85 -71.7 120.35 17.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.881 0.873 . . . . 0.0 111.616 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 51' ' ' SER . 33.2 m -117.71 161.42 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.01 -54.32 3.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -94.95 103.79 12.77 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.597 0.759 . . . . 0.0 109.586 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.17 -57.67 1.38 Allowed 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.983 2.456 . . . . 0.0 114.493 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 38.5 Cg_exo -57.27 -57.3 1.33 Allowed 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.628 1.974 . . . . 0.0 111.852 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.13 89.52 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.922 -169.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -78.26 -24.45 46.84 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 28.0 m -73.51 -43.4 60.15 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 75.5 mm-40 -68.47 -29.7 68.38 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.557 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -61.24 -50.79 71.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.816 0.697 . . . . 0.0 109.6 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.32 -31.92 71.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.592 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -57.45 -47.92 80.52 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.27 57.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.035 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.5 -36.9 79.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.473 1.109 . . . . 0.0 112.903 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' HB2' HG22 ' A' ' 27' ' ' VAL . 23.8 mt -98.61 -31.44 11.94 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.168 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.83 31.48 20.79 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 25' ' ' LEU . 22.7 m -123.81 174.66 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.251 1.02 . . . . 0.0 110.599 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.96 143.09 47.57 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.852 0.861 . . . . 0.0 109.306 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.46 132.9 28.51 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.674 2.25 . . . . 0.0 112.828 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 31' ' ' GLU . 7.8 p -71.09 -38.56 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.534 0.734 . . . . 0.0 109.907 171.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 40.3 mm-40 -118.21 134.0 55.4 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 p -141.07 126.15 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.443 0.697 . . . . 0.0 109.23 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -140.17 157.55 68.71 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.759 1.223 . . . . 0.0 109.212 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.25 -24.49 77.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.917 2.412 . . . . 0.0 113.831 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.4 t -127.1 13.49 7.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -155.99 154.34 30.94 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.969 -0.457 . . . . 0.0 110.411 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 t -144.69 157.62 44.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.153 0.981 . . . . 0.0 108.403 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -154.41 118.12 4.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.57 135.97 51.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 109.104 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' A' ' 46' ' ' LYS . 16.1 t -115.87 126.25 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 0.0 108.925 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.461 HD13 ' SD ' ' A' ' 45' ' ' MET . 10.3 mp -90.16 152.55 21.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.761 0.424 . . . . 0.0 110.257 -170.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -14.17 61.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.949 0.899 . . . . 0.0 111.699 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.55 -22.42 66.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.28 1.032 . . . . 0.0 111.789 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.66 1.08 40.0 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.818 -0.435 . . . . 0.0 113.343 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.73 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -95.34 169.99 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' A' ' 40' ' ' VAL . 79.3 tttt -133.7 135.9 44.34 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 7' ' ' THR . 1.2 tt -137.59 123.99 20.73 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.895 0.478 . . . . 0.0 110.013 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.15 167.75 15.21 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.48 111.81 11.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.436 ' HE1' ' HA ' ' A' ' 55' ' ' VAL . 2.2 t-105 -103.91 125.03 50.02 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.9 m -79.97 109.54 14.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.535 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 28.8 ptt-85 -67.71 -11.29 58.01 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.436 1.094 . . . . 0.0 113.618 -167.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -65.91 -17.83 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.937 0.495 . . . . 0.0 111.31 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -147.88 76.84 1.4 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.959 1.362 . . . . 0.0 109.161 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 10' ' ' TYR . 7.3 p -113.74 152.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.031 174.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.21 112.22 46.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.808 0.843 . . . . 0.0 109.852 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.9 142.0 61.19 Favored 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.157 1.092 . . . . 0.0 112.413 1.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -49.31 111.02 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.036 0.935 . . . . 0.0 111.78 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.98 107.16 4.17 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.12 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.535 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.3 p -113.53 85.6 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.455 0.645 . . . . 0.0 109.508 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.95 129.06 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.996 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -144.39 157.04 44.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.336 1.055 . . . . 0.0 109.007 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 -43.06 0.57 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.05 150.1 22.3 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.47 120.97 4.82 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.28 89.78 0.22 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.77 0.335 . . . . 0.0 112.601 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' CG ' ' HB ' ' B' ' 8' ' ' ILE . 2.9 pt-20 -102.5 164.39 11.69 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.451 0.643 . . . . 0.0 109.926 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.85 101.66 7.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.81 108.92 19.77 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.135 0.493 . . . . 0.0 111.167 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.38 116.21 24.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.277 1.431 . . . . 0.0 109.106 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -95.86 127.17 41.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.369 0.604 . . . . 0.0 112.075 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.29 161.92 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.787 1.235 . . . . 0.0 110.391 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.5 pt-20 -63.95 -38.74 92.21 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -163.85 -179.62 6.43 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 118.405 0.548 . . . . 0.0 112.013 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.4 -32.27 70.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.268 . . . . 0.0 112.595 -166.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.24 -48.17 82.7 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.027 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.443 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.5 mm-40 -65.26 -20.58 66.49 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.632 1.173 . . . . 0.0 112.993 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.6 -43.25 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.375 0.607 . . . . 0.0 109.924 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.66 -31.4 63.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.753 1.221 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 43.4 mt-10 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.122 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -69.62 -32.24 70.83 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.872 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -56.14 -57.33 12.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.912 0.885 . . . . 0.0 109.407 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.22 90.84 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.721 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.43 93.92 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 123.849 0.718 . . . . 0.0 114.097 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.87 -44.1 97.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.34 0.656 . . . . 0.0 109.869 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.09 -46.47 79.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.674 0.79 . . . . 0.0 110.42 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.9 -27.32 66.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.842 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.7 t -93.14 -10.61 35.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.801 0.84 . . . . 0.0 112.575 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 58.39 0.95 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 169.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.3 143.61 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.23 65.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.567 0.747 . . . . 0.0 111.48 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 53.3 ttm 65.03 83.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 165.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 83.69 2.0 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.499 0.666 . . . . 0.0 111.068 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 177.81 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.707 1.603 . . . . 0.0 108.652 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -80.15 118.5 72.72 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -49.85 102.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.926 3.084 . . . . 0.0 112.873 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.99 141.0 41.72 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.941 0.896 . . . . 0.0 110.262 -175.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 100.27 4.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.7 ttm -96.96 162.1 13.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.427 0.691 . . . . 0.0 109.331 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.17 -28.63 68.09 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.001 0.92 . . . . 0.0 112.45 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.7 -24.74 49.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.479 0.712 . . . . 0.0 110.523 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.16 175.93 21.99 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -74.05 101.01 3.75 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -111.67 147.56 35.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.409 0.623 . . . . 0.0 111.459 -165.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.502 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 5.8 t80 -144.21 144.03 31.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.692 1.197 . . . . 0.0 109.426 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.401 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 12.8 m -133.07 128.11 35.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.06 174.09 6.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.893 0.877 . . . . 0.0 110.033 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.03 122.59 17.36 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.505 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.1 p-10 -71.63 176.23 2.35 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.352 0.661 . . . . 0.0 109.352 172.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 27.8 Cg_endo -59.65 -12.92 19.34 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 122.305 2.004 . . . . 0.0 114.086 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.11 1.08 49.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.165 0.586 . . . . 0.0 111.677 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.3 p 66.3 33.47 7.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.821 1.649 . . . . 0.0 112.816 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -74.33 173.14 10.66 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 114' ' ' ARG . 16.5 mmt-85 -108.6 105.01 14.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -99.95 99.92 10.75 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.465 HH21 HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -98.48 96.62 8.12 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.502 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 27.6 t -86.51 119.24 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -139.46 161.04 38.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.53 112.81 18.96 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -69.31 141.1 54.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.612 0.765 . . . . 0.0 110.834 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 123.509 0.723 . . . . 0.0 110.269 179.177 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 m170 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -90.94 104.1 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.315 2.677 . . . . 0.0 112.996 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.73 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.2 p-10 -98.31 13.49 31.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.617 0.723 . . . . 0.0 109.975 166.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -129.27 128.7 43.76 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.887 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -130.35 138.14 50.26 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.486 ' HB ' ' CG ' ' A' ' 67' ' ' GLU . 31.1 mt -125.36 141.88 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.05 133.96 54.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.419 ' CE1' HG21 ' B' ' 55' ' ' VAL . 69.2 m-85 -76.58 120.75 22.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.925 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' B' ' 51' ' ' SER . 34.1 m -117.68 160.85 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -98.12 -54.85 2.95 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.36 0.264 . . . . 0.0 110.427 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -93.76 103.55 10.47 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.862 0.865 . . . . 0.0 109.345 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -55.86 -58.53 1.04 Allowed 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.253 2.635 . . . . 0.0 114.621 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 52.6 Cg_exo -56.34 -57.57 1.39 Allowed 'Trans proline' 0 C--N 1.404 3.478 0 CA-C-N 122.751 2.018 . . . . 0.0 112.09 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.92 90.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.794 -168.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.0 m -78.03 -24.99 47.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.357 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 41.8 m -73.08 -42.87 62.54 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 77.3 mm-40 -68.96 -29.52 67.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.571 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.66 -50.62 71.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.905 0.753 . . . . 0.0 109.59 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -67.97 -32.2 72.46 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.772 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.548 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 58.6 mtpt -57.09 -48.19 79.19 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.289 0.566 . . . . 0.0 112.466 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 -35.3 57.3 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.907 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.45 -36.71 78.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.353 1.061 . . . . 0.0 112.928 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.539 ' HB2' HG22 ' B' ' 27' ' ' VAL . 24.0 mt -99.01 -31.03 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.13 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 31.74 21.33 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.553 HG11 HD22 ' B' ' 41' ' ' LEU . 32.8 m -124.71 174.26 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.076 0.95 . . . . 0.0 110.838 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.07 139.1 34.51 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.892 0.877 . . . . 0.0 109.14 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.548 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 51.0 Cg_exo -60.84 131.88 39.65 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.291 2.661 . . . . 0.0 114.417 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.446 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.6 p -71.34 -36.88 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.794 0.838 . . . . 0.0 110.157 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 38.7 mm-40 -121.31 133.0 55.12 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 53.1 m -141.41 126.12 17.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 67.5 m -140.08 157.05 69.95 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.815 1.246 . . . . 0.0 109.091 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.06 -24.88 75.62 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.115 2.543 . . . . 0.0 114.11 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.1 t -127.34 13.65 7.12 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -156.13 154.39 30.82 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.877 -0.515 . . . . 0.0 110.355 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -144.8 157.04 44.32 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.16 0.984 . . . . 0.0 108.46 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tt -153.96 118.4 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -126.63 135.17 50.85 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.97 1.308 . . . . 0.0 109.161 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.581 HG22 ' HG3' ' B' ' 46' ' ' LYS . 18.6 t -114.5 126.43 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 109.047 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.553 HD22 HG11 ' B' ' 27' ' ' VAL . 16.6 mt -90.35 153.01 20.76 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -170.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.0 -13.73 62.2 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.892 0.877 . . . . 0.0 111.531 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -22.42 66.74 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 111.957 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 1.87 42.08 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.76 -0.467 . . . . 0.0 113.123 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.707 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -95.67 169.89 9.71 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.361 0.581 . . . . 0.0 109.826 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.581 ' HG3' HG22 ' B' ' 40' ' ' VAL . 76.3 tttt -133.25 136.56 45.63 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.79 123.91 20.36 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.928 0.491 . . . . 0.0 110.132 -170.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.98 167.85 15.39 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.57 111.53 10.74 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 162.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -103.69 125.41 50.16 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 20.4 m -80.1 109.62 14.73 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.635 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 32.7 ptt-85 -68.6 -10.25 54.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.358 1.063 . . . . 0.0 113.757 -167.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.83 -18.24 65.2 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.488 177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -147.52 77.02 1.42 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.544 1.164 . . . . 0.0 109.098 168.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' B' ' 10' ' ' TYR . 7.4 p -113.46 152.27 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.015 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' PRO . 40.9 mt-10 -114.59 112.42 45.73 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.76 169.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' B' ' 56' ' ' GLU . 82.3 Cg_endo -80.19 142.74 62.85 Favored 'Cis proline' 0 C--N 1.386 2.546 0 CA-C-N 119.589 0.889 . . . . 0.0 112.508 1.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -50.42 111.4 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.923 0.889 . . . . 0.0 111.564 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.12 107.42 4.21 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.143 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.635 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 30.5 p -114.33 85.45 2.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.681 0.753 . . . . 0.0 109.474 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.81 130.11 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.089 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -145.67 156.02 43.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.719 1.208 . . . . 0.0 108.814 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.86 -43.47 0.55 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 149.59 21.73 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.19 121.05 4.81 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 76.55 89.81 0.27 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.51 163.4 12.25 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.98 0.912 . . . . 0.0 109.178 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 tp -120.87 101.35 7.64 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 109.63 20.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.359 0.527 . . . . 0.0 111.343 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -87.01 116.35 25.0 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 108.918 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -95.98 126.19 41.05 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.217 0.532 . . . . 0.0 111.499 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.25 162.58 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.533 1.133 . . . . 0.0 110.48 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.4 pt-20 -64.21 -38.81 92.37 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -163.6 179.81 6.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.329 0.513 . . . . 0.0 112.149 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.88 -32.1 69.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.115 1.366 . . . . 0.0 112.804 -167.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -47.51 85.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.279 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 84.5 mm-40 -66.48 -19.59 65.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.212 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.49 -44.38 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.39 0.614 . . . . 0.0 109.597 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.82 -33.43 70.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.113 1.365 . . . . 0.0 111.367 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -65.23 -46.88 78.83 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.73 0.776 . . . . 0.0 109.91 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -68.93 -32.28 71.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.924 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.27 -57.55 11.77 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.576 0.75 . . . . 0.0 109.288 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.04 91.29 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.649 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.26 -44.23 94.04 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 123.726 0.641 . . . . 0.0 113.809 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' TRP . . . . . 0.412 ' HB3' HG11 ' B' ' 90' ' ' VAL . 37.6 m0 -62.89 -44.03 97.19 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.192 0.597 . . . . 0.0 109.902 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -56.89 -45.96 82.22 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 110.324 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.87 -27.14 66.42 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.904 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.1 t -93.6 -10.31 35.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.855 0.862 . . . . 0.0 112.22 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.12 58.84 0.96 Allowed Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 114.09 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' B' ' 92' ' ' MET . 5.1 p -104.4 144.73 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.48 63.92 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.246 0.618 . . . . 0.0 111.387 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.579 ' HB2' HG13 ' B' ' 90' ' ' VAL . 51.8 ttm 65.31 83.81 0.16 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.953 0.783 . . . . 0.0 113.06 165.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.402 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -117.19 84.09 2.09 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.413 0.625 . . . . 0.0 110.851 176.155 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' B' ' 106' ' ' THR . 51.5 tp60 177.22 121.57 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.762 1.625 . . . . 0.0 108.304 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -78.56 119.31 76.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.73 102.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.806 3.004 . . . . 0.0 112.556 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.09 140.52 42.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.0 0.92 . . . . 0.0 110.244 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.81 100.63 4.81 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.497 ' SD ' ' HD2' ' B' ' 101' ' ' PHE . 56.0 ttm -97.05 162.56 13.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.449 0.7 . . . . 0.0 109.356 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.84 -29.58 68.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.122 0.969 . . . . 0.0 112.018 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.497 ' HD2' ' SD ' ' B' ' 99' ' ' MET . 49.2 m-85 -77.29 -25.38 51.27 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.401 0.681 . . . . 0.0 110.369 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.77 176.5 22.97 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.962 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.39 101.48 4.11 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -112.36 147.47 36.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.185 0.517 . . . . 0.0 111.473 -165.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.521 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 6.2 t80 -144.31 143.97 31.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.67 1.188 . . . . 0.0 109.366 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.503 HG21 ' HG3' ' B' ' 114' ' ' ARG . 32.6 m -133.31 127.85 34.49 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.4 0.619 . . . . 0.0 110.276 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.72 174.1 6.03 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.992 0.917 . . . . 0.0 110.206 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.2 121.41 15.85 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.602 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 1.2 p30 -69.54 175.99 1.92 Allowed Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 123.67 0.788 . . . . 0.0 110.171 171.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 31.5 Cg_endo -60.48 -12.2 19.8 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.381 2.054 . . . . 0.0 113.901 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -97.57 0.47 47.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.2 0.6 . . . . 0.0 111.417 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 27.6 t 66.96 33.46 5.8 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.272 1.429 . . . . 0.0 112.245 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -75.18 173.36 10.91 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.503 ' HG3' HG21 ' B' ' 106' ' ' THR . 5.4 mpt_? -107.98 104.9 14.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.0 100.54 11.45 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 -97.91 95.47 7.52 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -166.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.521 ' HB ' ' HD2' ' B' ' 105' ' ' PHE . 36.0 t -86.29 119.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -139.22 160.86 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.56 112.58 18.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.45 138.4 55.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.087 0.555 . . . . 0.0 109.96 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.64 97.89 0.84 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.881 0.472 . . . . 0.0 109.999 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.063 -178.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.547 ' HG3' HD22 ' B' ' 25' ' ' LEU . 87.7 Cg_endo -85.76 86.17 1.03 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.696 2.264 . . . . 0.0 111.493 168.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.631 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 14.3 t70 -102.58 11.44 37.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.142 0.972 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.405 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -133.01 131.56 40.84 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -169.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.21 144.18 51.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.853 0.861 . . . . 0.0 109.167 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.455 HD12 ' NH1' ' B' ' 116' ' ' ARG . 1.8 mt -126.77 138.93 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.635 0.774 . . . . 0.0 109.51 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 68' ' ' LEU . 96.1 mt -95.24 137.44 34.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -77.05 98.88 5.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.076 177.445 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.492 HG11 HD23 ' A' ' 49' ' ' LEU . 20.1 m -109.74 169.78 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.23 -60.5 1.87 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.088 0.555 . . . . 0.0 110.003 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -102.32 98.39 10.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.941 0.896 . . . . 0.0 110.4 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.4 Cg_exo -49.12 -49.9 14.18 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.683 2.922 . . . . 0.0 115.984 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.77 -58.96 0.39 Allowed 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.217 1.828 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.86 89.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -59.51 -52.31 66.11 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 122.215 1.007 . . . . 0.0 109.507 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 59.1 m -80.49 -33.68 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -163.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 83.6 mm-40 -65.39 -37.46 87.06 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.888 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.97 -44.29 97.54 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -71.46 -28.27 63.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.214 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.6 mtpt -56.49 -51.05 69.96 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.315 0.507 . . . . 0.0 111.875 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.41 -38.09 56.15 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.311 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 115' ' ' LEU . 11.6 tp -59.79 -36.63 77.13 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.175 0.99 . . . . 0.0 112.34 -175.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD22 ' HG3' ' B' ' 4' ' ' PRO . 46.4 mt -96.9 -40.96 8.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.113 0.965 . . . . 0.0 109.357 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.83 30.85 8.11 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.605 0.566 . . . . 0.0 112.071 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.7 m -129.75 -178.39 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.427 1.091 . . . . 0.0 109.902 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.7 154.32 72.99 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.253 0.621 . . . . 0.0 109.753 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 11.4 Cg_exo -70.57 117.39 5.11 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.941 2.427 . . . . 0.0 111.954 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 39' ' ' PHE . 5.8 p -65.42 -40.52 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 47.3 mm-40 -113.41 128.76 56.56 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.755 0.822 . . . . 0.0 109.482 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -127.73 131.9 49.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.862 0.865 . . . . 0.0 109.267 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 t -137.22 147.72 59.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.25 -15.32 34.03 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.921 2.414 . . . . 0.0 114.226 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.49 7.74 5.84 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -157.97 153.37 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.612 0.365 . . . . 0.0 110.122 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 24.4 m -138.06 148.23 44.85 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.191 0.596 . . . . 0.0 109.612 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -146.16 129.2 16.51 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' HA ' HG12 ' A' ' 30' ' ' VAL . 2.6 p90 -134.49 148.18 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.176 0.99 . . . . 0.0 108.981 163.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' A' ' 46' ' ' LYS . 17.5 t -119.4 127.95 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.458 HD12 ' SD ' ' A' ' 45' ' ' MET . 37.7 mt -89.87 142.4 27.73 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -169.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.3 -14.3 62.89 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.069 0.948 . . . . 0.0 112.219 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.78 -9.87 58.94 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 110.912 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.2 32.91 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.483 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.66 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -97.01 172.29 7.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.009 0.904 . . . . 0.0 110.095 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG22 ' A' ' 40' ' ' VAL . 86.5 tttt -135.03 141.82 46.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.05 0.54 . . . . 0.0 109.679 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.88 123.41 15.0 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.829 0.452 . . . . 0.0 110.452 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -107.77 167.86 13.68 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.537 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.492 HD23 HG11 ' A' ' 11' ' ' VAL . 6.3 mp -134.04 107.96 8.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 166.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.554 ' HE3' ' NH2' ' B' ' 116' ' ' ARG . 6.0 t90 -105.19 130.52 53.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.405 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 37.4 m -80.01 121.57 25.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.041 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -65.73 -14.09 60.61 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.986 1.314 . . . . 0.0 113.492 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -76.24 -8.2 56.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.573 0.349 . . . . 0.0 111.101 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.426 HG23 ' HE1' ' A' ' 50' ' ' TRP . 12.1 t -136.9 6.39 2.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.117 0.567 . . . . 0.0 111.344 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.8 147.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.716 0.406 . . . . 0.0 110.885 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -128.25 111.25 19.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.754 0.822 . . . . 0.0 108.875 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.7 140.49 66.8 Favored 'Cis proline' 0 C--N 1.389 2.666 0 C-N-CA 124.76 -0.933 . . . . 0.0 113.736 4.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -50.56 116.53 1.96 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.757 1.223 . . . . 0.0 113.04 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.52 107.1 3.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.799 1.24 . . . . 0.0 108.194 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -97.85 87.29 3.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.89 142.4 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 108.828 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.443 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 8.1 p -151.53 132.41 14.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.197 1.399 . . . . 0.0 108.267 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.19 -65.2 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 N-CA-C 112.054 -0.419 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.49 64.26 0.1 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.04 131.7 8.07 Favored Glycine 0 N--CA 1.464 0.566 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 73.43 129.43 0.14 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 15.9 mt-10 -120.97 147.95 44.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.05 0.54 . . . . 0.0 109.599 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.466 HD22 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -120.47 106.37 11.75 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.0 122.85 34.9 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.482 0.658 . . . . 0.0 111.338 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.401 ' HB2' HG22 ' A' ' 117' ' ' VAL . 16.3 m-85 -102.56 108.35 19.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 107.529 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 29.2 mtm180 -91.29 123.49 34.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 112.201 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 118' ' ' TYR . 34.8 m -126.19 158.9 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.747 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.8 pt-20 -69.36 -34.17 74.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.066 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.492 HD22 ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -161.72 177.45 9.92 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 118.697 0.68 . . . . 0.0 112.55 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.06 -33.21 70.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.732 1.613 . . . . 0.0 112.84 -167.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.95 77.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.74 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.574 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 21.8 mm-40 -66.18 -24.42 66.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.791 0.836 . . . . 0.0 112.032 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.19 -43.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.541 0.686 . . . . 0.0 109.647 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.39 -33.66 74.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.241 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -65.58 -45.26 83.93 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.293 0.568 . . . . 0.0 109.941 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.6 m -68.87 -28.46 66.73 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.013 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.9 -61.26 2.74 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.6 0.714 . . . . 0.0 109.948 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.78 -34.23 77.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.494 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.23 -46.75 93.3 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 124.206 0.941 . . . . 0.0 113.36 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -63.71 -45.88 87.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.211 0.604 . . . . 0.0 110.197 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -57.01 -42.61 80.63 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.798 0.686 . . . . 0.0 110.836 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.09 -27.62 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.06 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -90.88 8.93 32.51 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.306 1.042 . . . . 0.0 112.643 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 46.47 4.61 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.147 169.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 p -101.6 148.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.1 79.07 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.931 0.492 . . . . 0.0 111.418 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.5 tpp 64.19 82.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.74 0.816 . . . . 0.0 112.891 166.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -134.11 84.92 2.15 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.086 0.47 . . . . 0.0 111.523 176.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 178.36 138.31 0.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.577 1.151 . . . . 0.0 109.565 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.85 119.97 68.83 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -54.12 111.41 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.938 2.425 . . . . 0.0 110.627 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.96 147.16 49.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.19 0.596 . . . . 0.0 111.231 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.02 104.8 4.23 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.608 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.418 ' SD ' ' CZ2' ' B' ' 50' ' ' TRP . 51.0 ttm -102.25 171.15 7.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.451 0.7 . . . . 0.0 109.939 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 99' ' ' MET . 19.1 mm-40 -49.63 -34.06 17.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.345 1.458 . . . . 0.0 113.092 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -101.68 -5.71 24.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.785 0.834 . . . . 0.0 111.469 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.16 -178.81 20.54 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 51.3 t80 -80.5 102.58 9.8 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.7 t -122.52 157.71 31.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.592 0.711 . . . . 0.0 111.466 -166.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.56 153.24 33.01 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.292 1.437 . . . . 0.0 108.249 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.481 HG21 ' HG3' ' A' ' 114' ' ' ARG . 23.5 m -146.81 127.68 14.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.149 0.431 . . . . 0.0 110.673 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.09 170.97 7.63 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.127 0.571 . . . . 0.0 110.724 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.4 117.42 23.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.773 0.429 . . . . 0.0 109.965 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.25 168.86 17.89 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.902 1.281 . . . . 0.0 110.856 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.31 -35.72 54.65 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.195 2.597 . . . . 0.0 114.499 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -87.48 1.18 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.307 0.643 . . . . 0.0 111.467 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 63.24 57.82 1.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.807 1.243 . . . . 0.0 112.36 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -93.19 -145.93 0.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 172.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG3' HG21 ' A' ' 106' ' ' THR . 0.1 OUTLIER -145.5 90.63 2.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.482 HD13 HD21 ' A' ' 24' ' ' LEU . 69.1 mt -96.07 104.82 16.78 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -171.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.743 HH12 HG23 ' B' ' 55' ' ' VAL . 1.8 mtp180 -101.98 146.52 27.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.374 0.27 . . . . 0.0 110.913 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 70' ' ' PHE . 15.3 t -127.69 127.57 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 166.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 72' ' ' VAL . 19.1 p90 -130.46 155.5 46.34 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.16 0.436 . . . . 0.0 111.275 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -109.37 121.15 44.54 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.97 108.62 10.16 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.34 0.4 . . . . 0.0 110.488 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 123.236 0.614 . . . . 0.0 109.64 176.059 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 15.0 p80 . . . . . 0 CA--C 1.556 1.177 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.553 ' HG3' HD22 ' A' ' 25' ' ' LEU . 86.5 Cg_endo -86.06 86.18 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.49 2.127 . . . . 0.0 111.522 168.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.66 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 9.0 p-10 -102.9 10.78 38.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.538 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.454 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -132.17 131.84 42.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -169.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -128.06 143.71 51.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.009 0.924 . . . . 0.0 108.968 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 35.8 mt -125.28 139.36 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.526 HD23 HD21 ' B' ' 47' ' ' LEU . 4.0 mm? -95.32 137.38 34.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.431 ' HE2' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -76.03 97.62 4.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.212 1.405 . . . . 0.0 109.593 177.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.423 HG11 HD23 ' B' ' 49' ' ' LEU . 22.7 m -109.48 170.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.21 -60.26 1.91 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.984 0.514 . . . . 0.0 110.335 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -102.23 97.72 9.09 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.147 0.979 . . . . 0.0 110.49 -169.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.45 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.1 Cg_exo -48.88 -51.65 10.12 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.79 2.993 . . . . 0.0 115.675 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.21 -60.16 0.42 Allowed 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.099 1.786 . . . . 0.0 111.536 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.61 88.97 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.945 0.498 . . . . 0.0 112.163 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' B' ' 20' ' ' PHE . 34.1 m -59.1 -52.07 67.31 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.352 1.072 . . . . 0.0 109.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 70.7 m -80.46 -33.75 36.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -163.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.52 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 82.8 mm-40 -65.33 -38.39 90.01 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.715 172.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' B' ' 90' ' ' VAL . 41.9 t80 -59.82 -45.82 91.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.33 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 36.1 m-85 -69.89 -29.42 66.62 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.805 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 52.3 mtpt -56.11 -51.21 68.72 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.182 0.515 . . . . 0.0 111.672 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.75 -38.42 54.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.439 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 8.5 tp -58.94 -36.64 75.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.424 1.09 . . . . 0.0 112.476 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 4' ' ' PRO . 53.5 mt -96.93 -41.18 8.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.347 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.14 30.41 8.29 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.2 m -129.63 -177.98 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.411 1.084 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -139.05 155.04 72.94 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 123.338 0.655 . . . . 0.0 109.622 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 3.0 Cg_exo -71.84 117.05 4.95 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.867 2.378 . . . . 0.0 111.458 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -65.36 -39.87 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 51.6 mm-40 -114.08 128.26 56.3 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.506 0.722 . . . . 0.0 109.436 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 48.2 t -127.03 132.37 50.75 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.064 0.945 . . . . 0.0 109.245 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.0 t -137.52 148.01 59.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.805 1.242 . . . . 0.0 107.745 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.44 -15.14 39.05 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.693 2.262 . . . . 0.0 113.952 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.45 7.96 5.89 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -157.83 153.68 26.8 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 122.078 -0.389 . . . . 0.0 110.2 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 18.1 m -138.28 147.91 44.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.22 0.608 . . . . 0.0 109.541 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.3 tm? -145.98 129.66 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 3.7 p90 -134.84 148.64 50.2 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 108.721 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -120.52 127.8 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.401 HD22 HG11 ' B' ' 27' ' ' VAL . 36.8 mt -89.02 142.32 27.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.243 0.617 . . . . 0.0 109.405 -168.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.21 62.8 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.58 -10.21 59.41 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.761 0.825 . . . . 0.0 110.61 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.27 -4.35 33.34 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.215 -0.77 . . . . 0.0 114.175 170.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.631 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -96.25 172.61 7.85 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.047 0.923 . . . . 0.0 110.297 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -135.78 141.93 44.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.796 0.438 . . . . 0.0 109.951 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.526 HD21 HD23 ' B' ' 9' ' ' LEU . 3.6 tt -141.73 123.03 14.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.01 0.433 . . . . 0.0 110.589 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.437 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -106.7 167.23 13.88 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 123.927 0.775 . . . . 0.0 111.372 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 9.2 mp -134.0 108.32 8.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 166.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.493 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -105.83 130.62 53.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.45 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 42.3 m -81.06 121.27 25.86 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.597 0.561 . . . . 0.0 110.933 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -64.97 -14.83 61.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.105 1.362 . . . . 0.0 113.809 -170.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -75.94 -7.49 54.71 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.819 0.448 . . . . 0.0 111.721 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.9 t -137.14 7.17 2.88 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.378 0.671 . . . . 0.0 111.198 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.743 HG23 HH12 ' A' ' 116' ' ' ARG . 9.8 p -62.82 148.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 122.265 0.226 . . . . 0.0 110.48 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.45 ' H ' HH22 ' A' ' 116' ' ' ARG . 17.9 mt-10 -127.73 110.99 20.57 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.585 0.754 . . . . 0.0 109.357 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.478 ' HG3' HD23 ' A' ' 93' ' ' LEU . 85.8 Cg_endo -75.39 139.77 63.16 Favored 'Cis proline' 0 C--N 1.388 2.612 0 CA-C-N 119.85 0.982 . . . . 0.0 113.805 4.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -49.58 116.32 1.71 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.735 1.214 . . . . 0.0 113.179 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.29 107.2 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.691 1.196 . . . . 0.0 108.471 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -97.81 87.48 4.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.22 141.99 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.427 1.091 . . . . 0.0 108.98 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 11.1 p -151.22 133.11 15.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.709 1.203 . . . . 0.0 108.186 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.73 -66.08 0.05 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.0 62.89 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.16 130.57 7.83 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 119.442 -0.644 . . . . 0.0 111.674 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 74.06 130.02 0.18 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 27.0 mt-10 -121.93 147.2 46.33 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -120.46 106.45 11.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.718 ' HA ' ' HG2' ' B' ' 116' ' ' ARG . . . -91.3 122.25 33.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.95 108.31 19.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.588 1.555 . . . . 0.0 107.523 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 56.9 mtm180 -91.97 122.75 34.78 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.419 0.628 . . . . 0.0 111.968 -174.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.42 HG22 ' O ' ' B' ' 118' ' ' TYR . 22.7 m -125.11 159.27 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.708 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' B' ' 74' ' ' ASN . 9.5 pt-20 -69.39 -34.66 74.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.423 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.463 HD22 ' HG3' ' B' ' 73' ' ' GLU . 6.0 p30 -161.18 176.67 11.02 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.714 0.688 . . . . 0.0 112.412 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -59.11 -32.34 69.74 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.704 1.602 . . . . 0.0 113.063 -168.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.97 -39.34 76.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.641 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -65.75 -24.37 66.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.589 0.756 . . . . 0.0 112.45 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.615 HG13 HG13 ' B' ' 117' ' ' VAL . 97.2 t -68.34 -42.96 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.503 0.721 . . . . 0.0 109.829 172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.15 -33.05 71.3 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.788 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 29.5 mt-10 -65.77 -45.9 80.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.419 0.628 . . . . 0.0 109.987 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 92.7 m -67.3 -29.81 69.5 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.996 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -59.89 -61.21 2.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.67 0.788 . . . . 0.0 110.093 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.91 76.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.42 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.33 90.18 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.122 0.888 . . . . 0.0 113.088 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' TRP . . . . . 0.478 ' HB3' HG21 ' B' ' 90' ' ' VAL . 44.9 m0 -62.55 -46.86 86.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.347 0.659 . . . . 0.0 110.038 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.89 -42.81 76.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.367 0.667 . . . . 0.0 111.065 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.73 -27.7 63.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.873 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -91.04 9.26 31.55 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 112.233 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.98 46.88 4.64 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.09 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.485 HG11 ' HB1' ' B' ' 107' ' ' ALA . 48.7 t -101.97 147.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.06 77.48 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.048 0.539 . . . . 0.0 111.449 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.34 82.53 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.705 0.802 . . . . 0.0 112.799 166.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 85.17 2.18 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 178.07 138.17 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.401 1.081 . . . . 0.0 109.301 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -90.21 119.88 69.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.18 111.51 0.73 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.719 2.279 . . . . 0.0 110.699 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.83 146.77 49.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.338 0.655 . . . . 0.0 111.279 -170.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 104.87 4.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.838 0.855 . . . . 0.0 109.812 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 51.9 ttm -101.93 170.14 8.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.07 0.948 . . . . 0.0 109.66 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -48.74 -34.47 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.257 1.423 . . . . 0.0 113.216 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -101.96 -5.4 24.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.773 0.829 . . . . 0.0 111.67 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.6 -178.6 20.93 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.311 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 52.1 t80 -80.99 102.59 10.26 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -122.61 158.05 30.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.664 0.745 . . . . 0.0 111.505 -167.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -153.2 152.73 31.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.365 1.466 . . . . 0.0 108.075 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.635 HG21 ' HG3' ' B' ' 114' ' ' ARG . 29.0 m -145.82 127.74 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.685 0.394 . . . . 0.0 110.21 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.485 ' HB1' HG11 ' B' ' 90' ' ' VAL . . . -107.56 171.22 7.51 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.06 0.544 . . . . 0.0 110.78 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.77 116.92 22.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.412 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.3 p30 -70.95 169.41 14.87 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.691 1.197 . . . . 0.0 111.242 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 10.9 Cg_endo -52.16 -35.63 63.52 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.431 2.754 . . . . 0.0 113.901 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.42 1.26 53.92 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.253 0.621 . . . . 0.0 111.461 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 62.69 57.99 1.69 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.63 1.172 . . . . 0.0 112.624 166.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -92.68 -146.23 0.22 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.635 ' HG3' HG21 ' B' ' 106' ' ' THR . 0.1 OUTLIER -144.72 89.63 2.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 85.8 mt -95.49 104.23 16.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -171.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.718 ' HG2' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -99.74 147.77 25.09 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.827 0.285 . . . . 0.0 111.696 -176.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.615 HG13 HG13 ' B' ' 78' ' ' VAL . 7.5 p -128.97 128.47 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 164.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.42 ' O ' HG22 ' B' ' 72' ' ' VAL . 14.3 p90 -130.13 155.56 45.99 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 122.199 -0.313 . . . . 0.0 111.062 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -109.62 120.92 43.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -76.27 107.0 8.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.364 0.415 . . . . 0.0 110.05 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.31 104.0 10.56 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.854 -0.97 . . . . 0.0 110.919 -177.454 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.0 m80 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 119.624 -0.227 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD3' HD22 ' B' ' 25' ' ' LEU . 69.4 Cg_endo -87.73 87.49 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.697 2.264 . . . . 0.0 111.364 170.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.809 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.7 p-10 -83.61 1.53 41.82 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.419 0.628 . . . . 0.0 110.815 172.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.06 120.5 31.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -172.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -111.96 137.66 49.66 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 46.3 mt -113.19 128.1 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 47' ' ' LEU . 4.2 mm? -93.93 145.13 24.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.636 ' HE1' HG21 ' A' ' 55' ' ' VAL . 38.4 t80 -102.57 105.14 15.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.192 -170.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.79 157.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.534 0.734 . . . . 0.0 109.199 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.408 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 12.6 p-10 -104.76 -43.01 5.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.528 0.731 . . . . 0.0 110.84 -177.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -94.53 105.62 19.28 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.256 0.623 . . . . 0.0 109.909 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.27 -59.46 0.89 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 C-N-CA 122.153 1.902 . . . . 0.0 113.461 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 40.6 Cg_endo -64.38 -56.5 0.43 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 122.433 1.905 . . . . 0.0 111.494 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.22 83.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.735 0.814 . . . . 0.0 112.206 -168.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -72.53 -39.69 67.35 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -65.69 -39.49 91.34 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.53 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 77.8 mm-40 -67.6 -34.53 77.19 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.372 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -64.69 -46.13 83.68 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.524 0.515 . . . . 0.0 109.911 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -65.62 -32.07 73.44 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.07 -51.07 69.16 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.284 0.564 . . . . 0.0 112.322 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.12 -39.91 65.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.152 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 tp -58.2 -47.02 84.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.145 1.378 . . . . 0.0 113.183 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.5 mt -86.44 -43.73 12.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.06 26.05 8.07 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 -174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.1 m -127.73 167.4 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.06 0.944 . . . . 0.0 110.243 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.01 151.28 46.36 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.783 0.833 . . . . 0.0 109.34 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 14.8 Cg_exo -67.88 117.05 4.62 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.545 2.163 . . . . 0.0 111.814 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG11 HG23 ' A' ' 40' ' ' VAL . 7.5 p -63.22 -38.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.751 . . . . 0.0 109.962 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 30.5 mm-40 -123.47 129.86 51.86 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.01 1.324 . . . . 0.0 107.775 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.6 p -136.26 135.36 38.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.308 0.575 . . . . 0.0 109.896 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.3 m -141.65 153.58 65.23 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.922 1.289 . . . . 0.0 108.512 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -56.92 -22.48 46.33 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.066 2.511 . . . . 0.0 113.726 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 t -128.12 10.49 6.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -158.83 137.46 10.98 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -123.71 153.96 40.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.389 0.676 . . . . 0.0 109.727 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.654 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 21.3 tp -147.43 125.66 12.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -132.79 142.25 48.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 108.367 168.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -119.38 131.48 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.0 mt -94.41 149.85 20.84 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -10.45 29.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.19 0.996 . . . . 0.0 112.029 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -65.12 -20.44 66.46 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.852 1.261 . . . . 0.0 112.237 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 -7.27 47.18 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.828 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -90.35 173.12 8.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.56 0.744 . . . . 0.0 110.38 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.8 tttt -141.8 139.53 32.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 9' ' ' LEU . 2.2 tt -138.09 120.13 15.54 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.494 0.318 . . . . 0.0 110.6 -169.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.19 165.73 17.26 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.625 0.631 . . . . 0.0 111.693 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.89 111.92 10.86 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -104.74 125.17 50.55 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.7 m -77.71 128.78 34.61 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.641 0.588 . . . . 0.0 109.874 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 13.6 ptm180 -66.88 -10.66 50.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -82.56 -12.64 57.59 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 118.047 0.385 . . . . 0.0 111.137 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 0.6 8.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.122 0.569 . . . . 0.0 111.123 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' HE1' ' A' ' 10' ' ' TYR . 10.7 p -61.13 140.13 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.189 0.519 . . . . 0.0 112.279 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.73 116.38 26.41 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.522 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 6.8 Cg_exo -72.38 144.04 79.24 Favored 'Cis proline' 0 C--N 1.383 2.384 0 C-N-CA 124.683 -0.966 . . . . 0.0 112.794 -3.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' HA ' HG13 ' A' ' 55' ' ' VAL . 13.7 mmmm -50.2 130.16 22.32 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.764 0.825 . . . . 0.0 111.833 173.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.99 136.33 23.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.751 0.821 . . . . 0.0 109.958 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 p -108.5 88.35 2.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.521 0.729 . . . . 0.0 109.485 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -161.37 144.04 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.773 0.829 . . . . 0.0 110.22 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 p -141.47 138.62 32.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.381 1.072 . . . . 0.0 108.356 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.71 20.07 79.65 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 22.23 30.42 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.79 -162.07 23.79 Favored Glycine 0 N--CA 1.473 1.154 0 CA-C-N 117.083 0.442 . . . . 0.0 112.308 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.58 95.9 0.05 OUTLIER Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HB3' ' HG3' ' A' ' 116' ' ' ARG . 1.9 mp0 -103.7 158.53 16.32 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 112.049 -170.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 68' ' ' LEU . 25.8 mt -118.89 102.4 8.76 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.498 173.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.95 106.31 17.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HB2' HG22 ' A' ' 117' ' ' VAL . 7.8 m-85 -83.95 112.21 19.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -90.18 127.43 36.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.421 0.629 . . . . 0.0 112.243 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.65 158.29 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.23 -38.05 89.65 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -160.43 177.37 10.64 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.512 0.596 . . . . 0.0 112.155 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.25 -28.62 69.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.944 1.298 . . . . 0.0 112.771 -165.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.78 -46.95 76.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.978 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -64.86 -22.43 66.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 0.0 112.651 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.26 -42.41 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.313 0.645 . . . . 0.0 109.668 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.03 -27.59 54.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.681 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 40.6 mt-10 -69.26 -43.85 73.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.668 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -65.74 -36.14 82.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.28 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' O ' ' HE1' ' A' ' 92' ' ' MET . 35.6 t80 -59.33 -57.18 14.15 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.794 0.807 . . . . 0.0 109.356 176.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.87 83.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.209 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.69 90.76 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.64 0.587 . . . . 0.0 114.361 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -67.44 -41.85 84.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.062 0.545 . . . . 0.0 110.155 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -58.8 -40.14 83.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.983 0.913 . . . . 0.0 110.297 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.77 66.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.461 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m -104.96 15.14 28.26 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.889 0.876 . . . . 0.0 113.205 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.45 30.32 19.36 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 163.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.09 127.45 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.251 0.62 . . . . 0.0 109.543 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 92' ' ' MET . . . -57.14 -51.0 71.07 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.684 0.794 . . . . 0.0 111.393 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.476 ' HE1' ' O ' ' A' ' 82' ' ' PHE . 6.7 ptm 52.15 80.95 0.09 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.291 1.436 . . . . 0.0 113.381 169.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.78 82.45 2.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -174.86 138.18 0.46 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.346 1.058 . . . . 0.0 109.066 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -80.49 122.4 82.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.54 112.35 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.575 2.183 . . . . 0.0 110.209 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.39 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.454 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HG2' ' HD1' ' A' ' 103' ' ' TYR . 19.3 mmtm -71.06 118.02 13.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.397 1.079 . . . . 0.0 111.506 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.5 tpp -110.09 176.62 4.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.507 1.523 . . . . 0.0 108.996 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -48.21 -41.01 26.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.75 1.22 . . . . 0.0 113.133 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -106.88 19.83 19.91 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.566 0.746 . . . . 0.0 111.603 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -167.83 12.42 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.986 0.354 . . . . 0.0 113.986 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.41 ' HD1' ' HG2' ' A' ' 98' ' ' LYS . 13.0 t80 -78.53 110.01 13.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.437 0.695 . . . . 0.0 109.707 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -138.77 168.69 19.25 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -168.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.42 169.35 24.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.028 0.931 . . . . 0.0 109.311 169.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.613 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 13.6 m -137.47 124.92 22.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.65 158.33 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.378 1.071 . . . . 0.0 110.78 -174.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.02 111.08 17.03 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.4 167.87 28.76 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.605 0.762 . . . . 0.0 110.258 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -43.02 -38.82 7.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.693 2.929 . . . . 0.0 115.652 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -89.14 2.02 54.77 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.833 0.453 . . . . 0.0 111.771 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.2 m 63.43 81.48 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.675 1.19 . . . . 0.0 111.354 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -131.53 165.37 23.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -97.0 106.46 18.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.08 102.71 11.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.232 0.613 . . . . 0.0 109.683 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.726 ' HD2' HD12 ' B' ' 8' ' ' ILE . 72.1 mtt-85 -89.66 148.55 23.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.693 0.397 . . . . 0.0 110.383 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 70' ' ' PHE . 40.5 t -137.38 127.96 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 166.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -130.75 167.58 18.61 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.27 0.941 . . . . 0.0 112.885 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.7 115.8 12.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.586 1.154 . . . . 0.0 108.08 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -79.77 117.39 20.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.672 0 C-N-CA 123.638 0.775 . . . . 0.0 109.417 177.074 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.35 87.57 0.66 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.53 2.153 . . . . 0.0 111.467 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.828 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 10.4 p-10 -83.43 1.67 40.4 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.014 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.42 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 0.9 OUTLIER -125.35 119.34 28.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -171.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -111.25 137.69 48.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.726 HD12 ' HD2' ' A' ' 116' ' ' ARG . 22.1 mt -113.84 127.66 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.14 145.26 24.54 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -102.63 105.84 16.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.622 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.13 157.35 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.696 0.798 . . . . 0.0 109.114 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -105.33 -42.8 5.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.511 0.724 . . . . 0.0 111.028 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.91 106.51 22.32 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.102 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 38.6 Cg_exo -55.03 -59.09 0.89 Allowed 'Trans proline' 0 CA--C 1.572 2.406 0 C-N-CA 122.049 1.833 . . . . 0.0 113.429 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 22.6 Cg_exo -64.78 -56.93 0.34 Allowed 'Trans proline' 0 C--N 1.4 3.259 0 CA-C-N 122.465 1.916 . . . . 0.0 111.316 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -44.8 81.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.598 0.759 . . . . 0.0 112.551 -168.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -70.79 -40.87 72.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 77.7 m -65.61 -39.36 91.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.542 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 79.7 mm-40 -67.85 -34.17 76.18 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.516 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.98 -45.96 83.46 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.206 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -65.77 -31.86 73.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.542 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.7 mtpt -56.03 -50.91 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.312 0.577 . . . . 0.0 112.266 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.24 -39.91 65.1 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.303 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -58.33 -46.83 85.46 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.174 1.39 . . . . 0.0 113.055 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.514 ' HB2' HG22 ' B' ' 27' ' ' VAL . 13.7 mt -87.1 -42.98 12.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.36 25.86 8.56 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.993 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 25' ' ' LEU . 33.4 m -127.26 167.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.934 0.894 . . . . 0.0 110.303 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.15 150.75 45.74 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.794 0.837 . . . . 0.0 109.483 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 42.2 Cg_endo -67.14 117.18 4.61 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.355 2.036 . . . . 0.0 112.218 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.515 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.1 p -63.68 -38.46 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.392 0.677 . . . . 0.0 109.97 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 34.6 mm-40 -122.69 129.94 52.38 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.925 1.29 . . . . 0.0 107.522 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -136.23 136.04 39.56 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.03 0.532 . . . . 0.0 110.066 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 55.6 m -142.49 151.64 58.16 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.921 1.288 . . . . 0.0 108.578 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.91 -23.62 28.38 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.19 2.593 . . . . 0.0 114.733 -176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -128.12 10.82 6.42 Favored 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -158.56 137.91 11.65 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -124.32 153.47 41.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.326 0.65 . . . . 0.0 110.035 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 35.8 tp -146.75 126.22 13.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 0.9 OUTLIER -132.93 142.31 48.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.569 1.148 . . . . 0.0 108.421 168.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.606 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.3 t -119.49 130.93 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.76 149.61 21.09 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -10.43 25.7 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.461 1.104 . . . . 0.0 112.071 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -65.36 -20.42 66.38 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.719 1.208 . . . . 0.0 112.244 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.31 -7.14 46.91 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -90.29 173.23 8.25 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.468 0.707 . . . . 0.0 110.491 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.606 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -141.7 139.62 32.98 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.34 120.15 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.42 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.02 165.53 17.4 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 123.78 0.705 . . . . 0.0 111.549 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.6 mt -134.25 111.66 10.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.549 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.0 t90 -104.71 125.36 50.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -77.86 128.76 34.47 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 123.581 0.551 . . . . 0.0 110.044 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -67.35 -10.65 53.09 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -81.93 -13.46 57.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.042 0.383 . . . . 0.0 111.388 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -124.13 1.77 8.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.182 0.593 . . . . 0.0 111.271 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' B' ' 58' ' ' LYS . 14.1 p -62.29 138.83 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.032 0.444 . . . . 0.0 111.757 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -122.1 116.83 29.77 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -73.6 145.21 83.4 Favored 'Cis proline' 0 C--N 1.384 2.442 0 C-N-CA 124.564 -1.015 . . . . 0.0 111.966 -2.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.555 ' HA ' HG13 ' B' ' 55' ' ' VAL . 12.4 mmmm -51.24 130.73 27.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.668 0.787 . . . . 0.0 111.628 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.17 23.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.925 0.89 . . . . 0.0 109.642 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.2 p -108.59 88.53 2.75 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.634 0.774 . . . . 0.0 109.175 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -161.86 143.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.785 0.834 . . . . 0.0 110.193 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -141.43 138.85 33.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.62 1.168 . . . . 0.0 108.425 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.79 79.76 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.13 21.74 32.84 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 114.419 0.528 . . . . 0.0 114.419 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.63 -160.27 23.72 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 117.053 0.427 . . . . 0.0 112.683 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.99 96.54 0.03 OUTLIER Glycine 0 C--N 1.351 1.41 0 C-N-CA 122.995 0.331 . . . . 0.0 112.557 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.3 mt-10 -103.36 159.84 15.21 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.114 0.483 . . . . 0.0 112.155 -170.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.56 102.24 8.5 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.444 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -86.21 107.3 17.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.011 0.434 . . . . 0.0 110.056 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.524 ' HB2' HG22 ' B' ' 117' ' ' VAL . 7.8 m-85 -85.97 111.93 20.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.417 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 32.3 mtm180 -90.18 126.33 35.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.29 0.567 . . . . 0.0 112.014 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 23.4 m -127.23 158.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.337 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.9 pt-20 -64.32 -37.74 88.58 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -160.76 178.2 9.69 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.777 0.717 . . . . 0.0 112.078 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.43 -28.93 69.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.162 1.385 . . . . 0.0 112.475 -164.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.75 -46.54 78.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.487 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 69.6 mm-40 -65.57 -22.45 66.69 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.264 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -66.35 -42.58 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.397 0.679 . . . . 0.0 109.626 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.87 -27.96 55.22 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.451 1.1 . . . . 0.0 110.401 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 43.5 mt-10 -68.41 -44.69 74.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.076 0.55 . . . . 0.0 109.867 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -65.27 -35.96 82.62 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.413 175.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -59.23 -56.96 15.41 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.75 0.786 . . . . 0.0 109.4 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.14 83.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.33 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.75 90.75 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.44 0.463 . . . . 0.0 113.97 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -67.15 -42.49 84.29 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.061 0.545 . . . . 0.0 109.992 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -58.01 -40.77 81.61 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.944 . . . . 0.0 110.14 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.2 67.24 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.411 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -104.35 15.11 28.92 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.05 0.94 . . . . 0.0 113.421 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.58 19.31 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 163.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.6 127.32 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.253 0.621 . . . . 0.0 109.386 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.7 -53.07 61.94 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.652 0.781 . . . . 0.0 111.268 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 22.9 ttp 54.19 81.04 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.793 1.237 . . . . 0.0 112.868 169.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 83.38 2.18 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -176.43 134.74 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.226 1.01 . . . . 0.0 108.366 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -79.16 123.7 84.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 112.26 2.07 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.527 2.151 . . . . 0.0 109.709 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.16 163.36 33.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.341 0.591 . . . . 0.0 111.59 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -71.22 118.59 14.21 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.299 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 37.0 ttm -112.02 179.42 4.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.561 1.145 . . . . 0.0 108.966 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.19 -41.61 49.8 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.697 1.199 . . . . 0.0 112.019 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -106.54 20.0 19.66 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.559 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.11 -167.68 12.38 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -78.7 110.19 13.62 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.533 0.733 . . . . 0.0 109.777 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' B' ' 116' ' ' ARG . 13.7 t -139.95 169.44 17.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -168.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -157.63 169.14 25.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.107 0.963 . . . . 0.0 109.232 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 20.6 m -136.62 125.19 23.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.57 158.21 16.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.42 1.088 . . . . 0.0 110.882 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.1 111.36 17.34 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.69 167.36 34.09 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.907 0.883 . . . . 0.0 110.402 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -42.16 -39.19 5.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 124.039 3.159 . . . . 0.0 115.346 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -89.38 2.36 54.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m 62.98 80.82 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.681 1.192 . . . . 0.0 111.589 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -130.49 165.66 22.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -95.66 106.13 18.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -108.41 102.62 11.71 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.45 ' HD2' ' OG1' ' B' ' 104' ' ' THR . 0.8 OUTLIER -87.11 147.98 25.42 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.356 0.663 . . . . 0.0 109.922 -178.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' B' ' 70' ' ' PHE . 42.3 t -137.44 128.36 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 164.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -130.71 167.05 19.45 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.368 0.986 . . . . 0.0 113.102 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.1 116.13 13.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.19 122.56 26.99 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.91 99.78 1.83 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 0.0 109.86 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.17 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.111 -175.394 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.455 ' HB3' HD21 ' B' ' 43' ' ' ASN . 23.0 m80 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 119.861 -0.114 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -97.36 96.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.869 2.379 . . . . 0.0 112.48 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.693 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.1 p-10 -93.72 13.6 21.76 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.295 0.569 . . . . 0.0 110.534 169.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.98 115.69 19.62 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.87 146.56 34.89 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.269 1.027 . . . . 0.0 108.691 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.5 HD12 ' HD2' ' B' ' 116' ' ' ARG . 55.9 mt -122.5 137.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.039 0.935 . . . . 0.0 109.037 176.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 68' ' ' LEU . 4.3 mm? -91.42 123.23 34.69 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 168.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.583 ' HE1' HG21 ' A' ' 55' ' ' VAL . 57.6 t80 -78.96 106.83 11.27 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.687 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.416 HG11 HD22 ' A' ' 49' ' ' LEU . 15.6 m -120.71 175.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.248 1.019 . . . . 0.0 109.908 -171.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.55 -61.46 1.49 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.59 0.756 . . . . 0.0 109.811 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.52 110.61 35.58 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 123.787 0.835 . . . . 0.0 110.093 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -58.8 -64.36 0.11 Allowed 'Trans proline' 0 CA--C 1.568 2.178 0 C-N-CA 122.323 2.015 . . . . 0.0 113.614 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.08 -38.75 35.14 Favored 'Trans proline' 0 C--N 1.402 3.343 0 CA-C-N 122.533 1.94 . . . . 0.0 111.204 -170.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.47 93.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.312 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -70.85 -35.34 72.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.3 m -58.41 -53.24 60.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.574 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 24.5 mm-40 -68.56 -37.07 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.258 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.1 t80 -59.46 -44.06 93.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.772 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.511 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 5.4 m-85 -72.99 -28.45 62.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.468 0.707 . . . . 0.0 110.73 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.3 -50.79 70.41 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.936 0.789 . . . . 0.0 112.037 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.23 -34.38 49.3 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.142 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.9 tp -61.42 -53.58 54.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.661 1.184 . . . . 0.0 111.988 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HB2' HG22 ' A' ' 27' ' ' VAL . 11.1 mt -76.62 -51.82 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.68 5.82 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.257 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 25' ' ' LEU . 21.0 m -131.35 176.21 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.359 1.063 . . . . 0.0 110.075 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.27 156.11 46.04 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.77 112.53 3.56 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 121.534 1.489 . . . . 0.0 110.554 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -37.45 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.892 0.477 . . . . 0.0 110.157 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 11.9 mm-40 -111.82 134.47 53.36 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 p -143.35 132.36 22.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 110.709 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -143.42 155.81 60.74 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.285 1.434 . . . . 0.0 108.263 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.3 -10.2 20.37 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.865 2.377 . . . . 0.0 114.123 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 t -126.56 -0.75 6.83 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -157.67 142.43 16.56 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -131.51 146.54 52.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.25 0.62 . . . . 0.0 110.106 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.0 tm? -133.68 120.27 20.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -108.11 140.52 41.18 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.686 1.595 . . . . 0.0 107.051 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 46' ' ' LYS . 26.4 t -124.21 126.8 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD13 ' SD ' ' A' ' 45' ' ' MET . 8.6 mp -99.79 148.72 24.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.169 0.587 . . . . 0.0 109.731 -172.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.96 -5.92 29.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.039 0.936 . . . . 0.0 111.928 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -21.67 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.121 0.968 . . . . 0.0 112.168 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.64 17.56 16.73 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -124.06 175.09 7.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.817 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 40' ' ' VAL . 78.3 tttt -145.91 140.62 27.1 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 68' ' ' LEU . 2.7 tt -138.32 120.66 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.203 0.601 . . . . 0.0 110.287 -169.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.85 166.55 15.76 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.667 0.651 . . . . 0.0 112.055 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 9' ' ' LEU . 95.3 mt -134.87 104.92 6.18 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.524 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.6 t90 -109.62 119.3 38.97 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 p -81.01 140.92 34.88 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.343 0.402 . . . . 0.0 111.159 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 29.3 ptt180 -69.68 -18.65 63.57 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -78.99 -8.58 59.05 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -127.84 7.68 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.874 0.47 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.583 HG21 ' HE1' ' A' ' 10' ' ' TYR . 9.9 p -75.8 150.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.61 0.243 . . . . 0.0 110.91 -175.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -126.37 115.58 23.33 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.77 0.828 . . . . 0.0 108.861 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 89.1 Cg_endo -77.01 141.01 68.02 Favored 'Cis proline' 0 C--N 1.386 2.511 0 C-N-CA 124.584 -1.007 . . . . 0.0 112.389 5.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 123.84 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.729 0.811 . . . . 0.0 110.29 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.38 170.74 17.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.541 1.137 . . . . 0.0 108.545 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.514 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 32.5 t -147.19 90.65 1.9 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.413 0.285 . . . . 0.0 110.237 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.08 144.15 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 109.685 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -146.62 124.14 11.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.45 -69.25 0.17 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.27 149.26 20.9 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.34 -22.64 0.2 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.681 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . -164.01 116.12 0.69 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.87 144.65 30.25 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -108.93 101.62 10.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -169.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -90.23 111.71 22.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.732 0.696 . . . . 0.0 111.52 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -91.18 111.97 23.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.117 1.367 . . . . 0.0 107.399 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.542 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 36.8 mtm180 -89.98 129.4 36.31 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.503 0.668 . . . . 0.0 112.336 -174.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.69 159.09 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.016 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.6 pt-20 -66.69 -34.91 78.91 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.43 HD22 ' HG3' ' A' ' 73' ' ' GLU . 8.3 p30 -163.27 178.29 8.3 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 118.757 0.708 . . . . 0.0 112.345 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.56 -31.27 67.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.408 1.483 . . . . 0.0 112.771 -168.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.97 -46.55 77.67 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.232 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.516 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 71.7 mm-40 -63.69 -22.71 67.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.181 0.993 . . . . 0.0 112.98 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.75 -42.04 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.212 0.605 . . . . 0.0 109.802 171.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -75.81 -29.06 58.56 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.164 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 36.5 mt-10 -71.81 -44.7 63.49 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.276 0.56 . . . . 0.0 109.641 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -65.38 -33.4 75.87 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.437 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -56.33 -59.4 5.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.701 0.8 . . . . 0.0 109.621 174.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.71 -38.26 89.73 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.714 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 -41.83 97.11 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.653 0.596 . . . . 0.0 113.632 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -64.41 -42.55 96.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.324 0.649 . . . . 0.0 110.305 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 31.8 ttpt -59.15 -42.97 91.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.017 0.927 . . . . 0.0 110.539 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.38 65.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.318 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.9 t -98.36 14.27 28.61 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.427 1.091 . . . . 0.0 112.944 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.09 29.06 35.13 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 165.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.7 t -86.47 130.61 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -62.85 -42.11 99.62 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.954 0.902 . . . . 0.0 112.325 -172.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 7.5 ptm 49.54 81.48 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.889 1.676 . . . . 0.0 114.301 166.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.01 83.04 1.76 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.476 0.655 . . . . 0.0 110.084 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 23.8 tm0? 178.07 120.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.434 1.493 . . . . 0.0 107.113 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.4 117.02 62.69 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.53 110.73 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 123.887 3.058 . . . . 0.0 113.329 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.58 146.04 44.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.226 1.01 . . . . 0.0 110.371 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 98.64 4.09 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 tpp -78.26 163.98 25.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.836 0.854 . . . . 0.0 109.49 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.23 -28.26 69.03 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.107 0.563 . . . . 0.0 111.795 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -99.67 15.41 26.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.972 0.909 . . . . 0.0 111.466 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.03 180.0 16.76 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.539 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -73.77 103.0 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -109.84 158.11 18.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.396 0.617 . . . . 0.0 111.401 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.407 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 3.3 t80 -143.93 142.09 30.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.21 1.404 . . . . 0.0 108.795 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.426 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 31.1 m -132.69 121.93 23.85 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.522 1.056 . . . . 0.0 110.76 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.69 150.48 26.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.103 0.961 . . . . 0.0 112.228 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -117.95 172.53 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.3 p-10 -144.34 -176.94 0.59 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 5.2 Cg_exo -38.14 -51.67 1.97 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.621 2.881 . . . . 0.0 114.016 168.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.08 -15.0 59.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.006 0.522 . . . . 0.0 111.684 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.02 52.24 0.2 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.65 1.18 . . . . 0.0 111.156 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -80.3 175.11 10.94 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.255 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -122.84 105.64 10.2 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -118.18 103.69 10.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.143 0.977 . . . . 0.0 109.206 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.543 HH11 HD11 ' B' ' 8' ' ' ILE . 77.9 ttt180 -88.17 146.14 25.55 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 123.266 0.626 . . . . 0.0 110.188 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.9 t -131.94 119.22 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 163.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.542 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 4.3 p90 -125.71 164.91 19.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.563 0.62 . . . . 0.0 111.223 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.83 111.65 13.31 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -75.04 117.2 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.438 0.563 . . . . 0.0 109.75 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 121.11 0.481 . . . . 0.0 109.708 -179.022 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 119.745 -0.169 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.514 ' HB2' HD22 ' A' ' 68' ' ' LEU . 46.5 Cg_endo -97.55 96.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.985 2.456 . . . . 0.0 112.432 170.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.691 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.8 p-10 -93.55 13.82 20.74 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.351 0.596 . . . . 0.0 110.692 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.15 115.59 19.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.74 146.71 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.283 1.033 . . . . 0.0 108.775 171.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.543 HD11 HH11 ' A' ' 116' ' ' ARG . 50.5 mt -122.57 137.47 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.002 0.921 . . . . 0.0 108.903 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.462 ' HG ' ' OH ' ' B' ' 21' ' ' TYR . 4.5 mm? -90.95 122.8 33.93 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.528 ' HE1' HG21 ' B' ' 55' ' ' VAL . 59.6 t80 -78.23 107.33 10.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.913 173.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.1 175.72 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.247 1.019 . . . . 0.0 109.788 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -105.9 -61.15 1.54 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.49 0.716 . . . . 0.0 110.233 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -87.15 110.82 36.4 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.896 0.878 . . . . 0.0 109.969 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.49 -65.67 0.08 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 122.369 2.046 . . . . 0.0 113.155 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.39 -38.94 49.79 Favored 'Trans proline' 0 C--N 1.403 3.441 0 CA-C-N 122.471 1.918 . . . . 0.0 111.81 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.17 -41.71 94.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -70.25 -35.39 73.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 33.3 m -58.12 -53.91 52.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.83 -37.37 81.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.126 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 73.7 t80 -59.71 -44.05 93.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.94 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 6.2 m-85 -72.98 -28.06 62.17 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.817 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' B' ' 18' ' ' THR . 58.4 mtpt -56.68 -50.64 71.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.95 0.795 . . . . 0.0 111.92 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.04 -34.6 50.4 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.971 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 21.8 tp -61.55 -53.41 56.64 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.558 1.143 . . . . 0.0 112.186 -174.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' B' ' 27' ' ' VAL . 12.3 mt -76.73 -51.13 12.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.64 25.06 6.13 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.232 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' B' ' 25' ' ' LEU . 28.5 m -130.8 176.19 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.302 1.041 . . . . 0.0 110.073 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -115.37 155.93 46.42 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.633 0.773 . . . . 0.0 109.13 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.69 112.65 3.58 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.604 1.536 . . . . 0.0 110.536 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.33 -37.46 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.838 0.455 . . . . 0.0 110.245 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.3 mm-40 -111.69 134.62 53.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 45.5 p -143.47 132.48 22.91 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 110.542 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -143.72 156.31 59.52 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.509 1.524 . . . . 0.0 108.133 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.06 -9.63 22.43 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.542 2.161 . . . . 0.0 113.57 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -126.7 -0.75 6.74 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -157.9 142.4 16.24 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 31.1 m -131.46 146.63 52.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.311 0.644 . . . . 0.0 110.056 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -134.12 119.91 19.47 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.77 140.75 40.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.652 1.581 . . . . 0.0 106.921 173.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.57 HG22 ' HG3' ' B' ' 46' ' ' LYS . 28.1 t -124.39 126.56 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.491 HD13 ' SD ' ' B' ' 45' ' ' MET . 9.6 mp -99.73 149.17 23.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.105 0.562 . . . . 0.0 109.887 -172.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.91 -6.3 31.97 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.957 0.903 . . . . 0.0 112.064 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.455 HD21 ' HB3' ' A' ' 3' ' ' HIS . 2.1 m-20 -68.23 -21.64 64.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.118 0.967 . . . . 0.0 112.025 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.31 17.77 16.8 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.126 -0.389 . . . . 0.0 112.126 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.693 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -123.78 174.8 7.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.692 0.797 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.57 ' HG3' HG22 ' B' ' 40' ' ' VAL . 79.4 tttt -145.47 140.48 27.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.91 121.17 16.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 -169.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.99 166.35 15.56 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.744 0.688 . . . . 0.0 112.001 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' B' ' 9' ' ' LEU . 93.3 mt -134.59 105.02 6.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 166.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -109.86 118.98 37.91 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 74.2 p -80.78 140.91 35.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.467 0.307 . . . . 0.0 110.947 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 36.2 ptt180 -70.06 -18.56 63.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -170.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -79.09 -8.58 59.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -127.78 7.22 6.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.853 0.461 . . . . 0.0 111.107 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.528 HG21 ' HE1' ' B' ' 10' ' ' TYR . 8.0 p -75.6 150.08 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.271 -0.268 . . . . 0.0 110.897 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.65 116.71 24.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.634 0.774 . . . . 0.0 109.521 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 87.1 Cg_endo -76.51 140.47 65.68 Favored 'Cis proline' 0 C--N 1.388 2.647 0 C-N-CA 124.593 -1.003 . . . . 0.0 112.407 4.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 123.29 14.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.676 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.74 170.96 17.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.716 1.206 . . . . 0.0 108.515 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 33.9 t -147.3 90.97 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.853 0.359 . . . . 0.0 110.42 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.52 143.4 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.717 0.807 . . . . 0.0 109.692 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.6 p -145.56 124.3 12.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.221 1.008 . . . . 0.0 108.716 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.67 -68.85 0.17 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.719 ' HA2' ' HD2' ' B' ' 114' ' ' ARG . . . -151.55 148.16 18.88 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.77 -23.39 0.2 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.681 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . -163.71 116.65 0.72 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -101.95 144.64 30.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 108.806 -171.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 tp -109.39 101.23 10.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.81 111.76 22.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.192 0.451 . . . . 0.0 111.462 -169.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.1 112.21 24.02 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.068 1.347 . . . . 0.0 107.446 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.439 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.8 mtm180 -90.16 127.84 36.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -174.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.5 160.1 40.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.283 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.463 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.4 pt-20 -67.54 -34.55 77.31 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -173.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.459 HD22 ' HG3' ' B' ' 73' ' ' GLU . 8.0 p30 -163.3 178.55 8.05 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.962 0.801 . . . . 0.0 112.562 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.85 -30.74 67.94 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.284 1.433 . . . . 0.0 112.567 -167.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.5 -46.5 76.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.076 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.463 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 60.9 mm-40 -63.6 -23.12 67.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.312 1.045 . . . . 0.0 112.465 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -42.25 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 121.325 0.583 . . . . 0.0 109.903 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.27 -29.1 60.06 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.296 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 28.8 mt-10 -71.97 -44.94 62.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.166 0.508 . . . . 0.0 109.853 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 57.4 m -64.79 -33.64 76.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.269 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -56.18 -59.86 4.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.719 0.807 . . . . 0.0 109.385 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.51 89.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.559 -173.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.75 96.71 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.652 0.595 . . . . 0.0 113.456 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -64.66 -42.05 95.67 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.261 0.625 . . . . 0.0 110.061 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -60.22 -42.41 95.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.511 0.724 . . . . 0.0 110.664 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.27 66.29 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.578 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 26.8 t -98.67 14.25 29.22 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.375 1.07 . . . . 0.0 112.545 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.25 29.25 34.12 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -86.56 130.51 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -62.68 -41.89 99.34 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.799 0.84 . . . . 0.0 112.597 -172.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 8.2 ptm 49.31 81.5 0.05 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.823 1.649 . . . . 0.0 114.316 166.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.417 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -113.36 83.03 1.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.611 -0.68 . . . . 0.0 110.37 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 24.6 tm0? 178.14 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -77.95 116.46 58.71 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.473 -0.775 . . . . 0.0 108.925 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.94 111.05 0.19 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.994 3.129 . . . . 0.0 113.216 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.12 145.98 45.51 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 110.534 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 98.61 3.84 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.455 ' HG3' ' H ' ' B' ' 101' ' ' PHE . 35.5 tpp -78.35 163.36 25.75 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.0 0.92 . . . . 0.0 109.495 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.48 -28.87 68.68 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.149 0.579 . . . . 0.0 111.777 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.455 ' H ' ' HG3' ' B' ' 99' ' ' MET . 71.3 m-85 -99.37 15.04 27.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.944 0.898 . . . . 0.0 111.38 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' B' ' 99' ' ' MET . . . 119.5 179.9 16.63 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.512 167.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -73.4 102.92 3.89 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -172.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 6.2 t -109.81 158.3 18.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.432 0.634 . . . . 0.0 111.511 -169.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.454 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 3.6 t80 -143.99 142.24 30.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.396 1.478 . . . . 0.0 108.579 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.44 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 m -133.06 121.89 23.34 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.372 0.987 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.16 150.29 27.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.113 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.91 171.33 8.14 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 165.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.431 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.0 p-10 -142.27 -176.81 0.59 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.631 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 22.0 Cg_exo -37.65 -52.11 1.66 Allowed 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.302 2.668 . . . . 0.0 114.403 166.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.96 -14.16 59.88 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.9 0.48 . . . . 0.0 111.719 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m 71.96 52.33 0.21 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.884 1.274 . . . . 0.0 111.044 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -79.86 176.18 9.96 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.116 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.719 ' HD2' ' HA2' ' B' ' 64' ' ' GLY . 0.0 OUTLIER -125.33 104.32 8.41 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.645 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 34.3 mt -118.12 103.8 10.22 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.222 1.009 . . . . 0.0 109.35 -170.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.5 ' HD2' HD12 ' A' ' 8' ' ' ILE . 58.8 mtt-85 -87.04 147.07 25.86 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 123.075 0.55 . . . . 0.0 110.911 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.56 118.89 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 163.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.439 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 9.6 p90 -125.7 164.89 19.65 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.482 0.583 . . . . 0.0 110.879 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.81 111.16 12.81 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.9 119.08 16.64 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 118.333 0.515 . . . . 0.0 110.51 -172.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.91 111.44 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.985 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.146 178.628 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 m80 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.97 129.1 11.21 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.925 2.417 . . . . 0.0 112.308 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.6 p-10 -113.19 10.87 18.66 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.571 0.701 . . . . 0.0 110.281 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.65 120.81 30.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -168.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -118.2 138.01 52.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.778 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 63.2 mt -123.98 126.59 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 84.9 mt -97.56 159.59 14.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -106.85 135.62 48.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.051 0.94 . . . . 0.0 109.428 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.4 m -127.94 179.38 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.288 0.949 . . . . 0.0 109.724 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -136.42 47.62 2.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 16' ' ' ALA . 51.6 t30 167.48 83.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.367 -168.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.4 -53.64 6.56 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 122.618 2.212 . . . . 0.0 114.606 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.59 -64.89 0.16 Allowed 'Trans proline' 0 C--N 1.403 3.424 0 CA-C-N 122.267 1.845 . . . . 0.0 113.509 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . . . -79.27 -37.37 38.01 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.993 -164.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -79.22 -24.43 43.1 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.863 0.102 . . . . 0.0 110.883 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -73.68 -42.71 60.92 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -64.37 -28.57 69.78 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.258 173.031 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.01 -48.07 72.39 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.536 0.523 . . . . 0.0 109.705 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.53 -29.8 68.46 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.431 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -57.86 -48.29 80.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 118.145 0.429 . . . . 0.0 111.999 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.97 63.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.783 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.25 -30.21 70.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.654 1.182 . . . . 0.0 112.654 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 27' ' ' VAL . 73.4 mt -106.12 -28.81 10.26 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.886 0.874 . . . . 0.0 110.248 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.89 21.97 47.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.229 0.331 . . . . 0.0 112.709 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.1 m -116.15 -178.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.042 0.937 . . . . 0.0 111.002 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -134.91 153.73 78.82 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.929 0.892 . . . . 0.0 109.236 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.71 134.11 23.34 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.629 2.22 . . . . 0.0 112.131 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.82 -41.88 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 31.7 mm-40 -121.89 143.61 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.23 1.012 . . . . 0.0 109.027 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -140.31 141.09 35.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.2 m -144.21 161.86 42.88 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.66 1.184 . . . . 0.0 108.767 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -53.11 -28.93 43.25 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 123.056 2.504 . . . . 0.0 113.624 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 t -127.69 -3.43 5.97 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -139.51 141.07 37.33 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.385 0.539 . . . . 0.0 110.447 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 t -125.03 137.88 54.22 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.554 1.142 . . . . 0.0 108.773 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.9 tp -127.52 114.38 17.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.504 ' HE1' ' HG ' ' A' ' 49' ' ' LEU . 2.7 p90 -129.68 108.35 10.13 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.98 1.312 . . . . 0.0 108.608 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 46' ' ' LYS . 20.5 t -89.85 134.54 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.436 HD12 ' SD ' ' A' ' 45' ' ' MET . 56.5 mt -95.4 140.33 30.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.615 0.366 . . . . 0.0 110.844 -173.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.2 27.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.524 1.13 . . . . 0.0 112.289 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -68.91 -15.68 63.55 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.588 1.155 . . . . 0.0 110.912 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.55 16.76 13.51 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 122.94 0.305 . . . . 0.0 113.172 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -126.38 176.04 7.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.404 0.682 . . . . 0.0 109.568 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG3' HG22 ' A' ' 40' ' ' VAL . 80.2 tttt -134.47 134.8 41.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.008 0.523 . . . . 0.0 109.887 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.555 HD11 HD21 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -131.05 143.18 50.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 -173.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.31 169.17 18.27 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.028 0.823 . . . . 0.0 111.984 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.504 ' HG ' ' HE1' ' A' ' 39' ' ' PHE . 80.8 mt -140.57 130.26 24.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.37 1.468 . . . . 0.0 107.768 164.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -127.92 128.37 45.0 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 49.6 m -80.42 125.17 29.6 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.977 0.511 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -65.62 -15.73 63.03 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.796 1.238 . . . . 0.0 114.283 -166.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -67.68 -24.01 65.37 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.187 0.595 . . . . 0.0 111.409 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -143.63 23.03 1.79 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.879 0.471 . . . . 0.0 110.617 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.47 150.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -126.63 115.61 22.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.875 -0.516 . . . . 0.0 110.008 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 11.9 Cg_exo -70.65 142.63 72.78 Favored 'Cis proline' 0 C--N 1.387 2.574 0 CA-C-N 119.313 0.79 . . . . 0.0 112.519 -1.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.49 109.86 1.77 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.412 0.625 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.07 41.29 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 110.144 -168.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -79.62 88.94 5.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.2 m -126.48 131.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -158.77 123.96 4.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.301 1.44 . . . . 0.0 108.312 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.1 -36.14 0.71 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 113' ' ' HIS . . . 154.22 -62.39 0.36 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 69.03 -116.75 7.46 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -172.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.91 40.65 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.762 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 7.8 pt-20 -103.87 162.6 12.98 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.886 0.85 . . . . 0.0 112.124 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 47' ' ' LEU . 64.6 tp -119.08 102.5 8.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.069 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.9 115.1 23.32 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.394 0.543 . . . . 0.0 112.072 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.82 107.67 19.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.565 1.546 . . . . 0.0 108.431 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.67 133.89 34.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.568 . . . . 0.0 112.497 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -138.38 161.57 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.623 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.1 pt-20 -65.51 -42.1 92.43 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -171.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -158.65 179.83 8.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 111.812 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -56.07 -34.97 66.46 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.684 -166.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.68 -46.49 82.17 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.156 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.585 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 72.0 mm-40 -63.83 -24.31 67.7 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.964 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.19 -43.85 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.729 0.776 . . . . 0.0 110.271 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.88 -28.34 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.108 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.6 mt-10 -69.38 -45.04 70.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.35 0.595 . . . . 0.0 109.504 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -63.11 -36.24 82.93 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.404 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -54.8 -56.46 19.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.865 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.94 84.29 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.93 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.0 94.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.67 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.533 ' HB3' HG11 ' A' ' 90' ' ' VAL . 33.5 m0 -63.86 -44.89 91.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.467 0.707 . . . . 0.0 110.044 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.405 ' HB2' ' SD ' ' A' ' 92' ' ' MET . 32.2 ttpt -58.66 -42.26 88.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 110.582 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.57 65.15 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.804 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.0 m -103.38 17.8 23.25 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.314 1.046 . . . . 0.0 111.946 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.06 7.99 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 163.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 92' ' ' MET . 4.1 p -96.84 142.35 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -41.46 83.99 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.154 0.582 . . . . 0.0 111.374 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.606 ' HB3' HG13 ' A' ' 90' ' ' VAL . 9.6 ptm 48.26 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.919 1.687 . . . . 0.0 113.992 168.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.51 85.83 2.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.644 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 179.52 130.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.898 1.279 . . . . 0.0 108.703 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -82.57 115.0 55.79 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 166.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.63 118.2 3.91 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.163 2.575 . . . . 0.0 112.064 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.14 147.23 52.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.602 0.761 . . . . 0.0 110.167 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -68.44 123.03 19.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.421 0.688 . . . . 0.0 110.778 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -121.91 170.73 9.51 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.078 1.351 . . . . 0.0 109.283 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.12 -42.85 60.96 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.511 1.124 . . . . 0.0 112.283 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -90.55 1.22 56.93 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.317 0.647 . . . . 0.0 111.988 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.45 -172.37 18.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.285 168.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 35.4 t80 -73.14 101.52 3.34 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -113.19 153.59 28.06 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.542 0.687 . . . . 0.0 111.369 -166.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.07 138.16 20.3 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.119 1.368 . . . . 0.0 108.528 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -129.64 125.4 36.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.588 0.631 . . . . 0.0 109.654 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.84 172.06 7.0 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.07 0.948 . . . . 0.0 110.839 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.27 124.25 25.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.609 0.763 . . . . 0.0 109.347 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 169.14 3.21 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 123.856 0.862 . . . . 0.0 111.572 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.73 -28.83 39.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.93 2.42 . . . . 0.0 113.069 168.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -93.56 13.97 20.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.205 1.002 . . . . 0.0 111.884 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m 54.96 81.19 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.57 1.548 . . . . 0.0 112.481 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.2 m170 -118.34 -173.26 2.43 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 12.1 mmm180 -121.76 112.64 18.64 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.46 101.86 8.06 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -96.6 96.25 8.52 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -171.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -84.33 114.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -128.23 161.4 29.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.227 0.467 . . . . 0.0 111.365 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -118.23 117.84 30.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.984 0.914 . . . . 0.0 109.063 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -79.25 120.36 23.63 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.806 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.66 129.49 10.92 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.746 2.298 . . . . 0.0 112.231 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.543 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.2 p-10 -112.75 9.86 19.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.588 0.755 . . . . 0.0 110.299 171.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.7 120.73 30.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 138.03 52.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.762 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 48.7 mt -124.05 125.9 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' B' ' 49' ' ' LEU . 11.2 mp -96.82 159.65 14.8 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.401 ' O ' ' NE2' ' B' ' 113' ' ' HIS . 15.4 p90 -107.05 135.14 49.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.169 0.988 . . . . 0.0 109.432 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 51' ' ' SER . 21.2 m -127.59 179.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.29 0.95 . . . . 0.0 109.702 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.17 47.12 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 108.861 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ASN . . . . . 0.58 ' ND2' ' HB3' ' B' ' 16' ' ' ALA . 56.0 t30 167.67 83.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.451 -167.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.08 -53.31 6.97 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.519 2.146 . . . . 0.0 114.562 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.5 -65.38 0.14 Allowed 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.171 1.914 . . . . 0.0 113.41 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.58 ' HB3' ' ND2' ' B' ' 13' ' ' ASN . . . -79.09 -37.36 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.928 -164.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.9 t -78.96 -23.72 44.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.51 0.141 . . . . 0.0 110.807 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 92.3 m -74.77 -42.01 58.97 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -64.59 -28.89 69.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.98 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.438 ' HZ ' HG22 ' B' ' 90' ' ' VAL . 60.7 t80 -65.66 -48.16 73.06 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.116 0.566 . . . . 0.0 109.949 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -68.56 -29.77 68.4 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.66 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' B' ' 18' ' ' THR . 53.9 mtpt -57.63 -48.44 79.43 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.208 0.458 . . . . 0.0 112.03 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.4 -39.19 62.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.604 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.0 -29.93 69.99 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.929 1.292 . . . . 0.0 112.54 -174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' B' ' 27' ' ' VAL . 69.3 mt -106.4 -28.97 10.02 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.043 0.937 . . . . 0.0 110.212 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.2 21.54 48.71 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.336 0.398 . . . . 0.0 112.65 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.9 m -115.87 -178.59 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.125 0.97 . . . . 0.0 110.943 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -134.98 153.15 78.37 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 109.099 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.02 133.58 23.55 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.607 2.204 . . . . 0.0 112.377 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' B' ' 31' ' ' GLU . 5.6 p -68.87 -42.06 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.419 ' HG2' HG13 ' B' ' 30' ' ' VAL . 46.2 mm-40 -122.02 143.25 49.61 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 40.0 p -140.32 140.79 35.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.521 0.728 . . . . 0.0 109.214 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 73.3 m -144.3 162.13 41.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.775 1.23 . . . . 0.0 108.821 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -53.52 -28.56 45.77 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.128 2.552 . . . . 0.0 113.871 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -128.06 -3.35 5.74 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -139.53 141.72 37.27 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.759 0.709 . . . . 0.0 110.359 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -126.17 137.46 53.57 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.549 1.14 . . . . 0.0 108.903 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.57 114.97 18.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.526 ' HE1' ' HG ' ' B' ' 49' ' ' LEU . 2.6 p90 -129.86 108.61 10.28 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.928 1.291 . . . . 0.0 108.54 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.615 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.6 t -89.85 134.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.814 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.42 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.9 mt -95.43 140.64 30.0 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 -173.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.05 -6.32 27.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.534 1.134 . . . . 0.0 112.371 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -69.4 -15.48 63.31 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.066 0.946 . . . . 0.0 110.953 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 16.79 13.31 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 122.937 0.304 . . . . 0.0 113.313 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -126.13 175.97 7.38 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.53 0.732 . . . . 0.0 109.735 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.615 ' HG3' HG22 ' B' ' 40' ' ' VAL . 83.0 tttt -134.19 134.84 42.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.016 0.526 . . . . 0.0 109.862 -174.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.54 HD11 HD21 ' B' ' 68' ' ' LEU . 0.4 OUTLIER -131.2 142.94 50.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.786 0.434 . . . . 0.0 110.926 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.97 169.02 17.94 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 124.146 0.879 . . . . 0.0 111.88 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.526 ' HG ' ' HE1' ' B' ' 39' ' ' PHE . 81.3 mt -140.74 130.27 24.02 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.369 1.467 . . . . 0.0 107.947 164.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -128.23 128.15 44.17 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.6 m -80.41 125.14 29.55 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.886 0.474 . . . . 0.0 110.894 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -65.17 -16.01 63.05 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.971 1.309 . . . . 0.0 114.248 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -67.56 -23.55 65.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.261 0.625 . . . . 0.0 111.505 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.8 t -144.09 22.14 1.73 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.847 0.459 . . . . 0.0 110.421 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.18 150.47 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.259 0.623 . . . . 0.0 109.45 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.78 117.36 22.46 Favored Pre-proline 0 N--CA 1.484 1.274 0 O-C-N 121.826 -0.546 . . . . 0.0 110.572 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.81 142.53 64.77 Favored 'Cis proline' 0 C--N 1.388 2.656 0 CA-C-N 119.362 0.808 . . . . 0.0 113.248 -4.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.04 110.57 1.85 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.238 0.615 . . . . 0.0 110.073 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.41 123.98 40.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.522 1.129 . . . . 0.0 110.094 -169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 52.9 m -79.04 88.91 4.78 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.5 131.21 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.56 124.18 4.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.254 1.422 . . . . 0.0 108.545 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -35.45 0.71 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' B' ' 113' ' ' HIS . . . 153.87 -62.72 0.37 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 69.25 -116.99 7.52 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -172.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 150.85 40.94 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 173.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.778 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 5.6 pt-20 -103.57 162.93 12.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.821 0.82 . . . . 0.0 112.219 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.54 HD21 HD11 ' B' ' 47' ' ' LEU . 59.4 tp -119.83 101.77 8.11 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.687 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.93 115.66 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.477 0.58 . . . . 0.0 112.025 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.32 107.09 18.97 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.544 1.538 . . . . 0.0 108.141 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.6 mtm180 -90.05 133.55 34.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.187 0.518 . . . . 0.0 112.134 -174.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -137.27 162.38 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.449 1.1 . . . . 0.0 110.6 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 16.1 pt-20 -65.41 -42.14 92.86 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.438 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -158.61 179.79 8.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.173 0.511 . . . . 0.0 112.367 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.44 -35.05 65.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.644 1.578 . . . . 0.0 112.741 -166.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.39 -46.01 81.79 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.048 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.599 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.7 mm-40 -64.24 -24.22 67.59 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.742 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.95 -43.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.761 0.791 . . . . 0.0 110.334 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -76.69 -28.26 55.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.843 -173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.8 mt-10 -68.89 -45.75 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 174.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -62.22 -35.97 80.54 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.732 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -56.18 -56.01 26.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.078 0.951 . . . . 0.0 109.745 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.8 84.26 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.687 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.97 -40.49 95.31 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.858 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.47 -44.78 93.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.637 0.775 . . . . 0.0 110.211 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.16 -41.2 92.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.42 0.688 . . . . 0.0 110.487 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.86 -26.96 64.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.791 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 43.6 m -103.82 17.88 23.15 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.269 1.028 . . . . 0.0 111.823 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.07 47.29 8.53 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 163.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.438 HG22 ' HZ ' ' B' ' 20' ' ' PHE . 57.6 t -95.45 141.16 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.88 87.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.231 0.612 . . . . 0.0 111.336 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 7.7 ptp 48.02 82.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.789 1.636 . . . . 0.0 114.289 168.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.446 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -107.15 84.78 2.03 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.735 177.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -178.31 131.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.978 1.311 . . . . 0.0 108.608 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' GLN . . . . . 0.415 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 51.1 mt-30 -82.7 114.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 6.2 Cg_endo -50.24 118.39 3.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.227 2.618 . . . . 0.0 112.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.57 148.56 52.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.593 0.757 . . . . 0.0 110.375 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.2 123.19 21.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.604 0.762 . . . . 0.0 109.986 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 45.7 ttm -121.94 170.84 9.4 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.934 1.293 . . . . 0.0 109.052 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.6 -43.3 56.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.714 1.206 . . . . 0.0 112.236 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.69 1.39 56.88 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.261 0.624 . . . . 0.0 112.184 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 127.69 -172.18 18.95 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.332 -0.395 . . . . 0.0 113.39 169.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.428 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 34.3 t80 -75.09 101.75 4.65 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -113.39 153.5 28.47 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.405 0.621 . . . . 0.0 111.404 -165.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 3.5 t80 -149.86 138.44 20.76 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.119 1.368 . . . . 0.0 108.488 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.537 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 m -129.7 125.81 36.81 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.1 172.1 6.99 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.07 0.948 . . . . 0.0 110.959 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.04 125.68 28.58 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.576 0.75 . . . . 0.0 109.224 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.16 170.87 3.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.932 0.893 . . . . 0.0 110.912 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.4 -28.1 52.17 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.815 2.343 . . . . 0.0 112.722 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.67 13.79 21.09 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.031 0.932 . . . . 0.0 111.76 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m 55.25 80.97 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.25 1.42 . . . . 0.0 112.506 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.455 ' HA ' ' HA2' ' B' ' 64' ' ' GLY . 16.4 m170 -118.25 -173.03 2.38 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.63 ' HB3' ' HB3' ' B' ' 67' ' ' GLU . 10.9 mmm180 -121.49 112.65 18.77 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.9 mt -120.28 101.72 8.0 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -94.41 95.13 8.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.51 115.17 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -128.14 161.61 28.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.372 0.533 . . . . 0.0 111.502 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.433 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -118.24 118.97 33.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 0.0 108.805 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -81.12 127.04 32.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.48 94.32 4.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.018 0.927 . . . . 0.0 108.527 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.789 -1.006 . . . . 0.0 111.342 -179.366 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.463 ' HB3' HD21 ' B' ' 43' ' ' ASN . 15.4 m170 . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 119.559 -0.258 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.97 156.79 3.33 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.905 2.403 . . . . 0.0 112.815 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.705 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.2 p-10 -148.38 16.83 1.04 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.39 1.076 . . . . 0.0 109.662 167.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.09 136.67 49.58 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -144.95 140.59 28.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.547 HG12 ' HA3' ' A' ' 48' ' ' GLY . 19.4 mt -122.84 131.93 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.396 0.678 . . . . 0.0 109.664 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -103.06 145.21 30.24 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -98.28 127.51 44.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 m -127.82 160.96 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.34 0.656 . . . . 0.0 109.966 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.78 -60.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.103 0.961 . . . . 0.0 110.963 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -95.6 99.08 4.27 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 123.418 0.687 . . . . 0.0 109.728 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.05 -54.0 5.81 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 123.129 2.552 . . . . 0.0 115.639 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.79 -53.74 4.12 Favored 'Trans proline' 0 C--N 1.4 3.277 0 CA-C-N 122.363 1.88 . . . . 0.0 112.323 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.44 88.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.512 -168.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -79.88 -26.78 40.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.319 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -72.43 -38.67 68.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.071 0.462 . . . . 0.0 112.003 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.6 mm-40 -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.837 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.0 t80 -67.01 -42.32 85.15 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.631 0.582 . . . . 0.0 109.649 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -71.37 -29.81 65.4 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.008 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 53.3 mtpt -57.65 -49.78 75.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 111.875 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.58 -30.59 57.07 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.1 tp -62.44 -52.65 62.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.597 1.159 . . . . 0.0 111.785 -177.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.4 mt -82.48 -40.62 20.84 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.456 1.102 . . . . 0.0 108.99 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.48 25.5 10.02 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.184 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 25' ' ' LEU . 28.3 m -126.21 177.89 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.854 0.861 . . . . 0.0 110.63 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.07 154.92 76.62 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.504 1.122 . . . . 0.0 108.644 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.61 125.07 13.72 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 121.96 1.773 . . . . 0.0 111.966 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.7 p -71.58 -39.83 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.17 0.51 . . . . 0.0 109.645 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.6 mm-40 -115.55 113.31 23.45 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 p -114.74 147.87 39.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.423 0.689 . . . . 0.0 110.877 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.3 t -148.29 151.7 37.57 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.76 1.224 . . . . 0.0 108.228 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.54 -20.61 69.34 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.349 2.033 . . . . 0.0 112.94 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -128.73 13.69 6.41 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -157.35 158.14 35.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 35.6 t -145.99 141.96 28.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.583 0.753 . . . . 0.0 109.018 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.5 tm? -137.59 114.67 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HE1' HD22 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -127.22 112.95 15.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.463 1.105 . . . . 0.0 109.078 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 46' ' ' LYS . 14.8 t -93.47 128.02 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.443 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.1 mt -91.37 141.82 28.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 110.068 -168.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.98 -9.61 40.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.676 0.791 . . . . 0.0 112.082 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.619 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 4.6 m-20 -69.5 -1.21 8.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.14 0.976 . . . . 0.0 112.91 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.0 48.81 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 117.813 0.279 . . . . 0.0 112.706 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.738 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -129.07 172.54 11.29 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.659 0.784 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -128.33 135.98 50.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.582 0.753 . . . . 0.0 109.264 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -131.25 124.73 31.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.129 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.547 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -100.34 166.85 19.97 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 37' ' ' SER . 10.1 tp -143.52 105.31 4.34 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HB2' HG21 ' A' ' 8' ' ' ILE . 2.8 t90 -105.09 131.78 52.15 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -73.35 126.45 30.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -68.75 -13.0 62.11 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 112.558 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -81.77 -8.25 59.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.236 0.614 . . . . 0.0 111.311 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 t -136.58 10.82 3.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 111.177 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.4 146.91 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.04 107.99 10.5 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.633 0.773 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' B' ' 94' ' ' GLN . 93.7 Cg_endo -73.74 133.47 30.97 Favored 'Cis proline' 0 C--N 1.382 2.307 0 CA-C-N 120.541 1.229 . . . . 0.0 114.157 13.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -59.74 124.74 21.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.577 1.151 . . . . 0.0 110.8 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.97 108.1 3.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.856 0.863 . . . . 0.0 109.535 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.7 t -89.41 87.0 6.92 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.75 138.22 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 109.252 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 p -150.44 122.28 8.13 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.5 -92.06 0.14 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.83 64.14 3.96 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 123.011 0.338 . . . . 0.0 112.495 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' B' ' 65' ' ' GLY . . . -98.83 173.91 27.32 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.54 159.27 45.48 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.632 -0.538 . . . . 0.0 112.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 9.6 pt-20 -102.31 145.44 29.46 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.603 0.701 . . . . 0.0 111.145 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.77 102.76 11.52 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 108.009 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.787 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -89.25 114.91 26.32 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.01 0.433 . . . . 0.0 112.035 -168.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.78 120.31 33.89 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.015 1.326 . . . . 0.0 108.374 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.53 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 32.3 mtm180 -96.4 127.48 42.43 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.812 0.815 . . . . 0.0 112.302 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.16 157.62 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.916 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 8.2 pt-20 -68.21 -34.87 77.04 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.89 -179.43 6.28 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.978 0.808 . . . . 0.0 112.752 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.35 -31.72 69.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.483 1.513 . . . . 0.0 113.016 -166.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.89 -44.87 79.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.08 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 19.2 mm-40 -65.82 -24.31 66.87 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.65 -44.91 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.574 0.749 . . . . 0.0 109.973 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.62 -28.34 56.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.694 0.798 . . . . 0.0 111.509 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 31.7 mt-10 -62.03 -44.24 97.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.611 0.719 . . . . 0.0 109.534 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -69.61 -35.0 74.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.988 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -54.52 -59.9 4.07 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.555 1.142 . . . . 0.0 109.977 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -64.42 -35.37 80.69 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.589 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.87 -46.81 79.97 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.836 0.71 . . . . 0.0 113.994 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -65.68 -40.82 92.77 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.898 0.479 . . . . 0.0 109.76 175.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.9 ttpt -57.64 -45.09 85.91 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.61 0.764 . . . . 0.0 110.479 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.75 -24.28 61.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -98.11 14.56 27.15 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.937 0.895 . . . . 0.0 111.689 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.86 41.17 8.31 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 115.222 164.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.1 p -89.21 149.4 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.04 -54.44 11.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.961 0.504 . . . . 0.0 110.796 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.506 ' HB2' HG13 ' A' ' 90' ' ' VAL . 47.5 ttm 68.67 84.94 0.14 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.246 0.966 . . . . 0.0 113.027 169.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -117.85 84.38 2.16 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.553 0.692 . . . . 0.0 110.965 173.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 106' ' ' THR . 53.1 tp60 178.04 122.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.768 1.627 . . . . 0.0 107.736 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.02 121.8 86.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 0.0 109.72 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 46.3 Cg_endo -64.95 108.34 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.766 2.31 . . . . 0.0 110.084 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.15 48.71 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.207 0.603 . . . . 0.0 110.543 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -67.81 131.63 45.89 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.421 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.519 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 12.4 ttt -141.04 -178.07 5.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.016 0.926 . . . . 0.0 109.245 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 99' ' ' MET . 7.4 mp0 -58.8 -37.36 76.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.609 1.164 . . . . 0.0 111.899 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 33.9 m-85 -84.33 -8.4 59.02 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.84 0.856 . . . . 0.0 111.119 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 116.41 -157.12 15.22 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -79.35 103.48 9.3 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.916 0.858 . . . . 0.0 108.956 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.43 HG21 ' SD ' ' A' ' 99' ' ' MET . 13.1 t -109.48 152.76 24.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.38 0.61 . . . . 0.0 110.84 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 6.5 t80 -143.19 145.22 32.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.921 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 5.4 m -135.73 132.65 37.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.485 0.584 . . . . 0.0 110.591 172.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.58 172.59 6.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.67 0.788 . . . . 0.0 110.341 170.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.64 116.06 12.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.504 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 7.2 p-10 -71.26 171.45 8.71 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 123.309 0.644 . . . . 0.0 110.277 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 9.6 Cg_endo -50.62 -40.09 55.63 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.873 2.382 . . . . 0.0 113.463 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.12 -1.04 54.23 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.637 0.775 . . . . 0.0 110.73 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m 64.6 75.24 0.38 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.784 1.234 . . . . 0.0 112.08 164.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.45 162.65 22.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 1.1 mpt_? -90.35 111.27 22.43 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.51 104.19 16.2 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.787 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 7.4 tpt180 -89.49 146.09 24.86 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.198 0.599 . . . . 0.0 110.144 -172.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.26 122.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 164.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 5.3 p90 -127.48 156.82 41.53 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.602 0.637 . . . . 0.0 110.928 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.409 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.48 112.57 17.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 171.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 49.7 t80 -77.74 116.39 18.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -171.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.644 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.579 178.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 29.2 m80 . . . . . 0 CA--C 1.55 0.973 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -91.83 155.4 3.4 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.983 2.456 . . . . 0.0 112.959 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.738 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 4.5 p-10 -146.58 17.28 1.3 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.301 1.04 . . . . 0.0 110.155 167.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.5 136.65 49.18 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.84 140.67 28.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.43 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 11.2 mt -122.9 132.43 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.341 0.656 . . . . 0.0 109.545 -176.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.96 145.37 30.51 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -99.29 127.35 45.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.465 1.106 . . . . 0.0 110.517 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.67 160.9 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.241 0.616 . . . . 0.0 109.95 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -95.54 -60.9 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.278 1.031 . . . . 0.0 110.883 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -95.93 99.05 4.48 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 123.564 0.746 . . . . 0.0 109.333 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.76 -54.86 4.39 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.107 2.538 . . . . 0.0 115.552 -169.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 -54.15 4.22 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 122.461 1.915 . . . . 0.0 112.123 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.83 89.06 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.465 -168.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 85.9 p -79.5 -27.82 41.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 39.9 m -71.32 -38.97 71.67 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.529 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 83.0 mm-40 -65.6 -33.93 77.05 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.729 172.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 53.2 t80 -66.79 -41.96 86.76 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -71.82 -29.69 64.69 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.258 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 10.3 mtpm? -57.87 -49.1 77.87 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.267 0.485 . . . . 0.0 112.177 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.68 57.15 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.656 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.505 HD11 HD13 ' B' ' 115' ' ' LEU . 13.4 tp -62.75 -52.78 61.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.447 1.099 . . . . 0.0 112.014 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.493 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.0 mt -82.21 -40.55 21.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.913 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.01 9.82 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.011 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.0 m -125.88 178.39 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.97 155.27 77.97 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.166 0.986 . . . . 0.0 108.526 171.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.34 124.59 13.13 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.125 1.884 . . . . 0.0 112.172 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.5 p -71.22 -40.4 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.08 0.552 . . . . 0.0 109.588 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 68.0 mm-40 -114.35 113.84 25.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 73.8 p -115.33 147.96 39.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.999 0.52 . . . . 0.0 110.83 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.2 t -148.48 151.27 35.97 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.532 1.133 . . . . 0.0 108.34 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.96 -20.68 68.38 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.424 2.082 . . . . 0.0 113.117 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -128.66 13.62 6.44 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -157.13 158.37 36.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.843 -0.536 . . . . 0.0 109.688 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . 34.7 t -146.07 141.83 27.97 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 109.086 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -137.52 114.6 10.79 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.04 113.08 15.97 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.527 1.131 . . . . 0.0 109.15 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' B' ' 46' ' ' LYS . 17.2 t -93.69 127.55 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.341 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.551 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.2 mt -91.26 141.36 28.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.062 0.545 . . . . 0.0 110.227 -169.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.36 -9.4 33.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.038 0.935 . . . . 0.0 112.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 4.2 m-20 -69.61 -1.93 10.21 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.159 0.983 . . . . 0.0 112.679 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.25 17.51 46.33 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.723 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.705 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -128.92 173.08 10.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.549 0.74 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.8 tttt -128.66 136.25 50.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.403 0.681 . . . . 0.0 109.482 -176.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.466 HD12 HD11 ' B' ' 41' ' ' LEU . 0.7 OUTLIER -131.06 124.68 31.38 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.27 166.36 20.93 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 37' ' ' SER . 9.5 tp -143.46 105.07 4.32 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -105.08 132.06 51.78 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 52.8 m -73.54 126.17 29.62 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -68.64 -13.12 62.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.581 0.752 . . . . 0.0 112.552 -172.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -81.41 -8.35 59.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.309 0.644 . . . . 0.0 111.331 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.3 t -136.59 10.87 3.18 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.255 0.622 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.82 146.99 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.97 108.85 10.64 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.584 0.754 . . . . 0.0 109.049 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.57 134.04 32.64 Favored 'Cis proline' 0 C--N 1.383 2.381 0 CA-C-N 120.339 1.157 . . . . 0.0 114.215 11.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -60.61 124.06 19.26 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.651 1.181 . . . . 0.0 111.22 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.32 108.02 3.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 109.508 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.4 p -89.2 86.07 6.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.32 140.43 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.166 0.986 . . . . 0.0 108.584 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -152.33 122.31 7.06 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.9 -91.84 0.14 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.22 63.81 4.29 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 123.041 0.353 . . . . 0.0 113.315 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' A' ' 65' ' ' GLY . . . -99.43 173.98 26.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.915 -0.381 . . . . 0.0 112.27 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.53 159.6 45.03 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 124.019 0.482 . . . . 0.0 112.097 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' B' ' 114' ' ' ARG . 9.2 pt-20 -101.99 145.35 29.4 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.458 0.647 . . . . 0.0 110.895 -176.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -110.06 102.92 11.59 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.29 114.83 26.25 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.183 0.516 . . . . 0.0 111.933 -168.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -93.36 120.51 33.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.041 1.336 . . . . 0.0 108.523 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.484 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 33.3 mtm105 -97.36 126.08 42.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.64 0.734 . . . . 0.0 112.188 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.98 157.82 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.348 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.451 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.1 pt-20 -67.04 -35.11 79.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -164.45 -179.05 5.76 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.91 -31.75 70.11 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.688 -166.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.521 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.28 -45.34 80.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.01 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.451 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 83.1 mm-40 -65.42 -24.1 67.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.261 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.68 -44.51 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.382 0.673 . . . . 0.0 109.858 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.21 -28.15 53.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.587 0.755 . . . . 0.0 111.364 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 40.4 mt-10 -62.54 -43.85 97.8 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.758 0.79 . . . . 0.0 109.325 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 54.3 m -69.89 -35.02 74.3 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.14 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -54.59 -59.68 4.37 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.47 1.108 . . . . 0.0 110.223 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.499 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -64.67 -34.87 79.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.539 -175.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.88 -47.29 76.3 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 123.729 0.643 . . . . 0.0 113.804 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.54 -41.09 93.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 34.3 ttpt -57.27 -45.0 84.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.591 0.756 . . . . 0.0 110.482 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.62 61.62 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.072 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -97.5 14.82 25.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.041 0.937 . . . . 0.0 111.931 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.67 41.43 8.29 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.3 p -89.6 149.4 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.25 -54.69 10.03 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.795 0.438 . . . . 0.0 110.691 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.514 ' HB2' HG13 ' B' ' 90' ' ' VAL . 49.1 ttm 68.76 84.99 0.14 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.944 0.777 . . . . 0.0 112.922 168.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.94 84.29 2.14 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 121.571 0.701 . . . . 0.0 110.821 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.412 ' HG3' ' HD3' ' A' ' 57' ' ' PRO . 24.1 tm0? 178.27 122.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.468 1.507 . . . . 0.0 107.14 173.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.41 120.63 82.55 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.366 0.667 . . . . 0.0 109.939 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 37.0 Cg_endo -63.38 108.41 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.795 2.33 . . . . 0.0 110.514 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.49 156.62 47.93 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.011 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -68.31 131.89 46.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.283 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.491 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 8.8 ttt -141.19 -178.42 5.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.96 0.904 . . . . 0.0 108.897 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' B' ' 99' ' ' MET . 7.3 mp0 -58.55 -37.61 76.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.429 1.092 . . . . 0.0 112.187 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -83.61 -8.69 59.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.778 0.831 . . . . 0.0 111.16 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 116.76 -156.65 15.5 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -79.61 103.49 9.55 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.044 0.922 . . . . 0.0 108.92 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.459 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.8 t -109.75 152.47 25.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.958 0.503 . . . . 0.0 110.582 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 7.3 t80 -142.98 144.72 32.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.8 1.24 . . . . 0.0 109.971 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -135.17 132.16 37.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.417 0.553 . . . . 0.0 110.705 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.56 172.63 6.71 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.718 0.807 . . . . 0.0 110.35 170.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.87 115.39 11.92 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.514 ' HB3' HD11 ' B' ' 115' ' ' LEU . 4.3 p-10 -69.8 170.83 8.54 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.58 0.752 . . . . 0.0 110.728 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 9.6 Cg_endo -50.66 -40.18 55.91 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.789 2.326 . . . . 0.0 113.199 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.76 -0.87 52.75 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.482 0.713 . . . . 0.0 111.053 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.0 m 64.17 74.75 0.4 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.741 1.217 . . . . 0.0 112.043 165.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -122.62 162.61 21.58 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 166.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 2.6 mpt_? -90.01 112.08 23.39 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.514 HD11 ' HB3' ' B' ' 109' ' ' ASP . 33.0 mt -98.97 104.37 16.4 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.735 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 30.4 mmt180 -87.55 146.24 25.87 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 123.804 0.841 . . . . 0.0 110.834 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 t -139.56 122.01 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 163.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.484 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.0 p90 -127.13 156.56 41.56 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.866 0.757 . . . . 0.0 111.132 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -123.57 112.52 17.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.38 118.76 20.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.4 94.35 6.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.347 -179.388 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.476 ' HB3' ' ND2' ' B' ' 43' ' ' ASN . 17.9 m-70 . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HG3' HD22 ' B' ' 25' ' ' LEU . 51.2 Cg_endo -90.83 48.65 0.75 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.361 2.708 . . . . 0.0 112.672 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.574 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 5.9 p-10 -75.47 14.81 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.173 0.989 . . . . 0.0 112.609 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.471 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.2 t80 -133.37 129.93 38.1 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.134 1.374 . . . . 0.0 108.137 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 8.2 t -127.33 140.86 51.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.237 1.015 . . . . 0.0 108.576 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 61.4 mt -118.8 137.24 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 HD21 ' A' ' 47' ' ' LEU . 4.3 mm? -96.72 146.28 25.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HE1' HG21 ' A' ' 55' ' ' VAL . 22.8 t80 -101.32 95.72 6.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.341 -167.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.471 HG12 ' HE1' ' A' ' 113' ' ' HIS . 27.0 m -108.87 -179.85 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.33 -53.87 1.7 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.876 0.47 . . . . 0.0 110.258 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.74 105.55 9.19 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 123.567 0.747 . . . . 0.0 110.764 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.68 -55.48 3.5 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 C-N-CA 122.735 2.29 . . . . 0.0 114.081 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.44 -58.9 0.5 Allowed 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 122.271 1.847 . . . . 0.0 112.312 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.71 95.51 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.337 -166.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.9 p -76.68 -34.83 58.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.287 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -69.11 -39.12 79.14 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.545 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 12.4 mm100 -64.3 -35.47 80.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.411 172.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 77.7 t80 -68.28 -39.46 82.14 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.27 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -70.41 -30.55 67.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.208 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.4 mtpt -57.13 -47.76 80.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.946 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.28 -34.53 55.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.223 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.0 tp -61.13 -31.46 71.16 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.861 1.265 . . . . 0.0 112.646 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' B' ' 4' ' ' PRO . 87.3 mt -105.46 -40.08 5.92 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.364 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.34 29.65 10.0 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 25' ' ' LEU . 16.9 m -126.51 -179.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.218 1.007 . . . . 0.0 109.616 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.83 150.8 68.93 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.546 0.738 . . . . 0.0 109.078 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.97 111.9 2.78 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.812 2.342 . . . . 0.0 112.099 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -64.02 -42.28 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.759 0.824 . . . . 0.0 110.598 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 28.5 mm-40 -111.49 145.49 38.94 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -154.55 152.23 29.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.326 0.584 . . . . 0.0 109.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 15.2 m -139.86 163.95 41.2 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.44 1.496 . . . . 0.0 107.655 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.19 -30.51 80.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.331 2.021 . . . . 0.0 113.069 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -130.04 23.11 5.29 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.552 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 88.7 t80 -153.63 159.28 42.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.091 0.556 . . . . 0.0 109.72 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.4 m -149.36 154.56 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 110.077 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -148.36 123.14 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.96 131.54 47.49 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.961 1.304 . . . . 0.0 108.46 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG22 ' HG3' ' A' ' 46' ' ' LYS . 33.8 t -109.6 126.29 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.74 0.816 . . . . 0.0 109.175 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.31 145.17 26.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.219 0.608 . . . . 0.0 109.652 -170.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.66 -5.56 12.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.974 0.91 . . . . 0.0 112.585 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 10.5 m120 -67.06 -9.12 35.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.445 1.098 . . . . 0.0 112.743 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.69 59.68 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.46 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -119.98 164.22 16.42 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.125 0.97 . . . . 0.0 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' A' ' 40' ' ' VAL . 73.6 tttt -132.02 138.83 48.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.498 HD21 HD23 ' A' ' 9' ' ' LEU . 1.2 tt -137.24 122.6 19.45 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -102.96 170.11 19.58 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.95 0.786 . . . . 0.0 111.653 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.73 109.59 5.77 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 1.9 t-105 -109.26 127.75 54.52 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -79.59 122.86 27.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.006 0.522 . . . . 0.0 110.118 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.35 -15.87 63.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.399 1.08 . . . . 0.0 112.686 -169.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -72.03 -8.88 57.11 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 122.842 0.457 . . . . 0.0 111.233 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -135.1 6.36 3.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.334 0.653 . . . . 0.0 111.244 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.568 HG21 ' HE1' ' A' ' 10' ' ' TYR . 8.3 p -62.75 148.63 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.539 0.335 . . . . 0.0 111.34 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -122.98 113.9 29.76 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.356 0.663 . . . . 0.0 109.783 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.41 144.92 80.67 Favored 'Cis proline' 0 C--N 1.379 2.174 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.084 1.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -52.86 128.29 26.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.66 1.184 . . . . 0.0 112.218 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' OH ' ' A' ' 10' ' ' TYR . . . -150.87 121.14 7.28 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.236 0.614 . . . . 0.0 110.98 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -91.29 86.94 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.34 124.64 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -152.33 123.69 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.114 1.366 . . . . 0.0 107.98 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.63 67.43 0.02 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -82.09 1.69 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.0 -142.92 45.68 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.377 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.552 ' H ' ' H ' ' B' ' 66' ' ' GLY . . . -65.96 151.76 51.93 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.2 mt-10 -102.14 152.89 20.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.164 0.507 . . . . 0.0 110.585 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.4 tp -118.84 102.23 8.65 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.08 115.63 26.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.19 0.519 . . . . 0.0 111.332 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -95.38 108.25 20.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 0.0 108.235 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -92.38 128.08 38.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.586 0.707 . . . . 0.0 111.975 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 118' ' ' TYR . 24.8 m -128.41 160.95 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 13.0 pt-20 -66.79 -35.19 79.49 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.512 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.3 p30 -165.05 178.56 6.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.7 0.682 . . . . 0.0 112.281 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.16 -31.98 63.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.786 1.634 . . . . 0.0 113.1 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.25 -46.87 84.87 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 123.902 0.751 . . . . 0.0 110.101 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.586 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 83.3 mm-40 -67.9 -23.03 65.06 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.653 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.62 -41.68 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.65 0.738 . . . . 0.0 109.904 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.27 -33.82 65.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 110.971 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 41.5 mt-10 -65.91 -44.69 84.45 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.626 0.727 . . . . 0.0 109.312 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -63.49 -37.61 87.95 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.952 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -55.13 -61.54 2.25 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.271 1.029 . . . . 0.0 110.466 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -68.79 -32.69 72.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.301 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.24 -46.39 90.99 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.483 0.489 . . . . 0.0 112.94 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.52 -43.74 98.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.258 0.623 . . . . 0.0 109.529 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -55.84 -45.76 78.31 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.451 0.7 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.74 61.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.297 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 t -100.56 4.1 43.22 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 111.829 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.57 52.91 2.72 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.401 167.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.8 p -94.76 153.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.14 -53.93 15.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.698 0.399 . . . . 0.0 110.771 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.524 ' HB2' HG13 ' A' ' 90' ' ' VAL . 48.6 ttm 64.53 83.8 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 169.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 82.55 1.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.305 0.574 . . . . 0.0 110.599 173.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 176.71 130.46 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.867 1.667 . . . . 0.0 108.303 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -82.15 123.68 79.3 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 107.05 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.469 2.779 . . . . 0.0 111.972 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.06 50.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.777 0.831 . . . . 0.0 111.254 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 98' ' ' LYS . 2.2 mmmm -70.77 100.63 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.545 0.738 . . . . 0.0 110.308 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.7 ttm -101.34 169.4 8.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.258 1.023 . . . . 0.0 108.815 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.12 -41.6 48.97 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.35 1.06 . . . . 0.0 112.136 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.08 -12.12 60.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.581 0.752 . . . . 0.0 111.164 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.96 -173.5 21.55 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.467 0.556 . . . . 0.0 111.933 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -77.14 100.81 5.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.2 t -113.44 147.5 37.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -167.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -140.78 134.21 29.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.098 0.959 . . . . 0.0 109.296 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.8 m -120.26 118.26 29.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.796 0.438 . . . . 0.0 110.272 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.01 169.69 8.35 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.143 0.577 . . . . 0.0 109.894 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.85 127.73 29.39 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.73 169.53 2.5 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.542 0.737 . . . . 0.0 110.791 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -49.51 -31.81 25.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.573 2.182 . . . . 0.0 112.444 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.52 4.0 41.76 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.543 1.137 . . . . 0.0 112.263 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.4 m 59.31 84.2 0.12 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.702 1.201 . . . . 0.0 112.259 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.471 ' HE1' HG12 ' A' ' 11' ' ' VAL . 22.5 m170 -122.73 176.57 5.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.075 0.55 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 67' ' ' GLU . 24.9 mmt180 -100.3 112.46 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.1 mt -111.78 100.32 8.84 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -99.5 93.33 5.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.247 0.219 . . . . 0.0 110.971 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.48 116.21 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 72' ' ' VAL . 23.5 p90 -125.19 168.49 13.37 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.027 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.85 112.04 13.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.75 114.42 18.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.648 0 C-N-CA 123.576 0.75 . . . . 0.0 109.535 -179.353 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.578 ' HG3' HD22 ' A' ' 25' ' ' LEU . 54.3 Cg_endo -90.57 49.69 0.89 Allowed 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.444 2.762 . . . . 0.0 112.851 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.9 p-10 -75.69 14.24 0.67 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.304 1.041 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.474 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.3 t80 -133.48 129.25 36.94 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.222 1.409 . . . . 0.0 108.2 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 8.2 t -126.85 141.3 51.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 55.6 mt -119.79 137.19 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.55 145.43 25.72 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.47 97.74 8.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.223 -169.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.457 HG12 ' HE1' ' B' ' 113' ' ' HIS . 30.5 m -109.14 179.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -123.78 -53.45 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.727 0.411 . . . . 0.0 110.405 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.11 105.12 8.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 123.635 0.774 . . . . 0.0 109.828 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.23 -55.25 3.83 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.576 2.184 . . . . 0.0 114.357 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 -58.63 0.52 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 CA-C-N 122.243 1.837 . . . . 0.0 112.248 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.36 -44.37 94.98 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.282 -166.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m -76.35 -34.57 58.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.662 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 63.3 m -69.34 -39.43 78.15 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.549 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.9 mm-40 -63.89 -35.89 82.15 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.527 172.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 58.2 t80 -68.08 -39.51 82.89 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.322 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -70.18 -30.64 67.81 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.329 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 61.2 mtpt -57.07 -47.63 80.52 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.59 -34.52 53.49 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.264 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 11.8 tp -60.66 -31.93 71.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.699 1.2 . . . . 0.0 112.641 -177.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.526 HD22 ' HG3' ' A' ' 4' ' ' PRO . 91.4 mt -105.07 -40.26 5.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.511 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.38 29.62 10.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 123.725 0.64 . . . . 0.0 111.823 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.4 m -126.62 -179.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.318 1.047 . . . . 0.0 109.809 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.33 150.81 70.0 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.432 0.693 . . . . 0.0 109.209 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.53 111.92 2.69 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.469 2.113 . . . . 0.0 112.26 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 p -64.17 -42.33 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.773 0.829 . . . . 0.0 110.287 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 18.9 mm-40 -111.41 145.93 38.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 108.302 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -154.85 152.05 29.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.279 0.562 . . . . 0.0 110.014 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 24.9 m -139.39 163.4 45.8 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.401 1.48 . . . . 0.0 107.616 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.77 -30.99 69.96 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.483 2.122 . . . . 0.0 113.325 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -130.29 23.0 5.19 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.544 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 70.0 t80 -153.75 159.2 41.87 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -149.37 154.42 38.9 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.826 0.851 . . . . 0.0 109.955 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -148.2 122.91 9.88 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.6 132.58 48.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.853 1.261 . . . . 0.0 108.544 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.5 t -109.99 126.47 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.667 0.787 . . . . 0.0 109.143 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.38 145.15 27.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.174 0.589 . . . . 0.0 109.537 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.16 -5.66 14.51 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.876 0.87 . . . . 0.0 112.655 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.569 ' HB2' ' HG2' ' B' ' 45' ' ' MET . 13.5 m120 -65.8 -10.42 37.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.642 1.177 . . . . 0.0 112.649 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.53 58.58 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.574 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 14.9 ptm -118.76 165.2 14.3 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.238 1.015 . . . . 0.0 109.249 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.55 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.77 139.46 47.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.1 tt -137.79 122.73 18.96 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.036 0.446 . . . . 0.0 110.502 -171.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.474 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.94 169.44 19.0 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 123.997 0.808 . . . . 0.0 111.434 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 45.8 mt -139.94 110.05 6.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -107.76 128.6 54.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -79.69 122.82 27.04 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.071 0.548 . . . . 0.0 110.185 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.433 ' O ' HG12 ' B' ' 55' ' ' VAL . 51.6 ptt85 -69.89 -15.08 63.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.323 1.049 . . . . 0.0 112.621 -169.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -72.62 -8.48 55.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 122.684 0.394 . . . . 0.0 111.132 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.2 t -134.81 4.16 3.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.569 0.748 . . . . 0.0 111.414 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' B' ' 52' ' ' ARG . 10.6 p -60.02 148.23 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.867 0.467 . . . . 0.0 111.562 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -123.68 113.81 28.67 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.804 0.841 . . . . 0.0 109.527 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.76 145.56 81.87 Favored 'Cis proline' 0 C--N 1.382 2.338 0 C-N-CA 124.516 -1.035 . . . . 0.0 113.16 1.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 128.66 30.3 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.553 1.141 . . . . 0.0 111.992 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.32 120.88 7.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.389 0.675 . . . . 0.0 110.886 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 35.6 p -91.12 87.25 6.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.34 124.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.364 0.665 . . . . 0.0 109.739 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -152.64 123.07 7.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.305 1.442 . . . . 0.0 108.123 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.85 67.83 0.02 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.67 -82.24 1.68 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.29 -142.33 44.3 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.809 -0.439 . . . . 0.0 112.452 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.552 ' H ' ' H ' ' A' ' 66' ' ' GLY . . . -66.86 152.46 52.66 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 174.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 10.4 mt-10 -103.9 152.08 22.38 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.042 0.537 . . . . 0.0 110.197 -172.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.441 HD21 HD11 ' B' ' 47' ' ' LEU . 35.4 tp -118.81 102.34 8.74 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.2 116.09 27.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.216 0.531 . . . . 0.0 111.194 -170.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' B' ' 117' ' ' VAL . 29.0 m-85 -96.28 107.96 20.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.135 1.374 . . . . 0.0 108.297 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -91.86 126.4 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.599 0.714 . . . . 0.0 111.89 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.408 HG22 ' O ' ' B' ' 118' ' ' TYR . 29.6 m -126.25 161.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.148 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.88 -34.62 78.19 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -174.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.401 HD22 ' HG3' ' B' ' 73' ' ' GLU . 7.7 p30 -165.78 179.0 6.19 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.648 0.658 . . . . 0.0 112.212 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.39 -31.49 65.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.519 1.528 . . . . 0.0 113.03 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.43 -46.42 86.39 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.181 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.481 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 72.4 mm-40 -68.16 -23.38 64.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.322 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.59 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.574 0.702 . . . . 0.0 109.69 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.48 -32.99 62.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.933 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 33.4 mt-10 -65.9 -44.31 85.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.534 0.683 . . . . 0.0 109.495 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.8 m -64.66 -36.45 84.3 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.991 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -55.03 -61.68 2.15 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.41 1.084 . . . . 0.0 110.28 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.11 -32.32 71.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.368 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.48 -45.66 92.55 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.53 0.519 . . . . 0.0 112.935 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -63.89 -43.19 96.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.333 0.653 . . . . 0.0 109.924 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.65 -45.76 77.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.592 0.757 . . . . 0.0 110.184 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.62 -20.73 61.23 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.345 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.95 4.15 44.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.796 0.838 . . . . 0.0 112.475 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 52.86 2.74 Favored Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 114.471 168.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' B' ' 92' ' ' MET . 4.9 p -94.57 153.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.82 -54.0 15.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.742 0.417 . . . . 0.0 110.991 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.53 ' HB2' HG13 ' B' ' 90' ' ' VAL . 52.9 ttm 64.43 83.7 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.841 0.713 . . . . 0.0 112.67 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.73 82.46 1.86 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.442 0.639 . . . . 0.0 110.741 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' B' ' 106' ' ' THR . 54.0 tp60 176.2 129.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.717 1.607 . . . . 0.0 108.242 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -80.89 123.45 82.22 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 168.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.33 107.11 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.499 2.799 . . . . 0.0 111.876 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.29 141.35 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 111.085 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 100.42 3.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.405 0.682 . . . . 0.0 109.358 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -100.59 170.38 8.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.912 0.885 . . . . 0.0 109.181 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.6 -41.62 54.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.236 1.014 . . . . 0.0 111.746 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -79.93 -11.21 59.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.644 0.777 . . . . 0.0 111.249 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.68 -172.79 21.78 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.9 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -78.56 101.05 7.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -113.7 147.51 38.06 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.895 0.478 . . . . 0.0 110.781 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.77 134.34 30.09 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 109.117 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 1.9 m -120.9 118.42 29.88 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.92 169.94 8.19 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.058 0.543 . . . . 0.0 109.704 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.2 128.51 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.86 170.22 2.73 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.597 0.759 . . . . 0.0 110.41 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.89 -31.88 28.27 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.779 2.319 . . . . 0.0 112.2 165.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.31 4.92 40.91 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.36 1.064 . . . . 0.0 112.047 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 61.0 m 58.53 84.67 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.802 1.241 . . . . 0.0 112.573 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.457 ' HE1' HG12 ' B' ' 11' ' ' VAL . 15.3 m170 -122.78 176.57 5.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.108 0.563 . . . . 0.0 109.612 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' B' ' 67' ' ' GLU . 9.5 mmt180 -100.75 112.48 24.9 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.32 100.6 8.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.594 HH11 ' HG3' ' B' ' 116' ' ' ARG . 8.3 mmt85 -96.8 92.19 6.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.876 -172.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' B' ' 70' ' ' PHE . 5.9 t -91.74 115.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.408 ' O ' HG22 ' B' ' 72' ' ' VAL . 15.9 p90 -124.71 169.02 12.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.789 0.268 . . . . 0.0 111.128 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.95 111.76 13.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.61 115.46 19.23 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.71 0.25 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.835 -174.418 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.0 94.77 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.801 2.334 . . . . 0.0 112.064 171.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.653 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.6 p-10 -96.61 16.7 18.15 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.424 0.63 . . . . 0.0 110.997 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.7 131.57 46.37 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.935 1.294 . . . . 0.0 107.562 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 142.97 49.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.362 1.065 . . . . 0.0 109.03 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 45.7 mt -124.0 139.1 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.546 0.739 . . . . 0.0 110.133 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 47' ' ' LEU . 3.7 mm? -112.02 143.5 42.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.051 0.941 . . . . 0.0 108.556 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.13 106.48 13.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.495 1.118 . . . . 0.0 111.347 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 51' ' ' SER . 14.8 m -107.24 149.38 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -97.06 -52.15 3.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.13 100.58 13.59 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.11 0.964 . . . . 0.0 109.646 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -53.67 -52.71 7.89 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.246 2.631 . . . . 0.0 115.384 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 47.3 Cg_exo -56.68 -51.16 9.69 Favored 'Trans proline' 0 C--N 1.4 3.255 0 CA-C-N 122.267 1.845 . . . . 0.0 112.414 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.19 -38.01 52.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.968 -165.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -78.76 -29.25 45.02 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.235 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 75.9 m -64.95 -48.29 74.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 81.5 mm-40 -66.36 -31.66 72.57 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.196 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -62.96 -48.94 76.73 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.855 0.722 . . . . 0.0 110.045 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -71.81 -29.07 64.05 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.409 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 18' ' ' THR . 56.3 mtpt -56.26 -45.64 79.98 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.753 0.706 . . . . 0.0 112.069 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -42.54 35.8 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.464 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.9 -46.33 85.09 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.904 1.282 . . . . 0.0 112.298 -172.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.39 -47.64 9.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.2 33.75 4.78 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.804 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.18 172.19 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.14 0.976 . . . . 0.0 110.312 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.2 146.75 54.99 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 57.3 Cg_endo -71.26 121.08 7.46 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.994 1.796 . . . . 0.0 112.19 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.76 -44.13 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.545 0.738 . . . . 0.0 110.636 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.6 mm-40 -120.86 107.23 12.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -111.08 144.86 39.54 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.173 0.511 . . . . 0.0 110.696 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -142.07 155.63 65.26 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.715 1.206 . . . . 0.0 108.432 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.92 -10.19 27.55 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.278 1.985 . . . . 0.0 113.146 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -129.29 5.3 5.24 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -157.01 154.84 30.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 70.5 m -140.88 139.89 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.608 0.763 . . . . 0.0 109.256 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 27.7 tp -131.62 121.02 23.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 2.2 p90 -134.28 150.32 50.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.969 0.907 . . . . 0.0 108.943 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 46' ' ' LYS . 19.2 t -126.46 133.9 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.476 ' HB2' ' HG3' ' A' ' 45' ' ' MET . 10.0 mp -97.73 144.72 27.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.25 -10.67 33.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.134 0.974 . . . . 0.0 112.673 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.04 -22.35 66.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.256 1.022 . . . . 0.0 112.127 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.17 16.04 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -116.23 171.88 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.851 0.86 . . . . 0.0 109.022 176.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -142.84 143.11 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.474 HD21 HD23 ' A' ' 9' ' ' LEU . 2.0 tt -142.3 122.19 13.59 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.99 0.424 . . . . 0.0 110.397 -169.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.26 151.97 17.56 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 76.5 mt -116.83 109.61 17.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 162.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.454 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.4 t90 -103.83 124.28 48.64 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 48.8 m -72.51 115.88 12.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -64.77 -8.57 15.46 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.73 1.212 . . . . 0.0 113.873 -169.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -9.89 59.7 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.574 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -135.23 3.01 3.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.837 0.455 . . . . 0.0 111.398 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 13.8 p -64.78 140.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.827 0.451 . . . . 0.0 110.948 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.38 106.76 21.33 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 3.0 Cg_endo -77.25 142.32 71.55 Favored 'Cis proline' 0 C--N 1.383 2.361 0 CA-C-N 120.156 1.091 . . . . 0.0 113.182 10.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HA ' HG13 ' A' ' 55' ' ' VAL . 2.8 tppp? -59.46 109.63 0.93 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.03 0.932 . . . . 0.0 111.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.67 107.58 10.71 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.817 1.247 . . . . 0.0 107.953 174.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 m -100.0 87.84 3.6 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.28 143.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.335 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 112' ' ' SER . 6.3 p -148.95 -176.43 5.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.431 1.092 . . . . 0.0 109.739 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.57 -71.37 2.47 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 32.71 7.27 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.37 59.76 4.94 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 146.14 7.2 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.314 0.483 . . . . 0.0 112.245 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 19.8 mt-10 -103.82 140.87 37.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.08 100.64 7.47 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.698 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -89.36 114.65 26.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.141 0.496 . . . . 0.0 111.777 -168.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -90.42 115.02 27.27 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.564 1.545 . . . . 0.0 107.585 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.657 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 31.3 mtm105 -91.34 128.37 37.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.13 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.17 159.15 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.018 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.4 pt-20 -65.52 -37.23 86.18 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -173.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -162.83 -177.76 5.71 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 118.407 0.549 . . . . 0.0 112.225 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.09 -34.1 71.6 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.75 1.22 . . . . 0.0 112.469 -166.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.26 -41.37 85.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.603 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.621 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 76.3 mm-40 -66.69 -23.06 66.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.079 0.952 . . . . 0.0 112.424 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.33 -40.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.932 0.493 . . . . 0.0 109.882 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.73 -31.37 61.81 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.974 0.91 . . . . 0.0 110.978 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.2 mt-10 -66.33 -47.43 73.55 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -62.99 -36.5 83.75 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.484 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -56.31 -61.39 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.211 1.004 . . . . 0.0 110.361 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.33 77.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.491 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.8 93.6 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.535 0.522 . . . . 0.0 113.373 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -66.65 -39.97 88.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.418 0.687 . . . . 0.0 109.965 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -60.39 -42.54 96.11 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.648 0.779 . . . . 0.0 110.362 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.31 65.14 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.738 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.0 t -95.84 7.2 46.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.315 1.046 . . . . 0.0 112.759 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.53 51.36 6.05 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.927 -0.579 . . . . 0.0 114.306 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.64 137.71 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.461 0.704 . . . . 0.0 109.169 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.05 97.98 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.805 0.842 . . . . 0.0 112.207 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.63 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 12.0 ptm 49.27 82.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.085 1.754 . . . . 0.0 115.409 164.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -114.65 86.12 2.38 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.095 0.558 . . . . 0.0 110.446 178.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 178.38 116.57 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.619 1.568 . . . . 0.0 107.551 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.83 124.36 89.25 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.52 97.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.965 2.444 . . . . 0.0 111.334 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.42 36.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.014 0.926 . . . . 0.0 110.187 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 98.5 2.37 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ttt -90.79 166.38 13.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.802 0.841 . . . . 0.0 109.233 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.34 -41.15 79.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.984 0.914 . . . . 0.0 111.972 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -81.34 -15.35 55.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.142 0.577 . . . . 0.0 111.693 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.55 179.4 22.66 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.182 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -78.05 105.72 9.44 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 118' ' ' TYR . 12.6 t -122.01 155.51 35.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.472 0.654 . . . . 0.0 111.455 -171.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -141.21 150.31 42.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.006 1.722 . . . . 0.0 108.304 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.7 m -136.09 133.66 37.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.996 0.816 . . . . 0.0 111.349 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.71 171.22 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.953 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.42 126.63 29.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.936 170.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.83 172.52 1.37 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.741 1.216 . . . . 0.0 111.798 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -56.18 -35.68 95.64 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.169 1.913 . . . . 0.0 111.446 161.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.86 -18.59 43.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.592 1.157 . . . . 0.0 110.898 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.495 ' O ' ' HB ' ' A' ' 62' ' ' THR . 22.2 m 68.13 101.69 0.05 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 126.262 1.825 . . . . 0.0 111.793 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.462 ' CE1' HG12 ' A' ' 11' ' ' VAL . 17.3 m80 -127.35 175.72 7.98 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.53 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -96.22 95.04 7.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.619 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 92.5 mt -95.6 104.4 16.31 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.698 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 9.9 mmm180 -86.15 143.52 27.97 Favored 'General case' 0 C--O 1.214 -0.816 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.43 111.25 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 166.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.657 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 3.6 p90 -120.84 167.18 12.79 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.264 0.483 . . . . 0.0 110.819 -172.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.25 110.9 8.07 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.402 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 52.0 t80 -76.65 116.9 17.74 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.135 0.425 . . . . 0.0 110.198 -168.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.317 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -88.55 94.83 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.619 2.212 . . . . 0.0 112.144 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.691 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.3 p-10 -96.29 16.48 18.25 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.343 0.592 . . . . 0.0 111.023 171.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.72 131.33 46.28 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.038 1.335 . . . . 0.0 107.587 -173.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 t -132.63 143.07 49.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.328 1.051 . . . . 0.0 108.964 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 16.7 mt -124.23 139.23 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.61 0.764 . . . . 0.0 109.971 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.87 143.09 44.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.047 0.939 . . . . 0.0 108.685 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -80.79 106.48 12.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.447 1.099 . . . . 0.0 111.181 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' B' ' 51' ' ' SER . 15.3 m -107.35 149.66 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -97.45 -52.31 3.84 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.202 -170.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -101.54 100.02 12.98 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.267 1.027 . . . . 0.0 109.685 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.45 -53.05 7.56 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.413 2.742 . . . . 0.0 115.766 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 22.6 Cg_endo -56.9 -50.92 10.11 Favored 'Trans proline' 0 C--N 1.399 3.234 0 CA-C-N 122.084 1.78 . . . . 0.0 112.077 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.09 -38.41 52.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.088 -165.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -78.94 -28.22 43.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.222 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 83.9 m -66.84 -47.25 72.54 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.555 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 69.6 mt-30 -65.1 -33.29 75.69 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.249 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 81.0 t80 -62.45 -48.71 78.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.531 0.732 . . . . 0.0 110.136 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.426 ' O ' ' HG ' ' B' ' 25' ' ' LEU . 41.6 m-85 -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.564 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -55.99 -45.59 78.96 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.87 0.759 . . . . 0.0 111.985 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.52 33.59 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.46 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.3 tp -58.2 -46.23 86.18 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.809 1.244 . . . . 0.0 112.247 -172.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 21' ' ' TYR . 10.8 mt -86.24 -47.74 9.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.79 32.93 4.89 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.597 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.92 171.74 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.164 0.986 . . . . 0.0 110.373 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -124.36 148.17 57.34 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 61.1 Cg_endo -72.7 120.96 7.0 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 121.876 1.718 . . . . 0.0 112.13 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.69 -44.36 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.564 0.746 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 58.8 mm-40 -120.4 108.32 13.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.27 1.028 . . . . 0.0 108.292 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 p -112.33 145.01 40.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.22 0.608 . . . . 0.0 110.347 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -143.02 153.67 60.74 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.141 1.376 . . . . 0.0 108.241 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.56 -10.58 26.89 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.319 2.013 . . . . 0.0 113.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.0 t -129.19 5.69 5.31 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.82 154.97 30.74 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 35.5 t -140.75 140.16 34.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.512 HD11 ' HE2' ' B' ' 46' ' ' LYS . 40.6 tp -132.15 120.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 2.4 p90 -134.01 150.42 51.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 0.0 108.885 170.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' B' ' 46' ' ' LYS . 17.5 t -126.84 134.13 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' B' ' 45' ' ' MET . 9.9 mp -97.53 144.36 27.31 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -10.2 30.04 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.152 0.981 . . . . 0.0 112.554 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.45 -22.2 66.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.406 1.082 . . . . 0.0 112.054 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.36 15.88 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.653 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -116.75 172.25 7.36 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.575 ' HG3' HG22 ' B' ' 40' ' ' VAL . 86.4 tttt -142.91 143.18 31.93 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.28 122.46 13.83 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.13 17.6 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 174.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 76.6 mt -117.04 109.63 17.21 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.423 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -103.82 124.39 48.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.8 m -72.55 116.42 12.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -65.55 -8.27 18.91 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.607 1.163 . . . . 0.0 113.789 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -79.34 -10.34 59.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.231 0.612 . . . . 0.0 111.548 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -134.78 2.43 3.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.88 0.472 . . . . 0.0 111.293 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 12.2 p -64.68 141.29 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.631 0.373 . . . . 0.0 110.851 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.07 107.66 19.9 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 123.909 0.884 . . . . 0.0 109.058 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.47 142.4 73.01 Favored 'Cis proline' 0 C--N 1.387 2.603 0 CA-C-N 119.906 1.002 . . . . 0.0 113.466 8.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.423 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.7 tppp? -58.91 110.17 0.97 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.058 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.82 107.34 10.41 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.823 1.249 . . . . 0.0 108.102 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -99.57 87.8 3.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.64 142.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.182 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' B' ' 112' ' ' SER . 6.2 p -147.65 -176.24 5.17 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.544 1.138 . . . . 0.0 110.149 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.4 -71.66 2.46 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.12 32.58 7.37 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.44 59.74 4.94 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 145.94 7.08 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.288 0.471 . . . . 0.0 112.197 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 18.4 mt-10 -103.62 141.1 36.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.86 100.33 7.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.08 114.76 26.04 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 0.0 111.925 -169.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -90.62 114.52 26.8 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 125.525 1.53 . . . . 0.0 107.453 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.593 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 36.4 mtm105 -90.65 127.08 36.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.934 -175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.22 159.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.159 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.1 pt-20 -65.51 -37.36 86.55 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -163.06 -177.37 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 118.5 0.591 . . . . 0.0 112.205 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -59.52 -33.68 71.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -166.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.09 84.66 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.806 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.552 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -67.05 -22.58 65.86 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.572 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.83 -40.71 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.852 172.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.22 -31.27 62.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.05 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.42 -47.51 73.02 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.113 0.483 . . . . 0.0 109.765 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -35.74 81.39 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.487 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -56.86 -61.35 2.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.696 0.798 . . . . 0.0 110.304 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -65.41 -34.0 77.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.653 -171.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.06 93.34 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.553 0.533 . . . . 0.0 113.326 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -66.28 -40.12 89.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.498 0.719 . . . . 0.0 109.905 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.6 ttpt -60.12 -42.58 95.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.636 0.774 . . . . 0.0 110.46 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.35 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.746 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 30.2 t -96.1 7.73 45.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.241 1.016 . . . . 0.0 112.762 -175.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 52.12 5.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.268 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.07 137.39 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.735 0.814 . . . . 0.0 109.201 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.78 97.99 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.904 0.882 . . . . 0.0 112.38 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 12.0 ptm 49.22 82.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 164.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.508 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -114.68 86.26 2.4 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.285 0.634 . . . . 0.0 110.405 178.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 52.0 tp60 177.78 116.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.768 1.627 . . . . 0.0 107.638 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.64 125.09 90.03 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.06 97.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.936 2.424 . . . . 0.0 110.943 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.65 146.93 37.79 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.02 0.928 . . . . 0.0 110.337 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 98.39 2.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 171.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 8.3 ttt -91.06 166.79 12.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.634 0.774 . . . . 0.0 109.104 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.0 -41.16 77.98 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.688 0.795 . . . . 0.0 112.079 -176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -81.54 -15.54 54.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.62 179.42 22.74 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.032 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -77.74 105.96 9.25 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 11.1 t -122.37 155.53 35.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.554 0.692 . . . . 0.0 111.395 -170.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -141.35 150.26 42.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.889 1.676 . . . . 0.0 108.318 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.5 m -136.05 133.6 37.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.992 0.815 . . . . 0.0 111.352 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.634 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.76 171.15 7.49 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.931 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.19 129.34 35.62 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.4 174.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.692 1.197 . . . . 0.0 110.8 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.11 -34.92 99.02 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.05 1.834 . . . . 0.0 110.828 162.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -82.36 -18.27 42.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.718 1.207 . . . . 0.0 110.818 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' SER . . . . . 0.494 ' O ' ' HB ' ' B' ' 62' ' ' THR . 40.3 m 67.79 101.85 0.05 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.15 1.78 . . . . 0.0 111.656 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.45 ' CE1' HG12 ' B' ' 11' ' ' VAL . 19.5 m80 -127.48 175.47 8.21 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 165.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.549 ' HA ' ' HE ' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -96.09 95.4 8.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.375 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' B' ' 107' ' ' ALA . 93.9 mt -95.64 104.83 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.66 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 34.3 mmt180 -84.47 143.57 29.29 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 25.2 t -137.42 111.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.593 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.5 p90 -120.65 167.46 12.42 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.023 0.374 . . . . 0.0 110.896 -172.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.73 111.44 8.19 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 167.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -77.65 123.47 26.69 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.196 0.453 . . . . 0.0 110.493 -168.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.39 94.59 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 118.891 -0.95 . . . . 0.0 110.923 -176.276 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 119.766 -0.159 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.36 56.47 1.41 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.476 2.784 . . . . 0.0 111.836 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.573 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.0 p-10 -78.36 4.07 13.96 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.886 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.0 OUTLIER -124.23 125.11 43.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.1 t -120.0 137.23 54.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 49.2 mt -116.14 135.07 57.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.364 0.666 . . . . 0.0 109.361 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 156.3 18.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.314 1.054 . . . . 0.0 108.308 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' OH ' HG11 ' A' ' 55' ' ' VAL . 4.0 t80 -110.04 108.36 18.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.823 -173.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.48 HG12 ' NE2' ' A' ' 113' ' ' HIS . 9.9 m -125.12 159.84 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.367 0.603 . . . . 0.0 110.957 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -97.41 -62.7 1.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.396 1.078 . . . . 0.0 109.461 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.28 106.52 13.86 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.224 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.49 -59.72 0.62 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 122.624 2.216 . . . . 0.0 113.959 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 29.8 Cg_endo -57.32 -50.65 10.44 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.355 1.877 . . . . 0.0 111.61 -174.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.07 90.57 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.262 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.8 t -78.69 -20.72 49.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.755 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 m -76.41 -45.49 31.36 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.679 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 57.7 mm-40 -68.61 -30.19 68.87 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.41 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 36.4 t80 -60.85 -51.25 70.12 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 124.115 0.885 . . . . 0.0 110.847 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.39 -27.76 63.55 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.784 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.5 mtpt -56.19 -50.83 70.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.392 0.542 . . . . 0.0 112.408 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.61 56.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.113 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 11.7 tp -60.91 -43.65 98.26 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.408 1.083 . . . . 0.0 112.15 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 27' ' ' VAL . 22.5 mt -95.21 -35.29 11.9 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.971 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.7 37.13 6.2 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.9 m -130.56 -177.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.489 1.116 . . . . 0.0 110.472 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.75 149.79 57.76 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.03 108.96 2.06 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.806 2.337 . . . . 0.0 111.697 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.76 -31.51 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.586 0.754 . . . . 0.0 110.571 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 48.5 mt-10 -119.42 143.15 47.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.291 1.037 . . . . 0.0 108.213 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -159.54 153.72 23.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.817 0.818 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -144.23 164.15 30.71 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 126.069 1.748 . . . . 0.0 107.473 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.58 -16.16 34.76 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.334 2.022 . . . . 0.0 113.484 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.8 t -127.92 13.05 6.79 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -154.38 159.94 41.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -153.37 153.91 33.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.489 1.116 . . . . 0.0 109.469 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.7 tm? -146.33 123.71 11.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -130.81 137.24 49.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.601 1.16 . . . . 0.0 108.307 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.536 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.7 t -112.09 123.0 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.633 HD12 ' SD ' ' A' ' 45' ' ' MET . 76.2 mt -89.34 148.73 23.36 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.96 0.504 . . . . 0.0 110.188 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -7.01 19.12 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.22 1.008 . . . . 0.0 113.513 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -82.03 4.41 22.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 111.789 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.3 64.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.629 -0.189 . . . . 0.0 112.629 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.633 ' SD ' HD12 ' A' ' 41' ' ' LEU . 5.1 ppp? -117.61 171.54 7.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.631 0.772 . . . . 0.0 109.779 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 40' ' ' VAL . 83.0 tttt -135.35 139.43 44.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 68' ' ' LEU . 1.2 tt -137.34 123.99 21.04 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.174 0.512 . . . . 0.0 110.113 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.411 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.94 169.97 20.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.828 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.9 tp -139.92 104.78 4.94 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -114.71 128.92 56.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.6 m -78.71 134.95 37.05 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.168 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.0 -19.96 64.97 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.755 0.822 . . . . 0.0 113.2 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -8.41 58.78 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -129.77 7.72 5.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.858 0.463 . . . . 0.0 111.33 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.503 HG11 ' OH ' ' A' ' 10' ' ' TYR . 11.8 p -69.87 147.43 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HB3' ' NE2' ' B' ' 94' ' ' GLN . 35.6 mt-10 -128.25 113.65 19.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 0.0 109.52 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.72 143.19 77.06 Favored 'Cis proline' 0 C--N 1.388 2.636 0 CA-C-N 119.723 0.937 . . . . 0.0 112.674 2.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -50.09 124.31 9.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.501 1.12 . . . . 0.0 112.063 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.41 155.68 43.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.172 0.989 . . . . 0.0 109.333 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.3 m -132.79 94.23 3.35 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.97 125.18 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.13 0.972 . . . . 0.0 108.855 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -140.09 142.62 36.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.761 0.824 . . . . 0.0 109.373 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.51 23.22 73.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.624 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' B' ' 61' ' ' VAL . . . -160.84 140.74 6.88 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.27 -156.23 26.85 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.59 172.0 54.81 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.525 0.191 . . . . 0.0 112.713 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 68.9 mt-10 -99.49 152.03 20.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 47' ' ' LEU . 45.8 tp -110.09 100.55 9.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -84.61 113.76 21.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.007 0.432 . . . . 0.0 111.571 -167.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -93.12 106.62 18.56 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.854 1.262 . . . . 0.0 107.921 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -90.62 131.37 36.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.122 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.04 165.08 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.49 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.1 pt-20 -69.38 -43.81 72.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.402 HD22 ' HG3' ' A' ' 73' ' ' GLU . 9.3 p30 -155.25 177.99 10.72 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.703 0.683 . . . . 0.0 112.626 -174.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.15 -32.96 70.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.158 1.383 . . . . 0.0 112.421 -167.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.34 -42.77 74.85 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.634 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 78.9 mm-40 -64.58 -24.16 67.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.644 0.778 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.24 -40.08 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.349 0.595 . . . . 0.0 110.003 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.1 -30.22 62.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.195 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -67.77 -42.99 80.84 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 109.141 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.7 m -65.01 -37.93 89.26 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.357 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.94 -60.92 2.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.921 0.888 . . . . 0.0 109.628 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -60.83 -39.17 88.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.733 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.6 -39.35 86.64 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.415 0.447 . . . . 0.0 113.828 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -67.89 -42.48 81.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.374 0.669 . . . . 0.0 109.64 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.7 ttpt -57.63 -43.88 85.16 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.791 0.836 . . . . 0.0 110.387 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.9 -30.56 71.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.692 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.5 m -102.24 14.8 30.98 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.099 0.959 . . . . 0.0 112.094 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 46.36 5.68 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 163.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -101.72 132.23 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.144 0.578 . . . . 0.0 109.745 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.51 95.13 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.918 0.887 . . . . 0.0 111.708 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 4.8 ptm 50.3 81.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.567 1.547 . . . . 0.0 113.771 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.52 83.67 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.61 -0.681 . . . . 0.0 109.962 -178.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' B' ' 56' ' ' GLU . 5.7 tp60 177.39 134.68 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.52 1.528 . . . . 0.0 108.028 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -79.31 120.67 81.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 15.6 Cg_endo -58.71 106.3 0.27 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.642 2.228 . . . . 0.0 110.378 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.85 152.36 46.41 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.309 0.644 . . . . 0.0 110.21 -175.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -62.42 137.79 58.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.543 0.737 . . . . 0.0 110.466 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.412 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 20.1 ttt -142.82 175.76 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 109.392 -175.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 99' ' ' MET . 11.5 tp10 -51.35 -32.37 25.44 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.453 1.501 . . . . 0.0 112.921 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.42 -5.22 23.12 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.663 0.785 . . . . 0.0 111.384 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.91 -167.51 20.18 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.078 176.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.7 101.59 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.409 HG21 ' SD ' ' A' ' 99' ' ' MET . 9.4 t -115.63 149.1 38.84 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.376 -167.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 3.2 t80 -146.51 129.41 16.33 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.573 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -120.66 119.22 32.21 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.26 159.04 16.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 -175.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -141.1 127.49 19.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 170.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.64 178.89 2.09 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.134 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -32.83 94.08 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.743 2.295 . . . . 0.0 113.644 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.83 -4.92 46.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.758 0.423 . . . . 0.0 111.18 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.0 m 72.45 60.02 0.13 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.118 1.367 . . . . 0.0 110.995 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.48 ' NE2' HG12 ' A' ' 11' ' ' VAL . 19.7 m170 -97.67 -167.09 1.47 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.17 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.43 93.87 1.94 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.7 mt -116.79 101.95 8.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.833 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 2.3 tmm_? -102.8 99.26 9.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.004 0.521 . . . . 0.0 111.29 -169.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.03 140.6 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.5 0.72 . . . . 0.0 109.226 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.499 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 16.7 p90 -143.66 161.69 37.88 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.659 0.663 . . . . 0.0 112.607 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.405 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -110.67 129.87 55.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.71 124.52 23.52 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.274 0.359 . . . . 0.0 110.367 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.545 0 O-C-N 123.772 0.67 . . . . 0.0 110.48 -178.018 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.8 56.01 1.66 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.499 2.799 . . . . 0.0 111.95 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.9 p-10 -77.59 3.91 12.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.685 0.794 . . . . 0.0 112.146 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -123.85 124.85 43.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -120.32 137.53 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 37.0 mt -117.3 134.76 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.374 0.67 . . . . 0.0 109.468 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.599 HD11 HD22 ' B' ' 68' ' ' LEU . 65.9 mt -90.56 155.69 18.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.334 1.064 . . . . 0.0 108.973 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.03 107.83 19.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 112.93 -1.941 . . . . 0.0 108.184 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.98 160.05 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.377 0.608 . . . . 0.0 110.838 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.81 -62.12 1.29 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.41 1.084 . . . . 0.0 109.713 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -90.78 105.92 13.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.391 0.676 . . . . 0.0 109.495 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -56.4 -60.97 0.38 Allowed 'Trans proline' 0 CA--C 1.573 2.443 0 C-N-CA 122.435 2.09 . . . . 0.0 113.878 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.7 -51.99 9.12 Favored 'Trans proline' 0 C--N 1.41 3.789 0 CA-C-N 122.47 1.918 . . . . 0.0 112.405 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.13 92.94 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.4 t -78.45 -20.61 50.62 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.1 m -76.88 -45.33 28.59 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.45 0.643 . . . . 0.0 111.652 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.487 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.2 mm-40 -67.92 -30.78 70.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.464 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 74.9 t80 -60.4 -50.91 71.7 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.786 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -72.19 -27.43 62.55 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.201 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 56.4 mtpt -56.27 -50.94 69.93 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.53 -36.06 57.91 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.051 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 8.8 tp -60.94 -43.25 98.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.074 0.95 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' B' ' 27' ' ' VAL . 27.0 mt -95.35 -35.49 11.75 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.07 36.85 6.17 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' B' ' 25' ' ' LEU . 34.2 m -130.38 -177.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.562 1.145 . . . . 0.0 110.256 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -140.75 149.21 55.85 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.66 0.784 . . . . 0.0 109.489 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.91 108.51 1.71 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.48 2.12 . . . . 0.0 112.019 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.18 -31.97 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.608 0.763 . . . . 0.0 110.516 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.668 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 45.4 mt-10 -119.31 143.42 47.38 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 167.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 21.5 t -159.54 153.63 23.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.651 0.739 . . . . 0.0 111.111 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 35.6 m -143.96 165.11 25.86 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 126.109 1.764 . . . . 0.0 107.357 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.12 -15.58 40.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.045 1.83 . . . . 0.0 113.103 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.3 t -128.11 13.02 6.7 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -154.3 159.55 41.3 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.013 -0.429 . . . . 0.0 110.78 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 60.6 m -153.3 154.01 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.555 1.142 . . . . 0.0 109.529 171.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -146.37 123.45 11.45 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -130.09 138.44 50.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.286 1.035 . . . . 0.0 108.654 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.526 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.3 t -112.51 123.41 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.698 HD12 ' SD ' ' B' ' 45' ' ' MET . 80.5 mt -89.98 148.6 22.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.837 0.455 . . . . 0.0 110.282 -168.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -7.56 21.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.119 0.968 . . . . 0.0 113.578 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -81.57 4.63 20.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.745 0.818 . . . . 0.0 112.251 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.06 11.86 64.4 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.698 ' SD ' HD12 ' B' ' 41' ' ' LEU . 5.0 ppp? -117.56 171.62 7.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.501 0.72 . . . . 0.0 109.597 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.526 ' HG3' HG22 ' B' ' 40' ' ' VAL . 84.3 tttt -135.73 140.05 44.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.2 tt -138.18 123.76 19.68 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.184 0.516 . . . . 0.0 110.269 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.88 168.98 19.67 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.844 0.735 . . . . 0.0 112.724 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 39.1 mt -137.81 105.2 5.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 169.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.474 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.5 t90 -114.32 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 50.9 m -78.72 134.61 37.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.423 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -68.02 -19.26 64.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 0.0 112.965 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -79.42 -9.15 59.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.5 0.32 . . . . 0.0 111.295 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.5 t -128.92 7.48 5.58 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.024 0.529 . . . . 0.0 111.318 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 11.8 p -69.66 147.15 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 94' ' ' GLN . 26.3 mt-10 -128.7 113.91 19.2 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.319 0.648 . . . . 0.0 110.056 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 94' ' ' GLN . 97.7 Cg_endo -73.0 143.57 78.26 Favored 'Cis proline' 0 C--N 1.387 2.583 0 CA-C-N 119.472 0.847 . . . . 0.0 113.226 2.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 126.14 18.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.097 0.959 . . . . 0.0 110.527 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.96 155.96 44.24 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.454 1.102 . . . . 0.0 109.715 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.4 m -132.7 92.55 3.07 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.617 0.767 . . . . 0.0 109.013 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.504 HG21 ' HA3' ' A' ' 64' ' ' GLY . 79.2 t -141.69 125.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.312 1.045 . . . . 0.0 108.568 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.7 p -140.07 141.71 36.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.83 0.852 . . . . 0.0 109.215 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.9 24.5 69.3 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.477 0.485 . . . . 0.0 112.395 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.85 139.26 5.87 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.86 -155.35 26.5 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 10' ' ' TYR . . . -77.43 172.64 55.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.569 ' HA ' ' HG3' ' B' ' 114' ' ' ARG . 6.0 mm-40 -99.68 151.24 21.44 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.599 HD22 HD11 ' B' ' 9' ' ' LEU . 50.1 tp -109.78 101.1 10.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -84.9 113.99 21.79 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.125 0.42 . . . . 0.0 111.604 -167.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -93.53 106.51 18.47 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -90.67 131.05 36.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.145 0.497 . . . . 0.0 111.893 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.65 165.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.4 1.08 . . . . 0.0 110.541 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.527 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.0 pt-20 -69.2 -44.1 72.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.518 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.434 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.9 p30 -155.23 178.15 10.54 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.762 0.71 . . . . 0.0 112.7 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.753 1.621 . . . . 0.0 112.608 -167.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.49 -42.26 75.01 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.708 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.527 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.3 mm-40 -65.39 -24.03 67.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.697 0.799 . . . . 0.0 112.458 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.35 -40.52 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.353 0.597 . . . . 0.0 110.009 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.28 -30.43 63.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.303 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 18.5 mt-10 -67.96 -43.0 80.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.702 0.763 . . . . 0.0 109.213 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.3 m -64.96 -37.58 88.13 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.193 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.49 -60.92 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.767 0.827 . . . . 0.0 109.531 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.446 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -60.66 -38.56 85.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.902 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.69 -39.72 86.03 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.43 0.456 . . . . 0.0 113.878 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -67.85 -42.06 81.96 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.394 0.678 . . . . 0.0 109.679 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.45 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 31.9 ttpt -58.89 -43.33 90.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 0.0 110.229 177.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.77 -30.24 70.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.664 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.6 m -102.55 14.93 30.68 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.926 0.891 . . . . 0.0 112.256 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.82 47.1 5.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.219 -0.9 . . . . 0.0 114.957 163.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.59 131.69 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.213 0.605 . . . . 0.0 109.499 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.89 92.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.86 0.864 . . . . 0.0 112.114 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.45 ' HE1' ' HB2' ' B' ' 86' ' ' LYS . 13.5 ptp 48.94 82.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.655 1.582 . . . . 0.0 114.128 172.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.418 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -106.67 83.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.453 0.644 . . . . 0.0 109.941 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.489 ' NE2' ' HB3' ' A' ' 56' ' ' GLU . 5.7 tp60 177.45 133.78 0.06 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 108.14 174.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -78.07 121.38 83.91 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 20.0 Cg_endo -60.12 106.34 0.33 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.654 2.236 . . . . 0.0 110.117 172.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.78 152.25 46.42 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.263 0.625 . . . . 0.0 110.158 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -62.89 138.48 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.328 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.482 ' SD ' HG21 ' B' ' 104' ' ' THR . 11.4 ttt -143.26 175.22 10.06 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.73 0.812 . . . . 0.0 109.007 -174.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' B' ' 99' ' ' MET . 11.3 tp10 -51.98 -32.57 34.17 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.113 1.365 . . . . 0.0 112.964 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.07 -6.37 23.42 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.614 0.765 . . . . 0.0 111.281 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 128.84 -168.2 20.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.528 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -76.02 101.23 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.482 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.4 t -115.1 149.06 38.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.501 0.667 . . . . 0.0 111.328 -167.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 2.6 t80 -146.48 129.37 16.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.465 1.506 . . . . 0.0 108.537 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 119.54 33.09 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.114 0.483 . . . . 0.0 109.812 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -107.35 158.71 16.94 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.875 0.87 . . . . 0.0 112.464 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.65 129.72 23.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.2 p-10 -88.33 179.94 1.51 Allowed Pre-proline 0 CA--C 1.575 1.905 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.346 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 25.4 Cg_endo -58.72 -32.22 96.53 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.499 2.132 . . . . 0.0 113.239 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.66 -5.3 47.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.787 0.435 . . . . 0.0 110.908 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m 72.7 60.4 0.12 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.137 1.375 . . . . 0.0 110.66 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -97.9 -168.23 1.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.377 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' B' ' 67' ' ' GLU . 4.2 tpp180 -149.13 94.94 2.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -175.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.01 101.78 8.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.017 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 3.4 tmt_? -100.28 98.12 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.167 0.587 . . . . 0.0 112.079 -169.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.29 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -143.48 161.42 38.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.714 0.688 . . . . 0.0 112.375 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -110.75 130.59 55.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 168.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -68.91 123.38 20.83 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.161 0.288 . . . . 0.0 110.664 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.86 106.64 17.21 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.973 -0.904 . . . . 0.0 111.064 -179.052 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.414 ' HB3' HD23 ' B' ' 41' ' ' LEU . 12.5 m170 . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -91.02 101.26 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.139 2.559 . . . . 0.0 112.737 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.77 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 4.2 p30 -85.03 -2.23 57.73 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.218 0.532 . . . . 0.0 111.06 169.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -118.46 112.27 19.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -168.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -109.76 131.71 54.82 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.52 132.42 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' HB2' HD12 ' A' ' 49' ' ' LEU . 90.2 mt -96.92 173.23 7.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.091 0.948 . . . . 0.0 108.941 173.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -130.38 120.29 24.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.442 -174.144 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG12 ' NE2' ' A' ' 113' ' ' HIS . 10.3 m -125.89 155.84 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.861 0.864 . . . . 0.0 109.679 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.84 -56.83 3.17 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -94.93 110.36 49.34 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.163 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 31.8 Cg_exo -54.94 -57.25 1.8 Allowed 'Trans proline' 0 CA--C 1.573 2.455 0 C-N-CA 122.749 2.3 . . . . 0.0 114.232 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 34.9 Cg_exo -58.32 -58.63 0.7 Allowed 'Trans proline' 0 C--N 1.401 3.319 0 CA-C-N 122.181 1.815 . . . . 0.0 112.146 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.71 95.22 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.753 0.821 . . . . 0.0 112.36 -167.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -76.42 -33.84 58.79 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 88.9 m -73.1 -39.77 65.52 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 20.6 mm-40 -59.75 -36.87 77.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.89 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.27 -44.51 94.91 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 110.233 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -70.91 -29.16 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.02 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 18' ' ' THR . 60.1 mtpt -56.63 -47.7 79.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.805 0.729 . . . . 0.0 112.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.87 47.28 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.758 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp -63.7 -40.59 97.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.516 1.126 . . . . 0.0 112.332 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' VAL . 32.2 mt -93.46 -38.55 11.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.18 24.85 18.22 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.537 0.523 . . . . 0.0 111.809 -173.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.3 m -118.58 174.91 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.024 0.93 . . . . 0.0 110.449 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.9 143.97 51.28 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 108.968 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.71 112.4 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.634 2.223 . . . . 0.0 111.402 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.74 -36.51 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.447 0.699 . . . . 0.0 109.769 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.8 mm-40 -112.02 87.03 2.47 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.5 p -90.19 127.62 36.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.43 0.692 . . . . 0.0 109.214 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -140.61 152.81 67.14 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.985 0.914 . . . . 0.0 108.538 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -46.35 -44.68 20.04 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.871 3.048 . . . . 0.0 114.646 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -126.92 15.94 7.39 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.6 151.3 37.87 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -140.58 142.72 35.07 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -139.53 121.08 15.17 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -133.05 131.72 40.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.554 1.141 . . . . 0.0 108.637 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 46' ' ' LYS . 16.2 t -109.49 129.62 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.039 -173.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.494 HD12 ' SD ' ' A' ' 45' ' ' MET . 49.4 mt -94.27 143.0 26.76 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.786 0.434 . . . . 0.0 110.445 -171.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -5.76 19.43 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.376 1.07 . . . . 0.0 112.299 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.501 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.7 OUTLIER -67.34 -19.51 65.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.769 1.228 . . . . 0.0 111.627 177.034 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.44 16.62 15.56 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.728 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -125.66 176.26 7.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.518 0.727 . . . . 0.0 109.54 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.6 tttt -140.32 137.53 34.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.02 118.55 18.94 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.772 0.429 . . . . 0.0 110.084 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.31 163.22 21.88 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.521 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 9' ' ' LEU . 1.1 tp -141.43 104.85 4.66 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.7 t90 -111.09 134.83 52.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.902 0.881 . . . . 0.0 108.678 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 54' ' ' THR . 35.9 m -75.83 136.39 40.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.751 0.31 . . . . 0.0 111.249 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -72.5 -9.86 59.08 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.993 0.917 . . . . 0.0 112.455 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -86.89 -8.8 56.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.202 0.601 . . . . 0.0 111.181 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 51' ' ' SER . 15.4 t -135.04 8.24 3.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.177 0.591 . . . . 0.0 111.339 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.2 p -68.28 143.45 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 122.58 0.352 . . . . 0.0 111.372 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.39 117.23 25.11 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.556 1.142 . . . . 0.0 108.706 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 12.4 Cg_exo -70.88 144.13 78.07 Favored 'Cis proline' 0 C--N 1.386 2.531 0 CA-C-N 119.681 0.922 . . . . 0.0 112.992 -1.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.17 128.76 37.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.149 0.98 . . . . 0.0 111.958 -177.002 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.45 109.03 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.764 1.226 . . . . 0.0 108.531 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.2 p -87.83 89.15 7.88 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.3 142.84 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.523 0.729 . . . . 0.0 109.847 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -138.96 135.55 34.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.226 1.01 . . . . 0.0 109.22 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.38 51.75 49.67 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.61 0.569 . . . . 0.0 114.227 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.18 44.99 0.42 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.87 -169.51 11.69 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.781 -0.209 . . . . 0.0 113.125 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.97 170.12 47.67 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 124.38 0.694 . . . . 0.0 113.009 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -98.53 160.04 14.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.918 0.887 . . . . 0.0 110.561 -171.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 68' ' ' LEU . 20.4 mt -107.09 101.23 10.66 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.54 103.53 14.48 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -82.46 106.17 14.11 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -84.72 128.89 34.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.816 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.74 157.92 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.811 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG3' HD22 ' A' ' 74' ' ' ASN . 10.9 pt-20 -68.17 -42.06 80.58 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.93 -172.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.45 HD22 ' HG3' ' A' ' 73' ' ' GLU . 9.5 p30 -151.05 174.38 13.24 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-O 121.49 0.662 . . . . 0.0 112.059 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.51 -27.64 69.11 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.41 -165.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.06 -42.11 76.69 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.304 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 80.3 mm-40 -62.87 -23.73 67.47 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.588 0.755 . . . . 0.0 112.568 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.5 -42.83 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.429 0.633 . . . . 0.0 110.457 171.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.76 -30.77 67.35 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.66 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -70.68 -43.11 69.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.371 0.605 . . . . 0.0 109.683 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -30.23 69.07 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.759 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -62.25 -60.88 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.898 0.879 . . . . 0.0 109.005 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.43 89.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.766 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.2 -45.13 94.45 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 124.115 0.885 . . . . 0.0 113.908 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -64.2 -45.52 87.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.17 0.588 . . . . 0.0 110.288 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.3 -46.02 76.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.576 0.75 . . . . 0.0 110.269 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.61 63.42 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.52 14.46 29.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 112.539 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 55.27 3.61 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.439 -0.8 . . . . 0.0 114.776 166.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.4 p -104.33 148.79 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.63 56.42 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.879 0.471 . . . . 0.0 111.456 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.552 ' HB2' HG13 ' A' ' 90' ' ' VAL . 55.5 ttm 63.56 84.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 166.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 86.75 2.63 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 121.332 0.587 . . . . 0.0 110.83 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 106' ' ' THR . 55.7 tp60 179.02 122.57 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.519 1.528 . . . . 0.0 108.187 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.54 114.94 49.7 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.61 107.26 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.385 2.723 . . . . 0.0 112.256 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.81 145.51 42.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 110.021 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 112.24 8.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.437 ' HG3' ' H ' ' A' ' 101' ' ' PHE . 49.4 tpp -100.46 162.63 12.81 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.64 -23.08 62.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.237 0.615 . . . . 0.0 111.007 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 99' ' ' MET . 15.5 m-85 -120.72 90.77 3.39 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.374 1.07 . . . . 0.0 108.555 174.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.48 152.08 1.12 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.558 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 84.8 t80 -71.97 101.06 2.6 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 165.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -109.25 151.26 26.77 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.813 0.816 . . . . 0.0 112.04 -161.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.74 149.75 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.563 1.545 . . . . 0.0 108.498 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 87.6 m -141.23 128.3 20.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.751 0.705 . . . . 0.0 110.497 171.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.99 155.91 18.91 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.137 0.575 . . . . 0.0 109.79 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.73 126.31 52.45 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.54 156.5 22.86 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.055 0.942 . . . . 0.0 111.484 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.56 -21.91 73.17 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.739 2.293 . . . . 0.0 112.431 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -92.29 -20.69 20.86 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.142 0.977 . . . . 0.0 110.559 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.2 m 72.63 90.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.873 1.669 . . . . 0.0 110.967 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.506 ' NE2' HG12 ' A' ' 11' ' ' VAL . 10.5 m80 -113.18 -92.32 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 113' ' ' HIS . 4.7 tpt180 167.98 109.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.281 1.032 . . . . 0.0 109.348 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.6 110.33 13.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.141 0.577 . . . . 0.0 111.175 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -95.3 147.55 23.37 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.337 0.517 . . . . 0.0 110.685 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.04 125.58 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -130.62 151.77 50.71 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.092 0.86 . . . . 0.0 111.489 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -103.81 117.55 34.63 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -77.64 111.96 13.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.329 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.3 m80 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.66 -0.209 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.41 ' HD3' HD22 ' A' ' 25' ' ' LEU . 65.0 Cg_endo -91.75 101.91 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.014 2.476 . . . . 0.0 112.237 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.728 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.9 p-10 -86.01 -1.68 57.58 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.416 0.627 . . . . 0.0 111.019 169.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.409 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.1 t80 -118.53 112.45 19.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -169.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -109.78 131.55 54.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 52.3 mt -113.8 132.86 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' B' ' 49' ' ' LEU . 93.2 mt -97.49 172.05 7.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.918 0.866 . . . . 0.0 109.005 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' B' ' 50' ' ' TRP . 30.9 m-85 -128.22 122.11 30.99 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.897 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.478 HG12 ' NE2' ' B' ' 113' ' ' HIS . 6.2 m -125.93 155.94 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.81 0.844 . . . . 0.0 109.523 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -88.01 -56.77 3.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.179 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -94.42 109.31 42.2 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.244 0.618 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.41 -56.92 2.1 Favored 'Trans proline' 0 CA--C 1.574 2.491 0 C-N-CA 122.68 2.254 . . . . 0.0 114.269 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.37 -58.79 0.54 Allowed 'Trans proline' 0 C--N 1.402 3.369 0 CA-C-N 122.179 1.814 . . . . 0.0 111.714 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.06 92.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.788 0.835 . . . . 0.0 112.494 -167.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -76.31 -33.82 59.04 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.023 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -73.11 -39.78 65.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.53 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 19.8 mm-40 -59.61 -37.33 78.29 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.712 172.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' B' ' 90' ' ' VAL . 78.2 t80 -62.5 -45.36 93.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.467 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.44 -29.27 65.81 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.025 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 63.4 mtpt -56.94 -47.33 80.9 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.794 0.725 . . . . 0.0 112.867 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.86 44.54 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.872 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -63.45 -40.23 96.6 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.614 1.166 . . . . 0.0 112.533 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' B' ' 27' ' ' VAL . 34.3 mt -93.57 -39.13 11.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.24 25.91 15.36 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.848 -173.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' B' ' 25' ' ' LEU . 18.2 m -119.38 175.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.093 0.957 . . . . 0.0 110.406 -176.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.31 140.66 37.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 50.8 Cg_exo -57.22 111.54 0.85 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.915 2.41 . . . . 0.0 112.29 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.91 -35.88 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 109.88 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 26.8 mm-40 -112.35 87.63 2.62 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.5 p -90.66 128.18 36.54 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -141.51 153.37 65.44 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -47.83 -44.29 27.29 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.764 2.976 . . . . 0.0 114.569 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -126.57 16.14 7.59 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -145.58 151.65 38.45 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -140.63 142.17 35.02 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.665 0.786 . . . . 0.0 108.889 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.68 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.3 tm? -138.98 121.14 15.77 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -133.04 132.0 41.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 108.607 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.538 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.5 t -110.45 129.46 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.921 0.888 . . . . 0.0 109.012 -173.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.494 HD22 ' SD ' ' B' ' 45' ' ' MET . 7.8 mp -93.66 142.76 26.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 0.0 110.135 -170.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.44 -5.89 21.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.986 0.914 . . . . 0.0 112.385 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.45 ' N ' HD22 ' B' ' 43' ' ' ASN . 0.8 OUTLIER -66.69 -19.74 65.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.659 1.183 . . . . 0.0 111.976 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.29 16.79 15.26 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.176 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.77 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.5 ppp? -125.52 175.95 7.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.747 0.819 . . . . 0.0 109.723 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.538 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -140.36 137.68 34.26 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -133.03 118.84 19.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.753 0.421 . . . . 0.0 110.234 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.409 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -97.47 163.33 21.76 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' B' ' 9' ' ' LEU . 1.1 tp -141.75 104.68 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 171.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 3.3 t90 -111.43 134.78 52.77 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.407 ' HB2' HG22 ' B' ' 54' ' ' THR . 35.3 m -76.12 136.56 39.83 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 111.355 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -72.48 -9.88 59.1 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.917 0.887 . . . . 0.0 112.335 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -87.18 -8.18 57.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.28 0.632 . . . . 0.0 111.095 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.407 HG22 ' HB2' ' B' ' 51' ' ' SER . 13.2 t -135.42 8.8 3.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.907 0.483 . . . . 0.0 111.342 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' B' ' 58' ' ' LYS . 4.0 p -67.93 143.3 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.38 0.272 . . . . 0.0 111.272 176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -123.81 117.49 27.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.246 1.018 . . . . 0.0 109.181 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.3 143.41 76.32 Favored 'Cis proline' 0 C--N 1.381 2.277 0 CA-C-N 120.098 1.071 . . . . 0.0 113.105 -1.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.535 ' HA ' HG13 ' B' ' 55' ' ' VAL . 3.1 tppp? -58.84 127.81 34.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.992 0.917 . . . . 0.0 112.66 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.08 108.92 3.1 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.78 1.232 . . . . 0.0 108.677 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -87.0 89.73 8.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.16 0.584 . . . . 0.0 109.507 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 142.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.551 0.741 . . . . 0.0 110.422 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -139.24 136.55 35.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 109.479 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.75 51.84 50.48 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.752 0.658 . . . . 0.0 114.172 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.05 45.72 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.45 -170.63 12.03 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.455 -0.372 . . . . 0.0 113.124 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.4 170.56 47.99 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.258 0.622 . . . . 0.0 112.975 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -99.93 159.81 14.8 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.589 0.756 . . . . 0.0 110.77 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.78 101.36 10.81 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.58 103.69 14.65 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -82.81 105.78 14.1 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 41.0 mtm105 -84.6 127.99 34.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.689 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.56 157.79 43.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.963 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.26 -42.39 83.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.037 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.99 174.33 13.27 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 121.497 0.665 . . . . 0.0 111.876 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.61 -27.7 69.12 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.139 -1.392 . . . . 0.0 112.461 -165.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.99 -41.84 77.3 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -63.56 -23.71 67.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.561 0.745 . . . . 0.0 112.392 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.33 -42.65 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.252 0.621 . . . . 0.0 110.631 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.43 -31.12 68.17 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.594 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.2 mt-10 -70.98 -42.69 69.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.408 0.623 . . . . 0.0 109.557 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -69.19 -29.81 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -62.64 -60.68 3.17 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.549 0.74 . . . . 0.0 109.143 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.17 88.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.801 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.06 94.38 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 124.041 0.838 . . . . 0.0 113.615 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -63.88 -45.7 88.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.308 0.643 . . . . 0.0 110.235 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.82 -45.7 78.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.582 0.753 . . . . 0.0 110.454 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.91 63.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.028 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -99.45 14.15 30.81 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.959 0.903 . . . . 0.0 112.43 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 54.25 3.65 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.709 -0.678 . . . . 0.0 114.751 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' B' ' 20' ' ' PHE . 38.3 t -104.26 147.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.248 0.619 . . . . 0.0 109.339 170.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.15 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.092 0.557 . . . . 0.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 55.0 ttm 63.84 84.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 166.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.62 86.77 2.64 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.863 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 22.9 tm0? 178.82 122.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.072 1.349 . . . . 0.0 107.644 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -79.58 114.48 45.94 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -48.64 107.53 0.14 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.567 2.845 . . . . 0.0 112.178 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.84 145.31 42.3 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.942 0.897 . . . . 0.0 109.941 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.28 112.38 8.3 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.521 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 16.5 ttm -101.18 162.91 12.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.78 -23.9 63.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 0.0 111.106 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' PHE . . . . . 0.521 ' H ' ' HG2' ' B' ' 99' ' ' MET . 96.3 m-85 -119.51 91.49 3.56 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.552 1.141 . . . . 0.0 109.033 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.78 151.56 1.13 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 80.1 t80 -71.8 100.87 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.3 t -108.77 151.14 26.61 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.948 0.88 . . . . 0.0 111.893 -161.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.544 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 9.6 t80 -141.15 149.23 41.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.036 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 62.6 m -141.57 128.19 20.25 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.982 0.81 . . . . 0.0 110.69 171.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.23 155.77 19.14 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.279 0.632 . . . . 0.0 109.935 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.61 128.43 54.53 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.22 156.86 57.54 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.197 0.999 . . . . 0.0 110.361 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.0 -21.71 72.38 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -92.93 -20.12 20.94 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.962 0.905 . . . . 0.0 110.377 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 40.2 m 71.9 90.99 0.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.965 1.706 . . . . 0.0 111.108 -176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.478 ' NE2' HG12 ' B' ' 11' ' ' VAL . 12.4 m170 -113.88 -91.68 0.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 167.32 109.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.577 1.151 . . . . 0.0 109.176 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -126.36 110.19 13.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.11 0.564 . . . . 0.0 111.153 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -92.56 147.86 22.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.215 0.606 . . . . 0.0 110.581 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -134.74 125.74 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 163.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.417 ' CE1' ' HG2' ' B' ' 71' ' ' ARG . 12.4 p90 -130.15 151.77 50.31 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.295 0.952 . . . . 0.0 111.479 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -104.11 116.46 32.24 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -74.84 107.61 7.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.24 100.19 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.905 0.753 . . . . 0.0 109.737 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.089 -174.393 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 70.1 Cg_endo -74.2 101.14 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.69 2.26 . . . . 0.0 111.563 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.614 ' HB3' ' HE ' ' B' ' 71' ' ' ARG . 27.0 t70 -113.52 1.78 15.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.031 0.932 . . . . 0.0 110.477 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -126.57 112.86 16.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -107.71 136.97 46.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 53.0 mt -119.99 135.0 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.617 0.767 . . . . 0.0 109.765 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.476 HD23 HD21 ' A' ' 47' ' ' LEU . 4.4 mm? -108.94 142.91 38.9 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 3.7 p90 -97.03 123.57 40.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.942 -173.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' SER . 22.9 m -127.91 162.12 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.669 -0.644 . . . . 0.0 109.823 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -116.85 45.8 1.78 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.724 1.21 . . . . 0.0 108.917 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 16' ' ' ALA . 47.9 t30 178.85 74.99 0.14 Allowed Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.868 -158.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.0 Cg_exo -58.62 -63.12 0.15 Allowed 'Trans proline' 0 CA--C 1.579 2.77 0 C-N-CA 122.183 1.922 . . . . 0.0 113.889 -177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 32.8 Cg_exo -60.27 -60.47 0.27 Allowed 'Trans proline' 0 C--N 1.404 3.465 0 CA-C-N 123.111 2.147 . . . . 0.0 112.331 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . . . -67.74 -39.18 84.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.589 -165.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.0 t -76.9 -28.53 55.36 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 86.3 m -71.77 -34.25 69.3 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.578 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 15.1 mm100 -64.41 -37.14 86.46 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.467 170.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.15 -43.09 88.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 12.2 m-85 -68.53 -31.21 70.29 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.796 176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -57.31 -46.14 83.49 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.269 0.486 . . . . 0.0 112.117 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.07 -35.42 56.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.418 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.9 tp -60.89 -41.52 96.21 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.247 1.419 . . . . 0.0 112.48 -177.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.494 HD22 ' HG3' ' B' ' 4' ' ' PRO . 25.3 mt -92.49 -45.18 8.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.256 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.5 28.23 6.45 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.044 -172.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.7 m -129.77 -178.97 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.063 0.945 . . . . 0.0 110.47 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -126.39 156.11 73.22 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.485 1.114 . . . . 0.0 108.504 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 47.7 Cg_endo -66.95 125.55 13.84 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.184 1.922 . . . . 0.0 112.413 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 40' ' ' VAL . 7.3 p -70.72 -35.81 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.549 0.739 . . . . 0.0 110.246 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 72.2 mm-40 -126.3 138.84 53.64 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 108.273 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -142.12 135.4 29.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 110.321 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 42.0 m -137.36 157.62 73.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.504 1.522 . . . . 0.0 108.398 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.8 -41.32 38.9 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.113 2.542 . . . . 0.0 114.098 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -127.92 21.95 6.31 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 85.2 t80 -149.99 152.94 35.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.09 0.556 . . . . 0.0 109.679 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 34.7 m -144.48 157.22 44.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.818 0.847 . . . . 0.0 109.455 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.7 tp -152.02 125.19 8.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.441 ' CZ ' ' HG ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -133.38 114.8 14.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.654 1.182 . . . . 0.0 109.194 174.469 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 30' ' ' VAL . 3.9 p -93.26 133.01 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.607 0.763 . . . . 0.0 109.589 174.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.438 HD13 ' SD ' ' A' ' 45' ' ' MET . 9.0 mp -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.213 0.605 . . . . 0.0 110.078 -170.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.48 -7.45 49.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.309 0.644 . . . . 0.0 111.528 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -73.54 -15.29 61.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.451 0.7 . . . . 0.0 110.221 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.36 -12.02 36.5 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 123.44 0.543 . . . . 0.0 113.808 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.595 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.5 ppp? -86.32 169.78 12.64 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.31 0.555 . . . . 0.0 110.216 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.67 138.27 48.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.452 0.301 . . . . 0.0 110.681 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.476 HD21 HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -136.12 130.6 33.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.032 0.533 . . . . 0.0 110.345 -170.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.76 166.17 13.12 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.627 0.632 . . . . 0.0 112.081 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 17.5 mt -136.47 106.98 6.48 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.455 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.5 t90 -109.8 129.45 55.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 53.3 m -72.33 129.97 39.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HG12 ' A' ' 55' ' ' VAL . 23.3 ptt180 -67.27 -18.7 65.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -75.88 -23.65 55.62 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.69 0.396 . . . . 0.0 110.94 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' HB2' ' A' ' 51' ' ' SER . 14.3 t -115.7 6.27 14.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.564 0.746 . . . . 0.0 111.479 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 9.5 p -71.72 151.97 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.35 117.03 17.68 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 122.994 0.518 . . . . 0.0 110.96 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.5 Cg_exo -73.59 140.46 67.35 Favored 'Cis proline' 0 C--N 1.391 2.799 0 CA-C-N 119.673 0.919 . . . . 0.0 111.163 0.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -60.46 110.1 1.18 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 110.083 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.1 108.61 19.77 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.461 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 p -81.47 85.96 6.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.55 141.74 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.089 0.955 . . . . 0.0 109.557 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -161.02 142.02 11.57 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.232 1.413 . . . . 0.0 108.827 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.62 -38.87 0.61 Allowed Glycine 0 C--N 1.345 1.081 0 O-C-N 123.129 0.268 . . . . 0.0 112.487 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.69 -77.42 0.05 OUTLIER Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.43 -137.14 19.89 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.06 167.19 54.62 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 16.8 mt-10 -103.75 152.48 21.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 47' ' ' LEU . 53.0 tp -117.71 98.61 6.46 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -90.95 114.71 27.28 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.392 0.615 . . . . 0.0 111.354 -169.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.0 m-85 -88.68 122.08 31.73 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.065 1.346 . . . . 0.0 108.79 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' B' ' 5' ' ' ASP . 41.3 mtm180 -99.01 129.88 45.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.501 0.667 . . . . 0.0 111.913 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.82 165.61 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.701 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.587 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.3 pt-20 -66.83 -39.73 87.77 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.2 p30 -162.5 -179.92 7.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.74 0.7 . . . . 0.0 112.094 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.02 -29.95 68.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.935 1.294 . . . . 0.0 112.913 -165.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.96 -47.8 76.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.046 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.5 mm-40 -64.7 -23.06 67.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.966 -1.016 . . . . 0.0 112.497 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 117' ' ' VAL . 63.9 t -66.51 -46.04 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.539 0.736 . . . . 0.0 109.729 174.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 27.6 t70 -72.65 -28.81 62.95 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.242 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.3 mt-10 -69.52 -41.35 76.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.397 0.618 . . . . 0.0 110.012 175.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.6 m -66.98 -32.86 74.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.858 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 37.0 t80 -54.13 -59.98 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.987 0.915 . . . . 0.0 109.515 172.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -61.08 -38.8 87.55 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.688 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.54 92.13 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 123.617 0.573 . . . . 0.0 114.257 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -63.71 -45.49 89.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.544 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.6 ttpt -56.07 -45.39 79.32 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.964 0.906 . . . . 0.0 110.256 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.51 68.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.976 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 m -98.89 13.63 31.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.144 0.978 . . . . 0.0 112.616 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.33 54.81 2.74 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.309 -0.859 . . . . 0.0 114.568 164.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.7 p -102.83 152.85 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.63 -47.83 65.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.076 0.398 . . . . 0.0 110.957 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.544 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 52.6 ttm 65.34 84.02 0.16 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 170.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.87 83.21 2.14 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 120.962 0.41 . . . . 0.0 111.013 173.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 17.4 tm0? 178.46 140.04 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -87.72 123.32 69.47 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.678 0.791 . . . . 0.0 110.882 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.64 98.17 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.426 2.084 . . . . 0.0 110.409 174.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.08 157.51 43.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.796 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.01 104.76 4.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.965 0.906 . . . . 0.0 108.977 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 ttt -100.61 173.83 6.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.818 0.847 . . . . 0.0 109.983 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -55.93 -36.45 67.76 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.596 1.158 . . . . 0.0 112.177 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 -8.39 51.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.735 0.814 . . . . 0.0 110.845 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 126.63 -173.25 18.19 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.029 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.27 105.97 7.62 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 t -131.53 166.76 20.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.718 0.407 . . . . 0.0 111.934 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.49 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -155.72 160.15 40.1 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.737 169.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 3.0 m -133.45 127.3 33.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.219 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . . . -107.33 152.67 23.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 110.474 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.32 116.57 32.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 115' ' ' LEU . 4.0 p-10 -68.81 170.45 8.41 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.675 0.79 . . . . 0.0 110.923 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -46.19 -39.54 20.89 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 123.412 2.742 . . . . 0.0 114.457 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.0 -11.96 55.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.579 0.752 . . . . 0.0 111.254 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 73.07 80.93 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.62 1.568 . . . . 0.0 111.679 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -120.07 -179.51 3.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.574 ' HD2' ' HD2' ' B' ' 57' ' ' PRO . 50.0 mmt-85 -103.27 99.16 9.0 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 109' ' ' ASP . 51.4 mt -97.12 103.37 15.29 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 25.7 mmt180 -89.11 148.54 23.63 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 123.967 0.907 . . . . 0.0 110.355 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 78' ' ' VAL . 9.3 p -138.67 130.57 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 159.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -137.56 163.3 31.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.437 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.15 111.72 16.24 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.76 119.67 15.24 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.63 0.581 . . . . 0.0 110.557 -169.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 122.996 0.518 . . . . 0.0 110.692 -177.512 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 119.702 -0.19 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 58.9 Cg_endo -72.95 101.55 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.695 2.264 . . . . 0.0 111.941 172.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.595 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 12.2 t70 -114.93 2.82 14.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.719 0.771 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.441 ' CD1' ' HG2' ' B' ' 46' ' ' LYS . 3.8 t80 -126.78 112.65 15.63 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -169.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -107.43 137.21 45.88 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 43.7 mt -120.35 135.57 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.511 0.724 . . . . 0.0 109.636 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.33 142.11 42.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.455 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 25.1 p90 -95.12 124.67 39.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.824 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 51' ' ' SER . 36.0 m -128.76 163.5 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.931 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -118.81 44.83 2.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.488 1.115 . . . . 0.0 108.19 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 179.39 74.84 0.16 Allowed Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.662 -158.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 23.8 Cg_exo -58.61 -63.81 0.13 Allowed 'Trans proline' 0 CA--C 1.578 2.718 0 C-N-CA 122.154 1.903 . . . . 0.0 114.016 -177.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 31.8 Cg_exo -59.51 -60.66 0.29 Allowed 'Trans proline' 0 C--N 1.404 3.464 0 CA-C-N 123.035 2.12 . . . . 0.0 112.575 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.45 85.77 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.679 -165.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -76.76 -28.6 55.79 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.3 m -71.58 -34.21 69.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.632 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.1 mm100 -63.88 -37.67 88.25 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.416 170.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.31 -42.63 88.01 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.704 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -68.15 -31.8 71.63 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.139 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.632 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 54.3 mtpt -56.84 -46.34 81.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.263 0.554 . . . . 0.0 111.805 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.36 -35.03 54.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.226 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.47 -41.08 96.71 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.341 . . . . 0.0 112.547 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -92.75 -44.89 8.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.16 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 28.79 6.34 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.986 -172.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' B' ' 25' ' ' LEU . 25.8 m -130.77 -179.49 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.927 0.891 . . . . 0.0 110.598 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.67 156.31 71.11 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 124.363 1.065 . . . . 0.0 108.368 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -67.82 126.0 14.0 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.39 2.06 . . . . 0.0 111.806 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.553 HG11 HG23 ' B' ' 40' ' ' VAL . 13.5 p -71.91 -33.69 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.287 0.635 . . . . 0.0 110.281 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' B' ' 30' ' ' VAL . 60.4 mm-40 -128.28 138.3 52.35 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.9 m -142.56 136.14 28.95 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.108 0.563 . . . . 0.0 110.28 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 35.2 m -137.74 160.02 66.55 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 125.295 1.438 . . . . 0.0 108.442 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -52.36 -40.11 71.55 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.136 2.557 . . . . 0.0 113.212 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -127.97 21.91 6.29 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 87.0 t80 -149.39 153.21 37.03 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.074 0.549 . . . . 0.0 109.745 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 71.1 m -144.57 156.97 44.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.785 0.834 . . . . 0.0 109.696 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 3.0 tt -151.77 126.47 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.36 113.53 12.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.934 1.294 . . . . 0.0 108.865 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.614 HG22 ' HG3' ' B' ' 46' ' ' LYS . 7.0 t -92.92 132.2 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.655 0.782 . . . . 0.0 109.336 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.447 HD21 HD13 ' B' ' 25' ' ' LEU . 36.0 mt -89.25 150.01 22.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.872 0.469 . . . . 0.0 110.262 -171.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.19 -7.96 52.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 111.609 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -71.91 -16.62 62.12 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.621 0.769 . . . . 0.0 110.379 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -12.17 35.49 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 123.436 0.541 . . . . 0.0 113.886 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.59 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -86.68 170.11 12.09 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.307 0.553 . . . . 0.0 109.958 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.614 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.7 tttt -131.51 137.34 48.49 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.961 0.504 . . . . 0.0 110.6 -175.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.447 HD11 HD21 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -135.67 131.43 35.7 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.334 -171.648 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.23 167.61 13.36 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.193 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.22 105.77 5.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.423 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -109.72 129.33 55.62 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 62.5 m -72.25 129.8 39.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.4 ' O ' HG12 ' B' ' 55' ' ' VAL . 33.3 ptt180 -67.27 -18.82 65.36 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -170.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.85 -23.95 55.74 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.653 0.381 . . . . 0.0 110.59 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.41 HG22 ' HB2' ' B' ' 51' ' ' SER . 13.6 t -115.6 6.58 14.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 7.9 p -72.09 152.41 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 122.05 -0.406 . . . . 0.0 109.99 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.458 ' HB2' HH22 ' A' ' 116' ' ' ARG . 30.6 mt-10 -130.86 116.49 17.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 122.976 0.51 . . . . 0.0 110.903 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.574 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 2.6 Cg_exo -73.35 140.49 67.48 Favored 'Cis proline' 0 C--N 1.387 2.554 0 CA-C-N 119.838 0.978 . . . . 0.0 111.068 0.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.35 110.1 1.16 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.926 0.766 . . . . 0.0 110.146 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.01 108.69 19.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.664 1.186 . . . . 0.0 108.376 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.3 p -81.42 85.19 6.5 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.94 143.32 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.867 0.867 . . . . 0.0 109.276 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.455 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 1.0 OUTLIER -162.31 141.41 9.29 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.335 1.454 . . . . 0.0 108.808 171.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.23 -38.08 0.59 Allowed Glycine 0 C--N 1.343 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 112.719 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.5 -77.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.49 -137.03 19.7 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.89 167.03 54.65 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.5 mt-10 -103.48 152.63 21.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.006 0.431 . . . . 0.0 110.525 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.447 HD21 HD11 ' B' ' 47' ' ' LEU . 57.5 tp -117.63 98.86 6.6 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.609 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.02 115.04 27.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.492 0.663 . . . . 0.0 111.381 -169.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' PHE . . . . . 0.545 ' HB2' HG22 ' B' ' 117' ' ' VAL . 6.5 m-85 -89.2 122.47 32.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.949 1.3 . . . . 0.0 108.538 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.614 ' HE ' ' HB3' ' A' ' 5' ' ' ASP . 38.9 mtm105 -99.17 128.89 45.37 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.417 0.687 . . . . 0.0 111.678 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.95 165.94 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.791 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.71 -39.91 88.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -174.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' B' ' 73' ' ' GLU . 8.8 p30 -162.49 -179.54 7.02 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.543 0.61 . . . . 0.0 112.151 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.62 -29.97 69.57 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.006 1.322 . . . . 0.0 112.784 -164.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -64.49 -48.08 76.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.59 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.3 mm-40 -64.8 -22.92 67.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.118 0.967 . . . . 0.0 112.45 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.68 -45.55 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.611 0.719 . . . . 0.0 109.7 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -72.95 -28.84 62.66 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.966 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.8 mt-10 -69.32 -41.41 76.74 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.466 0.65 . . . . 0.0 109.95 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.405 ' CG2' HG21 ' B' ' 117' ' ' VAL . 23.7 m -68.22 -31.81 71.58 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.669 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -54.27 -59.52 4.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.744 0.818 . . . . 0.0 109.893 172.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.46 86.89 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.552 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.35 92.05 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 123.836 0.71 . . . . 0.0 114.064 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -64.35 -45.56 87.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.959 0.504 . . . . 0.0 109.908 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -56.49 -44.27 80.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.912 0.885 . . . . 0.0 110.404 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.52 -29.34 67.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.93 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 13.1 33.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.967 0.907 . . . . 0.0 112.447 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.03 2.69 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.603 165.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.9 p -102.98 152.83 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.95 67.69 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.146 0.43 . . . . 0.0 111.097 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.504 ' HB2' HG13 ' B' ' 90' ' ' VAL . 48.5 tpp 64.84 83.63 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.896 0.748 . . . . 0.0 112.727 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.74 82.83 2.11 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' GLN . . . . . 0.418 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 15.4 tm0? 178.81 140.89 0.1 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.081 1.353 . . . . 0.0 107.477 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.0 123.39 67.54 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.573 0.749 . . . . 0.0 110.517 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.78 98.54 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.472 2.114 . . . . 0.0 110.244 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.14 157.36 44.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.79 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.97 105.16 4.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.926 0.89 . . . . 0.0 108.85 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.43 ' SD ' HG21 ' B' ' 104' ' ' THR . 10.8 ttt -100.87 172.99 6.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.204 1.002 . . . . 0.0 109.901 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -55.34 -36.71 66.56 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.45 1.1 . . . . 0.0 112.424 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.64 -8.3 52.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.787 0.835 . . . . 0.0 110.953 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 126.52 -173.14 18.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.133 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -76.74 106.49 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.43 HG21 ' SD ' ' B' ' 99' ' ' MET . 11.9 t -132.0 166.19 22.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 0.0 111.82 -169.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' PHE . . . . . 0.418 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 6.4 p90 -153.71 162.35 41.32 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.409 168.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 29.2 m -134.54 127.69 31.81 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.48 152.44 24.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.388 0.675 . . . . 0.0 110.523 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.11 117.61 34.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.473 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 5.8 p-10 -71.12 171.72 8.02 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.702 -0.666 . . . . 0.0 110.288 176.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 7.7 Cg_endo -46.9 -39.63 24.73 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.464 2.776 . . . . 0.0 114.194 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.18 -10.7 57.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.133 0.573 . . . . 0.0 111.604 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 15.3 m 72.98 82.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.108 1.363 . . . . 0.0 111.565 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.422 ' HE1' HG12 ' B' ' 11' ' ' VAL . 13.4 m80 -123.25 179.99 4.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -103.93 99.15 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.91 103.83 15.81 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.609 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 44.0 ttm-85 -89.02 148.2 23.87 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.618 0.767 . . . . 0.0 110.516 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' B' ' 70' ' ' PHE . 21.5 t -136.58 131.18 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -136.99 163.94 29.53 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' ALA . . . . . 0.426 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -124.67 111.71 15.91 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.86 119.32 13.9 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.757 0.661 . . . . 0.0 110.623 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 95.05 1.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.021 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.369 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -87.26 83.44 1.01 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.842 2.361 . . . . 0.0 111.765 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.781 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.9 p-10 -84.8 4.92 30.73 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 172.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.7 t80 -123.41 127.66 48.76 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.093 1.357 . . . . 0.0 107.681 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -126.36 136.1 52.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.959 0.904 . . . . 0.0 108.584 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 50.9 mt -119.56 137.16 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.696 0.798 . . . . 0.0 109.53 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.503 HD11 HD22 ' A' ' 68' ' ' LEU . 97.4 mt -108.08 140.56 41.09 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.523 ' HE2' ' HA ' ' A' ' 62' ' ' THR . 36.3 p90 -85.7 130.98 34.42 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.262 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.515 HG12 ' NE2' ' A' ' 113' ' ' HIS . 5.3 m -129.5 151.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.479 0.657 . . . . 0.0 110.575 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.46 -55.36 3.69 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.22 1.008 . . . . 0.0 109.938 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -105.15 98.4 15.97 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.54 0.736 . . . . 0.0 109.927 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.2 Cg_exo -51.78 -53.92 6.19 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.518 2.812 . . . . 0.0 115.185 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.29 -54.19 5.87 Favored 'Trans proline' 0 C--N 1.402 3.363 0 C-N-CA 122.53 2.153 . . . . 0.0 113.023 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.18 61.83 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.296 -168.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -77.38 -35.16 54.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.723 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 78.6 m -67.16 -43.31 82.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.568 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 19.4 mm100 -61.47 -35.02 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.63 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 t80 -64.05 -44.26 93.01 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 124.058 0.849 . . . . 0.0 110.142 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -71.55 -30.06 65.46 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.854 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -56.31 -50.51 71.23 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.252 0.549 . . . . 0.0 111.991 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -33.76 52.41 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.72 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 19.4 tp -60.99 -48.62 80.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.707 1.203 . . . . 0.0 112.801 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 27' ' ' VAL . 35.4 mt -84.94 -40.79 16.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.301 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 33.61 6.39 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -173.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.4 m -128.27 -178.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.29 1.036 . . . . 0.0 110.595 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -132.95 141.17 40.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.988 0.915 . . . . 0.0 108.865 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.555 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 18.9 Cg_exo -66.06 110.82 1.82 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.613 2.209 . . . . 0.0 111.793 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.99 -39.68 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 17.9 mm-40 -112.51 109.04 18.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.2 p -113.88 141.97 46.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.277 0.631 . . . . 0.0 109.655 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 66.1 m -142.94 160.92 51.22 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.988 1.315 . . . . 0.0 108.894 -175.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.43 -30.85 91.74 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.736 2.29 . . . . 0.0 113.013 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.5 t -127.55 19.39 6.78 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.173 0.589 . . . . 0.0 111.894 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.3 t80 -159.1 156.78 29.77 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.881 0.472 . . . . 0.0 110.345 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 m -146.47 150.31 35.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.474 1.11 . . . . 0.0 108.358 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -144.44 116.97 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -128.85 122.97 31.55 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.037 1.335 . . . . 0.0 108.542 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 46' ' ' LYS . 15.6 t -106.21 134.0 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.979 0.912 . . . . 0.0 109.425 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' SD ' ' A' ' 45' ' ' MET . 85.5 mt -95.19 147.18 23.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.562 0.345 . . . . 0.0 110.107 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -12.45 52.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.302 1.041 . . . . 0.0 112.199 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.5 -8.92 29.61 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.175 0.99 . . . . 0.0 112.931 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.1 53.75 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.811 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -114.56 170.84 8.01 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.9 0.88 . . . . 0.0 108.938 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 40' ' ' VAL . 75.9 tttt -133.75 134.22 42.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -128.28 118.13 22.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.775 0.43 . . . . 0.0 109.878 -174.163 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -96.56 166.54 24.08 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.717 0.675 . . . . 0.0 111.521 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 tp -143.38 102.44 3.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.484 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 6.2 t90 -111.05 130.29 55.65 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 36.2 m -68.28 126.91 31.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.154 0.284 . . . . 0.0 110.244 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.427 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 24.7 ptt180 -68.79 -13.4 62.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.922 0.889 . . . . 0.0 112.605 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -14.4 59.51 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.47 0.308 . . . . 0.0 110.878 176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.454 HG23 ' HE1' ' A' ' 50' ' ' TRP . 13.6 t -128.36 10.5 6.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.62 0.768 . . . . 0.0 110.785 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 58' ' ' LYS . 10.3 p -69.79 149.31 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 173.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -130.37 123.8 20.76 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 122.983 0.513 . . . . 0.0 110.638 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.84 137.84 50.29 Favored 'Cis proline' 0 C--N 1.387 2.604 0 C-N-CA 124.453 -1.061 . . . . 0.0 111.432 -6.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -50.81 110.68 0.45 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.516 0.726 . . . . 0.0 110.886 -175.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.47 110.0 22.16 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 p -83.13 87.22 6.92 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -153.31 150.96 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.738 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.523 ' HA ' ' HE2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -163.72 147.92 10.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.245 1.418 . . . . 0.0 109.279 170.395 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.28 -7.91 76.47 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.961 -0.563 . . . . 0.0 114.098 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' HD3' ' A' ' 114' ' ' ARG . . . -159.24 122.95 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 133.98 111.93 1.26 Allowed Glycine 0 C--N 1.34 0.781 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.414 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 77.25 109.82 0.15 Allowed Glycine 0 C--N 1.346 1.135 0 O-C-N 124.134 0.549 . . . . 0.0 111.735 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.8 mm-40 -98.24 136.7 38.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 HD11 ' A' ' 9' ' ' LEU . 52.0 tp -107.85 99.6 9.05 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -87.56 113.7 23.49 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -163.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -90.6 111.33 22.6 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 108.327 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -92.28 127.09 37.64 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.529 0.68 . . . . 0.0 111.818 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 118' ' ' TYR . 35.0 m -125.11 162.14 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.522 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.615 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.6 pt-20 -67.9 -35.6 78.76 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -163.25 -179.95 6.97 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.686 0.675 . . . . 0.0 112.746 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -61.58 -29.67 70.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.247 1.419 . . . . 0.0 112.725 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.07 -44.27 72.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.063 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.615 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 75.0 mm-40 -63.63 -23.05 67.22 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.696 0.798 . . . . 0.0 112.467 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -65.89 -41.63 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 0.0 110.519 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.62 -27.94 45.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.127 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.5 mt-10 -66.6 -41.48 88.39 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.89 0.852 . . . . 0.0 109.513 173.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -64.47 -38.1 89.85 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.606 . . . . 0.0 110.93 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -55.99 -60.48 3.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.764 0.826 . . . . 0.0 109.845 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.59 -36.44 82.63 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.199 -172.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.68 -47.76 83.61 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.71 0.631 . . . . 0.0 113.655 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -65.15 -39.17 92.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.41 0.684 . . . . 0.0 110.185 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.9 ttpt -61.46 -43.07 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.376 0.671 . . . . 0.0 110.009 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.11 67.56 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.736 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 t -100.73 7.45 43.84 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.3 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.42 56.91 2.43 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 166.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.414 HG13 ' HB3' ' A' ' 92' ' ' MET . 5.8 p -104.75 146.1 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' ALA . . . -72.58 -39.39 67.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.721 0.408 . . . . 0.0 111.519 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.414 ' HB3' HG13 ' A' ' 90' ' ' VAL . 4.1 ptm 49.68 79.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.138 1.775 . . . . 0.0 113.862 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -109.1 83.29 1.73 Allowed 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.489 -0.757 . . . . 0.0 109.424 177.431 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 18.2 tm0? 178.85 127.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -76.02 125.78 87.64 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 104' ' ' THR . 42.8 Cg_endo -65.71 98.47 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.295 1.997 . . . . 0.0 109.948 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.14 160.89 39.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.581 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -69.72 142.65 53.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.326 0.65 . . . . 0.0 110.762 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ttp -147.48 -178.07 6.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.972 0.909 . . . . 0.0 108.66 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.07 -37.28 61.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.867 1.267 . . . . 0.0 113.194 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.37 8.64 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.536 0.735 . . . . 0.0 111.486 -172.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.93 -160.44 13.48 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -79.3 109.5 13.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 8.9 t -105.42 147.65 28.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.338 0.655 . . . . 0.0 111.551 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.448 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 17.3 t80 -154.5 136.35 14.51 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.828 1.251 . . . . 0.0 109.57 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.1 m -137.72 123.55 20.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.37 139.95 42.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.36 0.664 . . . . 0.0 111.524 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -111.72 126.78 55.41 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 13.3 p-10 -78.6 179.78 1.63 Allowed Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.831 175.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 46.8 Cg_exo -44.52 -40.51 13.71 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.827 2.352 . . . . 0.0 114.188 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.35 -21.87 59.49 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.686 0.394 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.69 74.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.438 1.495 . . . . 0.0 110.846 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.515 ' NE2' HG12 ' A' ' 11' ' ' VAL . 19.2 m170 -103.86 -171.57 1.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.413 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.51 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 19.5 mmm180 -120.29 96.77 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.36 99.34 8.6 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -96.47 95.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.321 0.648 . . . . 0.0 111.329 -169.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.74 133.54 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HE2' ' HB2' ' A' ' 120' ' ' PHE . 9.1 p90 -136.8 177.96 7.44 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.816 0.734 . . . . 0.0 112.319 172.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.25 111.88 6.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.406 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 38.5 t80 -84.56 119.2 24.92 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 C-N-CA 123.51 0.724 . . . . 0.0 110.375 179.105 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m170 . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.0 83.35 1.08 Allowed 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.911 2.407 . . . . 0.0 111.563 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ASP . . . . . 0.811 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.2 p-10 -84.46 4.68 30.56 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.292 0.568 . . . . 0.0 111.228 172.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -123.37 127.34 48.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.11 1.364 . . . . 0.0 107.502 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 t -126.3 135.99 52.21 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 108.857 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.8 mt -119.46 136.78 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 109.548 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.49 140.42 40.48 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' TYR . . . . . 0.533 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 36.0 p90 -85.46 130.91 34.48 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.106 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.613 HG12 ' NE2' ' B' ' 113' ' ' HIS . 7.1 m -128.93 151.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.257 0.551 . . . . 0.0 110.536 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.69 -55.83 3.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.318 1.047 . . . . 0.0 109.721 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -105.5 97.36 14.05 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 124.081 0.953 . . . . 0.0 109.758 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.412 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.9 Cg_exo -51.31 -54.59 5.13 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.594 2.863 . . . . 0.0 115.379 -177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.86 -54.54 5.26 Favored 'Trans proline' 0 C--N 1.403 3.398 0 C-N-CA 122.38 2.053 . . . . 0.0 113.409 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.2 61.65 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.439 -168.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 82.8 p -77.7 -34.49 52.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 73.2 m -67.65 -43.71 79.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' GLN . . . . . 0.518 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.0 mm100 -62.12 -34.73 76.89 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.954 173.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 84.6 t80 -63.68 -44.54 93.4 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.023 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' TYR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 50.1 m-85 -70.8 -30.58 67.07 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.917 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' LYS . . . . . 0.526 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 62.1 mtpt -56.45 -50.17 72.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.087 0.47 . . . . 0.0 112.125 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.69 -34.14 52.94 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.662 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 15.4 tp -60.54 -49.29 78.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.68 1.192 . . . . 0.0 113.092 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.51 ' HB2' HG22 ' B' ' 27' ' ' VAL . 34.9 mt -84.26 -40.96 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.28 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.26 33.75 6.41 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' B' ' 25' ' ' LEU . 31.5 m -128.62 -178.75 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.059 . . . . 0.0 110.573 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.43 142.35 44.59 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.926 0.89 . . . . 0.0 109.209 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.526 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 16.7 Cg_exo -67.39 110.56 2.07 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.355 2.036 . . . . 0.0 111.828 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.72 -39.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.794 0.838 . . . . 0.0 110.388 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 23.4 mm-40 -112.99 108.95 18.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -113.84 142.2 46.39 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.368 0.667 . . . . 0.0 109.81 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 50.4 m -142.87 161.48 48.64 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.784 1.234 . . . . 0.0 109.028 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.11 -30.61 89.43 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.471 2.114 . . . . 0.0 112.965 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -127.72 19.62 6.66 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.222 0.609 . . . . 0.0 111.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 77.0 t80 -159.12 156.88 29.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.794 0.438 . . . . 0.0 110.232 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 68.6 m -146.55 150.5 35.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.475 1.11 . . . . 0.0 108.318 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -144.72 117.0 8.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -129.12 123.65 32.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.899 1.28 . . . . 0.0 108.492 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.573 HG22 ' HG3' ' B' ' 46' ' ' LYS . 19.9 t -107.29 133.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.785 0.834 . . . . 0.0 109.244 -172.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.462 HD12 ' SD ' ' B' ' 45' ' ' MET . 85.5 mt -95.0 147.48 23.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.685 0.394 . . . . 0.0 110.091 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -12.24 52.76 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.158 0.983 . . . . 0.0 112.216 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.93 -8.55 30.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.096 0.959 . . . . 0.0 112.682 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.13 16.15 54.44 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' MET . . . . . 0.781 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -114.84 170.79 8.07 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.82 0.848 . . . . 0.0 108.862 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.573 ' HG3' HG22 ' B' ' 40' ' ' VAL . 80.2 tttt -133.61 134.22 42.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -176.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.518 HD11 HD11 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -128.27 118.19 22.82 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -174.106 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.73 24.71 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 123.698 0.666 . . . . 0.0 111.623 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' B' ' 37' ' ' SER . 6.8 tp -143.64 102.23 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' TRP . . . . . 0.468 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 6.2 t90 -110.92 130.4 55.59 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 35.9 m -68.3 127.26 32.28 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.286 0.366 . . . . 0.0 110.131 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' B' ' 10' ' ' TYR . 21.1 ptt180 -69.42 -12.78 61.94 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.846 0.858 . . . . 0.0 112.604 -173.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -77.95 -15.46 58.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.508 0.323 . . . . 0.0 110.523 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -127.98 10.37 6.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.607 0.763 . . . . 0.0 111.036 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' B' ' 58' ' ' LYS . 7.8 p -69.99 150.01 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -131.32 123.07 19.37 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.002 0.521 . . . . 0.0 111.13 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.97 136.6 45.15 Favored 'Cis proline' 0 C--N 1.389 2.688 0 C-N-CA 124.348 -1.105 . . . . 0.0 110.969 -4.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.439 ' HA ' HG13 ' B' ' 55' ' ' VAL . 1.5 tmmm? -48.28 110.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.387 0.675 . . . . 0.0 111.284 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.51 109.94 22.08 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.4 p -83.59 85.92 7.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 29.2 m -150.68 151.89 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.247 1.019 . . . . 0.0 109.636 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.533 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 0.3 OUTLIER -164.57 147.91 9.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.006 1.322 . . . . 0.0 109.457 169.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.99 76.64 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.412 0.445 . . . . 0.0 113.779 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' GLY . . . . . 0.532 ' HA2' ' HD3' ' B' ' 114' ' ' ARG . . . -159.35 122.88 1.18 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 133.83 112.15 1.29 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.514 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 77.28 109.69 0.15 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 173.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.5 mm-40 -98.22 138.16 35.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -170.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.518 HD11 HD11 ' B' ' 47' ' ' LEU . 0.6 OUTLIER -110.68 98.75 7.84 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.04 113.14 23.38 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -161.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -89.85 111.5 22.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.877 1.271 . . . . 0.0 108.578 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -92.99 126.3 38.0 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.51 0.671 . . . . 0.0 111.838 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.63 162.6 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.559 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLU . . . . . 0.573 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.8 pt-20 -67.74 -35.17 78.26 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.2 p30 -163.63 179.71 7.0 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.685 0.675 . . . . 0.0 112.769 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.66 -29.58 70.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.207 1.403 . . . . 0.0 112.764 -166.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.03 -44.03 73.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.078 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLN . . . . . 0.573 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.1 mm-40 -63.84 -23.08 67.21 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.915 0.886 . . . . 0.0 112.548 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.77 -41.55 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.291 0.636 . . . . 0.0 110.41 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.44 -27.37 41.67 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.114 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.6 mt-10 -66.57 -41.37 88.68 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.758 0.79 . . . . 0.0 109.372 173.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.8 m -64.62 -37.87 89.06 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.928 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.01 -60.52 3.36 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 109.722 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.488 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.86 -36.19 81.76 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.237 -172.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.86 84.07 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.578 0.549 . . . . 0.0 113.684 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -65.74 -38.72 89.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.301 0.64 . . . . 0.0 110.261 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.7 ttpt -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 109.982 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.589 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -101.14 7.38 43.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.129 0.972 . . . . 0.0 112.565 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 57.47 2.4 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 115.382 0.913 . . . . 0.0 115.382 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 p -104.87 146.14 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' B' ' 108' ' ' ALA . . . -72.33 -39.14 68.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.937 0.495 . . . . 0.0 111.747 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 10.2 ptp 49.17 80.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.965 1.706 . . . . 0.0 113.911 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.435 HD13 ' N ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -109.15 83.17 1.71 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.849 0.833 . . . . 0.0 109.62 177.496 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 178.58 126.64 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.153 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -75.37 126.84 87.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 123.328 0.392 . . . . 0.0 110.455 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' B' ' 104' ' ' THR . 55.8 Cg_endo -67.11 98.53 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.418 2.079 . . . . 0.0 109.732 172.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.33 160.73 39.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -69.38 141.78 54.08 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.881 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' MET . . . . . 0.478 ' HG2' ' HB ' ' B' ' 104' ' ' THR . 1.1 ptp -145.35 -176.38 5.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.153 0.981 . . . . 0.0 109.281 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -55.66 -36.56 67.21 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.539 1.135 . . . . 0.0 112.61 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.94 8.73 42.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.453 0.701 . . . . 0.0 111.941 -173.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.76 -159.97 13.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.654 -0.579 . . . . 0.0 111.654 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -79.95 109.6 14.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' B' ' 99' ' ' MET . 6.9 t -105.99 149.27 26.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.268 0.556 . . . . 0.0 111.369 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -155.77 137.14 13.97 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.867 1.267 . . . . 0.0 109.416 168.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 49.2 m -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.15 139.63 42.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.468 0.707 . . . . 0.0 111.51 -173.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -111.07 129.11 56.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 16.4 p-10 -81.52 -179.99 1.69 Allowed Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.977 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 43.3 Cg_exo -44.46 -40.71 13.63 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.473 2.115 . . . . 0.0 114.409 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.7 -22.15 60.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.974 0.51 . . . . 0.0 110.658 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m 72.62 74.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.4 1.48 . . . . 0.0 110.66 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' HIS . . . . . 0.613 ' NE2' HG12 ' B' ' 11' ' ' VAL . 22.1 m170 -103.56 -171.36 1.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.402 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.532 ' HD3' ' HA2' ' B' ' 64' ' ' GLY . 22.6 mmm180 -120.4 96.71 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.2 99.52 8.79 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.484 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -95.23 94.93 8.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.874 0.47 . . . . 0.0 111.886 -169.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.0 t -85.55 133.86 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -137.5 177.68 7.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.059 0.845 . . . . 0.0 112.279 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.08 111.41 5.92 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -83.07 113.44 20.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.55 92.92 3.5 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.024 0.828 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -176.239 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.39 0.138 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 m -93.67 124.07 37.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -98.2 121.21 57.83 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.925 0.89 . . . . 0.0 110.529 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.49 114.29 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.932 2.421 . . . . 0.0 112.285 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.711 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.8 p-10 -99.01 11.43 39.02 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.352 0.596 . . . . 0.0 110.302 171.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -129.59 125.0 35.17 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.778 1.231 . . . . 0.0 107.875 -170.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -120.48 138.82 53.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.258 1.023 . . . . 0.0 108.503 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 55.8 mt -115.4 133.57 61.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 123.497 0.719 . . . . 0.0 109.066 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 HD21 ' A' ' 47' ' ' LEU . 9.1 mp -112.32 124.3 52.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 4.8 p90 -79.3 115.96 19.26 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.686 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 51' ' ' SER . 35.7 m -114.49 167.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.789 0.836 . . . . 0.0 109.191 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -96.68 -62.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.234 0.614 . . . . 0.0 110.322 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -106.16 96.31 13.0 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 123.351 0.66 . . . . 0.0 109.666 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 1.1 Cg_endo -44.9 -52.97 5.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.541 2.827 . . . . 0.0 115.809 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.41 -57.42 2.35 Favored 'Trans proline' 0 C--N 1.403 3.399 0 C-N-CA 122.416 2.077 . . . . 0.0 113.191 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.5 -37.41 77.17 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.4 m -77.43 -26.65 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.44 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 68.4 m -80.3 -38.95 29.69 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 82.9 mm-40 -67.01 -34.04 76.88 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.264 173.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -61.52 -49.45 76.67 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.673 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.2 m-85 -69.62 -27.18 64.86 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.616 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.6 mtpt -57.08 -51.75 68.04 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.144 0.429 . . . . 0.0 111.789 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.03 -32.26 39.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.916 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.0 tp -59.11 -53.24 60.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.041 0.936 . . . . 0.0 111.839 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB2' HG22 ' A' ' 27' ' ' VAL . 12.6 mt -83.11 -47.2 11.89 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.2 38.99 2.94 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 25' ' ' LEU . 30.4 m -128.42 171.12 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.328 1.051 . . . . 0.0 110.654 -176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.88 139.03 33.87 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.15 108.76 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.489 2.126 . . . . 0.0 111.593 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.81 -39.28 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.286 0.634 . . . . 0.0 109.973 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.721 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 35.9 mm-40 -118.51 149.11 41.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.305 1.042 . . . . 0.0 108.647 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 p -160.93 152.95 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.303 0.641 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 52.4 m -148.8 159.65 37.44 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.725 1.21 . . . . 0.0 108.448 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.59 -27.43 32.83 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.94 2.426 . . . . 0.0 113.798 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 14' ' ' PRO . 12.4 t -127.92 16.83 6.8 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.0 t80 -156.15 162.19 40.25 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.894 -0.504 . . . . 0.0 110.55 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 47.1 t -151.67 157.09 41.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.698 0.799 . . . . 0.0 109.351 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -152.31 128.92 10.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.16 141.86 46.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.443 1.097 . . . . 0.0 108.823 170.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.3 t -115.5 127.92 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.495 HD13 ' SD ' ' A' ' 45' ' ' MET . 10.0 mp -91.06 148.81 22.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.253 0.621 . . . . 0.0 110.187 -170.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.57 -8.51 34.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 111.809 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.81 -19.5 65.91 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.171 0.989 . . . . 0.0 111.724 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.04 47.35 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.736 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -113.37 174.72 5.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.877 0.871 . . . . 0.0 109.036 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HG3' HG22 ' A' ' 40' ' ' VAL . 82.7 tttt -139.23 140.92 37.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 9' ' ' LEU . 2.5 tt -140.07 123.26 16.84 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.817 0.341 . . . . 0.0 110.114 -171.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -104.68 160.3 15.59 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.793 0.711 . . . . 0.0 111.568 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 82.3 mt -126.11 106.46 9.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 164.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.589 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 4.9 t90 -105.08 123.19 47.39 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.6 t -70.7 130.82 42.76 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -65.48 -21.68 66.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 112.364 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -76.56 -8.28 56.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.392 0.277 . . . . 0.0 111.398 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -131.86 9.2 4.54 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.353 0.661 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.21 145.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.49 117.75 21.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 141.64 68.38 Favored 'Cis proline' 0 C--N 1.39 2.755 0 CA-C-N 119.935 1.013 . . . . 0.0 113.953 2.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.44 122.33 16.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.13 0.972 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.66 109.54 5.03 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.79 0.836 . . . . 0.0 109.996 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -85.36 85.5 7.44 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 121.875 0.845 . . . . 0.0 108.775 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.09 147.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 p -144.1 121.69 11.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.94 5.37 68.23 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.202 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.73 -34.78 72.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 121.303 0.391 . . . . 0.0 112.44 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' B' ' 10' ' ' TYR . . . -170.47 -161.54 21.23 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.214 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.55 110.26 0.24 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.497 ' HG2' ' HD2' ' A' ' 114' ' ' ARG . 24.1 mt-10 -123.99 130.09 52.0 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -171.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 9' ' ' LEU . 17.7 tp -115.84 101.57 8.91 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -88.08 109.87 20.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.834 0.35 . . . . 0.0 110.752 -171.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.493 ' HB2' HG22 ' A' ' 117' ' ' VAL . 22.4 m-85 -89.35 107.6 19.16 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -88.06 130.71 34.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.443 0.64 . . . . 0.0 111.273 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.08 159.13 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.816 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -66.15 -34.25 77.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -173.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 9.9 p30 -163.94 -179.9 6.57 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.513 0.673 . . . . 0.0 112.333 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.56 -29.7 70.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.492 1.517 . . . . 0.0 112.978 -165.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.86 -41.47 74.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.248 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.568 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 64.9 mm-40 -64.23 -23.87 67.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.655 0.782 . . . . 0.0 112.123 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.14 -42.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 121.533 0.682 . . . . 0.0 110.221 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.45 -29.7 59.74 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.471 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -66.01 -46.64 77.21 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.488 0.661 . . . . 0.0 109.522 173.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.2 m -65.46 -32.96 74.86 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.131 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.57 -61.37 2.65 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 123.687 0.795 . . . . 0.0 109.982 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.61 -35.57 80.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.31 -172.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.64 -46.67 93.24 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.593 0.558 . . . . 0.0 113.151 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.44 ' HB3' HG21 ' A' ' 90' ' ' VAL . 45.7 m0 -62.53 -43.23 99.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.438 0.695 . . . . 0.0 110.597 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -58.56 -43.13 89.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 110.596 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.19 -24.27 60.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.548 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 t -91.32 -0.22 57.62 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.301 1.041 . . . . 0.0 112.656 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.48 39.67 4.97 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.604 0.601 . . . . 0.0 114.604 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 85' ' ' TRP . 55.9 t -87.24 145.28 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.32 -51.07 67.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.96 0.504 . . . . 0.0 110.768 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.494 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 28.8 tpp 65.65 82.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.047 0.842 . . . . 0.0 111.898 169.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.41 84.01 2.22 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.569 0.7 . . . . 0.0 110.875 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 106' ' ' THR . 54.1 tp60 179.09 138.79 0.1 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.011 1.324 . . . . 0.0 108.679 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -83.49 121.88 76.71 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -63.04 102.21 0.3 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.639 2.226 . . . . 0.0 110.045 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.15 150.01 48.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.25 0.62 . . . . 0.0 111.363 -170.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -71.62 100.77 2.36 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.4 ttm -92.29 173.99 7.53 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.071 0.948 . . . . 0.0 109.498 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.66 -34.46 71.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.409 1.084 . . . . 0.0 111.732 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -87.69 -5.38 58.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.065 0.946 . . . . 0.0 110.978 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.61 -170.01 19.97 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.142 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -75.17 102.34 4.92 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 t -107.65 149.24 28.33 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.709 0.766 . . . . 0.0 110.019 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 1.8 t80 -144.68 140.53 28.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.016 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 26.5 m -136.63 127.66 27.76 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -106.3 171.95 7.08 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.844 0.457 . . . . 0.0 110.401 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.38 121.5 20.11 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 3.9 p-10 -77.76 177.31 2.81 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.999 0.92 . . . . 0.0 111.531 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 41.9 Cg_exo -42.05 -43.37 7.25 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.632 2.888 . . . . 0.0 114.946 170.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.56 -8.15 55.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.501 0.72 . . . . 0.0 111.247 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.5 m 64.6 87.55 0.11 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.055 1.342 . . . . 0.0 111.829 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -124.29 144.15 50.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.497 ' HD2' ' HG2' ' A' ' 67' ' ' GLU . 64.6 mtt180 -75.93 94.74 3.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.82 99.21 11.91 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.465 ' HG3' ' HZ3' ' B' ' 50' ' ' TRP . 2.6 tmt_? -98.2 96.11 7.87 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.789 0.836 . . . . 0.0 111.641 -165.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 70' ' ' PHE . 18.6 t -90.54 120.09 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -132.08 159.16 39.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.268 0.485 . . . . 0.0 112.276 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.91 112.03 17.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -74.03 129.27 37.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.579 0.352 . . . . 0.0 110.768 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.21 103.33 14.07 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.662 179.413 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.293 0.092 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 27.4 m -88.92 123.18 33.02 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.95 0.5 . . . . 0.0 109.659 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -98.19 120.79 58.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.807 0.843 . . . . 0.0 110.108 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.12 114.68 0.67 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.278 2.652 . . . . 0.0 112.486 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.736 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.6 p-10 -99.31 10.86 40.6 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.439 0.637 . . . . 0.0 109.955 171.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.472 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -129.05 124.43 34.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.192 . . . . 0.0 107.812 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -120.02 139.01 53.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.069 0.948 . . . . 0.0 108.443 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 54.9 mt -116.07 133.87 61.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.526 HD23 HD21 ' B' ' 47' ' ' LEU . 3.4 mm? -112.85 124.33 52.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.444 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 5.2 p90 -80.21 116.74 20.47 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.696 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 51' ' ' SER . 33.9 m -114.5 167.08 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.733 0.813 . . . . 0.0 109.118 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -96.62 -62.56 1.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.316 0.647 . . . . 0.0 110.087 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -105.98 97.5 15.61 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.339 0.655 . . . . 0.0 109.572 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.438 ' HG2' ' HA ' ' B' ' 35' ' ' THR . 74.2 Cg_exo -46.81 -52.04 8.23 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 123.426 2.751 . . . . 0.0 115.246 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.4 -57.58 2.26 Favored 'Trans proline' 0 C--N 1.404 3.493 0 C-N-CA 122.681 2.254 . . . . 0.0 113.041 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.99 74.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.31 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -77.34 -27.12 52.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.436 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 99.3 m -79.96 -38.76 31.61 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.525 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 87.1 mm-40 -67.3 -33.34 75.07 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.532 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -62.25 -48.9 77.88 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.789 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 23.9 m-85 -69.73 -27.59 65.09 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.562 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.8 mtpt -56.91 -51.68 68.14 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.238 0.472 . . . . 0.0 111.93 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.59 -32.56 41.96 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.081 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 18.5 tp -59.25 -53.08 62.37 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.046 0.938 . . . . 0.0 111.835 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.422 ' HB2' HG22 ' B' ' 27' ' ' VAL . 11.9 mt -83.36 -47.18 11.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.988 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.98 39.42 2.89 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.4 m -128.58 170.23 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.476 1.111 . . . . 0.0 110.665 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -125.28 141.31 38.35 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 57.5 Cg_endo -68.13 109.53 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.301 2.001 . . . . 0.0 111.248 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.15 -39.07 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.113 0.565 . . . . 0.0 109.75 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 24.1 mm-40 -118.59 149.16 41.83 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.725 1.21 . . . . 0.0 108.915 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -161.08 153.15 19.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 51.0 m -149.55 160.24 34.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.804 1.242 . . . . 0.0 108.502 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.5 -27.26 39.81 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.043 2.495 . . . . 0.0 113.596 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.438 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 11.6 t -128.05 16.92 6.73 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.477 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 73.4 t80 -156.04 161.58 40.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.783 -0.573 . . . . 0.0 110.406 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 73.9 m -150.76 157.84 43.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.963 0.905 . . . . 0.0 109.752 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 4.6 tt -152.97 128.26 9.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.452 ' HE1' HD22 ' B' ' 47' ' ' LEU . 0.5 OUTLIER -134.75 141.98 46.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.402 1.081 . . . . 0.0 108.995 169.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.553 HG22 ' HG3' ' B' ' 46' ' ' LYS . 14.8 t -115.33 127.9 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.491 HD13 ' SD ' ' B' ' 45' ' ' MET . 9.8 mp -90.83 148.96 22.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.301 0.64 . . . . 0.0 110.239 -170.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -8.61 36.05 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.301 1.04 . . . . 0.0 111.796 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -66.22 -18.98 65.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.464 1.105 . . . . 0.0 111.699 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.06 16.16 48.79 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.433 -0.348 . . . . 0.0 112.232 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.711 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -113.43 175.04 5.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.776 0.83 . . . . 0.0 109.046 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.6 tttt -139.98 140.64 36.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.526 HD21 HD23 ' B' ' 9' ' ' LEU . 2.8 tt -140.16 123.27 16.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.728 0.411 . . . . 0.0 110.09 -171.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.472 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -104.88 160.15 15.48 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.87 0.748 . . . . 0.0 111.522 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 81.6 mt -126.2 106.29 9.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 164.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.465 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 5.3 t90 -104.91 123.32 47.54 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 11.4 t -70.69 130.6 42.19 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.411 ' O ' HG12 ' B' ' 55' ' ' VAL . 31.8 ptt180 -65.92 -20.62 66.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.843 0.857 . . . . 0.0 112.447 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -77.18 -8.2 57.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.313 0.245 . . . . 0.0 110.869 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -132.01 9.12 4.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.308 0.643 . . . . 0.0 111.24 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 52' ' ' ARG . 9.0 p -71.73 145.79 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -127.41 116.72 21.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 94' ' ' GLN . 10.4 Cg_exo -71.15 140.06 62.25 Favored 'Cis proline' 0 C--N 1.39 2.746 0 CA-C-N 120.205 1.109 . . . . 0.0 113.455 3.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -60.42 121.2 11.49 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.431 1.092 . . . . 0.0 112.005 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.47 109.65 5.11 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.678 0.791 . . . . 0.0 109.876 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 p -85.11 85.36 7.48 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-O 122.109 0.957 . . . . 0.0 108.858 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.71 148.73 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.2 p -145.1 121.66 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.541 1.136 . . . . 0.0 108.003 167.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.54 4.98 69.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.19 -34.75 76.08 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.79 0.295 . . . . 0.0 112.518 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.74 -162.43 23.07 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.747 -0.227 . . . . 0.0 112.731 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.4 110.71 0.24 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.172 0.572 . . . . 0.0 111.746 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.6 mt-10 -124.09 129.82 51.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -171.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 68' ' ' LEU . 5.5 mt -114.06 102.17 9.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.19 110.04 20.38 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.342 0.519 . . . . 0.0 111.008 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.6 107.43 19.08 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.495 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.8 mtm105 -87.86 129.5 35.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.336 0.589 . . . . 0.0 110.98 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.84 159.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.111 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 8.7 pt-20 -66.5 -33.52 75.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.19 179.83 6.62 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.455 0.645 . . . . 0.0 112.5 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.973 -165.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.81 -42.0 77.89 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.439 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -64.54 -23.73 67.37 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.022 0.826 . . . . 0.0 112.129 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 -42.43 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.476 0.655 . . . . 0.0 110.288 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.0 -30.66 62.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.029 1.331 . . . . 0.0 111.404 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.0 mt-10 -66.64 -46.21 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.407 0.622 . . . . 0.0 109.651 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.0 m -65.62 -33.18 75.3 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.07 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -58.33 -61.48 2.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.836 0.854 . . . . 0.0 109.899 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.52 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.72 -35.58 80.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.222 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.72 93.15 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.857 0.723 . . . . 0.0 113.029 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -62.82 -43.26 99.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.335 0.654 . . . . 0.0 110.432 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 31.9 ttpt -58.39 -43.32 88.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.035 0.834 . . . . 0.0 110.627 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.68 -24.32 61.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.909 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 38.1 t -91.0 -0.44 57.75 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.41 1.084 . . . . 0.0 112.424 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.91 41.37 4.67 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 114.284 0.473 . . . . 0.0 114.284 169.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.8 p -88.95 146.48 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.53 67.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.805 0.442 . . . . 0.0 110.507 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.544 ' HB2' HG13 ' B' ' 90' ' ' VAL . 57.4 ttm 63.76 83.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.693 0.797 . . . . 0.0 112.843 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 83.91 2.21 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.638 0.733 . . . . 0.0 110.682 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' B' ' 106' ' ' THR . 57.2 tp60 179.41 139.48 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.756 1.222 . . . . 0.0 108.591 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.05 121.16 74.13 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 26.7 Cg_endo -62.48 102.22 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.566 2.177 . . . . 0.0 110.088 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.38 150.86 48.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.011 0.524 . . . . 0.0 111.548 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -72.74 100.87 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.798 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.44 ' SD ' HG21 ' B' ' 104' ' ' THR . 4.5 mtt -90.69 175.15 7.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.234 1.014 . . . . 0.0 110.213 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.08 -34.6 73.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.092 0.957 . . . . 0.0 111.024 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -87.42 -5.81 58.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.175 0.99 . . . . 0.0 111.037 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.81 -169.53 20.25 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.23 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -75.66 102.51 5.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.44 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.0 t -107.82 149.09 28.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 110.061 -173.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 11.3 t80 -144.32 141.13 29.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.038 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 28.9 m -136.77 127.38 26.99 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.1 171.79 7.15 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.657 0.383 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.03 122.65 22.11 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.472 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.7 p-10 -79.2 177.21 3.03 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.013 0.925 . . . . 0.0 111.219 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.1 Cg_exo -41.83 -43.19 6.72 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.485 2.79 . . . . 0.0 115.16 170.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.27 -9.22 53.6 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.726 0.81 . . . . 0.0 110.766 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 24.3 m 65.22 87.45 0.12 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.194 1.397 . . . . 0.0 111.66 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -124.47 143.79 50.45 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.454 ' HB2' ' HG2' ' B' ' 67' ' ' GLU . 67.4 mtm-85 -76.24 94.68 3.58 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -92.83 99.11 11.84 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.589 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 2.8 tmt_? -96.0 94.93 7.87 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.258 -165.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 t -90.32 120.32 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.454 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.3 p90 -131.98 159.34 39.02 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.506 0.594 . . . . 0.0 112.345 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.46 111.32 16.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.8 124.28 25.05 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.331 0.395 . . . . 0.0 110.256 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.79 93.5 7.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 111.265 -176.955 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.621 0.248 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.7 m -93.46 127.46 39.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.793 0.837 . . . . 0.0 109.89 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -104.1 106.82 55.04 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.09 0.956 . . . . 0.0 110.623 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.7 95.03 0.92 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.773 2.315 . . . . 0.0 112.416 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.701 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.5 p-10 -83.53 3.56 31.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.384 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -124.33 118.61 27.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.0 t -117.3 137.75 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.624 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 50.8 mt -119.66 137.49 53.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 47' ' ' LEU . 4.6 mm? -88.47 106.96 18.62 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 168.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -58.51 104.26 0.21 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.398 163.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.55 HG12 ' HE1' ' A' ' 113' ' ' HIS . 27.8 m -118.8 173.81 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.412 1.085 . . . . 0.0 108.614 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.0 -64.74 1.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.99 0.916 . . . . 0.0 109.974 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -72.51 110.78 8.9 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.959 -170.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.3 Cg_exo -60.21 -62.25 0.16 Allowed 'Trans proline' 0 CA--C 1.576 2.618 0 C-N-CA 121.655 1.57 . . . . 0.0 113.324 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 22.3 Cg_exo -64.7 -52.11 1.5 Allowed 'Trans proline' 0 C--N 1.406 3.6 0 CA-C-N 122.984 2.101 . . . . 0.0 111.64 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.88 89.52 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.303 -165.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.47 -41.28 47.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 71.2 m -56.9 -46.02 82.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.565 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.6 mm100 -65.37 -38.25 89.47 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.515 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CZ ' HG22 ' A' ' 90' ' ' VAL . 77.6 t80 -63.89 -45.7 88.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.327 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.68 -29.22 65.48 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.875 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -56.25 -48.32 76.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.44 0.564 . . . . 0.0 111.952 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 -38.74 50.47 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.075 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.51 -40.99 93.4 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.256 1.422 . . . . 0.0 113.02 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' A' ' 27' ' ' VAL . 18.6 mt -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 31.05 6.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.262 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 25' ' ' LEU . 26.8 m -132.76 166.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.057 0.943 . . . . 0.0 110.322 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -113.71 149.32 41.54 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.443 0.697 . . . . 0.0 110.051 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 11.9 Cg_exo -71.37 111.91 3.21 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.912 2.408 . . . . 0.0 111.131 173.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.24 -37.27 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.337 0.655 . . . . 0.0 109.936 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm-40 -109.6 121.99 46.44 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.7 p -131.34 131.14 43.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.99 0.516 . . . . 0.0 110.118 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -144.13 152.98 55.93 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.222 1.409 . . . . 0.0 108.294 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.39 -10.44 13.42 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.661 2.241 . . . . 0.0 114.364 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -129.5 -1.02 4.97 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -153.94 148.56 26.31 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 122.096 -0.378 . . . . 0.0 110.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -137.91 149.68 46.42 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 109.638 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -143.77 122.27 12.44 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.48 ' HZ ' HD13 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -133.54 137.19 45.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.42 1.488 . . . . 0.0 108.17 173.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 46' ' ' LYS . 22.0 t -116.27 127.5 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.838 0.855 . . . . 0.0 108.764 -172.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.9 mt -87.07 150.61 23.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.836 0.351 . . . . 0.0 110.122 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.88 -8.12 45.94 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 0.0 111.97 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.439 HD22 ' HB3' ' B' ' 5' ' ' ASP . 1.5 m-20 -72.77 -8.43 55.4 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.086 0.954 . . . . 0.0 112.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.11 16.75 42.94 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.724 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -119.61 171.93 8.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.799 0.84 . . . . 0.0 109.476 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 40' ' ' VAL . 66.0 tttt -132.77 141.08 48.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 9' ' ' LEU . 1.1 tt -138.45 122.04 17.39 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.202 0.525 . . . . 0.0 110.444 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.8 171.49 20.04 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.888 0.756 . . . . 0.0 112.26 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.48 HD13 ' HZ ' ' A' ' 39' ' ' PHE . 1.1 tp -140.37 118.84 12.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.1 t90 -115.44 122.67 46.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -84.28 125.3 32.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.988 0.515 . . . . 0.0 109.972 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 37.7 ptt180 -69.48 -9.35 53.37 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -167.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -75.02 -8.58 56.92 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -135.33 6.44 3.29 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.772 0.429 . . . . 0.0 111.089 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 52' ' ' ARG . 7.1 p -60.9 147.85 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.977 0.511 . . . . 0.0 110.814 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -119.25 115.08 34.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' B' ' 94' ' ' GLN . 81.7 Cg_endo -79.23 142.59 67.13 Favored 'Cis proline' 0 C--N 1.381 2.252 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.582 2.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -51.17 115.22 1.45 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 111.688 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.57 151.65 41.76 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.497 1.119 . . . . 0.0 109.094 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 20.1 m -134.95 87.09 2.31 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.09 123.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.769 0.828 . . . . 0.0 108.988 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 p -136.4 125.39 24.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.019 0.927 . . . . 0.0 109.651 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.71 67.47 0.83 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' HA2' HG13 ' B' ' 61' ' ' VAL . . . -169.72 54.15 0.2 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.98 169.6 19.15 Favored Glycine 0 C--O 1.242 0.62 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 80.88 106.84 0.31 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.6 pt-20 -130.61 146.39 52.1 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.721 0.808 . . . . 0.0 109.59 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.7 tp -117.19 103.88 10.63 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.95 0.9 . . . . 0.0 108.637 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.0 113.78 23.97 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.222 0.464 . . . . 0.0 111.312 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.64 110.14 21.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.037 1.335 . . . . 0.0 108.458 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -89.72 124.67 34.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.542 0.687 . . . . 0.0 112.421 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.59 158.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.795 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.0 pt-20 -64.46 -39.39 93.73 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -161.4 178.25 9.34 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.219 0.533 . . . . 0.0 112.073 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.2 -28.13 66.36 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.208 1.403 . . . . 0.0 112.462 -167.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.08 -50.71 69.49 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.54 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.6 mm-40 -64.3 -24.4 67.64 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.303 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.16 -45.68 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.361 0.601 . . . . 0.0 110.028 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.18 -29.98 63.22 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.54 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 33.1 mt-10 -66.51 -47.71 72.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -66.59 -29.25 69.27 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.706 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -60.11 -61.21 2.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.732 0.813 . . . . 0.0 109.593 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.02 -32.6 73.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.296 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.81 -45.69 91.87 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.648 0.593 . . . . 0.0 112.759 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.427 ' HB3' HG21 ' A' ' 90' ' ' VAL . 44.4 m0 -66.01 -41.11 91.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.524 0.73 . . . . 0.0 110.046 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.28 -43.6 88.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 0.0 110.612 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.32 -27.36 61.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.761 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -94.48 8.67 41.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.56 0.744 . . . . 0.0 111.829 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.58 54.03 3.23 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 167.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.47 HG11 ' HB1' ' A' ' 107' ' ' ALA . 60.0 t -102.87 142.63 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.42 -47.29 82.53 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.132 0.573 . . . . 0.0 111.367 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 ttm 60.24 83.53 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 165.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.57 85.15 2.31 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 122.037 -0.414 . . . . 0.0 110.651 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? 177.93 121.1 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.665 1.186 . . . . 0.0 108.426 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -72.22 114.05 26.05 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 17.7 Cg_endo -56.22 112.93 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.945 2.43 . . . . 0.0 111.186 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.4 147.71 50.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.63 0.772 . . . . 0.0 110.657 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -75.26 100.93 4.5 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.643 ' HG2' ' H ' ' A' ' 101' ' ' PHE . 55.4 ttm -90.2 161.87 15.51 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.48 -28.49 54.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.735 0.814 . . . . 0.0 110.781 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.643 ' H ' ' HG2' ' A' ' 99' ' ' MET . 74.5 m-85 -110.14 88.34 2.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 109.509 171.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.64 162.34 0.94 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 82.7 t80 -78.2 101.83 7.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -107.65 145.38 33.41 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.512 0.673 . . . . 0.0 110.471 -165.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 4.9 t80 -137.1 130.66 31.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.531 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.0 m -120.85 122.78 41.03 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.448 0.642 . . . . 0.0 110.108 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -105.16 172.86 6.56 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.464 0.706 . . . . 0.0 109.988 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.85 118.12 12.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -68.01 168.25 13.97 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.675 0.79 . . . . 0.0 110.101 171.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.77 -27.26 15.04 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.114 2.543 . . . . 0.0 114.825 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.3 8.06 41.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.794 0.837 . . . . 0.0 111.229 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 m 70.45 30.04 3.32 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.134 1.373 . . . . 0.0 113.896 165.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.55 ' HE1' HG12 ' A' ' 11' ' ' VAL . 14.1 m80 -84.32 178.59 7.71 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -110.96 117.34 33.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -106.12 100.61 10.15 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -101.04 97.85 8.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -167.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.3 t -88.11 118.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.08 167.05 15.9 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.197 0.453 . . . . 0.0 110.957 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -126.82 110.69 13.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -82.1 115.79 21.38 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.19 94.11 4.05 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.367 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.482 -178.247 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ptt? . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 8.5 m -101.56 124.18 46.81 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -103.5 106.6 52.71 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 124.426 1.09 . . . . 0.0 110.441 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.54 94.92 0.93 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.476 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.724 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 7.1 p-10 -83.05 3.4 30.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.105 0.562 . . . . 0.0 111.517 172.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.406 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.5 t80 -124.45 118.44 26.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -168.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -117.43 137.89 52.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.645 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 44.2 mt -119.72 137.08 54.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.45 HD23 HD21 ' B' ' 47' ' ' LEU . 4.6 mm? -88.14 106.86 18.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.43 105.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.06 163.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.522 HG12 ' HE1' ' B' ' 113' ' ' HIS . 22.4 m -119.1 173.79 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.621 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -105.93 -65.16 1.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.754 0.822 . . . . 0.0 109.882 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -72.12 110.78 8.63 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.782 -170.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.52 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 27.4 Cg_exo -59.99 -63.07 0.13 Allowed 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 121.691 1.594 . . . . 0.0 113.353 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 33.3 Cg_exo -63.08 -53.0 1.74 Allowed 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 123.195 2.177 . . . . 0.0 112.275 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.67 89.71 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.395 -165.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.11 -41.45 50.19 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.61 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 18.0 mm100 -65.71 -38.4 89.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.517 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -64.35 -44.89 90.04 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.749 0.656 . . . . 0.0 110.229 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -70.71 -29.51 65.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.904 -0.569 . . . . 0.0 109.884 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.61 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 58.9 mtpt -56.1 -48.38 76.26 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.486 0.585 . . . . 0.0 112.087 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.18 -38.98 50.52 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.04 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp -59.89 -41.4 91.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.203 1.401 . . . . 0.0 113.007 -174.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.482 ' HB2' HG22 ' B' ' 27' ' ' VAL . 19.7 mt -91.6 -41.27 10.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.315 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.44 30.87 7.07 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.28 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.0 m -132.86 167.11 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.093 0.957 . . . . 0.0 110.53 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -114.27 149.53 42.23 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.663 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 7.2 Cg_exo -72.12 111.48 3.19 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.91 2.406 . . . . 0.0 111.016 174.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.75 -36.72 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.949 0.5 . . . . 0.0 110.068 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.713 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.5 mm-40 -110.12 121.28 44.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -130.79 130.58 43.89 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.165 0.586 . . . . 0.0 110.111 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 91.9 p -143.94 155.98 58.88 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.461 1.104 . . . . 0.0 108.441 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.32 -10.2 17.8 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.685 2.257 . . . . 0.0 113.779 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -129.42 -1.17 5.0 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.9 148.91 26.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.184 0.447 . . . . 0.0 110.018 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 14.2 m -137.67 149.78 46.83 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.634 0.774 . . . . 0.0 109.2 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -143.98 121.6 11.82 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.94 138.52 46.94 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.156 1.383 . . . . 0.0 108.45 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.7 t -117.26 127.21 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.869 0.867 . . . . 0.0 108.756 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.478 HD12 ' SD ' ' B' ' 45' ' ' MET . 63.2 mt -87.1 150.58 23.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.95 -7.99 45.15 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.37 1.068 . . . . 0.0 111.89 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -73.28 -8.09 54.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.095 0.958 . . . . 0.0 111.948 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.04 16.81 42.94 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.701 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.4 ppp? -119.79 171.67 8.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.692 0.797 . . . . 0.0 109.378 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.6 141.17 48.56 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -173.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.45 HD21 HD23 ' B' ' 9' ' ' LEU . 1.1 tt -138.44 122.16 17.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 -172.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.406 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -103.86 170.57 19.11 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.863 0.745 . . . . 0.0 112.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 79.1 mt -138.59 119.83 14.69 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 164.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -115.27 122.68 46.71 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 39.1 m -83.59 125.49 31.86 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.784 0.434 . . . . 0.0 110.099 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 39.0 ptt180 -69.5 -8.45 47.1 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.92 -8.61 57.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.702 0.401 . . . . 0.0 111.48 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -135.52 4.78 3.14 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.184 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' B' ' 52' ' ' ARG . 7.5 p -57.8 147.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.128 0.571 . . . . 0.0 111.147 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.69 114.97 33.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.453 0.701 . . . . 0.0 109.143 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.33 143.09 68.68 Favored 'Cis proline' 0 C--N 1.382 2.31 0 C-N-CA 124.504 -1.04 . . . . 0.0 112.347 2.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.88 116.44 2.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.074 0.949 . . . . 0.0 110.861 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.63 151.22 41.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.988 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 49.5 m -134.67 86.96 2.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.412 HG13 ' HA2' ' A' ' 64' ' ' GLY . 7.5 p -156.27 123.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.244 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.4 p -135.49 126.46 27.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.834 0.854 . . . . 0.0 109.621 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.9 67.87 0.86 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.08 54.22 0.2 Allowed Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.88 169.76 19.25 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 80.74 107.26 0.3 Allowed Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.624 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 6.5 pt-20 -131.3 145.7 51.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.081 0.952 . . . . 0.0 109.079 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.5 tp -117.46 103.79 10.45 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.89 114.16 24.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.192 0.451 . . . . 0.0 111.252 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -91.2 109.98 21.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.918 1.287 . . . . 0.0 108.39 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.434 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.4 mtm180 -89.69 123.77 34.01 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.497 0.665 . . . . 0.0 111.991 -176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 159.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.781 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.9 pt-20 -64.79 -38.71 91.89 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -161.9 179.14 8.28 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.986 0.422 . . . . 0.0 112.064 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.0 -27.19 68.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.212 -166.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.11 -50.57 69.98 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.946 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.48 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 82.1 mm-40 -65.0 -24.1 67.41 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.39 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.18 -45.76 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.261 0.624 . . . . 0.0 110.087 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.24 -30.6 65.03 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.623 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 25.8 mt-10 -66.56 -47.22 73.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 109.421 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -66.91 -29.25 69.08 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.688 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.03 -61.39 2.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 0.0 109.621 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -67.17 -32.26 73.23 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.31 -173.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.65 -46.04 91.12 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.755 0.659 . . . . 0.0 112.826 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.51 -41.02 89.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.397 0.679 . . . . 0.0 109.708 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.8 ttpt -57.78 -43.62 85.67 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.769 0.827 . . . . 0.0 110.403 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.53 61.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.462 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -94.53 8.77 41.07 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.607 0.763 . . . . 0.0 111.685 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.97 54.49 3.19 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' B' ' 92' ' ' MET . 5.4 p -103.16 143.41 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 170.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.74 83.5 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.049 0.539 . . . . 0.0 111.284 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.647 ' HB2' HG13 ' B' ' 90' ' ' VAL . 53.6 ttm 59.64 83.64 0.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -118.57 85.74 2.41 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 122.027 -0.421 . . . . 0.0 110.498 175.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.485 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 45.1 tp60 177.2 119.89 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.099 1.36 . . . . 0.0 109.119 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.55 112.51 14.19 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.58 0.752 . . . . 0.0 109.08 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.597 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 10.9 Cg_endo -53.98 111.99 0.85 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.186 2.591 . . . . 0.0 111.835 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.38 147.62 50.27 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.686 0.794 . . . . 0.0 110.582 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 100.73 4.12 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.634 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 51.5 ttm -90.43 161.5 15.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.6 -28.06 53.01 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.623 0.769 . . . . 0.0 110.98 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.634 ' H ' ' HG2' ' B' ' 99' ' ' MET . 53.7 m-85 -110.02 88.18 2.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.391 1.077 . . . . 0.0 109.724 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.54 162.74 0.96 Allowed Glycine 0 C--N 1.354 1.56 0 N-CA-C 116.137 1.215 . . . . 0.0 116.137 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 84.7 t80 -78.89 101.96 7.98 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.7 t -107.62 145.34 33.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.585 0.707 . . . . 0.0 110.617 -165.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 6.2 t80 -137.41 131.62 32.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.928 1.291 . . . . 0.0 108.421 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 16.5 m -121.8 122.55 39.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 109.896 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.29 172.74 6.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.283 0.633 . . . . 0.0 109.702 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.53 117.21 12.22 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -66.81 168.99 8.86 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.62 0.768 . . . . 0.0 110.175 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.94 -27.37 20.76 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.336 2.69 . . . . 0.0 114.449 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.77 8.1 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.741 0.816 . . . . 0.0 111.488 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 51.1 m 70.04 30.74 3.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.223 1.409 . . . . 0.0 113.824 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.522 ' HE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -84.4 179.08 7.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 75.9 mmt-85 -111.32 117.82 34.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 37.7 mt -106.41 101.2 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -99.72 96.65 7.75 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.3 118.36 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.434 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.9 p90 -125.96 167.16 15.67 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.163 0.438 . . . . 0.0 110.988 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -127.0 110.73 13.28 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -82.7 118.18 23.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 93.85 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.349 0.66 . . . . 0.0 110.027 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.607 -176.698 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.845 0.355 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' B' ' 70' ' ' PHE . 35.7 m -136.15 143.37 44.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.359 1.064 . . . . 0.0 110.803 -163.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -123.18 117.46 28.21 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.537 0.735 . . . . 0.0 110.489 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HG3' HD22 ' B' ' 25' ' ' LEU . 41.5 Cg_endo -82.71 52.4 4.04 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.381 2.721 . . . . 0.0 111.768 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.903 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 36.7 t70 -75.64 5.07 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.215 1.006 . . . . 0.0 111.764 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -124.46 126.56 46.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.0 t -120.44 145.02 47.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 50' ' ' TRP . 52.7 mt -122.07 144.4 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.775 0.83 . . . . 0.0 108.921 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.567 HD21 HD22 ' A' ' 68' ' ' LEU . 4.3 mm? -91.64 134.27 34.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.42 ' OH ' HG11 ' A' ' 55' ' ' VAL . 10.8 t80 -85.02 99.4 10.99 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.36 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.5 HG12 ' NE2' ' A' ' 113' ' ' HIS . 3.0 m -112.89 159.43 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.561 0.745 . . . . 0.0 109.075 -172.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.34 -59.78 1.87 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -102.37 101.82 21.83 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.245 0.618 . . . . 0.0 109.696 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HG3' ' HB2' ' A' ' 51' ' ' SER . 44.5 Cg_exo -55.21 -55.93 2.75 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.056 2.504 . . . . 0.0 114.908 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.76 -54.74 4.34 Favored 'Trans proline' 0 C--N 1.403 3.407 0 CA-C-N 122.545 1.945 . . . . 0.0 112.379 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.07 96.52 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.74 0.65 . . . . 0.0 111.703 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -66.53 -47.08 74.04 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 96.5 m -67.48 -40.48 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.572 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.1 mm100 -64.49 -38.29 90.49 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.273 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -64.94 -42.23 94.83 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.389 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.425 ' OH ' ' HG ' ' A' ' 9' ' ' LEU . 49.7 m-85 -68.52 -29.67 68.31 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.533 0.606 . . . . 0.0 110.466 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -56.83 -49.43 75.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.204 0.526 . . . . 0.0 111.879 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.87 -40.07 63.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.92 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.7 tp -58.94 -42.7 90.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.478 1.511 . . . . 0.0 113.068 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' HB2' HG22 ' A' ' 27' ' ' VAL . 16.3 mt -96.66 -31.99 12.42 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.16 26.88 27.29 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.325 0.391 . . . . 0.0 112.313 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.9 m -123.42 -178.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.967 0.907 . . . . 0.0 109.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -142.07 151.41 58.89 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 37.6 Cg_endo -63.76 121.26 8.92 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.896 2.397 . . . . 0.0 112.773 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.34 -35.16 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.442 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 15.5 mm-40 -121.03 116.63 25.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.939 1.296 . . . . 0.0 108.233 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.5 p -123.04 131.26 53.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.253 0.621 . . . . 0.0 110.097 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -138.67 151.14 68.15 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.864 1.266 . . . . 0.0 108.292 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.64 -10.12 23.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.817 2.344 . . . . 0.0 113.389 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.481 ' HA ' ' HG2' ' A' ' 14' ' ' PRO . 4.9 t -125.96 -3.57 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -159.17 151.47 21.25 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.7 m -141.62 158.6 43.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.769 0.428 . . . . 0.0 110.349 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -154.27 126.02 7.63 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.9 p90 -134.0 150.4 51.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.476 1.11 . . . . 0.0 109.09 165.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.531 HG22 ' HG3' ' A' ' 46' ' ' LYS . 13.4 t -120.96 131.42 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.03 165.4 15.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.644 0.378 . . . . 0.0 111.464 -171.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.08 75.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.518 1.127 . . . . 0.0 112.869 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -69.91 -20.75 63.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.13 0.572 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 5.35 37.32 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.871 -0.961 . . . . 0.0 114.181 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.493 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.3 ppp? -74.06 166.26 23.7 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.346 1.073 . . . . 0.0 109.206 169.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HG3' HG22 ' A' ' 40' ' ' VAL . 49.3 tttt -126.97 139.69 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 9' ' ' LEU . 3.5 tt -137.62 118.36 14.08 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.89 0.376 . . . . 0.0 110.387 -172.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -105.2 168.97 15.99 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 124.226 0.917 . . . . 0.0 111.958 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.61 106.29 6.91 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.609 ' HB2' HG21 ' A' ' 8' ' ' ILE . 5.1 t90 -105.55 125.59 51.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.569 ' HB2' ' HG3' ' A' ' 14' ' ' PRO . 23.3 t -77.48 137.07 38.45 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.592 0.558 . . . . 0.0 110.597 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -71.59 -10.14 59.31 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.501 0.72 . . . . 0.0 112.906 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -85.14 -21.19 29.34 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.215 0.206 . . . . 0.0 110.731 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 51' ' ' SER . 7.1 t -116.27 4.59 13.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.148 0.579 . . . . 0.0 111.326 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.1 p -72.71 145.4 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.97 116.54 26.05 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.4 Cg_exo -77.16 138.19 52.35 Favored 'Cis proline' 0 C--N 1.383 2.387 0 CA-C-N 119.727 0.938 . . . . 0.0 112.038 2.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HA ' HG13 ' A' ' 55' ' ' VAL . 2.8 tmmm? -65.25 112.42 3.44 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.962 0.789 . . . . 0.0 109.722 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.27 128.89 55.51 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.306 1.042 . . . . 0.0 110.015 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -90.52 84.38 5.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 m -159.27 150.86 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 124.688 1.195 . . . . 0.0 109.274 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.87 127.11 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.703 1.601 . . . . 0.0 107.915 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.89 -46.56 0.29 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.72 144.71 9.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.33 -29.93 0.15 Allowed Glycine 0 N--CA 1.469 0.876 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 149.56 18.33 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.192 -1.004 . . . . 0.0 110.695 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 7.4 mm-40 -101.71 151.56 21.89 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 173.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.567 HD22 HD21 ' A' ' 9' ' ' LEU . 41.4 tp -109.99 101.92 10.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -87.54 117.96 26.69 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.522 ' HB2' HG22 ' A' ' 117' ' ' VAL . 8.7 m-85 -96.47 121.46 38.31 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.782 1.233 . . . . 0.0 107.896 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.441 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 39.9 mtm105 -99.98 126.74 46.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.23 162.45 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.174 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.38 -33.68 69.75 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.82 179.39 7.12 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.055 0.843 . . . . 0.0 112.288 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.44 -34.27 75.12 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.432 1.093 . . . . 0.0 112.272 -165.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.24 -43.87 96.83 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.213 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -65.22 -21.75 66.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.874 0.87 . . . . 0.0 112.738 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.17 -38.12 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.071 0.463 . . . . 0.0 110.06 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.35 -32.29 64.46 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.306 1.042 . . . . 0.0 111.324 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.0 mt-10 -68.76 -40.1 79.93 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.656 0.741 . . . . 0.0 109.192 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.414 HG21 HG21 ' A' ' 117' ' ' VAL . 99.5 m -68.62 -32.7 72.76 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.65 174.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -62.78 -60.76 3.04 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.821 0.819 . . . . 0.0 109.458 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.4 -37.28 85.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.841 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.35 -46.12 91.49 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.98 0.8 . . . . 0.0 113.638 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 115' ' ' LEU . 36.3 m0 -61.23 -50.35 73.45 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.235 0.614 . . . . 0.0 109.996 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.7 ttpt -52.58 -45.16 66.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.142 0.977 . . . . 0.0 110.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.98 61.08 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.294 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -97.77 11.12 38.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.814 0.845 . . . . 0.0 112.828 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 15.01 21.22 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.49 136.03 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 117.545 0.673 . . . . 0.0 110.321 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.68 72.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.428 1.091 . . . . 0.0 111.754 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.617 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 49.7 tpp 69.02 83.59 0.16 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.157 0.911 . . . . 0.0 112.849 165.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.27 86.47 2.28 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.0 0.52 . . . . 0.0 111.537 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.572 ' HG2' ' H ' ' A' ' 106' ' ' THR . 55.6 tp60 -179.67 140.77 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.882 0.873 . . . . 0.0 109.645 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -92.24 113.79 60.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' THR . 20.9 Cg_endo -61.63 108.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.243 1.962 . . . . 0.0 110.598 174.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.64 49.28 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.335 0.654 . . . . 0.0 110.219 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -63.07 106.26 0.82 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.588 0.755 . . . . 0.0 110.975 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 104' ' ' THR . 3.3 ttt -93.99 -176.38 3.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.843 0.857 . . . . 0.0 109.737 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 99' ' ' MET . 8.7 mm-40 -66.31 -27.67 68.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.02 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.73 92.72 3.38 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.8 161.74 3.24 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 36.0 t80 -69.09 103.76 1.96 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.138 1.375 . . . . 0.0 108.61 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 13.7 t -103.03 141.55 35.63 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.86 0.754 . . . . 0.0 111.683 -162.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -151.62 127.61 10.38 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.754 1.221 . . . . 0.0 109.636 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 42.3 m -135.24 125.82 26.93 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.07 162.05 21.92 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.062 0.545 . . . . 0.0 112.169 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.89 112.42 24.64 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.581 0.753 . . . . 0.0 109.599 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.4 p30 -71.96 177.27 1.77 Allowed Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.437 1.095 . . . . 0.0 112.05 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 25.5 Cg_exo -40.64 -50.48 3.86 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.949 3.099 . . . . 0.0 115.544 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 9.9 t70 -79.62 -17.86 52.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.6 m 71.93 61.32 0.14 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.412 1.485 . . . . 0.0 110.886 174.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.5 ' NE2' HG12 ' A' ' 11' ' ' VAL . 8.6 m80 -91.71 175.07 7.03 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.603 -1.18 . . . . 0.0 107.975 168.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -94.43 99.04 11.3 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HB3' ' CH2' ' A' ' 85' ' ' TRP . 81.9 mt -106.12 104.03 13.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.631 0.372 . . . . 0.0 110.011 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.545 ' NH1' ' HB3' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -93.31 147.18 23.15 Favored 'General case' 0 C--O 1.205 -1.269 0 C-N-CA 124.022 0.929 . . . . 0.0 110.01 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 70' ' ' PHE . 12.2 t -139.66 140.0 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 5.4 p90 -133.81 171.1 14.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.096 0.407 . . . . 0.0 111.635 172.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -131.06 113.95 14.56 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 166.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -75.11 129.25 37.23 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 93.27 1.9 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.722 0.639 . . . . 0.0 110.264 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.219 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.311 0.101 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 20.9 m -142.3 140.44 32.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.484 0.314 . . . . 0.0 111.056 -167.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -122.69 117.59 28.77 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.566 0.747 . . . . 0.0 110.056 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.474 ' HG3' HD22 ' A' ' 25' ' ' LEU . 42.0 Cg_endo -82.74 51.69 3.8 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.28 2.654 . . . . 0.0 111.89 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.493 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 30.3 t70 -75.96 5.92 5.89 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.179 0.99 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.01 126.08 45.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 15.2 t -120.4 145.66 46.97 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' B' ' 50' ' ' TRP . 59.4 mt -122.67 144.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 123.825 0.85 . . . . 0.0 108.768 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.572 HD21 HD22 ' B' ' 68' ' ' LEU . 4.3 mm? -91.59 134.12 34.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.85 99.3 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.448 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.511 HG12 ' NE2' ' B' ' 113' ' ' HIS . 3.2 m -112.72 159.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.691 0.796 . . . . 0.0 109.032 -172.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 -60.28 1.82 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -102.29 101.71 20.99 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.295 0.638 . . . . 0.0 109.881 -173.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' B' ' 51' ' ' SER . 32.5 Cg_exo -55.67 -55.55 2.93 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.952 2.435 . . . . 0.0 114.701 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.77 -54.82 4.2 Favored 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.594 1.962 . . . . 0.0 112.276 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.31 96.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.072 0.549 . . . . 0.0 111.768 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 69.1 m -65.31 -47.15 77.57 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 123.726 0.641 . . . . 0.0 109.364 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 51.9 m -67.46 -41.17 85.1 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -170.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.559 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 11.7 mm100 -64.09 -38.43 91.05 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.514 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.83 -41.95 95.34 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.394 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 42.6 m-85 -68.6 -29.9 68.53 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.579 0.627 . . . . 0.0 110.487 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -56.6 -49.48 74.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.194 0.521 . . . . 0.0 111.695 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.26 63.22 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.975 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 31.0 tp -58.93 -42.2 89.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.37 1.468 . . . . 0.0 113.232 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.54 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.4 mt -97.55 -30.53 12.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.74 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.67 30.4 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.6 m -122.93 -177.71 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.121 0.968 . . . . 0.0 109.823 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' B' ' 22' ' ' LYS . 6.5 p-10 -143.04 151.81 56.79 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 109.365 174.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 18.7 Cg_exo -65.53 121.25 8.61 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.95 2.433 . . . . 0.0 112.263 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.513 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.2 p -64.9 -36.68 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 21.0 mm-40 -120.89 116.83 25.91 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.872 1.269 . . . . 0.0 107.966 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -123.62 131.62 53.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.988 0.515 . . . . 0.0 109.933 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -138.97 150.34 64.87 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.833 1.253 . . . . 0.0 108.345 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.93 -10.33 22.41 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.507 2.138 . . . . 0.0 113.576 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 5.6 t -126.19 -3.27 6.92 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -159.14 151.64 21.51 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 73.3 m -141.87 159.08 42.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.628 0.371 . . . . 0.0 110.391 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 24.2 tp -154.81 125.56 7.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.6 p90 -133.89 150.2 51.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.253 1.021 . . . . 0.0 109.134 165.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.553 HG22 ' HG3' ' B' ' 46' ' ' LYS . 18.5 t -120.77 131.46 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.91 165.18 16.11 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.691 0.397 . . . . 0.0 111.553 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.69 76.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.641 1.177 . . . . 0.0 112.851 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -69.99 -20.47 63.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.004 0.522 . . . . 0.0 111.068 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.31 5.0 37.73 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-O 118.817 -0.99 . . . . 0.0 113.988 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.903 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 6.8 ptm -73.68 166.84 22.55 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.538 1.169 . . . . 0.0 109.27 169.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' B' ' 40' ' ' VAL . 73.1 tttt -127.25 139.5 52.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.534 HD21 HD23 ' B' ' 9' ' ' LEU . 3.6 tt -137.56 118.7 14.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.973 0.416 . . . . 0.0 110.254 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.93 169.09 16.34 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.315 0.96 . . . . 0.0 111.958 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.85 106.03 6.69 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 166.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.609 ' HB2' HG21 ' B' ' 8' ' ' ILE . 4.5 t90 -105.46 125.63 51.21 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.573 ' HB2' ' HG3' ' B' ' 14' ' ' PRO . 21.6 t -77.29 137.13 38.61 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.681 0.613 . . . . 0.0 110.716 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -71.92 -9.78 58.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -85.32 -20.14 30.44 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.493 0.317 . . . . 0.0 111.389 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.477 HG22 ' HB3' ' B' ' 51' ' ' SER . 11.9 t -117.02 4.41 12.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.392 0.677 . . . . 0.0 111.029 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' B' ' 58' ' ' LYS . 8.4 p -73.57 146.71 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.29 116.14 23.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -77.65 139.2 56.27 Favored 'Cis proline' 0 C--N 1.387 2.595 0 C-N-CA 124.706 -0.956 . . . . 0.0 111.869 3.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.517 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.1 tmmm? -66.18 112.5 3.96 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.85 0.719 . . . . 0.0 109.395 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.93 129.3 55.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.19 0.996 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 27.5 p -90.98 85.58 6.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 62' ' ' THR . 7.9 p -161.52 149.77 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.339 1.056 . . . . 0.0 109.567 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.434 HG23 ' O ' ' B' ' 61' ' ' VAL . 2.1 p -168.83 128.1 1.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.958 1.703 . . . . 0.0 107.65 169.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.21 -47.55 0.29 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.82 144.66 9.66 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.41 -29.87 0.15 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 149.45 18.1 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.162 -1.019 . . . . 0.0 110.657 170.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.596 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 11.2 mm-40 -101.51 151.85 21.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.572 HD22 HD21 ' B' ' 9' ' ' LEU . 44.1 tp -110.14 101.78 10.54 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -87.58 118.0 26.77 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.575 0.702 . . . . 0.0 111.208 -170.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.464 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 5.9 m-85 -96.05 121.55 37.92 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 42.2 mtm105 -100.4 125.01 46.63 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.68 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.91 163.2 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.135 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.1 pt-20 -71.3 -34.58 70.73 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.428 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -163.21 179.84 7.15 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.155 0.889 . . . . 0.0 112.482 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.13 -33.86 75.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.43 1.092 . . . . 0.0 111.891 -165.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.56 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.987 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.5 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.5 mm-40 -65.62 -22.06 66.63 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.691 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.64 -38.95 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 122.748 0.419 . . . . 0.0 109.924 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.93 -31.82 64.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.154 0.981 . . . . 0.0 111.436 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.9 mt-10 -69.88 -38.93 76.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.634 0.73 . . . . 0.0 109.53 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 68.3 m -68.34 -33.53 74.45 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.616 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -62.47 -61.01 2.74 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.739 0.781 . . . . 0.0 109.542 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.6 -36.9 84.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.667 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.84 89.03 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 124.001 0.813 . . . . 0.0 113.63 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' TRP . . . . . 0.409 ' HB3' HG21 ' B' ' 90' ' ' VAL . 42.1 m0 -60.6 -50.28 74.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.351 0.66 . . . . 0.0 109.551 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.612 ' HB2' ' HE3' ' B' ' 92' ' ' MET . 31.5 ttpt -53.42 -44.64 68.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.132 0.895 . . . . 0.0 111.003 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.69 61.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 m -98.19 10.64 40.08 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.722 0.809 . . . . 0.0 112.884 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.58 14.77 20.85 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' B' ' 85' ' ' TRP . 54.4 t -78.66 135.69 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 117.554 0.677 . . . . 0.0 110.413 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.95 -37.48 71.59 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.468 1.107 . . . . 0.0 111.764 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.612 ' HE3' ' HB2' ' B' ' 86' ' ' LYS . 45.0 tpp 69.83 83.16 0.15 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.126 0.891 . . . . 0.0 112.707 165.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.49 87.08 2.32 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.745 0.418 . . . . 0.0 111.512 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' B' ' 106' ' ' THR . 56.9 tp60 179.66 141.77 0.13 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.118 0.967 . . . . 0.0 109.856 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -93.51 113.24 59.69 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' B' ' 104' ' ' THR . 33.3 Cg_exo -60.26 108.64 0.53 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.472 2.115 . . . . 0.0 110.974 173.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.46 49.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.466 0.706 . . . . 0.0 110.541 -175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -62.48 106.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.817 0.847 . . . . 0.0 110.981 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.469 ' SD ' HG21 ' B' ' 104' ' ' THR . 3.3 ttt -93.9 -175.96 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.675 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' B' ' 99' ' ' MET . 10.4 mm-40 -66.54 -27.96 68.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.585 . . . . 0.0 111.015 174.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -128.89 92.24 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.286 1.034 . . . . 0.0 109.152 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 161.64 2.83 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 34.0 t80 -68.87 103.25 1.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 108.851 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.469 HG21 ' SD ' ' B' ' 99' ' ' MET . 5.3 t -103.67 142.11 34.9 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.163 0.892 . . . . 0.0 111.518 -161.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.487 ' HZ ' ' SD ' ' B' ' 92' ' ' MET . 14.2 t80 -151.6 127.81 10.53 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.499 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 60.4 m -134.99 125.92 27.55 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.43 162.03 22.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.007 0.523 . . . . 0.0 112.154 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.9 113.28 26.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.663 0.785 . . . . 0.0 109.165 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.555 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.8 p-10 -73.27 177.89 1.77 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 124.366 1.066 . . . . 0.0 111.745 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.7 Cg_exo -41.04 -50.3 4.24 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.919 3.079 . . . . 0.0 115.531 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 10.5 t70 -79.65 -17.64 53.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 71.72 61.1 0.15 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 125.329 1.451 . . . . 0.0 111.005 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.511 ' NE2' HG12 ' B' ' 11' ' ' VAL . 7.6 m80 -91.29 175.29 6.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.15 168.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -95.01 98.7 10.87 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.95 103.54 13.13 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 46.4 ttt180 -89.83 148.49 23.16 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 123.279 0.632 . . . . 0.0 110.455 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.23 140.59 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.526 1.13 . . . . 0.0 108.176 163.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' B' ' 103' ' ' TYR . 7.2 p90 -133.7 170.63 15.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -130.49 113.79 14.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -74.68 130.24 39.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 99.87 0.89 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.94 0.896 . . . . 0.0 110.998 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.405 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.444 176.448 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HB2' ' OE1' ' B' ' 77' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' B' ' 70' ' ' PHE . 54.4 m -140.82 145.96 36.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.444 0.698 . . . . 0.0 111.396 -168.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -133.88 96.95 15.8 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.601 0.76 . . . . 0.0 109.818 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.48 93.79 0.99 Allowed 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.195 1.93 . . . . 0.0 111.381 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 6.3 p-10 -109.25 14.63 23.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 0.0 109.454 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HD2' ' HD3' ' B' ' 71' ' ' ARG . 0.7 OUTLIER -131.5 141.91 49.86 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.919 -165.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 145.16 30.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.733 1.213 . . . . 0.0 108.117 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 51.4 mt -118.59 140.65 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.034 0.534 . . . . 0.0 110.661 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.56 118.53 37.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -74.42 122.5 23.09 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.981 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' SER . 11.7 m -122.14 163.7 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.17 -52.26 3.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -103.98 98.18 12.97 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.455 0.702 . . . . 0.0 110.079 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.49 -48.72 17.85 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.506 2.804 . . . . 0.0 115.858 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.89 -63.48 0.2 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 123.106 2.145 . . . . 0.0 112.419 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.62 89.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 0.0 112.125 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -66.82 -47.94 70.46 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.442 0.639 . . . . 0.0 110.425 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 65.8 m -75.96 -34.92 59.83 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.0 mm-40 -66.45 -33.74 76.39 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.102 0.876 . . . . 0.0 109.259 172.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 81.9 t80 -66.73 -42.83 85.67 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.002 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -71.21 -29.02 64.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.375 0.534 . . . . 0.0 110.377 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.0 mtpt -57.39 -48.9 77.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.935 0.398 . . . . 0.0 111.902 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.77 -35.68 62.56 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.024 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 12.9 tp -64.52 -30.58 71.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.602 1.161 . . . . 0.0 112.737 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' HG22 ' A' ' 27' ' ' VAL . 83.4 mt -104.03 -41.13 5.94 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.982 0.913 . . . . 0.0 109.565 176.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.73 34.06 6.16 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.0 m -123.72 -177.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.521 1.128 . . . . 0.0 110.484 -176.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -148.52 146.74 23.25 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.485 1.114 . . . . 0.0 108.833 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 19.1 Cg_exo -64.41 108.12 0.95 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.598 2.198 . . . . 0.0 111.909 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.1 -38.7 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.7 mm-40 -111.9 121.8 46.03 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -121.97 140.9 51.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.56 . . . . 0.0 110.358 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 36' ' ' PHE . 43.5 t -141.6 149.8 55.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.872 1.269 . . . . 0.0 107.949 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.22 -24.86 61.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.843 2.362 . . . . 0.0 113.572 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.3 t -128.01 9.2 6.27 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 85.9 t80 -149.22 150.59 32.85 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.708 0.403 . . . . 0.0 110.505 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 42.7 m -134.51 143.17 47.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.553 0.741 . . . . 0.0 109.697 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -138.51 119.62 14.53 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 6.8 p90 -131.98 147.86 52.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 108.127 167.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 1.6 p -126.33 134.98 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 109.306 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 47' ' ' LEU . 6.1 mp -95.26 150.78 19.87 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.261 -167.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.66 -9.14 57.8 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.952 0.901 . . . . 0.0 110.744 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 58.9 m-20 -70.73 -9.31 56.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.28 1.032 . . . . 0.0 111.441 170.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.7 63.99 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.041 0.353 . . . . 0.0 113.38 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' B' ' 4' ' ' PRO . 18.6 ptm -113.37 167.72 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.694 0.797 . . . . 0.0 109.175 177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 62.3 tttt -132.86 136.57 46.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.671 0.388 . . . . 0.0 109.991 -174.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 HD11 ' A' ' 41' ' ' LEU . 12.9 mt -125.38 123.7 39.91 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.714 0.805 . . . . 0.0 112.295 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.83 145.72 16.82 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 169.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 10.4 mp -117.29 105.19 11.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 161.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.33 129.79 54.86 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 69.2 m -72.5 130.82 41.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.27 0.356 . . . . 0.0 111.286 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 55' ' ' VAL . 42.6 ptt85 -66.15 -21.36 66.33 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.957 0.903 . . . . 0.0 111.913 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -81.33 -6.7 59.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.152 0.581 . . . . 0.0 111.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' HB2' ' A' ' 51' ' ' SER . 13.5 t -127.25 4.65 6.36 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.452 0.701 . . . . 0.0 110.784 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 52' ' ' ARG . 5.3 p -71.18 149.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.86 0.464 . . . . 0.0 111.47 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -130.6 121.47 19.23 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.874 0.87 . . . . 0.0 109.392 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.56 141.1 68.83 Favored 'Cis proline' 0 C--N 1.385 2.497 0 CA-C-N 119.943 1.015 . . . . 0.0 112.345 -1.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -55.1 132.04 46.43 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.114 0.966 . . . . 0.0 112.215 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.79 109.73 4.49 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.723 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.8 m -83.04 87.32 6.89 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.2 m -148.34 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.942 0.897 . . . . 0.0 109.445 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 p -150.81 135.57 17.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.655 1.182 . . . . 0.0 108.594 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.28 35.18 57.04 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.337 0.398 . . . . 0.0 113.139 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.53 29.25 2.61 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.21 -172.06 32.14 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 115.858 -0.171 . . . . 0.0 112.867 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' B' ' 66' ' ' GLY . . . 70.48 107.45 0.04 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.675 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 36.1 mt-10 -122.76 134.47 54.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.76 109.57 15.76 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.98 121.96 34.85 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.249 0.547 . . . . 0.0 110.767 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.528 ' HB2' HG22 ' A' ' 117' ' ' VAL . 40.6 m-85 -102.87 107.64 18.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.789 1.636 . . . . 0.0 108.747 -177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.6 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 25.4 mtm180 -92.54 132.46 36.82 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 112.053 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 161.86 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.316 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.2 pt-20 -65.8 -41.31 92.07 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -160.83 -178.87 7.12 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.57 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.42 -33.18 65.58 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.745 1.618 . . . . 0.0 113.072 -169.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.11 -46.0 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.84 0.456 . . . . 0.0 110.408 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.468 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 79.9 mm-40 -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.194 0.998 . . . . 0.0 112.537 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.2 -44.07 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.495 0.718 . . . . 0.0 109.841 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.36 -35.63 73.68 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.516 1.126 . . . . 0.0 111.035 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -65.93 -41.02 91.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.251 0.548 . . . . 0.0 109.866 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -63.47 -41.14 98.59 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.612 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.89 -57.8 11.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.398 0.679 . . . . 0.0 110.693 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.498 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -63.04 -41.2 99.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.254 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.44 -47.27 86.0 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.869 0.73 . . . . 0.0 113.547 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -62.1 -45.44 93.47 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.658 0.783 . . . . 0.0 109.826 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.4 ttpt -55.64 -43.0 75.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.115 0.966 . . . . 0.0 110.83 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.63 -26.94 61.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.239 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -93.29 8.21 41.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.937 0.895 . . . . 0.0 112.618 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.6 45.33 4.64 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 166.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.482 HG21 ' HB1' ' A' ' 107' ' ' ALA . 8.0 p -98.46 152.18 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 170.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.38 -62.34 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.601 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 30.2 ttp 61.24 82.75 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.173 0.989 . . . . 0.0 112.849 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 84.92 2.14 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.832 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 179.91 135.22 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 0.0 108.615 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.98 129.96 77.08 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.539 0.524 . . . . 0.0 109.923 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.58 96.42 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.752 2.301 . . . . 0.0 109.849 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.34 160.48 36.15 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.09 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 101.05 6.35 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.065 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 21.7 ttt -100.75 -178.92 3.92 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.982 1.313 . . . . 0.0 110.023 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 99' ' ' MET . 15.1 mm-40 -52.13 -41.02 62.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.654 1.182 . . . . 0.0 112.432 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 55.8 m-85 -96.55 11.96 33.29 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.614 -173.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.28 -165.47 12.79 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.86 112.04 19.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -141.87 169.24 17.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.839 0.455 . . . . 0.0 111.611 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 37.0 p90 -152.98 175.61 12.77 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.852 166.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.635 HG21 ' HG3' ' A' ' 114' ' ' ARG . 90.7 m -137.39 130.66 30.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.022 0.439 . . . . 0.0 110.178 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.22 168.18 9.24 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.443 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.7 112.33 6.82 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 5.9 p-10 -68.01 174.39 2.41 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.253 1.021 . . . . 0.0 111.134 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 16.0 Cg_exo -37.26 -49.94 1.66 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.197 3.265 . . . . 0.0 115.321 172.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -10.79 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.678 0.791 . . . . 0.0 111.177 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m 69.84 92.78 0.08 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.535 1.534 . . . . 0.0 112.188 168.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.459 ' CE1' HG12 ' A' ' 11' ' ' VAL . 16.4 m80 -124.21 149.2 46.66 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.675 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 22.0 ttp180 -81.03 95.16 6.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.291 0.567 . . . . 0.0 110.115 -171.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 mt -92.76 101.59 13.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -92.84 95.54 9.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.805 0.842 . . . . 0.0 110.869 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 70' ' ' PHE . 36.5 t -97.21 117.05 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -133.81 161.62 34.24 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.8 111.46 15.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 166.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 35.8 t80 -77.48 127.31 32.3 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.79 94.34 8.68 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -178.015 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.441 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 27.1 m -141.97 145.78 34.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.393 0.677 . . . . 0.0 110.993 -166.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 96.86 16.52 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.735 0.814 . . . . 0.0 109.898 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.424 ' O ' ' SD ' ' A' ' 45' ' ' MET . 73.7 Cg_endo -75.7 94.47 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.065 1.843 . . . . 0.0 111.267 164.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 8.7 p-10 -109.78 14.65 23.16 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.551 0.74 . . . . 0.0 109.487 168.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.6 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.3 OUTLIER -131.15 141.25 50.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.895 1.278 . . . . 0.0 107.687 -165.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.464 HG23 HD23 ' B' ' 47' ' ' LEU . 5.6 t -145.13 145.1 31.25 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.693 1.197 . . . . 0.0 108.261 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.3 mt -118.31 140.19 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.103 0.561 . . . . 0.0 110.73 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.3 117.48 34.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.425 ' H ' ' HD1' ' B' ' 10' ' ' TYR . 5.6 p90 -73.07 122.93 22.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.139 0.976 . . . . 0.0 111.397 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' B' ' 51' ' ' SER . 11.3 m -122.44 163.67 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -98.43 -52.14 3.74 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -104.06 98.65 14.2 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.397 0.679 . . . . 0.0 110.5 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.69 -48.61 18.52 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.609 2.873 . . . . 0.0 115.927 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 15.6 Cg_endo -55.14 -63.89 0.17 Allowed 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 123.002 2.108 . . . . 0.0 112.272 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.99 88.85 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.334 0.654 . . . . 0.0 112.088 -167.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -66.46 -48.16 70.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.494 0.664 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 89.1 m -75.65 -34.9 60.52 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -168.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 85.3 mm-40 -67.17 -33.96 76.51 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.3 1.0 . . . . 0.0 109.056 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 85.7 t80 -66.05 -43.35 87.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.004 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.416 ' CD2' HD21 ' B' ' 49' ' ' LEU . 40.8 m-85 -70.68 -29.45 65.78 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.418 0.553 . . . . 0.0 110.142 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' B' ' 18' ' ' THR . 57.3 mtpt -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.125 0.488 . . . . 0.0 112.04 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.8 62.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.158 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 13.3 tp -63.88 -30.72 71.78 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.581 1.152 . . . . 0.0 112.734 -175.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' B' ' 27' ' ' VAL . 66.7 mt -104.47 -41.09 5.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 109.45 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.78 34.1 6.13 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.6 m -124.19 -177.82 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.399 1.08 . . . . 0.0 110.833 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -147.23 146.6 25.94 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.203 1.001 . . . . 0.0 108.966 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 35.9 Cg_endo -63.38 108.54 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.408 2.072 . . . . 0.0 112.115 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -64.33 -38.38 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.31 0.644 . . . . 0.0 110.243 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 17.9 mm-40 -112.04 121.56 45.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.7 p -122.12 140.67 52.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.119 0.568 . . . . 0.0 110.488 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' B' ' 36' ' ' PHE . 30.7 t -141.71 149.47 53.62 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.963 1.305 . . . . 0.0 107.89 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.77 -24.99 58.45 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.7 2.267 . . . . 0.0 113.587 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -127.87 8.95 6.31 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' B' ' 33' ' ' SER . 85.8 t80 -149.0 150.6 33.09 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.606 0.362 . . . . 0.0 110.41 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 15.1 m -134.2 143.5 47.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.462 0.705 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tm? -139.4 119.15 13.2 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 5.9 p90 -131.91 148.0 52.51 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 167.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' B' ' 46' ' ' LYS . 5.6 t -125.92 134.28 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -172.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.524 HD21 HD13 ' B' ' 25' ' ' LEU . 52.3 mt -94.22 150.91 19.87 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.67 0.788 . . . . 0.0 110.775 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -9.42 58.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.082 0.953 . . . . 0.0 110.697 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 69.7 m-20 -70.63 -9.01 56.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.028 0.931 . . . . 0.0 111.699 170.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.16 11.54 62.87 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 116.59 -0.277 . . . . 0.0 113.342 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.578 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -115.1 167.2 11.03 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.88 0.872 . . . . 0.0 108.895 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' B' ' 40' ' ' VAL . 78.3 tttt -132.51 135.37 45.95 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.146 0.578 . . . . 0.0 109.659 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.464 HD23 HG23 ' B' ' 7' ' ' THR . 36.8 mt -124.94 123.87 40.83 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.775 0.83 . . . . 0.0 112.216 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.33 145.66 16.61 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 10.5 mp -117.53 105.2 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 161.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.26 129.97 54.81 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 69.5 m -72.73 130.48 40.61 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.199 0.312 . . . . 0.0 111.483 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.452 ' HD3' HG23 ' B' ' 62' ' ' THR . 31.7 ptt180 -66.48 -20.91 66.16 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.722 0.809 . . . . 0.0 111.995 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -81.05 -7.16 59.5 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.872 0.469 . . . . 0.0 111.514 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 51' ' ' SER . 14.1 t -126.88 5.44 6.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.295 0.638 . . . . 0.0 110.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.442 HG12 ' O ' ' B' ' 52' ' ' ARG . 5.5 p -71.57 149.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.808 0.443 . . . . 0.0 111.354 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -131.03 121.32 18.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.5 141.54 70.24 Favored 'Cis proline' 0 C--N 1.389 2.682 0 C-N-CA 124.622 -0.991 . . . . 0.0 112.294 -1.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -55.9 132.28 49.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.026 0.93 . . . . 0.0 111.928 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.04 109.52 4.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.578 0.751 . . . . 0.0 109.635 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -82.66 87.82 6.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.67 139.35 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.102 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.452 HG23 ' HD3' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -150.14 135.33 17.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.823 1.249 . . . . 0.0 108.65 174.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.01 58.91 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.375 0.422 . . . . 0.0 113.329 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.05 28.79 2.69 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.23 -172.11 32.15 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.749 -0.225 . . . . 0.0 112.997 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . 70.61 107.41 0.04 OUTLIER Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.672 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 35.0 mt-10 -122.72 134.54 54.45 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -119.82 109.48 15.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.95 122.3 35.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.388 0.613 . . . . 0.0 110.85 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.529 ' HB2' HG22 ' B' ' 117' ' ' VAL . 40.6 m-85 -103.22 107.67 18.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.754 1.621 . . . . 0.0 108.474 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.603 ' HD3' ' HD2' ' A' ' 6' ' ' PHE . 27.8 mtm180 -92.76 131.53 37.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.197 0.522 . . . . 0.0 111.84 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.17 162.33 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.271 1.028 . . . . 0.0 110.239 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.3 pt-20 -66.31 -40.17 89.79 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.57 -179.13 7.06 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.989 0.813 . . . . 0.0 112.676 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.99 -33.32 64.73 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.776 1.63 . . . . 0.0 113.421 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.01 78.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.586 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.7 mm-40 -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.358 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.96 -44.76 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.552 0.692 . . . . 0.0 109.715 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.75 -36.44 78.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.298 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -65.46 -41.57 93.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.349 0.595 . . . . 0.0 110.025 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.7 m -62.77 -41.23 99.14 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.659 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -58.12 -57.44 12.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.448 0.699 . . . . 0.0 110.616 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -63.52 -41.01 98.51 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.235 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.67 82.57 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.801 0.688 . . . . 0.0 113.41 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -61.77 -45.82 92.24 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.637 0.775 . . . . 0.0 109.884 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.1 ttpt -54.74 -43.41 72.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.171 0.988 . . . . 0.0 111.04 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.77 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.798 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -93.53 8.51 40.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.024 0.93 . . . . 0.0 112.374 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.17 45.77 4.64 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 114.859 0.703 . . . . 0.0 114.859 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.478 HG21 ' HB1' ' B' ' 107' ' ' ALA . 8.3 p -98.56 152.02 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.48 -61.93 1.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.607 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 30.3 ttp 60.86 83.11 0.15 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.231 1.012 . . . . 0.0 112.79 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.45 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -106.35 85.48 2.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.352 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 179.71 134.22 0.1 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 108.384 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -75.83 130.04 79.7 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.63 0.581 . . . . 0.0 109.893 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.98 95.78 0.67 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.731 2.287 . . . . 0.0 110.083 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.16 160.15 36.91 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -168.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 101.08 5.9 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.962 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.43 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 22.4 ttt -100.89 -178.78 3.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.134 1.374 . . . . 0.0 109.84 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' B' ' 99' ' ' MET . 5.7 mm-40 -52.86 -40.79 63.71 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.559 1.144 . . . . 0.0 112.182 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 55.0 m-85 -96.3 11.94 32.85 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.863 0.865 . . . . 0.0 111.673 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.84 -165.3 12.92 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.07 112.2 19.58 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -142.0 169.32 17.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.817 0.447 . . . . 0.0 111.588 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' B' ' 92' ' ' MET . 37.0 p90 -153.12 175.72 12.7 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.316 1.047 . . . . 0.0 108.731 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.656 HG21 ' HG3' ' B' ' 114' ' ' ARG . 96.8 m -137.49 130.8 30.91 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 110.138 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.32 168.45 9.06 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.505 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.86 112.23 6.71 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.483 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.6 p-10 -67.51 174.3 2.26 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.334 1.054 . . . . 0.0 111.551 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 17.3 Cg_exo -37.67 -49.78 1.92 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.938 3.092 . . . . 0.0 115.225 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.26 -10.21 50.4 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.46 0.704 . . . . 0.0 111.368 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 70.07 92.18 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.578 1.551 . . . . 0.0 112.047 168.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.466 ' CE1' HG12 ' B' ' 11' ' ' VAL . 15.7 m80 -123.77 149.37 45.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 170.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.672 ' HB3' ' HG2' ' B' ' 67' ' ' GLU . 21.8 ttp180 -81.15 95.34 6.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.136 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 mt -93.24 101.72 13.99 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -171.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -90.97 94.72 9.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.892 0.877 . . . . 0.0 111.131 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' B' ' 70' ' ' PHE . 36.8 t -97.61 117.47 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.353 0.979 . . . . 0.0 108.366 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -133.77 161.42 34.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 111.35 15.47 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 166.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 35.2 t80 -77.98 132.55 37.89 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.79 95.22 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.274 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.096 0 CA-C-O 118.963 -0.91 . . . . 0.0 111.033 -174.421 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG3' ' H ' ' A' ' 2' ' ' THR . 15.6 ptm . . . . . 0 CA--C 1.55 0.956 0 CA-C-O 120.035 -0.031 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.61 HG22 ' HB3' ' B' ' 70' ' ' PHE . 9.8 m -140.7 138.14 34.02 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.309 0.644 . . . . 0.0 110.836 -158.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -137.27 134.94 18.99 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.1 0.56 . . . . 0.0 111.752 -173.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -94.05 92.29 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.291 2.66 . . . . 0.0 113.066 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.1 p-10 -103.17 9.46 38.28 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.613 0.72 . . . . 0.0 110.044 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -132.59 136.23 46.42 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.793 1.237 . . . . 0.0 108.116 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -131.56 142.67 49.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.699 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 57.2 mt -120.79 134.83 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 68' ' ' LEU . 94.0 mt -82.11 131.58 35.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' B' ' 66' ' ' GLY . 23.7 t80 -85.31 105.04 15.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.803 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 49' ' ' LEU . 2.4 m -116.35 176.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.97 -57.95 2.2 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.052 0.941 . . . . 0.0 109.678 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -89.18 105.64 10.94 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.748 1.219 . . . . 0.0 109.309 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.79 -55.91 2.35 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.95 2.434 . . . . 0.0 113.704 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.81 -65.82 0.1 Allowed 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 122.109 1.789 . . . . 0.0 112.686 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -165.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.7 p -63.33 -55.43 24.65 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 99.6 m -67.3 -39.33 85.95 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -168.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.525 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 23.7 mm-40 -62.38 -41.11 98.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.817 1.247 . . . . 0.0 109.45 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 86.4 t80 -65.37 -39.98 92.98 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 110.049 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.442 ' OH ' HD21 ' A' ' 115' ' ' LEU . 61.4 m-85 -71.28 -31.42 67.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.594 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.1 mtpt -56.53 -46.33 80.66 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -37.7 51.17 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.272 175.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 14.9 tp -62.93 -30.91 71.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.268 1.027 . . . . 0.0 112.536 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 27' ' ' VAL . 46.1 mt -104.94 -37.63 6.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.008 0.923 . . . . 0.0 109.152 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.08 9.95 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -172.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 25' ' ' LEU . 23.9 m -128.15 159.37 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.963 0.905 . . . . 0.0 110.174 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -112.22 148.7 39.66 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.609 0.764 . . . . 0.0 109.625 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 16.8 Cg_exo -67.18 108.03 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.784 2.323 . . . . 0.0 111.076 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 39' ' ' PHE . 7.3 p -63.4 -34.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.706 0.629 . . . . 0.0 110.679 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.7 mm-40 -115.63 85.36 2.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -86.71 129.45 34.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.266 0.626 . . . . 0.0 110.095 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -137.49 150.78 69.57 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.745 0.818 . . . . 0.0 109.193 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.76 -42.78 42.85 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.714 2.943 . . . . 0.0 114.812 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -127.17 24.51 6.33 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.252 0.548 . . . . 0.0 112.276 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -153.77 152.42 30.71 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 33.5 t -134.66 142.65 46.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.387 0.675 . . . . 0.0 109.366 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -141.06 122.31 14.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 5.5 p90 -129.74 146.61 51.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.839 0.856 . . . . 0.0 108.993 164.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 46' ' ' LYS . 6.1 t -118.88 135.12 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.433 HD12 ' SD ' ' A' ' 45' ' ' MET . 38.5 mt -96.21 158.76 15.29 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.933 0.493 . . . . 0.0 110.517 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.59 -20.95 66.12 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.965 0.906 . . . . 0.0 112.465 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.898 0.879 . . . . 0.0 111.393 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.59 -14.17 42.46 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.733 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -72.91 154.96 40.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' HG22 ' A' ' 40' ' ' VAL . 81.6 tttt -119.23 139.74 51.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.55 115.52 11.55 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -168.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.35 170.7 21.6 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 123.901 0.763 . . . . 0.0 111.533 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 6.3 mp -139.5 107.7 5.77 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 165.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.9 t90 -105.09 124.05 48.87 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -76.79 139.25 40.31 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.374 0.67 . . . . 0.0 111.102 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.442 ' HD3' HG23 ' A' ' 62' ' ' THR . 39.2 ptt180 -73.0 -14.82 61.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.147 0.579 . . . . 0.0 112.244 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -85.72 -6.51 59.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 122.511 0.325 . . . . 0.0 111.157 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -129.37 8.51 5.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.367 0.667 . . . . 0.0 110.976 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.869 HG23 HH22 ' B' ' 116' ' ' ARG . 12.5 p -74.62 148.84 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.031 0.532 . . . . 0.0 111.734 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -128.19 116.03 20.19 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.827 0.851 . . . . 0.0 109.568 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.22 144.47 78.05 Favored 'Cis proline' 0 C--N 1.387 2.579 0 C-N-CA 124.52 -1.033 . . . . 0.0 112.743 1.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 55' ' ' VAL . 12.0 mmmm -53.17 114.11 1.35 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.694 0.798 . . . . 0.0 111.511 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.59 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.307 1.043 . . . . 0.0 109.44 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -98.09 89.3 4.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.28 0.632 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.74 124.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.102 0.561 . . . . 0.0 111.136 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.442 HG23 ' HD3' ' A' ' 52' ' ' ARG . 9.4 p -151.92 178.67 9.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.252 1.421 . . . . 0.0 108.631 171.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.59 -31.94 6.72 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -172.52 31.19 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 119.95 0.65 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.22 125.07 0.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.74 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.7 pt-20 -131.79 145.04 51.36 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -108.49 104.52 13.87 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -88.0 117.13 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 110.761 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB3' ' CG2' ' B' ' 2' ' ' THR . 7.6 m-85 -97.74 112.67 24.47 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 31.7 mtm105 -90.64 135.08 33.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.883 0.473 . . . . 0.0 111.696 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.91 173.3 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.283 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.584 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -74.84 -45.39 43.57 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.769 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.457 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.4 p30 -157.62 175.22 14.21 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.701 0.682 . . . . 0.0 112.393 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.01 -32.39 67.88 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.525 -166.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.59 -44.94 85.08 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.401 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.0 mm-40 -64.39 -25.45 68.03 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.72 -39.4 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.397 0.618 . . . . 0.0 109.866 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.22 -32.14 68.43 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.543 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.6 mt-10 -65.85 -41.31 91.88 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.593 0.711 . . . . 0.0 109.665 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 117' ' ' VAL . 14.7 m -71.25 -29.13 64.73 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.834 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.58 -61.1 2.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 0.0 109.632 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.46 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.94 -36.49 82.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.725 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.24 68.45 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.994 0.809 . . . . 0.0 113.712 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -63.1 -42.9 99.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.369 0.668 . . . . 0.0 110.333 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.7 ttpt -55.42 -47.0 76.64 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.953 0.783 . . . . 0.0 110.474 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.9 -15.28 59.73 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.414 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -92.12 -2.48 56.58 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.11 0.964 . . . . 0.0 111.939 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.92 3.25 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.914 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.13 150.79 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.22 -36.46 81.72 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.882 0.473 . . . . 0.0 111.8 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.5 tpp 65.83 83.14 0.17 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 85.89 2.25 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.491 0.662 . . . . 0.0 111.381 173.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 179.34 126.36 0.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.412 1.485 . . . . 0.0 108.639 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -79.85 109.95 14.04 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 167.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.2 119.38 6.25 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.786 2.324 . . . . 0.0 111.09 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 146.29 50.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.225 0.61 . . . . 0.0 110.745 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -73.92 101.94 3.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.851 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.7 ttm -98.35 174.76 6.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.879 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.95 -39.81 63.2 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.096 0.958 . . . . 0.0 112.233 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -91.55 6.97 43.6 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.583 0.753 . . . . 0.0 111.659 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 -163.78 12.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.003 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -76.13 102.15 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -113.06 147.51 37.12 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.186 0.517 . . . . 0.0 110.556 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -143.31 138.74 29.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.688 1.195 . . . . 0.0 109.536 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.6 m -134.91 119.91 18.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.027 0.83 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.57 161.03 14.98 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 122.966 0.506 . . . . 0.0 110.989 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.8 114.68 23.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 6.1 p-10 -70.3 176.67 1.72 Allowed Pre-proline 0 CA--C 1.567 1.608 0 C-N-CA 124.071 0.948 . . . . 0.0 111.336 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 1.4 Cg_endo -42.83 -41.71 8.74 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.853 3.035 . . . . 0.0 115.034 173.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -78.88 -25.97 43.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.542 0.337 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 t 73.38 85.86 0.11 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.811 1.644 . . . . 0.0 110.003 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.465 ' CE1' HG12 ' A' ' 11' ' ' VAL . 13.7 m80 -113.87 -173.98 2.38 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 3.0 mmp_? -100.57 112.73 25.15 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.442 HD21 ' OH ' ' A' ' 21' ' ' TYR . 84.2 mt -114.96 103.63 11.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.825 0.45 . . . . 0.0 110.188 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.61 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 51.4 ttt180 -90.69 140.16 30.04 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -174.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 81' ' ' THR . 40.4 t -134.24 119.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 164.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -128.49 164.87 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.288 0.494 . . . . 0.0 111.812 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.68 111.2 9.19 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -80.25 114.3 19.05 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.01 91.95 0.7 Allowed 'General case' 0 C--N 1.348 0.534 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.233 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.519 -175.754 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tmm? . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 61.8 m -67.31 135.93 54.08 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.044 1.337 . . . . 0.0 112.056 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -136.64 135.13 19.99 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 122.832 0.453 . . . . 0.0 111.027 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -94.44 93.13 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.203 2.602 . . . . 0.0 113.174 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.733 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 11.4 p-10 -104.58 9.66 35.27 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.798 0.809 . . . . 0.0 109.606 171.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.01 135.79 45.64 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 108.033 -168.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -131.35 143.12 50.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.74 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 50.4 mt -121.12 134.53 64.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.486 HD11 HD22 ' B' ' 68' ' ' LEU . 93.2 mt -81.71 131.69 35.27 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 173.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.429 ' HE2' HG21 ' B' ' 55' ' ' VAL . 23.1 t80 -85.43 105.07 15.79 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.752 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.462 HG12 ' CE1' ' B' ' 113' ' ' HIS . 2.5 m -116.14 176.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.969 0.908 . . . . 0.0 108.664 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.16 -57.29 2.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 109.775 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -89.82 105.92 12.59 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.478 1.111 . . . . 0.0 109.453 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 28.1 Cg_exo -56.78 -55.95 2.32 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.984 2.456 . . . . 0.0 113.799 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 53.7 Cg_exo -55.61 -66.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.402 3.362 0 CA-C-N 122.255 1.841 . . . . 0.0 112.728 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.85 81.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -62.67 -55.95 22.18 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.437 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 98.2 m -66.95 -39.31 87.24 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -168.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.571 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 20.8 mm-40 -62.25 -41.35 98.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.762 1.225 . . . . 0.0 109.264 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 90.1 t80 -65.07 -40.28 94.47 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.058 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.452 ' OH ' HD21 ' B' ' 115' ' ' LEU . 62.6 m-85 -71.2 -31.45 67.62 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.507 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 60.8 mtpt -56.28 -46.6 79.65 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.41 -37.57 51.54 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.53 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.6 tp -62.97 -30.91 71.95 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.471 1.109 . . . . 0.0 112.56 -174.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' B' ' 27' ' ' VAL . 46.6 mt -104.88 -37.71 6.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 109.071 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 33.25 9.66 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' B' ' 25' ' ' LEU . 21.5 m -128.8 158.57 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.043 0.937 . . . . 0.0 109.958 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -110.8 148.43 38.55 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 123.855 0.862 . . . . 0.0 109.693 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 20.3 Cg_exo -66.66 108.01 1.36 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.628 2.218 . . . . 0.0 111.338 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -63.2 -34.76 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.253 0.621 . . . . 0.0 110.593 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.657 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 30.7 mm-40 -115.62 85.59 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 34.1 p -86.74 129.55 34.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.334 0.653 . . . . 0.0 110.014 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -137.25 150.36 68.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.112 0.965 . . . . 0.0 109.382 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.52 -42.88 40.98 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.706 2.937 . . . . 0.0 114.725 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.7 t -127.26 24.36 6.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.949 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -153.75 152.43 30.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 39.3 t -134.94 142.79 46.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.269 0.627 . . . . 0.0 109.333 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.657 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.4 tm? -140.85 122.84 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' B' ' 30' ' ' VAL . 3.6 p90 -129.74 146.67 51.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 109.07 164.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' B' ' 46' ' ' LYS . 9.5 t -118.65 134.52 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.01 158.35 15.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.952 0.501 . . . . 0.0 110.647 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -22.19 66.53 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.121 0.969 . . . . 0.0 112.65 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' B' ' 45' ' ' MET . 18.9 p30 -66.66 -20.85 66.08 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 0.0 111.767 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.56 -13.22 42.93 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.241 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.622 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -73.5 155.41 39.24 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.566 ' HG3' HG22 ' B' ' 40' ' ' VAL . 79.2 tttt -119.41 140.11 50.93 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 tt -137.61 115.26 11.3 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.687 -168.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.05 170.79 21.95 Favored Glycine 0 C--N 1.349 1.284 0 C-N-CA 124.042 0.83 . . . . 0.0 111.579 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 5.4 mp -139.51 107.45 5.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 165.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -104.85 124.47 49.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.448 ' HB2' HG22 ' B' ' 54' ' ' THR . 15.8 m -76.77 139.39 40.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.385 0.674 . . . . 0.0 110.884 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -72.83 -15.12 61.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.274 0.63 . . . . 0.0 112.318 -173.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -85.82 -6.42 59.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.699 0.4 . . . . 0.0 110.824 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.448 HG22 ' HB2' ' B' ' 51' ' ' SER . 14.6 t -129.65 7.79 5.29 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.472 0.709 . . . . 0.0 111.162 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.429 HG21 ' HE2' ' B' ' 10' ' ' TYR . 8.4 p -74.61 149.68 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -128.59 115.86 19.56 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.177 0.991 . . . . 0.0 109.284 172.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.35 143.74 75.68 Favored 'Cis proline' 0 C--N 1.387 2.561 0 C-N-CA 124.626 -0.989 . . . . 0.0 112.675 1.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -52.22 114.39 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.591 0.756 . . . . 0.0 111.674 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.55 132.55 45.62 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 109.458 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 40.3 m -98.37 89.47 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.183 0.593 . . . . 0.0 109.421 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 p -155.58 124.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.193 0.597 . . . . 0.0 111.162 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -152.47 178.14 9.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.293 1.437 . . . . 0.0 108.665 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.44 -31.84 6.77 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-O 121.04 0.244 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.63 -172.66 31.38 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.83 119.71 0.63 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 75.23 126.06 0.18 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.699 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 3.7 pt-20 -132.98 143.4 49.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 110.218 -175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.486 HD22 HD11 ' B' ' 9' ' ' LEU . 43.0 tp -108.35 104.31 13.65 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -87.61 116.75 25.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.148 0.499 . . . . 0.0 110.861 -171.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.61 ' HB3' HG22 ' A' ' 2' ' ' THR . 7.6 m-85 -97.05 112.62 24.3 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.415 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 31.4 mtm180 -91.03 135.19 33.92 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 122.941 0.496 . . . . 0.0 111.622 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.611 HG21 ' HB3' ' B' ' 77' ' ' GLN . 1.3 p -140.4 173.14 10.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.131 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.77 -45.44 43.77 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -157.59 175.09 14.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 0.675 . . . . 0.0 112.292 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -58.78 -32.07 68.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.219 1.407 . . . . 0.0 112.398 -166.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.84 -45.03 83.74 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.349 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.611 ' HB3' HG21 ' B' ' 72' ' ' VAL . 73.1 mm-40 -64.5 -25.14 67.86 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.958 0.786 . . . . 0.0 112.574 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -71.43 -39.39 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.189 0.596 . . . . 0.0 109.728 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.96 -32.28 69.11 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 110.551 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.7 mt-10 -65.63 -41.06 93.11 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.615 0.721 . . . . 0.0 109.684 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.459 HG21 HG21 ' B' ' 117' ' ' VAL . 12.5 m -71.43 -29.43 64.87 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.8 -61.03 2.92 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.396 0.678 . . . . 0.0 109.475 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.458 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.73 -36.82 83.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.676 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 -50.52 66.18 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.608 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -63.19 -43.12 99.11 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.207 0.603 . . . . 0.0 110.27 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.9 ttpt -54.72 -47.41 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.765 0.826 . . . . 0.0 110.583 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.65 -15.67 59.75 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.612 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -92.22 -1.82 56.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 112.01 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.29 3.36 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.189 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.85 150.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp 65.82 83.18 0.17 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 85.91 2.25 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.442 0.639 . . . . 0.0 111.167 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 179.62 126.47 0.07 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.21 1.404 . . . . 0.0 108.387 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.99 110.71 17.14 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 17.3 Cg_endo -55.67 119.71 7.03 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.79 2.327 . . . . 0.0 110.409 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 145.81 50.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 0.0 111.034 -170.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -72.29 101.67 2.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.206 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.6 ttm -98.63 174.62 6.33 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.663 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -52.77 -40.28 63.02 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.825 0.85 . . . . 0.0 112.373 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.44 6.74 42.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.643 0.777 . . . . 0.0 111.989 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.69 -163.1 12.21 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -77.33 102.36 6.73 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -113.18 147.33 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.178 0.591 . . . . 0.0 110.487 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 4.7 t80 -143.31 138.9 29.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.733 1.213 . . . . 0.0 109.58 -176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 11.1 m -135.1 119.92 18.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.041 0.837 . . . . 0.0 110.347 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.76 160.68 15.29 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.929 0.492 . . . . 0.0 110.986 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.38 114.97 24.32 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.477 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.0 p-10 -70.19 177.56 1.33 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 124.182 0.993 . . . . 0.0 111.288 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 49.4 Cg_exo -43.75 -41.47 11.57 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.456 2.771 . . . . 0.0 115.265 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.95 -25.75 43.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 22.6 t 73.25 86.11 0.11 Allowed 'General case' 0 C--N 1.348 0.522 0 C-N-CA 125.777 1.631 . . . . 0.0 109.952 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.462 ' CE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -113.84 -173.88 2.36 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' B' ' 67' ' ' GLU . 3.9 mmp_? -100.37 113.01 25.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.452 HD21 ' OH ' ' B' ' 21' ' ' TYR . 85.4 mt -115.3 104.37 11.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.797 0.439 . . . . 0.0 109.969 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.869 HH22 HG23 ' A' ' 55' ' ' VAL . 22.3 mmt180 -88.32 140.94 28.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.508 0.723 . . . . 0.0 110.726 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.459 HG21 HG21 ' B' ' 81' ' ' THR . 59.8 t -135.52 120.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 162.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -128.73 165.44 20.9 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.384 0.538 . . . . 0.0 111.888 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.12 110.97 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -79.64 113.3 17.69 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 103.38 1.14 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.976 0.51 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.733 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.4 m -95.48 141.46 28.99 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -98.98 110.18 56.71 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.879 0.872 . . . . 0.0 110.886 -172.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.455 ' HD2' HD21 ' B' ' 41' ' ' LEU . 59.5 Cg_endo -90.89 97.09 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.878 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.3 p-10 -90.28 11.93 19.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.339 0.59 . . . . 0.0 110.694 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.449 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.6 t80 -133.08 135.05 45.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.811 1.244 . . . . 0.0 108.28 -168.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 140.8 41.97 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.349 1.059 . . . . 0.0 108.216 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.543 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 60.7 mt -119.21 141.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.7 138.01 46.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.5 132.93 35.33 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.488 176.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 51' ' ' SER . 29.0 m -130.6 158.7 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 121.653 -0.654 . . . . 0.0 110.451 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 22.9 t70 -95.34 -57.29 2.45 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.0 99.11 2.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.53 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 12' ' ' ASP . 50.1 Cg_exo -49.02 -55.69 3.91 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 122.756 2.304 . . . . 0.0 114.42 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -59.88 -54.91 1.96 Allowed 'Trans proline' 0 C--N 1.397 3.098 0 CA-C-N 122.16 1.807 . . . . 0.0 112.022 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.05 73.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.134 0.974 . . . . 0.0 111.823 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -79.89 -18.16 51.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.516 -173.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -76.98 -38.51 53.05 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 84.7 mm-40 -67.24 -30.23 70.08 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.52 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -60.45 -48.45 81.69 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.91 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.5 m-85 -68.71 -30.54 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.028 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.0 mtpt -57.78 -49.17 77.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.86 -31.89 51.73 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.715 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.5 tp -62.07 -50.78 70.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.681 1.192 . . . . 0.0 112.295 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 27' ' ' VAL . 14.9 mt -83.57 -47.58 11.15 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 29.56 5.25 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.998 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 25' ' ' LEU . 27.0 m -131.63 175.95 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.026 0.93 . . . . 0.0 110.358 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -124.24 151.25 65.76 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.128 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.55 106.45 1.25 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.78 2.32 . . . . 0.0 111.544 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.416 HG13 ' HG2' ' A' ' 31' ' ' GLU . 7.4 p -63.44 -39.45 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.507 0.723 . . . . 0.0 110.31 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 29.1 mm-40 -114.63 98.28 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.3 p -99.27 138.21 36.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.742 0.817 . . . . 0.0 110.917 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -143.39 150.58 52.01 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.975 1.31 . . . . 0.0 108.233 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.59 -22.35 51.24 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.859 2.373 . . . . 0.0 114.147 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -128.46 9.92 6.12 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.98 139.2 20.22 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.876 -0.515 . . . . 0.0 110.047 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -129.45 138.95 51.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.642 0.777 . . . . 0.0 109.203 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tm? -132.07 120.35 22.23 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.71 113.53 13.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.684 1.194 . . . . 0.0 109.098 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' A' ' 46' ' ' LYS . 12.6 t -94.65 139.68 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.226 1.01 . . . . 0.0 110.03 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -98.66 147.78 24.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.858 0.463 . . . . 0.0 110.244 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -4.81 34.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.756 0.822 . . . . 0.0 111.829 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -69.0 -10.2 56.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.453 1.101 . . . . 0.0 112.231 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.58 15.64 42.68 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.874 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -126.43 172.13 10.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.555 0.742 . . . . 0.0 109.185 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.4 tttt -136.54 135.29 38.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.09 0.556 . . . . 0.0 109.601 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD11 ' HG2' ' B' ' 4' ' ' PRO . 8.2 mt -124.72 124.55 42.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.571 0.749 . . . . 0.0 111.059 -176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.449 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.84 167.3 18.45 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.269 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 49' ' ' LEU . 5.5 tp -144.86 105.23 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.0 t90 -104.73 123.14 47.12 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 50.2 m -74.47 112.31 10.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.07 -1.93 1.12 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 114.532 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -79.48 -25.47 41.86 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.959 0.8 . . . . 0.0 110.802 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -112.69 12.58 19.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.441 0.696 . . . . 0.0 111.298 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 8.8 p -63.97 138.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.971 0.415 . . . . 0.0 111.49 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.21 114.49 33.43 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.16 140.52 64.87 Favored 'Cis proline' 0 C--N 1.385 2.464 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.073 3.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HA ' HG13 ' A' ' 55' ' ' VAL . 24.5 mmmt -49.12 125.48 10.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.101 1.36 . . . . 0.0 111.974 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.19 109.43 3.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.065 0.946 . . . . 0.0 110.498 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.8 t -97.32 88.55 4.46 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.48 135.99 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.596 0.758 . . . . 0.0 109.712 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 p -142.42 125.22 16.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.204 1.002 . . . . 0.0 110.182 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.57 -108.64 0.37 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.79 129.51 9.92 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.67 -32.23 0.03 OUTLIER Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.95 151.62 10.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.668 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 47.0 mt-10 -114.4 165.46 12.7 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.548 0.739 . . . . 0.0 110.787 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.91 103.56 9.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.58 118.49 30.08 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.231 0.469 . . . . 0.0 111.518 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -95.73 108.38 20.69 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.109 1.364 . . . . 0.0 107.688 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 38.6 mtm180 -85.3 130.06 34.68 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.438 0.637 . . . . 0.0 112.094 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.42 157.05 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.819 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HG3' HD22 ' A' ' 74' ' ' ASN . 9.7 pt-20 -67.62 -38.36 83.8 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -172.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.451 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.0 p30 -157.2 176.71 12.36 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.711 0.687 . . . . 0.0 112.631 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.57 -32.86 65.61 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.81 1.644 . . . . 0.0 112.66 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.563 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.36 -44.06 79.93 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.012 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -66.36 -24.5 66.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.837 0.855 . . . . 0.0 112.241 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.41 -41.73 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.57 -30.87 68.75 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.489 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.3 mt-10 -68.06 -43.46 78.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.445 ' HA ' ' HE1' ' B' ' 1' ' ' MET . 33.0 m -70.37 -28.85 65.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.52 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -64.15 -61.31 2.33 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.777 0.799 . . . . 0.0 109.133 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.76 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.895 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.22 91.46 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.39 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -61.51 -48.51 80.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.635 . . . . 0.0 110.385 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.5 ttpt -54.42 -43.53 71.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.841 0.856 . . . . 0.0 110.956 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.59 58.28 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.264 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -94.47 7.71 44.62 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.272 1.029 . . . . 0.0 112.183 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.61 24.5 30.5 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.421 170.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -84.0 133.58 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.528 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -56.71 -34.6 67.61 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.256 1.022 . . . . 0.0 112.625 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.494 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 49.8 tpp 67.85 82.99 0.17 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 163.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -134.33 86.36 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 177.65 136.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.631 1.572 . . . . 0.0 109.173 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.3 108.79 15.62 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 165.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 12.5 Cg_endo -55.53 118.79 5.59 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.819 2.346 . . . . 0.0 111.448 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.07 155.32 48.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.325 0.65 . . . . 0.0 110.419 -175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.25 118.61 13.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 110.813 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.8 ttm -115.52 166.81 11.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.069 0.948 . . . . 0.0 108.954 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -49.97 -40.32 43.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.696 1.598 . . . . 0.0 113.071 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -86.97 -19.97 27.97 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.357 0.663 . . . . 0.0 111.676 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.67 175.36 28.5 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 120.326 -0.152 . . . . 0.0 112.932 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 42.5 t80 -71.85 101.94 2.75 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -107.49 150.07 27.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.471 0.653 . . . . 0.0 112.165 -161.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 20.0 t80 -150.45 146.21 26.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.8 m -142.69 129.32 20.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.095 0.558 . . . . 0.0 109.65 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.17 149.02 43.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.464 0.706 . . . . 0.0 111.212 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.414 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -108.24 167.09 10.27 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' A' ' 91' ' ' ALA . 1.9 p-10 -133.07 -178.81 0.92 Allowed Pre-proline 0 CA--C 1.562 1.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -169.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 36.8 Cg_endo -62.92 -1.64 2.94 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.314 2.01 . . . . 0.0 114.943 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.73 0.13 13.12 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.481 0.582 . . . . 0.0 111.754 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m 70.14 33.85 2.57 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.829 1.252 . . . . 0.0 112.812 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.51 ' HB2' HD11 ' A' ' 115' ' ' LEU . 18.2 m170 -75.27 170.29 16.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.525 0.73 . . . . 0.0 110.032 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.668 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 13.6 mmm180 -118.91 108.91 15.38 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 113' ' ' HIS . 3.4 mp -121.41 108.9 14.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -93.38 147.23 23.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.897 0.479 . . . . 0.0 110.428 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.87 133.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.3 p90 -135.97 162.05 33.94 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.605 0.639 . . . . 0.0 111.738 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -111.07 124.38 52.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 171.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -81.66 108.77 15.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.129 0.422 . . . . 0.0 110.437 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.64 95.1 2.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.809 -0.995 . . . . 0.0 112.004 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.445 ' HE1' ' HA ' ' A' ' 81' ' ' THR . 20.1 ptm . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.538 0.208 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 19.5 m -132.88 142.39 48.9 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -98.08 110.7 57.05 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 123.892 0.877 . . . . 0.0 111.005 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.408 ' HG2' HD11 ' A' ' 47' ' ' LEU . 54.1 Cg_endo -91.61 96.95 0.21 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.664 2.243 . . . . 0.0 112.262 170.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.874 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.7 p-10 -90.18 12.29 18.44 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.372 0.606 . . . . 0.0 110.824 170.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.478 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -133.34 135.16 44.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.923 1.289 . . . . 0.0 108.164 -168.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -137.49 140.97 41.48 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.424 1.089 . . . . 0.0 108.146 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.8 140.51 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.343 0.657 . . . . 0.0 109.695 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.85 139.26 43.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -83.4 133.08 34.95 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.21 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' B' ' 51' ' ' SER . 35.9 m -129.07 158.65 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.122 0.569 . . . . 0.0 110.693 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -95.76 -58.33 2.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -92.13 100.7 3.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.885 . . . . 0.0 109.233 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.87 -55.72 3.79 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.431 2.087 . . . . 0.0 114.332 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 31.8 Cg_exo -59.16 -55.56 1.83 Allowed 'Trans proline' 0 C--N 1.395 2.974 0 CA-C-N 122.285 1.852 . . . . 0.0 112.275 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.72 74.99 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.969 -167.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -79.77 -18.37 51.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.563 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.6 m -77.93 -37.79 46.94 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 174.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 28.0 mm-40 -67.25 -30.71 70.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.297 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.77 -48.61 81.0 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.08 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 34.4 m-85 -68.59 -30.73 69.54 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.166 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -57.19 -49.63 75.39 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.739 0.7 . . . . 0.0 112.791 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.18 50.82 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.95 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 24.5 tp -62.25 -50.74 70.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.578 1.151 . . . . 0.0 112.159 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.446 ' HB2' HG22 ' B' ' 27' ' ' VAL . 16.8 mt -83.92 -47.35 11.13 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.25 30.47 5.03 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.101 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' B' ' 25' ' ' LEU . 31.4 m -131.86 175.31 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.321 1.048 . . . . 0.0 110.052 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -124.24 151.71 66.47 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.26 106.41 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.57 2.18 . . . . 0.0 111.296 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.03 -39.28 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.486 0.714 . . . . 0.0 110.142 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 65.1 mm-40 -115.13 98.79 6.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.922 0.889 . . . . 0.0 108.678 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.8 p -99.87 137.85 37.76 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.762 0.825 . . . . 0.0 110.764 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 150.8 54.66 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.018 1.327 . . . . 0.0 107.96 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.04 -21.89 52.74 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.788 2.325 . . . . 0.0 114.252 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -128.49 8.98 5.98 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -150.27 139.63 21.37 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.4 m -129.42 139.1 51.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.585 0.754 . . . . 0.0 109.111 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -132.24 119.96 21.53 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.18 113.25 13.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.683 1.193 . . . . 0.0 109.095 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' B' ' 46' ' ' LYS . 14.7 t -94.92 139.99 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.967 0.907 . . . . 0.0 110.115 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 4' ' ' PRO . 10.0 mp -98.93 146.93 25.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.143 0.577 . . . . 0.0 110.324 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.16 -5.17 33.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.923 0.889 . . . . 0.0 111.549 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.63 -9.32 53.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.612 1.165 . . . . 0.0 112.101 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.11 15.68 43.94 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.878 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -126.38 171.51 10.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.658 0.783 . . . . 0.0 109.162 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.5 tttt -136.26 135.23 38.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.127 0.571 . . . . 0.0 109.503 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mt -124.61 124.39 42.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.526 0.73 . . . . 0.0 111.064 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.478 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -101.58 167.31 18.78 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.199 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' B' ' 49' ' ' LEU . 5.7 tp -144.78 105.45 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -104.78 122.97 46.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 50.9 m -74.54 112.8 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -63.35 -2.38 1.46 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.273 1.429 . . . . 0.0 114.503 -170.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -79.08 -25.77 43.07 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.866 0.757 . . . . 0.0 110.656 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -112.81 12.06 19.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.372 0.669 . . . . 0.0 111.426 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' B' ' 58' ' ' LYS . 7.2 p -62.33 138.7 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.68 114.8 32.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.31 139.8 62.23 Favored 'Cis proline' 0 C--N 1.381 2.243 0 C-N-CA 124.525 -1.031 . . . . 0.0 113.51 3.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.436 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.9 mmmt -48.87 125.4 10.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.173 1.389 . . . . 0.0 112.232 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.43 109.98 3.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.062 0.945 . . . . 0.0 110.298 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.2 t -97.83 88.27 4.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.38 136.2 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.657 0.783 . . . . 0.0 109.679 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -143.76 124.93 14.51 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.001 0.92 . . . . 0.0 110.077 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.38 -108.43 0.36 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.65 129.5 9.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.44 -33.48 0.03 OUTLIER Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.64 152.57 11.1 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.543 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 2.2 pm0 -118.09 163.84 16.01 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.87 0.868 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -120.44 103.2 8.99 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.41 119.93 31.11 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.231 0.469 . . . . 0.0 111.536 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -97.66 108.01 20.63 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.404 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 34.8 mtm180 -85.28 128.37 34.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.014 0.525 . . . . 0.0 111.906 -177.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.42 157.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.051 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.26 -38.27 84.84 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -157.73 177.77 11.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.633 0.651 . . . . 0.0 112.52 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.86 -32.55 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.967 1.707 . . . . 0.0 112.545 -167.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -67.56 -43.86 79.62 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.431 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -66.37 -24.32 66.48 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.038 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -69.61 -42.23 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.54 -30.46 68.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 16.0 mt-10 -68.16 -43.22 78.72 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.342 0.592 . . . . 0.0 109.503 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -70.4 -28.77 65.34 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.591 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -64.62 -61.06 2.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.582 0.706 . . . . 0.0 109.114 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.24 90.53 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.929 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.56 90.54 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.199 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -60.93 -49.04 79.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 0.0 110.222 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.475 ' HB2' ' HE3' ' B' ' 92' ' ' MET . 31.8 ttpt -53.8 -44.28 70.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.008 0.923 . . . . 0.0 110.911 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.53 -22.5 58.99 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.3 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -94.48 7.8 44.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.194 0.998 . . . . 0.0 112.087 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.44 31.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 116.123 -0.489 . . . . 0.0 114.319 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.77 134.09 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.52 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -57.43 -34.44 68.95 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.116 0.967 . . . . 0.0 112.53 -172.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.475 ' HE3' ' HB2' ' B' ' 86' ' ' LYS . 50.0 tpp 67.07 83.31 0.17 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' B' ' 108' ' ' ALA . 0.0 OUTLIER -133.65 85.85 2.24 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 178.69 138.9 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.265 1.426 . . . . 0.0 109.279 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -83.12 109.98 20.65 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 165.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.556 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 18.2 Cg_endo -57.4 119.32 6.51 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.606 2.204 . . . . 0.0 110.796 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.78 154.2 48.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.377 0.671 . . . . 0.0 110.412 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -68.47 118.94 12.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 54.2 ttm -115.59 166.04 12.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.11 0.964 . . . . 0.0 109.126 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.02 -39.91 28.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.445 1.498 . . . . 0.0 113.349 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.99 -19.06 27.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.537 0.335 . . . . 0.0 111.485 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.33 173.94 27.39 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.987 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.583 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 45.4 t80 -70.72 102.08 2.23 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 150.11 27.14 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.521 0.677 . . . . 0.0 112.081 -162.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 16.4 t80 -150.42 146.49 26.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.182 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 20.1 m -143.69 128.27 18.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' B' ' 105' ' ' PHE . . . -121.13 149.03 43.39 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.28 0.632 . . . . 0.0 110.995 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ALA . . . . . 0.522 ' HB3' HD11 ' B' ' 93' ' ' LEU . . . -108.35 165.01 11.82 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.52 ' HA ' ' H ' ' B' ' 91' ' ' ALA . 1.9 p-10 -130.49 -177.63 0.7 Allowed Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.003 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 45.5 Cg_endo -63.8 -0.92 2.91 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.447 2.098 . . . . 0.0 114.773 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.44 ' OD1' ' HA ' ' B' ' 11' ' ' VAL . 3.1 t70 -115.98 0.14 12.96 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.093 0.557 . . . . 0.0 111.78 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.9 m 69.41 34.29 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.603 1.161 . . . . 0.0 112.725 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -75.18 171.34 14.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.602 0.761 . . . . 0.0 110.301 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.51 108.31 13.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -121.07 108.18 13.52 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.48 ' NH1' ' HG3' ' B' ' 67' ' ' GLU . 55.5 mtt180 -90.57 147.72 23.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.033 0.533 . . . . 0.0 111.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.99 132.81 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -135.85 161.95 34.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.549 0.613 . . . . 0.0 111.658 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -110.99 123.71 50.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -79.17 104.59 9.9 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.52 99.25 8.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.107 -175.485 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.4 m -134.35 142.78 47.33 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -98.68 109.69 54.22 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.847 0.859 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HG3' HD22 ' B' ' 25' ' ' LEU . 78.6 Cg_endo -81.77 72.08 6.45 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.493 2.129 . . . . 0.0 111.253 166.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.486 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.2 p-10 -80.43 9.88 5.35 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.404 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -134.56 134.32 41.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 107.717 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -138.2 139.58 39.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.237 1.015 . . . . 0.0 108.786 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.593 HG12 ' HA3' ' A' ' 48' ' ' GLY . 49.5 mt -128.03 143.03 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.134 0.573 . . . . 0.0 110.173 -172.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -108.63 144.95 35.69 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 32.1 m-85 -93.57 123.5 36.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.199 1.0 . . . . 0.0 111.207 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.412 HG12 ' HE1' ' A' ' 113' ' ' HIS . 23.9 m -124.89 161.02 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.188 0.995 . . . . 0.0 110.409 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.89 -63.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.132 0.973 . . . . 0.0 110.759 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -97.14 100.14 7.21 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.075 0.55 . . . . 0.0 110.154 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 35.1 Cg_exo -55.56 -51.63 9.44 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.296 2.664 . . . . 0.0 115.033 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.77 -51.62 10.76 Favored 'Trans proline' 0 C--N 1.405 3.525 0 CA-C-N 122.646 1.981 . . . . 0.0 112.48 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.92 -39.94 69.14 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 p -77.83 -34.85 51.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.817 0.447 . . . . 0.0 110.515 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 70.9 m -62.39 -47.78 82.63 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.524 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.3 mm100 -62.69 -35.51 79.92 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.125 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -64.89 -45.82 84.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.8 0.688 . . . . 0.0 109.415 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 20.5 m-85 -68.03 -32.89 73.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.279 -0.391 . . . . 0.0 109.997 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 63.2 mtpt -57.31 -47.89 80.35 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.34 -34.27 48.63 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.298 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.8 tp -60.21 -31.35 70.08 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.865 1.266 . . . . 0.0 112.473 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.501 HD22 ' HG3' ' B' ' 4' ' ' PRO . 26.1 mt -99.95 -48.56 4.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.16 28.63 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.995 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.01 -178.34 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.613 1.165 . . . . 0.0 110.747 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -130.76 142.93 47.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 124.342 1.057 . . . . 0.0 108.762 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 34.1 Cg_endo -63.93 119.94 7.16 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.602 2.201 . . . . 0.0 112.449 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.999 0.92 . . . . 0.0 110.455 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 57.9 mm-40 -116.23 90.04 3.24 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.3 p -90.04 149.48 22.5 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.894 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -151.76 151.48 28.46 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 125.037 1.335 . . . . 0.0 107.627 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.78 -20.1 68.09 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.451 2.101 . . . . 0.0 113.607 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -128.38 12.36 6.47 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.9 152.79 28.71 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -143.86 138.58 28.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 12.7 tp -126.42 115.72 20.05 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.3 p90 -131.21 112.89 13.21 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.922 1.289 . . . . 0.0 109.16 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.592 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 3.8 p -106.71 142.28 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.24 1.016 . . . . 0.0 110.079 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.16 157.25 17.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.622 0.769 . . . . 0.0 111.134 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -22.61 65.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.479 1.112 . . . . 0.0 112.593 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -70.19 -18.6 63.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.258 0.623 . . . . 0.0 112.032 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.48 15.82 16.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.445 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -103.23 154.03 19.76 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.017 0.909 . . . . 0.0 108.697 170.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.2 tttt -125.3 131.02 53.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -128.54 127.66 42.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.346 0.659 . . . . 0.0 109.883 -168.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -104.81 169.78 17.29 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.54 104.79 4.26 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.438 ' HB2' HG21 ' A' ' 8' ' ' ILE . 4.5 t90 -106.75 127.48 53.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.451 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 27.9 m -72.96 129.95 39.27 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.244 0.34 . . . . 0.0 110.126 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -68.34 -10.94 58.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.687 0.795 . . . . 0.0 112.493 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -81.95 -23.47 36.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -116.93 7.83 13.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.269 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 58' ' ' LYS . 10.5 p -67.68 140.53 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 122.712 0.405 . . . . 0.0 111.508 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HB3' HE22 ' B' ' 94' ' ' GLN . 70.7 mt-10 -125.56 114.6 25.18 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 170.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.503 ' HG2' ' CZ ' ' B' ' 114' ' ' ARG . 59.0 Cg_endo -78.14 141.51 66.06 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 124.491 -1.046 . . . . 0.0 113.194 4.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HA ' HG13 ' A' ' 55' ' ' VAL . 27.4 mmmt -49.43 123.0 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.252 1.421 . . . . 0.0 112.452 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HB2' ' NH2' ' B' ' 114' ' ' ARG . . . -155.57 109.18 2.79 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.318 1.047 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.8 p -85.08 87.08 7.34 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.0 124.19 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.7 p -151.51 122.34 7.55 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.302 1.441 . . . . 0.0 107.78 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.71 52.55 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.06 -132.18 10.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.89 -62.98 4.35 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.35 154.38 18.99 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 168.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 2.4 pt-20 -130.06 166.18 20.68 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.011 0.924 . . . . 0.0 110.27 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.2 tp -125.46 102.39 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.829 0.852 . . . . 0.0 109.457 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -92.48 110.72 22.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -169.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 12.3 m-85 -88.99 116.86 27.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.435 1.094 . . . . 0.0 108.419 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -95.21 130.7 41.85 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.87 162.74 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.345 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.9 pt-20 -66.12 -43.44 87.14 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.472 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 8.9 p30 -160.44 179.62 8.47 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.584 0.629 . . . . 0.0 112.568 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.79 -30.67 63.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -168.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.5 -52.56 64.01 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.786 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 81.0 mm-40 -65.76 -22.78 66.61 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.736 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.25 -46.09 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.465 0.65 . . . . 0.0 109.73 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.89 -28.54 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 110.676 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 35.8 mt-10 -65.06 -48.2 74.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.234 0.613 . . . . 0.0 110.013 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.8 m -68.31 -30.1 69.01 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -55.62 -58.72 6.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.96 0.904 . . . . 0.0 109.98 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.47 -35.53 80.49 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.493 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.09 -42.62 96.51 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 123.645 0.591 . . . . 0.0 113.588 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -66.6 -39.73 88.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.058 0.543 . . . . 0.0 110.233 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.431 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 32.7 ttpt -57.51 -44.84 85.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.474 0.71 . . . . 0.0 110.262 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.33 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 t -99.64 9.91 42.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.211 1.004 . . . . 0.0 112.378 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 55.57 2.77 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 165.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.5 p -102.79 148.71 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 168.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -57.15 5.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.552 0.341 . . . . 0.0 110.459 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.546 ' HB2' HG13 ' A' ' 90' ' ' VAL . 21.1 ttp 64.23 82.51 0.18 Allowed 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.225 0.953 . . . . 0.0 113.104 168.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.81 85.94 2.24 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 106' ' ' THR . 46.9 tp60 179.57 133.17 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.761 1.224 . . . . 0.0 108.954 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -83.45 122.47 77.01 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.254 0.622 . . . . 0.0 109.413 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 106.62 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.533 2.155 . . . . 0.0 110.835 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 152.36 50.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.089 0.556 . . . . 0.0 111.312 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -70.4 102.17 2.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.217 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.3 ttm -94.8 169.2 10.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.357 1.063 . . . . 0.0 109.193 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -43.64 -41.5 4.7 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.139 1.376 . . . . 0.0 113.568 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -87.96 -15.29 36.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.575 0.75 . . . . 0.0 111.907 -172.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.16 -170.83 25.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.969 -0.35 . . . . 0.0 112.59 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -76.71 101.69 5.89 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -108.07 149.38 28.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 110.344 -171.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.4 t80 -144.4 147.91 33.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.746 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 4.8 m -140.6 136.75 33.08 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.151 0.432 . . . . 0.0 110.924 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.38 172.78 6.64 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.837 0.855 . . . . 0.0 110.967 171.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.29 113.26 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.02 169.05 20.72 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.422 0.689 . . . . 0.0 110.016 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.5 -33.88 31.72 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.268 2.645 . . . . 0.0 114.59 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.0 12.0 23.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.08 0.552 . . . . 0.0 111.207 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 59.5 72.63 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 112.874 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.412 ' HE1' HG12 ' A' ' 11' ' ' VAL . 8.4 m80 -126.59 172.24 10.43 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.618 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 65.5 mmt-85 -102.52 104.87 15.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.81 102.59 14.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.849 HH22 HG23 ' B' ' 55' ' ' VAL . 15.3 mmt180 -88.04 147.52 24.94 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 123.578 0.751 . . . . 0.0 110.389 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.426 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 15.4 t -137.99 127.29 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 161.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -141.01 158.56 43.77 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.02 111.06 17.84 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -73.0 120.93 19.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.788 0.435 . . . . 0.0 109.831 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.83 93.08 6.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.179 -175.55 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.7 0.286 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 84.8 m -141.85 142.9 33.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.116 0.967 . . . . 0.0 108.61 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -99.24 110.93 59.9 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.592 0.757 . . . . 0.0 110.231 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.501 ' HG3' HD22 ' A' ' 25' ' ' LEU . 63.0 Cg_endo -82.99 71.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.622 2.214 . . . . 0.0 110.819 167.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.02 9.48 4.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.791 0.836 . . . . 0.0 111.27 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -134.51 134.29 41.29 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.097 1.359 . . . . 0.0 107.677 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -138.38 139.66 39.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.468 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 16.8 mt -128.74 143.35 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.081 0.553 . . . . 0.0 110.103 -172.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -110.01 144.06 39.11 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -91.87 123.94 35.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.12 0.968 . . . . 0.0 111.142 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.423 HG12 ' HE1' ' B' ' 113' ' ' HIS . 20.5 m -125.3 160.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 123.956 0.902 . . . . 0.0 110.308 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.75 -63.89 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.129 0.971 . . . . 0.0 111.154 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -96.12 98.42 4.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 123.625 0.77 . . . . 0.0 109.682 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -53.8 -52.72 7.82 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.854 2.37 . . . . 0.0 115.842 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.24 -52.64 8.54 Favored 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 123.162 2.165 . . . . 0.0 112.7 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.37 -40.08 70.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.482 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 75.8 p -77.49 -34.91 54.11 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.743 0.417 . . . . 0.0 110.765 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.5 m -63.04 -46.88 85.44 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.521 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 13.8 mm100 -63.54 -35.18 79.64 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.809 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 66.1 t80 -64.88 -45.52 85.64 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.776 0.672 . . . . 0.0 109.42 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.408 ' O ' ' HG ' ' B' ' 25' ' ' LEU . 30.3 m-85 -68.29 -32.79 73.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.225 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 62.7 mtpt -57.11 -48.03 79.64 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.3 -34.31 48.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 20.8 tp -60.25 -30.99 69.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.595 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.492 HD22 ' HG3' ' A' ' 4' ' ' PRO . 25.1 mt -100.47 -48.31 4.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.7 4.88 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.953 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.543 HG11 HD22 ' B' ' 41' ' ' LEU . 24.2 m -129.62 -178.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.648 1.179 . . . . 0.0 111.064 -174.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -130.41 144.81 54.82 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.816 0.847 . . . . 0.0 109.231 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 18.4 Cg_exo -65.86 120.64 7.85 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.411 2.074 . . . . 0.0 112.21 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' B' ' 31' ' ' GLU . 8.9 p -64.55 -42.32 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.159 0.984 . . . . 0.0 110.802 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 50.3 mm-40 -119.17 89.13 3.07 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -90.1 149.74 22.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -151.81 151.31 28.05 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.1 -20.29 70.88 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.422 2.081 . . . . 0.0 113.683 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -128.2 11.44 6.45 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.043 0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -155.6 153.01 29.43 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -143.93 138.45 28.52 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 12.9 tp -126.42 115.94 20.38 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.424 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.4 p90 -131.11 113.24 13.66 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.961 1.304 . . . . 0.0 109.215 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.628 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 4.3 p -107.1 141.94 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.267 1.027 . . . . 0.0 110.033 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.543 HD22 HG11 ' B' ' 27' ' ' VAL . 13.7 mt -105.5 157.27 17.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.529 0.732 . . . . 0.0 110.382 -169.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -21.72 64.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.381 1.072 . . . . 0.0 112.332 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.04 -18.38 62.57 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.99 0.516 . . . . 0.0 111.23 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.42 16.09 15.58 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 114.484 0.554 . . . . 0.0 114.484 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.2 ppp? -104.2 153.43 20.98 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.104 0.952 . . . . 0.0 108.607 170.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.628 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 53.6 tttt -124.69 130.97 53.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.92 127.96 44.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.31 0.644 . . . . 0.0 110.063 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.27 169.67 17.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 123.821 0.724 . . . . 0.0 111.293 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.66 104.51 4.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -106.7 126.85 52.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -72.75 129.6 38.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.66 -11.1 57.5 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.013 0.925 . . . . 0.0 112.38 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.02 -24.09 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.01 0.524 . . . . 0.0 111.141 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -116.62 8.66 13.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.282 0.633 . . . . 0.0 111.324 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.849 HG23 HH22 ' A' ' 116' ' ' ARG . 7.1 p -68.15 140.1 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.793 0.437 . . . . 0.0 111.382 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -124.84 114.0 26.78 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.5 141.49 64.83 Favored 'Cis proline' 0 C--N 1.381 2.287 0 C-N-CA 124.439 -1.067 . . . . 0.0 113.147 5.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.49 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.0 mmmt -49.55 123.14 7.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.144 1.378 . . . . 0.0 112.34 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.98 108.55 2.63 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.114 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.9 p -84.44 87.1 7.21 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.75 124.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.368 0.667 . . . . 0.0 110.482 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -152.51 121.87 6.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.997 1.319 . . . . 0.0 107.776 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.04 0.01 OUTLIER Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.48 -132.47 10.94 Favored Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.15 4.34 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.01 153.71 18.56 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.491 ' CG ' ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -128.61 168.13 16.18 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 110.542 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 tp -126.25 102.15 7.06 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.93 0.892 . . . . 0.0 109.437 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -92.57 111.32 22.87 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.756 0.312 . . . . 0.0 111.725 -169.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m-85 -89.37 116.96 27.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.47 1.108 . . . . 0.0 108.337 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -96.05 128.28 42.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.448 0.642 . . . . 0.0 111.566 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.78 164.14 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.646 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.28 -43.25 86.91 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.382 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -160.65 178.19 9.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.99 -32.02 52.78 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.197 1.799 . . . . 0.0 113.076 -170.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.557 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -61.32 -52.92 62.68 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.884 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 61.2 mm-40 -64.97 -23.1 67.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.763 1.225 . . . . 0.0 112.618 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.81 -45.84 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.386 0.613 . . . . 0.0 109.764 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.17 57.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.96 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.9 mt-10 -64.53 -48.72 74.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.208 0.603 . . . . 0.0 109.74 174.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -68.48 -29.58 68.24 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.891 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.76 -58.95 5.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.22 1.008 . . . . 0.0 109.666 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.67 -35.47 80.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.484 -174.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.46 96.9 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 123.337 0.398 . . . . 0.0 113.487 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -66.87 -39.39 87.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.989 0.516 . . . . 0.0 110.092 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.0 ttpt -57.88 -44.74 86.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.644 0.778 . . . . 0.0 110.478 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.7 67.39 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.792 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.8 t -99.91 9.79 42.38 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.097 0.959 . . . . 0.0 112.333 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.25 55.27 2.79 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 165.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.7 p -103.11 148.68 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.1 -56.88 6.36 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.57 0.348 . . . . 0.0 110.413 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 19.5 ttp 64.07 82.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 85.82 2.23 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.747 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' B' ' 106' ' ' THR . 5.8 tp60 -179.42 133.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.916 1.286 . . . . 0.0 108.836 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLN . . . . . 0.401 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 86.6 mt-30 -82.79 122.48 78.26 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.607 0.763 . . . . 0.0 109.355 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.523 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 19.0 Cg_endo -59.47 106.66 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.566 2.177 . . . . 0.0 110.181 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.3 152.47 50.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.287 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -71.52 102.67 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.75 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.8 ttm -94.67 169.13 10.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.635 1.174 . . . . 0.0 109.321 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -43.61 -41.87 4.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.487 1.515 . . . . 0.0 112.864 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.04 -14.93 37.7 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.632 0.773 . . . . 0.0 112.027 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.98 -171.05 25.06 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.988 -0.34 . . . . 0.0 112.553 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -76.33 101.42 5.49 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -107.86 149.46 28.24 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.583 0.706 . . . . 0.0 110.331 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 1.9 t80 -144.59 148.29 34.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.701 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 17.1 m -141.33 136.5 31.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.122 0.487 . . . . 0.0 110.474 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.39 172.88 6.58 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.957 0.903 . . . . 0.0 110.838 171.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.5 112.52 10.33 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.436 ' HB3' HD11 ' B' ' 115' ' ' LEU . 6.6 p-10 -72.9 167.57 32.7 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -48.34 -33.85 23.51 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.394 2.729 . . . . 0.0 114.864 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -92.24 12.22 23.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.123 0.569 . . . . 0.0 111.134 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 m 59.06 72.15 0.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.064 1.345 . . . . 0.0 112.738 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.423 ' HE1' HG12 ' B' ' 11' ' ' VAL . 8.6 m80 -125.64 171.58 10.47 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.57 ' NH2' ' HB2' ' A' ' 59' ' ' ALA . 17.2 mmt180 -101.17 105.04 16.13 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' B' ' 109' ' ' ASP . 39.0 mt -97.2 103.04 14.94 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.737 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 23.9 ttt180 -87.66 147.43 25.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.5 0.72 . . . . 0.0 110.404 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -137.86 127.22 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 160.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -141.22 158.69 43.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.65 110.8 17.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.74 123.39 23.22 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.86 100.79 13.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.965 0.506 . . . . 0.0 109.961 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.78 -1.011 . . . . 0.0 111.156 179.02 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.5 m -138.63 140.04 38.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.957 0.408 . . . . 0.0 111.655 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -130.75 148.02 68.47 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.151 0.98 . . . . 0.0 108.616 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 98.6 Cg_endo -86.38 143.39 7.57 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.213 1.942 . . . . 0.0 112.037 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.66 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 36.0 t70 -143.61 19.37 1.85 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.659 1.219 . . . . 0.0 109.009 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.73 148.09 35.16 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.653 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.494 HG23 HD23 ' A' ' 47' ' ' LEU . 3.8 t -151.72 139.21 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.869 0.868 . . . . 0.0 108.691 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.545 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 68.1 mt -123.71 137.7 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.577 0.751 . . . . 0.0 109.904 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.66 130.23 45.87 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 62' ' ' THR . 28.0 m-85 -80.42 115.19 19.82 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.27 0.628 . . . . 0.0 109.629 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG12 ' CE1' ' A' ' 113' ' ' HIS . 32.9 m -114.09 160.78 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.772 0.829 . . . . 0.0 109.241 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -97.08 -59.3 1.82 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.147 0.579 . . . . 0.0 110.497 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -98.48 100.77 9.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.305 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.28 -51.97 10.05 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.441 2.761 . . . . 0.0 115.523 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.21 -50.21 9.13 Favored 'Trans proline' 0 C--N 1.398 3.158 0 CA-C-N 122.136 1.798 . . . . 0.0 112.561 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.29 62.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.6 p -76.83 -36.21 57.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.479 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 95.2 m -64.51 -43.84 92.78 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 36.9 mt-30 -64.99 -35.11 80.12 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.205 174.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.3 t80 -66.15 -42.82 88.54 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 123.776 0.673 . . . . 0.0 109.552 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 34.1 m-85 -70.04 -28.39 65.43 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.789 -0.625 . . . . 0.0 109.873 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 60.6 mtpt -57.0 -50.61 72.18 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 118.789 0.722 . . . . 0.0 111.822 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.45 60.84 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.253 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 19.1 tp -61.79 -42.56 99.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.744 1.217 . . . . 0.0 112.388 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' HB2' HG22 ' A' ' 27' ' ' VAL . 18.4 mt -90.15 -43.01 10.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.67 28.62 6.95 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.2 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 25' ' ' LEU . 29.4 m -131.64 173.87 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.929 0.892 . . . . 0.0 110.224 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -124.84 150.22 65.22 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.965 0.906 . . . . 0.0 109.213 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.93 118.14 5.4 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.013 2.475 . . . . 0.0 112.267 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.8 -40.04 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.717 0.636 . . . . 0.0 110.298 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 36.3 mm-40 -117.92 146.7 43.76 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.326 1.05 . . . . 0.0 109.196 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.4 p -143.8 135.37 26.1 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -145.26 157.4 53.22 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.876 1.271 . . . . 0.0 108.772 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.12 -28.99 35.19 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 123.468 2.779 . . . . 0.0 113.999 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 5.19 7.98 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.57 130.23 12.31 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.833 -0.542 . . . . 0.0 111.194 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -117.62 130.89 56.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 7.1 tt -121.93 132.39 54.52 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.26 150.63 46.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.82 1.248 . . . . 0.0 108.687 167.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 2.0 p -130.46 132.64 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.59 155.89 20.27 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.368 0.667 . . . . 0.0 110.767 -165.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.15 -16.98 64.22 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.642 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -74.41 -15.38 60.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.132 0.973 . . . . 0.0 111.363 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.8 -19.88 30.04 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.896 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.703 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.7 ppp? -81.36 168.45 18.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.376 0.588 . . . . 0.0 109.929 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.6 tttt -133.83 140.2 46.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.502 0.321 . . . . 0.0 110.924 -169.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 7' ' ' THR . 55.0 mt -131.39 126.38 35.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.866 0.867 . . . . 0.0 111.898 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -102.79 167.9 17.78 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 174.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.54 108.41 6.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.1 t90 -104.81 118.53 36.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 25.2 p -75.85 127.7 33.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.189 0.518 . . . . 0.0 109.842 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.486 ' HD3' HG23 ' A' ' 62' ' ' THR . 40.3 ptt180 -74.43 -2.44 25.48 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.827 1.251 . . . . 0.0 114.015 -165.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -69.84 -18.63 63.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.835 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -148.03 21.76 1.1 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.857 0.463 . . . . 0.0 110.774 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 58' ' ' LYS . 8.7 p -59.37 147.2 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.806 0.442 . . . . 0.0 111.313 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.84 113.51 26.87 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.536 0.734 . . . . 0.0 109.117 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 1.2 Cg_endo -78.19 143.96 74.31 Favored 'Cis proline' 0 C--N 1.38 2.232 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.406 5.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HA ' HG13 ' A' ' 55' ' ' VAL . 11.9 mmmm -54.69 119.6 5.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.034 0.934 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.73 4.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.191 0.996 . . . . 0.0 109.441 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.7 m -91.48 82.86 5.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 m -155.4 131.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.012 1.325 . . . . 0.0 108.424 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.486 HG23 ' HD3' ' A' ' 52' ' ' ARG . 15.0 p -145.44 122.28 11.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.311 1.044 . . . . 0.0 108.634 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.72 -95.51 0.14 Allowed Glycine 0 C--N 1.349 1.305 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.639 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.95 -154.12 30.11 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.81 -48.09 3.81 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.29 132.48 3.75 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.563 ' HG2' ' HB ' ' B' ' 8' ' ' ILE . 15.8 pt-20 -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.08 0.952 . . . . 0.0 110.971 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.13 105.6 13.11 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -91.72 115.17 27.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.659 0.663 . . . . 0.0 112.546 -169.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.7 m-85 -96.44 115.75 27.94 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.728 1.211 . . . . 0.0 108.334 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.46 HH21 ' HB3' ' B' ' 5' ' ' ASP . 42.0 mtm180 -96.51 131.06 43.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.556 0.693 . . . . 0.0 111.494 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -125.45 165.98 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.186 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.1 pt-20 -65.45 -41.56 93.29 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.395 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.44 -178.68 3.63 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.218 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -58.99 -30.31 67.87 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.222 1.409 . . . . 0.0 112.887 -165.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.57 87.63 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.119 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.56 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 77.4 mm-40 -67.39 -22.33 65.56 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.646 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.78 -44.89 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.16 -32.17 68.6 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.497 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.98 -42.14 81.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.722 0.772 . . . . 0.0 110.197 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.6 m -72.36 -28.12 62.83 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.702 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -58.72 -61.75 2.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.839 0.856 . . . . 0.0 109.682 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.89 67.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.632 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.87 -51.57 56.32 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.877 0.736 . . . . 0.0 113.012 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -63.74 -40.46 96.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.082 0.553 . . . . 0.0 110.099 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 31.5 ttpt -56.15 -45.78 79.51 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.412 0.625 . . . . 0.0 110.828 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.34 -20.17 60.19 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.166 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.2 t -98.64 10.3 41.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.061 0.944 . . . . 0.0 112.14 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.55 5.82 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 168.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.89 153.56 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.51 2.75 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.829 0.452 . . . . 0.0 110.373 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 11.3 ttp 67.47 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.973 0.795 . . . . 0.0 112.859 171.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.32 85.13 2.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.194 0.521 . . . . 0.0 110.617 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 106' ' ' THR . 51.3 tp60 179.85 131.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.338 . . . . 0.0 109.145 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.59 117.79 69.21 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.65 105.19 0.1 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.397 2.732 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.9 148.93 25.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 110.815 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -90.46 99.02 12.12 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -102.95 -174.65 2.6 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.42 0.688 . . . . 0.0 111.885 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -55.91 -39.84 72.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.07 1.348 . . . . 0.0 112.766 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 89.9 m-85 -88.63 -4.83 58.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.279 0.632 . . . . 0.0 111.614 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.86 -160.22 21.74 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.731 -0.483 . . . . 0.0 113.413 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -80.26 100.47 8.36 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -109.18 153.59 23.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.596 0.758 . . . . 0.0 111.026 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.8 t80 -149.4 145.03 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.728 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 12.3 m -137.94 128.93 27.25 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.322 0.51 . . . . 0.0 109.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.89 174.63 5.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.997 0.919 . . . . 0.0 110.589 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.08 119.3 12.08 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.574 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.8 p-10 -73.87 -175.13 0.39 Allowed Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.588 0.755 . . . . 0.0 111.316 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 11.5 Cg_exo -38.91 -48.47 2.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.589 2.859 . . . . 0.0 114.846 165.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 113' ' ' HIS . 57.9 m-20 -89.73 3.92 51.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.393 0.677 . . . . 0.0 111.321 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.2 m 71.96 16.16 5.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 113.654 161.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.448 ' CE1' HG12 ' A' ' 11' ' ' VAL . 15.9 m80 -59.11 137.35 57.99 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -70.98 99.61 1.82 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.36 102.26 14.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.714 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 14.2 tpt180 -87.71 142.45 27.82 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.403 1.081 . . . . 0.0 110.664 -170.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.455 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 39.0 t -138.73 128.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.0 p90 -135.39 158.59 43.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.545 0.611 . . . . 0.0 111.931 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 113.04 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 34.8 t80 -78.43 114.91 17.76 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.26 93.89 0.66 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.199 0.937 . . . . 0.0 109.914 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.5 178.711 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.42 0.152 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 97.6 m -141.53 141.28 33.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.482 0.713 . . . . 0.0 111.332 -169.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -129.91 148.14 68.38 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 108.707 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 90.0 Cg_endo -86.72 141.84 6.59 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.342 2.028 . . . . 0.0 112.37 170.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.703 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 22.2 t70 -141.77 20.31 2.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.557 1.17 . . . . 0.0 109.221 171.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -143.47 148.0 35.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.751 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.474 HG23 HD23 ' B' ' 47' ' ' LEU . 3.7 t -151.83 139.3 19.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.563 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 46.8 mt -123.74 137.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.641 0.776 . . . . 0.0 109.879 -170.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.4 130.41 45.67 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.432 ' O ' HG22 ' B' ' 62' ' ' THR . 27.1 m-85 -80.44 115.6 20.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.604 172.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.443 HG12 ' CE1' ' B' ' 113' ' ' HIS . 32.7 m -114.43 160.72 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.705 0.802 . . . . 0.0 109.274 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.29 -58.56 1.98 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.712 0.405 . . . . 0.0 110.737 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -98.6 100.66 9.86 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.118 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.66 -52.18 9.57 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.319 2.679 . . . . 0.0 115.378 -172.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 25.4 Cg_endo -58.76 -50.73 8.49 Favored 'Trans proline' 0 C--N 1.398 3.139 0 CA-C-N 122.132 1.797 . . . . 0.0 112.532 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -37.66 64.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.635 -166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.5 p -76.51 -36.23 57.87 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.62 0.575 . . . . 0.0 109.453 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 96.9 m -65.04 -43.41 92.43 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' B' ' 15' ' ' PRO . 45.7 mt-30 -65.19 -35.34 80.77 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.793 174.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 75.5 t80 -65.81 -43.01 89.93 Favored 'General case' 0 C--N 1.347 0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 32.3 m-85 -69.81 -28.62 65.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.788 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 18' ' ' THR . 57.3 mtpt -57.16 -50.52 72.58 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.794 0.724 . . . . 0.0 112.112 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.58 61.8 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.536 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 19.0 tp -61.54 -42.69 99.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.599 1.159 . . . . 0.0 112.581 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -90.24 -42.56 10.94 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.97 29.31 6.91 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.899 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' B' ' 25' ' ' LEU . 28.2 m -131.42 174.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 124.097 0.959 . . . . 0.0 110.568 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -124.75 150.61 66.13 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.73 0.812 . . . . 0.0 109.155 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.16 118.92 5.96 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.49 2.127 . . . . 0.0 112.661 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.44 -40.05 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.27 0.628 . . . . 0.0 110.381 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.766 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 31.1 mm-40 -118.0 147.34 43.29 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.159 0.983 . . . . 0.0 108.666 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.3 p -144.27 135.38 25.36 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 57.1 m -145.02 156.41 55.01 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.106 1.362 . . . . 0.0 108.66 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.15 -30.17 24.63 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 124.039 3.159 . . . . 0.0 114.353 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -125.21 5.77 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -151.75 129.9 11.91 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.455 0.571 . . . . 0.0 111.086 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 42.6 m -117.21 130.73 56.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 39.9 tp -121.54 131.92 54.41 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.465 0.706 . . . . 0.0 109.608 -176.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.92 150.79 47.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.617 1.167 . . . . 0.0 108.455 167.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.483 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 2.7 p -130.29 133.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 41.2 mt -86.49 155.73 20.4 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.923 -165.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -16.76 64.33 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.667 0.787 . . . . 0.0 111.342 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -75.79 -14.53 60.31 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.709 0.804 . . . . 0.0 111.086 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.65 -19.78 30.53 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-O 119.753 -0.471 . . . . 0.0 113.874 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.66 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.8 ppp? -81.35 168.13 18.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.416 0.608 . . . . 0.0 110.061 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 78.3 tttt -133.96 140.29 46.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.488 0.315 . . . . 0.0 110.997 -169.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.474 HD23 HG23 ' B' ' 7' ' ' THR . 46.3 mt -131.47 126.25 34.54 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.843 0.857 . . . . 0.0 111.88 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.64 167.77 17.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -137.63 108.41 6.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.408 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 5.1 t90 -104.9 118.4 36.43 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 55.3 p -75.18 127.69 33.76 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.182 0.515 . . . . 0.0 110.084 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.497 ' HD3' HG23 ' B' ' 62' ' ' THR . 35.3 ptt180 -74.81 -2.97 29.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.688 1.195 . . . . 0.0 113.982 -165.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -19.45 64.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.618 0.767 . . . . 0.0 111.928 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -147.86 21.79 1.12 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.896 0.478 . . . . 0.0 110.625 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -59.57 146.98 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.757 0.423 . . . . 0.0 111.098 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.98 115.1 27.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.72 143.33 75.59 Favored 'Cis proline' 0 C--N 1.387 2.564 0 C-N-CA 124.462 -1.057 . . . . 0.0 112.955 2.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -53.22 119.32 4.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.972 0.909 . . . . 0.0 112.173 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.32 108.54 4.79 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.075 0.95 . . . . 0.0 109.147 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.2 m -91.13 82.87 5.52 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.4 131.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.892 1.277 . . . . 0.0 108.425 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.497 HG23 ' HD3' ' B' ' 52' ' ' ARG . 17.2 p -145.41 121.89 11.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.269 1.028 . . . . 0.0 108.526 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.07 -95.51 0.14 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 112.592 -0.203 . . . . 0.0 112.592 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.03 -154.14 30.19 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.9 -48.15 3.82 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.19 132.11 3.64 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.545 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 pt-20 -106.63 166.65 10.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.935 0.894 . . . . 0.0 110.853 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 tp -115.48 104.87 12.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.507 0.723 . . . . 0.0 109.247 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.747 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.22 115.62 28.17 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.611 0.641 . . . . 0.0 112.243 -168.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 7.8 m-85 -96.61 115.84 28.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.886 1.274 . . . . 0.0 108.368 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -96.48 128.59 43.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.273 0.629 . . . . 0.0 111.146 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.79 167.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.627 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.47 -40.86 89.59 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -167.75 -179.69 4.39 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.172 0.511 . . . . 0.0 112.362 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.31 -30.74 66.91 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.35 1.46 . . . . 0.0 112.89 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.586 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.44 -46.16 87.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.952 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.9 mm-40 -67.56 -21.98 65.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.904 0.882 . . . . 0.0 112.503 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.81 -43.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.39 -30.62 63.39 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.656 1.182 . . . . 0.0 110.982 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.1 mt-10 -69.17 -42.41 75.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.707 0.765 . . . . 0.0 110.189 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -71.89 -28.32 63.43 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.75 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.422 ' O ' ' HE1' ' B' ' 92' ' ' MET . 13.0 t80 -58.3 -62.28 1.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 0.0 109.359 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.427 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -69.39 -29.87 67.73 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.541 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.97 53.74 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.02 0.825 . . . . 0.0 113.027 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.7 -40.5 96.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.118 0.567 . . . . 0.0 110.073 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.8 ttpt -56.34 -45.25 80.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.637 . . . . 0.0 110.656 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 -20.82 60.01 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.172 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -98.36 10.85 39.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.125 0.97 . . . . 0.0 112.516 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.62 42.87 5.96 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.61 153.32 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.13 -59.64 2.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.812 0.445 . . . . 0.0 110.363 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.422 ' HE1' ' O ' ' B' ' 82' ' ' PHE . 30.9 ttm 67.37 84.97 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.866 0.729 . . . . 0.0 112.377 170.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.27 84.2 1.93 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.126 0.489 . . . . 0.0 110.645 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 55.6 tp60 -178.74 132.23 0.13 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.649 1.18 . . . . 0.0 108.833 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLN . . . . . 0.405 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 96.8 mt-30 -86.36 118.02 69.64 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 9.8 Cg_endo -52.66 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.547 2.831 . . . . 0.0 112.106 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.28 148.86 25.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.125 0.97 . . . . 0.0 110.772 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.81 99.36 12.38 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.446 ' SD ' HG21 ' B' ' 104' ' ' THR . 66.1 mtt -103.05 -173.56 2.34 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.288 0.635 . . . . 0.0 111.745 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -57.24 -39.49 75.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.052 1.341 . . . . 0.0 112.548 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 78.7 m-85 -88.76 -5.13 58.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.511 0.725 . . . . 0.0 111.399 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.67 -160.19 21.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.302 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -80.64 100.8 8.85 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.446 HG21 ' SD ' ' B' ' 99' ' ' MET . 12.0 t -109.45 153.99 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.838 -170.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 14.3 t80 -149.41 145.43 26.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.543 -177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.503 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 9.4 m -138.25 129.08 26.81 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.04 174.48 5.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 110.822 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.83 120.43 13.29 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.607 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.7 p-10 -75.54 -174.29 0.38 Allowed Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.683 0.793 . . . . 0.0 110.953 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.5 Cg_exo -40.34 -48.01 4.18 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.412 2.741 . . . . 0.0 114.519 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.427 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 65.0 m-20 -90.1 4.1 51.37 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.356 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 29.0 m 71.67 17.76 5.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.443 ' CE1' HG12 ' B' ' 11' ' ' VAL . 16.3 m80 -60.79 137.71 58.18 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -71.05 99.49 1.83 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.388 0.613 . . . . 0.0 109.439 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.8 mt -96.38 102.85 14.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 14.0 tpt180 -86.61 142.6 28.14 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.475 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -138.91 128.75 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -135.37 158.82 43.4 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.867 0.758 . . . . 0.0 111.744 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.7 112.57 21.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 84.9 t80 -76.59 108.99 9.97 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.3 101.47 8.95 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.941 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.9 m -140.29 120.2 13.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.965 -0.46 . . . . 0.0 111.374 -166.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -135.88 134.16 20.38 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.093 0.957 . . . . 0.0 110.044 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.62 103.77 0.23 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.325 2.683 . . . . 0.0 113.002 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.707 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 9.1 p-10 -97.71 12.49 33.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 166.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.6 129.09 43.94 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.873 -168.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.1 t -130.36 137.98 50.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.158 0.983 . . . . 0.0 108.348 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -124.33 141.83 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.2 131.93 55.69 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 55' ' ' VAL . 10.1 m-85 -71.7 120.35 17.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.881 0.873 . . . . 0.0 111.616 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 51' ' ' SER . 33.2 m -117.71 161.42 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.01 -54.32 3.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -94.95 103.79 12.77 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.597 0.759 . . . . 0.0 109.586 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.17 -57.67 1.38 Allowed 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.983 2.456 . . . . 0.0 114.493 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 38.5 Cg_exo -57.27 -57.3 1.33 Allowed 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.628 1.974 . . . . 0.0 111.852 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.13 89.52 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.922 -169.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -78.26 -24.45 46.84 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 28.0 m -73.51 -43.4 60.15 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 75.5 mm-40 -68.47 -29.7 68.38 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.557 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -61.24 -50.79 71.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.816 0.697 . . . . 0.0 109.6 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.32 -31.92 71.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.592 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -57.45 -47.92 80.52 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.27 57.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.035 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.5 -36.9 79.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.473 1.109 . . . . 0.0 112.903 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' HB2' HG22 ' A' ' 27' ' ' VAL . 23.8 mt -98.61 -31.44 11.94 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.168 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.83 31.48 20.79 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 25' ' ' LEU . 22.7 m -123.81 174.66 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.251 1.02 . . . . 0.0 110.599 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.96 143.09 47.57 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.852 0.861 . . . . 0.0 109.306 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.46 132.9 28.51 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.674 2.25 . . . . 0.0 112.828 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 31' ' ' GLU . 7.8 p -71.09 -38.56 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.534 0.734 . . . . 0.0 109.907 171.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 40.3 mm-40 -118.21 134.0 55.4 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 p -141.07 126.15 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.443 0.697 . . . . 0.0 109.23 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -140.17 157.55 68.71 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.759 1.223 . . . . 0.0 109.212 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.25 -24.49 77.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.917 2.412 . . . . 0.0 113.831 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.4 t -127.1 13.49 7.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -155.99 154.34 30.94 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.969 -0.457 . . . . 0.0 110.411 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 t -144.69 157.62 44.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.153 0.981 . . . . 0.0 108.403 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -154.41 118.12 4.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.57 135.97 51.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 109.104 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' A' ' 46' ' ' LYS . 16.1 t -115.87 126.25 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 0.0 108.925 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.461 HD13 ' SD ' ' A' ' 45' ' ' MET . 10.3 mp -90.16 152.55 21.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.761 0.424 . . . . 0.0 110.257 -170.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -14.17 61.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.949 0.899 . . . . 0.0 111.699 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.55 -22.42 66.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.28 1.032 . . . . 0.0 111.789 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.66 1.08 40.0 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.818 -0.435 . . . . 0.0 113.343 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.73 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -95.34 169.99 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' A' ' 40' ' ' VAL . 79.3 tttt -133.7 135.9 44.34 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 7' ' ' THR . 1.2 tt -137.59 123.99 20.73 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.895 0.478 . . . . 0.0 110.013 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.15 167.75 15.21 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.48 111.81 11.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.436 ' HE1' ' HA ' ' A' ' 55' ' ' VAL . 2.2 t-105 -103.91 125.03 50.02 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.9 m -79.97 109.54 14.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.535 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 28.8 ptt-85 -67.71 -11.29 58.01 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.436 1.094 . . . . 0.0 113.618 -167.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -65.91 -17.83 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.937 0.495 . . . . 0.0 111.31 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -147.88 76.84 1.4 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.959 1.362 . . . . 0.0 109.161 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 10' ' ' TYR . 7.3 p -113.74 152.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.031 174.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.21 112.22 46.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.808 0.843 . . . . 0.0 109.852 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.9 142.0 61.19 Favored 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.157 1.092 . . . . 0.0 112.413 1.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -49.31 111.02 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.036 0.935 . . . . 0.0 111.78 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.98 107.16 4.17 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.12 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.535 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.3 p -113.53 85.6 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.455 0.645 . . . . 0.0 109.508 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.95 129.06 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.996 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -144.39 157.04 44.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.336 1.055 . . . . 0.0 109.007 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 -43.06 0.57 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.05 150.1 22.3 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.47 120.97 4.82 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.28 89.78 0.22 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.77 0.335 . . . . 0.0 112.601 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' CG ' ' HB ' ' B' ' 8' ' ' ILE . 2.9 pt-20 -102.5 164.39 11.69 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.451 0.643 . . . . 0.0 109.926 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.85 101.66 7.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.81 108.92 19.77 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.135 0.493 . . . . 0.0 111.167 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.38 116.21 24.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.277 1.431 . . . . 0.0 109.106 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -95.86 127.17 41.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.369 0.604 . . . . 0.0 112.075 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.29 161.92 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.787 1.235 . . . . 0.0 110.391 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.5 pt-20 -63.95 -38.74 92.21 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -163.85 -179.62 6.43 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 118.405 0.548 . . . . 0.0 112.013 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.4 -32.27 70.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.268 . . . . 0.0 112.595 -166.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.24 -48.17 82.7 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.027 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.443 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.5 mm-40 -65.26 -20.58 66.49 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.632 1.173 . . . . 0.0 112.993 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.6 -43.25 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.375 0.607 . . . . 0.0 109.924 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.66 -31.4 63.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.753 1.221 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 43.4 mt-10 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.122 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -69.62 -32.24 70.83 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.872 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -56.14 -57.33 12.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.912 0.885 . . . . 0.0 109.407 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.22 90.84 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.721 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.43 93.92 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 123.849 0.718 . . . . 0.0 114.097 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.87 -44.1 97.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.34 0.656 . . . . 0.0 109.869 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.09 -46.47 79.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.674 0.79 . . . . 0.0 110.42 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.9 -27.32 66.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.842 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.7 t -93.14 -10.61 35.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.801 0.84 . . . . 0.0 112.575 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 58.39 0.95 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 169.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.3 143.61 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.23 65.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.567 0.747 . . . . 0.0 111.48 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 53.3 ttm 65.03 83.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 165.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 83.69 2.0 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.499 0.666 . . . . 0.0 111.068 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 177.81 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.707 1.603 . . . . 0.0 108.652 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -80.15 118.5 72.72 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -49.85 102.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.926 3.084 . . . . 0.0 112.873 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.99 141.0 41.72 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.941 0.896 . . . . 0.0 110.262 -175.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 100.27 4.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.7 ttm -96.96 162.1 13.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.427 0.691 . . . . 0.0 109.331 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.17 -28.63 68.09 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.001 0.92 . . . . 0.0 112.45 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.7 -24.74 49.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.479 0.712 . . . . 0.0 110.523 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.16 175.93 21.99 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -74.05 101.01 3.75 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -111.67 147.56 35.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.409 0.623 . . . . 0.0 111.459 -165.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.502 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 5.8 t80 -144.21 144.03 31.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.692 1.197 . . . . 0.0 109.426 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.401 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 12.8 m -133.07 128.11 35.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.06 174.09 6.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.893 0.877 . . . . 0.0 110.033 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.03 122.59 17.36 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.505 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.1 p-10 -71.63 176.23 2.35 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.352 0.661 . . . . 0.0 109.352 172.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 27.8 Cg_endo -59.65 -12.92 19.34 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 122.305 2.004 . . . . 0.0 114.086 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.11 1.08 49.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.165 0.586 . . . . 0.0 111.677 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.3 p 66.3 33.47 7.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.821 1.649 . . . . 0.0 112.816 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -74.33 173.14 10.66 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 114' ' ' ARG . 16.5 mmt-85 -108.6 105.01 14.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -99.95 99.92 10.75 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.465 HH21 HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -98.48 96.62 8.12 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.502 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 27.6 t -86.51 119.24 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -139.46 161.04 38.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.53 112.81 18.96 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -69.31 141.1 54.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.612 0.765 . . . . 0.0 110.834 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.93 98.73 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.509 0.723 . . . . 0.0 110.269 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.742 -1.032 . . . . 0.0 110.821 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.508 0.194 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 91.0 m -141.89 121.12 13.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.007 -168.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -135.82 133.97 20.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.751 0.82 . . . . 0.0 110.317 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -90.94 104.1 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.315 2.677 . . . . 0.0 112.996 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.73 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.2 p-10 -98.31 13.49 31.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.617 0.723 . . . . 0.0 109.975 166.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -129.27 128.7 43.76 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.887 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -130.35 138.14 50.26 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.486 ' HB ' ' CG ' ' A' ' 67' ' ' GLU . 31.1 mt -125.36 141.88 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.05 133.96 54.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.419 ' CE1' HG21 ' B' ' 55' ' ' VAL . 69.2 m-85 -76.58 120.75 22.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.925 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' B' ' 51' ' ' SER . 34.1 m -117.68 160.85 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -98.12 -54.85 2.95 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.36 0.264 . . . . 0.0 110.427 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -93.76 103.55 10.47 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.862 0.865 . . . . 0.0 109.345 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -55.86 -58.53 1.04 Allowed 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.253 2.635 . . . . 0.0 114.621 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 52.6 Cg_exo -56.34 -57.57 1.39 Allowed 'Trans proline' 0 C--N 1.404 3.478 0 CA-C-N 122.751 2.018 . . . . 0.0 112.09 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.92 90.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.794 -168.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.0 m -78.03 -24.99 47.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.357 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 41.8 m -73.08 -42.87 62.54 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 77.3 mm-40 -68.96 -29.52 67.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.571 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.66 -50.62 71.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.905 0.753 . . . . 0.0 109.59 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -67.97 -32.2 72.46 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.772 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.548 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 58.6 mtpt -57.09 -48.19 79.19 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.289 0.566 . . . . 0.0 112.466 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 -35.3 57.3 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.907 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.45 -36.71 78.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.353 1.061 . . . . 0.0 112.928 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.539 ' HB2' HG22 ' B' ' 27' ' ' VAL . 24.0 mt -99.01 -31.03 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.13 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 31.74 21.33 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.553 HG11 HD22 ' B' ' 41' ' ' LEU . 32.8 m -124.71 174.26 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.076 0.95 . . . . 0.0 110.838 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.07 139.1 34.51 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.892 0.877 . . . . 0.0 109.14 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.548 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 51.0 Cg_exo -60.84 131.88 39.65 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.291 2.661 . . . . 0.0 114.417 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.446 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.6 p -71.34 -36.88 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.794 0.838 . . . . 0.0 110.157 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 38.7 mm-40 -121.31 133.0 55.12 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 53.1 m -141.41 126.12 17.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 67.5 m -140.08 157.05 69.95 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.815 1.246 . . . . 0.0 109.091 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.06 -24.88 75.62 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.115 2.543 . . . . 0.0 114.11 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.1 t -127.34 13.65 7.12 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -156.13 154.39 30.82 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.877 -0.515 . . . . 0.0 110.355 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -144.8 157.04 44.32 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.16 0.984 . . . . 0.0 108.46 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tt -153.96 118.4 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -126.63 135.17 50.85 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.97 1.308 . . . . 0.0 109.161 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.581 HG22 ' HG3' ' B' ' 46' ' ' LYS . 18.6 t -114.5 126.43 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 109.047 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.553 HD22 HG11 ' B' ' 27' ' ' VAL . 16.6 mt -90.35 153.01 20.76 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -170.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.0 -13.73 62.2 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.892 0.877 . . . . 0.0 111.531 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -22.42 66.74 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 111.957 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 1.87 42.08 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.76 -0.467 . . . . 0.0 113.123 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.707 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -95.67 169.89 9.71 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.361 0.581 . . . . 0.0 109.826 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.581 ' HG3' HG22 ' B' ' 40' ' ' VAL . 76.3 tttt -133.25 136.56 45.63 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.79 123.91 20.36 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.928 0.491 . . . . 0.0 110.132 -170.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.98 167.85 15.39 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.57 111.53 10.74 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 162.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -103.69 125.41 50.16 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 20.4 m -80.1 109.62 14.73 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.635 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 32.7 ptt-85 -68.6 -10.25 54.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.358 1.063 . . . . 0.0 113.757 -167.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.83 -18.24 65.2 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.488 177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -147.52 77.02 1.42 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.544 1.164 . . . . 0.0 109.098 168.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' B' ' 10' ' ' TYR . 7.4 p -113.46 152.27 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.015 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' PRO . 40.9 mt-10 -114.59 112.42 45.73 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.76 169.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' B' ' 56' ' ' GLU . 82.3 Cg_endo -80.19 142.74 62.85 Favored 'Cis proline' 0 C--N 1.386 2.546 0 CA-C-N 119.589 0.889 . . . . 0.0 112.508 1.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -50.42 111.4 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.923 0.889 . . . . 0.0 111.564 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.12 107.42 4.21 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.143 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.635 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 30.5 p -114.33 85.45 2.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.681 0.753 . . . . 0.0 109.474 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.81 130.11 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.089 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -145.67 156.02 43.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.719 1.208 . . . . 0.0 108.814 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.86 -43.47 0.55 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 149.59 21.73 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.19 121.05 4.81 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 76.55 89.81 0.27 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.51 163.4 12.25 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.98 0.912 . . . . 0.0 109.178 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 tp -120.87 101.35 7.64 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 109.63 20.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.359 0.527 . . . . 0.0 111.343 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -87.01 116.35 25.0 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 108.918 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -95.98 126.19 41.05 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.217 0.532 . . . . 0.0 111.499 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.25 162.58 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.533 1.133 . . . . 0.0 110.48 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.4 pt-20 -64.21 -38.81 92.37 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -163.6 179.81 6.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.329 0.513 . . . . 0.0 112.149 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.88 -32.1 69.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.115 1.366 . . . . 0.0 112.804 -167.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -47.51 85.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.279 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 84.5 mm-40 -66.48 -19.59 65.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.212 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.49 -44.38 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.39 0.614 . . . . 0.0 109.597 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.82 -33.43 70.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.113 1.365 . . . . 0.0 111.367 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -65.23 -46.88 78.83 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.73 0.776 . . . . 0.0 109.91 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -68.93 -32.28 71.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.924 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.27 -57.55 11.77 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.576 0.75 . . . . 0.0 109.288 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.04 91.29 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.649 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.26 -44.23 94.04 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 123.726 0.641 . . . . 0.0 113.809 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' TRP . . . . . 0.412 ' HB3' HG11 ' B' ' 90' ' ' VAL . 37.6 m0 -62.89 -44.03 97.19 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.192 0.597 . . . . 0.0 109.902 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -56.89 -45.96 82.22 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 110.324 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.87 -27.14 66.42 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.904 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.1 t -93.6 -10.31 35.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.855 0.862 . . . . 0.0 112.22 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.12 58.84 0.96 Allowed Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 114.09 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' B' ' 92' ' ' MET . 5.1 p -104.4 144.73 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.48 63.92 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.246 0.618 . . . . 0.0 111.387 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.579 ' HB2' HG13 ' B' ' 90' ' ' VAL . 51.8 ttm 65.31 83.81 0.16 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.953 0.783 . . . . 0.0 113.06 165.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.402 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -117.19 84.09 2.09 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.413 0.625 . . . . 0.0 110.851 176.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' B' ' 106' ' ' THR . 51.5 tp60 177.22 121.57 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.762 1.625 . . . . 0.0 108.304 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -78.56 119.31 76.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.73 102.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.806 3.004 . . . . 0.0 112.556 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.09 140.52 42.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.0 0.92 . . . . 0.0 110.244 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.81 100.63 4.81 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.497 ' SD ' ' HD2' ' B' ' 101' ' ' PHE . 56.0 ttm -97.05 162.56 13.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.449 0.7 . . . . 0.0 109.356 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.84 -29.58 68.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.122 0.969 . . . . 0.0 112.018 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.497 ' HD2' ' SD ' ' B' ' 99' ' ' MET . 49.2 m-85 -77.29 -25.38 51.27 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.401 0.681 . . . . 0.0 110.369 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.77 176.5 22.97 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.962 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.39 101.48 4.11 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -112.36 147.47 36.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.185 0.517 . . . . 0.0 111.473 -165.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.521 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 6.2 t80 -144.31 143.97 31.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.67 1.188 . . . . 0.0 109.366 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.503 HG21 ' HG3' ' B' ' 114' ' ' ARG . 32.6 m -133.31 127.85 34.49 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.4 0.619 . . . . 0.0 110.276 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.72 174.1 6.03 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.992 0.917 . . . . 0.0 110.206 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.2 121.41 15.85 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.602 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 1.2 p30 -69.54 175.99 1.92 Allowed Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 123.67 0.788 . . . . 0.0 110.171 171.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 31.5 Cg_endo -60.48 -12.2 19.8 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.381 2.054 . . . . 0.0 113.901 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -97.57 0.47 47.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.2 0.6 . . . . 0.0 111.417 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 27.6 t 66.96 33.46 5.8 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.272 1.429 . . . . 0.0 112.245 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -75.18 173.36 10.91 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.503 ' HG3' HG21 ' B' ' 106' ' ' THR . 5.4 mpt_? -107.98 104.9 14.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.0 100.54 11.45 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 -97.91 95.47 7.52 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -166.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.521 ' HB ' ' HD2' ' B' ' 105' ' ' PHE . 36.0 t -86.29 119.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -139.22 160.86 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.56 112.58 18.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.45 138.4 55.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.087 0.555 . . . . 0.0 109.96 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.64 97.89 0.84 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.881 0.472 . . . . 0.0 109.999 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.063 -178.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 111.282 0.104 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.513 HG21 ' HB3' ' B' ' 70' ' ' PHE . 53.1 m -140.41 147.32 39.53 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.101 0.56 . . . . 0.0 111.495 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -102.37 114.93 65.19 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.275 1.03 . . . . 0.0 109.835 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.547 ' HG3' HD22 ' B' ' 25' ' ' LEU . 87.7 Cg_endo -85.76 86.17 1.03 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.696 2.264 . . . . 0.0 111.493 168.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.631 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 14.3 t70 -102.58 11.44 37.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.142 0.972 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -133.01 131.56 40.84 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -169.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.21 144.18 51.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.853 0.861 . . . . 0.0 109.167 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.455 HD12 ' NH1' ' B' ' 116' ' ' ARG . 1.8 mt -126.77 138.93 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.635 0.774 . . . . 0.0 109.51 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 68' ' ' LEU . 96.1 mt -95.24 137.44 34.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -77.05 98.88 5.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.076 177.445 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.492 HG11 HD23 ' A' ' 49' ' ' LEU . 20.1 m -109.74 169.78 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.23 -60.5 1.87 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.088 0.555 . . . . 0.0 110.003 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -102.32 98.39 10.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.941 0.896 . . . . 0.0 110.4 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.4 Cg_exo -49.12 -49.9 14.18 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.683 2.922 . . . . 0.0 115.984 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.77 -58.96 0.39 Allowed 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.217 1.828 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.86 89.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -59.51 -52.31 66.11 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 122.215 1.007 . . . . 0.0 109.507 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 59.1 m -80.49 -33.68 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -163.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 83.6 mm-40 -65.39 -37.46 87.06 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.888 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.97 -44.29 97.54 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -71.46 -28.27 63.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.214 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.6 mtpt -56.49 -51.05 69.96 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.315 0.507 . . . . 0.0 111.875 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.41 -38.09 56.15 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.311 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 115' ' ' LEU . 11.6 tp -59.79 -36.63 77.13 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.175 0.99 . . . . 0.0 112.34 -175.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD22 ' HG3' ' B' ' 4' ' ' PRO . 46.4 mt -96.9 -40.96 8.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.113 0.965 . . . . 0.0 109.357 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.83 30.85 8.11 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.605 0.566 . . . . 0.0 112.071 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.7 m -129.75 -178.39 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.427 1.091 . . . . 0.0 109.902 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.7 154.32 72.99 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.253 0.621 . . . . 0.0 109.753 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 11.4 Cg_exo -70.57 117.39 5.11 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.941 2.427 . . . . 0.0 111.954 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 39' ' ' PHE . 5.8 p -65.42 -40.52 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 47.3 mm-40 -113.41 128.76 56.56 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.755 0.822 . . . . 0.0 109.482 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -127.73 131.9 49.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.862 0.865 . . . . 0.0 109.267 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 t -137.22 147.72 59.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.25 -15.32 34.03 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.921 2.414 . . . . 0.0 114.226 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.49 7.74 5.84 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -157.97 153.37 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.612 0.365 . . . . 0.0 110.122 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 24.4 m -138.06 148.23 44.85 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.191 0.596 . . . . 0.0 109.612 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -146.16 129.2 16.51 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' HA ' HG12 ' A' ' 30' ' ' VAL . 2.6 p90 -134.49 148.18 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.176 0.99 . . . . 0.0 108.981 163.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' A' ' 46' ' ' LYS . 17.5 t -119.4 127.95 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.458 HD12 ' SD ' ' A' ' 45' ' ' MET . 37.7 mt -89.87 142.4 27.73 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -169.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.3 -14.3 62.89 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.069 0.948 . . . . 0.0 112.219 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.78 -9.87 58.94 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 110.912 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.2 32.91 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.483 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.66 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -97.01 172.29 7.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.009 0.904 . . . . 0.0 110.095 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG22 ' A' ' 40' ' ' VAL . 86.5 tttt -135.03 141.82 46.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.05 0.54 . . . . 0.0 109.679 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.88 123.41 15.0 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.829 0.452 . . . . 0.0 110.452 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -107.77 167.86 13.68 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.537 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.492 HD23 HG11 ' A' ' 11' ' ' VAL . 6.3 mp -134.04 107.96 8.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 166.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.554 ' HE3' ' NH2' ' B' ' 116' ' ' ARG . 6.0 t90 -105.19 130.52 53.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.405 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 37.4 m -80.01 121.57 25.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.041 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -65.73 -14.09 60.61 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.986 1.314 . . . . 0.0 113.492 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -76.24 -8.2 56.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.573 0.349 . . . . 0.0 111.101 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.426 HG23 ' HE1' ' A' ' 50' ' ' TRP . 12.1 t -136.9 6.39 2.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.117 0.567 . . . . 0.0 111.344 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.8 147.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.716 0.406 . . . . 0.0 110.885 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -128.25 111.25 19.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.754 0.822 . . . . 0.0 108.875 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.7 140.49 66.8 Favored 'Cis proline' 0 C--N 1.389 2.666 0 C-N-CA 124.76 -0.933 . . . . 0.0 113.736 4.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -50.56 116.53 1.96 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.757 1.223 . . . . 0.0 113.04 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.52 107.1 3.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.799 1.24 . . . . 0.0 108.194 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -97.85 87.29 3.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.89 142.4 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 108.828 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.443 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 8.1 p -151.53 132.41 14.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.197 1.399 . . . . 0.0 108.267 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.19 -65.2 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 N-CA-C 112.054 -0.419 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.49 64.26 0.1 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.04 131.7 8.07 Favored Glycine 0 N--CA 1.464 0.566 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 73.43 129.43 0.14 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 15.9 mt-10 -120.97 147.95 44.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.05 0.54 . . . . 0.0 109.599 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.466 HD22 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -120.47 106.37 11.75 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.0 122.85 34.9 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.482 0.658 . . . . 0.0 111.338 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HB3' HG21 ' B' ' 2' ' ' THR . 16.3 m-85 -102.56 108.35 19.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 107.529 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 29.2 mtm180 -91.29 123.49 34.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 112.201 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 118' ' ' TYR . 34.8 m -126.19 158.9 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.747 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.8 pt-20 -69.36 -34.17 74.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.066 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.492 HD22 ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -161.72 177.45 9.92 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 118.697 0.68 . . . . 0.0 112.55 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.06 -33.21 70.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.732 1.613 . . . . 0.0 112.84 -167.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.95 77.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.74 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.574 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 21.8 mm-40 -66.18 -24.42 66.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.791 0.836 . . . . 0.0 112.032 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.19 -43.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.541 0.686 . . . . 0.0 109.647 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.39 -33.66 74.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.241 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -65.58 -45.26 83.93 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.293 0.568 . . . . 0.0 109.941 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.6 m -68.87 -28.46 66.73 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.013 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.9 -61.26 2.74 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.6 0.714 . . . . 0.0 109.948 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.78 -34.23 77.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.494 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.23 -46.75 93.3 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 124.206 0.941 . . . . 0.0 113.36 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -63.71 -45.88 87.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.211 0.604 . . . . 0.0 110.197 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -57.01 -42.61 80.63 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.798 0.686 . . . . 0.0 110.836 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.09 -27.62 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.06 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -90.88 8.93 32.51 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.306 1.042 . . . . 0.0 112.643 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 46.47 4.61 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.147 169.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 p -101.6 148.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.1 79.07 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.931 0.492 . . . . 0.0 111.418 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.5 tpp 64.19 82.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.74 0.816 . . . . 0.0 112.891 166.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -134.11 84.92 2.15 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.086 0.47 . . . . 0.0 111.523 176.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 178.36 138.31 0.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.577 1.151 . . . . 0.0 109.565 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.85 119.97 68.83 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -54.12 111.41 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.938 2.425 . . . . 0.0 110.627 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.96 147.16 49.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.19 0.596 . . . . 0.0 111.231 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.02 104.8 4.23 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.608 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.418 ' SD ' ' CZ2' ' B' ' 50' ' ' TRP . 51.0 ttm -102.25 171.15 7.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.451 0.7 . . . . 0.0 109.939 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 99' ' ' MET . 19.1 mm-40 -49.63 -34.06 17.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.345 1.458 . . . . 0.0 113.092 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -101.68 -5.71 24.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.785 0.834 . . . . 0.0 111.469 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.16 -178.81 20.54 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 51.3 t80 -80.5 102.58 9.8 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.7 t -122.52 157.71 31.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.592 0.711 . . . . 0.0 111.466 -166.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.56 153.24 33.01 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.292 1.437 . . . . 0.0 108.249 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.481 HG21 ' HG3' ' A' ' 114' ' ' ARG . 23.5 m -146.81 127.68 14.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.149 0.431 . . . . 0.0 110.673 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.09 170.97 7.63 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.127 0.571 . . . . 0.0 110.724 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.4 117.42 23.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.773 0.429 . . . . 0.0 109.965 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.25 168.86 17.89 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.902 1.281 . . . . 0.0 110.856 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.31 -35.72 54.65 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.195 2.597 . . . . 0.0 114.499 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -87.48 1.18 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.307 0.643 . . . . 0.0 111.467 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 63.24 57.82 1.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.807 1.243 . . . . 0.0 112.36 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -93.19 -145.93 0.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 172.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG3' HG21 ' A' ' 106' ' ' THR . 0.1 OUTLIER -145.5 90.63 2.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.482 HD13 HD21 ' A' ' 24' ' ' LEU . 69.1 mt -96.07 104.82 16.78 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -171.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.743 HH12 HG23 ' B' ' 55' ' ' VAL . 1.8 mtp180 -101.98 146.52 27.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.374 0.27 . . . . 0.0 110.913 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 70' ' ' PHE . 15.3 t -127.69 127.57 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 166.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 72' ' ' VAL . 19.1 p90 -130.46 155.5 46.34 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.16 0.436 . . . . 0.0 111.275 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -109.37 121.15 44.54 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.97 108.62 10.16 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.34 0.4 . . . . 0.0 110.488 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.79 95.04 1.46 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.236 0.614 . . . . 0.0 109.64 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.19 -177.614 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.477 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.472 HG21 ' HB3' ' A' ' 70' ' ' PHE . 61.6 m -63.24 148.34 48.46 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 124.118 0.967 . . . . 0.0 111.592 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -100.96 114.49 65.82 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.009 0.923 . . . . 0.0 110.319 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.553 ' HG3' HD22 ' A' ' 25' ' ' LEU . 86.5 Cg_endo -86.06 86.18 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.49 2.127 . . . . 0.0 111.522 168.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.66 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 9.0 p-10 -102.9 10.78 38.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.538 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.454 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -132.17 131.84 42.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -169.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -128.06 143.71 51.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.009 0.924 . . . . 0.0 108.968 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 35.8 mt -125.28 139.36 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.526 HD23 HD21 ' B' ' 47' ' ' LEU . 4.0 mm? -95.32 137.38 34.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.431 ' HE2' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -76.03 97.62 4.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.212 1.405 . . . . 0.0 109.593 177.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.423 HG11 HD23 ' B' ' 49' ' ' LEU . 22.7 m -109.48 170.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.21 -60.26 1.91 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.984 0.514 . . . . 0.0 110.335 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -102.23 97.72 9.09 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.147 0.979 . . . . 0.0 110.49 -169.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.45 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.1 Cg_exo -48.88 -51.65 10.12 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.79 2.993 . . . . 0.0 115.675 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.21 -60.16 0.42 Allowed 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.099 1.786 . . . . 0.0 111.536 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.61 88.97 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.945 0.498 . . . . 0.0 112.163 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' B' ' 20' ' ' PHE . 34.1 m -59.1 -52.07 67.31 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.352 1.072 . . . . 0.0 109.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 70.7 m -80.46 -33.75 36.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -163.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.52 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 82.8 mm-40 -65.33 -38.39 90.01 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.715 172.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' B' ' 90' ' ' VAL . 41.9 t80 -59.82 -45.82 91.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.33 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 36.1 m-85 -69.89 -29.42 66.62 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.805 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 52.3 mtpt -56.11 -51.21 68.72 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.182 0.515 . . . . 0.0 111.672 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.75 -38.42 54.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.439 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 8.5 tp -58.94 -36.64 75.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.424 1.09 . . . . 0.0 112.476 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 4' ' ' PRO . 53.5 mt -96.93 -41.18 8.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.347 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.14 30.41 8.29 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.2 m -129.63 -177.98 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.411 1.084 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -139.05 155.04 72.94 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 123.338 0.655 . . . . 0.0 109.622 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 3.0 Cg_exo -71.84 117.05 4.95 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.867 2.378 . . . . 0.0 111.458 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -65.36 -39.87 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 51.6 mm-40 -114.08 128.26 56.3 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.506 0.722 . . . . 0.0 109.436 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 48.2 t -127.03 132.37 50.75 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.064 0.945 . . . . 0.0 109.245 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.0 t -137.52 148.01 59.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.805 1.242 . . . . 0.0 107.745 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.44 -15.14 39.05 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.693 2.262 . . . . 0.0 113.952 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.45 7.96 5.89 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -157.83 153.68 26.8 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 122.078 -0.389 . . . . 0.0 110.2 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 18.1 m -138.28 147.91 44.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.22 0.608 . . . . 0.0 109.541 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.3 tm? -145.98 129.66 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 3.7 p90 -134.84 148.64 50.2 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 108.721 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -120.52 127.8 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.401 HD22 HG11 ' B' ' 27' ' ' VAL . 36.8 mt -89.02 142.32 27.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.243 0.617 . . . . 0.0 109.405 -168.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.21 62.8 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.58 -10.21 59.41 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.761 0.825 . . . . 0.0 110.61 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.27 -4.35 33.34 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.215 -0.77 . . . . 0.0 114.175 170.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.631 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -96.25 172.61 7.85 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.047 0.923 . . . . 0.0 110.297 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -135.78 141.93 44.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.796 0.438 . . . . 0.0 109.951 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.526 HD21 HD23 ' B' ' 9' ' ' LEU . 3.6 tt -141.73 123.03 14.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.01 0.433 . . . . 0.0 110.589 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.437 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -106.7 167.23 13.88 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 123.927 0.775 . . . . 0.0 111.372 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 9.2 mp -134.0 108.32 8.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 166.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.493 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -105.83 130.62 53.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.45 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 42.3 m -81.06 121.27 25.86 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.597 0.561 . . . . 0.0 110.933 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -64.97 -14.83 61.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.105 1.362 . . . . 0.0 113.809 -170.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -75.94 -7.49 54.71 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.819 0.448 . . . . 0.0 111.721 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.9 t -137.14 7.17 2.88 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.378 0.671 . . . . 0.0 111.198 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.743 HG23 HH12 ' A' ' 116' ' ' ARG . 9.8 p -62.82 148.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 122.265 0.226 . . . . 0.0 110.48 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.45 ' H ' HH22 ' A' ' 116' ' ' ARG . 17.9 mt-10 -127.73 110.99 20.57 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.585 0.754 . . . . 0.0 109.357 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.478 ' HG3' HD23 ' A' ' 93' ' ' LEU . 85.8 Cg_endo -75.39 139.77 63.16 Favored 'Cis proline' 0 C--N 1.388 2.612 0 CA-C-N 119.85 0.982 . . . . 0.0 113.805 4.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -49.58 116.32 1.71 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.735 1.214 . . . . 0.0 113.179 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.29 107.2 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.691 1.196 . . . . 0.0 108.471 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -97.81 87.48 4.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.22 141.99 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.427 1.091 . . . . 0.0 108.98 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 11.1 p -151.22 133.11 15.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.709 1.203 . . . . 0.0 108.186 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.73 -66.08 0.05 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.0 62.89 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.16 130.57 7.83 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 119.442 -0.644 . . . . 0.0 111.674 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 74.06 130.02 0.18 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 27.0 mt-10 -121.93 147.2 46.33 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -120.46 106.45 11.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.718 ' HA ' ' HG2' ' B' ' 116' ' ' ARG . . . -91.3 122.25 33.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.513 ' HB3' HG21 ' A' ' 2' ' ' THR . 12.5 m-85 -101.95 108.31 19.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.588 1.555 . . . . 0.0 107.523 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 56.9 mtm180 -91.97 122.75 34.78 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.419 0.628 . . . . 0.0 111.968 -174.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.42 HG22 ' O ' ' B' ' 118' ' ' TYR . 22.7 m -125.11 159.27 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.708 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' B' ' 74' ' ' ASN . 9.5 pt-20 -69.39 -34.66 74.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.423 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.463 HD22 ' HG3' ' B' ' 73' ' ' GLU . 6.0 p30 -161.18 176.67 11.02 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.714 0.688 . . . . 0.0 112.412 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -59.11 -32.34 69.74 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.704 1.602 . . . . 0.0 113.063 -168.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.97 -39.34 76.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.641 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -65.75 -24.37 66.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.589 0.756 . . . . 0.0 112.45 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.615 HG13 HG13 ' B' ' 117' ' ' VAL . 97.2 t -68.34 -42.96 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.503 0.721 . . . . 0.0 109.829 172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.15 -33.05 71.3 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.788 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 29.5 mt-10 -65.77 -45.9 80.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.419 0.628 . . . . 0.0 109.987 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 92.7 m -67.3 -29.81 69.5 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.996 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -59.89 -61.21 2.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.67 0.788 . . . . 0.0 110.093 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.91 76.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.42 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.33 90.18 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.122 0.888 . . . . 0.0 113.088 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' TRP . . . . . 0.478 ' HB3' HG21 ' B' ' 90' ' ' VAL . 44.9 m0 -62.55 -46.86 86.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.347 0.659 . . . . 0.0 110.038 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.89 -42.81 76.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.367 0.667 . . . . 0.0 111.065 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.73 -27.7 63.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.873 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -91.04 9.26 31.55 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 112.233 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.98 46.88 4.64 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.09 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.485 HG11 ' HB1' ' B' ' 107' ' ' ALA . 48.7 t -101.97 147.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.06 77.48 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.048 0.539 . . . . 0.0 111.449 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.34 82.53 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.705 0.802 . . . . 0.0 112.799 166.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 85.17 2.18 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 178.07 138.17 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.401 1.081 . . . . 0.0 109.301 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -90.21 119.88 69.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.18 111.51 0.73 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.719 2.279 . . . . 0.0 110.699 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.83 146.77 49.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.338 0.655 . . . . 0.0 111.279 -170.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 104.87 4.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.838 0.855 . . . . 0.0 109.812 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 51.9 ttm -101.93 170.14 8.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.07 0.948 . . . . 0.0 109.66 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -48.74 -34.47 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.257 1.423 . . . . 0.0 113.216 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -101.96 -5.4 24.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.773 0.829 . . . . 0.0 111.67 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.6 -178.6 20.93 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.311 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 52.1 t80 -80.99 102.59 10.26 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -122.61 158.05 30.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.664 0.745 . . . . 0.0 111.505 -167.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -153.2 152.73 31.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.365 1.466 . . . . 0.0 108.075 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.635 HG21 ' HG3' ' B' ' 114' ' ' ARG . 29.0 m -145.82 127.74 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.685 0.394 . . . . 0.0 110.21 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.485 ' HB1' HG11 ' B' ' 90' ' ' VAL . . . -107.56 171.22 7.51 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.06 0.544 . . . . 0.0 110.78 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.77 116.92 22.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.412 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.3 p30 -70.95 169.41 14.87 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.691 1.197 . . . . 0.0 111.242 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 10.9 Cg_endo -52.16 -35.63 63.52 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.431 2.754 . . . . 0.0 113.901 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.42 1.26 53.92 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.253 0.621 . . . . 0.0 111.461 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 62.69 57.99 1.69 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.63 1.172 . . . . 0.0 112.624 166.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -92.68 -146.23 0.22 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.635 ' HG3' HG21 ' B' ' 106' ' ' THR . 0.1 OUTLIER -144.72 89.63 2.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 85.8 mt -95.49 104.23 16.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -171.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.718 ' HG2' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -99.74 147.77 25.09 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.827 0.285 . . . . 0.0 111.696 -176.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.615 HG13 HG13 ' B' ' 78' ' ' VAL . 7.5 p -128.97 128.47 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 164.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.42 ' O ' HG22 ' B' ' 72' ' ' VAL . 14.3 p90 -130.13 155.56 45.99 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 122.199 -0.313 . . . . 0.0 111.062 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -109.62 120.92 43.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -76.27 107.0 8.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.364 0.415 . . . . 0.0 110.05 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.31 104.0 10.56 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.854 -0.97 . . . . 0.0 110.919 -177.454 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.684 -0.117 . . . . 0.0 110.684 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.431 ' N ' ' SD ' ' A' ' 1' ' ' MET . 16.4 m -82.1 148.28 28.64 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -108.69 127.72 26.88 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.798 0.839 . . . . 0.0 110.614 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD3' HD22 ' B' ' 25' ' ' LEU . 69.4 Cg_endo -87.73 87.49 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.697 2.264 . . . . 0.0 111.364 170.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.809 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.7 p-10 -83.61 1.53 41.82 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.419 0.628 . . . . 0.0 110.815 172.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.06 120.5 31.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -172.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -111.96 137.66 49.66 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 46.3 mt -113.19 128.1 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 47' ' ' LEU . 4.2 mm? -93.93 145.13 24.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.636 ' HE1' HG21 ' A' ' 55' ' ' VAL . 38.4 t80 -102.57 105.14 15.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.192 -170.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.79 157.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.534 0.734 . . . . 0.0 109.199 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.408 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 12.6 p-10 -104.76 -43.01 5.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.528 0.731 . . . . 0.0 110.84 -177.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -94.53 105.62 19.28 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.256 0.623 . . . . 0.0 109.909 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.27 -59.46 0.89 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 C-N-CA 122.153 1.902 . . . . 0.0 113.461 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 40.6 Cg_endo -64.38 -56.5 0.43 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 122.433 1.905 . . . . 0.0 111.494 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.22 83.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.735 0.814 . . . . 0.0 112.206 -168.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -72.53 -39.69 67.35 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -65.69 -39.49 91.34 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.53 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 77.8 mm-40 -67.6 -34.53 77.19 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.372 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -64.69 -46.13 83.68 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.524 0.515 . . . . 0.0 109.911 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -65.62 -32.07 73.44 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.07 -51.07 69.16 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.284 0.564 . . . . 0.0 112.322 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.12 -39.91 65.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.152 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 tp -58.2 -47.02 84.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.145 1.378 . . . . 0.0 113.183 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.5 mt -86.44 -43.73 12.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.06 26.05 8.07 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 -174.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.1 m -127.73 167.4 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.06 0.944 . . . . 0.0 110.243 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.01 151.28 46.36 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.783 0.833 . . . . 0.0 109.34 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 14.8 Cg_exo -67.88 117.05 4.62 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.545 2.163 . . . . 0.0 111.814 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG11 HG23 ' A' ' 40' ' ' VAL . 7.5 p -63.22 -38.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.751 . . . . 0.0 109.962 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 30.5 mm-40 -123.47 129.86 51.86 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.01 1.324 . . . . 0.0 107.775 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.6 p -136.26 135.36 38.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.308 0.575 . . . . 0.0 109.896 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.3 m -141.65 153.58 65.23 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.922 1.289 . . . . 0.0 108.512 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -56.92 -22.48 46.33 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.066 2.511 . . . . 0.0 113.726 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 t -128.12 10.49 6.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -158.83 137.46 10.98 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -123.71 153.96 40.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.389 0.676 . . . . 0.0 109.727 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.654 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 21.3 tp -147.43 125.66 12.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -132.79 142.25 48.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 108.367 168.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -119.38 131.48 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.0 mt -94.41 149.85 20.84 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -10.45 29.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.19 0.996 . . . . 0.0 112.029 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -65.12 -20.44 66.46 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.852 1.261 . . . . 0.0 112.237 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 -7.27 47.18 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.828 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -90.35 173.12 8.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.56 0.744 . . . . 0.0 110.38 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.8 tttt -141.8 139.53 32.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 9' ' ' LEU . 2.2 tt -138.09 120.13 15.54 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.494 0.318 . . . . 0.0 110.6 -169.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.19 165.73 17.26 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.625 0.631 . . . . 0.0 111.693 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.89 111.92 10.86 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -104.74 125.17 50.55 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.7 m -77.71 128.78 34.61 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.641 0.588 . . . . 0.0 109.874 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 13.6 ptm180 -66.88 -10.66 50.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -82.56 -12.64 57.59 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 118.047 0.385 . . . . 0.0 111.137 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 0.6 8.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.122 0.569 . . . . 0.0 111.123 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' HE1' ' A' ' 10' ' ' TYR . 10.7 p -61.13 140.13 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.189 0.519 . . . . 0.0 112.279 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.73 116.38 26.41 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.522 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 6.8 Cg_exo -72.38 144.04 79.24 Favored 'Cis proline' 0 C--N 1.383 2.384 0 C-N-CA 124.683 -0.966 . . . . 0.0 112.794 -3.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' HA ' HG13 ' A' ' 55' ' ' VAL . 13.7 mmmm -50.2 130.16 22.32 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.764 0.825 . . . . 0.0 111.833 173.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.99 136.33 23.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.751 0.821 . . . . 0.0 109.958 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 p -108.5 88.35 2.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.521 0.729 . . . . 0.0 109.485 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -161.37 144.04 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.773 0.829 . . . . 0.0 110.22 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 p -141.47 138.62 32.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.381 1.072 . . . . 0.0 108.356 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.71 20.07 79.65 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 22.23 30.42 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.79 -162.07 23.79 Favored Glycine 0 N--CA 1.473 1.154 0 CA-C-N 117.083 0.442 . . . . 0.0 112.308 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.58 95.9 0.05 OUTLIER Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HB3' ' HG3' ' A' ' 116' ' ' ARG . 1.9 mp0 -103.7 158.53 16.32 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 112.049 -170.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 68' ' ' LEU . 25.8 mt -118.89 102.4 8.76 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.498 173.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.95 106.31 17.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HB2' HG22 ' A' ' 117' ' ' VAL . 7.8 m-85 -83.95 112.21 19.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -90.18 127.43 36.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.421 0.629 . . . . 0.0 112.243 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.65 158.29 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.23 -38.05 89.65 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -160.43 177.37 10.64 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.512 0.596 . . . . 0.0 112.155 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.25 -28.62 69.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.944 1.298 . . . . 0.0 112.771 -165.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.78 -46.95 76.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.978 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -64.86 -22.43 66.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 0.0 112.651 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.26 -42.41 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.313 0.645 . . . . 0.0 109.668 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.03 -27.59 54.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.681 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 40.6 mt-10 -69.26 -43.85 73.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.668 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -65.74 -36.14 82.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.28 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' O ' ' HE1' ' A' ' 92' ' ' MET . 35.6 t80 -59.33 -57.18 14.15 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.794 0.807 . . . . 0.0 109.356 176.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.87 83.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.209 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.69 90.76 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.64 0.587 . . . . 0.0 114.361 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -67.44 -41.85 84.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.062 0.545 . . . . 0.0 110.155 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -58.8 -40.14 83.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.983 0.913 . . . . 0.0 110.297 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.77 66.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.461 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m -104.96 15.14 28.26 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.889 0.876 . . . . 0.0 113.205 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.45 30.32 19.36 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 163.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.09 127.45 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.251 0.62 . . . . 0.0 109.543 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 92' ' ' MET . . . -57.14 -51.0 71.07 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.684 0.794 . . . . 0.0 111.393 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.476 ' HE1' ' O ' ' A' ' 82' ' ' PHE . 6.7 ptm 52.15 80.95 0.09 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.291 1.436 . . . . 0.0 113.381 169.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.78 82.45 2.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -174.86 138.18 0.46 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.346 1.058 . . . . 0.0 109.066 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -80.49 122.4 82.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.54 112.35 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.575 2.183 . . . . 0.0 110.209 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.39 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.454 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HG2' ' HD1' ' A' ' 103' ' ' TYR . 19.3 mmtm -71.06 118.02 13.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.397 1.079 . . . . 0.0 111.506 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.5 tpp -110.09 176.62 4.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.507 1.523 . . . . 0.0 108.996 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -48.21 -41.01 26.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.75 1.22 . . . . 0.0 113.133 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -106.88 19.83 19.91 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.566 0.746 . . . . 0.0 111.603 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -167.83 12.42 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.986 0.354 . . . . 0.0 113.986 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.41 ' HD1' ' HG2' ' A' ' 98' ' ' LYS . 13.0 t80 -78.53 110.01 13.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.437 0.695 . . . . 0.0 109.707 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -138.77 168.69 19.25 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -168.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.42 169.35 24.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.028 0.931 . . . . 0.0 109.311 169.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.613 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 13.6 m -137.47 124.92 22.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.65 158.33 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.378 1.071 . . . . 0.0 110.78 -174.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.02 111.08 17.03 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.4 167.87 28.76 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.605 0.762 . . . . 0.0 110.258 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -43.02 -38.82 7.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.693 2.929 . . . . 0.0 115.652 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -89.14 2.02 54.77 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.833 0.453 . . . . 0.0 111.771 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.2 m 63.43 81.48 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.675 1.19 . . . . 0.0 111.354 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -131.53 165.37 23.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -97.0 106.46 18.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.08 102.71 11.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.232 0.613 . . . . 0.0 109.683 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.726 ' HD2' HD12 ' B' ' 8' ' ' ILE . 72.1 mtt-85 -89.66 148.55 23.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.693 0.397 . . . . 0.0 110.383 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 70' ' ' PHE . 40.5 t -137.38 127.96 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 166.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -130.75 167.58 18.61 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.27 0.941 . . . . 0.0 112.885 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.7 115.8 12.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.586 1.154 . . . . 0.0 108.08 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -79.77 117.39 20.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.56 99.17 2.46 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.638 0.775 . . . . 0.0 109.417 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.12 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.582 0.229 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -79.29 148.86 31.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.774 0.83 . . . . 0.0 109.529 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -108.39 126.89 28.56 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.009 0.924 . . . . 0.0 110.028 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.35 87.57 0.66 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.53 2.153 . . . . 0.0 111.467 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.828 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 10.4 p-10 -83.43 1.67 40.4 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.014 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.42 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 0.9 OUTLIER -125.35 119.34 28.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -171.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -111.25 137.69 48.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.726 HD12 ' HD2' ' A' ' 116' ' ' ARG . 22.1 mt -113.84 127.66 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.14 145.26 24.54 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -102.63 105.84 16.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.622 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.13 157.35 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.696 0.798 . . . . 0.0 109.114 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -105.33 -42.8 5.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.511 0.724 . . . . 0.0 111.028 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.91 106.51 22.32 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.102 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 38.6 Cg_exo -55.03 -59.09 0.89 Allowed 'Trans proline' 0 CA--C 1.572 2.406 0 C-N-CA 122.049 1.833 . . . . 0.0 113.429 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 22.6 Cg_exo -64.78 -56.93 0.34 Allowed 'Trans proline' 0 C--N 1.4 3.259 0 CA-C-N 122.465 1.916 . . . . 0.0 111.316 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -44.8 81.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.598 0.759 . . . . 0.0 112.551 -168.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -70.79 -40.87 72.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 77.7 m -65.61 -39.36 91.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.542 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 79.7 mm-40 -67.85 -34.17 76.18 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.516 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.98 -45.96 83.46 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.206 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -65.77 -31.86 73.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.542 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.7 mtpt -56.03 -50.91 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.312 0.577 . . . . 0.0 112.266 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.24 -39.91 65.1 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.303 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -58.33 -46.83 85.46 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.174 1.39 . . . . 0.0 113.055 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.514 ' HB2' HG22 ' B' ' 27' ' ' VAL . 13.7 mt -87.1 -42.98 12.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.36 25.86 8.56 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.993 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 25' ' ' LEU . 33.4 m -127.26 167.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.934 0.894 . . . . 0.0 110.303 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.15 150.75 45.74 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.794 0.837 . . . . 0.0 109.483 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 42.2 Cg_endo -67.14 117.18 4.61 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.355 2.036 . . . . 0.0 112.218 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.515 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.1 p -63.68 -38.46 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.392 0.677 . . . . 0.0 109.97 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 34.6 mm-40 -122.69 129.94 52.38 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.925 1.29 . . . . 0.0 107.522 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -136.23 136.04 39.56 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.03 0.532 . . . . 0.0 110.066 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 55.6 m -142.49 151.64 58.16 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.921 1.288 . . . . 0.0 108.578 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.91 -23.62 28.38 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.19 2.593 . . . . 0.0 114.733 -176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -128.12 10.82 6.42 Favored 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -158.56 137.91 11.65 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -124.32 153.47 41.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.326 0.65 . . . . 0.0 110.035 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 35.8 tp -146.75 126.22 13.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 0.9 OUTLIER -132.93 142.31 48.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.569 1.148 . . . . 0.0 108.421 168.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.606 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.3 t -119.49 130.93 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.76 149.61 21.09 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -10.43 25.7 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.461 1.104 . . . . 0.0 112.071 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -65.36 -20.42 66.38 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.719 1.208 . . . . 0.0 112.244 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.31 -7.14 46.91 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -90.29 173.23 8.25 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.468 0.707 . . . . 0.0 110.491 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.606 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -141.7 139.62 32.98 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.34 120.15 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.42 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.02 165.53 17.4 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 123.78 0.705 . . . . 0.0 111.549 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.6 mt -134.25 111.66 10.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.549 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.0 t90 -104.71 125.36 50.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -77.86 128.76 34.47 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 123.581 0.551 . . . . 0.0 110.044 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -67.35 -10.65 53.09 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -81.93 -13.46 57.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.042 0.383 . . . . 0.0 111.388 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -124.13 1.77 8.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.182 0.593 . . . . 0.0 111.271 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' B' ' 58' ' ' LYS . 14.1 p -62.29 138.83 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.032 0.444 . . . . 0.0 111.757 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -122.1 116.83 29.77 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -73.6 145.21 83.4 Favored 'Cis proline' 0 C--N 1.384 2.442 0 C-N-CA 124.564 -1.015 . . . . 0.0 111.966 -2.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.555 ' HA ' HG13 ' B' ' 55' ' ' VAL . 12.4 mmmm -51.24 130.73 27.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.668 0.787 . . . . 0.0 111.628 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.17 23.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.925 0.89 . . . . 0.0 109.642 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.2 p -108.59 88.53 2.75 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.634 0.774 . . . . 0.0 109.175 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -161.86 143.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.785 0.834 . . . . 0.0 110.193 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -141.43 138.85 33.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.62 1.168 . . . . 0.0 108.425 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.79 79.76 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.13 21.74 32.84 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 114.419 0.528 . . . . 0.0 114.419 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.63 -160.27 23.72 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 117.053 0.427 . . . . 0.0 112.683 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.99 96.54 0.03 OUTLIER Glycine 0 C--N 1.351 1.41 0 C-N-CA 122.995 0.331 . . . . 0.0 112.557 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.3 mt-10 -103.36 159.84 15.21 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.114 0.483 . . . . 0.0 112.155 -170.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.56 102.24 8.5 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.444 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -86.21 107.3 17.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.011 0.434 . . . . 0.0 110.056 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.524 ' HB2' HG22 ' B' ' 117' ' ' VAL . 7.8 m-85 -85.97 111.93 20.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.417 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 32.3 mtm180 -90.18 126.33 35.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.29 0.567 . . . . 0.0 112.014 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 23.4 m -127.23 158.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.337 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.9 pt-20 -64.32 -37.74 88.58 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -160.76 178.2 9.69 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.777 0.717 . . . . 0.0 112.078 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.43 -28.93 69.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.162 1.385 . . . . 0.0 112.475 -164.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.75 -46.54 78.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.487 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 69.6 mm-40 -65.57 -22.45 66.69 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.264 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -66.35 -42.58 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.397 0.679 . . . . 0.0 109.626 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.87 -27.96 55.22 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.451 1.1 . . . . 0.0 110.401 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 43.5 mt-10 -68.41 -44.69 74.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.076 0.55 . . . . 0.0 109.867 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -65.27 -35.96 82.62 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.413 175.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -59.23 -56.96 15.41 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.75 0.786 . . . . 0.0 109.4 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.14 83.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.33 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.75 90.75 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.44 0.463 . . . . 0.0 113.97 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -67.15 -42.49 84.29 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.061 0.545 . . . . 0.0 109.992 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -58.01 -40.77 81.61 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.944 . . . . 0.0 110.14 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.2 67.24 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.411 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -104.35 15.11 28.92 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.05 0.94 . . . . 0.0 113.421 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.58 19.31 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 163.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.6 127.32 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.253 0.621 . . . . 0.0 109.386 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.7 -53.07 61.94 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.652 0.781 . . . . 0.0 111.268 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 22.9 ttp 54.19 81.04 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.793 1.237 . . . . 0.0 112.868 169.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 83.38 2.18 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -176.43 134.74 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.226 1.01 . . . . 0.0 108.366 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -79.16 123.7 84.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 112.26 2.07 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.527 2.151 . . . . 0.0 109.709 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.16 163.36 33.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.341 0.591 . . . . 0.0 111.59 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -71.22 118.59 14.21 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.299 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 37.0 ttm -112.02 179.42 4.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.561 1.145 . . . . 0.0 108.966 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.19 -41.61 49.8 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.697 1.199 . . . . 0.0 112.019 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -106.54 20.0 19.66 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.559 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.11 -167.68 12.38 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -78.7 110.19 13.62 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.533 0.733 . . . . 0.0 109.777 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' B' ' 116' ' ' ARG . 13.7 t -139.95 169.44 17.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -168.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -157.63 169.14 25.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.107 0.963 . . . . 0.0 109.232 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 20.6 m -136.62 125.19 23.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.57 158.21 16.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.42 1.088 . . . . 0.0 110.882 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.1 111.36 17.34 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.69 167.36 34.09 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.907 0.883 . . . . 0.0 110.402 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -42.16 -39.19 5.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 124.039 3.159 . . . . 0.0 115.346 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -89.38 2.36 54.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m 62.98 80.82 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.681 1.192 . . . . 0.0 111.589 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -130.49 165.66 22.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -95.66 106.13 18.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -108.41 102.62 11.71 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.45 ' HD2' ' OG1' ' B' ' 104' ' ' THR . 0.8 OUTLIER -87.11 147.98 25.42 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.356 0.663 . . . . 0.0 109.922 -178.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' B' ' 70' ' ' PHE . 42.3 t -137.44 128.36 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 164.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -130.71 167.05 19.45 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.368 0.986 . . . . 0.0 113.102 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.1 116.13 13.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.19 122.56 26.99 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.91 99.78 1.83 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 0.0 109.86 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.17 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.111 -175.394 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.676 0.274 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.5 m -85.36 134.71 34.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.455 ' HB3' HD21 ' B' ' 43' ' ' ASN . 23.0 m80 -93.38 116.29 66.27 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.849 0.859 . . . . 0.0 110.934 -174.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -97.36 96.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.869 2.379 . . . . 0.0 112.48 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.693 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.1 p-10 -93.72 13.6 21.76 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.295 0.569 . . . . 0.0 110.534 169.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.98 115.69 19.62 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.87 146.56 34.89 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.269 1.027 . . . . 0.0 108.691 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.5 HD12 ' HD2' ' B' ' 116' ' ' ARG . 55.9 mt -122.5 137.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.039 0.935 . . . . 0.0 109.037 176.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 68' ' ' LEU . 4.3 mm? -91.42 123.23 34.69 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 168.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.583 ' HE1' HG21 ' A' ' 55' ' ' VAL . 57.6 t80 -78.96 106.83 11.27 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.687 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.416 HG11 HD22 ' A' ' 49' ' ' LEU . 15.6 m -120.71 175.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.248 1.019 . . . . 0.0 109.908 -171.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.55 -61.46 1.49 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.59 0.756 . . . . 0.0 109.811 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.52 110.61 35.58 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 123.787 0.835 . . . . 0.0 110.093 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -58.8 -64.36 0.11 Allowed 'Trans proline' 0 CA--C 1.568 2.178 0 C-N-CA 122.323 2.015 . . . . 0.0 113.614 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.08 -38.75 35.14 Favored 'Trans proline' 0 C--N 1.402 3.343 0 CA-C-N 122.533 1.94 . . . . 0.0 111.204 -170.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.47 93.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.312 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -70.85 -35.34 72.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.3 m -58.41 -53.24 60.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.574 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 24.5 mm-40 -68.56 -37.07 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.258 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.1 t80 -59.46 -44.06 93.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.772 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.511 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 5.4 m-85 -72.99 -28.45 62.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.468 0.707 . . . . 0.0 110.73 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.3 -50.79 70.41 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.936 0.789 . . . . 0.0 112.037 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.23 -34.38 49.3 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.142 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.9 tp -61.42 -53.58 54.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.661 1.184 . . . . 0.0 111.988 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HB2' HG22 ' A' ' 27' ' ' VAL . 11.1 mt -76.62 -51.82 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.68 5.82 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.257 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 25' ' ' LEU . 21.0 m -131.35 176.21 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.359 1.063 . . . . 0.0 110.075 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.27 156.11 46.04 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.77 112.53 3.56 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 121.534 1.489 . . . . 0.0 110.554 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -37.45 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.892 0.477 . . . . 0.0 110.157 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 11.9 mm-40 -111.82 134.47 53.36 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 p -143.35 132.36 22.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 110.709 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -143.42 155.81 60.74 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.285 1.434 . . . . 0.0 108.263 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.3 -10.2 20.37 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.865 2.377 . . . . 0.0 114.123 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 t -126.56 -0.75 6.83 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -157.67 142.43 16.56 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -131.51 146.54 52.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.25 0.62 . . . . 0.0 110.106 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.0 tm? -133.68 120.27 20.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -108.11 140.52 41.18 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.686 1.595 . . . . 0.0 107.051 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 46' ' ' LYS . 26.4 t -124.21 126.8 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD13 ' SD ' ' A' ' 45' ' ' MET . 8.6 mp -99.79 148.72 24.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.169 0.587 . . . . 0.0 109.731 -172.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.96 -5.92 29.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.039 0.936 . . . . 0.0 111.928 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -21.67 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.121 0.968 . . . . 0.0 112.168 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.64 17.56 16.73 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -124.06 175.09 7.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.817 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 40' ' ' VAL . 78.3 tttt -145.91 140.62 27.1 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 68' ' ' LEU . 2.7 tt -138.32 120.66 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.203 0.601 . . . . 0.0 110.287 -169.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.85 166.55 15.76 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.667 0.651 . . . . 0.0 112.055 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 9' ' ' LEU . 95.3 mt -134.87 104.92 6.18 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.524 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.6 t90 -109.62 119.3 38.97 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 p -81.01 140.92 34.88 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.343 0.402 . . . . 0.0 111.159 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 29.3 ptt180 -69.68 -18.65 63.57 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -78.99 -8.58 59.05 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -127.84 7.68 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.874 0.47 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.583 HG21 ' HE1' ' A' ' 10' ' ' TYR . 9.9 p -75.8 150.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.61 0.243 . . . . 0.0 110.91 -175.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -126.37 115.58 23.33 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.77 0.828 . . . . 0.0 108.861 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 89.1 Cg_endo -77.01 141.01 68.02 Favored 'Cis proline' 0 C--N 1.386 2.511 0 C-N-CA 124.584 -1.007 . . . . 0.0 112.389 5.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 123.84 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.729 0.811 . . . . 0.0 110.29 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.38 170.74 17.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.541 1.137 . . . . 0.0 108.545 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.514 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 32.5 t -147.19 90.65 1.9 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.413 0.285 . . . . 0.0 110.237 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.08 144.15 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 109.685 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -146.62 124.14 11.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.45 -69.25 0.17 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.27 149.26 20.9 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.34 -22.64 0.2 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.681 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . -164.01 116.12 0.69 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.87 144.65 30.25 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -108.93 101.62 10.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -169.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -90.23 111.71 22.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.732 0.696 . . . . 0.0 111.52 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -91.18 111.97 23.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.117 1.367 . . . . 0.0 107.399 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.542 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 36.8 mtm180 -89.98 129.4 36.31 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.503 0.668 . . . . 0.0 112.336 -174.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.69 159.09 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.016 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.6 pt-20 -66.69 -34.91 78.91 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.43 HD22 ' HG3' ' A' ' 73' ' ' GLU . 8.3 p30 -163.27 178.29 8.3 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 118.757 0.708 . . . . 0.0 112.345 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.56 -31.27 67.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.408 1.483 . . . . 0.0 112.771 -168.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.97 -46.55 77.67 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.232 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.516 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 71.7 mm-40 -63.69 -22.71 67.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.181 0.993 . . . . 0.0 112.98 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.75 -42.04 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.212 0.605 . . . . 0.0 109.802 171.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -75.81 -29.06 58.56 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.164 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 36.5 mt-10 -71.81 -44.7 63.49 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.276 0.56 . . . . 0.0 109.641 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -65.38 -33.4 75.87 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.437 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -56.33 -59.4 5.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.701 0.8 . . . . 0.0 109.621 174.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.71 -38.26 89.73 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.714 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 -41.83 97.11 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.653 0.596 . . . . 0.0 113.632 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -64.41 -42.55 96.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.324 0.649 . . . . 0.0 110.305 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 31.8 ttpt -59.15 -42.97 91.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.017 0.927 . . . . 0.0 110.539 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.38 65.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.318 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.9 t -98.36 14.27 28.61 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.427 1.091 . . . . 0.0 112.944 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.09 29.06 35.13 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 165.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.7 t -86.47 130.61 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -62.85 -42.11 99.62 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.954 0.902 . . . . 0.0 112.325 -172.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 7.5 ptm 49.54 81.48 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.889 1.676 . . . . 0.0 114.301 166.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.01 83.04 1.76 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.476 0.655 . . . . 0.0 110.084 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 23.8 tm0? 178.07 120.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.434 1.493 . . . . 0.0 107.113 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.4 117.02 62.69 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.53 110.73 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 123.887 3.058 . . . . 0.0 113.329 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.58 146.04 44.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.226 1.01 . . . . 0.0 110.371 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 98.64 4.09 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 tpp -78.26 163.98 25.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.836 0.854 . . . . 0.0 109.49 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.23 -28.26 69.03 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.107 0.563 . . . . 0.0 111.795 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -99.67 15.41 26.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.972 0.909 . . . . 0.0 111.466 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.03 180.0 16.76 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.539 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -73.77 103.0 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -109.84 158.11 18.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.396 0.617 . . . . 0.0 111.401 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.407 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 3.3 t80 -143.93 142.09 30.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.21 1.404 . . . . 0.0 108.795 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.426 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 31.1 m -132.69 121.93 23.85 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.522 1.056 . . . . 0.0 110.76 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.69 150.48 26.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.103 0.961 . . . . 0.0 112.228 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -117.95 172.53 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.3 p-10 -144.34 -176.94 0.59 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 5.2 Cg_exo -38.14 -51.67 1.97 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.621 2.881 . . . . 0.0 114.016 168.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.08 -15.0 59.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.006 0.522 . . . . 0.0 111.684 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.02 52.24 0.2 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.65 1.18 . . . . 0.0 111.156 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -80.3 175.11 10.94 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.255 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -122.84 105.64 10.2 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -118.18 103.69 10.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.143 0.977 . . . . 0.0 109.206 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.543 HH11 HD11 ' B' ' 8' ' ' ILE . 77.9 ttt180 -88.17 146.14 25.55 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 123.266 0.626 . . . . 0.0 110.188 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.9 t -131.94 119.22 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 163.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.542 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 4.3 p90 -125.71 164.91 19.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.563 0.62 . . . . 0.0 111.223 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.83 111.65 13.31 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -75.04 117.2 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.438 0.563 . . . . 0.0 109.75 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.84 100.56 2.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.11 0.481 . . . . 0.0 109.708 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.272 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.669 0.271 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 17.9 m -126.67 136.28 52.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -93.04 115.98 65.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.959 0.904 . . . . 0.0 110.666 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.514 ' HB2' HD22 ' A' ' 68' ' ' LEU . 46.5 Cg_endo -97.55 96.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.985 2.456 . . . . 0.0 112.432 170.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.691 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.8 p-10 -93.55 13.82 20.74 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.351 0.596 . . . . 0.0 110.692 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.15 115.59 19.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.74 146.71 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.283 1.033 . . . . 0.0 108.775 171.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.543 HD11 HH11 ' A' ' 116' ' ' ARG . 50.5 mt -122.57 137.47 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.002 0.921 . . . . 0.0 108.903 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.462 ' HG ' ' OH ' ' B' ' 21' ' ' TYR . 4.5 mm? -90.95 122.8 33.93 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.528 ' HE1' HG21 ' B' ' 55' ' ' VAL . 59.6 t80 -78.23 107.33 10.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.913 173.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.1 175.72 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.247 1.019 . . . . 0.0 109.788 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -105.9 -61.15 1.54 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.49 0.716 . . . . 0.0 110.233 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -87.15 110.82 36.4 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.896 0.878 . . . . 0.0 109.969 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.49 -65.67 0.08 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 122.369 2.046 . . . . 0.0 113.155 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.39 -38.94 49.79 Favored 'Trans proline' 0 C--N 1.403 3.441 0 CA-C-N 122.471 1.918 . . . . 0.0 111.81 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.17 -41.71 94.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -70.25 -35.39 73.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 33.3 m -58.12 -53.91 52.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.83 -37.37 81.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.126 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 73.7 t80 -59.71 -44.05 93.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.94 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 6.2 m-85 -72.98 -28.06 62.17 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.817 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' B' ' 18' ' ' THR . 58.4 mtpt -56.68 -50.64 71.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.95 0.795 . . . . 0.0 111.92 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.04 -34.6 50.4 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.971 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 21.8 tp -61.55 -53.41 56.64 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.558 1.143 . . . . 0.0 112.186 -174.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' B' ' 27' ' ' VAL . 12.3 mt -76.73 -51.13 12.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.64 25.06 6.13 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.232 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' B' ' 25' ' ' LEU . 28.5 m -130.8 176.19 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.302 1.041 . . . . 0.0 110.073 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -115.37 155.93 46.42 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.633 0.773 . . . . 0.0 109.13 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.69 112.65 3.58 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.604 1.536 . . . . 0.0 110.536 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.33 -37.46 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.838 0.455 . . . . 0.0 110.245 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.3 mm-40 -111.69 134.62 53.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 45.5 p -143.47 132.48 22.91 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 110.542 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -143.72 156.31 59.52 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.509 1.524 . . . . 0.0 108.133 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.06 -9.63 22.43 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.542 2.161 . . . . 0.0 113.57 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -126.7 -0.75 6.74 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -157.9 142.4 16.24 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 31.1 m -131.46 146.63 52.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.311 0.644 . . . . 0.0 110.056 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -134.12 119.91 19.47 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.77 140.75 40.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.652 1.581 . . . . 0.0 106.921 173.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.57 HG22 ' HG3' ' B' ' 46' ' ' LYS . 28.1 t -124.39 126.56 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.491 HD13 ' SD ' ' B' ' 45' ' ' MET . 9.6 mp -99.73 149.17 23.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.105 0.562 . . . . 0.0 109.887 -172.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.91 -6.3 31.97 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.957 0.903 . . . . 0.0 112.064 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.455 HD21 ' HB3' ' A' ' 3' ' ' HIS . 2.1 m-20 -68.23 -21.64 64.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.118 0.967 . . . . 0.0 112.025 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.31 17.77 16.8 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.126 -0.389 . . . . 0.0 112.126 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.693 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -123.78 174.8 7.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.692 0.797 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.57 ' HG3' HG22 ' B' ' 40' ' ' VAL . 79.4 tttt -145.47 140.48 27.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.91 121.17 16.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 -169.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.99 166.35 15.56 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.744 0.688 . . . . 0.0 112.001 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' B' ' 9' ' ' LEU . 93.3 mt -134.59 105.02 6.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 166.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -109.86 118.98 37.91 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 74.2 p -80.78 140.91 35.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.467 0.307 . . . . 0.0 110.947 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 36.2 ptt180 -70.06 -18.56 63.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -170.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -79.09 -8.58 59.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -127.78 7.22 6.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.853 0.461 . . . . 0.0 111.107 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.528 HG21 ' HE1' ' B' ' 10' ' ' TYR . 8.0 p -75.6 150.08 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.271 -0.268 . . . . 0.0 110.897 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.65 116.71 24.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.634 0.774 . . . . 0.0 109.521 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 87.1 Cg_endo -76.51 140.47 65.68 Favored 'Cis proline' 0 C--N 1.388 2.647 0 C-N-CA 124.593 -1.003 . . . . 0.0 112.407 4.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 123.29 14.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.676 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.74 170.96 17.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.716 1.206 . . . . 0.0 108.515 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 33.9 t -147.3 90.97 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.853 0.359 . . . . 0.0 110.42 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.52 143.4 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.717 0.807 . . . . 0.0 109.692 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.6 p -145.56 124.3 12.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.221 1.008 . . . . 0.0 108.716 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.67 -68.85 0.17 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.719 ' HA2' ' HD2' ' B' ' 114' ' ' ARG . . . -151.55 148.16 18.88 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.77 -23.39 0.2 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.681 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . -163.71 116.65 0.72 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -101.95 144.64 30.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 108.806 -171.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 tp -109.39 101.23 10.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.81 111.76 22.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.192 0.451 . . . . 0.0 111.462 -169.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.1 112.21 24.02 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.068 1.347 . . . . 0.0 107.446 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.439 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.8 mtm180 -90.16 127.84 36.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -174.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.5 160.1 40.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.283 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.463 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.4 pt-20 -67.54 -34.55 77.31 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -173.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.459 HD22 ' HG3' ' B' ' 73' ' ' GLU . 8.0 p30 -163.3 178.55 8.05 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.962 0.801 . . . . 0.0 112.562 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.85 -30.74 67.94 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.284 1.433 . . . . 0.0 112.567 -167.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.5 -46.5 76.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.076 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.463 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 60.9 mm-40 -63.6 -23.12 67.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.312 1.045 . . . . 0.0 112.465 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -42.25 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 121.325 0.583 . . . . 0.0 109.903 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.27 -29.1 60.06 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.296 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 28.8 mt-10 -71.97 -44.94 62.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.166 0.508 . . . . 0.0 109.853 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 57.4 m -64.79 -33.64 76.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.269 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -56.18 -59.86 4.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.719 0.807 . . . . 0.0 109.385 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.51 89.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.559 -173.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.75 96.71 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.652 0.595 . . . . 0.0 113.456 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -64.66 -42.05 95.67 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.261 0.625 . . . . 0.0 110.061 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -60.22 -42.41 95.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.511 0.724 . . . . 0.0 110.664 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.27 66.29 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.578 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 26.8 t -98.67 14.25 29.22 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.375 1.07 . . . . 0.0 112.545 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.25 29.25 34.12 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -86.56 130.51 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -62.68 -41.89 99.34 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.799 0.84 . . . . 0.0 112.597 -172.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 8.2 ptm 49.31 81.5 0.05 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.823 1.649 . . . . 0.0 114.316 166.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.417 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -113.36 83.03 1.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.611 -0.68 . . . . 0.0 110.37 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 24.6 tm0? 178.14 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -77.95 116.46 58.71 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.473 -0.775 . . . . 0.0 108.925 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.94 111.05 0.19 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.994 3.129 . . . . 0.0 113.216 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.12 145.98 45.51 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 110.534 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 98.61 3.84 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.455 ' HG3' ' H ' ' B' ' 101' ' ' PHE . 35.5 tpp -78.35 163.36 25.75 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.0 0.92 . . . . 0.0 109.495 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.48 -28.87 68.68 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.149 0.579 . . . . 0.0 111.777 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.455 ' H ' ' HG3' ' B' ' 99' ' ' MET . 71.3 m-85 -99.37 15.04 27.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.944 0.898 . . . . 0.0 111.38 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' B' ' 99' ' ' MET . . . 119.5 179.9 16.63 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.512 167.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -73.4 102.92 3.89 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -172.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 6.2 t -109.81 158.3 18.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.432 0.634 . . . . 0.0 111.511 -169.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.454 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 3.6 t80 -143.99 142.24 30.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.396 1.478 . . . . 0.0 108.579 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.44 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 m -133.06 121.89 23.34 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.372 0.987 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.16 150.29 27.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.113 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.91 171.33 8.14 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 165.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.431 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.0 p-10 -142.27 -176.81 0.59 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.631 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 22.0 Cg_exo -37.65 -52.11 1.66 Allowed 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.302 2.668 . . . . 0.0 114.403 166.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.96 -14.16 59.88 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.9 0.48 . . . . 0.0 111.719 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m 71.96 52.33 0.21 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.884 1.274 . . . . 0.0 111.044 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -79.86 176.18 9.96 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.116 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.719 ' HD2' ' HA2' ' B' ' 64' ' ' GLY . 0.0 OUTLIER -125.33 104.32 8.41 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 34.3 mt -118.12 103.8 10.22 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.222 1.009 . . . . 0.0 109.35 -170.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.5 ' HD2' HD12 ' A' ' 8' ' ' ILE . 58.8 mtt-85 -87.04 147.07 25.86 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 123.075 0.55 . . . . 0.0 110.911 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.56 118.89 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 163.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.439 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 9.6 p90 -125.7 164.89 19.65 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.482 0.583 . . . . 0.0 110.879 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.81 111.16 12.81 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.9 119.08 16.64 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 118.333 0.515 . . . . 0.0 110.51 -172.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.91 111.44 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.985 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.146 178.628 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.461 ' N ' ' SD ' ' A' ' 1' ' ' MET . 26.9 m -113.57 131.48 56.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -121.71 117.61 29.91 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.766 0.826 . . . . 0.0 109.206 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.97 129.1 11.21 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.925 2.417 . . . . 0.0 112.308 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.6 p-10 -113.19 10.87 18.66 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.571 0.701 . . . . 0.0 110.281 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.65 120.81 30.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -168.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -118.2 138.01 52.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.778 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 63.2 mt -123.98 126.59 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 84.9 mt -97.56 159.59 14.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -106.85 135.62 48.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.051 0.94 . . . . 0.0 109.428 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.4 m -127.94 179.38 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.288 0.949 . . . . 0.0 109.724 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -136.42 47.62 2.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 16' ' ' ALA . 51.6 t30 167.48 83.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.367 -168.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.4 -53.64 6.56 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 122.618 2.212 . . . . 0.0 114.606 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.59 -64.89 0.16 Allowed 'Trans proline' 0 C--N 1.403 3.424 0 CA-C-N 122.267 1.845 . . . . 0.0 113.509 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . . . -79.27 -37.37 38.01 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.993 -164.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -79.22 -24.43 43.1 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.863 0.102 . . . . 0.0 110.883 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -73.68 -42.71 60.92 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -64.37 -28.57 69.78 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.258 173.031 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.01 -48.07 72.39 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.536 0.523 . . . . 0.0 109.705 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.53 -29.8 68.46 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.431 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -57.86 -48.29 80.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 118.145 0.429 . . . . 0.0 111.999 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.97 63.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.783 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.25 -30.21 70.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.654 1.182 . . . . 0.0 112.654 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 27' ' ' VAL . 73.4 mt -106.12 -28.81 10.26 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.886 0.874 . . . . 0.0 110.248 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.89 21.97 47.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.229 0.331 . . . . 0.0 112.709 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.1 m -116.15 -178.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.042 0.937 . . . . 0.0 111.002 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -134.91 153.73 78.82 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.929 0.892 . . . . 0.0 109.236 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.71 134.11 23.34 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.629 2.22 . . . . 0.0 112.131 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.82 -41.88 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 31.7 mm-40 -121.89 143.61 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.23 1.012 . . . . 0.0 109.027 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -140.31 141.09 35.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.2 m -144.21 161.86 42.88 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.66 1.184 . . . . 0.0 108.767 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -53.11 -28.93 43.25 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 123.056 2.504 . . . . 0.0 113.624 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 t -127.69 -3.43 5.97 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -139.51 141.07 37.33 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.385 0.539 . . . . 0.0 110.447 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 t -125.03 137.88 54.22 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.554 1.142 . . . . 0.0 108.773 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.9 tp -127.52 114.38 17.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.504 ' HE1' ' HG ' ' A' ' 49' ' ' LEU . 2.7 p90 -129.68 108.35 10.13 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.98 1.312 . . . . 0.0 108.608 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 46' ' ' LYS . 20.5 t -89.85 134.54 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.436 HD12 ' SD ' ' A' ' 45' ' ' MET . 56.5 mt -95.4 140.33 30.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.615 0.366 . . . . 0.0 110.844 -173.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.2 27.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.524 1.13 . . . . 0.0 112.289 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -68.91 -15.68 63.55 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.588 1.155 . . . . 0.0 110.912 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.55 16.76 13.51 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 122.94 0.305 . . . . 0.0 113.172 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -126.38 176.04 7.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.404 0.682 . . . . 0.0 109.568 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG3' HG22 ' A' ' 40' ' ' VAL . 80.2 tttt -134.47 134.8 41.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.008 0.523 . . . . 0.0 109.887 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.555 HD11 HD21 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -131.05 143.18 50.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 -173.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.31 169.17 18.27 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.028 0.823 . . . . 0.0 111.984 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' HG ' ' HE1' ' A' ' 39' ' ' PHE . 80.8 mt -140.57 130.26 24.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.37 1.468 . . . . 0.0 107.768 164.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -127.92 128.37 45.0 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 49.6 m -80.42 125.17 29.6 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.977 0.511 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -65.62 -15.73 63.03 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.796 1.238 . . . . 0.0 114.283 -166.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -67.68 -24.01 65.37 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.187 0.595 . . . . 0.0 111.409 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -143.63 23.03 1.79 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.879 0.471 . . . . 0.0 110.617 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.47 150.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -126.63 115.61 22.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.875 -0.516 . . . . 0.0 110.008 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 11.9 Cg_exo -70.65 142.63 72.78 Favored 'Cis proline' 0 C--N 1.387 2.574 0 CA-C-N 119.313 0.79 . . . . 0.0 112.519 -1.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.49 109.86 1.77 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.412 0.625 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.07 41.29 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 110.144 -168.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -79.62 88.94 5.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.2 m -126.48 131.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -158.77 123.96 4.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.301 1.44 . . . . 0.0 108.312 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.1 -36.14 0.71 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 113' ' ' HIS . . . 154.22 -62.39 0.36 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 69.03 -116.75 7.46 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -172.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.91 40.65 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.762 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 7.8 pt-20 -103.87 162.6 12.98 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.886 0.85 . . . . 0.0 112.124 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 47' ' ' LEU . 64.6 tp -119.08 102.5 8.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.069 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.9 115.1 23.32 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.394 0.543 . . . . 0.0 112.072 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.82 107.67 19.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.565 1.546 . . . . 0.0 108.431 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.67 133.89 34.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.568 . . . . 0.0 112.497 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -138.38 161.57 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.623 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.1 pt-20 -65.51 -42.1 92.43 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -171.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -158.65 179.83 8.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 111.812 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -56.07 -34.97 66.46 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.684 -166.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.68 -46.49 82.17 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.156 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.585 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 72.0 mm-40 -63.83 -24.31 67.7 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.964 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.19 -43.85 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.729 0.776 . . . . 0.0 110.271 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.88 -28.34 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.108 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.6 mt-10 -69.38 -45.04 70.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.35 0.595 . . . . 0.0 109.504 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -63.11 -36.24 82.93 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.404 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -54.8 -56.46 19.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.865 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.94 84.29 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.93 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.0 94.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.67 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.533 ' HB3' HG11 ' A' ' 90' ' ' VAL . 33.5 m0 -63.86 -44.89 91.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.467 0.707 . . . . 0.0 110.044 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.405 ' HB2' ' SD ' ' A' ' 92' ' ' MET . 32.2 ttpt -58.66 -42.26 88.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 110.582 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.57 65.15 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.804 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.0 m -103.38 17.8 23.25 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.314 1.046 . . . . 0.0 111.946 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.06 7.99 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 163.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 92' ' ' MET . 4.1 p -96.84 142.35 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -41.46 83.99 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.154 0.582 . . . . 0.0 111.374 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.606 ' HB3' HG13 ' A' ' 90' ' ' VAL . 9.6 ptm 48.26 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.919 1.687 . . . . 0.0 113.992 168.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.51 85.83 2.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.644 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 179.52 130.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.898 1.279 . . . . 0.0 108.703 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -82.57 115.0 55.79 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 166.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.63 118.2 3.91 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.163 2.575 . . . . 0.0 112.064 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.14 147.23 52.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.602 0.761 . . . . 0.0 110.167 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -68.44 123.03 19.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.421 0.688 . . . . 0.0 110.778 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -121.91 170.73 9.51 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.078 1.351 . . . . 0.0 109.283 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.12 -42.85 60.96 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.511 1.124 . . . . 0.0 112.283 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -90.55 1.22 56.93 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.317 0.647 . . . . 0.0 111.988 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.45 -172.37 18.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.285 168.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 35.4 t80 -73.14 101.52 3.34 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -113.19 153.59 28.06 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.542 0.687 . . . . 0.0 111.369 -166.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.07 138.16 20.3 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.119 1.368 . . . . 0.0 108.528 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -129.64 125.4 36.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.588 0.631 . . . . 0.0 109.654 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.84 172.06 7.0 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.07 0.948 . . . . 0.0 110.839 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.27 124.25 25.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.609 0.763 . . . . 0.0 109.347 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 169.14 3.21 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 123.856 0.862 . . . . 0.0 111.572 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.73 -28.83 39.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.93 2.42 . . . . 0.0 113.069 168.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -93.56 13.97 20.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.205 1.002 . . . . 0.0 111.884 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m 54.96 81.19 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.57 1.548 . . . . 0.0 112.481 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.2 m170 -118.34 -173.26 2.43 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 12.1 mmm180 -121.76 112.64 18.64 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.46 101.86 8.06 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -96.6 96.25 8.52 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -171.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -84.33 114.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -128.23 161.4 29.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.227 0.467 . . . . 0.0 111.365 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -118.23 117.84 30.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.984 0.914 . . . . 0.0 109.063 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -79.25 120.36 23.63 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.9 96.92 0.15 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.153 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.911 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 18.3 m -67.6 131.43 45.61 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.216 1.007 . . . . 0.0 112.676 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -121.49 117.96 30.0 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 123.934 0.893 . . . . 0.0 109.477 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.66 129.49 10.92 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.746 2.298 . . . . 0.0 112.231 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.543 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.2 p-10 -112.75 9.86 19.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.588 0.755 . . . . 0.0 110.299 171.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.7 120.73 30.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 138.03 52.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.762 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 48.7 mt -124.05 125.9 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' B' ' 49' ' ' LEU . 11.2 mp -96.82 159.65 14.8 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.401 ' O ' ' NE2' ' B' ' 113' ' ' HIS . 15.4 p90 -107.05 135.14 49.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.169 0.988 . . . . 0.0 109.432 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 51' ' ' SER . 21.2 m -127.59 179.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.29 0.95 . . . . 0.0 109.702 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.17 47.12 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 108.861 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASN . . . . . 0.58 ' ND2' ' HB3' ' B' ' 16' ' ' ALA . 56.0 t30 167.67 83.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.451 -167.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.08 -53.31 6.97 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.519 2.146 . . . . 0.0 114.562 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.5 -65.38 0.14 Allowed 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.171 1.914 . . . . 0.0 113.41 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.58 ' HB3' ' ND2' ' B' ' 13' ' ' ASN . . . -79.09 -37.36 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.928 -164.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.9 t -78.96 -23.72 44.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.51 0.141 . . . . 0.0 110.807 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 92.3 m -74.77 -42.01 58.97 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -64.59 -28.89 69.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.98 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.438 ' HZ ' HG22 ' B' ' 90' ' ' VAL . 60.7 t80 -65.66 -48.16 73.06 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.116 0.566 . . . . 0.0 109.949 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -68.56 -29.77 68.4 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.66 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' B' ' 18' ' ' THR . 53.9 mtpt -57.63 -48.44 79.43 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.208 0.458 . . . . 0.0 112.03 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.4 -39.19 62.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.604 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.0 -29.93 69.99 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.929 1.292 . . . . 0.0 112.54 -174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' B' ' 27' ' ' VAL . 69.3 mt -106.4 -28.97 10.02 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.043 0.937 . . . . 0.0 110.212 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.2 21.54 48.71 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.336 0.398 . . . . 0.0 112.65 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.9 m -115.87 -178.59 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.125 0.97 . . . . 0.0 110.943 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -134.98 153.15 78.37 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 109.099 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.02 133.58 23.55 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.607 2.204 . . . . 0.0 112.377 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' B' ' 31' ' ' GLU . 5.6 p -68.87 -42.06 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.419 ' HG2' HG13 ' B' ' 30' ' ' VAL . 46.2 mm-40 -122.02 143.25 49.61 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 40.0 p -140.32 140.79 35.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.521 0.728 . . . . 0.0 109.214 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 73.3 m -144.3 162.13 41.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.775 1.23 . . . . 0.0 108.821 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -53.52 -28.56 45.77 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.128 2.552 . . . . 0.0 113.871 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -128.06 -3.35 5.74 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -139.53 141.72 37.27 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.759 0.709 . . . . 0.0 110.359 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -126.17 137.46 53.57 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.549 1.14 . . . . 0.0 108.903 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.57 114.97 18.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.526 ' HE1' ' HG ' ' B' ' 49' ' ' LEU . 2.6 p90 -129.86 108.61 10.28 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.928 1.291 . . . . 0.0 108.54 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.615 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.6 t -89.85 134.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.814 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.42 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.9 mt -95.43 140.64 30.0 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 -173.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.05 -6.32 27.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.534 1.134 . . . . 0.0 112.371 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -69.4 -15.48 63.31 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.066 0.946 . . . . 0.0 110.953 174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 16.79 13.31 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 122.937 0.304 . . . . 0.0 113.313 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -126.13 175.97 7.38 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.53 0.732 . . . . 0.0 109.735 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.615 ' HG3' HG22 ' B' ' 40' ' ' VAL . 83.0 tttt -134.19 134.84 42.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.016 0.526 . . . . 0.0 109.862 -174.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.54 HD11 HD21 ' B' ' 68' ' ' LEU . 0.4 OUTLIER -131.2 142.94 50.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.786 0.434 . . . . 0.0 110.926 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.97 169.02 17.94 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 124.146 0.879 . . . . 0.0 111.88 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.526 ' HG ' ' HE1' ' B' ' 39' ' ' PHE . 81.3 mt -140.74 130.27 24.02 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.369 1.467 . . . . 0.0 107.947 164.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -128.23 128.15 44.17 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.6 m -80.41 125.14 29.55 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.886 0.474 . . . . 0.0 110.894 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -65.17 -16.01 63.05 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.971 1.309 . . . . 0.0 114.248 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -67.56 -23.55 65.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.261 0.625 . . . . 0.0 111.505 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.8 t -144.09 22.14 1.73 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.847 0.459 . . . . 0.0 110.421 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.18 150.47 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.259 0.623 . . . . 0.0 109.45 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.78 117.36 22.46 Favored Pre-proline 0 N--CA 1.484 1.274 0 O-C-N 121.826 -0.546 . . . . 0.0 110.572 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.81 142.53 64.77 Favored 'Cis proline' 0 C--N 1.388 2.656 0 CA-C-N 119.362 0.808 . . . . 0.0 113.248 -4.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.04 110.57 1.85 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.238 0.615 . . . . 0.0 110.073 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.41 123.98 40.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.522 1.129 . . . . 0.0 110.094 -169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 52.9 m -79.04 88.91 4.78 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.5 131.21 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.56 124.18 4.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.254 1.422 . . . . 0.0 108.545 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -35.45 0.71 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' B' ' 113' ' ' HIS . . . 153.87 -62.72 0.37 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 69.25 -116.99 7.52 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -172.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 150.85 40.94 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 173.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.778 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 5.6 pt-20 -103.57 162.93 12.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.821 0.82 . . . . 0.0 112.219 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.54 HD21 HD11 ' B' ' 47' ' ' LEU . 59.4 tp -119.83 101.77 8.11 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.687 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.93 115.66 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.477 0.58 . . . . 0.0 112.025 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.32 107.09 18.97 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.544 1.538 . . . . 0.0 108.141 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.6 mtm180 -90.05 133.55 34.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.187 0.518 . . . . 0.0 112.134 -174.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -137.27 162.38 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.449 1.1 . . . . 0.0 110.6 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 16.1 pt-20 -65.41 -42.14 92.86 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.438 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -158.61 179.79 8.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.173 0.511 . . . . 0.0 112.367 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.44 -35.05 65.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.644 1.578 . . . . 0.0 112.741 -166.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.39 -46.01 81.79 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.048 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.599 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.7 mm-40 -64.24 -24.22 67.59 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.742 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.95 -43.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.761 0.791 . . . . 0.0 110.334 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -76.69 -28.26 55.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.843 -173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.8 mt-10 -68.89 -45.75 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 174.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -62.22 -35.97 80.54 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.732 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -56.18 -56.01 26.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.078 0.951 . . . . 0.0 109.745 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.8 84.26 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.687 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.97 -40.49 95.31 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.858 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.47 -44.78 93.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.637 0.775 . . . . 0.0 110.211 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.16 -41.2 92.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.42 0.688 . . . . 0.0 110.487 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.86 -26.96 64.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.791 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 43.6 m -103.82 17.88 23.15 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.269 1.028 . . . . 0.0 111.823 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.07 47.29 8.53 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 163.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.438 HG22 ' HZ ' ' B' ' 20' ' ' PHE . 57.6 t -95.45 141.16 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.88 87.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.231 0.612 . . . . 0.0 111.336 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 7.7 ptp 48.02 82.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.789 1.636 . . . . 0.0 114.289 168.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.446 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -107.15 84.78 2.03 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.735 177.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -178.31 131.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.978 1.311 . . . . 0.0 108.608 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' GLN . . . . . 0.415 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 51.1 mt-30 -82.7 114.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 6.2 Cg_endo -50.24 118.39 3.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.227 2.618 . . . . 0.0 112.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.57 148.56 52.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.593 0.757 . . . . 0.0 110.375 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.2 123.19 21.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.604 0.762 . . . . 0.0 109.986 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 45.7 ttm -121.94 170.84 9.4 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.934 1.293 . . . . 0.0 109.052 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.6 -43.3 56.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.714 1.206 . . . . 0.0 112.236 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.69 1.39 56.88 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.261 0.624 . . . . 0.0 112.184 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 127.69 -172.18 18.95 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.332 -0.395 . . . . 0.0 113.39 169.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.428 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 34.3 t80 -75.09 101.75 4.65 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -113.39 153.5 28.47 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.405 0.621 . . . . 0.0 111.404 -165.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 3.5 t80 -149.86 138.44 20.76 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.119 1.368 . . . . 0.0 108.488 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.537 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 m -129.7 125.81 36.81 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.1 172.1 6.99 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.07 0.948 . . . . 0.0 110.959 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.04 125.68 28.58 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.576 0.75 . . . . 0.0 109.224 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.16 170.87 3.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.932 0.893 . . . . 0.0 110.912 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.4 -28.1 52.17 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.815 2.343 . . . . 0.0 112.722 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.67 13.79 21.09 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.031 0.932 . . . . 0.0 111.76 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m 55.25 80.97 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.25 1.42 . . . . 0.0 112.506 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.455 ' HA ' ' HA2' ' B' ' 64' ' ' GLY . 16.4 m170 -118.25 -173.03 2.38 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.63 ' HB3' ' HB3' ' B' ' 67' ' ' GLU . 10.9 mmm180 -121.49 112.65 18.77 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.9 mt -120.28 101.72 8.0 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -94.41 95.13 8.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.51 115.17 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -128.14 161.61 28.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.372 0.533 . . . . 0.0 111.502 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.433 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -118.24 118.97 33.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 0.0 108.805 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -81.12 127.04 32.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.48 94.32 4.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.018 0.927 . . . . 0.0 108.527 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.789 -1.006 . . . . 0.0 111.342 -179.366 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.761 0.315 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -83.71 130.55 34.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.642 0.777 . . . . 0.0 109.623 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' HB3' HD21 ' B' ' 43' ' ' ASN . 15.4 m170 -96.45 112.78 61.07 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 -173.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.97 156.79 3.33 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.905 2.403 . . . . 0.0 112.815 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.705 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.2 p-10 -148.38 16.83 1.04 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.39 1.076 . . . . 0.0 109.662 167.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.09 136.67 49.58 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -144.95 140.59 28.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.547 HG12 ' HA3' ' A' ' 48' ' ' GLY . 19.4 mt -122.84 131.93 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.396 0.678 . . . . 0.0 109.664 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -103.06 145.21 30.24 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -98.28 127.51 44.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 m -127.82 160.96 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.34 0.656 . . . . 0.0 109.966 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.78 -60.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.103 0.961 . . . . 0.0 110.963 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -95.6 99.08 4.27 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 123.418 0.687 . . . . 0.0 109.728 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.05 -54.0 5.81 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 123.129 2.552 . . . . 0.0 115.639 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.79 -53.74 4.12 Favored 'Trans proline' 0 C--N 1.4 3.277 0 CA-C-N 122.363 1.88 . . . . 0.0 112.323 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.44 88.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.512 -168.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -79.88 -26.78 40.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.319 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -72.43 -38.67 68.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.071 0.462 . . . . 0.0 112.003 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.6 mm-40 -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.837 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.0 t80 -67.01 -42.32 85.15 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.631 0.582 . . . . 0.0 109.649 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -71.37 -29.81 65.4 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.008 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 53.3 mtpt -57.65 -49.78 75.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 111.875 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.58 -30.59 57.07 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.1 tp -62.44 -52.65 62.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.597 1.159 . . . . 0.0 111.785 -177.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.4 mt -82.48 -40.62 20.84 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.456 1.102 . . . . 0.0 108.99 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.48 25.5 10.02 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.184 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 25' ' ' LEU . 28.3 m -126.21 177.89 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.854 0.861 . . . . 0.0 110.63 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.07 154.92 76.62 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.504 1.122 . . . . 0.0 108.644 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.61 125.07 13.72 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 121.96 1.773 . . . . 0.0 111.966 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.7 p -71.58 -39.83 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.17 0.51 . . . . 0.0 109.645 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.6 mm-40 -115.55 113.31 23.45 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 p -114.74 147.87 39.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.423 0.689 . . . . 0.0 110.877 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.3 t -148.29 151.7 37.57 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.76 1.224 . . . . 0.0 108.228 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.54 -20.61 69.34 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.349 2.033 . . . . 0.0 112.94 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -128.73 13.69 6.41 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -157.35 158.14 35.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 35.6 t -145.99 141.96 28.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.583 0.753 . . . . 0.0 109.018 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.5 tm? -137.59 114.67 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HE1' HD22 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -127.22 112.95 15.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.463 1.105 . . . . 0.0 109.078 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 46' ' ' LYS . 14.8 t -93.47 128.02 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.443 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.1 mt -91.37 141.82 28.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 110.068 -168.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.98 -9.61 40.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.676 0.791 . . . . 0.0 112.082 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.619 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 4.6 m-20 -69.5 -1.21 8.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.14 0.976 . . . . 0.0 112.91 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.0 48.81 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 117.813 0.279 . . . . 0.0 112.706 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.738 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -129.07 172.54 11.29 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.659 0.784 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -128.33 135.98 50.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.582 0.753 . . . . 0.0 109.264 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -131.25 124.73 31.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.129 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.547 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -100.34 166.85 19.97 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 37' ' ' SER . 10.1 tp -143.52 105.31 4.34 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HB2' HG21 ' A' ' 8' ' ' ILE . 2.8 t90 -105.09 131.78 52.15 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -73.35 126.45 30.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -68.75 -13.0 62.11 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 112.558 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -81.77 -8.25 59.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.236 0.614 . . . . 0.0 111.311 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 t -136.58 10.82 3.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 111.177 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.4 146.91 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.04 107.99 10.5 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.633 0.773 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' B' ' 94' ' ' GLN . 93.7 Cg_endo -73.74 133.47 30.97 Favored 'Cis proline' 0 C--N 1.382 2.307 0 CA-C-N 120.541 1.229 . . . . 0.0 114.157 13.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -59.74 124.74 21.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.577 1.151 . . . . 0.0 110.8 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.97 108.1 3.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.856 0.863 . . . . 0.0 109.535 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.7 t -89.41 87.0 6.92 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.75 138.22 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 109.252 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 p -150.44 122.28 8.13 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.5 -92.06 0.14 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.83 64.14 3.96 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 123.011 0.338 . . . . 0.0 112.495 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' B' ' 65' ' ' GLY . . . -98.83 173.91 27.32 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.54 159.27 45.48 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.632 -0.538 . . . . 0.0 112.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 9.6 pt-20 -102.31 145.44 29.46 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.603 0.701 . . . . 0.0 111.145 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.77 102.76 11.52 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 108.009 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.787 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -89.25 114.91 26.32 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.01 0.433 . . . . 0.0 112.035 -168.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.78 120.31 33.89 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.015 1.326 . . . . 0.0 108.374 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.53 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 32.3 mtm180 -96.4 127.48 42.43 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.812 0.815 . . . . 0.0 112.302 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.16 157.62 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.916 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 8.2 pt-20 -68.21 -34.87 77.04 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.89 -179.43 6.28 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.978 0.808 . . . . 0.0 112.752 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.35 -31.72 69.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.483 1.513 . . . . 0.0 113.016 -166.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.89 -44.87 79.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.08 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 19.2 mm-40 -65.82 -24.31 66.87 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.65 -44.91 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.574 0.749 . . . . 0.0 109.973 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.62 -28.34 56.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.694 0.798 . . . . 0.0 111.509 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 31.7 mt-10 -62.03 -44.24 97.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.611 0.719 . . . . 0.0 109.534 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -69.61 -35.0 74.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.988 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -54.52 -59.9 4.07 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.555 1.142 . . . . 0.0 109.977 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -64.42 -35.37 80.69 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.589 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.87 -46.81 79.97 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.836 0.71 . . . . 0.0 113.994 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -65.68 -40.82 92.77 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.898 0.479 . . . . 0.0 109.76 175.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.9 ttpt -57.64 -45.09 85.91 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.61 0.764 . . . . 0.0 110.479 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.75 -24.28 61.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -98.11 14.56 27.15 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.937 0.895 . . . . 0.0 111.689 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.86 41.17 8.31 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 115.222 164.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.1 p -89.21 149.4 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.04 -54.44 11.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.961 0.504 . . . . 0.0 110.796 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.506 ' HB2' HG13 ' A' ' 90' ' ' VAL . 47.5 ttm 68.67 84.94 0.14 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.246 0.966 . . . . 0.0 113.027 169.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -117.85 84.38 2.16 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.553 0.692 . . . . 0.0 110.965 173.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 106' ' ' THR . 53.1 tp60 178.04 122.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.768 1.627 . . . . 0.0 107.736 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.02 121.8 86.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 0.0 109.72 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 46.3 Cg_endo -64.95 108.34 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.766 2.31 . . . . 0.0 110.084 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.15 48.71 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.207 0.603 . . . . 0.0 110.543 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -67.81 131.63 45.89 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.421 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.519 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 12.4 ttt -141.04 -178.07 5.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.016 0.926 . . . . 0.0 109.245 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 99' ' ' MET . 7.4 mp0 -58.8 -37.36 76.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.609 1.164 . . . . 0.0 111.899 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 33.9 m-85 -84.33 -8.4 59.02 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.84 0.856 . . . . 0.0 111.119 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 116.41 -157.12 15.22 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -79.35 103.48 9.3 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.916 0.858 . . . . 0.0 108.956 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.43 HG21 ' SD ' ' A' ' 99' ' ' MET . 13.1 t -109.48 152.76 24.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.38 0.61 . . . . 0.0 110.84 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 6.5 t80 -143.19 145.22 32.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.921 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 5.4 m -135.73 132.65 37.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.485 0.584 . . . . 0.0 110.591 172.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.58 172.59 6.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.67 0.788 . . . . 0.0 110.341 170.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.64 116.06 12.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.504 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 7.2 p-10 -71.26 171.45 8.71 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 123.309 0.644 . . . . 0.0 110.277 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 9.6 Cg_endo -50.62 -40.09 55.63 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.873 2.382 . . . . 0.0 113.463 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.12 -1.04 54.23 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.637 0.775 . . . . 0.0 110.73 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m 64.6 75.24 0.38 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.784 1.234 . . . . 0.0 112.08 164.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.45 162.65 22.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 1.1 mpt_? -90.35 111.27 22.43 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.51 104.19 16.2 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.787 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 7.4 tpt180 -89.49 146.09 24.86 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.198 0.599 . . . . 0.0 110.144 -172.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.26 122.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 164.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 5.3 p90 -127.48 156.82 41.53 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.602 0.637 . . . . 0.0 110.928 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.48 112.57 17.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 171.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 49.7 t80 -77.74 116.39 18.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -171.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.5 94.38 9.69 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.579 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -178.707 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.901 0.382 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.1 m -79.94 130.97 35.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 109.874 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -98.23 112.3 61.74 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.776 0.83 . . . . 0.0 110.754 -171.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -91.83 155.4 3.4 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.983 2.456 . . . . 0.0 112.959 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.738 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 4.5 p-10 -146.58 17.28 1.3 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.301 1.04 . . . . 0.0 110.155 167.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.5 136.65 49.18 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.84 140.67 28.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.43 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 11.2 mt -122.9 132.43 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.341 0.656 . . . . 0.0 109.545 -176.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.96 145.37 30.51 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -99.29 127.35 45.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.465 1.106 . . . . 0.0 110.517 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.67 160.9 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.241 0.616 . . . . 0.0 109.95 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -95.54 -60.9 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.278 1.031 . . . . 0.0 110.883 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -95.93 99.05 4.48 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 123.564 0.746 . . . . 0.0 109.333 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.76 -54.86 4.39 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.107 2.538 . . . . 0.0 115.552 -169.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 -54.15 4.22 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 122.461 1.915 . . . . 0.0 112.123 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.83 89.06 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.465 -168.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 85.9 p -79.5 -27.82 41.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 39.9 m -71.32 -38.97 71.67 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.529 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 83.0 mm-40 -65.6 -33.93 77.05 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.729 172.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 53.2 t80 -66.79 -41.96 86.76 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -71.82 -29.69 64.69 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.258 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 10.3 mtpm? -57.87 -49.1 77.87 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.267 0.485 . . . . 0.0 112.177 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.68 57.15 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.656 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.505 HD11 HD13 ' B' ' 115' ' ' LEU . 13.4 tp -62.75 -52.78 61.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.447 1.099 . . . . 0.0 112.014 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.493 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.0 mt -82.21 -40.55 21.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.913 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.01 9.82 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.011 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.0 m -125.88 178.39 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.97 155.27 77.97 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.166 0.986 . . . . 0.0 108.526 171.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.34 124.59 13.13 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.125 1.884 . . . . 0.0 112.172 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.5 p -71.22 -40.4 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.08 0.552 . . . . 0.0 109.588 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 68.0 mm-40 -114.35 113.84 25.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 73.8 p -115.33 147.96 39.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.999 0.52 . . . . 0.0 110.83 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.2 t -148.48 151.27 35.97 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.532 1.133 . . . . 0.0 108.34 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.96 -20.68 68.38 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.424 2.082 . . . . 0.0 113.117 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -128.66 13.62 6.44 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -157.13 158.37 36.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.843 -0.536 . . . . 0.0 109.688 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . 34.7 t -146.07 141.83 27.97 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 109.086 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -137.52 114.6 10.79 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.04 113.08 15.97 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.527 1.131 . . . . 0.0 109.15 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' B' ' 46' ' ' LYS . 17.2 t -93.69 127.55 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.341 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.551 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.2 mt -91.26 141.36 28.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.062 0.545 . . . . 0.0 110.227 -169.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.36 -9.4 33.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.038 0.935 . . . . 0.0 112.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 4.2 m-20 -69.61 -1.93 10.21 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.159 0.983 . . . . 0.0 112.679 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.25 17.51 46.33 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.723 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.705 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -128.92 173.08 10.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.549 0.74 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.8 tttt -128.66 136.25 50.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.403 0.681 . . . . 0.0 109.482 -176.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.466 HD12 HD11 ' B' ' 41' ' ' LEU . 0.7 OUTLIER -131.06 124.68 31.38 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.27 166.36 20.93 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 37' ' ' SER . 9.5 tp -143.46 105.07 4.32 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -105.08 132.06 51.78 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 52.8 m -73.54 126.17 29.62 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -68.64 -13.12 62.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.581 0.752 . . . . 0.0 112.552 -172.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -81.41 -8.35 59.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.309 0.644 . . . . 0.0 111.331 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.3 t -136.59 10.87 3.18 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.255 0.622 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.82 146.99 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.97 108.85 10.64 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.584 0.754 . . . . 0.0 109.049 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.57 134.04 32.64 Favored 'Cis proline' 0 C--N 1.383 2.381 0 CA-C-N 120.339 1.157 . . . . 0.0 114.215 11.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -60.61 124.06 19.26 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.651 1.181 . . . . 0.0 111.22 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.32 108.02 3.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 109.508 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.4 p -89.2 86.07 6.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.32 140.43 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.166 0.986 . . . . 0.0 108.584 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -152.33 122.31 7.06 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.9 -91.84 0.14 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.22 63.81 4.29 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 123.041 0.353 . . . . 0.0 113.315 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' A' ' 65' ' ' GLY . . . -99.43 173.98 26.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.915 -0.381 . . . . 0.0 112.27 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.53 159.6 45.03 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 124.019 0.482 . . . . 0.0 112.097 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' B' ' 114' ' ' ARG . 9.2 pt-20 -101.99 145.35 29.4 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.458 0.647 . . . . 0.0 110.895 -176.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -110.06 102.92 11.59 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.29 114.83 26.25 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.183 0.516 . . . . 0.0 111.933 -168.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -93.36 120.51 33.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.041 1.336 . . . . 0.0 108.523 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.484 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 33.3 mtm105 -97.36 126.08 42.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.64 0.734 . . . . 0.0 112.188 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.98 157.82 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.348 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.451 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.1 pt-20 -67.04 -35.11 79.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -164.45 -179.05 5.76 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.91 -31.75 70.11 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.688 -166.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.521 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.28 -45.34 80.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.01 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.451 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 83.1 mm-40 -65.42 -24.1 67.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.261 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.68 -44.51 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.382 0.673 . . . . 0.0 109.858 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.21 -28.15 53.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.587 0.755 . . . . 0.0 111.364 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 40.4 mt-10 -62.54 -43.85 97.8 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.758 0.79 . . . . 0.0 109.325 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 54.3 m -69.89 -35.02 74.3 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.14 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -54.59 -59.68 4.37 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.47 1.108 . . . . 0.0 110.223 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.499 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -64.67 -34.87 79.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.539 -175.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.88 -47.29 76.3 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 123.729 0.643 . . . . 0.0 113.804 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.54 -41.09 93.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 34.3 ttpt -57.27 -45.0 84.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.591 0.756 . . . . 0.0 110.482 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.62 61.62 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.072 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -97.5 14.82 25.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.041 0.937 . . . . 0.0 111.931 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.67 41.43 8.29 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.3 p -89.6 149.4 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.25 -54.69 10.03 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.795 0.438 . . . . 0.0 110.691 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.514 ' HB2' HG13 ' B' ' 90' ' ' VAL . 49.1 ttm 68.76 84.99 0.14 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.944 0.777 . . . . 0.0 112.922 168.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.94 84.29 2.14 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 121.571 0.701 . . . . 0.0 110.821 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.412 ' HG3' ' HD3' ' A' ' 57' ' ' PRO . 24.1 tm0? 178.27 122.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.468 1.507 . . . . 0.0 107.14 173.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.41 120.63 82.55 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.366 0.667 . . . . 0.0 109.939 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 37.0 Cg_endo -63.38 108.41 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.795 2.33 . . . . 0.0 110.514 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.49 156.62 47.93 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.011 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -68.31 131.89 46.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.283 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.491 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 8.8 ttt -141.19 -178.42 5.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.96 0.904 . . . . 0.0 108.897 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' B' ' 99' ' ' MET . 7.3 mp0 -58.55 -37.61 76.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.429 1.092 . . . . 0.0 112.187 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -83.61 -8.69 59.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.778 0.831 . . . . 0.0 111.16 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 116.76 -156.65 15.5 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -79.61 103.49 9.55 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.044 0.922 . . . . 0.0 108.92 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.459 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.8 t -109.75 152.47 25.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.958 0.503 . . . . 0.0 110.582 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 7.3 t80 -142.98 144.72 32.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.8 1.24 . . . . 0.0 109.971 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -135.17 132.16 37.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.417 0.553 . . . . 0.0 110.705 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.56 172.63 6.71 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.718 0.807 . . . . 0.0 110.35 170.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.87 115.39 11.92 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.514 ' HB3' HD11 ' B' ' 115' ' ' LEU . 4.3 p-10 -69.8 170.83 8.54 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.58 0.752 . . . . 0.0 110.728 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 9.6 Cg_endo -50.66 -40.18 55.91 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.789 2.326 . . . . 0.0 113.199 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.76 -0.87 52.75 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.482 0.713 . . . . 0.0 111.053 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.0 m 64.17 74.75 0.4 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.741 1.217 . . . . 0.0 112.043 165.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -122.62 162.61 21.58 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 166.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 2.6 mpt_? -90.01 112.08 23.39 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.514 HD11 ' HB3' ' B' ' 109' ' ' ASP . 33.0 mt -98.97 104.37 16.4 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.735 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 30.4 mmt180 -87.55 146.24 25.87 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 123.804 0.841 . . . . 0.0 110.834 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 t -139.56 122.01 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 163.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.484 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.0 p90 -127.13 156.56 41.56 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.866 0.757 . . . . 0.0 111.132 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -123.57 112.52 17.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.38 118.76 20.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.4 94.35 6.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.347 -179.388 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HB2' ' OE1' ' B' ' 77' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.422 ' HA ' HG12 ' B' ' 72' ' ' VAL . 85.3 m -141.32 146.98 37.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.788 0.835 . . . . 0.0 111.395 -165.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.476 ' HB3' ' ND2' ' B' ' 43' ' ' ASN . 17.9 m-70 -136.78 103.05 9.23 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 124.376 1.071 . . . . 0.0 108.491 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HG3' HD22 ' B' ' 25' ' ' LEU . 51.2 Cg_endo -90.83 48.65 0.75 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.361 2.708 . . . . 0.0 112.672 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.574 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 5.9 p-10 -75.47 14.81 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.173 0.989 . . . . 0.0 112.609 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.2 t80 -133.37 129.93 38.1 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.134 1.374 . . . . 0.0 108.137 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 8.2 t -127.33 140.86 51.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.237 1.015 . . . . 0.0 108.576 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 61.4 mt -118.8 137.24 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 HD21 ' A' ' 47' ' ' LEU . 4.3 mm? -96.72 146.28 25.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HE1' HG21 ' A' ' 55' ' ' VAL . 22.8 t80 -101.32 95.72 6.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.341 -167.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.471 HG12 ' HE1' ' A' ' 113' ' ' HIS . 27.0 m -108.87 -179.85 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.33 -53.87 1.7 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.876 0.47 . . . . 0.0 110.258 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.74 105.55 9.19 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 123.567 0.747 . . . . 0.0 110.764 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.68 -55.48 3.5 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 C-N-CA 122.735 2.29 . . . . 0.0 114.081 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.44 -58.9 0.5 Allowed 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 122.271 1.847 . . . . 0.0 112.312 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.71 95.51 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.337 -166.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.9 p -76.68 -34.83 58.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.287 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -69.11 -39.12 79.14 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.545 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 12.4 mm100 -64.3 -35.47 80.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.411 172.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 77.7 t80 -68.28 -39.46 82.14 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.27 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -70.41 -30.55 67.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.208 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.4 mtpt -57.13 -47.76 80.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.946 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.28 -34.53 55.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.223 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.0 tp -61.13 -31.46 71.16 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.861 1.265 . . . . 0.0 112.646 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' B' ' 4' ' ' PRO . 87.3 mt -105.46 -40.08 5.92 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.364 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.34 29.65 10.0 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 25' ' ' LEU . 16.9 m -126.51 -179.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.218 1.007 . . . . 0.0 109.616 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.83 150.8 68.93 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.546 0.738 . . . . 0.0 109.078 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.97 111.9 2.78 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.812 2.342 . . . . 0.0 112.099 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -64.02 -42.28 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.759 0.824 . . . . 0.0 110.598 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 28.5 mm-40 -111.49 145.49 38.94 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -154.55 152.23 29.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.326 0.584 . . . . 0.0 109.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 15.2 m -139.86 163.95 41.2 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.44 1.496 . . . . 0.0 107.655 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.19 -30.51 80.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.331 2.021 . . . . 0.0 113.069 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -130.04 23.11 5.29 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.552 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 88.7 t80 -153.63 159.28 42.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.091 0.556 . . . . 0.0 109.72 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.4 m -149.36 154.56 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 110.077 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -148.36 123.14 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.96 131.54 47.49 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.961 1.304 . . . . 0.0 108.46 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG22 ' HG3' ' A' ' 46' ' ' LYS . 33.8 t -109.6 126.29 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.74 0.816 . . . . 0.0 109.175 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.31 145.17 26.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.219 0.608 . . . . 0.0 109.652 -170.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.66 -5.56 12.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.974 0.91 . . . . 0.0 112.585 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 10.5 m120 -67.06 -9.12 35.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.445 1.098 . . . . 0.0 112.743 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.69 59.68 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.46 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -119.98 164.22 16.42 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.125 0.97 . . . . 0.0 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' A' ' 40' ' ' VAL . 73.6 tttt -132.02 138.83 48.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.498 HD21 HD23 ' A' ' 9' ' ' LEU . 1.2 tt -137.24 122.6 19.45 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -102.96 170.11 19.58 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.95 0.786 . . . . 0.0 111.653 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.73 109.59 5.77 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 1.9 t-105 -109.26 127.75 54.52 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -79.59 122.86 27.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.006 0.522 . . . . 0.0 110.118 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.35 -15.87 63.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.399 1.08 . . . . 0.0 112.686 -169.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -72.03 -8.88 57.11 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 122.842 0.457 . . . . 0.0 111.233 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -135.1 6.36 3.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.334 0.653 . . . . 0.0 111.244 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG21 ' HE1' ' A' ' 10' ' ' TYR . 8.3 p -62.75 148.63 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.539 0.335 . . . . 0.0 111.34 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -122.98 113.9 29.76 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.356 0.663 . . . . 0.0 109.783 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.41 144.92 80.67 Favored 'Cis proline' 0 C--N 1.379 2.174 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.084 1.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -52.86 128.29 26.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.66 1.184 . . . . 0.0 112.218 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' OH ' ' A' ' 10' ' ' TYR . . . -150.87 121.14 7.28 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.236 0.614 . . . . 0.0 110.98 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -91.29 86.94 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.34 124.64 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -152.33 123.69 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.114 1.366 . . . . 0.0 107.98 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.63 67.43 0.02 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -82.09 1.69 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.0 -142.92 45.68 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.377 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.552 ' H ' ' H ' ' B' ' 66' ' ' GLY . . . -65.96 151.76 51.93 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.2 mt-10 -102.14 152.89 20.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.164 0.507 . . . . 0.0 110.585 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.4 tp -118.84 102.23 8.65 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.08 115.63 26.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.19 0.519 . . . . 0.0 111.332 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB3' ' CG2' ' B' ' 2' ' ' THR . 30.8 m-85 -95.38 108.25 20.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 0.0 108.235 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -92.38 128.08 38.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.586 0.707 . . . . 0.0 111.975 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 118' ' ' TYR . 24.8 m -128.41 160.95 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 13.0 pt-20 -66.79 -35.19 79.49 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.512 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.3 p30 -165.05 178.56 6.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.7 0.682 . . . . 0.0 112.281 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.16 -31.98 63.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.786 1.634 . . . . 0.0 113.1 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.25 -46.87 84.87 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 123.902 0.751 . . . . 0.0 110.101 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.586 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 83.3 mm-40 -67.9 -23.03 65.06 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.653 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.62 -41.68 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.65 0.738 . . . . 0.0 109.904 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.27 -33.82 65.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 110.971 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 41.5 mt-10 -65.91 -44.69 84.45 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.626 0.727 . . . . 0.0 109.312 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -63.49 -37.61 87.95 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.952 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -55.13 -61.54 2.25 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.271 1.029 . . . . 0.0 110.466 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -68.79 -32.69 72.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.301 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.24 -46.39 90.99 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.483 0.489 . . . . 0.0 112.94 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.52 -43.74 98.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.258 0.623 . . . . 0.0 109.529 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -55.84 -45.76 78.31 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.451 0.7 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.74 61.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.297 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 t -100.56 4.1 43.22 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 111.829 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.57 52.91 2.72 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.401 167.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.8 p -94.76 153.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.14 -53.93 15.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.698 0.399 . . . . 0.0 110.771 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.524 ' HB2' HG13 ' A' ' 90' ' ' VAL . 48.6 ttm 64.53 83.8 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 169.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 82.55 1.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.305 0.574 . . . . 0.0 110.599 173.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 176.71 130.46 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.867 1.667 . . . . 0.0 108.303 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -82.15 123.68 79.3 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 107.05 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.469 2.779 . . . . 0.0 111.972 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.06 50.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.777 0.831 . . . . 0.0 111.254 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 98' ' ' LYS . 2.2 mmmm -70.77 100.63 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.545 0.738 . . . . 0.0 110.308 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.7 ttm -101.34 169.4 8.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.258 1.023 . . . . 0.0 108.815 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.12 -41.6 48.97 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.35 1.06 . . . . 0.0 112.136 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.08 -12.12 60.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.581 0.752 . . . . 0.0 111.164 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.96 -173.5 21.55 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.467 0.556 . . . . 0.0 111.933 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -77.14 100.81 5.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.2 t -113.44 147.5 37.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -167.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -140.78 134.21 29.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.098 0.959 . . . . 0.0 109.296 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.8 m -120.26 118.26 29.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.796 0.438 . . . . 0.0 110.272 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.01 169.69 8.35 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.143 0.577 . . . . 0.0 109.894 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.85 127.73 29.39 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.73 169.53 2.5 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.542 0.737 . . . . 0.0 110.791 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -49.51 -31.81 25.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.573 2.182 . . . . 0.0 112.444 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.52 4.0 41.76 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.543 1.137 . . . . 0.0 112.263 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.4 m 59.31 84.2 0.12 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.702 1.201 . . . . 0.0 112.259 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.471 ' HE1' HG12 ' A' ' 11' ' ' VAL . 22.5 m170 -122.73 176.57 5.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.075 0.55 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 67' ' ' GLU . 24.9 mmt180 -100.3 112.46 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.1 mt -111.78 100.32 8.84 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -99.5 93.33 5.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.247 0.219 . . . . 0.0 110.971 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.48 116.21 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 72' ' ' VAL . 23.5 p90 -125.19 168.49 13.37 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.027 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.85 112.04 13.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.75 114.42 18.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.9 95.31 6.7 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.576 0.75 . . . . 0.0 109.535 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 CA-C-O 119.167 -0.796 . . . . 0.0 112.383 178.472 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptm . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 27.6 m -143.12 144.53 32.26 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -135.47 103.73 10.28 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.592 1.157 . . . . 0.0 108.889 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.578 ' HG3' HD22 ' A' ' 25' ' ' LEU . 54.3 Cg_endo -90.57 49.69 0.89 Allowed 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.444 2.762 . . . . 0.0 112.851 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.9 p-10 -75.69 14.24 0.67 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.304 1.041 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.474 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.3 t80 -133.48 129.25 36.94 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.222 1.409 . . . . 0.0 108.2 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 8.2 t -126.85 141.3 51.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 55.6 mt -119.79 137.19 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.55 145.43 25.72 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.47 97.74 8.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.223 -169.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.457 HG12 ' HE1' ' B' ' 113' ' ' HIS . 30.5 m -109.14 179.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -123.78 -53.45 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.727 0.411 . . . . 0.0 110.405 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.11 105.12 8.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 123.635 0.774 . . . . 0.0 109.828 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.23 -55.25 3.83 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.576 2.184 . . . . 0.0 114.357 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 -58.63 0.52 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 CA-C-N 122.243 1.837 . . . . 0.0 112.248 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.36 -44.37 94.98 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.282 -166.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m -76.35 -34.57 58.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.662 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 63.3 m -69.34 -39.43 78.15 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.549 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.9 mm-40 -63.89 -35.89 82.15 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.527 172.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 58.2 t80 -68.08 -39.51 82.89 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.322 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -70.18 -30.64 67.81 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.329 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 61.2 mtpt -57.07 -47.63 80.52 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.59 -34.52 53.49 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.264 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 11.8 tp -60.66 -31.93 71.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.699 1.2 . . . . 0.0 112.641 -177.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.526 HD22 ' HG3' ' A' ' 4' ' ' PRO . 91.4 mt -105.07 -40.26 5.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.511 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.38 29.62 10.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 123.725 0.64 . . . . 0.0 111.823 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.4 m -126.62 -179.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.318 1.047 . . . . 0.0 109.809 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.33 150.81 70.0 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.432 0.693 . . . . 0.0 109.209 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.53 111.92 2.69 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.469 2.113 . . . . 0.0 112.26 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 p -64.17 -42.33 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.773 0.829 . . . . 0.0 110.287 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 18.9 mm-40 -111.41 145.93 38.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 108.302 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -154.85 152.05 29.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.279 0.562 . . . . 0.0 110.014 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 24.9 m -139.39 163.4 45.8 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.401 1.48 . . . . 0.0 107.616 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.77 -30.99 69.96 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.483 2.122 . . . . 0.0 113.325 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -130.29 23.0 5.19 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.544 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 70.0 t80 -153.75 159.2 41.87 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -149.37 154.42 38.9 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.826 0.851 . . . . 0.0 109.955 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -148.2 122.91 9.88 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.6 132.58 48.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.853 1.261 . . . . 0.0 108.544 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.5 t -109.99 126.47 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.667 0.787 . . . . 0.0 109.143 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.38 145.15 27.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.174 0.589 . . . . 0.0 109.537 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.16 -5.66 14.51 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.876 0.87 . . . . 0.0 112.655 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.569 ' HB2' ' HG2' ' B' ' 45' ' ' MET . 13.5 m120 -65.8 -10.42 37.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.642 1.177 . . . . 0.0 112.649 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.53 58.58 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.574 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 14.9 ptm -118.76 165.2 14.3 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.238 1.015 . . . . 0.0 109.249 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.55 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.77 139.46 47.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.1 tt -137.79 122.73 18.96 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.036 0.446 . . . . 0.0 110.502 -171.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.474 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.94 169.44 19.0 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 123.997 0.808 . . . . 0.0 111.434 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 45.8 mt -139.94 110.05 6.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -107.76 128.6 54.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -79.69 122.82 27.04 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.071 0.548 . . . . 0.0 110.185 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.433 ' O ' HG12 ' B' ' 55' ' ' VAL . 51.6 ptt85 -69.89 -15.08 63.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.323 1.049 . . . . 0.0 112.621 -169.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -72.62 -8.48 55.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 122.684 0.394 . . . . 0.0 111.132 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.2 t -134.81 4.16 3.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.569 0.748 . . . . 0.0 111.414 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' B' ' 52' ' ' ARG . 10.6 p -60.02 148.23 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.867 0.467 . . . . 0.0 111.562 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -123.68 113.81 28.67 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.804 0.841 . . . . 0.0 109.527 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.76 145.56 81.87 Favored 'Cis proline' 0 C--N 1.382 2.338 0 C-N-CA 124.516 -1.035 . . . . 0.0 113.16 1.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 128.66 30.3 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.553 1.141 . . . . 0.0 111.992 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.32 120.88 7.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.389 0.675 . . . . 0.0 110.886 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 35.6 p -91.12 87.25 6.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.34 124.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.364 0.665 . . . . 0.0 109.739 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -152.64 123.07 7.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.305 1.442 . . . . 0.0 108.123 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.85 67.83 0.02 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.67 -82.24 1.68 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.29 -142.33 44.3 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.809 -0.439 . . . . 0.0 112.452 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.552 ' H ' ' H ' ' A' ' 66' ' ' GLY . . . -66.86 152.46 52.66 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 174.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 10.4 mt-10 -103.9 152.08 22.38 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.042 0.537 . . . . 0.0 110.197 -172.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.441 HD21 HD11 ' B' ' 47' ' ' LEU . 35.4 tp -118.81 102.34 8.74 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.2 116.09 27.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.216 0.531 . . . . 0.0 111.194 -170.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' B' ' 117' ' ' VAL . 29.0 m-85 -96.28 107.96 20.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.135 1.374 . . . . 0.0 108.297 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -91.86 126.4 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.599 0.714 . . . . 0.0 111.89 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 2' ' ' THR . 29.6 m -126.25 161.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.148 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.88 -34.62 78.19 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -174.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.401 HD22 ' HG3' ' B' ' 73' ' ' GLU . 7.7 p30 -165.78 179.0 6.19 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.648 0.658 . . . . 0.0 112.212 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.39 -31.49 65.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.519 1.528 . . . . 0.0 113.03 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.43 -46.42 86.39 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.181 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.481 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 72.4 mm-40 -68.16 -23.38 64.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.322 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.59 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.574 0.702 . . . . 0.0 109.69 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.48 -32.99 62.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.933 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 33.4 mt-10 -65.9 -44.31 85.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.534 0.683 . . . . 0.0 109.495 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.8 m -64.66 -36.45 84.3 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.991 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -55.03 -61.68 2.15 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.41 1.084 . . . . 0.0 110.28 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.11 -32.32 71.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.368 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.48 -45.66 92.55 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.53 0.519 . . . . 0.0 112.935 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -63.89 -43.19 96.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.333 0.653 . . . . 0.0 109.924 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.65 -45.76 77.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.592 0.757 . . . . 0.0 110.184 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.62 -20.73 61.23 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.345 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.95 4.15 44.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.796 0.838 . . . . 0.0 112.475 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 52.86 2.74 Favored Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 114.471 168.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' B' ' 92' ' ' MET . 4.9 p -94.57 153.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.82 -54.0 15.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.742 0.417 . . . . 0.0 110.991 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.53 ' HB2' HG13 ' B' ' 90' ' ' VAL . 52.9 ttm 64.43 83.7 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.841 0.713 . . . . 0.0 112.67 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.73 82.46 1.86 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.442 0.639 . . . . 0.0 110.741 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' B' ' 106' ' ' THR . 54.0 tp60 176.2 129.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.717 1.607 . . . . 0.0 108.242 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -80.89 123.45 82.22 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 168.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.33 107.11 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.499 2.799 . . . . 0.0 111.876 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.29 141.35 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 111.085 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 100.42 3.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.405 0.682 . . . . 0.0 109.358 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -100.59 170.38 8.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.912 0.885 . . . . 0.0 109.181 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.6 -41.62 54.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.236 1.014 . . . . 0.0 111.746 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -79.93 -11.21 59.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.644 0.777 . . . . 0.0 111.249 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.68 -172.79 21.78 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.9 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -78.56 101.05 7.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -113.7 147.51 38.06 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.895 0.478 . . . . 0.0 110.781 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.77 134.34 30.09 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 109.117 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 1.9 m -120.9 118.42 29.88 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.92 169.94 8.19 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.058 0.543 . . . . 0.0 109.704 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.2 128.51 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.86 170.22 2.73 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.597 0.759 . . . . 0.0 110.41 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.89 -31.88 28.27 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.779 2.319 . . . . 0.0 112.2 165.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.31 4.92 40.91 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.36 1.064 . . . . 0.0 112.047 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 61.0 m 58.53 84.67 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.802 1.241 . . . . 0.0 112.573 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.457 ' HE1' HG12 ' B' ' 11' ' ' VAL . 15.3 m170 -122.78 176.57 5.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.108 0.563 . . . . 0.0 109.612 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' B' ' 67' ' ' GLU . 9.5 mmt180 -100.75 112.48 24.9 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.32 100.6 8.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.594 HH11 ' HG3' ' B' ' 116' ' ' ARG . 8.3 mmt85 -96.8 92.19 6.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.876 -172.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' B' ' 70' ' ' PHE . 5.9 t -91.74 115.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.408 ' O ' HG22 ' B' ' 72' ' ' VAL . 15.9 p90 -124.71 169.02 12.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.789 0.268 . . . . 0.0 111.128 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.95 111.76 13.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.61 115.46 19.23 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.71 0.25 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.835 -174.418 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.476 0.179 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -91.8 133.48 35.59 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -96.67 112.12 59.3 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.052 0.941 . . . . 0.0 110.746 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.0 94.77 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.801 2.334 . . . . 0.0 112.064 171.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.653 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.6 p-10 -96.61 16.7 18.15 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.424 0.63 . . . . 0.0 110.997 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.7 131.57 46.37 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.935 1.294 . . . . 0.0 107.562 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 142.97 49.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.362 1.065 . . . . 0.0 109.03 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 45.7 mt -124.0 139.1 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.546 0.739 . . . . 0.0 110.133 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 47' ' ' LEU . 3.7 mm? -112.02 143.5 42.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.051 0.941 . . . . 0.0 108.556 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.13 106.48 13.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.495 1.118 . . . . 0.0 111.347 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 51' ' ' SER . 14.8 m -107.24 149.38 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -97.06 -52.15 3.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.13 100.58 13.59 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.11 0.964 . . . . 0.0 109.646 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -53.67 -52.71 7.89 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.246 2.631 . . . . 0.0 115.384 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 47.3 Cg_exo -56.68 -51.16 9.69 Favored 'Trans proline' 0 C--N 1.4 3.255 0 CA-C-N 122.267 1.845 . . . . 0.0 112.414 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.19 -38.01 52.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.968 -165.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -78.76 -29.25 45.02 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.235 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 75.9 m -64.95 -48.29 74.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 81.5 mm-40 -66.36 -31.66 72.57 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.196 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -62.96 -48.94 76.73 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.855 0.722 . . . . 0.0 110.045 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -71.81 -29.07 64.05 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.409 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 18' ' ' THR . 56.3 mtpt -56.26 -45.64 79.98 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.753 0.706 . . . . 0.0 112.069 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -42.54 35.8 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.464 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.9 -46.33 85.09 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.904 1.282 . . . . 0.0 112.298 -172.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.39 -47.64 9.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.2 33.75 4.78 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.804 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.18 172.19 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.14 0.976 . . . . 0.0 110.312 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.2 146.75 54.99 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 57.3 Cg_endo -71.26 121.08 7.46 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.994 1.796 . . . . 0.0 112.19 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.76 -44.13 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.545 0.738 . . . . 0.0 110.636 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.6 mm-40 -120.86 107.23 12.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -111.08 144.86 39.54 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.173 0.511 . . . . 0.0 110.696 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -142.07 155.63 65.26 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.715 1.206 . . . . 0.0 108.432 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.92 -10.19 27.55 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.278 1.985 . . . . 0.0 113.146 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -129.29 5.3 5.24 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -157.01 154.84 30.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 70.5 m -140.88 139.89 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.608 0.763 . . . . 0.0 109.256 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 27.7 tp -131.62 121.02 23.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 2.2 p90 -134.28 150.32 50.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.969 0.907 . . . . 0.0 108.943 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 46' ' ' LYS . 19.2 t -126.46 133.9 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.476 ' HB2' ' HG3' ' A' ' 45' ' ' MET . 10.0 mp -97.73 144.72 27.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.25 -10.67 33.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.134 0.974 . . . . 0.0 112.673 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.04 -22.35 66.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.256 1.022 . . . . 0.0 112.127 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.17 16.04 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -116.23 171.88 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.851 0.86 . . . . 0.0 109.022 176.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -142.84 143.11 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.474 HD21 HD23 ' A' ' 9' ' ' LEU . 2.0 tt -142.3 122.19 13.59 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.99 0.424 . . . . 0.0 110.397 -169.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.26 151.97 17.56 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 76.5 mt -116.83 109.61 17.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 162.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.454 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.4 t90 -103.83 124.28 48.64 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 48.8 m -72.51 115.88 12.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -64.77 -8.57 15.46 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.73 1.212 . . . . 0.0 113.873 -169.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -9.89 59.7 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.574 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -135.23 3.01 3.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.837 0.455 . . . . 0.0 111.398 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 13.8 p -64.78 140.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.827 0.451 . . . . 0.0 110.948 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.38 106.76 21.33 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 3.0 Cg_endo -77.25 142.32 71.55 Favored 'Cis proline' 0 C--N 1.383 2.361 0 CA-C-N 120.156 1.091 . . . . 0.0 113.182 10.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HA ' HG13 ' A' ' 55' ' ' VAL . 2.8 tppp? -59.46 109.63 0.93 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.03 0.932 . . . . 0.0 111.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.67 107.58 10.71 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.817 1.247 . . . . 0.0 107.953 174.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 m -100.0 87.84 3.6 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.28 143.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.335 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 112' ' ' SER . 6.3 p -148.95 -176.43 5.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.431 1.092 . . . . 0.0 109.739 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.57 -71.37 2.47 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 32.71 7.27 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.37 59.76 4.94 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 146.14 7.2 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.314 0.483 . . . . 0.0 112.245 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 19.8 mt-10 -103.82 140.87 37.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.08 100.64 7.47 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.698 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -89.36 114.65 26.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.141 0.496 . . . . 0.0 111.777 -168.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -90.42 115.02 27.27 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.564 1.545 . . . . 0.0 107.585 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.657 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 31.3 mtm105 -91.34 128.37 37.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.13 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.17 159.15 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.018 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.4 pt-20 -65.52 -37.23 86.18 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -173.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -162.83 -177.76 5.71 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 118.407 0.549 . . . . 0.0 112.225 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.09 -34.1 71.6 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.75 1.22 . . . . 0.0 112.469 -166.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.26 -41.37 85.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.603 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.621 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 76.3 mm-40 -66.69 -23.06 66.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.079 0.952 . . . . 0.0 112.424 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.33 -40.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.932 0.493 . . . . 0.0 109.882 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.73 -31.37 61.81 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.974 0.91 . . . . 0.0 110.978 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.2 mt-10 -66.33 -47.43 73.55 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -62.99 -36.5 83.75 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.484 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -56.31 -61.39 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.211 1.004 . . . . 0.0 110.361 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.33 77.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.491 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.8 93.6 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.535 0.522 . . . . 0.0 113.373 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -66.65 -39.97 88.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.418 0.687 . . . . 0.0 109.965 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -60.39 -42.54 96.11 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.648 0.779 . . . . 0.0 110.362 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.31 65.14 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.738 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.0 t -95.84 7.2 46.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.315 1.046 . . . . 0.0 112.759 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.53 51.36 6.05 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.927 -0.579 . . . . 0.0 114.306 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.64 137.71 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.461 0.704 . . . . 0.0 109.169 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.05 97.98 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.805 0.842 . . . . 0.0 112.207 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.63 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 12.0 ptm 49.27 82.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.085 1.754 . . . . 0.0 115.409 164.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -114.65 86.12 2.38 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.095 0.558 . . . . 0.0 110.446 178.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 178.38 116.57 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.619 1.568 . . . . 0.0 107.551 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.83 124.36 89.25 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.52 97.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.965 2.444 . . . . 0.0 111.334 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.42 36.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.014 0.926 . . . . 0.0 110.187 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 98.5 2.37 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ttt -90.79 166.38 13.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.802 0.841 . . . . 0.0 109.233 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.34 -41.15 79.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.984 0.914 . . . . 0.0 111.972 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -81.34 -15.35 55.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.142 0.577 . . . . 0.0 111.693 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.55 179.4 22.66 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.182 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -78.05 105.72 9.44 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 118' ' ' TYR . 12.6 t -122.01 155.51 35.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.472 0.654 . . . . 0.0 111.455 -171.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -141.21 150.31 42.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.006 1.722 . . . . 0.0 108.304 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.7 m -136.09 133.66 37.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.996 0.816 . . . . 0.0 111.349 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.71 171.22 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.953 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.42 126.63 29.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.936 170.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.83 172.52 1.37 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.741 1.216 . . . . 0.0 111.798 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -56.18 -35.68 95.64 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.169 1.913 . . . . 0.0 111.446 161.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.86 -18.59 43.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.592 1.157 . . . . 0.0 110.898 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.495 ' O ' ' HB ' ' A' ' 62' ' ' THR . 22.2 m 68.13 101.69 0.05 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 126.262 1.825 . . . . 0.0 111.793 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.462 ' CE1' HG12 ' A' ' 11' ' ' VAL . 17.3 m80 -127.35 175.72 7.98 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.53 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -96.22 95.04 7.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.619 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 92.5 mt -95.6 104.4 16.31 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.698 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 9.9 mmm180 -86.15 143.52 27.97 Favored 'General case' 0 C--O 1.214 -0.816 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.43 111.25 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 166.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.657 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 3.6 p90 -120.84 167.18 12.79 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.264 0.483 . . . . 0.0 110.819 -172.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.25 110.9 8.07 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.402 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 52.0 t80 -76.65 116.9 17.74 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.135 0.425 . . . . 0.0 110.198 -168.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.25 95.51 8.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.889 -0.951 . . . . 0.0 110.875 179.055 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.641 0.257 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -81.8 134.23 35.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.37 0.668 . . . . 0.0 109.525 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -97.28 111.72 58.98 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 123.858 0.863 . . . . 0.0 110.426 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -88.55 94.83 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.619 2.212 . . . . 0.0 112.144 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.691 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.3 p-10 -96.29 16.48 18.25 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.343 0.592 . . . . 0.0 111.023 171.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.72 131.33 46.28 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.038 1.335 . . . . 0.0 107.587 -173.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 t -132.63 143.07 49.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.328 1.051 . . . . 0.0 108.964 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 16.7 mt -124.23 139.23 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.61 0.764 . . . . 0.0 109.971 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.87 143.09 44.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.047 0.939 . . . . 0.0 108.685 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -80.79 106.48 12.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.447 1.099 . . . . 0.0 111.181 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' B' ' 51' ' ' SER . 15.3 m -107.35 149.66 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -97.45 -52.31 3.84 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.202 -170.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -101.54 100.02 12.98 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.267 1.027 . . . . 0.0 109.685 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.45 -53.05 7.56 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.413 2.742 . . . . 0.0 115.766 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 22.6 Cg_endo -56.9 -50.92 10.11 Favored 'Trans proline' 0 C--N 1.399 3.234 0 CA-C-N 122.084 1.78 . . . . 0.0 112.077 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.09 -38.41 52.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.088 -165.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -78.94 -28.22 43.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.222 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 83.9 m -66.84 -47.25 72.54 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.555 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 69.6 mt-30 -65.1 -33.29 75.69 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.249 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 81.0 t80 -62.45 -48.71 78.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.531 0.732 . . . . 0.0 110.136 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.426 ' O ' ' HG ' ' B' ' 25' ' ' LEU . 41.6 m-85 -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.564 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -55.99 -45.59 78.96 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.87 0.759 . . . . 0.0 111.985 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.52 33.59 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.46 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.3 tp -58.2 -46.23 86.18 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.809 1.244 . . . . 0.0 112.247 -172.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 21' ' ' TYR . 10.8 mt -86.24 -47.74 9.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.79 32.93 4.89 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.597 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.92 171.74 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.164 0.986 . . . . 0.0 110.373 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -124.36 148.17 57.34 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 61.1 Cg_endo -72.7 120.96 7.0 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 121.876 1.718 . . . . 0.0 112.13 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.69 -44.36 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.564 0.746 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 58.8 mm-40 -120.4 108.32 13.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.27 1.028 . . . . 0.0 108.292 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 p -112.33 145.01 40.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.22 0.608 . . . . 0.0 110.347 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -143.02 153.67 60.74 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.141 1.376 . . . . 0.0 108.241 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.56 -10.58 26.89 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.319 2.013 . . . . 0.0 113.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.0 t -129.19 5.69 5.31 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.82 154.97 30.74 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 35.5 t -140.75 140.16 34.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.512 HD11 ' HE2' ' B' ' 46' ' ' LYS . 40.6 tp -132.15 120.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 2.4 p90 -134.01 150.42 51.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 0.0 108.885 170.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' B' ' 46' ' ' LYS . 17.5 t -126.84 134.13 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' B' ' 45' ' ' MET . 9.9 mp -97.53 144.36 27.31 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -10.2 30.04 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.152 0.981 . . . . 0.0 112.554 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.45 -22.2 66.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.406 1.082 . . . . 0.0 112.054 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.36 15.88 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.653 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -116.75 172.25 7.36 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.575 ' HG3' HG22 ' B' ' 40' ' ' VAL . 86.4 tttt -142.91 143.18 31.93 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.28 122.46 13.83 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.13 17.6 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 174.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 76.6 mt -117.04 109.63 17.21 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.423 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -103.82 124.39 48.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.8 m -72.55 116.42 12.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -65.55 -8.27 18.91 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.607 1.163 . . . . 0.0 113.789 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -79.34 -10.34 59.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.231 0.612 . . . . 0.0 111.548 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -134.78 2.43 3.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.88 0.472 . . . . 0.0 111.293 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 12.2 p -64.68 141.29 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.631 0.373 . . . . 0.0 110.851 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.07 107.66 19.9 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 123.909 0.884 . . . . 0.0 109.058 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.47 142.4 73.01 Favored 'Cis proline' 0 C--N 1.387 2.603 0 CA-C-N 119.906 1.002 . . . . 0.0 113.466 8.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.423 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.7 tppp? -58.91 110.17 0.97 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.058 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.82 107.34 10.41 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.823 1.249 . . . . 0.0 108.102 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -99.57 87.8 3.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.64 142.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.182 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' B' ' 112' ' ' SER . 6.2 p -147.65 -176.24 5.17 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.544 1.138 . . . . 0.0 110.149 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.4 -71.66 2.46 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.12 32.58 7.37 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.44 59.74 4.94 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 145.94 7.08 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.288 0.471 . . . . 0.0 112.197 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 18.4 mt-10 -103.62 141.1 36.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.86 100.33 7.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.08 114.76 26.04 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 0.0 111.925 -169.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -90.62 114.52 26.8 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 125.525 1.53 . . . . 0.0 107.453 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.593 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 36.4 mtm105 -90.65 127.08 36.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.934 -175.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.22 159.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.159 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.1 pt-20 -65.51 -37.36 86.55 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -163.06 -177.37 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 118.5 0.591 . . . . 0.0 112.205 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -59.52 -33.68 71.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -166.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.09 84.66 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.806 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.552 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -67.05 -22.58 65.86 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.572 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.83 -40.71 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.852 172.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.22 -31.27 62.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.05 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.42 -47.51 73.02 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.113 0.483 . . . . 0.0 109.765 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -35.74 81.39 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.487 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -56.86 -61.35 2.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.696 0.798 . . . . 0.0 110.304 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -65.41 -34.0 77.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.653 -171.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.06 93.34 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.553 0.533 . . . . 0.0 113.326 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -66.28 -40.12 89.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.498 0.719 . . . . 0.0 109.905 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.6 ttpt -60.12 -42.58 95.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.636 0.774 . . . . 0.0 110.46 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.35 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.746 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 30.2 t -96.1 7.73 45.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.241 1.016 . . . . 0.0 112.762 -175.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 52.12 5.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.268 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.07 137.39 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.735 0.814 . . . . 0.0 109.201 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.78 97.99 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.904 0.882 . . . . 0.0 112.38 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 12.0 ptm 49.22 82.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 164.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.508 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -114.68 86.26 2.4 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.285 0.634 . . . . 0.0 110.405 178.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 52.0 tp60 177.78 116.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.768 1.627 . . . . 0.0 107.638 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.64 125.09 90.03 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.06 97.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.936 2.424 . . . . 0.0 110.943 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.65 146.93 37.79 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.02 0.928 . . . . 0.0 110.337 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 98.39 2.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 171.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 8.3 ttt -91.06 166.79 12.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.634 0.774 . . . . 0.0 109.104 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.0 -41.16 77.98 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.688 0.795 . . . . 0.0 112.079 -176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -81.54 -15.54 54.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.62 179.42 22.74 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.032 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -77.74 105.96 9.25 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 11.1 t -122.37 155.53 35.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.554 0.692 . . . . 0.0 111.395 -170.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -141.35 150.26 42.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.889 1.676 . . . . 0.0 108.318 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.5 m -136.05 133.6 37.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.992 0.815 . . . . 0.0 111.352 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.634 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.76 171.15 7.49 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.931 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.19 129.34 35.62 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.4 174.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.692 1.197 . . . . 0.0 110.8 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.11 -34.92 99.02 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.05 1.834 . . . . 0.0 110.828 162.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -82.36 -18.27 42.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.718 1.207 . . . . 0.0 110.818 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' SER . . . . . 0.494 ' O ' ' HB ' ' B' ' 62' ' ' THR . 40.3 m 67.79 101.85 0.05 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.15 1.78 . . . . 0.0 111.656 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.45 ' CE1' HG12 ' B' ' 11' ' ' VAL . 19.5 m80 -127.48 175.47 8.21 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 165.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.549 ' HA ' ' HE ' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -96.09 95.4 8.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.375 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' B' ' 107' ' ' ALA . 93.9 mt -95.64 104.83 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.66 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 34.3 mmt180 -84.47 143.57 29.29 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 25.2 t -137.42 111.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.593 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.5 p90 -120.65 167.46 12.42 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.023 0.374 . . . . 0.0 110.896 -172.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.73 111.44 8.19 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 167.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -77.65 123.47 26.69 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.196 0.453 . . . . 0.0 110.493 -168.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.39 94.59 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 118.891 -0.95 . . . . 0.0 110.923 -176.276 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 m -85.84 145.82 27.03 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.012 0.525 . . . . 0.0 110.056 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -102.35 107.67 54.28 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.692 0.797 . . . . 0.0 110.908 -173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.36 56.47 1.41 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.476 2.784 . . . . 0.0 111.836 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.573 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.0 p-10 -78.36 4.07 13.96 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.886 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.0 OUTLIER -124.23 125.11 43.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.1 t -120.0 137.23 54.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 49.2 mt -116.14 135.07 57.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.364 0.666 . . . . 0.0 109.361 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 156.3 18.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.314 1.054 . . . . 0.0 108.308 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' OH ' HG11 ' A' ' 55' ' ' VAL . 4.0 t80 -110.04 108.36 18.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.823 -173.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.48 HG12 ' NE2' ' A' ' 113' ' ' HIS . 9.9 m -125.12 159.84 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.367 0.603 . . . . 0.0 110.957 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -97.41 -62.7 1.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.396 1.078 . . . . 0.0 109.461 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.28 106.52 13.86 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.224 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.49 -59.72 0.62 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 122.624 2.216 . . . . 0.0 113.959 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 29.8 Cg_endo -57.32 -50.65 10.44 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.355 1.877 . . . . 0.0 111.61 -174.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.07 90.57 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.262 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.8 t -78.69 -20.72 49.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.755 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 m -76.41 -45.49 31.36 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.679 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 57.7 mm-40 -68.61 -30.19 68.87 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.41 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 36.4 t80 -60.85 -51.25 70.12 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 124.115 0.885 . . . . 0.0 110.847 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.39 -27.76 63.55 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.784 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.5 mtpt -56.19 -50.83 70.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.392 0.542 . . . . 0.0 112.408 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.61 56.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.113 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 11.7 tp -60.91 -43.65 98.26 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.408 1.083 . . . . 0.0 112.15 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 27' ' ' VAL . 22.5 mt -95.21 -35.29 11.9 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.971 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.7 37.13 6.2 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.9 m -130.56 -177.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.489 1.116 . . . . 0.0 110.472 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.75 149.79 57.76 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.03 108.96 2.06 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.806 2.337 . . . . 0.0 111.697 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.76 -31.51 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.586 0.754 . . . . 0.0 110.571 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 48.5 mt-10 -119.42 143.15 47.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.291 1.037 . . . . 0.0 108.213 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -159.54 153.72 23.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.817 0.818 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -144.23 164.15 30.71 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 126.069 1.748 . . . . 0.0 107.473 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.58 -16.16 34.76 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.334 2.022 . . . . 0.0 113.484 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.8 t -127.92 13.05 6.79 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -154.38 159.94 41.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -153.37 153.91 33.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.489 1.116 . . . . 0.0 109.469 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.7 tm? -146.33 123.71 11.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -130.81 137.24 49.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.601 1.16 . . . . 0.0 108.307 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.536 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.7 t -112.09 123.0 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.633 HD12 ' SD ' ' A' ' 45' ' ' MET . 76.2 mt -89.34 148.73 23.36 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.96 0.504 . . . . 0.0 110.188 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -7.01 19.12 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.22 1.008 . . . . 0.0 113.513 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -82.03 4.41 22.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 111.789 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.3 64.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.629 -0.189 . . . . 0.0 112.629 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.633 ' SD ' HD12 ' A' ' 41' ' ' LEU . 5.1 ppp? -117.61 171.54 7.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.631 0.772 . . . . 0.0 109.779 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 40' ' ' VAL . 83.0 tttt -135.35 139.43 44.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 68' ' ' LEU . 1.2 tt -137.34 123.99 21.04 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.174 0.512 . . . . 0.0 110.113 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.94 169.97 20.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.828 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.9 tp -139.92 104.78 4.94 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -114.71 128.92 56.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.6 m -78.71 134.95 37.05 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.168 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.0 -19.96 64.97 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.755 0.822 . . . . 0.0 113.2 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -8.41 58.78 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -129.77 7.72 5.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.858 0.463 . . . . 0.0 111.33 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG11 ' OH ' ' A' ' 10' ' ' TYR . 11.8 p -69.87 147.43 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HB3' ' NE2' ' B' ' 94' ' ' GLN . 35.6 mt-10 -128.25 113.65 19.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 0.0 109.52 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.72 143.19 77.06 Favored 'Cis proline' 0 C--N 1.388 2.636 0 CA-C-N 119.723 0.937 . . . . 0.0 112.674 2.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -50.09 124.31 9.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.501 1.12 . . . . 0.0 112.063 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.41 155.68 43.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.172 0.989 . . . . 0.0 109.333 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.3 m -132.79 94.23 3.35 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.97 125.18 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.13 0.972 . . . . 0.0 108.855 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -140.09 142.62 36.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.761 0.824 . . . . 0.0 109.373 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.51 23.22 73.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.624 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' B' ' 61' ' ' VAL . . . -160.84 140.74 6.88 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.27 -156.23 26.85 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.59 172.0 54.81 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.525 0.191 . . . . 0.0 112.713 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 68.9 mt-10 -99.49 152.03 20.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 47' ' ' LEU . 45.8 tp -110.09 100.55 9.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -84.61 113.76 21.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.007 0.432 . . . . 0.0 111.571 -167.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -93.12 106.62 18.56 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.854 1.262 . . . . 0.0 107.921 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -90.62 131.37 36.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.122 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.04 165.08 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.49 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.1 pt-20 -69.38 -43.81 72.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.402 HD22 ' HG3' ' A' ' 73' ' ' GLU . 9.3 p30 -155.25 177.99 10.72 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.703 0.683 . . . . 0.0 112.626 -174.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.15 -32.96 70.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.158 1.383 . . . . 0.0 112.421 -167.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.34 -42.77 74.85 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.634 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 78.9 mm-40 -64.58 -24.16 67.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.644 0.778 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.24 -40.08 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.349 0.595 . . . . 0.0 110.003 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.1 -30.22 62.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.195 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -67.77 -42.99 80.84 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 109.141 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.7 m -65.01 -37.93 89.26 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.357 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.94 -60.92 2.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.921 0.888 . . . . 0.0 109.628 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -60.83 -39.17 88.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.733 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.6 -39.35 86.64 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.415 0.447 . . . . 0.0 113.828 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -67.89 -42.48 81.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.374 0.669 . . . . 0.0 109.64 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.7 ttpt -57.63 -43.88 85.16 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.791 0.836 . . . . 0.0 110.387 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.9 -30.56 71.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.692 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.5 m -102.24 14.8 30.98 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.099 0.959 . . . . 0.0 112.094 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 46.36 5.68 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 163.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -101.72 132.23 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.144 0.578 . . . . 0.0 109.745 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.51 95.13 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.918 0.887 . . . . 0.0 111.708 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 4.8 ptm 50.3 81.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.567 1.547 . . . . 0.0 113.771 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.52 83.67 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.61 -0.681 . . . . 0.0 109.962 -178.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' B' ' 56' ' ' GLU . 5.7 tp60 177.39 134.68 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.52 1.528 . . . . 0.0 108.028 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -79.31 120.67 81.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 15.6 Cg_endo -58.71 106.3 0.27 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.642 2.228 . . . . 0.0 110.378 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.85 152.36 46.41 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.309 0.644 . . . . 0.0 110.21 -175.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -62.42 137.79 58.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.543 0.737 . . . . 0.0 110.466 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.412 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 20.1 ttt -142.82 175.76 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 109.392 -175.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 99' ' ' MET . 11.5 tp10 -51.35 -32.37 25.44 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.453 1.501 . . . . 0.0 112.921 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.42 -5.22 23.12 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.663 0.785 . . . . 0.0 111.384 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.91 -167.51 20.18 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.078 176.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.7 101.59 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.409 HG21 ' SD ' ' A' ' 99' ' ' MET . 9.4 t -115.63 149.1 38.84 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.376 -167.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 3.2 t80 -146.51 129.41 16.33 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.573 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -120.66 119.22 32.21 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.26 159.04 16.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 -175.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -141.1 127.49 19.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 170.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.64 178.89 2.09 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.134 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -32.83 94.08 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.743 2.295 . . . . 0.0 113.644 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.83 -4.92 46.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.758 0.423 . . . . 0.0 111.18 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.0 m 72.45 60.02 0.13 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.118 1.367 . . . . 0.0 110.995 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.48 ' NE2' HG12 ' A' ' 11' ' ' VAL . 19.7 m170 -97.67 -167.09 1.47 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.17 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.43 93.87 1.94 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.7 mt -116.79 101.95 8.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.833 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 2.3 tmm_? -102.8 99.26 9.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.004 0.521 . . . . 0.0 111.29 -169.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.03 140.6 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.5 0.72 . . . . 0.0 109.226 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.499 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 16.7 p90 -143.66 161.69 37.88 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.659 0.663 . . . . 0.0 112.607 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.405 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -110.67 129.87 55.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.71 124.52 23.52 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.274 0.359 . . . . 0.0 110.367 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.75 94.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.772 0.67 . . . . 0.0 110.48 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.801 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -177.391 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m -77.4 145.91 36.92 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 110.233 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -102.73 107.42 54.35 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.8 56.01 1.66 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.499 2.799 . . . . 0.0 111.95 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.9 p-10 -77.59 3.91 12.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.685 0.794 . . . . 0.0 112.146 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -123.85 124.85 43.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -120.32 137.53 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 37.0 mt -117.3 134.76 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.374 0.67 . . . . 0.0 109.468 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.599 HD11 HD22 ' B' ' 68' ' ' LEU . 65.9 mt -90.56 155.69 18.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.334 1.064 . . . . 0.0 108.973 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.03 107.83 19.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 112.93 -1.941 . . . . 0.0 108.184 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.98 160.05 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.377 0.608 . . . . 0.0 110.838 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.81 -62.12 1.29 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.41 1.084 . . . . 0.0 109.713 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -90.78 105.92 13.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.391 0.676 . . . . 0.0 109.495 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -56.4 -60.97 0.38 Allowed 'Trans proline' 0 CA--C 1.573 2.443 0 C-N-CA 122.435 2.09 . . . . 0.0 113.878 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.7 -51.99 9.12 Favored 'Trans proline' 0 C--N 1.41 3.789 0 CA-C-N 122.47 1.918 . . . . 0.0 112.405 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.13 92.94 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.4 t -78.45 -20.61 50.62 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.1 m -76.88 -45.33 28.59 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.45 0.643 . . . . 0.0 111.652 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.487 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.2 mm-40 -67.92 -30.78 70.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.464 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 74.9 t80 -60.4 -50.91 71.7 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.786 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -72.19 -27.43 62.55 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.201 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 56.4 mtpt -56.27 -50.94 69.93 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.53 -36.06 57.91 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.051 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 8.8 tp -60.94 -43.25 98.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.074 0.95 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' B' ' 27' ' ' VAL . 27.0 mt -95.35 -35.49 11.75 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.07 36.85 6.17 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' B' ' 25' ' ' LEU . 34.2 m -130.38 -177.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.562 1.145 . . . . 0.0 110.256 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -140.75 149.21 55.85 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.66 0.784 . . . . 0.0 109.489 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.91 108.51 1.71 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.48 2.12 . . . . 0.0 112.019 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.18 -31.97 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.608 0.763 . . . . 0.0 110.516 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.668 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 45.4 mt-10 -119.31 143.42 47.38 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 167.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 21.5 t -159.54 153.63 23.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.651 0.739 . . . . 0.0 111.111 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 35.6 m -143.96 165.11 25.86 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 126.109 1.764 . . . . 0.0 107.357 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.12 -15.58 40.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.045 1.83 . . . . 0.0 113.103 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.3 t -128.11 13.02 6.7 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -154.3 159.55 41.3 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.013 -0.429 . . . . 0.0 110.78 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 60.6 m -153.3 154.01 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.555 1.142 . . . . 0.0 109.529 171.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -146.37 123.45 11.45 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -130.09 138.44 50.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.286 1.035 . . . . 0.0 108.654 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.526 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.3 t -112.51 123.41 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.698 HD12 ' SD ' ' B' ' 45' ' ' MET . 80.5 mt -89.98 148.6 22.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.837 0.455 . . . . 0.0 110.282 -168.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -7.56 21.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.119 0.968 . . . . 0.0 113.578 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -81.57 4.63 20.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.745 0.818 . . . . 0.0 112.251 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.06 11.86 64.4 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.698 ' SD ' HD12 ' B' ' 41' ' ' LEU . 5.0 ppp? -117.56 171.62 7.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.501 0.72 . . . . 0.0 109.597 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.526 ' HG3' HG22 ' B' ' 40' ' ' VAL . 84.3 tttt -135.73 140.05 44.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.2 tt -138.18 123.76 19.68 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.184 0.516 . . . . 0.0 110.269 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.88 168.98 19.67 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.844 0.735 . . . . 0.0 112.724 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 39.1 mt -137.81 105.2 5.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 169.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.474 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.5 t90 -114.32 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 50.9 m -78.72 134.61 37.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.423 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -68.02 -19.26 64.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 0.0 112.965 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -79.42 -9.15 59.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.5 0.32 . . . . 0.0 111.295 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.5 t -128.92 7.48 5.58 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.024 0.529 . . . . 0.0 111.318 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 11.8 p -69.66 147.15 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 94' ' ' GLN . 26.3 mt-10 -128.7 113.91 19.2 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.319 0.648 . . . . 0.0 110.056 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 94' ' ' GLN . 97.7 Cg_endo -73.0 143.57 78.26 Favored 'Cis proline' 0 C--N 1.387 2.583 0 CA-C-N 119.472 0.847 . . . . 0.0 113.226 2.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 126.14 18.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.097 0.959 . . . . 0.0 110.527 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.96 155.96 44.24 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.454 1.102 . . . . 0.0 109.715 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.4 m -132.7 92.55 3.07 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.617 0.767 . . . . 0.0 109.013 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.504 HG21 ' HA3' ' A' ' 64' ' ' GLY . 79.2 t -141.69 125.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.312 1.045 . . . . 0.0 108.568 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.7 p -140.07 141.71 36.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.83 0.852 . . . . 0.0 109.215 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.9 24.5 69.3 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.477 0.485 . . . . 0.0 112.395 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.85 139.26 5.87 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.86 -155.35 26.5 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 10' ' ' TYR . . . -77.43 172.64 55.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.569 ' HA ' ' HG3' ' B' ' 114' ' ' ARG . 6.0 mm-40 -99.68 151.24 21.44 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.599 HD22 HD11 ' B' ' 9' ' ' LEU . 50.1 tp -109.78 101.1 10.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -84.9 113.99 21.79 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.125 0.42 . . . . 0.0 111.604 -167.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -93.53 106.51 18.47 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -90.67 131.05 36.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.145 0.497 . . . . 0.0 111.893 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.65 165.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.4 1.08 . . . . 0.0 110.541 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.527 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.0 pt-20 -69.2 -44.1 72.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.518 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.434 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.9 p30 -155.23 178.15 10.54 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.762 0.71 . . . . 0.0 112.7 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.753 1.621 . . . . 0.0 112.608 -167.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.49 -42.26 75.01 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.708 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.527 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.3 mm-40 -65.39 -24.03 67.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.697 0.799 . . . . 0.0 112.458 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.35 -40.52 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.353 0.597 . . . . 0.0 110.009 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.28 -30.43 63.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.303 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 18.5 mt-10 -67.96 -43.0 80.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.702 0.763 . . . . 0.0 109.213 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.3 m -64.96 -37.58 88.13 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.193 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.49 -60.92 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.767 0.827 . . . . 0.0 109.531 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.446 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -60.66 -38.56 85.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.902 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.69 -39.72 86.03 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.43 0.456 . . . . 0.0 113.878 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -67.85 -42.06 81.96 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.394 0.678 . . . . 0.0 109.679 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.45 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 31.9 ttpt -58.89 -43.33 90.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 0.0 110.229 177.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.77 -30.24 70.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.664 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.6 m -102.55 14.93 30.68 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.926 0.891 . . . . 0.0 112.256 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.82 47.1 5.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.219 -0.9 . . . . 0.0 114.957 163.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.59 131.69 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.213 0.605 . . . . 0.0 109.499 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.89 92.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.86 0.864 . . . . 0.0 112.114 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.45 ' HE1' ' HB2' ' B' ' 86' ' ' LYS . 13.5 ptp 48.94 82.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.655 1.582 . . . . 0.0 114.128 172.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.418 ' H ' HD22 ' B' ' 93' ' ' LEU . 0.0 OUTLIER -106.67 83.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.453 0.644 . . . . 0.0 109.941 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.489 ' NE2' ' HB3' ' A' ' 56' ' ' GLU . 5.7 tp60 177.45 133.78 0.06 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 108.14 174.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -78.07 121.38 83.91 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 20.0 Cg_endo -60.12 106.34 0.33 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.654 2.236 . . . . 0.0 110.117 172.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.78 152.25 46.42 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.263 0.625 . . . . 0.0 110.158 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -62.89 138.48 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.328 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.482 ' SD ' HG21 ' B' ' 104' ' ' THR . 11.4 ttt -143.26 175.22 10.06 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.73 0.812 . . . . 0.0 109.007 -174.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' B' ' 99' ' ' MET . 11.3 tp10 -51.98 -32.57 34.17 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.113 1.365 . . . . 0.0 112.964 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.07 -6.37 23.42 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.614 0.765 . . . . 0.0 111.281 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 128.84 -168.2 20.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.528 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -76.02 101.23 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.482 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.4 t -115.1 149.06 38.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.501 0.667 . . . . 0.0 111.328 -167.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 2.6 t80 -146.48 129.37 16.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.465 1.506 . . . . 0.0 108.537 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 119.54 33.09 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.114 0.483 . . . . 0.0 109.812 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -107.35 158.71 16.94 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.875 0.87 . . . . 0.0 112.464 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.65 129.72 23.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.2 p-10 -88.33 179.94 1.51 Allowed Pre-proline 0 CA--C 1.575 1.905 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.346 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 25.4 Cg_endo -58.72 -32.22 96.53 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.499 2.132 . . . . 0.0 113.239 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.66 -5.3 47.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.787 0.435 . . . . 0.0 110.908 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m 72.7 60.4 0.12 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.137 1.375 . . . . 0.0 110.66 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -97.9 -168.23 1.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.377 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' B' ' 67' ' ' GLU . 4.2 tpp180 -149.13 94.94 2.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -175.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.01 101.78 8.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.017 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 3.4 tmt_? -100.28 98.12 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.167 0.587 . . . . 0.0 112.079 -169.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.29 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -143.48 161.42 38.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.714 0.688 . . . . 0.0 112.375 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -110.75 130.59 55.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 168.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -68.91 123.38 20.83 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.161 0.288 . . . . 0.0 110.664 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.86 106.64 17.21 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.973 -0.904 . . . . 0.0 111.064 -179.052 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.338 0.113 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m -80.36 144.92 32.34 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.414 ' HB3' HD23 ' B' ' 41' ' ' LEU . 12.5 m170 -115.17 128.26 26.09 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.503 0.721 . . . . 0.0 109.854 -176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -91.02 101.26 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.139 2.559 . . . . 0.0 112.737 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.77 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 4.2 p30 -85.03 -2.23 57.73 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.218 0.532 . . . . 0.0 111.06 169.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -118.46 112.27 19.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -168.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -109.76 131.71 54.82 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.52 132.42 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' HB2' HD12 ' A' ' 49' ' ' LEU . 90.2 mt -96.92 173.23 7.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.091 0.948 . . . . 0.0 108.941 173.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -130.38 120.29 24.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.442 -174.144 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG12 ' NE2' ' A' ' 113' ' ' HIS . 10.3 m -125.89 155.84 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.861 0.864 . . . . 0.0 109.679 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.84 -56.83 3.17 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -94.93 110.36 49.34 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.163 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 31.8 Cg_exo -54.94 -57.25 1.8 Allowed 'Trans proline' 0 CA--C 1.573 2.455 0 C-N-CA 122.749 2.3 . . . . 0.0 114.232 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 34.9 Cg_exo -58.32 -58.63 0.7 Allowed 'Trans proline' 0 C--N 1.401 3.319 0 CA-C-N 122.181 1.815 . . . . 0.0 112.146 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.71 95.22 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.753 0.821 . . . . 0.0 112.36 -167.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -76.42 -33.84 58.79 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 88.9 m -73.1 -39.77 65.52 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 20.6 mm-40 -59.75 -36.87 77.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.89 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.27 -44.51 94.91 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 110.233 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -70.91 -29.16 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.02 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 18' ' ' THR . 60.1 mtpt -56.63 -47.7 79.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.805 0.729 . . . . 0.0 112.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.87 47.28 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.758 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp -63.7 -40.59 97.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.516 1.126 . . . . 0.0 112.332 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' VAL . 32.2 mt -93.46 -38.55 11.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.18 24.85 18.22 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.537 0.523 . . . . 0.0 111.809 -173.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.3 m -118.58 174.91 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.024 0.93 . . . . 0.0 110.449 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.9 143.97 51.28 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 108.968 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.71 112.4 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.634 2.223 . . . . 0.0 111.402 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.74 -36.51 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.447 0.699 . . . . 0.0 109.769 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.8 mm-40 -112.02 87.03 2.47 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.5 p -90.19 127.62 36.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.43 0.692 . . . . 0.0 109.214 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -140.61 152.81 67.14 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.985 0.914 . . . . 0.0 108.538 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -46.35 -44.68 20.04 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.871 3.048 . . . . 0.0 114.646 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -126.92 15.94 7.39 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.6 151.3 37.87 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -140.58 142.72 35.07 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -139.53 121.08 15.17 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -133.05 131.72 40.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.554 1.141 . . . . 0.0 108.637 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 46' ' ' LYS . 16.2 t -109.49 129.62 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.039 -173.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.494 HD12 ' SD ' ' A' ' 45' ' ' MET . 49.4 mt -94.27 143.0 26.76 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.786 0.434 . . . . 0.0 110.445 -171.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -5.76 19.43 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.376 1.07 . . . . 0.0 112.299 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.501 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.7 OUTLIER -67.34 -19.51 65.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.769 1.228 . . . . 0.0 111.627 177.034 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.44 16.62 15.56 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.728 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -125.66 176.26 7.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.518 0.727 . . . . 0.0 109.54 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.6 tttt -140.32 137.53 34.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.02 118.55 18.94 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.772 0.429 . . . . 0.0 110.084 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.31 163.22 21.88 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.521 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 9' ' ' LEU . 1.1 tp -141.43 104.85 4.66 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.7 t90 -111.09 134.83 52.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.902 0.881 . . . . 0.0 108.678 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 54' ' ' THR . 35.9 m -75.83 136.39 40.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.751 0.31 . . . . 0.0 111.249 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -72.5 -9.86 59.08 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.993 0.917 . . . . 0.0 112.455 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -86.89 -8.8 56.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.202 0.601 . . . . 0.0 111.181 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 51' ' ' SER . 15.4 t -135.04 8.24 3.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.177 0.591 . . . . 0.0 111.339 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.2 p -68.28 143.45 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 122.58 0.352 . . . . 0.0 111.372 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.39 117.23 25.11 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.556 1.142 . . . . 0.0 108.706 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 12.4 Cg_exo -70.88 144.13 78.07 Favored 'Cis proline' 0 C--N 1.386 2.531 0 CA-C-N 119.681 0.922 . . . . 0.0 112.992 -1.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.17 128.76 37.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.149 0.98 . . . . 0.0 111.958 -177.002 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.45 109.03 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.764 1.226 . . . . 0.0 108.531 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.2 p -87.83 89.15 7.88 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.3 142.84 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.523 0.729 . . . . 0.0 109.847 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -138.96 135.55 34.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.226 1.01 . . . . 0.0 109.22 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.38 51.75 49.67 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.61 0.569 . . . . 0.0 114.227 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.18 44.99 0.42 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.87 -169.51 11.69 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.781 -0.209 . . . . 0.0 113.125 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.97 170.12 47.67 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 124.38 0.694 . . . . 0.0 113.009 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -98.53 160.04 14.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.918 0.887 . . . . 0.0 110.561 -171.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 68' ' ' LEU . 20.4 mt -107.09 101.23 10.66 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.54 103.53 14.48 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -82.46 106.17 14.11 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -84.72 128.89 34.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.816 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.74 157.92 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.811 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG3' HD22 ' A' ' 74' ' ' ASN . 10.9 pt-20 -68.17 -42.06 80.58 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.93 -172.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.45 HD22 ' HG3' ' A' ' 73' ' ' GLU . 9.5 p30 -151.05 174.38 13.24 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-O 121.49 0.662 . . . . 0.0 112.059 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.51 -27.64 69.11 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.41 -165.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.06 -42.11 76.69 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.304 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 80.3 mm-40 -62.87 -23.73 67.47 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.588 0.755 . . . . 0.0 112.568 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.5 -42.83 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.429 0.633 . . . . 0.0 110.457 171.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.76 -30.77 67.35 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.66 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -70.68 -43.11 69.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.371 0.605 . . . . 0.0 109.683 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -30.23 69.07 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.759 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -62.25 -60.88 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.898 0.879 . . . . 0.0 109.005 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.43 89.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.766 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.2 -45.13 94.45 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 124.115 0.885 . . . . 0.0 113.908 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -64.2 -45.52 87.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.17 0.588 . . . . 0.0 110.288 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.3 -46.02 76.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.576 0.75 . . . . 0.0 110.269 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.61 63.42 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.52 14.46 29.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 112.539 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 55.27 3.61 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.439 -0.8 . . . . 0.0 114.776 166.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.4 p -104.33 148.79 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.63 56.42 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.879 0.471 . . . . 0.0 111.456 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.552 ' HB2' HG13 ' A' ' 90' ' ' VAL . 55.5 ttm 63.56 84.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 166.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 86.75 2.63 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 121.332 0.587 . . . . 0.0 110.83 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 106' ' ' THR . 55.7 tp60 179.02 122.57 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.519 1.528 . . . . 0.0 108.187 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.54 114.94 49.7 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.61 107.26 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.385 2.723 . . . . 0.0 112.256 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.81 145.51 42.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 110.021 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 112.24 8.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.437 ' HG3' ' H ' ' A' ' 101' ' ' PHE . 49.4 tpp -100.46 162.63 12.81 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.64 -23.08 62.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.237 0.615 . . . . 0.0 111.007 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 99' ' ' MET . 15.5 m-85 -120.72 90.77 3.39 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.374 1.07 . . . . 0.0 108.555 174.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.48 152.08 1.12 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.558 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 84.8 t80 -71.97 101.06 2.6 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 165.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -109.25 151.26 26.77 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.813 0.816 . . . . 0.0 112.04 -161.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.74 149.75 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.563 1.545 . . . . 0.0 108.498 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 87.6 m -141.23 128.3 20.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.751 0.705 . . . . 0.0 110.497 171.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.99 155.91 18.91 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.137 0.575 . . . . 0.0 109.79 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.73 126.31 52.45 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.54 156.5 22.86 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.055 0.942 . . . . 0.0 111.484 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.56 -21.91 73.17 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.739 2.293 . . . . 0.0 112.431 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -92.29 -20.69 20.86 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.142 0.977 . . . . 0.0 110.559 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.2 m 72.63 90.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.873 1.669 . . . . 0.0 110.967 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.506 ' NE2' HG12 ' A' ' 11' ' ' VAL . 10.5 m80 -113.18 -92.32 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 113' ' ' HIS . 4.7 tpt180 167.98 109.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.281 1.032 . . . . 0.0 109.348 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.6 110.33 13.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.141 0.577 . . . . 0.0 111.175 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -95.3 147.55 23.37 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.337 0.517 . . . . 0.0 110.685 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.04 125.58 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -130.62 151.77 50.71 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.092 0.86 . . . . 0.0 111.489 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -103.81 117.55 34.63 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -77.64 111.96 13.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.67 94.78 1.04 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.084 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.364 -175.28 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.408 ' HE2' ' HB2' ' B' ' 1' ' ' MET . 3.5 ppp? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 11.9 m -133.42 146.59 51.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -115.75 129.13 25.4 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.499 0.72 . . . . 0.0 110.572 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.41 ' HD3' HD22 ' A' ' 25' ' ' LEU . 65.0 Cg_endo -91.75 101.91 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.014 2.476 . . . . 0.0 112.237 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.728 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.9 p-10 -86.01 -1.68 57.58 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.416 0.627 . . . . 0.0 111.019 169.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.409 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.1 t80 -118.53 112.45 19.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -169.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -109.78 131.55 54.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 52.3 mt -113.8 132.86 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' B' ' 49' ' ' LEU . 93.2 mt -97.49 172.05 7.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.918 0.866 . . . . 0.0 109.005 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' B' ' 50' ' ' TRP . 30.9 m-85 -128.22 122.11 30.99 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.897 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.478 HG12 ' NE2' ' B' ' 113' ' ' HIS . 6.2 m -125.93 155.94 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.81 0.844 . . . . 0.0 109.523 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -88.01 -56.77 3.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.179 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -94.42 109.31 42.2 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.244 0.618 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.41 -56.92 2.1 Favored 'Trans proline' 0 CA--C 1.574 2.491 0 C-N-CA 122.68 2.254 . . . . 0.0 114.269 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.37 -58.79 0.54 Allowed 'Trans proline' 0 C--N 1.402 3.369 0 CA-C-N 122.179 1.814 . . . . 0.0 111.714 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.06 92.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.788 0.835 . . . . 0.0 112.494 -167.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -76.31 -33.82 59.04 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.023 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -73.11 -39.78 65.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.53 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 19.8 mm-40 -59.61 -37.33 78.29 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.712 172.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' B' ' 90' ' ' VAL . 78.2 t80 -62.5 -45.36 93.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.467 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.44 -29.27 65.81 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.025 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 63.4 mtpt -56.94 -47.33 80.9 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.794 0.725 . . . . 0.0 112.867 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.86 44.54 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.872 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -63.45 -40.23 96.6 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.614 1.166 . . . . 0.0 112.533 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' B' ' 27' ' ' VAL . 34.3 mt -93.57 -39.13 11.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.24 25.91 15.36 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.848 -173.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' B' ' 25' ' ' LEU . 18.2 m -119.38 175.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.093 0.957 . . . . 0.0 110.406 -176.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.31 140.66 37.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 50.8 Cg_exo -57.22 111.54 0.85 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.915 2.41 . . . . 0.0 112.29 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.91 -35.88 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 109.88 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 26.8 mm-40 -112.35 87.63 2.62 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.5 p -90.66 128.18 36.54 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -141.51 153.37 65.44 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -47.83 -44.29 27.29 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.764 2.976 . . . . 0.0 114.569 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -126.57 16.14 7.59 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -145.58 151.65 38.45 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -140.63 142.17 35.02 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.665 0.786 . . . . 0.0 108.889 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.68 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.3 tm? -138.98 121.14 15.77 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -133.04 132.0 41.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 108.607 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.538 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.5 t -110.45 129.46 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.921 0.888 . . . . 0.0 109.012 -173.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.494 HD22 ' SD ' ' B' ' 45' ' ' MET . 7.8 mp -93.66 142.76 26.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 0.0 110.135 -170.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.44 -5.89 21.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.986 0.914 . . . . 0.0 112.385 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.45 ' N ' HD22 ' B' ' 43' ' ' ASN . 0.8 OUTLIER -66.69 -19.74 65.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.659 1.183 . . . . 0.0 111.976 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.29 16.79 15.26 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.176 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.77 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.5 ppp? -125.52 175.95 7.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.747 0.819 . . . . 0.0 109.723 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.538 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -140.36 137.68 34.26 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -133.03 118.84 19.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.753 0.421 . . . . 0.0 110.234 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.409 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -97.47 163.33 21.76 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' B' ' 9' ' ' LEU . 1.1 tp -141.75 104.68 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 171.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 3.3 t90 -111.43 134.78 52.77 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.407 ' HB2' HG22 ' B' ' 54' ' ' THR . 35.3 m -76.12 136.56 39.83 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 111.355 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -72.48 -9.88 59.1 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.917 0.887 . . . . 0.0 112.335 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -87.18 -8.18 57.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.28 0.632 . . . . 0.0 111.095 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.407 HG22 ' HB2' ' B' ' 51' ' ' SER . 13.2 t -135.42 8.8 3.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.907 0.483 . . . . 0.0 111.342 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' B' ' 58' ' ' LYS . 4.0 p -67.93 143.3 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.38 0.272 . . . . 0.0 111.272 176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -123.81 117.49 27.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.246 1.018 . . . . 0.0 109.181 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.3 143.41 76.32 Favored 'Cis proline' 0 C--N 1.381 2.277 0 CA-C-N 120.098 1.071 . . . . 0.0 113.105 -1.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.535 ' HA ' HG13 ' B' ' 55' ' ' VAL . 3.1 tppp? -58.84 127.81 34.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.992 0.917 . . . . 0.0 112.66 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.08 108.92 3.1 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.78 1.232 . . . . 0.0 108.677 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -87.0 89.73 8.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.16 0.584 . . . . 0.0 109.507 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 142.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.551 0.741 . . . . 0.0 110.422 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -139.24 136.55 35.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 109.479 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.75 51.84 50.48 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.752 0.658 . . . . 0.0 114.172 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.05 45.72 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.45 -170.63 12.03 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.455 -0.372 . . . . 0.0 113.124 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.4 170.56 47.99 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.258 0.622 . . . . 0.0 112.975 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -99.93 159.81 14.8 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.589 0.756 . . . . 0.0 110.77 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.78 101.36 10.81 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.58 103.69 14.65 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -82.81 105.78 14.1 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 41.0 mtm105 -84.6 127.99 34.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.689 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.56 157.79 43.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.963 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.26 -42.39 83.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.037 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.99 174.33 13.27 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 121.497 0.665 . . . . 0.0 111.876 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.61 -27.7 69.12 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.139 -1.392 . . . . 0.0 112.461 -165.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.99 -41.84 77.3 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -63.56 -23.71 67.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.561 0.745 . . . . 0.0 112.392 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.33 -42.65 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.252 0.621 . . . . 0.0 110.631 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.43 -31.12 68.17 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.594 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.2 mt-10 -70.98 -42.69 69.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.408 0.623 . . . . 0.0 109.557 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -69.19 -29.81 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -62.64 -60.68 3.17 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.549 0.74 . . . . 0.0 109.143 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.17 88.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.801 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.06 94.38 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 124.041 0.838 . . . . 0.0 113.615 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -63.88 -45.7 88.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.308 0.643 . . . . 0.0 110.235 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.82 -45.7 78.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.582 0.753 . . . . 0.0 110.454 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.91 63.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.028 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -99.45 14.15 30.81 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.959 0.903 . . . . 0.0 112.43 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 54.25 3.65 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.709 -0.678 . . . . 0.0 114.751 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' B' ' 20' ' ' PHE . 38.3 t -104.26 147.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.248 0.619 . . . . 0.0 109.339 170.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.15 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.092 0.557 . . . . 0.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 55.0 ttm 63.84 84.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 166.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.62 86.77 2.64 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.863 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 22.9 tm0? 178.82 122.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.072 1.349 . . . . 0.0 107.644 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -79.58 114.48 45.94 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -48.64 107.53 0.14 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.567 2.845 . . . . 0.0 112.178 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.84 145.31 42.3 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.942 0.897 . . . . 0.0 109.941 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.28 112.38 8.3 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.521 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 16.5 ttm -101.18 162.91 12.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.78 -23.9 63.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 0.0 111.106 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' PHE . . . . . 0.521 ' H ' ' HG2' ' B' ' 99' ' ' MET . 96.3 m-85 -119.51 91.49 3.56 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.552 1.141 . . . . 0.0 109.033 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.78 151.56 1.13 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 80.1 t80 -71.8 100.87 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.3 t -108.77 151.14 26.61 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.948 0.88 . . . . 0.0 111.893 -161.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.544 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 9.6 t80 -141.15 149.23 41.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.036 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 62.6 m -141.57 128.19 20.25 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.982 0.81 . . . . 0.0 110.69 171.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.23 155.77 19.14 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.279 0.632 . . . . 0.0 109.935 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.61 128.43 54.53 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.22 156.86 57.54 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.197 0.999 . . . . 0.0 110.361 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.0 -21.71 72.38 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -92.93 -20.12 20.94 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.962 0.905 . . . . 0.0 110.377 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 40.2 m 71.9 90.99 0.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.965 1.706 . . . . 0.0 111.108 -176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.478 ' NE2' HG12 ' B' ' 11' ' ' VAL . 12.4 m170 -113.88 -91.68 0.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 167.32 109.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.577 1.151 . . . . 0.0 109.176 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -126.36 110.19 13.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.11 0.564 . . . . 0.0 111.153 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -92.56 147.86 22.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.215 0.606 . . . . 0.0 110.581 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -134.74 125.74 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 163.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.417 ' CE1' ' HG2' ' B' ' 71' ' ' ARG . 12.4 p90 -130.15 151.77 50.31 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.295 0.952 . . . . 0.0 111.479 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -104.11 116.46 32.24 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -74.84 107.61 7.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.24 100.19 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.905 0.753 . . . . 0.0 109.737 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.089 -174.393 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.429 0.156 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.448 HG22 ' HB3' ' B' ' 70' ' ' PHE . 72.3 m -133.95 135.19 43.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.933 0.893 . . . . 0.0 110.101 -168.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.25 101.3 28.5 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.137 0.575 . . . . 0.0 111.516 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 70.1 Cg_endo -74.2 101.14 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.69 2.26 . . . . 0.0 111.563 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.614 ' HB3' ' HE ' ' B' ' 71' ' ' ARG . 27.0 t70 -113.52 1.78 15.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.031 0.932 . . . . 0.0 110.477 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -126.57 112.86 16.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -107.71 136.97 46.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 53.0 mt -119.99 135.0 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.617 0.767 . . . . 0.0 109.765 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.476 HD23 HD21 ' A' ' 47' ' ' LEU . 4.4 mm? -108.94 142.91 38.9 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 3.7 p90 -97.03 123.57 40.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.942 -173.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' SER . 22.9 m -127.91 162.12 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.669 -0.644 . . . . 0.0 109.823 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -116.85 45.8 1.78 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.724 1.21 . . . . 0.0 108.917 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 16' ' ' ALA . 47.9 t30 178.85 74.99 0.14 Allowed Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.868 -158.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.0 Cg_exo -58.62 -63.12 0.15 Allowed 'Trans proline' 0 CA--C 1.579 2.77 0 C-N-CA 122.183 1.922 . . . . 0.0 113.889 -177.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 32.8 Cg_exo -60.27 -60.47 0.27 Allowed 'Trans proline' 0 C--N 1.404 3.465 0 CA-C-N 123.111 2.147 . . . . 0.0 112.331 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . . . -67.74 -39.18 84.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.589 -165.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.0 t -76.9 -28.53 55.36 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 86.3 m -71.77 -34.25 69.3 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.578 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 15.1 mm100 -64.41 -37.14 86.46 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.467 170.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.15 -43.09 88.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 12.2 m-85 -68.53 -31.21 70.29 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.796 176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -57.31 -46.14 83.49 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.269 0.486 . . . . 0.0 112.117 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.07 -35.42 56.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.418 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.9 tp -60.89 -41.52 96.21 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.247 1.419 . . . . 0.0 112.48 -177.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.494 HD22 ' HG3' ' B' ' 4' ' ' PRO . 25.3 mt -92.49 -45.18 8.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.256 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.5 28.23 6.45 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.044 -172.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.7 m -129.77 -178.97 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.063 0.945 . . . . 0.0 110.47 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -126.39 156.11 73.22 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.485 1.114 . . . . 0.0 108.504 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 47.7 Cg_endo -66.95 125.55 13.84 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.184 1.922 . . . . 0.0 112.413 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 40' ' ' VAL . 7.3 p -70.72 -35.81 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.549 0.739 . . . . 0.0 110.246 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 72.2 mm-40 -126.3 138.84 53.64 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 108.273 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -142.12 135.4 29.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 110.321 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 42.0 m -137.36 157.62 73.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.504 1.522 . . . . 0.0 108.398 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.8 -41.32 38.9 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.113 2.542 . . . . 0.0 114.098 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -127.92 21.95 6.31 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 85.2 t80 -149.99 152.94 35.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.09 0.556 . . . . 0.0 109.679 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 34.7 m -144.48 157.22 44.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.818 0.847 . . . . 0.0 109.455 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.7 tp -152.02 125.19 8.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.441 ' CZ ' ' HG ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -133.38 114.8 14.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.654 1.182 . . . . 0.0 109.194 174.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 30' ' ' VAL . 3.9 p -93.26 133.01 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.607 0.763 . . . . 0.0 109.589 174.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.438 HD13 ' SD ' ' A' ' 45' ' ' MET . 9.0 mp -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.213 0.605 . . . . 0.0 110.078 -170.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.48 -7.45 49.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.309 0.644 . . . . 0.0 111.528 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -73.54 -15.29 61.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.451 0.7 . . . . 0.0 110.221 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.36 -12.02 36.5 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 123.44 0.543 . . . . 0.0 113.808 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.595 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.5 ppp? -86.32 169.78 12.64 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.31 0.555 . . . . 0.0 110.216 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.67 138.27 48.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.452 0.301 . . . . 0.0 110.681 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.476 HD21 HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -136.12 130.6 33.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.032 0.533 . . . . 0.0 110.345 -170.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.76 166.17 13.12 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.627 0.632 . . . . 0.0 112.081 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 17.5 mt -136.47 106.98 6.48 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.455 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.5 t90 -109.8 129.45 55.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 53.3 m -72.33 129.97 39.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HG12 ' A' ' 55' ' ' VAL . 23.3 ptt180 -67.27 -18.7 65.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -75.88 -23.65 55.62 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.69 0.396 . . . . 0.0 110.94 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' HB2' ' A' ' 51' ' ' SER . 14.3 t -115.7 6.27 14.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.564 0.746 . . . . 0.0 111.479 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 9.5 p -71.72 151.97 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.35 117.03 17.68 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 122.994 0.518 . . . . 0.0 110.96 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.5 Cg_exo -73.59 140.46 67.35 Favored 'Cis proline' 0 C--N 1.391 2.799 0 CA-C-N 119.673 0.919 . . . . 0.0 111.163 0.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -60.46 110.1 1.18 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 110.083 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.1 108.61 19.77 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.461 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 p -81.47 85.96 6.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.55 141.74 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.089 0.955 . . . . 0.0 109.557 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -161.02 142.02 11.57 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.232 1.413 . . . . 0.0 108.827 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.62 -38.87 0.61 Allowed Glycine 0 C--N 1.345 1.081 0 O-C-N 123.129 0.268 . . . . 0.0 112.487 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.69 -77.42 0.05 OUTLIER Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.43 -137.14 19.89 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.06 167.19 54.62 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 16.8 mt-10 -103.75 152.48 21.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 47' ' ' LEU . 53.0 tp -117.71 98.61 6.46 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -90.95 114.71 27.28 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.392 0.615 . . . . 0.0 111.354 -169.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.0 m-85 -88.68 122.08 31.73 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.065 1.346 . . . . 0.0 108.79 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' B' ' 5' ' ' ASP . 41.3 mtm180 -99.01 129.88 45.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.501 0.667 . . . . 0.0 111.913 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.82 165.61 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.701 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.587 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.3 pt-20 -66.83 -39.73 87.77 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.2 p30 -162.5 -179.92 7.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.74 0.7 . . . . 0.0 112.094 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.02 -29.95 68.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.935 1.294 . . . . 0.0 112.913 -165.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.96 -47.8 76.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.046 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.5 mm-40 -64.7 -23.06 67.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.966 -1.016 . . . . 0.0 112.497 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 117' ' ' VAL . 63.9 t -66.51 -46.04 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.539 0.736 . . . . 0.0 109.729 174.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 27.6 t70 -72.65 -28.81 62.95 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.242 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.3 mt-10 -69.52 -41.35 76.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.397 0.618 . . . . 0.0 110.012 175.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.6 m -66.98 -32.86 74.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.858 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 37.0 t80 -54.13 -59.98 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.987 0.915 . . . . 0.0 109.515 172.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -61.08 -38.8 87.55 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.688 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.54 92.13 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 123.617 0.573 . . . . 0.0 114.257 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -63.71 -45.49 89.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.544 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.6 ttpt -56.07 -45.39 79.32 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.964 0.906 . . . . 0.0 110.256 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.51 68.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.976 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 m -98.89 13.63 31.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.144 0.978 . . . . 0.0 112.616 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.33 54.81 2.74 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.309 -0.859 . . . . 0.0 114.568 164.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.7 p -102.83 152.85 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.63 -47.83 65.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.076 0.398 . . . . 0.0 110.957 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.544 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 52.6 ttm 65.34 84.02 0.16 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 170.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.87 83.21 2.14 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 120.962 0.41 . . . . 0.0 111.013 173.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 17.4 tm0? 178.46 140.04 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -87.72 123.32 69.47 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.678 0.791 . . . . 0.0 110.882 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.64 98.17 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.426 2.084 . . . . 0.0 110.409 174.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.08 157.51 43.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.796 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.01 104.76 4.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.965 0.906 . . . . 0.0 108.977 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 ttt -100.61 173.83 6.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.818 0.847 . . . . 0.0 109.983 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -55.93 -36.45 67.76 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.596 1.158 . . . . 0.0 112.177 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 -8.39 51.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.735 0.814 . . . . 0.0 110.845 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 126.63 -173.25 18.19 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.029 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.27 105.97 7.62 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 t -131.53 166.76 20.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.718 0.407 . . . . 0.0 111.934 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.49 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -155.72 160.15 40.1 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.737 169.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 3.0 m -133.45 127.3 33.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.219 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . . . -107.33 152.67 23.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 110.474 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.32 116.57 32.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 115' ' ' LEU . 4.0 p-10 -68.81 170.45 8.41 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.675 0.79 . . . . 0.0 110.923 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -46.19 -39.54 20.89 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 123.412 2.742 . . . . 0.0 114.457 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.0 -11.96 55.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.579 0.752 . . . . 0.0 111.254 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 73.07 80.93 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.62 1.568 . . . . 0.0 111.679 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -120.07 -179.51 3.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.574 ' HD2' ' HD2' ' B' ' 57' ' ' PRO . 50.0 mmt-85 -103.27 99.16 9.0 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 109' ' ' ASP . 51.4 mt -97.12 103.37 15.29 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 25.7 mmt180 -89.11 148.54 23.63 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 123.967 0.907 . . . . 0.0 110.355 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 78' ' ' VAL . 9.3 p -138.67 130.57 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 159.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -137.56 163.3 31.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.437 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.15 111.72 16.24 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.76 119.67 15.24 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.63 0.581 . . . . 0.0 110.557 -169.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.94 95.04 4.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.996 0.518 . . . . 0.0 110.692 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.815 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.433 179.1 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.673 0.273 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.469 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 88.1 m -139.61 135.69 33.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 110.535 -164.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.08 99.6 28.3 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.162 0.585 . . . . 0.0 110.969 -168.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 58.9 Cg_endo -72.95 101.55 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.695 2.264 . . . . 0.0 111.941 172.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.595 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 12.2 t70 -114.93 2.82 14.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.719 0.771 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.441 ' CD1' ' HG2' ' B' ' 46' ' ' LYS . 3.8 t80 -126.78 112.65 15.63 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -169.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -107.43 137.21 45.88 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 43.7 mt -120.35 135.57 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.511 0.724 . . . . 0.0 109.636 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.33 142.11 42.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.455 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 25.1 p90 -95.12 124.67 39.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.824 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 51' ' ' SER . 36.0 m -128.76 163.5 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.931 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -118.81 44.83 2.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.488 1.115 . . . . 0.0 108.19 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 179.39 74.84 0.16 Allowed Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.662 -158.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 23.8 Cg_exo -58.61 -63.81 0.13 Allowed 'Trans proline' 0 CA--C 1.578 2.718 0 C-N-CA 122.154 1.903 . . . . 0.0 114.016 -177.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 31.8 Cg_exo -59.51 -60.66 0.29 Allowed 'Trans proline' 0 C--N 1.404 3.464 0 CA-C-N 123.035 2.12 . . . . 0.0 112.575 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.45 85.77 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.679 -165.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -76.76 -28.6 55.79 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.3 m -71.58 -34.21 69.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.632 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.1 mm100 -63.88 -37.67 88.25 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.416 170.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.31 -42.63 88.01 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.704 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -68.15 -31.8 71.63 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.139 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.632 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 54.3 mtpt -56.84 -46.34 81.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.263 0.554 . . . . 0.0 111.805 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.36 -35.03 54.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.226 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.47 -41.08 96.71 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.341 . . . . 0.0 112.547 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -92.75 -44.89 8.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.16 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 28.79 6.34 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.986 -172.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' B' ' 25' ' ' LEU . 25.8 m -130.77 -179.49 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.927 0.891 . . . . 0.0 110.598 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.67 156.31 71.11 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 124.363 1.065 . . . . 0.0 108.368 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -67.82 126.0 14.0 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.39 2.06 . . . . 0.0 111.806 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.553 HG11 HG23 ' B' ' 40' ' ' VAL . 13.5 p -71.91 -33.69 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.287 0.635 . . . . 0.0 110.281 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' B' ' 30' ' ' VAL . 60.4 mm-40 -128.28 138.3 52.35 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.9 m -142.56 136.14 28.95 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.108 0.563 . . . . 0.0 110.28 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 35.2 m -137.74 160.02 66.55 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 125.295 1.438 . . . . 0.0 108.442 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -52.36 -40.11 71.55 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.136 2.557 . . . . 0.0 113.212 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -127.97 21.91 6.29 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 87.0 t80 -149.39 153.21 37.03 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.074 0.549 . . . . 0.0 109.745 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 71.1 m -144.57 156.97 44.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.785 0.834 . . . . 0.0 109.696 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 3.0 tt -151.77 126.47 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.36 113.53 12.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.934 1.294 . . . . 0.0 108.865 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.614 HG22 ' HG3' ' B' ' 46' ' ' LYS . 7.0 t -92.92 132.2 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.655 0.782 . . . . 0.0 109.336 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.447 HD21 HD13 ' B' ' 25' ' ' LEU . 36.0 mt -89.25 150.01 22.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.872 0.469 . . . . 0.0 110.262 -171.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.19 -7.96 52.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 111.609 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -71.91 -16.62 62.12 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.621 0.769 . . . . 0.0 110.379 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -12.17 35.49 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 123.436 0.541 . . . . 0.0 113.886 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.59 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -86.68 170.11 12.09 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.307 0.553 . . . . 0.0 109.958 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.614 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.7 tttt -131.51 137.34 48.49 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.961 0.504 . . . . 0.0 110.6 -175.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.447 HD11 HD21 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -135.67 131.43 35.7 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.334 -171.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.23 167.61 13.36 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.193 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.22 105.77 5.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.423 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -109.72 129.33 55.62 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 62.5 m -72.25 129.8 39.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.4 ' O ' HG12 ' B' ' 55' ' ' VAL . 33.3 ptt180 -67.27 -18.82 65.36 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -170.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.85 -23.95 55.74 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.653 0.381 . . . . 0.0 110.59 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.41 HG22 ' HB2' ' B' ' 51' ' ' SER . 13.6 t -115.6 6.58 14.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 7.9 p -72.09 152.41 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 122.05 -0.406 . . . . 0.0 109.99 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.458 ' HB2' HH22 ' A' ' 116' ' ' ARG . 30.6 mt-10 -130.86 116.49 17.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 122.976 0.51 . . . . 0.0 110.903 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.574 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 2.6 Cg_exo -73.35 140.49 67.48 Favored 'Cis proline' 0 C--N 1.387 2.554 0 CA-C-N 119.838 0.978 . . . . 0.0 111.068 0.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.35 110.1 1.16 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.926 0.766 . . . . 0.0 110.146 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.01 108.69 19.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.664 1.186 . . . . 0.0 108.376 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.3 p -81.42 85.19 6.5 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.94 143.32 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.867 0.867 . . . . 0.0 109.276 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.455 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 1.0 OUTLIER -162.31 141.41 9.29 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.335 1.454 . . . . 0.0 108.808 171.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.23 -38.08 0.59 Allowed Glycine 0 C--N 1.343 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 112.719 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.5 -77.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.49 -137.03 19.7 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.89 167.03 54.65 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.5 mt-10 -103.48 152.63 21.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.006 0.431 . . . . 0.0 110.525 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.447 HD21 HD11 ' B' ' 47' ' ' LEU . 57.5 tp -117.63 98.86 6.6 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.609 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.02 115.04 27.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.492 0.663 . . . . 0.0 111.381 -169.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' PHE . . . . . 0.545 ' HB2' HG22 ' B' ' 117' ' ' VAL . 6.5 m-85 -89.2 122.47 32.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.949 1.3 . . . . 0.0 108.538 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.614 ' HE ' ' HB3' ' A' ' 5' ' ' ASP . 38.9 mtm105 -99.17 128.89 45.37 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.417 0.687 . . . . 0.0 111.678 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.406 HG13 HG23 ' A' ' 2' ' ' THR . 22.7 m -129.95 165.94 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.791 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.71 -39.91 88.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -174.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' B' ' 73' ' ' GLU . 8.8 p30 -162.49 -179.54 7.02 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.543 0.61 . . . . 0.0 112.151 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.62 -29.97 69.57 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.006 1.322 . . . . 0.0 112.784 -164.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -64.49 -48.08 76.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.59 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.3 mm-40 -64.8 -22.92 67.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.118 0.967 . . . . 0.0 112.45 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.68 -45.55 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.611 0.719 . . . . 0.0 109.7 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -72.95 -28.84 62.66 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.966 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.8 mt-10 -69.32 -41.41 76.74 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.466 0.65 . . . . 0.0 109.95 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.405 ' CG2' HG21 ' B' ' 117' ' ' VAL . 23.7 m -68.22 -31.81 71.58 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.669 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -54.27 -59.52 4.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.744 0.818 . . . . 0.0 109.893 172.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.46 86.89 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.552 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.35 92.05 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 123.836 0.71 . . . . 0.0 114.064 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -64.35 -45.56 87.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.959 0.504 . . . . 0.0 109.908 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -56.49 -44.27 80.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.912 0.885 . . . . 0.0 110.404 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.52 -29.34 67.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.93 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 13.1 33.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.967 0.907 . . . . 0.0 112.447 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.03 2.69 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.603 165.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.9 p -102.98 152.83 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.95 67.69 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.146 0.43 . . . . 0.0 111.097 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.504 ' HB2' HG13 ' B' ' 90' ' ' VAL . 48.5 tpp 64.84 83.63 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.896 0.748 . . . . 0.0 112.727 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.74 82.83 2.11 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' GLN . . . . . 0.418 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 15.4 tm0? 178.81 140.89 0.1 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.081 1.353 . . . . 0.0 107.477 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.0 123.39 67.54 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.573 0.749 . . . . 0.0 110.517 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.78 98.54 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.472 2.114 . . . . 0.0 110.244 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.14 157.36 44.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.79 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.97 105.16 4.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.926 0.89 . . . . 0.0 108.85 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.43 ' SD ' HG21 ' B' ' 104' ' ' THR . 10.8 ttt -100.87 172.99 6.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.204 1.002 . . . . 0.0 109.901 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -55.34 -36.71 66.56 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.45 1.1 . . . . 0.0 112.424 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.64 -8.3 52.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.787 0.835 . . . . 0.0 110.953 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 126.52 -173.14 18.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.133 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -76.74 106.49 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.43 HG21 ' SD ' ' B' ' 99' ' ' MET . 11.9 t -132.0 166.19 22.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 0.0 111.82 -169.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' PHE . . . . . 0.418 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 6.4 p90 -153.71 162.35 41.32 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.409 168.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 29.2 m -134.54 127.69 31.81 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.48 152.44 24.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.388 0.675 . . . . 0.0 110.523 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.11 117.61 34.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.473 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 5.8 p-10 -71.12 171.72 8.02 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.702 -0.666 . . . . 0.0 110.288 176.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 7.7 Cg_endo -46.9 -39.63 24.73 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.464 2.776 . . . . 0.0 114.194 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.18 -10.7 57.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.133 0.573 . . . . 0.0 111.604 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 15.3 m 72.98 82.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.108 1.363 . . . . 0.0 111.565 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.422 ' HE1' HG12 ' B' ' 11' ' ' VAL . 13.4 m80 -123.25 179.99 4.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -103.93 99.15 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.91 103.83 15.81 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.609 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 44.0 ttm-85 -89.02 148.2 23.87 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.618 0.767 . . . . 0.0 110.516 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' B' ' 70' ' ' PHE . 21.5 t -136.58 131.18 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -136.99 163.94 29.53 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ALA . . . . . 0.426 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -124.67 111.71 15.91 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.86 119.32 13.9 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.757 0.661 . . . . 0.0 110.623 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 95.05 1.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.021 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.369 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -71.1 138.51 49.78 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.069 0.548 . . . . 0.0 109.758 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -96.98 112.2 59.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 0.0 110.705 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -87.26 83.44 1.01 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.842 2.361 . . . . 0.0 111.765 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.781 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.9 p-10 -84.8 4.92 30.73 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 172.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.7 t80 -123.41 127.66 48.76 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.093 1.357 . . . . 0.0 107.681 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -126.36 136.1 52.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.959 0.904 . . . . 0.0 108.584 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 50.9 mt -119.56 137.16 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.696 0.798 . . . . 0.0 109.53 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.503 HD11 HD22 ' A' ' 68' ' ' LEU . 97.4 mt -108.08 140.56 41.09 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.523 ' HE2' ' HA ' ' A' ' 62' ' ' THR . 36.3 p90 -85.7 130.98 34.42 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.262 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.515 HG12 ' NE2' ' A' ' 113' ' ' HIS . 5.3 m -129.5 151.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.479 0.657 . . . . 0.0 110.575 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.46 -55.36 3.69 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.22 1.008 . . . . 0.0 109.938 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -105.15 98.4 15.97 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.54 0.736 . . . . 0.0 109.927 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.2 Cg_exo -51.78 -53.92 6.19 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.518 2.812 . . . . 0.0 115.185 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.29 -54.19 5.87 Favored 'Trans proline' 0 C--N 1.402 3.363 0 C-N-CA 122.53 2.153 . . . . 0.0 113.023 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.18 61.83 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.296 -168.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -77.38 -35.16 54.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.723 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 78.6 m -67.16 -43.31 82.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.568 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 19.4 mm100 -61.47 -35.02 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.63 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 t80 -64.05 -44.26 93.01 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 124.058 0.849 . . . . 0.0 110.142 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -71.55 -30.06 65.46 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.854 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -56.31 -50.51 71.23 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.252 0.549 . . . . 0.0 111.991 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -33.76 52.41 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.72 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 19.4 tp -60.99 -48.62 80.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.707 1.203 . . . . 0.0 112.801 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 27' ' ' VAL . 35.4 mt -84.94 -40.79 16.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.301 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 33.61 6.39 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -173.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.4 m -128.27 -178.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.29 1.036 . . . . 0.0 110.595 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -132.95 141.17 40.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.988 0.915 . . . . 0.0 108.865 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.555 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 18.9 Cg_exo -66.06 110.82 1.82 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.613 2.209 . . . . 0.0 111.793 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.99 -39.68 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 17.9 mm-40 -112.51 109.04 18.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.2 p -113.88 141.97 46.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.277 0.631 . . . . 0.0 109.655 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 66.1 m -142.94 160.92 51.22 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.988 1.315 . . . . 0.0 108.894 -175.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.43 -30.85 91.74 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.736 2.29 . . . . 0.0 113.013 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.5 t -127.55 19.39 6.78 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.173 0.589 . . . . 0.0 111.894 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.3 t80 -159.1 156.78 29.77 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.881 0.472 . . . . 0.0 110.345 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 m -146.47 150.31 35.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.474 1.11 . . . . 0.0 108.358 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -144.44 116.97 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -128.85 122.97 31.55 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.037 1.335 . . . . 0.0 108.542 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 46' ' ' LYS . 15.6 t -106.21 134.0 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.979 0.912 . . . . 0.0 109.425 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' SD ' ' A' ' 45' ' ' MET . 85.5 mt -95.19 147.18 23.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.562 0.345 . . . . 0.0 110.107 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -12.45 52.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.302 1.041 . . . . 0.0 112.199 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.5 -8.92 29.61 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.175 0.99 . . . . 0.0 112.931 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.1 53.75 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.811 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -114.56 170.84 8.01 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.9 0.88 . . . . 0.0 108.938 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 40' ' ' VAL . 75.9 tttt -133.75 134.22 42.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -128.28 118.13 22.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.775 0.43 . . . . 0.0 109.878 -174.163 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -96.56 166.54 24.08 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.717 0.675 . . . . 0.0 111.521 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 tp -143.38 102.44 3.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.484 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 6.2 t90 -111.05 130.29 55.65 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 36.2 m -68.28 126.91 31.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.154 0.284 . . . . 0.0 110.244 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.427 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 24.7 ptt180 -68.79 -13.4 62.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.922 0.889 . . . . 0.0 112.605 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -14.4 59.51 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.47 0.308 . . . . 0.0 110.878 176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.454 HG23 ' HE1' ' A' ' 50' ' ' TRP . 13.6 t -128.36 10.5 6.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.62 0.768 . . . . 0.0 110.785 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 58' ' ' LYS . 10.3 p -69.79 149.31 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 173.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -130.37 123.8 20.76 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 122.983 0.513 . . . . 0.0 110.638 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.84 137.84 50.29 Favored 'Cis proline' 0 C--N 1.387 2.604 0 C-N-CA 124.453 -1.061 . . . . 0.0 111.432 -6.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -50.81 110.68 0.45 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.516 0.726 . . . . 0.0 110.886 -175.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.47 110.0 22.16 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 p -83.13 87.22 6.92 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -153.31 150.96 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.738 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.523 ' HA ' ' HE2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -163.72 147.92 10.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.245 1.418 . . . . 0.0 109.279 170.395 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.28 -7.91 76.47 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.961 -0.563 . . . . 0.0 114.098 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' HD3' ' A' ' 114' ' ' ARG . . . -159.24 122.95 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 133.98 111.93 1.26 Allowed Glycine 0 C--N 1.34 0.781 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.414 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 77.25 109.82 0.15 Allowed Glycine 0 C--N 1.346 1.135 0 O-C-N 124.134 0.549 . . . . 0.0 111.735 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.8 mm-40 -98.24 136.7 38.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 HD11 ' A' ' 9' ' ' LEU . 52.0 tp -107.85 99.6 9.05 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -87.56 113.7 23.49 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -163.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -90.6 111.33 22.6 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 108.327 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -92.28 127.09 37.64 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.529 0.68 . . . . 0.0 111.818 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 118' ' ' TYR . 35.0 m -125.11 162.14 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.522 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.615 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.6 pt-20 -67.9 -35.6 78.76 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -163.25 -179.95 6.97 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.686 0.675 . . . . 0.0 112.746 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -61.58 -29.67 70.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.247 1.419 . . . . 0.0 112.725 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.07 -44.27 72.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.063 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.615 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 75.0 mm-40 -63.63 -23.05 67.22 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.696 0.798 . . . . 0.0 112.467 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -65.89 -41.63 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 0.0 110.519 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.62 -27.94 45.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.127 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.5 mt-10 -66.6 -41.48 88.39 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.89 0.852 . . . . 0.0 109.513 173.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -64.47 -38.1 89.85 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.606 . . . . 0.0 110.93 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -55.99 -60.48 3.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.764 0.826 . . . . 0.0 109.845 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.59 -36.44 82.63 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.199 -172.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.68 -47.76 83.61 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.71 0.631 . . . . 0.0 113.655 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -65.15 -39.17 92.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.41 0.684 . . . . 0.0 110.185 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.9 ttpt -61.46 -43.07 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.376 0.671 . . . . 0.0 110.009 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.11 67.56 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.736 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 t -100.73 7.45 43.84 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.3 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.42 56.91 2.43 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 166.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.414 HG13 ' HB3' ' A' ' 92' ' ' MET . 5.8 p -104.75 146.1 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' ALA . . . -72.58 -39.39 67.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.721 0.408 . . . . 0.0 111.519 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.414 ' HB3' HG13 ' A' ' 90' ' ' VAL . 4.1 ptm 49.68 79.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.138 1.775 . . . . 0.0 113.862 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -109.1 83.29 1.73 Allowed 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.489 -0.757 . . . . 0.0 109.424 177.431 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 18.2 tm0? 178.85 127.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -76.02 125.78 87.64 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 104' ' ' THR . 42.8 Cg_endo -65.71 98.47 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.295 1.997 . . . . 0.0 109.948 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.14 160.89 39.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.581 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -69.72 142.65 53.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.326 0.65 . . . . 0.0 110.762 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ttp -147.48 -178.07 6.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.972 0.909 . . . . 0.0 108.66 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.07 -37.28 61.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.867 1.267 . . . . 0.0 113.194 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.37 8.64 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.536 0.735 . . . . 0.0 111.486 -172.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.93 -160.44 13.48 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -79.3 109.5 13.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 8.9 t -105.42 147.65 28.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.338 0.655 . . . . 0.0 111.551 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.448 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 17.3 t80 -154.5 136.35 14.51 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.828 1.251 . . . . 0.0 109.57 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.1 m -137.72 123.55 20.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.37 139.95 42.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.36 0.664 . . . . 0.0 111.524 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -111.72 126.78 55.41 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 13.3 p-10 -78.6 179.78 1.63 Allowed Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.831 175.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 46.8 Cg_exo -44.52 -40.51 13.71 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.827 2.352 . . . . 0.0 114.188 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.35 -21.87 59.49 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.686 0.394 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.69 74.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.438 1.495 . . . . 0.0 110.846 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.515 ' NE2' HG12 ' A' ' 11' ' ' VAL . 19.2 m170 -103.86 -171.57 1.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.413 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.51 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 19.5 mmm180 -120.29 96.77 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.36 99.34 8.6 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -96.47 95.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.321 0.648 . . . . 0.0 111.329 -169.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.74 133.54 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HE2' ' HB2' ' A' ' 120' ' ' PHE . 9.1 p90 -136.8 177.96 7.44 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.816 0.734 . . . . 0.0 112.319 172.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.25 111.88 6.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.406 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 38.5 t80 -84.56 119.2 24.92 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.6 100.5 3.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.51 0.724 . . . . 0.0 110.375 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -178.935 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ppp? . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.264 0.078 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.2 m -136.81 138.71 41.12 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -97.04 112.18 59.96 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 0.0 111.043 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.0 83.35 1.08 Allowed 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.911 2.407 . . . . 0.0 111.563 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASP . . . . . 0.811 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.2 p-10 -84.46 4.68 30.56 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.292 0.568 . . . . 0.0 111.228 172.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -123.37 127.34 48.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.11 1.364 . . . . 0.0 107.502 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 t -126.3 135.99 52.21 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 108.857 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.8 mt -119.46 136.78 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 109.548 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.49 140.42 40.48 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' TYR . . . . . 0.533 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 36.0 p90 -85.46 130.91 34.48 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.106 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.613 HG12 ' NE2' ' B' ' 113' ' ' HIS . 7.1 m -128.93 151.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.257 0.551 . . . . 0.0 110.536 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.69 -55.83 3.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.318 1.047 . . . . 0.0 109.721 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -105.5 97.36 14.05 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 124.081 0.953 . . . . 0.0 109.758 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.412 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.9 Cg_exo -51.31 -54.59 5.13 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.594 2.863 . . . . 0.0 115.379 -177.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.86 -54.54 5.26 Favored 'Trans proline' 0 C--N 1.403 3.398 0 C-N-CA 122.38 2.053 . . . . 0.0 113.409 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.2 61.65 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.439 -168.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 82.8 p -77.7 -34.49 52.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 73.2 m -67.65 -43.71 79.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' GLN . . . . . 0.518 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.0 mm100 -62.12 -34.73 76.89 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.954 173.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 84.6 t80 -63.68 -44.54 93.4 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.023 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 50.1 m-85 -70.8 -30.58 67.07 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.917 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.526 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 62.1 mtpt -56.45 -50.17 72.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.087 0.47 . . . . 0.0 112.125 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.69 -34.14 52.94 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.662 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 15.4 tp -60.54 -49.29 78.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.68 1.192 . . . . 0.0 113.092 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.51 ' HB2' HG22 ' B' ' 27' ' ' VAL . 34.9 mt -84.26 -40.96 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.28 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.26 33.75 6.41 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' B' ' 25' ' ' LEU . 31.5 m -128.62 -178.75 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.059 . . . . 0.0 110.573 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.43 142.35 44.59 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.926 0.89 . . . . 0.0 109.209 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.526 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 16.7 Cg_exo -67.39 110.56 2.07 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.355 2.036 . . . . 0.0 111.828 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.72 -39.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.794 0.838 . . . . 0.0 110.388 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 23.4 mm-40 -112.99 108.95 18.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -113.84 142.2 46.39 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.368 0.667 . . . . 0.0 109.81 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 50.4 m -142.87 161.48 48.64 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.784 1.234 . . . . 0.0 109.028 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.11 -30.61 89.43 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.471 2.114 . . . . 0.0 112.965 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -127.72 19.62 6.66 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.222 0.609 . . . . 0.0 111.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 77.0 t80 -159.12 156.88 29.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.794 0.438 . . . . 0.0 110.232 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 68.6 m -146.55 150.5 35.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.475 1.11 . . . . 0.0 108.318 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -144.72 117.0 8.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -129.12 123.65 32.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.899 1.28 . . . . 0.0 108.492 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.573 HG22 ' HG3' ' B' ' 46' ' ' LYS . 19.9 t -107.29 133.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.785 0.834 . . . . 0.0 109.244 -172.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.462 HD12 ' SD ' ' B' ' 45' ' ' MET . 85.5 mt -95.0 147.48 23.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.685 0.394 . . . . 0.0 110.091 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -12.24 52.76 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.158 0.983 . . . . 0.0 112.216 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.93 -8.55 30.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.096 0.959 . . . . 0.0 112.682 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.13 16.15 54.44 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' MET . . . . . 0.781 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -114.84 170.79 8.07 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.82 0.848 . . . . 0.0 108.862 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.573 ' HG3' HG22 ' B' ' 40' ' ' VAL . 80.2 tttt -133.61 134.22 42.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -176.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.518 HD11 HD11 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -128.27 118.19 22.82 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -174.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.73 24.71 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 123.698 0.666 . . . . 0.0 111.623 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' B' ' 37' ' ' SER . 6.8 tp -143.64 102.23 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' TRP . . . . . 0.468 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 6.2 t90 -110.92 130.4 55.59 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 35.9 m -68.3 127.26 32.28 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.286 0.366 . . . . 0.0 110.131 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' B' ' 10' ' ' TYR . 21.1 ptt180 -69.42 -12.78 61.94 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.846 0.858 . . . . 0.0 112.604 -173.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -77.95 -15.46 58.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.508 0.323 . . . . 0.0 110.523 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -127.98 10.37 6.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.607 0.763 . . . . 0.0 111.036 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' B' ' 58' ' ' LYS . 7.8 p -69.99 150.01 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -131.32 123.07 19.37 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.002 0.521 . . . . 0.0 111.13 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.97 136.6 45.15 Favored 'Cis proline' 0 C--N 1.389 2.688 0 C-N-CA 124.348 -1.105 . . . . 0.0 110.969 -4.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.439 ' HA ' HG13 ' B' ' 55' ' ' VAL . 1.5 tmmm? -48.28 110.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.387 0.675 . . . . 0.0 111.284 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.51 109.94 22.08 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.4 p -83.59 85.92 7.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 29.2 m -150.68 151.89 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.247 1.019 . . . . 0.0 109.636 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.533 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 0.3 OUTLIER -164.57 147.91 9.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.006 1.322 . . . . 0.0 109.457 169.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.99 76.64 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.412 0.445 . . . . 0.0 113.779 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.532 ' HA2' ' HD3' ' B' ' 114' ' ' ARG . . . -159.35 122.88 1.18 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 133.83 112.15 1.29 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.514 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 77.28 109.69 0.15 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 173.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.5 mm-40 -98.22 138.16 35.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -170.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.518 HD11 HD11 ' B' ' 47' ' ' LEU . 0.6 OUTLIER -110.68 98.75 7.84 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.04 113.14 23.38 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -161.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -89.85 111.5 22.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.877 1.271 . . . . 0.0 108.578 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -92.99 126.3 38.0 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.51 0.671 . . . . 0.0 111.838 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.63 162.6 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.559 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLU . . . . . 0.573 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.8 pt-20 -67.74 -35.17 78.26 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.2 p30 -163.63 179.71 7.0 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.685 0.675 . . . . 0.0 112.769 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.66 -29.58 70.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.207 1.403 . . . . 0.0 112.764 -166.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.03 -44.03 73.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.078 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLN . . . . . 0.573 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.1 mm-40 -63.84 -23.08 67.21 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.915 0.886 . . . . 0.0 112.548 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.77 -41.55 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.291 0.636 . . . . 0.0 110.41 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.44 -27.37 41.67 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.114 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.6 mt-10 -66.57 -41.37 88.68 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.758 0.79 . . . . 0.0 109.372 173.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.8 m -64.62 -37.87 89.06 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.928 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.01 -60.52 3.36 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 109.722 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.488 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.86 -36.19 81.76 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.237 -172.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.86 84.07 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.578 0.549 . . . . 0.0 113.684 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -65.74 -38.72 89.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.301 0.64 . . . . 0.0 110.261 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.7 ttpt -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 109.982 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.589 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -101.14 7.38 43.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.129 0.972 . . . . 0.0 112.565 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 57.47 2.4 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 115.382 0.913 . . . . 0.0 115.382 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 p -104.87 146.14 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' B' ' 108' ' ' ALA . . . -72.33 -39.14 68.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.937 0.495 . . . . 0.0 111.747 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 10.2 ptp 49.17 80.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.965 1.706 . . . . 0.0 113.911 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.435 HD13 ' N ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -109.15 83.17 1.71 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.849 0.833 . . . . 0.0 109.62 177.496 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 178.58 126.64 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.153 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -75.37 126.84 87.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 123.328 0.392 . . . . 0.0 110.455 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' B' ' 104' ' ' THR . 55.8 Cg_endo -67.11 98.53 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.418 2.079 . . . . 0.0 109.732 172.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.33 160.73 39.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -69.38 141.78 54.08 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.881 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' MET . . . . . 0.478 ' HG2' ' HB ' ' B' ' 104' ' ' THR . 1.1 ptp -145.35 -176.38 5.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.153 0.981 . . . . 0.0 109.281 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -55.66 -36.56 67.21 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.539 1.135 . . . . 0.0 112.61 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.94 8.73 42.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.453 0.701 . . . . 0.0 111.941 -173.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.76 -159.97 13.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.654 -0.579 . . . . 0.0 111.654 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -79.95 109.6 14.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' B' ' 99' ' ' MET . 6.9 t -105.99 149.27 26.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.268 0.556 . . . . 0.0 111.369 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -155.77 137.14 13.97 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.867 1.267 . . . . 0.0 109.416 168.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 49.2 m -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.15 139.63 42.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.468 0.707 . . . . 0.0 111.51 -173.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -111.07 129.11 56.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 16.4 p-10 -81.52 -179.99 1.69 Allowed Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.977 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 43.3 Cg_exo -44.46 -40.71 13.63 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.473 2.115 . . . . 0.0 114.409 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.7 -22.15 60.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.974 0.51 . . . . 0.0 110.658 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m 72.62 74.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.4 1.48 . . . . 0.0 110.66 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' HIS . . . . . 0.613 ' NE2' HG12 ' B' ' 11' ' ' VAL . 22.1 m170 -103.56 -171.36 1.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.402 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.532 ' HD3' ' HA2' ' B' ' 64' ' ' GLY . 22.6 mmm180 -120.4 96.71 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.2 99.52 8.79 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.484 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -95.23 94.93 8.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.874 0.47 . . . . 0.0 111.886 -169.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.0 t -85.55 133.86 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -137.5 177.68 7.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.059 0.845 . . . . 0.0 112.279 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.08 111.41 5.92 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -83.07 113.44 20.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.55 92.92 3.5 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.024 0.828 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -176.239 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.4 m80 . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 119.512 -0.28 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.49 114.29 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.932 2.421 . . . . 0.0 112.285 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.711 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.8 p-10 -99.01 11.43 39.02 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.352 0.596 . . . . 0.0 110.302 171.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -129.59 125.0 35.17 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.778 1.231 . . . . 0.0 107.875 -170.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -120.48 138.82 53.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.258 1.023 . . . . 0.0 108.503 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 55.8 mt -115.4 133.57 61.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 123.497 0.719 . . . . 0.0 109.066 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 HD21 ' A' ' 47' ' ' LEU . 9.1 mp -112.32 124.3 52.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 4.8 p90 -79.3 115.96 19.26 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.686 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 51' ' ' SER . 35.7 m -114.49 167.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.789 0.836 . . . . 0.0 109.191 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -96.68 -62.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.234 0.614 . . . . 0.0 110.322 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.16 96.31 13.0 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 123.351 0.66 . . . . 0.0 109.666 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 1.1 Cg_endo -44.9 -52.97 5.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.541 2.827 . . . . 0.0 115.809 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.41 -57.42 2.35 Favored 'Trans proline' 0 C--N 1.403 3.399 0 C-N-CA 122.416 2.077 . . . . 0.0 113.191 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.5 -37.41 77.17 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.4 m -77.43 -26.65 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.44 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 68.4 m -80.3 -38.95 29.69 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 82.9 mm-40 -67.01 -34.04 76.88 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.264 173.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -61.52 -49.45 76.67 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.673 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.2 m-85 -69.62 -27.18 64.86 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.616 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.6 mtpt -57.08 -51.75 68.04 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.144 0.429 . . . . 0.0 111.789 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.03 -32.26 39.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.916 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.0 tp -59.11 -53.24 60.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.041 0.936 . . . . 0.0 111.839 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB2' HG22 ' A' ' 27' ' ' VAL . 12.6 mt -83.11 -47.2 11.89 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.2 38.99 2.94 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 25' ' ' LEU . 30.4 m -128.42 171.12 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.328 1.051 . . . . 0.0 110.654 -176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.88 139.03 33.87 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.15 108.76 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.489 2.126 . . . . 0.0 111.593 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.81 -39.28 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.286 0.634 . . . . 0.0 109.973 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.721 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 35.9 mm-40 -118.51 149.11 41.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.305 1.042 . . . . 0.0 108.647 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 p -160.93 152.95 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.303 0.641 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 52.4 m -148.8 159.65 37.44 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.725 1.21 . . . . 0.0 108.448 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.59 -27.43 32.83 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.94 2.426 . . . . 0.0 113.798 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 14' ' ' PRO . 12.4 t -127.92 16.83 6.8 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.0 t80 -156.15 162.19 40.25 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.894 -0.504 . . . . 0.0 110.55 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 47.1 t -151.67 157.09 41.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.698 0.799 . . . . 0.0 109.351 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -152.31 128.92 10.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.16 141.86 46.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.443 1.097 . . . . 0.0 108.823 170.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.3 t -115.5 127.92 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.495 HD13 ' SD ' ' A' ' 45' ' ' MET . 10.0 mp -91.06 148.81 22.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.253 0.621 . . . . 0.0 110.187 -170.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.57 -8.51 34.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 111.809 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.81 -19.5 65.91 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.171 0.989 . . . . 0.0 111.724 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.04 47.35 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.736 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -113.37 174.72 5.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.877 0.871 . . . . 0.0 109.036 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HG3' HG22 ' A' ' 40' ' ' VAL . 82.7 tttt -139.23 140.92 37.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 9' ' ' LEU . 2.5 tt -140.07 123.26 16.84 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.817 0.341 . . . . 0.0 110.114 -171.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -104.68 160.3 15.59 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.793 0.711 . . . . 0.0 111.568 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 82.3 mt -126.11 106.46 9.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 164.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.589 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 4.9 t90 -105.08 123.19 47.39 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.6 t -70.7 130.82 42.76 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -65.48 -21.68 66.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 112.364 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -76.56 -8.28 56.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.392 0.277 . . . . 0.0 111.398 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -131.86 9.2 4.54 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.353 0.661 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.21 145.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.49 117.75 21.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 141.64 68.38 Favored 'Cis proline' 0 C--N 1.39 2.755 0 CA-C-N 119.935 1.013 . . . . 0.0 113.953 2.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.44 122.33 16.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.13 0.972 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.66 109.54 5.03 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.79 0.836 . . . . 0.0 109.996 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -85.36 85.5 7.44 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 121.875 0.845 . . . . 0.0 108.775 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.09 147.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 p -144.1 121.69 11.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.94 5.37 68.23 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.202 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.73 -34.78 72.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 121.303 0.391 . . . . 0.0 112.44 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' B' ' 10' ' ' TYR . . . -170.47 -161.54 21.23 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.214 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.55 110.26 0.24 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.497 ' HG2' ' HD2' ' A' ' 114' ' ' ARG . 24.1 mt-10 -123.99 130.09 52.0 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -171.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 9' ' ' LEU . 17.7 tp -115.84 101.57 8.91 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -88.08 109.87 20.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.834 0.35 . . . . 0.0 110.752 -171.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.493 ' HB2' HG22 ' A' ' 117' ' ' VAL . 22.4 m-85 -89.35 107.6 19.16 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -88.06 130.71 34.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.443 0.64 . . . . 0.0 111.273 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.08 159.13 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.816 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -66.15 -34.25 77.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -173.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 9.9 p30 -163.94 -179.9 6.57 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.513 0.673 . . . . 0.0 112.333 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.56 -29.7 70.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.492 1.517 . . . . 0.0 112.978 -165.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.86 -41.47 74.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.248 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.568 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 64.9 mm-40 -64.23 -23.87 67.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.655 0.782 . . . . 0.0 112.123 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.14 -42.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 121.533 0.682 . . . . 0.0 110.221 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.45 -29.7 59.74 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.471 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -66.01 -46.64 77.21 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.488 0.661 . . . . 0.0 109.522 173.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.2 m -65.46 -32.96 74.86 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.131 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.57 -61.37 2.65 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 123.687 0.795 . . . . 0.0 109.982 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.61 -35.57 80.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.31 -172.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.64 -46.67 93.24 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.593 0.558 . . . . 0.0 113.151 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.44 ' HB3' HG21 ' A' ' 90' ' ' VAL . 45.7 m0 -62.53 -43.23 99.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.438 0.695 . . . . 0.0 110.597 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -58.56 -43.13 89.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 110.596 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.19 -24.27 60.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.548 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 t -91.32 -0.22 57.62 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.301 1.041 . . . . 0.0 112.656 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.48 39.67 4.97 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.604 0.601 . . . . 0.0 114.604 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 85' ' ' TRP . 55.9 t -87.24 145.28 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.32 -51.07 67.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.96 0.504 . . . . 0.0 110.768 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.494 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 28.8 tpp 65.65 82.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.047 0.842 . . . . 0.0 111.898 169.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.41 84.01 2.22 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.569 0.7 . . . . 0.0 110.875 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 106' ' ' THR . 54.1 tp60 179.09 138.79 0.1 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.011 1.324 . . . . 0.0 108.679 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -83.49 121.88 76.71 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -63.04 102.21 0.3 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.639 2.226 . . . . 0.0 110.045 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.15 150.01 48.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.25 0.62 . . . . 0.0 111.363 -170.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -71.62 100.77 2.36 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.4 ttm -92.29 173.99 7.53 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.071 0.948 . . . . 0.0 109.498 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.66 -34.46 71.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.409 1.084 . . . . 0.0 111.732 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -87.69 -5.38 58.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.065 0.946 . . . . 0.0 110.978 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.61 -170.01 19.97 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.142 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -75.17 102.34 4.92 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 t -107.65 149.24 28.33 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.709 0.766 . . . . 0.0 110.019 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 1.8 t80 -144.68 140.53 28.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.016 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 26.5 m -136.63 127.66 27.76 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -106.3 171.95 7.08 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.844 0.457 . . . . 0.0 110.401 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.38 121.5 20.11 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 3.9 p-10 -77.76 177.31 2.81 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.999 0.92 . . . . 0.0 111.531 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 41.9 Cg_exo -42.05 -43.37 7.25 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.632 2.888 . . . . 0.0 114.946 170.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.56 -8.15 55.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.501 0.72 . . . . 0.0 111.247 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.5 m 64.6 87.55 0.11 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.055 1.342 . . . . 0.0 111.829 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -124.29 144.15 50.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.497 ' HD2' ' HG2' ' A' ' 67' ' ' GLU . 64.6 mtt180 -75.93 94.74 3.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.82 99.21 11.91 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.465 ' HG3' ' HZ3' ' B' ' 50' ' ' TRP . 2.6 tmt_? -98.2 96.11 7.87 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.789 0.836 . . . . 0.0 111.641 -165.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 70' ' ' PHE . 18.6 t -90.54 120.09 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -132.08 159.16 39.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.268 0.485 . . . . 0.0 112.276 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.91 112.03 17.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -74.03 129.27 37.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.579 0.352 . . . . 0.0 110.768 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.055 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.015 -0.516 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.12 114.68 0.67 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.278 2.652 . . . . 0.0 112.486 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.736 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.6 p-10 -99.31 10.86 40.6 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.439 0.637 . . . . 0.0 109.955 171.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.472 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -129.05 124.43 34.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.192 . . . . 0.0 107.812 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -120.02 139.01 53.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.069 0.948 . . . . 0.0 108.443 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 54.9 mt -116.07 133.87 61.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.526 HD23 HD21 ' B' ' 47' ' ' LEU . 3.4 mm? -112.85 124.33 52.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.444 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 5.2 p90 -80.21 116.74 20.47 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.696 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 51' ' ' SER . 33.9 m -114.5 167.08 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.733 0.813 . . . . 0.0 109.118 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -96.62 -62.56 1.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.316 0.647 . . . . 0.0 110.087 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -105.98 97.5 15.61 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.339 0.655 . . . . 0.0 109.572 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.438 ' HG2' ' HA ' ' B' ' 35' ' ' THR . 74.2 Cg_exo -46.81 -52.04 8.23 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 123.426 2.751 . . . . 0.0 115.246 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.4 -57.58 2.26 Favored 'Trans proline' 0 C--N 1.404 3.493 0 C-N-CA 122.681 2.254 . . . . 0.0 113.041 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.99 74.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.31 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -77.34 -27.12 52.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.436 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 99.3 m -79.96 -38.76 31.61 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.525 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 87.1 mm-40 -67.3 -33.34 75.07 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.532 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -62.25 -48.9 77.88 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.789 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 23.9 m-85 -69.73 -27.59 65.09 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.562 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.8 mtpt -56.91 -51.68 68.14 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.238 0.472 . . . . 0.0 111.93 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.59 -32.56 41.96 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.081 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 18.5 tp -59.25 -53.08 62.37 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.046 0.938 . . . . 0.0 111.835 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.422 ' HB2' HG22 ' B' ' 27' ' ' VAL . 11.9 mt -83.36 -47.18 11.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.988 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.98 39.42 2.89 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.4 m -128.58 170.23 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.476 1.111 . . . . 0.0 110.665 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -125.28 141.31 38.35 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 57.5 Cg_endo -68.13 109.53 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.301 2.001 . . . . 0.0 111.248 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.15 -39.07 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.113 0.565 . . . . 0.0 109.75 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 24.1 mm-40 -118.59 149.16 41.83 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.725 1.21 . . . . 0.0 108.915 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -161.08 153.15 19.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 51.0 m -149.55 160.24 34.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.804 1.242 . . . . 0.0 108.502 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.5 -27.26 39.81 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.043 2.495 . . . . 0.0 113.596 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.438 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 11.6 t -128.05 16.92 6.73 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.477 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 73.4 t80 -156.04 161.58 40.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.783 -0.573 . . . . 0.0 110.406 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 73.9 m -150.76 157.84 43.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.963 0.905 . . . . 0.0 109.752 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 4.6 tt -152.97 128.26 9.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.452 ' HE1' HD22 ' B' ' 47' ' ' LEU . 0.5 OUTLIER -134.75 141.98 46.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.402 1.081 . . . . 0.0 108.995 169.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.553 HG22 ' HG3' ' B' ' 46' ' ' LYS . 14.8 t -115.33 127.9 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.491 HD13 ' SD ' ' B' ' 45' ' ' MET . 9.8 mp -90.83 148.96 22.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.301 0.64 . . . . 0.0 110.239 -170.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -8.61 36.05 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.301 1.04 . . . . 0.0 111.796 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -66.22 -18.98 65.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.464 1.105 . . . . 0.0 111.699 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.06 16.16 48.79 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.433 -0.348 . . . . 0.0 112.232 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.711 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -113.43 175.04 5.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.776 0.83 . . . . 0.0 109.046 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.6 tttt -139.98 140.64 36.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.526 HD21 HD23 ' B' ' 9' ' ' LEU . 2.8 tt -140.16 123.27 16.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.728 0.411 . . . . 0.0 110.09 -171.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.472 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -104.88 160.15 15.48 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.87 0.748 . . . . 0.0 111.522 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 81.6 mt -126.2 106.29 9.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 164.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.465 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 5.3 t90 -104.91 123.32 47.54 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 11.4 t -70.69 130.6 42.19 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.411 ' O ' HG12 ' B' ' 55' ' ' VAL . 31.8 ptt180 -65.92 -20.62 66.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.843 0.857 . . . . 0.0 112.447 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -77.18 -8.2 57.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.313 0.245 . . . . 0.0 110.869 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -132.01 9.12 4.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.308 0.643 . . . . 0.0 111.24 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 52' ' ' ARG . 9.0 p -71.73 145.79 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -127.41 116.72 21.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 94' ' ' GLN . 10.4 Cg_exo -71.15 140.06 62.25 Favored 'Cis proline' 0 C--N 1.39 2.746 0 CA-C-N 120.205 1.109 . . . . 0.0 113.455 3.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -60.42 121.2 11.49 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.431 1.092 . . . . 0.0 112.005 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.47 109.65 5.11 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.678 0.791 . . . . 0.0 109.876 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 p -85.11 85.36 7.48 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-O 122.109 0.957 . . . . 0.0 108.858 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.71 148.73 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.2 p -145.1 121.66 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.541 1.136 . . . . 0.0 108.003 167.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.54 4.98 69.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.19 -34.75 76.08 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.79 0.295 . . . . 0.0 112.518 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.74 -162.43 23.07 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.747 -0.227 . . . . 0.0 112.731 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.4 110.71 0.24 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.172 0.572 . . . . 0.0 111.746 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.6 mt-10 -124.09 129.82 51.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -171.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 68' ' ' LEU . 5.5 mt -114.06 102.17 9.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.19 110.04 20.38 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.342 0.519 . . . . 0.0 111.008 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.6 107.43 19.08 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.495 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.8 mtm105 -87.86 129.5 35.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.336 0.589 . . . . 0.0 110.98 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.84 159.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.111 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 8.7 pt-20 -66.5 -33.52 75.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.19 179.83 6.62 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.455 0.645 . . . . 0.0 112.5 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.973 -165.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.81 -42.0 77.89 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.439 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -64.54 -23.73 67.37 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.022 0.826 . . . . 0.0 112.129 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 -42.43 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.476 0.655 . . . . 0.0 110.288 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.0 -30.66 62.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.029 1.331 . . . . 0.0 111.404 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.0 mt-10 -66.64 -46.21 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.407 0.622 . . . . 0.0 109.651 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.0 m -65.62 -33.18 75.3 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.07 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -58.33 -61.48 2.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.836 0.854 . . . . 0.0 109.899 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.52 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.72 -35.58 80.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.222 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.72 93.15 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.857 0.723 . . . . 0.0 113.029 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -62.82 -43.26 99.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.335 0.654 . . . . 0.0 110.432 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 31.9 ttpt -58.39 -43.32 88.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.035 0.834 . . . . 0.0 110.627 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.68 -24.32 61.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.909 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 38.1 t -91.0 -0.44 57.75 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.41 1.084 . . . . 0.0 112.424 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.91 41.37 4.67 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 114.284 0.473 . . . . 0.0 114.284 169.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.8 p -88.95 146.48 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.53 67.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.805 0.442 . . . . 0.0 110.507 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.544 ' HB2' HG13 ' B' ' 90' ' ' VAL . 57.4 ttm 63.76 83.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.693 0.797 . . . . 0.0 112.843 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 83.91 2.21 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.638 0.733 . . . . 0.0 110.682 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' B' ' 106' ' ' THR . 57.2 tp60 179.41 139.48 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.756 1.222 . . . . 0.0 108.591 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.05 121.16 74.13 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 26.7 Cg_endo -62.48 102.22 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.566 2.177 . . . . 0.0 110.088 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.38 150.86 48.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.011 0.524 . . . . 0.0 111.548 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -72.74 100.87 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.798 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.44 ' SD ' HG21 ' B' ' 104' ' ' THR . 4.5 mtt -90.69 175.15 7.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.234 1.014 . . . . 0.0 110.213 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.08 -34.6 73.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.092 0.957 . . . . 0.0 111.024 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -87.42 -5.81 58.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.175 0.99 . . . . 0.0 111.037 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.81 -169.53 20.25 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.23 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -75.66 102.51 5.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.44 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.0 t -107.82 149.09 28.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 110.061 -173.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 11.3 t80 -144.32 141.13 29.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.038 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 28.9 m -136.77 127.38 26.99 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.1 171.79 7.15 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.657 0.383 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.03 122.65 22.11 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.472 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.7 p-10 -79.2 177.21 3.03 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.013 0.925 . . . . 0.0 111.219 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.1 Cg_exo -41.83 -43.19 6.72 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.485 2.79 . . . . 0.0 115.16 170.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.27 -9.22 53.6 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.726 0.81 . . . . 0.0 110.766 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 24.3 m 65.22 87.45 0.12 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.194 1.397 . . . . 0.0 111.66 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -124.47 143.79 50.45 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.454 ' HB2' ' HG2' ' B' ' 67' ' ' GLU . 67.4 mtm-85 -76.24 94.68 3.58 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -92.83 99.11 11.84 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.589 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 2.8 tmt_? -96.0 94.93 7.87 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.258 -165.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 t -90.32 120.32 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.454 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.3 p90 -131.98 159.34 39.02 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.506 0.594 . . . . 0.0 112.345 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.46 111.32 16.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.8 124.28 25.05 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.331 0.395 . . . . 0.0 110.256 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.79 93.5 7.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 111.265 -176.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m80 . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.7 95.03 0.92 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.773 2.315 . . . . 0.0 112.416 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.701 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.5 p-10 -83.53 3.56 31.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.384 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -124.33 118.61 27.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.0 t -117.3 137.75 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.624 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 50.8 mt -119.66 137.49 53.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 47' ' ' LEU . 4.6 mm? -88.47 106.96 18.62 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 168.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -58.51 104.26 0.21 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.398 163.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.55 HG12 ' HE1' ' A' ' 113' ' ' HIS . 27.8 m -118.8 173.81 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.412 1.085 . . . . 0.0 108.614 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.0 -64.74 1.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.99 0.916 . . . . 0.0 109.974 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -72.51 110.78 8.9 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.959 -170.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.3 Cg_exo -60.21 -62.25 0.16 Allowed 'Trans proline' 0 CA--C 1.576 2.618 0 C-N-CA 121.655 1.57 . . . . 0.0 113.324 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 22.3 Cg_exo -64.7 -52.11 1.5 Allowed 'Trans proline' 0 C--N 1.406 3.6 0 CA-C-N 122.984 2.101 . . . . 0.0 111.64 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.88 89.52 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.303 -165.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.47 -41.28 47.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 71.2 m -56.9 -46.02 82.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.565 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.6 mm100 -65.37 -38.25 89.47 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.515 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CZ ' HG22 ' A' ' 90' ' ' VAL . 77.6 t80 -63.89 -45.7 88.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.327 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.68 -29.22 65.48 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.875 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -56.25 -48.32 76.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.44 0.564 . . . . 0.0 111.952 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 -38.74 50.47 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.075 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.51 -40.99 93.4 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.256 1.422 . . . . 0.0 113.02 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' A' ' 27' ' ' VAL . 18.6 mt -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 31.05 6.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.262 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 25' ' ' LEU . 26.8 m -132.76 166.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.057 0.943 . . . . 0.0 110.322 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -113.71 149.32 41.54 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.443 0.697 . . . . 0.0 110.051 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 11.9 Cg_exo -71.37 111.91 3.21 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.912 2.408 . . . . 0.0 111.131 173.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.24 -37.27 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.337 0.655 . . . . 0.0 109.936 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm-40 -109.6 121.99 46.44 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.7 p -131.34 131.14 43.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.99 0.516 . . . . 0.0 110.118 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -144.13 152.98 55.93 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.222 1.409 . . . . 0.0 108.294 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.39 -10.44 13.42 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.661 2.241 . . . . 0.0 114.364 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -129.5 -1.02 4.97 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -153.94 148.56 26.31 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 122.096 -0.378 . . . . 0.0 110.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -137.91 149.68 46.42 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 109.638 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -143.77 122.27 12.44 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.48 ' HZ ' HD13 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -133.54 137.19 45.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.42 1.488 . . . . 0.0 108.17 173.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 46' ' ' LYS . 22.0 t -116.27 127.5 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.838 0.855 . . . . 0.0 108.764 -172.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.9 mt -87.07 150.61 23.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.836 0.351 . . . . 0.0 110.122 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.88 -8.12 45.94 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 0.0 111.97 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.439 HD22 ' HB3' ' B' ' 5' ' ' ASP . 1.5 m-20 -72.77 -8.43 55.4 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.086 0.954 . . . . 0.0 112.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.11 16.75 42.94 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.724 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -119.61 171.93 8.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.799 0.84 . . . . 0.0 109.476 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 40' ' ' VAL . 66.0 tttt -132.77 141.08 48.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 9' ' ' LEU . 1.1 tt -138.45 122.04 17.39 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.202 0.525 . . . . 0.0 110.444 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.8 171.49 20.04 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.888 0.756 . . . . 0.0 112.26 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.48 HD13 ' HZ ' ' A' ' 39' ' ' PHE . 1.1 tp -140.37 118.84 12.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.1 t90 -115.44 122.67 46.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -84.28 125.3 32.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.988 0.515 . . . . 0.0 109.972 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 37.7 ptt180 -69.48 -9.35 53.37 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -167.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -75.02 -8.58 56.92 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -135.33 6.44 3.29 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.772 0.429 . . . . 0.0 111.089 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 52' ' ' ARG . 7.1 p -60.9 147.85 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.977 0.511 . . . . 0.0 110.814 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -119.25 115.08 34.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' B' ' 94' ' ' GLN . 81.7 Cg_endo -79.23 142.59 67.13 Favored 'Cis proline' 0 C--N 1.381 2.252 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.582 2.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -51.17 115.22 1.45 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 111.688 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.57 151.65 41.76 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.497 1.119 . . . . 0.0 109.094 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 20.1 m -134.95 87.09 2.31 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.09 123.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.769 0.828 . . . . 0.0 108.988 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 p -136.4 125.39 24.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.019 0.927 . . . . 0.0 109.651 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.71 67.47 0.83 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' HA2' HG13 ' B' ' 61' ' ' VAL . . . -169.72 54.15 0.2 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.98 169.6 19.15 Favored Glycine 0 C--O 1.242 0.62 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 80.88 106.84 0.31 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.6 pt-20 -130.61 146.39 52.1 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.721 0.808 . . . . 0.0 109.59 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.7 tp -117.19 103.88 10.63 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.95 0.9 . . . . 0.0 108.637 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.0 113.78 23.97 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.222 0.464 . . . . 0.0 111.312 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.64 110.14 21.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.037 1.335 . . . . 0.0 108.458 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -89.72 124.67 34.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.542 0.687 . . . . 0.0 112.421 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.59 158.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.795 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.0 pt-20 -64.46 -39.39 93.73 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -161.4 178.25 9.34 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.219 0.533 . . . . 0.0 112.073 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.2 -28.13 66.36 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.208 1.403 . . . . 0.0 112.462 -167.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.08 -50.71 69.49 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.54 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.6 mm-40 -64.3 -24.4 67.64 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.303 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.16 -45.68 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.361 0.601 . . . . 0.0 110.028 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.18 -29.98 63.22 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.54 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 33.1 mt-10 -66.51 -47.71 72.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -66.59 -29.25 69.27 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.706 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -60.11 -61.21 2.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.732 0.813 . . . . 0.0 109.593 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.02 -32.6 73.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.296 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.81 -45.69 91.87 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.648 0.593 . . . . 0.0 112.759 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.427 ' HB3' HG21 ' A' ' 90' ' ' VAL . 44.4 m0 -66.01 -41.11 91.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.524 0.73 . . . . 0.0 110.046 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.28 -43.6 88.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 0.0 110.612 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.32 -27.36 61.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.761 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -94.48 8.67 41.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.56 0.744 . . . . 0.0 111.829 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.58 54.03 3.23 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 167.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.47 HG11 ' HB1' ' A' ' 107' ' ' ALA . 60.0 t -102.87 142.63 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.42 -47.29 82.53 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.132 0.573 . . . . 0.0 111.367 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 ttm 60.24 83.53 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 165.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.57 85.15 2.31 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 122.037 -0.414 . . . . 0.0 110.651 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? 177.93 121.1 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.665 1.186 . . . . 0.0 108.426 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -72.22 114.05 26.05 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 17.7 Cg_endo -56.22 112.93 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.945 2.43 . . . . 0.0 111.186 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.4 147.71 50.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.63 0.772 . . . . 0.0 110.657 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -75.26 100.93 4.5 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.643 ' HG2' ' H ' ' A' ' 101' ' ' PHE . 55.4 ttm -90.2 161.87 15.51 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.48 -28.49 54.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.735 0.814 . . . . 0.0 110.781 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.643 ' H ' ' HG2' ' A' ' 99' ' ' MET . 74.5 m-85 -110.14 88.34 2.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 109.509 171.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.64 162.34 0.94 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 82.7 t80 -78.2 101.83 7.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -107.65 145.38 33.41 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.512 0.673 . . . . 0.0 110.471 -165.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 4.9 t80 -137.1 130.66 31.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.531 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.0 m -120.85 122.78 41.03 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.448 0.642 . . . . 0.0 110.108 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -105.16 172.86 6.56 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.464 0.706 . . . . 0.0 109.988 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.85 118.12 12.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -68.01 168.25 13.97 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.675 0.79 . . . . 0.0 110.101 171.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.77 -27.26 15.04 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.114 2.543 . . . . 0.0 114.825 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.3 8.06 41.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.794 0.837 . . . . 0.0 111.229 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 m 70.45 30.04 3.32 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.134 1.373 . . . . 0.0 113.896 165.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.55 ' HE1' HG12 ' A' ' 11' ' ' VAL . 14.1 m80 -84.32 178.59 7.71 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -110.96 117.34 33.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -106.12 100.61 10.15 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -101.04 97.85 8.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -167.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.3 t -88.11 118.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.08 167.05 15.9 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.197 0.453 . . . . 0.0 110.957 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -126.82 110.69 13.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -82.1 115.79 21.38 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.724 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 m80 . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 119.636 -0.221 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.54 94.92 0.93 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.476 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.724 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 7.1 p-10 -83.05 3.4 30.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.105 0.562 . . . . 0.0 111.517 172.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.406 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.5 t80 -124.45 118.44 26.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -168.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -117.43 137.89 52.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.645 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 44.2 mt -119.72 137.08 54.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.45 HD23 HD21 ' B' ' 47' ' ' LEU . 4.6 mm? -88.14 106.86 18.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.43 105.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.06 163.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.522 HG12 ' HE1' ' B' ' 113' ' ' HIS . 22.4 m -119.1 173.79 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.621 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -105.93 -65.16 1.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.754 0.822 . . . . 0.0 109.882 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -72.12 110.78 8.63 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.782 -170.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.52 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 27.4 Cg_exo -59.99 -63.07 0.13 Allowed 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 121.691 1.594 . . . . 0.0 113.353 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 33.3 Cg_exo -63.08 -53.0 1.74 Allowed 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 123.195 2.177 . . . . 0.0 112.275 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.67 89.71 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.395 -165.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.11 -41.45 50.19 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.61 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 18.0 mm100 -65.71 -38.4 89.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.517 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -64.35 -44.89 90.04 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.749 0.656 . . . . 0.0 110.229 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -70.71 -29.51 65.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.904 -0.569 . . . . 0.0 109.884 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.61 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 58.9 mtpt -56.1 -48.38 76.26 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.486 0.585 . . . . 0.0 112.087 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.18 -38.98 50.52 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.04 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp -59.89 -41.4 91.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.203 1.401 . . . . 0.0 113.007 -174.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.482 ' HB2' HG22 ' B' ' 27' ' ' VAL . 19.7 mt -91.6 -41.27 10.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.315 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.44 30.87 7.07 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.28 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.0 m -132.86 167.11 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.093 0.957 . . . . 0.0 110.53 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -114.27 149.53 42.23 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.663 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 7.2 Cg_exo -72.12 111.48 3.19 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.91 2.406 . . . . 0.0 111.016 174.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.75 -36.72 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.949 0.5 . . . . 0.0 110.068 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.713 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.5 mm-40 -110.12 121.28 44.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -130.79 130.58 43.89 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.165 0.586 . . . . 0.0 110.111 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 91.9 p -143.94 155.98 58.88 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.461 1.104 . . . . 0.0 108.441 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.32 -10.2 17.8 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.685 2.257 . . . . 0.0 113.779 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -129.42 -1.17 5.0 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.9 148.91 26.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.184 0.447 . . . . 0.0 110.018 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 14.2 m -137.67 149.78 46.83 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.634 0.774 . . . . 0.0 109.2 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -143.98 121.6 11.82 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.94 138.52 46.94 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.156 1.383 . . . . 0.0 108.45 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.7 t -117.26 127.21 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.869 0.867 . . . . 0.0 108.756 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.478 HD12 ' SD ' ' B' ' 45' ' ' MET . 63.2 mt -87.1 150.58 23.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.95 -7.99 45.15 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.37 1.068 . . . . 0.0 111.89 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -73.28 -8.09 54.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.095 0.958 . . . . 0.0 111.948 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.04 16.81 42.94 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.701 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.4 ppp? -119.79 171.67 8.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.692 0.797 . . . . 0.0 109.378 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.6 141.17 48.56 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -173.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.45 HD21 HD23 ' B' ' 9' ' ' LEU . 1.1 tt -138.44 122.16 17.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 -172.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.406 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -103.86 170.57 19.11 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.863 0.745 . . . . 0.0 112.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 79.1 mt -138.59 119.83 14.69 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 164.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -115.27 122.68 46.71 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 39.1 m -83.59 125.49 31.86 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.784 0.434 . . . . 0.0 110.099 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 39.0 ptt180 -69.5 -8.45 47.1 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.92 -8.61 57.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.702 0.401 . . . . 0.0 111.48 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -135.52 4.78 3.14 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.184 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' B' ' 52' ' ' ARG . 7.5 p -57.8 147.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.128 0.571 . . . . 0.0 111.147 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.69 114.97 33.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.453 0.701 . . . . 0.0 109.143 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.33 143.09 68.68 Favored 'Cis proline' 0 C--N 1.382 2.31 0 C-N-CA 124.504 -1.04 . . . . 0.0 112.347 2.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.88 116.44 2.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.074 0.949 . . . . 0.0 110.861 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.63 151.22 41.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.988 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 49.5 m -134.67 86.96 2.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.412 HG13 ' HA2' ' A' ' 64' ' ' GLY . 7.5 p -156.27 123.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.244 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.4 p -135.49 126.46 27.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.834 0.854 . . . . 0.0 109.621 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.9 67.87 0.86 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.08 54.22 0.2 Allowed Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.88 169.76 19.25 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 80.74 107.26 0.3 Allowed Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.624 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 6.5 pt-20 -131.3 145.7 51.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.081 0.952 . . . . 0.0 109.079 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.5 tp -117.46 103.79 10.45 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.89 114.16 24.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.192 0.451 . . . . 0.0 111.252 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -91.2 109.98 21.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.918 1.287 . . . . 0.0 108.39 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.434 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.4 mtm180 -89.69 123.77 34.01 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.497 0.665 . . . . 0.0 111.991 -176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 159.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.781 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.9 pt-20 -64.79 -38.71 91.89 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -161.9 179.14 8.28 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.986 0.422 . . . . 0.0 112.064 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.0 -27.19 68.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.212 -166.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.11 -50.57 69.98 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.946 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.48 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 82.1 mm-40 -65.0 -24.1 67.41 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.39 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.18 -45.76 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.261 0.624 . . . . 0.0 110.087 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.24 -30.6 65.03 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.623 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 25.8 mt-10 -66.56 -47.22 73.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 109.421 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -66.91 -29.25 69.08 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.688 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.03 -61.39 2.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 0.0 109.621 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -67.17 -32.26 73.23 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.31 -173.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.65 -46.04 91.12 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.755 0.659 . . . . 0.0 112.826 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.51 -41.02 89.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.397 0.679 . . . . 0.0 109.708 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.8 ttpt -57.78 -43.62 85.67 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.769 0.827 . . . . 0.0 110.403 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.53 61.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.462 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -94.53 8.77 41.07 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.607 0.763 . . . . 0.0 111.685 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.97 54.49 3.19 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' B' ' 92' ' ' MET . 5.4 p -103.16 143.41 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 170.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.74 83.5 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.049 0.539 . . . . 0.0 111.284 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.647 ' HB2' HG13 ' B' ' 90' ' ' VAL . 53.6 ttm 59.64 83.64 0.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -118.57 85.74 2.41 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 122.027 -0.421 . . . . 0.0 110.498 175.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.485 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 45.1 tp60 177.2 119.89 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.099 1.36 . . . . 0.0 109.119 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.55 112.51 14.19 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.58 0.752 . . . . 0.0 109.08 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.597 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 10.9 Cg_endo -53.98 111.99 0.85 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.186 2.591 . . . . 0.0 111.835 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.38 147.62 50.27 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.686 0.794 . . . . 0.0 110.582 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 100.73 4.12 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.634 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 51.5 ttm -90.43 161.5 15.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.6 -28.06 53.01 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.623 0.769 . . . . 0.0 110.98 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.634 ' H ' ' HG2' ' B' ' 99' ' ' MET . 53.7 m-85 -110.02 88.18 2.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.391 1.077 . . . . 0.0 109.724 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.54 162.74 0.96 Allowed Glycine 0 C--N 1.354 1.56 0 N-CA-C 116.137 1.215 . . . . 0.0 116.137 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 84.7 t80 -78.89 101.96 7.98 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.7 t -107.62 145.34 33.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.585 0.707 . . . . 0.0 110.617 -165.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 6.2 t80 -137.41 131.62 32.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.928 1.291 . . . . 0.0 108.421 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 16.5 m -121.8 122.55 39.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 109.896 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.29 172.74 6.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.283 0.633 . . . . 0.0 109.702 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.53 117.21 12.22 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -66.81 168.99 8.86 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.62 0.768 . . . . 0.0 110.175 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.94 -27.37 20.76 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.336 2.69 . . . . 0.0 114.449 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.77 8.1 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.741 0.816 . . . . 0.0 111.488 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 51.1 m 70.04 30.74 3.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.223 1.409 . . . . 0.0 113.824 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.522 ' HE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -84.4 179.08 7.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 75.9 mmt-85 -111.32 117.82 34.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 37.7 mt -106.41 101.2 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -99.72 96.65 7.75 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.3 118.36 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.434 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.9 p90 -125.96 167.16 15.67 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.163 0.438 . . . . 0.0 110.988 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -127.0 110.73 13.28 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -82.7 118.18 23.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 93.85 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.349 0.66 . . . . 0.0 110.027 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.607 -176.698 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m80 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HG3' HD22 ' B' ' 25' ' ' LEU . 41.5 Cg_endo -82.71 52.4 4.04 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.381 2.721 . . . . 0.0 111.768 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.903 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 36.7 t70 -75.64 5.07 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.215 1.006 . . . . 0.0 111.764 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.419 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -124.46 126.56 46.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.0 t -120.44 145.02 47.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 50' ' ' TRP . 52.7 mt -122.07 144.4 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.775 0.83 . . . . 0.0 108.921 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.567 HD21 HD22 ' A' ' 68' ' ' LEU . 4.3 mm? -91.64 134.27 34.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.42 ' OH ' HG11 ' A' ' 55' ' ' VAL . 10.8 t80 -85.02 99.4 10.99 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.36 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.5 HG12 ' NE2' ' A' ' 113' ' ' HIS . 3.0 m -112.89 159.43 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.561 0.745 . . . . 0.0 109.075 -172.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.34 -59.78 1.87 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -102.37 101.82 21.83 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.245 0.618 . . . . 0.0 109.696 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HG3' ' HB2' ' A' ' 51' ' ' SER . 44.5 Cg_exo -55.21 -55.93 2.75 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.056 2.504 . . . . 0.0 114.908 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.76 -54.74 4.34 Favored 'Trans proline' 0 C--N 1.403 3.407 0 CA-C-N 122.545 1.945 . . . . 0.0 112.379 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.07 96.52 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.74 0.65 . . . . 0.0 111.703 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -66.53 -47.08 74.04 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 96.5 m -67.48 -40.48 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.572 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.1 mm100 -64.49 -38.29 90.49 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.273 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -64.94 -42.23 94.83 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.389 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.425 ' OH ' ' HG ' ' A' ' 9' ' ' LEU . 49.7 m-85 -68.52 -29.67 68.31 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.533 0.606 . . . . 0.0 110.466 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -56.83 -49.43 75.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.204 0.526 . . . . 0.0 111.879 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.87 -40.07 63.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.92 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.7 tp -58.94 -42.7 90.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.478 1.511 . . . . 0.0 113.068 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' HB2' HG22 ' A' ' 27' ' ' VAL . 16.3 mt -96.66 -31.99 12.42 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.16 26.88 27.29 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.325 0.391 . . . . 0.0 112.313 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.9 m -123.42 -178.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.967 0.907 . . . . 0.0 109.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -142.07 151.41 58.89 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 37.6 Cg_endo -63.76 121.26 8.92 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.896 2.397 . . . . 0.0 112.773 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.34 -35.16 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.442 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 15.5 mm-40 -121.03 116.63 25.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.939 1.296 . . . . 0.0 108.233 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.5 p -123.04 131.26 53.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.253 0.621 . . . . 0.0 110.097 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -138.67 151.14 68.15 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.864 1.266 . . . . 0.0 108.292 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.64 -10.12 23.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.817 2.344 . . . . 0.0 113.389 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.481 ' HA ' ' HG2' ' A' ' 14' ' ' PRO . 4.9 t -125.96 -3.57 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -159.17 151.47 21.25 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.7 m -141.62 158.6 43.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.769 0.428 . . . . 0.0 110.349 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -154.27 126.02 7.63 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.9 p90 -134.0 150.4 51.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.476 1.11 . . . . 0.0 109.09 165.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.531 HG22 ' HG3' ' A' ' 46' ' ' LYS . 13.4 t -120.96 131.42 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.03 165.4 15.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.644 0.378 . . . . 0.0 111.464 -171.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.08 75.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.518 1.127 . . . . 0.0 112.869 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -69.91 -20.75 63.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.13 0.572 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 5.35 37.32 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.871 -0.961 . . . . 0.0 114.181 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.493 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.3 ppp? -74.06 166.26 23.7 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.346 1.073 . . . . 0.0 109.206 169.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HG3' HG22 ' A' ' 40' ' ' VAL . 49.3 tttt -126.97 139.69 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 9' ' ' LEU . 3.5 tt -137.62 118.36 14.08 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.89 0.376 . . . . 0.0 110.387 -172.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -105.2 168.97 15.99 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 124.226 0.917 . . . . 0.0 111.958 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.61 106.29 6.91 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.609 ' HB2' HG21 ' A' ' 8' ' ' ILE . 5.1 t90 -105.55 125.59 51.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.569 ' HB2' ' HG3' ' A' ' 14' ' ' PRO . 23.3 t -77.48 137.07 38.45 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.592 0.558 . . . . 0.0 110.597 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -71.59 -10.14 59.31 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.501 0.72 . . . . 0.0 112.906 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -85.14 -21.19 29.34 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.215 0.206 . . . . 0.0 110.731 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 51' ' ' SER . 7.1 t -116.27 4.59 13.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.148 0.579 . . . . 0.0 111.326 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.1 p -72.71 145.4 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.97 116.54 26.05 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.4 Cg_exo -77.16 138.19 52.35 Favored 'Cis proline' 0 C--N 1.383 2.387 0 CA-C-N 119.727 0.938 . . . . 0.0 112.038 2.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HA ' HG13 ' A' ' 55' ' ' VAL . 2.8 tmmm? -65.25 112.42 3.44 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.962 0.789 . . . . 0.0 109.722 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.27 128.89 55.51 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.306 1.042 . . . . 0.0 110.015 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -90.52 84.38 5.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 m -159.27 150.86 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 124.688 1.195 . . . . 0.0 109.274 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.87 127.11 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.703 1.601 . . . . 0.0 107.915 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.89 -46.56 0.29 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.72 144.71 9.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.33 -29.93 0.15 Allowed Glycine 0 N--CA 1.469 0.876 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 149.56 18.33 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.192 -1.004 . . . . 0.0 110.695 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 7.4 mm-40 -101.71 151.56 21.89 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 173.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.567 HD22 HD21 ' A' ' 9' ' ' LEU . 41.4 tp -109.99 101.92 10.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -87.54 117.96 26.69 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.522 ' HB2' HG22 ' A' ' 117' ' ' VAL . 8.7 m-85 -96.47 121.46 38.31 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.782 1.233 . . . . 0.0 107.896 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.441 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 39.9 mtm105 -99.98 126.74 46.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.23 162.45 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.174 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.38 -33.68 69.75 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.82 179.39 7.12 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.055 0.843 . . . . 0.0 112.288 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.44 -34.27 75.12 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.432 1.093 . . . . 0.0 112.272 -165.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.24 -43.87 96.83 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.213 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -65.22 -21.75 66.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.874 0.87 . . . . 0.0 112.738 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.17 -38.12 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.071 0.463 . . . . 0.0 110.06 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.35 -32.29 64.46 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.306 1.042 . . . . 0.0 111.324 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.0 mt-10 -68.76 -40.1 79.93 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.656 0.741 . . . . 0.0 109.192 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.414 HG21 HG21 ' A' ' 117' ' ' VAL . 99.5 m -68.62 -32.7 72.76 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.65 174.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -62.78 -60.76 3.04 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.821 0.819 . . . . 0.0 109.458 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.4 -37.28 85.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.841 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.35 -46.12 91.49 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.98 0.8 . . . . 0.0 113.638 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 115' ' ' LEU . 36.3 m0 -61.23 -50.35 73.45 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.235 0.614 . . . . 0.0 109.996 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.7 ttpt -52.58 -45.16 66.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.142 0.977 . . . . 0.0 110.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.98 61.08 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.294 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -97.77 11.12 38.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.814 0.845 . . . . 0.0 112.828 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 15.01 21.22 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.49 136.03 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 117.545 0.673 . . . . 0.0 110.321 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.68 72.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.428 1.091 . . . . 0.0 111.754 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.617 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 49.7 tpp 69.02 83.59 0.16 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.157 0.911 . . . . 0.0 112.849 165.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.27 86.47 2.28 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.0 0.52 . . . . 0.0 111.537 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.572 ' HG2' ' H ' ' A' ' 106' ' ' THR . 55.6 tp60 -179.67 140.77 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.882 0.873 . . . . 0.0 109.645 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -92.24 113.79 60.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' THR . 20.9 Cg_endo -61.63 108.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.243 1.962 . . . . 0.0 110.598 174.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.64 49.28 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.335 0.654 . . . . 0.0 110.219 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -63.07 106.26 0.82 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.588 0.755 . . . . 0.0 110.975 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 104' ' ' THR . 3.3 ttt -93.99 -176.38 3.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.843 0.857 . . . . 0.0 109.737 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 99' ' ' MET . 8.7 mm-40 -66.31 -27.67 68.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.02 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.73 92.72 3.38 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.8 161.74 3.24 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 36.0 t80 -69.09 103.76 1.96 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.138 1.375 . . . . 0.0 108.61 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 13.7 t -103.03 141.55 35.63 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.86 0.754 . . . . 0.0 111.683 -162.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -151.62 127.61 10.38 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.754 1.221 . . . . 0.0 109.636 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 42.3 m -135.24 125.82 26.93 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.07 162.05 21.92 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.062 0.545 . . . . 0.0 112.169 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.89 112.42 24.64 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.581 0.753 . . . . 0.0 109.599 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.547 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.4 p30 -71.96 177.27 1.77 Allowed Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.437 1.095 . . . . 0.0 112.05 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 25.5 Cg_exo -40.64 -50.48 3.86 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.949 3.099 . . . . 0.0 115.544 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 9.9 t70 -79.62 -17.86 52.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.6 m 71.93 61.32 0.14 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.412 1.485 . . . . 0.0 110.886 174.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.5 ' NE2' HG12 ' A' ' 11' ' ' VAL . 8.6 m80 -91.71 175.07 7.03 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.603 -1.18 . . . . 0.0 107.975 168.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -94.43 99.04 11.3 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HB3' ' CH2' ' A' ' 85' ' ' TRP . 81.9 mt -106.12 104.03 13.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.631 0.372 . . . . 0.0 110.011 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.545 ' NH1' ' HB3' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -93.31 147.18 23.15 Favored 'General case' 0 C--O 1.205 -1.269 0 C-N-CA 124.022 0.929 . . . . 0.0 110.01 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 70' ' ' PHE . 12.2 t -139.66 140.0 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 5.4 p90 -133.81 171.1 14.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.096 0.407 . . . . 0.0 111.635 172.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -131.06 113.95 14.56 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 166.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -75.11 129.25 37.23 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 O-C-N 123.722 0.639 . . . . 0.0 110.264 -174.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 m80 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.474 ' HG3' HD22 ' A' ' 25' ' ' LEU . 42.0 Cg_endo -82.74 51.69 3.8 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.28 2.654 . . . . 0.0 111.89 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.493 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 30.3 t70 -75.96 5.92 5.89 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.179 0.99 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.01 126.08 45.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 15.2 t -120.4 145.66 46.97 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' B' ' 50' ' ' TRP . 59.4 mt -122.67 144.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 123.825 0.85 . . . . 0.0 108.768 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.572 HD21 HD22 ' B' ' 68' ' ' LEU . 4.3 mm? -91.59 134.12 34.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.85 99.3 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.448 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.511 HG12 ' NE2' ' B' ' 113' ' ' HIS . 3.2 m -112.72 159.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.691 0.796 . . . . 0.0 109.032 -172.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 -60.28 1.82 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -102.29 101.71 20.99 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.295 0.638 . . . . 0.0 109.881 -173.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' B' ' 51' ' ' SER . 32.5 Cg_exo -55.67 -55.55 2.93 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.952 2.435 . . . . 0.0 114.701 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.77 -54.82 4.2 Favored 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.594 1.962 . . . . 0.0 112.276 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.31 96.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.072 0.549 . . . . 0.0 111.768 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 69.1 m -65.31 -47.15 77.57 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 123.726 0.641 . . . . 0.0 109.364 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 51.9 m -67.46 -41.17 85.1 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -170.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.559 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 11.7 mm100 -64.09 -38.43 91.05 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.514 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.83 -41.95 95.34 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.394 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 42.6 m-85 -68.6 -29.9 68.53 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.579 0.627 . . . . 0.0 110.487 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -56.6 -49.48 74.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.194 0.521 . . . . 0.0 111.695 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.26 63.22 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.975 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 31.0 tp -58.93 -42.2 89.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.37 1.468 . . . . 0.0 113.232 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.54 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.4 mt -97.55 -30.53 12.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.74 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.67 30.4 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.6 m -122.93 -177.71 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.121 0.968 . . . . 0.0 109.823 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' B' ' 22' ' ' LYS . 6.5 p-10 -143.04 151.81 56.79 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 109.365 174.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 18.7 Cg_exo -65.53 121.25 8.61 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.95 2.433 . . . . 0.0 112.263 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.513 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.2 p -64.9 -36.68 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 21.0 mm-40 -120.89 116.83 25.91 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.872 1.269 . . . . 0.0 107.966 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -123.62 131.62 53.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.988 0.515 . . . . 0.0 109.933 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -138.97 150.34 64.87 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.833 1.253 . . . . 0.0 108.345 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.93 -10.33 22.41 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.507 2.138 . . . . 0.0 113.576 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 5.6 t -126.19 -3.27 6.92 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -159.14 151.64 21.51 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 73.3 m -141.87 159.08 42.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.628 0.371 . . . . 0.0 110.391 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 24.2 tp -154.81 125.56 7.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.6 p90 -133.89 150.2 51.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.253 1.021 . . . . 0.0 109.134 165.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.553 HG22 ' HG3' ' B' ' 46' ' ' LYS . 18.5 t -120.77 131.46 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.91 165.18 16.11 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.691 0.397 . . . . 0.0 111.553 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.69 76.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.641 1.177 . . . . 0.0 112.851 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -69.99 -20.47 63.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.004 0.522 . . . . 0.0 111.068 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.31 5.0 37.73 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-O 118.817 -0.99 . . . . 0.0 113.988 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.903 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 6.8 ptm -73.68 166.84 22.55 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.538 1.169 . . . . 0.0 109.27 169.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' B' ' 40' ' ' VAL . 73.1 tttt -127.25 139.5 52.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.534 HD21 HD23 ' B' ' 9' ' ' LEU . 3.6 tt -137.56 118.7 14.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.973 0.416 . . . . 0.0 110.254 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.93 169.09 16.34 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.315 0.96 . . . . 0.0 111.958 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.85 106.03 6.69 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 166.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.609 ' HB2' HG21 ' B' ' 8' ' ' ILE . 4.5 t90 -105.46 125.63 51.21 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.573 ' HB2' ' HG3' ' B' ' 14' ' ' PRO . 21.6 t -77.29 137.13 38.61 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.681 0.613 . . . . 0.0 110.716 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -71.92 -9.78 58.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -85.32 -20.14 30.44 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.493 0.317 . . . . 0.0 111.389 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.477 HG22 ' HB3' ' B' ' 51' ' ' SER . 11.9 t -117.02 4.41 12.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.392 0.677 . . . . 0.0 111.029 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' B' ' 58' ' ' LYS . 8.4 p -73.57 146.71 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.29 116.14 23.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -77.65 139.2 56.27 Favored 'Cis proline' 0 C--N 1.387 2.595 0 C-N-CA 124.706 -0.956 . . . . 0.0 111.869 3.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.517 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.1 tmmm? -66.18 112.5 3.96 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.85 0.719 . . . . 0.0 109.395 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.93 129.3 55.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.19 0.996 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 27.5 p -90.98 85.58 6.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 62' ' ' THR . 7.9 p -161.52 149.77 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.339 1.056 . . . . 0.0 109.567 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.434 HG23 ' O ' ' B' ' 61' ' ' VAL . 2.1 p -168.83 128.1 1.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.958 1.703 . . . . 0.0 107.65 169.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.21 -47.55 0.29 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.82 144.66 9.66 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.41 -29.87 0.15 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 149.45 18.1 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.162 -1.019 . . . . 0.0 110.657 170.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.596 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 11.2 mm-40 -101.51 151.85 21.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.572 HD22 HD21 ' B' ' 9' ' ' LEU . 44.1 tp -110.14 101.78 10.54 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -87.58 118.0 26.77 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.575 0.702 . . . . 0.0 111.208 -170.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -96.05 121.55 37.92 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 42.2 mtm105 -100.4 125.01 46.63 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.68 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.91 163.2 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.135 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.1 pt-20 -71.3 -34.58 70.73 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.428 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -163.21 179.84 7.15 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.155 0.889 . . . . 0.0 112.482 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.13 -33.86 75.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.43 1.092 . . . . 0.0 111.891 -165.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.56 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.987 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.5 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.5 mm-40 -65.62 -22.06 66.63 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.691 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.64 -38.95 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 122.748 0.419 . . . . 0.0 109.924 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.93 -31.82 64.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.154 0.981 . . . . 0.0 111.436 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.9 mt-10 -69.88 -38.93 76.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.634 0.73 . . . . 0.0 109.53 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 68.3 m -68.34 -33.53 74.45 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.616 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -62.47 -61.01 2.74 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.739 0.781 . . . . 0.0 109.542 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.6 -36.9 84.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.667 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.84 89.03 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 124.001 0.813 . . . . 0.0 113.63 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . 0.409 ' HB3' HG21 ' B' ' 90' ' ' VAL . 42.1 m0 -60.6 -50.28 74.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.351 0.66 . . . . 0.0 109.551 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.612 ' HB2' ' HE3' ' B' ' 92' ' ' MET . 31.5 ttpt -53.42 -44.64 68.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.132 0.895 . . . . 0.0 111.003 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.69 61.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 m -98.19 10.64 40.08 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.722 0.809 . . . . 0.0 112.884 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.58 14.77 20.85 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' B' ' 85' ' ' TRP . 54.4 t -78.66 135.69 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 117.554 0.677 . . . . 0.0 110.413 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.95 -37.48 71.59 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.468 1.107 . . . . 0.0 111.764 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.612 ' HE3' ' HB2' ' B' ' 86' ' ' LYS . 45.0 tpp 69.83 83.16 0.15 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.126 0.891 . . . . 0.0 112.707 165.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.49 87.08 2.32 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.745 0.418 . . . . 0.0 111.512 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' B' ' 106' ' ' THR . 56.9 tp60 179.66 141.77 0.13 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.118 0.967 . . . . 0.0 109.856 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -93.51 113.24 59.69 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' B' ' 104' ' ' THR . 33.3 Cg_exo -60.26 108.64 0.53 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.472 2.115 . . . . 0.0 110.974 173.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.46 49.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.466 0.706 . . . . 0.0 110.541 -175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -62.48 106.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.817 0.847 . . . . 0.0 110.981 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.469 ' SD ' HG21 ' B' ' 104' ' ' THR . 3.3 ttt -93.9 -175.96 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.675 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' B' ' 99' ' ' MET . 10.4 mm-40 -66.54 -27.96 68.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.585 . . . . 0.0 111.015 174.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -128.89 92.24 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.286 1.034 . . . . 0.0 109.152 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 161.64 2.83 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 34.0 t80 -68.87 103.25 1.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 108.851 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.469 HG21 ' SD ' ' B' ' 99' ' ' MET . 5.3 t -103.67 142.11 34.9 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.163 0.892 . . . . 0.0 111.518 -161.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.487 ' HZ ' ' SD ' ' B' ' 92' ' ' MET . 14.2 t80 -151.6 127.81 10.53 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.499 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 60.4 m -134.99 125.92 27.55 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.43 162.03 22.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.007 0.523 . . . . 0.0 112.154 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.9 113.28 26.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.663 0.785 . . . . 0.0 109.165 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.555 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.8 p-10 -73.27 177.89 1.77 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 124.366 1.066 . . . . 0.0 111.745 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.7 Cg_exo -41.04 -50.3 4.24 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.919 3.079 . . . . 0.0 115.531 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 10.5 t70 -79.65 -17.64 53.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 71.72 61.1 0.15 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 125.329 1.451 . . . . 0.0 111.005 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.511 ' NE2' HG12 ' B' ' 11' ' ' VAL . 7.6 m80 -91.29 175.29 6.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.15 168.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -95.01 98.7 10.87 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.95 103.54 13.13 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 46.4 ttt180 -89.83 148.49 23.16 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 123.279 0.632 . . . . 0.0 110.455 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.23 140.59 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.526 1.13 . . . . 0.0 108.176 163.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' B' ' 103' ' ' TYR . 7.2 p90 -133.7 170.63 15.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -130.49 113.79 14.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -74.68 130.24 39.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 99.87 0.89 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.94 0.896 . . . . 0.0 110.998 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.405 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.444 176.448 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.48 93.79 0.99 Allowed 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.195 1.93 . . . . 0.0 111.381 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 6.3 p-10 -109.25 14.63 23.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 0.0 109.454 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HD2' ' HD3' ' B' ' 71' ' ' ARG . 0.7 OUTLIER -131.5 141.91 49.86 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.919 -165.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 145.16 30.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.733 1.213 . . . . 0.0 108.117 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 51.4 mt -118.59 140.65 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.034 0.534 . . . . 0.0 110.661 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.56 118.53 37.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -74.42 122.5 23.09 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.981 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' SER . 11.7 m -122.14 163.7 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.17 -52.26 3.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -103.98 98.18 12.97 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.455 0.702 . . . . 0.0 110.079 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.49 -48.72 17.85 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.506 2.804 . . . . 0.0 115.858 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.89 -63.48 0.2 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 123.106 2.145 . . . . 0.0 112.419 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.62 89.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 0.0 112.125 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -66.82 -47.94 70.46 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.442 0.639 . . . . 0.0 110.425 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 65.8 m -75.96 -34.92 59.83 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.0 mm-40 -66.45 -33.74 76.39 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.102 0.876 . . . . 0.0 109.259 172.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 81.9 t80 -66.73 -42.83 85.67 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.002 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -71.21 -29.02 64.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.375 0.534 . . . . 0.0 110.377 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.0 mtpt -57.39 -48.9 77.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.935 0.398 . . . . 0.0 111.902 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.77 -35.68 62.56 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.024 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 12.9 tp -64.52 -30.58 71.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.602 1.161 . . . . 0.0 112.737 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' HG22 ' A' ' 27' ' ' VAL . 83.4 mt -104.03 -41.13 5.94 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.982 0.913 . . . . 0.0 109.565 176.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.73 34.06 6.16 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.0 m -123.72 -177.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.521 1.128 . . . . 0.0 110.484 -176.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -148.52 146.74 23.25 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.485 1.114 . . . . 0.0 108.833 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 19.1 Cg_exo -64.41 108.12 0.95 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.598 2.198 . . . . 0.0 111.909 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.1 -38.7 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.7 mm-40 -111.9 121.8 46.03 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -121.97 140.9 51.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.56 . . . . 0.0 110.358 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 36' ' ' PHE . 43.5 t -141.6 149.8 55.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.872 1.269 . . . . 0.0 107.949 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.22 -24.86 61.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.843 2.362 . . . . 0.0 113.572 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.3 t -128.01 9.2 6.27 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 85.9 t80 -149.22 150.59 32.85 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.708 0.403 . . . . 0.0 110.505 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 42.7 m -134.51 143.17 47.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.553 0.741 . . . . 0.0 109.697 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -138.51 119.62 14.53 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 6.8 p90 -131.98 147.86 52.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 108.127 167.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 1.6 p -126.33 134.98 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 109.306 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 47' ' ' LEU . 6.1 mp -95.26 150.78 19.87 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.261 -167.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.66 -9.14 57.8 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.952 0.901 . . . . 0.0 110.744 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 58.9 m-20 -70.73 -9.31 56.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.28 1.032 . . . . 0.0 111.441 170.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.7 63.99 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.041 0.353 . . . . 0.0 113.38 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' B' ' 4' ' ' PRO . 18.6 ptm -113.37 167.72 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.694 0.797 . . . . 0.0 109.175 177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 62.3 tttt -132.86 136.57 46.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.671 0.388 . . . . 0.0 109.991 -174.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 HD11 ' A' ' 41' ' ' LEU . 12.9 mt -125.38 123.7 39.91 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.714 0.805 . . . . 0.0 112.295 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.83 145.72 16.82 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 169.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 10.4 mp -117.29 105.19 11.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 161.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.33 129.79 54.86 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 69.2 m -72.5 130.82 41.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.27 0.356 . . . . 0.0 111.286 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 55' ' ' VAL . 42.6 ptt85 -66.15 -21.36 66.33 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.957 0.903 . . . . 0.0 111.913 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -81.33 -6.7 59.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.152 0.581 . . . . 0.0 111.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' HB2' ' A' ' 51' ' ' SER . 13.5 t -127.25 4.65 6.36 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.452 0.701 . . . . 0.0 110.784 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 52' ' ' ARG . 5.3 p -71.18 149.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.86 0.464 . . . . 0.0 111.47 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -130.6 121.47 19.23 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.874 0.87 . . . . 0.0 109.392 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.56 141.1 68.83 Favored 'Cis proline' 0 C--N 1.385 2.497 0 CA-C-N 119.943 1.015 . . . . 0.0 112.345 -1.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -55.1 132.04 46.43 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.114 0.966 . . . . 0.0 112.215 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.79 109.73 4.49 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.723 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.8 m -83.04 87.32 6.89 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.2 m -148.34 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.942 0.897 . . . . 0.0 109.445 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 p -150.81 135.57 17.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.655 1.182 . . . . 0.0 108.594 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.28 35.18 57.04 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.337 0.398 . . . . 0.0 113.139 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.53 29.25 2.61 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.21 -172.06 32.14 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 115.858 -0.171 . . . . 0.0 112.867 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' B' ' 66' ' ' GLY . . . 70.48 107.45 0.04 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.675 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 36.1 mt-10 -122.76 134.47 54.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.76 109.57 15.76 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.98 121.96 34.85 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.249 0.547 . . . . 0.0 110.767 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.528 ' HB2' HG22 ' A' ' 117' ' ' VAL . 40.6 m-85 -102.87 107.64 18.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.789 1.636 . . . . 0.0 108.747 -177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.6 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 25.4 mtm180 -92.54 132.46 36.82 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 112.053 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 161.86 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.316 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.2 pt-20 -65.8 -41.31 92.07 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -160.83 -178.87 7.12 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.57 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.42 -33.18 65.58 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.745 1.618 . . . . 0.0 113.072 -169.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.11 -46.0 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.84 0.456 . . . . 0.0 110.408 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.468 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 79.9 mm-40 -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.194 0.998 . . . . 0.0 112.537 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.2 -44.07 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.495 0.718 . . . . 0.0 109.841 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.36 -35.63 73.68 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.516 1.126 . . . . 0.0 111.035 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -65.93 -41.02 91.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.251 0.548 . . . . 0.0 109.866 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -63.47 -41.14 98.59 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.612 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.89 -57.8 11.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.398 0.679 . . . . 0.0 110.693 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.498 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -63.04 -41.2 99.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.254 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.44 -47.27 86.0 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.869 0.73 . . . . 0.0 113.547 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -62.1 -45.44 93.47 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.658 0.783 . . . . 0.0 109.826 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.4 ttpt -55.64 -43.0 75.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.115 0.966 . . . . 0.0 110.83 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.63 -26.94 61.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.239 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -93.29 8.21 41.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.937 0.895 . . . . 0.0 112.618 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.6 45.33 4.64 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 166.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.482 HG21 ' HB1' ' A' ' 107' ' ' ALA . 8.0 p -98.46 152.18 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 170.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.38 -62.34 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.601 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 30.2 ttp 61.24 82.75 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.173 0.989 . . . . 0.0 112.849 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 84.92 2.14 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.832 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 179.91 135.22 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 0.0 108.615 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.98 129.96 77.08 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.539 0.524 . . . . 0.0 109.923 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.58 96.42 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.752 2.301 . . . . 0.0 109.849 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.34 160.48 36.15 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.09 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 101.05 6.35 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.065 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 21.7 ttt -100.75 -178.92 3.92 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.982 1.313 . . . . 0.0 110.023 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 99' ' ' MET . 15.1 mm-40 -52.13 -41.02 62.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.654 1.182 . . . . 0.0 112.432 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 55.8 m-85 -96.55 11.96 33.29 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.614 -173.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.28 -165.47 12.79 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.86 112.04 19.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -141.87 169.24 17.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.839 0.455 . . . . 0.0 111.611 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.411 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 37.0 p90 -152.98 175.61 12.77 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.852 166.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.635 HG21 ' HG3' ' A' ' 114' ' ' ARG . 90.7 m -137.39 130.66 30.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.022 0.439 . . . . 0.0 110.178 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.22 168.18 9.24 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.443 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.7 112.33 6.82 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 5.9 p-10 -68.01 174.39 2.41 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.253 1.021 . . . . 0.0 111.134 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 16.0 Cg_exo -37.26 -49.94 1.66 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.197 3.265 . . . . 0.0 115.321 172.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -10.79 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.678 0.791 . . . . 0.0 111.177 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m 69.84 92.78 0.08 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.535 1.534 . . . . 0.0 112.188 168.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.459 ' CE1' HG12 ' A' ' 11' ' ' VAL . 16.4 m80 -124.21 149.2 46.66 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.675 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 22.0 ttp180 -81.03 95.16 6.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.291 0.567 . . . . 0.0 110.115 -171.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 mt -92.76 101.59 13.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -92.84 95.54 9.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.805 0.842 . . . . 0.0 110.869 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 70' ' ' PHE . 36.5 t -97.21 117.05 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -133.81 161.62 34.24 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.8 111.46 15.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 166.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 35.8 t80 -77.48 127.31 32.3 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 m80 . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.424 ' O ' ' SD ' ' A' ' 45' ' ' MET . 73.7 Cg_endo -75.7 94.47 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.065 1.843 . . . . 0.0 111.267 164.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 8.7 p-10 -109.78 14.65 23.16 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.551 0.74 . . . . 0.0 109.487 168.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.6 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.3 OUTLIER -131.15 141.25 50.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.895 1.278 . . . . 0.0 107.687 -165.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.464 HG23 HD23 ' B' ' 47' ' ' LEU . 5.6 t -145.13 145.1 31.25 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.693 1.197 . . . . 0.0 108.261 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.3 mt -118.31 140.19 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.103 0.561 . . . . 0.0 110.73 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.3 117.48 34.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.425 ' HD1' ' H ' ' B' ' 10' ' ' TYR . 5.6 p90 -73.07 122.93 22.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.139 0.976 . . . . 0.0 111.397 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' B' ' 51' ' ' SER . 11.3 m -122.44 163.67 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -98.43 -52.14 3.74 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -104.06 98.65 14.2 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.397 0.679 . . . . 0.0 110.5 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.69 -48.61 18.52 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.609 2.873 . . . . 0.0 115.927 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 15.6 Cg_endo -55.14 -63.89 0.17 Allowed 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 123.002 2.108 . . . . 0.0 112.272 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.99 88.85 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.334 0.654 . . . . 0.0 112.088 -167.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -66.46 -48.16 70.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.494 0.664 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 89.1 m -75.65 -34.9 60.52 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -168.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 85.3 mm-40 -67.17 -33.96 76.51 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.3 1.0 . . . . 0.0 109.056 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 85.7 t80 -66.05 -43.35 87.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.004 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.416 ' CD2' HD21 ' B' ' 49' ' ' LEU . 40.8 m-85 -70.68 -29.45 65.78 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.418 0.553 . . . . 0.0 110.142 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.3 mtpt -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.125 0.488 . . . . 0.0 112.04 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.8 62.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.158 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 13.3 tp -63.88 -30.72 71.78 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.581 1.152 . . . . 0.0 112.734 -175.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' B' ' 27' ' ' VAL . 66.7 mt -104.47 -41.09 5.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 109.45 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.78 34.1 6.13 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.6 m -124.19 -177.82 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.399 1.08 . . . . 0.0 110.833 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -147.23 146.6 25.94 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.203 1.001 . . . . 0.0 108.966 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 35.9 Cg_endo -63.38 108.54 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.408 2.072 . . . . 0.0 112.115 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -64.33 -38.38 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.31 0.644 . . . . 0.0 110.243 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 17.9 mm-40 -112.04 121.56 45.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.7 p -122.12 140.67 52.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.119 0.568 . . . . 0.0 110.488 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' B' ' 36' ' ' PHE . 30.7 t -141.71 149.47 53.62 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.963 1.305 . . . . 0.0 107.89 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.77 -24.99 58.45 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.7 2.267 . . . . 0.0 113.587 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -127.87 8.95 6.31 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' B' ' 33' ' ' SER . 85.8 t80 -149.0 150.6 33.09 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.606 0.362 . . . . 0.0 110.41 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 15.1 m -134.2 143.5 47.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.462 0.705 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tm? -139.4 119.15 13.2 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 5.9 p90 -131.91 148.0 52.51 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 167.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' B' ' 46' ' ' LYS . 5.6 t -125.92 134.28 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -172.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.524 HD21 HD13 ' B' ' 25' ' ' LEU . 52.3 mt -94.22 150.91 19.87 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.67 0.788 . . . . 0.0 110.775 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -9.42 58.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.082 0.953 . . . . 0.0 110.697 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 69.7 m-20 -70.63 -9.01 56.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.028 0.931 . . . . 0.0 111.699 170.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.16 11.54 62.87 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 116.59 -0.277 . . . . 0.0 113.342 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.578 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -115.1 167.2 11.03 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.88 0.872 . . . . 0.0 108.895 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' B' ' 40' ' ' VAL . 78.3 tttt -132.51 135.37 45.95 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.146 0.578 . . . . 0.0 109.659 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.464 HD23 HG23 ' B' ' 7' ' ' THR . 36.8 mt -124.94 123.87 40.83 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.775 0.83 . . . . 0.0 112.216 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.33 145.66 16.61 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 10.5 mp -117.53 105.2 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 161.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.26 129.97 54.81 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 69.5 m -72.73 130.48 40.61 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.199 0.312 . . . . 0.0 111.483 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.452 ' HD3' HG23 ' B' ' 62' ' ' THR . 31.7 ptt180 -66.48 -20.91 66.16 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.722 0.809 . . . . 0.0 111.995 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -81.05 -7.16 59.5 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.872 0.469 . . . . 0.0 111.514 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 51' ' ' SER . 14.1 t -126.88 5.44 6.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.295 0.638 . . . . 0.0 110.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.442 HG12 ' O ' ' B' ' 52' ' ' ARG . 5.5 p -71.57 149.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.808 0.443 . . . . 0.0 111.354 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -131.03 121.32 18.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.5 141.54 70.24 Favored 'Cis proline' 0 C--N 1.389 2.682 0 C-N-CA 124.622 -0.991 . . . . 0.0 112.294 -1.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -55.9 132.28 49.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.026 0.93 . . . . 0.0 111.928 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.04 109.52 4.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.578 0.751 . . . . 0.0 109.635 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -82.66 87.82 6.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.67 139.35 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.102 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.452 HG23 ' HD3' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -150.14 135.33 17.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.823 1.249 . . . . 0.0 108.65 174.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.01 58.91 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.375 0.422 . . . . 0.0 113.329 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.05 28.79 2.69 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.23 -172.11 32.15 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.749 -0.225 . . . . 0.0 112.997 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . 70.61 107.41 0.04 OUTLIER Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.672 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 35.0 mt-10 -122.72 134.54 54.45 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -119.82 109.48 15.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.95 122.3 35.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.388 0.613 . . . . 0.0 110.85 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.529 ' HB2' HG22 ' B' ' 117' ' ' VAL . 40.6 m-85 -103.22 107.67 18.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.754 1.621 . . . . 0.0 108.474 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.603 ' HD3' ' HD2' ' A' ' 6' ' ' PHE . 27.8 mtm180 -92.76 131.53 37.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.197 0.522 . . . . 0.0 111.84 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.17 162.33 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.271 1.028 . . . . 0.0 110.239 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.3 pt-20 -66.31 -40.17 89.79 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.57 -179.13 7.06 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.989 0.813 . . . . 0.0 112.676 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.99 -33.32 64.73 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.776 1.63 . . . . 0.0 113.421 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.01 78.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.586 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.7 mm-40 -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.358 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.96 -44.76 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.552 0.692 . . . . 0.0 109.715 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.75 -36.44 78.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.298 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -65.46 -41.57 93.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.349 0.595 . . . . 0.0 110.025 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.7 m -62.77 -41.23 99.14 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.659 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -58.12 -57.44 12.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.448 0.699 . . . . 0.0 110.616 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -63.52 -41.01 98.51 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.235 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.67 82.57 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.801 0.688 . . . . 0.0 113.41 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -61.77 -45.82 92.24 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.637 0.775 . . . . 0.0 109.884 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.1 ttpt -54.74 -43.41 72.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.171 0.988 . . . . 0.0 111.04 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.77 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.798 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -93.53 8.51 40.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.024 0.93 . . . . 0.0 112.374 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.17 45.77 4.64 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 114.859 0.703 . . . . 0.0 114.859 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.478 HG21 ' HB1' ' B' ' 107' ' ' ALA . 8.3 p -98.56 152.02 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.48 -61.93 1.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.607 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 30.3 ttp 60.86 83.11 0.15 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.231 1.012 . . . . 0.0 112.79 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.45 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -106.35 85.48 2.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.352 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 179.71 134.22 0.1 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 108.384 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -75.83 130.04 79.7 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.63 0.581 . . . . 0.0 109.893 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.98 95.78 0.67 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.731 2.287 . . . . 0.0 110.083 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.16 160.15 36.91 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -168.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 101.08 5.9 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.962 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.43 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 22.4 ttt -100.89 -178.78 3.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.134 1.374 . . . . 0.0 109.84 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' B' ' 99' ' ' MET . 5.7 mm-40 -52.86 -40.79 63.71 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.559 1.144 . . . . 0.0 112.182 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 55.0 m-85 -96.3 11.94 32.85 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.863 0.865 . . . . 0.0 111.673 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.84 -165.3 12.92 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.07 112.2 19.58 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -142.0 169.32 17.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.817 0.447 . . . . 0.0 111.588 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' B' ' 92' ' ' MET . 37.0 p90 -153.12 175.72 12.7 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.316 1.047 . . . . 0.0 108.731 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.656 HG21 ' HG3' ' B' ' 114' ' ' ARG . 96.8 m -137.49 130.8 30.91 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 110.138 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.32 168.45 9.06 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.505 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.86 112.23 6.71 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.483 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.6 p-10 -67.51 174.3 2.26 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.334 1.054 . . . . 0.0 111.551 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 17.3 Cg_exo -37.67 -49.78 1.92 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.938 3.092 . . . . 0.0 115.225 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.26 -10.21 50.4 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.46 0.704 . . . . 0.0 111.368 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 70.07 92.18 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.578 1.551 . . . . 0.0 112.047 168.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.466 ' CE1' HG12 ' B' ' 11' ' ' VAL . 15.7 m80 -123.77 149.37 45.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 170.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.672 ' HB3' ' HG2' ' B' ' 67' ' ' GLU . 21.8 ttp180 -81.15 95.34 6.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.136 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 mt -93.24 101.72 13.99 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -171.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -90.97 94.72 9.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.892 0.877 . . . . 0.0 111.131 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' B' ' 70' ' ' PHE . 36.8 t -97.61 117.47 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.353 0.979 . . . . 0.0 108.366 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -133.77 161.42 34.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 111.35 15.47 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 166.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 35.2 t80 -77.98 132.55 37.89 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.79 95.22 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.274 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.096 0 CA-C-O 118.963 -0.91 . . . . 0.0 111.033 -174.421 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -94.05 92.29 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.291 2.66 . . . . 0.0 113.066 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.1 p-10 -103.17 9.46 38.28 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.613 0.72 . . . . 0.0 110.044 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -132.59 136.23 46.42 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.793 1.237 . . . . 0.0 108.116 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -131.56 142.67 49.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.699 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 57.2 mt -120.79 134.83 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 68' ' ' LEU . 94.0 mt -82.11 131.58 35.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' B' ' 66' ' ' GLY . 23.7 t80 -85.31 105.04 15.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.803 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 49' ' ' LEU . 2.4 m -116.35 176.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.97 -57.95 2.2 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.052 0.941 . . . . 0.0 109.678 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -89.18 105.64 10.94 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.748 1.219 . . . . 0.0 109.309 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.79 -55.91 2.35 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.95 2.434 . . . . 0.0 113.704 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.81 -65.82 0.1 Allowed 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 122.109 1.789 . . . . 0.0 112.686 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -165.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.7 p -63.33 -55.43 24.65 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 99.6 m -67.3 -39.33 85.95 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -168.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.525 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 23.7 mm-40 -62.38 -41.11 98.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.817 1.247 . . . . 0.0 109.45 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 86.4 t80 -65.37 -39.98 92.98 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 110.049 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.442 ' OH ' HD21 ' A' ' 115' ' ' LEU . 61.4 m-85 -71.28 -31.42 67.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.594 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.1 mtpt -56.53 -46.33 80.66 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -37.7 51.17 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.272 175.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 14.9 tp -62.93 -30.91 71.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.268 1.027 . . . . 0.0 112.536 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 27' ' ' VAL . 46.1 mt -104.94 -37.63 6.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.008 0.923 . . . . 0.0 109.152 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.08 9.95 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -172.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 25' ' ' LEU . 23.9 m -128.15 159.37 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.963 0.905 . . . . 0.0 110.174 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -112.22 148.7 39.66 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.609 0.764 . . . . 0.0 109.625 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 16.8 Cg_exo -67.18 108.03 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.784 2.323 . . . . 0.0 111.076 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 39' ' ' PHE . 7.3 p -63.4 -34.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.706 0.629 . . . . 0.0 110.679 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.7 mm-40 -115.63 85.36 2.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -86.71 129.45 34.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.266 0.626 . . . . 0.0 110.095 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -137.49 150.78 69.57 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.745 0.818 . . . . 0.0 109.193 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.76 -42.78 42.85 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.714 2.943 . . . . 0.0 114.812 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -127.17 24.51 6.33 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.252 0.548 . . . . 0.0 112.276 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -153.77 152.42 30.71 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 33.5 t -134.66 142.65 46.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.387 0.675 . . . . 0.0 109.366 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -141.06 122.31 14.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.542 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 5.5 p90 -129.74 146.61 51.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.839 0.856 . . . . 0.0 108.993 164.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 46' ' ' LYS . 6.1 t -118.88 135.12 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.433 HD12 ' SD ' ' A' ' 45' ' ' MET . 38.5 mt -96.21 158.76 15.29 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.933 0.493 . . . . 0.0 110.517 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.59 -20.95 66.12 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.965 0.906 . . . . 0.0 112.465 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.898 0.879 . . . . 0.0 111.393 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.59 -14.17 42.46 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.733 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -72.91 154.96 40.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' HG22 ' A' ' 40' ' ' VAL . 81.6 tttt -119.23 139.74 51.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.55 115.52 11.55 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -168.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.35 170.7 21.6 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 123.901 0.763 . . . . 0.0 111.533 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 6.3 mp -139.5 107.7 5.77 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 165.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.9 t90 -105.09 124.05 48.87 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -76.79 139.25 40.31 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.374 0.67 . . . . 0.0 111.102 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.442 ' HD3' HG23 ' A' ' 62' ' ' THR . 39.2 ptt180 -73.0 -14.82 61.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.147 0.579 . . . . 0.0 112.244 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -85.72 -6.51 59.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 122.511 0.325 . . . . 0.0 111.157 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -129.37 8.51 5.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.367 0.667 . . . . 0.0 110.976 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.869 HG23 HH22 ' B' ' 116' ' ' ARG . 12.5 p -74.62 148.84 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.031 0.532 . . . . 0.0 111.734 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -128.19 116.03 20.19 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.827 0.851 . . . . 0.0 109.568 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.22 144.47 78.05 Favored 'Cis proline' 0 C--N 1.387 2.579 0 C-N-CA 124.52 -1.033 . . . . 0.0 112.743 1.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 55' ' ' VAL . 12.0 mmmm -53.17 114.11 1.35 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.694 0.798 . . . . 0.0 111.511 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.59 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.307 1.043 . . . . 0.0 109.44 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -98.09 89.3 4.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.28 0.632 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.74 124.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.102 0.561 . . . . 0.0 111.136 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.442 HG23 ' HD3' ' A' ' 52' ' ' ARG . 9.4 p -151.92 178.67 9.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.252 1.421 . . . . 0.0 108.631 171.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.59 -31.94 6.72 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -172.52 31.19 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 119.95 0.65 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.22 125.07 0.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.74 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.7 pt-20 -131.79 145.04 51.36 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -108.49 104.52 13.87 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -88.0 117.13 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 110.761 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -97.74 112.67 24.47 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 31.7 mtm105 -90.64 135.08 33.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.883 0.473 . . . . 0.0 111.696 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.91 173.3 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.283 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.584 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -74.84 -45.39 43.57 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.769 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.457 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.4 p30 -157.62 175.22 14.21 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.701 0.682 . . . . 0.0 112.393 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.01 -32.39 67.88 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.525 -166.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.59 -44.94 85.08 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.401 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.0 mm-40 -64.39 -25.45 68.03 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.72 -39.4 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.397 0.618 . . . . 0.0 109.866 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.22 -32.14 68.43 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.543 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.6 mt-10 -65.85 -41.31 91.88 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.593 0.711 . . . . 0.0 109.665 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 117' ' ' VAL . 14.7 m -71.25 -29.13 64.73 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.834 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.58 -61.1 2.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 0.0 109.632 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.46 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.94 -36.49 82.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.725 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.24 68.45 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.994 0.809 . . . . 0.0 113.712 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -63.1 -42.9 99.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.369 0.668 . . . . 0.0 110.333 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.7 ttpt -55.42 -47.0 76.64 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.953 0.783 . . . . 0.0 110.474 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.9 -15.28 59.73 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.414 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -92.12 -2.48 56.58 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.11 0.964 . . . . 0.0 111.939 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.92 3.25 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.914 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.13 150.79 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.22 -36.46 81.72 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.882 0.473 . . . . 0.0 111.8 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.5 tpp 65.83 83.14 0.17 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 85.89 2.25 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.491 0.662 . . . . 0.0 111.381 173.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 179.34 126.36 0.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.412 1.485 . . . . 0.0 108.639 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -79.85 109.95 14.04 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 167.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.2 119.38 6.25 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.786 2.324 . . . . 0.0 111.09 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 146.29 50.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.225 0.61 . . . . 0.0 110.745 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -73.92 101.94 3.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.851 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.7 ttm -98.35 174.76 6.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.879 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.95 -39.81 63.2 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.096 0.958 . . . . 0.0 112.233 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -91.55 6.97 43.6 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.583 0.753 . . . . 0.0 111.659 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 -163.78 12.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.003 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -76.13 102.15 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -113.06 147.51 37.12 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.186 0.517 . . . . 0.0 110.556 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -143.31 138.74 29.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.688 1.195 . . . . 0.0 109.536 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.6 m -134.91 119.91 18.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.027 0.83 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.57 161.03 14.98 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 122.966 0.506 . . . . 0.0 110.989 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.8 114.68 23.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 6.1 p-10 -70.3 176.67 1.72 Allowed Pre-proline 0 CA--C 1.567 1.608 0 C-N-CA 124.071 0.948 . . . . 0.0 111.336 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 1.4 Cg_endo -42.83 -41.71 8.74 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.853 3.035 . . . . 0.0 115.034 173.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -78.88 -25.97 43.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.542 0.337 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 t 73.38 85.86 0.11 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.811 1.644 . . . . 0.0 110.003 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.465 ' CE1' HG12 ' A' ' 11' ' ' VAL . 13.7 m80 -113.87 -173.98 2.38 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 3.0 mmp_? -100.57 112.73 25.15 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.442 HD21 ' OH ' ' A' ' 21' ' ' TYR . 84.2 mt -114.96 103.63 11.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.825 0.45 . . . . 0.0 110.188 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.61 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 51.4 ttt180 -90.69 140.16 30.04 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -174.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 81' ' ' THR . 40.4 t -134.24 119.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 164.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -128.49 164.87 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.288 0.494 . . . . 0.0 111.812 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.68 111.2 9.19 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -80.25 114.3 19.05 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 0.534 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.147 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -94.44 93.13 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.203 2.602 . . . . 0.0 113.174 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.733 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 11.4 p-10 -104.58 9.66 35.27 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.798 0.809 . . . . 0.0 109.606 171.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.01 135.79 45.64 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 108.033 -168.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -131.35 143.12 50.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.74 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 50.4 mt -121.12 134.53 64.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.486 HD11 HD22 ' B' ' 68' ' ' LEU . 93.2 mt -81.71 131.69 35.27 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 173.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.429 ' HE2' HG21 ' B' ' 55' ' ' VAL . 23.1 t80 -85.43 105.07 15.79 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.752 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.462 HG12 ' CE1' ' B' ' 113' ' ' HIS . 2.5 m -116.14 176.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.969 0.908 . . . . 0.0 108.664 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.16 -57.29 2.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 109.775 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -89.82 105.92 12.59 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.478 1.111 . . . . 0.0 109.453 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 28.1 Cg_exo -56.78 -55.95 2.32 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.984 2.456 . . . . 0.0 113.799 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 53.7 Cg_exo -55.61 -66.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.402 3.362 0 CA-C-N 122.255 1.841 . . . . 0.0 112.728 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.85 81.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -62.67 -55.95 22.18 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.437 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 98.2 m -66.95 -39.31 87.24 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -168.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.571 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 20.8 mm-40 -62.25 -41.35 98.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.762 1.225 . . . . 0.0 109.264 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 90.1 t80 -65.07 -40.28 94.47 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.058 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.452 ' OH ' HD21 ' B' ' 115' ' ' LEU . 62.6 m-85 -71.2 -31.45 67.62 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.507 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 60.8 mtpt -56.28 -46.6 79.65 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.41 -37.57 51.54 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.53 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.6 tp -62.97 -30.91 71.95 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.471 1.109 . . . . 0.0 112.56 -174.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' B' ' 27' ' ' VAL . 46.6 mt -104.88 -37.71 6.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 109.071 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 33.25 9.66 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' B' ' 25' ' ' LEU . 21.5 m -128.8 158.57 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.043 0.937 . . . . 0.0 109.958 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -110.8 148.43 38.55 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 123.855 0.862 . . . . 0.0 109.693 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 20.3 Cg_exo -66.66 108.01 1.36 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.628 2.218 . . . . 0.0 111.338 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -63.2 -34.76 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.253 0.621 . . . . 0.0 110.593 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.657 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 30.7 mm-40 -115.62 85.59 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 34.1 p -86.74 129.55 34.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.334 0.653 . . . . 0.0 110.014 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -137.25 150.36 68.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.112 0.965 . . . . 0.0 109.382 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.52 -42.88 40.98 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.706 2.937 . . . . 0.0 114.725 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.7 t -127.26 24.36 6.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.949 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -153.75 152.43 30.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 39.3 t -134.94 142.79 46.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.269 0.627 . . . . 0.0 109.333 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.657 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.4 tm? -140.85 122.84 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' B' ' 30' ' ' VAL . 3.6 p90 -129.74 146.67 51.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 109.07 164.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' B' ' 46' ' ' LYS . 9.5 t -118.65 134.52 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.01 158.35 15.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.952 0.501 . . . . 0.0 110.647 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -22.19 66.53 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.121 0.969 . . . . 0.0 112.65 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' B' ' 45' ' ' MET . 18.9 p30 -66.66 -20.85 66.08 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 0.0 111.767 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.56 -13.22 42.93 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.241 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.622 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -73.5 155.41 39.24 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.566 ' HG3' HG22 ' B' ' 40' ' ' VAL . 79.2 tttt -119.41 140.11 50.93 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 tt -137.61 115.26 11.3 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.687 -168.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.05 170.79 21.95 Favored Glycine 0 C--N 1.349 1.284 0 C-N-CA 124.042 0.83 . . . . 0.0 111.579 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 5.4 mp -139.51 107.45 5.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 165.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -104.85 124.47 49.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.448 ' HB2' HG22 ' B' ' 54' ' ' THR . 15.8 m -76.77 139.39 40.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.385 0.674 . . . . 0.0 110.884 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -72.83 -15.12 61.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.274 0.63 . . . . 0.0 112.318 -173.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -85.82 -6.42 59.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.699 0.4 . . . . 0.0 110.824 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.448 HG22 ' HB2' ' B' ' 51' ' ' SER . 14.6 t -129.65 7.79 5.29 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.472 0.709 . . . . 0.0 111.162 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.429 HG21 ' HE2' ' B' ' 10' ' ' TYR . 8.4 p -74.61 149.68 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -128.59 115.86 19.56 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.177 0.991 . . . . 0.0 109.284 172.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.35 143.74 75.68 Favored 'Cis proline' 0 C--N 1.387 2.561 0 C-N-CA 124.626 -0.989 . . . . 0.0 112.675 1.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -52.22 114.39 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.591 0.756 . . . . 0.0 111.674 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.55 132.55 45.62 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 109.458 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 40.3 m -98.37 89.47 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.183 0.593 . . . . 0.0 109.421 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 p -155.58 124.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.193 0.597 . . . . 0.0 111.162 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -152.47 178.14 9.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.293 1.437 . . . . 0.0 108.665 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.44 -31.84 6.77 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-O 121.04 0.244 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.63 -172.66 31.38 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.83 119.71 0.63 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 75.23 126.06 0.18 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.699 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 3.7 pt-20 -132.98 143.4 49.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 110.218 -175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.486 HD22 HD11 ' B' ' 9' ' ' LEU . 43.0 tp -108.35 104.31 13.65 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -87.61 116.75 25.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.148 0.499 . . . . 0.0 110.861 -171.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.401 ' HB2' HG22 ' B' ' 117' ' ' VAL . 7.6 m-85 -97.05 112.62 24.3 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.415 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 31.4 mtm180 -91.03 135.19 33.92 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 122.941 0.496 . . . . 0.0 111.622 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.611 HG21 ' HB3' ' B' ' 77' ' ' GLN . 1.3 p -140.4 173.14 10.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.131 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.77 -45.44 43.77 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -157.59 175.09 14.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 0.675 . . . . 0.0 112.292 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -58.78 -32.07 68.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.219 1.407 . . . . 0.0 112.398 -166.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.84 -45.03 83.74 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.349 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.611 ' HB3' HG21 ' B' ' 72' ' ' VAL . 73.1 mm-40 -64.5 -25.14 67.86 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.958 0.786 . . . . 0.0 112.574 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -71.43 -39.39 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.189 0.596 . . . . 0.0 109.728 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.96 -32.28 69.11 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 110.551 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.7 mt-10 -65.63 -41.06 93.11 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.615 0.721 . . . . 0.0 109.684 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.459 HG21 HG21 ' B' ' 117' ' ' VAL . 12.5 m -71.43 -29.43 64.87 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.8 -61.03 2.92 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.396 0.678 . . . . 0.0 109.475 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.458 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.73 -36.82 83.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.676 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 -50.52 66.18 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.608 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -63.19 -43.12 99.11 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.207 0.603 . . . . 0.0 110.27 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.9 ttpt -54.72 -47.41 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.765 0.826 . . . . 0.0 110.583 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.65 -15.67 59.75 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.612 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -92.22 -1.82 56.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 112.01 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.29 3.36 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.189 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.85 150.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp 65.82 83.18 0.17 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 85.91 2.25 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.442 0.639 . . . . 0.0 111.167 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 179.62 126.47 0.07 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.21 1.404 . . . . 0.0 108.387 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.99 110.71 17.14 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 17.3 Cg_endo -55.67 119.71 7.03 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.79 2.327 . . . . 0.0 110.409 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 145.81 50.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 0.0 111.034 -170.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -72.29 101.67 2.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.206 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.6 ttm -98.63 174.62 6.33 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.663 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -52.77 -40.28 63.02 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.825 0.85 . . . . 0.0 112.373 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.44 6.74 42.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.643 0.777 . . . . 0.0 111.989 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.69 -163.1 12.21 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -77.33 102.36 6.73 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -113.18 147.33 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.178 0.591 . . . . 0.0 110.487 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 4.7 t80 -143.31 138.9 29.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.733 1.213 . . . . 0.0 109.58 -176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 11.1 m -135.1 119.92 18.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.041 0.837 . . . . 0.0 110.347 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.76 160.68 15.29 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.929 0.492 . . . . 0.0 110.986 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.38 114.97 24.32 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.477 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.0 p-10 -70.19 177.56 1.33 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 124.182 0.993 . . . . 0.0 111.288 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 49.4 Cg_exo -43.75 -41.47 11.57 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.456 2.771 . . . . 0.0 115.265 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.95 -25.75 43.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 22.6 t 73.25 86.11 0.11 Allowed 'General case' 0 C--N 1.348 0.522 0 C-N-CA 125.777 1.631 . . . . 0.0 109.952 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.462 ' CE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -113.84 -173.88 2.36 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' B' ' 67' ' ' GLU . 3.9 mmp_? -100.37 113.01 25.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.452 HD21 ' OH ' ' B' ' 21' ' ' TYR . 85.4 mt -115.3 104.37 11.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.797 0.439 . . . . 0.0 109.969 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.869 HH22 HG23 ' A' ' 55' ' ' VAL . 22.3 mmt180 -88.32 140.94 28.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.508 0.723 . . . . 0.0 110.726 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.459 HG21 HG21 ' B' ' 81' ' ' THR . 59.8 t -135.52 120.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 162.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -128.73 165.44 20.9 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.384 0.538 . . . . 0.0 111.888 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.12 110.97 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -79.64 113.3 17.69 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 103.38 1.14 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.976 0.51 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.455 ' HD2' HD21 ' B' ' 41' ' ' LEU . 59.5 Cg_endo -90.89 97.09 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.878 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.3 p-10 -90.28 11.93 19.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.339 0.59 . . . . 0.0 110.694 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.449 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.6 t80 -133.08 135.05 45.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.811 1.244 . . . . 0.0 108.28 -168.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 140.8 41.97 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.349 1.059 . . . . 0.0 108.216 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.543 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 60.7 mt -119.21 141.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.7 138.01 46.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.5 132.93 35.33 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.488 176.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 51' ' ' SER . 29.0 m -130.6 158.7 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 121.653 -0.654 . . . . 0.0 110.451 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 22.9 t70 -95.34 -57.29 2.45 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.0 99.11 2.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.53 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 12' ' ' ASP . 50.1 Cg_exo -49.02 -55.69 3.91 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 122.756 2.304 . . . . 0.0 114.42 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -59.88 -54.91 1.96 Allowed 'Trans proline' 0 C--N 1.397 3.098 0 CA-C-N 122.16 1.807 . . . . 0.0 112.022 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.05 73.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.134 0.974 . . . . 0.0 111.823 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -79.89 -18.16 51.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.516 -173.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -76.98 -38.51 53.05 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 84.7 mm-40 -67.24 -30.23 70.08 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.52 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -60.45 -48.45 81.69 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.91 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.5 m-85 -68.71 -30.54 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.028 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.0 mtpt -57.78 -49.17 77.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.86 -31.89 51.73 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.715 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.5 tp -62.07 -50.78 70.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.681 1.192 . . . . 0.0 112.295 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 27' ' ' VAL . 14.9 mt -83.57 -47.58 11.15 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 29.56 5.25 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.998 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 25' ' ' LEU . 27.0 m -131.63 175.95 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.026 0.93 . . . . 0.0 110.358 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -124.24 151.25 65.76 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.128 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.55 106.45 1.25 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.78 2.32 . . . . 0.0 111.544 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.416 HG13 ' HG2' ' A' ' 31' ' ' GLU . 7.4 p -63.44 -39.45 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.507 0.723 . . . . 0.0 110.31 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 29.1 mm-40 -114.63 98.28 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.3 p -99.27 138.21 36.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.742 0.817 . . . . 0.0 110.917 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -143.39 150.58 52.01 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.975 1.31 . . . . 0.0 108.233 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.59 -22.35 51.24 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.859 2.373 . . . . 0.0 114.147 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -128.46 9.92 6.12 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.98 139.2 20.22 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.876 -0.515 . . . . 0.0 110.047 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -129.45 138.95 51.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.642 0.777 . . . . 0.0 109.203 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tm? -132.07 120.35 22.23 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.71 113.53 13.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.684 1.194 . . . . 0.0 109.098 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' A' ' 46' ' ' LYS . 12.6 t -94.65 139.68 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.226 1.01 . . . . 0.0 110.03 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -98.66 147.78 24.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.858 0.463 . . . . 0.0 110.244 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -4.81 34.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.756 0.822 . . . . 0.0 111.829 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -69.0 -10.2 56.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.453 1.101 . . . . 0.0 112.231 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.58 15.64 42.68 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.874 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -126.43 172.13 10.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.555 0.742 . . . . 0.0 109.185 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.4 tttt -136.54 135.29 38.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.09 0.556 . . . . 0.0 109.601 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.408 HD11 ' HG2' ' B' ' 4' ' ' PRO . 8.2 mt -124.72 124.55 42.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.571 0.749 . . . . 0.0 111.059 -176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.449 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.84 167.3 18.45 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.269 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 49' ' ' LEU . 5.5 tp -144.86 105.23 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.0 t90 -104.73 123.14 47.12 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 50.2 m -74.47 112.31 10.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.07 -1.93 1.12 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 114.532 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -79.48 -25.47 41.86 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.959 0.8 . . . . 0.0 110.802 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -112.69 12.58 19.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.441 0.696 . . . . 0.0 111.298 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 8.8 p -63.97 138.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.971 0.415 . . . . 0.0 111.49 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.21 114.49 33.43 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.16 140.52 64.87 Favored 'Cis proline' 0 C--N 1.385 2.464 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.073 3.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HA ' HG13 ' A' ' 55' ' ' VAL . 24.5 mmmt -49.12 125.48 10.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.101 1.36 . . . . 0.0 111.974 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.19 109.43 3.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.065 0.946 . . . . 0.0 110.498 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.8 t -97.32 88.55 4.46 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.48 135.99 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.596 0.758 . . . . 0.0 109.712 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 p -142.42 125.22 16.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.204 1.002 . . . . 0.0 110.182 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.57 -108.64 0.37 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.79 129.51 9.92 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.67 -32.23 0.03 OUTLIER Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.95 151.62 10.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.668 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 47.0 mt-10 -114.4 165.46 12.7 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.548 0.739 . . . . 0.0 110.787 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.91 103.56 9.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.58 118.49 30.08 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.231 0.469 . . . . 0.0 111.518 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -95.73 108.38 20.69 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.109 1.364 . . . . 0.0 107.688 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 38.6 mtm180 -85.3 130.06 34.68 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.438 0.637 . . . . 0.0 112.094 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.42 157.05 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.819 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HG3' HD22 ' A' ' 74' ' ' ASN . 9.7 pt-20 -67.62 -38.36 83.8 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -172.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.451 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.0 p30 -157.2 176.71 12.36 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.711 0.687 . . . . 0.0 112.631 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.57 -32.86 65.61 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.81 1.644 . . . . 0.0 112.66 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.563 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.36 -44.06 79.93 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.012 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -66.36 -24.5 66.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.837 0.855 . . . . 0.0 112.241 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.41 -41.73 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.57 -30.87 68.75 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.489 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.3 mt-10 -68.06 -43.46 78.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -70.37 -28.85 65.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.52 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -64.15 -61.31 2.33 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.777 0.799 . . . . 0.0 109.133 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.76 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.895 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.22 91.46 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.39 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -61.51 -48.51 80.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.635 . . . . 0.0 110.385 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.5 ttpt -54.42 -43.53 71.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.841 0.856 . . . . 0.0 110.956 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.59 58.28 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.264 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -94.47 7.71 44.62 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.272 1.029 . . . . 0.0 112.183 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.61 24.5 30.5 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.421 170.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -84.0 133.58 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.528 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -56.71 -34.6 67.61 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.256 1.022 . . . . 0.0 112.625 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.494 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 49.8 tpp 67.85 82.99 0.17 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 163.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -134.33 86.36 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 177.65 136.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.631 1.572 . . . . 0.0 109.173 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.3 108.79 15.62 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 165.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 12.5 Cg_endo -55.53 118.79 5.59 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.819 2.346 . . . . 0.0 111.448 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.07 155.32 48.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.325 0.65 . . . . 0.0 110.419 -175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.25 118.61 13.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 110.813 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.8 ttm -115.52 166.81 11.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.069 0.948 . . . . 0.0 108.954 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -49.97 -40.32 43.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.696 1.598 . . . . 0.0 113.071 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -86.97 -19.97 27.97 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.357 0.663 . . . . 0.0 111.676 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.67 175.36 28.5 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 120.326 -0.152 . . . . 0.0 112.932 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 42.5 t80 -71.85 101.94 2.75 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -107.49 150.07 27.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.471 0.653 . . . . 0.0 112.165 -161.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 20.0 t80 -150.45 146.21 26.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.8 m -142.69 129.32 20.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.095 0.558 . . . . 0.0 109.65 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.17 149.02 43.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.464 0.706 . . . . 0.0 111.212 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.414 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -108.24 167.09 10.27 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' A' ' 91' ' ' ALA . 1.9 p-10 -133.07 -178.81 0.92 Allowed Pre-proline 0 CA--C 1.562 1.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -169.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 36.8 Cg_endo -62.92 -1.64 2.94 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.314 2.01 . . . . 0.0 114.943 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.73 0.13 13.12 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.481 0.582 . . . . 0.0 111.754 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m 70.14 33.85 2.57 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.829 1.252 . . . . 0.0 112.812 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.51 ' HB2' HD11 ' A' ' 115' ' ' LEU . 18.2 m170 -75.27 170.29 16.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.525 0.73 . . . . 0.0 110.032 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.668 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 13.6 mmm180 -118.91 108.91 15.38 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 113' ' ' HIS . 3.4 mp -121.41 108.9 14.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -93.38 147.23 23.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.897 0.479 . . . . 0.0 110.428 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.87 133.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.3 p90 -135.97 162.05 33.94 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.605 0.639 . . . . 0.0 111.738 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -111.07 124.38 52.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 171.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -81.66 108.77 15.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.129 0.422 . . . . 0.0 110.437 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.847 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 119.551 -0.261 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.408 ' HG2' HD11 ' A' ' 47' ' ' LEU . 54.1 Cg_endo -91.61 96.95 0.21 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.664 2.243 . . . . 0.0 112.262 170.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.874 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.7 p-10 -90.18 12.29 18.44 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.372 0.606 . . . . 0.0 110.824 170.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.478 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -133.34 135.16 44.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.923 1.289 . . . . 0.0 108.164 -168.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -137.49 140.97 41.48 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.424 1.089 . . . . 0.0 108.146 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.8 140.51 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.343 0.657 . . . . 0.0 109.695 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.85 139.26 43.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -83.4 133.08 34.95 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.21 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' B' ' 51' ' ' SER . 35.9 m -129.07 158.65 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.122 0.569 . . . . 0.0 110.693 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -95.76 -58.33 2.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -92.13 100.7 3.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.885 . . . . 0.0 109.233 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.87 -55.72 3.79 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.431 2.087 . . . . 0.0 114.332 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 31.8 Cg_exo -59.16 -55.56 1.83 Allowed 'Trans proline' 0 C--N 1.395 2.974 0 CA-C-N 122.285 1.852 . . . . 0.0 112.275 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.72 74.99 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.969 -167.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -79.77 -18.37 51.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.563 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.6 m -77.93 -37.79 46.94 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 174.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 28.0 mm-40 -67.25 -30.71 70.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.297 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.77 -48.61 81.0 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.08 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 34.4 m-85 -68.59 -30.73 69.54 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.166 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -57.19 -49.63 75.39 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.739 0.7 . . . . 0.0 112.791 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.18 50.82 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.95 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 24.5 tp -62.25 -50.74 70.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.578 1.151 . . . . 0.0 112.159 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.446 ' HB2' HG22 ' B' ' 27' ' ' VAL . 16.8 mt -83.92 -47.35 11.13 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.25 30.47 5.03 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.101 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' B' ' 25' ' ' LEU . 31.4 m -131.86 175.31 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.321 1.048 . . . . 0.0 110.052 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -124.24 151.71 66.47 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.26 106.41 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.57 2.18 . . . . 0.0 111.296 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.03 -39.28 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.486 0.714 . . . . 0.0 110.142 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 65.1 mm-40 -115.13 98.79 6.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.922 0.889 . . . . 0.0 108.678 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.8 p -99.87 137.85 37.76 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.762 0.825 . . . . 0.0 110.764 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 150.8 54.66 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.018 1.327 . . . . 0.0 107.96 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.04 -21.89 52.74 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.788 2.325 . . . . 0.0 114.252 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -128.49 8.98 5.98 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -150.27 139.63 21.37 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.4 m -129.42 139.1 51.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.585 0.754 . . . . 0.0 109.111 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -132.24 119.96 21.53 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.18 113.25 13.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.683 1.193 . . . . 0.0 109.095 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' B' ' 46' ' ' LYS . 14.7 t -94.92 139.99 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.967 0.907 . . . . 0.0 110.115 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 4' ' ' PRO . 10.0 mp -98.93 146.93 25.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.143 0.577 . . . . 0.0 110.324 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.16 -5.17 33.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.923 0.889 . . . . 0.0 111.549 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.63 -9.32 53.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.612 1.165 . . . . 0.0 112.101 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.11 15.68 43.94 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.878 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -126.38 171.51 10.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.658 0.783 . . . . 0.0 109.162 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.5 tttt -136.26 135.23 38.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.127 0.571 . . . . 0.0 109.503 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mt -124.61 124.39 42.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.526 0.73 . . . . 0.0 111.064 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.478 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -101.58 167.31 18.78 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.199 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' B' ' 49' ' ' LEU . 5.7 tp -144.78 105.45 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -104.78 122.97 46.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 50.9 m -74.54 112.8 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -63.35 -2.38 1.46 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.273 1.429 . . . . 0.0 114.503 -170.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -79.08 -25.77 43.07 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.866 0.757 . . . . 0.0 110.656 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -112.81 12.06 19.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.372 0.669 . . . . 0.0 111.426 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' B' ' 58' ' ' LYS . 7.2 p -62.33 138.7 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.68 114.8 32.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.31 139.8 62.23 Favored 'Cis proline' 0 C--N 1.381 2.243 0 C-N-CA 124.525 -1.031 . . . . 0.0 113.51 3.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.436 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.9 mmmt -48.87 125.4 10.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.173 1.389 . . . . 0.0 112.232 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.43 109.98 3.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.062 0.945 . . . . 0.0 110.298 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.2 t -97.83 88.27 4.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.38 136.2 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.657 0.783 . . . . 0.0 109.679 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -143.76 124.93 14.51 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.001 0.92 . . . . 0.0 110.077 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.38 -108.43 0.36 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.65 129.5 9.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.44 -33.48 0.03 OUTLIER Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.64 152.57 11.1 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.543 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 2.2 pm0 -118.09 163.84 16.01 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.87 0.868 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -120.44 103.2 8.99 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.41 119.93 31.11 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.231 0.469 . . . . 0.0 111.536 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -97.66 108.01 20.63 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.404 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 34.8 mtm180 -85.28 128.37 34.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.014 0.525 . . . . 0.0 111.906 -177.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.42 157.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.051 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.26 -38.27 84.84 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -157.73 177.77 11.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.633 0.651 . . . . 0.0 112.52 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.86 -32.55 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.967 1.707 . . . . 0.0 112.545 -167.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -67.56 -43.86 79.62 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.431 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -66.37 -24.32 66.48 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.038 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -69.61 -42.23 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.54 -30.46 68.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 16.0 mt-10 -68.16 -43.22 78.72 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.342 0.592 . . . . 0.0 109.503 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -70.4 -28.77 65.34 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.591 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -64.62 -61.06 2.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.582 0.706 . . . . 0.0 109.114 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.24 90.53 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.929 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.56 90.54 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.199 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -60.93 -49.04 79.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 0.0 110.222 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.475 ' HB2' ' HE3' ' B' ' 92' ' ' MET . 31.8 ttpt -53.8 -44.28 70.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.008 0.923 . . . . 0.0 110.911 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.53 -22.5 58.99 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.3 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -94.48 7.8 44.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.194 0.998 . . . . 0.0 112.087 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.44 31.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 116.123 -0.489 . . . . 0.0 114.319 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.77 134.09 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.52 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -57.43 -34.44 68.95 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.116 0.967 . . . . 0.0 112.53 -172.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.475 ' HE3' ' HB2' ' B' ' 86' ' ' LYS . 50.0 tpp 67.07 83.31 0.17 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' B' ' 108' ' ' ALA . 0.0 OUTLIER -133.65 85.85 2.24 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 178.69 138.9 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.265 1.426 . . . . 0.0 109.279 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -83.12 109.98 20.65 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 165.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.556 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 18.2 Cg_endo -57.4 119.32 6.51 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.606 2.204 . . . . 0.0 110.796 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.78 154.2 48.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.377 0.671 . . . . 0.0 110.412 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -68.47 118.94 12.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 54.2 ttm -115.59 166.04 12.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.11 0.964 . . . . 0.0 109.126 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.02 -39.91 28.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.445 1.498 . . . . 0.0 113.349 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.99 -19.06 27.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.537 0.335 . . . . 0.0 111.485 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.33 173.94 27.39 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.987 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.583 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 45.4 t80 -70.72 102.08 2.23 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 150.11 27.14 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.521 0.677 . . . . 0.0 112.081 -162.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 16.4 t80 -150.42 146.49 26.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.182 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 20.1 m -143.69 128.27 18.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' B' ' 105' ' ' PHE . . . -121.13 149.03 43.39 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.28 0.632 . . . . 0.0 110.995 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . 0.522 ' HB3' HD11 ' B' ' 93' ' ' LEU . . . -108.35 165.01 11.82 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.52 ' HA ' ' H ' ' B' ' 91' ' ' ALA . 1.9 p-10 -130.49 -177.63 0.7 Allowed Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.003 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 45.5 Cg_endo -63.8 -0.92 2.91 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.447 2.098 . . . . 0.0 114.773 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.44 ' OD1' ' HA ' ' B' ' 11' ' ' VAL . 3.1 t70 -115.98 0.14 12.96 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.093 0.557 . . . . 0.0 111.78 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.9 m 69.41 34.29 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.603 1.161 . . . . 0.0 112.725 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -75.18 171.34 14.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.602 0.761 . . . . 0.0 110.301 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.51 108.31 13.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -121.07 108.18 13.52 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.48 ' NH1' ' HG3' ' B' ' 67' ' ' GLU . 55.5 mtt180 -90.57 147.72 23.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.033 0.533 . . . . 0.0 111.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.99 132.81 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -135.85 161.95 34.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.549 0.613 . . . . 0.0 111.658 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -110.99 123.71 50.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -79.17 104.59 9.9 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.52 99.25 8.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.107 -175.485 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HG3' HD22 ' B' ' 25' ' ' LEU . 78.6 Cg_endo -81.77 72.08 6.45 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.493 2.129 . . . . 0.0 111.253 166.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.486 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.2 p-10 -80.43 9.88 5.35 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.404 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -134.56 134.32 41.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 107.717 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -138.2 139.58 39.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.237 1.015 . . . . 0.0 108.786 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.593 HG12 ' HA3' ' A' ' 48' ' ' GLY . 49.5 mt -128.03 143.03 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.134 0.573 . . . . 0.0 110.173 -172.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -108.63 144.95 35.69 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 32.1 m-85 -93.57 123.5 36.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.199 1.0 . . . . 0.0 111.207 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.412 HG12 ' HE1' ' A' ' 113' ' ' HIS . 23.9 m -124.89 161.02 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.188 0.995 . . . . 0.0 110.409 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.89 -63.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.132 0.973 . . . . 0.0 110.759 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -97.14 100.14 7.21 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.075 0.55 . . . . 0.0 110.154 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 35.1 Cg_exo -55.56 -51.63 9.44 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.296 2.664 . . . . 0.0 115.033 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.77 -51.62 10.76 Favored 'Trans proline' 0 C--N 1.405 3.525 0 CA-C-N 122.646 1.981 . . . . 0.0 112.48 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.92 -39.94 69.14 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 p -77.83 -34.85 51.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.817 0.447 . . . . 0.0 110.515 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 70.9 m -62.39 -47.78 82.63 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.524 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.3 mm100 -62.69 -35.51 79.92 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.125 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -64.89 -45.82 84.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.8 0.688 . . . . 0.0 109.415 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 20.5 m-85 -68.03 -32.89 73.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.279 -0.391 . . . . 0.0 109.997 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 63.2 mtpt -57.31 -47.89 80.35 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.34 -34.27 48.63 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.298 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.8 tp -60.21 -31.35 70.08 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.865 1.266 . . . . 0.0 112.473 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.501 HD22 ' HG3' ' B' ' 4' ' ' PRO . 26.1 mt -99.95 -48.56 4.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.16 28.63 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.995 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.01 -178.34 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.613 1.165 . . . . 0.0 110.747 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -130.76 142.93 47.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 124.342 1.057 . . . . 0.0 108.762 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 34.1 Cg_endo -63.93 119.94 7.16 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.602 2.201 . . . . 0.0 112.449 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.999 0.92 . . . . 0.0 110.455 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 57.9 mm-40 -116.23 90.04 3.24 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.3 p -90.04 149.48 22.5 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.894 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -151.76 151.48 28.46 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 125.037 1.335 . . . . 0.0 107.627 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.78 -20.1 68.09 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.451 2.101 . . . . 0.0 113.607 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -128.38 12.36 6.47 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.9 152.79 28.71 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -143.86 138.58 28.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 12.7 tp -126.42 115.72 20.05 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.3 p90 -131.21 112.89 13.21 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.922 1.289 . . . . 0.0 109.16 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.592 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 3.8 p -106.71 142.28 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.24 1.016 . . . . 0.0 110.079 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.16 157.25 17.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.622 0.769 . . . . 0.0 111.134 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -22.61 65.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.479 1.112 . . . . 0.0 112.593 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.404 HD21 ' HG3' ' A' ' 45' ' ' MET . 1.9 p-10 -70.19 -18.6 63.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.258 0.623 . . . . 0.0 112.032 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.48 15.82 16.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.445 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.404 ' HG3' HD21 ' A' ' 43' ' ' ASN . 3.7 ppp? -103.23 154.03 19.76 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.017 0.909 . . . . 0.0 108.697 170.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.2 tttt -125.3 131.02 53.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -128.54 127.66 42.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.346 0.659 . . . . 0.0 109.883 -168.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -104.81 169.78 17.29 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.54 104.79 4.26 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.438 ' HB2' HG21 ' A' ' 8' ' ' ILE . 4.5 t90 -106.75 127.48 53.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.451 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 27.9 m -72.96 129.95 39.27 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.244 0.34 . . . . 0.0 110.126 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -68.34 -10.94 58.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.687 0.795 . . . . 0.0 112.493 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -81.95 -23.47 36.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -116.93 7.83 13.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.269 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 58' ' ' LYS . 10.5 p -67.68 140.53 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 122.712 0.405 . . . . 0.0 111.508 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HB3' HE22 ' B' ' 94' ' ' GLN . 70.7 mt-10 -125.56 114.6 25.18 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 170.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.503 ' HG2' ' CZ ' ' B' ' 114' ' ' ARG . 59.0 Cg_endo -78.14 141.51 66.06 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 124.491 -1.046 . . . . 0.0 113.194 4.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HA ' HG13 ' A' ' 55' ' ' VAL . 27.4 mmmt -49.43 123.0 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.252 1.421 . . . . 0.0 112.452 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HB2' ' NH2' ' B' ' 114' ' ' ARG . . . -155.57 109.18 2.79 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.318 1.047 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.8 p -85.08 87.08 7.34 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.0 124.19 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.7 p -151.51 122.34 7.55 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.302 1.441 . . . . 0.0 107.78 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.71 52.55 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.06 -132.18 10.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.89 -62.98 4.35 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.35 154.38 18.99 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 168.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 2.4 pt-20 -130.06 166.18 20.68 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.011 0.924 . . . . 0.0 110.27 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.2 tp -125.46 102.39 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.829 0.852 . . . . 0.0 109.457 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -92.48 110.72 22.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -169.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 12.3 m-85 -88.99 116.86 27.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.435 1.094 . . . . 0.0 108.419 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -95.21 130.7 41.85 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.87 162.74 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.345 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.9 pt-20 -66.12 -43.44 87.14 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.472 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 8.9 p30 -160.44 179.62 8.47 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.584 0.629 . . . . 0.0 112.568 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.79 -30.67 63.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -168.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.5 -52.56 64.01 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.786 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 81.0 mm-40 -65.76 -22.78 66.61 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.736 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.25 -46.09 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.465 0.65 . . . . 0.0 109.73 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.89 -28.54 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 110.676 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 35.8 mt-10 -65.06 -48.2 74.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.234 0.613 . . . . 0.0 110.013 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.8 m -68.31 -30.1 69.01 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -55.62 -58.72 6.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.96 0.904 . . . . 0.0 109.98 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.47 -35.53 80.49 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.493 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.09 -42.62 96.51 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 123.645 0.591 . . . . 0.0 113.588 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -66.6 -39.73 88.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.058 0.543 . . . . 0.0 110.233 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.431 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 32.7 ttpt -57.51 -44.84 85.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.474 0.71 . . . . 0.0 110.262 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.33 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 t -99.64 9.91 42.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.211 1.004 . . . . 0.0 112.378 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 55.57 2.77 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 165.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.5 p -102.79 148.71 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 168.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -57.15 5.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.552 0.341 . . . . 0.0 110.459 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.546 ' HB2' HG13 ' A' ' 90' ' ' VAL . 21.1 ttp 64.23 82.51 0.18 Allowed 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.225 0.953 . . . . 0.0 113.104 168.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.81 85.94 2.24 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 106' ' ' THR . 46.9 tp60 179.57 133.17 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.761 1.224 . . . . 0.0 108.954 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -83.45 122.47 77.01 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.254 0.622 . . . . 0.0 109.413 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 106.62 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.533 2.155 . . . . 0.0 110.835 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 152.36 50.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.089 0.556 . . . . 0.0 111.312 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -70.4 102.17 2.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.217 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.3 ttm -94.8 169.2 10.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.357 1.063 . . . . 0.0 109.193 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -43.64 -41.5 4.7 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.139 1.376 . . . . 0.0 113.568 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -87.96 -15.29 36.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.575 0.75 . . . . 0.0 111.907 -172.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.16 -170.83 25.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.969 -0.35 . . . . 0.0 112.59 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -76.71 101.69 5.89 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -108.07 149.38 28.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 110.344 -171.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.4 t80 -144.4 147.91 33.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.746 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 4.8 m -140.6 136.75 33.08 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.151 0.432 . . . . 0.0 110.924 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.38 172.78 6.64 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.837 0.855 . . . . 0.0 110.967 171.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.29 113.26 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.02 169.05 20.72 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.422 0.689 . . . . 0.0 110.016 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.5 -33.88 31.72 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.268 2.645 . . . . 0.0 114.59 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.0 12.0 23.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.08 0.552 . . . . 0.0 111.207 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 59.5 72.63 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 112.874 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.412 ' HE1' HG12 ' A' ' 11' ' ' VAL . 8.4 m80 -126.59 172.24 10.43 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.618 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 65.5 mmt-85 -102.52 104.87 15.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.81 102.59 14.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.849 HH22 HG23 ' B' ' 55' ' ' VAL . 15.3 mmt180 -88.04 147.52 24.94 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 123.578 0.751 . . . . 0.0 110.389 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.426 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 15.4 t -137.99 127.29 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 161.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -141.01 158.56 43.77 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.02 111.06 17.84 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -73.0 120.93 19.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.788 0.435 . . . . 0.0 109.831 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.511 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.423 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.501 ' HG3' HD22 ' A' ' 25' ' ' LEU . 63.0 Cg_endo -82.99 71.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.622 2.214 . . . . 0.0 110.819 167.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.02 9.48 4.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.791 0.836 . . . . 0.0 111.27 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -134.51 134.29 41.29 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.097 1.359 . . . . 0.0 107.677 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -138.38 139.66 39.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.468 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 16.8 mt -128.74 143.35 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.081 0.553 . . . . 0.0 110.103 -172.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -110.01 144.06 39.11 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -91.87 123.94 35.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.12 0.968 . . . . 0.0 111.142 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.423 HG12 ' HE1' ' B' ' 113' ' ' HIS . 20.5 m -125.3 160.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 123.956 0.902 . . . . 0.0 110.308 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.75 -63.89 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.129 0.971 . . . . 0.0 111.154 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -96.12 98.42 4.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 123.625 0.77 . . . . 0.0 109.682 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -53.8 -52.72 7.82 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.854 2.37 . . . . 0.0 115.842 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.24 -52.64 8.54 Favored 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 123.162 2.165 . . . . 0.0 112.7 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.37 -40.08 70.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.482 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 75.8 p -77.49 -34.91 54.11 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.743 0.417 . . . . 0.0 110.765 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.5 m -63.04 -46.88 85.44 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.521 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 13.8 mm100 -63.54 -35.18 79.64 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.809 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 66.1 t80 -64.88 -45.52 85.64 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.776 0.672 . . . . 0.0 109.42 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.408 ' O ' ' HG ' ' B' ' 25' ' ' LEU . 30.3 m-85 -68.29 -32.79 73.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.225 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 62.7 mtpt -57.11 -48.03 79.64 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.3 -34.31 48.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 20.8 tp -60.25 -30.99 69.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.595 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.492 HD22 ' HG3' ' A' ' 4' ' ' PRO . 25.1 mt -100.47 -48.31 4.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.7 4.88 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.953 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.543 HG11 HD22 ' B' ' 41' ' ' LEU . 24.2 m -129.62 -178.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.648 1.179 . . . . 0.0 111.064 -174.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -130.41 144.81 54.82 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.816 0.847 . . . . 0.0 109.231 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 18.4 Cg_exo -65.86 120.64 7.85 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.411 2.074 . . . . 0.0 112.21 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' B' ' 31' ' ' GLU . 8.9 p -64.55 -42.32 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.159 0.984 . . . . 0.0 110.802 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 50.3 mm-40 -119.17 89.13 3.07 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -90.1 149.74 22.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -151.81 151.31 28.05 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.1 -20.29 70.88 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.422 2.081 . . . . 0.0 113.683 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -128.2 11.44 6.45 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.043 0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -155.6 153.01 29.43 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -143.93 138.45 28.52 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 12.9 tp -126.42 115.94 20.38 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.424 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.4 p90 -131.11 113.24 13.66 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.961 1.304 . . . . 0.0 109.215 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.628 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 4.3 p -107.1 141.94 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.267 1.027 . . . . 0.0 110.033 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.543 HD22 HG11 ' B' ' 27' ' ' VAL . 13.7 mt -105.5 157.27 17.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.529 0.732 . . . . 0.0 110.382 -169.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -21.72 64.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.381 1.072 . . . . 0.0 112.332 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.04 -18.38 62.57 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.99 0.516 . . . . 0.0 111.23 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.42 16.09 15.58 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 114.484 0.554 . . . . 0.0 114.484 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.2 ppp? -104.2 153.43 20.98 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.104 0.952 . . . . 0.0 108.607 170.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.628 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 53.6 tttt -124.69 130.97 53.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.92 127.96 44.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.31 0.644 . . . . 0.0 110.063 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.27 169.67 17.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 123.821 0.724 . . . . 0.0 111.293 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.66 104.51 4.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -106.7 126.85 52.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -72.75 129.6 38.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.66 -11.1 57.5 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.013 0.925 . . . . 0.0 112.38 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.02 -24.09 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.01 0.524 . . . . 0.0 111.141 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -116.62 8.66 13.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.282 0.633 . . . . 0.0 111.324 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.849 HG23 HH22 ' A' ' 116' ' ' ARG . 7.1 p -68.15 140.1 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.793 0.437 . . . . 0.0 111.382 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -124.84 114.0 26.78 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.5 141.49 64.83 Favored 'Cis proline' 0 C--N 1.381 2.287 0 C-N-CA 124.439 -1.067 . . . . 0.0 113.147 5.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.49 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.0 mmmt -49.55 123.14 7.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.144 1.378 . . . . 0.0 112.34 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.98 108.55 2.63 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.114 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.9 p -84.44 87.1 7.21 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.75 124.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.368 0.667 . . . . 0.0 110.482 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -152.51 121.87 6.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.997 1.319 . . . . 0.0 107.776 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.04 0.01 OUTLIER Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.48 -132.47 10.94 Favored Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.15 4.34 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.01 153.71 18.56 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.491 ' CG ' ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -128.61 168.13 16.18 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 110.542 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 tp -126.25 102.15 7.06 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.93 0.892 . . . . 0.0 109.437 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -92.57 111.32 22.87 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.756 0.312 . . . . 0.0 111.725 -169.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m-85 -89.37 116.96 27.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.47 1.108 . . . . 0.0 108.337 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -96.05 128.28 42.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.448 0.642 . . . . 0.0 111.566 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.78 164.14 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.646 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.28 -43.25 86.91 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.382 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -160.65 178.19 9.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.99 -32.02 52.78 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.197 1.799 . . . . 0.0 113.076 -170.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.557 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -61.32 -52.92 62.68 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.884 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 61.2 mm-40 -64.97 -23.1 67.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.763 1.225 . . . . 0.0 112.618 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.81 -45.84 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.386 0.613 . . . . 0.0 109.764 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.17 57.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.96 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.9 mt-10 -64.53 -48.72 74.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.208 0.603 . . . . 0.0 109.74 174.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -68.48 -29.58 68.24 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.891 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.76 -58.95 5.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.22 1.008 . . . . 0.0 109.666 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.67 -35.47 80.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.484 -174.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.46 96.9 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 123.337 0.398 . . . . 0.0 113.487 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -66.87 -39.39 87.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.989 0.516 . . . . 0.0 110.092 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.0 ttpt -57.88 -44.74 86.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.644 0.778 . . . . 0.0 110.478 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.7 67.39 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.792 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.8 t -99.91 9.79 42.38 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.097 0.959 . . . . 0.0 112.333 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.25 55.27 2.79 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 165.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.7 p -103.11 148.68 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.1 -56.88 6.36 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.57 0.348 . . . . 0.0 110.413 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 19.5 ttp 64.07 82.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 85.82 2.23 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.747 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' B' ' 106' ' ' THR . 5.8 tp60 -179.42 133.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.916 1.286 . . . . 0.0 108.836 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . 0.401 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 86.6 mt-30 -82.79 122.48 78.26 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.607 0.763 . . . . 0.0 109.355 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.523 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 19.0 Cg_endo -59.47 106.66 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.566 2.177 . . . . 0.0 110.181 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.3 152.47 50.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.287 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -71.52 102.67 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.75 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.8 ttm -94.67 169.13 10.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.635 1.174 . . . . 0.0 109.321 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -43.61 -41.87 4.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.487 1.515 . . . . 0.0 112.864 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.04 -14.93 37.7 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.632 0.773 . . . . 0.0 112.027 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.98 -171.05 25.06 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.988 -0.34 . . . . 0.0 112.553 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -76.33 101.42 5.49 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -107.86 149.46 28.24 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.583 0.706 . . . . 0.0 110.331 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 1.9 t80 -144.59 148.29 34.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.701 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 17.1 m -141.33 136.5 31.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.122 0.487 . . . . 0.0 110.474 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.39 172.88 6.58 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.957 0.903 . . . . 0.0 110.838 171.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.5 112.52 10.33 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.436 ' HB3' HD11 ' B' ' 115' ' ' LEU . 6.6 p-10 -72.9 167.57 32.7 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -48.34 -33.85 23.51 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.394 2.729 . . . . 0.0 114.864 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -92.24 12.22 23.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.123 0.569 . . . . 0.0 111.134 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 m 59.06 72.15 0.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.064 1.345 . . . . 0.0 112.738 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.423 ' HE1' HG12 ' B' ' 11' ' ' VAL . 8.6 m80 -125.64 171.58 10.47 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.57 ' NH2' ' HB2' ' A' ' 59' ' ' ALA . 17.2 mmt180 -101.17 105.04 16.13 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' B' ' 109' ' ' ASP . 39.0 mt -97.2 103.04 14.94 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.737 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 23.9 ttt180 -87.66 147.43 25.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.5 0.72 . . . . 0.0 110.404 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -137.86 127.22 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 160.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -141.22 158.69 43.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.65 110.8 17.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.74 123.39 23.22 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.86 100.79 13.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.965 0.506 . . . . 0.0 109.961 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.78 -1.011 . . . . 0.0 111.156 179.02 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 98.6 Cg_endo -86.38 143.39 7.57 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.213 1.942 . . . . 0.0 112.037 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.66 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 36.0 t70 -143.61 19.37 1.85 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.659 1.219 . . . . 0.0 109.009 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.73 148.09 35.16 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.653 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.494 HG23 HD23 ' A' ' 47' ' ' LEU . 3.8 t -151.72 139.21 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.869 0.868 . . . . 0.0 108.691 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.545 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 68.1 mt -123.71 137.7 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.577 0.751 . . . . 0.0 109.904 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.66 130.23 45.87 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 62' ' ' THR . 28.0 m-85 -80.42 115.19 19.82 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.27 0.628 . . . . 0.0 109.629 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG12 ' CE1' ' A' ' 113' ' ' HIS . 32.9 m -114.09 160.78 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.772 0.829 . . . . 0.0 109.241 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -97.08 -59.3 1.82 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.147 0.579 . . . . 0.0 110.497 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -98.48 100.77 9.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.305 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.28 -51.97 10.05 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.441 2.761 . . . . 0.0 115.523 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.21 -50.21 9.13 Favored 'Trans proline' 0 C--N 1.398 3.158 0 CA-C-N 122.136 1.798 . . . . 0.0 112.561 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.29 62.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.6 p -76.83 -36.21 57.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.479 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 95.2 m -64.51 -43.84 92.78 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 36.9 mt-30 -64.99 -35.11 80.12 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.205 174.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.3 t80 -66.15 -42.82 88.54 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 123.776 0.673 . . . . 0.0 109.552 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 34.1 m-85 -70.04 -28.39 65.43 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.789 -0.625 . . . . 0.0 109.873 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 60.6 mtpt -57.0 -50.61 72.18 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 118.789 0.722 . . . . 0.0 111.822 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.45 60.84 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.253 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 19.1 tp -61.79 -42.56 99.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.744 1.217 . . . . 0.0 112.388 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' HB2' HG22 ' A' ' 27' ' ' VAL . 18.4 mt -90.15 -43.01 10.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.67 28.62 6.95 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.2 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 25' ' ' LEU . 29.4 m -131.64 173.87 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.929 0.892 . . . . 0.0 110.224 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -124.84 150.22 65.22 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.965 0.906 . . . . 0.0 109.213 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.93 118.14 5.4 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.013 2.475 . . . . 0.0 112.267 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.8 -40.04 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.717 0.636 . . . . 0.0 110.298 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 36.3 mm-40 -117.92 146.7 43.76 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.326 1.05 . . . . 0.0 109.196 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.4 p -143.8 135.37 26.1 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -145.26 157.4 53.22 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.876 1.271 . . . . 0.0 108.772 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.12 -28.99 35.19 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 123.468 2.779 . . . . 0.0 113.999 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 5.19 7.98 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.57 130.23 12.31 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.833 -0.542 . . . . 0.0 111.194 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -117.62 130.89 56.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 7.1 tt -121.93 132.39 54.52 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.26 150.63 46.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.82 1.248 . . . . 0.0 108.687 167.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 2.0 p -130.46 132.64 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.59 155.89 20.27 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.368 0.667 . . . . 0.0 110.767 -165.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.15 -16.98 64.22 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.642 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -74.41 -15.38 60.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.132 0.973 . . . . 0.0 111.363 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.8 -19.88 30.04 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.896 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.703 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.7 ppp? -81.36 168.45 18.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.376 0.588 . . . . 0.0 109.929 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.6 tttt -133.83 140.2 46.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.502 0.321 . . . . 0.0 110.924 -169.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 7' ' ' THR . 55.0 mt -131.39 126.38 35.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.866 0.867 . . . . 0.0 111.898 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -102.79 167.9 17.78 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 174.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.54 108.41 6.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.1 t90 -104.81 118.53 36.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 25.2 p -75.85 127.7 33.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.189 0.518 . . . . 0.0 109.842 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.486 ' HD3' HG23 ' A' ' 62' ' ' THR . 40.3 ptt180 -74.43 -2.44 25.48 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.827 1.251 . . . . 0.0 114.015 -165.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -69.84 -18.63 63.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.835 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -148.03 21.76 1.1 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.857 0.463 . . . . 0.0 110.774 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 58' ' ' LYS . 8.7 p -59.37 147.2 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.806 0.442 . . . . 0.0 111.313 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.84 113.51 26.87 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.536 0.734 . . . . 0.0 109.117 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 1.2 Cg_endo -78.19 143.96 74.31 Favored 'Cis proline' 0 C--N 1.38 2.232 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.406 5.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HA ' HG13 ' A' ' 55' ' ' VAL . 11.9 mmmm -54.69 119.6 5.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.034 0.934 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.73 4.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.191 0.996 . . . . 0.0 109.441 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.7 m -91.48 82.86 5.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 m -155.4 131.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.012 1.325 . . . . 0.0 108.424 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.486 HG23 ' HD3' ' A' ' 52' ' ' ARG . 15.0 p -145.44 122.28 11.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.311 1.044 . . . . 0.0 108.634 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.72 -95.51 0.14 Allowed Glycine 0 C--N 1.349 1.305 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.639 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.95 -154.12 30.11 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.81 -48.09 3.81 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.29 132.48 3.75 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.563 ' HG2' ' HB ' ' B' ' 8' ' ' ILE . 15.8 pt-20 -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.08 0.952 . . . . 0.0 110.971 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.13 105.6 13.11 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -91.72 115.17 27.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.659 0.663 . . . . 0.0 112.546 -169.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.7 m-85 -96.44 115.75 27.94 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.728 1.211 . . . . 0.0 108.334 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.46 HH21 ' HB3' ' B' ' 5' ' ' ASP . 42.0 mtm180 -96.51 131.06 43.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.556 0.693 . . . . 0.0 111.494 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -125.45 165.98 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.186 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.1 pt-20 -65.45 -41.56 93.29 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.395 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.44 -178.68 3.63 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.218 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -58.99 -30.31 67.87 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.222 1.409 . . . . 0.0 112.887 -165.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.57 87.63 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.119 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.56 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 77.4 mm-40 -67.39 -22.33 65.56 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.646 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.78 -44.89 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.16 -32.17 68.6 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.497 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.98 -42.14 81.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.722 0.772 . . . . 0.0 110.197 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.6 m -72.36 -28.12 62.83 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.702 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -58.72 -61.75 2.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.839 0.856 . . . . 0.0 109.682 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.89 67.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.632 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.87 -51.57 56.32 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.877 0.736 . . . . 0.0 113.012 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -63.74 -40.46 96.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.082 0.553 . . . . 0.0 110.099 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 31.5 ttpt -56.15 -45.78 79.51 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.412 0.625 . . . . 0.0 110.828 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.34 -20.17 60.19 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.166 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.2 t -98.64 10.3 41.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.061 0.944 . . . . 0.0 112.14 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.55 5.82 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 168.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.89 153.56 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.51 2.75 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.829 0.452 . . . . 0.0 110.373 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 11.3 ttp 67.47 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.973 0.795 . . . . 0.0 112.859 171.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.32 85.13 2.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.194 0.521 . . . . 0.0 110.617 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 106' ' ' THR . 51.3 tp60 179.85 131.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.338 . . . . 0.0 109.145 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.59 117.79 69.21 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.65 105.19 0.1 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.397 2.732 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.9 148.93 25.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 110.815 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -90.46 99.02 12.12 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -102.95 -174.65 2.6 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.42 0.688 . . . . 0.0 111.885 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -55.91 -39.84 72.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.07 1.348 . . . . 0.0 112.766 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 89.9 m-85 -88.63 -4.83 58.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.279 0.632 . . . . 0.0 111.614 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.86 -160.22 21.74 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.731 -0.483 . . . . 0.0 113.413 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -80.26 100.47 8.36 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -109.18 153.59 23.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.596 0.758 . . . . 0.0 111.026 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.8 t80 -149.4 145.03 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.728 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 12.3 m -137.94 128.93 27.25 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.322 0.51 . . . . 0.0 109.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.89 174.63 5.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.997 0.919 . . . . 0.0 110.589 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.08 119.3 12.08 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.574 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.8 p-10 -73.87 -175.13 0.39 Allowed Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.588 0.755 . . . . 0.0 111.316 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 11.5 Cg_exo -38.91 -48.47 2.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.589 2.859 . . . . 0.0 114.846 165.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 113' ' ' HIS . 57.9 m-20 -89.73 3.92 51.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.393 0.677 . . . . 0.0 111.321 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.2 m 71.96 16.16 5.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 113.654 161.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.448 ' CE1' HG12 ' A' ' 11' ' ' VAL . 15.9 m80 -59.11 137.35 57.99 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -70.98 99.61 1.82 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.36 102.26 14.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.714 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 14.2 tpt180 -87.71 142.45 27.82 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.403 1.081 . . . . 0.0 110.664 -170.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.455 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 39.0 t -138.73 128.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.0 p90 -135.39 158.59 43.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.545 0.611 . . . . 0.0 111.931 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 113.04 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 34.8 t80 -78.43 114.91 17.76 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.642 0 O-C-N 124.199 0.937 . . . . 0.0 109.914 179.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 90.0 Cg_endo -86.72 141.84 6.59 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.342 2.028 . . . . 0.0 112.37 170.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.703 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 22.2 t70 -141.77 20.31 2.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.557 1.17 . . . . 0.0 109.221 171.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -143.47 148.0 35.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.751 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.474 HG23 HD23 ' B' ' 47' ' ' LEU . 3.7 t -151.83 139.3 19.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.563 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 46.8 mt -123.74 137.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.641 0.776 . . . . 0.0 109.879 -170.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.4 130.41 45.67 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.432 ' O ' HG22 ' B' ' 62' ' ' THR . 27.1 m-85 -80.44 115.6 20.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.604 172.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.443 HG12 ' CE1' ' B' ' 113' ' ' HIS . 32.7 m -114.43 160.72 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.705 0.802 . . . . 0.0 109.274 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.29 -58.56 1.98 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.712 0.405 . . . . 0.0 110.737 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -98.6 100.66 9.86 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.118 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.66 -52.18 9.57 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.319 2.679 . . . . 0.0 115.378 -172.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 25.4 Cg_endo -58.76 -50.73 8.49 Favored 'Trans proline' 0 C--N 1.398 3.139 0 CA-C-N 122.132 1.797 . . . . 0.0 112.532 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -37.66 64.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.635 -166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.5 p -76.51 -36.23 57.87 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.62 0.575 . . . . 0.0 109.453 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 96.9 m -65.04 -43.41 92.43 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' B' ' 15' ' ' PRO . 45.7 mt-30 -65.19 -35.34 80.77 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.793 174.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 75.5 t80 -65.81 -43.01 89.93 Favored 'General case' 0 C--N 1.347 0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 32.3 m-85 -69.81 -28.62 65.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.788 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 18' ' ' THR . 57.3 mtpt -57.16 -50.52 72.58 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.794 0.724 . . . . 0.0 112.112 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.58 61.8 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.536 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 19.0 tp -61.54 -42.69 99.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.599 1.159 . . . . 0.0 112.581 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -90.24 -42.56 10.94 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.97 29.31 6.91 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.899 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' B' ' 25' ' ' LEU . 28.2 m -131.42 174.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 124.097 0.959 . . . . 0.0 110.568 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -124.75 150.61 66.13 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.73 0.812 . . . . 0.0 109.155 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.16 118.92 5.96 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.49 2.127 . . . . 0.0 112.661 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.44 -40.05 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.27 0.628 . . . . 0.0 110.381 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.766 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 31.1 mm-40 -118.0 147.34 43.29 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.159 0.983 . . . . 0.0 108.666 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.3 p -144.27 135.38 25.36 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 57.1 m -145.02 156.41 55.01 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.106 1.362 . . . . 0.0 108.66 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.15 -30.17 24.63 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 124.039 3.159 . . . . 0.0 114.353 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -125.21 5.77 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -151.75 129.9 11.91 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.455 0.571 . . . . 0.0 111.086 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 42.6 m -117.21 130.73 56.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 39.9 tp -121.54 131.92 54.41 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.465 0.706 . . . . 0.0 109.608 -176.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.92 150.79 47.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.617 1.167 . . . . 0.0 108.455 167.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.483 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 2.7 p -130.29 133.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 41.2 mt -86.49 155.73 20.4 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.923 -165.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -16.76 64.33 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.667 0.787 . . . . 0.0 111.342 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -14.53 60.31 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.709 0.804 . . . . 0.0 111.086 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.65 -19.78 30.53 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-O 119.753 -0.471 . . . . 0.0 113.874 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.66 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.8 ppp? -81.35 168.13 18.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.416 0.608 . . . . 0.0 110.061 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 78.3 tttt -133.96 140.29 46.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.488 0.315 . . . . 0.0 110.997 -169.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.474 HD23 HG23 ' B' ' 7' ' ' THR . 46.3 mt -131.47 126.25 34.54 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.843 0.857 . . . . 0.0 111.88 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.64 167.77 17.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -137.63 108.41 6.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.408 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 5.1 t90 -104.9 118.4 36.43 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 55.3 p -75.18 127.69 33.76 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.182 0.515 . . . . 0.0 110.084 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.497 ' HD3' HG23 ' B' ' 62' ' ' THR . 35.3 ptt180 -74.81 -2.97 29.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.688 1.195 . . . . 0.0 113.982 -165.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -19.45 64.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.618 0.767 . . . . 0.0 111.928 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -147.86 21.79 1.12 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.896 0.478 . . . . 0.0 110.625 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -59.57 146.98 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.757 0.423 . . . . 0.0 111.098 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.98 115.1 27.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.72 143.33 75.59 Favored 'Cis proline' 0 C--N 1.387 2.564 0 C-N-CA 124.462 -1.057 . . . . 0.0 112.955 2.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -53.22 119.32 4.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.972 0.909 . . . . 0.0 112.173 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.32 108.54 4.79 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.075 0.95 . . . . 0.0 109.147 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.2 m -91.13 82.87 5.52 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.4 131.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.892 1.277 . . . . 0.0 108.425 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.497 HG23 ' HD3' ' B' ' 52' ' ' ARG . 17.2 p -145.41 121.89 11.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.269 1.028 . . . . 0.0 108.526 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.07 -95.51 0.14 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 112.592 -0.203 . . . . 0.0 112.592 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.03 -154.14 30.19 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.9 -48.15 3.82 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.19 132.11 3.64 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.545 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 pt-20 -106.63 166.65 10.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.935 0.894 . . . . 0.0 110.853 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 tp -115.48 104.87 12.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.507 0.723 . . . . 0.0 109.247 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.747 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.22 115.62 28.17 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.611 0.641 . . . . 0.0 112.243 -168.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 7.8 m-85 -96.61 115.84 28.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.886 1.274 . . . . 0.0 108.368 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -96.48 128.59 43.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.273 0.629 . . . . 0.0 111.146 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.79 167.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.627 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.47 -40.86 89.59 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -167.75 -179.69 4.39 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.172 0.511 . . . . 0.0 112.362 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.31 -30.74 66.91 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.35 1.46 . . . . 0.0 112.89 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.586 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.44 -46.16 87.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.952 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.9 mm-40 -67.56 -21.98 65.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.904 0.882 . . . . 0.0 112.503 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.81 -43.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.39 -30.62 63.39 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.656 1.182 . . . . 0.0 110.982 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.1 mt-10 -69.17 -42.41 75.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.707 0.765 . . . . 0.0 110.189 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -71.89 -28.32 63.43 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.75 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.422 ' O ' ' HE1' ' B' ' 92' ' ' MET . 13.0 t80 -58.3 -62.28 1.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 0.0 109.359 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.427 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -69.39 -29.87 67.73 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.541 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.97 53.74 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.02 0.825 . . . . 0.0 113.027 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.7 -40.5 96.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.118 0.567 . . . . 0.0 110.073 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.8 ttpt -56.34 -45.25 80.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.637 . . . . 0.0 110.656 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 -20.82 60.01 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.172 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -98.36 10.85 39.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.125 0.97 . . . . 0.0 112.516 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.62 42.87 5.96 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.61 153.32 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.13 -59.64 2.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.812 0.445 . . . . 0.0 110.363 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.422 ' HE1' ' O ' ' B' ' 82' ' ' PHE . 30.9 ttm 67.37 84.97 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.866 0.729 . . . . 0.0 112.377 170.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.27 84.2 1.93 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.126 0.489 . . . . 0.0 110.645 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 55.6 tp60 -178.74 132.23 0.13 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.649 1.18 . . . . 0.0 108.833 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . 0.405 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 96.8 mt-30 -86.36 118.02 69.64 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 9.8 Cg_endo -52.66 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.547 2.831 . . . . 0.0 112.106 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.28 148.86 25.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.125 0.97 . . . . 0.0 110.772 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.81 99.36 12.38 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.446 ' SD ' HG21 ' B' ' 104' ' ' THR . 66.1 mtt -103.05 -173.56 2.34 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.288 0.635 . . . . 0.0 111.745 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -57.24 -39.49 75.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.052 1.341 . . . . 0.0 112.548 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 78.7 m-85 -88.76 -5.13 58.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.511 0.725 . . . . 0.0 111.399 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.67 -160.19 21.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.302 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -80.64 100.8 8.85 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.446 HG21 ' SD ' ' B' ' 99' ' ' MET . 12.0 t -109.45 153.99 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.838 -170.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 14.3 t80 -149.41 145.43 26.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.543 -177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.503 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 9.4 m -138.25 129.08 26.81 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.04 174.48 5.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 110.822 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.83 120.43 13.29 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.607 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.7 p-10 -75.54 -174.29 0.38 Allowed Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.683 0.793 . . . . 0.0 110.953 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.5 Cg_exo -40.34 -48.01 4.18 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.412 2.741 . . . . 0.0 114.519 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.427 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 65.0 m-20 -90.1 4.1 51.37 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.356 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 29.0 m 71.67 17.76 5.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.443 ' CE1' HG12 ' B' ' 11' ' ' VAL . 16.3 m80 -60.79 137.71 58.18 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -71.05 99.49 1.83 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.388 0.613 . . . . 0.0 109.439 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.8 mt -96.38 102.85 14.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 14.0 tpt180 -86.61 142.6 28.14 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.475 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -138.91 128.75 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -135.37 158.82 43.4 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.867 0.758 . . . . 0.0 111.744 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.7 112.57 21.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 84.9 t80 -76.59 108.99 9.97 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.3 101.47 8.95 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m80 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.62 103.77 0.23 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.325 2.683 . . . . 0.0 113.002 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.707 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 9.1 p-10 -97.71 12.49 33.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 166.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.6 129.09 43.94 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.873 -168.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.1 t -130.36 137.98 50.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.158 0.983 . . . . 0.0 108.348 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -124.33 141.83 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.2 131.93 55.69 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 55' ' ' VAL . 10.1 m-85 -71.7 120.35 17.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.881 0.873 . . . . 0.0 111.616 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 51' ' ' SER . 33.2 m -117.71 161.42 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.01 -54.32 3.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -94.95 103.79 12.77 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.597 0.759 . . . . 0.0 109.586 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.17 -57.67 1.38 Allowed 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.983 2.456 . . . . 0.0 114.493 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 38.5 Cg_exo -57.27 -57.3 1.33 Allowed 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.628 1.974 . . . . 0.0 111.852 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.13 89.52 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.922 -169.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -78.26 -24.45 46.84 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 28.0 m -73.51 -43.4 60.15 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 75.5 mm-40 -68.47 -29.7 68.38 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.557 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -61.24 -50.79 71.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.816 0.697 . . . . 0.0 109.6 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.32 -31.92 71.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.592 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -57.45 -47.92 80.52 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.27 57.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.035 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.5 -36.9 79.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.473 1.109 . . . . 0.0 112.903 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' HB2' HG22 ' A' ' 27' ' ' VAL . 23.8 mt -98.61 -31.44 11.94 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.168 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.83 31.48 20.79 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 25' ' ' LEU . 22.7 m -123.81 174.66 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.251 1.02 . . . . 0.0 110.599 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.96 143.09 47.57 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.852 0.861 . . . . 0.0 109.306 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.46 132.9 28.51 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.674 2.25 . . . . 0.0 112.828 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 31' ' ' GLU . 7.8 p -71.09 -38.56 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.534 0.734 . . . . 0.0 109.907 171.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 40.3 mm-40 -118.21 134.0 55.4 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 p -141.07 126.15 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.443 0.697 . . . . 0.0 109.23 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -140.17 157.55 68.71 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.759 1.223 . . . . 0.0 109.212 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.25 -24.49 77.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.917 2.412 . . . . 0.0 113.831 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.4 t -127.1 13.49 7.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -155.99 154.34 30.94 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.969 -0.457 . . . . 0.0 110.411 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 t -144.69 157.62 44.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.153 0.981 . . . . 0.0 108.403 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -154.41 118.12 4.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.57 135.97 51.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 109.104 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' A' ' 46' ' ' LYS . 16.1 t -115.87 126.25 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 0.0 108.925 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.461 HD13 ' SD ' ' A' ' 45' ' ' MET . 10.3 mp -90.16 152.55 21.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.761 0.424 . . . . 0.0 110.257 -170.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -14.17 61.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.949 0.899 . . . . 0.0 111.699 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.55 -22.42 66.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.28 1.032 . . . . 0.0 111.789 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.66 1.08 40.0 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.818 -0.435 . . . . 0.0 113.343 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.73 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -95.34 169.99 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' A' ' 40' ' ' VAL . 79.3 tttt -133.7 135.9 44.34 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 7' ' ' THR . 1.2 tt -137.59 123.99 20.73 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.895 0.478 . . . . 0.0 110.013 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.15 167.75 15.21 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.48 111.81 11.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.436 ' HE1' ' HA ' ' A' ' 55' ' ' VAL . 2.2 t-105 -103.91 125.03 50.02 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.9 m -79.97 109.54 14.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.535 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 28.8 ptt-85 -67.71 -11.29 58.01 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.436 1.094 . . . . 0.0 113.618 -167.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -65.91 -17.83 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.937 0.495 . . . . 0.0 111.31 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -147.88 76.84 1.4 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.959 1.362 . . . . 0.0 109.161 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 10' ' ' TYR . 7.3 p -113.74 152.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.031 174.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.21 112.22 46.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.808 0.843 . . . . 0.0 109.852 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.9 142.0 61.19 Favored 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.157 1.092 . . . . 0.0 112.413 1.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -49.31 111.02 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.036 0.935 . . . . 0.0 111.78 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.98 107.16 4.17 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.12 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.535 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.3 p -113.53 85.6 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.455 0.645 . . . . 0.0 109.508 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.95 129.06 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.996 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -144.39 157.04 44.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.336 1.055 . . . . 0.0 109.007 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 -43.06 0.57 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.05 150.1 22.3 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.47 120.97 4.82 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.28 89.78 0.22 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.77 0.335 . . . . 0.0 112.601 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' CG ' ' HB ' ' B' ' 8' ' ' ILE . 2.9 pt-20 -102.5 164.39 11.69 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.451 0.643 . . . . 0.0 109.926 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.85 101.66 7.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.81 108.92 19.77 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.135 0.493 . . . . 0.0 111.167 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.38 116.21 24.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.277 1.431 . . . . 0.0 109.106 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -95.86 127.17 41.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.369 0.604 . . . . 0.0 112.075 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.29 161.92 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.787 1.235 . . . . 0.0 110.391 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.5 pt-20 -63.95 -38.74 92.21 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -163.85 -179.62 6.43 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 118.405 0.548 . . . . 0.0 112.013 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.4 -32.27 70.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.268 . . . . 0.0 112.595 -166.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.24 -48.17 82.7 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.027 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.443 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.5 mm-40 -65.26 -20.58 66.49 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.632 1.173 . . . . 0.0 112.993 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.6 -43.25 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.375 0.607 . . . . 0.0 109.924 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.66 -31.4 63.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.753 1.221 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 43.4 mt-10 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.122 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -69.62 -32.24 70.83 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.872 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -56.14 -57.33 12.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.912 0.885 . . . . 0.0 109.407 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.22 90.84 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.721 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.43 93.92 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 123.849 0.718 . . . . 0.0 114.097 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.87 -44.1 97.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.34 0.656 . . . . 0.0 109.869 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.09 -46.47 79.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.674 0.79 . . . . 0.0 110.42 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.9 -27.32 66.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.842 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.7 t -93.14 -10.61 35.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.801 0.84 . . . . 0.0 112.575 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 58.39 0.95 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 169.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.3 143.61 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.23 65.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.567 0.747 . . . . 0.0 111.48 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 53.3 ttm 65.03 83.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 165.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 83.69 2.0 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.499 0.666 . . . . 0.0 111.068 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 177.81 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.707 1.603 . . . . 0.0 108.652 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -80.15 118.5 72.72 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -49.85 102.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.926 3.084 . . . . 0.0 112.873 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.99 141.0 41.72 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.941 0.896 . . . . 0.0 110.262 -175.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 100.27 4.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.7 ttm -96.96 162.1 13.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.427 0.691 . . . . 0.0 109.331 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.17 -28.63 68.09 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.001 0.92 . . . . 0.0 112.45 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.7 -24.74 49.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.479 0.712 . . . . 0.0 110.523 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.16 175.93 21.99 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -74.05 101.01 3.75 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -111.67 147.56 35.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.409 0.623 . . . . 0.0 111.459 -165.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.502 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 5.8 t80 -144.21 144.03 31.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.692 1.197 . . . . 0.0 109.426 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.401 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 12.8 m -133.07 128.11 35.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.06 174.09 6.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.893 0.877 . . . . 0.0 110.033 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.03 122.59 17.36 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.505 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.1 p-10 -71.63 176.23 2.35 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.352 0.661 . . . . 0.0 109.352 172.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 27.8 Cg_endo -59.65 -12.92 19.34 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 122.305 2.004 . . . . 0.0 114.086 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.11 1.08 49.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.165 0.586 . . . . 0.0 111.677 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.3 p 66.3 33.47 7.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.821 1.649 . . . . 0.0 112.816 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -74.33 173.14 10.66 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 114' ' ' ARG . 16.5 mmt-85 -108.6 105.01 14.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -99.95 99.92 10.75 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.465 HH21 HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -98.48 96.62 8.12 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.502 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 27.6 t -86.51 119.24 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -139.46 161.04 38.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.53 112.81 18.96 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -69.31 141.1 54.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.612 0.765 . . . . 0.0 110.834 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 123.509 0.723 . . . . 0.0 110.269 179.177 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 m170 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -90.94 104.1 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.315 2.677 . . . . 0.0 112.996 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.73 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.2 p-10 -98.31 13.49 31.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.617 0.723 . . . . 0.0 109.975 166.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -129.27 128.7 43.76 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.887 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -130.35 138.14 50.26 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.486 ' HB ' ' CG ' ' A' ' 67' ' ' GLU . 31.1 mt -125.36 141.88 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.05 133.96 54.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.419 ' CE1' HG21 ' B' ' 55' ' ' VAL . 69.2 m-85 -76.58 120.75 22.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.925 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' B' ' 51' ' ' SER . 34.1 m -117.68 160.85 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -98.12 -54.85 2.95 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.36 0.264 . . . . 0.0 110.427 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -93.76 103.55 10.47 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.862 0.865 . . . . 0.0 109.345 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -55.86 -58.53 1.04 Allowed 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.253 2.635 . . . . 0.0 114.621 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 52.6 Cg_exo -56.34 -57.57 1.39 Allowed 'Trans proline' 0 C--N 1.404 3.478 0 CA-C-N 122.751 2.018 . . . . 0.0 112.09 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.92 90.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.794 -168.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.0 m -78.03 -24.99 47.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.357 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 41.8 m -73.08 -42.87 62.54 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 77.3 mm-40 -68.96 -29.52 67.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.571 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.66 -50.62 71.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.905 0.753 . . . . 0.0 109.59 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -67.97 -32.2 72.46 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.772 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.548 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 58.6 mtpt -57.09 -48.19 79.19 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.289 0.566 . . . . 0.0 112.466 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 -35.3 57.3 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.907 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.45 -36.71 78.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.353 1.061 . . . . 0.0 112.928 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.539 ' HB2' HG22 ' B' ' 27' ' ' VAL . 24.0 mt -99.01 -31.03 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.13 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 31.74 21.33 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.553 HG11 HD22 ' B' ' 41' ' ' LEU . 32.8 m -124.71 174.26 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.076 0.95 . . . . 0.0 110.838 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.07 139.1 34.51 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.892 0.877 . . . . 0.0 109.14 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.548 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 51.0 Cg_exo -60.84 131.88 39.65 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.291 2.661 . . . . 0.0 114.417 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.446 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.6 p -71.34 -36.88 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.794 0.838 . . . . 0.0 110.157 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 38.7 mm-40 -121.31 133.0 55.12 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 53.1 m -141.41 126.12 17.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 67.5 m -140.08 157.05 69.95 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.815 1.246 . . . . 0.0 109.091 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.06 -24.88 75.62 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.115 2.543 . . . . 0.0 114.11 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.1 t -127.34 13.65 7.12 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -156.13 154.39 30.82 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.877 -0.515 . . . . 0.0 110.355 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -144.8 157.04 44.32 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.16 0.984 . . . . 0.0 108.46 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tt -153.96 118.4 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -126.63 135.17 50.85 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.97 1.308 . . . . 0.0 109.161 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.581 HG22 ' HG3' ' B' ' 46' ' ' LYS . 18.6 t -114.5 126.43 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 109.047 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.553 HD22 HG11 ' B' ' 27' ' ' VAL . 16.6 mt -90.35 153.01 20.76 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -170.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.0 -13.73 62.2 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.892 0.877 . . . . 0.0 111.531 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -22.42 66.74 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 111.957 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 1.87 42.08 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.76 -0.467 . . . . 0.0 113.123 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.707 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -95.67 169.89 9.71 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.361 0.581 . . . . 0.0 109.826 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.581 ' HG3' HG22 ' B' ' 40' ' ' VAL . 76.3 tttt -133.25 136.56 45.63 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.79 123.91 20.36 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.928 0.491 . . . . 0.0 110.132 -170.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.98 167.85 15.39 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.57 111.53 10.74 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 162.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -103.69 125.41 50.16 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 20.4 m -80.1 109.62 14.73 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.635 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 32.7 ptt-85 -68.6 -10.25 54.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.358 1.063 . . . . 0.0 113.757 -167.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.83 -18.24 65.2 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.488 177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -147.52 77.02 1.42 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.544 1.164 . . . . 0.0 109.098 168.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' B' ' 10' ' ' TYR . 7.4 p -113.46 152.27 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.015 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' PRO . 40.9 mt-10 -114.59 112.42 45.73 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.76 169.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' B' ' 56' ' ' GLU . 82.3 Cg_endo -80.19 142.74 62.85 Favored 'Cis proline' 0 C--N 1.386 2.546 0 CA-C-N 119.589 0.889 . . . . 0.0 112.508 1.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -50.42 111.4 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.923 0.889 . . . . 0.0 111.564 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.12 107.42 4.21 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.143 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.635 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 30.5 p -114.33 85.45 2.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.681 0.753 . . . . 0.0 109.474 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.81 130.11 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.089 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -145.67 156.02 43.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.719 1.208 . . . . 0.0 108.814 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.86 -43.47 0.55 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 149.59 21.73 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.19 121.05 4.81 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 76.55 89.81 0.27 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.51 163.4 12.25 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.98 0.912 . . . . 0.0 109.178 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 tp -120.87 101.35 7.64 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 109.63 20.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.359 0.527 . . . . 0.0 111.343 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -87.01 116.35 25.0 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 108.918 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -95.98 126.19 41.05 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.217 0.532 . . . . 0.0 111.499 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.25 162.58 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.533 1.133 . . . . 0.0 110.48 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.4 pt-20 -64.21 -38.81 92.37 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -163.6 179.81 6.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.329 0.513 . . . . 0.0 112.149 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.88 -32.1 69.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.115 1.366 . . . . 0.0 112.804 -167.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -47.51 85.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.279 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 84.5 mm-40 -66.48 -19.59 65.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.212 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.49 -44.38 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.39 0.614 . . . . 0.0 109.597 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.82 -33.43 70.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.113 1.365 . . . . 0.0 111.367 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -65.23 -46.88 78.83 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.73 0.776 . . . . 0.0 109.91 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -68.93 -32.28 71.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.924 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.27 -57.55 11.77 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.576 0.75 . . . . 0.0 109.288 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.04 91.29 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.649 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.26 -44.23 94.04 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 123.726 0.641 . . . . 0.0 113.809 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . 0.412 ' HB3' HG11 ' B' ' 90' ' ' VAL . 37.6 m0 -62.89 -44.03 97.19 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.192 0.597 . . . . 0.0 109.902 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -56.89 -45.96 82.22 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 110.324 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.87 -27.14 66.42 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.904 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.1 t -93.6 -10.31 35.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.855 0.862 . . . . 0.0 112.22 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.12 58.84 0.96 Allowed Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 114.09 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' B' ' 92' ' ' MET . 5.1 p -104.4 144.73 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.48 63.92 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.246 0.618 . . . . 0.0 111.387 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.579 ' HB2' HG13 ' B' ' 90' ' ' VAL . 51.8 ttm 65.31 83.81 0.16 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.953 0.783 . . . . 0.0 113.06 165.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.402 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -117.19 84.09 2.09 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.413 0.625 . . . . 0.0 110.851 176.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' B' ' 106' ' ' THR . 51.5 tp60 177.22 121.57 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.762 1.625 . . . . 0.0 108.304 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -78.56 119.31 76.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.73 102.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.806 3.004 . . . . 0.0 112.556 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.09 140.52 42.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.0 0.92 . . . . 0.0 110.244 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.81 100.63 4.81 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.497 ' SD ' ' HD2' ' B' ' 101' ' ' PHE . 56.0 ttm -97.05 162.56 13.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.449 0.7 . . . . 0.0 109.356 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.84 -29.58 68.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.122 0.969 . . . . 0.0 112.018 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.497 ' HD2' ' SD ' ' B' ' 99' ' ' MET . 49.2 m-85 -77.29 -25.38 51.27 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.401 0.681 . . . . 0.0 110.369 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.77 176.5 22.97 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.962 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.39 101.48 4.11 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -112.36 147.47 36.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.185 0.517 . . . . 0.0 111.473 -165.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.521 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 6.2 t80 -144.31 143.97 31.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.67 1.188 . . . . 0.0 109.366 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.503 HG21 ' HG3' ' B' ' 114' ' ' ARG . 32.6 m -133.31 127.85 34.49 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.4 0.619 . . . . 0.0 110.276 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.72 174.1 6.03 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.992 0.917 . . . . 0.0 110.206 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.2 121.41 15.85 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.602 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 1.2 p30 -69.54 175.99 1.92 Allowed Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 123.67 0.788 . . . . 0.0 110.171 171.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 31.5 Cg_endo -60.48 -12.2 19.8 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.381 2.054 . . . . 0.0 113.901 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -97.57 0.47 47.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.2 0.6 . . . . 0.0 111.417 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 27.6 t 66.96 33.46 5.8 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.272 1.429 . . . . 0.0 112.245 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -75.18 173.36 10.91 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.503 ' HG3' HG21 ' B' ' 106' ' ' THR . 5.4 mpt_? -107.98 104.9 14.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.0 100.54 11.45 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 -97.91 95.47 7.52 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -166.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.521 ' HB ' ' HD2' ' B' ' 105' ' ' PHE . 36.0 t -86.29 119.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -139.22 160.86 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.56 112.58 18.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.45 138.4 55.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.087 0.555 . . . . 0.0 109.96 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.64 97.89 0.84 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.881 0.472 . . . . 0.0 109.999 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.063 -178.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.547 ' HG3' HD22 ' B' ' 25' ' ' LEU . 87.7 Cg_endo -85.76 86.17 1.03 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.696 2.264 . . . . 0.0 111.493 168.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.631 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 14.3 t70 -102.58 11.44 37.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.142 0.972 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.405 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -133.01 131.56 40.84 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -169.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.21 144.18 51.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.853 0.861 . . . . 0.0 109.167 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.455 HD12 ' NH1' ' B' ' 116' ' ' ARG . 1.8 mt -126.77 138.93 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.635 0.774 . . . . 0.0 109.51 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 68' ' ' LEU . 96.1 mt -95.24 137.44 34.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -77.05 98.88 5.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.076 177.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.492 HG11 HD23 ' A' ' 49' ' ' LEU . 20.1 m -109.74 169.78 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.23 -60.5 1.87 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.088 0.555 . . . . 0.0 110.003 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -102.32 98.39 10.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.941 0.896 . . . . 0.0 110.4 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.4 Cg_exo -49.12 -49.9 14.18 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.683 2.922 . . . . 0.0 115.984 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.77 -58.96 0.39 Allowed 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.217 1.828 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.86 89.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -59.51 -52.31 66.11 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 122.215 1.007 . . . . 0.0 109.507 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 59.1 m -80.49 -33.68 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -163.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 83.6 mm-40 -65.39 -37.46 87.06 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.888 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.97 -44.29 97.54 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -71.46 -28.27 63.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.214 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.6 mtpt -56.49 -51.05 69.96 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.315 0.507 . . . . 0.0 111.875 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.41 -38.09 56.15 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.311 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 115' ' ' LEU . 11.6 tp -59.79 -36.63 77.13 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.175 0.99 . . . . 0.0 112.34 -175.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD22 ' HG3' ' B' ' 4' ' ' PRO . 46.4 mt -96.9 -40.96 8.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.113 0.965 . . . . 0.0 109.357 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.83 30.85 8.11 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.605 0.566 . . . . 0.0 112.071 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.7 m -129.75 -178.39 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.427 1.091 . . . . 0.0 109.902 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.7 154.32 72.99 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.253 0.621 . . . . 0.0 109.753 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 11.4 Cg_exo -70.57 117.39 5.11 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.941 2.427 . . . . 0.0 111.954 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 39' ' ' PHE . 5.8 p -65.42 -40.52 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 47.3 mm-40 -113.41 128.76 56.56 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.755 0.822 . . . . 0.0 109.482 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -127.73 131.9 49.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.862 0.865 . . . . 0.0 109.267 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 t -137.22 147.72 59.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.25 -15.32 34.03 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.921 2.414 . . . . 0.0 114.226 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.49 7.74 5.84 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -157.97 153.37 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.612 0.365 . . . . 0.0 110.122 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 24.4 m -138.06 148.23 44.85 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.191 0.596 . . . . 0.0 109.612 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -146.16 129.2 16.51 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.567 ' HA ' HG12 ' A' ' 30' ' ' VAL . 2.6 p90 -134.49 148.18 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.176 0.99 . . . . 0.0 108.981 163.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' A' ' 46' ' ' LYS . 17.5 t -119.4 127.95 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.458 HD12 ' SD ' ' A' ' 45' ' ' MET . 37.7 mt -89.87 142.4 27.73 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -169.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.3 -14.3 62.89 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.069 0.948 . . . . 0.0 112.219 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.518 HD22 ' HB3' ' B' ' 5' ' ' ASP . 66.5 t30 -71.78 -9.87 58.94 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 110.912 174.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.2 32.91 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.483 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.66 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -97.01 172.29 7.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.009 0.904 . . . . 0.0 110.095 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG22 ' A' ' 40' ' ' VAL . 86.5 tttt -135.03 141.82 46.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.05 0.54 . . . . 0.0 109.679 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.88 123.41 15.0 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.829 0.452 . . . . 0.0 110.452 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -107.77 167.86 13.68 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.537 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.492 HD23 HG11 ' A' ' 11' ' ' VAL . 6.3 mp -134.04 107.96 8.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 166.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.554 ' HE3' ' NH2' ' B' ' 116' ' ' ARG . 6.0 t90 -105.19 130.52 53.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.405 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 37.4 m -80.01 121.57 25.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.041 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -65.73 -14.09 60.61 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.986 1.314 . . . . 0.0 113.492 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -76.24 -8.2 56.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.573 0.349 . . . . 0.0 111.101 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.426 HG23 ' HE1' ' A' ' 50' ' ' TRP . 12.1 t -136.9 6.39 2.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.117 0.567 . . . . 0.0 111.344 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.8 147.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.716 0.406 . . . . 0.0 110.885 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -128.25 111.25 19.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.754 0.822 . . . . 0.0 108.875 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.7 140.49 66.8 Favored 'Cis proline' 0 C--N 1.389 2.666 0 C-N-CA 124.76 -0.933 . . . . 0.0 113.736 4.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -50.56 116.53 1.96 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.757 1.223 . . . . 0.0 113.04 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.52 107.1 3.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.799 1.24 . . . . 0.0 108.194 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -97.85 87.29 3.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.89 142.4 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 108.828 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.443 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 8.1 p -151.53 132.41 14.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.197 1.399 . . . . 0.0 108.267 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.19 -65.2 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 N-CA-C 112.054 -0.419 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.49 64.26 0.1 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.04 131.7 8.07 Favored Glycine 0 N--CA 1.464 0.566 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 73.43 129.43 0.14 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 15.9 mt-10 -120.97 147.95 44.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.05 0.54 . . . . 0.0 109.599 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.466 HD22 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -120.47 106.37 11.75 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.0 122.85 34.9 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.482 0.658 . . . . 0.0 111.338 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.401 ' HB2' HG22 ' A' ' 117' ' ' VAL . 16.3 m-85 -102.56 108.35 19.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 107.529 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 29.2 mtm180 -91.29 123.49 34.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 112.201 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 118' ' ' TYR . 34.8 m -126.19 158.9 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.747 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.8 pt-20 -69.36 -34.17 74.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.066 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.492 HD22 ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -161.72 177.45 9.92 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 118.697 0.68 . . . . 0.0 112.55 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.06 -33.21 70.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.732 1.613 . . . . 0.0 112.84 -167.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.95 77.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.74 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.574 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 21.8 mm-40 -66.18 -24.42 66.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.791 0.836 . . . . 0.0 112.032 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.19 -43.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.541 0.686 . . . . 0.0 109.647 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.39 -33.66 74.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.241 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -65.58 -45.26 83.93 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.293 0.568 . . . . 0.0 109.941 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.6 m -68.87 -28.46 66.73 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.013 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.9 -61.26 2.74 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.6 0.714 . . . . 0.0 109.948 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.78 -34.23 77.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.494 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.23 -46.75 93.3 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 124.206 0.941 . . . . 0.0 113.36 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -63.71 -45.88 87.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.211 0.604 . . . . 0.0 110.197 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -57.01 -42.61 80.63 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.798 0.686 . . . . 0.0 110.836 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.09 -27.62 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.06 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -90.88 8.93 32.51 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.306 1.042 . . . . 0.0 112.643 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 46.47 4.61 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.147 169.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 p -101.6 148.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.1 79.07 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.931 0.492 . . . . 0.0 111.418 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.5 tpp 64.19 82.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.74 0.816 . . . . 0.0 112.891 166.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -134.11 84.92 2.15 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.086 0.47 . . . . 0.0 111.523 176.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 178.36 138.31 0.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.577 1.151 . . . . 0.0 109.565 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.85 119.97 68.83 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -54.12 111.41 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.938 2.425 . . . . 0.0 110.627 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.96 147.16 49.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.19 0.596 . . . . 0.0 111.231 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.02 104.8 4.23 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.608 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.418 ' SD ' ' CZ2' ' B' ' 50' ' ' TRP . 51.0 ttm -102.25 171.15 7.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.451 0.7 . . . . 0.0 109.939 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 99' ' ' MET . 19.1 mm-40 -49.63 -34.06 17.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.345 1.458 . . . . 0.0 113.092 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -101.68 -5.71 24.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.785 0.834 . . . . 0.0 111.469 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.16 -178.81 20.54 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 51.3 t80 -80.5 102.58 9.8 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.7 t -122.52 157.71 31.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.592 0.711 . . . . 0.0 111.466 -166.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.56 153.24 33.01 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.292 1.437 . . . . 0.0 108.249 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.481 HG21 ' HG3' ' A' ' 114' ' ' ARG . 23.5 m -146.81 127.68 14.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.149 0.431 . . . . 0.0 110.673 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.09 170.97 7.63 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.127 0.571 . . . . 0.0 110.724 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.4 117.42 23.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.773 0.429 . . . . 0.0 109.965 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.25 168.86 17.89 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.902 1.281 . . . . 0.0 110.856 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.31 -35.72 54.65 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.195 2.597 . . . . 0.0 114.499 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -87.48 1.18 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.307 0.643 . . . . 0.0 111.467 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 63.24 57.82 1.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.807 1.243 . . . . 0.0 112.36 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -93.19 -145.93 0.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 172.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG3' HG21 ' A' ' 106' ' ' THR . 0.1 OUTLIER -145.5 90.63 2.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.482 HD13 HD21 ' A' ' 24' ' ' LEU . 69.1 mt -96.07 104.82 16.78 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -171.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.743 HH12 HG23 ' B' ' 55' ' ' VAL . 1.8 mtp180 -101.98 146.52 27.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.374 0.27 . . . . 0.0 110.913 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 70' ' ' PHE . 15.3 t -127.69 127.57 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 166.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 72' ' ' VAL . 19.1 p90 -130.46 155.5 46.34 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.16 0.436 . . . . 0.0 111.275 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -109.37 121.15 44.54 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.97 108.62 10.16 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.34 0.4 . . . . 0.0 110.488 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 123.236 0.614 . . . . 0.0 109.64 176.059 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 . . . . . 0 CA--C 1.556 1.177 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.553 ' HG3' HD22 ' A' ' 25' ' ' LEU . 86.5 Cg_endo -86.06 86.18 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.49 2.127 . . . . 0.0 111.522 168.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.66 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 9.0 p-10 -102.9 10.78 38.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.538 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.454 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -132.17 131.84 42.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -169.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -128.06 143.71 51.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.009 0.924 . . . . 0.0 108.968 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 35.8 mt -125.28 139.36 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.526 HD23 HD21 ' B' ' 47' ' ' LEU . 4.0 mm? -95.32 137.38 34.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.431 ' HE2' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -76.03 97.62 4.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.212 1.405 . . . . 0.0 109.593 177.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.423 HG11 HD23 ' B' ' 49' ' ' LEU . 22.7 m -109.48 170.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.21 -60.26 1.91 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.984 0.514 . . . . 0.0 110.335 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -102.23 97.72 9.09 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.147 0.979 . . . . 0.0 110.49 -169.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.45 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.1 Cg_exo -48.88 -51.65 10.12 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.79 2.993 . . . . 0.0 115.675 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.21 -60.16 0.42 Allowed 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.099 1.786 . . . . 0.0 111.536 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.61 88.97 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.945 0.498 . . . . 0.0 112.163 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' B' ' 20' ' ' PHE . 34.1 m -59.1 -52.07 67.31 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.352 1.072 . . . . 0.0 109.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 70.7 m -80.46 -33.75 36.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -163.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.52 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 82.8 mm-40 -65.33 -38.39 90.01 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.715 172.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' B' ' 90' ' ' VAL . 41.9 t80 -59.82 -45.82 91.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.33 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 36.1 m-85 -69.89 -29.42 66.62 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.805 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 52.3 mtpt -56.11 -51.21 68.72 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.182 0.515 . . . . 0.0 111.672 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.75 -38.42 54.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.439 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 8.5 tp -58.94 -36.64 75.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.424 1.09 . . . . 0.0 112.476 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 4' ' ' PRO . 53.5 mt -96.93 -41.18 8.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.347 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.14 30.41 8.29 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.2 m -129.63 -177.98 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.411 1.084 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -139.05 155.04 72.94 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 123.338 0.655 . . . . 0.0 109.622 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 3.0 Cg_exo -71.84 117.05 4.95 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.867 2.378 . . . . 0.0 111.458 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -65.36 -39.87 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 51.6 mm-40 -114.08 128.26 56.3 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.506 0.722 . . . . 0.0 109.436 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 48.2 t -127.03 132.37 50.75 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.064 0.945 . . . . 0.0 109.245 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.0 t -137.52 148.01 59.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.805 1.242 . . . . 0.0 107.745 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.44 -15.14 39.05 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.693 2.262 . . . . 0.0 113.952 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.45 7.96 5.89 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -157.83 153.68 26.8 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 122.078 -0.389 . . . . 0.0 110.2 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 18.1 m -138.28 147.91 44.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.22 0.608 . . . . 0.0 109.541 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.3 tm? -145.98 129.66 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 3.7 p90 -134.84 148.64 50.2 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 108.721 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -120.52 127.8 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.401 HD22 HG11 ' B' ' 27' ' ' VAL . 36.8 mt -89.02 142.32 27.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.243 0.617 . . . . 0.0 109.405 -168.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.21 62.8 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.58 -10.21 59.41 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.761 0.825 . . . . 0.0 110.61 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.27 -4.35 33.34 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.215 -0.77 . . . . 0.0 114.175 170.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.631 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -96.25 172.61 7.85 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.047 0.923 . . . . 0.0 110.297 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -135.78 141.93 44.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.796 0.438 . . . . 0.0 109.951 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.526 HD21 HD23 ' B' ' 9' ' ' LEU . 3.6 tt -141.73 123.03 14.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.01 0.433 . . . . 0.0 110.589 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.437 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -106.7 167.23 13.88 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 123.927 0.775 . . . . 0.0 111.372 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 9.2 mp -134.0 108.32 8.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 166.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.493 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -105.83 130.62 53.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.45 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 42.3 m -81.06 121.27 25.86 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.597 0.561 . . . . 0.0 110.933 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -64.97 -14.83 61.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.105 1.362 . . . . 0.0 113.809 -170.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -75.94 -7.49 54.71 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.819 0.448 . . . . 0.0 111.721 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.9 t -137.14 7.17 2.88 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.378 0.671 . . . . 0.0 111.198 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.743 HG23 HH12 ' A' ' 116' ' ' ARG . 9.8 p -62.82 148.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 122.265 0.226 . . . . 0.0 110.48 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.45 ' H ' HH22 ' A' ' 116' ' ' ARG . 17.9 mt-10 -127.73 110.99 20.57 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.585 0.754 . . . . 0.0 109.357 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.478 ' HG3' HD23 ' A' ' 93' ' ' LEU . 85.8 Cg_endo -75.39 139.77 63.16 Favored 'Cis proline' 0 C--N 1.388 2.612 0 CA-C-N 119.85 0.982 . . . . 0.0 113.805 4.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -49.58 116.32 1.71 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.735 1.214 . . . . 0.0 113.179 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.29 107.2 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.691 1.196 . . . . 0.0 108.471 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -97.81 87.48 4.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.22 141.99 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.427 1.091 . . . . 0.0 108.98 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 11.1 p -151.22 133.11 15.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.709 1.203 . . . . 0.0 108.186 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.73 -66.08 0.05 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.0 62.89 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.16 130.57 7.83 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 119.442 -0.644 . . . . 0.0 111.674 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 74.06 130.02 0.18 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 27.0 mt-10 -121.93 147.2 46.33 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -120.46 106.45 11.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.718 ' HA ' ' HG2' ' B' ' 116' ' ' ARG . . . -91.3 122.25 33.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -101.95 108.31 19.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.588 1.555 . . . . 0.0 107.523 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 56.9 mtm180 -91.97 122.75 34.78 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.419 0.628 . . . . 0.0 111.968 -174.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.42 HG22 ' O ' ' B' ' 118' ' ' TYR . 22.7 m -125.11 159.27 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.708 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' B' ' 74' ' ' ASN . 9.5 pt-20 -69.39 -34.66 74.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.423 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.463 HD22 ' HG3' ' B' ' 73' ' ' GLU . 6.0 p30 -161.18 176.67 11.02 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.714 0.688 . . . . 0.0 112.412 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -59.11 -32.34 69.74 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.704 1.602 . . . . 0.0 113.063 -168.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.97 -39.34 76.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.641 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -65.75 -24.37 66.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.589 0.756 . . . . 0.0 112.45 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.615 HG13 HG13 ' B' ' 117' ' ' VAL . 97.2 t -68.34 -42.96 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.503 0.721 . . . . 0.0 109.829 172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.15 -33.05 71.3 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.788 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 29.5 mt-10 -65.77 -45.9 80.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.419 0.628 . . . . 0.0 109.987 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 92.7 m -67.3 -29.81 69.5 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.996 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -59.89 -61.21 2.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.67 0.788 . . . . 0.0 110.093 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.91 76.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.42 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.33 90.18 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.122 0.888 . . . . 0.0 113.088 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . 0.478 ' HB3' HG21 ' B' ' 90' ' ' VAL . 44.9 m0 -62.55 -46.86 86.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.347 0.659 . . . . 0.0 110.038 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.89 -42.81 76.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.367 0.667 . . . . 0.0 111.065 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.73 -27.7 63.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.873 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -91.04 9.26 31.55 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 112.233 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.98 46.88 4.64 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.09 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.485 HG11 ' HB1' ' B' ' 107' ' ' ALA . 48.7 t -101.97 147.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.06 77.48 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.048 0.539 . . . . 0.0 111.449 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.34 82.53 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.705 0.802 . . . . 0.0 112.799 166.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 85.17 2.18 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 178.07 138.17 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.401 1.081 . . . . 0.0 109.301 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -90.21 119.88 69.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.18 111.51 0.73 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.719 2.279 . . . . 0.0 110.699 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.83 146.77 49.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.338 0.655 . . . . 0.0 111.279 -170.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 104.87 4.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.838 0.855 . . . . 0.0 109.812 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 51.9 ttm -101.93 170.14 8.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.07 0.948 . . . . 0.0 109.66 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -48.74 -34.47 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.257 1.423 . . . . 0.0 113.216 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -101.96 -5.4 24.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.773 0.829 . . . . 0.0 111.67 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.6 -178.6 20.93 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.311 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 52.1 t80 -80.99 102.59 10.26 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -122.61 158.05 30.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.664 0.745 . . . . 0.0 111.505 -167.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -153.2 152.73 31.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.365 1.466 . . . . 0.0 108.075 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.635 HG21 ' HG3' ' B' ' 114' ' ' ARG . 29.0 m -145.82 127.74 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.685 0.394 . . . . 0.0 110.21 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.485 ' HB1' HG11 ' B' ' 90' ' ' VAL . . . -107.56 171.22 7.51 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.06 0.544 . . . . 0.0 110.78 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.77 116.92 22.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.412 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.3 p30 -70.95 169.41 14.87 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.691 1.197 . . . . 0.0 111.242 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 10.9 Cg_endo -52.16 -35.63 63.52 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.431 2.754 . . . . 0.0 113.901 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.42 1.26 53.92 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.253 0.621 . . . . 0.0 111.461 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 62.69 57.99 1.69 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.63 1.172 . . . . 0.0 112.624 166.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -92.68 -146.23 0.22 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.635 ' HG3' HG21 ' B' ' 106' ' ' THR . 0.1 OUTLIER -144.72 89.63 2.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 85.8 mt -95.49 104.23 16.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -171.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.718 ' HG2' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -99.74 147.77 25.09 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.827 0.285 . . . . 0.0 111.696 -176.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.615 HG13 HG13 ' B' ' 78' ' ' VAL . 7.5 p -128.97 128.47 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 164.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.42 ' O ' HG22 ' B' ' 72' ' ' VAL . 14.3 p90 -130.13 155.56 45.99 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 122.199 -0.313 . . . . 0.0 111.062 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -109.62 120.92 43.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -76.27 107.0 8.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.364 0.415 . . . . 0.0 110.05 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.31 104.0 10.56 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.854 -0.97 . . . . 0.0 110.919 -177.454 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.0 m80 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 119.624 -0.227 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD3' HD22 ' B' ' 25' ' ' LEU . 69.4 Cg_endo -87.73 87.49 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.697 2.264 . . . . 0.0 111.364 170.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.809 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.7 p-10 -83.61 1.53 41.82 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.419 0.628 . . . . 0.0 110.815 172.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.06 120.5 31.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -172.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -111.96 137.66 49.66 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 46.3 mt -113.19 128.1 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 47' ' ' LEU . 4.2 mm? -93.93 145.13 24.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.636 ' HE1' HG21 ' A' ' 55' ' ' VAL . 38.4 t80 -102.57 105.14 15.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.192 -170.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.79 157.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.534 0.734 . . . . 0.0 109.199 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.408 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 12.6 p-10 -104.76 -43.01 5.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.528 0.731 . . . . 0.0 110.84 -177.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -94.53 105.62 19.28 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.256 0.623 . . . . 0.0 109.909 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.27 -59.46 0.89 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 C-N-CA 122.153 1.902 . . . . 0.0 113.461 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 40.6 Cg_endo -64.38 -56.5 0.43 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 122.433 1.905 . . . . 0.0 111.494 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.22 83.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.735 0.814 . . . . 0.0 112.206 -168.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -72.53 -39.69 67.35 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -65.69 -39.49 91.34 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.53 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 77.8 mm-40 -67.6 -34.53 77.19 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.372 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -64.69 -46.13 83.68 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.524 0.515 . . . . 0.0 109.911 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -65.62 -32.07 73.44 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.07 -51.07 69.16 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.284 0.564 . . . . 0.0 112.322 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.12 -39.91 65.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.152 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 tp -58.2 -47.02 84.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.145 1.378 . . . . 0.0 113.183 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.5 mt -86.44 -43.73 12.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.06 26.05 8.07 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 -174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.1 m -127.73 167.4 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.06 0.944 . . . . 0.0 110.243 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.01 151.28 46.36 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.783 0.833 . . . . 0.0 109.34 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 14.8 Cg_exo -67.88 117.05 4.62 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.545 2.163 . . . . 0.0 111.814 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG11 HG23 ' A' ' 40' ' ' VAL . 7.5 p -63.22 -38.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.751 . . . . 0.0 109.962 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 30.5 mm-40 -123.47 129.86 51.86 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.01 1.324 . . . . 0.0 107.775 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.6 p -136.26 135.36 38.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.308 0.575 . . . . 0.0 109.896 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.3 m -141.65 153.58 65.23 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.922 1.289 . . . . 0.0 108.512 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -56.92 -22.48 46.33 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.066 2.511 . . . . 0.0 113.726 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 t -128.12 10.49 6.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -158.83 137.46 10.98 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -123.71 153.96 40.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.389 0.676 . . . . 0.0 109.727 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.654 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 21.3 tp -147.43 125.66 12.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -132.79 142.25 48.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 108.367 168.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -119.38 131.48 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.0 mt -94.41 149.85 20.84 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -10.45 29.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.19 0.996 . . . . 0.0 112.029 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -65.12 -20.44 66.46 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.852 1.261 . . . . 0.0 112.237 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 -7.27 47.18 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.828 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -90.35 173.12 8.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.56 0.744 . . . . 0.0 110.38 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.8 tttt -141.8 139.53 32.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 9' ' ' LEU . 2.2 tt -138.09 120.13 15.54 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.494 0.318 . . . . 0.0 110.6 -169.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.19 165.73 17.26 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.625 0.631 . . . . 0.0 111.693 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.89 111.92 10.86 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -104.74 125.17 50.55 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.7 m -77.71 128.78 34.61 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.641 0.588 . . . . 0.0 109.874 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 13.6 ptm180 -66.88 -10.66 50.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -82.56 -12.64 57.59 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 118.047 0.385 . . . . 0.0 111.137 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 0.6 8.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.122 0.569 . . . . 0.0 111.123 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' HE1' ' A' ' 10' ' ' TYR . 10.7 p -61.13 140.13 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.189 0.519 . . . . 0.0 112.279 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.73 116.38 26.41 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.522 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 6.8 Cg_exo -72.38 144.04 79.24 Favored 'Cis proline' 0 C--N 1.383 2.384 0 C-N-CA 124.683 -0.966 . . . . 0.0 112.794 -3.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' HA ' HG13 ' A' ' 55' ' ' VAL . 13.7 mmmm -50.2 130.16 22.32 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.764 0.825 . . . . 0.0 111.833 173.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.99 136.33 23.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.751 0.821 . . . . 0.0 109.958 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 p -108.5 88.35 2.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.521 0.729 . . . . 0.0 109.485 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -161.37 144.04 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.773 0.829 . . . . 0.0 110.22 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 p -141.47 138.62 32.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.381 1.072 . . . . 0.0 108.356 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.71 20.07 79.65 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 22.23 30.42 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.79 -162.07 23.79 Favored Glycine 0 N--CA 1.473 1.154 0 CA-C-N 117.083 0.442 . . . . 0.0 112.308 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.58 95.9 0.05 OUTLIER Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HB3' ' HG3' ' A' ' 116' ' ' ARG . 1.9 mp0 -103.7 158.53 16.32 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 112.049 -170.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 68' ' ' LEU . 25.8 mt -118.89 102.4 8.76 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.498 173.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.95 106.31 17.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HB2' HG22 ' A' ' 117' ' ' VAL . 7.8 m-85 -83.95 112.21 19.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -90.18 127.43 36.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.421 0.629 . . . . 0.0 112.243 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.65 158.29 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.23 -38.05 89.65 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -160.43 177.37 10.64 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.512 0.596 . . . . 0.0 112.155 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.25 -28.62 69.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.944 1.298 . . . . 0.0 112.771 -165.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.78 -46.95 76.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.978 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -64.86 -22.43 66.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 0.0 112.651 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.26 -42.41 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.313 0.645 . . . . 0.0 109.668 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.03 -27.59 54.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.681 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 40.6 mt-10 -69.26 -43.85 73.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.668 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -65.74 -36.14 82.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.28 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' O ' ' HE1' ' A' ' 92' ' ' MET . 35.6 t80 -59.33 -57.18 14.15 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.794 0.807 . . . . 0.0 109.356 176.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.87 83.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.209 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.69 90.76 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.64 0.587 . . . . 0.0 114.361 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -67.44 -41.85 84.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.062 0.545 . . . . 0.0 110.155 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -58.8 -40.14 83.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.983 0.913 . . . . 0.0 110.297 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.77 66.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.461 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m -104.96 15.14 28.26 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.889 0.876 . . . . 0.0 113.205 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.45 30.32 19.36 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 163.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.09 127.45 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.251 0.62 . . . . 0.0 109.543 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 92' ' ' MET . . . -57.14 -51.0 71.07 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.684 0.794 . . . . 0.0 111.393 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.476 ' HE1' ' O ' ' A' ' 82' ' ' PHE . 6.7 ptm 52.15 80.95 0.09 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.291 1.436 . . . . 0.0 113.381 169.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.439 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.78 82.45 2.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -174.86 138.18 0.46 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.346 1.058 . . . . 0.0 109.066 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -80.49 122.4 82.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.54 112.35 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.575 2.183 . . . . 0.0 110.209 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.39 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.454 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HG2' ' HD1' ' A' ' 103' ' ' TYR . 19.3 mmtm -71.06 118.02 13.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.397 1.079 . . . . 0.0 111.506 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.5 tpp -110.09 176.62 4.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.507 1.523 . . . . 0.0 108.996 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -48.21 -41.01 26.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.75 1.22 . . . . 0.0 113.133 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -106.88 19.83 19.91 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.566 0.746 . . . . 0.0 111.603 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -167.83 12.42 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.986 0.354 . . . . 0.0 113.986 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.41 ' HD1' ' HG2' ' A' ' 98' ' ' LYS . 13.0 t80 -78.53 110.01 13.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.437 0.695 . . . . 0.0 109.707 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -138.77 168.69 19.25 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -168.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.42 169.35 24.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.028 0.931 . . . . 0.0 109.311 169.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.613 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 13.6 m -137.47 124.92 22.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.65 158.33 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.378 1.071 . . . . 0.0 110.78 -174.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.02 111.08 17.03 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.4 167.87 28.76 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.605 0.762 . . . . 0.0 110.258 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -43.02 -38.82 7.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.693 2.929 . . . . 0.0 115.652 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -89.14 2.02 54.77 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.833 0.453 . . . . 0.0 111.771 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.2 m 63.43 81.48 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.675 1.19 . . . . 0.0 111.354 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -131.53 165.37 23.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -97.0 106.46 18.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.08 102.71 11.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.232 0.613 . . . . 0.0 109.683 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.726 ' HD2' HD12 ' B' ' 8' ' ' ILE . 72.1 mtt-85 -89.66 148.55 23.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.693 0.397 . . . . 0.0 110.383 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 70' ' ' PHE . 40.5 t -137.38 127.96 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 166.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -130.75 167.58 18.61 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.27 0.941 . . . . 0.0 112.885 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.7 115.8 12.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.586 1.154 . . . . 0.0 108.08 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -79.77 117.39 20.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.672 0 C-N-CA 123.638 0.775 . . . . 0.0 109.417 177.074 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.35 87.57 0.66 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.53 2.153 . . . . 0.0 111.467 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.828 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 10.4 p-10 -83.43 1.67 40.4 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.014 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.42 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 0.9 OUTLIER -125.35 119.34 28.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -171.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -111.25 137.69 48.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.726 HD12 ' HD2' ' A' ' 116' ' ' ARG . 22.1 mt -113.84 127.66 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.14 145.26 24.54 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -102.63 105.84 16.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.622 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.13 157.35 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.696 0.798 . . . . 0.0 109.114 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -105.33 -42.8 5.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.511 0.724 . . . . 0.0 111.028 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.91 106.51 22.32 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.102 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 38.6 Cg_exo -55.03 -59.09 0.89 Allowed 'Trans proline' 0 CA--C 1.572 2.406 0 C-N-CA 122.049 1.833 . . . . 0.0 113.429 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 22.6 Cg_exo -64.78 -56.93 0.34 Allowed 'Trans proline' 0 C--N 1.4 3.259 0 CA-C-N 122.465 1.916 . . . . 0.0 111.316 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -44.8 81.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.598 0.759 . . . . 0.0 112.551 -168.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -70.79 -40.87 72.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 77.7 m -65.61 -39.36 91.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.542 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 79.7 mm-40 -67.85 -34.17 76.18 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.516 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.98 -45.96 83.46 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.206 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -65.77 -31.86 73.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.542 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.7 mtpt -56.03 -50.91 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.312 0.577 . . . . 0.0 112.266 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.24 -39.91 65.1 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.303 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -58.33 -46.83 85.46 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.174 1.39 . . . . 0.0 113.055 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.514 ' HB2' HG22 ' B' ' 27' ' ' VAL . 13.7 mt -87.1 -42.98 12.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.36 25.86 8.56 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.993 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 25' ' ' LEU . 33.4 m -127.26 167.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.934 0.894 . . . . 0.0 110.303 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.15 150.75 45.74 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.794 0.837 . . . . 0.0 109.483 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 42.2 Cg_endo -67.14 117.18 4.61 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.355 2.036 . . . . 0.0 112.218 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.515 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.1 p -63.68 -38.46 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.392 0.677 . . . . 0.0 109.97 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 34.6 mm-40 -122.69 129.94 52.38 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.925 1.29 . . . . 0.0 107.522 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -136.23 136.04 39.56 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.03 0.532 . . . . 0.0 110.066 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 55.6 m -142.49 151.64 58.16 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.921 1.288 . . . . 0.0 108.578 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.91 -23.62 28.38 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.19 2.593 . . . . 0.0 114.733 -176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -128.12 10.82 6.42 Favored 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -158.56 137.91 11.65 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -124.32 153.47 41.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.326 0.65 . . . . 0.0 110.035 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 35.8 tp -146.75 126.22 13.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 0.9 OUTLIER -132.93 142.31 48.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.569 1.148 . . . . 0.0 108.421 168.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.606 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.3 t -119.49 130.93 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.76 149.61 21.09 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -10.43 25.7 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.461 1.104 . . . . 0.0 112.071 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -65.36 -20.42 66.38 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.719 1.208 . . . . 0.0 112.244 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.31 -7.14 46.91 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -90.29 173.23 8.25 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.468 0.707 . . . . 0.0 110.491 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.606 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -141.7 139.62 32.98 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.34 120.15 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.42 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.02 165.53 17.4 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 123.78 0.705 . . . . 0.0 111.549 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.6 mt -134.25 111.66 10.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.549 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.0 t90 -104.71 125.36 50.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -77.86 128.76 34.47 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 123.581 0.551 . . . . 0.0 110.044 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -67.35 -10.65 53.09 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -81.93 -13.46 57.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.042 0.383 . . . . 0.0 111.388 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -124.13 1.77 8.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.182 0.593 . . . . 0.0 111.271 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' B' ' 58' ' ' LYS . 14.1 p -62.29 138.83 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.032 0.444 . . . . 0.0 111.757 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -122.1 116.83 29.77 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -73.6 145.21 83.4 Favored 'Cis proline' 0 C--N 1.384 2.442 0 C-N-CA 124.564 -1.015 . . . . 0.0 111.966 -2.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.555 ' HA ' HG13 ' B' ' 55' ' ' VAL . 12.4 mmmm -51.24 130.73 27.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.668 0.787 . . . . 0.0 111.628 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.17 23.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.925 0.89 . . . . 0.0 109.642 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.2 p -108.59 88.53 2.75 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.634 0.774 . . . . 0.0 109.175 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -161.86 143.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.785 0.834 . . . . 0.0 110.193 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -141.43 138.85 33.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.62 1.168 . . . . 0.0 108.425 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.79 79.76 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.13 21.74 32.84 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 114.419 0.528 . . . . 0.0 114.419 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.63 -160.27 23.72 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 117.053 0.427 . . . . 0.0 112.683 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.99 96.54 0.03 OUTLIER Glycine 0 C--N 1.351 1.41 0 C-N-CA 122.995 0.331 . . . . 0.0 112.557 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.3 mt-10 -103.36 159.84 15.21 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.114 0.483 . . . . 0.0 112.155 -170.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.56 102.24 8.5 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.444 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -86.21 107.3 17.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.011 0.434 . . . . 0.0 110.056 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.524 ' HB2' HG22 ' B' ' 117' ' ' VAL . 7.8 m-85 -85.97 111.93 20.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.417 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 32.3 mtm180 -90.18 126.33 35.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.29 0.567 . . . . 0.0 112.014 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 23.4 m -127.23 158.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.337 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.9 pt-20 -64.32 -37.74 88.58 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -160.76 178.2 9.69 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.777 0.717 . . . . 0.0 112.078 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.43 -28.93 69.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.162 1.385 . . . . 0.0 112.475 -164.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.75 -46.54 78.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.487 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 69.6 mm-40 -65.57 -22.45 66.69 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.264 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -66.35 -42.58 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.397 0.679 . . . . 0.0 109.626 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.87 -27.96 55.22 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.451 1.1 . . . . 0.0 110.401 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 43.5 mt-10 -68.41 -44.69 74.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.076 0.55 . . . . 0.0 109.867 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -65.27 -35.96 82.62 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.413 175.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -59.23 -56.96 15.41 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.75 0.786 . . . . 0.0 109.4 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.14 83.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.33 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.75 90.75 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.44 0.463 . . . . 0.0 113.97 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -67.15 -42.49 84.29 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.061 0.545 . . . . 0.0 109.992 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -58.01 -40.77 81.61 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.944 . . . . 0.0 110.14 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.2 67.24 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.411 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -104.35 15.11 28.92 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.05 0.94 . . . . 0.0 113.421 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.58 19.31 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 163.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.6 127.32 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.253 0.621 . . . . 0.0 109.386 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.7 -53.07 61.94 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.652 0.781 . . . . 0.0 111.268 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 22.9 ttp 54.19 81.04 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.793 1.237 . . . . 0.0 112.868 169.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 83.38 2.18 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -176.43 134.74 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.226 1.01 . . . . 0.0 108.366 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -79.16 123.7 84.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 112.26 2.07 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.527 2.151 . . . . 0.0 109.709 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.16 163.36 33.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.341 0.591 . . . . 0.0 111.59 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -71.22 118.59 14.21 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.299 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 37.0 ttm -112.02 179.42 4.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.561 1.145 . . . . 0.0 108.966 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.19 -41.61 49.8 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.697 1.199 . . . . 0.0 112.019 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -106.54 20.0 19.66 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.559 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.11 -167.68 12.38 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -78.7 110.19 13.62 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.533 0.733 . . . . 0.0 109.777 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' B' ' 116' ' ' ARG . 13.7 t -139.95 169.44 17.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -168.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -157.63 169.14 25.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.107 0.963 . . . . 0.0 109.232 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 20.6 m -136.62 125.19 23.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.57 158.21 16.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.42 1.088 . . . . 0.0 110.882 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.1 111.36 17.34 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.69 167.36 34.09 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.907 0.883 . . . . 0.0 110.402 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -42.16 -39.19 5.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 124.039 3.159 . . . . 0.0 115.346 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -89.38 2.36 54.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m 62.98 80.82 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.681 1.192 . . . . 0.0 111.589 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -130.49 165.66 22.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -95.66 106.13 18.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -108.41 102.62 11.71 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.45 ' HD2' ' OG1' ' B' ' 104' ' ' THR . 0.8 OUTLIER -87.11 147.98 25.42 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.356 0.663 . . . . 0.0 109.922 -178.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' B' ' 70' ' ' PHE . 42.3 t -137.44 128.36 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 164.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -130.71 167.05 19.45 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.368 0.986 . . . . 0.0 113.102 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.1 116.13 13.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.19 122.56 26.99 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.91 99.78 1.83 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 0.0 109.86 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.17 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.111 -175.394 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.455 ' HB3' HD21 ' B' ' 43' ' ' ASN . 23.0 m80 . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 119.861 -0.114 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -97.36 96.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.869 2.379 . . . . 0.0 112.48 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.693 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.1 p-10 -93.72 13.6 21.76 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.295 0.569 . . . . 0.0 110.534 169.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.98 115.69 19.62 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.87 146.56 34.89 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.269 1.027 . . . . 0.0 108.691 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.5 HD12 ' HD2' ' B' ' 116' ' ' ARG . 55.9 mt -122.5 137.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.039 0.935 . . . . 0.0 109.037 176.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 68' ' ' LEU . 4.3 mm? -91.42 123.23 34.69 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 168.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.583 ' HE1' HG21 ' A' ' 55' ' ' VAL . 57.6 t80 -78.96 106.83 11.27 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.687 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.416 HG11 HD22 ' A' ' 49' ' ' LEU . 15.6 m -120.71 175.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.248 1.019 . . . . 0.0 109.908 -171.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.55 -61.46 1.49 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.59 0.756 . . . . 0.0 109.811 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.52 110.61 35.58 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 123.787 0.835 . . . . 0.0 110.093 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -58.8 -64.36 0.11 Allowed 'Trans proline' 0 CA--C 1.568 2.178 0 C-N-CA 122.323 2.015 . . . . 0.0 113.614 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.08 -38.75 35.14 Favored 'Trans proline' 0 C--N 1.402 3.343 0 CA-C-N 122.533 1.94 . . . . 0.0 111.204 -170.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.47 93.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.312 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -70.85 -35.34 72.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.3 m -58.41 -53.24 60.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.574 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 24.5 mm-40 -68.56 -37.07 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.258 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.1 t80 -59.46 -44.06 93.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.772 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.511 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 5.4 m-85 -72.99 -28.45 62.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.468 0.707 . . . . 0.0 110.73 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.3 -50.79 70.41 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.936 0.789 . . . . 0.0 112.037 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.23 -34.38 49.3 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.142 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.9 tp -61.42 -53.58 54.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.661 1.184 . . . . 0.0 111.988 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HB2' HG22 ' A' ' 27' ' ' VAL . 11.1 mt -76.62 -51.82 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.68 5.82 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.257 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 25' ' ' LEU . 21.0 m -131.35 176.21 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.359 1.063 . . . . 0.0 110.075 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.27 156.11 46.04 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.77 112.53 3.56 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 121.534 1.489 . . . . 0.0 110.554 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -37.45 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.892 0.477 . . . . 0.0 110.157 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 11.9 mm-40 -111.82 134.47 53.36 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 p -143.35 132.36 22.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 110.709 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -143.42 155.81 60.74 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.285 1.434 . . . . 0.0 108.263 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.3 -10.2 20.37 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.865 2.377 . . . . 0.0 114.123 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 t -126.56 -0.75 6.83 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -157.67 142.43 16.56 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -131.51 146.54 52.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.25 0.62 . . . . 0.0 110.106 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.0 tm? -133.68 120.27 20.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -108.11 140.52 41.18 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.686 1.595 . . . . 0.0 107.051 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 46' ' ' LYS . 26.4 t -124.21 126.8 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD13 ' SD ' ' A' ' 45' ' ' MET . 8.6 mp -99.79 148.72 24.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.169 0.587 . . . . 0.0 109.731 -172.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.96 -5.92 29.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.039 0.936 . . . . 0.0 111.928 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -21.67 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.121 0.968 . . . . 0.0 112.168 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.64 17.56 16.73 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -124.06 175.09 7.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.817 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 40' ' ' VAL . 78.3 tttt -145.91 140.62 27.1 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 68' ' ' LEU . 2.7 tt -138.32 120.66 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.203 0.601 . . . . 0.0 110.287 -169.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.85 166.55 15.76 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.667 0.651 . . . . 0.0 112.055 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 9' ' ' LEU . 95.3 mt -134.87 104.92 6.18 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.524 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.6 t90 -109.62 119.3 38.97 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 p -81.01 140.92 34.88 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.343 0.402 . . . . 0.0 111.159 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 29.3 ptt180 -69.68 -18.65 63.57 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -78.99 -8.58 59.05 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -127.84 7.68 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.874 0.47 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.583 HG21 ' HE1' ' A' ' 10' ' ' TYR . 9.9 p -75.8 150.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.61 0.243 . . . . 0.0 110.91 -175.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -126.37 115.58 23.33 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.77 0.828 . . . . 0.0 108.861 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 89.1 Cg_endo -77.01 141.01 68.02 Favored 'Cis proline' 0 C--N 1.386 2.511 0 C-N-CA 124.584 -1.007 . . . . 0.0 112.389 5.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 123.84 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.729 0.811 . . . . 0.0 110.29 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.38 170.74 17.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.541 1.137 . . . . 0.0 108.545 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.514 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 32.5 t -147.19 90.65 1.9 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.413 0.285 . . . . 0.0 110.237 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.08 144.15 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 109.685 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -146.62 124.14 11.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.45 -69.25 0.17 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.27 149.26 20.9 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.34 -22.64 0.2 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.681 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . -164.01 116.12 0.69 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.87 144.65 30.25 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -108.93 101.62 10.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -169.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -90.23 111.71 22.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.732 0.696 . . . . 0.0 111.52 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -91.18 111.97 23.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.117 1.367 . . . . 0.0 107.399 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.542 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 36.8 mtm180 -89.98 129.4 36.31 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.503 0.668 . . . . 0.0 112.336 -174.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.69 159.09 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.016 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.6 pt-20 -66.69 -34.91 78.91 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.43 HD22 ' HG3' ' A' ' 73' ' ' GLU . 8.3 p30 -163.27 178.29 8.3 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 118.757 0.708 . . . . 0.0 112.345 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.56 -31.27 67.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.408 1.483 . . . . 0.0 112.771 -168.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.97 -46.55 77.67 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.232 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.516 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 71.7 mm-40 -63.69 -22.71 67.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.181 0.993 . . . . 0.0 112.98 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.75 -42.04 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.212 0.605 . . . . 0.0 109.802 171.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -75.81 -29.06 58.56 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.164 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 36.5 mt-10 -71.81 -44.7 63.49 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.276 0.56 . . . . 0.0 109.641 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -65.38 -33.4 75.87 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.437 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -56.33 -59.4 5.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.701 0.8 . . . . 0.0 109.621 174.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.71 -38.26 89.73 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.714 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 -41.83 97.11 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.653 0.596 . . . . 0.0 113.632 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -64.41 -42.55 96.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.324 0.649 . . . . 0.0 110.305 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 31.8 ttpt -59.15 -42.97 91.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.017 0.927 . . . . 0.0 110.539 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.38 65.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.318 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.9 t -98.36 14.27 28.61 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.427 1.091 . . . . 0.0 112.944 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.09 29.06 35.13 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 165.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.7 t -86.47 130.61 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -62.85 -42.11 99.62 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.954 0.902 . . . . 0.0 112.325 -172.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 7.5 ptm 49.54 81.48 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.889 1.676 . . . . 0.0 114.301 166.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.01 83.04 1.76 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.476 0.655 . . . . 0.0 110.084 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 23.8 tm0? 178.07 120.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.434 1.493 . . . . 0.0 107.113 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.4 117.02 62.69 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.53 110.73 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 123.887 3.058 . . . . 0.0 113.329 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.58 146.04 44.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.226 1.01 . . . . 0.0 110.371 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 98.64 4.09 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 tpp -78.26 163.98 25.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.836 0.854 . . . . 0.0 109.49 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.23 -28.26 69.03 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.107 0.563 . . . . 0.0 111.795 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -99.67 15.41 26.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.972 0.909 . . . . 0.0 111.466 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.03 180.0 16.76 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.539 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -73.77 103.0 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -109.84 158.11 18.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.396 0.617 . . . . 0.0 111.401 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.407 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 3.3 t80 -143.93 142.09 30.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.21 1.404 . . . . 0.0 108.795 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.426 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 31.1 m -132.69 121.93 23.85 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.522 1.056 . . . . 0.0 110.76 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.69 150.48 26.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.103 0.961 . . . . 0.0 112.228 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -117.95 172.53 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.3 p-10 -144.34 -176.94 0.59 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 5.2 Cg_exo -38.14 -51.67 1.97 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.621 2.881 . . . . 0.0 114.016 168.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.08 -15.0 59.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.006 0.522 . . . . 0.0 111.684 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.02 52.24 0.2 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.65 1.18 . . . . 0.0 111.156 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -80.3 175.11 10.94 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.255 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -122.84 105.64 10.2 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -118.18 103.69 10.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.143 0.977 . . . . 0.0 109.206 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.543 HH11 HD11 ' B' ' 8' ' ' ILE . 77.9 ttt180 -88.17 146.14 25.55 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 123.266 0.626 . . . . 0.0 110.188 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.9 t -131.94 119.22 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 163.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.542 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 4.3 p90 -125.71 164.91 19.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.563 0.62 . . . . 0.0 111.223 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.83 111.65 13.31 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -75.04 117.2 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.438 0.563 . . . . 0.0 109.75 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 121.11 0.481 . . . . 0.0 109.708 -179.022 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 CA--C 1.547 0.854 0 CA-C-O 119.745 -0.169 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.514 ' HB2' HD22 ' A' ' 68' ' ' LEU . 46.5 Cg_endo -97.55 96.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.985 2.456 . . . . 0.0 112.432 170.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.691 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.8 p-10 -93.55 13.82 20.74 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.351 0.596 . . . . 0.0 110.692 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.15 115.59 19.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.74 146.71 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.283 1.033 . . . . 0.0 108.775 171.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.543 HD11 HH11 ' A' ' 116' ' ' ARG . 50.5 mt -122.57 137.47 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.002 0.921 . . . . 0.0 108.903 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.462 ' HG ' ' OH ' ' B' ' 21' ' ' TYR . 4.5 mm? -90.95 122.8 33.93 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.528 ' HE1' HG21 ' B' ' 55' ' ' VAL . 59.6 t80 -78.23 107.33 10.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.913 173.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.1 175.72 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.247 1.019 . . . . 0.0 109.788 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -105.9 -61.15 1.54 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.49 0.716 . . . . 0.0 110.233 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -87.15 110.82 36.4 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.896 0.878 . . . . 0.0 109.969 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.49 -65.67 0.08 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 122.369 2.046 . . . . 0.0 113.155 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.39 -38.94 49.79 Favored 'Trans proline' 0 C--N 1.403 3.441 0 CA-C-N 122.471 1.918 . . . . 0.0 111.81 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.17 -41.71 94.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -70.25 -35.39 73.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 33.3 m -58.12 -53.91 52.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.83 -37.37 81.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.126 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 73.7 t80 -59.71 -44.05 93.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.94 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 6.2 m-85 -72.98 -28.06 62.17 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.817 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' B' ' 18' ' ' THR . 58.4 mtpt -56.68 -50.64 71.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.95 0.795 . . . . 0.0 111.92 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.04 -34.6 50.4 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.971 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 21.8 tp -61.55 -53.41 56.64 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.558 1.143 . . . . 0.0 112.186 -174.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' B' ' 27' ' ' VAL . 12.3 mt -76.73 -51.13 12.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.64 25.06 6.13 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.232 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' B' ' 25' ' ' LEU . 28.5 m -130.8 176.19 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.302 1.041 . . . . 0.0 110.073 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -115.37 155.93 46.42 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.633 0.773 . . . . 0.0 109.13 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.69 112.65 3.58 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.604 1.536 . . . . 0.0 110.536 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.33 -37.46 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.838 0.455 . . . . 0.0 110.245 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.3 mm-40 -111.69 134.62 53.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 45.5 p -143.47 132.48 22.91 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 110.542 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -143.72 156.31 59.52 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.509 1.524 . . . . 0.0 108.133 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.06 -9.63 22.43 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.542 2.161 . . . . 0.0 113.57 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -126.7 -0.75 6.74 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -157.9 142.4 16.24 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 31.1 m -131.46 146.63 52.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.311 0.644 . . . . 0.0 110.056 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -134.12 119.91 19.47 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.77 140.75 40.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.652 1.581 . . . . 0.0 106.921 173.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.57 HG22 ' HG3' ' B' ' 46' ' ' LYS . 28.1 t -124.39 126.56 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.491 HD13 ' SD ' ' B' ' 45' ' ' MET . 9.6 mp -99.73 149.17 23.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.105 0.562 . . . . 0.0 109.887 -172.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.91 -6.3 31.97 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.957 0.903 . . . . 0.0 112.064 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.455 HD21 ' HB3' ' A' ' 3' ' ' HIS . 2.1 m-20 -68.23 -21.64 64.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.118 0.967 . . . . 0.0 112.025 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.31 17.77 16.8 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.126 -0.389 . . . . 0.0 112.126 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.693 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -123.78 174.8 7.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.692 0.797 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.57 ' HG3' HG22 ' B' ' 40' ' ' VAL . 79.4 tttt -145.47 140.48 27.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.91 121.17 16.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 -169.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.99 166.35 15.56 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.744 0.688 . . . . 0.0 112.001 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' B' ' 9' ' ' LEU . 93.3 mt -134.59 105.02 6.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 166.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -109.86 118.98 37.91 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 74.2 p -80.78 140.91 35.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.467 0.307 . . . . 0.0 110.947 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 36.2 ptt180 -70.06 -18.56 63.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -170.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -79.09 -8.58 59.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -127.78 7.22 6.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.853 0.461 . . . . 0.0 111.107 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.528 HG21 ' HE1' ' B' ' 10' ' ' TYR . 8.0 p -75.6 150.08 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.271 -0.268 . . . . 0.0 110.897 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.65 116.71 24.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.634 0.774 . . . . 0.0 109.521 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 87.1 Cg_endo -76.51 140.47 65.68 Favored 'Cis proline' 0 C--N 1.388 2.647 0 C-N-CA 124.593 -1.003 . . . . 0.0 112.407 4.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 123.29 14.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.676 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.74 170.96 17.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.716 1.206 . . . . 0.0 108.515 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 33.9 t -147.3 90.97 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.853 0.359 . . . . 0.0 110.42 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.52 143.4 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.717 0.807 . . . . 0.0 109.692 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.6 p -145.56 124.3 12.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.221 1.008 . . . . 0.0 108.716 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.67 -68.85 0.17 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.719 ' HA2' ' HD2' ' B' ' 114' ' ' ARG . . . -151.55 148.16 18.88 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.77 -23.39 0.2 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.681 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . -163.71 116.65 0.72 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -101.95 144.64 30.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 108.806 -171.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 tp -109.39 101.23 10.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.81 111.76 22.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.192 0.451 . . . . 0.0 111.462 -169.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.1 112.21 24.02 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.068 1.347 . . . . 0.0 107.446 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.439 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.8 mtm180 -90.16 127.84 36.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -174.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.5 160.1 40.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.283 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.463 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.4 pt-20 -67.54 -34.55 77.31 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -173.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.459 HD22 ' HG3' ' B' ' 73' ' ' GLU . 8.0 p30 -163.3 178.55 8.05 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.962 0.801 . . . . 0.0 112.562 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.85 -30.74 67.94 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.284 1.433 . . . . 0.0 112.567 -167.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.5 -46.5 76.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.076 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.463 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 60.9 mm-40 -63.6 -23.12 67.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.312 1.045 . . . . 0.0 112.465 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -42.25 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 121.325 0.583 . . . . 0.0 109.903 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.27 -29.1 60.06 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.296 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 28.8 mt-10 -71.97 -44.94 62.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.166 0.508 . . . . 0.0 109.853 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 57.4 m -64.79 -33.64 76.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.269 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -56.18 -59.86 4.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.719 0.807 . . . . 0.0 109.385 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.51 89.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.559 -173.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.75 96.71 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.652 0.595 . . . . 0.0 113.456 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -64.66 -42.05 95.67 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.261 0.625 . . . . 0.0 110.061 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -60.22 -42.41 95.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.511 0.724 . . . . 0.0 110.664 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.27 66.29 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.578 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 26.8 t -98.67 14.25 29.22 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.375 1.07 . . . . 0.0 112.545 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.25 29.25 34.12 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -86.56 130.51 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -62.68 -41.89 99.34 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.799 0.84 . . . . 0.0 112.597 -172.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 8.2 ptm 49.31 81.5 0.05 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.823 1.649 . . . . 0.0 114.316 166.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.417 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -113.36 83.03 1.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.611 -0.68 . . . . 0.0 110.37 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 24.6 tm0? 178.14 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -77.95 116.46 58.71 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.473 -0.775 . . . . 0.0 108.925 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.94 111.05 0.19 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.994 3.129 . . . . 0.0 113.216 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.12 145.98 45.51 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 110.534 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 98.61 3.84 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.455 ' HG3' ' H ' ' B' ' 101' ' ' PHE . 35.5 tpp -78.35 163.36 25.75 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.0 0.92 . . . . 0.0 109.495 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.48 -28.87 68.68 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.149 0.579 . . . . 0.0 111.777 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.455 ' H ' ' HG3' ' B' ' 99' ' ' MET . 71.3 m-85 -99.37 15.04 27.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.944 0.898 . . . . 0.0 111.38 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' B' ' 99' ' ' MET . . . 119.5 179.9 16.63 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.512 167.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -73.4 102.92 3.89 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -172.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 6.2 t -109.81 158.3 18.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.432 0.634 . . . . 0.0 111.511 -169.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.454 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 3.6 t80 -143.99 142.24 30.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.396 1.478 . . . . 0.0 108.579 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.44 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 m -133.06 121.89 23.34 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.372 0.987 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.16 150.29 27.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.113 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.91 171.33 8.14 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 165.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.431 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.0 p-10 -142.27 -176.81 0.59 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.631 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 22.0 Cg_exo -37.65 -52.11 1.66 Allowed 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.302 2.668 . . . . 0.0 114.403 166.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.96 -14.16 59.88 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.9 0.48 . . . . 0.0 111.719 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m 71.96 52.33 0.21 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.884 1.274 . . . . 0.0 111.044 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -79.86 176.18 9.96 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.116 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.719 ' HD2' ' HA2' ' B' ' 64' ' ' GLY . 0.0 OUTLIER -125.33 104.32 8.41 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 34.3 mt -118.12 103.8 10.22 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.222 1.009 . . . . 0.0 109.35 -170.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.5 ' HD2' HD12 ' A' ' 8' ' ' ILE . 58.8 mtt-85 -87.04 147.07 25.86 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 123.075 0.55 . . . . 0.0 110.911 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.56 118.89 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 163.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.439 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 9.6 p90 -125.7 164.89 19.65 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.482 0.583 . . . . 0.0 110.879 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.81 111.16 12.81 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.9 119.08 16.64 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 118.333 0.515 . . . . 0.0 110.51 -172.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.91 111.44 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.985 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.146 178.628 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 m80 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.97 129.1 11.21 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.925 2.417 . . . . 0.0 112.308 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.6 p-10 -113.19 10.87 18.66 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.571 0.701 . . . . 0.0 110.281 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.65 120.81 30.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -168.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -118.2 138.01 52.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.778 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 63.2 mt -123.98 126.59 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 84.9 mt -97.56 159.59 14.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -106.85 135.62 48.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.051 0.94 . . . . 0.0 109.428 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.4 m -127.94 179.38 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.288 0.949 . . . . 0.0 109.724 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -136.42 47.62 2.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 16' ' ' ALA . 51.6 t30 167.48 83.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.367 -168.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.4 -53.64 6.56 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 122.618 2.212 . . . . 0.0 114.606 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.59 -64.89 0.16 Allowed 'Trans proline' 0 C--N 1.403 3.424 0 CA-C-N 122.267 1.845 . . . . 0.0 113.509 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . . . -79.27 -37.37 38.01 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.993 -164.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -79.22 -24.43 43.1 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.863 0.102 . . . . 0.0 110.883 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -73.68 -42.71 60.92 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -64.37 -28.57 69.78 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.258 173.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.01 -48.07 72.39 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.536 0.523 . . . . 0.0 109.705 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.53 -29.8 68.46 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.431 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -57.86 -48.29 80.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 118.145 0.429 . . . . 0.0 111.999 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.97 63.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.783 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.25 -30.21 70.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.654 1.182 . . . . 0.0 112.654 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 27' ' ' VAL . 73.4 mt -106.12 -28.81 10.26 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.886 0.874 . . . . 0.0 110.248 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.89 21.97 47.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.229 0.331 . . . . 0.0 112.709 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.1 m -116.15 -178.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.042 0.937 . . . . 0.0 111.002 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -134.91 153.73 78.82 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.929 0.892 . . . . 0.0 109.236 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.71 134.11 23.34 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.629 2.22 . . . . 0.0 112.131 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.82 -41.88 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 31.7 mm-40 -121.89 143.61 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.23 1.012 . . . . 0.0 109.027 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -140.31 141.09 35.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.2 m -144.21 161.86 42.88 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.66 1.184 . . . . 0.0 108.767 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -53.11 -28.93 43.25 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 123.056 2.504 . . . . 0.0 113.624 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 t -127.69 -3.43 5.97 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -139.51 141.07 37.33 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.385 0.539 . . . . 0.0 110.447 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 t -125.03 137.88 54.22 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.554 1.142 . . . . 0.0 108.773 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.9 tp -127.52 114.38 17.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.504 ' HE1' ' HG ' ' A' ' 49' ' ' LEU . 2.7 p90 -129.68 108.35 10.13 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.98 1.312 . . . . 0.0 108.608 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 46' ' ' LYS . 20.5 t -89.85 134.54 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.436 HD12 ' SD ' ' A' ' 45' ' ' MET . 56.5 mt -95.4 140.33 30.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.615 0.366 . . . . 0.0 110.844 -173.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.2 27.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.524 1.13 . . . . 0.0 112.289 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' B' ' 5' ' ' ASP . 53.6 t30 -68.91 -15.68 63.55 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.588 1.155 . . . . 0.0 110.912 173.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.55 16.76 13.51 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 122.94 0.305 . . . . 0.0 113.172 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -126.38 176.04 7.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.404 0.682 . . . . 0.0 109.568 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG3' HG22 ' A' ' 40' ' ' VAL . 80.2 tttt -134.47 134.8 41.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.008 0.523 . . . . 0.0 109.887 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.555 HD11 HD21 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -131.05 143.18 50.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 -173.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.31 169.17 18.27 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.028 0.823 . . . . 0.0 111.984 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.504 ' HG ' ' HE1' ' A' ' 39' ' ' PHE . 80.8 mt -140.57 130.26 24.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.37 1.468 . . . . 0.0 107.768 164.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -127.92 128.37 45.0 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 49.6 m -80.42 125.17 29.6 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.977 0.511 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -65.62 -15.73 63.03 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.796 1.238 . . . . 0.0 114.283 -166.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -67.68 -24.01 65.37 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.187 0.595 . . . . 0.0 111.409 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -143.63 23.03 1.79 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.879 0.471 . . . . 0.0 110.617 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.47 150.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -126.63 115.61 22.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.875 -0.516 . . . . 0.0 110.008 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 11.9 Cg_exo -70.65 142.63 72.78 Favored 'Cis proline' 0 C--N 1.387 2.574 0 CA-C-N 119.313 0.79 . . . . 0.0 112.519 -1.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.49 109.86 1.77 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.412 0.625 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.07 41.29 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 110.144 -168.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -79.62 88.94 5.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.2 m -126.48 131.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -158.77 123.96 4.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.301 1.44 . . . . 0.0 108.312 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.1 -36.14 0.71 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 113' ' ' HIS . . . 154.22 -62.39 0.36 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 69.03 -116.75 7.46 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -172.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.91 40.65 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.762 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 7.8 pt-20 -103.87 162.6 12.98 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.886 0.85 . . . . 0.0 112.124 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 47' ' ' LEU . 64.6 tp -119.08 102.5 8.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.069 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.9 115.1 23.32 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.394 0.543 . . . . 0.0 112.072 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.82 107.67 19.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.565 1.546 . . . . 0.0 108.431 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.67 133.89 34.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.568 . . . . 0.0 112.497 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -138.38 161.57 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.623 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.1 pt-20 -65.51 -42.1 92.43 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -171.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -158.65 179.83 8.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 111.812 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -56.07 -34.97 66.46 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.684 -166.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.68 -46.49 82.17 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.156 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.585 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 72.0 mm-40 -63.83 -24.31 67.7 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.964 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.19 -43.85 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.729 0.776 . . . . 0.0 110.271 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.88 -28.34 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.108 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.6 mt-10 -69.38 -45.04 70.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.35 0.595 . . . . 0.0 109.504 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -63.11 -36.24 82.93 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.404 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -54.8 -56.46 19.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.865 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.94 84.29 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.93 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.0 94.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.67 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.533 ' HB3' HG11 ' A' ' 90' ' ' VAL . 33.5 m0 -63.86 -44.89 91.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.467 0.707 . . . . 0.0 110.044 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.405 ' HB2' ' SD ' ' A' ' 92' ' ' MET . 32.2 ttpt -58.66 -42.26 88.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 110.582 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.57 65.15 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.804 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.0 m -103.38 17.8 23.25 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.314 1.046 . . . . 0.0 111.946 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.06 7.99 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 163.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 92' ' ' MET . 4.1 p -96.84 142.35 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -41.46 83.99 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.154 0.582 . . . . 0.0 111.374 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.606 ' HB3' HG13 ' A' ' 90' ' ' VAL . 9.6 ptm 48.26 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.919 1.687 . . . . 0.0 113.992 168.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.51 85.83 2.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.644 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 179.52 130.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.898 1.279 . . . . 0.0 108.703 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -82.57 115.0 55.79 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 166.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.63 118.2 3.91 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.163 2.575 . . . . 0.0 112.064 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.14 147.23 52.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.602 0.761 . . . . 0.0 110.167 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -68.44 123.03 19.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.421 0.688 . . . . 0.0 110.778 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -121.91 170.73 9.51 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.078 1.351 . . . . 0.0 109.283 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.12 -42.85 60.96 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.511 1.124 . . . . 0.0 112.283 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -90.55 1.22 56.93 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.317 0.647 . . . . 0.0 111.988 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.45 -172.37 18.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.285 168.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 35.4 t80 -73.14 101.52 3.34 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -113.19 153.59 28.06 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.542 0.687 . . . . 0.0 111.369 -166.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.07 138.16 20.3 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.119 1.368 . . . . 0.0 108.528 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -129.64 125.4 36.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.588 0.631 . . . . 0.0 109.654 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.84 172.06 7.0 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.07 0.948 . . . . 0.0 110.839 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.27 124.25 25.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.609 0.763 . . . . 0.0 109.347 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 169.14 3.21 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 123.856 0.862 . . . . 0.0 111.572 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.73 -28.83 39.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.93 2.42 . . . . 0.0 113.069 168.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -93.56 13.97 20.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.205 1.002 . . . . 0.0 111.884 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m 54.96 81.19 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.57 1.548 . . . . 0.0 112.481 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.2 m170 -118.34 -173.26 2.43 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 12.1 mmm180 -121.76 112.64 18.64 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.46 101.86 8.06 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -96.6 96.25 8.52 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -171.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -84.33 114.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -128.23 161.4 29.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.227 0.467 . . . . 0.0 111.365 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -118.23 117.84 30.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.984 0.914 . . . . 0.0 109.063 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -79.25 120.36 23.63 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.806 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.66 129.49 10.92 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.746 2.298 . . . . 0.0 112.231 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.543 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.2 p-10 -112.75 9.86 19.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.588 0.755 . . . . 0.0 110.299 171.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.7 120.73 30.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 138.03 52.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.762 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 48.7 mt -124.05 125.9 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' B' ' 49' ' ' LEU . 11.2 mp -96.82 159.65 14.8 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.401 ' O ' ' NE2' ' B' ' 113' ' ' HIS . 15.4 p90 -107.05 135.14 49.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.169 0.988 . . . . 0.0 109.432 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 51' ' ' SER . 21.2 m -127.59 179.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.29 0.95 . . . . 0.0 109.702 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.17 47.12 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 108.861 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . 0.58 ' ND2' ' HB3' ' B' ' 16' ' ' ALA . 56.0 t30 167.67 83.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.451 -167.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.08 -53.31 6.97 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.519 2.146 . . . . 0.0 114.562 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.5 -65.38 0.14 Allowed 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.171 1.914 . . . . 0.0 113.41 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.58 ' HB3' ' ND2' ' B' ' 13' ' ' ASN . . . -79.09 -37.36 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.928 -164.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.9 t -78.96 -23.72 44.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.51 0.141 . . . . 0.0 110.807 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 92.3 m -74.77 -42.01 58.97 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -64.59 -28.89 69.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.98 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.438 ' HZ ' HG22 ' B' ' 90' ' ' VAL . 60.7 t80 -65.66 -48.16 73.06 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.116 0.566 . . . . 0.0 109.949 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -68.56 -29.77 68.4 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.66 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' B' ' 18' ' ' THR . 53.9 mtpt -57.63 -48.44 79.43 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.208 0.458 . . . . 0.0 112.03 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.4 -39.19 62.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.604 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.0 -29.93 69.99 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.929 1.292 . . . . 0.0 112.54 -174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' B' ' 27' ' ' VAL . 69.3 mt -106.4 -28.97 10.02 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.043 0.937 . . . . 0.0 110.212 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.2 21.54 48.71 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.336 0.398 . . . . 0.0 112.65 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.9 m -115.87 -178.59 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.125 0.97 . . . . 0.0 110.943 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -134.98 153.15 78.37 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 109.099 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.02 133.58 23.55 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.607 2.204 . . . . 0.0 112.377 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' B' ' 31' ' ' GLU . 5.6 p -68.87 -42.06 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.419 ' HG2' HG13 ' B' ' 30' ' ' VAL . 46.2 mm-40 -122.02 143.25 49.61 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 40.0 p -140.32 140.79 35.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.521 0.728 . . . . 0.0 109.214 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 73.3 m -144.3 162.13 41.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.775 1.23 . . . . 0.0 108.821 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -53.52 -28.56 45.77 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.128 2.552 . . . . 0.0 113.871 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -128.06 -3.35 5.74 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -139.53 141.72 37.27 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.759 0.709 . . . . 0.0 110.359 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -126.17 137.46 53.57 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.549 1.14 . . . . 0.0 108.903 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.57 114.97 18.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.526 ' HE1' ' HG ' ' B' ' 49' ' ' LEU . 2.6 p90 -129.86 108.61 10.28 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.928 1.291 . . . . 0.0 108.54 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.615 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.6 t -89.85 134.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.814 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.42 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.9 mt -95.43 140.64 30.0 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 -173.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.05 -6.32 27.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.534 1.134 . . . . 0.0 112.371 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 5' ' ' ASP . 3.9 t30 -69.4 -15.48 63.31 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.066 0.946 . . . . 0.0 110.953 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 16.79 13.31 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 122.937 0.304 . . . . 0.0 113.313 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -126.13 175.97 7.38 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.53 0.732 . . . . 0.0 109.735 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.615 ' HG3' HG22 ' B' ' 40' ' ' VAL . 83.0 tttt -134.19 134.84 42.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.016 0.526 . . . . 0.0 109.862 -174.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.54 HD11 HD21 ' B' ' 68' ' ' LEU . 0.4 OUTLIER -131.2 142.94 50.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.786 0.434 . . . . 0.0 110.926 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.97 169.02 17.94 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 124.146 0.879 . . . . 0.0 111.88 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.526 ' HG ' ' HE1' ' B' ' 39' ' ' PHE . 81.3 mt -140.74 130.27 24.02 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.369 1.467 . . . . 0.0 107.947 164.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -128.23 128.15 44.17 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.6 m -80.41 125.14 29.55 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.886 0.474 . . . . 0.0 110.894 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -65.17 -16.01 63.05 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.971 1.309 . . . . 0.0 114.248 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -67.56 -23.55 65.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.261 0.625 . . . . 0.0 111.505 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.8 t -144.09 22.14 1.73 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.847 0.459 . . . . 0.0 110.421 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.18 150.47 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.259 0.623 . . . . 0.0 109.45 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.78 117.36 22.46 Favored Pre-proline 0 N--CA 1.484 1.274 0 O-C-N 121.826 -0.546 . . . . 0.0 110.572 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.81 142.53 64.77 Favored 'Cis proline' 0 C--N 1.388 2.656 0 CA-C-N 119.362 0.808 . . . . 0.0 113.248 -4.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.04 110.57 1.85 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.238 0.615 . . . . 0.0 110.073 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.41 123.98 40.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.522 1.129 . . . . 0.0 110.094 -169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 52.9 m -79.04 88.91 4.78 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.5 131.21 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.56 124.18 4.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.254 1.422 . . . . 0.0 108.545 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -35.45 0.71 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' B' ' 113' ' ' HIS . . . 153.87 -62.72 0.37 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 69.25 -116.99 7.52 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -172.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 150.85 40.94 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 173.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.778 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 5.6 pt-20 -103.57 162.93 12.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.821 0.82 . . . . 0.0 112.219 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.54 HD21 HD11 ' B' ' 47' ' ' LEU . 59.4 tp -119.83 101.77 8.11 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.687 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.93 115.66 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.477 0.58 . . . . 0.0 112.025 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.32 107.09 18.97 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.544 1.538 . . . . 0.0 108.141 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.6 mtm180 -90.05 133.55 34.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.187 0.518 . . . . 0.0 112.134 -174.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -137.27 162.38 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.449 1.1 . . . . 0.0 110.6 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 16.1 pt-20 -65.41 -42.14 92.86 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.438 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -158.61 179.79 8.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.173 0.511 . . . . 0.0 112.367 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.44 -35.05 65.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.644 1.578 . . . . 0.0 112.741 -166.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.39 -46.01 81.79 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.048 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.599 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.7 mm-40 -64.24 -24.22 67.59 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.742 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.95 -43.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.761 0.791 . . . . 0.0 110.334 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -76.69 -28.26 55.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.843 -173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.8 mt-10 -68.89 -45.75 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 174.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -62.22 -35.97 80.54 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.732 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -56.18 -56.01 26.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.078 0.951 . . . . 0.0 109.745 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.8 84.26 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.687 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.97 -40.49 95.31 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.858 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.47 -44.78 93.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.637 0.775 . . . . 0.0 110.211 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.16 -41.2 92.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.42 0.688 . . . . 0.0 110.487 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.86 -26.96 64.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.791 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 43.6 m -103.82 17.88 23.15 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.269 1.028 . . . . 0.0 111.823 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.07 47.29 8.53 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 163.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.438 HG22 ' HZ ' ' B' ' 20' ' ' PHE . 57.6 t -95.45 141.16 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.88 87.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.231 0.612 . . . . 0.0 111.336 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 7.7 ptp 48.02 82.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.789 1.636 . . . . 0.0 114.289 168.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.446 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -107.15 84.78 2.03 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.735 177.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -178.31 131.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.978 1.311 . . . . 0.0 108.608 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . 0.415 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 51.1 mt-30 -82.7 114.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 6.2 Cg_endo -50.24 118.39 3.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.227 2.618 . . . . 0.0 112.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.57 148.56 52.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.593 0.757 . . . . 0.0 110.375 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.2 123.19 21.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.604 0.762 . . . . 0.0 109.986 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 45.7 ttm -121.94 170.84 9.4 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.934 1.293 . . . . 0.0 109.052 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.6 -43.3 56.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.714 1.206 . . . . 0.0 112.236 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.69 1.39 56.88 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.261 0.624 . . . . 0.0 112.184 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 127.69 -172.18 18.95 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.332 -0.395 . . . . 0.0 113.39 169.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.428 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 34.3 t80 -75.09 101.75 4.65 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -113.39 153.5 28.47 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.405 0.621 . . . . 0.0 111.404 -165.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 3.5 t80 -149.86 138.44 20.76 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.119 1.368 . . . . 0.0 108.488 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.537 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 m -129.7 125.81 36.81 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.1 172.1 6.99 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.07 0.948 . . . . 0.0 110.959 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.04 125.68 28.58 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.576 0.75 . . . . 0.0 109.224 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.16 170.87 3.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.932 0.893 . . . . 0.0 110.912 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.4 -28.1 52.17 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.815 2.343 . . . . 0.0 112.722 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.67 13.79 21.09 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.031 0.932 . . . . 0.0 111.76 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m 55.25 80.97 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.25 1.42 . . . . 0.0 112.506 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.455 ' HA ' ' HA2' ' B' ' 64' ' ' GLY . 16.4 m170 -118.25 -173.03 2.38 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.63 ' HB3' ' HB3' ' B' ' 67' ' ' GLU . 10.9 mmm180 -121.49 112.65 18.77 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.9 mt -120.28 101.72 8.0 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -94.41 95.13 8.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.51 115.17 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -128.14 161.61 28.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.372 0.533 . . . . 0.0 111.502 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.433 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -118.24 118.97 33.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 0.0 108.805 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -81.12 127.04 32.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.48 94.32 4.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.018 0.927 . . . . 0.0 108.527 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.789 -1.006 . . . . 0.0 111.342 -179.366 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.463 ' HB3' HD21 ' B' ' 43' ' ' ASN . 15.4 m170 . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 119.559 -0.258 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.97 156.79 3.33 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.905 2.403 . . . . 0.0 112.815 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.705 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.2 p-10 -148.38 16.83 1.04 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.39 1.076 . . . . 0.0 109.662 167.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.09 136.67 49.58 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -144.95 140.59 28.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.547 HG12 ' HA3' ' A' ' 48' ' ' GLY . 19.4 mt -122.84 131.93 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.396 0.678 . . . . 0.0 109.664 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -103.06 145.21 30.24 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -98.28 127.51 44.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 m -127.82 160.96 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.34 0.656 . . . . 0.0 109.966 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.78 -60.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.103 0.961 . . . . 0.0 110.963 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -95.6 99.08 4.27 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 123.418 0.687 . . . . 0.0 109.728 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.05 -54.0 5.81 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 123.129 2.552 . . . . 0.0 115.639 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.79 -53.74 4.12 Favored 'Trans proline' 0 C--N 1.4 3.277 0 CA-C-N 122.363 1.88 . . . . 0.0 112.323 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.44 88.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.512 -168.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -79.88 -26.78 40.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.319 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -72.43 -38.67 68.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.071 0.462 . . . . 0.0 112.003 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.6 mm-40 -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.837 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.0 t80 -67.01 -42.32 85.15 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.631 0.582 . . . . 0.0 109.649 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -71.37 -29.81 65.4 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.008 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 53.3 mtpt -57.65 -49.78 75.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 111.875 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.58 -30.59 57.07 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.1 tp -62.44 -52.65 62.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.597 1.159 . . . . 0.0 111.785 -177.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.4 mt -82.48 -40.62 20.84 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.456 1.102 . . . . 0.0 108.99 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.48 25.5 10.02 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.184 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 25' ' ' LEU . 28.3 m -126.21 177.89 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.854 0.861 . . . . 0.0 110.63 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.07 154.92 76.62 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.504 1.122 . . . . 0.0 108.644 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.61 125.07 13.72 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 121.96 1.773 . . . . 0.0 111.966 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.7 p -71.58 -39.83 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.17 0.51 . . . . 0.0 109.645 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.6 mm-40 -115.55 113.31 23.45 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 p -114.74 147.87 39.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.423 0.689 . . . . 0.0 110.877 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.3 t -148.29 151.7 37.57 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.76 1.224 . . . . 0.0 108.228 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.54 -20.61 69.34 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.349 2.033 . . . . 0.0 112.94 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -128.73 13.69 6.41 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -157.35 158.14 35.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 35.6 t -145.99 141.96 28.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.583 0.753 . . . . 0.0 109.018 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.5 tm? -137.59 114.67 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HE1' HD22 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -127.22 112.95 15.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.463 1.105 . . . . 0.0 109.078 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 46' ' ' LYS . 14.8 t -93.47 128.02 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.443 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.1 mt -91.37 141.82 28.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 110.068 -168.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.98 -9.61 40.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.676 0.791 . . . . 0.0 112.082 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.619 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 4.6 m-20 -69.5 -1.21 8.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.14 0.976 . . . . 0.0 112.91 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.0 48.81 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 117.813 0.279 . . . . 0.0 112.706 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.738 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -129.07 172.54 11.29 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.659 0.784 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -128.33 135.98 50.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.582 0.753 . . . . 0.0 109.264 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -131.25 124.73 31.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.547 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -100.34 166.85 19.97 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 37' ' ' SER . 10.1 tp -143.52 105.31 4.34 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HB2' HG21 ' A' ' 8' ' ' ILE . 2.8 t90 -105.09 131.78 52.15 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -73.35 126.45 30.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -68.75 -13.0 62.11 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 112.558 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -81.77 -8.25 59.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.236 0.614 . . . . 0.0 111.311 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 t -136.58 10.82 3.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 111.177 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.4 146.91 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.04 107.99 10.5 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.633 0.773 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' B' ' 94' ' ' GLN . 93.7 Cg_endo -73.74 133.47 30.97 Favored 'Cis proline' 0 C--N 1.382 2.307 0 CA-C-N 120.541 1.229 . . . . 0.0 114.157 13.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -59.74 124.74 21.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.577 1.151 . . . . 0.0 110.8 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.97 108.1 3.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.856 0.863 . . . . 0.0 109.535 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.7 t -89.41 87.0 6.92 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.75 138.22 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 109.252 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 p -150.44 122.28 8.13 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.5 -92.06 0.14 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.83 64.14 3.96 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 123.011 0.338 . . . . 0.0 112.495 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' B' ' 65' ' ' GLY . . . -98.83 173.91 27.32 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.54 159.27 45.48 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.632 -0.538 . . . . 0.0 112.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 9.6 pt-20 -102.31 145.44 29.46 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.603 0.701 . . . . 0.0 111.145 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.77 102.76 11.52 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 108.009 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.787 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -89.25 114.91 26.32 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.01 0.433 . . . . 0.0 112.035 -168.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.78 120.31 33.89 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.015 1.326 . . . . 0.0 108.374 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.53 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 32.3 mtm180 -96.4 127.48 42.43 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.812 0.815 . . . . 0.0 112.302 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.16 157.62 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.916 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 8.2 pt-20 -68.21 -34.87 77.04 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.89 -179.43 6.28 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.978 0.808 . . . . 0.0 112.752 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.35 -31.72 69.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.483 1.513 . . . . 0.0 113.016 -166.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.89 -44.87 79.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.08 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 19.2 mm-40 -65.82 -24.31 66.87 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.65 -44.91 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.574 0.749 . . . . 0.0 109.973 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.62 -28.34 56.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.694 0.798 . . . . 0.0 111.509 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 31.7 mt-10 -62.03 -44.24 97.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.611 0.719 . . . . 0.0 109.534 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -69.61 -35.0 74.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.988 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -54.52 -59.9 4.07 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.555 1.142 . . . . 0.0 109.977 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -64.42 -35.37 80.69 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.589 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.87 -46.81 79.97 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.836 0.71 . . . . 0.0 113.994 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -65.68 -40.82 92.77 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.898 0.479 . . . . 0.0 109.76 175.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.9 ttpt -57.64 -45.09 85.91 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.61 0.764 . . . . 0.0 110.479 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.75 -24.28 61.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -98.11 14.56 27.15 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.937 0.895 . . . . 0.0 111.689 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.86 41.17 8.31 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 115.222 164.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.1 p -89.21 149.4 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.04 -54.44 11.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.961 0.504 . . . . 0.0 110.796 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.506 ' HB2' HG13 ' A' ' 90' ' ' VAL . 47.5 ttm 68.67 84.94 0.14 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.246 0.966 . . . . 0.0 113.027 169.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -117.85 84.38 2.16 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.553 0.692 . . . . 0.0 110.965 173.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 106' ' ' THR . 53.1 tp60 178.04 122.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.768 1.627 . . . . 0.0 107.736 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.02 121.8 86.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 0.0 109.72 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 46.3 Cg_endo -64.95 108.34 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.766 2.31 . . . . 0.0 110.084 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.15 48.71 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.207 0.603 . . . . 0.0 110.543 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -67.81 131.63 45.89 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.421 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.519 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 12.4 ttt -141.04 -178.07 5.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.016 0.926 . . . . 0.0 109.245 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 99' ' ' MET . 7.4 mp0 -58.8 -37.36 76.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.609 1.164 . . . . 0.0 111.899 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 33.9 m-85 -84.33 -8.4 59.02 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.84 0.856 . . . . 0.0 111.119 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 116.41 -157.12 15.22 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -79.35 103.48 9.3 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.916 0.858 . . . . 0.0 108.956 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.43 HG21 ' SD ' ' A' ' 99' ' ' MET . 13.1 t -109.48 152.76 24.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.38 0.61 . . . . 0.0 110.84 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 6.5 t80 -143.19 145.22 32.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.921 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 5.4 m -135.73 132.65 37.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.485 0.584 . . . . 0.0 110.591 172.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.58 172.59 6.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.67 0.788 . . . . 0.0 110.341 170.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.64 116.06 12.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.504 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 7.2 p-10 -71.26 171.45 8.71 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 123.309 0.644 . . . . 0.0 110.277 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 9.6 Cg_endo -50.62 -40.09 55.63 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.873 2.382 . . . . 0.0 113.463 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.12 -1.04 54.23 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.637 0.775 . . . . 0.0 110.73 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m 64.6 75.24 0.38 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.784 1.234 . . . . 0.0 112.08 164.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.45 162.65 22.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 1.1 mpt_? -90.35 111.27 22.43 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.51 104.19 16.2 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.787 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 7.4 tpt180 -89.49 146.09 24.86 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.198 0.599 . . . . 0.0 110.144 -172.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.26 122.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 164.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 5.3 p90 -127.48 156.82 41.53 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.602 0.637 . . . . 0.0 110.928 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.409 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.48 112.57 17.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 171.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 49.7 t80 -77.74 116.39 18.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -171.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.644 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.579 178.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 29.2 m80 . . . . . 0 CA--C 1.55 0.973 0 CA-C-O 119.541 -0.266 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -91.83 155.4 3.4 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.983 2.456 . . . . 0.0 112.959 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.738 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 4.5 p-10 -146.58 17.28 1.3 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.301 1.04 . . . . 0.0 110.155 167.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.5 136.65 49.18 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.84 140.67 28.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.43 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 11.2 mt -122.9 132.43 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.341 0.656 . . . . 0.0 109.545 -176.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.96 145.37 30.51 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -99.29 127.35 45.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.465 1.106 . . . . 0.0 110.517 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.67 160.9 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.241 0.616 . . . . 0.0 109.95 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -95.54 -60.9 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.278 1.031 . . . . 0.0 110.883 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -95.93 99.05 4.48 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 123.564 0.746 . . . . 0.0 109.333 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.76 -54.86 4.39 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.107 2.538 . . . . 0.0 115.552 -169.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 -54.15 4.22 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 122.461 1.915 . . . . 0.0 112.123 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.83 89.06 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.465 -168.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 85.9 p -79.5 -27.82 41.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 39.9 m -71.32 -38.97 71.67 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.529 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 83.0 mm-40 -65.6 -33.93 77.05 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.729 172.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 53.2 t80 -66.79 -41.96 86.76 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -71.82 -29.69 64.69 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.258 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 10.3 mtpm? -57.87 -49.1 77.87 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.267 0.485 . . . . 0.0 112.177 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.68 57.15 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.656 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.505 HD11 HD13 ' B' ' 115' ' ' LEU . 13.4 tp -62.75 -52.78 61.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.447 1.099 . . . . 0.0 112.014 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.493 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.0 mt -82.21 -40.55 21.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.913 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.01 9.82 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.011 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.0 m -125.88 178.39 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.97 155.27 77.97 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.166 0.986 . . . . 0.0 108.526 171.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.34 124.59 13.13 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.125 1.884 . . . . 0.0 112.172 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.5 p -71.22 -40.4 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.08 0.552 . . . . 0.0 109.588 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 68.0 mm-40 -114.35 113.84 25.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 73.8 p -115.33 147.96 39.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.999 0.52 . . . . 0.0 110.83 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.2 t -148.48 151.27 35.97 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.532 1.133 . . . . 0.0 108.34 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.96 -20.68 68.38 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.424 2.082 . . . . 0.0 113.117 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -128.66 13.62 6.44 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -157.13 158.37 36.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.843 -0.536 . . . . 0.0 109.688 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . 34.7 t -146.07 141.83 27.97 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 109.086 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -137.52 114.6 10.79 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.04 113.08 15.97 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.527 1.131 . . . . 0.0 109.15 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' B' ' 46' ' ' LYS . 17.2 t -93.69 127.55 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.341 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.551 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.2 mt -91.26 141.36 28.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.062 0.545 . . . . 0.0 110.227 -169.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.36 -9.4 33.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.038 0.935 . . . . 0.0 112.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 4.2 m-20 -69.61 -1.93 10.21 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.159 0.983 . . . . 0.0 112.679 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.25 17.51 46.33 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.723 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.705 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -128.92 173.08 10.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.549 0.74 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.8 tttt -128.66 136.25 50.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.403 0.681 . . . . 0.0 109.482 -176.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.466 HD12 HD11 ' B' ' 41' ' ' LEU . 0.7 OUTLIER -131.06 124.68 31.38 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.27 166.36 20.93 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 37' ' ' SER . 9.5 tp -143.46 105.07 4.32 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -105.08 132.06 51.78 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 52.8 m -73.54 126.17 29.62 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -68.64 -13.12 62.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.581 0.752 . . . . 0.0 112.552 -172.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -81.41 -8.35 59.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.309 0.644 . . . . 0.0 111.331 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.3 t -136.59 10.87 3.18 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.255 0.622 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.82 146.99 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.97 108.85 10.64 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.584 0.754 . . . . 0.0 109.049 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.57 134.04 32.64 Favored 'Cis proline' 0 C--N 1.383 2.381 0 CA-C-N 120.339 1.157 . . . . 0.0 114.215 11.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -60.61 124.06 19.26 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.651 1.181 . . . . 0.0 111.22 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.32 108.02 3.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 109.508 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.4 p -89.2 86.07 6.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.32 140.43 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.166 0.986 . . . . 0.0 108.584 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -152.33 122.31 7.06 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.9 -91.84 0.14 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.22 63.81 4.29 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 123.041 0.353 . . . . 0.0 113.315 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' A' ' 65' ' ' GLY . . . -99.43 173.98 26.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.915 -0.381 . . . . 0.0 112.27 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.53 159.6 45.03 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 124.019 0.482 . . . . 0.0 112.097 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' B' ' 114' ' ' ARG . 9.2 pt-20 -101.99 145.35 29.4 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.458 0.647 . . . . 0.0 110.895 -176.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -110.06 102.92 11.59 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.29 114.83 26.25 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.183 0.516 . . . . 0.0 111.933 -168.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -93.36 120.51 33.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.041 1.336 . . . . 0.0 108.523 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.484 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 33.3 mtm105 -97.36 126.08 42.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.64 0.734 . . . . 0.0 112.188 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.98 157.82 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.348 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.451 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.1 pt-20 -67.04 -35.11 79.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -164.45 -179.05 5.76 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.91 -31.75 70.11 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.688 -166.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.521 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.28 -45.34 80.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.01 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.451 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 83.1 mm-40 -65.42 -24.1 67.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.261 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.68 -44.51 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.382 0.673 . . . . 0.0 109.858 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.21 -28.15 53.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.587 0.755 . . . . 0.0 111.364 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 40.4 mt-10 -62.54 -43.85 97.8 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.758 0.79 . . . . 0.0 109.325 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 54.3 m -69.89 -35.02 74.3 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.14 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -54.59 -59.68 4.37 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.47 1.108 . . . . 0.0 110.223 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.499 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -64.67 -34.87 79.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.539 -175.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.88 -47.29 76.3 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 123.729 0.643 . . . . 0.0 113.804 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.54 -41.09 93.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 34.3 ttpt -57.27 -45.0 84.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.591 0.756 . . . . 0.0 110.482 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.62 61.62 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.072 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -97.5 14.82 25.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.041 0.937 . . . . 0.0 111.931 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.67 41.43 8.29 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.3 p -89.6 149.4 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.25 -54.69 10.03 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.795 0.438 . . . . 0.0 110.691 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.514 ' HB2' HG13 ' B' ' 90' ' ' VAL . 49.1 ttm 68.76 84.99 0.14 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.944 0.777 . . . . 0.0 112.922 168.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.94 84.29 2.14 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 121.571 0.701 . . . . 0.0 110.821 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.412 ' HG3' ' HD3' ' A' ' 57' ' ' PRO . 24.1 tm0? 178.27 122.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.468 1.507 . . . . 0.0 107.14 173.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.41 120.63 82.55 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.366 0.667 . . . . 0.0 109.939 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 37.0 Cg_endo -63.38 108.41 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.795 2.33 . . . . 0.0 110.514 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.49 156.62 47.93 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.011 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -68.31 131.89 46.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.283 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.491 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 8.8 ttt -141.19 -178.42 5.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.96 0.904 . . . . 0.0 108.897 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' B' ' 99' ' ' MET . 7.3 mp0 -58.55 -37.61 76.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.429 1.092 . . . . 0.0 112.187 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -83.61 -8.69 59.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.778 0.831 . . . . 0.0 111.16 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 116.76 -156.65 15.5 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -79.61 103.49 9.55 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.044 0.922 . . . . 0.0 108.92 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.459 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.8 t -109.75 152.47 25.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.958 0.503 . . . . 0.0 110.582 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 7.3 t80 -142.98 144.72 32.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.8 1.24 . . . . 0.0 109.971 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -135.17 132.16 37.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.417 0.553 . . . . 0.0 110.705 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.56 172.63 6.71 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.718 0.807 . . . . 0.0 110.35 170.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.87 115.39 11.92 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.514 ' HB3' HD11 ' B' ' 115' ' ' LEU . 4.3 p-10 -69.8 170.83 8.54 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.58 0.752 . . . . 0.0 110.728 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 9.6 Cg_endo -50.66 -40.18 55.91 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.789 2.326 . . . . 0.0 113.199 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.76 -0.87 52.75 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.482 0.713 . . . . 0.0 111.053 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.0 m 64.17 74.75 0.4 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.741 1.217 . . . . 0.0 112.043 165.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -122.62 162.61 21.58 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 166.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 2.6 mpt_? -90.01 112.08 23.39 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.514 HD11 ' HB3' ' B' ' 109' ' ' ASP . 33.0 mt -98.97 104.37 16.4 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.735 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 30.4 mmt180 -87.55 146.24 25.87 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 123.804 0.841 . . . . 0.0 110.834 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 t -139.56 122.01 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 163.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.484 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.0 p90 -127.13 156.56 41.56 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.866 0.757 . . . . 0.0 111.132 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -123.57 112.52 17.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.38 118.76 20.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.4 94.35 6.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.347 -179.388 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.476 ' HB3' ' ND2' ' B' ' 43' ' ' ASN . 17.9 m-70 . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HG3' HD22 ' B' ' 25' ' ' LEU . 51.2 Cg_endo -90.83 48.65 0.75 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.361 2.708 . . . . 0.0 112.672 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.574 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 5.9 p-10 -75.47 14.81 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.173 0.989 . . . . 0.0 112.609 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.471 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.2 t80 -133.37 129.93 38.1 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.134 1.374 . . . . 0.0 108.137 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 8.2 t -127.33 140.86 51.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.237 1.015 . . . . 0.0 108.576 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 61.4 mt -118.8 137.24 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 HD21 ' A' ' 47' ' ' LEU . 4.3 mm? -96.72 146.28 25.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HE1' HG21 ' A' ' 55' ' ' VAL . 22.8 t80 -101.32 95.72 6.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.341 -167.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.471 HG12 ' HE1' ' A' ' 113' ' ' HIS . 27.0 m -108.87 -179.85 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.33 -53.87 1.7 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.876 0.47 . . . . 0.0 110.258 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.74 105.55 9.19 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 123.567 0.747 . . . . 0.0 110.764 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.68 -55.48 3.5 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 C-N-CA 122.735 2.29 . . . . 0.0 114.081 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.44 -58.9 0.5 Allowed 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 122.271 1.847 . . . . 0.0 112.312 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.71 95.51 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.337 -166.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.9 p -76.68 -34.83 58.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.287 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -69.11 -39.12 79.14 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.545 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 12.4 mm100 -64.3 -35.47 80.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.411 172.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 77.7 t80 -68.28 -39.46 82.14 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.27 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -70.41 -30.55 67.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.208 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.4 mtpt -57.13 -47.76 80.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.946 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.28 -34.53 55.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.223 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.0 tp -61.13 -31.46 71.16 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.861 1.265 . . . . 0.0 112.646 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' B' ' 4' ' ' PRO . 87.3 mt -105.46 -40.08 5.92 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.364 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.34 29.65 10.0 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 25' ' ' LEU . 16.9 m -126.51 -179.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.218 1.007 . . . . 0.0 109.616 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.83 150.8 68.93 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.546 0.738 . . . . 0.0 109.078 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.97 111.9 2.78 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.812 2.342 . . . . 0.0 112.099 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -64.02 -42.28 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.759 0.824 . . . . 0.0 110.598 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 28.5 mm-40 -111.49 145.49 38.94 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -154.55 152.23 29.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.326 0.584 . . . . 0.0 109.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 15.2 m -139.86 163.95 41.2 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.44 1.496 . . . . 0.0 107.655 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.19 -30.51 80.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.331 2.021 . . . . 0.0 113.069 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -130.04 23.11 5.29 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.552 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 88.7 t80 -153.63 159.28 42.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.091 0.556 . . . . 0.0 109.72 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.4 m -149.36 154.56 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 110.077 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -148.36 123.14 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.96 131.54 47.49 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.961 1.304 . . . . 0.0 108.46 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.523 HG22 ' HG3' ' A' ' 46' ' ' LYS . 33.8 t -109.6 126.29 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.74 0.816 . . . . 0.0 109.175 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.31 145.17 26.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.219 0.608 . . . . 0.0 109.652 -170.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.66 -5.56 12.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.974 0.91 . . . . 0.0 112.585 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 10.5 m120 -67.06 -9.12 35.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.445 1.098 . . . . 0.0 112.743 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.69 59.68 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.46 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -119.98 164.22 16.42 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.125 0.97 . . . . 0.0 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' A' ' 40' ' ' VAL . 73.6 tttt -132.02 138.83 48.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.498 HD21 HD23 ' A' ' 9' ' ' LEU . 1.2 tt -137.24 122.6 19.45 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -102.96 170.11 19.58 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.95 0.786 . . . . 0.0 111.653 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.73 109.59 5.77 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 1.9 t-105 -109.26 127.75 54.52 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -79.59 122.86 27.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.006 0.522 . . . . 0.0 110.118 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.35 -15.87 63.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.399 1.08 . . . . 0.0 112.686 -169.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -72.03 -8.88 57.11 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 122.842 0.457 . . . . 0.0 111.233 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -135.1 6.36 3.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.334 0.653 . . . . 0.0 111.244 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.568 HG21 ' HE1' ' A' ' 10' ' ' TYR . 8.3 p -62.75 148.63 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.539 0.335 . . . . 0.0 111.34 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -122.98 113.9 29.76 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.356 0.663 . . . . 0.0 109.783 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.41 144.92 80.67 Favored 'Cis proline' 0 C--N 1.379 2.174 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.084 1.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -52.86 128.29 26.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.66 1.184 . . . . 0.0 112.218 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' OH ' ' A' ' 10' ' ' TYR . . . -150.87 121.14 7.28 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.236 0.614 . . . . 0.0 110.98 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -91.29 86.94 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.34 124.64 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -152.33 123.69 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.114 1.366 . . . . 0.0 107.98 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.63 67.43 0.02 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -82.09 1.69 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.0 -142.92 45.68 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.377 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.552 ' H ' ' H ' ' B' ' 66' ' ' GLY . . . -65.96 151.76 51.93 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.2 mt-10 -102.14 152.89 20.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.164 0.507 . . . . 0.0 110.585 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.4 tp -118.84 102.23 8.65 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.08 115.63 26.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.19 0.519 . . . . 0.0 111.332 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -95.38 108.25 20.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 0.0 108.235 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -92.38 128.08 38.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.586 0.707 . . . . 0.0 111.975 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 118' ' ' TYR . 24.8 m -128.41 160.95 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 13.0 pt-20 -66.79 -35.19 79.49 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.512 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.3 p30 -165.05 178.56 6.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.7 0.682 . . . . 0.0 112.281 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.16 -31.98 63.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.786 1.634 . . . . 0.0 113.1 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.25 -46.87 84.87 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 123.902 0.751 . . . . 0.0 110.101 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.586 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 83.3 mm-40 -67.9 -23.03 65.06 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.653 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.62 -41.68 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.65 0.738 . . . . 0.0 109.904 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.27 -33.82 65.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 110.971 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 41.5 mt-10 -65.91 -44.69 84.45 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.626 0.727 . . . . 0.0 109.312 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -63.49 -37.61 87.95 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.952 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -55.13 -61.54 2.25 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.271 1.029 . . . . 0.0 110.466 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -68.79 -32.69 72.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.301 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.24 -46.39 90.99 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.483 0.489 . . . . 0.0 112.94 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.52 -43.74 98.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.258 0.623 . . . . 0.0 109.529 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -55.84 -45.76 78.31 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.451 0.7 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.74 61.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.297 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 t -100.56 4.1 43.22 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 111.829 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.57 52.91 2.72 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.401 167.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.8 p -94.76 153.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.14 -53.93 15.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.698 0.399 . . . . 0.0 110.771 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.524 ' HB2' HG13 ' A' ' 90' ' ' VAL . 48.6 ttm 64.53 83.8 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 169.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 82.55 1.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.305 0.574 . . . . 0.0 110.599 173.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 176.71 130.46 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.867 1.667 . . . . 0.0 108.303 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -82.15 123.68 79.3 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 107.05 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.469 2.779 . . . . 0.0 111.972 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.06 50.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.777 0.831 . . . . 0.0 111.254 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 98' ' ' LYS . 2.2 mmmm -70.77 100.63 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.545 0.738 . . . . 0.0 110.308 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.7 ttm -101.34 169.4 8.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.258 1.023 . . . . 0.0 108.815 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.12 -41.6 48.97 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.35 1.06 . . . . 0.0 112.136 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.08 -12.12 60.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.581 0.752 . . . . 0.0 111.164 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.96 -173.5 21.55 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.467 0.556 . . . . 0.0 111.933 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -77.14 100.81 5.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.2 t -113.44 147.5 37.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -167.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -140.78 134.21 29.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.098 0.959 . . . . 0.0 109.296 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.8 m -120.26 118.26 29.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.796 0.438 . . . . 0.0 110.272 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.01 169.69 8.35 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.143 0.577 . . . . 0.0 109.894 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.85 127.73 29.39 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.73 169.53 2.5 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.542 0.737 . . . . 0.0 110.791 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -49.51 -31.81 25.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.573 2.182 . . . . 0.0 112.444 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.52 4.0 41.76 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.543 1.137 . . . . 0.0 112.263 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.4 m 59.31 84.2 0.12 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.702 1.201 . . . . 0.0 112.259 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.471 ' HE1' HG12 ' A' ' 11' ' ' VAL . 22.5 m170 -122.73 176.57 5.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.075 0.55 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 67' ' ' GLU . 24.9 mmt180 -100.3 112.46 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.1 mt -111.78 100.32 8.84 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -99.5 93.33 5.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.247 0.219 . . . . 0.0 110.971 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.48 116.21 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 72' ' ' VAL . 23.5 p90 -125.19 168.49 13.37 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.027 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.85 112.04 13.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.75 114.42 18.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.648 0 C-N-CA 123.576 0.75 . . . . 0.0 109.535 -179.353 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.578 ' HG3' HD22 ' A' ' 25' ' ' LEU . 54.3 Cg_endo -90.57 49.69 0.89 Allowed 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.444 2.762 . . . . 0.0 112.851 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.9 p-10 -75.69 14.24 0.67 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.304 1.041 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.474 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.3 t80 -133.48 129.25 36.94 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.222 1.409 . . . . 0.0 108.2 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 8.2 t -126.85 141.3 51.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 55.6 mt -119.79 137.19 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.55 145.43 25.72 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.47 97.74 8.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.223 -169.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.457 HG12 ' HE1' ' B' ' 113' ' ' HIS . 30.5 m -109.14 179.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -123.78 -53.45 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.727 0.411 . . . . 0.0 110.405 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.11 105.12 8.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 123.635 0.774 . . . . 0.0 109.828 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.23 -55.25 3.83 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.576 2.184 . . . . 0.0 114.357 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 -58.63 0.52 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 CA-C-N 122.243 1.837 . . . . 0.0 112.248 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.36 -44.37 94.98 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.282 -166.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m -76.35 -34.57 58.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.662 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 63.3 m -69.34 -39.43 78.15 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.549 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.9 mm-40 -63.89 -35.89 82.15 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.527 172.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 58.2 t80 -68.08 -39.51 82.89 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.322 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -70.18 -30.64 67.81 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.329 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 61.2 mtpt -57.07 -47.63 80.52 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.59 -34.52 53.49 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.264 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 11.8 tp -60.66 -31.93 71.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.699 1.2 . . . . 0.0 112.641 -177.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.526 HD22 ' HG3' ' A' ' 4' ' ' PRO . 91.4 mt -105.07 -40.26 5.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.511 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.38 29.62 10.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 123.725 0.64 . . . . 0.0 111.823 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.4 m -126.62 -179.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.318 1.047 . . . . 0.0 109.809 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.33 150.81 70.0 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.432 0.693 . . . . 0.0 109.209 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.53 111.92 2.69 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.469 2.113 . . . . 0.0 112.26 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 p -64.17 -42.33 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.773 0.829 . . . . 0.0 110.287 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 18.9 mm-40 -111.41 145.93 38.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 108.302 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -154.85 152.05 29.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.279 0.562 . . . . 0.0 110.014 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 24.9 m -139.39 163.4 45.8 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.401 1.48 . . . . 0.0 107.616 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.77 -30.99 69.96 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.483 2.122 . . . . 0.0 113.325 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -130.29 23.0 5.19 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.544 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 70.0 t80 -153.75 159.2 41.87 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -149.37 154.42 38.9 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.826 0.851 . . . . 0.0 109.955 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -148.2 122.91 9.88 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.6 132.58 48.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.853 1.261 . . . . 0.0 108.544 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.5 t -109.99 126.47 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.667 0.787 . . . . 0.0 109.143 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.38 145.15 27.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.174 0.589 . . . . 0.0 109.537 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.16 -5.66 14.51 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.876 0.87 . . . . 0.0 112.655 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.569 ' HB2' ' HG2' ' B' ' 45' ' ' MET . 13.5 m120 -65.8 -10.42 37.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.642 1.177 . . . . 0.0 112.649 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.53 58.58 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.574 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 14.9 ptm -118.76 165.2 14.3 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.238 1.015 . . . . 0.0 109.249 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.55 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.77 139.46 47.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.1 tt -137.79 122.73 18.96 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.036 0.446 . . . . 0.0 110.502 -171.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.474 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.94 169.44 19.0 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 123.997 0.808 . . . . 0.0 111.434 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 45.8 mt -139.94 110.05 6.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -107.76 128.6 54.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -79.69 122.82 27.04 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.071 0.548 . . . . 0.0 110.185 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.433 ' O ' HG12 ' B' ' 55' ' ' VAL . 51.6 ptt85 -69.89 -15.08 63.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.323 1.049 . . . . 0.0 112.621 -169.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -72.62 -8.48 55.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 122.684 0.394 . . . . 0.0 111.132 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.2 t -134.81 4.16 3.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.569 0.748 . . . . 0.0 111.414 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' B' ' 52' ' ' ARG . 10.6 p -60.02 148.23 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.867 0.467 . . . . 0.0 111.562 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -123.68 113.81 28.67 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.804 0.841 . . . . 0.0 109.527 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.76 145.56 81.87 Favored 'Cis proline' 0 C--N 1.382 2.338 0 C-N-CA 124.516 -1.035 . . . . 0.0 113.16 1.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 128.66 30.3 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.553 1.141 . . . . 0.0 111.992 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.32 120.88 7.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.389 0.675 . . . . 0.0 110.886 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 35.6 p -91.12 87.25 6.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.34 124.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.364 0.665 . . . . 0.0 109.739 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -152.64 123.07 7.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.305 1.442 . . . . 0.0 108.123 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.85 67.83 0.02 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.67 -82.24 1.68 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.29 -142.33 44.3 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.809 -0.439 . . . . 0.0 112.452 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.552 ' H ' ' H ' ' A' ' 66' ' ' GLY . . . -66.86 152.46 52.66 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 174.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 10.4 mt-10 -103.9 152.08 22.38 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.042 0.537 . . . . 0.0 110.197 -172.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.441 HD21 HD11 ' B' ' 47' ' ' LEU . 35.4 tp -118.81 102.34 8.74 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.2 116.09 27.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.216 0.531 . . . . 0.0 111.194 -170.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' B' ' 117' ' ' VAL . 29.0 m-85 -96.28 107.96 20.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.135 1.374 . . . . 0.0 108.297 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -91.86 126.4 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.599 0.714 . . . . 0.0 111.89 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.408 HG22 ' O ' ' B' ' 118' ' ' TYR . 29.6 m -126.25 161.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.148 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.88 -34.62 78.19 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -174.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.401 HD22 ' HG3' ' B' ' 73' ' ' GLU . 7.7 p30 -165.78 179.0 6.19 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.648 0.658 . . . . 0.0 112.212 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.39 -31.49 65.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.519 1.528 . . . . 0.0 113.03 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.43 -46.42 86.39 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.181 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.481 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 72.4 mm-40 -68.16 -23.38 64.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.322 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.59 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.574 0.702 . . . . 0.0 109.69 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.48 -32.99 62.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.933 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 33.4 mt-10 -65.9 -44.31 85.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.534 0.683 . . . . 0.0 109.495 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.8 m -64.66 -36.45 84.3 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.991 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -55.03 -61.68 2.15 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.41 1.084 . . . . 0.0 110.28 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.11 -32.32 71.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.368 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.48 -45.66 92.55 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.53 0.519 . . . . 0.0 112.935 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -63.89 -43.19 96.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.333 0.653 . . . . 0.0 109.924 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.65 -45.76 77.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.592 0.757 . . . . 0.0 110.184 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.62 -20.73 61.23 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.345 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.95 4.15 44.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.796 0.838 . . . . 0.0 112.475 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 52.86 2.74 Favored Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 114.471 168.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' B' ' 92' ' ' MET . 4.9 p -94.57 153.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.82 -54.0 15.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.742 0.417 . . . . 0.0 110.991 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.53 ' HB2' HG13 ' B' ' 90' ' ' VAL . 52.9 ttm 64.43 83.7 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.841 0.713 . . . . 0.0 112.67 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.73 82.46 1.86 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.442 0.639 . . . . 0.0 110.741 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' B' ' 106' ' ' THR . 54.0 tp60 176.2 129.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.717 1.607 . . . . 0.0 108.242 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.89 123.45 82.22 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 168.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.33 107.11 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.499 2.799 . . . . 0.0 111.876 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.29 141.35 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 111.085 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 100.42 3.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.405 0.682 . . . . 0.0 109.358 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -100.59 170.38 8.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.912 0.885 . . . . 0.0 109.181 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.6 -41.62 54.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.236 1.014 . . . . 0.0 111.746 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -79.93 -11.21 59.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.644 0.777 . . . . 0.0 111.249 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.68 -172.79 21.78 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.9 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -78.56 101.05 7.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -113.7 147.51 38.06 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.895 0.478 . . . . 0.0 110.781 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.77 134.34 30.09 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 109.117 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 1.9 m -120.9 118.42 29.88 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.92 169.94 8.19 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.058 0.543 . . . . 0.0 109.704 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.2 128.51 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.86 170.22 2.73 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.597 0.759 . . . . 0.0 110.41 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.89 -31.88 28.27 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.779 2.319 . . . . 0.0 112.2 165.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.31 4.92 40.91 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.36 1.064 . . . . 0.0 112.047 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 61.0 m 58.53 84.67 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.802 1.241 . . . . 0.0 112.573 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.457 ' HE1' HG12 ' B' ' 11' ' ' VAL . 15.3 m170 -122.78 176.57 5.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.108 0.563 . . . . 0.0 109.612 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' B' ' 67' ' ' GLU . 9.5 mmt180 -100.75 112.48 24.9 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.32 100.6 8.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.594 ' HG3' HH11 ' B' ' 116' ' ' ARG . 8.3 mmt85 -96.8 92.19 6.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.876 -172.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' B' ' 70' ' ' PHE . 5.9 t -91.74 115.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.408 ' O ' HG22 ' B' ' 72' ' ' VAL . 15.9 p90 -124.71 169.02 12.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.789 0.268 . . . . 0.0 111.128 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.95 111.76 13.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.61 115.46 19.23 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.71 0.25 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.835 -174.418 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 m170 . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 119.821 -0.133 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.0 94.77 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.801 2.334 . . . . 0.0 112.064 171.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.653 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.6 p-10 -96.61 16.7 18.15 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.424 0.63 . . . . 0.0 110.997 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.7 131.57 46.37 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.935 1.294 . . . . 0.0 107.562 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 142.97 49.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.362 1.065 . . . . 0.0 109.03 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 45.7 mt -124.0 139.1 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.546 0.739 . . . . 0.0 110.133 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 47' ' ' LEU . 3.7 mm? -112.02 143.5 42.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.051 0.941 . . . . 0.0 108.556 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.13 106.48 13.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.495 1.118 . . . . 0.0 111.347 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 51' ' ' SER . 14.8 m -107.24 149.38 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -97.06 -52.15 3.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.13 100.58 13.59 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.11 0.964 . . . . 0.0 109.646 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -53.67 -52.71 7.89 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.246 2.631 . . . . 0.0 115.384 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 47.3 Cg_exo -56.68 -51.16 9.69 Favored 'Trans proline' 0 C--N 1.4 3.255 0 CA-C-N 122.267 1.845 . . . . 0.0 112.414 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.19 -38.01 52.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.968 -165.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -78.76 -29.25 45.02 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.235 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 75.9 m -64.95 -48.29 74.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 81.5 mm-40 -66.36 -31.66 72.57 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.196 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -62.96 -48.94 76.73 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.855 0.722 . . . . 0.0 110.045 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -71.81 -29.07 64.05 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.409 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 18' ' ' THR . 56.3 mtpt -56.26 -45.64 79.98 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.753 0.706 . . . . 0.0 112.069 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -42.54 35.8 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.464 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.9 -46.33 85.09 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.904 1.282 . . . . 0.0 112.298 -172.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.39 -47.64 9.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.2 33.75 4.78 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.804 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.18 172.19 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.14 0.976 . . . . 0.0 110.312 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.2 146.75 54.99 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 57.3 Cg_endo -71.26 121.08 7.46 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.994 1.796 . . . . 0.0 112.19 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.76 -44.13 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.545 0.738 . . . . 0.0 110.636 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.6 mm-40 -120.86 107.23 12.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -111.08 144.86 39.54 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.173 0.511 . . . . 0.0 110.696 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -142.07 155.63 65.26 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.715 1.206 . . . . 0.0 108.432 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.92 -10.19 27.55 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.278 1.985 . . . . 0.0 113.146 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -129.29 5.3 5.24 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -157.01 154.84 30.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 70.5 m -140.88 139.89 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.608 0.763 . . . . 0.0 109.256 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 27.7 tp -131.62 121.02 23.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 2.2 p90 -134.28 150.32 50.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.969 0.907 . . . . 0.0 108.943 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 46' ' ' LYS . 19.2 t -126.46 133.9 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.476 ' HB2' ' HG3' ' A' ' 45' ' ' MET . 10.0 mp -97.73 144.72 27.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.25 -10.67 33.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.134 0.974 . . . . 0.0 112.673 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.04 -22.35 66.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.256 1.022 . . . . 0.0 112.127 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.17 16.04 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -116.23 171.88 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.851 0.86 . . . . 0.0 109.022 176.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -142.84 143.11 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.474 HD21 HD23 ' A' ' 9' ' ' LEU . 2.0 tt -142.3 122.19 13.59 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.99 0.424 . . . . 0.0 110.397 -169.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.26 151.97 17.56 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 76.5 mt -116.83 109.61 17.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 162.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.454 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.4 t90 -103.83 124.28 48.64 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 48.8 m -72.51 115.88 12.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -64.77 -8.57 15.46 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.73 1.212 . . . . 0.0 113.873 -169.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -9.89 59.7 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.574 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -135.23 3.01 3.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.837 0.455 . . . . 0.0 111.398 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 13.8 p -64.78 140.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.827 0.451 . . . . 0.0 110.948 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.38 106.76 21.33 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 3.0 Cg_endo -77.25 142.32 71.55 Favored 'Cis proline' 0 C--N 1.383 2.361 0 CA-C-N 120.156 1.091 . . . . 0.0 113.182 10.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HA ' HG13 ' A' ' 55' ' ' VAL . 2.8 tppp? -59.46 109.63 0.93 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.03 0.932 . . . . 0.0 111.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.67 107.58 10.71 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.817 1.247 . . . . 0.0 107.953 174.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 m -100.0 87.84 3.6 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.28 143.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.335 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 112' ' ' SER . 6.3 p -148.95 -176.43 5.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.431 1.092 . . . . 0.0 109.739 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.57 -71.37 2.47 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 32.71 7.27 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.37 59.76 4.94 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 146.14 7.2 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.314 0.483 . . . . 0.0 112.245 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 19.8 mt-10 -103.82 140.87 37.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.08 100.64 7.47 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.698 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -89.36 114.65 26.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.141 0.496 . . . . 0.0 111.777 -168.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -90.42 115.02 27.27 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.564 1.545 . . . . 0.0 107.585 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.657 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 31.3 mtm105 -91.34 128.37 37.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.13 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.17 159.15 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.018 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.4 pt-20 -65.52 -37.23 86.18 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -173.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -162.83 -177.76 5.71 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 118.407 0.549 . . . . 0.0 112.225 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.09 -34.1 71.6 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.75 1.22 . . . . 0.0 112.469 -166.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.26 -41.37 85.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.603 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.621 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 76.3 mm-40 -66.69 -23.06 66.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.079 0.952 . . . . 0.0 112.424 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.33 -40.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.932 0.493 . . . . 0.0 109.882 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.73 -31.37 61.81 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.974 0.91 . . . . 0.0 110.978 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.2 mt-10 -66.33 -47.43 73.55 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -62.99 -36.5 83.75 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.484 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -56.31 -61.39 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.211 1.004 . . . . 0.0 110.361 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.33 77.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.491 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.8 93.6 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.535 0.522 . . . . 0.0 113.373 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -66.65 -39.97 88.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.418 0.687 . . . . 0.0 109.965 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -60.39 -42.54 96.11 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.648 0.779 . . . . 0.0 110.362 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.31 65.14 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.738 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.0 t -95.84 7.2 46.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.315 1.046 . . . . 0.0 112.759 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.53 51.36 6.05 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.927 -0.579 . . . . 0.0 114.306 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.64 137.71 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.461 0.704 . . . . 0.0 109.169 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.05 97.98 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.805 0.842 . . . . 0.0 112.207 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.63 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 12.0 ptm 49.27 82.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.085 1.754 . . . . 0.0 115.409 164.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.465 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -114.65 86.12 2.38 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.095 0.558 . . . . 0.0 110.446 178.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 178.38 116.57 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.619 1.568 . . . . 0.0 107.551 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.83 124.36 89.25 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.52 97.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.965 2.444 . . . . 0.0 111.334 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.42 36.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.014 0.926 . . . . 0.0 110.187 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 98.5 2.37 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ttt -90.79 166.38 13.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.802 0.841 . . . . 0.0 109.233 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.34 -41.15 79.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.984 0.914 . . . . 0.0 111.972 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -81.34 -15.35 55.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.142 0.577 . . . . 0.0 111.693 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.55 179.4 22.66 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.182 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -78.05 105.72 9.44 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 118' ' ' TYR . 12.6 t -122.01 155.51 35.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.472 0.654 . . . . 0.0 111.455 -171.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -141.21 150.31 42.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.006 1.722 . . . . 0.0 108.304 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.7 m -136.09 133.66 37.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.996 0.816 . . . . 0.0 111.349 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.71 171.22 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.953 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.42 126.63 29.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.936 170.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.83 172.52 1.37 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.741 1.216 . . . . 0.0 111.798 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -56.18 -35.68 95.64 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.169 1.913 . . . . 0.0 111.446 161.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.86 -18.59 43.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.592 1.157 . . . . 0.0 110.898 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.495 ' O ' ' HB ' ' A' ' 62' ' ' THR . 22.2 m 68.13 101.69 0.05 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 126.262 1.825 . . . . 0.0 111.793 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.462 ' CE1' HG12 ' A' ' 11' ' ' VAL . 17.3 m80 -127.35 175.72 7.98 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -96.22 95.04 7.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 92.5 mt -95.6 104.4 16.31 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.698 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 9.9 mmm180 -86.15 143.52 27.97 Favored 'General case' 0 C--O 1.214 -0.816 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.43 111.25 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 166.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.657 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 3.6 p90 -120.84 167.18 12.79 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.264 0.483 . . . . 0.0 110.819 -172.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.25 110.9 8.07 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.402 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 52.0 t80 -76.65 116.9 17.74 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.135 0.425 . . . . 0.0 110.198 -168.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.317 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -88.55 94.83 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.619 2.212 . . . . 0.0 112.144 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.691 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.3 p-10 -96.29 16.48 18.25 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.343 0.592 . . . . 0.0 111.023 171.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.72 131.33 46.28 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.038 1.335 . . . . 0.0 107.587 -173.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 t -132.63 143.07 49.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.328 1.051 . . . . 0.0 108.964 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 16.7 mt -124.23 139.23 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.61 0.764 . . . . 0.0 109.971 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.87 143.09 44.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.047 0.939 . . . . 0.0 108.685 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -80.79 106.48 12.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.447 1.099 . . . . 0.0 111.181 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' B' ' 51' ' ' SER . 15.3 m -107.35 149.66 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -97.45 -52.31 3.84 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.202 -170.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -101.54 100.02 12.98 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.267 1.027 . . . . 0.0 109.685 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.45 -53.05 7.56 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.413 2.742 . . . . 0.0 115.766 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 22.6 Cg_endo -56.9 -50.92 10.11 Favored 'Trans proline' 0 C--N 1.399 3.234 0 CA-C-N 122.084 1.78 . . . . 0.0 112.077 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.09 -38.41 52.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.088 -165.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -78.94 -28.22 43.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.222 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 83.9 m -66.84 -47.25 72.54 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.555 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.0 mt-30 -65.1 -33.29 75.69 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.249 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 81.0 t80 -62.45 -48.71 78.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.531 0.732 . . . . 0.0 110.136 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.426 ' O ' ' HG ' ' B' ' 25' ' ' LEU . 41.6 m-85 -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.564 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -55.99 -45.59 78.96 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.87 0.759 . . . . 0.0 111.985 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.52 33.59 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.46 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.3 tp -58.2 -46.23 86.18 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.809 1.244 . . . . 0.0 112.247 -172.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 21' ' ' TYR . 10.8 mt -86.24 -47.74 9.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.79 32.93 4.89 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.597 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.92 171.74 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.164 0.986 . . . . 0.0 110.373 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -124.36 148.17 57.34 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 61.1 Cg_endo -72.7 120.96 7.0 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 121.876 1.718 . . . . 0.0 112.13 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.69 -44.36 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.564 0.746 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 58.8 mm-40 -120.4 108.32 13.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.27 1.028 . . . . 0.0 108.292 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 p -112.33 145.01 40.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.22 0.608 . . . . 0.0 110.347 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -143.02 153.67 60.74 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.141 1.376 . . . . 0.0 108.241 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.56 -10.58 26.89 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.319 2.013 . . . . 0.0 113.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.0 t -129.19 5.69 5.31 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.82 154.97 30.74 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 35.5 t -140.75 140.16 34.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.512 HD11 ' HE2' ' B' ' 46' ' ' LYS . 40.6 tp -132.15 120.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 2.4 p90 -134.01 150.42 51.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 0.0 108.885 170.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' B' ' 46' ' ' LYS . 17.5 t -126.84 134.13 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' B' ' 45' ' ' MET . 9.9 mp -97.53 144.36 27.31 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -10.2 30.04 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.152 0.981 . . . . 0.0 112.554 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.45 -22.2 66.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.406 1.082 . . . . 0.0 112.054 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.36 15.88 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.653 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -116.75 172.25 7.36 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.575 ' HG3' HG22 ' B' ' 40' ' ' VAL . 86.4 tttt -142.91 143.18 31.93 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.28 122.46 13.83 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.13 17.6 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 174.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 76.6 mt -117.04 109.63 17.21 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.423 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -103.82 124.39 48.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.8 m -72.55 116.42 12.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -65.55 -8.27 18.91 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.607 1.163 . . . . 0.0 113.789 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -79.34 -10.34 59.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.231 0.612 . . . . 0.0 111.548 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -134.78 2.43 3.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.88 0.472 . . . . 0.0 111.293 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 12.2 p -64.68 141.29 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.631 0.373 . . . . 0.0 110.851 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.07 107.66 19.9 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 123.909 0.884 . . . . 0.0 109.058 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.47 142.4 73.01 Favored 'Cis proline' 0 C--N 1.387 2.603 0 CA-C-N 119.906 1.002 . . . . 0.0 113.466 8.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.423 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.7 tppp? -58.91 110.17 0.97 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.058 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.82 107.34 10.41 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.823 1.249 . . . . 0.0 108.102 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -99.57 87.8 3.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.64 142.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.182 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' B' ' 112' ' ' SER . 6.2 p -147.65 -176.24 5.17 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.544 1.138 . . . . 0.0 110.149 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.4 -71.66 2.46 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.12 32.58 7.37 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.44 59.74 4.94 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 145.94 7.08 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.288 0.471 . . . . 0.0 112.197 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 18.4 mt-10 -103.62 141.1 36.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.86 100.33 7.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.08 114.76 26.04 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 0.0 111.925 -169.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -90.62 114.52 26.8 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 125.525 1.53 . . . . 0.0 107.453 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.593 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 36.4 mtm105 -90.65 127.08 36.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.934 -175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.22 159.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.159 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.1 pt-20 -65.51 -37.36 86.55 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -163.06 -177.37 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 118.5 0.591 . . . . 0.0 112.205 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -59.52 -33.68 71.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -166.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.09 84.66 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.806 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.552 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -67.05 -22.58 65.86 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.572 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.83 -40.71 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.852 172.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.22 -31.27 62.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.05 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.42 -47.51 73.02 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.113 0.483 . . . . 0.0 109.765 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -35.74 81.39 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.487 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -56.86 -61.35 2.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.696 0.798 . . . . 0.0 110.304 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -65.41 -34.0 77.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.653 -171.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.06 93.34 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.553 0.533 . . . . 0.0 113.326 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -66.28 -40.12 89.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.498 0.719 . . . . 0.0 109.905 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.6 ttpt -60.12 -42.58 95.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.636 0.774 . . . . 0.0 110.46 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.35 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.746 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 30.2 t -96.1 7.73 45.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.241 1.016 . . . . 0.0 112.762 -175.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 52.12 5.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.268 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.07 137.39 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.735 0.814 . . . . 0.0 109.201 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.78 97.99 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.904 0.882 . . . . 0.0 112.38 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 12.0 ptm 49.22 82.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 164.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.508 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -114.68 86.26 2.4 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.285 0.634 . . . . 0.0 110.405 178.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 52.0 tp60 177.78 116.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.768 1.627 . . . . 0.0 107.638 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.64 125.09 90.03 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.06 97.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.936 2.424 . . . . 0.0 110.943 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.65 146.93 37.79 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.02 0.928 . . . . 0.0 110.337 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 98.39 2.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 171.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 8.3 ttt -91.06 166.79 12.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.634 0.774 . . . . 0.0 109.104 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.0 -41.16 77.98 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.688 0.795 . . . . 0.0 112.079 -176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -81.54 -15.54 54.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.62 179.42 22.74 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.032 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -77.74 105.96 9.25 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 11.1 t -122.37 155.53 35.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.554 0.692 . . . . 0.0 111.395 -170.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -141.35 150.26 42.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.889 1.676 . . . . 0.0 108.318 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.5 m -136.05 133.6 37.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.992 0.815 . . . . 0.0 111.352 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.634 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.76 171.15 7.49 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.931 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.19 129.34 35.62 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.4 174.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.692 1.197 . . . . 0.0 110.8 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.11 -34.92 99.02 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.05 1.834 . . . . 0.0 110.828 162.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -82.36 -18.27 42.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.718 1.207 . . . . 0.0 110.818 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . 0.494 ' O ' ' HB ' ' B' ' 62' ' ' THR . 40.3 m 67.79 101.85 0.05 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.15 1.78 . . . . 0.0 111.656 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.45 ' CE1' HG12 ' B' ' 11' ' ' VAL . 19.5 m80 -127.48 175.47 8.21 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 165.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.549 ' HA ' ' HE ' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -96.09 95.4 8.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' B' ' 107' ' ' ALA . 93.9 mt -95.64 104.83 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.66 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 34.3 mmt180 -84.47 143.57 29.29 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 25.2 t -137.42 111.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.593 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.5 p90 -120.65 167.46 12.42 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.023 0.374 . . . . 0.0 110.896 -172.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.73 111.44 8.19 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 167.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -77.65 123.47 26.69 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.196 0.453 . . . . 0.0 110.493 -168.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.39 94.59 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 118.891 -0.95 . . . . 0.0 110.923 -176.276 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 119.766 -0.159 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.36 56.47 1.41 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.476 2.784 . . . . 0.0 111.836 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.573 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.0 p-10 -78.36 4.07 13.96 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.886 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.0 OUTLIER -124.23 125.11 43.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.1 t -120.0 137.23 54.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 49.2 mt -116.14 135.07 57.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.364 0.666 . . . . 0.0 109.361 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 156.3 18.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.314 1.054 . . . . 0.0 108.308 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' OH ' HG11 ' A' ' 55' ' ' VAL . 4.0 t80 -110.04 108.36 18.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.823 -173.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.48 HG12 ' NE2' ' A' ' 113' ' ' HIS . 9.9 m -125.12 159.84 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.367 0.603 . . . . 0.0 110.957 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -97.41 -62.7 1.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.396 1.078 . . . . 0.0 109.461 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.28 106.52 13.86 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.224 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.49 -59.72 0.62 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 122.624 2.216 . . . . 0.0 113.959 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 29.8 Cg_endo -57.32 -50.65 10.44 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.355 1.877 . . . . 0.0 111.61 -174.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.07 90.57 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.262 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.8 t -78.69 -20.72 49.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.755 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 m -76.41 -45.49 31.36 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.679 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 57.7 mm-40 -68.61 -30.19 68.87 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.41 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 36.4 t80 -60.85 -51.25 70.12 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 124.115 0.885 . . . . 0.0 110.847 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.39 -27.76 63.55 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.784 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.5 mtpt -56.19 -50.83 70.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.392 0.542 . . . . 0.0 112.408 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.61 56.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.113 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 11.7 tp -60.91 -43.65 98.26 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.408 1.083 . . . . 0.0 112.15 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 27' ' ' VAL . 22.5 mt -95.21 -35.29 11.9 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.971 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.7 37.13 6.2 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.9 m -130.56 -177.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.489 1.116 . . . . 0.0 110.472 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.75 149.79 57.76 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.03 108.96 2.06 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.806 2.337 . . . . 0.0 111.697 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.76 -31.51 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.586 0.754 . . . . 0.0 110.571 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 48.5 mt-10 -119.42 143.15 47.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.291 1.037 . . . . 0.0 108.213 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -159.54 153.72 23.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.817 0.818 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -144.23 164.15 30.71 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 126.069 1.748 . . . . 0.0 107.473 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.58 -16.16 34.76 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.334 2.022 . . . . 0.0 113.484 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.8 t -127.92 13.05 6.79 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -154.38 159.94 41.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -153.37 153.91 33.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.489 1.116 . . . . 0.0 109.469 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.7 tm? -146.33 123.71 11.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -130.81 137.24 49.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.601 1.16 . . . . 0.0 108.307 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.536 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.7 t -112.09 123.0 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.633 HD12 ' SD ' ' A' ' 45' ' ' MET . 76.2 mt -89.34 148.73 23.36 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.96 0.504 . . . . 0.0 110.188 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -7.01 19.12 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.22 1.008 . . . . 0.0 113.513 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -82.03 4.41 22.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 111.789 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.3 64.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.629 -0.189 . . . . 0.0 112.629 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.633 ' SD ' HD12 ' A' ' 41' ' ' LEU . 5.1 ppp? -117.61 171.54 7.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.631 0.772 . . . . 0.0 109.779 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 40' ' ' VAL . 83.0 tttt -135.35 139.43 44.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 68' ' ' LEU . 1.2 tt -137.34 123.99 21.04 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.174 0.512 . . . . 0.0 110.113 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.411 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.94 169.97 20.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.828 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.9 tp -139.92 104.78 4.94 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -114.71 128.92 56.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.6 m -78.71 134.95 37.05 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.168 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.0 -19.96 64.97 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.755 0.822 . . . . 0.0 113.2 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -8.41 58.78 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -129.77 7.72 5.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.858 0.463 . . . . 0.0 111.33 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.503 HG11 ' OH ' ' A' ' 10' ' ' TYR . 11.8 p -69.87 147.43 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HB3' ' NE2' ' B' ' 94' ' ' GLN . 35.6 mt-10 -128.25 113.65 19.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 0.0 109.52 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.72 143.19 77.06 Favored 'Cis proline' 0 C--N 1.388 2.636 0 CA-C-N 119.723 0.937 . . . . 0.0 112.674 2.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -50.09 124.31 9.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.501 1.12 . . . . 0.0 112.063 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.41 155.68 43.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.172 0.989 . . . . 0.0 109.333 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.3 m -132.79 94.23 3.35 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.97 125.18 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.13 0.972 . . . . 0.0 108.855 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -140.09 142.62 36.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.761 0.824 . . . . 0.0 109.373 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.51 23.22 73.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.624 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' B' ' 61' ' ' VAL . . . -160.84 140.74 6.88 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.27 -156.23 26.85 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.59 172.0 54.81 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.525 0.191 . . . . 0.0 112.713 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 68.9 mt-10 -99.49 152.03 20.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 47' ' ' LEU . 45.8 tp -110.09 100.55 9.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -84.61 113.76 21.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.007 0.432 . . . . 0.0 111.571 -167.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -93.12 106.62 18.56 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.854 1.262 . . . . 0.0 107.921 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -90.62 131.37 36.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.122 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.04 165.08 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.49 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.1 pt-20 -69.38 -43.81 72.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.402 HD22 ' HG3' ' A' ' 73' ' ' GLU . 9.3 p30 -155.25 177.99 10.72 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.703 0.683 . . . . 0.0 112.626 -174.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.15 -32.96 70.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.158 1.383 . . . . 0.0 112.421 -167.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.34 -42.77 74.85 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.634 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 78.9 mm-40 -64.58 -24.16 67.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.644 0.778 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.24 -40.08 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.349 0.595 . . . . 0.0 110.003 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.1 -30.22 62.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.195 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -67.77 -42.99 80.84 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 109.141 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.7 m -65.01 -37.93 89.26 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.357 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.94 -60.92 2.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.921 0.888 . . . . 0.0 109.628 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -60.83 -39.17 88.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.733 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.6 -39.35 86.64 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.415 0.447 . . . . 0.0 113.828 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -67.89 -42.48 81.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.374 0.669 . . . . 0.0 109.64 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.7 ttpt -57.63 -43.88 85.16 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.791 0.836 . . . . 0.0 110.387 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.9 -30.56 71.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.692 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.5 m -102.24 14.8 30.98 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.099 0.959 . . . . 0.0 112.094 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 46.36 5.68 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 163.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -101.72 132.23 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.144 0.578 . . . . 0.0 109.745 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.51 95.13 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.918 0.887 . . . . 0.0 111.708 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 4.8 ptm 50.3 81.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.567 1.547 . . . . 0.0 113.771 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.52 83.67 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.61 -0.681 . . . . 0.0 109.962 -178.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' B' ' 56' ' ' GLU . 5.7 tp60 177.39 134.68 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.52 1.528 . . . . 0.0 108.028 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -79.31 120.67 81.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 15.6 Cg_endo -58.71 106.3 0.27 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.642 2.228 . . . . 0.0 110.378 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.85 152.36 46.41 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.309 0.644 . . . . 0.0 110.21 -175.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -62.42 137.79 58.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.543 0.737 . . . . 0.0 110.466 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.412 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 20.1 ttt -142.82 175.76 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 109.392 -175.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 99' ' ' MET . 11.5 tp10 -51.35 -32.37 25.44 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.453 1.501 . . . . 0.0 112.921 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.42 -5.22 23.12 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.663 0.785 . . . . 0.0 111.384 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.91 -167.51 20.18 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.078 176.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.7 101.59 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.409 HG21 ' SD ' ' A' ' 99' ' ' MET . 9.4 t -115.63 149.1 38.84 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.376 -167.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 3.2 t80 -146.51 129.41 16.33 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.573 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -120.66 119.22 32.21 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.26 159.04 16.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 -175.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -141.1 127.49 19.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 170.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.64 178.89 2.09 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.134 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -32.83 94.08 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.743 2.295 . . . . 0.0 113.644 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.83 -4.92 46.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.758 0.423 . . . . 0.0 111.18 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.0 m 72.45 60.02 0.13 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.118 1.367 . . . . 0.0 110.995 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.48 ' NE2' HG12 ' A' ' 11' ' ' VAL . 19.7 m170 -97.67 -167.09 1.47 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.17 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.43 93.87 1.94 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.7 mt -116.79 101.95 8.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.833 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 2.3 tmm_? -102.8 99.26 9.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.004 0.521 . . . . 0.0 111.29 -169.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.03 140.6 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.5 0.72 . . . . 0.0 109.226 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.499 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 16.7 p90 -143.66 161.69 37.88 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.659 0.663 . . . . 0.0 112.607 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.405 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -110.67 129.87 55.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.71 124.52 23.52 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.274 0.359 . . . . 0.0 110.367 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.545 0 O-C-N 123.772 0.67 . . . . 0.0 110.48 -178.018 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.8 56.01 1.66 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.499 2.799 . . . . 0.0 111.95 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.9 p-10 -77.59 3.91 12.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.685 0.794 . . . . 0.0 112.146 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -123.85 124.85 43.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -120.32 137.53 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 37.0 mt -117.3 134.76 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.374 0.67 . . . . 0.0 109.468 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.599 HD11 HD22 ' B' ' 68' ' ' LEU . 65.9 mt -90.56 155.69 18.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.334 1.064 . . . . 0.0 108.973 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.03 107.83 19.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 112.93 -1.941 . . . . 0.0 108.184 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.98 160.05 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.377 0.608 . . . . 0.0 110.838 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.81 -62.12 1.29 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.41 1.084 . . . . 0.0 109.713 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -90.78 105.92 13.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.391 0.676 . . . . 0.0 109.495 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -56.4 -60.97 0.38 Allowed 'Trans proline' 0 CA--C 1.573 2.443 0 C-N-CA 122.435 2.09 . . . . 0.0 113.878 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.7 -51.99 9.12 Favored 'Trans proline' 0 C--N 1.41 3.789 0 CA-C-N 122.47 1.918 . . . . 0.0 112.405 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.13 92.94 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.4 t -78.45 -20.61 50.62 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.1 m -76.88 -45.33 28.59 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.45 0.643 . . . . 0.0 111.652 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.487 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.2 mm-40 -67.92 -30.78 70.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.464 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 74.9 t80 -60.4 -50.91 71.7 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.786 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -72.19 -27.43 62.55 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.201 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 56.4 mtpt -56.27 -50.94 69.93 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.53 -36.06 57.91 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.051 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 8.8 tp -60.94 -43.25 98.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.074 0.95 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' B' ' 27' ' ' VAL . 27.0 mt -95.35 -35.49 11.75 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.07 36.85 6.17 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' B' ' 25' ' ' LEU . 34.2 m -130.38 -177.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.562 1.145 . . . . 0.0 110.256 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -140.75 149.21 55.85 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.66 0.784 . . . . 0.0 109.489 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.91 108.51 1.71 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.48 2.12 . . . . 0.0 112.019 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.18 -31.97 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.608 0.763 . . . . 0.0 110.516 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.668 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 45.4 mt-10 -119.31 143.42 47.38 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 167.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 21.5 t -159.54 153.63 23.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.651 0.739 . . . . 0.0 111.111 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 35.6 m -143.96 165.11 25.86 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 126.109 1.764 . . . . 0.0 107.357 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.12 -15.58 40.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.045 1.83 . . . . 0.0 113.103 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.3 t -128.11 13.02 6.7 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -154.3 159.55 41.3 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.013 -0.429 . . . . 0.0 110.78 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 60.6 m -153.3 154.01 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.555 1.142 . . . . 0.0 109.529 171.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -146.37 123.45 11.45 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -130.09 138.44 50.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.286 1.035 . . . . 0.0 108.654 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.526 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.3 t -112.51 123.41 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.698 HD12 ' SD ' ' B' ' 45' ' ' MET . 80.5 mt -89.98 148.6 22.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.837 0.455 . . . . 0.0 110.282 -168.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -7.56 21.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.119 0.968 . . . . 0.0 113.578 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -81.57 4.63 20.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.745 0.818 . . . . 0.0 112.251 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.06 11.86 64.4 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.698 ' SD ' HD12 ' B' ' 41' ' ' LEU . 5.0 ppp? -117.56 171.62 7.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.501 0.72 . . . . 0.0 109.597 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.526 ' HG3' HG22 ' B' ' 40' ' ' VAL . 84.3 tttt -135.73 140.05 44.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.2 tt -138.18 123.76 19.68 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.184 0.516 . . . . 0.0 110.269 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.88 168.98 19.67 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.844 0.735 . . . . 0.0 112.724 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 39.1 mt -137.81 105.2 5.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 169.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.474 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.5 t90 -114.32 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 50.9 m -78.72 134.61 37.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.423 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -68.02 -19.26 64.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 0.0 112.965 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -79.42 -9.15 59.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.5 0.32 . . . . 0.0 111.295 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.5 t -128.92 7.48 5.58 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.024 0.529 . . . . 0.0 111.318 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 11.8 p -69.66 147.15 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 94' ' ' GLN . 26.3 mt-10 -128.7 113.91 19.2 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.319 0.648 . . . . 0.0 110.056 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 94' ' ' GLN . 97.7 Cg_endo -73.0 143.57 78.26 Favored 'Cis proline' 0 C--N 1.387 2.583 0 CA-C-N 119.472 0.847 . . . . 0.0 113.226 2.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 126.14 18.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.097 0.959 . . . . 0.0 110.527 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.96 155.96 44.24 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.454 1.102 . . . . 0.0 109.715 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.4 m -132.7 92.55 3.07 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.617 0.767 . . . . 0.0 109.013 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.504 HG21 ' HA3' ' A' ' 64' ' ' GLY . 79.2 t -141.69 125.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.312 1.045 . . . . 0.0 108.568 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.7 p -140.07 141.71 36.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.83 0.852 . . . . 0.0 109.215 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.9 24.5 69.3 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.477 0.485 . . . . 0.0 112.395 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.85 139.26 5.87 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.86 -155.35 26.5 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 10' ' ' TYR . . . -77.43 172.64 55.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.569 ' HA ' ' HG3' ' B' ' 114' ' ' ARG . 6.0 mm-40 -99.68 151.24 21.44 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.599 HD22 HD11 ' B' ' 9' ' ' LEU . 50.1 tp -109.78 101.1 10.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -84.9 113.99 21.79 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.125 0.42 . . . . 0.0 111.604 -167.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -93.53 106.51 18.47 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -90.67 131.05 36.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.145 0.497 . . . . 0.0 111.893 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.65 165.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.4 1.08 . . . . 0.0 110.541 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.527 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.0 pt-20 -69.2 -44.1 72.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.518 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.434 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.9 p30 -155.23 178.15 10.54 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.762 0.71 . . . . 0.0 112.7 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.753 1.621 . . . . 0.0 112.608 -167.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.49 -42.26 75.01 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.708 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.527 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.3 mm-40 -65.39 -24.03 67.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.697 0.799 . . . . 0.0 112.458 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.35 -40.52 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.353 0.597 . . . . 0.0 110.009 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.28 -30.43 63.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.303 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 18.5 mt-10 -67.96 -43.0 80.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.702 0.763 . . . . 0.0 109.213 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.3 m -64.96 -37.58 88.13 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.193 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.49 -60.92 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.767 0.827 . . . . 0.0 109.531 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.446 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -60.66 -38.56 85.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.902 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.69 -39.72 86.03 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.43 0.456 . . . . 0.0 113.878 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -67.85 -42.06 81.96 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.394 0.678 . . . . 0.0 109.679 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.45 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 31.9 ttpt -58.89 -43.33 90.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 0.0 110.229 177.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.77 -30.24 70.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.664 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.6 m -102.55 14.93 30.68 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.926 0.891 . . . . 0.0 112.256 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.82 47.1 5.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.219 -0.9 . . . . 0.0 114.957 163.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.59 131.69 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.213 0.605 . . . . 0.0 109.499 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.89 92.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.86 0.864 . . . . 0.0 112.114 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.45 ' HE1' ' HB2' ' B' ' 86' ' ' LYS . 13.5 ptp 48.94 82.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.655 1.582 . . . . 0.0 114.128 172.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.418 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -106.67 83.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.453 0.644 . . . . 0.0 109.941 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.489 ' NE2' ' HB3' ' A' ' 56' ' ' GLU . 5.7 tp60 177.45 133.78 0.06 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 108.14 174.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -78.07 121.38 83.91 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 20.0 Cg_endo -60.12 106.34 0.33 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.654 2.236 . . . . 0.0 110.117 172.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.78 152.25 46.42 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.263 0.625 . . . . 0.0 110.158 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -62.89 138.48 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.328 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.482 ' SD ' HG21 ' B' ' 104' ' ' THR . 11.4 ttt -143.26 175.22 10.06 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.73 0.812 . . . . 0.0 109.007 -174.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' B' ' 99' ' ' MET . 11.3 tp10 -51.98 -32.57 34.17 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.113 1.365 . . . . 0.0 112.964 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.07 -6.37 23.42 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.614 0.765 . . . . 0.0 111.281 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 128.84 -168.2 20.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.528 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -76.02 101.23 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.482 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.4 t -115.1 149.06 38.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.501 0.667 . . . . 0.0 111.328 -167.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 2.6 t80 -146.48 129.37 16.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.465 1.506 . . . . 0.0 108.537 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 119.54 33.09 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.114 0.483 . . . . 0.0 109.812 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -107.35 158.71 16.94 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.875 0.87 . . . . 0.0 112.464 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.65 129.72 23.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.2 p-10 -88.33 179.94 1.51 Allowed Pre-proline 0 CA--C 1.575 1.905 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.346 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 25.4 Cg_endo -58.72 -32.22 96.53 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.499 2.132 . . . . 0.0 113.239 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.66 -5.3 47.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.787 0.435 . . . . 0.0 110.908 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m 72.7 60.4 0.12 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.137 1.375 . . . . 0.0 110.66 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -97.9 -168.23 1.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.377 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' B' ' 67' ' ' GLU . 4.2 tpp180 -149.13 94.94 2.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -175.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.01 101.78 8.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.017 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 3.4 tmt_? -100.28 98.12 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.167 0.587 . . . . 0.0 112.079 -169.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.29 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -143.48 161.42 38.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.714 0.688 . . . . 0.0 112.375 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -110.75 130.59 55.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 168.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -68.91 123.38 20.83 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.161 0.288 . . . . 0.0 110.664 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.86 106.64 17.21 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.973 -0.904 . . . . 0.0 111.064 -179.052 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.414 ' HB3' HD23 ' B' ' 41' ' ' LEU . 7.2 m-70 . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -91.02 101.26 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.139 2.559 . . . . 0.0 112.737 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.77 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 4.2 p30 -85.03 -2.23 57.73 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.218 0.532 . . . . 0.0 111.06 169.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -118.46 112.27 19.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -168.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -109.76 131.71 54.82 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.52 132.42 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.411 ' HB2' HD12 ' A' ' 49' ' ' LEU . 90.2 mt -96.92 173.23 7.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.091 0.948 . . . . 0.0 108.941 173.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -130.38 120.29 24.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.442 -174.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG12 ' NE2' ' A' ' 113' ' ' HIS . 10.3 m -125.89 155.84 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.861 0.864 . . . . 0.0 109.679 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.84 -56.83 3.17 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -94.93 110.36 49.34 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.163 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 31.8 Cg_exo -54.94 -57.25 1.8 Allowed 'Trans proline' 0 CA--C 1.573 2.455 0 C-N-CA 122.749 2.3 . . . . 0.0 114.232 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 34.9 Cg_exo -58.32 -58.63 0.7 Allowed 'Trans proline' 0 C--N 1.401 3.319 0 CA-C-N 122.181 1.815 . . . . 0.0 112.146 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.71 95.22 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.753 0.821 . . . . 0.0 112.36 -167.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -76.42 -33.84 58.79 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 88.9 m -73.1 -39.77 65.52 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -59.75 -36.87 77.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.89 172.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.27 -44.51 94.91 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 110.233 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -70.91 -29.16 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.02 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 18' ' ' THR . 60.1 mtpt -56.63 -47.7 79.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.805 0.729 . . . . 0.0 112.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.87 47.28 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.758 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp -63.7 -40.59 97.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.516 1.126 . . . . 0.0 112.332 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' VAL . 32.2 mt -93.46 -38.55 11.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.18 24.85 18.22 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.537 0.523 . . . . 0.0 111.809 -173.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.3 m -118.58 174.91 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.024 0.93 . . . . 0.0 110.449 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.9 143.97 51.28 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 108.968 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.71 112.4 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.634 2.223 . . . . 0.0 111.402 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.74 -36.51 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.447 0.699 . . . . 0.0 109.769 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.8 mm-40 -112.02 87.03 2.47 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.5 p -90.19 127.62 36.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.43 0.692 . . . . 0.0 109.214 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -140.61 152.81 67.14 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.985 0.914 . . . . 0.0 108.538 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -46.35 -44.68 20.04 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.871 3.048 . . . . 0.0 114.646 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -126.92 15.94 7.39 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.6 151.3 37.87 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -140.58 142.72 35.07 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -139.53 121.08 15.17 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -133.05 131.72 40.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.554 1.141 . . . . 0.0 108.637 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 46' ' ' LYS . 16.2 t -109.49 129.62 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.039 -173.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.494 HD12 ' SD ' ' A' ' 45' ' ' MET . 49.4 mt -94.27 143.0 26.76 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.786 0.434 . . . . 0.0 110.445 -171.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -5.76 19.43 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.376 1.07 . . . . 0.0 112.299 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.501 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.7 OUTLIER -67.34 -19.51 65.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.769 1.228 . . . . 0.0 111.627 177.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.44 16.62 15.56 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.728 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -125.66 176.26 7.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.518 0.727 . . . . 0.0 109.54 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.6 tttt -140.32 137.53 34.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.02 118.55 18.94 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.772 0.429 . . . . 0.0 110.084 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.31 163.22 21.88 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.521 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 9' ' ' LEU . 1.1 tp -141.43 104.85 4.66 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.7 t90 -111.09 134.83 52.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.902 0.881 . . . . 0.0 108.678 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 54' ' ' THR . 35.9 m -75.83 136.39 40.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.751 0.31 . . . . 0.0 111.249 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -72.5 -9.86 59.08 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.993 0.917 . . . . 0.0 112.455 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -86.89 -8.8 56.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.202 0.601 . . . . 0.0 111.181 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 51' ' ' SER . 15.4 t -135.04 8.24 3.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.177 0.591 . . . . 0.0 111.339 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.2 p -68.28 143.45 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 122.58 0.352 . . . . 0.0 111.372 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.39 117.23 25.11 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.556 1.142 . . . . 0.0 108.706 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 12.4 Cg_exo -70.88 144.13 78.07 Favored 'Cis proline' 0 C--N 1.386 2.531 0 CA-C-N 119.681 0.922 . . . . 0.0 112.992 -1.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.17 128.76 37.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.149 0.98 . . . . 0.0 111.958 -177.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.45 109.03 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.764 1.226 . . . . 0.0 108.531 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.2 p -87.83 89.15 7.88 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.3 142.84 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.523 0.729 . . . . 0.0 109.847 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -138.96 135.55 34.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.226 1.01 . . . . 0.0 109.22 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.38 51.75 49.67 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.61 0.569 . . . . 0.0 114.227 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.18 44.99 0.42 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.87 -169.51 11.69 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.781 -0.209 . . . . 0.0 113.125 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.97 170.12 47.67 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 124.38 0.694 . . . . 0.0 113.009 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -98.53 160.04 14.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.918 0.887 . . . . 0.0 110.561 -171.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 68' ' ' LEU . 20.4 mt -107.09 101.23 10.66 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.54 103.53 14.48 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -82.46 106.17 14.11 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -84.72 128.89 34.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.816 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.74 157.92 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.811 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG3' HD22 ' A' ' 74' ' ' ASN . 10.9 pt-20 -68.17 -42.06 80.58 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.93 -172.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.45 HD22 ' HG3' ' A' ' 73' ' ' GLU . 9.5 p30 -151.05 174.38 13.24 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-O 121.49 0.662 . . . . 0.0 112.059 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.51 -27.64 69.11 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.41 -165.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.06 -42.11 76.69 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.304 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 80.3 mm-40 -62.87 -23.73 67.47 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.588 0.755 . . . . 0.0 112.568 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.5 -42.83 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.429 0.633 . . . . 0.0 110.457 171.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.76 -30.77 67.35 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.66 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -70.68 -43.11 69.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.371 0.605 . . . . 0.0 109.683 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -30.23 69.07 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.759 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -62.25 -60.88 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.898 0.879 . . . . 0.0 109.005 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.43 89.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.766 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.2 -45.13 94.45 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 124.115 0.885 . . . . 0.0 113.908 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -64.2 -45.52 87.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.17 0.588 . . . . 0.0 110.288 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.3 -46.02 76.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.576 0.75 . . . . 0.0 110.269 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.61 63.42 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.52 14.46 29.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 112.539 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 55.27 3.61 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.439 -0.8 . . . . 0.0 114.776 166.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.4 p -104.33 148.79 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.63 56.42 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.879 0.471 . . . . 0.0 111.456 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.552 ' HB2' HG13 ' A' ' 90' ' ' VAL . 55.5 ttm 63.56 84.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 166.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 86.75 2.63 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 121.332 0.587 . . . . 0.0 110.83 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 106' ' ' THR . 55.7 tp60 179.02 122.57 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.519 1.528 . . . . 0.0 108.187 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.54 114.94 49.7 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.61 107.26 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.385 2.723 . . . . 0.0 112.256 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.81 145.51 42.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 110.021 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 112.24 8.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.437 ' HG3' ' H ' ' A' ' 101' ' ' PHE . 49.4 tpp -100.46 162.63 12.81 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.64 -23.08 62.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.237 0.615 . . . . 0.0 111.007 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 99' ' ' MET . 15.5 m-85 -120.72 90.77 3.39 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.374 1.07 . . . . 0.0 108.555 174.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.48 152.08 1.12 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.558 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 84.8 t80 -71.97 101.06 2.6 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 165.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -109.25 151.26 26.77 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.813 0.816 . . . . 0.0 112.04 -161.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.74 149.75 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.563 1.545 . . . . 0.0 108.498 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 87.6 m -141.23 128.3 20.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.751 0.705 . . . . 0.0 110.497 171.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.99 155.91 18.91 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.137 0.575 . . . . 0.0 109.79 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.73 126.31 52.45 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.54 156.5 22.86 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.055 0.942 . . . . 0.0 111.484 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.56 -21.91 73.17 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.739 2.293 . . . . 0.0 112.431 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -92.29 -20.69 20.86 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.142 0.977 . . . . 0.0 110.559 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.2 m 72.63 90.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.873 1.669 . . . . 0.0 110.967 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.506 ' NE2' HG12 ' A' ' 11' ' ' VAL . 10.5 m80 -113.18 -92.32 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 113' ' ' HIS . 4.7 tpt180 167.98 109.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.281 1.032 . . . . 0.0 109.348 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.6 110.33 13.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.141 0.577 . . . . 0.0 111.175 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -95.3 147.55 23.37 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.337 0.517 . . . . 0.0 110.685 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.04 125.58 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -130.62 151.77 50.71 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.092 0.86 . . . . 0.0 111.489 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -103.81 117.55 34.63 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -77.64 111.96 13.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.329 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.3 m80 . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.66 -0.209 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.41 ' HD3' HD22 ' A' ' 25' ' ' LEU . 65.0 Cg_endo -91.75 101.91 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.014 2.476 . . . . 0.0 112.237 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.728 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.9 p-10 -86.01 -1.68 57.58 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.416 0.627 . . . . 0.0 111.019 169.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.409 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.1 t80 -118.53 112.45 19.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -169.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -109.78 131.55 54.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 52.3 mt -113.8 132.86 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' B' ' 49' ' ' LEU . 93.2 mt -97.49 172.05 7.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.918 0.866 . . . . 0.0 109.005 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' B' ' 50' ' ' TRP . 30.9 m-85 -128.22 122.11 30.99 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.897 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.478 HG12 ' NE2' ' B' ' 113' ' ' HIS . 6.2 m -125.93 155.94 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.81 0.844 . . . . 0.0 109.523 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -88.01 -56.77 3.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.179 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -94.42 109.31 42.2 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.244 0.618 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.41 -56.92 2.1 Favored 'Trans proline' 0 CA--C 1.574 2.491 0 C-N-CA 122.68 2.254 . . . . 0.0 114.269 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.37 -58.79 0.54 Allowed 'Trans proline' 0 C--N 1.402 3.369 0 CA-C-N 122.179 1.814 . . . . 0.0 111.714 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.06 92.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.788 0.835 . . . . 0.0 112.494 -167.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -76.31 -33.82 59.04 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.023 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -73.11 -39.78 65.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.53 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 0.0 OUTLIER -59.61 -37.33 78.29 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.712 172.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' B' ' 90' ' ' VAL . 78.2 t80 -62.5 -45.36 93.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.467 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.44 -29.27 65.81 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.025 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 63.4 mtpt -56.94 -47.33 80.9 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.794 0.725 . . . . 0.0 112.867 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.86 44.54 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.872 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -63.45 -40.23 96.6 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.614 1.166 . . . . 0.0 112.533 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' B' ' 27' ' ' VAL . 34.3 mt -93.57 -39.13 11.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.24 25.91 15.36 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.848 -173.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' B' ' 25' ' ' LEU . 18.2 m -119.38 175.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.093 0.957 . . . . 0.0 110.406 -176.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.31 140.66 37.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 50.8 Cg_exo -57.22 111.54 0.85 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.915 2.41 . . . . 0.0 112.29 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.91 -35.88 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 109.88 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 26.8 mm-40 -112.35 87.63 2.62 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.5 p -90.66 128.18 36.54 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -141.51 153.37 65.44 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -47.83 -44.29 27.29 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.764 2.976 . . . . 0.0 114.569 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -126.57 16.14 7.59 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -145.58 151.65 38.45 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -140.63 142.17 35.02 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.665 0.786 . . . . 0.0 108.889 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.68 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.3 tm? -138.98 121.14 15.77 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -133.04 132.0 41.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 108.607 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.538 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.5 t -110.45 129.46 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.921 0.888 . . . . 0.0 109.012 -173.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.494 HD22 ' SD ' ' B' ' 45' ' ' MET . 7.8 mp -93.66 142.76 26.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 0.0 110.135 -170.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.44 -5.89 21.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.986 0.914 . . . . 0.0 112.385 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.45 HD22 ' N ' ' B' ' 43' ' ' ASN . 0.8 OUTLIER -66.69 -19.74 65.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.659 1.183 . . . . 0.0 111.976 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.29 16.79 15.26 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.176 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.77 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.5 ppp? -125.52 175.95 7.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.747 0.819 . . . . 0.0 109.723 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.538 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -140.36 137.68 34.26 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -133.03 118.84 19.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.753 0.421 . . . . 0.0 110.234 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.409 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -97.47 163.33 21.76 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' B' ' 9' ' ' LEU . 1.1 tp -141.75 104.68 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 171.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 3.3 t90 -111.43 134.78 52.77 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.407 ' HB2' HG22 ' B' ' 54' ' ' THR . 35.3 m -76.12 136.56 39.83 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 111.355 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -72.48 -9.88 59.1 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.917 0.887 . . . . 0.0 112.335 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -87.18 -8.18 57.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.28 0.632 . . . . 0.0 111.095 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.407 HG22 ' HB2' ' B' ' 51' ' ' SER . 13.2 t -135.42 8.8 3.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.907 0.483 . . . . 0.0 111.342 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' B' ' 58' ' ' LYS . 4.0 p -67.93 143.3 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.38 0.272 . . . . 0.0 111.272 176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -123.81 117.49 27.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.246 1.018 . . . . 0.0 109.181 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.3 143.41 76.32 Favored 'Cis proline' 0 C--N 1.381 2.277 0 CA-C-N 120.098 1.071 . . . . 0.0 113.105 -1.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.535 ' HA ' HG13 ' B' ' 55' ' ' VAL . 3.1 tppp? -58.84 127.81 34.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.992 0.917 . . . . 0.0 112.66 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.08 108.92 3.1 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.78 1.232 . . . . 0.0 108.677 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -87.0 89.73 8.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.16 0.584 . . . . 0.0 109.507 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 142.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.551 0.741 . . . . 0.0 110.422 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -139.24 136.55 35.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 109.479 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.75 51.84 50.48 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.752 0.658 . . . . 0.0 114.172 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.05 45.72 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.45 -170.63 12.03 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.455 -0.372 . . . . 0.0 113.124 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.4 170.56 47.99 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.258 0.622 . . . . 0.0 112.975 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -99.93 159.81 14.8 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.589 0.756 . . . . 0.0 110.77 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.78 101.36 10.81 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.58 103.69 14.65 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -82.81 105.78 14.1 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 41.0 mtm105 -84.6 127.99 34.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.689 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.56 157.79 43.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.963 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.26 -42.39 83.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.037 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.99 174.33 13.27 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 121.497 0.665 . . . . 0.0 111.876 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.61 -27.7 69.12 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.139 -1.392 . . . . 0.0 112.461 -165.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.99 -41.84 77.3 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -63.56 -23.71 67.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.561 0.745 . . . . 0.0 112.392 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.33 -42.65 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.252 0.621 . . . . 0.0 110.631 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.43 -31.12 68.17 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.594 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.2 mt-10 -70.98 -42.69 69.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.408 0.623 . . . . 0.0 109.557 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -69.19 -29.81 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -62.64 -60.68 3.17 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.549 0.74 . . . . 0.0 109.143 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.17 88.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.801 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.06 94.38 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 124.041 0.838 . . . . 0.0 113.615 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -63.88 -45.7 88.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.308 0.643 . . . . 0.0 110.235 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.82 -45.7 78.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.582 0.753 . . . . 0.0 110.454 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.91 63.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.028 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -99.45 14.15 30.81 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.959 0.903 . . . . 0.0 112.43 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 54.25 3.65 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.709 -0.678 . . . . 0.0 114.751 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' B' ' 20' ' ' PHE . 38.3 t -104.26 147.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.248 0.619 . . . . 0.0 109.339 170.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.15 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.092 0.557 . . . . 0.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 55.0 ttm 63.84 84.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 166.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.62 86.77 2.64 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.863 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 22.9 tm0? 178.82 122.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.072 1.349 . . . . 0.0 107.644 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -79.58 114.48 45.94 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -48.64 107.53 0.14 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.567 2.845 . . . . 0.0 112.178 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.84 145.31 42.3 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.942 0.897 . . . . 0.0 109.941 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.28 112.38 8.3 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.521 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 16.5 ttm -101.18 162.91 12.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.78 -23.9 63.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 0.0 111.106 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . 0.521 ' H ' ' HG2' ' B' ' 99' ' ' MET . 96.3 m-85 -119.51 91.49 3.56 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.552 1.141 . . . . 0.0 109.033 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.78 151.56 1.13 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 80.1 t80 -71.8 100.87 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.3 t -108.77 151.14 26.61 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.948 0.88 . . . . 0.0 111.893 -161.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.544 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 9.6 t80 -141.15 149.23 41.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.036 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 62.6 m -141.57 128.19 20.25 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.982 0.81 . . . . 0.0 110.69 171.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.23 155.77 19.14 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.279 0.632 . . . . 0.0 109.935 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.61 128.43 54.53 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.22 156.86 57.54 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.197 0.999 . . . . 0.0 110.361 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.0 -21.71 72.38 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -92.93 -20.12 20.94 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.962 0.905 . . . . 0.0 110.377 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 40.2 m 71.9 90.99 0.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.965 1.706 . . . . 0.0 111.108 -176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.478 ' NE2' HG12 ' B' ' 11' ' ' VAL . 12.4 m170 -113.88 -91.68 0.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 167.32 109.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.577 1.151 . . . . 0.0 109.176 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -126.36 110.19 13.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.11 0.564 . . . . 0.0 111.153 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -92.56 147.86 22.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.215 0.606 . . . . 0.0 110.581 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -134.74 125.74 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 163.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.417 ' CE1' ' HG2' ' B' ' 71' ' ' ARG . 12.4 p90 -130.15 151.77 50.31 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.295 0.952 . . . . 0.0 111.479 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -104.11 116.46 32.24 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -74.84 107.61 7.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.24 100.19 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.905 0.753 . . . . 0.0 109.737 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.089 -174.393 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 70.1 Cg_endo -74.2 101.14 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.69 2.26 . . . . 0.0 111.563 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.614 ' HB3' ' HE ' ' B' ' 71' ' ' ARG . 27.0 t70 -113.52 1.78 15.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.031 0.932 . . . . 0.0 110.477 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -126.57 112.86 16.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -107.71 136.97 46.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 53.0 mt -119.99 135.0 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.617 0.767 . . . . 0.0 109.765 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.476 HD23 HD21 ' A' ' 47' ' ' LEU . 4.4 mm? -108.94 142.91 38.9 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 3.7 p90 -97.03 123.57 40.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.942 -173.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' SER . 22.9 m -127.91 162.12 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.669 -0.644 . . . . 0.0 109.823 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -116.85 45.8 1.78 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.724 1.21 . . . . 0.0 108.917 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 16' ' ' ALA . 47.9 t30 178.85 74.99 0.14 Allowed Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.868 -158.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.0 Cg_exo -58.62 -63.12 0.15 Allowed 'Trans proline' 0 CA--C 1.579 2.77 0 C-N-CA 122.183 1.922 . . . . 0.0 113.889 -177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 32.8 Cg_exo -60.27 -60.47 0.27 Allowed 'Trans proline' 0 C--N 1.404 3.465 0 CA-C-N 123.111 2.147 . . . . 0.0 112.331 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . . . -67.74 -39.18 84.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.589 -165.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.0 t -76.9 -28.53 55.36 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 86.3 m -71.77 -34.25 69.3 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.578 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 15.1 mm100 -64.41 -37.14 86.46 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.467 170.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.15 -43.09 88.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 12.2 m-85 -68.53 -31.21 70.29 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.796 176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -57.31 -46.14 83.49 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.269 0.486 . . . . 0.0 112.117 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.07 -35.42 56.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.418 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.9 tp -60.89 -41.52 96.21 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.247 1.419 . . . . 0.0 112.48 -177.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.494 HD22 ' HG3' ' B' ' 4' ' ' PRO . 25.3 mt -92.49 -45.18 8.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.256 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.5 28.23 6.45 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.044 -172.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.7 m -129.77 -178.97 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.063 0.945 . . . . 0.0 110.47 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -126.39 156.11 73.22 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.485 1.114 . . . . 0.0 108.504 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 47.7 Cg_endo -66.95 125.55 13.84 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.184 1.922 . . . . 0.0 112.413 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 40' ' ' VAL . 7.3 p -70.72 -35.81 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.549 0.739 . . . . 0.0 110.246 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 72.2 mm-40 -126.3 138.84 53.64 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 108.273 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -142.12 135.4 29.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 110.321 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 42.0 m -137.36 157.62 73.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.504 1.522 . . . . 0.0 108.398 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.8 -41.32 38.9 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.113 2.542 . . . . 0.0 114.098 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -127.92 21.95 6.31 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 85.2 t80 -149.99 152.94 35.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.09 0.556 . . . . 0.0 109.679 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 34.7 m -144.48 157.22 44.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.818 0.847 . . . . 0.0 109.455 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.7 tp -152.02 125.19 8.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.441 ' CZ ' ' HG ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -133.38 114.8 14.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.654 1.182 . . . . 0.0 109.194 174.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 30' ' ' VAL . 3.9 p -93.26 133.01 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.607 0.763 . . . . 0.0 109.589 174.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.438 HD13 ' SD ' ' A' ' 45' ' ' MET . 9.0 mp -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.213 0.605 . . . . 0.0 110.078 -170.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.48 -7.45 49.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.309 0.644 . . . . 0.0 111.528 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -73.54 -15.29 61.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.451 0.7 . . . . 0.0 110.221 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.36 -12.02 36.5 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 123.44 0.543 . . . . 0.0 113.808 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.595 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.5 ppp? -86.32 169.78 12.64 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.31 0.555 . . . . 0.0 110.216 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.67 138.27 48.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.452 0.301 . . . . 0.0 110.681 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.476 HD21 HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -136.12 130.6 33.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.032 0.533 . . . . 0.0 110.345 -170.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.76 166.17 13.12 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.627 0.632 . . . . 0.0 112.081 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 17.5 mt -136.47 106.98 6.48 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.455 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.5 t90 -109.8 129.45 55.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 53.3 m -72.33 129.97 39.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HG12 ' A' ' 55' ' ' VAL . 23.3 ptt180 -67.27 -18.7 65.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -75.88 -23.65 55.62 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.69 0.396 . . . . 0.0 110.94 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' HB2' ' A' ' 51' ' ' SER . 14.3 t -115.7 6.27 14.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.564 0.746 . . . . 0.0 111.479 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 9.5 p -71.72 151.97 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.35 117.03 17.68 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 122.994 0.518 . . . . 0.0 110.96 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.5 Cg_exo -73.59 140.46 67.35 Favored 'Cis proline' 0 C--N 1.391 2.799 0 CA-C-N 119.673 0.919 . . . . 0.0 111.163 0.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -60.46 110.1 1.18 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 110.083 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.1 108.61 19.77 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.461 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 p -81.47 85.96 6.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.55 141.74 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.089 0.955 . . . . 0.0 109.557 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -161.02 142.02 11.57 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.232 1.413 . . . . 0.0 108.827 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.62 -38.87 0.61 Allowed Glycine 0 C--N 1.345 1.081 0 O-C-N 123.129 0.268 . . . . 0.0 112.487 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.69 -77.42 0.05 OUTLIER Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.43 -137.14 19.89 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.06 167.19 54.62 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 16.8 mt-10 -103.75 152.48 21.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 47' ' ' LEU . 53.0 tp -117.71 98.61 6.46 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -90.95 114.71 27.28 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.392 0.615 . . . . 0.0 111.354 -169.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.0 m-85 -88.68 122.08 31.73 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.065 1.346 . . . . 0.0 108.79 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' B' ' 5' ' ' ASP . 41.3 mtm180 -99.01 129.88 45.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.501 0.667 . . . . 0.0 111.913 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.82 165.61 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.701 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.587 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.3 pt-20 -66.83 -39.73 87.77 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.2 p30 -162.5 -179.92 7.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.74 0.7 . . . . 0.0 112.094 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.02 -29.95 68.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.935 1.294 . . . . 0.0 112.913 -165.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.96 -47.8 76.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.046 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.5 mm-40 -64.7 -23.06 67.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.966 -1.016 . . . . 0.0 112.497 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 117' ' ' VAL . 63.9 t -66.51 -46.04 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.539 0.736 . . . . 0.0 109.729 174.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 27.6 t70 -72.65 -28.81 62.95 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.242 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.3 mt-10 -69.52 -41.35 76.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.397 0.618 . . . . 0.0 110.012 175.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.6 m -66.98 -32.86 74.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.858 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 37.0 t80 -54.13 -59.98 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.987 0.915 . . . . 0.0 109.515 172.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -61.08 -38.8 87.55 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.688 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.54 92.13 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 123.617 0.573 . . . . 0.0 114.257 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -63.71 -45.49 89.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.544 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.6 ttpt -56.07 -45.39 79.32 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.964 0.906 . . . . 0.0 110.256 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.51 68.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.976 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 m -98.89 13.63 31.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.144 0.978 . . . . 0.0 112.616 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.33 54.81 2.74 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.309 -0.859 . . . . 0.0 114.568 164.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.7 p -102.83 152.85 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.63 -47.83 65.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.076 0.398 . . . . 0.0 110.957 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.544 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 52.6 ttm 65.34 84.02 0.16 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 170.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.87 83.21 2.14 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 120.962 0.41 . . . . 0.0 111.013 173.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 17.4 tm0? 178.46 140.04 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -87.72 123.32 69.47 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.678 0.791 . . . . 0.0 110.882 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.64 98.17 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.426 2.084 . . . . 0.0 110.409 174.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.08 157.51 43.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.796 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.01 104.76 4.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.965 0.906 . . . . 0.0 108.977 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 ttt -100.61 173.83 6.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.818 0.847 . . . . 0.0 109.983 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -55.93 -36.45 67.76 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.596 1.158 . . . . 0.0 112.177 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 -8.39 51.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.735 0.814 . . . . 0.0 110.845 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 126.63 -173.25 18.19 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.029 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.27 105.97 7.62 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 t -131.53 166.76 20.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.718 0.407 . . . . 0.0 111.934 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.49 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -155.72 160.15 40.1 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.737 169.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 3.0 m -133.45 127.3 33.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.219 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . . . -107.33 152.67 23.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 110.474 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.32 116.57 32.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 115' ' ' LEU . 4.0 p-10 -68.81 170.45 8.41 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.675 0.79 . . . . 0.0 110.923 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -46.19 -39.54 20.89 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 123.412 2.742 . . . . 0.0 114.457 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.0 -11.96 55.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.579 0.752 . . . . 0.0 111.254 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 73.07 80.93 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.62 1.568 . . . . 0.0 111.679 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -120.07 -179.51 3.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.574 ' HD2' ' HD2' ' B' ' 57' ' ' PRO . 50.0 mmt-85 -103.27 99.16 9.0 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 109' ' ' ASP . 51.4 mt -97.12 103.37 15.29 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 25.7 mmt180 -89.11 148.54 23.63 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 123.967 0.907 . . . . 0.0 110.355 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 78' ' ' VAL . 9.3 p -138.67 130.57 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 159.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -137.56 163.3 31.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.437 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.15 111.72 16.24 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.76 119.67 15.24 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.63 0.581 . . . . 0.0 110.557 -169.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.768 0 C-N-CA 122.996 0.518 . . . . 0.0 110.692 -177.512 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 119.702 -0.19 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 58.9 Cg_endo -72.95 101.55 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.695 2.264 . . . . 0.0 111.941 172.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.595 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 12.2 t70 -114.93 2.82 14.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.719 0.771 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.441 ' CD1' ' HG2' ' B' ' 46' ' ' LYS . 3.8 t80 -126.78 112.65 15.63 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -169.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -107.43 137.21 45.88 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 43.7 mt -120.35 135.57 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.511 0.724 . . . . 0.0 109.636 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.33 142.11 42.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.455 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 25.1 p90 -95.12 124.67 39.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.824 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 51' ' ' SER . 36.0 m -128.76 163.5 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.931 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -118.81 44.83 2.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.488 1.115 . . . . 0.0 108.19 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 179.39 74.84 0.16 Allowed Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.662 -158.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 23.8 Cg_exo -58.61 -63.81 0.13 Allowed 'Trans proline' 0 CA--C 1.578 2.718 0 C-N-CA 122.154 1.903 . . . . 0.0 114.016 -177.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 31.8 Cg_exo -59.51 -60.66 0.29 Allowed 'Trans proline' 0 C--N 1.404 3.464 0 CA-C-N 123.035 2.12 . . . . 0.0 112.575 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.45 85.77 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.679 -165.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -76.76 -28.6 55.79 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.3 m -71.58 -34.21 69.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.632 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.1 mm100 -63.88 -37.67 88.25 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.416 170.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.31 -42.63 88.01 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.704 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -68.15 -31.8 71.63 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.139 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.632 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 54.3 mtpt -56.84 -46.34 81.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.263 0.554 . . . . 0.0 111.805 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.36 -35.03 54.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.226 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.47 -41.08 96.71 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.341 . . . . 0.0 112.547 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -92.75 -44.89 8.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.16 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 28.79 6.34 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.986 -172.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' B' ' 25' ' ' LEU . 25.8 m -130.77 -179.49 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.927 0.891 . . . . 0.0 110.598 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.67 156.31 71.11 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 124.363 1.065 . . . . 0.0 108.368 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -67.82 126.0 14.0 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.39 2.06 . . . . 0.0 111.806 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.553 HG11 HG23 ' B' ' 40' ' ' VAL . 13.5 p -71.91 -33.69 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.287 0.635 . . . . 0.0 110.281 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' B' ' 30' ' ' VAL . 60.4 mm-40 -128.28 138.3 52.35 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.9 m -142.56 136.14 28.95 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.108 0.563 . . . . 0.0 110.28 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 35.2 m -137.74 160.02 66.55 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 125.295 1.438 . . . . 0.0 108.442 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -52.36 -40.11 71.55 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.136 2.557 . . . . 0.0 113.212 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -127.97 21.91 6.29 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 87.0 t80 -149.39 153.21 37.03 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.074 0.549 . . . . 0.0 109.745 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 71.1 m -144.57 156.97 44.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.785 0.834 . . . . 0.0 109.696 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 3.0 tt -151.77 126.47 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.36 113.53 12.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.934 1.294 . . . . 0.0 108.865 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.614 HG22 ' HG3' ' B' ' 46' ' ' LYS . 7.0 t -92.92 132.2 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.655 0.782 . . . . 0.0 109.336 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.447 HD21 HD13 ' B' ' 25' ' ' LEU . 36.0 mt -89.25 150.01 22.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.872 0.469 . . . . 0.0 110.262 -171.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.19 -7.96 52.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 111.609 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -71.91 -16.62 62.12 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.621 0.769 . . . . 0.0 110.379 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -12.17 35.49 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 123.436 0.541 . . . . 0.0 113.886 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.59 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -86.68 170.11 12.09 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.307 0.553 . . . . 0.0 109.958 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.614 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.7 tttt -131.51 137.34 48.49 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.961 0.504 . . . . 0.0 110.6 -175.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.447 HD11 HD21 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -135.67 131.43 35.7 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.334 -171.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.23 167.61 13.36 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.193 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.22 105.77 5.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.423 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -109.72 129.33 55.62 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 62.5 m -72.25 129.8 39.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.4 ' O ' HG12 ' B' ' 55' ' ' VAL . 33.3 ptt180 -67.27 -18.82 65.36 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -170.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.85 -23.95 55.74 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.653 0.381 . . . . 0.0 110.59 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.41 HG22 ' HB2' ' B' ' 51' ' ' SER . 13.6 t -115.6 6.58 14.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 7.9 p -72.09 152.41 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 122.05 -0.406 . . . . 0.0 109.99 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.458 ' HB2' HH22 ' A' ' 116' ' ' ARG . 30.6 mt-10 -130.86 116.49 17.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 122.976 0.51 . . . . 0.0 110.903 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.574 ' HD2' ' HD2' ' A' ' 114' ' ' ARG . 2.6 Cg_exo -73.35 140.49 67.48 Favored 'Cis proline' 0 C--N 1.387 2.554 0 CA-C-N 119.838 0.978 . . . . 0.0 111.068 0.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.35 110.1 1.16 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.926 0.766 . . . . 0.0 110.146 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.01 108.69 19.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.664 1.186 . . . . 0.0 108.376 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.3 p -81.42 85.19 6.5 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.94 143.32 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.867 0.867 . . . . 0.0 109.276 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.455 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 1.0 OUTLIER -162.31 141.41 9.29 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.335 1.454 . . . . 0.0 108.808 171.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.23 -38.08 0.59 Allowed Glycine 0 C--N 1.343 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 112.719 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.5 -77.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.49 -137.03 19.7 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.89 167.03 54.65 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.5 mt-10 -103.48 152.63 21.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.006 0.431 . . . . 0.0 110.525 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.447 HD21 HD11 ' B' ' 47' ' ' LEU . 57.5 tp -117.63 98.86 6.6 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.609 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.02 115.04 27.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.492 0.663 . . . . 0.0 111.381 -169.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . 0.545 ' HB2' HG22 ' B' ' 117' ' ' VAL . 6.5 m-85 -89.2 122.47 32.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.949 1.3 . . . . 0.0 108.538 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.614 ' HE ' ' HB3' ' A' ' 5' ' ' ASP . 38.9 mtm105 -99.17 128.89 45.37 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.417 0.687 . . . . 0.0 111.678 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -129.95 165.94 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.791 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.71 -39.91 88.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -174.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' B' ' 73' ' ' GLU . 8.8 p30 -162.49 -179.54 7.02 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.543 0.61 . . . . 0.0 112.151 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.62 -29.97 69.57 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.006 1.322 . . . . 0.0 112.784 -164.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -64.49 -48.08 76.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.59 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.3 mm-40 -64.8 -22.92 67.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.118 0.967 . . . . 0.0 112.45 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.68 -45.55 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.611 0.719 . . . . 0.0 109.7 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -72.95 -28.84 62.66 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.966 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.8 mt-10 -69.32 -41.41 76.74 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.466 0.65 . . . . 0.0 109.95 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.405 ' CG2' HG21 ' B' ' 117' ' ' VAL . 23.7 m -68.22 -31.81 71.58 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.669 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -54.27 -59.52 4.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.744 0.818 . . . . 0.0 109.893 172.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.46 86.89 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.552 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.35 92.05 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 123.836 0.71 . . . . 0.0 114.064 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -64.35 -45.56 87.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.959 0.504 . . . . 0.0 109.908 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -56.49 -44.27 80.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.912 0.885 . . . . 0.0 110.404 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.52 -29.34 67.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.93 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 13.1 33.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.967 0.907 . . . . 0.0 112.447 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.03 2.69 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.603 165.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.9 p -102.98 152.83 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.95 67.69 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.146 0.43 . . . . 0.0 111.097 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.504 ' HB2' HG13 ' B' ' 90' ' ' VAL . 48.5 tpp 64.84 83.63 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.896 0.748 . . . . 0.0 112.727 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.74 82.83 2.11 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . 0.418 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 15.4 tm0? 178.81 140.89 0.1 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.081 1.353 . . . . 0.0 107.477 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.0 123.39 67.54 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.573 0.749 . . . . 0.0 110.517 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.78 98.54 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.472 2.114 . . . . 0.0 110.244 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.14 157.36 44.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.79 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.97 105.16 4.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.926 0.89 . . . . 0.0 108.85 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.43 ' SD ' HG21 ' B' ' 104' ' ' THR . 10.8 ttt -100.87 172.99 6.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.204 1.002 . . . . 0.0 109.901 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -55.34 -36.71 66.56 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.45 1.1 . . . . 0.0 112.424 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.64 -8.3 52.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.787 0.835 . . . . 0.0 110.953 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 126.52 -173.14 18.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.133 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -76.74 106.49 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.43 HG21 ' SD ' ' B' ' 99' ' ' MET . 11.9 t -132.0 166.19 22.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 0.0 111.82 -169.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . 0.418 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 6.4 p90 -153.71 162.35 41.32 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.409 168.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 29.2 m -134.54 127.69 31.81 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.48 152.44 24.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.388 0.675 . . . . 0.0 110.523 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.11 117.61 34.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.473 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 5.8 p-10 -71.12 171.72 8.02 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.702 -0.666 . . . . 0.0 110.288 176.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 7.7 Cg_endo -46.9 -39.63 24.73 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.464 2.776 . . . . 0.0 114.194 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.18 -10.7 57.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.133 0.573 . . . . 0.0 111.604 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 15.3 m 72.98 82.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.108 1.363 . . . . 0.0 111.565 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.422 ' HE1' HG12 ' B' ' 11' ' ' VAL . 13.4 m80 -123.25 179.99 4.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -103.93 99.15 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.91 103.83 15.81 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.609 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 44.0 ttm-85 -89.02 148.2 23.87 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.618 0.767 . . . . 0.0 110.516 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' B' ' 70' ' ' PHE . 21.5 t -136.58 131.18 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -136.99 163.94 29.53 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . 0.426 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -124.67 111.71 15.91 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.86 119.32 13.9 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.757 0.661 . . . . 0.0 110.623 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 95.05 1.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.021 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.369 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -87.26 83.44 1.01 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.842 2.361 . . . . 0.0 111.765 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.781 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.9 p-10 -84.8 4.92 30.73 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 172.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.7 t80 -123.41 127.66 48.76 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.093 1.357 . . . . 0.0 107.681 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -126.36 136.1 52.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.959 0.904 . . . . 0.0 108.584 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 50.9 mt -119.56 137.16 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.696 0.798 . . . . 0.0 109.53 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.503 HD11 HD22 ' A' ' 68' ' ' LEU . 97.4 mt -108.08 140.56 41.09 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.523 ' HE2' ' HA ' ' A' ' 62' ' ' THR . 36.3 p90 -85.7 130.98 34.42 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.262 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.515 HG12 ' NE2' ' A' ' 113' ' ' HIS . 5.3 m -129.5 151.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.479 0.657 . . . . 0.0 110.575 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.46 -55.36 3.69 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.22 1.008 . . . . 0.0 109.938 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -105.15 98.4 15.97 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.54 0.736 . . . . 0.0 109.927 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.2 Cg_exo -51.78 -53.92 6.19 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.518 2.812 . . . . 0.0 115.185 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.29 -54.19 5.87 Favored 'Trans proline' 0 C--N 1.402 3.363 0 C-N-CA 122.53 2.153 . . . . 0.0 113.023 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.18 61.83 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.296 -168.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -77.38 -35.16 54.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.723 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 78.6 m -67.16 -43.31 82.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.568 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 19.4 mm100 -61.47 -35.02 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.63 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 t80 -64.05 -44.26 93.01 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 124.058 0.849 . . . . 0.0 110.142 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -71.55 -30.06 65.46 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.854 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -56.31 -50.51 71.23 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.252 0.549 . . . . 0.0 111.991 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -33.76 52.41 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.72 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 19.4 tp -60.99 -48.62 80.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.707 1.203 . . . . 0.0 112.801 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 27' ' ' VAL . 35.4 mt -84.94 -40.79 16.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.301 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 33.61 6.39 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -173.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.4 m -128.27 -178.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.29 1.036 . . . . 0.0 110.595 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -132.95 141.17 40.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.988 0.915 . . . . 0.0 108.865 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.555 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 18.9 Cg_exo -66.06 110.82 1.82 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.613 2.209 . . . . 0.0 111.793 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.99 -39.68 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 17.9 mm-40 -112.51 109.04 18.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.2 p -113.88 141.97 46.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.277 0.631 . . . . 0.0 109.655 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 66.1 m -142.94 160.92 51.22 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.988 1.315 . . . . 0.0 108.894 -175.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.43 -30.85 91.74 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.736 2.29 . . . . 0.0 113.013 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.5 t -127.55 19.39 6.78 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.173 0.589 . . . . 0.0 111.894 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.3 t80 -159.1 156.78 29.77 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.881 0.472 . . . . 0.0 110.345 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 m -146.47 150.31 35.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.474 1.11 . . . . 0.0 108.358 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -144.44 116.97 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -128.85 122.97 31.55 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.037 1.335 . . . . 0.0 108.542 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 46' ' ' LYS . 15.6 t -106.21 134.0 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.979 0.912 . . . . 0.0 109.425 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' SD ' ' A' ' 45' ' ' MET . 85.5 mt -95.19 147.18 23.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.562 0.345 . . . . 0.0 110.107 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -12.45 52.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.302 1.041 . . . . 0.0 112.199 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.5 -8.92 29.61 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.175 0.99 . . . . 0.0 112.931 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.1 53.75 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.811 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -114.56 170.84 8.01 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.9 0.88 . . . . 0.0 108.938 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 40' ' ' VAL . 75.9 tttt -133.75 134.22 42.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -128.28 118.13 22.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.775 0.43 . . . . 0.0 109.878 -174.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -96.56 166.54 24.08 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.717 0.675 . . . . 0.0 111.521 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 tp -143.38 102.44 3.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.484 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 6.2 t90 -111.05 130.29 55.65 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 36.2 m -68.28 126.91 31.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.154 0.284 . . . . 0.0 110.244 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.427 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 24.7 ptt180 -68.79 -13.4 62.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.922 0.889 . . . . 0.0 112.605 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -14.4 59.51 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.47 0.308 . . . . 0.0 110.878 176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.454 HG23 ' HE1' ' A' ' 50' ' ' TRP . 13.6 t -128.36 10.5 6.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.62 0.768 . . . . 0.0 110.785 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 58' ' ' LYS . 10.3 p -69.79 149.31 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 173.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -130.37 123.8 20.76 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 122.983 0.513 . . . . 0.0 110.638 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.84 137.84 50.29 Favored 'Cis proline' 0 C--N 1.387 2.604 0 C-N-CA 124.453 -1.061 . . . . 0.0 111.432 -6.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -50.81 110.68 0.45 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.516 0.726 . . . . 0.0 110.886 -175.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.47 110.0 22.16 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 p -83.13 87.22 6.92 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -153.31 150.96 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.738 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.523 ' HA ' ' HE2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -163.72 147.92 10.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.245 1.418 . . . . 0.0 109.279 170.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.28 -7.91 76.47 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.961 -0.563 . . . . 0.0 114.098 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' HD3' ' A' ' 114' ' ' ARG . . . -159.24 122.95 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 133.98 111.93 1.26 Allowed Glycine 0 C--N 1.34 0.781 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.414 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 77.25 109.82 0.15 Allowed Glycine 0 C--N 1.346 1.135 0 O-C-N 124.134 0.549 . . . . 0.0 111.735 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.8 mm-40 -98.24 136.7 38.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 HD11 ' A' ' 9' ' ' LEU . 52.0 tp -107.85 99.6 9.05 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -87.56 113.7 23.49 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -163.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -90.6 111.33 22.6 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 108.327 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -92.28 127.09 37.64 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.529 0.68 . . . . 0.0 111.818 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 118' ' ' TYR . 35.0 m -125.11 162.14 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.522 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.615 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.6 pt-20 -67.9 -35.6 78.76 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -163.25 -179.95 6.97 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.686 0.675 . . . . 0.0 112.746 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -61.58 -29.67 70.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.247 1.419 . . . . 0.0 112.725 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.07 -44.27 72.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.063 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.615 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 75.0 mm-40 -63.63 -23.05 67.22 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.696 0.798 . . . . 0.0 112.467 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -65.89 -41.63 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 0.0 110.519 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.62 -27.94 45.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.127 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.5 mt-10 -66.6 -41.48 88.39 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.89 0.852 . . . . 0.0 109.513 173.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -64.47 -38.1 89.85 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.606 . . . . 0.0 110.93 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -55.99 -60.48 3.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.764 0.826 . . . . 0.0 109.845 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.59 -36.44 82.63 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.199 -172.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.68 -47.76 83.61 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.71 0.631 . . . . 0.0 113.655 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -65.15 -39.17 92.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.41 0.684 . . . . 0.0 110.185 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.9 ttpt -61.46 -43.07 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.376 0.671 . . . . 0.0 110.009 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.11 67.56 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.736 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 t -100.73 7.45 43.84 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.3 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.42 56.91 2.43 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 166.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.414 HG13 ' HB3' ' A' ' 92' ' ' MET . 5.8 p -104.75 146.1 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' ALA . . . -72.58 -39.39 67.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.721 0.408 . . . . 0.0 111.519 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.414 ' HB3' HG13 ' A' ' 90' ' ' VAL . 4.1 ptm 49.68 79.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.138 1.775 . . . . 0.0 113.862 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -109.1 83.29 1.73 Allowed 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.489 -0.757 . . . . 0.0 109.424 177.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 18.2 tm0? 178.85 127.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -76.02 125.78 87.64 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 104' ' ' THR . 42.8 Cg_endo -65.71 98.47 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.295 1.997 . . . . 0.0 109.948 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.14 160.89 39.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.581 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -69.72 142.65 53.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.326 0.65 . . . . 0.0 110.762 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ttp -147.48 -178.07 6.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.972 0.909 . . . . 0.0 108.66 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.07 -37.28 61.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.867 1.267 . . . . 0.0 113.194 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.37 8.64 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.536 0.735 . . . . 0.0 111.486 -172.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.93 -160.44 13.48 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -79.3 109.5 13.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 8.9 t -105.42 147.65 28.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.338 0.655 . . . . 0.0 111.551 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.448 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 17.3 t80 -154.5 136.35 14.51 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.828 1.251 . . . . 0.0 109.57 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.1 m -137.72 123.55 20.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.37 139.95 42.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.36 0.664 . . . . 0.0 111.524 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -111.72 126.78 55.41 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 13.3 p-10 -78.6 179.78 1.63 Allowed Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.831 175.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 46.8 Cg_exo -44.52 -40.51 13.71 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.827 2.352 . . . . 0.0 114.188 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.35 -21.87 59.49 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.686 0.394 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.69 74.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.438 1.495 . . . . 0.0 110.846 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.515 ' NE2' HG12 ' A' ' 11' ' ' VAL . 19.2 m170 -103.86 -171.57 1.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.413 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.51 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 19.5 mmm180 -120.29 96.77 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.36 99.34 8.6 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -96.47 95.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.321 0.648 . . . . 0.0 111.329 -169.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.74 133.54 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HE2' ' HB2' ' A' ' 120' ' ' PHE . 9.1 p90 -136.8 177.96 7.44 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.816 0.734 . . . . 0.0 112.319 172.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.25 111.88 6.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.406 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 38.5 t80 -84.56 119.2 24.92 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 C-N-CA 123.51 0.724 . . . . 0.0 110.375 179.105 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m170 . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.0 83.35 1.08 Allowed 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.911 2.407 . . . . 0.0 111.563 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ASP . . . . . 0.811 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.2 p-10 -84.46 4.68 30.56 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.292 0.568 . . . . 0.0 111.228 172.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -123.37 127.34 48.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.11 1.364 . . . . 0.0 107.502 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 t -126.3 135.99 52.21 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 108.857 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.8 mt -119.46 136.78 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 109.548 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.49 140.42 40.48 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' TYR . . . . . 0.533 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 36.0 p90 -85.46 130.91 34.48 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.106 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.613 HG12 ' NE2' ' B' ' 113' ' ' HIS . 7.1 m -128.93 151.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.257 0.551 . . . . 0.0 110.536 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.69 -55.83 3.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.318 1.047 . . . . 0.0 109.721 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -105.5 97.36 14.05 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 124.081 0.953 . . . . 0.0 109.758 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.412 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.9 Cg_exo -51.31 -54.59 5.13 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.594 2.863 . . . . 0.0 115.379 -177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.86 -54.54 5.26 Favored 'Trans proline' 0 C--N 1.403 3.398 0 C-N-CA 122.38 2.053 . . . . 0.0 113.409 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.2 61.65 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.439 -168.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 82.8 p -77.7 -34.49 52.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 73.2 m -67.65 -43.71 79.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' GLN . . . . . 0.518 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.0 mm100 -62.12 -34.73 76.89 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.954 173.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 84.6 t80 -63.68 -44.54 93.4 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.023 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' TYR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 50.1 m-85 -70.8 -30.58 67.07 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.917 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' LYS . . . . . 0.526 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 62.1 mtpt -56.45 -50.17 72.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.087 0.47 . . . . 0.0 112.125 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.69 -34.14 52.94 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.662 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 15.4 tp -60.54 -49.29 78.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.68 1.192 . . . . 0.0 113.092 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.51 ' HB2' HG22 ' B' ' 27' ' ' VAL . 34.9 mt -84.26 -40.96 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.28 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.26 33.75 6.41 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' B' ' 25' ' ' LEU . 31.5 m -128.62 -178.75 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.059 . . . . 0.0 110.573 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.43 142.35 44.59 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.926 0.89 . . . . 0.0 109.209 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.526 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 16.7 Cg_exo -67.39 110.56 2.07 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.355 2.036 . . . . 0.0 111.828 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.72 -39.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.794 0.838 . . . . 0.0 110.388 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 23.4 mm-40 -112.99 108.95 18.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -113.84 142.2 46.39 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.368 0.667 . . . . 0.0 109.81 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 50.4 m -142.87 161.48 48.64 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.784 1.234 . . . . 0.0 109.028 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.11 -30.61 89.43 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.471 2.114 . . . . 0.0 112.965 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -127.72 19.62 6.66 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.222 0.609 . . . . 0.0 111.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 77.0 t80 -159.12 156.88 29.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.794 0.438 . . . . 0.0 110.232 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 68.6 m -146.55 150.5 35.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.475 1.11 . . . . 0.0 108.318 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -144.72 117.0 8.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -129.12 123.65 32.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.899 1.28 . . . . 0.0 108.492 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.573 HG22 ' HG3' ' B' ' 46' ' ' LYS . 19.9 t -107.29 133.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.785 0.834 . . . . 0.0 109.244 -172.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.462 HD12 ' SD ' ' B' ' 45' ' ' MET . 85.5 mt -95.0 147.48 23.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.685 0.394 . . . . 0.0 110.091 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -12.24 52.76 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.158 0.983 . . . . 0.0 112.216 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.93 -8.55 30.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.096 0.959 . . . . 0.0 112.682 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.13 16.15 54.44 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' MET . . . . . 0.781 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -114.84 170.79 8.07 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.82 0.848 . . . . 0.0 108.862 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.573 ' HG3' HG22 ' B' ' 40' ' ' VAL . 80.2 tttt -133.61 134.22 42.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -176.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.518 HD11 HD11 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -128.27 118.19 22.82 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -174.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.73 24.71 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 123.698 0.666 . . . . 0.0 111.623 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' B' ' 37' ' ' SER . 6.8 tp -143.64 102.23 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' TRP . . . . . 0.468 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 6.2 t90 -110.92 130.4 55.59 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 35.9 m -68.3 127.26 32.28 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.286 0.366 . . . . 0.0 110.131 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' B' ' 10' ' ' TYR . 21.1 ptt180 -69.42 -12.78 61.94 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.846 0.858 . . . . 0.0 112.604 -173.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -77.95 -15.46 58.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.508 0.323 . . . . 0.0 110.523 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -127.98 10.37 6.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.607 0.763 . . . . 0.0 111.036 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' B' ' 58' ' ' LYS . 7.8 p -69.99 150.01 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -131.32 123.07 19.37 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.002 0.521 . . . . 0.0 111.13 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.97 136.6 45.15 Favored 'Cis proline' 0 C--N 1.389 2.688 0 C-N-CA 124.348 -1.105 . . . . 0.0 110.969 -4.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.439 ' HA ' HG13 ' B' ' 55' ' ' VAL . 1.5 tmmm? -48.28 110.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.387 0.675 . . . . 0.0 111.284 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.51 109.94 22.08 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.4 p -83.59 85.92 7.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 29.2 m -150.68 151.89 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.247 1.019 . . . . 0.0 109.636 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.533 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 0.3 OUTLIER -164.57 147.91 9.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.006 1.322 . . . . 0.0 109.457 169.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.99 76.64 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.412 0.445 . . . . 0.0 113.779 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . 0.532 ' HA2' ' HD3' ' B' ' 114' ' ' ARG . . . -159.35 122.88 1.18 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 133.83 112.15 1.29 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.514 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 77.28 109.69 0.15 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 173.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.5 mm-40 -98.22 138.16 35.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -170.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.518 HD11 HD11 ' B' ' 47' ' ' LEU . 0.6 OUTLIER -110.68 98.75 7.84 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.04 113.14 23.38 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -161.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -89.85 111.5 22.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.877 1.271 . . . . 0.0 108.578 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -92.99 126.3 38.0 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.51 0.671 . . . . 0.0 111.838 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.63 162.6 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.559 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLU . . . . . 0.573 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.8 pt-20 -67.74 -35.17 78.26 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.2 p30 -163.63 179.71 7.0 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.685 0.675 . . . . 0.0 112.769 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.66 -29.58 70.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.207 1.403 . . . . 0.0 112.764 -166.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.03 -44.03 73.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.078 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLN . . . . . 0.573 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.1 mm-40 -63.84 -23.08 67.21 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.915 0.886 . . . . 0.0 112.548 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.77 -41.55 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.291 0.636 . . . . 0.0 110.41 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.44 -27.37 41.67 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.114 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.6 mt-10 -66.57 -41.37 88.68 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.758 0.79 . . . . 0.0 109.372 173.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.8 m -64.62 -37.87 89.06 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.928 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.01 -60.52 3.36 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 109.722 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.488 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.86 -36.19 81.76 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.237 -172.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.86 84.07 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.578 0.549 . . . . 0.0 113.684 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -65.74 -38.72 89.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.301 0.64 . . . . 0.0 110.261 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.7 ttpt -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 109.982 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.589 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -101.14 7.38 43.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.129 0.972 . . . . 0.0 112.565 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 57.47 2.4 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 115.382 0.913 . . . . 0.0 115.382 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 p -104.87 146.14 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' B' ' 108' ' ' ALA . . . -72.33 -39.14 68.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.937 0.495 . . . . 0.0 111.747 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 10.2 ptp 49.17 80.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.965 1.706 . . . . 0.0 113.911 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.435 HD13 ' N ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -109.15 83.17 1.71 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.849 0.833 . . . . 0.0 109.62 177.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 178.58 126.64 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.153 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -75.37 126.84 87.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 123.328 0.392 . . . . 0.0 110.455 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' B' ' 104' ' ' THR . 55.8 Cg_endo -67.11 98.53 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.418 2.079 . . . . 0.0 109.732 172.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.33 160.73 39.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -69.38 141.78 54.08 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.881 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' MET . . . . . 0.478 ' HG2' ' HB ' ' B' ' 104' ' ' THR . 1.1 ptp -145.35 -176.38 5.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.153 0.981 . . . . 0.0 109.281 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -55.66 -36.56 67.21 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.539 1.135 . . . . 0.0 112.61 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.94 8.73 42.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.453 0.701 . . . . 0.0 111.941 -173.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.76 -159.97 13.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.654 -0.579 . . . . 0.0 111.654 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -79.95 109.6 14.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' B' ' 99' ' ' MET . 6.9 t -105.99 149.27 26.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.268 0.556 . . . . 0.0 111.369 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -155.77 137.14 13.97 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.867 1.267 . . . . 0.0 109.416 168.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 49.2 m -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.15 139.63 42.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.468 0.707 . . . . 0.0 111.51 -173.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -111.07 129.11 56.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 16.4 p-10 -81.52 -179.99 1.69 Allowed Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.977 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 43.3 Cg_exo -44.46 -40.71 13.63 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.473 2.115 . . . . 0.0 114.409 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.7 -22.15 60.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.974 0.51 . . . . 0.0 110.658 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m 72.62 74.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.4 1.48 . . . . 0.0 110.66 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' HIS . . . . . 0.613 ' NE2' HG12 ' B' ' 11' ' ' VAL . 22.1 m170 -103.56 -171.36 1.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.402 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.532 ' HD3' ' HA2' ' B' ' 64' ' ' GLY . 22.6 mmm180 -120.4 96.71 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.2 99.52 8.79 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.484 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -95.23 94.93 8.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.874 0.47 . . . . 0.0 111.886 -169.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.0 t -85.55 133.86 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -137.5 177.68 7.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.059 0.845 . . . . 0.0 112.279 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.08 111.41 5.92 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -83.07 113.44 20.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.55 92.92 3.5 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.024 0.828 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -176.239 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.39 0.138 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 m -93.67 124.07 37.42 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -98.2 121.21 57.83 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.925 0.89 . . . . 0.0 110.529 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.49 114.29 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.932 2.421 . . . . 0.0 112.285 174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.711 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.8 p-10 -99.01 11.43 39.02 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.352 0.596 . . . . 0.0 110.302 171.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -129.59 125.0 35.17 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.778 1.231 . . . . 0.0 107.875 -170.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -120.48 138.82 53.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.258 1.023 . . . . 0.0 108.503 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 55.8 mt -115.4 133.57 61.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 123.497 0.719 . . . . 0.0 109.066 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 HD21 ' A' ' 47' ' ' LEU . 9.1 mp -112.32 124.3 52.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 4.8 p90 -79.3 115.96 19.26 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.686 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 51' ' ' SER . 35.7 m -114.49 167.33 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.789 0.836 . . . . 0.0 109.191 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -96.68 -62.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.234 0.614 . . . . 0.0 110.322 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -106.16 96.31 13.0 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 123.351 0.66 . . . . 0.0 109.666 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 35' ' ' THR . 1.1 Cg_endo -44.9 -52.97 5.66 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 123.541 2.827 . . . . 0.0 115.809 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.41 -57.42 2.35 Favored 'Trans proline' 0 C--N 1.403 3.399 0 C-N-CA 122.416 2.077 . . . . 0.0 113.191 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.5 -37.41 77.17 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.226 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.4 m -77.43 -26.65 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.44 -175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 68.4 m -80.3 -38.95 29.69 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 82.9 mm-40 -67.01 -34.04 76.88 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.264 173.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -61.52 -49.45 76.67 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.673 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.2 m-85 -69.62 -27.18 64.86 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.616 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.6 mtpt -57.08 -51.75 68.04 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.144 0.429 . . . . 0.0 111.789 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.03 -32.26 39.53 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.916 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.0 tp -59.11 -53.24 60.58 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.041 0.936 . . . . 0.0 111.839 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB2' HG22 ' A' ' 27' ' ' VAL . 12.6 mt -83.11 -47.2 11.89 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.2 38.99 2.94 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 25' ' ' LEU . 30.4 m -128.42 171.12 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.328 1.051 . . . . 0.0 110.654 -176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.88 139.03 33.87 Favored Pre-proline 0 N--CA 1.484 1.246 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.15 108.76 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.489 2.126 . . . . 0.0 111.593 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.81 -39.28 85.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.286 0.634 . . . . 0.0 109.973 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.721 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 35.9 mm-40 -118.51 149.11 41.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.305 1.042 . . . . 0.0 108.647 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 p -160.93 152.95 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.303 0.641 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 52.4 m -148.8 159.65 37.44 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.725 1.21 . . . . 0.0 108.448 -176.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.59 -27.43 32.83 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.94 2.426 . . . . 0.0 113.798 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 14' ' ' PRO . 12.4 t -127.92 16.83 6.8 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.0 t80 -156.15 162.19 40.25 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.894 -0.504 . . . . 0.0 110.55 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 47.1 t -151.67 157.09 41.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.698 0.799 . . . . 0.0 109.351 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -152.31 128.92 10.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.16 141.86 46.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.443 1.097 . . . . 0.0 108.823 170.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.3 t -115.5 127.92 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.495 HD13 ' SD ' ' A' ' 45' ' ' MET . 10.0 mp -91.06 148.81 22.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.253 0.621 . . . . 0.0 110.187 -170.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.57 -8.51 34.78 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 111.809 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.81 -19.5 65.91 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.171 0.989 . . . . 0.0 111.724 171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.65 16.04 47.35 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 112.016 -0.434 . . . . 0.0 112.016 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.736 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -113.37 174.72 5.78 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.877 0.871 . . . . 0.0 109.036 176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HG3' HG22 ' A' ' 40' ' ' VAL . 82.7 tttt -139.23 140.92 37.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 9' ' ' LEU . 2.5 tt -140.07 123.26 16.84 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.817 0.341 . . . . 0.0 110.114 -171.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -104.68 160.3 15.59 Favored Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.793 0.711 . . . . 0.0 111.568 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 82.3 mt -126.11 106.46 9.59 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 164.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.589 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 4.9 t90 -105.08 123.19 47.39 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.6 t -70.7 130.82 42.76 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -65.48 -21.68 66.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.977 0.911 . . . . 0.0 112.364 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -76.56 -8.28 56.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.392 0.277 . . . . 0.0 111.398 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.3 t -131.86 9.2 4.54 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.353 0.661 . . . . 0.0 111.132 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.21 145.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -127.49 117.75 21.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.39 141.64 68.38 Favored 'Cis proline' 0 C--N 1.39 2.755 0 CA-C-N 119.935 1.013 . . . . 0.0 113.953 2.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.44 122.33 16.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.13 0.972 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.66 109.54 5.03 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.79 0.836 . . . . 0.0 109.996 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.6 p -85.36 85.5 7.44 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 121.875 0.845 . . . . 0.0 108.775 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.1 t -140.09 147.6 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 p -144.1 121.69 11.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.94 5.37 68.23 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.202 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.73 -34.78 72.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-O 121.303 0.391 . . . . 0.0 112.44 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' B' ' 10' ' ' TYR . . . -170.47 -161.54 21.23 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.214 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.55 110.26 0.24 Allowed Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.497 ' HG2' ' HD2' ' A' ' 114' ' ' ARG . 24.1 mt-10 -123.99 130.09 52.0 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -171.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 9' ' ' LEU . 17.7 tp -115.84 101.57 8.91 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -88.08 109.87 20.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.834 0.35 . . . . 0.0 110.752 -171.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.493 ' HB2' HG22 ' A' ' 117' ' ' VAL . 22.4 m-85 -89.35 107.6 19.16 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -88.06 130.71 34.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.443 0.64 . . . . 0.0 111.273 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.08 159.13 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.816 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -66.15 -34.25 77.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -173.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 9.9 p30 -163.94 -179.9 6.57 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.513 0.673 . . . . 0.0 112.333 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.56 -29.7 70.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.492 1.517 . . . . 0.0 112.978 -165.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.86 -41.47 74.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.248 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.568 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 64.9 mm-40 -64.23 -23.87 67.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.655 0.782 . . . . 0.0 112.123 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.14 -42.34 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 121.533 0.682 . . . . 0.0 110.221 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.45 -29.7 59.74 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.471 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -66.01 -46.64 77.21 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.488 0.661 . . . . 0.0 109.522 173.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.2 m -65.46 -32.96 74.86 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.131 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.57 -61.37 2.65 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 123.687 0.795 . . . . 0.0 109.982 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.61 -35.57 80.51 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.31 -172.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.64 -46.67 93.24 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.593 0.558 . . . . 0.0 113.151 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.44 ' HB3' HG21 ' A' ' 90' ' ' VAL . 45.7 m0 -62.53 -43.23 99.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.438 0.695 . . . . 0.0 110.597 174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -58.56 -43.13 89.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 110.596 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.19 -24.27 60.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.548 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 t -91.32 -0.22 57.62 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.301 1.041 . . . . 0.0 112.656 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.48 39.67 4.97 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.604 0.601 . . . . 0.0 114.604 168.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 85' ' ' TRP . 55.9 t -87.24 145.28 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.32 -51.07 67.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.96 0.504 . . . . 0.0 110.768 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.494 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 28.8 tpp 65.65 82.46 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.047 0.842 . . . . 0.0 111.898 169.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.41 84.01 2.22 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.569 0.7 . . . . 0.0 110.875 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 106' ' ' THR . 54.1 tp60 179.09 138.79 0.1 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.011 1.324 . . . . 0.0 108.679 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -83.49 121.88 76.71 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -63.04 102.21 0.3 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.639 2.226 . . . . 0.0 110.045 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.15 150.01 48.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.25 0.62 . . . . 0.0 111.363 -170.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt -71.62 100.77 2.36 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.4 ttm -92.29 173.99 7.53 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.071 0.948 . . . . 0.0 109.498 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.66 -34.46 71.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.409 1.084 . . . . 0.0 111.732 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -87.69 -5.38 58.72 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.065 0.946 . . . . 0.0 110.978 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.61 -170.01 19.97 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.142 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -75.17 102.34 4.92 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.1 t -107.65 149.24 28.33 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.709 0.766 . . . . 0.0 110.019 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 1.8 t80 -144.68 140.53 28.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.016 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 26.5 m -136.63 127.66 27.76 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -106.3 171.95 7.08 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.844 0.457 . . . . 0.0 110.401 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.38 121.5 20.11 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 3.9 p-10 -77.76 177.31 2.81 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.999 0.92 . . . . 0.0 111.531 176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 41.9 Cg_exo -42.05 -43.37 7.25 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 123.632 2.888 . . . . 0.0 114.946 170.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -88.56 -8.15 55.25 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.501 0.72 . . . . 0.0 111.247 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.5 m 64.6 87.55 0.11 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.055 1.342 . . . . 0.0 111.829 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -124.29 144.15 50.15 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.497 ' HD2' ' HG2' ' A' ' 67' ' ' GLU . 64.6 mtt180 -75.93 94.74 3.42 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.9 mt -92.82 99.21 11.91 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.465 ' HG3' ' HZ3' ' B' ' 50' ' ' TRP . 2.6 tmt_? -98.2 96.11 7.87 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.789 0.836 . . . . 0.0 111.641 -165.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 70' ' ' PHE . 18.6 t -90.54 120.09 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -132.08 159.16 39.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.268 0.485 . . . . 0.0 112.276 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.91 112.03 17.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -74.03 129.27 37.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 122.579 0.352 . . . . 0.0 110.768 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.21 103.33 14.07 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.662 179.413 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.293 0.092 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 27.4 m -88.92 123.18 33.02 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.95 0.5 . . . . 0.0 109.659 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -98.19 120.79 58.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.807 0.843 . . . . 0.0 110.108 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -89.12 114.68 0.67 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 123.278 2.652 . . . . 0.0 112.486 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.736 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.6 p-10 -99.31 10.86 40.6 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.439 0.637 . . . . 0.0 109.955 171.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.472 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -129.05 124.43 34.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.679 1.192 . . . . 0.0 107.812 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -120.02 139.01 53.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.069 0.948 . . . . 0.0 108.443 173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 54.9 mt -116.07 133.87 61.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.526 HD23 HD21 ' B' ' 47' ' ' LEU . 3.4 mm? -112.85 124.33 52.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.444 ' CE1' ' HA3' ' A' ' 65' ' ' GLY . 5.2 p90 -80.21 116.74 20.47 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.696 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 51' ' ' SER . 33.9 m -114.5 167.08 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.733 0.813 . . . . 0.0 109.118 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -96.62 -62.56 1.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.316 0.647 . . . . 0.0 110.087 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -105.98 97.5 15.61 Favored Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 123.339 0.655 . . . . 0.0 109.572 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.438 ' HG2' ' HA ' ' B' ' 35' ' ' THR . 74.2 Cg_exo -46.81 -52.04 8.23 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 123.426 2.751 . . . . 0.0 115.246 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -49.4 -57.58 2.26 Favored 'Trans proline' 0 C--N 1.404 3.493 0 C-N-CA 122.681 2.254 . . . . 0.0 113.041 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.99 74.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.31 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -77.34 -27.12 52.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.436 -175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.44 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 99.3 m -79.96 -38.76 31.61 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.525 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 87.1 mm-40 -67.3 -33.34 75.07 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.532 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -62.25 -48.9 77.88 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.789 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 23.9 m-85 -69.73 -27.59 65.09 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.562 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.8 mtpt -56.91 -51.68 68.14 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.238 0.472 . . . . 0.0 111.93 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.59 -32.56 41.96 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.081 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 18.5 tp -59.25 -53.08 62.37 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.046 0.938 . . . . 0.0 111.835 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.422 ' HB2' HG22 ' B' ' 27' ' ' VAL . 11.9 mt -83.36 -47.18 11.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.612 -1.176 . . . . 0.0 107.988 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.98 39.42 2.89 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.4 m -128.58 170.23 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.476 1.111 . . . . 0.0 110.665 -176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -125.28 141.31 38.35 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.404 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 57.5 Cg_endo -68.13 109.53 1.99 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.301 2.001 . . . . 0.0 111.248 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.15 -39.07 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.113 0.565 . . . . 0.0 109.75 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 24.1 mm-40 -118.59 149.16 41.83 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.725 1.21 . . . . 0.0 108.915 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 75.9 p -161.08 153.15 19.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 51.0 m -149.55 160.24 34.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.804 1.242 . . . . 0.0 108.502 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -53.5 -27.26 39.81 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.043 2.495 . . . . 0.0 113.596 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.438 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 11.6 t -128.05 16.92 6.73 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.477 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 73.4 t80 -156.04 161.58 40.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.783 -0.573 . . . . 0.0 110.406 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 73.9 m -150.76 157.84 43.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.963 0.905 . . . . 0.0 109.752 173.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.729 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 4.6 tt -152.97 128.26 9.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.452 ' HE1' HD22 ' B' ' 47' ' ' LEU . 0.5 OUTLIER -134.75 141.98 46.61 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.402 1.081 . . . . 0.0 108.995 169.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.553 HG22 ' HG3' ' B' ' 46' ' ' LYS . 14.8 t -115.33 127.9 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.491 HD13 ' SD ' ' B' ' 45' ' ' MET . 9.8 mp -90.83 148.96 22.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.301 0.64 . . . . 0.0 110.239 -170.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -8.61 36.05 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.301 1.04 . . . . 0.0 111.796 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -66.22 -18.98 65.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.464 1.105 . . . . 0.0 111.699 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.06 16.16 48.79 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.433 -0.348 . . . . 0.0 112.232 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.711 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -113.43 175.04 5.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.776 0.83 . . . . 0.0 109.046 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.6 tttt -139.98 140.64 36.33 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.526 HD21 HD23 ' B' ' 9' ' ' LEU . 2.8 tt -140.16 123.27 16.74 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.728 0.411 . . . . 0.0 110.09 -171.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.472 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -104.88 160.15 15.48 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.87 0.748 . . . . 0.0 111.522 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 81.6 mt -126.2 106.29 9.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 164.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.465 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 5.3 t90 -104.91 123.32 47.54 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 11.4 t -70.69 130.6 42.19 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.411 ' O ' HG12 ' B' ' 55' ' ' VAL . 31.8 ptt180 -65.92 -20.62 66.28 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.843 0.857 . . . . 0.0 112.447 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -77.18 -8.2 57.14 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.313 0.245 . . . . 0.0 110.869 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -132.01 9.12 4.48 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.308 0.643 . . . . 0.0 111.24 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 52' ' ' ARG . 9.0 p -71.73 145.79 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -127.41 116.72 21.4 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.448 ' HG3' ' HB2' ' A' ' 94' ' ' GLN . 10.4 Cg_exo -71.15 140.06 62.25 Favored 'Cis proline' 0 C--N 1.39 2.746 0 CA-C-N 120.205 1.109 . . . . 0.0 113.455 3.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -60.42 121.2 11.49 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.431 1.092 . . . . 0.0 112.005 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.47 109.65 5.11 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 123.678 0.791 . . . . 0.0 109.876 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 p -85.11 85.36 7.48 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-O 122.109 0.957 . . . . 0.0 108.858 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.9 t -139.71 148.73 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.2 p -145.1 121.66 11.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.541 1.136 . . . . 0.0 108.003 167.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.54 4.98 69.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.19 -34.75 76.08 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.79 0.295 . . . . 0.0 112.518 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.74 -162.43 23.07 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.747 -0.227 . . . . 0.0 112.731 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.4 110.71 0.24 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.172 0.572 . . . . 0.0 111.746 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 31.6 mt-10 -124.09 129.82 51.51 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -171.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' B' ' 68' ' ' LEU . 5.5 mt -114.06 102.17 9.92 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.19 110.04 20.38 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.342 0.519 . . . . 0.0 111.008 -173.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.6 107.43 19.08 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.495 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.8 mtm105 -87.86 129.5 35.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.336 0.589 . . . . 0.0 110.98 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.84 159.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.111 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 8.7 pt-20 -66.5 -33.52 75.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -173.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -164.19 179.83 6.62 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-O 121.455 0.645 . . . . 0.0 112.5 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 113.875 -1.511 . . . . 0.0 112.973 -165.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.81 -42.0 77.89 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.439 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -64.54 -23.73 67.37 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.022 0.826 . . . . 0.0 112.129 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.36 -42.43 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.476 0.655 . . . . 0.0 110.288 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.0 -30.66 62.59 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.029 1.331 . . . . 0.0 111.404 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.0 mt-10 -66.64 -46.21 76.54 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.407 0.622 . . . . 0.0 109.651 174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.0 m -65.62 -33.18 75.3 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.07 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -58.33 -61.48 2.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.836 0.854 . . . . 0.0 109.899 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.52 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.72 -35.58 80.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.471 -1.241 . . . . 0.0 112.222 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.6 -46.72 93.15 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.857 0.723 . . . . 0.0 113.029 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -62.82 -43.26 99.26 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.335 0.654 . . . . 0.0 110.432 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 31.9 ttpt -58.39 -43.32 88.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.035 0.834 . . . . 0.0 110.627 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.68 -24.32 61.0 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.909 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 38.1 t -91.0 -0.44 57.75 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.41 1.084 . . . . 0.0 112.424 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.91 41.37 4.67 Favored Glycine 0 C--N 1.354 1.574 0 N-CA-C 114.284 0.473 . . . . 0.0 114.284 169.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.8 p -88.95 146.48 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.24 -50.53 67.61 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.805 0.442 . . . . 0.0 110.507 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.544 ' HB2' HG13 ' B' ' 90' ' ' VAL . 57.4 ttm 63.76 83.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.693 0.797 . . . . 0.0 112.843 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.51 83.91 2.21 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 121.638 0.733 . . . . 0.0 110.682 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' B' ' 106' ' ' THR . 57.2 tp60 179.41 139.48 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.756 1.222 . . . . 0.0 108.591 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -85.05 121.16 74.13 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 174.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.501 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 26.7 Cg_endo -62.48 102.22 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.566 2.177 . . . . 0.0 110.088 171.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -126.38 150.86 48.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.011 0.524 . . . . 0.0 111.548 -170.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -72.74 100.87 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.798 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.44 ' SD ' HG21 ' B' ' 104' ' ' THR . 4.5 mtt -90.69 175.15 7.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.234 1.014 . . . . 0.0 110.213 175.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.08 -34.6 73.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.092 0.957 . . . . 0.0 111.024 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -87.42 -5.81 58.69 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.175 0.99 . . . . 0.0 111.037 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.81 -169.53 20.25 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.23 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -75.66 102.51 5.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.44 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.0 t -107.82 149.09 28.66 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.572 0.701 . . . . 0.0 110.061 -173.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 11.3 t80 -144.32 141.13 29.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.038 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 28.9 m -136.77 127.38 26.99 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.1 171.79 7.15 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 122.657 0.383 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.03 122.65 22.11 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.472 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.7 p-10 -79.2 177.21 3.03 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.013 0.925 . . . . 0.0 111.219 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.1 Cg_exo -41.83 -43.19 6.72 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 123.485 2.79 . . . . 0.0 115.16 170.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.27 -9.22 53.6 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.726 0.81 . . . . 0.0 110.766 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 24.3 m 65.22 87.45 0.12 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.194 1.397 . . . . 0.0 111.66 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -124.47 143.79 50.45 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.454 ' HB2' ' HG2' ' B' ' 67' ' ' GLU . 67.4 mtm-85 -76.24 94.68 3.58 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 54.0 mt -92.83 99.11 11.84 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.589 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 2.8 tmt_? -96.0 94.93 7.87 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.258 -165.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 t -90.32 120.32 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.454 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.3 p90 -131.98 159.34 39.02 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.506 0.594 . . . . 0.0 112.345 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -122.46 111.32 16.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.8 124.28 25.05 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.331 0.395 . . . . 0.0 110.256 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.79 93.5 7.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 111.265 -176.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.621 0.248 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.7 m -93.46 127.46 39.11 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.793 0.837 . . . . 0.0 109.89 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -104.1 106.82 55.04 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.09 0.956 . . . . 0.0 110.623 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.7 95.03 0.92 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.773 2.315 . . . . 0.0 112.416 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.701 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.5 p-10 -83.53 3.56 31.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.384 172.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -124.33 118.61 27.14 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -168.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.0 t -117.3 137.75 52.21 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.624 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 50.8 mt -119.66 137.49 53.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 47' ' ' LEU . 4.6 mm? -88.47 106.96 18.62 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 168.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -58.51 104.26 0.21 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.251 -1.34 . . . . 0.0 108.398 163.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.55 HG12 ' HE1' ' A' ' 113' ' ' HIS . 27.8 m -118.8 173.81 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.412 1.085 . . . . 0.0 108.614 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -106.0 -64.74 1.13 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.99 0.916 . . . . 0.0 109.974 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -72.51 110.78 8.9 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.959 -170.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.3 Cg_exo -60.21 -62.25 0.16 Allowed 'Trans proline' 0 CA--C 1.576 2.618 0 C-N-CA 121.655 1.57 . . . . 0.0 113.324 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 22.3 Cg_exo -64.7 -52.11 1.5 Allowed 'Trans proline' 0 C--N 1.406 3.6 0 CA-C-N 122.984 2.101 . . . . 0.0 111.64 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.88 89.52 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.303 -165.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.47 -41.28 47.77 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 71.2 m -56.9 -46.02 82.22 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.565 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.6 mm100 -65.37 -38.25 89.47 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.515 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.406 ' CZ ' HG22 ' A' ' 90' ' ' VAL . 77.6 t80 -63.89 -45.7 88.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.327 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -70.68 -29.22 65.48 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.875 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -56.25 -48.32 76.76 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 118.44 0.564 . . . . 0.0 111.952 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.25 -38.74 50.47 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.075 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.51 -40.99 93.4 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.256 1.422 . . . . 0.0 113.02 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' A' ' 27' ' ' VAL . 18.6 mt -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.13 31.05 6.73 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.262 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' A' ' 25' ' ' LEU . 26.8 m -132.76 166.88 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.057 0.943 . . . . 0.0 110.322 -175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -113.71 149.32 41.54 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.443 0.697 . . . . 0.0 110.051 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 11.9 Cg_exo -71.37 111.91 3.21 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.912 2.408 . . . . 0.0 111.131 173.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.24 -37.27 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.337 0.655 . . . . 0.0 109.936 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 mm-40 -109.6 121.99 46.44 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.7 p -131.34 131.14 43.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.99 0.516 . . . . 0.0 110.118 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.8 t -144.13 152.98 55.93 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.222 1.409 . . . . 0.0 108.294 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.39 -10.44 13.42 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.661 2.241 . . . . 0.0 114.364 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -129.5 -1.02 4.97 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -153.94 148.56 26.31 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 122.096 -0.378 . . . . 0.0 110.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.8 m -137.91 149.68 46.42 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 109.638 177.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -143.77 122.27 12.44 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.48 ' HZ ' HD13 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -133.54 137.19 45.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.42 1.488 . . . . 0.0 108.17 173.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 46' ' ' LYS . 22.0 t -116.27 127.5 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.838 0.855 . . . . 0.0 108.764 -172.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.9 mt -87.07 150.61 23.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.836 0.351 . . . . 0.0 110.122 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.88 -8.12 45.94 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.246 1.018 . . . . 0.0 111.97 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.439 HD22 ' HB3' ' B' ' 5' ' ' ASP . 1.5 m-20 -72.77 -8.43 55.4 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.086 0.954 . . . . 0.0 112.03 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.11 16.75 42.94 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.724 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -119.61 171.93 8.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.799 0.84 . . . . 0.0 109.476 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 40' ' ' VAL . 66.0 tttt -132.77 141.08 48.33 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 9' ' ' LEU . 1.1 tt -138.45 122.04 17.39 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.202 0.525 . . . . 0.0 110.444 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.8 171.49 20.04 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 123.888 0.756 . . . . 0.0 112.26 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.48 HD13 ' HZ ' ' A' ' 39' ' ' PHE . 1.1 tp -140.37 118.84 12.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 166.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.1 t90 -115.44 122.67 46.49 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 t -84.28 125.3 32.12 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.988 0.515 . . . . 0.0 109.972 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 37.7 ptt180 -69.48 -9.35 53.37 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -167.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -75.02 -8.58 56.92 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -135.33 6.44 3.29 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.772 0.429 . . . . 0.0 111.089 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 52' ' ' ARG . 7.1 p -60.9 147.85 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.977 0.511 . . . . 0.0 110.814 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -119.25 115.08 34.53 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' B' ' 94' ' ' GLN . 81.7 Cg_endo -79.23 142.59 67.13 Favored 'Cis proline' 0 C--N 1.381 2.252 0 C-N-CA 124.469 -1.055 . . . . 0.0 112.582 2.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -51.17 115.22 1.45 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.592 1.157 . . . . 0.0 111.688 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.57 151.65 41.76 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.497 1.119 . . . . 0.0 109.094 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 20.1 m -134.95 87.09 2.31 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -157.09 123.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.769 0.828 . . . . 0.0 108.988 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.4 p -136.4 125.39 24.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.019 0.927 . . . . 0.0 109.651 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.71 67.47 0.83 Allowed Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.412 ' HA2' HG13 ' B' ' 61' ' ' VAL . . . -169.72 54.15 0.2 Allowed Glycine 0 C--N 1.345 1.05 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.98 169.6 19.15 Favored Glycine 0 C--O 1.242 0.62 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 80.88 106.84 0.31 Allowed Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.6 pt-20 -130.61 146.39 52.1 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.721 0.808 . . . . 0.0 109.59 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.7 tp -117.19 103.88 10.63 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.95 0.9 . . . . 0.0 108.637 -171.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.0 113.78 23.97 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 118.222 0.464 . . . . 0.0 111.312 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.64 110.14 21.3 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 125.037 1.335 . . . . 0.0 108.458 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -89.72 124.67 34.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.542 0.687 . . . . 0.0 112.421 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.59 158.94 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.795 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.0 pt-20 -64.46 -39.39 93.73 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -172.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -161.4 178.25 9.34 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.219 0.533 . . . . 0.0 112.073 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.2 -28.13 66.36 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.208 1.403 . . . . 0.0 112.462 -167.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.08 -50.71 69.49 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.857 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.54 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.6 mm-40 -64.3 -24.4 67.64 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.303 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.16 -45.68 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-O 121.361 0.601 . . . . 0.0 110.028 173.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -73.18 -29.98 63.22 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.54 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 33.1 mt-10 -66.51 -47.71 72.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -66.59 -29.25 69.27 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.706 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -60.11 -61.21 2.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.732 0.813 . . . . 0.0 109.593 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.02 -32.6 73.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.296 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.81 -45.69 91.87 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.648 0.593 . . . . 0.0 112.759 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.427 ' HB3' HG21 ' A' ' 90' ' ' VAL . 44.4 m0 -66.01 -41.11 91.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.524 0.73 . . . . 0.0 110.046 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.28 -43.6 88.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.608 0.763 . . . . 0.0 110.612 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.32 -27.36 61.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.761 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -94.48 8.67 41.3 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.56 0.744 . . . . 0.0 111.829 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.58 54.03 3.23 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 167.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.47 HG11 ' HB1' ' A' ' 107' ' ' ALA . 60.0 t -102.87 142.63 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.42 -47.29 82.53 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.132 0.573 . . . . 0.0 111.367 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 ttm 60.24 83.53 0.14 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 165.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.57 85.15 2.31 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 122.037 -0.414 . . . . 0.0 110.651 175.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? 177.93 121.1 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.665 1.186 . . . . 0.0 108.426 172.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -72.22 114.05 26.05 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 17.7 Cg_endo -56.22 112.93 1.22 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.945 2.43 . . . . 0.0 111.186 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.4 147.71 50.28 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.63 0.772 . . . . 0.0 110.657 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -75.26 100.93 4.5 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.643 ' HG2' ' H ' ' A' ' 101' ' ' PHE . 55.4 ttm -90.2 161.87 15.51 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -55.48 -28.49 54.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.735 0.814 . . . . 0.0 110.781 172.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.643 ' H ' ' HG2' ' A' ' 99' ' ' MET . 74.5 m-85 -110.14 88.34 2.74 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 109.509 171.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.64 162.34 0.94 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 82.7 t80 -78.2 101.83 7.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -107.65 145.38 33.41 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.512 0.673 . . . . 0.0 110.471 -165.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 4.9 t80 -137.1 130.66 31.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.531 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.0 m -120.85 122.78 41.03 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.448 0.642 . . . . 0.0 110.108 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB1' HG11 ' A' ' 90' ' ' VAL . . . -105.16 172.86 6.56 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.464 0.706 . . . . 0.0 109.988 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.85 118.12 12.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -68.01 168.25 13.97 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.675 0.79 . . . . 0.0 110.101 171.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.77 -27.26 15.04 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.114 2.543 . . . . 0.0 114.825 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.3 8.06 41.89 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.794 0.837 . . . . 0.0 111.229 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.4 m 70.45 30.04 3.32 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.134 1.373 . . . . 0.0 113.896 165.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.55 ' HE1' HG12 ' A' ' 11' ' ' VAL . 14.1 m80 -84.32 178.59 7.71 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -110.96 117.34 33.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -106.12 100.61 10.15 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -101.04 97.85 8.37 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -167.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.3 t -88.11 118.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -126.08 167.05 15.9 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 118.197 0.453 . . . . 0.0 110.957 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -126.82 110.69 13.35 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -82.1 115.79 21.38 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.19 94.11 4.05 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.367 0 CA-C-O 119.054 -0.859 . . . . 0.0 112.482 -178.247 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ptt? . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 8.5 m -101.56 124.18 46.81 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -103.5 106.6 52.71 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 124.426 1.09 . . . . 0.0 110.441 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.54 94.92 0.93 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.476 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.724 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 7.1 p-10 -83.05 3.4 30.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.105 0.562 . . . . 0.0 111.517 172.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.406 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.5 t80 -124.45 118.44 26.66 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -168.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -117.43 137.89 52.2 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.645 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 44.2 mt -119.72 137.08 54.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.45 HD23 HD21 ' B' ' 47' ' ' LEU . 4.6 mm? -88.14 106.86 18.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -58.43 105.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.06 163.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.522 HG12 ' HE1' ' B' ' 113' ' ' HIS . 22.4 m -119.1 173.79 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 124.353 1.061 . . . . 0.0 108.621 -175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -105.93 -65.16 1.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.754 0.822 . . . . 0.0 109.882 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -72.12 110.78 8.63 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.782 -170.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.52 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 27.4 Cg_exo -59.99 -63.07 0.13 Allowed 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 121.691 1.594 . . . . 0.0 113.353 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 33.3 Cg_exo -63.08 -53.0 1.74 Allowed 'Trans proline' 0 C--N 1.404 3.461 0 CA-C-N 123.195 2.177 . . . . 0.0 112.275 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.67 89.71 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.395 -165.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -76.11 -41.45 50.19 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.61 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 18.0 mm100 -65.71 -38.4 89.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.517 174.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -64.35 -44.89 90.04 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.749 0.656 . . . . 0.0 110.229 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -70.71 -29.51 65.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 118.904 -0.569 . . . . 0.0 109.884 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.61 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 58.9 mtpt -56.1 -48.38 76.26 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.486 0.585 . . . . 0.0 112.087 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.18 -38.98 50.52 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.04 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 tp -59.89 -41.4 91.52 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.203 1.401 . . . . 0.0 113.007 -174.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.482 ' HB2' HG22 ' B' ' 27' ' ' VAL . 19.7 mt -91.6 -41.27 10.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.955 -1.021 . . . . 0.0 108.315 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.44 30.87 7.07 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.28 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.0 m -132.86 167.11 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.093 0.957 . . . . 0.0 110.53 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -114.27 149.53 42.23 Favored Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 123.514 0.726 . . . . 0.0 109.663 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 7.2 Cg_exo -72.12 111.48 3.19 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.91 2.406 . . . . 0.0 111.016 174.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.75 -36.72 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 122.949 0.5 . . . . 0.0 110.068 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.713 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.5 mm-40 -110.12 121.28 44.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 78.5 p -130.79 130.58 43.89 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.165 0.586 . . . . 0.0 110.111 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 91.9 p -143.94 155.98 58.88 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.461 1.104 . . . . 0.0 108.441 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.32 -10.2 17.8 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.685 2.257 . . . . 0.0 113.779 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -129.42 -1.17 5.0 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -153.9 148.91 26.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.184 0.447 . . . . 0.0 110.018 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 14.2 m -137.67 149.78 46.83 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.634 0.774 . . . . 0.0 109.2 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -143.98 121.6 11.82 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.94 138.52 46.94 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.156 1.383 . . . . 0.0 108.45 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.7 t -117.26 127.21 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.869 0.867 . . . . 0.0 108.756 -171.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.478 HD12 ' SD ' ' B' ' 45' ' ' MET . 63.2 mt -87.1 150.58 23.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -172.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.95 -7.99 45.15 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.37 1.068 . . . . 0.0 111.89 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -73.28 -8.09 54.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.095 0.958 . . . . 0.0 111.948 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.04 16.81 42.94 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.701 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.4 ppp? -119.79 171.67 8.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.692 0.797 . . . . 0.0 109.378 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.6 141.17 48.56 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -173.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.45 HD21 HD23 ' B' ' 9' ' ' LEU . 1.1 tt -138.44 122.16 17.54 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 -172.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.406 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -103.86 170.57 19.11 Favored Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.863 0.745 . . . . 0.0 112.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 79.1 mt -138.59 119.83 14.69 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 164.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -115.27 122.68 46.71 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 39.1 m -83.59 125.49 31.86 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.784 0.434 . . . . 0.0 110.099 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 39.0 ptt180 -69.5 -8.45 47.1 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -75.92 -8.61 57.34 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.702 0.401 . . . . 0.0 111.48 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -135.52 4.78 3.14 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.184 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' B' ' 52' ' ' ARG . 7.5 p -57.8 147.82 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.128 0.571 . . . . 0.0 111.147 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.69 114.97 33.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.453 0.701 . . . . 0.0 109.143 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.33 143.09 68.68 Favored 'Cis proline' 0 C--N 1.382 2.31 0 C-N-CA 124.504 -1.04 . . . . 0.0 112.347 2.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.88 116.44 2.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.074 0.949 . . . . 0.0 110.861 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.63 151.22 41.23 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.988 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 49.5 m -134.67 86.96 2.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.412 HG13 ' HA2' ' A' ' 64' ' ' GLY . 7.5 p -156.27 123.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.244 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 10.4 p -135.49 126.46 27.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.834 0.854 . . . . 0.0 109.621 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.9 67.87 0.86 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.08 54.22 0.2 Allowed Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.88 169.76 19.25 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 80.74 107.26 0.3 Allowed Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.624 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 6.5 pt-20 -131.3 145.7 51.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.081 0.952 . . . . 0.0 109.079 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.5 tp -117.46 103.79 10.45 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.89 114.16 24.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.192 0.451 . . . . 0.0 111.252 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -91.2 109.98 21.25 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.918 1.287 . . . . 0.0 108.39 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.434 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.4 mtm180 -89.69 123.77 34.01 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.497 0.665 . . . . 0.0 111.991 -176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -130.18 159.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.781 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.9 pt-20 -64.79 -38.71 91.89 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -172.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -161.9 179.14 8.28 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.986 0.422 . . . . 0.0 112.064 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.0 -27.19 68.13 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.212 -166.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.11 -50.57 69.98 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.946 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.48 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 82.1 mm-40 -65.0 -24.1 67.41 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.39 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -68.18 -45.76 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.261 0.624 . . . . 0.0 110.087 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.24 -30.6 65.03 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.623 -175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 25.8 mt-10 -66.56 -47.22 73.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.396 0.617 . . . . 0.0 109.421 175.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -66.91 -29.25 69.08 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.688 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.03 -61.39 2.64 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.73 0.812 . . . . 0.0 109.621 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -67.17 -32.26 73.23 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.31 -173.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.65 -46.04 91.12 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.755 0.659 . . . . 0.0 112.826 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -66.51 -41.02 89.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.397 0.679 . . . . 0.0 109.708 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.8 ttpt -57.78 -43.62 85.67 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.769 0.827 . . . . 0.0 110.403 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.53 61.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.462 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 16.9 t -94.53 8.77 41.07 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.607 0.763 . . . . 0.0 111.685 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.97 54.49 3.19 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 114.476 0.55 . . . . 0.0 114.476 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' B' ' 92' ' ' MET . 5.4 p -103.16 143.41 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 170.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.74 83.5 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.049 0.539 . . . . 0.0 111.284 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.647 ' HB2' HG13 ' B' ' 90' ' ' VAL . 53.6 ttm 59.64 83.64 0.13 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 165.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -118.57 85.74 2.41 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 122.027 -0.421 . . . . 0.0 110.498 175.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.485 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 45.1 tp60 177.2 119.89 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.099 1.36 . . . . 0.0 109.119 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.55 112.51 14.19 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.58 0.752 . . . . 0.0 109.08 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.597 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 10.9 Cg_endo -53.98 111.99 0.85 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.186 2.591 . . . . 0.0 111.835 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.38 147.62 50.27 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.686 0.794 . . . . 0.0 110.582 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 100.73 4.12 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.634 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 51.5 ttm -90.43 161.5 15.52 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.6 -28.06 53.01 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.623 0.769 . . . . 0.0 110.98 172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.634 ' H ' ' HG2' ' B' ' 99' ' ' MET . 53.7 m-85 -110.02 88.18 2.69 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.391 1.077 . . . . 0.0 109.724 170.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.54 162.74 0.96 Allowed Glycine 0 C--N 1.354 1.56 0 N-CA-C 116.137 1.215 . . . . 0.0 116.137 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 84.7 t80 -78.89 101.96 7.98 Favored 'General case' 0 C--N 1.346 0.44 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 169.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.7 t -107.62 145.34 33.41 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.585 0.707 . . . . 0.0 110.617 -165.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 6.2 t80 -137.41 131.62 32.28 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.928 1.291 . . . . 0.0 108.421 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 16.5 m -121.8 122.55 39.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 109.896 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.29 172.74 6.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.283 0.633 . . . . 0.0 109.702 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.53 117.21 12.22 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -66.81 168.99 8.86 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.62 0.768 . . . . 0.0 110.175 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.94 -27.37 20.76 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.336 2.69 . . . . 0.0 114.449 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.77 8.1 40.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.741 0.816 . . . . 0.0 111.488 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 51.1 m 70.04 30.74 3.5 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.223 1.409 . . . . 0.0 113.824 165.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.522 ' HE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -84.4 179.08 7.51 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 172.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 75.9 mmt-85 -111.32 117.82 34.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 37.7 mt -106.41 101.2 10.68 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 -99.72 96.65 7.75 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -167.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -88.3 118.36 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.434 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.9 p90 -125.96 167.16 15.67 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.163 0.438 . . . . 0.0 110.988 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -127.0 110.73 13.28 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -82.7 118.18 23.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -173.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.41 93.85 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.349 0.66 . . . . 0.0 110.027 176.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.76 -1.022 . . . . 0.0 112.607 -176.698 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.845 0.355 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' B' ' 70' ' ' PHE . 35.7 m -136.15 143.37 44.45 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.359 1.064 . . . . 0.0 110.803 -163.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -123.18 117.46 28.21 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.537 0.735 . . . . 0.0 110.489 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HG3' HD22 ' B' ' 25' ' ' LEU . 41.5 Cg_endo -82.71 52.4 4.04 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 123.381 2.721 . . . . 0.0 111.768 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.903 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 36.7 t70 -75.64 5.07 6.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.215 1.006 . . . . 0.0 111.764 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.9 OUTLIER -124.46 126.56 46.1 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.0 t -120.44 145.02 47.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 50' ' ' TRP . 52.7 mt -122.07 144.4 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 123.775 0.83 . . . . 0.0 108.921 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.567 HD21 HD22 ' A' ' 68' ' ' LEU . 4.3 mm? -91.64 134.27 34.84 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.42 ' OH ' HG11 ' A' ' 55' ' ' VAL . 10.8 t80 -85.02 99.4 10.99 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.36 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.5 HG12 ' NE2' ' A' ' 113' ' ' HIS . 3.0 m -112.89 159.43 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.561 0.745 . . . . 0.0 109.075 -172.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.34 -59.78 1.87 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -102.37 101.82 21.83 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.245 0.618 . . . . 0.0 109.696 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.569 ' HG3' ' HB2' ' A' ' 51' ' ' SER . 44.5 Cg_exo -55.21 -55.93 2.75 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.056 2.504 . . . . 0.0 114.908 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.76 -54.74 4.34 Favored 'Trans proline' 0 C--N 1.403 3.407 0 CA-C-N 122.545 1.945 . . . . 0.0 112.379 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.07 96.52 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.74 0.65 . . . . 0.0 111.703 -173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -66.53 -47.08 74.04 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 96.5 m -67.48 -40.48 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.572 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 14.1 mm100 -64.49 -38.29 90.49 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.273 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -64.94 -42.23 94.83 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.389 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.425 ' OH ' ' HG ' ' A' ' 9' ' ' LEU . 49.7 m-85 -68.52 -29.67 68.31 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.533 0.606 . . . . 0.0 110.466 176.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.572 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -56.83 -49.43 75.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.204 0.526 . . . . 0.0 111.879 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.87 -40.07 63.49 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.92 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.7 tp -58.94 -42.7 90.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.478 1.511 . . . . 0.0 113.068 -174.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' HB2' HG22 ' A' ' 27' ' ' VAL . 16.3 mt -96.66 -31.99 12.42 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.16 26.88 27.29 Favored Glycine 0 C--N 1.341 0.855 0 O-C-N 123.325 0.391 . . . . 0.0 112.313 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.9 m -123.42 -178.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.967 0.907 . . . . 0.0 109.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' HG2' ' A' ' 22' ' ' LYS . 1.0 OUTLIER -142.07 151.41 58.89 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 37.6 Cg_endo -63.76 121.26 8.92 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.896 2.397 . . . . 0.0 112.773 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.34 -35.16 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.442 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 15.5 mm-40 -121.03 116.63 25.41 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.939 1.296 . . . . 0.0 108.233 174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.5 p -123.04 131.26 53.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.253 0.621 . . . . 0.0 110.097 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -138.67 151.14 68.15 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.864 1.266 . . . . 0.0 108.292 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.64 -10.12 23.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.817 2.344 . . . . 0.0 113.389 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.481 ' HA ' ' HG2' ' A' ' 14' ' ' PRO . 4.9 t -125.96 -3.57 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -159.17 151.47 21.25 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.7 m -141.62 158.6 43.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.769 0.428 . . . . 0.0 110.349 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -154.27 126.02 7.63 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.9 p90 -134.0 150.4 51.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.476 1.11 . . . . 0.0 109.09 165.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.531 HG22 ' HG3' ' A' ' 46' ' ' LYS . 13.4 t -120.96 131.42 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.03 165.4 15.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.644 0.378 . . . . 0.0 111.464 -171.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.79 -33.08 75.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.518 1.127 . . . . 0.0 112.869 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -69.91 -20.75 63.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.13 0.572 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.33 5.35 37.32 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 118.871 -0.961 . . . . 0.0 114.181 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.493 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.3 ppp? -74.06 166.26 23.7 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.346 1.073 . . . . 0.0 109.206 169.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' HG3' HG22 ' A' ' 40' ' ' VAL . 49.3 tttt -126.97 139.69 52.86 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 9' ' ' LEU . 3.5 tt -137.62 118.36 14.08 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.89 0.376 . . . . 0.0 110.387 -172.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -105.2 168.97 15.99 Favored Glycine 0 C--N 1.352 1.442 0 C-N-CA 124.226 0.917 . . . . 0.0 111.958 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -134.61 106.29 6.91 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 166.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.609 ' HB2' HG21 ' A' ' 8' ' ' ILE . 5.1 t90 -105.55 125.59 51.16 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.569 ' HB2' ' HG3' ' A' ' 14' ' ' PRO . 23.3 t -77.48 137.07 38.45 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.592 0.558 . . . . 0.0 110.597 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -71.59 -10.14 59.31 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.501 0.72 . . . . 0.0 112.906 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -85.14 -21.19 29.34 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.215 0.206 . . . . 0.0 110.731 174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 51' ' ' SER . 7.1 t -116.27 4.59 13.52 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.148 0.579 . . . . 0.0 111.326 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.613 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.1 p -72.71 145.4 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.97 116.54 26.05 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.4 Cg_exo -77.16 138.19 52.35 Favored 'Cis proline' 0 C--N 1.383 2.387 0 CA-C-N 119.727 0.938 . . . . 0.0 112.038 2.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HA ' HG13 ' A' ' 55' ' ' VAL . 2.8 tmmm? -65.25 112.42 3.44 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.962 0.789 . . . . 0.0 109.722 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.27 128.89 55.51 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.306 1.042 . . . . 0.0 110.015 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -90.52 84.38 5.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 m -159.27 150.86 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 124.688 1.195 . . . . 0.0 109.274 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.87 127.11 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.703 1.601 . . . . 0.0 107.915 170.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.89 -46.56 0.29 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.72 144.71 9.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.33 -29.93 0.15 Allowed Glycine 0 N--CA 1.469 0.876 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.56 149.56 18.33 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 114.192 -1.004 . . . . 0.0 110.695 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 7.4 mm-40 -101.71 151.56 21.89 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 173.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.567 HD22 HD21 ' A' ' 9' ' ' LEU . 41.4 tp -109.99 101.92 10.7 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -87.54 117.96 26.69 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.624 0.726 . . . . 0.0 111.296 -170.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.522 ' HB2' HG22 ' A' ' 117' ' ' VAL . 8.7 m-85 -96.47 121.46 38.31 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.782 1.233 . . . . 0.0 107.896 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.441 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 39.9 mtm105 -99.98 126.74 46.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -129.23 162.45 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.174 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.38 -33.68 69.75 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.82 179.39 7.12 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.055 0.843 . . . . 0.0 112.288 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.44 -34.27 75.12 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.432 1.093 . . . . 0.0 112.272 -165.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.24 -43.87 96.83 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.213 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -65.22 -21.75 66.79 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.874 0.87 . . . . 0.0 112.738 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.17 -38.12 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.071 0.463 . . . . 0.0 110.06 173.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.35 -32.29 64.46 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 124.306 1.042 . . . . 0.0 111.324 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.0 mt-10 -68.76 -40.1 79.93 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.656 0.741 . . . . 0.0 109.192 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.414 HG21 HG21 ' A' ' 117' ' ' VAL . 99.5 m -68.62 -32.7 72.76 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.65 174.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -62.78 -60.76 3.04 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.821 0.819 . . . . 0.0 109.458 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.4 -37.28 85.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.841 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.35 -46.12 91.49 Favored Glycine 0 C--N 1.347 1.146 0 O-C-N 123.98 0.8 . . . . 0.0 113.638 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 115' ' ' LEU . 36.3 m0 -61.23 -50.35 73.45 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.235 0.614 . . . . 0.0 109.996 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.7 ttpt -52.58 -45.16 66.35 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.142 0.977 . . . . 0.0 110.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.53 -23.98 61.08 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.294 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.8 m -97.77 11.12 38.27 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.814 0.845 . . . . 0.0 112.828 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.08 15.01 21.22 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.8 t -78.49 136.03 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 117.545 0.673 . . . . 0.0 110.321 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.68 72.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.428 1.091 . . . . 0.0 111.754 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.617 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 49.7 tpp 69.02 83.59 0.16 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.157 0.911 . . . . 0.0 112.849 165.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.27 86.47 2.28 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.0 0.52 . . . . 0.0 111.537 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.572 ' HG2' ' H ' ' A' ' 106' ' ' THR . 55.6 tp60 -179.67 140.77 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.882 0.873 . . . . 0.0 109.645 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -92.24 113.79 60.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 104' ' ' THR . 20.9 Cg_endo -61.63 108.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.243 1.962 . . . . 0.0 110.598 174.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.64 49.28 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.335 0.654 . . . . 0.0 110.219 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -63.07 106.26 0.82 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.588 0.755 . . . . 0.0 110.975 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 104' ' ' THR . 3.3 ttt -93.99 -176.38 3.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.843 0.857 . . . . 0.0 109.737 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 99' ' ' MET . 8.7 mm-40 -66.31 -27.67 68.09 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.132 0.573 . . . . 0.0 111.02 174.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.73 92.72 3.38 Favored 'General case' 0 C--O 1.247 0.948 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.8 161.74 3.24 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 115.872 1.109 . . . . 0.0 115.872 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 36.0 t80 -69.09 103.76 1.96 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.138 1.375 . . . . 0.0 108.61 172.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 13.7 t -103.03 141.55 35.63 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.86 0.754 . . . . 0.0 111.683 -162.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -151.62 127.61 10.38 Favored 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 124.754 1.221 . . . . 0.0 109.636 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.603 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 42.3 m -135.24 125.82 26.93 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.07 162.05 21.92 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.062 0.545 . . . . 0.0 112.169 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.89 112.42 24.64 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.581 0.753 . . . . 0.0 109.599 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.547 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.4 p30 -71.96 177.27 1.77 Allowed Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.437 1.095 . . . . 0.0 112.05 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 25.5 Cg_exo -40.64 -50.48 3.86 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 123.949 3.099 . . . . 0.0 115.544 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 9.9 t70 -79.62 -17.86 52.85 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.6 m 71.93 61.32 0.14 Allowed 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.412 1.485 . . . . 0.0 110.886 174.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.5 ' NE2' HG12 ' A' ' 11' ' ' VAL . 8.6 m80 -91.71 175.07 7.03 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.603 -1.18 . . . . 0.0 107.975 168.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -94.43 99.04 11.3 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HB3' ' CH2' ' A' ' 85' ' ' TRP . 81.9 mt -106.12 104.03 13.64 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.631 0.372 . . . . 0.0 110.011 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.545 ' NH1' ' HB3' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -93.31 147.18 23.15 Favored 'General case' 0 C--O 1.205 -1.269 0 C-N-CA 124.022 0.929 . . . . 0.0 110.01 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 70' ' ' PHE . 12.2 t -139.66 140.0 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 5.4 p90 -133.81 171.1 14.61 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.096 0.407 . . . . 0.0 111.635 172.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -131.06 113.95 14.56 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 166.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -75.11 129.25 37.23 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 93.27 1.9 Allowed 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.722 0.639 . . . . 0.0 110.264 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.219 178.232 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.311 0.101 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 20.9 m -142.3 140.44 32.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.484 0.314 . . . . 0.0 111.056 -167.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -122.69 117.59 28.77 Favored Pre-proline 0 N--CA 1.479 0.987 0 C-N-CA 123.566 0.747 . . . . 0.0 110.056 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.474 ' HG3' HD22 ' A' ' 25' ' ' LEU . 42.0 Cg_endo -82.74 51.69 3.8 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.28 2.654 . . . . 0.0 111.89 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.493 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 30.3 t70 -75.96 5.92 5.89 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 122.179 0.99 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.01 126.08 45.66 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 15.2 t -120.4 145.66 46.97 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 171.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' B' ' 50' ' ' TRP . 59.4 mt -122.67 144.09 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 123.825 0.85 . . . . 0.0 108.768 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.572 HD21 HD22 ' B' ' 68' ' ' LEU . 4.3 mm? -91.59 134.12 34.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 168.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -84.85 99.3 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.006 -1.452 . . . . 0.0 107.448 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.511 HG12 ' NE2' ' B' ' 113' ' ' HIS . 3.2 m -112.72 159.02 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.691 0.796 . . . . 0.0 109.032 -172.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -93.36 -60.28 1.82 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -102.29 101.71 20.99 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.295 0.638 . . . . 0.0 109.881 -173.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' B' ' 51' ' ' SER . 32.5 Cg_exo -55.67 -55.55 2.93 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.952 2.435 . . . . 0.0 114.701 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.77 -54.82 4.2 Favored 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.594 1.962 . . . . 0.0 112.276 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.31 96.52 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.072 0.549 . . . . 0.0 111.768 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 69.1 m -65.31 -47.15 77.57 Favored 'General case' 0 C--N 1.351 0.641 0 O-C-N 123.726 0.641 . . . . 0.0 109.364 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 51.9 m -67.46 -41.17 85.1 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -170.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.559 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 11.7 mm100 -64.09 -38.43 91.05 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.514 173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -64.83 -41.95 95.34 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.394 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 42.6 m-85 -68.6 -29.9 68.53 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.579 0.627 . . . . 0.0 110.487 176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.559 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -56.6 -49.48 74.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.194 0.521 . . . . 0.0 111.695 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.93 -40.26 63.22 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.975 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 31.0 tp -58.93 -42.2 89.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.37 1.468 . . . . 0.0 113.232 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.54 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.4 mt -97.55 -30.53 12.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.74 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.67 30.4 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.6 m -122.93 -177.71 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 124.121 0.968 . . . . 0.0 109.823 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' B' ' 22' ' ' LYS . 6.5 p-10 -143.04 151.81 56.79 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 109.365 174.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 18.7 Cg_exo -65.53 121.25 8.61 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.95 2.433 . . . . 0.0 112.263 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.513 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.2 p -64.9 -36.68 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 21.0 mm-40 -120.89 116.83 25.91 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.872 1.269 . . . . 0.0 107.966 175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -123.62 131.62 53.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.988 0.515 . . . . 0.0 109.933 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -138.97 150.34 64.87 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.833 1.253 . . . . 0.0 108.345 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.93 -10.33 22.41 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.507 2.138 . . . . 0.0 113.576 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' B' ' 14' ' ' PRO . 5.6 t -126.19 -3.27 6.92 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -159.14 151.64 21.51 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 73.3 m -141.87 159.08 42.96 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.628 0.371 . . . . 0.0 110.391 175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 24.2 tp -154.81 125.56 7.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.6 p90 -133.89 150.2 51.34 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.253 1.021 . . . . 0.0 109.134 165.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.553 HG22 ' HG3' ' B' ' 46' ' ' LYS . 18.5 t -120.77 131.46 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 61.7 mt -86.91 165.18 16.11 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.691 0.397 . . . . 0.0 111.553 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.69 76.34 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.641 1.177 . . . . 0.0 112.851 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -69.99 -20.47 63.29 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.004 0.522 . . . . 0.0 111.068 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.31 5.0 37.73 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-O 118.817 -0.99 . . . . 0.0 113.988 173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.903 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 6.8 ptm -73.68 166.84 22.55 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.538 1.169 . . . . 0.0 109.27 169.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' B' ' 40' ' ' VAL . 73.1 tttt -127.25 139.5 52.86 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.534 HD21 HD23 ' B' ' 9' ' ' LEU . 3.6 tt -137.56 118.7 14.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.973 0.416 . . . . 0.0 110.254 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.93 169.09 16.34 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.315 0.96 . . . . 0.0 111.958 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.85 106.03 6.69 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 166.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.609 ' HB2' HG21 ' B' ' 8' ' ' ILE . 4.5 t90 -105.46 125.63 51.21 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.573 ' HB2' ' HG3' ' B' ' 14' ' ' PRO . 21.6 t -77.29 137.13 38.61 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 123.681 0.613 . . . . 0.0 110.716 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -71.92 -9.78 58.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -85.32 -20.14 30.44 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.493 0.317 . . . . 0.0 111.389 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.477 HG22 ' HB3' ' B' ' 51' ' ' SER . 11.9 t -117.02 4.41 12.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.392 0.677 . . . . 0.0 111.029 -177.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' B' ' 58' ' ' LYS . 8.4 p -73.57 146.71 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.29 116.14 23.45 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -77.65 139.2 56.27 Favored 'Cis proline' 0 C--N 1.387 2.595 0 C-N-CA 124.706 -0.956 . . . . 0.0 111.869 3.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.517 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.1 tmmm? -66.18 112.5 3.96 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.85 0.719 . . . . 0.0 109.395 -177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.93 129.3 55.96 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.19 0.996 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 27.5 p -90.98 85.58 6.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 62' ' ' THR . 7.9 p -161.52 149.77 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.339 1.056 . . . . 0.0 109.567 -176.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.434 HG23 ' O ' ' B' ' 61' ' ' VAL . 2.1 p -168.83 128.1 1.1 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.958 1.703 . . . . 0.0 107.65 169.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.21 -47.55 0.29 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 112.327 -0.309 . . . . 0.0 112.327 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.82 144.66 9.66 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.98 -0.448 . . . . 0.0 111.98 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.41 -29.87 0.15 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 149.45 18.1 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.162 -1.019 . . . . 0.0 110.657 170.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.596 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 11.2 mm-40 -101.51 151.85 21.47 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.572 HD22 HD21 ' B' ' 9' ' ' LEU . 44.1 tp -110.14 101.78 10.54 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.452 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -87.58 118.0 26.77 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.575 0.702 . . . . 0.0 111.208 -170.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.464 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 5.9 m-85 -96.05 121.55 37.92 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 42.2 mtm105 -100.4 125.01 46.63 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.68 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 29.2 m -126.91 163.2 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.135 176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.1 pt-20 -71.3 -34.58 70.73 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.428 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -163.21 179.84 7.15 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 119.155 0.889 . . . . 0.0 112.482 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.13 -33.86 75.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.43 1.092 . . . . 0.0 111.891 -165.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.56 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.29 -43.67 97.23 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.987 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.5 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.5 mm-40 -65.62 -22.06 66.63 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.691 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.64 -38.95 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 122.748 0.419 . . . . 0.0 109.924 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.93 -31.82 64.87 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.154 0.981 . . . . 0.0 111.436 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.9 mt-10 -69.88 -38.93 76.52 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.634 0.73 . . . . 0.0 109.53 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 68.3 m -68.34 -33.53 74.45 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.616 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -62.47 -61.01 2.74 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.739 0.781 . . . . 0.0 109.542 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.6 -36.9 84.22 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.667 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.55 -46.84 89.03 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 124.001 0.813 . . . . 0.0 113.63 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . 0.409 ' HB3' HG21 ' B' ' 90' ' ' VAL . 42.1 m0 -60.6 -50.28 74.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.351 0.66 . . . . 0.0 109.551 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.612 ' HB2' ' HE3' ' B' ' 92' ' ' MET . 31.5 ttpt -53.42 -44.64 68.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.132 0.895 . . . . 0.0 111.003 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.35 -23.69 61.18 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.324 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 m -98.19 10.64 40.08 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.722 0.809 . . . . 0.0 112.884 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.58 14.77 20.85 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' B' ' 85' ' ' TRP . 54.4 t -78.66 135.69 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 117.554 0.677 . . . . 0.0 110.413 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.95 -37.48 71.59 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.468 1.107 . . . . 0.0 111.764 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.612 ' HE3' ' HB2' ' B' ' 86' ' ' LYS . 45.0 tpp 69.83 83.16 0.15 Allowed 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.126 0.891 . . . . 0.0 112.707 165.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.49 87.08 2.32 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.745 0.418 . . . . 0.0 111.512 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.575 ' HG2' ' H ' ' B' ' 106' ' ' THR . 56.9 tp60 179.66 141.77 0.13 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.118 0.967 . . . . 0.0 109.856 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -93.51 113.24 59.69 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' B' ' 104' ' ' THR . 33.3 Cg_exo -60.26 108.64 0.53 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.472 2.115 . . . . 0.0 110.974 173.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.22 143.46 49.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.466 0.706 . . . . 0.0 110.541 -175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -62.48 106.24 0.74 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.817 0.847 . . . . 0.0 110.981 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.469 ' SD ' HG21 ' B' ' 104' ' ' THR . 3.3 ttt -93.9 -175.96 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.675 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' B' ' 99' ' ' MET . 10.4 mm-40 -66.54 -27.96 68.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.161 0.585 . . . . 0.0 111.015 174.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -128.89 92.24 3.36 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.286 1.034 . . . . 0.0 109.152 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.38 161.64 2.83 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 116.085 1.194 . . . . 0.0 116.085 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 34.0 t80 -68.87 103.25 1.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.133 1.373 . . . . 0.0 108.851 172.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.469 HG21 ' SD ' ' B' ' 99' ' ' MET . 5.3 t -103.67 142.11 34.9 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.163 0.892 . . . . 0.0 111.518 -161.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.487 ' HZ ' ' SD ' ' B' ' 92' ' ' MET . 14.2 t80 -151.6 127.81 10.53 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.499 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 60.4 m -134.99 125.92 27.55 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -122.43 162.03 22.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.007 0.523 . . . . 0.0 112.154 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -108.9 113.28 26.05 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.663 0.785 . . . . 0.0 109.165 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.555 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.8 p-10 -73.27 177.89 1.77 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 124.366 1.066 . . . . 0.0 111.745 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.7 Cg_exo -41.04 -50.3 4.24 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.919 3.079 . . . . 0.0 115.531 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' B' ' 113' ' ' HIS . 10.5 t70 -79.65 -17.64 53.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 71.72 61.1 0.15 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 125.329 1.451 . . . . 0.0 111.005 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.511 ' NE2' HG12 ' B' ' 11' ' ' VAL . 7.6 m80 -91.29 175.29 6.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.15 168.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -95.01 98.7 10.87 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 81.4 mt -104.95 103.54 13.13 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 46.4 ttt180 -89.83 148.49 23.16 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 123.279 0.632 . . . . 0.0 110.455 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 12.6 p -141.23 140.59 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.526 1.13 . . . . 0.0 108.176 163.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' B' ' 103' ' ' TYR . 7.2 p90 -133.7 170.63 15.26 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -130.49 113.79 14.72 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -74.68 130.24 39.17 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 99.87 0.89 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.94 0.896 . . . . 0.0 110.998 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.405 0 CA-C-O 119.689 -0.506 . . . . 0.0 112.444 176.448 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HB2' ' OE1' ' B' ' 77' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' B' ' 70' ' ' PHE . 54.4 m -140.82 145.96 36.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.444 0.698 . . . . 0.0 111.396 -168.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -133.88 96.95 15.8 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.601 0.76 . . . . 0.0 109.818 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.48 93.79 0.99 Allowed 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 122.195 1.93 . . . . 0.0 111.381 164.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' B' ' 43' ' ' ASN . 6.3 p-10 -109.25 14.63 23.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 0.0 109.454 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HD2' ' HD3' ' B' ' 71' ' ' ARG . 0.7 OUTLIER -131.5 141.91 49.86 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.919 -165.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 145.16 30.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.733 1.213 . . . . 0.0 108.117 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 51.4 mt -118.59 140.65 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.034 0.534 . . . . 0.0 110.661 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.56 118.53 37.03 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -74.42 122.5 23.09 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.981 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' SER . 11.7 m -122.14 163.7 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.17 -52.26 3.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -103.98 98.18 12.97 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.455 0.702 . . . . 0.0 110.079 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.49 -48.72 17.85 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.506 2.804 . . . . 0.0 115.858 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.89 -63.48 0.2 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 CA-C-N 123.106 2.145 . . . . 0.0 112.419 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.62 89.35 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 0.0 112.125 -167.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -66.82 -47.94 70.46 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.442 0.639 . . . . 0.0 110.425 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.406 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 65.8 m -75.96 -34.92 59.83 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.0 mm-40 -66.45 -33.74 76.39 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.102 0.876 . . . . 0.0 109.259 172.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 81.9 t80 -66.73 -42.83 85.67 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.002 177.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -71.21 -29.02 64.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.375 0.534 . . . . 0.0 110.377 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.0 mtpt -57.39 -48.9 77.86 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.935 0.398 . . . . 0.0 111.902 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.77 -35.68 62.56 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.024 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 12.9 tp -64.52 -30.58 71.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.602 1.161 . . . . 0.0 112.737 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' HG22 ' A' ' 27' ' ' VAL . 83.4 mt -104.03 -41.13 5.94 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.982 0.913 . . . . 0.0 109.565 176.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.73 34.06 6.16 Favored Glycine 0 N--CA 1.471 1.029 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.0 m -123.72 -177.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.521 1.128 . . . . 0.0 110.484 -176.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -148.52 146.74 23.25 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.485 1.114 . . . . 0.0 108.833 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 19.1 Cg_exo -64.41 108.12 0.95 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.598 2.198 . . . . 0.0 111.909 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.1 -38.7 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.7 mm-40 -111.9 121.8 46.03 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.1 p -121.97 140.9 51.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.56 . . . . 0.0 110.358 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 36' ' ' PHE . 43.5 t -141.6 149.8 55.13 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.872 1.269 . . . . 0.0 107.949 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.22 -24.86 61.58 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.843 2.362 . . . . 0.0 113.572 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.3 t -128.01 9.2 6.27 Favored 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 85.9 t80 -149.22 150.59 32.85 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.708 0.403 . . . . 0.0 110.505 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 42.7 m -134.51 143.17 47.29 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.553 0.741 . . . . 0.0 109.697 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.6 tm? -138.51 119.62 14.53 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 6.8 p90 -131.98 147.86 52.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 108.127 167.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 1.6 p -126.33 134.98 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 109.306 -173.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 47' ' ' LEU . 6.1 mp -95.26 150.78 19.87 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.261 -167.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.66 -9.14 57.8 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.952 0.901 . . . . 0.0 110.744 172.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 58.9 m-20 -70.73 -9.31 56.99 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.28 1.032 . . . . 0.0 111.441 170.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.7 63.99 Favored Glycine 0 C--N 1.353 1.503 0 C-N-CA 123.041 0.353 . . . . 0.0 113.38 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.424 ' SD ' ' O ' ' B' ' 4' ' ' PRO . 18.6 ptm -113.37 167.72 10.34 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.694 0.797 . . . . 0.0 109.175 177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 62.3 tttt -132.86 136.57 46.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.671 0.388 . . . . 0.0 109.991 -174.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 HD11 ' A' ' 41' ' ' LEU . 12.9 mt -125.38 123.7 39.91 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.714 0.805 . . . . 0.0 112.295 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.83 145.72 16.82 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 169.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 10.4 mp -117.29 105.19 11.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 161.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.33 129.79 54.86 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 69.2 m -72.5 130.82 41.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 123.27 0.356 . . . . 0.0 111.286 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 55' ' ' VAL . 42.6 ptt85 -66.15 -21.36 66.33 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.957 0.903 . . . . 0.0 111.913 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -81.33 -6.7 59.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.152 0.581 . . . . 0.0 111.606 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.474 HG22 ' HB2' ' A' ' 51' ' ' SER . 13.5 t -127.25 4.65 6.36 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.452 0.701 . . . . 0.0 110.784 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 52' ' ' ARG . 5.3 p -71.18 149.43 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.86 0.464 . . . . 0.0 111.47 -177.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -130.6 121.47 19.23 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.874 0.87 . . . . 0.0 109.392 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.56 141.1 68.83 Favored 'Cis proline' 0 C--N 1.385 2.497 0 CA-C-N 119.943 1.015 . . . . 0.0 112.345 -1.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -55.1 132.04 46.43 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.114 0.966 . . . . 0.0 112.215 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.79 109.73 4.49 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.723 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.8 m -83.04 87.32 6.89 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.2 m -148.34 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.942 0.897 . . . . 0.0 109.445 -176.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 p -150.81 135.57 17.33 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.655 1.182 . . . . 0.0 108.594 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.28 35.18 57.04 Favored Glycine 0 C--N 1.345 1.054 0 O-C-N 123.337 0.398 . . . . 0.0 113.139 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.53 29.25 2.61 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.21 -172.06 32.14 Favored Glycine 0 C--O 1.241 0.547 0 CA-C-N 115.858 -0.171 . . . . 0.0 112.867 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' B' ' 66' ' ' GLY . . . 70.48 107.45 0.04 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.675 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 36.1 mt-10 -122.76 134.47 54.44 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.76 109.57 15.76 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.98 121.96 34.85 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.249 0.547 . . . . 0.0 110.767 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.528 ' HB2' HG22 ' A' ' 117' ' ' VAL . 40.6 m-85 -102.87 107.64 18.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.789 1.636 . . . . 0.0 108.747 -177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.6 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 25.4 mtm180 -92.54 132.46 36.82 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 112.053 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 161.86 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.316 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 10.2 pt-20 -65.8 -41.31 92.07 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -160.83 -178.87 7.12 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 118.85 0.75 . . . . 0.0 112.57 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -56.42 -33.18 65.58 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.745 1.618 . . . . 0.0 113.072 -169.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.11 -46.0 79.15 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.84 0.456 . . . . 0.0 110.408 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.468 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 79.9 mm-40 -65.68 -23.2 66.73 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.194 0.998 . . . . 0.0 112.537 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.2 -44.07 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.495 0.718 . . . . 0.0 109.841 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -70.36 -35.63 73.68 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.516 1.126 . . . . 0.0 111.035 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -65.93 -41.02 91.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.251 0.548 . . . . 0.0 109.866 178.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.2 m -63.47 -41.14 98.59 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.612 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.89 -57.8 11.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.398 0.679 . . . . 0.0 110.693 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.498 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -63.04 -41.2 99.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.254 -175.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.44 -47.27 86.0 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 123.869 0.73 . . . . 0.0 113.547 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -62.1 -45.44 93.47 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.658 0.783 . . . . 0.0 109.826 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.4 ttpt -55.64 -43.0 75.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.115 0.966 . . . . 0.0 110.83 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.63 -26.94 61.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.239 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -93.29 8.21 41.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.937 0.895 . . . . 0.0 112.618 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.6 45.33 4.64 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 166.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.482 HG21 ' HB1' ' A' ' 107' ' ' ALA . 8.0 p -98.46 152.18 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 170.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.38 -62.34 1.51 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.601 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 30.2 ttp 61.24 82.75 0.16 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.173 0.989 . . . . 0.0 112.849 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.77 84.92 2.14 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.832 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 179.91 135.22 0.11 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 0.0 108.615 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -76.98 129.96 77.08 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 123.539 0.524 . . . . 0.0 109.923 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.58 96.42 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.752 2.301 . . . . 0.0 109.849 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.34 160.48 36.15 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.09 -169.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 101.05 6.35 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.065 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 21.7 ttt -100.75 -178.92 3.92 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.982 1.313 . . . . 0.0 110.023 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 99' ' ' MET . 15.1 mm-40 -52.13 -41.02 62.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.654 1.182 . . . . 0.0 112.432 177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 55.8 m-85 -96.55 11.96 33.29 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.614 -173.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.28 -165.47 12.79 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.86 112.04 19.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -141.87 169.24 17.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.839 0.455 . . . . 0.0 111.611 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 37.0 p90 -152.98 175.61 12.77 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.852 166.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.635 HG21 ' HG3' ' A' ' 114' ' ' ARG . 90.7 m -137.39 130.66 30.94 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.022 0.439 . . . . 0.0 110.178 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.22 168.18 9.24 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.443 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.7 112.33 6.82 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 5.9 p-10 -68.01 174.39 2.41 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.253 1.021 . . . . 0.0 111.134 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 16.0 Cg_exo -37.26 -49.94 1.66 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.197 3.265 . . . . 0.0 115.321 172.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -10.79 48.78 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.678 0.791 . . . . 0.0 111.177 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.6 m 69.84 92.78 0.08 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.535 1.534 . . . . 0.0 112.188 168.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.459 ' CE1' HG12 ' A' ' 11' ' ' VAL . 16.4 m80 -124.21 149.2 46.66 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 171.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.675 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 22.0 ttp180 -81.03 95.16 6.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 121.291 0.567 . . . . 0.0 110.115 -171.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 mt -92.76 101.59 13.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -92.84 95.54 9.58 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.805 0.842 . . . . 0.0 110.869 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 70' ' ' PHE . 36.5 t -97.21 117.05 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -133.81 161.62 34.24 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.8 111.46 15.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 166.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 35.8 t80 -77.48 127.31 32.3 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.79 94.34 8.68 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -178.015 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.441 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 27.1 m -141.97 145.78 34.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.393 0.677 . . . . 0.0 110.993 -166.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 96.86 16.52 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.735 0.814 . . . . 0.0 109.898 175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.424 ' O ' ' SD ' ' A' ' 45' ' ' MET . 73.7 Cg_endo -75.7 94.47 1.0 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.065 1.843 . . . . 0.0 111.267 164.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 43' ' ' ASN . 8.7 p-10 -109.78 14.65 23.16 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.551 0.74 . . . . 0.0 109.487 168.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.6 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.3 OUTLIER -131.15 141.25 50.08 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.895 1.278 . . . . 0.0 107.687 -165.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.464 HG23 HD23 ' B' ' 47' ' ' LEU . 5.6 t -145.13 145.1 31.25 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.693 1.197 . . . . 0.0 108.261 175.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.3 mt -118.31 140.19 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.103 0.561 . . . . 0.0 110.73 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.3 117.48 34.2 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.425 ' HD1' ' H ' ' B' ' 10' ' ' TYR . 5.6 p90 -73.07 122.93 22.59 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.139 0.976 . . . . 0.0 111.397 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' B' ' 51' ' ' SER . 11.3 m -122.44 163.67 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -98.43 -52.14 3.74 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -104.06 98.65 14.2 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.397 0.679 . . . . 0.0 110.5 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.69 -48.61 18.52 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.609 2.873 . . . . 0.0 115.927 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 15.6 Cg_endo -55.14 -63.89 0.17 Allowed 'Trans proline' 0 C--N 1.401 3.3 0 CA-C-N 123.002 2.108 . . . . 0.0 112.272 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.99 88.85 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.334 0.654 . . . . 0.0 112.088 -167.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -66.46 -48.16 70.82 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.494 0.664 . . . . 0.0 110.547 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 89.1 m -75.65 -34.9 60.52 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -168.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 85.3 mm-40 -67.17 -33.96 76.51 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.3 1.0 . . . . 0.0 109.056 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 85.7 t80 -66.05 -43.35 87.76 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.004 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.416 ' CD2' HD21 ' B' ' 49' ' ' LEU . 40.8 m-85 -70.68 -29.45 65.78 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.418 0.553 . . . . 0.0 110.142 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.3 mtpt -57.29 -48.71 78.21 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.125 0.488 . . . . 0.0 112.04 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.8 62.14 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.158 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 13.3 tp -63.88 -30.72 71.78 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.581 1.152 . . . . 0.0 112.734 -175.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' B' ' 27' ' ' VAL . 66.7 mt -104.47 -41.09 5.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 109.45 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.78 34.1 6.13 Favored Glycine 0 N--CA 1.47 0.951 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' B' ' 25' ' ' LEU . 35.6 m -124.19 -177.82 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.399 1.08 . . . . 0.0 110.833 -176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -147.23 146.6 25.94 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.203 1.001 . . . . 0.0 108.966 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 35.9 Cg_endo -63.38 108.54 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.408 2.072 . . . . 0.0 112.115 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -64.33 -38.38 82.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.31 0.644 . . . . 0.0 110.243 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 17.9 mm-40 -112.04 121.56 45.32 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.7 p -122.12 140.67 52.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.119 0.568 . . . . 0.0 110.488 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' B' ' 36' ' ' PHE . 30.7 t -141.71 149.47 53.62 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.963 1.305 . . . . 0.0 107.89 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.77 -24.99 58.45 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.7 2.267 . . . . 0.0 113.587 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -127.87 8.95 6.31 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' B' ' 33' ' ' SER . 85.8 t80 -149.0 150.6 33.09 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.606 0.362 . . . . 0.0 110.41 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 15.1 m -134.2 143.5 47.9 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.462 0.705 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tm? -139.4 119.15 13.2 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 5.9 p90 -131.91 148.0 52.51 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 167.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' B' ' 46' ' ' LYS . 5.6 t -125.92 134.28 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -172.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.524 HD21 HD13 ' B' ' 25' ' ' LEU . 52.3 mt -94.22 150.91 19.87 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.67 0.788 . . . . 0.0 110.775 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -9.42 58.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.082 0.953 . . . . 0.0 110.697 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 69.7 m-20 -70.63 -9.01 56.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.028 0.931 . . . . 0.0 111.699 170.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.16 11.54 62.87 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-N 116.59 -0.277 . . . . 0.0 113.342 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.578 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -115.1 167.2 11.03 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.88 0.872 . . . . 0.0 108.895 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' B' ' 40' ' ' VAL . 78.3 tttt -132.51 135.37 45.95 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.146 0.578 . . . . 0.0 109.659 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.464 HD23 HG23 ' B' ' 7' ' ' THR . 36.8 mt -124.94 123.87 40.83 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.775 0.83 . . . . 0.0 112.216 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.33 145.66 16.61 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 10.5 mp -117.53 105.2 11.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 161.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -107.26 129.97 54.81 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 69.5 m -72.73 130.48 40.61 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.199 0.312 . . . . 0.0 111.483 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.452 ' HD3' HG23 ' B' ' 62' ' ' THR . 31.7 ptt180 -66.48 -20.91 66.16 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.722 0.809 . . . . 0.0 111.995 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -81.05 -7.16 59.5 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.872 0.469 . . . . 0.0 111.514 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 51' ' ' SER . 14.1 t -126.88 5.44 6.6 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.295 0.638 . . . . 0.0 110.944 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.442 HG12 ' O ' ' B' ' 52' ' ' ARG . 5.5 p -71.57 149.54 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.808 0.443 . . . . 0.0 111.354 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -131.03 121.32 18.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.5 141.54 70.24 Favored 'Cis proline' 0 C--N 1.389 2.682 0 C-N-CA 124.622 -0.991 . . . . 0.0 112.294 -1.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -55.9 132.28 49.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.026 0.93 . . . . 0.0 111.928 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.04 109.52 4.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.578 0.751 . . . . 0.0 109.635 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 39.3 m -82.66 87.82 6.72 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.67 139.35 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.102 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.452 HG23 ' HD3' ' B' ' 52' ' ' ARG . 0.8 OUTLIER -150.14 135.33 17.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.823 1.249 . . . . 0.0 108.65 174.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.78 35.01 58.91 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.375 0.422 . . . . 0.0 113.329 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.05 28.79 2.69 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.23 -172.11 32.15 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 115.749 -0.225 . . . . 0.0 112.997 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.468 ' HA2' ' HA2' ' A' ' 66' ' ' GLY . . . 70.61 107.41 0.04 OUTLIER Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.672 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 35.0 mt-10 -122.72 134.54 54.45 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.5 tp -119.82 109.48 15.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.95 122.3 35.17 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.388 0.613 . . . . 0.0 110.85 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.529 ' HB2' HG22 ' B' ' 117' ' ' VAL . 40.6 m-85 -103.22 107.67 18.58 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.754 1.621 . . . . 0.0 108.474 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.603 ' HD3' ' HD2' ' A' ' 6' ' ' PHE . 27.8 mtm180 -92.76 131.53 37.74 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.197 0.522 . . . . 0.0 111.84 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.17 162.33 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.271 1.028 . . . . 0.0 110.239 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.3 pt-20 -66.31 -40.17 89.79 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -161.57 -179.13 7.06 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 118.989 0.813 . . . . 0.0 112.676 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -55.99 -33.32 64.73 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.776 1.63 . . . . 0.0 113.421 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.01 78.89 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.583 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.586 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.7 mm-40 -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.358 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.96 -44.76 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.552 0.692 . . . . 0.0 109.715 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.75 -36.44 78.37 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.298 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -65.46 -41.57 93.24 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.349 0.595 . . . . 0.0 110.025 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.7 m -62.77 -41.23 99.14 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.659 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -58.12 -57.44 12.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.448 0.699 . . . . 0.0 110.616 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -63.52 -41.01 98.51 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.235 -175.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.22 -47.67 82.57 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.801 0.688 . . . . 0.0 113.41 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -61.77 -45.82 92.24 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.637 0.775 . . . . 0.0 109.884 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.1 ttpt -54.74 -43.41 72.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.171 0.988 . . . . 0.0 111.04 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.77 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.798 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.8 m -93.53 8.51 40.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.024 0.93 . . . . 0.0 112.374 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.17 45.77 4.64 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 114.859 0.703 . . . . 0.0 114.859 166.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.478 HG21 ' HB1' ' B' ' 107' ' ' ALA . 8.3 p -98.56 152.02 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 170.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.48 -61.93 1.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.607 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 30.3 ttp 60.86 83.11 0.15 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.231 1.012 . . . . 0.0 112.79 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.45 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -106.35 85.48 2.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.352 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 179.71 134.22 0.1 Allowed 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 108.384 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -75.83 130.04 79.7 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.63 0.581 . . . . 0.0 109.893 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.98 95.78 0.67 Allowed 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.731 2.287 . . . . 0.0 110.083 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.16 160.15 36.91 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -168.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.04 101.08 5.9 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.962 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.43 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 22.4 ttt -100.89 -178.78 3.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.134 1.374 . . . . 0.0 109.84 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' B' ' 99' ' ' MET . 5.7 mm-40 -52.86 -40.79 63.71 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.559 1.144 . . . . 0.0 112.182 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 55.0 m-85 -96.3 11.94 32.85 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.863 0.865 . . . . 0.0 111.673 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.84 -165.3 12.92 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -83.07 112.2 19.58 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.7 t -142.0 169.32 17.82 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.817 0.447 . . . . 0.0 111.588 -168.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' B' ' 92' ' ' MET . 37.0 p90 -153.12 175.72 12.7 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.316 1.047 . . . . 0.0 108.731 166.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.656 HG21 ' HG3' ' B' ' 114' ' ' ARG . 96.8 m -137.49 130.8 30.91 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 110.138 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.32 168.45 9.06 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.505 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.86 112.23 6.71 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.483 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 4.6 p-10 -67.51 174.3 2.26 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.334 1.054 . . . . 0.0 111.551 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 17.3 Cg_exo -37.67 -49.78 1.92 Allowed 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.938 3.092 . . . . 0.0 115.225 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -88.26 -10.21 50.4 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.46 0.704 . . . . 0.0 111.368 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 70.07 92.18 0.09 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.578 1.551 . . . . 0.0 112.047 168.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.466 ' CE1' HG12 ' B' ' 11' ' ' VAL . 15.7 m80 -123.77 149.37 45.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 170.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.672 ' HB3' ' HG2' ' B' ' 67' ' ' GLU . 21.8 ttp180 -81.15 95.34 6.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.136 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 62.3 mt -93.24 101.72 13.99 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -171.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -90.97 94.72 9.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.892 0.877 . . . . 0.0 111.131 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' B' ' 70' ' ' PHE . 36.8 t -97.61 117.47 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 119.353 0.979 . . . . 0.0 108.366 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -133.77 161.42 34.76 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.71 111.35 15.47 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 166.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 35.2 t80 -77.98 132.55 37.89 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -173.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.79 95.22 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.274 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.096 0 CA-C-O 118.963 -0.91 . . . . 0.0 111.033 -174.421 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG3' ' H ' ' A' ' 2' ' ' THR . 15.6 ptm . . . . . 0 CA--C 1.55 0.956 0 CA-C-O 120.035 -0.031 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.61 HG22 ' HB3' ' B' ' 70' ' ' PHE . 9.8 m -140.7 138.14 34.02 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.309 0.644 . . . . 0.0 110.836 -158.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -137.27 134.94 18.99 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.1 0.56 . . . . 0.0 111.752 -173.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -94.05 92.29 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.291 2.66 . . . . 0.0 113.066 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.1 p-10 -103.17 9.46 38.28 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.613 0.72 . . . . 0.0 110.044 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -132.59 136.23 46.42 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.793 1.237 . . . . 0.0 108.116 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -131.56 142.67 49.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.699 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 57.2 mt -120.79 134.83 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 68' ' ' LEU . 94.0 mt -82.11 131.58 35.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' B' ' 66' ' ' GLY . 23.7 t80 -85.31 105.04 15.68 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.803 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 49' ' ' LEU . 2.4 m -116.35 176.68 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.97 -57.95 2.2 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.052 0.941 . . . . 0.0 109.678 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -89.18 105.64 10.94 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.748 1.219 . . . . 0.0 109.309 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.79 -55.91 2.35 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.95 2.434 . . . . 0.0 113.704 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.81 -65.82 0.1 Allowed 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 122.109 1.789 . . . . 0.0 112.686 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.73 81.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -165.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 98.7 p -63.33 -55.43 24.65 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 99.6 m -67.3 -39.33 85.95 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -168.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.525 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 23.7 mm-40 -62.38 -41.11 98.38 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.817 1.247 . . . . 0.0 109.45 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 86.4 t80 -65.37 -39.98 92.98 Favored 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.776 0.672 . . . . 0.0 110.049 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.442 ' OH ' HD21 ' A' ' 115' ' ' LEU . 61.4 m-85 -71.28 -31.42 67.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.594 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.1 mtpt -56.53 -46.33 80.66 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -37.7 51.17 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.272 175.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 14.9 tp -62.93 -30.91 71.92 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.268 1.027 . . . . 0.0 112.536 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 27' ' ' VAL . 46.1 mt -104.94 -37.63 6.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.008 0.923 . . . . 0.0 109.152 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.01 33.08 9.95 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.585 . . . . 0.0 111.636 -172.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 25' ' ' LEU . 23.9 m -128.15 159.37 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.963 0.905 . . . . 0.0 110.174 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -112.22 148.7 39.66 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 123.609 0.764 . . . . 0.0 109.625 175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 16.8 Cg_exo -67.18 108.03 1.47 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.784 2.323 . . . . 0.0 111.076 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 39' ' ' PHE . 7.3 p -63.4 -34.45 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.706 0.629 . . . . 0.0 110.679 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.7 mm-40 -115.63 85.36 2.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -86.71 129.45 34.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.266 0.626 . . . . 0.0 110.095 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -137.49 150.78 69.57 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.745 0.818 . . . . 0.0 109.193 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -49.76 -42.78 42.85 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 123.714 2.943 . . . . 0.0 114.812 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -127.17 24.51 6.33 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.252 0.548 . . . . 0.0 112.276 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -153.77 152.42 30.71 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.58 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 33.5 t -134.66 142.65 46.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.387 0.675 . . . . 0.0 109.366 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -141.06 122.31 14.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 5.5 p90 -129.74 146.61 51.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.839 0.856 . . . . 0.0 108.993 164.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 46' ' ' LYS . 6.1 t -118.88 135.12 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.433 HD12 ' SD ' ' A' ' 45' ' ' MET . 38.5 mt -96.21 158.76 15.29 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.933 0.493 . . . . 0.0 110.517 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.59 -20.95 66.12 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.965 0.906 . . . . 0.0 112.465 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -67.57 -20.84 65.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.898 0.879 . . . . 0.0 111.393 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.59 -14.17 42.46 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.733 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -72.91 154.96 40.34 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 174.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.565 ' HG3' HG22 ' A' ' 40' ' ' VAL . 81.6 tttt -119.23 139.74 51.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.55 115.52 11.55 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 121.253 0.549 . . . . 0.0 110.586 -168.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.35 170.7 21.6 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 123.901 0.763 . . . . 0.0 111.533 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 6.3 mp -139.5 107.7 5.77 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 165.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.9 t90 -105.09 124.05 48.87 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 m -76.79 139.25 40.31 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.374 0.67 . . . . 0.0 111.102 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.442 ' HD3' HG23 ' A' ' 62' ' ' THR . 39.2 ptt180 -73.0 -14.82 61.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.147 0.579 . . . . 0.0 112.244 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -85.72 -6.51 59.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 122.511 0.325 . . . . 0.0 111.157 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -129.37 8.51 5.49 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.367 0.667 . . . . 0.0 110.976 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.869 HG23 HH22 ' B' ' 116' ' ' ARG . 12.5 p -74.62 148.84 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 123.031 0.532 . . . . 0.0 111.734 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -128.19 116.03 20.19 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.827 0.851 . . . . 0.0 109.568 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.22 144.47 78.05 Favored 'Cis proline' 0 C--N 1.387 2.579 0 C-N-CA 124.52 -1.033 . . . . 0.0 112.743 1.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 55' ' ' VAL . 12.0 mmmm -53.17 114.11 1.35 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.694 0.798 . . . . 0.0 111.511 174.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.59 46.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.307 1.043 . . . . 0.0 109.44 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -98.09 89.3 4.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.28 0.632 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.74 124.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.102 0.561 . . . . 0.0 111.136 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.442 HG23 ' HD3' ' A' ' 52' ' ' ARG . 9.4 p -151.92 178.67 9.18 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.252 1.421 . . . . 0.0 108.631 171.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.59 -31.94 6.72 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.61 -172.52 31.19 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.94 119.95 0.65 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.22 125.07 0.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.74 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 6.7 pt-20 -131.79 145.04 51.36 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.253 0.549 . . . . 0.0 110.652 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -108.49 104.52 13.87 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -88.0 117.13 26.66 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.41 0.624 . . . . 0.0 110.761 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB3' ' CG2' ' B' ' 2' ' ' THR . 7.6 m-85 -97.74 112.67 24.47 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 31.7 mtm105 -90.64 135.08 33.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.883 0.473 . . . . 0.0 111.696 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.91 173.3 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.283 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.584 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.5 pt-20 -74.84 -45.39 43.57 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.919 -1.037 . . . . 0.0 113.769 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.457 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.4 p30 -157.62 175.22 14.21 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.701 0.682 . . . . 0.0 112.393 -176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.01 -32.39 67.88 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.525 -166.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.59 -44.94 85.08 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.401 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.0 mm-40 -64.39 -25.45 68.03 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.72 -39.4 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 121.397 0.618 . . . . 0.0 109.866 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.22 -32.14 68.43 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.543 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.6 mt-10 -65.85 -41.31 91.88 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.593 0.711 . . . . 0.0 109.665 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 117' ' ' VAL . 14.7 m -71.25 -29.13 64.73 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.834 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -59.58 -61.1 2.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.545 0.688 . . . . 0.0 109.632 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.46 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.94 -36.49 82.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.725 -175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.24 68.45 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.994 0.809 . . . . 0.0 113.712 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -63.1 -42.9 99.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.369 0.668 . . . . 0.0 110.333 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.7 ttpt -55.42 -47.0 76.64 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.953 0.783 . . . . 0.0 110.474 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.9 -15.28 59.73 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.414 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -92.12 -2.48 56.58 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.11 0.964 . . . . 0.0 111.939 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.92 3.25 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 113.914 171.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -98.13 150.79 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.22 -36.46 81.72 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.882 0.473 . . . . 0.0 111.8 -177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 61.5 tpp 65.83 83.14 0.17 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 85.89 2.25 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.491 0.662 . . . . 0.0 111.381 173.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 179.34 126.36 0.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.412 1.485 . . . . 0.0 108.639 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -79.85 109.95 14.04 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 167.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.2 119.38 6.25 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.786 2.324 . . . . 0.0 111.09 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 146.29 50.44 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.225 0.61 . . . . 0.0 110.745 -169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -73.92 101.94 3.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.851 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.7 ttm -98.35 174.76 6.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.134 -1.394 . . . . 0.0 108.879 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.95 -39.81 63.2 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.096 0.958 . . . . 0.0 112.233 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -91.55 6.97 43.6 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.583 0.753 . . . . 0.0 111.659 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 -163.78 12.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.003 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -76.13 102.15 5.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 15.0 t -113.06 147.51 37.12 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.186 0.517 . . . . 0.0 110.556 -171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -143.31 138.74 29.73 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.688 1.195 . . . . 0.0 109.536 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.6 m -134.91 119.91 18.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.027 0.83 . . . . 0.0 110.47 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.57 161.03 14.98 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 122.966 0.506 . . . . 0.0 110.989 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.8 114.68 23.64 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.493 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 6.1 p-10 -70.3 176.67 1.72 Allowed Pre-proline 0 CA--C 1.567 1.608 0 C-N-CA 124.071 0.948 . . . . 0.0 111.336 176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 1.4 Cg_endo -42.83 -41.71 8.74 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 123.853 3.035 . . . . 0.0 115.034 173.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -78.88 -25.97 43.91 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.542 0.337 . . . . 0.0 110.103 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.8 t 73.38 85.86 0.11 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.811 1.644 . . . . 0.0 110.003 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.465 ' CE1' HG12 ' A' ' 11' ' ' VAL . 13.7 m80 -113.87 -173.98 2.38 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 3.0 mmp_? -100.57 112.73 25.15 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 173.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.442 HD21 ' OH ' ' A' ' 21' ' ' TYR . 84.2 mt -114.96 103.63 11.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.825 0.45 . . . . 0.0 110.188 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.61 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 51.4 ttt180 -90.69 140.16 30.04 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 123.135 0.574 . . . . 0.0 110.81 -174.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 81' ' ' THR . 40.4 t -134.24 119.92 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 164.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -128.49 164.87 21.83 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.288 0.494 . . . . 0.0 111.812 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.68 111.2 9.19 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -80.25 114.3 19.05 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.01 91.95 0.7 Allowed 'General case' 0 C--N 1.348 0.534 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.233 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.519 -175.754 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tmm? . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 61.8 m -67.31 135.93 54.08 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.044 1.337 . . . . 0.0 112.056 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -136.64 135.13 19.99 Favored Pre-proline 0 N--CA 1.487 1.413 0 C-N-CA 122.832 0.453 . . . . 0.0 111.027 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -94.44 93.13 0.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.203 2.602 . . . . 0.0 113.174 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.733 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 11.4 p-10 -104.58 9.66 35.27 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.798 0.809 . . . . 0.0 109.606 171.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.01 135.79 45.64 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 108.033 -168.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.5 t -131.35 143.12 50.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.74 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 50.4 mt -121.12 134.53 64.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.486 HD11 HD22 ' B' ' 68' ' ' LEU . 93.2 mt -81.71 131.69 35.27 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 173.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.429 ' HE2' HG21 ' B' ' 55' ' ' VAL . 23.1 t80 -85.43 105.07 15.79 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.752 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.462 HG12 ' CE1' ' B' ' 113' ' ' HIS . 2.5 m -116.14 176.75 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.969 0.908 . . . . 0.0 108.664 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -115.16 -57.29 2.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 109.775 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -89.82 105.92 12.59 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.478 1.111 . . . . 0.0 109.453 -173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 28.1 Cg_exo -56.78 -55.95 2.32 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.984 2.456 . . . . 0.0 113.799 -177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 53.7 Cg_exo -55.61 -66.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.402 3.362 0 CA-C-N 122.255 1.841 . . . . 0.0 112.728 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.85 81.8 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -165.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 55.2 m -62.67 -55.95 22.18 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.437 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 98.2 m -66.95 -39.31 87.24 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -168.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.571 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 20.8 mm-40 -62.25 -41.35 98.36 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.762 1.225 . . . . 0.0 109.264 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 90.1 t80 -65.07 -40.28 94.47 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.058 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.452 ' OH ' HD21 ' B' ' 115' ' ' LEU . 62.6 m-85 -71.2 -31.45 67.62 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.507 176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 60.8 mtpt -56.28 -46.6 79.65 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.41 -37.57 51.54 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.53 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.6 tp -62.97 -30.91 71.95 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.471 1.109 . . . . 0.0 112.56 -174.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' B' ' 27' ' ' VAL . 46.6 mt -104.88 -37.71 6.91 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 109.071 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.21 33.25 9.66 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' B' ' 25' ' ' LEU . 21.5 m -128.8 158.57 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.043 0.937 . . . . 0.0 109.958 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -110.8 148.43 38.55 Favored Pre-proline 0 N--CA 1.483 1.2 0 C-N-CA 123.855 0.862 . . . . 0.0 109.693 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 20.3 Cg_exo -66.66 108.01 1.36 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.628 2.218 . . . . 0.0 111.338 174.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -63.2 -34.76 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.253 0.621 . . . . 0.0 110.593 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.657 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 30.7 mm-40 -115.62 85.59 2.31 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 34.1 p -86.74 129.55 34.83 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.334 0.653 . . . . 0.0 110.014 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -137.25 150.36 68.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.112 0.965 . . . . 0.0 109.382 -173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.52 -42.88 40.98 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.706 2.937 . . . . 0.0 114.725 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.7 t -127.26 24.36 6.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.003 0.43 . . . . 0.0 111.949 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -153.75 152.43 30.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 39.3 t -134.94 142.79 46.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.269 0.627 . . . . 0.0 109.333 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.657 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.4 tm? -140.85 122.84 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 173.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' B' ' 30' ' ' VAL . 3.6 p90 -129.74 146.67 51.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.848 0.859 . . . . 0.0 109.07 164.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' B' ' 46' ' ' LYS . 9.5 t -118.65 134.52 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.01 158.35 15.49 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.952 0.501 . . . . 0.0 110.647 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -22.19 66.53 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.121 0.969 . . . . 0.0 112.65 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' B' ' 45' ' ' MET . 18.9 p30 -66.66 -20.85 66.08 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 0.0 111.767 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.56 -13.22 42.93 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 113.241 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.622 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -73.5 155.41 39.24 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.566 ' HG3' HG22 ' B' ' 40' ' ' VAL . 79.2 tttt -119.41 140.11 50.93 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 tt -137.61 115.26 11.3 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.687 -168.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.05 170.79 21.95 Favored Glycine 0 C--N 1.349 1.284 0 C-N-CA 124.042 0.83 . . . . 0.0 111.579 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 5.4 mp -139.51 107.45 5.69 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 165.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -104.85 124.47 49.51 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.448 ' HB2' HG22 ' B' ' 54' ' ' THR . 15.8 m -76.77 139.39 40.39 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.385 0.674 . . . . 0.0 110.884 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -72.83 -15.12 61.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.274 0.63 . . . . 0.0 112.318 -173.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -85.82 -6.42 59.1 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.699 0.4 . . . . 0.0 110.824 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.448 HG22 ' HB2' ' B' ' 51' ' ' SER . 14.6 t -129.65 7.79 5.29 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.472 0.709 . . . . 0.0 111.162 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.429 HG21 ' HE2' ' B' ' 10' ' ' TYR . 8.4 p -74.61 149.68 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -128.59 115.86 19.56 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.177 0.991 . . . . 0.0 109.284 172.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.35 143.74 75.68 Favored 'Cis proline' 0 C--N 1.387 2.561 0 C-N-CA 124.626 -0.989 . . . . 0.0 112.675 1.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -52.22 114.39 1.32 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.591 0.756 . . . . 0.0 111.674 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.55 132.55 45.62 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.28 1.032 . . . . 0.0 109.458 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 40.3 m -98.37 89.47 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.183 0.593 . . . . 0.0 109.421 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 2.9 p -155.58 124.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.193 0.597 . . . . 0.0 111.162 -177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -152.47 178.14 9.87 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.293 1.437 . . . . 0.0 108.665 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.44 -31.84 6.77 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-O 121.04 0.244 . . . . 0.0 112.552 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.63 -172.66 31.38 Favored Glycine 0 C--O 1.242 0.634 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.83 119.71 0.63 Allowed Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 75.23 126.06 0.18 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.699 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 3.7 pt-20 -132.98 143.4 49.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 110.218 -175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.486 HD22 HD11 ' B' ' 9' ' ' LEU . 43.0 tp -108.35 104.31 13.65 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -87.61 116.75 25.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.148 0.499 . . . . 0.0 110.861 -171.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.61 ' HB3' HG22 ' A' ' 2' ' ' THR . 7.6 m-85 -97.05 112.62 24.3 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.415 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 31.4 mtm180 -91.03 135.19 33.92 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 122.941 0.496 . . . . 0.0 111.622 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.611 HG21 ' HB3' ' B' ' 77' ' ' GLN . 1.3 p -140.4 173.14 10.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.131 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -74.77 -45.44 43.77 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -157.59 175.09 14.39 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 118.684 0.675 . . . . 0.0 112.292 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -58.78 -32.07 68.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.219 1.407 . . . . 0.0 112.398 -166.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.84 -45.03 83.74 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.349 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.611 ' HB3' HG21 ' B' ' 72' ' ' VAL . 73.1 mm-40 -64.5 -25.14 67.86 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 123.958 0.786 . . . . 0.0 112.574 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -71.43 -39.39 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.189 0.596 . . . . 0.0 109.728 175.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.96 -32.28 69.11 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.353 1.061 . . . . 0.0 110.551 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.7 mt-10 -65.63 -41.06 93.11 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.615 0.721 . . . . 0.0 109.684 175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.459 HG21 HG21 ' B' ' 117' ' ' VAL . 12.5 m -71.43 -29.43 64.87 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.8 -61.03 2.92 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.396 0.678 . . . . 0.0 109.475 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.458 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.73 -36.82 83.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.676 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 -50.52 66.18 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.608 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -63.19 -43.12 99.11 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.207 0.603 . . . . 0.0 110.27 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.9 ttpt -54.72 -47.41 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.765 0.826 . . . . 0.0 110.583 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.65 -15.67 59.75 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.612 178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -92.22 -1.82 56.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 112.01 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.86 43.29 3.36 Favored Glycine 0 C--N 1.353 1.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.189 170.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.85 150.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.24 81.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.941 0.496 . . . . 0.0 111.788 -177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 61.2 tpp 65.82 83.18 0.17 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 85.91 2.25 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.442 0.639 . . . . 0.0 111.167 172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 179.62 126.47 0.07 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.21 1.404 . . . . 0.0 108.387 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.99 110.71 17.14 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 17.3 Cg_endo -55.67 119.71 7.03 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.79 2.327 . . . . 0.0 110.409 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.14 145.81 50.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.152 0.581 . . . . 0.0 111.034 -170.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -72.29 101.67 2.92 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.206 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.6 ttm -98.63 174.62 6.33 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.663 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -52.77 -40.28 63.02 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.825 0.85 . . . . 0.0 112.373 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -90.44 6.74 42.1 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.643 0.777 . . . . 0.0 111.989 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.69 -163.1 12.21 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.724 168.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -77.33 102.36 6.73 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -113.18 147.33 37.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.178 0.591 . . . . 0.0 110.487 -170.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 4.7 t80 -143.31 138.9 29.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.733 1.213 . . . . 0.0 109.58 -176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 11.1 m -135.1 119.92 18.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.041 0.837 . . . . 0.0 110.347 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.76 160.68 15.29 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.929 0.492 . . . . 0.0 110.986 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.38 114.97 24.32 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.477 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.0 p-10 -70.19 177.56 1.33 Allowed Pre-proline 0 CA--C 1.569 1.676 0 C-N-CA 124.182 0.993 . . . . 0.0 111.288 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 49.4 Cg_exo -43.75 -41.47 11.57 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 123.456 2.771 . . . . 0.0 115.265 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -78.95 -25.75 43.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 120.701 0.286 . . . . 0.0 110.244 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 22.6 t 73.25 86.11 0.11 Allowed 'General case' 0 C--N 1.348 0.522 0 C-N-CA 125.777 1.631 . . . . 0.0 109.952 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.462 ' CE1' HG12 ' B' ' 11' ' ' VAL . 14.3 m80 -113.84 -173.88 2.36 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' B' ' 67' ' ' GLU . 3.9 mmp_? -100.37 113.01 25.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.452 HD21 ' OH ' ' B' ' 21' ' ' TYR . 85.4 mt -115.3 104.37 11.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.797 0.439 . . . . 0.0 109.969 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.869 HH22 HG23 ' A' ' 55' ' ' VAL . 22.3 mmt180 -88.32 140.94 28.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.508 0.723 . . . . 0.0 110.726 -174.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.459 HG21 HG21 ' B' ' 81' ' ' THR . 59.8 t -135.52 120.48 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 162.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -128.73 165.44 20.9 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.384 0.538 . . . . 0.0 111.888 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.12 110.97 8.76 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -79.64 113.3 17.69 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 103.38 1.14 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.976 0.51 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.259 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.4 m -95.48 141.46 28.99 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -98.98 110.18 56.71 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.879 0.872 . . . . 0.0 110.886 -172.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.455 ' HD2' HD21 ' B' ' 41' ' ' LEU . 59.5 Cg_endo -90.89 97.09 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.878 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.3 p-10 -90.28 11.93 19.73 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.339 0.59 . . . . 0.0 110.694 170.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.449 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.6 t80 -133.08 135.05 45.07 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.811 1.244 . . . . 0.0 108.28 -168.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -137.21 140.8 41.97 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.349 1.059 . . . . 0.0 108.216 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.543 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 60.7 mt -119.21 141.57 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.7 138.01 46.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.586 ' HD1' ' H ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -81.5 132.93 35.33 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.488 176.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 51' ' ' SER . 29.0 m -130.6 158.7 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 121.653 -0.654 . . . . 0.0 110.451 175.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 22.9 t70 -95.34 -57.29 2.45 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -93.0 99.11 2.73 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.53 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 12' ' ' ASP . 50.1 Cg_exo -49.02 -55.69 3.91 Favored 'Trans proline' 0 CA--C 1.572 2.39 0 C-N-CA 122.756 2.304 . . . . 0.0 114.42 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -59.88 -54.91 1.96 Allowed 'Trans proline' 0 C--N 1.397 3.098 0 CA-C-N 122.16 1.807 . . . . 0.0 112.022 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.38 -50.05 73.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.134 0.974 . . . . 0.0 111.823 -167.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -79.89 -18.16 51.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.516 -173.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -76.98 -38.51 53.05 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 84.7 mm-40 -67.24 -30.23 70.08 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.52 172.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -60.45 -48.45 81.69 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.91 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 27.5 m-85 -68.71 -30.54 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 118.846 -0.597 . . . . 0.0 111.028 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.0 mtpt -57.78 -49.17 77.5 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.86 -31.89 51.73 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.715 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.5 tp -62.07 -50.78 70.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.681 1.192 . . . . 0.0 112.295 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 27' ' ' VAL . 14.9 mt -83.57 -47.58 11.15 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.71 29.56 5.25 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.998 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 25' ' ' LEU . 27.0 m -131.63 175.95 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 124.026 0.93 . . . . 0.0 110.358 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -124.24 151.25 65.76 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.668 0.787 . . . . 0.0 109.128 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.55 106.45 1.25 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.78 2.32 . . . . 0.0 111.544 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.416 HG13 ' HG2' ' A' ' 31' ' ' GLU . 7.4 p -63.44 -39.45 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.507 0.723 . . . . 0.0 110.31 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 29.1 mm-40 -114.63 98.28 6.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.3 p -99.27 138.21 36.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.742 0.817 . . . . 0.0 110.917 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -143.39 150.58 52.01 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.975 1.31 . . . . 0.0 108.233 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.59 -22.35 51.24 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.859 2.373 . . . . 0.0 114.147 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.9 t -128.46 9.92 6.12 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.98 139.2 20.22 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.876 -0.515 . . . . 0.0 110.047 -177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -129.45 138.95 51.72 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.642 0.777 . . . . 0.0 109.203 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tm? -132.07 120.35 22.23 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.71 113.53 13.09 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.684 1.194 . . . . 0.0 109.098 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.499 HG22 ' HG3' ' A' ' 46' ' ' LYS . 12.6 t -94.65 139.68 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.226 1.01 . . . . 0.0 110.03 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.3 mt -98.66 147.78 24.49 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.858 0.463 . . . . 0.0 110.244 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.86 -4.81 34.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.756 0.822 . . . . 0.0 111.829 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -69.0 -10.2 56.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.453 1.101 . . . . 0.0 112.231 174.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.58 15.64 42.68 Favored Glycine 0 C--N 1.349 1.264 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.874 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -126.43 172.13 10.44 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.555 0.742 . . . . 0.0 109.185 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.4 tttt -136.54 135.29 38.35 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.09 0.556 . . . . 0.0 109.601 -173.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD11 ' HG2' ' B' ' 4' ' ' PRO . 8.2 mt -124.72 124.55 42.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.571 0.749 . . . . 0.0 111.059 -176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.449 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.84 167.3 18.45 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.269 176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 49' ' ' LEU . 5.5 tp -144.86 105.23 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 3.0 t90 -104.73 123.14 47.12 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 50.2 m -74.47 112.31 10.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 176.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.07 -1.93 1.12 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 114.532 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -79.48 -25.47 41.86 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.959 0.8 . . . . 0.0 110.802 174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.6 t -112.69 12.58 19.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.441 0.696 . . . . 0.0 111.298 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 8.8 p -63.97 138.67 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 120.971 0.415 . . . . 0.0 111.49 -178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -120.21 114.49 33.43 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.16 140.52 64.87 Favored 'Cis proline' 0 C--N 1.385 2.464 0 C-N-CA 124.557 -1.018 . . . . 0.0 113.073 3.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HA ' HG13 ' A' ' 55' ' ' VAL . 24.5 mmmt -49.12 125.48 10.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.101 1.36 . . . . 0.0 111.974 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.19 109.43 3.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.065 0.946 . . . . 0.0 110.498 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.8 t -97.32 88.55 4.46 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.48 135.99 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.596 0.758 . . . . 0.0 109.712 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.3 p -142.42 125.22 16.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.204 1.002 . . . . 0.0 110.182 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.57 -108.64 0.37 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 112.33 -0.308 . . . . 0.0 112.33 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.79 129.51 9.92 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.67 -32.23 0.03 OUTLIER Glycine 0 N--CA 1.468 0.817 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.95 151.62 10.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.668 ' HG2' ' HB3' ' A' ' 114' ' ' ARG . 47.0 mt-10 -114.4 165.46 12.7 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.548 0.739 . . . . 0.0 110.787 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 31.1 tp -120.91 103.56 9.16 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.58 118.49 30.08 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.231 0.469 . . . . 0.0 111.518 -171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -95.73 108.38 20.69 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 125.109 1.364 . . . . 0.0 107.688 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' HD3' ' HD3' ' B' ' 46' ' ' LYS . 38.6 mtm180 -85.3 130.06 34.68 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.438 0.637 . . . . 0.0 112.094 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.42 157.05 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.819 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HG3' HD22 ' A' ' 74' ' ' ASN . 9.7 pt-20 -67.62 -38.36 83.8 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -172.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.451 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.0 p30 -157.2 176.71 12.36 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 118.711 0.687 . . . . 0.0 112.631 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.57 -32.86 65.61 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.81 1.644 . . . . 0.0 112.66 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.563 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.36 -44.06 79.93 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.012 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -66.36 -24.5 66.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.837 0.855 . . . . 0.0 112.241 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.41 -41.73 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -69.57 -30.87 68.75 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.489 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 28.3 mt-10 -68.06 -43.46 78.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.445 ' HA ' ' HE1' ' B' ' 1' ' ' MET . 33.0 m -70.37 -28.85 65.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.52 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -64.15 -61.31 2.33 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.777 0.799 . . . . 0.0 109.133 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.03 -38.98 90.76 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.895 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.22 91.46 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.39 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -61.51 -48.51 80.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.635 . . . . 0.0 110.385 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.494 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.5 ttpt -54.42 -43.53 71.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.841 0.856 . . . . 0.0 110.956 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.59 58.28 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.264 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -94.47 7.71 44.62 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.272 1.029 . . . . 0.0 112.183 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.61 24.5 30.5 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.421 170.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -84.0 133.58 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.528 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -56.71 -34.6 67.61 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.256 1.022 . . . . 0.0 112.625 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.494 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 49.8 tpp 67.85 82.99 0.17 Allowed 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 163.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -134.33 86.36 2.26 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 177.65 136.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.631 1.572 . . . . 0.0 109.173 168.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -84.3 108.79 15.62 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 165.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 12.5 Cg_endo -55.53 118.79 5.59 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.819 2.346 . . . . 0.0 111.448 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.07 155.32 48.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.325 0.65 . . . . 0.0 110.419 -175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.25 118.61 13.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 110.813 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.8 ttm -115.52 166.81 11.48 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.069 0.948 . . . . 0.0 108.954 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -49.97 -40.32 43.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.696 1.598 . . . . 0.0 113.071 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -86.97 -19.97 27.97 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.357 0.663 . . . . 0.0 111.676 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.67 175.36 28.5 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 120.326 -0.152 . . . . 0.0 112.932 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 42.5 t80 -71.85 101.94 2.75 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 t -107.49 150.07 27.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.471 0.653 . . . . 0.0 112.165 -161.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.568 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 20.0 t80 -150.45 146.21 26.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.8 m -142.69 129.32 20.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.095 0.558 . . . . 0.0 109.65 174.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.17 149.02 43.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.464 0.706 . . . . 0.0 111.212 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.414 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -108.24 167.09 10.27 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.528 ' HA ' ' H ' ' A' ' 91' ' ' ALA . 1.9 p-10 -133.07 -178.81 0.92 Allowed Pre-proline 0 CA--C 1.562 1.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -169.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 36.8 Cg_endo -62.92 -1.64 2.94 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.314 2.01 . . . . 0.0 114.943 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -115.73 0.13 13.12 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 118.481 0.582 . . . . 0.0 111.754 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.7 m 70.14 33.85 2.57 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.829 1.252 . . . . 0.0 112.812 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.51 ' HB2' HD11 ' A' ' 115' ' ' LEU . 18.2 m170 -75.27 170.29 16.37 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.525 0.73 . . . . 0.0 110.032 172.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.668 ' HB3' ' HG2' ' A' ' 67' ' ' GLU . 13.6 mmm180 -118.91 108.91 15.38 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 113' ' ' HIS . 3.4 mp -121.41 108.9 14.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -93.38 147.23 23.12 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.897 0.479 . . . . 0.0 110.428 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.87 133.04 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.3 p90 -135.97 162.05 33.94 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.605 0.639 . . . . 0.0 111.738 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -111.07 124.38 52.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 171.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -81.66 108.77 15.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.129 0.422 . . . . 0.0 110.437 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.64 95.1 2.77 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.809 -0.995 . . . . 0.0 112.004 -179.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.445 ' HE1' ' HA ' ' A' ' 81' ' ' THR . 20.1 ptm . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.538 0.208 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 19.5 m -132.88 142.39 48.9 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -98.08 110.7 57.05 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 123.892 0.877 . . . . 0.0 111.005 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.408 ' HG2' HD11 ' A' ' 47' ' ' LEU . 54.1 Cg_endo -91.61 96.95 0.21 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.664 2.243 . . . . 0.0 112.262 170.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.874 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.7 p-10 -90.18 12.29 18.44 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.372 0.606 . . . . 0.0 110.824 170.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.478 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.2 t80 -133.34 135.16 44.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.923 1.289 . . . . 0.0 108.164 -168.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -137.49 140.97 41.48 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.424 1.089 . . . . 0.0 108.146 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 51.4 mt -119.8 140.51 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.343 0.657 . . . . 0.0 109.695 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.85 139.26 43.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -83.4 133.08 34.95 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.21 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' B' ' 51' ' ' SER . 35.9 m -129.07 158.65 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.122 0.569 . . . . 0.0 110.693 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -95.76 -58.33 2.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -92.13 100.7 3.82 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.885 . . . . 0.0 109.233 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.87 -55.72 3.79 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.431 2.087 . . . . 0.0 114.332 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 31.8 Cg_exo -59.16 -55.56 1.83 Allowed 'Trans proline' 0 C--N 1.395 2.974 0 CA-C-N 122.285 1.852 . . . . 0.0 112.275 -177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.72 74.99 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.969 -167.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -79.77 -18.37 51.21 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.563 -173.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.6 m -77.93 -37.79 46.94 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 174.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 28.0 mm-40 -67.25 -30.71 70.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.297 172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -59.77 -48.61 81.0 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.08 175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 34.4 m-85 -68.59 -30.73 69.54 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.166 175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -57.19 -49.63 75.39 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.739 0.7 . . . . 0.0 112.791 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.94 -31.18 50.82 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.95 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 24.5 tp -62.25 -50.74 70.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.578 1.151 . . . . 0.0 112.159 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.446 ' HB2' HG22 ' B' ' 27' ' ' VAL . 16.8 mt -83.92 -47.35 11.13 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.25 30.47 5.03 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.101 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' B' ' 25' ' ' LEU . 31.4 m -131.86 175.31 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.321 1.048 . . . . 0.0 110.052 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -124.24 151.71 66.47 Favored Pre-proline 0 N--CA 1.482 1.153 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.26 106.41 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.57 2.18 . . . . 0.0 111.296 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.03 -39.28 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.486 0.714 . . . . 0.0 110.142 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 65.1 mm-40 -115.13 98.79 6.99 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.922 0.889 . . . . 0.0 108.678 175.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 57.8 p -99.87 137.85 37.76 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.762 0.825 . . . . 0.0 110.764 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -142.85 150.8 54.66 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.018 1.327 . . . . 0.0 107.96 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.04 -21.89 52.74 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.788 2.325 . . . . 0.0 114.252 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.4 t -128.49 8.98 5.98 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -150.27 139.63 21.37 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 18.4 m -129.42 139.1 51.75 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.585 0.754 . . . . 0.0 109.111 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -132.24 119.96 21.53 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -132.18 113.25 13.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.683 1.193 . . . . 0.0 109.095 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' B' ' 46' ' ' LYS . 14.7 t -94.92 139.99 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.967 0.907 . . . . 0.0 110.115 -177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.455 HD21 ' HD2' ' A' ' 4' ' ' PRO . 10.0 mp -98.93 146.93 25.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.143 0.577 . . . . 0.0 110.324 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.16 -5.17 33.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.923 0.889 . . . . 0.0 111.549 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.63 -9.32 53.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.612 1.165 . . . . 0.0 112.101 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.11 15.68 43.94 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.878 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.5 ppp? -126.38 171.51 10.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.658 0.783 . . . . 0.0 109.162 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.5 tttt -136.26 135.23 38.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.127 0.571 . . . . 0.0 109.503 -174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mt -124.61 124.39 42.12 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.526 0.73 . . . . 0.0 111.064 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.478 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -101.58 167.31 18.78 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.199 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' B' ' 49' ' ' LEU . 5.7 tp -144.78 105.45 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -104.78 122.97 46.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 50.9 m -74.54 112.8 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -63.35 -2.38 1.46 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.273 1.429 . . . . 0.0 114.503 -170.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -79.08 -25.77 43.07 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.866 0.757 . . . . 0.0 110.656 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -112.81 12.06 19.45 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.372 0.669 . . . . 0.0 111.426 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' B' ' 58' ' ' LYS . 7.2 p -62.33 138.7 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.68 114.8 32.56 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.31 139.8 62.23 Favored 'Cis proline' 0 C--N 1.381 2.243 0 C-N-CA 124.525 -1.031 . . . . 0.0 113.51 3.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.436 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.9 mmmt -48.87 125.4 10.22 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.173 1.389 . . . . 0.0 112.232 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.43 109.98 3.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.062 0.945 . . . . 0.0 110.298 -171.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.2 t -97.83 88.27 4.25 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.38 136.2 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.657 0.783 . . . . 0.0 109.679 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -143.76 124.93 14.51 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.001 0.92 . . . . 0.0 110.077 -178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.38 -108.43 0.36 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.65 129.5 9.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.44 -33.48 0.03 OUTLIER Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -179.64 152.57 11.1 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.543 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 2.2 pm0 -118.09 163.84 16.01 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.87 0.868 . . . . 0.0 110.772 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -120.44 103.2 8.99 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.41 119.93 31.11 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.231 0.469 . . . . 0.0 111.536 -171.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -97.66 108.01 20.63 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.404 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 34.8 mtm180 -85.28 128.37 34.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.014 0.525 . . . . 0.0 111.906 -177.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.42 157.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.051 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.26 -38.27 84.84 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -172.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -157.73 177.77 11.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.633 0.651 . . . . 0.0 112.52 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.86 -32.55 67.77 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.967 1.707 . . . . 0.0 112.545 -167.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -67.56 -43.86 79.62 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.431 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -66.37 -24.32 66.48 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.038 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -69.61 -42.23 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.54 -30.46 68.28 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.427 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 16.0 mt-10 -68.16 -43.22 78.72 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.342 0.592 . . . . 0.0 109.503 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -70.4 -28.77 65.34 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.591 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -64.62 -61.06 2.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.582 0.706 . . . . 0.0 109.114 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.24 90.53 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.929 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.56 90.54 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.199 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -60.93 -49.04 79.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.191 0.596 . . . . 0.0 110.222 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.475 ' HB2' ' HE3' ' B' ' 92' ' ' MET . 31.8 ttpt -53.8 -44.28 70.03 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.008 0.923 . . . . 0.0 110.911 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.53 -22.5 58.99 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.3 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 24.2 t -94.48 7.8 44.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.194 0.998 . . . . 0.0 112.087 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.39 24.44 31.2 Favored Glycine 0 C--N 1.353 1.482 0 CA-C-N 116.123 -0.489 . . . . 0.0 114.319 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.77 134.09 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.52 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -57.43 -34.44 68.95 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.116 0.967 . . . . 0.0 112.53 -172.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.475 ' HE3' ' HB2' ' B' ' 86' ' ' LYS . 50.0 tpp 67.07 83.31 0.17 Allowed 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' B' ' 108' ' ' ALA . 0.0 OUTLIER -133.65 85.85 2.24 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 178.69 138.9 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.265 1.426 . . . . 0.0 109.279 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -83.12 109.98 20.65 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 165.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.556 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 18.2 Cg_endo -57.4 119.32 6.51 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.606 2.204 . . . . 0.0 110.796 177.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.78 154.2 48.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.377 0.671 . . . . 0.0 110.412 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -68.47 118.94 12.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 54.2 ttm -115.59 166.04 12.36 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.11 0.964 . . . . 0.0 109.126 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.02 -39.91 28.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.445 1.498 . . . . 0.0 113.349 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.99 -19.06 27.71 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.537 0.335 . . . . 0.0 111.485 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 158.33 173.94 27.39 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.987 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.583 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 45.4 t80 -70.72 102.08 2.23 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.3 t -107.42 150.11 27.14 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.521 0.677 . . . . 0.0 112.081 -162.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 16.4 t80 -150.42 146.49 26.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.182 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 20.1 m -143.69 128.27 18.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.425 ' HB2' ' CZ ' ' B' ' 105' ' ' PHE . . . -121.13 149.03 43.39 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.28 0.632 . . . . 0.0 110.995 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . 0.522 ' HB3' HD11 ' B' ' 93' ' ' LEU . . . -108.35 165.01 11.82 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 170.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.52 ' HA ' ' H ' ' B' ' 91' ' ' ALA . 1.9 p-10 -130.49 -177.63 0.7 Allowed Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.003 -171.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 45.5 Cg_endo -63.8 -0.92 2.91 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.447 2.098 . . . . 0.0 114.773 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.44 ' OD1' ' HA ' ' B' ' 11' ' ' VAL . 3.1 t70 -115.98 0.14 12.96 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.093 0.557 . . . . 0.0 111.78 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.9 m 69.41 34.29 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.603 1.161 . . . . 0.0 112.725 174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -75.18 171.34 14.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.602 0.761 . . . . 0.0 110.301 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.51 108.31 13.47 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -121.07 108.18 13.52 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.48 ' NH1' ' HG3' ' B' ' 67' ' ' GLU . 55.5 mtt180 -90.57 147.72 23.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.033 0.533 . . . . 0.0 111.459 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.99 132.81 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 165.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -135.85 161.95 34.17 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.549 0.613 . . . . 0.0 111.658 174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -110.99 123.71 50.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -79.17 104.59 9.9 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.52 99.25 8.84 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.107 -175.485 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.4 m -134.35 142.78 47.33 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -98.68 109.69 54.22 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.847 0.859 . . . . 0.0 110.493 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HG3' HD22 ' B' ' 25' ' ' LEU . 78.6 Cg_endo -81.77 72.08 6.45 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.493 2.129 . . . . 0.0 111.253 166.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.486 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 8.2 p-10 -80.43 9.88 5.35 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.404 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -134.56 134.32 41.22 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 107.717 -173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -138.2 139.58 39.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.237 1.015 . . . . 0.0 108.786 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.593 HG12 ' HA3' ' A' ' 48' ' ' GLY . 49.5 mt -128.03 143.03 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.134 0.573 . . . . 0.0 110.173 -172.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -108.63 144.95 35.69 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 32.1 m-85 -93.57 123.5 36.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.199 1.0 . . . . 0.0 111.207 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.412 HG12 ' HE1' ' A' ' 113' ' ' HIS . 23.9 m -124.89 161.02 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.188 0.995 . . . . 0.0 110.409 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -93.89 -63.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.132 0.973 . . . . 0.0 110.759 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -97.14 100.14 7.21 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.075 0.55 . . . . 0.0 110.154 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 35.1 Cg_exo -55.56 -51.63 9.44 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.296 2.664 . . . . 0.0 115.033 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.77 -51.62 10.76 Favored 'Trans proline' 0 C--N 1.405 3.525 0 CA-C-N 122.646 1.981 . . . . 0.0 112.48 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.92 -39.94 69.14 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.715 -169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.2 p -77.83 -34.85 51.74 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 122.817 0.447 . . . . 0.0 110.515 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 70.9 m -62.39 -47.78 82.63 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.524 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 16.3 mm100 -62.69 -35.51 79.92 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.125 175.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -64.89 -45.82 84.33 Favored 'General case' 0 C--N 1.352 0.696 0 O-C-N 123.8 0.688 . . . . 0.0 109.415 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 20.5 m-85 -68.03 -32.89 73.57 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.279 -0.391 . . . . 0.0 109.997 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 63.2 mtpt -57.31 -47.89 80.35 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.34 -34.27 48.63 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.298 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 18.8 tp -60.21 -31.35 70.08 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.865 1.266 . . . . 0.0 112.473 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.501 HD22 ' HG3' ' B' ' 4' ' ' PRO . 26.1 mt -99.95 -48.56 4.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.16 28.63 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.995 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.01 -178.34 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.613 1.165 . . . . 0.0 110.747 -174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -130.76 142.93 47.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 124.342 1.057 . . . . 0.0 108.762 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 34.1 Cg_endo -63.93 119.94 7.16 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.602 2.201 . . . . 0.0 112.449 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.09 -44.24 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.999 0.92 . . . . 0.0 110.455 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 57.9 mm-40 -116.23 90.04 3.24 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.3 p -90.04 149.48 22.5 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.894 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.1 t -151.76 151.48 28.46 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 125.037 1.335 . . . . 0.0 107.627 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.78 -20.1 68.09 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.451 2.101 . . . . 0.0 113.607 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -128.38 12.36 6.47 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -155.9 152.79 28.71 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.2 m -143.86 138.58 28.72 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 12.7 tp -126.42 115.72 20.05 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 1.3 p90 -131.21 112.89 13.21 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.922 1.289 . . . . 0.0 109.16 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.592 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 3.8 p -106.71 142.28 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.24 1.016 . . . . 0.0 110.079 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mp -106.16 157.25 17.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.622 0.769 . . . . 0.0 111.134 -169.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -22.61 65.33 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.479 1.112 . . . . 0.0 112.593 -176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.404 HD21 ' HG3' ' A' ' 45' ' ' MET . 1.9 p-10 -70.19 -18.6 63.19 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.258 0.623 . . . . 0.0 112.032 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.48 15.82 16.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.433 -0.648 . . . . 0.0 114.445 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.404 ' HG3' HD21 ' A' ' 43' ' ' ASN . 3.7 ppp? -103.23 154.03 19.76 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.017 0.909 . . . . 0.0 108.697 170.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.592 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.2 tttt -125.3 131.02 53.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -128.54 127.66 42.78 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.346 0.659 . . . . 0.0 109.883 -168.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.593 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -104.81 169.78 17.29 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.54 104.79 4.26 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.438 ' HB2' HG21 ' A' ' 8' ' ' ILE . 4.5 t90 -106.75 127.48 53.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.451 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 27.9 m -72.96 129.95 39.27 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.244 0.34 . . . . 0.0 110.126 176.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -68.34 -10.94 58.45 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.687 0.795 . . . . 0.0 112.493 -173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -81.95 -23.47 36.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -116.93 7.83 13.33 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.297 0.639 . . . . 0.0 111.269 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 58' ' ' LYS . 10.5 p -67.68 140.53 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 122.712 0.405 . . . . 0.0 111.508 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.457 ' HB3' HE22 ' B' ' 94' ' ' GLN . 70.7 mt-10 -125.56 114.6 25.18 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 170.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.503 ' HG2' ' CZ ' ' B' ' 114' ' ' ARG . 59.0 Cg_endo -78.14 141.51 66.06 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 124.491 -1.046 . . . . 0.0 113.194 4.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HA ' HG13 ' A' ' 55' ' ' VAL . 27.4 mmmt -49.43 123.0 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.252 1.421 . . . . 0.0 112.452 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HB2' ' NH2' ' B' ' 114' ' ' ARG . . . -155.57 109.18 2.79 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.318 1.047 . . . . 0.0 109.059 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.8 p -85.08 87.08 7.34 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.0 124.19 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.466 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.7 p -151.51 122.34 7.55 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.302 1.441 . . . . 0.0 107.78 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.71 52.55 0.01 OUTLIER Glycine 0 N--CA 1.472 1.045 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.06 -132.18 10.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.89 -62.98 4.35 Favored Glycine 0 C--N 1.356 1.669 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.35 154.38 18.99 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 168.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 2.4 pt-20 -130.06 166.18 20.68 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.011 0.924 . . . . 0.0 110.27 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.2 tp -125.46 102.39 7.38 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.829 0.852 . . . . 0.0 109.457 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -92.48 110.72 22.14 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -169.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 12.3 m-85 -88.99 116.86 27.59 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.435 1.094 . . . . 0.0 108.419 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -95.21 130.7 41.85 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.87 162.74 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.345 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.9 pt-20 -66.12 -43.44 87.14 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.472 -176.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.445 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 8.9 p30 -160.44 179.62 8.47 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.584 0.629 . . . . 0.0 112.568 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.79 -30.67 63.89 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.617 1.567 . . . . 0.0 112.709 -168.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.5 -52.56 64.01 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.786 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 81.0 mm-40 -65.76 -22.78 66.61 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.736 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.25 -46.09 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.465 0.65 . . . . 0.0 109.73 172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -75.89 -28.54 58.14 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 110.676 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 35.8 mt-10 -65.06 -48.2 74.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.234 0.613 . . . . 0.0 110.013 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.8 m -68.31 -30.1 69.01 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -55.62 -58.72 6.62 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.96 0.904 . . . . 0.0 109.98 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.47 -35.53 80.49 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 113.871 -1.513 . . . . 0.0 112.493 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.09 -42.62 96.51 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 123.645 0.591 . . . . 0.0 113.588 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -66.6 -39.73 88.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.058 0.543 . . . . 0.0 110.233 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.431 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 32.7 ttpt -57.51 -44.84 85.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.474 0.71 . . . . 0.0 110.262 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.53 -30.33 68.14 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.753 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 t -99.64 9.91 42.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.211 1.004 . . . . 0.0 112.378 -173.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 55.57 2.77 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 165.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.5 p -102.79 148.71 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 168.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.02 -57.15 5.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.552 0.341 . . . . 0.0 110.459 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.546 ' HB2' HG13 ' A' ' 90' ' ' VAL . 21.1 ttp 64.23 82.51 0.18 Allowed 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.225 0.953 . . . . 0.0 113.104 168.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.81 85.94 2.24 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' A' ' 106' ' ' THR . 46.9 tp60 179.57 133.17 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.761 1.224 . . . . 0.0 108.954 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -83.45 122.47 77.01 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.254 0.622 . . . . 0.0 109.413 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 106.62 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.533 2.155 . . . . 0.0 110.835 168.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 152.36 50.17 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.089 0.556 . . . . 0.0 111.312 -174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -70.4 102.17 2.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.217 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.3 ttm -94.8 169.2 10.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.357 1.063 . . . . 0.0 109.193 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -43.64 -41.5 4.7 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.139 1.376 . . . . 0.0 113.568 175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -87.96 -15.29 36.93 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.575 0.75 . . . . 0.0 111.907 -172.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.16 -170.83 25.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.969 -0.35 . . . . 0.0 112.59 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -76.71 101.69 5.89 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.8 t -108.07 149.38 28.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.461 0.648 . . . . 0.0 110.344 -171.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.447 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.4 t80 -144.4 147.91 33.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.746 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 4.8 m -140.6 136.75 33.08 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.151 0.432 . . . . 0.0 110.924 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.38 172.78 6.64 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.837 0.855 . . . . 0.0 110.967 171.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.29 113.26 11.1 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -74.02 169.05 20.72 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.422 0.689 . . . . 0.0 110.016 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.5 -33.88 31.72 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.268 2.645 . . . . 0.0 114.59 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -92.0 12.0 23.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.08 0.552 . . . . 0.0 111.207 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 59.5 72.63 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 112.874 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.412 ' HE1' HG12 ' A' ' 11' ' ' VAL . 8.4 m80 -126.59 172.24 10.43 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.618 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 65.5 mmt-85 -102.52 104.87 15.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.81 102.59 14.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.849 HH22 HG23 ' B' ' 55' ' ' VAL . 15.3 mmt180 -88.04 147.52 24.94 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 123.578 0.751 . . . . 0.0 110.389 -173.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.426 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 15.4 t -137.99 127.29 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 161.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -141.01 158.56 43.77 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.02 111.06 17.84 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -73.0 120.93 19.31 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.788 0.435 . . . . 0.0 109.831 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.83 93.08 6.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.318 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.179 -175.55 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.7 0.286 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 84.8 m -141.85 142.9 33.14 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.116 0.967 . . . . 0.0 108.61 170.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -99.24 110.93 59.9 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.592 0.757 . . . . 0.0 110.231 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.501 ' HG3' HD22 ' A' ' 25' ' ' LEU . 63.0 Cg_endo -82.99 71.34 6.35 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.622 2.214 . . . . 0.0 110.819 167.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.02 9.48 4.31 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.791 0.836 . . . . 0.0 111.27 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -134.51 134.29 41.29 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.097 1.359 . . . . 0.0 107.677 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -138.38 139.66 39.08 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.468 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 16.8 mt -128.74 143.35 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.081 0.553 . . . . 0.0 110.103 -172.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -110.01 144.06 39.11 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -91.87 123.94 35.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.12 0.968 . . . . 0.0 111.142 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.423 HG12 ' HE1' ' B' ' 113' ' ' HIS . 20.5 m -125.3 160.77 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 123.956 0.902 . . . . 0.0 110.308 -177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -92.75 -63.89 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.129 0.971 . . . . 0.0 111.154 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -96.12 98.42 4.03 Favored Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 123.625 0.77 . . . . 0.0 109.682 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -53.8 -52.72 7.82 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 122.854 2.37 . . . . 0.0 115.842 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.24 -52.64 8.54 Favored 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 123.162 2.165 . . . . 0.0 112.7 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.37 -40.08 70.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.482 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 75.8 p -77.49 -34.91 54.11 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.743 0.417 . . . . 0.0 110.765 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.5 m -63.04 -46.88 85.44 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.521 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 13.8 mm100 -63.54 -35.18 79.64 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.809 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 66.1 t80 -64.88 -45.52 85.64 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 123.776 0.672 . . . . 0.0 109.42 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.408 ' O ' ' HG ' ' B' ' 25' ' ' LEU . 30.3 m-85 -68.29 -32.79 73.19 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.225 177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 62.7 mtpt -57.11 -48.03 79.64 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.3 -34.31 48.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 20.8 tp -60.25 -30.99 69.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.788 1.235 . . . . 0.0 112.595 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.492 HD22 ' HG3' ' A' ' 4' ' ' PRO . 25.1 mt -100.47 -48.31 4.59 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.0 28.7 4.88 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.953 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.543 HG11 HD22 ' B' ' 41' ' ' LEU . 24.2 m -129.62 -178.25 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 124.648 1.179 . . . . 0.0 111.064 -174.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -130.41 144.81 54.82 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.816 0.847 . . . . 0.0 109.231 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 18.4 Cg_exo -65.86 120.64 7.85 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.411 2.074 . . . . 0.0 112.21 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' B' ' 31' ' ' GLU . 8.9 p -64.55 -42.32 94.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 124.159 0.984 . . . . 0.0 110.802 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 50.3 mm-40 -119.17 89.13 3.07 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.0 m -90.1 149.74 22.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.838 -177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -151.81 151.31 28.05 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.1 -20.29 70.88 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.422 2.081 . . . . 0.0 113.683 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -128.2 11.44 6.45 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.043 0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -155.6 153.01 29.43 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -143.93 138.45 28.52 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 12.9 tp -126.42 115.94 20.38 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.424 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 1.4 p90 -131.11 113.24 13.66 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.961 1.304 . . . . 0.0 109.215 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.628 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 4.3 p -107.1 141.94 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.267 1.027 . . . . 0.0 110.033 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.543 HD22 HG11 ' B' ' 27' ' ' VAL . 13.7 mt -105.5 157.27 17.48 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.529 0.732 . . . . 0.0 110.382 -169.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -21.72 64.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.381 1.072 . . . . 0.0 112.332 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -71.04 -18.38 62.57 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.99 0.516 . . . . 0.0 111.23 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.42 16.09 15.58 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 114.484 0.554 . . . . 0.0 114.484 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.486 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.2 ppp? -104.2 153.43 20.98 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.104 0.952 . . . . 0.0 108.607 170.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.628 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 53.6 tttt -124.69 130.97 53.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.92 127.96 44.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.31 0.644 . . . . 0.0 110.063 -169.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.27 169.67 17.75 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 123.821 0.724 . . . . 0.0 111.293 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.66 104.51 4.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.445 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -106.7 126.85 52.82 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 58.7 m -72.75 129.6 38.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.66 -11.1 57.5 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.013 0.925 . . . . 0.0 112.38 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -82.02 -24.09 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.01 0.524 . . . . 0.0 111.141 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.8 t -116.62 8.66 13.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.282 0.633 . . . . 0.0 111.324 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.849 HG23 HH22 ' A' ' 116' ' ' ARG . 7.1 p -68.15 140.1 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 122.793 0.437 . . . . 0.0 111.382 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -124.84 114.0 26.78 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.5 141.49 64.83 Favored 'Cis proline' 0 C--N 1.381 2.287 0 C-N-CA 124.439 -1.067 . . . . 0.0 113.147 5.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.49 ' HA ' HG13 ' B' ' 55' ' ' VAL . 26.0 mmmt -49.55 123.14 7.2 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.144 1.378 . . . . 0.0 112.34 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.98 108.55 2.63 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.114 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.9 p -84.44 87.1 7.21 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.75 124.55 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.368 0.667 . . . . 0.0 110.482 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -152.51 121.87 6.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.997 1.319 . . . . 0.0 107.776 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.04 54.04 0.01 OUTLIER Glycine 0 N--CA 1.47 0.921 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.48 -132.47 10.94 Favored Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.15 4.34 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.01 153.71 18.56 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 168.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.491 ' CG ' ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -128.61 168.13 16.18 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 123.473 0.709 . . . . 0.0 110.542 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 tp -126.25 102.15 7.06 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.93 0.892 . . . . 0.0 109.437 -173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -92.57 111.32 22.87 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.756 0.312 . . . . 0.0 111.725 -169.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m-85 -89.37 116.96 27.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.47 1.108 . . . . 0.0 108.337 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -96.05 128.28 42.81 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.448 0.642 . . . . 0.0 111.566 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -127.78 164.14 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.646 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.28 -43.25 86.91 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.382 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -160.65 178.19 9.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.99 -32.02 52.78 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.197 1.799 . . . . 0.0 113.076 -170.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.557 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -61.32 -52.92 62.68 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.884 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.543 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 61.2 mm-40 -64.97 -23.1 67.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.763 1.225 . . . . 0.0 112.618 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.81 -45.84 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 121.386 0.613 . . . . 0.0 109.764 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -76.1 -28.17 57.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.96 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.9 mt-10 -64.53 -48.72 74.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.208 0.603 . . . . 0.0 109.74 174.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -68.48 -29.58 68.24 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.891 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.76 -58.95 5.69 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.22 1.008 . . . . 0.0 109.666 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.67 -35.47 80.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.484 -174.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -42.46 96.9 Favored Glycine 0 CA--C 1.526 0.763 0 O-C-N 123.337 0.398 . . . . 0.0 113.487 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -66.87 -39.39 87.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.989 0.516 . . . . 0.0 110.092 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.0 ttpt -57.88 -44.74 86.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.644 0.778 . . . . 0.0 110.478 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.5 -29.7 67.39 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.792 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 32.8 t -99.91 9.79 42.38 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.097 0.959 . . . . 0.0 112.333 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.25 55.27 2.79 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 165.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.7 p -103.11 148.68 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.1 -56.88 6.36 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.57 0.348 . . . . 0.0 110.413 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.494 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 19.5 ttp 64.07 82.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 169.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 85.82 2.23 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.747 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.488 ' HB3' ' O ' ' B' ' 106' ' ' THR . 5.8 tp60 -179.42 133.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.916 1.286 . . . . 0.0 108.836 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . 0.401 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 86.6 mt-30 -82.79 122.48 78.26 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.607 0.763 . . . . 0.0 109.355 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.523 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 19.0 Cg_endo -59.47 106.66 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.566 2.177 . . . . 0.0 110.181 169.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.3 152.47 50.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.173 0.589 . . . . 0.0 111.287 -173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -71.52 102.67 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.75 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 52.8 ttm -94.67 169.13 10.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.635 1.174 . . . . 0.0 109.321 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -43.61 -41.87 4.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.487 1.515 . . . . 0.0 112.864 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -88.04 -14.93 37.7 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.632 0.773 . . . . 0.0 112.027 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.98 -171.05 25.06 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.988 -0.34 . . . . 0.0 112.553 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -76.33 101.42 5.49 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 8.2 t -107.86 149.46 28.24 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.583 0.706 . . . . 0.0 110.331 -171.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 1.9 t80 -144.59 148.29 34.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.701 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 17.1 m -141.33 136.5 31.58 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.122 0.487 . . . . 0.0 110.474 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.39 172.88 6.58 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.957 0.903 . . . . 0.0 110.838 171.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.5 112.52 10.33 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.436 ' HB3' HD11 ' B' ' 115' ' ' LEU . 6.6 p-10 -72.9 167.57 32.7 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 123.584 0.754 . . . . 0.0 110.579 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -48.34 -33.85 23.51 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.394 2.729 . . . . 0.0 114.864 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -92.24 12.22 23.08 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.123 0.569 . . . . 0.0 111.134 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 30.9 m 59.06 72.15 0.55 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.064 1.345 . . . . 0.0 112.738 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.423 ' HE1' HG12 ' B' ' 11' ' ' VAL . 8.6 m80 -125.64 171.58 10.47 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.57 ' NH2' ' HB2' ' A' ' 59' ' ' ALA . 17.2 mmt180 -101.17 105.04 16.13 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' B' ' 109' ' ' ASP . 39.0 mt -97.2 103.04 14.94 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.737 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 23.9 ttt180 -87.66 147.43 25.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.5 0.72 . . . . 0.0 110.404 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -137.86 127.22 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 160.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -141.22 158.69 43.56 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.65 110.8 17.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -72.74 123.39 23.22 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.86 100.79 13.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.965 0.506 . . . . 0.0 109.961 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.78 -1.011 . . . . 0.0 111.156 179.02 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.5 m -138.63 140.04 38.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.957 0.408 . . . . 0.0 111.655 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -130.75 148.02 68.47 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.151 0.98 . . . . 0.0 108.616 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 98.6 Cg_endo -86.38 143.39 7.57 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.213 1.942 . . . . 0.0 112.037 170.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.66 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 36.0 t70 -143.61 19.37 1.85 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 122.659 1.219 . . . . 0.0 109.009 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -143.73 148.09 35.16 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.653 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.494 HG23 HD23 ' A' ' 47' ' ' LEU . 3.8 t -151.72 139.21 19.55 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.869 0.868 . . . . 0.0 108.691 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.545 ' HB ' ' HG2' ' B' ' 67' ' ' GLU . 68.1 mt -123.71 137.7 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.577 0.751 . . . . 0.0 109.904 -170.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.66 130.23 45.87 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 62' ' ' THR . 28.0 m-85 -80.42 115.19 19.82 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.27 0.628 . . . . 0.0 109.629 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG12 ' CE1' ' A' ' 113' ' ' HIS . 32.9 m -114.09 160.78 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.772 0.829 . . . . 0.0 109.241 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -97.08 -59.3 1.82 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.147 0.579 . . . . 0.0 110.497 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -98.48 100.77 9.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.305 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.28 -51.97 10.05 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.441 2.761 . . . . 0.0 115.523 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.21 -50.21 9.13 Favored 'Trans proline' 0 C--N 1.398 3.158 0 CA-C-N 122.136 1.798 . . . . 0.0 112.561 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.29 62.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -166.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.6 p -76.83 -36.21 57.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.479 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 95.2 m -64.51 -43.84 92.78 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 36.9 mt-30 -64.99 -35.11 80.12 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.205 174.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.3 t80 -66.15 -42.82 88.54 Favored 'General case' 0 C--N 1.346 0.453 0 O-C-N 123.776 0.673 . . . . 0.0 109.552 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 34.1 m-85 -70.04 -28.39 65.43 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 118.789 -0.625 . . . . 0.0 109.873 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 60.6 mtpt -57.0 -50.61 72.18 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 118.789 0.722 . . . . 0.0 111.822 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.45 60.84 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.253 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 19.1 tp -61.79 -42.56 99.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.744 1.217 . . . . 0.0 112.388 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' HB2' HG22 ' A' ' 27' ' ' VAL . 18.4 mt -90.15 -43.01 10.73 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.67 28.62 6.95 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.2 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 25' ' ' LEU . 29.4 m -131.64 173.87 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.929 0.892 . . . . 0.0 110.224 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -124.84 150.22 65.22 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.965 0.906 . . . . 0.0 109.213 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.93 118.14 5.4 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 123.013 2.475 . . . . 0.0 112.267 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.8 -40.04 87.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.717 0.636 . . . . 0.0 110.298 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 36.3 mm-40 -117.92 146.7 43.76 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.326 1.05 . . . . 0.0 109.196 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.4 p -143.8 135.37 26.1 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -145.26 157.4 53.22 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.876 1.271 . . . . 0.0 108.772 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -52.12 -28.99 35.19 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 123.468 2.779 . . . . 0.0 113.999 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -124.98 5.19 7.98 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.57 130.23 12.31 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.833 -0.542 . . . . 0.0 111.194 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.9 m -117.62 130.89 56.66 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 7.1 tt -121.93 132.39 54.52 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.26 150.63 46.86 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.82 1.248 . . . . 0.0 108.687 167.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.541 ' HB ' ' HG3' ' A' ' 46' ' ' LYS . 2.0 p -130.46 132.64 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.59 155.89 20.27 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.368 0.667 . . . . 0.0 110.767 -165.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.15 -16.98 64.22 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.642 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -74.41 -15.38 60.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.132 0.973 . . . . 0.0 111.363 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.8 -19.88 30.04 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.896 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.703 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.7 ppp? -81.36 168.45 18.37 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 117.376 0.588 . . . . 0.0 109.929 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 74.6 tttt -133.83 140.2 46.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.502 0.321 . . . . 0.0 110.924 -169.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 7' ' ' THR . 55.0 mt -131.39 126.38 35.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.866 0.867 . . . . 0.0 111.898 -174.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.43 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -102.79 167.9 17.78 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 174.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.54 108.41 6.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.1 t90 -104.81 118.53 36.77 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 25.2 p -75.85 127.7 33.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.189 0.518 . . . . 0.0 109.842 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.486 ' HD3' HG23 ' A' ' 62' ' ' THR . 40.3 ptt180 -74.43 -2.44 25.48 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.827 1.251 . . . . 0.0 114.015 -165.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -69.84 -18.63 63.45 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.347 0.659 . . . . 0.0 111.835 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.7 t -148.03 21.76 1.1 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.857 0.463 . . . . 0.0 110.774 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 58' ' ' LYS . 8.7 p -59.37 147.2 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.806 0.442 . . . . 0.0 111.313 174.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.84 113.51 26.87 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.536 0.734 . . . . 0.0 109.117 175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 1.2 Cg_endo -78.19 143.96 74.31 Favored 'Cis proline' 0 C--N 1.38 2.232 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.406 5.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HA ' HG13 ' A' ' 55' ' ' VAL . 11.9 mmmm -54.69 119.6 5.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.034 0.934 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.73 4.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.191 0.996 . . . . 0.0 109.441 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.7 m -91.48 82.86 5.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.6 m -155.4 131.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.012 1.325 . . . . 0.0 108.424 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.486 HG23 ' HD3' ' A' ' 52' ' ' ARG . 15.0 p -145.44 122.28 11.26 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.311 1.044 . . . . 0.0 108.634 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.72 -95.51 0.14 Allowed Glycine 0 C--N 1.349 1.305 0 C-N-CA 121.84 -0.219 . . . . 0.0 112.639 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.95 -154.12 30.11 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.81 -48.09 3.81 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.29 132.48 3.75 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.563 ' HG2' ' HB ' ' B' ' 8' ' ' ILE . 15.8 pt-20 -106.9 166.42 10.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.08 0.952 . . . . 0.0 110.971 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.13 105.6 13.11 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.714 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -91.72 115.17 27.83 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.659 0.663 . . . . 0.0 112.546 -169.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.7 m-85 -96.44 115.75 27.94 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.728 1.211 . . . . 0.0 108.334 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.46 HH21 ' HB3' ' B' ' 5' ' ' ASP . 42.0 mtm180 -96.51 131.06 43.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.556 0.693 . . . . 0.0 111.494 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -125.45 165.98 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.186 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.1 pt-20 -65.45 -41.56 93.29 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.395 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.44 -178.68 3.63 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.116 0.484 . . . . 0.0 112.218 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -58.99 -30.31 67.87 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.222 1.409 . . . . 0.0 112.887 -165.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.57 87.63 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.119 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.56 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 77.4 mm-40 -67.39 -22.33 65.56 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.646 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.2 t -67.78 -44.89 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.16 -32.17 68.6 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.497 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -67.98 -42.14 81.29 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.722 0.772 . . . . 0.0 110.197 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.6 m -72.36 -28.12 62.83 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.702 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -58.72 -61.75 2.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.839 0.856 . . . . 0.0 109.682 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.89 67.6 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.632 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.87 -51.57 56.32 Favored Glycine 0 C--N 1.341 0.829 0 O-C-N 123.877 0.736 . . . . 0.0 113.012 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -63.74 -40.46 96.78 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.082 0.553 . . . . 0.0 110.099 175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HB2' ' HE1' ' A' ' 92' ' ' MET . 31.5 ttpt -56.15 -45.78 79.51 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.412 0.625 . . . . 0.0 110.828 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.34 -20.17 60.19 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.166 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.2 t -98.64 10.3 41.37 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.061 0.944 . . . . 0.0 112.14 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.42 43.55 5.82 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 168.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.8 p -94.89 153.56 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 170.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.51 2.75 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.829 0.452 . . . . 0.0 110.373 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.479 ' SD ' ' CE1' ' A' ' 105' ' ' PHE . 11.3 ttp 67.47 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.973 0.795 . . . . 0.0 112.859 171.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.32 85.13 2.09 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.194 0.521 . . . . 0.0 110.617 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.513 ' HB3' ' O ' ' A' ' 106' ' ' THR . 51.3 tp60 179.85 131.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.046 1.338 . . . . 0.0 109.145 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.59 117.79 69.21 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.65 105.19 0.1 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.397 2.732 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.9 148.93 25.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 110.815 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -90.46 99.02 12.12 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -102.95 -174.65 2.6 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.42 0.688 . . . . 0.0 111.885 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -55.91 -39.84 72.21 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.07 1.348 . . . . 0.0 112.766 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 89.9 m-85 -88.63 -4.83 58.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.279 0.632 . . . . 0.0 111.614 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.86 -160.22 21.74 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.731 -0.483 . . . . 0.0 113.413 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -80.26 100.47 8.36 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.7 t -109.18 153.59 23.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.596 0.758 . . . . 0.0 111.026 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.479 ' CE1' ' SD ' ' A' ' 92' ' ' MET . 1.8 t80 -149.4 145.03 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.728 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 12.3 m -137.94 128.93 27.25 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 118.322 0.51 . . . . 0.0 109.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.89 174.63 5.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.997 0.919 . . . . 0.0 110.589 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.08 119.3 12.08 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.574 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.8 p-10 -73.87 -175.13 0.39 Allowed Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.588 0.755 . . . . 0.0 111.316 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 11.5 Cg_exo -38.91 -48.47 2.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.589 2.859 . . . . 0.0 114.846 165.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB2' ' CE1' ' A' ' 113' ' ' HIS . 57.9 m-20 -89.73 3.92 51.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.393 0.677 . . . . 0.0 111.321 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.2 m 71.96 16.16 5.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.231 1.012 . . . . 0.0 113.654 161.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.448 ' CE1' HG12 ' A' ' 11' ' ' VAL . 15.9 m80 -59.11 137.35 57.99 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -70.98 99.61 1.82 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.6 mt -96.36 102.26 14.02 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.714 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 14.2 tpt180 -87.71 142.45 27.82 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.403 1.081 . . . . 0.0 110.664 -170.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.455 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 39.0 t -138.73 128.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 71' ' ' ARG . 12.0 p90 -135.39 158.59 43.98 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.545 0.611 . . . . 0.0 111.931 176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 113.04 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 34.8 t80 -78.43 114.91 17.76 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.26 93.89 0.66 Allowed 'General case' 0 C--O 1.241 0.642 0 O-C-N 124.199 0.937 . . . . 0.0 109.914 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.5 178.711 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.42 0.152 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 97.6 m -141.53 141.28 33.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.482 0.713 . . . . 0.0 111.332 -169.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -129.91 148.14 68.38 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.274 1.03 . . . . 0.0 108.707 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 90.0 Cg_endo -86.72 141.84 6.59 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.342 2.028 . . . . 0.0 112.37 170.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.703 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 22.2 t70 -141.77 20.31 2.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.557 1.17 . . . . 0.0 109.221 171.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -143.47 148.0 35.4 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.751 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.474 HG23 HD23 ' B' ' 47' ' ' LEU . 3.7 t -151.83 139.3 19.54 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.563 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 46.8 mt -123.74 137.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.641 0.776 . . . . 0.0 109.879 -170.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -99.4 130.41 45.67 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.432 ' O ' HG22 ' B' ' 62' ' ' THR . 27.1 m-85 -80.44 115.6 20.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.604 172.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.443 HG12 ' CE1' ' B' ' 113' ' ' HIS . 32.7 m -114.43 160.72 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.705 0.802 . . . . 0.0 109.274 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.29 -58.56 1.98 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.712 0.405 . . . . 0.0 110.737 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -98.6 100.66 9.86 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.118 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.66 -52.18 9.57 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.319 2.679 . . . . 0.0 115.378 -172.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 25.4 Cg_endo -58.76 -50.73 8.49 Favored 'Trans proline' 0 C--N 1.398 3.139 0 CA-C-N 122.132 1.797 . . . . 0.0 112.532 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.99 -37.66 64.37 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.635 -166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 77.5 p -76.51 -36.23 57.87 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.62 0.575 . . . . 0.0 109.453 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 96.9 m -65.04 -43.41 92.43 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' B' ' 15' ' ' PRO . 45.7 mt-30 -65.19 -35.34 80.77 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.793 174.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 75.5 t80 -65.81 -43.01 89.93 Favored 'General case' 0 C--N 1.347 0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 32.3 m-85 -69.81 -28.62 65.87 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 118.746 -0.645 . . . . 0.0 109.788 175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 18' ' ' THR . 57.3 mtpt -57.16 -50.52 72.58 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.794 0.724 . . . . 0.0 112.112 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.58 61.8 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.536 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 19.0 tp -61.54 -42.69 99.2 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.599 1.159 . . . . 0.0 112.581 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -90.24 -42.56 10.94 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.97 29.31 6.91 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.899 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' B' ' 25' ' ' LEU . 28.2 m -131.42 174.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 124.097 0.959 . . . . 0.0 110.568 -177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -124.75 150.61 66.13 Favored Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 123.73 0.812 . . . . 0.0 109.155 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.16 118.92 5.96 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.49 2.127 . . . . 0.0 112.661 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.44 -40.05 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.27 0.628 . . . . 0.0 110.381 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.766 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 31.1 mm-40 -118.0 147.34 43.29 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.159 0.983 . . . . 0.0 108.666 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.3 p -144.27 135.38 25.36 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 57.1 m -145.02 156.41 55.01 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.106 1.362 . . . . 0.0 108.66 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.15 -30.17 24.63 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 124.039 3.159 . . . . 0.0 114.353 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -125.21 5.77 7.81 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -151.75 129.9 11.91 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.455 0.571 . . . . 0.0 111.086 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 42.6 m -117.21 130.73 56.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 171.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 39.9 tp -121.54 131.92 54.41 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.465 0.706 . . . . 0.0 109.608 -176.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.92 150.79 47.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.617 1.167 . . . . 0.0 108.455 167.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.483 ' HB ' ' HG3' ' B' ' 46' ' ' LYS . 2.7 p -130.29 133.25 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 41.2 mt -86.49 155.73 20.4 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.923 -165.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -16.76 64.33 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.667 0.787 . . . . 0.0 111.342 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -14.53 60.31 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.709 0.804 . . . . 0.0 111.086 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.65 -19.78 30.53 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-O 119.753 -0.471 . . . . 0.0 113.874 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.66 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.8 ppp? -81.35 168.13 18.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.416 0.608 . . . . 0.0 110.061 176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.483 ' HG3' ' HB ' ' B' ' 40' ' ' VAL . 78.3 tttt -133.96 140.29 46.66 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.488 0.315 . . . . 0.0 110.997 -169.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.474 HD23 HG23 ' B' ' 7' ' ' THR . 46.3 mt -131.47 126.25 34.54 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.843 0.857 . . . . 0.0 111.88 -173.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.64 167.77 17.85 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 86.8 mt -137.63 108.41 6.65 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 165.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.408 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 5.1 t90 -104.9 118.4 36.43 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 55.3 p -75.18 127.69 33.76 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.182 0.515 . . . . 0.0 110.084 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.497 ' HD3' HG23 ' B' ' 62' ' ' THR . 35.3 ptt180 -74.81 -2.97 29.05 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.688 1.195 . . . . 0.0 113.982 -165.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -68.57 -19.45 64.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.618 0.767 . . . . 0.0 111.928 -177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -147.86 21.79 1.12 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.896 0.478 . . . . 0.0 110.625 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -59.57 146.98 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.757 0.423 . . . . 0.0 111.098 174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.98 115.1 27.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.72 143.33 75.59 Favored 'Cis proline' 0 C--N 1.387 2.564 0 C-N-CA 124.462 -1.057 . . . . 0.0 112.955 2.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -53.22 119.32 4.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.972 0.909 . . . . 0.0 112.173 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.32 108.54 4.79 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.075 0.95 . . . . 0.0 109.147 -178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 26.2 m -91.13 82.87 5.52 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.4 131.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.892 1.277 . . . . 0.0 108.425 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.497 HG23 ' HD3' ' B' ' 52' ' ' ARG . 17.2 p -145.41 121.89 11.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.269 1.028 . . . . 0.0 108.526 176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 158.07 -95.51 0.14 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 112.592 -0.203 . . . . 0.0 112.592 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.03 -154.14 30.19 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.9 -48.15 3.82 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.19 132.11 3.64 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.545 ' HG2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 pt-20 -106.63 166.65 10.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.935 0.894 . . . . 0.0 110.853 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 tp -115.48 104.87 12.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.507 0.723 . . . . 0.0 109.247 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.747 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.22 115.62 28.17 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 118.611 0.641 . . . . 0.0 112.243 -168.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 7.8 m-85 -96.61 115.84 28.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.886 1.274 . . . . 0.0 108.368 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -96.48 128.59 43.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.273 0.629 . . . . 0.0 111.146 -178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.79 167.04 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.627 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.47 -40.86 89.59 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -167.75 -179.69 4.39 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.172 0.511 . . . . 0.0 112.362 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.31 -30.74 66.91 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.35 1.46 . . . . 0.0 112.89 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.586 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.44 -46.16 87.57 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.952 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.61 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.9 mm-40 -67.56 -21.98 65.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.904 0.882 . . . . 0.0 112.503 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 63.3 t -67.81 -43.73 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.39 -30.62 63.39 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 124.656 1.182 . . . . 0.0 110.982 -176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.586 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 39.1 mt-10 -69.17 -42.41 75.92 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.707 0.765 . . . . 0.0 110.189 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 49.7 m -71.89 -28.32 63.43 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.75 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.422 ' O ' ' HE1' ' B' ' 92' ' ' MET . 13.0 t80 -58.3 -62.28 1.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 0.0 109.359 174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.427 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -69.39 -29.87 67.73 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.541 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.97 53.74 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.02 0.825 . . . . 0.0 113.027 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -63.7 -40.5 96.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.118 0.567 . . . . 0.0 110.073 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.8 ttpt -56.34 -45.25 80.49 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.291 0.637 . . . . 0.0 110.656 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 -20.82 60.01 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.172 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 51.9 m -98.36 10.85 39.79 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.125 0.97 . . . . 0.0 112.516 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.62 42.87 5.96 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -94.61 153.32 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.13 -59.64 2.7 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.812 0.445 . . . . 0.0 110.363 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.422 ' HE1' ' O ' ' B' ' 82' ' ' PHE . 30.9 ttm 67.37 84.97 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.866 0.729 . . . . 0.0 112.377 170.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.27 84.2 1.93 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-O 121.126 0.489 . . . . 0.0 110.645 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.554 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 55.6 tp60 -178.74 132.23 0.13 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.649 1.18 . . . . 0.0 108.833 176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . 0.405 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 96.8 mt-30 -86.36 118.02 69.64 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 9.8 Cg_endo -52.66 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.547 2.831 . . . . 0.0 112.106 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.28 148.86 25.31 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.125 0.97 . . . . 0.0 110.772 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.81 99.36 12.38 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.446 ' SD ' HG21 ' B' ' 104' ' ' THR . 66.1 mtt -103.05 -173.56 2.34 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.288 0.635 . . . . 0.0 111.745 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -57.24 -39.49 75.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.052 1.341 . . . . 0.0 112.548 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' B' ' 120' ' ' PHE . 78.7 m-85 -88.76 -5.13 58.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.511 0.725 . . . . 0.0 111.399 -176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.67 -160.19 21.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.735 -0.481 . . . . 0.0 113.302 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -80.64 100.8 8.85 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.446 HG21 ' SD ' ' B' ' 99' ' ' MET . 12.0 t -109.45 153.99 23.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.689 0.757 . . . . 0.0 110.838 -170.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 14.3 t80 -149.41 145.43 26.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.543 -177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.503 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 9.4 m -138.25 129.08 26.81 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.04 174.48 5.87 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 110.822 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.83 120.43 13.29 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.607 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 6.7 p-10 -75.54 -174.29 0.38 Allowed Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.683 0.793 . . . . 0.0 110.953 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 27.5 Cg_exo -40.34 -48.01 4.18 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.412 2.741 . . . . 0.0 114.519 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.427 ' HB2' ' CE1' ' B' ' 113' ' ' HIS . 65.0 m-20 -90.1 4.1 51.37 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.29 0.636 . . . . 0.0 111.356 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 29.0 m 71.67 17.76 5.44 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.443 ' CE1' HG12 ' B' ' 11' ' ' VAL . 16.3 m80 -60.79 137.71 58.18 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 66.4 mmt-85 -71.05 99.49 1.83 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.388 0.613 . . . . 0.0 109.439 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.8 mt -96.38 102.85 14.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.747 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 14.0 tpt180 -86.61 142.6 28.14 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.475 -170.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 t -138.91 128.75 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -135.37 158.82 43.4 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.867 0.758 . . . . 0.0 111.744 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.7 112.57 21.4 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' B' ' 101' ' ' PHE . 84.9 t80 -76.59 108.99 9.97 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.3 101.47 8.95 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 175.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptm . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.9 m -140.29 120.2 13.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.965 -0.46 . . . . 0.0 111.374 -166.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -135.88 134.16 20.38 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.093 0.957 . . . . 0.0 110.044 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -91.62 103.77 0.23 Allowed 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.325 2.683 . . . . 0.0 113.002 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.707 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 9.1 p-10 -97.71 12.49 33.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.738 0.78 . . . . 0.0 109.848 166.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -129.6 129.09 43.94 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.873 -168.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 9.1 t -130.36 137.98 50.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.158 0.983 . . . . 0.0 108.348 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -124.33 141.83 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.4 mp -113.2 131.93 55.69 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CE1' HG21 ' A' ' 55' ' ' VAL . 10.1 m-85 -71.7 120.35 17.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.881 0.873 . . . . 0.0 111.616 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 51' ' ' SER . 33.2 m -117.71 161.42 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -99.01 -54.32 3.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -94.95 103.79 12.77 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.597 0.759 . . . . 0.0 109.586 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -56.17 -57.67 1.38 Allowed 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.983 2.456 . . . . 0.0 114.493 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 38.5 Cg_exo -57.27 -57.3 1.33 Allowed 'Trans proline' 0 C--N 1.402 3.381 0 CA-C-N 122.628 1.974 . . . . 0.0 111.852 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.13 89.52 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.922 -169.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.1 m -78.26 -24.45 46.84 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.239 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.43 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 28.0 m -73.51 -43.4 60.15 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 75.5 mm-40 -68.47 -29.7 68.38 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.557 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -61.24 -50.79 71.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.816 0.697 . . . . 0.0 109.6 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -68.32 -31.92 71.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 119.033 -0.508 . . . . 0.0 110.592 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 61.2 mtpt -57.45 -47.92 80.52 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.27 57.97 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.035 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.5 -36.9 79.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.473 1.109 . . . . 0.0 112.903 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' HB2' HG22 ' A' ' 27' ' ' VAL . 23.8 mt -98.61 -31.44 11.94 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.168 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.83 31.48 20.79 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 25' ' ' LEU . 22.7 m -123.81 174.66 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.251 1.02 . . . . 0.0 110.599 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.96 143.09 47.57 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.852 0.861 . . . . 0.0 109.306 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.46 132.9 28.51 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.674 2.25 . . . . 0.0 112.828 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.429 HG13 ' HG2' ' A' ' 31' ' ' GLU . 7.8 p -71.09 -38.56 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.534 0.734 . . . . 0.0 109.907 171.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 40.3 mm-40 -118.21 134.0 55.4 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 p -141.07 126.15 18.35 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.443 0.697 . . . . 0.0 109.23 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -140.17 157.55 68.71 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.759 1.223 . . . . 0.0 109.212 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.25 -24.49 77.42 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.917 2.412 . . . . 0.0 113.831 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.4 t -127.1 13.49 7.24 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -155.99 154.34 30.94 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.969 -0.457 . . . . 0.0 110.411 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.5 t -144.69 157.62 44.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.153 0.981 . . . . 0.0 108.403 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -154.41 118.12 4.64 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.57 135.97 51.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 109.104 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' A' ' 46' ' ' LYS . 16.1 t -115.87 126.25 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 0.0 108.925 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.461 HD13 ' SD ' ' A' ' 45' ' ' MET . 10.3 mp -90.16 152.55 21.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.761 0.424 . . . . 0.0 110.257 -170.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.44 -14.17 61.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.949 0.899 . . . . 0.0 111.699 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -65.55 -22.42 66.7 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.28 1.032 . . . . 0.0 111.789 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.66 1.08 40.0 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.818 -0.435 . . . . 0.0 113.343 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.73 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -95.34 169.99 9.69 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.113 0.565 . . . . 0.0 109.873 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HG3' HG22 ' A' ' 40' ' ' VAL . 79.3 tttt -133.7 135.9 44.34 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 7' ' ' THR . 1.2 tt -137.59 123.99 20.73 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.895 0.478 . . . . 0.0 110.013 -170.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.15 167.75 15.21 Favored Glycine 0 C--N 1.344 1.013 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -133.48 111.81 11.02 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 162.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.436 ' HE1' ' HA ' ' A' ' 55' ' ' VAL . 2.2 t-105 -103.91 125.03 50.02 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.9 m -79.97 109.54 14.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.535 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 28.8 ptt-85 -67.71 -11.29 58.01 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.436 1.094 . . . . 0.0 113.618 -167.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -65.91 -17.83 64.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.937 0.495 . . . . 0.0 111.31 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -147.88 76.84 1.4 Allowed 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.959 1.362 . . . . 0.0 109.161 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 10' ' ' TYR . 7.3 p -113.74 152.63 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.031 174.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -114.21 112.22 46.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.808 0.843 . . . . 0.0 109.852 170.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.9 142.0 61.19 Favored 'Cis proline' 0 C--N 1.381 2.263 0 CA-C-N 120.157 1.092 . . . . 0.0 112.413 1.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -49.31 111.02 0.43 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.036 0.935 . . . . 0.0 111.78 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.98 107.16 4.17 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.12 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.535 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 22.3 p -113.53 85.6 2.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.455 0.645 . . . . 0.0 109.508 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.95 129.06 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.996 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -144.39 157.04 44.45 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.336 1.055 . . . . 0.0 109.007 170.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 -43.06 0.57 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.05 150.1 22.3 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.47 120.97 4.82 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 75.28 89.78 0.22 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.77 0.335 . . . . 0.0 112.601 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' CG ' ' HB ' ' B' ' 8' ' ' ILE . 2.9 pt-20 -102.5 164.39 11.69 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.451 0.643 . . . . 0.0 109.926 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.85 101.66 7.85 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.81 108.92 19.77 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.135 0.493 . . . . 0.0 111.167 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -86.38 116.21 24.4 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.277 1.431 . . . . 0.0 109.106 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -95.86 127.17 41.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.369 0.604 . . . . 0.0 112.075 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.29 161.92 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.787 1.235 . . . . 0.0 110.391 177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.5 pt-20 -63.95 -38.74 92.21 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -163.85 -179.62 6.43 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 118.405 0.548 . . . . 0.0 112.013 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.4 -32.27 70.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.268 . . . . 0.0 112.595 -166.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -61.24 -48.17 82.7 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.027 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.443 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 63.5 mm-40 -65.26 -20.58 66.49 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.632 1.173 . . . . 0.0 112.993 -177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.6 -43.25 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.375 0.607 . . . . 0.0 109.924 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.66 -31.4 63.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.753 1.221 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 43.4 mt-10 -67.18 -45.19 77.7 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.122 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 m -69.62 -32.24 70.83 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.872 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -56.14 -57.33 12.64 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.912 0.885 . . . . 0.0 109.407 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.22 90.84 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.721 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.19 -44.43 93.92 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 123.849 0.718 . . . . 0.0 114.097 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.87 -44.1 97.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.34 0.656 . . . . 0.0 109.869 175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.09 -46.47 79.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.674 0.79 . . . . 0.0 110.42 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.9 -27.32 66.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.842 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.7 t -93.14 -10.61 35.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.801 0.84 . . . . 0.0 112.575 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.64 58.39 0.95 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 169.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.4 t -104.3 143.61 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.23 65.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.567 0.747 . . . . 0.0 111.48 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 53.3 ttm 65.03 83.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 165.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 83.69 2.0 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.499 0.666 . . . . 0.0 111.068 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 177.81 122.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.707 1.603 . . . . 0.0 108.652 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -80.15 118.5 72.72 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -49.85 102.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.926 3.084 . . . . 0.0 112.873 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.99 141.0 41.72 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.941 0.896 . . . . 0.0 110.262 -175.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.94 100.27 4.8 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 175.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 46.7 ttm -96.96 162.1 13.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.427 0.691 . . . . 0.0 109.331 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.17 -28.63 68.09 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.001 0.92 . . . . 0.0 112.45 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -77.7 -24.74 49.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.479 0.712 . . . . 0.0 110.523 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.16 175.93 21.99 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.851 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -74.05 101.01 3.75 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -111.67 147.56 35.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.409 0.623 . . . . 0.0 111.459 -165.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.502 ' HD2' ' HB ' ' A' ' 117' ' ' VAL . 5.8 t80 -144.21 144.03 31.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.692 1.197 . . . . 0.0 109.426 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.401 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 12.8 m -133.07 128.11 35.5 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.06 174.09 6.03 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.893 0.877 . . . . 0.0 110.033 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.03 122.59 17.36 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.505 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 4.1 p-10 -71.63 176.23 2.35 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.352 0.661 . . . . 0.0 109.352 172.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 27.8 Cg_endo -59.65 -12.92 19.34 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 122.305 2.004 . . . . 0.0 114.086 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.11 1.08 49.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.165 0.586 . . . . 0.0 111.677 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.3 p 66.3 33.47 7.11 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.821 1.649 . . . . 0.0 112.816 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -74.33 173.14 10.66 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 114' ' ' ARG . 16.5 mmt-85 -108.6 105.01 14.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.4 mt -99.95 99.92 10.75 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.465 HH21 HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -98.48 96.62 8.12 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -167.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.502 ' HB ' ' HD2' ' A' ' 105' ' ' PHE . 27.6 t -86.51 119.24 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -139.46 161.04 38.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.53 112.81 18.96 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -69.31 141.1 54.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.612 0.765 . . . . 0.0 110.834 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.93 98.73 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.509 0.723 . . . . 0.0 110.269 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.742 -1.032 . . . . 0.0 110.821 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.508 0.194 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 91.0 m -141.89 121.12 13.03 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 111.007 -168.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -135.82 133.97 20.32 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 123.751 0.82 . . . . 0.0 110.317 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -90.94 104.1 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.315 2.677 . . . . 0.0 112.996 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.73 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.2 p-10 -98.31 13.49 31.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.617 0.723 . . . . 0.0 109.975 166.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -129.27 128.7 43.76 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.221 -1.354 . . . . 0.0 107.887 -168.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -130.35 138.14 50.26 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.486 ' HB ' ' CG ' ' A' ' 67' ' ' GLU . 31.1 mt -125.36 141.88 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 mt -113.05 133.96 54.74 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.419 ' CE1' HG21 ' B' ' 55' ' ' VAL . 69.2 m-85 -76.58 120.75 22.22 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.925 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' B' ' 51' ' ' SER . 34.1 m -117.68 160.85 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -98.12 -54.85 2.95 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.36 0.264 . . . . 0.0 110.427 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -93.76 103.55 10.47 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.862 0.865 . . . . 0.0 109.345 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -55.86 -58.53 1.04 Allowed 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.253 2.635 . . . . 0.0 114.621 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.483 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 52.6 Cg_exo -56.34 -57.57 1.39 Allowed 'Trans proline' 0 C--N 1.404 3.478 0 CA-C-N 122.751 2.018 . . . . 0.0 112.09 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.92 90.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.794 -168.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 18.0 m -78.03 -24.99 47.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.357 -175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 41.8 m -73.08 -42.87 62.54 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' B' ' 15' ' ' PRO . 77.3 mm-40 -68.96 -29.52 67.76 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.571 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.66 -50.62 71.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.905 0.753 . . . . 0.0 109.59 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -67.97 -32.2 72.46 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.772 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.548 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 58.6 mtpt -57.09 -48.19 79.19 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.289 0.566 . . . . 0.0 112.466 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 -35.3 57.3 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.907 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.45 -36.71 78.87 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.353 1.061 . . . . 0.0 112.928 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.539 ' HB2' HG22 ' B' ' 27' ' ' VAL . 24.0 mt -99.01 -31.03 12.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.13 177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 31.74 21.33 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -173.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.553 HG11 HD22 ' B' ' 41' ' ' LEU . 32.8 m -124.71 174.26 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 124.076 0.95 . . . . 0.0 110.838 -177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -131.07 139.1 34.51 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.892 0.877 . . . . 0.0 109.14 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.548 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 51.0 Cg_exo -60.84 131.88 39.65 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.291 2.661 . . . . 0.0 114.417 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.446 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.6 p -71.34 -36.88 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.794 0.838 . . . . 0.0 110.157 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 38.7 mm-40 -121.31 133.0 55.12 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 53.1 m -141.41 126.12 17.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 67.5 m -140.08 157.05 69.95 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.815 1.246 . . . . 0.0 109.091 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.06 -24.88 75.62 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.115 2.543 . . . . 0.0 114.11 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.1 t -127.34 13.65 7.12 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -156.13 154.39 30.82 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.877 -0.515 . . . . 0.0 110.355 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -144.8 157.04 44.32 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.16 0.984 . . . . 0.0 108.46 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.0 tt -153.96 118.4 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -126.63 135.17 50.85 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.97 1.308 . . . . 0.0 109.161 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.581 HG22 ' HG3' ' B' ' 46' ' ' LYS . 18.6 t -114.5 126.43 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.364 1.066 . . . . 0.0 109.047 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.553 HD22 HG11 ' B' ' 27' ' ' VAL . 16.6 mt -90.35 153.01 20.76 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -170.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.0 -13.73 62.2 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.892 0.877 . . . . 0.0 111.531 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -22.42 66.74 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 111.957 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.01 1.87 42.08 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.76 -0.467 . . . . 0.0 113.123 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.707 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -95.67 169.89 9.71 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.361 0.581 . . . . 0.0 109.826 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.581 ' HG3' HG22 ' B' ' 40' ' ' VAL . 76.3 tttt -133.25 136.56 45.63 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.79 123.91 20.36 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.928 0.491 . . . . 0.0 110.132 -170.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.98 167.85 15.39 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.57 111.53 10.74 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 162.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -103.69 125.41 50.16 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 20.4 m -80.1 109.62 14.73 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.635 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 32.7 ptt-85 -68.6 -10.25 54.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.358 1.063 . . . . 0.0 113.757 -167.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -65.83 -18.24 65.2 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.701 0.4 . . . . 0.0 111.488 177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -147.52 77.02 1.42 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.544 1.164 . . . . 0.0 109.098 168.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' B' ' 10' ' ' TYR . 7.4 p -113.46 152.27 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.015 174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' B' ' 57' ' ' PRO . 40.9 mt-10 -114.59 112.42 45.73 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.668 0.787 . . . . 0.0 109.76 169.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' B' ' 56' ' ' GLU . 82.3 Cg_endo -80.19 142.74 62.85 Favored 'Cis proline' 0 C--N 1.386 2.546 0 CA-C-N 119.589 0.889 . . . . 0.0 112.508 1.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -50.42 111.4 0.53 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.923 0.889 . . . . 0.0 111.564 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.12 107.42 4.21 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.574 -1.194 . . . . 0.0 108.143 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.635 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 30.5 p -114.33 85.45 2.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.681 0.753 . . . . 0.0 109.474 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -162.81 130.11 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.089 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 20.5 p -145.67 156.02 43.37 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.719 1.208 . . . . 0.0 108.814 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.86 -43.47 0.55 Allowed Glycine 0 C--N 1.342 0.874 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 149.59 21.73 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.19 121.05 4.81 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 76.55 89.81 0.27 Allowed Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -102.51 163.4 12.25 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.98 0.912 . . . . 0.0 109.178 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.8 tp -120.87 101.35 7.64 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.68 109.63 20.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 118.359 0.527 . . . . 0.0 111.343 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -87.01 116.35 25.0 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 108.918 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -95.98 126.19 41.05 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.217 0.532 . . . . 0.0 111.499 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.25 162.58 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.533 1.133 . . . . 0.0 110.48 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.4 pt-20 -64.21 -38.81 92.37 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -163.6 179.81 6.95 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.329 0.513 . . . . 0.0 112.149 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.88 -32.1 69.18 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.115 1.366 . . . . 0.0 112.804 -167.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.53 -47.51 85.24 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.279 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.57 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 84.5 mm-40 -66.48 -19.59 65.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.212 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.49 -44.38 83.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.39 0.614 . . . . 0.0 109.597 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.82 -33.43 70.69 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.113 1.365 . . . . 0.0 111.367 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -65.23 -46.88 78.83 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.73 0.776 . . . . 0.0 109.91 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -68.93 -32.28 71.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.924 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.27 -57.55 11.77 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.576 0.75 . . . . 0.0 109.288 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.33 -46.04 91.29 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.649 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.26 -44.23 94.04 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 123.726 0.641 . . . . 0.0 113.809 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . 0.412 ' HB3' HG11 ' B' ' 90' ' ' VAL . 37.6 m0 -62.89 -44.03 97.19 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.192 0.597 . . . . 0.0 109.902 175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -56.89 -45.96 82.22 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 110.324 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.87 -27.14 66.42 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.904 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.1 t -93.6 -10.31 35.11 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.855 0.862 . . . . 0.0 112.22 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.12 58.84 0.96 Allowed Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.222 -0.445 . . . . 0.0 114.09 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' B' ' 92' ' ' MET . 5.1 p -104.4 144.73 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 169.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.48 63.92 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.246 0.618 . . . . 0.0 111.387 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.579 ' HB2' HG13 ' B' ' 90' ' ' VAL . 51.8 ttm 65.31 83.81 0.16 Allowed 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.953 0.783 . . . . 0.0 113.06 165.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.402 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -117.19 84.09 2.09 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.413 0.625 . . . . 0.0 110.851 176.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' B' ' 106' ' ' THR . 51.5 tp60 177.22 121.57 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.762 1.625 . . . . 0.0 108.304 172.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -78.56 119.31 76.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.73 102.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.806 3.004 . . . . 0.0 112.556 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.09 140.52 42.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.0 0.92 . . . . 0.0 110.244 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.81 100.63 4.81 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.497 ' SD ' ' HD2' ' B' ' 101' ' ' PHE . 56.0 ttm -97.05 162.56 13.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.449 0.7 . . . . 0.0 109.356 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.84 -29.58 68.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.122 0.969 . . . . 0.0 112.018 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.497 ' HD2' ' SD ' ' B' ' 99' ' ' MET . 49.2 m-85 -77.29 -25.38 51.27 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.401 0.681 . . . . 0.0 110.369 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 149.77 176.5 22.97 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.962 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -74.39 101.48 4.11 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.5 t -112.36 147.47 36.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.185 0.517 . . . . 0.0 111.473 -165.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.521 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 6.2 t80 -144.31 143.97 31.25 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.67 1.188 . . . . 0.0 109.366 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.503 HG21 ' HG3' ' B' ' 114' ' ' ARG . 32.6 m -133.31 127.85 34.49 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.4 0.619 . . . . 0.0 110.276 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.72 174.1 6.03 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.992 0.917 . . . . 0.0 110.206 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.2 121.41 15.85 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.602 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 1.2 p30 -69.54 175.99 1.92 Allowed Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 123.67 0.788 . . . . 0.0 110.171 171.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 31.5 Cg_endo -60.48 -12.2 19.8 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.381 2.054 . . . . 0.0 113.901 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -97.57 0.47 47.43 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.2 0.6 . . . . 0.0 111.417 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 27.6 t 66.96 33.46 5.8 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.272 1.429 . . . . 0.0 112.245 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -75.18 173.36 10.91 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.503 ' HG3' HG21 ' B' ' 106' ' ' THR . 5.4 mpt_? -107.98 104.9 14.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.0 100.54 11.45 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 28.3 ttt85 -97.91 95.47 7.52 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -166.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.521 ' HB ' ' HD2' ' B' ' 105' ' ' PHE . 36.0 t -86.29 119.36 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -139.22 160.86 38.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.56 112.58 18.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.45 138.4 55.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.087 0.555 . . . . 0.0 109.96 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.64 97.89 0.84 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.881 0.472 . . . . 0.0 109.999 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.063 -178.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 111.282 0.104 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.513 HG21 ' HB3' ' B' ' 70' ' ' PHE . 53.1 m -140.41 147.32 39.53 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.101 0.56 . . . . 0.0 111.495 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -102.37 114.93 65.19 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.275 1.03 . . . . 0.0 109.835 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.547 ' HG3' HD22 ' B' ' 25' ' ' LEU . 87.7 Cg_endo -85.76 86.17 1.03 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.696 2.264 . . . . 0.0 111.493 168.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.631 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 14.3 t70 -102.58 11.44 37.8 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.142 0.972 . . . . 0.0 110.062 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.1 t80 -133.01 131.56 40.84 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -169.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -128.21 144.18 51.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.853 0.861 . . . . 0.0 109.167 175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.455 HD12 ' NH1' ' B' ' 116' ' ' ARG . 1.8 mt -126.77 138.93 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 123.635 0.774 . . . . 0.0 109.51 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 68' ' ' LEU . 96.1 mt -95.24 137.44 34.29 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -77.05 98.88 5.14 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.076 177.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.492 HG11 HD23 ' A' ' 49' ' ' LEU . 20.1 m -109.74 169.78 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -113.23 -60.5 1.87 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.088 0.555 . . . . 0.0 110.003 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -102.32 98.39 10.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.941 0.896 . . . . 0.0 110.4 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.405 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.4 Cg_exo -49.12 -49.9 14.18 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.683 2.922 . . . . 0.0 115.984 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -60.77 -58.96 0.39 Allowed 'Trans proline' 0 C--N 1.401 3.332 0 CA-C-N 122.217 1.828 . . . . 0.0 110.858 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.86 89.86 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 -171.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.9 m -59.51 -52.31 66.11 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 122.215 1.007 . . . . 0.0 109.507 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 59.1 m -80.49 -33.68 36.37 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -163.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.548 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 83.6 mm-40 -65.39 -37.46 87.06 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.888 172.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -60.97 -44.29 97.54 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.172 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -71.46 -28.27 63.84 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.214 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.548 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.6 mtpt -56.49 -51.05 69.96 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.315 0.507 . . . . 0.0 111.875 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.41 -38.09 56.15 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.311 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.482 HD21 HD13 ' A' ' 115' ' ' LEU . 11.6 tp -59.79 -36.63 77.13 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.175 0.99 . . . . 0.0 112.34 -175.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD22 ' HG3' ' B' ' 4' ' ' PRO . 46.4 mt -96.9 -40.96 8.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.113 0.965 . . . . 0.0 109.357 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.83 30.85 8.11 Favored Glycine 0 C--N 1.344 1.02 0 O-C-N 123.605 0.566 . . . . 0.0 112.071 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.7 m -129.75 -178.39 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.427 1.091 . . . . 0.0 109.902 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.7 154.32 72.99 Favored Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 123.253 0.621 . . . . 0.0 109.753 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 11.4 Cg_exo -70.57 117.39 5.11 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.941 2.427 . . . . 0.0 111.954 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 39' ' ' PHE . 5.8 p -65.42 -40.52 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 172.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 47.3 mm-40 -113.41 128.76 56.56 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 123.755 0.822 . . . . 0.0 109.482 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.9 t -127.73 131.9 49.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.862 0.865 . . . . 0.0 109.267 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 t -137.22 147.72 59.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.25 -15.32 34.03 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.921 2.414 . . . . 0.0 114.226 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.49 7.74 5.84 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -157.97 153.37 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.612 0.365 . . . . 0.0 110.122 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 24.4 m -138.06 148.23 44.85 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.191 0.596 . . . . 0.0 109.612 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.8 tm? -146.16 129.2 16.51 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.567 ' HA ' HG12 ' A' ' 30' ' ' VAL . 2.6 p90 -134.49 148.18 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.176 0.99 . . . . 0.0 108.981 163.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' A' ' 46' ' ' LYS . 17.5 t -119.4 127.95 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.458 HD12 ' SD ' ' A' ' 45' ' ' MET . 37.7 mt -89.87 142.4 27.73 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -169.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.3 -14.3 62.89 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.069 0.948 . . . . 0.0 112.219 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.518 HD22 ' HB3' ' B' ' 5' ' ' ASP . 66.5 t30 -71.78 -9.87 58.94 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 110.912 174.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.2 32.91 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.483 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.66 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -97.01 172.29 7.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.009 0.904 . . . . 0.0 110.095 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG22 ' A' ' 40' ' ' VAL . 86.5 tttt -135.03 141.82 46.25 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.05 0.54 . . . . 0.0 109.679 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tt -141.88 123.41 15.0 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.829 0.452 . . . . 0.0 110.452 -169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -107.77 167.86 13.68 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.537 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.492 HD23 HG11 ' A' ' 11' ' ' VAL . 6.3 mp -134.04 107.96 8.07 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 166.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.554 ' HE3' ' NH2' ' B' ' 116' ' ' ARG . 6.0 t90 -105.19 130.52 53.33 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.405 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 37.4 m -80.01 121.57 25.66 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.041 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -65.73 -14.09 60.61 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.986 1.314 . . . . 0.0 113.492 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -76.24 -8.2 56.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.573 0.349 . . . . 0.0 111.101 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.426 HG23 ' HE1' ' A' ' 50' ' ' TRP . 12.1 t -136.9 6.39 2.89 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.117 0.567 . . . . 0.0 111.344 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -59.8 147.83 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.716 0.406 . . . . 0.0 110.885 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -128.25 111.25 19.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.754 0.822 . . . . 0.0 108.875 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.7 140.49 66.8 Favored 'Cis proline' 0 C--N 1.389 2.666 0 C-N-CA 124.76 -0.933 . . . . 0.0 113.736 4.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -50.56 116.53 1.96 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.757 1.223 . . . . 0.0 113.04 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.52 107.1 3.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.799 1.24 . . . . 0.0 108.194 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -97.85 87.29 3.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -139.89 142.4 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 108.828 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.443 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 8.1 p -151.53 132.41 14.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.197 1.399 . . . . 0.0 108.267 174.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.19 -65.2 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 N-CA-C 112.054 -0.419 . . . . 0.0 112.054 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.49 64.26 0.1 OUTLIER Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.04 131.7 8.07 Favored Glycine 0 N--CA 1.464 0.566 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 73.43 129.43 0.14 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 15.9 mt-10 -120.97 147.95 44.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.05 0.54 . . . . 0.0 109.599 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.466 HD22 HD11 ' A' ' 9' ' ' LEU . 39.9 tp -120.47 106.37 11.75 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -92.0 122.85 34.9 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.482 0.658 . . . . 0.0 111.338 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HB3' HG21 ' B' ' 2' ' ' THR . 16.3 m-85 -102.56 108.35 19.61 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 107.529 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' HD3' ' HD2' ' B' ' 6' ' ' PHE . 29.2 mtm180 -91.29 123.49 34.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.447 0.642 . . . . 0.0 112.201 -175.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 118' ' ' TYR . 34.8 m -126.19 158.9 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.747 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.8 pt-20 -69.36 -34.17 74.17 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.066 -173.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.492 HD22 ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -161.72 177.45 9.92 Favored 'General case' 0 C--N 1.366 1.292 0 CA-C-N 118.697 0.68 . . . . 0.0 112.55 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -59.06 -33.21 70.53 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.732 1.613 . . . . 0.0 112.84 -167.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.49 -38.95 77.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.74 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.574 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 21.8 mm-40 -66.18 -24.42 66.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.791 0.836 . . . . 0.0 112.032 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.19 -43.45 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.541 0.686 . . . . 0.0 109.647 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.39 -33.66 74.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.241 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -65.58 -45.26 83.93 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.293 0.568 . . . . 0.0 109.941 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.6 m -68.87 -28.46 66.73 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.013 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.9 -61.26 2.74 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.6 0.714 . . . . 0.0 109.948 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.78 -34.23 77.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.494 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.23 -46.75 93.3 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 124.206 0.941 . . . . 0.0 113.36 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -63.71 -45.88 87.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.211 0.604 . . . . 0.0 110.197 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -57.01 -42.61 80.63 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.798 0.686 . . . . 0.0 110.836 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.09 -27.62 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.06 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -90.88 8.93 32.51 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.306 1.042 . . . . 0.0 112.643 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 46.47 4.61 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 114.147 169.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.9 p -101.6 148.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.1 79.07 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.931 0.492 . . . . 0.0 111.418 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.5 tpp 64.19 82.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.74 0.816 . . . . 0.0 112.891 166.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' B' ' 57' ' ' PRO . 0.0 OUTLIER -134.11 84.92 2.15 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.086 0.47 . . . . 0.0 111.523 176.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 178.36 138.31 0.09 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.577 1.151 . . . . 0.0 109.565 172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.85 119.97 68.83 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -54.12 111.41 0.7 Allowed 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.938 2.425 . . . . 0.0 110.627 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.96 147.16 49.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.19 0.596 . . . . 0.0 111.231 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.02 104.8 4.23 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.608 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.418 ' SD ' ' CZ2' ' B' ' 50' ' ' TRP . 51.0 ttm -102.25 171.15 7.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.451 0.7 . . . . 0.0 109.939 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 99' ' ' MET . 19.1 mm-40 -49.63 -34.06 17.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.345 1.458 . . . . 0.0 113.092 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -101.68 -5.71 24.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.785 0.834 . . . . 0.0 111.469 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.16 -178.81 20.54 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.159 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 51.3 t80 -80.5 102.58 9.8 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.7 t -122.52 157.71 31.43 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.592 0.711 . . . . 0.0 111.466 -166.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.56 153.24 33.01 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.292 1.437 . . . . 0.0 108.249 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.481 HG21 ' HG3' ' A' ' 114' ' ' ARG . 23.5 m -146.81 127.68 14.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.149 0.431 . . . . 0.0 110.673 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.09 170.97 7.63 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.127 0.571 . . . . 0.0 110.724 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.4 117.42 23.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.773 0.429 . . . . 0.0 109.965 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.25 168.86 17.89 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.902 1.281 . . . . 0.0 110.856 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.31 -35.72 54.65 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.195 2.597 . . . . 0.0 114.499 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -87.48 1.18 54.22 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.307 0.643 . . . . 0.0 111.467 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.6 m 63.24 57.82 1.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.807 1.243 . . . . 0.0 112.36 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -93.19 -145.93 0.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 172.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG3' HG21 ' A' ' 106' ' ' THR . 0.1 OUTLIER -145.5 90.63 2.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.482 HD13 HD21 ' A' ' 24' ' ' LEU . 69.1 mt -96.07 104.82 16.78 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -171.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.743 HH12 HG23 ' B' ' 55' ' ' VAL . 1.8 mtp180 -101.98 146.52 27.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.374 0.27 . . . . 0.0 110.913 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 70' ' ' PHE . 15.3 t -127.69 127.57 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 166.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 72' ' ' VAL . 19.1 p90 -130.46 155.5 46.34 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.16 0.436 . . . . 0.0 111.275 -178.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -109.37 121.15 44.54 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.97 108.62 10.16 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.34 0.4 . . . . 0.0 110.488 -175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.79 95.04 1.46 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.236 0.614 . . . . 0.0 109.64 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.19 -177.614 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.477 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.472 HG21 ' HB3' ' A' ' 70' ' ' PHE . 61.6 m -63.24 148.34 48.46 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 124.118 0.967 . . . . 0.0 111.592 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -100.96 114.49 65.82 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.009 0.923 . . . . 0.0 110.319 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.553 ' HG3' HD22 ' A' ' 25' ' ' LEU . 86.5 Cg_endo -86.06 86.18 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.49 2.127 . . . . 0.0 111.522 168.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.66 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 9.0 p-10 -102.9 10.78 38.12 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.538 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.454 ' HD2' ' HD3' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -132.17 131.84 42.6 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -169.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.6 t -128.06 143.71 51.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.009 0.924 . . . . 0.0 108.968 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 35.8 mt -125.28 139.36 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.526 HD23 HD21 ' B' ' 47' ' ' LEU . 4.0 mm? -95.32 137.38 34.45 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.431 ' HE2' ' HG2' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -76.03 97.62 4.09 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.212 1.405 . . . . 0.0 109.593 177.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.423 HG11 HD23 ' B' ' 49' ' ' LEU . 22.7 m -109.48 170.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.21 -60.26 1.91 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 122.984 0.514 . . . . 0.0 110.335 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -102.23 97.72 9.09 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 124.147 0.979 . . . . 0.0 110.49 -169.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.45 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.1 Cg_exo -48.88 -51.65 10.12 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.79 2.993 . . . . 0.0 115.675 -168.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.21 -60.16 0.42 Allowed 'Trans proline' 0 C--N 1.399 3.203 0 CA-C-N 122.099 1.786 . . . . 0.0 111.536 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.61 88.97 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.945 0.498 . . . . 0.0 112.163 -170.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' B' ' 20' ' ' PHE . 34.1 m -59.1 -52.07 67.31 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 122.352 1.072 . . . . 0.0 109.677 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 70.7 m -80.46 -33.75 36.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -163.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.52 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 82.8 mm-40 -65.33 -38.39 90.01 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.715 172.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' B' ' 90' ' ' VAL . 41.9 t80 -59.82 -45.82 91.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.33 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 36.1 m-85 -69.89 -29.42 66.62 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.805 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 52.3 mtpt -56.11 -51.21 68.72 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 121.182 0.515 . . . . 0.0 111.672 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.75 -38.42 54.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.439 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 8.5 tp -58.94 -36.64 75.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.424 1.09 . . . . 0.0 112.476 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' A' ' 4' ' ' PRO . 53.5 mt -96.93 -41.18 8.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.347 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.14 30.41 8.29 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' B' ' 25' ' ' LEU . 27.2 m -129.63 -177.98 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.411 1.084 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -139.05 155.04 72.94 Favored Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 123.338 0.655 . . . . 0.0 109.622 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 3.0 Cg_exo -71.84 117.05 4.95 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.867 2.378 . . . . 0.0 111.458 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' B' ' 39' ' ' PHE . 7.6 p -65.36 -39.87 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.631 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 51.6 mm-40 -114.08 128.26 56.3 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.506 0.722 . . . . 0.0 109.436 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 48.2 t -127.03 132.37 50.75 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.064 0.945 . . . . 0.0 109.245 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.0 t -137.52 148.01 59.84 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.805 1.242 . . . . 0.0 107.745 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.44 -15.14 39.05 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.693 2.262 . . . . 0.0 113.952 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -128.45 7.96 5.89 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -157.83 153.68 26.8 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 122.078 -0.389 . . . . 0.0 110.2 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 18.1 m -138.28 147.91 44.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.22 0.608 . . . . 0.0 109.541 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 2.3 tm? -145.98 129.66 17.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 3.7 p90 -134.84 148.64 50.2 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.22 1.008 . . . . 0.0 108.721 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -120.52 127.8 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.401 HD22 HG11 ' B' ' 27' ' ' VAL . 36.8 mt -89.02 142.32 27.74 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.243 0.617 . . . . 0.0 109.405 -168.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.09 -14.21 62.8 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -71.58 -10.21 59.41 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.761 0.825 . . . . 0.0 110.61 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.27 -4.35 33.34 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.215 -0.77 . . . . 0.0 114.175 170.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.631 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -96.25 172.61 7.85 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.047 0.923 . . . . 0.0 110.297 177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -135.78 141.93 44.86 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.796 0.438 . . . . 0.0 109.951 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.526 HD21 HD23 ' B' ' 9' ' ' LEU . 3.6 tt -141.73 123.03 14.83 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.01 0.433 . . . . 0.0 110.589 -169.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.437 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -106.7 167.23 13.88 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 123.927 0.775 . . . . 0.0 111.372 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 9.2 mp -134.0 108.32 8.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 166.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.493 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -105.83 130.62 53.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.45 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 42.3 m -81.06 121.27 25.86 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 123.597 0.561 . . . . 0.0 110.933 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -64.97 -14.83 61.24 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.105 1.362 . . . . 0.0 113.809 -170.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -75.94 -7.49 54.71 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.819 0.448 . . . . 0.0 111.721 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.9 t -137.14 7.17 2.88 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.378 0.671 . . . . 0.0 111.198 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.743 HG23 HH12 ' A' ' 116' ' ' ARG . 9.8 p -62.82 148.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 122.265 0.226 . . . . 0.0 110.48 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.45 ' H ' HH22 ' A' ' 116' ' ' ARG . 17.9 mt-10 -127.73 110.99 20.57 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 123.585 0.754 . . . . 0.0 109.357 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.478 ' HG3' HD23 ' A' ' 93' ' ' LEU . 85.8 Cg_endo -75.39 139.77 63.16 Favored 'Cis proline' 0 C--N 1.388 2.612 0 CA-C-N 119.85 0.982 . . . . 0.0 113.805 4.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -49.58 116.32 1.71 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.735 1.214 . . . . 0.0 113.179 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.29 107.2 3.98 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.691 1.196 . . . . 0.0 108.471 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.3 p -97.81 87.48 4.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.22 141.99 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.427 1.091 . . . . 0.0 108.98 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 11.1 p -151.22 133.11 15.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.709 1.203 . . . . 0.0 108.186 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.73 -66.08 0.05 OUTLIER Glycine 0 C--N 1.348 1.195 0 N-CA-C 112.099 -0.4 . . . . 0.0 112.099 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.0 62.89 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.16 130.57 7.83 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 119.442 -0.644 . . . . 0.0 111.674 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 74.06 130.02 0.18 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' B' ' 114' ' ' ARG . 27.0 mt-10 -121.93 147.2 46.33 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -166.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.0 tp -120.46 106.45 11.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.718 ' HA ' ' HG2' ' B' ' 116' ' ' ARG . . . -91.3 122.25 33.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -172.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.513 ' HB3' HG21 ' A' ' 2' ' ' THR . 12.5 m-85 -101.95 108.31 19.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.588 1.555 . . . . 0.0 107.523 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 56.9 mtm180 -91.97 122.75 34.78 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.419 0.628 . . . . 0.0 111.968 -174.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.42 HG22 ' O ' ' B' ' 118' ' ' TYR . 22.7 m -125.11 159.27 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.708 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' B' ' 74' ' ' ASN . 9.5 pt-20 -69.39 -34.66 74.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.423 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.463 HD22 ' HG3' ' B' ' 73' ' ' GLU . 6.0 p30 -161.18 176.67 11.02 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.714 0.688 . . . . 0.0 112.412 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -59.11 -32.34 69.74 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.704 1.602 . . . . 0.0 113.063 -168.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.97 -39.34 76.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.641 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -65.75 -24.37 66.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.589 0.756 . . . . 0.0 112.45 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.615 HG13 HG13 ' B' ' 117' ' ' VAL . 97.2 t -68.34 -42.96 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.503 0.721 . . . . 0.0 109.829 172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.15 -33.05 71.3 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.788 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 29.5 mt-10 -65.77 -45.9 80.79 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.419 0.628 . . . . 0.0 109.987 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 92.7 m -67.3 -29.81 69.5 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.996 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -59.89 -61.21 2.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.67 0.788 . . . . 0.0 110.093 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.07 -33.91 76.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.42 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.47 -47.33 90.18 Favored Glycine 0 C--N 1.343 0.953 0 O-C-N 124.122 0.888 . . . . 0.0 113.088 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . 0.478 ' HB3' HG21 ' B' ' 90' ' ' VAL . 44.9 m0 -62.55 -46.86 86.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.347 0.659 . . . . 0.0 110.038 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.89 -42.81 76.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.367 0.667 . . . . 0.0 111.065 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.73 -27.7 63.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.873 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -91.04 9.26 31.55 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.439 1.096 . . . . 0.0 112.233 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.98 46.88 4.64 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.09 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.485 HG11 ' HB1' ' B' ' 107' ' ' ALA . 48.7 t -101.97 147.44 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.06 77.48 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.048 0.539 . . . . 0.0 111.449 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 51.3 tpp 64.34 82.53 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.705 0.802 . . . . 0.0 112.799 166.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 85.17 2.18 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.011 0.434 . . . . 0.0 111.524 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 178.07 138.17 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.401 1.081 . . . . 0.0 109.301 172.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -90.21 119.88 69.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.18 111.51 0.73 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.719 2.279 . . . . 0.0 110.699 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.83 146.77 49.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.338 0.655 . . . . 0.0 111.279 -170.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 104.87 4.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.838 0.855 . . . . 0.0 109.812 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 51.9 ttm -101.93 170.14 8.33 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.07 0.948 . . . . 0.0 109.66 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -48.74 -34.47 12.19 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.257 1.423 . . . . 0.0 113.216 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -101.96 -5.4 24.71 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.773 0.829 . . . . 0.0 111.67 -171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 142.6 -178.6 20.93 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.311 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 52.1 t80 -80.99 102.59 10.26 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 15.2 t -122.61 158.05 30.82 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.664 0.745 . . . . 0.0 111.505 -167.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -153.2 152.73 31.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.365 1.466 . . . . 0.0 108.075 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.635 HG21 ' HG3' ' B' ' 114' ' ' ARG . 29.0 m -145.82 127.74 15.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.685 0.394 . . . . 0.0 110.21 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.485 ' HB1' HG11 ' B' ' 90' ' ' VAL . . . -107.56 171.22 7.51 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.06 0.544 . . . . 0.0 110.78 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.77 116.92 22.36 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.412 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.3 p30 -70.95 169.41 14.87 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.691 1.197 . . . . 0.0 111.242 175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 10.9 Cg_endo -52.16 -35.63 63.52 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.431 2.754 . . . . 0.0 113.901 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -87.42 1.26 53.92 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.253 0.621 . . . . 0.0 111.461 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.3 m 62.69 57.99 1.69 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.63 1.172 . . . . 0.0 112.624 166.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -92.68 -146.23 0.22 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 171.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.635 ' HG3' HG21 ' B' ' 106' ' ' THR . 0.1 OUTLIER -144.72 89.63 2.0 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 85.8 mt -95.49 104.23 16.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -171.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.718 ' HG2' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -99.74 147.77 25.09 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.827 0.285 . . . . 0.0 111.696 -176.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.615 HG13 HG13 ' B' ' 78' ' ' VAL . 7.5 p -128.97 128.47 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 164.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.42 ' O ' HG22 ' B' ' 72' ' ' VAL . 14.3 p90 -130.13 155.56 45.99 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 122.199 -0.313 . . . . 0.0 111.062 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.423 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -109.62 120.92 43.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -76.27 107.0 8.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.364 0.415 . . . . 0.0 110.05 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.31 104.0 10.56 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.854 -0.97 . . . . 0.0 110.919 -177.454 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.684 -0.117 . . . . 0.0 110.684 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.431 ' N ' ' SD ' ' A' ' 1' ' ' MET . 16.4 m -82.1 148.28 28.64 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -108.69 127.72 26.88 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.798 0.839 . . . . 0.0 110.614 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD3' HD22 ' B' ' 25' ' ' LEU . 69.4 Cg_endo -87.73 87.49 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.697 2.264 . . . . 0.0 111.364 170.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.809 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.7 p-10 -83.61 1.53 41.82 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.419 0.628 . . . . 0.0 110.815 172.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.06 120.5 31.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -172.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -111.96 137.66 49.66 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 46.3 mt -113.19 128.1 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 47' ' ' LEU . 4.2 mm? -93.93 145.13 24.86 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 173.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.636 ' HE1' HG21 ' A' ' 55' ' ' VAL . 38.4 t80 -102.57 105.14 15.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.192 -170.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.79 157.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.534 0.734 . . . . 0.0 109.199 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.408 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 12.6 p-10 -104.76 -43.01 5.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.528 0.731 . . . . 0.0 110.84 -177.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -94.53 105.62 19.28 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.256 0.623 . . . . 0.0 109.909 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.27 -59.46 0.89 Allowed 'Trans proline' 0 CA--C 1.571 2.362 0 C-N-CA 122.153 1.902 . . . . 0.0 113.461 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 40.6 Cg_endo -64.38 -56.5 0.43 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 CA-C-N 122.433 1.905 . . . . 0.0 111.494 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.27 -44.22 83.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.735 0.814 . . . . 0.0 112.206 -168.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -72.53 -39.69 67.35 Favored 'General case' 0 C--N 1.344 0.359 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.8 m -65.69 -39.49 91.34 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.53 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 77.8 mm-40 -67.6 -34.53 77.19 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.372 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -64.69 -46.13 83.68 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 123.524 0.515 . . . . 0.0 109.911 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -65.62 -32.07 73.44 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.07 -51.07 69.16 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.284 0.564 . . . . 0.0 112.322 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.12 -39.91 65.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.152 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 tp -58.2 -47.02 84.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.145 1.378 . . . . 0.0 113.183 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.5 mt -86.44 -43.73 12.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.06 26.05 8.07 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.078 -174.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.1 m -127.73 167.4 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.06 0.944 . . . . 0.0 110.243 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.01 151.28 46.36 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.783 0.833 . . . . 0.0 109.34 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 14.8 Cg_exo -67.88 117.05 4.62 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.545 2.163 . . . . 0.0 111.814 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG11 HG23 ' A' ' 40' ' ' VAL . 7.5 p -63.22 -38.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.751 . . . . 0.0 109.962 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 30.5 mm-40 -123.47 129.86 51.86 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.01 1.324 . . . . 0.0 107.775 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.6 p -136.26 135.36 38.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.308 0.575 . . . . 0.0 109.896 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.3 m -141.65 153.58 65.23 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.922 1.289 . . . . 0.0 108.512 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -56.92 -22.48 46.33 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 123.066 2.511 . . . . 0.0 113.726 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.9 t -128.12 10.49 6.37 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -158.83 137.46 10.98 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -123.71 153.96 40.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.389 0.676 . . . . 0.0 109.727 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.654 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 21.3 tp -147.43 125.66 12.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -132.79 142.25 48.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 108.367 168.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 46' ' ' LYS . 20.8 t -119.38 131.48 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.0 mt -94.41 149.85 20.84 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -172.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.97 -10.45 29.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.19 0.996 . . . . 0.0 112.029 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -65.12 -20.44 66.46 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.852 1.261 . . . . 0.0 112.237 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 -7.27 47.18 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.828 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -90.35 173.12 8.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.56 0.744 . . . . 0.0 110.38 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.8 tttt -141.8 139.53 32.78 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 9' ' ' LEU . 2.2 tt -138.09 120.13 15.54 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.494 0.318 . . . . 0.0 110.6 -169.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.19 165.73 17.26 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.625 0.631 . . . . 0.0 111.693 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.89 111.92 10.86 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -104.74 125.17 50.55 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.7 m -77.71 128.78 34.61 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.641 0.588 . . . . 0.0 109.874 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 12' ' ' ASP . 13.6 ptm180 -66.88 -10.66 50.81 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -82.56 -12.64 57.59 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 118.047 0.385 . . . . 0.0 111.137 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 0.6 8.06 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.122 0.569 . . . . 0.0 111.123 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' HE1' ' A' ' 10' ' ' TYR . 10.7 p -61.13 140.13 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 121.189 0.519 . . . . 0.0 112.279 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.73 116.38 26.41 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.522 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 6.8 Cg_exo -72.38 144.04 79.24 Favored 'Cis proline' 0 C--N 1.383 2.384 0 C-N-CA 124.683 -0.966 . . . . 0.0 112.794 -3.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' HA ' HG13 ' A' ' 55' ' ' VAL . 13.7 mmmm -50.2 130.16 22.32 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.764 0.825 . . . . 0.0 111.833 173.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.99 136.33 23.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.751 0.821 . . . . 0.0 109.958 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 p -108.5 88.35 2.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.521 0.729 . . . . 0.0 109.485 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -161.37 144.04 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.773 0.829 . . . . 0.0 110.22 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 p -141.47 138.62 32.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.381 1.072 . . . . 0.0 108.356 170.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.71 20.07 79.65 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 22.23 30.42 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.79 -162.07 23.79 Favored Glycine 0 N--CA 1.473 1.154 0 CA-C-N 117.083 0.442 . . . . 0.0 112.308 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.58 95.9 0.05 OUTLIER Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.916 -0.473 . . . . 0.0 111.916 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HB3' ' HG3' ' A' ' 116' ' ' ARG . 1.9 mp0 -103.7 158.53 16.32 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.201 0.524 . . . . 0.0 112.049 -170.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 68' ' ' LEU . 25.8 mt -118.89 102.4 8.76 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.498 173.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.95 106.31 17.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HB2' HG22 ' A' ' 117' ' ' VAL . 7.8 m-85 -83.95 112.21 19.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 -90.18 127.43 36.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.421 0.629 . . . . 0.0 112.243 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.65 158.29 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.216 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.23 -38.05 89.65 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -160.43 177.37 10.64 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.512 0.596 . . . . 0.0 112.155 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.25 -28.62 69.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.944 1.298 . . . . 0.0 112.771 -165.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.78 -46.95 76.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.978 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -64.86 -22.43 66.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.844 0.858 . . . . 0.0 112.651 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.26 -42.41 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.313 0.645 . . . . 0.0 109.668 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.03 -27.59 54.55 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.681 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 40.6 mt-10 -69.26 -43.85 73.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.212 0.605 . . . . 0.0 109.668 175.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.9 m -65.74 -36.14 82.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.28 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' O ' ' HE1' ' A' ' 92' ' ' MET . 35.6 t80 -59.33 -57.18 14.15 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.794 0.807 . . . . 0.0 109.356 176.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.93 -37.87 83.81 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.209 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.69 90.76 Favored Glycine 0 C--N 1.343 0.964 0 O-C-N 123.64 0.587 . . . . 0.0 114.361 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -67.44 -41.85 84.08 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.062 0.545 . . . . 0.0 110.155 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -58.8 -40.14 83.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.983 0.913 . . . . 0.0 110.297 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.77 66.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.461 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m -104.96 15.14 28.26 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.889 0.876 . . . . 0.0 113.205 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.45 30.32 19.36 Favored Glycine 0 C--N 1.353 1.489 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 163.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.09 127.45 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.251 0.62 . . . . 0.0 109.543 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 92' ' ' MET . . . -57.14 -51.0 71.07 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.684 0.794 . . . . 0.0 111.393 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.476 ' HE1' ' O ' ' A' ' 82' ' ' PHE . 6.7 ptm 52.15 80.95 0.09 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.291 1.436 . . . . 0.0 113.381 169.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.439 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.78 82.45 2.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.244 0.545 . . . . 0.0 110.059 -177.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -174.86 138.18 0.46 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.346 1.058 . . . . 0.0 109.066 174.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -80.49 122.4 82.46 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.54 112.35 1.74 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.575 2.183 . . . . 0.0 110.209 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.71 163.39 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.454 -172.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HG2' ' HD1' ' A' ' 103' ' ' TYR . 19.3 mmtm -71.06 118.02 13.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.397 1.079 . . . . 0.0 111.506 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 49.5 tpp -110.09 176.62 4.99 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.507 1.523 . . . . 0.0 108.996 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -48.21 -41.01 26.13 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.75 1.22 . . . . 0.0 113.133 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -106.88 19.83 19.91 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.566 0.746 . . . . 0.0 111.603 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -167.83 12.42 Favored Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.986 0.354 . . . . 0.0 113.986 168.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.41 ' HD1' ' HG2' ' A' ' 98' ' ' LYS . 13.0 t80 -78.53 110.01 13.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.437 0.695 . . . . 0.0 109.707 -168.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.5 t -138.77 168.69 19.25 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -168.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -157.42 169.35 24.91 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.028 0.931 . . . . 0.0 109.311 169.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.613 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 13.6 m -137.47 124.92 22.02 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.65 158.33 16.78 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.378 1.071 . . . . 0.0 110.78 -174.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.02 111.08 17.03 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.4 167.87 28.76 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.605 0.762 . . . . 0.0 110.258 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -43.02 -38.82 7.48 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.693 2.929 . . . . 0.0 115.652 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -89.14 2.02 54.77 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.833 0.453 . . . . 0.0 111.771 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 31.2 m 63.43 81.48 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.675 1.19 . . . . 0.0 111.354 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -131.53 165.37 23.75 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 170.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -97.0 106.46 18.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.08 102.71 11.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.232 0.613 . . . . 0.0 109.683 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.726 ' HD2' HD12 ' B' ' 8' ' ' ILE . 72.1 mtt-85 -89.66 148.55 23.25 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.693 0.397 . . . . 0.0 110.383 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 70' ' ' PHE . 40.5 t -137.38 127.96 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 166.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -130.75 167.58 18.61 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.27 0.941 . . . . 0.0 112.885 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.7 115.8 12.45 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.586 1.154 . . . . 0.0 108.08 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -79.77 117.39 20.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.56 99.17 2.46 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.638 0.775 . . . . 0.0 109.417 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.12 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.582 0.229 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -79.29 148.86 31.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.774 0.83 . . . . 0.0 109.529 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -108.39 126.89 28.56 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.009 0.924 . . . . 0.0 110.028 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -87.35 87.57 0.66 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.53 2.153 . . . . 0.0 111.467 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.828 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 10.4 p-10 -83.43 1.67 40.4 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.014 171.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.42 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 0.9 OUTLIER -125.35 119.34 28.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -171.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -111.25 137.69 48.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 172.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.726 HD12 ' HD2' ' A' ' 116' ' ' ARG . 22.1 mt -113.84 127.66 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -93.14 145.26 24.54 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -102.63 105.84 16.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.622 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.13 157.35 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.696 0.798 . . . . 0.0 109.114 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -105.33 -42.8 5.15 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.511 0.724 . . . . 0.0 111.028 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.91 106.51 22.32 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.102 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 38.6 Cg_exo -55.03 -59.09 0.89 Allowed 'Trans proline' 0 CA--C 1.572 2.406 0 C-N-CA 122.049 1.833 . . . . 0.0 113.429 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 19' ' ' GLN . 22.6 Cg_exo -64.78 -56.93 0.34 Allowed 'Trans proline' 0 C--N 1.4 3.259 0 CA-C-N 122.465 1.916 . . . . 0.0 111.316 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -44.8 81.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.598 0.759 . . . . 0.0 112.551 -168.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 13.1 m -70.79 -40.87 72.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 77.7 m -65.61 -39.36 91.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.542 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 79.7 mm-40 -67.85 -34.17 76.18 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.516 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.98 -45.96 83.46 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.206 177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -65.77 -31.86 73.07 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.542 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 57.7 mtpt -56.03 -50.91 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.312 0.577 . . . . 0.0 112.266 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.24 -39.91 65.1 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.303 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -58.33 -46.83 85.46 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.174 1.39 . . . . 0.0 113.055 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.514 ' HB2' HG22 ' B' ' 27' ' ' VAL . 13.7 mt -87.1 -42.98 12.63 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.36 25.86 8.56 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.993 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 25' ' ' LEU . 33.4 m -127.26 167.76 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.934 0.894 . . . . 0.0 110.303 -177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.15 150.75 45.74 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.794 0.837 . . . . 0.0 109.483 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 42.2 Cg_endo -67.14 117.18 4.61 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.355 2.036 . . . . 0.0 112.218 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.515 HG13 ' HG2' ' B' ' 31' ' ' GLU . 7.1 p -63.68 -38.46 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.392 0.677 . . . . 0.0 109.97 177.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 34.6 mm-40 -122.69 129.94 52.38 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.925 1.29 . . . . 0.0 107.522 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 52.5 p -136.23 136.04 39.56 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.03 0.532 . . . . 0.0 110.066 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 55.6 m -142.49 151.64 58.16 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.921 1.288 . . . . 0.0 108.578 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.91 -23.62 28.38 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.19 2.593 . . . . 0.0 114.733 -176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -128.12 10.82 6.42 Favored 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -158.56 137.91 11.65 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 50.1 m -124.32 153.47 41.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.326 0.65 . . . . 0.0 110.035 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.645 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 35.8 tp -146.75 126.22 13.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.412 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 0.9 OUTLIER -132.93 142.31 48.82 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.569 1.148 . . . . 0.0 108.421 168.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.606 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.3 t -119.49 130.93 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.76 149.61 21.09 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -172.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.52 -10.43 25.7 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.461 1.104 . . . . 0.0 112.071 177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -65.36 -20.42 66.38 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.719 1.208 . . . . 0.0 112.244 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.31 -7.14 46.91 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.352 -0.299 . . . . 0.0 112.352 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.809 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -90.29 173.23 8.25 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.468 0.707 . . . . 0.0 110.491 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.606 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -141.7 139.62 32.98 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.34 120.15 15.31 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.753 0.311 . . . . 0.0 110.67 -169.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.42 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.02 165.53 17.4 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 123.78 0.705 . . . . 0.0 111.549 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 84.6 mt -134.25 111.66 10.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.549 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.0 t90 -104.71 125.36 50.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 38.9 m -77.86 128.76 34.47 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 123.581 0.551 . . . . 0.0 110.044 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -67.35 -10.65 53.09 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -81.93 -13.46 57.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.042 0.383 . . . . 0.0 111.388 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -124.13 1.77 8.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.182 0.593 . . . . 0.0 111.271 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' B' ' 58' ' ' LYS . 14.1 p -62.29 138.83 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.032 0.444 . . . . 0.0 111.757 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -122.1 116.83 29.77 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 3.9 Cg_exo -73.6 145.21 83.4 Favored 'Cis proline' 0 C--N 1.384 2.442 0 C-N-CA 124.564 -1.015 . . . . 0.0 111.966 -2.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.555 ' HA ' HG13 ' B' ' 55' ' ' VAL . 12.4 mmmm -51.24 130.73 27.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.668 0.787 . . . . 0.0 111.628 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.17 23.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.925 0.89 . . . . 0.0 109.642 -176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.2 p -108.59 88.53 2.75 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.634 0.774 . . . . 0.0 109.175 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -161.86 143.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.785 0.834 . . . . 0.0 110.193 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 16.5 p -141.43 138.85 33.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.62 1.168 . . . . 0.0 108.425 170.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.57 19.79 79.76 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.13 21.74 32.84 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 114.419 0.528 . . . . 0.0 114.419 -177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.63 -160.27 23.72 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 117.053 0.427 . . . . 0.0 112.683 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.99 96.54 0.03 OUTLIER Glycine 0 C--N 1.351 1.41 0 C-N-CA 122.995 0.331 . . . . 0.0 112.557 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.3 mt-10 -103.36 159.84 15.21 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 121.114 0.483 . . . . 0.0 112.155 -170.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 26.4 mt -119.56 102.24 8.5 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.444 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -86.21 107.3 17.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.011 0.434 . . . . 0.0 110.056 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.524 ' HB2' HG22 ' B' ' 117' ' ' VAL . 7.8 m-85 -85.97 111.93 20.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.417 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 32.3 mtm180 -90.18 126.33 35.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.29 0.567 . . . . 0.0 112.014 -175.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 23.4 m -127.23 158.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.337 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.9 pt-20 -64.32 -37.74 88.58 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -172.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -160.76 178.2 9.69 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.777 0.717 . . . . 0.0 112.078 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -61.43 -28.93 69.62 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.162 1.385 . . . . 0.0 112.475 -164.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.75 -46.54 78.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.487 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 69.6 mm-40 -65.57 -22.45 66.69 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.264 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.4 t -66.35 -42.58 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.397 0.679 . . . . 0.0 109.626 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.87 -27.96 55.22 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 124.451 1.1 . . . . 0.0 110.401 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 43.5 mt-10 -68.41 -44.69 74.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.076 0.55 . . . . 0.0 109.867 175.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -65.27 -35.96 82.62 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.413 175.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -59.23 -56.96 15.41 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-O 121.75 0.786 . . . . 0.0 109.4 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.04 -37.14 83.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.33 -175.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.58 -39.75 90.75 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.44 0.463 . . . . 0.0 113.97 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -67.15 -42.49 84.29 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.061 0.545 . . . . 0.0 109.992 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -58.01 -40.77 81.61 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.944 . . . . 0.0 110.14 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.09 -29.2 67.24 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.411 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m -104.35 15.11 28.92 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.05 0.94 . . . . 0.0 113.421 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.58 19.31 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 163.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.6 127.32 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.253 0.621 . . . . 0.0 109.386 173.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.7 -53.07 61.94 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.652 0.781 . . . . 0.0 111.268 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 22.9 ttp 54.19 81.04 0.11 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.793 1.237 . . . . 0.0 112.868 169.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.29 83.38 2.18 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -176.43 134.74 0.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.226 1.01 . . . . 0.0 108.366 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -79.16 123.7 84.72 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 112.26 2.07 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.527 2.151 . . . . 0.0 109.709 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -144.16 163.36 33.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.341 0.591 . . . . 0.0 111.59 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -71.22 118.59 14.21 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.299 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 37.0 ttm -112.02 179.42 4.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.561 1.145 . . . . 0.0 108.966 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.19 -41.61 49.8 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.697 1.199 . . . . 0.0 112.019 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -106.54 20.0 19.66 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.559 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.11 -167.68 12.38 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 114.004 0.362 . . . . 0.0 114.004 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -78.7 110.19 13.62 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.533 0.733 . . . . 0.0 109.777 -168.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' B' ' 116' ' ' ARG . 13.7 t -139.95 169.44 17.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -168.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -157.63 169.14 25.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.107 0.963 . . . . 0.0 109.232 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 20.6 m -136.62 125.19 23.64 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.57 158.21 16.85 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.42 1.088 . . . . 0.0 110.882 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.1 111.36 17.34 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.69 167.36 34.09 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.907 0.883 . . . . 0.0 110.402 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -42.16 -39.19 5.84 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 124.039 3.159 . . . . 0.0 115.346 174.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -89.38 2.36 54.54 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m 62.98 80.82 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.681 1.192 . . . . 0.0 111.589 174.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -130.49 165.66 22.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -95.66 106.13 18.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 75.2 mt -108.41 102.62 11.71 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.45 ' HD2' ' OG1' ' B' ' 104' ' ' THR . 0.8 OUTLIER -87.11 147.98 25.42 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.356 0.663 . . . . 0.0 109.922 -178.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' B' ' 70' ' ' PHE . 42.3 t -137.44 128.36 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 164.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -130.71 167.05 19.45 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.368 0.986 . . . . 0.0 113.102 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.1 116.13 13.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.19 122.56 26.99 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.91 99.78 1.83 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 0.0 109.86 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.17 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.111 -175.394 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.676 0.274 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.5 m -85.36 134.71 34.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.455 ' HB3' HD21 ' B' ' 43' ' ' ASN . 23.0 m80 -93.38 116.29 66.27 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 123.849 0.859 . . . . 0.0 110.934 -174.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -97.36 96.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.869 2.379 . . . . 0.0 112.48 169.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.693 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.1 p-10 -93.72 13.6 21.76 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.295 0.569 . . . . 0.0 110.534 169.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.98 115.69 19.62 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.87 146.56 34.89 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.269 1.027 . . . . 0.0 108.691 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.5 HD12 ' HD2' ' B' ' 116' ' ' ARG . 55.9 mt -122.5 137.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.039 0.935 . . . . 0.0 109.037 176.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 68' ' ' LEU . 4.3 mm? -91.42 123.23 34.69 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 168.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.583 ' HE1' HG21 ' A' ' 55' ' ' VAL . 57.6 t80 -78.96 106.83 11.27 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.687 174.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.416 HG11 HD22 ' A' ' 49' ' ' LEU . 15.6 m -120.71 175.69 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.248 1.019 . . . . 0.0 109.908 -171.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.55 -61.46 1.49 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.59 0.756 . . . . 0.0 109.811 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.52 110.61 35.58 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 123.787 0.835 . . . . 0.0 110.093 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -58.8 -64.36 0.11 Allowed 'Trans proline' 0 CA--C 1.568 2.178 0 C-N-CA 122.323 2.015 . . . . 0.0 113.614 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -64.08 -38.75 35.14 Favored 'Trans proline' 0 C--N 1.402 3.343 0 CA-C-N 122.533 1.94 . . . . 0.0 111.204 -170.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.45 -41.47 93.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.312 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 97.6 p -70.85 -35.34 72.38 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 175.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.3 m -58.41 -53.24 60.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.574 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 24.5 mm-40 -68.56 -37.07 79.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.258 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 76.1 t80 -59.46 -44.06 93.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.772 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.511 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 5.4 m-85 -72.99 -28.45 62.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.468 0.707 . . . . 0.0 110.73 176.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.3 mtpt -56.3 -50.79 70.41 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 118.936 0.789 . . . . 0.0 112.037 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.23 -34.38 49.3 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.142 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 21.9 tp -61.42 -53.58 54.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.661 1.184 . . . . 0.0 111.988 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HB2' HG22 ' A' ' 27' ' ' VAL . 11.1 mt -76.62 -51.82 10.85 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.92 25.68 5.82 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.257 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 25' ' ' LEU . 21.0 m -131.35 176.21 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.359 1.063 . . . . 0.0 110.075 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.27 156.11 46.04 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.77 112.53 3.56 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 121.534 1.489 . . . . 0.0 110.554 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -37.45 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.892 0.477 . . . . 0.0 110.157 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 11.9 mm-40 -111.82 134.47 53.36 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 p -143.35 132.36 22.93 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.029 0.442 . . . . 0.0 110.709 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -143.42 155.81 60.74 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.285 1.434 . . . . 0.0 108.263 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.3 -10.2 20.37 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.865 2.377 . . . . 0.0 114.123 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.6 t -126.56 -0.75 6.83 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -157.67 142.43 16.56 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.7 m -131.51 146.54 52.28 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.25 0.62 . . . . 0.0 110.106 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.677 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.0 tm? -133.68 120.27 20.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -108.11 140.52 41.18 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.686 1.595 . . . . 0.0 107.051 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 46' ' ' LYS . 26.4 t -124.21 126.8 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD13 ' SD ' ' A' ' 45' ' ' MET . 8.6 mp -99.79 148.72 24.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.169 0.587 . . . . 0.0 109.731 -172.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.96 -5.92 29.6 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.039 0.936 . . . . 0.0 111.928 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -21.67 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.121 0.968 . . . . 0.0 112.168 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.64 17.56 16.73 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -124.06 175.09 7.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.582 0.753 . . . . 0.0 109.817 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 40' ' ' VAL . 78.3 tttt -145.91 140.62 27.1 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -175.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 68' ' ' LEU . 2.7 tt -138.32 120.66 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.203 0.601 . . . . 0.0 110.287 -169.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.85 166.55 15.76 Favored Glycine 0 C--N 1.347 1.146 0 C-N-CA 123.667 0.651 . . . . 0.0 112.055 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 9' ' ' LEU . 95.3 mt -134.87 104.92 6.18 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 167.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.524 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.6 t90 -109.62 119.3 38.97 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 p -81.01 140.92 34.88 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.343 0.402 . . . . 0.0 111.159 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HD2' ' HA ' ' A' ' 60' ' ' SER . 29.3 ptt180 -69.68 -18.65 63.57 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -170.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -78.99 -8.58 59.05 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -127.84 7.68 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.874 0.47 . . . . 0.0 111.148 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.583 HG21 ' HE1' ' A' ' 10' ' ' TYR . 9.9 p -75.8 150.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.61 0.243 . . . . 0.0 110.91 -175.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -126.37 115.58 23.33 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.77 0.828 . . . . 0.0 108.861 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 89.1 Cg_endo -77.01 141.01 68.02 Favored 'Cis proline' 0 C--N 1.386 2.511 0 C-N-CA 124.584 -1.007 . . . . 0.0 112.389 5.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 123.84 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.729 0.811 . . . . 0.0 110.29 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.38 170.74 17.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.541 1.137 . . . . 0.0 108.545 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.514 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 32.5 t -147.19 90.65 1.9 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.413 0.285 . . . . 0.0 110.237 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.08 144.15 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 109.685 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -146.62 124.14 11.73 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.45 -69.25 0.17 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.27 149.26 20.9 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.34 -22.64 0.2 Allowed Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.681 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . -164.01 116.12 0.69 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.87 144.65 30.25 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -108.93 101.62 10.7 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -169.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -90.23 111.71 22.97 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.732 0.696 . . . . 0.0 111.52 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -91.18 111.97 23.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 125.117 1.367 . . . . 0.0 107.399 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.542 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 36.8 mtm180 -89.98 129.4 36.31 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.503 0.668 . . . . 0.0 112.336 -174.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.69 159.09 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.016 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 11.6 pt-20 -66.69 -34.91 78.91 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.43 HD22 ' HG3' ' A' ' 73' ' ' GLU . 8.3 p30 -163.27 178.29 8.3 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 118.757 0.708 . . . . 0.0 112.345 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.56 -31.27 67.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.408 1.483 . . . . 0.0 112.771 -168.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -65.97 -46.55 77.67 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.232 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.516 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 71.7 mm-40 -63.69 -22.71 67.04 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.181 0.993 . . . . 0.0 112.98 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.75 -42.04 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.212 0.605 . . . . 0.0 109.802 171.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -75.81 -29.06 58.56 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 114.651 -1.158 . . . . 0.0 111.164 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 36.5 mt-10 -71.81 -44.7 63.49 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.276 0.56 . . . . 0.0 109.641 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.8 m -65.38 -33.4 75.87 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.437 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -56.33 -59.4 5.01 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.701 0.8 . . . . 0.0 109.621 174.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -62.71 -38.26 89.73 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.714 -173.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.99 -41.83 97.11 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 123.653 0.596 . . . . 0.0 113.632 176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -64.41 -42.55 96.02 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.324 0.649 . . . . 0.0 110.305 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 31.8 ttpt -59.15 -42.97 91.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.017 0.927 . . . . 0.0 110.539 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.38 65.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.318 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.9 t -98.36 14.27 28.61 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.427 1.091 . . . . 0.0 112.944 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.09 29.06 35.13 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 165.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.7 t -86.47 130.61 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 109' ' ' ASP . . . -62.85 -42.11 99.62 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.954 0.902 . . . . 0.0 112.325 -172.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 7.5 ptm 49.54 81.48 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.889 1.676 . . . . 0.0 114.301 166.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.01 83.04 1.76 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.476 0.655 . . . . 0.0 110.084 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 23.8 tm0? 178.07 120.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.434 1.493 . . . . 0.0 107.113 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.4 117.02 62.69 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.53 110.73 0.2 Allowed 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 123.887 3.058 . . . . 0.0 113.329 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.58 146.04 44.91 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.226 1.01 . . . . 0.0 110.371 -171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 98.64 4.09 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 43.5 tpp -78.26 163.98 25.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.836 0.854 . . . . 0.0 109.49 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.23 -28.26 69.03 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.107 0.563 . . . . 0.0 111.795 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -99.67 15.41 26.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.972 0.909 . . . . 0.0 111.466 176.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.03 180.0 16.76 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.539 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -73.77 103.0 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.5 t -109.84 158.11 18.5 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.396 0.617 . . . . 0.0 111.401 -168.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.407 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 3.3 t80 -143.93 142.09 30.57 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.21 1.404 . . . . 0.0 108.795 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.426 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 31.1 m -132.69 121.93 23.85 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 119.522 1.056 . . . . 0.0 110.76 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.69 150.48 26.88 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.103 0.961 . . . . 0.0 112.228 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -117.95 172.53 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 165.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 8.3 p-10 -144.34 -176.94 0.59 Allowed Pre-proline 0 N--CA 1.483 1.194 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 5.2 Cg_exo -38.14 -51.67 1.97 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.621 2.881 . . . . 0.0 114.016 168.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.08 -15.0 59.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.006 0.522 . . . . 0.0 111.684 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.02 52.24 0.2 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.65 1.18 . . . . 0.0 111.156 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -80.3 175.11 10.94 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.255 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -122.84 105.64 10.2 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -118.18 103.69 10.1 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.143 0.977 . . . . 0.0 109.206 -171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.543 HH11 HD11 ' B' ' 8' ' ' ILE . 77.9 ttt180 -88.17 146.14 25.55 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 123.266 0.626 . . . . 0.0 110.188 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.9 t -131.94 119.22 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 163.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.542 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 4.3 p90 -125.71 164.91 19.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.563 0.62 . . . . 0.0 111.223 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.83 111.65 13.31 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -75.04 117.2 16.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.438 0.563 . . . . 0.0 109.75 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.84 100.56 2.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.11 0.481 . . . . 0.0 109.708 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.847 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.272 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.669 0.271 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 17.9 m -126.67 136.28 52.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -93.04 115.98 65.79 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 123.959 0.904 . . . . 0.0 110.666 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.514 ' HB2' HD22 ' A' ' 68' ' ' LEU . 46.5 Cg_endo -97.55 96.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.985 2.456 . . . . 0.0 112.432 170.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.691 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.8 p-10 -93.55 13.82 20.74 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.351 0.596 . . . . 0.0 110.692 169.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.15 115.59 19.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -109.74 146.71 34.47 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.283 1.033 . . . . 0.0 108.775 171.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.543 HD11 HH11 ' A' ' 116' ' ' ARG . 50.5 mt -122.57 137.47 55.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.002 0.921 . . . . 0.0 108.903 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.462 ' HG ' ' OH ' ' B' ' 21' ' ' TYR . 4.5 mm? -90.95 122.8 33.93 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.528 ' HE1' HG21 ' B' ' 55' ' ' VAL . 59.6 t80 -78.23 107.33 10.75 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.913 173.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.1 175.72 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.247 1.019 . . . . 0.0 109.788 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -105.9 -61.15 1.54 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.49 0.716 . . . . 0.0 110.233 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -87.15 110.82 36.4 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.896 0.878 . . . . 0.0 109.969 -177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -59.49 -65.67 0.08 OUTLIER 'Trans proline' 0 CA--C 1.567 2.143 0 C-N-CA 122.369 2.046 . . . . 0.0 113.155 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.39 -38.94 49.79 Favored 'Trans proline' 0 C--N 1.403 3.441 0 CA-C-N 122.471 1.918 . . . . 0.0 111.81 -171.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.17 -41.71 94.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.664 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -70.25 -35.39 73.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 33.3 m -58.12 -53.91 52.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.83 -37.37 81.84 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.126 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 73.7 t80 -59.71 -44.05 93.87 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.94 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 6.2 m-85 -72.98 -28.06 62.17 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.817 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' B' ' 18' ' ' THR . 58.4 mtpt -56.68 -50.64 71.53 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.95 0.795 . . . . 0.0 111.92 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.04 -34.6 50.4 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.971 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 21.8 tp -61.55 -53.41 56.64 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.558 1.143 . . . . 0.0 112.186 -174.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' B' ' 27' ' ' VAL . 12.3 mt -76.73 -51.13 12.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.64 25.06 6.13 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.232 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' B' ' 25' ' ' LEU . 28.5 m -130.8 176.19 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.302 1.041 . . . . 0.0 110.073 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -115.37 155.93 46.42 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 123.633 0.773 . . . . 0.0 109.13 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.69 112.65 3.58 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 121.604 1.536 . . . . 0.0 110.536 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.33 -37.46 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 122.838 0.455 . . . . 0.0 110.245 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 12.3 mm-40 -111.69 134.62 53.14 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 45.5 p -143.47 132.48 22.91 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.118 0.485 . . . . 0.0 110.542 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.7 m -143.72 156.31 59.52 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.509 1.524 . . . . 0.0 108.133 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.06 -9.63 22.43 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.542 2.161 . . . . 0.0 113.57 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -126.7 -0.75 6.74 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -157.9 142.4 16.24 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 31.1 m -131.46 146.63 52.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.311 0.644 . . . . 0.0 110.056 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.707 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -134.12 119.91 19.47 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.77 140.75 40.37 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.652 1.581 . . . . 0.0 106.921 173.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.57 HG22 ' HG3' ' B' ' 46' ' ' LYS . 28.1 t -124.39 126.56 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.491 HD13 ' SD ' ' B' ' 45' ' ' MET . 9.6 mp -99.73 149.17 23.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.105 0.562 . . . . 0.0 109.887 -172.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.91 -6.3 31.97 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.957 0.903 . . . . 0.0 112.064 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.455 HD21 ' HB3' ' A' ' 3' ' ' HIS . 2.1 m-20 -68.23 -21.64 64.83 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.118 0.967 . . . . 0.0 112.025 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.31 17.77 16.8 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 112.126 -0.389 . . . . 0.0 112.126 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.693 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -123.78 174.8 7.27 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.692 0.797 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.57 ' HG3' HG22 ' B' ' 40' ' ' VAL . 79.4 tttt -145.47 140.48 27.58 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.91 121.17 16.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 -169.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.99 166.35 15.56 Favored Glycine 0 C--N 1.347 1.17 0 C-N-CA 123.744 0.688 . . . . 0.0 112.001 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' B' ' 9' ' ' LEU . 93.3 mt -134.59 105.02 6.31 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 166.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -109.86 118.98 37.91 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 74.2 p -80.78 140.91 35.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.467 0.307 . . . . 0.0 110.947 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' B' ' 60' ' ' SER . 36.2 ptt180 -70.06 -18.56 63.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -170.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -79.09 -8.58 59.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.6 t -127.78 7.22 6.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.853 0.461 . . . . 0.0 111.107 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.528 HG21 ' HE1' ' B' ' 10' ' ' TYR . 8.0 p -75.6 150.08 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.271 -0.268 . . . . 0.0 110.897 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.65 116.71 24.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.634 0.774 . . . . 0.0 109.521 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.426 ' HD3' ' HB ' ' A' ' 106' ' ' THR . 87.1 Cg_endo -76.51 140.47 65.68 Favored 'Cis proline' 0 C--N 1.388 2.647 0 C-N-CA 124.593 -1.003 . . . . 0.0 112.407 4.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 123.29 14.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.676 -176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.74 170.96 17.02 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.716 1.206 . . . . 0.0 108.515 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' B' ' 52' ' ' ARG . 33.9 t -147.3 90.97 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.853 0.359 . . . . 0.0 110.42 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.52 143.4 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.717 0.807 . . . . 0.0 109.692 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.6 p -145.56 124.3 12.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.221 1.008 . . . . 0.0 108.716 174.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 168.67 -68.85 0.17 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 112.08 -0.408 . . . . 0.0 112.08 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.719 ' HA2' ' HD2' ' B' ' 114' ' ' ARG . . . -151.55 148.16 18.88 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.77 -23.39 0.2 Allowed Glycine 0 N--CA 1.473 1.161 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.681 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . -163.71 116.65 0.72 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -101.95 144.64 30.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.114 0.965 . . . . 0.0 108.806 -171.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 28.8 tp -109.39 101.23 10.22 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.496 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.81 111.76 22.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.192 0.451 . . . . 0.0 111.462 -169.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.1 112.21 24.02 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.068 1.347 . . . . 0.0 107.446 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.439 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 31.8 mtm180 -90.16 127.84 36.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.439 0.638 . . . . 0.0 111.985 -174.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.5 160.1 40.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.283 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.463 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.4 pt-20 -67.54 -34.55 77.31 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -173.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.459 HD22 ' HG3' ' B' ' 73' ' ' GLU . 8.0 p30 -163.3 178.55 8.05 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.962 0.801 . . . . 0.0 112.562 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -58.85 -30.74 67.94 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.284 1.433 . . . . 0.0 112.567 -167.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.5 -46.5 76.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.076 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.463 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 60.9 mm-40 -63.6 -23.12 67.25 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.312 1.045 . . . . 0.0 112.465 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -42.25 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 121.325 0.583 . . . . 0.0 109.903 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.27 -29.1 60.06 Favored 'General case' 0 C--N 1.353 0.74 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.296 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 28.8 mt-10 -71.97 -44.94 62.73 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.166 0.508 . . . . 0.0 109.853 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 57.4 m -64.79 -33.64 76.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.269 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -56.18 -59.86 4.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.719 0.807 . . . . 0.0 109.385 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.51 89.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.559 -173.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.75 96.71 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.652 0.595 . . . . 0.0 113.456 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -64.66 -42.05 95.67 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.261 0.625 . . . . 0.0 110.061 173.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -60.22 -42.41 95.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.511 0.724 . . . . 0.0 110.664 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.27 66.29 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.578 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 26.8 t -98.67 14.25 29.22 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.375 1.07 . . . . 0.0 112.545 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.25 29.25 34.12 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -86.56 130.51 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.425 ' H ' ' HA ' ' B' ' 109' ' ' ASP . . . -62.68 -41.89 99.34 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.799 0.84 . . . . 0.0 112.597 -172.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.469 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 8.2 ptm 49.31 81.5 0.05 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.823 1.649 . . . . 0.0 114.316 166.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.417 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -113.36 83.03 1.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.611 -0.68 . . . . 0.0 110.37 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 24.6 tm0? 178.14 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -77.95 116.46 58.71 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 118.473 -0.775 . . . . 0.0 108.925 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.94 111.05 0.19 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 123.994 3.129 . . . . 0.0 113.216 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.12 145.98 45.51 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.184 0.994 . . . . 0.0 110.534 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 98.61 3.84 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.455 ' HG3' ' H ' ' B' ' 101' ' ' PHE . 35.5 tpp -78.35 163.36 25.75 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.0 0.92 . . . . 0.0 109.495 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.48 -28.87 68.68 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.149 0.579 . . . . 0.0 111.777 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.455 ' H ' ' HG3' ' B' ' 99' ' ' MET . 71.3 m-85 -99.37 15.04 27.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.944 0.898 . . . . 0.0 111.38 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' B' ' 99' ' ' MET . . . 119.5 179.9 16.63 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.512 167.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -73.4 102.92 3.89 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -172.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 6.2 t -109.81 158.3 18.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.432 0.634 . . . . 0.0 111.511 -169.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.454 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 3.6 t80 -143.99 142.24 30.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.396 1.478 . . . . 0.0 108.579 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.44 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 4.5 m -133.06 121.89 23.34 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 119.372 0.987 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.16 150.29 27.42 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.085 0.954 . . . . 0.0 112.113 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.91 171.33 8.14 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 165.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.431 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.0 p-10 -142.27 -176.81 0.59 Allowed Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.631 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 22.0 Cg_exo -37.65 -52.11 1.66 Allowed 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.302 2.668 . . . . 0.0 114.403 166.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -76.96 -14.16 59.88 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.9 0.48 . . . . 0.0 111.719 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m 71.96 52.33 0.21 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.884 1.274 . . . . 0.0 111.044 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -79.86 176.18 9.96 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.116 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.719 ' HD2' ' HA2' ' B' ' 64' ' ' GLY . 0.0 OUTLIER -125.33 104.32 8.41 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 34.3 mt -118.12 103.8 10.22 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.222 1.009 . . . . 0.0 109.35 -170.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.5 ' HD2' HD12 ' A' ' 8' ' ' ILE . 58.8 mtt-85 -87.04 147.07 25.86 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 123.075 0.55 . . . . 0.0 110.911 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.56 118.89 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 163.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.439 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 9.6 p90 -125.7 164.89 19.65 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.482 0.583 . . . . 0.0 110.879 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.81 111.16 12.81 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -72.9 119.08 16.64 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 118.333 0.515 . . . . 0.0 110.51 -172.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.91 111.44 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.985 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.573 -1.126 . . . . 0.0 112.146 178.628 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' A' ' 2' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.461 ' N ' ' SD ' ' A' ' 1' ' ' MET . 26.9 m -113.57 131.48 56.08 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 0.0 110.467 175.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -121.71 117.61 29.91 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 123.766 0.826 . . . . 0.0 109.206 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.97 129.1 11.21 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.925 2.417 . . . . 0.0 112.308 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 6.6 p-10 -113.19 10.87 18.66 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.571 0.701 . . . . 0.0 110.281 170.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.65 120.81 30.43 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -168.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -118.2 138.01 52.61 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.778 ' HB ' ' HG3' ' B' ' 67' ' ' GLU . 63.2 mt -123.98 126.59 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 49' ' ' LEU . 84.9 mt -97.56 159.59 14.83 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -106.85 135.62 48.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.051 0.94 . . . . 0.0 109.428 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' SER . 18.4 m -127.94 179.38 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.288 0.949 . . . . 0.0 109.724 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -136.42 47.62 2.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 16' ' ' ALA . 51.6 t30 167.48 83.34 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.521 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.367 -168.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.4 -53.64 6.56 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 122.618 2.212 . . . . 0.0 114.606 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -52.59 -64.89 0.16 Allowed 'Trans proline' 0 C--N 1.403 3.424 0 CA-C-N 122.267 1.845 . . . . 0.0 113.509 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . . . -79.27 -37.37 38.01 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.993 -164.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -79.22 -24.43 43.1 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.863 0.102 . . . . 0.0 110.883 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -73.68 -42.71 60.92 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.523 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -64.37 -28.57 69.78 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.258 173.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -66.01 -48.07 72.39 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 123.536 0.523 . . . . 0.0 109.705 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -68.53 -29.8 68.46 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 118.971 -0.538 . . . . 0.0 110.431 176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.523 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -57.86 -48.29 80.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 118.145 0.429 . . . . 0.0 111.999 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.15 -38.97 63.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.783 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.25 -30.21 70.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.654 1.182 . . . . 0.0 112.654 -174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 27' ' ' VAL . 73.4 mt -106.12 -28.81 10.26 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.886 0.874 . . . . 0.0 110.248 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.89 21.97 47.91 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.229 0.331 . . . . 0.0 112.709 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.1 m -116.15 -178.55 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.042 0.937 . . . . 0.0 111.002 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -134.91 153.73 78.82 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 123.929 0.892 . . . . 0.0 109.236 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.71 134.11 23.34 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.629 2.22 . . . . 0.0 112.131 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.82 -41.88 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 31.7 mm-40 -121.89 143.61 49.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.23 1.012 . . . . 0.0 109.027 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -140.31 141.09 35.77 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.2 m -144.21 161.86 42.88 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.66 1.184 . . . . 0.0 108.767 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -53.11 -28.93 43.25 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 123.056 2.504 . . . . 0.0 113.624 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.6 t -127.69 -3.43 5.97 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -139.51 141.07 37.33 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.385 0.539 . . . . 0.0 110.447 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 t -125.03 137.88 54.22 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.554 1.142 . . . . 0.0 108.773 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.9 tp -127.52 114.38 17.36 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.504 ' HE1' ' HG ' ' A' ' 49' ' ' LEU . 2.7 p90 -129.68 108.35 10.13 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.98 1.312 . . . . 0.0 108.608 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 46' ' ' LYS . 20.5 t -89.85 134.54 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.911 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.436 HD12 ' SD ' ' A' ' 45' ' ' MET . 56.5 mt -95.4 140.33 30.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.615 0.366 . . . . 0.0 110.844 -173.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.17 -6.2 27.28 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.524 1.13 . . . . 0.0 112.289 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' B' ' 5' ' ' ASP . 53.6 t30 -68.91 -15.68 63.55 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.588 1.155 . . . . 0.0 110.912 173.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.55 16.76 13.51 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 122.94 0.305 . . . . 0.0 113.172 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.543 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -126.38 176.04 7.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.404 0.682 . . . . 0.0 109.568 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG3' HG22 ' A' ' 40' ' ' VAL . 80.2 tttt -134.47 134.8 41.93 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.008 0.523 . . . . 0.0 109.887 -174.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.555 HD11 HD21 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -131.05 143.18 50.49 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.988 0.423 . . . . 0.0 110.931 -173.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -126.31 169.17 18.27 Favored Glycine 0 N--CA 1.477 1.411 0 C-N-CA 124.028 0.823 . . . . 0.0 111.984 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' HG ' ' HE1' ' A' ' 39' ' ' PHE . 80.8 mt -140.57 130.26 24.29 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.37 1.468 . . . . 0.0 107.768 164.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -127.92 128.37 45.0 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 49.6 m -80.42 125.17 29.6 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.977 0.511 . . . . 0.0 111.009 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -65.62 -15.73 63.03 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.796 1.238 . . . . 0.0 114.283 -166.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -67.68 -24.01 65.37 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.187 0.595 . . . . 0.0 111.409 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.6 t -143.63 23.03 1.79 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.879 0.471 . . . . 0.0 110.617 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.47 150.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -126.63 115.61 22.78 Favored Pre-proline 0 N--CA 1.484 1.26 0 O-C-N 121.875 -0.516 . . . . 0.0 110.008 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 11.9 Cg_exo -70.65 142.63 72.78 Favored 'Cis proline' 0 C--N 1.387 2.574 0 CA-C-N 119.313 0.79 . . . . 0.0 112.519 -1.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.49 109.86 1.77 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.412 0.625 . . . . 0.0 110.553 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.85 124.07 41.29 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.612 1.165 . . . . 0.0 110.144 -168.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.6 m -79.62 88.94 5.12 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.2 m -126.48 131.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -158.77 123.96 4.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.301 1.44 . . . . 0.0 108.312 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.1 -36.14 0.71 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 113' ' ' HIS . . . 154.22 -62.39 0.36 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 69.03 -116.75 7.46 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -172.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.58 150.91 40.65 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 173.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.762 ' HG3' ' HB ' ' B' ' 8' ' ' ILE . 7.8 pt-20 -103.87 162.6 12.98 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.886 0.85 . . . . 0.0 112.124 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 47' ' ' LEU . 64.6 tp -119.08 102.5 8.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.209 -1.359 . . . . 0.0 108.069 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.9 115.1 23.32 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.394 0.543 . . . . 0.0 112.072 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -90.82 107.67 19.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.565 1.546 . . . . 0.0 108.431 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.3 mtm180 -90.67 133.89 34.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.292 0.568 . . . . 0.0 112.497 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.3 m -138.38 161.57 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.623 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.1 pt-20 -65.51 -42.1 92.43 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -171.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -158.65 179.83 8.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.442 0.639 . . . . 0.0 111.812 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -56.07 -34.97 66.46 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 113.784 -1.553 . . . . 0.0 112.684 -166.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.68 -46.49 82.17 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.156 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.585 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 72.0 mm-40 -63.83 -24.31 67.7 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.964 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.19 -43.85 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.729 0.776 . . . . 0.0 110.271 172.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -75.88 -28.34 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.947 -1.479 . . . . 0.0 111.108 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.6 mt-10 -69.38 -45.04 70.26 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.35 0.595 . . . . 0.0 109.504 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.6 m -63.11 -36.24 82.93 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.404 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -54.8 -56.46 19.15 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.299 1.04 . . . . 0.0 109.865 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.94 84.29 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.93 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.0 94.14 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.67 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.533 ' HB3' HG11 ' A' ' 90' ' ' VAL . 33.5 m0 -63.86 -44.89 91.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.467 0.707 . . . . 0.0 110.044 175.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.405 ' HB2' ' SD ' ' A' ' 92' ' ' MET . 32.2 ttpt -58.66 -42.26 88.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.872 0.869 . . . . 0.0 110.582 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.65 -27.57 65.15 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.804 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.0 m -103.38 17.8 23.25 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.314 1.046 . . . . 0.0 111.946 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.06 7.99 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 163.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 92' ' ' MET . 4.1 p -96.84 142.35 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.6 -41.46 83.99 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.154 0.582 . . . . 0.0 111.374 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.606 ' HB3' HG13 ' A' ' 90' ' ' VAL . 9.6 ptm 48.26 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.919 1.687 . . . . 0.0 113.992 168.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.51 85.83 2.2 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.644 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 179.52 130.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.898 1.279 . . . . 0.0 108.703 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -82.57 115.0 55.79 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 166.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.63 118.2 3.91 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.163 2.575 . . . . 0.0 112.064 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.14 147.23 52.58 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.602 0.761 . . . . 0.0 110.167 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -68.44 123.03 19.68 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.421 0.688 . . . . 0.0 110.778 176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -121.91 170.73 9.51 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.078 1.351 . . . . 0.0 109.283 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.12 -42.85 60.96 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.511 1.124 . . . . 0.0 112.283 176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -90.55 1.22 56.93 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.317 0.647 . . . . 0.0 111.988 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.45 -172.37 18.78 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.285 168.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 35.4 t80 -73.14 101.52 3.34 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.8 t -113.19 153.59 28.06 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.542 0.687 . . . . 0.0 111.369 -166.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -150.07 138.16 20.3 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.119 1.368 . . . . 0.0 108.528 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.6 m -129.64 125.4 36.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.588 0.631 . . . . 0.0 109.654 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.84 172.06 7.0 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.07 0.948 . . . . 0.0 110.839 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.27 124.25 25.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.609 0.763 . . . . 0.0 109.347 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 169.14 3.21 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 123.856 0.862 . . . . 0.0 111.572 171.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -52.73 -28.83 39.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.93 2.42 . . . . 0.0 113.069 168.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -93.56 13.97 20.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.205 1.002 . . . . 0.0 111.884 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m 54.96 81.19 0.11 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.57 1.548 . . . . 0.0 112.481 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 11.2 m170 -118.34 -173.26 2.43 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 12.1 mmm180 -121.76 112.64 18.64 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.46 101.86 8.06 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -96.6 96.25 8.52 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -171.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.7 t -84.33 114.87 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -128.23 161.4 29.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.227 0.467 . . . . 0.0 111.365 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -118.23 117.84 30.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 123.984 0.914 . . . . 0.0 109.063 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -79.25 120.36 23.63 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.9 96.92 0.15 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.153 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.911 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptm . . . . . 0 CA--C 1.553 1.079 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 18.3 m -67.6 131.43 45.61 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.216 1.007 . . . . 0.0 112.676 -170.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -121.49 117.96 30.0 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 123.934 0.893 . . . . 0.0 109.477 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.66 129.49 10.92 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 122.746 2.298 . . . . 0.0 112.231 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.543 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.2 p-10 -112.75 9.86 19.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.588 0.755 . . . . 0.0 110.299 171.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -126.7 120.73 30.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.1 t -118.24 138.03 52.62 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.762 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 48.7 mt -124.05 125.9 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' B' ' 49' ' ' LEU . 11.2 mp -96.82 159.65 14.8 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.401 ' O ' ' NE2' ' B' ' 113' ' ' HIS . 15.4 p90 -107.05 135.14 49.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.169 0.988 . . . . 0.0 109.432 -174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 51' ' ' SER . 21.2 m -127.59 179.24 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 119.29 0.95 . . . . 0.0 109.702 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.17 47.12 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.837 0.855 . . . . 0.0 108.861 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . 0.58 ' ND2' ' HB3' ' B' ' 16' ' ' ALA . 56.0 t30 167.67 83.86 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.451 -167.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.08 -53.31 6.97 Favored 'Trans proline' 0 CA--C 1.571 2.329 0 C-N-CA 122.519 2.146 . . . . 0.0 114.562 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.5 -65.38 0.14 Allowed 'Trans proline' 0 C--N 1.397 3.107 0 C-N-CA 122.171 1.914 . . . . 0.0 113.41 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.58 ' HB3' ' ND2' ' B' ' 13' ' ' ASN . . . -79.09 -37.36 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.928 -164.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 19.9 t -78.96 -23.72 44.37 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.51 0.141 . . . . 0.0 110.807 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 92.3 m -74.77 -42.01 58.97 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -64.59 -28.89 69.94 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.98 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.438 ' HZ ' HG22 ' B' ' 90' ' ' VAL . 60.7 t80 -65.66 -48.16 73.06 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.116 0.566 . . . . 0.0 109.949 178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -68.56 -29.77 68.4 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.66 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' B' ' 18' ' ' THR . 53.9 mtpt -57.63 -48.44 79.43 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.208 0.458 . . . . 0.0 112.03 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.4 -39.19 62.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.604 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.0 -29.93 69.99 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.929 1.292 . . . . 0.0 112.54 -174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.485 ' HB2' HG22 ' B' ' 27' ' ' VAL . 69.3 mt -106.4 -28.97 10.02 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.043 0.937 . . . . 0.0 110.212 176.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.2 21.54 48.71 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 123.336 0.398 . . . . 0.0 112.65 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' B' ' 25' ' ' LEU . 24.9 m -115.87 -178.59 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 124.125 0.97 . . . . 0.0 110.943 -176.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -134.98 153.15 78.37 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 109.099 174.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.02 133.58 23.55 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.607 2.204 . . . . 0.0 112.377 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' B' ' 31' ' ' GLU . 5.6 p -68.87 -42.06 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.419 ' HG2' HG13 ' B' ' 30' ' ' VAL . 46.2 mm-40 -122.02 143.25 49.61 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.399 1.08 . . . . 0.0 109.099 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 40.0 p -140.32 140.79 35.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.521 0.728 . . . . 0.0 109.214 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 73.3 m -144.3 162.13 41.31 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.775 1.23 . . . . 0.0 108.821 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -53.52 -28.56 45.77 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.128 2.552 . . . . 0.0 113.871 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -128.06 -3.35 5.74 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -139.53 141.72 37.27 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 118.759 0.709 . . . . 0.0 110.359 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -126.17 137.46 53.57 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.549 1.14 . . . . 0.0 108.903 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 tt -127.57 114.97 18.11 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.526 ' HE1' ' HG ' ' B' ' 49' ' ' LEU . 2.6 p90 -129.86 108.61 10.28 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.928 1.291 . . . . 0.0 108.54 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.615 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.6 t -89.85 134.8 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.814 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.42 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.9 mt -95.43 140.64 30.0 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.845 0.355 . . . . 0.0 110.767 -173.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.05 -6.32 27.4 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.534 1.134 . . . . 0.0 112.371 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 5' ' ' ASP . 3.9 t30 -69.4 -15.48 63.31 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.066 0.946 . . . . 0.0 110.953 174.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 16.79 13.31 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 122.937 0.304 . . . . 0.0 113.313 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.1 ppp? -126.13 175.97 7.38 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.53 0.732 . . . . 0.0 109.735 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.615 ' HG3' HG22 ' B' ' 40' ' ' VAL . 83.0 tttt -134.19 134.84 42.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.016 0.526 . . . . 0.0 109.862 -174.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.54 HD11 HD21 ' B' ' 68' ' ' LEU . 0.4 OUTLIER -131.2 142.94 50.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.786 0.434 . . . . 0.0 110.926 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.97 169.02 17.94 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 124.146 0.879 . . . . 0.0 111.88 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.526 ' HG ' ' HE1' ' B' ' 39' ' ' PHE . 81.3 mt -140.74 130.27 24.02 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.369 1.467 . . . . 0.0 107.947 164.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -128.23 128.15 44.17 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.6 m -80.41 125.14 29.55 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 122.886 0.474 . . . . 0.0 110.894 -179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -65.17 -16.01 63.05 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.971 1.309 . . . . 0.0 114.248 -167.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -67.56 -23.55 65.43 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.261 0.625 . . . . 0.0 111.505 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.8 t -144.09 22.14 1.73 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 122.847 0.459 . . . . 0.0 110.421 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -57.18 150.47 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.259 0.623 . . . . 0.0 109.45 169.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -126.78 117.36 22.46 Favored Pre-proline 0 N--CA 1.484 1.274 0 O-C-N 121.826 -0.546 . . . . 0.0 110.572 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.81 142.53 64.77 Favored 'Cis proline' 0 C--N 1.388 2.656 0 CA-C-N 119.362 0.808 . . . . 0.0 113.248 -4.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.04 110.57 1.85 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.238 0.615 . . . . 0.0 110.073 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.41 123.98 40.46 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.522 1.129 . . . . 0.0 110.094 -169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 52.9 m -79.04 88.91 4.78 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.5 131.21 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.56 124.18 4.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.254 1.422 . . . . 0.0 108.545 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -35.45 0.71 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' B' ' 113' ' ' HIS . . . 153.87 -62.72 0.37 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 174.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.586 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 69.25 -116.99 7.52 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -172.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.36 150.85 40.94 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.911 -0.476 . . . . 0.0 111.911 173.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.778 ' HG3' ' HB ' ' A' ' 8' ' ' ILE . 5.6 pt-20 -103.57 162.93 12.64 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.821 0.82 . . . . 0.0 112.219 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.54 HD21 HD11 ' B' ' 47' ' ' LEU . 59.4 tp -119.83 101.77 8.11 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.687 -177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.93 115.66 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.477 0.58 . . . . 0.0 112.025 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.32 107.09 18.97 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.544 1.538 . . . . 0.0 108.141 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' A' ' 46' ' ' LYS . 36.6 mtm180 -90.05 133.55 34.77 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.187 0.518 . . . . 0.0 112.134 -174.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -137.27 162.38 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.449 1.1 . . . . 0.0 110.6 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 16.1 pt-20 -65.41 -42.14 92.86 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.438 ' ND2' ' HG3' ' B' ' 73' ' ' GLU . 9.5 p30 -158.61 179.79 8.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.173 0.511 . . . . 0.0 112.367 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.44 -35.05 65.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.644 1.578 . . . . 0.0 112.741 -166.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -65.39 -46.01 81.79 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.048 -175.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.599 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.7 mm-40 -64.24 -24.22 67.59 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.742 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.95 -43.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.761 0.791 . . . . 0.0 110.334 172.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -76.69 -28.26 55.83 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.843 -173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 30.8 mt-10 -68.89 -45.75 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.427 0.632 . . . . 0.0 109.709 174.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 95.5 m -62.22 -35.97 80.54 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.732 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -56.18 -56.01 26.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.078 0.951 . . . . 0.0 109.745 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.8 84.26 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.687 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.97 -40.49 95.31 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.54 -0.755 . . . . 0.0 113.858 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -63.47 -44.78 93.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.637 0.775 . . . . 0.0 110.211 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -60.16 -41.2 92.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.42 0.688 . . . . 0.0 110.487 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.86 -26.96 64.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.791 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 43.6 m -103.82 17.88 23.15 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.269 1.028 . . . . 0.0 111.823 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.07 47.29 8.53 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 115.701 1.04 . . . . 0.0 115.701 163.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.438 HG22 ' HZ ' ' B' ' 20' ' ' PHE . 57.6 t -95.45 141.16 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.88 87.13 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.231 0.612 . . . . 0.0 111.336 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 7.7 ptp 48.02 82.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.789 1.636 . . . . 0.0 114.289 168.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.446 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -107.15 84.78 2.03 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.735 177.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -178.31 131.99 0.14 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.978 1.311 . . . . 0.0 108.608 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . 0.415 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 51.1 mt-30 -82.7 114.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 6.2 Cg_endo -50.24 118.39 3.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.227 2.618 . . . . 0.0 112.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.57 148.56 52.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.593 0.757 . . . . 0.0 110.375 -173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.2 123.19 21.03 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.604 0.762 . . . . 0.0 109.986 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 45.7 ttm -121.94 170.84 9.4 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.934 1.293 . . . . 0.0 109.052 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.6 -43.3 56.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.714 1.206 . . . . 0.0 112.236 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -90.69 1.39 56.88 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.261 0.624 . . . . 0.0 112.184 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 127.69 -172.18 18.95 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 116.332 -0.395 . . . . 0.0 113.39 169.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.428 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 34.3 t80 -75.09 101.75 4.65 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -113.39 153.5 28.47 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.405 0.621 . . . . 0.0 111.404 -165.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 3.5 t80 -149.86 138.44 20.76 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.119 1.368 . . . . 0.0 108.488 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.537 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 m -129.7 125.81 36.81 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.1 172.1 6.99 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.07 0.948 . . . . 0.0 110.959 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.04 125.68 28.58 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.576 0.75 . . . . 0.0 109.224 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.16 170.87 3.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 123.932 0.893 . . . . 0.0 110.912 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -54.4 -28.1 52.17 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.815 2.343 . . . . 0.0 112.722 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.67 13.79 21.09 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.031 0.932 . . . . 0.0 111.76 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 49.1 m 55.25 80.97 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.25 1.42 . . . . 0.0 112.506 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.455 ' HA ' ' HA2' ' B' ' 64' ' ' GLY . 16.4 m170 -118.25 -173.03 2.38 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.63 ' HB3' ' HB3' ' B' ' 67' ' ' GLU . 10.9 mmm180 -121.49 112.65 18.77 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 71.9 mt -120.28 101.72 8.0 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -94.41 95.13 8.66 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -84.51 115.17 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -128.14 161.61 28.85 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.372 0.533 . . . . 0.0 111.502 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.433 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -118.24 118.97 33.29 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 0.0 108.805 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -81.12 127.04 32.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -119.48 94.32 4.37 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.018 0.927 . . . . 0.0 108.527 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.789 -1.006 . . . . 0.0 111.342 -179.366 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.761 0.315 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 m -83.71 130.55 34.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.642 0.777 . . . . 0.0 109.623 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' HB3' HD21 ' B' ' 43' ' ' ASN . 15.4 m170 -96.45 112.78 61.07 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.888 0.875 . . . . 0.0 111.274 -173.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -91.97 156.79 3.33 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.905 2.403 . . . . 0.0 112.815 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.705 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.2 p-10 -148.38 16.83 1.04 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.39 1.076 . . . . 0.0 109.662 167.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.09 136.67 49.58 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -169.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 t -144.95 140.59 28.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.547 HG12 ' HA3' ' A' ' 48' ' ' GLY . 19.4 mt -122.84 131.93 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.396 0.678 . . . . 0.0 109.664 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.441 HD23 HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -103.06 145.21 30.24 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -98.28 127.51 44.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.117 0.967 . . . . 0.0 110.768 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.7 m -127.82 160.96 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.34 0.656 . . . . 0.0 109.966 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -95.78 -60.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.103 0.961 . . . . 0.0 110.963 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -95.6 99.08 4.27 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 123.418 0.687 . . . . 0.0 109.728 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.05 -54.0 5.81 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 123.129 2.552 . . . . 0.0 115.639 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -57.79 -53.74 4.12 Favored 'Trans proline' 0 C--N 1.4 3.277 0 CA-C-N 122.363 1.88 . . . . 0.0 112.323 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.44 88.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.512 -168.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.7 m -79.88 -26.78 40.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.319 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -72.43 -38.67 68.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.071 0.462 . . . . 0.0 112.003 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 86.6 mm-40 -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.837 172.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 67.0 t80 -67.01 -42.32 85.15 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.631 0.582 . . . . 0.0 109.649 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -71.37 -29.81 65.4 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.008 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 53.3 mtpt -57.65 -49.78 75.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 111.875 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.58 -30.59 57.07 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.662 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.1 tp -62.44 -52.65 62.69 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.597 1.159 . . . . 0.0 111.785 -177.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 27' ' ' VAL . 15.4 mt -82.48 -40.62 20.84 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.456 1.102 . . . . 0.0 108.99 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.48 25.5 10.02 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.184 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 25' ' ' LEU . 28.3 m -126.21 177.89 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.854 0.861 . . . . 0.0 110.63 -176.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.07 154.92 76.62 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.504 1.122 . . . . 0.0 108.644 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.61 125.07 13.72 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 121.96 1.773 . . . . 0.0 111.966 174.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.7 p -71.58 -39.83 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.17 0.51 . . . . 0.0 109.645 171.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 39.6 mm-40 -115.55 113.31 23.45 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 p -114.74 147.87 39.13 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.423 0.689 . . . . 0.0 110.877 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.3 t -148.29 151.7 37.57 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.76 1.224 . . . . 0.0 108.228 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.54 -20.61 69.34 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.349 2.033 . . . . 0.0 112.94 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -128.73 13.69 6.41 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -157.35 158.14 35.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 35.6 t -145.99 141.96 28.19 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.583 0.753 . . . . 0.0 109.018 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.5 tm? -137.59 114.67 10.79 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.401 ' HE1' HD22 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -127.22 112.95 15.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.463 1.105 . . . . 0.0 109.078 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 46' ' ' LYS . 14.8 t -93.47 128.02 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.443 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD12 ' SD ' ' A' ' 45' ' ' MET . 57.1 mt -91.37 141.82 28.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 110.068 -168.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.98 -9.61 40.53 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.676 0.791 . . . . 0.0 112.082 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.619 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 4.6 m-20 -69.5 -1.21 8.02 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.14 0.976 . . . . 0.0 112.91 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.0 48.81 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 117.813 0.279 . . . . 0.0 112.706 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.738 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.9 ppp? -129.07 172.54 11.29 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.659 0.784 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -128.33 135.98 50.34 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.582 0.753 . . . . 0.0 109.264 -175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -131.25 124.73 31.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.547 ' HA3' HG12 ' A' ' 8' ' ' ILE . . . -100.34 166.85 19.97 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 37' ' ' SER . 10.1 tp -143.52 105.31 4.34 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 171.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HB2' HG21 ' A' ' 8' ' ' ILE . 2.8 t90 -105.09 131.78 52.15 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -73.35 126.45 30.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 173.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -68.75 -13.0 62.11 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 112.558 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -81.77 -8.25 59.68 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.236 0.614 . . . . 0.0 111.311 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 t -136.58 10.82 3.18 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.187 0.595 . . . . 0.0 111.177 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.0 p -71.4 146.91 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.04 107.99 10.5 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 123.633 0.773 . . . . 0.0 108.92 176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HG3' ' B' ' 94' ' ' GLN . 93.7 Cg_endo -73.74 133.47 30.97 Favored 'Cis proline' 0 C--N 1.382 2.307 0 CA-C-N 120.541 1.229 . . . . 0.0 114.157 13.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -59.74 124.74 21.1 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.577 1.151 . . . . 0.0 110.8 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.97 108.1 3.23 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.856 0.863 . . . . 0.0 109.535 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.7 t -89.41 87.0 6.92 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.75 138.22 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.244 1.018 . . . . 0.0 109.252 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 p -150.44 122.28 8.13 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.5 -92.06 0.14 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.83 64.14 3.96 Favored Glycine 0 C--N 1.343 0.923 0 C-N-CA 123.011 0.338 . . . . 0.0 112.495 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' B' ' 65' ' ' GLY . . . -98.83 173.91 27.32 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 177.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.54 159.27 45.48 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-O 119.632 -0.538 . . . . 0.0 112.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 9.6 pt-20 -102.31 145.44 29.46 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.603 0.701 . . . . 0.0 111.145 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.8 tp -109.77 102.76 11.52 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.708 1.203 . . . . 0.0 108.009 -175.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.787 ' HA ' ' HB3' ' A' ' 116' ' ' ARG . . . -89.25 114.91 26.32 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.01 0.433 . . . . 0.0 112.035 -168.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.78 120.31 33.89 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.015 1.326 . . . . 0.0 108.374 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.53 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 32.3 mtm180 -96.4 127.48 42.43 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.812 0.815 . . . . 0.0 112.302 -176.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.16 157.62 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.916 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 8.2 pt-20 -68.21 -34.87 77.04 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -172.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.89 -179.43 6.28 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 118.978 0.808 . . . . 0.0 112.752 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -59.35 -31.72 69.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.483 1.513 . . . . 0.0 113.016 -166.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -66.89 -44.87 79.74 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.08 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 19.2 mm-40 -65.82 -24.31 66.87 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.676 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.65 -44.91 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.574 0.749 . . . . 0.0 109.973 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.62 -28.34 56.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.694 0.798 . . . . 0.0 111.509 -175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 31.7 mt-10 -62.03 -44.24 97.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.611 0.719 . . . . 0.0 109.534 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -69.61 -35.0 74.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.988 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -54.52 -59.9 4.07 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.555 1.142 . . . . 0.0 109.977 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -64.42 -35.37 80.69 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.589 -175.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.87 -46.81 79.97 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 123.836 0.71 . . . . 0.0 113.994 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -65.68 -40.82 92.77 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.898 0.479 . . . . 0.0 109.76 175.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 33.9 ttpt -57.64 -45.09 85.91 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.61 0.764 . . . . 0.0 110.479 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.75 -24.28 61.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.092 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -98.11 14.56 27.15 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.937 0.895 . . . . 0.0 111.689 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.86 41.17 8.31 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 115.222 164.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.1 p -89.21 149.4 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.04 -54.44 11.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.961 0.504 . . . . 0.0 110.796 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.506 ' HB2' HG13 ' A' ' 90' ' ' VAL . 47.5 ttm 68.67 84.94 0.14 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.246 0.966 . . . . 0.0 113.027 169.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -117.85 84.38 2.16 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.553 0.692 . . . . 0.0 110.965 173.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 106' ' ' THR . 53.1 tp60 178.04 122.56 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.768 1.627 . . . . 0.0 107.736 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.02 121.8 86.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.4 0.68 . . . . 0.0 109.72 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 46.3 Cg_endo -64.95 108.34 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.766 2.31 . . . . 0.0 110.084 178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.15 48.71 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.207 0.603 . . . . 0.0 110.543 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -67.81 131.63 45.89 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.421 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.519 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 12.4 ttt -141.04 -178.07 5.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.016 0.926 . . . . 0.0 109.245 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 99' ' ' MET . 7.4 mp0 -58.8 -37.36 76.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.609 1.164 . . . . 0.0 111.899 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 33.9 m-85 -84.33 -8.4 59.02 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.84 0.856 . . . . 0.0 111.119 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 116.41 -157.12 15.22 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -79.35 103.48 9.3 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.916 0.858 . . . . 0.0 108.956 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.43 HG21 ' SD ' ' A' ' 99' ' ' MET . 13.1 t -109.48 152.76 24.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.38 0.61 . . . . 0.0 110.84 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 6.5 t80 -143.19 145.22 32.6 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.921 177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 5.4 m -135.73 132.65 37.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.485 0.584 . . . . 0.0 110.591 172.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -106.58 172.59 6.73 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.67 0.788 . . . . 0.0 110.341 170.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.64 116.06 12.74 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.504 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 7.2 p-10 -71.26 171.45 8.71 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 123.309 0.644 . . . . 0.0 110.277 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 9.6 Cg_endo -50.62 -40.09 55.63 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.873 2.382 . . . . 0.0 113.463 176.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.12 -1.04 54.23 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.637 0.775 . . . . 0.0 110.73 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.6 m 64.6 75.24 0.38 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.784 1.234 . . . . 0.0 112.08 164.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -123.45 162.65 22.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 1.1 mpt_? -90.35 111.27 22.43 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.51 104.19 16.2 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.787 ' HB3' ' HA ' ' A' ' 69' ' ' ALA . 7.4 tpt180 -89.49 146.09 24.86 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.198 0.599 . . . . 0.0 110.144 -172.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 t -139.26 122.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 164.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 5.3 p90 -127.48 156.82 41.53 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.602 0.637 . . . . 0.0 110.928 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.48 112.57 17.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 171.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 49.7 t80 -77.74 116.39 18.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -171.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -87.5 94.38 9.69 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.579 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 -178.707 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.901 0.382 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 22.1 m -79.94 130.97 35.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 109.874 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -98.23 112.3 61.74 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.776 0.83 . . . . 0.0 110.754 -171.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -91.83 155.4 3.4 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.983 2.456 . . . . 0.0 112.959 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.738 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 4.5 p-10 -146.58 17.28 1.3 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.301 1.04 . . . . 0.0 110.155 167.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -130.5 136.65 49.18 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -144.84 140.67 28.55 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.43 ' HB ' ' HG3' ' A' ' 67' ' ' GLU . 11.2 mt -122.9 132.43 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.341 0.656 . . . . 0.0 109.545 -176.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.96 145.37 30.51 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -99.29 127.35 45.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.465 1.106 . . . . 0.0 110.517 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.67 160.9 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 123.241 0.616 . . . . 0.0 109.95 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -95.54 -60.9 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.278 1.031 . . . . 0.0 110.883 -171.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -95.93 99.05 4.48 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 123.564 0.746 . . . . 0.0 109.333 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -52.76 -54.86 4.39 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.107 2.538 . . . . 0.0 115.552 -169.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.58 -54.15 4.22 Favored 'Trans proline' 0 C--N 1.4 3.245 0 CA-C-N 122.461 1.915 . . . . 0.0 112.123 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.33 -41.83 89.06 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.465 -168.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 85.9 p -79.5 -27.82 41.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.211 -175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 39.9 m -71.32 -38.97 71.67 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.529 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 83.0 mm-40 -65.6 -33.93 77.05 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.729 172.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 53.2 t80 -66.79 -41.96 86.76 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -71.82 -29.69 64.69 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.017 -0.516 . . . . 0.0 110.258 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 10.3 mtpm? -57.87 -49.1 77.87 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.267 0.485 . . . . 0.0 112.177 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.56 -30.68 57.15 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.656 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.505 HD11 HD13 ' B' ' 115' ' ' LEU . 13.4 tp -62.75 -52.78 61.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.447 1.099 . . . . 0.0 112.014 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.493 ' HB2' HG22 ' B' ' 27' ' ' VAL . 17.0 mt -82.21 -40.55 21.51 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.913 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.01 9.82 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.011 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.0 m -125.88 178.39 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.97 155.27 77.97 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.166 0.986 . . . . 0.0 108.526 171.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.34 124.59 13.13 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.125 1.884 . . . . 0.0 112.172 174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.5 p -71.22 -40.4 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.08 0.552 . . . . 0.0 109.588 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 68.0 mm-40 -114.35 113.84 25.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 174.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 73.8 p -115.33 147.96 39.84 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.999 0.52 . . . . 0.0 110.83 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.2 t -148.48 151.27 35.97 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.532 1.133 . . . . 0.0 108.34 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.96 -20.68 68.38 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.424 2.082 . . . . 0.0 113.117 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -128.66 13.62 6.44 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -157.13 158.37 36.21 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.843 -0.536 . . . . 0.0 109.688 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 49' ' ' LEU . 34.7 t -146.07 141.83 27.97 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.591 0.756 . . . . 0.0 109.086 176.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.5 tm? -137.52 114.6 10.79 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.04 113.08 15.97 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.527 1.131 . . . . 0.0 109.15 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' B' ' 46' ' ' LYS . 17.2 t -93.69 127.55 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.341 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.551 HD12 ' SD ' ' B' ' 45' ' ' MET . 53.2 mt -91.26 141.36 28.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.062 0.545 . . . . 0.0 110.227 -169.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.36 -9.4 33.0 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.038 0.935 . . . . 0.0 112.261 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.565 ' HB3' ' HB3' ' A' ' 5' ' ' ASP . 4.2 m-20 -69.61 -1.93 10.21 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.159 0.983 . . . . 0.0 112.679 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.25 17.51 46.33 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-O 120.197 -0.224 . . . . 0.0 112.723 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.705 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -128.92 173.08 10.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.549 0.74 . . . . 0.0 109.426 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.559 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.8 tttt -128.66 136.25 50.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.403 0.681 . . . . 0.0 109.482 -176.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.466 HD12 HD11 ' B' ' 41' ' ' LEU . 0.7 OUTLIER -131.06 124.68 31.38 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -175.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.27 166.36 20.93 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 37' ' ' SER . 9.5 tp -143.46 105.07 4.32 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -105.08 132.06 51.78 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 52.8 m -73.54 126.17 29.62 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -68.64 -13.12 62.15 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.581 0.752 . . . . 0.0 112.552 -172.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -81.41 -8.35 59.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.309 0.644 . . . . 0.0 111.331 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.3 t -136.59 10.87 3.18 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.255 0.622 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.82 146.99 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -134.97 108.85 10.64 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.584 0.754 . . . . 0.0 109.049 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.57 134.04 32.64 Favored 'Cis proline' 0 C--N 1.383 2.381 0 CA-C-N 120.339 1.157 . . . . 0.0 114.215 11.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -60.61 124.06 19.26 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.651 1.181 . . . . 0.0 111.22 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.32 108.02 3.33 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 109.508 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.4 p -89.2 86.07 6.78 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.32 140.43 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.166 0.986 . . . . 0.0 108.584 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -152.33 122.31 7.06 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.9 -91.84 0.14 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.22 63.81 4.29 Favored Glycine 0 C--N 1.343 0.955 0 C-N-CA 123.041 0.353 . . . . 0.0 113.315 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.442 ' HA2' ' HA2' ' A' ' 65' ' ' GLY . . . -99.43 173.98 26.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.915 -0.381 . . . . 0.0 112.27 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.53 159.6 45.03 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 124.019 0.482 . . . . 0.0 112.097 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' B' ' 114' ' ' ARG . 9.2 pt-20 -101.99 145.35 29.4 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.458 0.647 . . . . 0.0 110.895 -176.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -110.06 102.92 11.59 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.29 114.83 26.25 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.183 0.516 . . . . 0.0 111.933 -168.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -93.36 120.51 33.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.041 1.336 . . . . 0.0 108.523 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.484 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 33.3 mtm105 -97.36 126.08 42.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.64 0.734 . . . . 0.0 112.188 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.98 157.82 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.348 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.451 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.1 pt-20 -67.04 -35.11 79.16 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -164.45 -179.05 5.76 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.91 -31.75 70.11 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.99 -1.459 . . . . 0.0 112.688 -166.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.521 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -66.28 -45.34 80.79 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.01 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.451 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 83.1 mm-40 -65.42 -24.1 67.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.261 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.68 -44.51 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.382 0.673 . . . . 0.0 109.858 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -77.21 -28.15 53.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.587 0.755 . . . . 0.0 111.364 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 40.4 mt-10 -62.54 -43.85 97.8 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.758 0.79 . . . . 0.0 109.325 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 54.3 m -69.89 -35.02 74.3 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.14 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -54.59 -59.68 4.37 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.47 1.108 . . . . 0.0 110.223 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.499 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -64.67 -34.87 79.31 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.539 -175.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.88 -47.29 76.3 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 123.729 0.643 . . . . 0.0 113.804 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -65.54 -41.09 93.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 34.3 ttpt -57.27 -45.0 84.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.591 0.756 . . . . 0.0 110.482 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.62 61.62 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.072 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -97.5 14.82 25.15 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.041 0.937 . . . . 0.0 111.931 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.67 41.43 8.29 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 115.507 0.963 . . . . 0.0 115.507 164.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.3 p -89.6 149.4 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.25 -54.69 10.03 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.795 0.438 . . . . 0.0 110.691 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.514 ' HB2' HG13 ' B' ' 90' ' ' VAL . 49.1 ttm 68.76 84.99 0.14 Allowed 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.944 0.777 . . . . 0.0 112.922 168.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.94 84.29 2.14 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 121.571 0.701 . . . . 0.0 110.821 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.412 ' HG3' ' HD3' ' A' ' 57' ' ' PRO . 24.1 tm0? 178.27 122.92 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.468 1.507 . . . . 0.0 107.14 173.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -75.41 120.63 82.55 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.366 0.667 . . . . 0.0 109.939 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 37.0 Cg_endo -63.38 108.41 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.795 2.33 . . . . 0.0 110.514 177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.49 156.62 47.93 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.011 -173.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -68.31 131.89 46.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.283 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.491 ' HG2' ' H ' ' B' ' 100' ' ' GLU . 8.8 ttt -141.19 -178.42 5.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.96 0.904 . . . . 0.0 108.897 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.491 ' H ' ' HG2' ' B' ' 99' ' ' MET . 7.3 mp0 -58.55 -37.61 76.07 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.429 1.092 . . . . 0.0 112.187 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -83.61 -8.69 59.26 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.778 0.831 . . . . 0.0 111.16 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 116.76 -156.65 15.5 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -79.61 103.49 9.55 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.044 0.922 . . . . 0.0 108.92 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.459 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.8 t -109.75 152.47 25.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.958 0.503 . . . . 0.0 110.582 -171.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.538 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 7.3 t80 -142.98 144.72 32.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.8 1.24 . . . . 0.0 109.971 178.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 3.2 m -135.17 132.16 37.65 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.417 0.553 . . . . 0.0 110.705 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -106.56 172.63 6.71 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.718 0.807 . . . . 0.0 110.35 170.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.87 115.39 11.92 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.514 ' HB3' HD11 ' B' ' 115' ' ' LEU . 4.3 p-10 -69.8 170.83 8.54 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.58 0.752 . . . . 0.0 110.728 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 9.6 Cg_endo -50.66 -40.18 55.91 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.789 2.326 . . . . 0.0 113.199 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -83.76 -0.87 52.75 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.482 0.713 . . . . 0.0 111.053 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 20.0 m 64.17 74.75 0.4 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.741 1.217 . . . . 0.0 112.043 165.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -122.62 162.61 21.58 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 166.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' B' ' 67' ' ' GLU . 2.6 mpt_? -90.01 112.08 23.39 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.514 HD11 ' HB3' ' B' ' 109' ' ' ASP . 33.0 mt -98.97 104.37 16.4 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.735 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 30.4 mmt180 -87.55 146.24 25.87 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 123.804 0.841 . . . . 0.0 110.834 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 t -139.56 122.01 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 163.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.484 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 6.0 p90 -127.13 156.56 41.56 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.866 0.757 . . . . 0.0 111.132 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -123.57 112.52 17.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.38 118.76 20.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.4 94.35 6.78 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.087 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.347 -179.388 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HB2' ' OE1' ' B' ' 77' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.422 ' HA ' HG12 ' B' ' 72' ' ' VAL . 85.3 m -141.32 146.98 37.39 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.788 0.835 . . . . 0.0 111.395 -165.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.476 ' HB3' ' ND2' ' B' ' 43' ' ' ASN . 17.9 m-70 -136.78 103.05 9.23 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 124.376 1.071 . . . . 0.0 108.491 176.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HG3' HD22 ' B' ' 25' ' ' LEU . 51.2 Cg_endo -90.83 48.65 0.75 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 123.361 2.708 . . . . 0.0 112.672 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.574 ' HA ' ' SD ' ' B' ' 45' ' ' MET . 5.9 p-10 -75.47 14.81 0.54 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.173 0.989 . . . . 0.0 112.609 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.2 t80 -133.37 129.93 38.1 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.134 1.374 . . . . 0.0 108.137 -169.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 8.2 t -127.33 140.86 51.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.237 1.015 . . . . 0.0 108.576 173.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 61.4 mt -118.8 137.24 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 HD21 ' A' ' 47' ' ' LEU . 4.3 mm? -96.72 146.28 25.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' HE1' HG21 ' A' ' 55' ' ' VAL . 22.8 t80 -101.32 95.72 6.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.341 -167.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.471 HG12 ' HE1' ' A' ' 113' ' ' HIS . 27.0 m -108.87 -179.85 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -124.33 -53.87 1.7 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.876 0.47 . . . . 0.0 110.258 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -87.74 105.55 9.19 Favored Pre-proline 0 N--CA 1.489 1.499 0 C-N-CA 123.567 0.747 . . . . 0.0 110.764 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -53.68 -55.48 3.5 Favored 'Trans proline' 0 CA--C 1.572 2.414 0 C-N-CA 122.735 2.29 . . . . 0.0 114.081 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.44 -58.9 0.5 Allowed 'Trans proline' 0 C--N 1.399 3.217 0 CA-C-N 122.271 1.847 . . . . 0.0 112.312 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.71 95.51 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.337 -166.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.9 p -76.68 -34.83 58.2 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.287 -173.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -69.11 -39.12 79.14 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.545 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 12.4 mm100 -64.3 -35.47 80.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.411 172.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 77.7 t80 -68.28 -39.46 82.14 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.27 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -70.41 -30.55 67.47 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.208 174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 57.4 mtpt -57.13 -47.76 80.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.946 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.28 -34.53 55.58 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.223 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 15.0 tp -61.13 -31.46 71.16 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.861 1.265 . . . . 0.0 112.646 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' B' ' 4' ' ' PRO . 87.3 mt -105.46 -40.08 5.92 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.364 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.34 29.65 10.0 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 25' ' ' LEU . 16.9 m -126.51 -179.17 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.218 1.007 . . . . 0.0 109.616 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.83 150.8 68.93 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 123.546 0.738 . . . . 0.0 109.078 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.97 111.9 2.78 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.812 2.342 . . . . 0.0 112.099 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 p -64.02 -42.28 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.759 0.824 . . . . 0.0 110.598 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 28.5 mm-40 -111.49 145.49 38.94 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 170.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.3 p -154.55 152.23 29.81 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.326 0.584 . . . . 0.0 109.976 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 15.2 m -139.86 163.95 41.2 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.44 1.496 . . . . 0.0 107.655 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.19 -30.51 80.07 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.331 2.021 . . . . 0.0 113.069 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -130.04 23.11 5.29 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.552 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 88.7 t80 -153.63 159.28 42.05 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.091 0.556 . . . . 0.0 109.72 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 55.4 m -149.36 154.56 39.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 110.077 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.9 tm? -148.36 123.14 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -128.96 131.54 47.49 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.961 1.304 . . . . 0.0 108.46 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.523 HG22 ' HG3' ' A' ' 46' ' ' LYS . 33.8 t -109.6 126.29 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.74 0.816 . . . . 0.0 109.175 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 mp -98.31 145.17 26.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.219 0.608 . . . . 0.0 109.652 -170.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.66 -5.56 12.21 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.974 0.91 . . . . 0.0 112.585 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' B' ' 5' ' ' ASP . 10.5 m120 -67.06 -9.12 35.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.445 1.098 . . . . 0.0 112.743 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.63 16.69 59.68 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.46 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.1 ppp? -119.98 164.22 16.42 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.125 0.97 . . . . 0.0 109.261 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' A' ' 40' ' ' VAL . 73.6 tttt -132.02 138.83 48.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.498 HD21 HD23 ' A' ' 9' ' ' LEU . 1.2 tt -137.24 122.6 19.45 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.07 0.462 . . . . 0.0 110.539 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -102.96 170.11 19.58 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.95 0.786 . . . . 0.0 111.653 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tp -141.73 109.59 5.77 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 1.9 t-105 -109.26 127.75 54.52 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -79.59 122.86 27.02 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.006 0.522 . . . . 0.0 110.118 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -69.35 -15.87 63.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.399 1.08 . . . . 0.0 112.686 -169.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -72.03 -8.88 57.11 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 122.842 0.457 . . . . 0.0 111.233 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 t -135.1 6.36 3.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.334 0.653 . . . . 0.0 111.244 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG21 ' HE1' ' A' ' 10' ' ' TYR . 8.3 p -62.75 148.63 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.539 0.335 . . . . 0.0 111.34 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -122.98 113.9 29.76 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.356 0.663 . . . . 0.0 109.783 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.41 144.92 80.67 Favored 'Cis proline' 0 C--N 1.379 2.174 0 C-N-CA 124.727 -0.947 . . . . 0.0 113.084 1.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -52.86 128.29 26.4 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.66 1.184 . . . . 0.0 112.218 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' OH ' ' A' ' 10' ' ' TYR . . . -150.87 121.14 7.28 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.236 0.614 . . . . 0.0 110.98 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 p -91.29 86.94 6.29 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 p -147.34 124.64 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.26 0.624 . . . . 0.0 109.963 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -152.33 123.69 7.71 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.114 1.366 . . . . 0.0 107.98 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.63 67.43 0.02 OUTLIER Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.59 -82.09 1.69 Allowed Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.0 -142.92 45.68 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.377 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.552 ' H ' ' H ' ' B' ' 66' ' ' GLY . . . -65.96 151.76 51.93 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.2 mt-10 -102.14 152.89 20.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.164 0.507 . . . . 0.0 110.585 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.4 tp -118.84 102.23 8.65 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.08 115.63 26.76 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.19 0.519 . . . . 0.0 111.332 -170.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB3' ' CG2' ' B' ' 2' ' ' THR . 30.8 m-85 -95.38 108.25 20.43 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 0.0 108.235 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -92.38 128.08 38.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.586 0.707 . . . . 0.0 111.975 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 118' ' ' TYR . 24.8 m -128.41 160.95 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.962 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 13.0 pt-20 -66.79 -35.19 79.49 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 113.348 0.869 . . . . 0.0 113.348 -174.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.512 HD22 ' HG3' ' A' ' 73' ' ' GLU . 7.3 p30 -165.05 178.56 6.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.7 0.682 . . . . 0.0 112.281 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -56.16 -31.98 63.88 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.786 1.634 . . . . 0.0 113.1 -169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -63.25 -46.87 84.87 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 123.902 0.751 . . . . 0.0 110.101 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.586 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 83.3 mm-40 -67.9 -23.03 65.06 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.653 -178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -66.62 -41.68 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 121.65 0.738 . . . . 0.0 109.904 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.27 -33.82 65.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.061 1.344 . . . . 0.0 110.971 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 41.5 mt-10 -65.91 -44.69 84.45 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.626 0.727 . . . . 0.0 109.312 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.4 m -63.49 -37.61 87.95 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.952 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -55.13 -61.54 2.25 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.271 1.029 . . . . 0.0 110.466 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -68.79 -32.69 72.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.301 -172.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.24 -46.39 90.99 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.483 0.489 . . . . 0.0 112.94 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.52 -43.74 98.07 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.258 0.623 . . . . 0.0 109.529 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.8 ttpt -55.84 -45.76 78.31 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.451 0.7 . . . . 0.0 110.301 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.29 -20.74 61.46 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.297 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 t -100.56 4.1 43.22 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 111.829 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.57 52.91 2.72 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-N 115.878 -0.601 . . . . 0.0 114.401 167.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.8 p -94.76 153.16 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 173.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.14 -53.93 15.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.698 0.399 . . . . 0.0 110.771 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.524 ' HB2' HG13 ' A' ' 90' ' ' VAL . 48.6 ttm 64.53 83.8 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 169.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.88 82.55 1.88 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.305 0.574 . . . . 0.0 110.599 173.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 176.71 130.46 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.867 1.667 . . . . 0.0 108.303 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -82.15 123.68 79.3 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -48.19 107.05 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.469 2.779 . . . . 0.0 111.972 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.41 140.06 50.44 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.777 0.831 . . . . 0.0 111.254 -171.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' A' ' 98' ' ' LYS . 2.2 mmmm -70.77 100.63 1.93 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.545 0.738 . . . . 0.0 110.308 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 50.7 ttm -101.34 169.4 8.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.258 1.023 . . . . 0.0 108.815 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.12 -41.6 48.97 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.35 1.06 . . . . 0.0 112.136 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.08 -12.12 60.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.581 0.752 . . . . 0.0 111.164 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.96 -173.5 21.55 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.467 0.556 . . . . 0.0 111.933 176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -77.14 100.81 5.88 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.2 t -113.44 147.5 37.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.099 0.476 . . . . 0.0 110.623 -167.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -140.78 134.21 29.88 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.098 0.959 . . . . 0.0 109.296 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.8 m -120.26 118.26 29.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.796 0.438 . . . . 0.0 110.272 -177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.01 169.69 8.35 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.143 0.577 . . . . 0.0 109.894 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.85 127.73 29.39 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.73 169.53 2.5 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.542 0.737 . . . . 0.0 110.791 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -49.51 -31.81 25.22 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.573 2.182 . . . . 0.0 112.444 165.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.52 4.0 41.76 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.543 1.137 . . . . 0.0 112.263 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.4 m 59.31 84.2 0.12 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.702 1.201 . . . . 0.0 112.259 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.471 ' HE1' HG12 ' A' ' 11' ' ' VAL . 22.5 m170 -122.73 176.57 5.89 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.075 0.55 . . . . 0.0 109.754 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 67' ' ' GLU . 24.9 mmt180 -100.3 112.46 24.8 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 169.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.1 mt -111.78 100.32 8.84 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -99.5 93.33 5.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.247 0.219 . . . . 0.0 110.971 -172.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.5 p -92.48 116.21 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 72' ' ' VAL . 23.5 p90 -125.19 168.49 13.37 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.027 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.85 112.04 13.71 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -79.75 114.42 18.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.9 95.31 6.7 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.576 0.75 . . . . 0.0 109.535 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 CA-C-O 119.167 -0.796 . . . . 0.0 112.383 178.472 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptm . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 27.6 m -143.12 144.53 32.26 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -169.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -135.47 103.73 10.28 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.592 1.157 . . . . 0.0 108.889 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.578 ' HG3' HD22 ' A' ' 25' ' ' LEU . 54.3 Cg_endo -90.57 49.69 0.89 Allowed 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 123.444 2.762 . . . . 0.0 112.851 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 8.9 p-10 -75.69 14.24 0.67 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.304 1.041 . . . . 0.0 112.516 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.474 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.3 t80 -133.48 129.25 36.94 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.222 1.409 . . . . 0.0 108.2 -169.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 8.2 t -126.85 141.3 51.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.358 1.063 . . . . 0.0 108.827 173.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 55.6 mt -119.79 137.19 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.55 145.43 25.72 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.47 97.74 8.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.223 -169.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.457 HG12 ' HE1' ' B' ' 113' ' ' HIS . 30.5 m -109.14 179.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -123.78 -53.45 1.77 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.727 0.411 . . . . 0.0 110.405 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.11 105.12 8.31 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 123.635 0.774 . . . . 0.0 109.828 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.23 -55.25 3.83 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.576 2.184 . . . . 0.0 114.357 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.99 -58.63 0.52 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 CA-C-N 122.243 1.837 . . . . 0.0 112.248 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.36 -44.37 94.98 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.282 -166.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m -76.35 -34.57 58.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.662 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.45 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 63.3 m -69.34 -39.43 78.15 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.549 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.9 mm-40 -63.89 -35.89 82.15 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.527 172.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 58.2 t80 -68.08 -39.51 82.89 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 118.956 -0.545 . . . . 0.0 110.322 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -70.18 -30.64 67.81 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 119.013 -0.518 . . . . 0.0 110.329 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 61.2 mtpt -57.07 -47.63 80.52 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.59 -34.52 53.49 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.264 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 11.8 tp -60.66 -31.93 71.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.699 1.2 . . . . 0.0 112.641 -177.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.526 HD22 ' HG3' ' A' ' 4' ' ' PRO . 91.4 mt -105.07 -40.26 5.95 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.511 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.38 29.62 10.0 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 123.725 0.64 . . . . 0.0 111.823 -169.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' B' ' 25' ' ' LEU . 29.4 m -126.62 -179.58 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 124.318 1.047 . . . . 0.0 109.809 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -137.33 150.81 70.0 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 123.432 0.693 . . . . 0.0 109.209 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.53 111.92 2.69 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.469 2.113 . . . . 0.0 112.26 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 p -64.17 -42.33 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.773 0.829 . . . . 0.0 110.287 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 18.9 mm-40 -111.41 145.93 38.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.199 1.0 . . . . 0.0 108.302 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.6 p -154.85 152.05 29.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.279 0.562 . . . . 0.0 110.014 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 24.9 m -139.39 163.4 45.8 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.401 1.48 . . . . 0.0 107.616 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.77 -30.99 69.96 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.483 2.122 . . . . 0.0 113.325 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -130.29 23.0 5.19 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.544 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 70.0 t80 -153.75 159.2 41.87 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 65.6 m -149.37 154.42 38.9 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.826 0.851 . . . . 0.0 109.955 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -148.2 122.91 9.88 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -128.6 132.58 48.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.853 1.261 . . . . 0.0 108.544 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' B' ' 46' ' ' LYS . 22.5 t -109.99 126.47 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.667 0.787 . . . . 0.0 109.143 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.38 145.15 27.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.174 0.589 . . . . 0.0 109.537 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.16 -5.66 14.51 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.876 0.87 . . . . 0.0 112.655 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.569 ' HB2' ' HG2' ' B' ' 45' ' ' MET . 13.5 m120 -65.8 -10.42 37.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.642 1.177 . . . . 0.0 112.649 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.53 58.58 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.574 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 14.9 ptm -118.76 165.2 14.3 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.238 1.015 . . . . 0.0 109.249 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.55 ' HG3' HG22 ' B' ' 40' ' ' VAL . 82.0 tttt -132.77 139.46 47.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.1 tt -137.79 122.73 18.96 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.036 0.446 . . . . 0.0 110.502 -171.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.474 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -102.94 169.44 19.0 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 123.997 0.808 . . . . 0.0 111.434 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 45.8 mt -139.94 110.05 6.51 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 167.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -107.76 128.6 54.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 26.7 m -79.69 122.82 27.04 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.071 0.548 . . . . 0.0 110.185 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.433 ' O ' HG12 ' B' ' 55' ' ' VAL . 51.6 ptt85 -69.89 -15.08 63.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.323 1.049 . . . . 0.0 112.621 -169.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -72.62 -8.48 55.45 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 122.684 0.394 . . . . 0.0 111.132 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 13.2 t -134.81 4.16 3.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.569 0.748 . . . . 0.0 111.414 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' B' ' 52' ' ' ARG . 10.6 p -60.02 148.23 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.867 0.467 . . . . 0.0 111.562 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -123.68 113.81 28.67 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 123.804 0.841 . . . . 0.0 109.527 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.76 145.56 81.87 Favored 'Cis proline' 0 C--N 1.382 2.338 0 C-N-CA 124.516 -1.035 . . . . 0.0 113.16 1.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.68 128.66 30.3 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.553 1.141 . . . . 0.0 111.992 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.32 120.88 7.45 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.389 0.675 . . . . 0.0 110.886 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 35.6 p -91.12 87.25 6.48 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.34 124.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.364 0.665 . . . . 0.0 109.739 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -152.64 123.07 7.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.305 1.442 . . . . 0.0 108.123 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.85 67.83 0.02 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.67 -82.24 1.68 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.29 -142.33 44.3 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.809 -0.439 . . . . 0.0 112.452 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.552 ' H ' ' H ' ' A' ' 66' ' ' GLY . . . -66.86 152.46 52.66 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 174.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 10.4 mt-10 -103.9 152.08 22.38 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.042 0.537 . . . . 0.0 110.197 -172.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.441 HD21 HD11 ' B' ' 47' ' ' LEU . 35.4 tp -118.81 102.34 8.74 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.2 116.09 27.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.216 0.531 . . . . 0.0 111.194 -170.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' B' ' 117' ' ' VAL . 29.0 m-85 -96.28 107.96 20.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.135 1.374 . . . . 0.0 108.297 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -91.86 126.4 36.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.599 0.714 . . . . 0.0 111.89 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 2' ' ' THR . 29.6 m -126.25 161.81 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.148 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 10.5 pt-20 -66.88 -34.62 78.19 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -174.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.401 HD22 ' HG3' ' B' ' 73' ' ' GLU . 7.7 p30 -165.78 179.0 6.19 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 118.648 0.658 . . . . 0.0 112.212 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.39 -31.49 65.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.519 1.528 . . . . 0.0 113.03 -168.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -63.43 -46.42 86.39 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.181 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.481 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 72.4 mm-40 -68.16 -23.38 64.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.322 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.59 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.574 0.702 . . . . 0.0 109.69 172.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.48 -32.99 62.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.933 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 33.4 mt-10 -65.9 -44.31 85.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.534 0.683 . . . . 0.0 109.495 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 46.8 m -64.66 -36.45 84.3 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.991 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -55.03 -61.68 2.15 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.41 1.084 . . . . 0.0 110.28 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.11 -32.32 71.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.368 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.48 -45.66 92.55 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.53 0.519 . . . . 0.0 112.935 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -63.89 -43.19 96.77 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.333 0.653 . . . . 0.0 109.924 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -55.65 -45.76 77.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.592 0.757 . . . . 0.0 110.184 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.62 -20.73 61.23 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.345 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.95 4.15 44.77 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.796 0.838 . . . . 0.0 112.475 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.51 52.86 2.74 Favored Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.796 -0.638 . . . . 0.0 114.471 168.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' B' ' 92' ' ' MET . 4.9 p -94.57 153.07 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.82 -54.0 15.61 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.742 0.417 . . . . 0.0 110.991 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.53 ' HB2' HG13 ' B' ' 90' ' ' VAL . 52.9 ttm 64.43 83.7 0.16 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.841 0.713 . . . . 0.0 112.67 169.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.73 82.46 1.86 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.442 0.639 . . . . 0.0 110.741 173.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' B' ' 106' ' ' THR . 54.0 tp60 176.2 129.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.717 1.607 . . . . 0.0 108.242 172.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.89 123.45 82.22 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 168.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.33 107.11 0.12 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.499 2.799 . . . . 0.0 111.876 175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.29 141.35 48.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 111.085 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 100.42 3.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.405 0.682 . . . . 0.0 109.358 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 47.5 ttm -100.59 170.38 8.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.912 0.885 . . . . 0.0 109.181 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -50.6 -41.62 54.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.236 1.014 . . . . 0.0 111.746 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -79.93 -11.21 59.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.644 0.777 . . . . 0.0 111.249 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 134.68 -172.79 21.78 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.9 175.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -78.56 101.05 7.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 13.0 t -113.7 147.51 38.06 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.895 0.478 . . . . 0.0 110.781 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -140.77 134.34 30.09 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.186 0.994 . . . . 0.0 109.117 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' B' ' 94' ' ' GLN . 1.9 m -120.9 118.42 29.88 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.92 169.94 8.19 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.058 0.543 . . . . 0.0 109.704 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.2 128.51 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.86 170.22 2.73 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.597 0.759 . . . . 0.0 110.41 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -49.89 -31.88 28.27 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.779 2.319 . . . . 0.0 112.2 165.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -87.31 4.92 40.91 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.36 1.064 . . . . 0.0 112.047 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 61.0 m 58.53 84.67 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.802 1.241 . . . . 0.0 112.573 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.457 ' HE1' HG12 ' B' ' 11' ' ' VAL . 15.3 m170 -122.78 176.57 5.9 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.108 0.563 . . . . 0.0 109.612 174.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' B' ' 67' ' ' GLU . 9.5 mmt180 -100.75 112.48 24.9 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 169.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 73.0 mt -112.32 100.6 8.93 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.594 ' HG3' HH11 ' B' ' 116' ' ' ARG . 8.3 mmt85 -96.8 92.19 6.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.876 -172.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' B' ' 70' ' ' PHE . 5.9 t -91.74 115.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.408 ' O ' HG22 ' B' ' 72' ' ' VAL . 15.9 p90 -124.71 169.02 12.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.789 0.268 . . . . 0.0 111.128 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.95 111.76 13.36 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -79.61 115.46 19.23 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.71 0.25 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.803 -0.998 . . . . 0.0 112.835 -174.418 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.476 0.179 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -91.8 133.48 35.59 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -96.67 112.12 59.3 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.052 0.941 . . . . 0.0 110.746 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.0 94.77 0.35 Allowed 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.801 2.334 . . . . 0.0 112.064 171.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.653 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.6 p-10 -96.61 16.7 18.15 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.424 0.63 . . . . 0.0 110.997 172.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.7 131.57 46.37 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.935 1.294 . . . . 0.0 107.562 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 142.97 49.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.362 1.065 . . . . 0.0 109.03 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 45.7 mt -124.0 139.1 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.546 0.739 . . . . 0.0 110.133 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.474 HD23 HD21 ' A' ' 47' ' ' LEU . 3.7 mm? -112.02 143.5 42.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.051 0.941 . . . . 0.0 108.556 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -81.13 106.48 13.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.495 1.118 . . . . 0.0 111.347 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 51' ' ' SER . 14.8 m -107.24 149.38 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -97.06 -52.15 3.96 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.667 -171.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.13 100.58 13.59 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.11 0.964 . . . . 0.0 109.646 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -53.67 -52.71 7.89 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 123.246 2.631 . . . . 0.0 115.384 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 47.3 Cg_exo -56.68 -51.16 9.69 Favored 'Trans proline' 0 C--N 1.4 3.255 0 CA-C-N 122.267 1.845 . . . . 0.0 112.414 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.19 -38.01 52.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.968 -165.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -78.76 -29.25 45.02 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.235 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.448 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 75.9 m -64.95 -48.29 74.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 173.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 81.5 mm-40 -66.36 -31.66 72.57 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.196 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -62.96 -48.94 76.73 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.855 0.722 . . . . 0.0 110.045 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -71.81 -29.07 64.05 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.409 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 18' ' ' THR . 56.3 mtpt -56.26 -45.64 79.98 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 118.753 0.706 . . . . 0.0 112.069 178.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.42 -42.54 35.8 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.464 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -57.9 -46.33 85.09 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.904 1.282 . . . . 0.0 112.298 -172.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.39 -47.64 9.15 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.2 33.75 4.78 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.804 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.18 172.19 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.14 0.976 . . . . 0.0 110.312 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.2 146.75 54.99 Favored Pre-proline 0 N--CA 1.482 1.148 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 57.3 Cg_endo -71.26 121.08 7.46 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.994 1.796 . . . . 0.0 112.19 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.76 -44.13 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.545 0.738 . . . . 0.0 110.636 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 38.6 mm-40 -120.86 107.23 12.45 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.8 p -111.08 144.86 39.54 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.173 0.511 . . . . 0.0 110.696 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.1 m -142.07 155.63 65.26 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.715 1.206 . . . . 0.0 108.432 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.92 -10.19 27.55 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.278 1.985 . . . . 0.0 113.146 178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -129.29 5.3 5.24 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -157.01 154.84 30.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 70.5 m -140.88 139.89 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.608 0.763 . . . . 0.0 109.256 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 27.7 tp -131.62 121.02 23.64 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 29' ' ' PRO . 2.2 p90 -134.28 150.32 50.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.969 0.907 . . . . 0.0 108.943 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 46' ' ' LYS . 19.2 t -126.46 133.9 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -174.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.476 ' HB2' ' HG3' ' A' ' 45' ' ' MET . 10.0 mp -97.73 144.72 27.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -173.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.25 -10.67 33.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.134 0.974 . . . . 0.0 112.673 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.04 -22.35 66.43 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.256 1.022 . . . . 0.0 112.127 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.41 17.17 16.04 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 4.4 ppp? -116.23 171.88 7.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.851 0.86 . . . . 0.0 109.022 176.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HG3' HG22 ' A' ' 40' ' ' VAL . 85.1 tttt -142.84 143.11 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.474 HD21 HD23 ' A' ' 9' ' ' LEU . 2.0 tt -142.3 122.19 13.59 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 120.99 0.424 . . . . 0.0 110.397 -169.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.26 151.97 17.56 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 76.5 mt -116.83 109.61 17.31 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 162.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.454 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.4 t90 -103.83 124.28 48.64 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 48.8 m -72.51 115.88 12.3 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -64.77 -8.57 15.46 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.73 1.212 . . . . 0.0 113.873 -169.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -9.89 59.7 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 0.0 111.574 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -135.23 3.01 3.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.837 0.455 . . . . 0.0 111.398 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 13.8 p -64.78 140.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.827 0.451 . . . . 0.0 110.948 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.38 106.76 21.33 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.753 0.821 . . . . 0.0 108.986 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' B' ' 94' ' ' GLN . 3.0 Cg_endo -77.25 142.32 71.55 Favored 'Cis proline' 0 C--N 1.383 2.361 0 CA-C-N 120.156 1.091 . . . . 0.0 113.182 10.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HA ' HG13 ' A' ' 55' ' ' VAL . 2.8 tppp? -59.46 109.63 0.93 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.03 0.932 . . . . 0.0 111.897 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.67 107.58 10.71 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.817 1.247 . . . . 0.0 107.953 174.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 m -100.0 87.84 3.6 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -159.28 143.23 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.335 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 112' ' ' SER . 6.3 p -148.95 -176.43 5.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.431 1.092 . . . . 0.0 109.739 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.57 -71.37 2.47 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.79 32.71 7.27 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.37 59.76 4.94 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 146.14 7.2 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.314 0.483 . . . . 0.0 112.245 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 19.8 mt-10 -103.82 140.87 37.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.08 100.64 7.47 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.698 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -89.36 114.65 26.1 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.141 0.496 . . . . 0.0 111.777 -168.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -90.42 115.02 27.27 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.564 1.545 . . . . 0.0 107.585 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.657 ' HG2' ' HE1' ' A' ' 118' ' ' TYR . 31.3 mtm105 -91.34 128.37 37.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.13 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.17 159.15 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.018 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 14.4 pt-20 -65.52 -37.23 86.18 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -173.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -162.83 -177.76 5.71 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 118.407 0.549 . . . . 0.0 112.225 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -59.09 -34.1 71.6 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.75 1.22 . . . . 0.0 112.469 -166.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -67.26 -41.37 85.69 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.603 -175.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.621 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 76.3 mm-40 -66.69 -23.06 66.08 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.079 0.952 . . . . 0.0 112.424 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.33 -40.43 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.932 0.493 . . . . 0.0 109.882 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -74.73 -31.37 61.81 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 123.974 0.91 . . . . 0.0 110.978 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.2 mt-10 -66.33 -47.43 73.55 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 m -62.99 -36.5 83.75 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.484 176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -56.31 -61.39 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.211 1.004 . . . . 0.0 110.361 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.67 -34.33 77.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.491 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.91 -40.8 93.6 Favored Glycine 0 C--N 1.342 0.902 0 O-C-N 123.535 0.522 . . . . 0.0 113.373 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -66.65 -39.97 88.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.418 0.687 . . . . 0.0 109.965 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -60.39 -42.54 96.11 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.648 0.779 . . . . 0.0 110.362 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.31 65.14 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.738 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.0 t -95.84 7.2 46.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.315 1.046 . . . . 0.0 112.759 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.53 51.36 6.05 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.927 -0.579 . . . . 0.0 114.306 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.64 137.71 29.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.461 0.704 . . . . 0.0 109.169 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.05 97.98 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.805 0.842 . . . . 0.0 112.207 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.63 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 12.0 ptm 49.27 82.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.085 1.754 . . . . 0.0 115.409 164.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.465 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -114.65 86.12 2.38 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.095 0.558 . . . . 0.0 110.446 178.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 178.38 116.57 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.619 1.568 . . . . 0.0 107.551 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.83 124.36 89.25 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.52 97.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.965 2.444 . . . . 0.0 111.334 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.64 147.42 36.77 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.014 0.926 . . . . 0.0 110.187 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.65 98.5 2.37 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.0 ttt -90.79 166.38 13.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.802 0.841 . . . . 0.0 109.233 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.34 -41.15 79.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.984 0.914 . . . . 0.0 111.972 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -81.34 -15.35 55.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.142 0.577 . . . . 0.0 111.693 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.55 179.4 22.66 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.182 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -78.05 105.72 9.44 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 118' ' ' TYR . 12.6 t -122.01 155.51 35.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.472 0.654 . . . . 0.0 111.455 -171.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -141.21 150.31 42.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.006 1.722 . . . . 0.0 108.304 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.7 m -136.09 133.66 37.56 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.996 0.816 . . . . 0.0 111.349 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -105.71 171.22 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.953 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.42 126.63 29.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.936 170.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.83 172.52 1.37 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.741 1.216 . . . . 0.0 111.798 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -56.18 -35.68 95.64 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.169 1.913 . . . . 0.0 111.446 161.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.86 -18.59 43.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.592 1.157 . . . . 0.0 110.898 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.495 ' O ' ' HB ' ' A' ' 62' ' ' THR . 22.2 m 68.13 101.69 0.05 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 126.262 1.825 . . . . 0.0 111.793 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.462 ' CE1' HG12 ' A' ' 11' ' ' VAL . 17.3 m80 -127.35 175.72 7.98 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -96.22 95.04 7.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 92.5 mt -95.6 104.4 16.31 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.698 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 9.9 mmm180 -86.15 143.52 27.97 Favored 'General case' 0 C--O 1.214 -0.816 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.0 t -136.43 111.25 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 166.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.657 ' HE1' ' HG2' ' A' ' 71' ' ' ARG . 3.6 p90 -120.84 167.18 12.79 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.264 0.483 . . . . 0.0 110.819 -172.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.25 110.9 8.07 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.402 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 52.0 t80 -76.65 116.9 17.74 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.135 0.425 . . . . 0.0 110.198 -168.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.25 95.51 8.16 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.889 -0.951 . . . . 0.0 110.875 179.055 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.641 0.257 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -81.8 134.23 35.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.37 0.668 . . . . 0.0 109.525 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -97.28 111.72 58.98 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 123.858 0.863 . . . . 0.0 110.426 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -88.55 94.83 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.619 2.212 . . . . 0.0 112.144 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.691 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.3 p-10 -96.29 16.48 18.25 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.343 0.592 . . . . 0.0 111.023 171.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.72 131.33 46.28 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.038 1.335 . . . . 0.0 107.587 -173.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 t -132.63 143.07 49.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.328 1.051 . . . . 0.0 108.964 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 16.7 mt -124.23 139.23 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.61 0.764 . . . . 0.0 109.971 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.87 143.09 44.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.047 0.939 . . . . 0.0 108.685 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -80.79 106.48 12.84 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.447 1.099 . . . . 0.0 111.181 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' B' ' 51' ' ' SER . 15.3 m -107.35 149.66 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -97.45 -52.31 3.84 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.202 -170.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -101.54 100.02 12.98 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.267 1.027 . . . . 0.0 109.685 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.45 -53.05 7.56 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.413 2.742 . . . . 0.0 115.766 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' B' ' 19' ' ' GLN . 22.6 Cg_endo -56.9 -50.92 10.11 Favored 'Trans proline' 0 C--N 1.399 3.234 0 CA-C-N 122.084 1.78 . . . . 0.0 112.077 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.09 -38.41 52.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.088 -165.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.4 t -78.94 -28.22 43.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.222 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 83.9 m -66.84 -47.25 72.54 Favored 'General case' 0 C--N 1.348 0.532 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.555 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 22.0 mt-30 -65.1 -33.29 75.69 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.249 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 81.0 t80 -62.45 -48.71 78.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.531 0.732 . . . . 0.0 110.136 -177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.426 ' O ' ' HG ' ' B' ' 25' ' ' LEU . 41.6 m-85 -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.564 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 59.0 mtpt -55.99 -45.59 78.96 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.87 0.759 . . . . 0.0 111.985 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -42.52 33.59 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.46 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 14.3 tp -58.2 -46.23 86.18 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.809 1.244 . . . . 0.0 112.247 -172.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' B' ' 21' ' ' TYR . 10.8 mt -86.24 -47.74 9.16 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.79 32.93 4.89 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.597 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -120.92 171.74 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.164 0.986 . . . . 0.0 110.373 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -124.36 148.17 57.34 Favored Pre-proline 0 N--CA 1.481 1.095 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' B' ' 39' ' ' PHE . 61.1 Cg_endo -72.7 120.96 7.0 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 121.876 1.718 . . . . 0.0 112.13 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.69 -44.36 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.564 0.746 . . . . 0.0 110.625 176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 58.8 mm-40 -120.4 108.32 13.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.27 1.028 . . . . 0.0 108.292 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 p -112.33 145.01 40.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.22 0.608 . . . . 0.0 110.347 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t -143.02 153.67 60.74 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.141 1.376 . . . . 0.0 108.241 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.56 -10.58 26.89 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.319 2.013 . . . . 0.0 113.491 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 7.0 t -129.19 5.69 5.31 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.82 154.97 30.74 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' B' ' 49' ' ' LEU . 35.5 t -140.75 140.16 34.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.512 HD11 ' HE2' ' B' ' 46' ' ' LYS . 40.6 tp -132.15 120.48 22.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.439 ' HB3' ' HA ' ' B' ' 29' ' ' PRO . 2.4 p90 -134.01 150.42 51.24 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.012 0.925 . . . . 0.0 108.885 170.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' B' ' 46' ' ' LYS . 17.5 t -126.84 134.13 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.514 ' HB2' ' HG3' ' B' ' 45' ' ' MET . 9.9 mp -97.53 144.36 27.31 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.24 -10.2 30.04 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.152 0.981 . . . . 0.0 112.554 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -66.45 -22.2 66.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.406 1.082 . . . . 0.0 112.054 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.36 15.88 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.653 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 4.3 ppp? -116.75 172.25 7.36 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.575 ' HG3' HG22 ' B' ' 40' ' ' VAL . 86.4 tttt -142.91 143.18 31.93 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.4 tt -142.28 122.46 13.83 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.945 0.402 . . . . 0.0 110.511 -169.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.21 152.13 17.6 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 174.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' B' ' 37' ' ' SER . 76.6 mt -117.04 109.63 17.21 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 162.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.423 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.7 t90 -103.82 124.39 48.83 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 49.8 m -72.55 116.42 12.99 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -65.55 -8.27 18.91 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.607 1.163 . . . . 0.0 113.789 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -79.34 -10.34 59.79 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.231 0.612 . . . . 0.0 111.548 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -134.78 2.43 3.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.88 0.472 . . . . 0.0 111.293 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 12.2 p -64.68 141.29 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.631 0.373 . . . . 0.0 110.851 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.07 107.66 19.9 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 123.909 0.884 . . . . 0.0 109.058 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.47 142.4 73.01 Favored 'Cis proline' 0 C--N 1.387 2.603 0 CA-C-N 119.906 1.002 . . . . 0.0 113.466 8.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.423 ' HA ' HG13 ' B' ' 55' ' ' VAL . 2.7 tppp? -58.91 110.17 0.97 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.058 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.82 107.34 10.41 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.823 1.249 . . . . 0.0 108.102 173.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 19.3 m -99.57 87.8 3.68 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.64 142.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.182 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' B' ' 112' ' ' SER . 6.2 p -147.65 -176.24 5.17 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.544 1.138 . . . . 0.0 110.149 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.4 -71.66 2.46 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.12 32.58 7.37 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.44 59.74 4.94 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 145.94 7.08 Favored Glycine 0 C--N 1.353 1.515 0 C-N-CA 123.288 0.471 . . . . 0.0 112.197 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 18.4 mt-10 -103.62 141.1 36.63 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.86 100.33 7.32 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' B' ' 116' ' ' ARG . . . -89.08 114.76 26.04 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 0.0 111.925 -169.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -90.62 114.52 26.8 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 125.525 1.53 . . . . 0.0 107.453 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.593 ' HG2' ' HE1' ' B' ' 118' ' ' TYR . 36.4 mtm105 -90.65 127.08 36.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.934 -175.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.22 159.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.159 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 9.1 pt-20 -65.51 -37.36 86.55 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -163.06 -177.37 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 118.5 0.591 . . . . 0.0 112.205 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -59.52 -33.68 71.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.739 1.216 . . . . 0.0 112.397 -166.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.59 -41.09 84.66 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.806 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.552 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 76.6 mm-40 -67.05 -22.58 65.86 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.572 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.83 -40.71 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.852 172.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.22 -31.27 62.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.05 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -66.42 -47.51 73.02 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.113 0.483 . . . . 0.0 109.765 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -35.74 81.39 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.487 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -56.86 -61.35 2.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.696 0.798 . . . . 0.0 110.304 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.473 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -65.41 -34.0 77.28 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.653 -171.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -67.01 -41.06 93.34 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.553 0.533 . . . . 0.0 113.326 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -66.28 -40.12 89.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.498 0.719 . . . . 0.0 109.905 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 32.6 ttpt -60.12 -42.58 95.05 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.636 0.774 . . . . 0.0 110.46 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.35 64.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.746 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 30.2 t -96.1 7.73 45.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.241 1.016 . . . . 0.0 112.762 -175.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 52.12 5.98 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.806 -0.634 . . . . 0.0 114.268 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.07 137.39 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.735 0.814 . . . . 0.0 109.201 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.78 97.99 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.904 0.882 . . . . 0.0 112.38 -174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 12.0 ptm 49.22 82.57 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 164.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.508 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -114.68 86.26 2.4 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.285 0.634 . . . . 0.0 110.405 178.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.565 ' HB2' ' HG3' ' A' ' 57' ' ' PRO . 52.0 tp60 177.78 116.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.768 1.627 . . . . 0.0 107.638 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -66.64 125.09 90.03 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.06 97.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.936 2.424 . . . . 0.0 110.943 172.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -112.65 146.93 37.79 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.02 0.928 . . . . 0.0 110.337 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.14 98.39 2.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 171.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . . . . . . . . . 8.3 ttt -91.06 166.79 12.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.634 0.774 . . . . 0.0 109.104 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -57.0 -41.16 77.98 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.688 0.795 . . . . 0.0 112.079 -176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -81.54 -15.54 54.52 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.205 0.602 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 146.62 179.42 22.74 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.485 -0.325 . . . . 0.0 113.032 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -77.74 105.96 9.25 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -174.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 118' ' ' TYR . 11.1 t -122.37 155.53 35.84 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.554 0.692 . . . . 0.0 111.395 -170.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -141.35 150.26 42.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.889 1.676 . . . . 0.0 108.318 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 25.5 m -136.05 133.6 37.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.992 0.815 . . . . 0.0 111.352 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.634 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -105.76 171.15 7.49 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.931 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -134.19 129.34 35.62 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.4 174.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.692 1.197 . . . . 0.0 110.8 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.11 -34.92 99.02 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.05 1.834 . . . . 0.0 110.828 162.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -82.36 -18.27 42.68 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.718 1.207 . . . . 0.0 110.818 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . 0.494 ' O ' ' HB ' ' B' ' 62' ' ' THR . 40.3 m 67.79 101.85 0.05 Allowed 'General case' 0 C--N 1.35 0.604 0 C-N-CA 126.15 1.78 . . . . 0.0 111.656 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.45 ' CE1' HG12 ' B' ' 11' ' ' VAL . 19.5 m80 -127.48 175.47 8.21 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 165.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.549 ' HA ' ' HE ' ' B' ' 114' ' ' ARG . 0.6 OUTLIER -96.09 95.4 8.14 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' B' ' 107' ' ' ALA . 93.9 mt -95.64 104.83 16.76 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.66 ' HB2' ' HA ' ' B' ' 69' ' ' ALA . 34.3 mmt180 -84.47 143.57 29.29 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 25.2 t -137.42 111.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 165.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.593 ' HE1' ' HG2' ' B' ' 71' ' ' ARG . 5.5 p90 -120.65 167.46 12.42 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.023 0.374 . . . . 0.0 110.896 -172.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.73 111.44 8.19 Favored 'General case' 0 C--O 1.212 -0.878 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 167.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -77.65 123.47 26.69 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.196 0.453 . . . . 0.0 110.493 -168.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.39 94.59 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 118.891 -0.95 . . . . 0.0 110.923 -176.276 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.66 0.267 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.9 m -85.84 145.82 27.03 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.012 0.525 . . . . 0.0 110.056 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -102.35 107.67 54.28 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.692 0.797 . . . . 0.0 110.908 -173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.36 56.47 1.41 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.476 2.784 . . . . 0.0 111.836 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.573 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 7.0 p-10 -78.36 4.07 13.96 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.886 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.0 OUTLIER -124.23 125.11 43.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -176.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 10.1 t -120.0 137.23 54.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 49.2 mt -116.14 135.07 57.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.364 0.666 . . . . 0.0 109.361 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 156.3 18.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.314 1.054 . . . . 0.0 108.308 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' OH ' HG11 ' A' ' 55' ' ' VAL . 4.0 t80 -110.04 108.36 18.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.823 -173.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.48 HG12 ' NE2' ' A' ' 113' ' ' HIS . 9.9 m -125.12 159.84 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.367 0.603 . . . . 0.0 110.957 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -97.41 -62.7 1.21 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.396 1.078 . . . . 0.0 109.461 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -89.28 106.52 13.86 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.224 -175.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.49 -59.72 0.62 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 122.624 2.216 . . . . 0.0 113.959 -178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 29.8 Cg_endo -57.32 -50.65 10.44 Favored 'Trans proline' 0 C--N 1.406 3.591 0 CA-C-N 122.355 1.877 . . . . 0.0 111.61 -174.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.65 -43.07 90.57 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.262 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.8 t -78.69 -20.72 49.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.755 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 m -76.41 -45.49 31.36 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.679 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 57.7 mm-40 -68.61 -30.19 68.87 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.41 176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 36.4 t80 -60.85 -51.25 70.12 Favored 'General case' 0 C--N 1.35 0.62 0 O-C-N 124.115 0.885 . . . . 0.0 110.847 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -71.39 -27.76 63.55 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 118.858 -0.592 . . . . 0.0 110.784 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 56.5 mtpt -56.19 -50.83 70.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 118.392 0.542 . . . . 0.0 112.408 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.61 56.84 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.113 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 11.7 tp -60.91 -43.65 98.26 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.408 1.083 . . . . 0.0 112.15 -175.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 27' ' ' VAL . 22.5 mt -95.21 -35.29 11.9 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.971 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.7 37.13 6.2 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' LEU . 33.9 m -130.56 -177.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.489 1.116 . . . . 0.0 110.472 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -140.75 149.79 57.76 Favored Pre-proline 0 N--CA 1.48 1.048 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.03 108.96 2.06 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.806 2.337 . . . . 0.0 111.697 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.76 -31.51 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.586 0.754 . . . . 0.0 110.571 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.683 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 48.5 mt-10 -119.42 143.15 47.63 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.291 1.037 . . . . 0.0 108.213 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -159.54 153.72 23.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.817 0.818 . . . . 0.0 111.292 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -144.23 164.15 30.71 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 126.069 1.748 . . . . 0.0 107.473 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.58 -16.16 34.76 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.334 2.022 . . . . 0.0 113.484 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.8 t -127.92 13.05 6.79 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -154.38 159.94 41.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.0 m -153.37 153.91 33.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.489 1.116 . . . . 0.0 109.469 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.7 tm? -146.33 123.71 11.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -130.81 137.24 49.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.601 1.16 . . . . 0.0 108.307 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.536 HG22 ' HG3' ' A' ' 46' ' ' LYS . 21.7 t -112.09 123.0 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.633 HD12 ' SD ' ' A' ' 45' ' ' MET . 76.2 mt -89.34 148.73 23.36 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.96 0.504 . . . . 0.0 110.188 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.96 -7.01 19.12 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.22 1.008 . . . . 0.0 113.513 -174.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -82.03 4.41 22.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.677 0.791 . . . . 0.0 111.789 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.3 64.66 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.629 -0.189 . . . . 0.0 112.629 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.633 ' SD ' HD12 ' A' ' 41' ' ' LEU . 5.1 ppp? -117.61 171.54 7.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.631 0.772 . . . . 0.0 109.779 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 40' ' ' VAL . 83.0 tttt -135.35 139.43 44.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 68' ' ' LEU . 1.2 tt -137.34 123.99 21.04 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.174 0.512 . . . . 0.0 110.113 -172.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -101.94 169.97 20.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.828 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.9 tp -139.92 104.78 4.94 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -114.71 128.92 56.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.6 m -78.71 134.95 37.05 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.168 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -68.0 -19.96 64.97 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.755 0.822 . . . . 0.0 113.2 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -78.84 -8.41 58.78 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.4 t -129.77 7.72 5.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.858 0.463 . . . . 0.0 111.33 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG11 ' OH ' ' A' ' 10' ' ' TYR . 11.8 p -69.87 147.43 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' HB3' ' NE2' ' B' ' 94' ' ' GLN . 35.6 mt-10 -128.25 113.65 19.89 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 0.0 109.52 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.72 143.19 77.06 Favored 'Cis proline' 0 C--N 1.388 2.636 0 CA-C-N 119.723 0.937 . . . . 0.0 112.674 2.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -50.09 124.31 9.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.501 1.12 . . . . 0.0 112.063 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.41 155.68 43.86 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.172 0.989 . . . . 0.0 109.333 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.3 m -132.79 94.23 3.35 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.97 125.18 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.13 0.972 . . . . 0.0 108.855 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 p -140.09 142.62 36.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.761 0.824 . . . . 0.0 109.373 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.51 23.22 73.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.624 -176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.504 ' HA3' HG21 ' B' ' 61' ' ' VAL . . . -160.84 140.74 6.88 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 145.27 -156.23 26.85 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.59 172.0 54.81 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.525 0.191 . . . . 0.0 112.713 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 68.9 mt-10 -99.49 152.03 20.47 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -173.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 47' ' ' LEU . 45.8 tp -110.09 100.55 9.46 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 171.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -84.61 113.76 21.5 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.007 0.432 . . . . 0.0 111.571 -167.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -93.12 106.62 18.56 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.854 1.262 . . . . 0.0 107.921 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -90.62 131.37 36.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.122 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.04 165.08 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.49 176.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 9.1 pt-20 -69.38 -43.81 72.79 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.402 HD22 ' HG3' ' A' ' 73' ' ' GLU . 9.3 p30 -155.25 177.99 10.72 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.703 0.683 . . . . 0.0 112.626 -174.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -59.15 -32.96 70.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.158 1.383 . . . . 0.0 112.421 -167.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.34 -42.77 74.85 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.634 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 78.9 mm-40 -64.58 -24.16 67.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.644 0.778 . . . . 0.0 112.727 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.24 -40.08 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.349 0.595 . . . . 0.0 110.003 172.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.1 -30.22 62.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.195 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 30.0 mt-10 -67.77 -42.99 80.84 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 109.141 175.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.7 m -65.01 -37.93 89.26 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.357 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.94 -60.92 2.98 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.921 0.888 . . . . 0.0 109.628 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -60.83 -39.17 88.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.733 -172.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.6 -39.35 86.64 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.415 0.447 . . . . 0.0 113.828 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -67.89 -42.48 81.12 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.374 0.669 . . . . 0.0 109.64 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.7 ttpt -57.63 -43.88 85.16 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.791 0.836 . . . . 0.0 110.387 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.9 -30.56 71.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.692 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.5 m -102.24 14.8 30.98 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.099 0.959 . . . . 0.0 112.094 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 46.36 5.68 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 115.314 0.886 . . . . 0.0 115.314 163.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.8 t -101.72 132.23 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.144 0.578 . . . . 0.0 109.745 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.51 95.13 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.918 0.887 . . . . 0.0 111.708 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 4.8 ptm 50.3 81.68 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.567 1.547 . . . . 0.0 113.771 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -106.52 83.67 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.61 -0.681 . . . . 0.0 109.962 -178.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' NE2' ' HB3' ' B' ' 56' ' ' GLU . 5.7 tp60 177.39 134.68 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.52 1.528 . . . . 0.0 108.028 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -79.31 120.67 81.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 15.6 Cg_endo -58.71 106.3 0.27 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.642 2.228 . . . . 0.0 110.378 172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.85 152.36 46.41 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.309 0.644 . . . . 0.0 110.21 -175.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -62.42 137.79 58.33 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.543 0.737 . . . . 0.0 110.466 173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.412 ' HG2' ' H ' ' A' ' 100' ' ' GLU . 20.1 ttt -142.82 175.76 9.58 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 109.392 -175.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' H ' ' HG2' ' A' ' 99' ' ' MET . 11.5 tp10 -51.35 -32.37 25.44 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.453 1.501 . . . . 0.0 112.921 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.42 -5.22 23.12 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.663 0.785 . . . . 0.0 111.384 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 127.91 -167.51 20.18 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.078 176.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -76.7 101.59 5.85 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.409 HG21 ' SD ' ' A' ' 99' ' ' MET . 9.4 t -115.63 149.1 38.84 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.376 -167.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 96' ' ' PRO . 3.2 t80 -146.51 129.41 16.33 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 113.908 -1.496 . . . . 0.0 108.573 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.7 m -120.66 119.22 32.21 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -107.26 159.04 16.65 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.373 -175.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 93' ' ' LEU . . . -141.1 127.49 19.89 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 170.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -85.64 178.89 2.09 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.134 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.97 -32.83 94.08 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.743 2.295 . . . . 0.0 113.644 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -76.83 -4.92 46.13 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.758 0.423 . . . . 0.0 111.18 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.0 m 72.45 60.02 0.13 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.118 1.367 . . . . 0.0 110.995 171.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.48 ' NE2' HG12 ' A' ' 11' ' ' VAL . 19.7 m170 -97.67 -167.09 1.47 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.17 174.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.43 93.87 1.94 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.7 mt -116.79 101.95 8.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.557 -1.202 . . . . 0.0 108.833 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 2.3 tmm_? -102.8 99.26 9.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.004 0.521 . . . . 0.0 111.29 -169.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.03 140.6 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.5 0.72 . . . . 0.0 109.226 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.499 ' HB3' ' NH1' ' A' ' 116' ' ' ARG . 16.7 p90 -143.66 161.69 37.88 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 118.659 0.663 . . . . 0.0 112.607 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.405 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -110.67 129.87 55.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 168.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.71 124.52 23.52 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.274 0.359 . . . . 0.0 110.367 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.75 94.4 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.772 0.67 . . . . 0.0 110.48 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.801 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -177.391 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m -77.4 145.91 36.92 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 110.233 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -102.73 107.42 54.35 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -89.8 56.01 1.66 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.499 2.799 . . . . 0.0 111.95 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 5.9 p-10 -77.59 3.91 12.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.685 0.794 . . . . 0.0 112.146 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -123.85 124.85 43.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' B' ' 47' ' ' LEU . 10.1 t -120.32 137.53 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 37.0 mt -117.3 134.76 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.374 0.67 . . . . 0.0 109.468 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.599 HD11 HD22 ' B' ' 68' ' ' LEU . 65.9 mt -90.56 155.69 18.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.334 1.064 . . . . 0.0 108.973 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -107.03 107.83 19.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 112.93 -1.941 . . . . 0.0 108.184 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.98 160.05 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.377 0.608 . . . . 0.0 110.838 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.81 -62.12 1.29 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.41 1.084 . . . . 0.0 109.713 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -90.78 105.92 13.72 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.391 0.676 . . . . 0.0 109.495 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -56.4 -60.97 0.38 Allowed 'Trans proline' 0 CA--C 1.573 2.443 0 C-N-CA 122.435 2.09 . . . . 0.0 113.878 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.7 -51.99 9.12 Favored 'Trans proline' 0 C--N 1.41 3.789 0 CA-C-N 122.47 1.918 . . . . 0.0 112.405 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.13 92.94 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.624 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 48.4 t -78.45 -20.61 50.62 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.736 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.1 m -76.88 -45.33 28.59 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.45 0.643 . . . . 0.0 111.652 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.487 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.2 mm-40 -67.92 -30.78 70.19 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 113.958 -1.474 . . . . 0.0 109.464 175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 74.9 t80 -60.4 -50.91 71.7 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.786 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -72.19 -27.43 62.55 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.201 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 56.4 mtpt -56.27 -50.94 69.93 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.53 -36.06 57.91 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.051 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' B' ' 20' ' ' PHE . 8.8 tp -60.94 -43.25 98.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.074 0.95 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' B' ' 27' ' ' VAL . 27.0 mt -95.35 -35.49 11.75 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.07 36.85 6.17 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' B' ' 25' ' ' LEU . 34.2 m -130.38 -177.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.562 1.145 . . . . 0.0 110.256 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -140.75 149.21 55.85 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.66 0.784 . . . . 0.0 109.489 174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.91 108.51 1.71 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.48 2.12 . . . . 0.0 112.019 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.18 -31.97 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.608 0.763 . . . . 0.0 110.516 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.668 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 45.4 mt-10 -119.31 143.42 47.38 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 167.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 21.5 t -159.54 153.63 23.45 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.651 0.739 . . . . 0.0 111.111 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 35.6 m -143.96 165.11 25.86 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 126.109 1.764 . . . . 0.0 107.357 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -61.12 -15.58 40.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.045 1.83 . . . . 0.0 113.103 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.3 t -128.11 13.02 6.7 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -154.3 159.55 41.3 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 122.013 -0.429 . . . . 0.0 110.78 -176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' B' ' 49' ' ' LEU . 60.6 m -153.3 154.01 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.555 1.142 . . . . 0.0 109.529 171.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.668 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.7 tm? -146.37 123.45 11.45 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -130.09 138.44 50.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.286 1.035 . . . . 0.0 108.654 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.526 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.3 t -112.51 123.41 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.698 HD12 ' SD ' ' B' ' 45' ' ' MET . 80.5 mt -89.98 148.6 22.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.837 0.455 . . . . 0.0 110.282 -168.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.68 -7.56 21.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.119 0.968 . . . . 0.0 113.578 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -81.57 4.63 20.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.745 0.818 . . . . 0.0 112.251 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.06 11.86 64.4 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 112.593 -0.203 . . . . 0.0 112.593 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.698 ' SD ' HD12 ' B' ' 41' ' ' LEU . 5.0 ppp? -117.56 171.62 7.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.501 0.72 . . . . 0.0 109.597 -177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.526 ' HG3' HG22 ' B' ' 40' ' ' VAL . 84.3 tttt -135.73 140.05 44.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' B' ' 7' ' ' THR . 1.2 tt -138.18 123.76 19.68 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.184 0.516 . . . . 0.0 110.269 -172.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.88 168.98 19.67 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 123.844 0.735 . . . . 0.0 112.724 -178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' B' ' 37' ' ' SER . 39.1 mt -137.81 105.2 5.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 169.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.474 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.5 t90 -114.32 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 50.9 m -78.72 134.61 37.07 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.423 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -68.02 -19.26 64.89 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 0.0 112.965 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -79.42 -9.15 59.54 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.5 0.32 . . . . 0.0 111.295 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 8.5 t -128.92 7.48 5.58 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.024 0.529 . . . . 0.0 111.318 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.474 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 11.8 p -69.66 147.15 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.469 ' HB3' ' NE2' ' A' ' 94' ' ' GLN . 26.3 mt-10 -128.7 113.91 19.2 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.319 0.648 . . . . 0.0 110.056 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 94' ' ' GLN . 97.7 Cg_endo -73.0 143.57 78.26 Favored 'Cis proline' 0 C--N 1.387 2.583 0 CA-C-N 119.472 0.847 . . . . 0.0 113.226 2.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.62 126.14 18.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.097 0.959 . . . . 0.0 110.527 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.96 155.96 44.24 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.454 1.102 . . . . 0.0 109.715 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.4 m -132.7 92.55 3.07 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.617 0.767 . . . . 0.0 109.013 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.504 HG21 ' HA3' ' A' ' 64' ' ' GLY . 79.2 t -141.69 125.42 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.312 1.045 . . . . 0.0 108.568 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 7.7 p -140.07 141.71 36.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.83 0.852 . . . . 0.0 109.215 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.9 24.5 69.3 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.477 0.485 . . . . 0.0 112.395 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.85 139.26 5.87 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.044 -0.422 . . . . 0.0 112.044 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.86 -155.35 26.5 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 10' ' ' TYR . . . -77.43 172.64 55.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.569 ' HA ' ' HG3' ' B' ' 114' ' ' ARG . 6.0 mm-40 -99.68 151.24 21.44 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.599 HD22 HD11 ' B' ' 9' ' ' LEU . 50.1 tp -109.78 101.1 10.0 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -84.9 113.99 21.79 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.125 0.42 . . . . 0.0 111.604 -167.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -93.53 106.51 18.47 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 37.1 mtm180 -90.67 131.05 36.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.145 0.497 . . . . 0.0 111.893 -175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.65 165.5 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.4 1.08 . . . . 0.0 110.541 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.527 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.0 pt-20 -69.2 -44.1 72.79 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.518 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.434 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.9 p30 -155.23 178.15 10.54 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.762 0.71 . . . . 0.0 112.7 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -58.27 -33.49 69.47 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.753 1.621 . . . . 0.0 112.608 -167.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.49 -42.26 75.01 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.708 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.527 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 79.3 mm-40 -65.39 -24.03 67.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.697 0.799 . . . . 0.0 112.458 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.35 -40.52 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.353 0.597 . . . . 0.0 110.009 172.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -73.28 -30.43 63.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.303 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 18.5 mt-10 -67.96 -43.0 80.04 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.702 0.763 . . . . 0.0 109.213 175.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.3 m -64.96 -37.58 88.13 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.193 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -58.49 -60.92 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.767 0.827 . . . . 0.0 109.531 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.446 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -60.66 -38.56 85.28 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.902 -172.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.69 -39.72 86.03 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.43 0.456 . . . . 0.0 113.878 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -67.85 -42.06 81.96 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.394 0.678 . . . . 0.0 109.679 175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.45 ' HB2' ' HE1' ' B' ' 92' ' ' MET . 31.9 ttpt -58.89 -43.33 90.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 0.0 110.229 177.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.77 -30.24 70.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.664 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 40.6 m -102.55 14.93 30.68 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.926 0.891 . . . . 0.0 112.256 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.82 47.1 5.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.219 -0.9 . . . . 0.0 114.957 163.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 95.0 t -102.59 131.69 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.213 0.605 . . . . 0.0 109.499 173.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.89 92.33 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.86 0.864 . . . . 0.0 112.114 -175.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.45 ' HE1' ' HB2' ' B' ' 86' ' ' LYS . 13.5 ptp 48.94 82.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.655 1.582 . . . . 0.0 114.128 172.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.418 HD22 ' H ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -106.67 83.48 1.86 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.453 0.644 . . . . 0.0 109.941 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.489 ' NE2' ' HB3' ' A' ' 56' ' ' GLU . 5.7 tp60 177.45 133.78 0.06 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.599 1.559 . . . . 0.0 108.14 174.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -78.07 121.38 83.91 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' B' ' 105' ' ' PHE . 20.0 Cg_endo -60.12 106.34 0.33 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.654 2.236 . . . . 0.0 110.117 172.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.78 152.25 46.42 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.263 0.625 . . . . 0.0 110.158 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -62.89 138.48 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.328 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.482 ' SD ' HG21 ' B' ' 104' ' ' THR . 11.4 ttt -143.26 175.22 10.06 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.73 0.812 . . . . 0.0 109.007 -174.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.48 ' H ' ' HG2' ' B' ' 99' ' ' MET . 11.3 tp10 -51.98 -32.57 34.17 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.113 1.365 . . . . 0.0 112.964 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -102.07 -6.37 23.42 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.614 0.765 . . . . 0.0 111.281 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 128.84 -168.2 20.69 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.528 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -76.02 101.23 5.18 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.482 HG21 ' SD ' ' B' ' 99' ' ' MET . 14.4 t -115.1 149.06 38.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.501 0.667 . . . . 0.0 111.328 -167.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' B' ' 96' ' ' PRO . 2.6 t80 -146.48 129.37 16.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.465 1.506 . . . . 0.0 108.537 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 26.4 m -120.72 119.54 33.09 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.114 0.483 . . . . 0.0 109.812 -174.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -107.35 158.71 16.94 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.875 0.87 . . . . 0.0 112.464 -174.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.65 129.72 23.44 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 3.2 p-10 -88.33 179.94 1.51 Allowed Pre-proline 0 CA--C 1.575 1.905 0 CA-C-O 118.343 -0.836 . . . . 0.0 109.346 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 25.4 Cg_endo -58.72 -32.22 96.53 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.499 2.132 . . . . 0.0 113.239 176.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.66 -5.3 47.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.787 0.435 . . . . 0.0 110.908 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m 72.7 60.4 0.12 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.137 1.375 . . . . 0.0 110.66 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -97.9 -168.23 1.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.377 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' B' ' 67' ' ' GLU . 4.2 tpp180 -149.13 94.94 2.31 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -175.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 58.1 mt -117.01 101.78 8.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.017 -171.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 3.4 tmt_? -100.28 98.12 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.167 0.587 . . . . 0.0 112.079 -169.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -83.29 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -143.48 161.42 38.49 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.714 0.688 . . . . 0.0 112.375 167.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -110.75 130.59 55.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 168.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -68.91 123.38 20.83 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.161 0.288 . . . . 0.0 110.664 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.86 106.64 17.21 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.886 0 CA-C-O 118.973 -0.904 . . . . 0.0 111.064 -179.052 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.338 0.113 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m -80.36 144.92 32.34 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.414 ' HB3' HD23 ' B' ' 41' ' ' LEU . 7.2 m-70 -115.17 128.26 26.09 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 123.503 0.721 . . . . 0.0 109.854 -176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -91.02 101.26 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 123.139 2.559 . . . . 0.0 112.737 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.77 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 4.2 p30 -85.03 -2.23 57.73 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.218 0.532 . . . . 0.0 111.06 169.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -118.46 112.27 19.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -168.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -109.76 131.71 54.82 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 43.3 mt -114.52 132.42 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.411 ' HB2' HD12 ' A' ' 49' ' ' LEU . 90.2 mt -96.92 173.23 7.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.091 0.948 . . . . 0.0 108.941 173.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -130.38 120.29 24.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.442 -174.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG12 ' NE2' ' A' ' 113' ' ' HIS . 10.3 m -125.89 155.84 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.861 0.864 . . . . 0.0 109.679 -174.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -87.84 -56.83 3.17 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -94.93 110.36 49.34 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-O 118.889 -0.576 . . . . 0.0 110.163 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 31.8 Cg_exo -54.94 -57.25 1.8 Allowed 'Trans proline' 0 CA--C 1.573 2.455 0 C-N-CA 122.749 2.3 . . . . 0.0 114.232 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 34.9 Cg_exo -58.32 -58.63 0.7 Allowed 'Trans proline' 0 C--N 1.401 3.319 0 CA-C-N 122.181 1.815 . . . . 0.0 112.146 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.71 95.22 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.753 0.821 . . . . 0.0 112.36 -167.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -76.42 -33.84 58.79 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 88.9 m -73.1 -39.77 65.52 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -59.75 -36.87 77.5 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.89 172.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.27 -44.51 94.91 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.231 0.957 . . . . 0.0 110.233 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -70.91 -29.16 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.02 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 18' ' ' THR . 60.1 mtpt -56.63 -47.7 79.13 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.805 0.729 . . . . 0.0 112.943 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.13 -36.87 47.28 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.758 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.7 tp -63.7 -40.59 97.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.516 1.126 . . . . 0.0 112.332 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' VAL . 32.2 mt -93.46 -38.55 11.37 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.18 24.85 18.22 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.537 0.523 . . . . 0.0 111.809 -173.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.3 m -118.58 174.91 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.024 0.93 . . . . 0.0 110.449 -176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -131.9 143.97 51.28 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 123.584 0.754 . . . . 0.0 108.968 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.71 112.4 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.634 2.223 . . . . 0.0 111.402 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.74 -36.51 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.447 0.699 . . . . 0.0 109.769 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 12.8 mm-40 -112.02 87.03 2.47 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.5 p -90.19 127.62 36.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.43 0.692 . . . . 0.0 109.214 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -140.61 152.81 67.14 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.985 0.914 . . . . 0.0 108.538 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -46.35 -44.68 20.04 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.871 3.048 . . . . 0.0 114.646 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.0 t -126.92 15.94 7.39 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -145.6 151.3 37.87 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -140.58 142.72 35.07 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 2.3 tt -139.53 121.08 15.17 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -133.05 131.72 40.96 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.554 1.141 . . . . 0.0 108.637 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 46' ' ' LYS . 16.2 t -109.49 129.62 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.039 -173.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.494 HD12 ' SD ' ' A' ' 45' ' ' MET . 49.4 mt -94.27 143.0 26.76 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.786 0.434 . . . . 0.0 110.445 -171.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.11 -5.76 19.43 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.376 1.07 . . . . 0.0 112.299 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.501 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.7 OUTLIER -67.34 -19.51 65.45 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.769 1.228 . . . . 0.0 111.627 177.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.44 16.62 15.56 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.961 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.728 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.4 ppp? -125.66 176.26 7.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.518 0.727 . . . . 0.0 109.54 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 40' ' ' VAL . 76.6 tttt -140.32 137.53 34.21 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 tt -133.02 118.55 18.94 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.772 0.429 . . . . 0.0 110.084 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.31 163.22 21.88 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.521 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 9' ' ' LEU . 1.1 tp -141.43 104.85 4.66 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 171.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 5.7 t90 -111.09 134.83 52.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.902 0.881 . . . . 0.0 108.678 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 54' ' ' THR . 35.9 m -75.83 136.39 40.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.751 0.31 . . . . 0.0 111.249 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -72.5 -9.86 59.08 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.993 0.917 . . . . 0.0 112.455 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -86.89 -8.8 56.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.202 0.601 . . . . 0.0 111.181 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 51' ' ' SER . 15.4 t -135.04 8.24 3.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.177 0.591 . . . . 0.0 111.339 -176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 58' ' ' LYS . 13.2 p -68.28 143.45 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 122.58 0.352 . . . . 0.0 111.372 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.39 117.23 25.11 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.556 1.142 . . . . 0.0 108.706 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 12.4 Cg_exo -70.88 144.13 78.07 Favored 'Cis proline' 0 C--N 1.386 2.531 0 CA-C-N 119.681 0.922 . . . . 0.0 112.992 -1.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -61.17 128.76 37.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.149 0.98 . . . . 0.0 111.958 -177.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.45 109.03 3.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.764 1.226 . . . . 0.0 108.531 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.2 p -87.83 89.15 7.88 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.3 142.84 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.523 0.729 . . . . 0.0 109.847 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.5 p -138.96 135.55 34.47 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.226 1.01 . . . . 0.0 109.22 173.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.38 51.75 49.67 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.61 0.569 . . . . 0.0 114.227 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.18 44.99 0.42 Allowed Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.87 -169.51 11.69 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.781 -0.209 . . . . 0.0 113.125 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.97 170.12 47.67 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 124.38 0.694 . . . . 0.0 113.009 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -98.53 160.04 14.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.918 0.887 . . . . 0.0 110.561 -171.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 68' ' ' LEU . 20.4 mt -107.09 101.23 10.66 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 160.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.54 103.53 14.48 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -82.46 106.17 14.11 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -84.72 128.89 34.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.816 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.74 157.92 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.811 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' HG3' HD22 ' A' ' 74' ' ' ASN . 10.9 pt-20 -68.17 -42.06 80.58 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.93 -172.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.45 HD22 ' HG3' ' A' ' 73' ' ' GLU . 9.5 p30 -151.05 174.38 13.24 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-O 121.49 0.662 . . . . 0.0 112.059 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.51 -27.64 69.11 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.41 -165.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.06 -42.11 76.69 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.304 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 80.3 mm-40 -62.87 -23.73 67.47 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.588 0.755 . . . . 0.0 112.568 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.0 t -69.5 -42.83 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.429 0.633 . . . . 0.0 110.457 171.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.76 -30.77 67.35 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.66 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.8 mt-10 -70.68 -43.11 69.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.371 0.605 . . . . 0.0 109.683 176.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -30.23 69.07 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.759 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -62.25 -60.88 2.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.898 0.879 . . . . 0.0 109.005 176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.43 89.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.011 -1.45 . . . . 0.0 111.766 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.2 -45.13 94.45 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 124.115 0.885 . . . . 0.0 113.908 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -64.2 -45.52 87.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.17 0.588 . . . . 0.0 110.288 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.3 -46.02 76.23 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.576 0.75 . . . . 0.0 110.269 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.61 63.42 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.013 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -99.52 14.46 29.83 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.927 0.891 . . . . 0.0 112.539 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 55.27 3.61 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 115.439 -0.8 . . . . 0.0 114.776 166.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 92' ' ' MET . 4.4 p -104.33 148.79 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.06 -51.63 56.42 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.879 0.471 . . . . 0.0 111.456 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.552 ' HB2' HG13 ' A' ' 90' ' ' VAL . 55.5 ttm 63.56 84.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 166.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.57 86.75 2.63 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 121.332 0.587 . . . . 0.0 110.83 173.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 106' ' ' THR . 55.7 tp60 179.02 122.57 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.519 1.528 . . . . 0.0 108.187 175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.54 114.94 49.7 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.61 107.26 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.385 2.723 . . . . 0.0 112.256 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.81 145.51 42.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.038 0.935 . . . . 0.0 110.021 -175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 112.24 8.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.437 ' HG3' ' H ' ' A' ' 101' ' ' PHE . 49.4 tpp -100.46 162.63 12.81 Favored 'General case' 0 C--O 1.245 0.817 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.64 -23.08 62.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.237 0.615 . . . . 0.0 111.007 172.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 99' ' ' MET . 15.5 m-85 -120.72 90.77 3.39 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.374 1.07 . . . . 0.0 108.555 174.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.48 152.08 1.12 Allowed Glycine 0 C--N 1.347 1.16 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.558 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 84.8 t80 -71.97 101.06 2.6 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 165.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -109.25 151.26 26.77 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.813 0.816 . . . . 0.0 112.04 -161.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.74 149.75 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.563 1.545 . . . . 0.0 108.498 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 87.6 m -141.23 128.3 20.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.751 0.705 . . . . 0.0 110.497 171.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.99 155.91 18.91 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.137 0.575 . . . . 0.0 109.79 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.73 126.31 52.45 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.54 156.5 22.86 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.055 0.942 . . . . 0.0 111.484 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.56 -21.91 73.17 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.739 2.293 . . . . 0.0 112.431 170.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -92.29 -20.69 20.86 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.142 0.977 . . . . 0.0 110.559 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.2 m 72.63 90.36 0.09 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.873 1.669 . . . . 0.0 110.967 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.506 ' NE2' HG12 ' A' ' 11' ' ' VAL . 10.5 m80 -113.18 -92.32 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 171.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 113' ' ' HIS . 4.7 tpt180 167.98 109.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.281 1.032 . . . . 0.0 109.348 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.9 mt -126.6 110.33 13.09 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.141 0.577 . . . . 0.0 111.175 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -95.3 147.55 23.37 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 118.337 0.517 . . . . 0.0 110.685 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -134.04 125.58 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 166.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -130.62 151.77 50.71 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.092 0.86 . . . . 0.0 111.489 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 103' ' ' TYR . . . -103.81 117.55 34.63 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -77.64 111.96 13.95 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.67 94.78 1.04 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.084 0 CA-C-O 118.984 -0.898 . . . . 0.0 111.364 -175.28 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.408 ' HE2' ' HB2' ' B' ' 1' ' ' MET . 3.5 ppp? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 11.9 m -133.42 146.59 51.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -115.75 129.13 25.4 Favored Pre-proline 0 N--CA 1.482 1.171 0 C-N-CA 123.499 0.72 . . . . 0.0 110.572 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.41 ' HD3' HD22 ' A' ' 25' ' ' LEU . 65.0 Cg_endo -91.75 101.91 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.014 2.476 . . . . 0.0 112.237 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.728 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.9 p-10 -86.01 -1.68 57.58 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.416 0.627 . . . . 0.0 111.019 169.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.409 ' HE1' ' N ' ' B' ' 48' ' ' GLY . 1.1 t80 -118.53 112.45 19.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -169.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -109.78 131.55 54.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 52.3 mt -113.8 132.86 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' B' ' 49' ' ' LEU . 93.2 mt -97.49 172.05 7.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.918 0.866 . . . . 0.0 109.005 173.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' B' ' 50' ' ' TRP . 30.9 m-85 -128.22 122.11 30.99 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.897 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.478 HG12 ' NE2' ' B' ' 113' ' ' HIS . 6.2 m -125.93 155.94 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.81 0.844 . . . . 0.0 109.523 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -88.01 -56.77 3.19 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.179 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -94.42 109.31 42.2 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.244 0.618 . . . . 0.0 110.162 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.41 -56.92 2.1 Favored 'Trans proline' 0 CA--C 1.574 2.491 0 C-N-CA 122.68 2.254 . . . . 0.0 114.269 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.37 -58.79 0.54 Allowed 'Trans proline' 0 C--N 1.402 3.369 0 CA-C-N 122.179 1.814 . . . . 0.0 111.714 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.13 -44.06 92.02 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.788 0.835 . . . . 0.0 112.494 -167.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 20.4 m -76.31 -33.82 59.04 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.023 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 97.2 m -73.11 -39.78 65.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.826 1.046 . . . . 0.0 113.826 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.53 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 0.0 OUTLIER -59.61 -37.33 78.29 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.712 172.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' B' ' 90' ' ' VAL . 78.2 t80 -62.5 -45.36 93.35 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.467 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -70.44 -29.27 65.81 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.025 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.53 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 63.4 mtpt -56.94 -47.33 80.9 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 118.794 0.725 . . . . 0.0 112.867 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.49 -36.86 44.54 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.872 176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -63.45 -40.23 96.6 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.614 1.166 . . . . 0.0 112.533 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.408 ' HB2' HG22 ' B' ' 27' ' ' VAL . 34.3 mt -93.57 -39.13 11.01 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.24 25.91 15.36 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.848 -173.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' B' ' 25' ' ' LEU . 18.2 m -119.38 175.68 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.093 0.957 . . . . 0.0 110.406 -176.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -133.31 140.66 37.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 50.8 Cg_exo -57.22 111.54 0.85 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.915 2.41 . . . . 0.0 112.29 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.91 -35.88 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.455 0.702 . . . . 0.0 109.88 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 26.8 mm-40 -112.35 87.63 2.62 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 47.5 p -90.66 128.18 36.54 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 6.2 t -141.51 153.37 65.44 Favored Pre-proline 0 CA--C 1.556 1.186 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -47.83 -44.29 27.29 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.764 2.976 . . . . 0.0 114.569 -175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -126.57 16.14 7.59 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -145.58 151.65 38.45 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -140.63 142.17 35.02 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.665 0.786 . . . . 0.0 108.889 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.68 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.3 tm? -138.98 121.14 15.77 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -133.04 132.0 41.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 108.607 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.538 HG22 ' HG3' ' B' ' 46' ' ' LYS . 21.5 t -110.45 129.46 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.921 0.888 . . . . 0.0 109.012 -173.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.494 HD22 ' SD ' ' B' ' 45' ' ' MET . 7.8 mp -93.66 142.76 26.98 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 0.0 110.135 -170.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.44 -5.89 21.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.986 0.914 . . . . 0.0 112.385 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.45 HD22 ' N ' ' B' ' 43' ' ' ASN . 0.8 OUTLIER -66.69 -19.74 65.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.659 1.183 . . . . 0.0 111.976 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.29 16.79 15.26 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.176 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.77 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.5 ppp? -125.52 175.95 7.18 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.747 0.819 . . . . 0.0 109.723 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.538 ' HG3' HG22 ' B' ' 40' ' ' VAL . 81.3 tttt -140.36 137.68 34.26 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tt -133.03 118.84 19.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.753 0.421 . . . . 0.0 110.234 -170.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.409 ' N ' ' HE1' ' B' ' 6' ' ' PHE . . . -97.47 163.33 21.76 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' B' ' 9' ' ' LEU . 1.1 tp -141.75 104.68 4.57 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 171.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.435 ' O ' ' HA ' ' B' ' 10' ' ' TYR . 3.3 t90 -111.43 134.78 52.77 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.407 ' HB2' HG22 ' B' ' 54' ' ' THR . 35.3 m -76.12 136.56 39.83 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 111.355 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -72.48 -9.88 59.1 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.917 0.887 . . . . 0.0 112.335 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -87.18 -8.18 57.17 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.28 0.632 . . . . 0.0 111.095 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.407 HG22 ' HB2' ' B' ' 51' ' ' SER . 13.2 t -135.42 8.8 3.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.907 0.483 . . . . 0.0 111.342 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' B' ' 58' ' ' LYS . 4.0 p -67.93 143.3 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.38 0.272 . . . . 0.0 111.272 176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -123.81 117.49 27.38 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.246 1.018 . . . . 0.0 109.181 171.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.3 143.41 76.32 Favored 'Cis proline' 0 C--N 1.381 2.277 0 CA-C-N 120.098 1.071 . . . . 0.0 113.105 -1.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.535 ' HA ' HG13 ' B' ' 55' ' ' VAL . 3.1 tppp? -58.84 127.81 34.06 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.992 0.917 . . . . 0.0 112.66 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.08 108.92 3.1 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.78 1.232 . . . . 0.0 108.677 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -87.0 89.73 8.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.16 0.584 . . . . 0.0 109.507 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 142.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.551 0.741 . . . . 0.0 110.422 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 18.4 p -139.24 136.55 35.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.28 1.032 . . . . 0.0 109.479 173.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.75 51.84 50.48 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.752 0.658 . . . . 0.0 114.172 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.05 45.72 0.42 Allowed Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 176.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.45 -170.63 12.03 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.455 -0.372 . . . . 0.0 113.124 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.4 170.56 47.99 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.258 0.622 . . . . 0.0 112.975 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -99.93 159.81 14.8 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.589 0.756 . . . . 0.0 110.77 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.78 101.36 10.81 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 161.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.58 103.69 14.65 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -82.81 105.78 14.1 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.417 ' HG2' ' CE1' ' B' ' 118' ' ' TYR . 41.0 mtm105 -84.6 127.99 34.36 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.689 -175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.56 157.79 43.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.963 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.26 -42.39 83.99 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.037 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.99 174.33 13.27 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-O 121.497 0.665 . . . . 0.0 111.876 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.61 -27.7 69.12 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.139 -1.392 . . . . 0.0 112.461 -165.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -68.99 -41.84 77.3 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -63.56 -23.71 67.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.561 0.745 . . . . 0.0 112.392 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.33 -42.65 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.252 0.621 . . . . 0.0 110.631 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.43 -31.12 68.17 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.594 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.2 mt-10 -70.98 -42.69 69.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.408 0.623 . . . . 0.0 109.557 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -69.19 -29.81 67.87 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.671 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -62.64 -60.68 3.17 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.549 0.74 . . . . 0.0 109.143 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.17 88.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.801 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.06 94.38 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 124.041 0.838 . . . . 0.0 113.615 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -63.88 -45.7 88.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.308 0.643 . . . . 0.0 110.235 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -55.82 -45.7 78.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.582 0.753 . . . . 0.0 110.454 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.91 63.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.028 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 57.9 m -99.45 14.15 30.81 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.959 0.903 . . . . 0.0 112.43 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 54.25 3.65 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.709 -0.678 . . . . 0.0 114.751 165.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.419 HG22 ' CE1' ' B' ' 20' ' ' PHE . 38.3 t -104.26 147.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 123.248 0.619 . . . . 0.0 109.339 170.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.29 -52.15 56.02 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.092 0.557 . . . . 0.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 55.0 ttm 63.84 84.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 166.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.62 86.77 2.64 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.863 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 22.9 tm0? 178.82 122.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.072 1.349 . . . . 0.0 107.644 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -79.58 114.48 45.94 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -48.64 107.53 0.14 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.567 2.845 . . . . 0.0 112.178 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.84 145.31 42.3 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.942 0.897 . . . . 0.0 109.941 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.28 112.38 8.3 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.521 ' HG2' ' H ' ' B' ' 101' ' ' PHE . 16.5 ttm -101.18 162.91 12.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.78 -23.9 63.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.065 0.546 . . . . 0.0 111.106 173.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . 0.521 ' H ' ' HG2' ' B' ' 99' ' ' MET . 96.3 m-85 -119.51 91.49 3.56 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.552 1.141 . . . . 0.0 109.033 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.78 151.56 1.13 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . 0.586 ' HB3' ' HB3' ' B' ' 119' ' ' ALA . 80.1 t80 -71.8 100.87 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 12.3 t -108.77 151.14 26.61 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.948 0.88 . . . . 0.0 111.893 -161.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.544 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 9.6 t80 -141.15 149.23 41.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.447 -1.706 . . . . 0.0 109.036 -178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 62.6 m -141.57 128.19 20.25 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.982 0.81 . . . . 0.0 110.69 171.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.23 155.77 19.14 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.279 0.632 . . . . 0.0 109.935 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.61 128.43 54.53 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.22 156.86 57.54 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.197 0.999 . . . . 0.0 110.361 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.0 -21.71 72.38 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.666 2.244 . . . . 0.0 112.466 170.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -92.93 -20.12 20.94 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.962 0.905 . . . . 0.0 110.377 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 40.2 m 71.9 90.99 0.09 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.965 1.706 . . . . 0.0 111.108 -176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.478 ' NE2' HG12 ' B' ' 11' ' ' VAL . 12.4 m170 -113.88 -91.68 0.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 171.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 167.32 109.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.577 1.151 . . . . 0.0 109.176 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -126.36 110.19 13.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.11 0.564 . . . . 0.0 111.153 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -92.56 147.86 22.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.215 0.606 . . . . 0.0 110.581 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -134.74 125.74 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 163.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.417 ' CE1' ' HG2' ' B' ' 71' ' ' ARG . 12.4 p90 -130.15 151.77 50.31 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.295 0.952 . . . . 0.0 111.479 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.586 ' HB3' ' HB3' ' B' ' 103' ' ' TYR . . . -104.11 116.46 32.24 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -74.84 107.61 7.04 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.24 100.19 0.44 Allowed 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.905 0.753 . . . . 0.0 109.737 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.924 -0.931 . . . . 0.0 112.089 -174.393 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.429 0.156 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.448 HG22 ' HB3' ' B' ' 70' ' ' PHE . 72.3 m -133.95 135.19 43.36 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.933 0.893 . . . . 0.0 110.101 -168.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -126.25 101.3 28.5 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.137 0.575 . . . . 0.0 111.516 -169.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' B' ' 70' ' ' PHE . 70.1 Cg_endo -74.2 101.14 1.38 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.69 2.26 . . . . 0.0 111.563 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.614 ' HB3' ' HE ' ' B' ' 71' ' ' ARG . 27.0 t70 -113.52 1.78 15.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.031 0.932 . . . . 0.0 110.477 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -126.57 112.86 16.02 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -107.71 136.97 46.55 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 53.0 mt -119.99 135.0 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.617 0.767 . . . . 0.0 109.765 -175.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.476 HD23 HD21 ' A' ' 47' ' ' LEU . 4.4 mm? -108.94 142.91 38.9 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 3.7 p90 -97.03 123.57 40.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.942 -173.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' SER . 22.9 m -127.91 162.12 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.669 -0.644 . . . . 0.0 109.823 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -116.85 45.8 1.78 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.724 1.21 . . . . 0.0 108.917 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 16' ' ' ALA . 47.9 t30 178.85 74.99 0.14 Allowed Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.868 -158.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HB2' ' HD3' ' A' ' 15' ' ' PRO . 23.0 Cg_exo -58.62 -63.12 0.15 Allowed 'Trans proline' 0 CA--C 1.579 2.77 0 C-N-CA 122.183 1.922 . . . . 0.0 113.889 -177.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 14' ' ' PRO . 32.8 Cg_exo -60.27 -60.47 0.27 Allowed 'Trans proline' 0 C--N 1.404 3.465 0 CA-C-N 123.111 2.147 . . . . 0.0 112.331 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB3' ' OD1' ' A' ' 13' ' ' ASN . . . -67.74 -39.18 84.27 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.589 -165.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.0 t -76.9 -28.53 55.36 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.426 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 86.3 m -71.77 -34.25 69.3 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 176.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.578 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 15.1 mm100 -64.41 -37.14 86.46 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.467 170.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.15 -43.09 88.0 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.658 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 24' ' ' LEU . 12.2 m-85 -68.53 -31.21 70.29 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.796 176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 58.6 mtpt -57.31 -46.14 83.49 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 118.269 0.486 . . . . 0.0 112.117 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.07 -35.42 56.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.418 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 21' ' ' TYR . 24.9 tp -60.89 -41.52 96.21 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.247 1.419 . . . . 0.0 112.48 -177.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.494 HD22 ' HG3' ' B' ' 4' ' ' PRO . 25.3 mt -92.49 -45.18 8.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.256 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.5 28.23 6.45 Favored Glycine 0 N--CA 1.472 1.056 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.044 -172.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 25' ' ' LEU . 24.7 m -129.77 -178.97 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.063 0.945 . . . . 0.0 110.47 -176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -126.39 156.11 73.22 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.485 1.114 . . . . 0.0 108.504 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 47.7 Cg_endo -66.95 125.55 13.84 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.184 1.922 . . . . 0.0 112.413 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG11 HG12 ' A' ' 40' ' ' VAL . 7.3 p -70.72 -35.81 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.549 0.739 . . . . 0.0 110.246 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 72.2 mm-40 -126.3 138.84 53.64 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.587 1.155 . . . . 0.0 108.273 177.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -142.12 135.4 29.04 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.327 0.651 . . . . 0.0 110.321 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 42.0 m -137.36 157.62 73.75 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.504 1.522 . . . . 0.0 108.398 -176.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.8 -41.32 38.9 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.113 2.542 . . . . 0.0 114.098 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -127.92 21.95 6.31 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 85.2 t80 -149.99 152.94 35.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.09 0.556 . . . . 0.0 109.679 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 49' ' ' LEU . 34.7 m -144.48 157.22 44.34 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.818 0.847 . . . . 0.0 109.455 177.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.675 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 9.7 tp -152.02 125.19 8.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.441 ' CZ ' ' HG ' ' A' ' 49' ' ' LEU . 0.7 OUTLIER -133.38 114.8 14.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.654 1.182 . . . . 0.0 109.194 174.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG12 HG11 ' A' ' 30' ' ' VAL . 3.9 p -93.26 133.01 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.607 0.763 . . . . 0.0 109.589 174.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.438 HD13 ' SD ' ' A' ' 45' ' ' MET . 9.0 mp -90.11 149.98 22.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.213 0.605 . . . . 0.0 110.078 -170.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.48 -7.45 49.98 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.309 0.644 . . . . 0.0 111.528 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -73.54 -15.29 61.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.451 0.7 . . . . 0.0 110.221 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.36 -12.02 36.5 Favored Glycine 0 C--N 1.355 1.617 0 C-N-CA 123.44 0.543 . . . . 0.0 113.808 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.595 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.5 ppp? -86.32 169.78 12.64 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.31 0.555 . . . . 0.0 110.216 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -131.67 138.27 48.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.452 0.301 . . . . 0.0 110.681 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.476 HD21 HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -136.12 130.6 33.59 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.032 0.533 . . . . 0.0 110.345 -170.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.76 166.17 13.12 Favored Glycine 0 C--N 1.349 1.287 0 C-N-CA 123.627 0.632 . . . . 0.0 112.081 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 17.5 mt -136.47 106.98 6.48 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 165.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.455 ' NE1' ' HA ' ' A' ' 55' ' ' VAL . 2.5 t90 -109.8 129.45 55.63 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 53.3 m -72.33 129.97 39.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HG12 ' A' ' 55' ' ' VAL . 23.3 ptt180 -67.27 -18.7 65.32 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -75.88 -23.65 55.62 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.69 0.396 . . . . 0.0 110.94 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' HB2' ' A' ' 51' ' ' SER . 14.3 t -115.7 6.27 14.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.564 0.746 . . . . 0.0 111.479 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 9.5 p -71.72 151.97 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.35 117.03 17.68 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 122.994 0.518 . . . . 0.0 110.96 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.533 ' HD3' ' HB ' ' B' ' 106' ' ' THR . 5.5 Cg_exo -73.59 140.46 67.35 Favored 'Cis proline' 0 C--N 1.391 2.799 0 CA-C-N 119.673 0.919 . . . . 0.0 111.163 0.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -60.46 110.1 1.18 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.953 0.783 . . . . 0.0 110.083 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.1 108.61 19.77 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.461 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 p -81.47 85.96 6.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 p -142.55 141.74 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.089 0.955 . . . . 0.0 109.557 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 p -161.02 142.02 11.57 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.232 1.413 . . . . 0.0 108.827 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.62 -38.87 0.61 Allowed Glycine 0 C--N 1.345 1.081 0 O-C-N 123.129 0.268 . . . . 0.0 112.487 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.69 -77.42 0.05 OUTLIER Glycine 0 C--N 1.34 0.789 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.43 -137.14 19.89 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.06 167.19 54.62 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 112.127 -0.389 . . . . 0.0 112.127 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 16.8 mt-10 -103.75 152.48 21.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 47' ' ' LEU . 53.0 tp -117.71 98.61 6.46 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' HA ' ' HB2' ' A' ' 116' ' ' ARG . . . -90.95 114.71 27.28 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.392 0.615 . . . . 0.0 111.354 -169.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.505 ' HA ' ' HA ' ' B' ' 4' ' ' PRO . 4.0 m-85 -88.68 122.08 31.73 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.065 1.346 . . . . 0.0 108.79 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' HE ' ' HB3' ' B' ' 5' ' ' ASP . 41.3 mtm180 -99.01 129.88 45.32 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.501 0.667 . . . . 0.0 111.913 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.1 m -130.82 165.61 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.701 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.587 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.3 pt-20 -66.83 -39.73 87.77 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.2 p30 -162.5 -179.92 7.3 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.74 0.7 . . . . 0.0 112.094 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.02 -29.95 68.83 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.935 1.294 . . . . 0.0 112.913 -165.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -64.96 -47.8 76.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.046 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 69.5 mm-40 -64.7 -23.06 67.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.966 -1.016 . . . . 0.0 112.497 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 117' ' ' VAL . 63.9 t -66.51 -46.04 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.539 0.736 . . . . 0.0 109.729 174.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 82' ' ' PHE . 27.6 t70 -72.65 -28.81 62.95 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.075 -1.421 . . . . 0.0 111.242 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 22.3 mt-10 -69.52 -41.35 76.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.397 0.618 . . . . 0.0 110.012 175.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.6 m -66.98 -32.86 74.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.858 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 37.0 t80 -54.13 -59.98 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.987 0.915 . . . . 0.0 109.515 172.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -61.08 -38.8 87.55 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.688 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.54 92.13 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 123.617 0.573 . . . . 0.0 114.257 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 49.0 m0 -63.71 -45.49 89.74 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.544 ' HB2' ' HE3' ' A' ' 92' ' ' MET . 32.6 ttpt -56.07 -45.39 79.32 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.964 0.906 . . . . 0.0 110.256 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.51 68.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.976 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.3 m -98.89 13.63 31.84 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.144 0.978 . . . . 0.0 112.616 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.33 54.81 2.74 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-N 115.309 -0.859 . . . . 0.0 114.568 164.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 92' ' ' MET . 3.7 p -102.83 152.85 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 170.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.63 -47.83 65.62 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.076 0.398 . . . . 0.0 110.957 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.544 ' HE3' ' HB2' ' A' ' 86' ' ' LYS . 52.6 ttm 65.34 84.02 0.16 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 170.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.87 83.21 2.14 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 120.962 0.41 . . . . 0.0 111.013 173.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 17.4 tm0? 178.46 140.04 0.09 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -87.72 123.32 69.47 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.678 0.791 . . . . 0.0 110.882 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.64 98.17 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.426 2.084 . . . . 0.0 110.409 174.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.08 157.51 43.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.796 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.01 104.76 4.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.965 0.906 . . . . 0.0 108.977 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.1 ttt -100.61 173.83 6.36 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.818 0.847 . . . . 0.0 109.983 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -55.93 -36.45 67.76 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.596 1.158 . . . . 0.0 112.177 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -90.11 -8.39 51.47 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.735 0.814 . . . . 0.0 110.845 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 119' ' ' ALA . . . 126.63 -173.25 18.19 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.029 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -76.27 105.97 7.62 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -172.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.9 t -131.53 166.76 20.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.718 0.407 . . . . 0.0 111.934 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.49 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -155.72 160.15 40.1 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.737 169.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' B' ' 57' ' ' PRO . 3.0 m -133.45 127.3 33.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.894 0.378 . . . . 0.0 110.219 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . . . -107.33 152.67 23.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.265 0.626 . . . . 0.0 110.474 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.32 116.57 32.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 115' ' ' LEU . 4.0 p-10 -68.81 170.45 8.41 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 123.675 0.79 . . . . 0.0 110.923 174.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -46.19 -39.54 20.89 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 123.412 2.742 . . . . 0.0 114.457 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.0 -11.96 55.97 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.579 0.752 . . . . 0.0 111.254 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 73.07 80.93 0.13 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.62 1.568 . . . . 0.0 111.679 170.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -120.07 -179.51 3.95 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.574 ' HD2' ' HD2' ' B' ' 57' ' ' PRO . 50.0 mmt-85 -103.27 99.16 9.0 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 109' ' ' ASP . 51.4 mt -97.12 103.37 15.29 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.525 ' HB2' ' HA ' ' A' ' 69' ' ' ALA . 25.7 mmt180 -89.11 148.54 23.63 Favored 'General case' 0 C--O 1.208 -1.114 0 C-N-CA 123.967 0.907 . . . . 0.0 110.355 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.549 HG13 HG13 ' A' ' 78' ' ' VAL . 9.3 p -138.67 130.57 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 159.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -137.56 163.3 31.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.437 ' O ' ' HA3' ' A' ' 102' ' ' GLY . . . -124.15 111.72 16.24 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -70.76 119.67 15.24 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.63 0.581 . . . . 0.0 110.557 -169.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.94 95.04 4.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.996 0.518 . . . . 0.0 110.692 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.815 0 CA-C-O 118.749 -1.028 . . . . 0.0 112.433 179.1 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.673 0.273 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.469 ' CG2' ' HB3' ' A' ' 70' ' ' PHE . 88.1 m -139.61 135.69 33.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.788 0.835 . . . . 0.0 110.535 -164.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.08 99.6 28.3 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.162 0.585 . . . . 0.0 110.969 -168.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 70' ' ' PHE . 58.9 Cg_endo -72.95 101.55 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.695 2.264 . . . . 0.0 111.941 172.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.595 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 12.2 t70 -114.93 2.82 14.39 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.719 0.771 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.441 ' CD1' ' HG2' ' B' ' 46' ' ' LYS . 3.8 t80 -126.78 112.65 15.63 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -169.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 t -107.43 137.21 45.88 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 43.7 mt -120.35 135.57 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.511 0.724 . . . . 0.0 109.636 -175.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.33 142.11 42.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.455 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 25.1 p90 -95.12 124.67 39.28 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.824 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 51' ' ' SER . 36.0 m -128.76 163.5 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.557 -0.714 . . . . 0.0 109.931 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -118.81 44.83 2.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.488 1.115 . . . . 0.0 108.19 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 179.39 74.84 0.16 Allowed Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.662 -158.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' B' ' 15' ' ' PRO . 23.8 Cg_exo -58.61 -63.81 0.13 Allowed 'Trans proline' 0 CA--C 1.578 2.718 0 C-N-CA 122.154 1.903 . . . . 0.0 114.016 -177.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' B' ' 14' ' ' PRO . 31.8 Cg_exo -59.51 -60.66 0.29 Allowed 'Trans proline' 0 C--N 1.404 3.464 0 CA-C-N 123.035 2.12 . . . . 0.0 112.575 -177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.45 85.77 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.679 -165.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.9 t -76.76 -28.6 55.79 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 96.3 m -71.58 -34.21 69.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.632 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.1 mm100 -63.88 -37.67 88.25 Favored 'General case' 0 C--N 1.361 1.097 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.416 170.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.31 -42.63 88.01 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.704 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -68.15 -31.8 71.63 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.139 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.632 ' HD3' ' HA ' ' B' ' 19' ' ' GLN . 54.3 mtpt -56.84 -46.34 81.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.263 0.554 . . . . 0.0 111.805 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.36 -35.03 54.96 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.226 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.47 -41.08 96.71 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.051 1.341 . . . . 0.0 112.547 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' B' ' 27' ' ' VAL . 18.9 mt -92.75 -44.89 8.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.16 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.1 28.79 6.34 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.986 -172.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' B' ' 25' ' ' LEU . 25.8 m -130.77 -179.49 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.927 0.891 . . . . 0.0 110.598 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -125.67 156.31 71.11 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 124.363 1.065 . . . . 0.0 108.368 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -67.82 126.0 14.0 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.39 2.06 . . . . 0.0 111.806 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.553 HG11 HG23 ' B' ' 40' ' ' VAL . 13.5 p -71.91 -33.69 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 123.287 0.635 . . . . 0.0 110.281 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.517 ' HG2' HG13 ' B' ' 30' ' ' VAL . 60.4 mm-40 -128.28 138.3 52.35 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.9 m -142.56 136.14 28.95 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.108 0.563 . . . . 0.0 110.28 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 35.2 m -137.74 160.02 66.55 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 125.295 1.438 . . . . 0.0 108.442 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -52.36 -40.11 71.55 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.136 2.557 . . . . 0.0 113.212 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -127.97 21.91 6.29 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 87.0 t80 -149.39 153.21 37.03 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.074 0.549 . . . . 0.0 109.745 177.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 71.1 m -144.57 156.97 44.4 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.785 0.834 . . . . 0.0 109.696 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 3.0 tt -151.77 126.47 9.57 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.36 113.53 12.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.934 1.294 . . . . 0.0 108.865 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.614 HG22 ' HG3' ' B' ' 46' ' ' LYS . 7.0 t -92.92 132.2 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.655 0.782 . . . . 0.0 109.336 175.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.447 HD21 HD13 ' B' ' 25' ' ' LEU . 36.0 mt -89.25 150.01 22.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.872 0.469 . . . . 0.0 110.262 -171.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.19 -7.96 52.12 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 111.609 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -71.91 -16.62 62.12 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.621 0.769 . . . . 0.0 110.379 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -12.17 35.49 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 123.436 0.541 . . . . 0.0 113.886 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.59 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.3 ppp? -86.68 170.11 12.09 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 117.307 0.553 . . . . 0.0 109.958 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.614 ' HG3' HG22 ' B' ' 40' ' ' VAL . 87.7 tttt -131.51 137.34 48.49 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.961 0.504 . . . . 0.0 110.6 -175.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.447 HD11 HD21 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -135.67 131.43 35.7 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.967 0.507 . . . . 0.0 110.334 -171.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -108.23 167.61 13.36 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.193 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 tp -139.22 105.77 5.33 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.423 ' NE1' ' HA ' ' B' ' 55' ' ' VAL . 2.1 t90 -109.72 129.33 55.62 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' B' ' 11' ' ' VAL . 62.5 m -72.25 129.8 39.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.4 ' O ' HG12 ' B' ' 55' ' ' VAL . 33.3 ptt180 -67.27 -18.82 65.36 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -170.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -75.85 -23.95 55.74 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.653 0.381 . . . . 0.0 110.59 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.41 HG22 ' HB2' ' B' ' 51' ' ' SER . 13.6 t -115.6 6.58 14.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.511 0.724 . . . . 0.0 111.229 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HA ' ' NE1' ' B' ' 50' ' ' TRP . 7.9 p -72.09 152.41 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 122.05 -0.406 . . . . 0.0 109.99 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.458 ' HB2' HH22 ' A' ' 116' ' ' ARG . 30.6 mt-10 -130.86 116.49 17.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 122.976 0.51 . . . . 0.0 110.903 -177.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.574 ' HD2' ' HD2' ' A' ' 114' ' ' ARG . 2.6 Cg_exo -73.35 140.49 67.48 Favored 'Cis proline' 0 C--N 1.387 2.554 0 CA-C-N 119.838 0.978 . . . . 0.0 111.068 0.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -60.35 110.1 1.16 Allowed 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.926 0.766 . . . . 0.0 110.146 -175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.01 108.69 19.91 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.664 1.186 . . . . 0.0 108.376 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.3 p -81.42 85.19 6.5 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.94 143.32 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.867 0.867 . . . . 0.0 109.276 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.455 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 1.0 OUTLIER -162.31 141.41 9.29 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.335 1.454 . . . . 0.0 108.808 171.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.23 -38.08 0.59 Allowed Glycine 0 C--N 1.343 0.945 0 O-C-N 123.281 0.363 . . . . 0.0 112.719 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.5 -77.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.49 -137.03 19.7 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.89 167.03 54.65 Favored Glycine 0 C--N 1.346 1.1 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.5 mt-10 -103.48 152.63 21.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.006 0.431 . . . . 0.0 110.525 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.447 HD21 HD11 ' B' ' 47' ' ' LEU . 57.5 tp -117.63 98.86 6.6 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.609 ' HA ' ' HB3' ' B' ' 116' ' ' ARG . . . -91.02 115.04 27.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.492 0.663 . . . . 0.0 111.381 -169.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . 0.545 ' HB2' HG22 ' B' ' 117' ' ' VAL . 6.5 m-85 -89.2 122.47 32.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.949 1.3 . . . . 0.0 108.538 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.614 ' HE ' ' HB3' ' A' ' 5' ' ' ASP . 38.9 mtm105 -99.17 128.89 45.37 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.417 0.687 . . . . 0.0 111.678 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.406 HG13 HG23 ' A' ' 2' ' ' THR . 22.7 m -129.95 165.94 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.791 177.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.7 pt-20 -66.71 -39.91 88.23 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -174.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' B' ' 73' ' ' GLU . 8.8 p30 -162.49 -179.54 7.02 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 118.543 0.61 . . . . 0.0 112.151 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -60.62 -29.97 69.57 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.006 1.322 . . . . 0.0 112.784 -164.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -64.49 -48.08 76.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.164 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.59 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 77.3 mm-40 -64.8 -22.92 67.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.118 0.967 . . . . 0.0 112.45 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 51.2 t -66.68 -45.55 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.611 0.719 . . . . 0.0 109.7 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -72.95 -28.84 62.66 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.966 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 31.8 mt-10 -69.32 -41.41 76.74 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.466 0.65 . . . . 0.0 109.95 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.405 ' CG2' HG21 ' B' ' 117' ' ' VAL . 23.7 m -68.22 -31.81 71.58 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.669 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -54.27 -59.52 4.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.744 0.818 . . . . 0.0 109.893 172.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.46 86.89 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.552 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.35 92.05 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 123.836 0.71 . . . . 0.0 114.064 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.9 m0 -64.35 -45.56 87.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.959 0.504 . . . . 0.0 109.908 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -56.49 -44.27 80.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.912 0.885 . . . . 0.0 110.404 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.52 -29.34 67.9 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.93 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 54.1 m -98.78 13.1 33.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.967 0.907 . . . . 0.0 112.447 -176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.28 55.03 2.69 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.231 -0.895 . . . . 0.0 114.603 165.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' B' ' 92' ' ' MET . 3.9 p -102.98 152.83 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.69 -46.95 67.69 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 118.146 0.43 . . . . 0.0 111.097 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.504 ' HB2' HG13 ' B' ' 90' ' ' VAL . 48.5 tpp 64.84 83.63 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 123.896 0.748 . . . . 0.0 112.727 170.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.74 82.83 2.11 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . 0.418 ' OE1' ' HA ' ' B' ' 105' ' ' PHE . 15.4 tm0? 178.81 140.89 0.1 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.081 1.353 . . . . 0.0 107.477 175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.0 123.39 67.54 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 123.573 0.749 . . . . 0.0 110.517 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.78 98.54 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.472 2.114 . . . . 0.0 110.244 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.14 157.36 44.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.79 -171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.97 105.16 4.34 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.926 0.89 . . . . 0.0 108.85 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.43 ' SD ' HG21 ' B' ' 104' ' ' THR . 10.8 ttt -100.87 172.99 6.7 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.204 1.002 . . . . 0.0 109.901 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -55.34 -36.71 66.56 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.45 1.1 . . . . 0.0 112.424 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.64 -8.3 52.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.787 0.835 . . . . 0.0 110.953 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' B' ' 119' ' ' ALA . . . 126.52 -173.14 18.14 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.133 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -76.74 106.49 8.43 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.43 HG21 ' SD ' ' B' ' 99' ' ' MET . 11.9 t -132.0 166.19 22.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.837 0.351 . . . . 0.0 111.82 -169.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . 0.418 ' HA ' ' OE1' ' B' ' 94' ' ' GLN . 6.4 p90 -153.71 162.35 41.32 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.409 168.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 57' ' ' PRO . 29.2 m -134.54 127.69 31.81 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.953 0.406 . . . . 0.0 110.315 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.48 152.44 24.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.388 0.675 . . . . 0.0 110.523 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.11 117.61 34.61 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.473 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 5.8 p-10 -71.12 171.72 8.02 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.702 -0.666 . . . . 0.0 110.288 176.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 7.7 Cg_endo -46.9 -39.63 24.73 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.464 2.776 . . . . 0.0 114.194 175.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -84.18 -10.7 57.52 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.133 0.573 . . . . 0.0 111.604 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 15.3 m 72.98 82.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.108 1.363 . . . . 0.0 111.565 169.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.422 ' HE1' HG12 ' B' ' 11' ' ' VAL . 13.4 m80 -123.25 179.99 4.51 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -103.93 99.15 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.91 103.83 15.81 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.609 ' HB3' ' HA ' ' B' ' 69' ' ' ALA . 44.0 ttm-85 -89.02 148.2 23.87 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 123.618 0.767 . . . . 0.0 110.516 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' B' ' 70' ' ' PHE . 21.5 t -136.58 131.18 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 159.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -136.99 163.94 29.53 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . 0.426 ' O ' ' HA3' ' B' ' 102' ' ' GLY . . . -124.67 111.71 15.91 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.86 119.32 13.9 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.757 0.661 . . . . 0.0 110.623 -169.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.96 95.05 1.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.021 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.369 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -71.1 138.51 49.78 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.069 0.548 . . . . 0.0 109.758 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -96.98 112.2 59.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.857 0.863 . . . . 0.0 110.705 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -87.26 83.44 1.01 Allowed 'Trans proline' 0 C--N 1.361 1.193 0 C-N-CA 122.842 2.361 . . . . 0.0 111.765 169.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.781 ' HA ' ' HG2' ' B' ' 45' ' ' MET . 5.9 p-10 -84.8 4.92 30.73 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.143 172.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 1.7 t80 -123.41 127.66 48.76 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.093 1.357 . . . . 0.0 107.681 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.4 t -126.36 136.1 52.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.959 0.904 . . . . 0.0 108.584 175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' B' ' 67' ' ' GLU . 50.9 mt -119.56 137.16 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.696 0.798 . . . . 0.0 109.53 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.503 HD11 HD22 ' A' ' 68' ' ' LEU . 97.4 mt -108.08 140.56 41.09 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.523 ' HE2' ' HA ' ' A' ' 62' ' ' THR . 36.3 p90 -85.7 130.98 34.42 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.262 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.515 HG12 ' NE2' ' A' ' 113' ' ' HIS . 5.3 m -129.5 151.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-O 121.479 0.657 . . . . 0.0 110.575 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.46 -55.36 3.69 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.22 1.008 . . . . 0.0 109.938 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -105.15 98.4 15.97 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.54 0.736 . . . . 0.0 109.927 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HG3' ' OG ' ' A' ' 51' ' ' SER . 52.2 Cg_exo -51.78 -53.92 6.19 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.518 2.812 . . . . 0.0 115.185 -176.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.29 -54.19 5.87 Favored 'Trans proline' 0 C--N 1.402 3.363 0 C-N-CA 122.53 2.153 . . . . 0.0 113.023 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.93 -38.18 61.83 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.296 -168.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -77.38 -35.16 54.7 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.723 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.428 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 78.6 m -67.16 -43.31 82.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.568 ' HA ' ' HD3' ' A' ' 22' ' ' LYS . 19.4 mm100 -61.47 -35.02 76.46 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.63 173.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 87.4 t80 -64.05 -44.26 93.01 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 124.058 0.849 . . . . 0.0 110.142 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -71.55 -30.06 65.46 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.854 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 19' ' ' GLN . 62.2 mtpt -56.31 -50.51 71.23 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.252 0.549 . . . . 0.0 111.991 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.8 -33.76 52.41 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.72 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 20' ' ' PHE . 19.4 tp -60.99 -48.62 80.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.707 1.203 . . . . 0.0 112.801 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB2' HG22 ' A' ' 27' ' ' VAL . 35.4 mt -84.94 -40.79 16.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.301 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 33.61 6.39 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -173.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 25' ' ' LEU . 31.4 m -128.27 -178.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.29 1.036 . . . . 0.0 110.595 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -132.95 141.17 40.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.988 0.915 . . . . 0.0 108.865 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.555 ' HD3' ' HG2' ' A' ' 22' ' ' LYS . 18.9 Cg_exo -66.06 110.82 1.82 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.613 2.209 . . . . 0.0 111.793 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.99 -39.68 86.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.657 0.783 . . . . 0.0 110.317 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 38' ' ' LEU . 17.9 mm-40 -112.51 109.04 18.39 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.2 p -113.88 141.97 46.69 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.277 0.631 . . . . 0.0 109.655 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 66.1 m -142.94 160.92 51.22 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.988 1.315 . . . . 0.0 108.894 -175.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.43 -30.85 91.74 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.736 2.29 . . . . 0.0 113.013 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.5 t -127.55 19.39 6.78 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.173 0.589 . . . . 0.0 111.894 -175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 77.3 t80 -159.1 156.78 29.77 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.881 0.472 . . . . 0.0 110.345 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.3 m -146.47 150.31 35.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.474 1.11 . . . . 0.0 108.358 174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 1.4 tm? -144.44 116.97 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -128.85 122.97 31.55 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.037 1.335 . . . . 0.0 108.542 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 46' ' ' LYS . 15.6 t -106.21 134.0 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.979 0.912 . . . . 0.0 109.425 -173.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' SD ' ' A' ' 45' ' ' MET . 85.5 mt -95.19 147.18 23.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.562 0.345 . . . . 0.0 110.107 -173.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.39 -12.45 52.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.302 1.041 . . . . 0.0 112.199 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.5 -8.92 29.61 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.175 0.99 . . . . 0.0 112.931 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.41 16.1 53.75 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 112.39 -0.284 . . . . 0.0 112.39 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.811 ' HG2' ' HA ' ' B' ' 5' ' ' ASP . 5.0 ppp? -114.56 170.84 8.01 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.9 0.88 . . . . 0.0 108.938 176.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 40' ' ' VAL . 75.9 tttt -133.75 134.22 42.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.477 HD11 HD21 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -128.28 118.13 22.71 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.775 0.43 . . . . 0.0 109.878 -174.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' N ' ' HE1' ' A' ' 6' ' ' PHE . . . -96.56 166.54 24.08 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.717 0.675 . . . . 0.0 111.521 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 tp -143.38 102.44 3.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.484 ' HZ3' ' HG3' ' B' ' 116' ' ' ARG . 6.2 t90 -111.05 130.29 55.65 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 36.2 m -68.28 126.91 31.06 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.154 0.284 . . . . 0.0 110.244 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.427 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 24.7 ptt180 -68.79 -13.4 62.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.922 0.889 . . . . 0.0 112.605 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.05 -14.4 59.51 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.47 0.308 . . . . 0.0 110.878 176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.454 HG23 ' HE1' ' A' ' 50' ' ' TRP . 13.6 t -128.36 10.5 6.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.62 0.768 . . . . 0.0 110.785 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 58' ' ' LYS . 10.3 p -69.79 149.31 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 173.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -130.37 123.8 20.76 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 122.983 0.513 . . . . 0.0 110.638 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.84 137.84 50.29 Favored 'Cis proline' 0 C--N 1.387 2.604 0 C-N-CA 124.453 -1.061 . . . . 0.0 111.432 -6.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -50.81 110.68 0.45 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.516 0.726 . . . . 0.0 110.886 -175.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.47 110.0 22.16 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.6 p -83.13 87.22 6.92 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -153.31 150.96 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.738 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.523 ' HA ' ' HE2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -163.72 147.92 10.41 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.245 1.418 . . . . 0.0 109.279 170.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.28 -7.91 76.47 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.961 -0.563 . . . . 0.0 114.098 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' HD3' ' A' ' 114' ' ' ARG . . . -159.24 122.95 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' B' ' 65' ' ' GLY . . . 133.98 111.93 1.26 Allowed Glycine 0 C--N 1.34 0.781 0 CA-C-O 119.69 -0.506 . . . . 0.0 112.414 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' B' ' 66' ' ' GLY . . . 77.25 109.82 0.15 Allowed Glycine 0 C--N 1.346 1.135 0 O-C-N 124.134 0.549 . . . . 0.0 111.735 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' B' ' 8' ' ' ILE . 23.8 mm-40 -98.24 136.7 38.06 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 HD11 ' A' ' 9' ' ' LEU . 52.0 tp -107.85 99.6 9.05 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 116' ' ' ARG . . . -87.56 113.7 23.49 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -163.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -90.6 111.33 22.6 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 124.867 1.267 . . . . 0.0 108.327 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -92.28 127.09 37.64 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.529 0.68 . . . . 0.0 111.818 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 118' ' ' TYR . 35.0 m -125.11 162.14 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.522 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.615 ' HG2' ' HG3' ' A' ' 77' ' ' GLN . 12.6 pt-20 -67.9 -35.6 78.76 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 73' ' ' GLU . 10.0 p30 -163.25 -179.95 6.97 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.686 0.675 . . . . 0.0 112.746 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -61.58 -29.67 70.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.247 1.419 . . . . 0.0 112.725 -166.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' GLU . . . -69.07 -44.27 72.89 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.063 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.615 ' HG3' ' HG2' ' A' ' 73' ' ' GLU . 75.0 mm-40 -63.63 -23.05 67.22 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.696 0.798 . . . . 0.0 112.467 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -65.89 -41.63 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 0.0 110.519 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.62 -27.94 45.53 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.127 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 76' ' ' ALA . 27.5 mt-10 -66.6 -41.48 88.39 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.89 0.852 . . . . 0.0 109.513 173.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -64.47 -38.1 89.85 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 113.668 -1.606 . . . . 0.0 110.93 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -55.99 -60.48 3.42 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.764 0.826 . . . . 0.0 109.845 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HA ' ' HE2' ' A' ' 86' ' ' LYS . . . -66.59 -36.44 82.63 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.199 -172.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.68 -47.76 83.61 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.71 0.631 . . . . 0.0 113.655 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 42.5 m0 -65.15 -39.17 92.61 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.41 0.684 . . . . 0.0 110.185 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 83' ' ' ALA . 32.9 ttpt -61.46 -43.07 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.376 0.671 . . . . 0.0 110.009 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.11 67.56 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.736 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 t -100.73 7.45 43.84 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.3 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.42 56.91 2.43 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 166.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.414 HG13 ' HB3' ' A' ' 92' ' ' MET . 5.8 p -104.75 146.1 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' ALA . . . -72.58 -39.39 67.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 122.721 0.408 . . . . 0.0 111.519 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.414 ' HB3' HG13 ' A' ' 90' ' ' VAL . 4.1 ptm 49.68 79.87 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.138 1.775 . . . . 0.0 113.862 171.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -109.1 83.29 1.73 Allowed 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.489 -0.757 . . . . 0.0 109.424 177.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 105' ' ' PHE . 18.2 tm0? 178.85 127.54 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -76.02 125.78 87.64 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 122.66 0.384 . . . . 0.0 110.04 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 104' ' ' THR . 42.8 Cg_endo -65.71 98.47 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.295 1.997 . . . . 0.0 109.948 172.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.14 160.89 39.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.581 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -69.72 142.65 53.27 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.326 0.65 . . . . 0.0 110.762 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ttp -147.48 -178.07 6.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.972 0.909 . . . . 0.0 108.66 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -53.07 -37.28 61.51 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.867 1.267 . . . . 0.0 113.194 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -101.37 8.64 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.536 0.735 . . . . 0.0 111.486 -172.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.93 -160.44 13.48 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -79.3 109.5 13.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 8.9 t -105.42 147.65 28.02 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.338 0.655 . . . . 0.0 111.551 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.448 ' HA ' ' OE1' ' A' ' 94' ' ' GLN . 17.3 t80 -154.5 136.35 14.51 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 124.828 1.251 . . . . 0.0 109.57 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.1 m -137.72 123.55 20.03 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 92' ' ' MET . . . -108.37 139.95 42.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.36 0.664 . . . . 0.0 111.524 -173.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -111.72 126.78 55.41 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 169.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 13.3 p-10 -78.6 179.78 1.63 Allowed Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 118.753 -0.641 . . . . 0.0 110.831 175.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 109' ' ' ASP . 46.8 Cg_exo -44.52 -40.51 13.71 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.827 2.352 . . . . 0.0 114.188 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -74.35 -21.87 59.49 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.686 0.394 . . . . 0.0 110.598 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m 72.69 74.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.438 1.495 . . . . 0.0 110.846 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.515 ' NE2' HG12 ' A' ' 11' ' ' VAL . 19.2 m170 -103.86 -171.57 1.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.413 175.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.51 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 19.5 mmm180 -120.29 96.77 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.9 mt -109.36 99.34 8.6 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -96.47 95.17 7.83 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.321 0.648 . . . . 0.0 111.329 -169.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.7 t -85.74 133.54 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HE2' ' HB2' ' A' ' 120' ' ' PHE . 9.1 p90 -136.8 177.96 7.44 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.816 0.734 . . . . 0.0 112.319 172.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.25 111.88 6.11 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.406 ' HB2' ' HE2' ' A' ' 118' ' ' TYR . 38.5 t80 -84.56 119.2 24.92 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.6 100.5 3.94 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.51 0.724 . . . . 0.0 110.375 179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -178.935 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ppp? . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.264 0.078 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . . . . . . . . . 86.2 m -136.81 138.71 41.12 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -97.04 112.18 59.96 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 0.0 111.043 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.0 83.35 1.08 Allowed 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.911 2.407 . . . . 0.0 111.563 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASP . . . . . 0.811 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 6.2 p-10 -84.46 4.68 30.56 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.292 0.568 . . . . 0.0 111.228 172.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -123.37 127.34 48.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.11 1.364 . . . . 0.0 107.502 -168.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.7 t -126.3 135.99 52.21 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.958 0.903 . . . . 0.0 108.857 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 67' ' ' GLU . 50.8 mt -119.46 136.78 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 109.548 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.49 140.42 40.48 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' TYR . . . . . 0.533 ' HE2' ' HA ' ' B' ' 62' ' ' THR . 36.0 p90 -85.46 130.91 34.48 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.106 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.613 HG12 ' NE2' ' B' ' 113' ' ' HIS . 7.1 m -128.93 151.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.257 0.551 . . . . 0.0 110.536 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -88.69 -55.83 3.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.318 1.047 . . . . 0.0 109.721 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -105.5 97.36 14.05 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 124.081 0.953 . . . . 0.0 109.758 -177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.412 ' HG3' ' OG ' ' B' ' 51' ' ' SER . 50.9 Cg_exo -51.31 -54.59 5.13 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.594 2.863 . . . . 0.0 115.379 -177.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.86 -54.54 5.26 Favored 'Trans proline' 0 C--N 1.403 3.398 0 C-N-CA 122.38 2.053 . . . . 0.0 113.409 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.0 -38.2 61.65 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.439 -168.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 82.8 p -77.7 -34.49 52.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' B' ' 22' ' ' LYS . 73.2 m -67.65 -43.71 79.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . 0.518 ' HA ' ' HD3' ' B' ' 22' ' ' LYS . 16.0 mm100 -62.12 -34.73 76.89 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.954 173.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' B' ' 24' ' ' LEU . 84.6 t80 -63.68 -44.54 93.4 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.023 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 24' ' ' LEU . 50.1 m-85 -70.8 -30.58 67.07 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.917 177.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.526 ' HG2' ' HD3' ' B' ' 29' ' ' PRO . 62.1 mtpt -56.45 -50.17 72.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.087 0.47 . . . . 0.0 112.125 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.69 -34.14 52.94 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.662 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' B' ' 21' ' ' TYR . 15.4 tp -60.54 -49.29 78.13 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.68 1.192 . . . . 0.0 113.092 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.51 ' HB2' HG22 ' B' ' 27' ' ' VAL . 34.9 mt -84.26 -40.96 17.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.28 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.26 33.75 6.41 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -172.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' B' ' 25' ' ' LEU . 31.5 m -128.62 -178.75 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.346 1.059 . . . . 0.0 110.573 -176.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -132.43 142.35 44.59 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.926 0.89 . . . . 0.0 109.209 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.526 ' HD3' ' HG2' ' B' ' 22' ' ' LYS . 16.7 Cg_exo -67.39 110.56 2.07 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.355 2.036 . . . . 0.0 111.828 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.72 -39.74 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.794 0.838 . . . . 0.0 110.388 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.612 ' HB2' ' HB3' ' B' ' 38' ' ' LEU . 23.4 mm-40 -112.99 108.95 18.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 20.5 p -113.84 142.2 46.39 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.368 0.667 . . . . 0.0 109.81 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' B' ' 36' ' ' PHE . 50.4 m -142.87 161.48 48.64 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.784 1.234 . . . . 0.0 109.028 -175.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -61.11 -30.61 89.43 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.471 2.114 . . . . 0.0 112.965 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -127.72 19.62 6.66 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.222 0.609 . . . . 0.0 111.501 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' HB2' ' B' ' 33' ' ' SER . 77.0 t80 -159.12 156.88 29.89 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.794 0.438 . . . . 0.0 110.232 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 68.6 m -146.55 150.5 35.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.475 1.11 . . . . 0.0 108.318 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' B' ' 31' ' ' GLU . 1.6 tm? -144.72 117.0 8.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -129.12 123.65 32.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.899 1.28 . . . . 0.0 108.492 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.573 HG22 ' HG3' ' B' ' 46' ' ' LYS . 19.9 t -107.29 133.73 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.785 0.834 . . . . 0.0 109.244 -172.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.462 HD12 ' SD ' ' B' ' 45' ' ' MET . 85.5 mt -95.0 147.48 23.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.685 0.394 . . . . 0.0 110.091 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.84 -12.24 52.76 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.158 0.983 . . . . 0.0 112.216 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -66.93 -8.55 30.25 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.096 0.959 . . . . 0.0 112.682 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.13 16.15 54.44 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' MET . . . . . 0.781 ' HG2' ' HA ' ' A' ' 5' ' ' ASP . 5.0 ppp? -114.84 170.79 8.07 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 123.82 0.848 . . . . 0.0 108.862 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.573 ' HG3' HG22 ' B' ' 40' ' ' VAL . 80.2 tttt -133.61 134.22 42.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -176.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.518 HD11 HD11 ' B' ' 68' ' ' LEU . 0.8 OUTLIER -128.27 118.19 22.82 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -174.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.14 166.73 24.71 Favored Glycine 0 C--N 1.34 0.8 0 C-N-CA 123.698 0.666 . . . . 0.0 111.623 177.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' B' ' 37' ' ' SER . 6.8 tp -143.64 102.23 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' TRP . . . . . 0.468 ' HZ3' ' HG3' ' A' ' 116' ' ' ARG . 6.2 t90 -110.92 130.4 55.59 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' B' ' 14' ' ' PRO . 35.9 m -68.3 127.26 32.28 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.286 0.366 . . . . 0.0 110.131 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' B' ' 10' ' ' TYR . 21.1 ptt180 -69.42 -12.78 61.94 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.846 0.858 . . . . 0.0 112.604 -173.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -77.95 -15.46 58.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.508 0.323 . . . . 0.0 110.523 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.1 t -127.98 10.37 6.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.607 0.763 . . . . 0.0 111.036 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' B' ' 58' ' ' LYS . 7.8 p -69.99 150.01 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -131.32 123.07 19.37 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.002 0.521 . . . . 0.0 111.13 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.97 136.6 45.15 Favored 'Cis proline' 0 C--N 1.389 2.688 0 C-N-CA 124.348 -1.105 . . . . 0.0 110.969 -4.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.439 ' HA ' HG13 ' B' ' 55' ' ' VAL . 1.5 tmmm? -48.28 110.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.387 0.675 . . . . 0.0 111.284 -176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.51 109.94 22.08 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.4 p -83.59 85.92 7.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 29.2 m -150.68 151.89 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.247 1.019 . . . . 0.0 109.636 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.533 ' HA ' ' HE2' ' B' ' 10' ' ' TYR . 0.3 OUTLIER -164.57 147.91 9.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.006 1.322 . . . . 0.0 109.457 169.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.46 -7.99 76.64 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.412 0.445 . . . . 0.0 113.779 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.532 ' HA2' ' HD3' ' B' ' 114' ' ' ARG . . . -159.35 122.88 1.18 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' A' ' 65' ' ' GLY . . . 133.83 112.15 1.29 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-O 119.825 -0.43 . . . . 0.0 112.514 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 66' ' ' GLY . . . 77.28 109.69 0.15 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 173.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 23.5 mm-40 -98.22 138.16 35.9 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -170.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.518 HD11 HD11 ' B' ' 47' ' ' LEU . 0.6 OUTLIER -110.68 98.75 7.84 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' B' ' 116' ' ' ARG . . . -88.04 113.14 23.38 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -161.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -89.85 111.5 22.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.877 1.271 . . . . 0.0 108.578 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -92.99 126.3 38.0 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.51 0.671 . . . . 0.0 111.838 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.63 162.6 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.222 -1.354 . . . . 0.0 109.559 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLU . . . . . 0.573 ' HG2' ' HG3' ' B' ' 77' ' ' GLN . 11.8 pt-20 -67.74 -35.17 78.26 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' B' ' 73' ' ' GLU . 9.2 p30 -163.63 179.71 7.0 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 118.685 0.675 . . . . 0.0 112.769 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.66 -29.58 70.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.207 1.403 . . . . 0.0 112.764 -166.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' B' ' 80' ' ' GLU . . . -69.03 -44.03 73.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.078 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLN . . . . . 0.573 ' HG3' ' HG2' ' B' ' 73' ' ' GLU . 81.1 mm-40 -63.84 -23.08 67.21 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 123.915 0.886 . . . . 0.0 112.548 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.77 -41.55 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.291 0.636 . . . . 0.0 110.41 172.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.44 -27.37 41.67 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.114 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' B' ' 76' ' ' ALA . 35.6 mt-10 -66.57 -41.37 88.68 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.758 0.79 . . . . 0.0 109.372 173.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 67.8 m -64.62 -37.87 89.06 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.928 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.01 -60.52 3.36 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 109.722 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.488 ' HA ' ' HE2' ' B' ' 86' ' ' LYS . . . -66.86 -36.19 81.76 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.237 -172.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.32 -47.86 84.07 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 123.578 0.549 . . . . 0.0 113.684 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -65.74 -38.72 89.88 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.301 0.64 . . . . 0.0 110.261 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' B' ' 83' ' ' ALA . 33.7 ttpt -61.64 -42.58 99.1 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.79 0.836 . . . . 0.0 109.982 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.589 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -101.14 7.38 43.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.129 0.972 . . . . 0.0 112.565 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.94 57.47 2.4 Favored Glycine 0 C--N 1.355 1.621 0 N-CA-C 115.382 0.913 . . . . 0.0 115.382 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 p -104.87 146.14 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' B' ' 108' ' ' ALA . . . -72.33 -39.14 68.42 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.937 0.495 . . . . 0.0 111.747 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' B' ' 107' ' ' ALA . 10.2 ptp 49.17 80.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.965 1.706 . . . . 0.0 113.911 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.435 HD13 ' N ' ' B' ' 93' ' ' LEU . 0.0 OUTLIER -109.15 83.17 1.71 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.849 0.833 . . . . 0.0 109.62 177.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 178.58 126.64 0.06 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.153 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -75.37 126.84 87.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 123.328 0.392 . . . . 0.0 110.455 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' B' ' 104' ' ' THR . 55.8 Cg_endo -67.11 98.53 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.418 2.079 . . . . 0.0 109.732 172.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.33 160.73 39.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -69.38 141.78 54.08 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.881 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' MET . . . . . 0.478 ' HG2' ' HB ' ' B' ' 104' ' ' THR . 1.1 ptp -145.35 -176.38 5.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.153 0.981 . . . . 0.0 109.281 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -55.66 -36.56 67.21 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.539 1.135 . . . . 0.0 112.61 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.94 8.73 42.93 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.453 0.701 . . . . 0.0 111.941 -173.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.76 -159.97 13.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.654 -0.579 . . . . 0.0 111.654 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -79.95 109.6 14.54 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' B' ' 99' ' ' MET . 6.9 t -105.99 149.27 26.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.268 0.556 . . . . 0.0 111.369 -171.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -155.77 137.14 13.97 Favored 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.867 1.267 . . . . 0.0 109.416 168.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 49.2 m -138.4 123.28 18.87 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 92' ' ' MET . . . -108.15 139.63 42.54 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.468 0.707 . . . . 0.0 111.51 -173.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -111.07 129.11 56.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' B' ' 110' ' ' PRO . 16.4 p-10 -81.52 -179.99 1.69 Allowed Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.977 177.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' B' ' 109' ' ' ASP . 43.3 Cg_exo -44.46 -40.71 13.63 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.473 2.115 . . . . 0.0 114.409 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.7 -22.15 60.01 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.974 0.51 . . . . 0.0 110.658 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m 72.62 74.41 0.15 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.4 1.48 . . . . 0.0 110.66 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' HIS . . . . . 0.613 ' NE2' HG12 ' B' ' 11' ' ' VAL . 22.1 m170 -103.56 -171.36 1.92 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.402 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.532 ' HD3' ' HA2' ' B' ' 64' ' ' GLY . 22.6 mmm180 -120.4 96.71 5.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.2 99.52 8.79 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.484 ' HG3' ' HZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -95.23 94.93 8.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.874 0.47 . . . . 0.0 111.886 -169.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 15.0 t -85.55 133.86 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -137.5 177.68 7.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 119.059 0.845 . . . . 0.0 112.279 171.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.08 111.41 5.92 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -83.07 113.44 20.61 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.55 92.92 3.5 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 124.024 0.828 . . . . 0.0 109.244 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -176.239 . . . . . . . . 0 0 . 1 stop_ save_